Citrus Sinensis ID: 047245

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380
Protein Sequence
MGSKTSTMLLLLMIFWFQYTTVQCQEKMNPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF
Secondary Structure (PSIPRED)
cccccccccEEEEEcccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHHHHHHHcccccccccccccEEEEEEEccccEEEEEEcccccccccccccHHHHHHHHHHHHHHHcccccccccEEEEEEcccEEEEEEcccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHccccc
Secondary Structure Prediction (SSPRO)
cccccEEEEEEcccEEccEcccccccccccccccccccccccHEEEEEHHHHHHHHHHHHHHHHHHHHHccccccccHccccccccccEcHHHHHHHHccccccccccccccEEEEEcccccEEEEEEEcccccccccccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEEcccHccEEEcccccccHcHHcHHHEEcccEEEccccccHHHHHccccccccHHHHHHEEEEEEHccccccccccccccccHHHHHHHHHHHHcccHHHHccHHHccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHcccccc
Coil and Loop (DISEMBL)
MGSKTSTMLLLLMIFWFQYTTVQcqekmnpnskptefknGVKKIILSIALGVVTGLIGAILFACFVRCFVgymnqtpiikgpvifspkidpKTLQAALANENrllgsspdgkyyrTVLDNGLTVAVRRVEafesgspekqnKSVKRRIQQELEVLASLRHRNLMSlrayvpessrFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYlhftcnpqilhynlkptnvmldaeftprladfglaklmpgsliatsaysapecfqnrsytdksdifSFGMILAVLLtgrdptapffaeaasggSLGRWLRHLQHAGEAREALDrsilgeeveeDEMLMAVRIAVVClsdspadrpssdelvpmltqlhsf
Flexible Loop (DISEMBL)
MGSKTSTMLLLLMIFWFQYTTVQCQEKMNPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENrllgsspdgkyyRTVLDNGLTVAVRRVEafesgspekqnksvkrRIQQELEVLASLRHRNLMSLrayvpessrFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSdspadrpssdelvpmltqlhsf
Low Complexity Region (SEG)
MGSKTSTMLLLLMIFWFQYTTVQCQEKMNPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF
Disordered region (IsUnstruct)
*******MLLLLMIFWFQYTTVQCQ***********FKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVE*********************LEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCL***********************
Disordered Region (DISOPRED)
*****ST*LLLLMIFWFQYTTV************************SIALGVVTGLIGAILFACFVRCFV****************PKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVE******************QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP**AEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS*
Disordered Region (DISEMBL)
MGSKTSTMLLLLMIFWFQYTTVQCQEKMNPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAF**************RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF
Disordered Region (DISPRO)
***KTSTMLLLLMIFWFQYTTVQCQ**************GVKKIILSIALGVVTGLIGAILFACFVRCFVGY*N*****KGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEA************VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT*****
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGSKTSTMLLLLMIFWFQYTTVQCQEKMNPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	380	2.2.26 [Sep-21-2011]
Q9LYU7	401	Inactive leucine-rich rep	yes	no	0.913	0.865	0.676	1e-138
Q9SKB2	641	Leucine-rich repeat recep	no	no	0.871	0.516	0.338	4e-54
C0LGF4	591	LRR receptor-like serine/	no	no	0.889	0.571	0.317	1e-45
C0LGL9	589	LRR receptor-like serine/	no	no	0.878	0.567	0.321	2e-45
Q9SYM9	355	Receptor-like serine/thre	no	no	0.839	0.898	0.327	5e-41
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.697	0.240	0.333	1e-39
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.7	0.220	0.316	1e-39
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.713	0.260	0.342	1e-39
O64477	828	G-type lectin S-receptor-	no	no	0.697	0.320	0.324	2e-39
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.7	0.220	0.316	3e-39

>sp|Q9LYU7|CRN_ARATH Inactive leucine-rich repeat receptor-like protein kinase CORYNE OS=Arabidopsis thaliana GN=CRN PE=1 SV=1

 Score =  493 bits (1268), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 236/349 (67%), Positives = 283/349 (81%), Gaps = 2/349 (0%)

Query: 34  PTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKT 93
           P E +   K I++SI  G++TGL+ A++ A  VR  V +M QTPI+KGPV+FSPKI PK+
Sbjct: 53  PLESRITSKVIVISIVSGILTGLVSALVLAFLVRSIVKFMKQTPILKGPVVFSPKITPKS 112

Query: 94  LQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFES--GSPEKQNKSVKRRIQQE 151
           L AAL+N  +LLGS  +GKYY+ VLDNGL VAV+R+ + E         +KSVKRR+Q+E
Sbjct: 113 LHAALSNGIQLLGSDLNGKYYKMVLDNGLVVAVKRLGSLEGVGSPESSSSKSVKRRLQKE 172

Query: 152 LEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIA 211
           LE+LA LRHRNLMSLRAYV ES  F LVYDY+  GSLED M+++R  +++LGWE+RLR+A
Sbjct: 173 LELLAGLRHRNLMSLRAYVRESDEFSLVYDYMPNGSLEDVMNKVRTKEVELGWEIRLRVA 232

Query: 212 VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAP 271
           VG++KGLQYLHF+C  QILHYNLKPTNVMLD+EF PRLAD GLAK+MP S  A S YSAP
Sbjct: 233 VGIVKGLQYLHFSCETQILHYNLKPTNVMLDSEFEPRLADCGLAKIMPSSHTAVSCYSAP 292

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA 331
           E  Q+  YTDKSDIFSFGMIL VLLTGRDPT PF  E+ASGGSLG+WL+HLQ +GEAREA
Sbjct: 293 ESSQSNRYTDKSDIFSFGMILGVLLTGRDPTHPFCEESASGGSLGQWLKHLQQSGEAREA 352

Query: 332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF 380
           LD++ILGEEVEEDEMLMA+RI ++CLSD PADRPSSDELV MLTQLHSF
Sbjct: 353 LDKTILGEEVEEDEMLMALRITIICLSDFPADRPSSDELVHMLTQLHSF 401

Involved in the perception of CLV3 peptide that acts as a mobile signal regulating meristems maintenance. Modulates root, shoot and flower apical meristems maintenance and floral organ development regulation, probably via CLAVATA (CLV)-like pathways involving at least CLV3 and CLE19.
Arabidopsis thaliana (taxid: 3702)

>sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1

 Score =  212 bits (539), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 120/354 (33%), Positives = 194/354 (54%), Gaps = 23/354 (6%)

Query: 45  ILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRL 104
           IL   +G + G I   +F+   +  +  +  +    GP IFSP I      A L NE  L
Sbjct: 288 ILGFVVGAIGGTISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEAL 347

Query: 105 -----LGSSPDGKYYRTVL--DNGLTVAVRRVEAFESGSPEKQNKSVK------RRIQQE 151
                +G    G+ ++  L   NG  +AV++V      + E  ++  K      R+I+ E
Sbjct: 348 ASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSE 407

Query: 152 LEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIA 211
           +  +  +RHRNL+ L A+V      YLVY+Y++ GSL+D +  ++    +L W  R +IA
Sbjct: 408 INTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIA 467

Query: 212 VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI-------- 263
           +G+  GL+YLH   NP+I+H +LKP NV+LD +   R++DFGLAK MP ++         
Sbjct: 468 LGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVA 527

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQ 323
            T  Y APE +Q   +TDK DI+SFG+IL +L+ G+ P+  FF +     SL +W+R++ 
Sbjct: 528 GTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFF-QHTDEMSLIKWMRNII 586

Query: 324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
            +     A+D  ++ +  +E +ML+ ++IA  C  D P  RP+S ++  ML+Q+
Sbjct: 587 TSENPSLAIDPKLMDQGFDE-QMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQI 639

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  184 bits (467), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 122/384 (31%), Positives = 202/384 (52%), Gaps = 46/384 (11%)

Query: 18  QYTTVQCQEKM-NPNSKPTEFKNGVK---KIILSIALGVVTGLIGAILFACFVRCF---- 69
           ++  V CQ+   NP+S     +N  K   K+++S +  V   L+ A++  CF  CF    
Sbjct: 209 KHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVALM--CFWGCFLYKK 266

Query: 70  ------------VGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTV 117
                       VG      +  G + +S K   K L+  + NE  ++G    G  Y+  
Sbjct: 267 LGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLE--MLNEEHIIGCGGFGTVYKLA 324

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           +D+G   A++R+         K N+   R  ++ELE+L S++HR L++LR Y    +   
Sbjct: 325 MDDGKVFALKRIL--------KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 376

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           L+YDYL  GSL++A+    E   QL W+ R+ I +G  KGL YLH  C+P+I+H ++K +
Sbjct: 377 LLYDYLPGGSLDEAL---HERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSS 433

Query: 238 NVMLDAEFTPRLADFGLAKLMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGM 290
           N++LD     R++DFGLAKL+          +  T  Y APE  Q+   T+K+D++SFG+
Sbjct: 434 NILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGV 493

Query: 291 ILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAV 350
           ++  +L+G+ PT   F E   G ++  WL+ L      R+ +D +  G ++E  + L++ 
Sbjct: 494 LVLEVLSGKRPTDASFIE--KGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLS- 550

Query: 351 RIAVVCLSDSPADRPSSDELVPML 374
            IA  C+S SP +RP+   +V +L
Sbjct: 551 -IATQCVSPSPEERPTMHRVVQLL 573

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGL9|FEI2_ARATH LRR receptor-like serine/threonine-protein kinase FEI 2 OS=Arabidopsis thaliana GN=FEI2 PE=1 SV=1

 Score =  183 bits (464), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 122/379 (32%), Positives = 198/379 (52%), Gaps = 45/379 (11%)

Query: 22  VQCQEKMNPNSK--PT-EFKNGVKKIILSIALGVVTGLIGAILFACFVRCF--------- 69
           + C +  N  +   PT +  N  K++++S A   V GL+  +   CF  CF         
Sbjct: 212 IVCNDSGNSTASGSPTGQGGNNPKRLLIS-ASATVGGLL-LVALMCFWGCFLYKKLGRVE 269

Query: 70  -------VGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGL 122
                  VG      +  G + ++ K   K L++   NE  ++G    G  Y+  +D+G 
Sbjct: 270 SKSLVIDVGGGASIVMFHGDLPYASKDIIKKLESL--NEEHIIGCGGFGTVYKLSMDDGN 327

Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
             A++R+         K N+   R  ++ELE+L S++HR L++LR Y    +   L+YDY
Sbjct: 328 VFALKRIV--------KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDY 379

Query: 183 LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD 242
           L  GSL++A+ +  E   QL W+ R+ I +G  KGL YLH  C+P+I+H ++K +N++LD
Sbjct: 380 LPGGSLDEALHKRGE---QLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 436

Query: 243 AEFTPRLADFGLAKLMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVL 295
                R++DFGLAKL+          +  T  Y APE  Q+   T+K+D++SFG+++  +
Sbjct: 437 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 496

Query: 296 LTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV 355
           L+G+ PT   F E   G ++  WL  L     A+E +D S  G E E  + L++  IA  
Sbjct: 497 LSGKLPTDASFIE--KGFNIVGWLNFLISENRAKEIVDLSCEGVERESLDALLS--IATK 552

Query: 356 CLSDSPADRPSSDELVPML 374
           C+S SP +RP+   +V +L
Sbjct: 553 CVSSSPDERPTMHRVVQLL 571

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1

 Score =  169 bits (427), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 116/354 (32%), Positives = 174/354 (49%), Gaps = 35/354 (9%)

Query: 42  KKIILSIALGVVTGLIGAILFACFV-----RCFVGYMNQTPIIKGP--VIFSPKI----- 89
           K+    I + VV  +IG I+ A        R    + N  P+  G   V+F  ++     
Sbjct: 5   KETTFYITISVVAFVIGKIVIALLFYKRWKRKHTIHENGFPVKGGGKMVMFRSQLLNSVS 64

Query: 90  -DPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
            D    +    +   +LGS   G  YR V+D+  T AV+R+     G+ E+      R  
Sbjct: 65  SDMFMKKTHKLSNKDILGSGGFGTVYRLVIDDSTTFAVKRLN---RGTSERD-----RGF 116

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
            +ELE +A ++HRN+++L  Y        L+Y+ +  GSL    D     +  L W  R 
Sbjct: 117 HRELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSL----DSFLHGRKALDWASRY 172

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSL 262
           RIAVG  +G+ YLH  C P I+H ++K +N++LD     R++DFGLA LM        + 
Sbjct: 173 RIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTF 232

Query: 263 IA-TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH 321
           +A T  Y APE F     T K D++SFG++L  LLTGR PT   F E   G  L  W++ 
Sbjct: 233 VAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFE--EGTKLVTWVKG 290

Query: 322 LQHAGEAREALDRSILGEEVEEDEMLMAV-RIAVVCLSDSPADRPSSDELVPML 374
           +         +D  + G  V+E+E +  V  IA++CL   PA RP+  E+V +L
Sbjct: 291 VVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLL 344

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  164 bits (415), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/285 (33%), Positives = 151/285 (52%), Gaps = 20/285 (7%)

Query: 101  ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
            E+ +LG    G  Y+  +  G  +AV+++ +   G+      S     + E+  L  +RH
Sbjct: 801  EDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGA------SSDNSFRAEISTLGKIRH 854

Query: 161  RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            RN++ L  +    +   L+Y+Y+  GSL + + R  +N L L W  R RIA+G  +GL Y
Sbjct: 855  RNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCL-LDWNARYRIALGAAEGLCY 913

Query: 221  LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSLIATSAYSAPEC 273
            LH  C PQI+H ++K  N++LD  F   + DFGLAKL+         ++  +  Y APE 
Sbjct: 914  LHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEY 973

Query: 274  FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH-LQHAGEAREAL 332
                  T+K DI+SFG++L  L+TG+ P  P       GG L  W+R  +++     E  
Sbjct: 974  AYTMKVTEKCDIYSFGVVLLELITGKPPVQPL----EQGGDLVNWVRRSIRNMIPTIEMF 1029

Query: 333  D-RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ 376
            D R    ++    EM + ++IA+ C S+SPA RP+  E+V M+T+
Sbjct: 1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  164 bits (414), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 158/291 (54%), Gaps = 25/291 (8%)

Query: 100  NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
            + + L+GS   G  Y+  L +G  VA++++    SG  +       R    E+E +  ++
Sbjct: 889  HNDSLVGSGGFGDVYKAQLKDGSVVAIKKL-IHVSGQGD-------REFTAEMETIGKIK 940

Query: 160  HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
            HRNL+ L  Y        LVY+Y++ GSLED +   ++  ++L W  R +IA+G  +GL 
Sbjct: 941  HRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLA 1000

Query: 220  YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAP 271
            +LH  C P I+H ++K +NV+LD     R++DFG+A+LM          +L  T  Y  P
Sbjct: 1001 FLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1060

Query: 272  ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG--SLGRWLRHLQHAGEAR 329
            E +Q+   + K D++S+G++L  LLTG+ PT     ++A  G  +L  W++ L   G+  
Sbjct: 1061 EYYQSFRCSTKGDVYSYGVVLLELLTGKQPT-----DSADFGDNNLVGWVK-LHAKGKIT 1114

Query: 330  EALDRSILGEEVE-EDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
            +  DR +L E+   E E+L  +++A  CL D    RP+  +++ M  ++ +
Sbjct: 1115 DVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQA 1165

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  164 bits (414), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 100/292 (34%), Positives = 162/292 (55%), Gaps = 21/292 (7%)

Query: 97  ALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR---IQQELE 153
            L+  + +LG    G  Y+  + NG  +AV+++         K+N  ++RR   +  E++
Sbjct: 717 CLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWG-----KNKENGKIRRRKSGVLAEVD 771

Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG-WEVRLRIAV 212
           VL ++RHRN++ L           L+Y+Y+  GSL+D +    +       W    +IA+
Sbjct: 772 VLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAI 831

Query: 213 GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG----SLIATS-A 267
           GV +G+ YLH  C+P I+H +LKP+N++LDA+F  R+ADFG+AKL+      S++A S  
Sbjct: 832 GVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDESMSVVAGSYG 891

Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR-HLQHAG 326
           Y APE         KSDI+S+G+IL  ++TG+    P F E   G S+  W+R  L+   
Sbjct: 892 YIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGE---GNSIVDWVRSKLKTKE 948

Query: 327 EAREALDRSILGEEVE--EDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ 376
           +  E LD+S +G       +EM   +RIA++C S SP DRP   +++ +L +
Sbjct: 949 DVEEVLDKS-MGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQE 999

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  163 bits (412), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 97/299 (32%), Positives = 163/299 (54%), Gaps = 34/299 (11%)

Query: 92  KTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQE 151
           + LQ A  N +  LG    G  ++  L +   +AV+R+E    G  EKQ        + E
Sbjct: 486 RELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQG--EKQ-------FRTE 536

Query: 152 LEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM--DRIRENQLQLGWEVRLR 209
           +  + +++H NL+ LR +  E S+  LVYDY+  GSL+  +  +++ E ++ LGW++R +
Sbjct: 537 VVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEE-KIVLGWKLRFQ 595

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSL 262
           IA+G  +GL YLH  C   I+H ++KP N++LD++F P++ADFGLAKL+         ++
Sbjct: 596 IALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTM 655

Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP-------FFAEAASGGSL 315
             T  Y APE     + T K+D++S+GM+L  L++GR  T         FF   A+    
Sbjct: 656 RGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAA---- 711

Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
                 L   G+ R  +D  + G+ V+ +E+  A ++A  C+ D  + RP+  ++V +L
Sbjct: 712 ----TILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQIL 766

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  162 bits (411), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 158/291 (54%), Gaps = 25/291 (8%)

Query: 100  NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
            + + L+GS   G  Y+  L +G  VA++++    SG  +       R    E+E +  ++
Sbjct: 889  HNDSLVGSGGFGDVYKAQLKDGSVVAIKKL-IHVSGQGD-------REFTAEMETIGKIK 940

Query: 160  HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
            HRNL+ L  Y        LVY+Y++ GSLED +   ++  ++L W  R +IA+G  +GL 
Sbjct: 941  HRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLA 1000

Query: 220  YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAP 271
            +LH  C P I+H ++K +NV+LD     R++DFG+A+LM          +L  T  Y  P
Sbjct: 1001 FLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPP 1060

Query: 272  ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG--SLGRWLRHLQHAGEAR 329
            E +Q+   + K D++S+G++L  LLTG+ PT     ++A  G  +L  W++ L   G+  
Sbjct: 1061 EYYQSFRCSTKGDVYSYGVVLLELLTGKQPT-----DSADFGDNNLVGWVK-LHAKGKIT 1114

Query: 330  EALDRSILGEEVE-EDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
            +  DR +L E+   E E+L  +++A  CL D    RP+  +++ M  ++ +
Sbjct: 1115 DVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQA 1165

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
255543198	1369	ATP binding protein, putative [Ricinus c	0.984	0.273	0.755	1e-165
356567188	1231	PREDICTED: ADP-ribosylation factor GTPas	0.955	0.294	0.695	1e-151
356523716	1228	PREDICTED: ADP-ribosylation factor GTPas	0.955	0.295	0.690	1e-150
296085518	374	unnamed protein product [Vitis vinifera]	0.928	0.943	0.687	1e-148
224057838	308	predicted protein [Populus trichocarpa]	0.810	1.0	0.831	1e-147
357502665	356	LRR receptor-like serine/threonine-prote	0.905	0.966	0.721	1e-143
339790487	375	receptor like protein kinase SOL2 [Solan	0.971	0.984	0.664	1e-141
297811445	402	predicted protein [Arabidopsis lyrata su	0.913	0.863	0.690	1e-140
339790489	375	receptor like protein kinase SOL2 [Solan	0.971	0.984	0.664	1e-140
449469220	1191	PREDICTED: ADP-ribosylation factor GTPas	0.897	0.286	0.725	1e-140

>gi|255543198|ref|XP_002512662.1| ATP binding protein, putative [Ricinus communis] gi|223548623|gb|EEF50114.1| ATP binding protein, putative [Ricinus communis]

 Score =  588 bits (1517), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 291/385 (75%), Positives = 324/385 (84%), Gaps = 11/385 (2%)

Query: 7    TMLLLLMIFWFQYTTVQCQE---KMNPN--------SKPTEFKNGVKKIILSIALGVVTG 55
            T LLLL+ F F  + VQC E   +M  +        S+P++F  G+K+I++S+ LGV+TG
Sbjct: 985  TALLLLLSFCFHPSIVQCLESRTRMTRHLSTQPPSPSRPSQFNTGLKRILISVILGVLTG 1044

Query: 56   LIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYR 115
            L GAIL A  VRC V YMN+TPI+KGPVIFSPKI  KTLQ+ALA+EN+LLGSS +G YYR
Sbjct: 1045 LSGAILCAYLVRCLVRYMNRTPILKGPVIFSPKIASKTLQSALASENQLLGSSSNGNYYR 1104

Query: 116  TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR 175
            TVLDNGLT+AV+R+E FESGSPE+QNKSVKRRIQQELE LASLRHRNLMSLRAYV ES R
Sbjct: 1105 TVLDNGLTIAVKRLEPFESGSPERQNKSVKRRIQQELERLASLRHRNLMSLRAYVRESDR 1164

Query: 176  FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            F LVYDY+ +GSLEDAM R+REN LQL WEVRLRIAVG++KGL+YLHF C PQILHYNLK
Sbjct: 1165 FSLVYDYVPSGSLEDAMSRVRENHLQLSWEVRLRIAVGIVKGLRYLHFDCVPQILHYNLK 1224

Query: 236  PTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVL 295
            PTNVMLDAEF PRLAD GLAKLMP    AT  YSAPECFQN  YTDKSDIFSFGMIL VL
Sbjct: 1225 PTNVMLDAEFEPRLADCGLAKLMPNLDRATCGYSAPECFQNCRYTDKSDIFSFGMILGVL 1284

Query: 296  LTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV 355
            LTGRDPT PFF EAASGGSLGRWLRHLQ AGEA+EALD+SILGEE EEDEMLMAVRI+VV
Sbjct: 1285 LTGRDPTDPFFGEAASGGSLGRWLRHLQQAGEAKEALDKSILGEEGEEDEMLMAVRISVV 1344

Query: 356  CLSDSPADRPSSDELVPMLTQLHSF 380
            CLSD PADRPSSDELV ML+QLHSF
Sbjct: 1345 CLSDLPADRPSSDELVLMLSQLHSF 1369

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567188|ref|XP_003551803.1| PREDICTED: ADP-ribosylation factor GTPase-activating protein AGD3-like [Glycine max]

 Score =  541 bits (1393), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 263/378 (69%), Positives = 301/378 (79%), Gaps = 15/378 (3%)

Query: 18   QYTTVQCQEKMNPN---------------SKPTEFKNGVKKIILSIALGVVTGLIGAILF 62
             + T+QCQ +++ +                  + +K+  +KIILS+ LG VTGL+ + LF
Sbjct: 854  HHNTMQCQGRLSKHVSSEPPSPSRSTPSPPSSSGYKDDPRKIILSMVLGAVTGLVSSALF 913

Query: 63   ACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGL 122
            A  VRC V Y+N+TPI+KGPVIFSPKI P TLQ+ALA EN LLGSSP+GKYY+TVLDNGL
Sbjct: 914  ALVVRCVVQYLNRTPILKGPVIFSPKIAPMTLQSALAKENHLLGSSPNGKYYKTVLDNGL 973

Query: 123  TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
            T+AV+R+  FES SPE + KSVKR+IQ ELE+LASLRHRNLMSLRAYV E   F LVYDY
Sbjct: 974  TIAVKRLTPFESNSPEAKRKSVKRQIQTELELLASLRHRNLMSLRAYVREPDGFSLVYDY 1033

Query: 183  LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD 242
            + TGSL D + ++REN+L  GWEVRLRIAVGV+KGLQYLHFTC PQILHYNLKPTNVMLD
Sbjct: 1034 VSTGSLADVLSKVRENELPFGWEVRLRIAVGVVKGLQYLHFTCVPQILHYNLKPTNVMLD 1093

Query: 243  AEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT 302
            AEF PRLAD+GLAKL+P     +S Y+ PECF N  YTDKSDIFSFGMIL VLLTG+DPT
Sbjct: 1094 AEFEPRLADYGLAKLLPNLDGGSSLYTPPECFHNCRYTDKSDIFSFGMILGVLLTGKDPT 1153

Query: 303  APFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPA 362
             PFF EAASGGSLG WLRHLQ AGEA EALD+S+LGEE EEDEMLMAVRIA  CLSD PA
Sbjct: 1154 DPFFGEAASGGSLGCWLRHLQQAGEAHEALDKSMLGEEGEEDEMLMAVRIAAACLSDMPA 1213

Query: 363  DRPSSDELVPMLTQLHSF 380
            DRPSSDELV MLTQLHSF
Sbjct: 1214 DRPSSDELVHMLTQLHSF 1231

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523716|ref|XP_003530481.1| PREDICTED: ADP-ribosylation factor GTPase-activating protein AGD3-like [Glycine max]

 Score =  536 bits (1381), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 261/378 (69%), Positives = 302/378 (79%), Gaps = 15/378 (3%)

Query: 18   QYTTVQCQEKMNPN---------------SKPTEFKNGVKKIILSIALGVVTGLIGAILF 62
             + TVQCQ +++ +                  + +K+  +KIILS+ LG VTGL+ ++LF
Sbjct: 851  HHNTVQCQGRLSKHVSSEPPSPSRPSSAAPSSSGYKDDPRKIILSMVLGAVTGLVCSVLF 910

Query: 63   ACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGL 122
            A  VRC V Y+N+TPI+KGPVIFSPKI  KTLQ+ALA EN LLGSSP+GKYY+T+LDNGL
Sbjct: 911  ALVVRCVVQYLNRTPILKGPVIFSPKIASKTLQSALAKENHLLGSSPNGKYYKTMLDNGL 970

Query: 123  TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
            T+AV+R+  FES SPE + KSVKR+IQ ELE+LASLR+RNLMSLRAYV E   F LVYDY
Sbjct: 971  TIAVKRLTPFESNSPEAKRKSVKRQIQTELELLASLRNRNLMSLRAYVREPDGFSLVYDY 1030

Query: 183  LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD 242
              TGSL D ++R+REN+L  GWEVRLRIAVGV+KGLQYLHFTC PQILHYNLKPTNVMLD
Sbjct: 1031 ASTGSLADVLNRVRENELPFGWEVRLRIAVGVVKGLQYLHFTCVPQILHYNLKPTNVMLD 1090

Query: 243  AEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT 302
            AEF PRLAD+GLAKL+P     +S Y+ PECF N  YTDKSDIFSFG+IL VLLT +DPT
Sbjct: 1091 AEFEPRLADYGLAKLLPNLDRGSSLYTPPECFHNCRYTDKSDIFSFGIILGVLLTSKDPT 1150

Query: 303  APFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPA 362
             PFF EAASGGSLG WLRHLQ AGE+REALD+S+LGEE EEDEMLMAVRIA  CLSD PA
Sbjct: 1151 DPFFGEAASGGSLGCWLRHLQQAGESREALDKSMLGEEGEEDEMLMAVRIAAACLSDMPA 1210

Query: 363  DRPSSDELVPMLTQLHSF 380
            DRPSSDELV MLTQLHSF
Sbjct: 1211 DRPSSDELVHMLTQLHSF 1228

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085518|emb|CBI29250.3| unnamed protein product [Vitis vinifera]

 Score =  529 bits (1363), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 268/390 (68%), Positives = 306/390 (78%), Gaps = 37/390 (9%)

Query: 2   GSKTS--TMLLLLMIFWFQYTTVQCQE----KMNPNSKPT-----EFKNGVKKIILSIAL 50
            SKTS   + LL ++ +  +  V+CQE    +++ +S P+     EFK+G+KKIILSI  
Sbjct: 11  ASKTSREAISLLFLLIFIHFYNVKCQENIINRVSTDSSPSPSREAEFKSGLKKIILSIVF 70

Query: 51  GVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPD 110
           GV+TGL+ A L A  V C V YMN+TPI+KGPV+FSPKI PKT+Q+AL            
Sbjct: 71  GVLTGLLSAALCAGIVHCVVRYMNRTPILKGPVVFSPKIAPKTVQSALD----------- 119

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
                          ++R+E FE+GSPE Q+KSVKRRIQQELE+LA+LRHRNLMSLRAYV
Sbjct: 120 ---------------IKRLEPFETGSPETQSKSVKRRIQQELEMLANLRHRNLMSLRAYV 164

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +S RF LVYDY+ TGSLEDAM+R+RENQLQL WEVRLRIAVGVIKGLQYLHF+C P+IL
Sbjct: 165 RDSDRFSLVYDYVPTGSLEDAMNRVRENQLQLSWEVRLRIAVGVIKGLQYLHFSCVPRIL 224

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGM 290
           HYNLKPTNVMLDAEF PRLAD GLAKLMP    A S YSAPECFQN  YT+KSD+FSFG+
Sbjct: 225 HYNLKPTNVMLDAEFEPRLADCGLAKLMPNLDRAASGYSAPECFQNCRYTEKSDVFSFGV 284

Query: 291 ILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAV 350
           IL VLLTGRDP  PFF+EAA GGSLGRWLRHLQ AGEAREALD+SILGEEVEEDEMLMAV
Sbjct: 285 ILGVLLTGRDPMDPFFSEAAGGGSLGRWLRHLQQAGEAREALDKSILGEEVEEDEMLMAV 344

Query: 351 RIAVVCLSDSPADRPSSDELVPMLTQLHSF 380
           RIAVVCLSD PADRPSSDELVPMLTQLHSF
Sbjct: 345 RIAVVCLSDLPADRPSSDELVPMLTQLHSF 374

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224057838|ref|XP_002299349.1| predicted protein [Populus trichocarpa] gi|222846607|gb|EEE84154.1| predicted protein [Populus trichocarpa]

 Score =  527 bits (1357), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 256/308 (83%), Positives = 276/308 (89%)

Query: 73  MNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAF 132
           M +TPI+KGPVIFSPKI PK+LQ+AL NEN+LLGSS +GKYYRTVLDNGLT+AV+R E F
Sbjct: 1   MKRTPILKGPVIFSPKITPKSLQSALENENQLLGSSSNGKYYRTVLDNGLTIAVKRFEPF 60

Query: 133 ESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM 192
           E GSPE+Q+KSVKRRIQQELE+LASLRHRNLMSLRAYV E  RF LVYD + TGSLEDAM
Sbjct: 61  EIGSPERQSKSVKRRIQQELEMLASLRHRNLMSLRAYVREPDRFSLVYDCVPTGSLEDAM 120

Query: 193 DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
           +R+REN+LQLGWEVRLRIAVGVIKGL+YLHF C PQILHYNLKP NV+LDAEF PRLADF
Sbjct: 121 NRVRENELQLGWEVRLRIAVGVIKGLRYLHFDCVPQILHYNLKPRNVILDAEFEPRLADF 180

Query: 253 GLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
           GLAKL P    ATS YSAPECFQN  YTDKSD+FSFGMIL VLLTGRDPT PFF E ASG
Sbjct: 181 GLAKLTPNLDRATSGYSAPECFQNCRYTDKSDVFSFGMILGVLLTGRDPTDPFFRETASG 240

Query: 313 GSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP 372
           GSLG WLRHLQ AGEAREALD+SILGEEVEEDEMLMAVRIAVVCLSD PADRPSSDELVP
Sbjct: 241 GSLGPWLRHLQQAGEAREALDKSILGEEVEEDEMLMAVRIAVVCLSDMPADRPSSDELVP 300

Query: 373 MLTQLHSF 380
           ML+QLHSF
Sbjct: 301 MLSQLHSF 308

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357502665|ref|XP_003621621.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula] gi|355496636|gb|AES77839.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula]

 Score =  513 bits (1322), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 249/345 (72%), Positives = 287/345 (83%), Gaps = 1/345 (0%)

Query: 37  FKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQA 96
           +K+  +KII+SI LG VTGLIG++LFA  +RC V Y+N+TPI+KGPVIFSPKI  KTLQ 
Sbjct: 12  YKDDPRKIIISIVLGAVTGLIGSVLFAFVIRCVVWYLNRTPILKGPVIFSPKIASKTLQV 71

Query: 97  ALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA 156
           AL  EN +LGSSP+GKYY+TVL+NGL +AV+R+  FES SPE + KSVKR+IQ ELE+LA
Sbjct: 72  ALTKENHMLGSSPNGKYYKTVLENGLIIAVKRLTPFESNSPESRKKSVKRQIQMELELLA 131

Query: 157 SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK 216
           SLRHRNLMSLRAYV E+  F LVYDY+ TGSL D M+R+REN+LQ+GWE RLRIAVGV+K
Sbjct: 132 SLRHRNLMSLRAYVRENDGFSLVYDYVSTGSLADVMNRVRENELQIGWEARLRIAVGVVK 191

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQN 276
           GLQYLHFTC PQILH+NLKPTNVMLDAEF PRLAD+GLAKL+P      S    PEC  N
Sbjct: 192 GLQYLHFTCVPQILHFNLKPTNVMLDAEFEPRLADYGLAKLLPNLDRGISVNIPPECSHN 251

Query: 277 RS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
            S YT+KSDIFSFGMIL VLLTG+DPT PFF EA+ GGSLG WLRHL+ AGE REALD+S
Sbjct: 252 CSRYTEKSDIFSFGMILGVLLTGKDPTDPFFGEASRGGSLGCWLRHLKQAGEEREALDKS 311

Query: 336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF 380
           ILGE+ EEDEMLMAV IA  CLSD PA+RPSSDELV MLTQL+SF
Sbjct: 312 ILGEQGEEDEMLMAVGIAAACLSDMPAERPSSDELVHMLTQLNSF 356

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|339790487|dbj|BAK52400.1| receptor like protein kinase SOL2 [Solanum lycopersicum] gi|339790491|dbj|BAK52402.1| receptor like protein kinase SOL2 [Solanum peruvianum] gi|339790493|dbj|BAK52403.1| receptor like protein kinase SOL2 [Solanum lycopersicum]

 Score =  506 bits (1304), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 249/375 (66%), Positives = 300/375 (80%), Gaps = 6/375 (1%)

Query: 9   LLLLMIFWFQYTTVQCQEKM--NPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFV 66
           +L L     Q  +V C  ++  + NS   +FKN  ++I LSI  G+ TGLI A++FA  V
Sbjct: 4   VLKLCFLCLQLISVHCHGRILKDDNSSSDQFKNRFQRIFLSILFGMFTGLICALVFAWLV 63

Query: 67  RCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAV 126
           R FV Y+N+ PI+KGPV+FSPKI PKTLQ+AL N+ +L+GSS  GKY+RTVLDNGLTVAV
Sbjct: 64  RSFVRYINKAPILKGPVVFSPKIPPKTLQSALDNDTQLIGSSNSGKYFRTVLDNGLTVAV 123

Query: 127 RRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG 186
           +R+E    GSP+   KS KRRIQ ELE++A LRHRNLMSLRAYV ES+ F+LVYDY+ +G
Sbjct: 124 KRMEP---GSPQLHTKSFKRRIQHELELIAGLRHRNLMSLRAYVRESNTFFLVYDYVNSG 180

Query: 187 SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT 246
           SLED M+++RENQLQL WEVRLRIAVG++K LQYLHF+CNP +LH NLKPTNVMLDAEF 
Sbjct: 181 SLEDVMNKVRENQLQLTWEVRLRIAVGIVKALQYLHFSCNPTVLHRNLKPTNVMLDAEFE 240

Query: 247 PRLADFGLAKLMPG-SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
           PRLAD GLAK++P  +L A S Y  PE FQ+  YTDKSD+FSFG+IL VLLTG+ PT PF
Sbjct: 241 PRLADCGLAKIIPTLNLPAASNYGPPESFQSCRYTDKSDVFSFGVILGVLLTGKYPTDPF 300

Query: 306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP 365
           F + ++GGSL  WL+ LQ AG+AREALD+SILGEEVEEDEMLMAV+IAVVCLSD PADRP
Sbjct: 301 FGDTSTGGSLACWLQRLQEAGDAREALDKSILGEEVEEDEMLMAVKIAVVCLSDMPADRP 360

Query: 366 SSDELVPMLTQLHSF 380
           SSDELV MLTQL+SF
Sbjct: 361 SSDELVSMLTQLNSF 375

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297811445|ref|XP_002873606.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297319443|gb|EFH49865.1| predicted protein [Arabidopsis lyrata subsp. lyrata]

 Score =  505 bits (1301), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 241/349 (69%), Positives = 285/349 (81%), Gaps = 2/349 (0%)

Query: 34  PTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKT 93
           P E +   K I++SI  G++TGL+ A++ A  VR  V YM QTPI+KGPV+FSPKI PK+
Sbjct: 54  PLESRITSKVIVVSIVSGILTGLVSALVLAFLVRSIVKYMKQTPILKGPVVFSPKITPKS 113

Query: 94  LQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFES-GSPE-KQNKSVKRRIQQE 151
           L AAL N  +LLGS P+GKYY+ VLDNGL VAV+R+ + E  GSPE   +KSVKRR+Q+E
Sbjct: 114 LHAALGNGIQLLGSDPNGKYYKMVLDNGLVVAVKRLGSLEGIGSPETNSSKSVKRRLQKE 173

Query: 152 LEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIA 211
           LE+LA LRHRNLMSLRAYV ES  F LVYDY+  GSLED M ++R  +++LGWE+RLR+A
Sbjct: 174 LELLAGLRHRNLMSLRAYVRESDEFSLVYDYMPNGSLEDVMHKVRTKEVELGWEIRLRVA 233

Query: 212 VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAP 271
           VG++KGLQYLHF+C  QILHYNLKPTNVMLD+EF PRLAD GLAK+MP S  A   YSAP
Sbjct: 234 VGIVKGLQYLHFSCETQILHYNLKPTNVMLDSEFEPRLADCGLAKIMPSSHTAVFCYSAP 293

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA 331
           E  Q+  YTDKSDIFSFGMIL VLLTGRDPT PF  E+ASGGSLG+WL+HLQ +GEAREA
Sbjct: 294 ESSQSNRYTDKSDIFSFGMILGVLLTGRDPTHPFCEESASGGSLGQWLKHLQQSGEAREA 353

Query: 332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF 380
           LD++ILGEEVEEDEMLMA+RI ++CLSD PADRPSSDELV MLTQLHSF
Sbjct: 354 LDKTILGEEVEEDEMLMALRITIICLSDFPADRPSSDELVHMLTQLHSF 402

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|339790489|dbj|BAK52401.1| receptor like protein kinase SOL2 [Solanum pennellii]

 Score =  505 bits (1300), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 249/375 (66%), Positives = 299/375 (79%), Gaps = 6/375 (1%)

Query: 9   LLLLMIFWFQYTTVQCQEKM--NPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFV 66
           +L L     Q  +V C  ++  + NS    FKN  ++I LSI  G+ TGLI A++FA  V
Sbjct: 4   VLKLCFLCLQLISVHCHGRILKDDNSSSDLFKNRFQRIFLSILFGMFTGLICALVFAWLV 63

Query: 67  RCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAV 126
           R FV Y+N+ PI+KGPV+FSPKI PKTLQ+AL N+ +L+GSS  GKY+RTVLDNGLTVAV
Sbjct: 64  RSFVRYINKAPILKGPVVFSPKIPPKTLQSALDNDTQLIGSSNSGKYFRTVLDNGLTVAV 123

Query: 127 RRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG 186
           +R+E    GSP+   KS KRRIQ ELE++A LRHRNLMSLRAYV ES+ F+LVYDY+ +G
Sbjct: 124 KRMEP---GSPQLHTKSFKRRIQHELELIAGLRHRNLMSLRAYVRESNTFFLVYDYVNSG 180

Query: 187 SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT 246
           SLED M+++RENQLQL WEVRLRIAVG++K LQYLHF+CNP +LH NLKPTNVMLDAEF 
Sbjct: 181 SLEDVMNKVRENQLQLTWEVRLRIAVGIVKALQYLHFSCNPTVLHRNLKPTNVMLDAEFE 240

Query: 247 PRLADFGLAKLMPG-SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
           PRLAD GLAK++P  +L A S Y  PE FQ+  YTDKSD+FSFG+IL VLLTG+ PT PF
Sbjct: 241 PRLADCGLAKIIPTLNLPAASNYGPPESFQSCRYTDKSDVFSFGVILGVLLTGKYPTDPF 300

Query: 306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP 365
           F + ++GGSL  WL+ LQ AG+AREALD+SILGEEVEEDEMLMAV+IAVVCLSD PADRP
Sbjct: 301 FGDTSTGGSLACWLQRLQEAGDAREALDKSILGEEVEEDEMLMAVKIAVVCLSDMPADRP 360

Query: 366 SSDELVPMLTQLHSF 380
           SSDELV MLTQL+SF
Sbjct: 361 SSDELVSMLTQLNSF 375

Source: Solanum pennellii

Species: Solanum pennellii

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449469220|ref|XP_004152319.1| PREDICTED: ADP-ribosylation factor GTPase-activating protein AGD3-like [Cucumis sativus]

 Score =  503 bits (1296), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 251/346 (72%), Positives = 291/346 (84%), Gaps = 5/346 (1%)

Query: 36   EFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQ 95
            +FKNGV++II S+ LGVVTGL+G+ LFAC +R FV Y+N+TPI+KGPVIFSP IDPKTL 
Sbjct: 850  QFKNGVRRIIFSVLLGVVTGLMGSFLFACLIRSFVRYLNKTPILKGPVIFSPIIDPKTLH 909

Query: 96   AALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVL 155
             AL NEN+LLGS+P GKYYRT+LDNGLT+AV+R+E    GS     KS KR+ Q +LE L
Sbjct: 910  LALRNENQLLGSNPHGKYYRTILDNGLTIAVKRLE----GSENTARKSEKRQTQLQLERL 965

Query: 156  ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
            A LRHRNLMSLRAYV E    +LVYDY+ TGSLED M R+REN+++LGWE+RL IAVGVI
Sbjct: 966  ARLRHRNLMSLRAYVGEGEGVWLVYDYVGTGSLEDVMKRVRENEVRLGWEIRLGIAVGVI 1025

Query: 216  KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-SLIATSAYSAPECF 274
            KGLQYLHF C+PQILHYNLKP+NVMLD E+ PRLAD GL KL    ++ +TSAY++PEC 
Sbjct: 1026 KGLQYLHFECDPQILHYNLKPSNVMLDGEYEPRLADCGLPKLFSNLNMASTSAYTSPECL 1085

Query: 275  QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
            Q+  Y+DKSDIFSFGMILAVLLTG+DPT PFF EAASGGSLG+WLRHLQ AGEAREALD+
Sbjct: 1086 QDCRYSDKSDIFSFGMILAVLLTGKDPTDPFFGEAASGGSLGQWLRHLQVAGEAREALDK 1145

Query: 335  SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF 380
            SI+GEE EEDEMLMAVRIAVVCLS+   DRPSSDELV MLTQLHSF
Sbjct: 1146 SIIGEEGEEDEMLMAVRIAVVCLSEQAIDRPSSDELVHMLTQLHSF 1191

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
TAIR|locus:2183906	401	CRN "CORYNE" [Arabidopsis thal	0.994	0.942	0.640	4.6e-128
TAIR|locus:2045228	641	SOBIR1 "SUPPRESSOR OF BIR1 1"	0.913	0.541	0.343	6.5e-51
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.892	0.572	0.317	3.5e-43
TAIR|locus:2058759	589	FEI2 "FEI 2" [Arabidopsis thal	0.878	0.567	0.321	3.5e-43
TAIR|locus:2170668	604	AT5G62710 [Arabidopsis thalian	0.694	0.437	0.350	8.4e-42
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.707	0.235	0.331	6.4e-40
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.726	0.285	0.318	1.1e-39
TAIR|locus:2203000	355	AT1G78530 [Arabidopsis thalian	0.689	0.738	0.364	1.8e-39
TAIR|locus:2161158	1041	PXY "PHLOEM INTERCALATED WITH	0.710	0.259	0.343	6.2e-39
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.85	0.287	0.324	4.9e-38

TAIR|locus:2183906 CRN "CORYNE" [Arabidopsis thaliana (taxid:3702)]

 Score = 1257 (447.5 bits), Expect = 4.6e-128, P = 4.6e-128
 Identities = 249/389 (64%), Positives = 305/389 (78%)

Query:     3 SKTSTMLLLLMIFWFQYTTVQ--CQEKM-------NPNSKPTEFKNGVKKIILSIALGVV 53
             S T ++LLL  + +F  T+    C+ +        + +S P E +   K I++SI  G++
Sbjct:    13 SNTISLLLLFFLVFFSRTSTSTSCRRRTVKHLSTTSTSSTPLESRITSKVIVISIVSGIL 72

Query:    54 TGLIGAILFACFVRCFVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKY 113
             TGL+ A++ A  VR  V +M QTPI+KGPV+FSPKI PK+L AAL+N  +LLGS  +GKY
Sbjct:    73 TGLVSALVLAFLVRSIVKFMKQTPILKGPVVFSPKITPKSLHAALSNGIQLLGSDLNGKY 132

Query:   114 YRTVLDNGLTVAVRRVEAFES-GSPEKQN-KSVKRRIQQELEVLASLRHRNLMSLRAYVP 171
             Y+ VLDNGL VAV+R+ + E  GSPE  + KSVKRR+Q+ELE+LA LRHRNLMSLRAYV 
Sbjct:   133 YKMVLDNGLVVAVKRLGSLEGVGSPESSSSKSVKRRLQKELELLAGLRHRNLMSLRAYVR 192

Query:   172 ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILH 231
             ES  F LVYDY+  GSLED M+++R  +++LGWE+RLR+AVG++KGLQYLHF+C  QILH
Sbjct:   193 ESDEFSLVYDYMPNGSLEDVMNKVRTKEVELGWEIRLRVAVGIVKGLQYLHFSCETQILH 252

Query:   232 YNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMI 291
             YNLKPTNVMLD+EF PRLAD GLAK+MP S  A S YSAPE  Q+  YTDKSDIFSFGMI
Sbjct:   253 YNLKPTNVMLDSEFEPRLADCGLAKIMPSSHTAVSCYSAPESSQSNRYTDKSDIFSFGMI 312

Query:   292 LAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR 351
             L VLLTGRDPT PF  E+ASGGSLG+WL+HLQ +GEAREALD++ILGEEVEEDEMLMA+R
Sbjct:   313 LGVLLTGRDPTHPFCEESASGGSLGQWLKHLQQSGEAREALDKTILGEEVEEDEMLMALR 372

Query:   352 IAVVCLSDSPADRPSSDELVPMLTQLHSF 380
             I ++CLSD PADRPSSDELV MLTQLHSF
Sbjct:   373 ITIICLSDFPADRPSSDELVHMLTQLHSF 401

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009909 "regulation of flower development" evidence=RCA;IMP

GO:0010073 "meristem maintenance" evidence=IGI;RCA

GO:0010082 "regulation of root meristem growth" evidence=IGI

GO:0010075 "regulation of meristem growth" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0019900 "kinase binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0006406 "mRNA export from nucleus" evidence=RCA

GO:0007155 "cell adhesion" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010074 "maintenance of meristem identity" evidence=RCA

GO:0010090 "trichome morphogenesis" evidence=RCA

GO:0016570 "histone modification" evidence=RCA

GO:0045010 "actin nucleation" evidence=RCA

GO:0048449 "floral organ formation" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 529 (191.3 bits), Expect = 6.5e-51, P = 6.5e-51
 Identities = 128/373 (34%), Positives = 206/373 (55%)

Query:    27 KMNPNSKPTEFKNGVKKIILSIALGVVTGLIGAILFACFVRCFVGYMNQTPIIKGPVIFS 86
             K+    K ++ K  V   IL   +G + G I   +F+   +  +  +  +    GP IFS
Sbjct:   271 KLKKKKKKSK-KKKVAAWILGFVVGAIGGTISGFVFSVLFKLIIQAIRGSEKPPGPSIFS 329

Query:    87 PKIDPKTLQAALANENRL-----LGSSPDGKYYRTVL--DNGLTVAVRRV-----EAFES 134
             P I      A L NE  L     +G    G+ ++  L   NG  +AV++V     +A E 
Sbjct:   330 PLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDADEL 389

Query:   135 GSPEKQ--NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM 192
                + +  NK + R+I+ E+  +  +RHRNL+ L A+V      YLVY+Y++ GSL+D +
Sbjct:   390 TDEDSKFLNKKM-RQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDIL 448

Query:   193 DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
               ++    +L W  R +IA+G+  GL+YLH   NP+I+H +LKP NV+LD +   R++DF
Sbjct:   449 TDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDF 508

Query:   253 GLAKLMPGSL--IATS------AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             GLAK MP ++  I TS       Y APE +Q   +TDK DI+SFG+IL +L+ G+ P+  
Sbjct:   509 GLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDE 568

Query:   305 FFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADR 364
             FF +     SL +W+R++  +     A+D  ++ +  +E +ML+ ++IA  C  D P  R
Sbjct:   569 FF-QHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDE-QMLLVLKIACYCTLDDPKQR 626

Query:   365 PSSDELVPMLTQL 377
             P+S ++  ML+Q+
Sbjct:   627 PNSKDVRTMLSQI 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010942 "positive regulation of cell death" evidence=IMP

GO:0031349 "positive regulation of defense response" evidence=IMP

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0060862 "negative regulation of floral organ abscission" evidence=IGI

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 456 (165.6 bits), Expect = 3.5e-43, P = 3.5e-43
 Identities = 122/384 (31%), Positives = 208/384 (54%)

Query:    18 QYTTVQCQEKM-NPNSKPTEFKNGVK---KIILSIALGVVTGLIGAILFACFVRCFV--- 70
             ++  V CQ+   NP+S     +N  K   K+++S +  V   L+ A++  CF  CF+   
Sbjct:   209 KHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVALM--CFWGCFLYKK 266

Query:    71 -GYMNQTPIIK------------GPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTV 117
              G +    + K            G + +S K   K L+  + NE  ++G    G  Y+  
Sbjct:   267 LGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLE--MLNEEHIIGCGGFGTVYKLA 324

Query:   118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
             +D+G   A++R+         K N+   R  ++ELE+L S++HR L++LR Y    +   
Sbjct:   325 MDDGKVFALKRIL--------KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 376

Query:   178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
             L+YDYL  GSL++A+  +   + QL W+ R+ I +G  KGL YLH  C+P+I+H ++K +
Sbjct:   377 LLYDYLPGGSLDEAL-HVERGE-QLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSS 434

Query:   238 NVMLDAEFTPRLADFGLAKLMPG------SLIA-TSAYSAPECFQNRSYTDKSDIFSFGM 290
             N++LD     R++DFGLAKL+        +++A T  Y APE  Q+   T+K+D++SFG+
Sbjct:   435 NILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGV 494

Query:   291 ILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAV 350
             ++  +L+G+ PT   F E   G ++  WL+ L      R+ +D +  G ++E  + L++ 
Sbjct:   495 LVLEVLSGKRPTDASFIE--KGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLS- 551

Query:   351 RIAVVCLSDSPADRPSSDELVPML 374
              IA  C+S SP +RP+   +V +L
Sbjct:   552 -IATQCVSPSPEERPTMHRVVQLL 574

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 456 (165.6 bits), Expect = 3.5e-43, P = 3.5e-43
 Identities = 122/379 (32%), Positives = 203/379 (53%)

Query:    22 VQCQEKMNPNSK--PT-EFKNGVKKIILSIALGVVTGLIGAILFACFVRCFV----GYMN 74
             + C +  N  +   PT +  N  K++++S A   V GL+  +   CF  CF+    G + 
Sbjct:   212 IVCNDSGNSTASGSPTGQGGNNPKRLLIS-ASATVGGLL-LVALMCFWGCFLYKKLGRVE 269

Query:    75 QTPII------------KGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGL 122
                ++             G + ++ K   K L++   NE  ++G    G  Y+  +D+G 
Sbjct:   270 SKSLVIDVGGGASIVMFHGDLPYASKDIIKKLESL--NEEHIIGCGGFGTVYKLSMDDGN 327

Query:   123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
               A++R+         K N+   R  ++ELE+L S++HR L++LR Y    +   L+YDY
Sbjct:   328 VFALKRIV--------KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDY 379

Query:   183 LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD 242
             L  GSL++A+ +  E   QL W+ R+ I +G  KGL YLH  C+P+I+H ++K +N++LD
Sbjct:   380 LPGGSLDEALHKRGE---QLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 436

Query:   243 AEFTPRLADFGLAKLMPG------SLIA-TSAYSAPECFQNRSYTDKSDIFSFGMILAVL 295
                  R++DFGLAKL+        +++A T  Y APE  Q+   T+K+D++SFG+++  +
Sbjct:   437 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 496

Query:   296 LTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV 355
             L+G+ PT   F E   G ++  WL  L     A+E +D S  G E E  + L++  IA  
Sbjct:   497 LSGKLPTDASFIE--KGFNIVGWLNFLISENRAKEIVDLSCEGVERESLDALLS--IATK 552

Query:   356 CLSDSPADRPSSDELVPML 374
             C+S SP +RP+   +V +L
Sbjct:   553 CVSSSPDERPTMHRVVQLL 571

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)]

 Score = 443 (161.0 bits), Expect = 8.4e-42, P = 8.4e-42
 Identities = 100/285 (35%), Positives = 170/285 (59%)

Query:   100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
             +E  ++GS   G  YR V+++  T AV++++    GS         R  ++E+E+L S++
Sbjct:   313 DEEDIVGSGGFGTVYRMVMNDLGTFAVKKIDRSRQGSD--------RVFEREVEILGSVK 364

Query:   160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM-DRIRENQLQLGWEVRLRIAVGVIKGL 218
             H NL++LR Y    S   L+YDYL  GSL+D + +R +E+ L L W  RL+IA+G  +GL
Sbjct:   365 HINLVNLRGYCRLPSSRLLIYDYLTLGSLDDLLHERAQEDGL-LNWNARLKIALGSARGL 423

Query:   219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG------SLIA-TSAYSAP 271
              YLH  C+P+I+H ++K +N++L+ +  PR++DFGLAKL+        +++A T  Y AP
Sbjct:   424 AYLHHDCSPKIVHRDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAP 483

Query:   272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA 331
             E  QN   T+KSD++SFG++L  L+TG+ PT P F +   G ++  W+  +       + 
Sbjct:   484 EYLQNGRATEKSDVYSFGVLLLELVTGKRPTDPIFVKR--GLNVVGWMNTVLKENRLEDV 541

Query:   332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ 376
             +D+     +V+E+ +   + IA  C   +P +RP+ +++  +L Q
Sbjct:   542 IDKRCT--DVDEESVEALLEIAERCTDANPENRPAMNQVAQLLEQ 584

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 415 (151.1 bits), Expect = 6.4e-40, Sum P(2) = 6.4e-40
 Identities = 95/287 (33%), Positives = 161/287 (56%)

Query:   101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLR 159
             E  ++G    G  YR  +DNG  +AV+++  A  +G  +++ K+V+     E++ L ++R
Sbjct:   788 EPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIR 847

Query:   160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
             H+N++         +   L+YDY+  GSL   +   R + L   W++R RI +G  +GL 
Sbjct:   848 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLD--WDLRYRILLGAAQGLA 905

Query:   220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSL------IATS-AYSAP 271
             YLH  C P I+H ++K  N+++  +F P +ADFGLAKL+  G +      +A S  Y AP
Sbjct:   906 YLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAP 965

Query:   272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA 331
             E   +   T+KSD++S+G+++  +LTG+ P  P   E   G  L  W+R  Q+ G   E 
Sbjct:   966 EYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPE---GIHLVDWVR--QNRGSL-EV 1019

Query:   332 LDRSILGE-EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
             LD ++    E E DEM+  +  A++C++ SP +RP+  ++  ML ++
Sbjct:  1020 LDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEI 1066

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 405 (147.6 bits), Expect = 1.1e-39, Sum P(3) = 1.1e-39
 Identities = 94/295 (31%), Positives = 163/295 (55%)

Query:    90 DPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKS-VKRRI 148
             D + +  +L ++N ++G    G  YR  L +G  VAV+++ +  +     ++K  + + +
Sbjct:   648 DQREILESLVDKN-IVGHGGSGTVYRVELKSGEVVAVKKLWSQSNKDSASEDKMHLNKEL 706

Query:   149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
             + E+E L S+RH+N++ L +Y        LVY+Y+  G+L DA+ +     + L W  R 
Sbjct:   707 KTEVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALHK---GFVHLEWRTRH 763

Query:   209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------- 261
             +IAVGV +GL YLH   +P I+H ++K TN++LD  + P++ADFG+AK++          
Sbjct:   764 QIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDSTTT 823

Query:   262 -LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR 320
              +  T  Y APE   +   T K D++SFG++L  L+TG+ P    F E     ++  W+ 
Sbjct:   824 VMAGTYGYLAPEYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGE---NKNIVNWVS 880

Query:   321 HLQHAGEAR-EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
                   E   E LD+ +   E  + +M+ A+R+A+ C S +P  RP+ +E+V +L
Sbjct:   881 TKIDTKEGLIETLDKRL--SESSKADMINALRVAIRCTSRTPTIRPTMNEVVQLL 933

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)]

 Score = 421 (153.3 bits), Expect = 1.8e-39, P = 1.8e-39
 Identities = 104/285 (36%), Positives = 154/285 (54%)

Query:    98 LANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS 157
             L+N++ +LGS   G  YR V+D+  T AV+R+     G+ E+      R   +ELE +A 
Sbjct:    75 LSNKD-ILGSGGFGTVYRLVIDDSTTFAVKRLNR---GTSERD-----RGFHRELEAMAD 125

Query:   158 LRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
             ++HRN+++L  Y        L+Y+ +  GSL    D     +  L W  R RIAVG  +G
Sbjct:   126 IKHRNIVTLHGYFTSPHYNLLIYELMPNGSL----DSFLHGRKALDWASRYRIAVGAARG 181

Query:   218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-P-----GSLIA-TSAYSA 270
             + YLH  C P I+H ++K +N++LD     R++DFGLA LM P      + +A T  Y A
Sbjct:   182 ISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTFVAGTFGYLA 241

Query:   271 PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE 330
             PE F     T K D++SFG++L  LLTGR PT   F E   G  L  W++ +        
Sbjct:   242 PEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFE--EGTKLVTWVKGVVRDQREEV 299

Query:   331 ALDRSILGEEVEEDEMLMAV-RIAVVCLSDSPADRPSSDELVPML 374
              +D  + G  V+E+E +  V  IA++CL   PA RP+  E+V +L
Sbjct:   300 VIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLL 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)]

 Score = 417 (151.9 bits), Expect = 6.2e-39, Sum P(2) = 6.2e-39
 Identities = 100/291 (34%), Positives = 162/291 (55%)

Query:    98 LANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR---IQQELEV 154
             L+  + +LG    G  Y+  + NG  +AV+++         K+N  ++RR   +  E++V
Sbjct:   718 LSKTDNILGMGSTGTVYKAEMPNGEIIAVKKL-----WGKNKENGKIRRRKSGVLAEVDV 772

Query:   155 LASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG-WEVRLRIAVG 213
             L ++RHRN++ L           L+Y+Y+  GSL+D +    +       W    +IA+G
Sbjct:   773 LGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIG 832

Query:   214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG----SLIATS-AY 268
             V +G+ YLH  C+P I+H +LKP+N++LDA+F  R+ADFG+AKL+      S++A S  Y
Sbjct:   833 VAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDESMSVVAGSYGY 892

Query:   269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH-LQHAGE 327
              APE         KSDI+S+G+IL  ++TG+    P F E   G S+  W+R  L+   +
Sbjct:   893 IAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGE---GNSIVDWVRSKLKTKED 949

Query:   328 AREALDRSILGEEVE--EDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ 376
               E LD+S +G       +EM   +RIA++C S SP DRP   +++ +L +
Sbjct:   950 VEEVLDKS-MGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQE 999

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010089 "xylem development" evidence=IMP

GO:0010223 "secondary shoot formation" evidence=IMP

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 419 (152.6 bits), Expect = 4.9e-38, P = 4.9e-38
 Identities = 116/357 (32%), Positives = 188/357 (52%)

Query:    44 IILSIALGVVTGLIGAILFACFVRCFVG----YMN-QTPIIK-GPVIFSPK--IDPKTLQ 95
             II+S  +G ++ L+ AI+   F+R  V     Y++ + P  +   + F PK     K + 
Sbjct:   755 IIVSSVIGGISLLLIAIVVH-FLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDIL 813

Query:    96 AALA--NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE 153
              A    +++ ++G    G  Y+ V+ +G T+AV+++E+   G+    N +     + E+ 
Sbjct:   814 EATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNT-DNSFRAEIL 872

Query:   154 VLASLRHRNLMSLRA--YVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIA 211
              L  +RHRN++ L +  Y   S+   L+Y+Y+  GSL + +   + + +   W  R  IA
Sbjct:   873 TLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMD--WPTRFAIA 930

Query:   212 VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MP----GSLIAT 265
             +G  +GL YLH  C P+I+H ++K  N+++D  F   + DFGLAK+  MP     S +A 
Sbjct:   931 LGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAG 990

Query:   266 S-AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR-HLQ 323
             S  Y APE       T+K DI+SFG++L  LLTG+ P  P       GG L  W R H++
Sbjct:   991 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPL----EQGGDLATWTRNHIR 1046

Query:   324 HAGEAREALDRSILGEEVEED----EMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ 376
                   E LD  +   +VE+D     M+   +IAV+C   SP+DRP+  E+V ML +
Sbjct:  1047 DHSLTSEILDPYLT--KVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LYU7	CRN_ARATH	No assigned EC number	0.6762	0.9131	0.8653	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00006189001 SubName- Full=Chromosome chr1 scaffold_166, whole genome shotgun sequence; (390 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	380
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-37
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-23
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-22
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-21
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-18
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-14
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-10
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-09
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-08
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-06
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	0.001
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  133 bits (336), Expect = 4e-37
 Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 22/200 (11%)

Query: 105 LGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G  Y       G  VA++ +        ++ + S+   + +E+E+L  L H N+
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII-------KKEDSSSLLEELLREIEILKKLNHPNI 53

Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           + L     + +  YLV +Y + GSL+   D ++EN+ +L  +  LRI + +++GL+YLH 
Sbjct: 54  VKLYGVFEDENHLYLVMEYCEGGSLK---DLLKENEGKLSEDEILRILLQILEGLEYLHS 110

Query: 224 TCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAKLMPG------SLIATSAYSAPECFQN 276
                I+H +LKP N++LD+     +LADFGL+KL+        +++ T AY APE    
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167

Query: 277 R-SYTDKSDIFSFGMILAVL 295
           +  Y++KSDI+S G+IL  L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  131 bits (332), Expect = 5e-36
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R LGS   G  Y+      G  VAV+ +          +     +  ++E+ +L  L H 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKIL------KKRSEKSKKDQTARREIRILRRLSHP 58

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L     +    YLV +Y + G L    D +      L  +   +IA+ +++GL+YL
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDL---FDYLSRGG-PLSEDEAKKIALQILRGLEYL 114

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------PGSLIATSAYSAPE-CF 274
           H   +  I+H +LKP N++LD     ++ADFGLAK +        + + T  Y APE   
Sbjct: 115 H---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL 171

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE-ALD 333
               Y  K D++S G+IL  LLTG+    PF                        +  L 
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK---PPF-----------------SGENILDQLQLI 211

Query: 334 RSILGEEVEEDE------MLMAVRIAVVCLSDSPADRPSSDELV 371
           R ILG  +E DE         A  +   CL+  P+ RP+++E++
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  127 bits (322), Expect = 1e-34
 Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 22/195 (11%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
             G  VA++ +        +K+ K  + RI +E+++L  L+H N++ L     +  + YL
Sbjct: 22  KTGKLVAIKVI-------KKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYL 74

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V +Y + G L    D +++       E R      ++  L+YLH   +  I+H +LKP N
Sbjct: 75  VMEYCEGGDL---FDLLKKRGRLSEDEAR-FYLRQILSALEYLH---SKGIVHRDLKPEN 127

Query: 239 VMLDAEFTPRLADFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILA 293
           ++LD +   +LADFGLA+ +       + + T  Y APE    + Y    DI+S G+IL 
Sbjct: 128 ILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILY 187

Query: 294 VLLTGRDPTAPFFAE 308
            LLTG+    PF  +
Sbjct: 188 ELLTGK---PPFPGD 199

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  119 bits (300), Expect = 2e-29
 Identities = 78/293 (26%), Positives = 135/293 (46%), Gaps = 26/293 (8%)

Query: 85  FSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSV 144
            S  I    + ++L  EN +        Y    + NG+   V+ +    S          
Sbjct: 679 VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS------- 731

Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
                 E+  +  L+H N++ L          YL+++Y++  +L + +         L W
Sbjct: 732 -----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSW 779

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPGSL 262
           E R +IA+G+ K L++LH  C+P ++  NL P  +++D +  P L    L  L       
Sbjct: 780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKC 838

Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
             +SAY APE  + +  T+KSDI+ FG+IL  LLTG+ P     AE    GS+  W R+ 
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYC 895

Query: 323 QHAGEAREALDRSILGE-EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
                    +D SI G+  V ++E++  + +A+ C +  P  RP +++++  L
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  101 bits (255), Expect = 6e-25
 Identities = 44/189 (23%), Positives = 86/189 (45%), Gaps = 20/189 (10%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           GK         + VAV+ ++     + E+Q         +E  ++  L H N++ L    
Sbjct: 18  GKLKGKGGKKKVEVAVKTLKE---DASEQQ----IEEFLREARIMRKLDHPNVVKLLGVC 70

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            E    Y+V +Y++ G L      +R+N+ +L     L  A+ + +G++YL    +   +
Sbjct: 71  TEEEPLYIVMEYMEGGDLLS---YLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNFI 124

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQNRSYTDKS 283
           H +L   N ++      +++DFGL++ +                + APE  +   +T KS
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKS 184

Query: 284 DIFSFGMIL 292
           D++SFG++L
Sbjct: 185 DVWSFGVLL 193

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =   99 bits (250), Expect = 3e-24
 Identities = 66/282 (23%), Positives = 119/282 (42%), Gaps = 57/282 (20%)

Query: 106 GSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           GSS  G  Y+      G   A++++           ++  ++++ +EL+ L S     ++
Sbjct: 12  GSS--GVVYKVRHKPTGKIYALKKIHVDG-------DEEFRKQLLRELKTLRSCESPYVV 62

Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDR---IRENQLQLGWEVRLRIAVGVIKGLQYL 221
                  +     +V +Y+  GSL D + +   I E  L         IA  ++KGL YL
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKGLDYL 115

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQ 275
           H   +  I+H ++KP+N++++++   ++ADFG++K++  +L      + T  Y +PE  Q
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
             SY+  +DI+S G+ L     G+ P  P        G    +             L ++
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLP-------PGQPSFF------------ELMQA 214

Query: 336 ILGEEVEE-------DEMLMAVRIAVVCLSDSPADRPSSDEL 370
           I               E    +     CL   P  RPS+ EL
Sbjct: 215 ICDGPPPSLPAEEFSPEFRDFISA---CLQKDPKKRPSAAEL 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =   99 bits (250), Expect = 3e-24
 Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 27/196 (13%)

Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES 173
            +        VAV+ ++   S       +  ++   +E  V+  L H N++ L     E 
Sbjct: 16  LKGKDGKTTEVAVKTLKEDAS-------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68

Query: 174 SRFYLVYDYLQTGSLEDAMDRIRENQLQ-----LGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
              YLV +Y++ G L D + + R          L  +  L  A+ + KG++YL    + +
Sbjct: 69  EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKK 125

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS--------APECFQNRSYT 280
            +H +L   N ++  +   +++DFGL++ +                   APE  ++  +T
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFT 185

Query: 281 DKSDIFSFGMILAVLL 296
            KSD++SFG    VLL
Sbjct: 186 SKSDVWSFG----VLL 197

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 51/170 (30%), Positives = 91/170 (53%), Gaps = 9/170 (5%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRA--YVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           N  ++++I +ELE+  S +   ++          SS   +  +Y + GSL+    ++++ 
Sbjct: 39  NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----L 254
             ++G +V  +IA  V+KGL YLH   + +I+H ++KP+N++L  +   +L DFG    L
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155

Query: 255 AKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
              + G+   TS Y APE  Q + Y+  SD++S G+ L  +   R P  P
Sbjct: 156 VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  100 bits (250), Expect = 1e-23
 Identities = 79/286 (27%), Positives = 120/286 (41%), Gaps = 35/286 (12%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-R 161
           R LG    G+ Y    D    VA++ +         +       R  +E+++LASL H  
Sbjct: 6   RKLGEGSFGEVYL-ARDR-KLVALKVLA-----KKLESKSKEVERFLREIQILASLNHPP 58

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L  +  +    YLV +Y+  GSLED + +    +  L     L I   ++  L+YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 222 HFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKLMPG------------SLIATSAY 268
           H      I+H ++KP N++LD +    +L DFGLAKL+P             + + T  Y
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 269 SAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA 325
            APE          +  SDI+S G+ L  LLTG     PF  E  S  +     + L+  
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP---PFEGEKNSSAT----SQTLKII 227

Query: 326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
            E       S L     E     A  +    L+  P +R SS   +
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 97.2 bits (243), Expect = 3e-23
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 61/288 (21%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           + +G    GK Y      +G    ++ ++   S   EK+    +     E+++L  L H 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDL--SNMSEKE----REDALNEVKILKKLNHP 59

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR-------IRENQLQLGWEVRLRIAVGV 214
           N++       E  +  +V +Y   G L   + +         E Q+ L W V+L +A   
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWFVQLCLA--- 115

Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------LIATSAY 268
              L+YLH   + +ILH ++KP N+ L +    +L DFG++K++  +      ++ T  Y
Sbjct: 116 ---LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169

Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA 328
            +PE  QN+ Y  KSDI+S G +L  L T +    PF                    GE 
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLK---HPF-------------------EGEN 207

Query: 329 REALDRSILGEEVEE------DEMLMAVRIAVVCLSDSPADRPSSDEL 370
              L   IL  +          E+   V      L   P +RPS  ++
Sbjct: 208 LLELALKILKGQYPPIPSQYSSELRNLVSS---LLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 96.1 bits (240), Expect = 7e-23
 Identities = 45/194 (23%), Positives = 84/194 (43%), Gaps = 25/194 (12%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           G          + VAV+ ++     + E+Q +       +E  ++  L H N++ L    
Sbjct: 18  GTLKGKGDGKEVEVAVKTLK---EDASEQQIEE----FLREARIMRKLDHPNIVKLLGVC 70

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQ-LGWEVRLRIAVGVIKGLQYLHFTCNPQI 229
            E     +V +Y+  G L D    +R+N+ + L     L  A+ + +G++YL    +   
Sbjct: 71  TEEEPLMIVMEYMPGGDLLD---YLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNF 124

Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-------APECFQNRSYTDK 282
           +H +L   N ++      +++DFGL++ +                  APE  +   +T K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184

Query: 283 SDIFSFGMILAVLL 296
           SD++SFG    VLL
Sbjct: 185 SDVWSFG----VLL 194

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 30/213 (14%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
            LLG    G  Y     D G  +AV+ VE     S E+        +++E+ +L+SL+H 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEEL-----EALEREIRILSSLQHP 59

Query: 162 NLMS-LRAYVPESSRFYLVY-DYLQTGSLEDAMDR---IRENQLQLGWEVRLRIAVGVIK 216
           N++    +   E      ++ +Y+  GSL   + +   + E  ++       +    +++
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIR-------KYTRQILE 112

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MPGSLIATSAY 268
           GL YLH   +  I+H ++K  N+++D++   +LADFG AK           GS+  T  +
Sbjct: 113 GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            APE  +   Y   +DI+S G  +  + TG+ P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.4 bits (235), Expect = 4e-22
 Identities = 71/296 (23%), Positives = 126/296 (42%), Gaps = 41/296 (13%)

Query: 103 RLLGSSPDGKYYRTVLDN-----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS 157
           + LG    GK      D      G  VAV+ +            +  +   ++E+E+L +
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-------SGEEQHRSDFEREIEILRT 62

Query: 158 LRHRNLMSLR--AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
           L H N++  +     P      L+ +YL +GSL D +   + ++ Q+  +  L  +  + 
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQIC 119

Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------ 269
           KG+ YL    + + +H +L   N+++++E   +++DFGLAK++P                
Sbjct: 120 KGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 270 ---APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA---PFFAEAASGGSLGRWLRHLQ 323
              APEC +   ++  SD++SFG+ L  L T  DP+      F            +  L 
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 324 HAGEAREALDR-SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH 378
              +  E L R     +EV     LM      +C    P DRPS  +L+ ++ +L 
Sbjct: 237 ELLKEGERLPRPPSCPDEV---YDLM-----KLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 93.3 bits (233), Expect = 7e-22
 Identities = 43/190 (22%), Positives = 89/190 (46%), Gaps = 21/190 (11%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           G            VAV+ ++    G+ E++    +    +E  ++  L H N++ L    
Sbjct: 18  GTLKGDGEGTETKVAVKTLKE---GASEEE----REEFLEEASIMKKLSHPNIVRLLGVC 70

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +    Y+V +Y+  G L D    +R++  +L  +  L++A+ + KG++YL    +   +
Sbjct: 71  TQGEPLYIVTEYMPGGDLLD---FLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNFV 124

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSYTDK 282
           H +L   N ++      +++DFGL++ +                 + APE  ++  +T K
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSK 184

Query: 283 SDIFSFGMIL 292
           SD++SFG++L
Sbjct: 185 SDVWSFGVLL 194

Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 29/217 (13%)

Query: 116 TVLDNGLTVAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES 173
              + G TVA+++V     E G P        R    E++ L + +H  ++ L    P  
Sbjct: 20  KDRETGETVALKKVALRRLEGGIPN----QALR----EIKALQACQHPYVVKLLDVFPHG 71

Query: 174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
           S F LV +Y+ +  L + + R  E  L    +V+      ++KG+ Y+H      I+H +
Sbjct: 72  SGFVLVMEYMPS-DLSEVL-RDEERPLPEA-QVK-SYMRMLLKGVAYMH---ANGIMHRD 124

Query: 234 LKPTNVMLDAEFTPRLADFGLAKLM-------PGSLIATSAYSAPEC-FQNRSYTDKSDI 285
           LKP N+++ A+   ++ADFGLA+L            +AT  Y APE  +  R Y    D+
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDL 184

Query: 286 FSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
           ++ G I A LL G    +P F        L    R L
Sbjct: 185 WAVGCIFAELLNG----SPLFPGENDIEQLAIVFRTL 217

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 56/190 (29%), Positives = 101/190 (53%), Gaps = 20/190 (10%)

Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY 180
           G  +AV+ +         + N++++++I +EL++L       ++        +    +  
Sbjct: 26  GKIMAVKTIRL-------EINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78

Query: 181 DYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           +Y+  GSL+  +  ++    +  LG     +IAV V+KGL YLH     +I+H ++KP+N
Sbjct: 79  EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--EKHKIIHRDVKPSN 131

Query: 239 VMLDAEFTPRLADFGLAKLMPGSL----IATSAYSAPECFQNRSYTDKSDIFSFGMILAV 294
           +++++    +L DFG++  +  SL    + TS+Y APE  Q   Y+ KSDI+S G+ L  
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191

Query: 295 LLTGRDPTAP 304
           L TGR P  P
Sbjct: 192 LATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 24/196 (12%)

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
              G  VA++++          +++ + +   +E+++L  L H N++ L          Y
Sbjct: 21  KLTGEIVAIKKI------KLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           LV++++ T    D    I++ Q  L   +       +++GL + H   +  ILH +LKP 
Sbjct: 75  LVFEFMDT----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPE 127

Query: 238 NVMLDAEFTPRLADFGLAKLMPGS------LIATSAYSAPEC-FQNRSYTDKSDIFSFGM 290
           N++++ E   +LADFGLA+            + T  Y APE    ++ Y+   DI+S G 
Sbjct: 128 NLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGC 187

Query: 291 ILAVLLTGRDPTAPFF 306
           I A LL+ R    P F
Sbjct: 188 IFAELLSRR----PLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 90.7 bits (226), Expect = 6e-21
 Identities = 50/193 (25%), Positives = 97/193 (50%), Gaps = 31/193 (16%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS-LRAYVPESSRFYL 178
            G  VA++ +        E + K  K +I  E+++L   +H N++    +Y+ +    ++
Sbjct: 24  TGKEVAIKVI------KLESKEK--KEKIINEIQILKKCKHPNIVKYYGSYLKKDEL-WI 74

Query: 179 VYDYLQTGSLEDAMD----RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
           V ++   GSL+D +      + E+Q+         +   ++KGL+YLH   +  I+H ++
Sbjct: 75  VMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKGLEYLH---SNGIIHRDI 124

Query: 235 KPTNVMLDAEFTPRLADFGLAKLM-----PGSLIATSAYSAPECFQNRSYTDKSDIFSFG 289
           K  N++L ++   +L DFGL+  +       +++ T  + APE    + Y  K+DI+S G
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184

Query: 290 MILAV-LLTGRDP 301
            I A+ L  G+ P
Sbjct: 185 -ITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.2 bits (224), Expect = 9e-21
 Identities = 47/155 (30%), Positives = 87/155 (56%), Gaps = 7/155 (4%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E+ +LAS+ H N++S +    + ++  +V +Y   G L  A+ + ++ +  +  +   RI
Sbjct: 49  EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL----IATS 266
            + +++GLQ LH     +ILH +LK  N++L A    ++ D G++K++  ++    I T 
Sbjct: 109 FIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTP 165

Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            Y APE ++ R Y+ KSDI+S G +L  + T   P
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 29/241 (12%)

Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+++I +EL+++   R   ++S        +   +  +++  GSL    DRI +    +
Sbjct: 45  SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPI 100

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
             E+  +IAV V++GL YL+     +I+H ++KP+N+++++    +L DFG++  +  S+
Sbjct: 101 PVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158

Query: 263 ----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRW 318
               + TS Y +PE  Q   YT KSD++S G+ +  L  G+ P A  F+     G     
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDDDGQDDPM 216

Query: 319 --LRHLQHAGEAREALDRSILGEEV----EEDEMLMAVRIAVVCLSDSPADRPSSDELVP 372
             L  LQ            I+ E        D           CL   P +RP+  +L  
Sbjct: 217 GILDLLQQ-----------IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265

Query: 373 M 373
           M
Sbjct: 266 M 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 41/278 (14%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
            LLGS   G  Y  + LD+G   AV+ V   + G   +  +   ++++QE+ +L+ L+H 
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG---QTGQEAVKQLEQEIALLSKLQHP 62

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR---IRENQLQLGWEVRLRIAVGVIKGL 218
           N++       E    Y+  + +  GSL   + +     E  ++L           ++ GL
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-------QILLGL 115

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL-----MPGSLIATSAYSAPE- 272
           +YLH   +   +H ++K  N+++D     +LADFG+AK         S   +  + APE 
Sbjct: 116 EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL 332
             Q   Y   +DI+S G  +  + TG+ P +     AA           +   G ++E  
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----------VFKIGRSKEL- 220

Query: 333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
                   + +     A    + CL   P+ RP++ EL
Sbjct: 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 12/159 (7%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I  E E+L    H  ++ L     +    Y++ +Y   G L      +R+  L   +  R
Sbjct: 40  IFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL---WTILRDRGLFDEYTAR 96

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-----SL 262
             IA  V+   +YLH   N  I++ +LKP N++LD+    +L DFG AK +       + 
Sbjct: 97  FYIA-CVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152

Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             T  Y APE   N+ Y    D +S G++L  LLTGR P
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 29/230 (12%)

Query: 151 ELEVLASLRHRNLMSL--RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           E+ +L  L+H N++    R     +   Y+V +Y + G L   + + ++ +  +  E   
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 209 RIAVGVIKGLQYLHF--TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL---- 262
           RI   ++  L   H        +LH +LKP N+ LDA    +L DFGLAK++        
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 263 --IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR 320
             + T  Y +PE   + SY +KSDI+S G ++  L        PF   A +         
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS---PPF--TARN--------- 214

Query: 321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
            LQ A + +E   R I      E   L  V I    L+  P  RPS++EL
Sbjct: 215 QLQLASKIKEGKFRRIPYRYSSE---LNEV-IK-SMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 49/196 (25%), Positives = 100/196 (51%), Gaps = 19/196 (9%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           R LGS   G+ +  +  N + VA++ +++         +   ++  Q+E++ L  LRH++
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVRVAIKILKS--------DDLLKQQDFQKEVQALKRLRHKH 63

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+SL A        Y++ + ++ GSL   +       L +     + +A  V +G+ YL 
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV--ASLIDMACQVAEGMAYLE 121

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA------YSAPECFQN 276
                  +H +L   N+++  +   ++ADFGLA+L+   +  +S       ++APE   +
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178

Query: 277 RSYTDKSDIFSFGMIL 292
            +++ KSD++SFG++L
Sbjct: 179 GTFSTKSDVWSFGILL 194

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 104 LLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           L+G    G  Y+ + L+ G  VA++++      S EK  +   + I QE+++L +L+H N
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQI------SLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           ++     +  S   Y++ +Y + GSL           E+ +             V++GL 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-------VYVYQVLQGLA 113

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSLIATSAYSAPEC 273
           YLH      ++H ++K  N++   +   +LADFG+A           S++ T  + APE 
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV 170

Query: 274 FQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            +    +  SDI+S G  +  LLTG  P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 84.5 bits (209), Expect = 9e-19
 Identities = 51/173 (29%), Positives = 98/173 (56%), Gaps = 26/173 (15%)

Query: 136 SPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI 195
           SP+++ +S     ++E+ VL++++H N++  +    E+   Y+V DY + G L   ++  
Sbjct: 39  SPKEREES-----RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ 93

Query: 196 R-----ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
           R     E+Q+ L W V++ +A      L+++H   + +ILH ++K  N+ L  + T +L 
Sbjct: 94  RGVLFPEDQI-LDWFVQICLA------LKHVH---DRKILHRDIKSQNIFLTKDGTIKLG 143

Query: 251 DFGLAKLMPGSL------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           DFG+A+++  ++      I T  Y +PE  +NR Y +KSDI++ G +L  + T
Sbjct: 144 DFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.7 bits (208), Expect = 1e-18
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 19/180 (10%)

Query: 138 EKQNKSVKRRIQQ---ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR 194
           +K+    ++ ++    E  +L+ + H  ++ L        + YLV +Y   G L   +  
Sbjct: 27  KKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHL-- 84

Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
               + +   E     A  ++  L+YLH   +  I++ +LKP N++LDA+   +L DFGL
Sbjct: 85  --SKEGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGL 139

Query: 255 AKLMP------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           AK +        +   T  Y APE    + Y    D +S G++L  +LTG+    PF+AE
Sbjct: 140 AKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK---PPFYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 7e-18
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 28/213 (13%)

Query: 103 RLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS 157
           ++LGS   G  Y+ V         + VA++ +   E  SP+   +     I  E  V+AS
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKE-----ILDEAYVMAS 65

Query: 158 LRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
           + H +++ L      SS+  L+   +  G L   +D +R ++  +G +  L   V + KG
Sbjct: 66  VDHPHVVRLLGICL-SSQVQLITQLMPLGCL---LDYVRNHKDNIGSQYLLNWCVQIAKG 121

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSA-----YS 269
           + YL      +++H +L   NV++      ++ DFGLAKL+        A        + 
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           A E   +R YT KSD++S+G+ +  L+T G  P
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 81.9 bits (202), Expect = 9e-18
 Identities = 53/176 (30%), Positives = 93/176 (52%), Gaps = 22/176 (12%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
            K     K   ++E+ +LA ++H N+++  A   E+ R ++V +Y   G L   ++R R 
Sbjct: 36  TKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG 95

Query: 197 ----ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLAD 251
               E+Q+ L W V++ +      GL+++H   + +ILH ++K  N+ L       +L D
Sbjct: 96  VLFSEDQI-LSWFVQISL------GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGD 145

Query: 252 FGLAKLMPGSL------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           FG+A+ +  S+      + T  Y +PE  QNR Y +K+DI+S G +L  L T + P
Sbjct: 146 FGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 18/164 (10%)

Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE---DAMDRIRENQLQL 202
           R +  E  +L  L H  L++L     +    YLV D L  G L        +  E Q++ 
Sbjct: 45  RNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF 104

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-KLMPGS 261
                      ++  L+YLH   +  I+H ++KP N++LD +    + DF +A K+ P +
Sbjct: 105 -------WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154

Query: 262 LI----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           L      T  Y APE    + Y+   D +S G+     L G+ P
Sbjct: 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 59/285 (20%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
           + G  VA+++    ES    + +K VK+   +E+ +L  LRH NL++L        R YL
Sbjct: 24  ETGQIVAIKKF--LES----EDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V++++    L+D    + +    L      +    +++G+++ H   +  I+H ++KP N
Sbjct: 78  VFEFVDHTVLDD----LEKYPNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPEN 130

Query: 239 VMLDAEFTPRLADFGLAKLM--PGSL----IATSAYSAPECF-QNRSYTDKSDIFSFGMI 291
           +++      +L DFG A+ +  PG +    +AT  Y APE    +  Y    DI++ G +
Sbjct: 131 ILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCL 190

Query: 292 LAVLLTGRDPTAPFFAEAASGGS-----------LGRWLRHLQHAGEAREALDRSILGE- 339
           +  +LTG +P  P       G S           LG  +   Q      E   ++ L   
Sbjct: 191 VTEMLTG-EPLFP-------GDSDIDQLYHIIKCLGNLIPRHQ------EIFQKNPLFAG 236

Query: 340 ----EVEEDEML---------MAVRIAVVCLSDSPADRPSSDELV 371
               EV+E E L         + + +A  CL   P DRPSS +L+
Sbjct: 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 72/269 (26%), Positives = 119/269 (44%), Gaps = 46/269 (17%)

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           L N   VA++R++       EK   SV   +++E++ ++   H N++            +
Sbjct: 23  LPNNEKVAIKRIDL------EKCQTSVDE-LRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV---GVIKGLQYLHFTCNPQILHYNL 234
           LV  YL  GSL D M          G      IA     V+KGL+YLH   N QI H ++
Sbjct: 76  LVMPYLSGGSLLDIMKSS----YPRGGLDEAIIATVLKEVLKGLEYLH--SNGQI-HRDI 128

Query: 235 KPTNVMLDAEFTPRLADFGLA----------KLMPGSLIATSAYSAPECF-QNRSYTDKS 283
           K  N++L  + + ++ADFG++          + +  + + T  + APE   Q   Y  K+
Sbjct: 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA 188

Query: 284 DIFSFGMILAV-LLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVE 342
           DI+SFG I A+ L TG  P + +         +   +  LQ+        D   L    +
Sbjct: 189 DIWSFG-ITAIELATGAAPYSKYPP-------MKVLMLTLQN--------DPPSLETGAD 232

Query: 343 EDEMLMAVRIAVV-CLSDSPADRPSSDEL 370
             +   + R  +  CL   P+ RP+++EL
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEEL 261

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.9 bits (198), Expect = 6e-17
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 37/204 (18%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
           + G  VA+++++    G  ++    +     +E+++L  L+H N++ L       S   L
Sbjct: 23  ETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK--------GLQYLHFTCNPQIL 230
           V+++++T  LE     I++          + +    IK        GL+YLH   +  IL
Sbjct: 80  VFEFMET-DLEKV---IKDK--------SIVLTPADIKSYMLMTLRGLEYLH---SNWIL 124

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPEC-FQNRSYTDKS 283
           H +LKP N+++ ++   +LADFGLA+            + T  Y APE  F  R Y    
Sbjct: 125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGV 184

Query: 284 DIFSFGMILAVLLTGRDPTAPFFA 307
           D++S G I A LL       PF  
Sbjct: 185 DMWSVGCIFAELLLRV----PFLP 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 43/282 (15%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +G    GK Y  V LD G  +AV+ +   +   P    K++K  I  E++VL  L+H 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDP----KTIKE-IADEMKVLELLKHP 59

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           NL+          + Y+  +Y   G+LE+ +    E+   L   V     + +++GL YL
Sbjct: 60  NLVKYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYL 115

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPG----SLIATSAYSAP 271
           H   +  I+H ++KP N+ LD     +L DFG A          G    SL  T AY AP
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172

Query: 272 ECFQNRSYTDK---SDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA 328
           E             +DI+S G ++  + TG+ P +    E      +G       H    
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-----AGHKPPI 227

Query: 329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
            ++L  S  G++  +            CL   P  RP++ EL
Sbjct: 228 PDSLQLSPEGKDFLDR-----------CLESDPKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 50/197 (25%), Positives = 92/197 (46%), Gaps = 25/197 (12%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
             G  VA+++ +  E       ++ VK+   +E++VL  LRH N+++L+       R YL
Sbjct: 24  ATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V++Y++   LE     +  +   L  +        +++ + Y H   +  I+H ++KP N
Sbjct: 78  VFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPEN 130

Query: 239 VMLDAEFTPRLADFGLAKLMPG-------SLIATSAYSAPECF-QNRSYTDKSDIFSFGM 290
           +++      +L DFG A+ +           +AT  Y APE    + +Y    D+++ G 
Sbjct: 131 ILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGC 190

Query: 291 ILAVLLTGRDPTAPFFA 307
           I+A LL G     P F 
Sbjct: 191 IMAELLDGE----PLFP 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 8/167 (4%)

Query: 131 AFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED 190
           AF     E+ +KS+   + +   +   LRH N++       E+ R Y+V D ++   L +
Sbjct: 40  AFGKDKRER-DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE 98

Query: 191 AMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
             + ++E + +   E    I V ++  L+YLH     +I+H +L P N+ML  +    + 
Sbjct: 99  HFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTIT 156

Query: 251 DFGLAKLMP-----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           DFGLAK         S++ T  YS PE  +N  Y +K+D+++FG IL
Sbjct: 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCIL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.7 bits (195), Expect = 3e-16
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 37/205 (18%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRA--YVPESSRF 176
             G  VA++++           +    +RI +E+++L  LRH N++ L      P    F
Sbjct: 23  RTGRKVAIKKISNVF------DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76

Query: 177 ---YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
              Y+V + ++T    D + ++ ++   L  +        +++GL+YLH + N  ++H +
Sbjct: 77  NDVYIVTELMET----D-LHKVIKSPQPLTDDHIQYFLYQILRGLKYLH-SAN--VIHRD 128

Query: 234 LKPTNVMLDAEFTPRLADFGLAKLM------PGSL---IATSAYSAPE---CFQNRSYTD 281
           LKP+N+++++    ++ DFGLA+ +       G L   + T  Y APE         YT 
Sbjct: 129 LKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR--YTK 186

Query: 282 KSDIFSFGMILAVLLTGRDPTAPFF 306
             DI+S G I A LLT +    P F
Sbjct: 187 AIDIWSVGCIFAELLTRK----PLF 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)

Query: 181 DYLQTGSLEDAMD---RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +++  GSL+  +    RI EN L        +I++ V++GL YL      +I+H ++KP+
Sbjct: 79  EHMDGGSLDQVLKKAGRIPENILG-------KISIAVLRGLTYLRE--KHKIMHRDVKPS 129

Query: 238 NVMLDAEFTPRLADFG----LAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA 293
           N+++++    +L DFG    L   M  S + T +Y +PE  Q   YT +SDI+S G+ L 
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189

Query: 294 VLLTGRDPT--------APFFAEAASGGSLGRWLR 320
            +  GR P            F    S G      R
Sbjct: 190 EMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 5e-16
 Identities = 52/172 (30%), Positives = 88/172 (51%), Gaps = 16/172 (9%)

Query: 139 KQNKSVKRRIQQ---ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI 195
           K  K      Q    E  V+ +LRH NL+ L   V + +  Y+V +Y+  GSL D + R 
Sbjct: 35  KCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RS 93

Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA 255
           R   + +    +L  A+ V +G++YL        +H +L   NV++  +   +++DFGLA
Sbjct: 94  RGRAV-ITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149

Query: 256 KLMPGSLIATSA-----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           K    S    S      ++APE  + + ++ KSD++SFG++L  + + GR P
Sbjct: 150 K--EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 37/174 (21%)

Query: 151 ELEVLASLRHRNLMSLRAYV--PESSRFYLVYDYLQ---TGSLEDAMDRIRENQL----- 200
           E+++L  LRH N++ L+  V        Y+V++Y+    TG L+    +  E+Q+     
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK 107

Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-- 258
           QL            ++GLQYLH   +  ILH ++K +N++++ +   +LADFGLA+    
Sbjct: 108 QL------------LEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152

Query: 259 PGSLIATSA-----YSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
             S   T+      Y  PE       Y  + D++S G ILA L  G+    P F
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK----PIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 6e-16
 Identities = 57/222 (25%), Positives = 108/222 (48%), Gaps = 28/222 (12%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           +LLG    G+ Y    +D G  +AV++V  F+  SPE + +     ++ E+++L +L+H 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVP-FDPDSPETKKEV--NALECEIQLLKNLQHE 64

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ----LGWEVRLRIAVGVIKG 217
            ++     + +     +  +Y+  GS++D        QL+    L   V  +    +++G
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKD--------QLKAYGALTETVTRKYTRQILEG 116

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM---------PGSLIATSAY 268
           ++YLH   +  I+H ++K  N++ D+    +L DFG +K +           S+  T  +
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
            +PE      Y  K+D++S G  +  +LT + P A F A AA
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 29/208 (13%)

Query: 104 LLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
            LG    G  Y+ +  + G  VA++ V   E              I +E+ +L       
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE----------IIKEISILKQCDSPY 59

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV---GVIKGLQ 219
           ++       +++  ++V +Y   GS+ D M +I    L    E    IA      +KGL+
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLT---EEE--IAAILYQTLKGLE 113

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------PGSLIATSAYSAPEC 273
           YLH     + +H ++K  N++L+ E   +LADFG++  +        ++I T  + APE 
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 274 FQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            Q   Y +K+DI+S G+    +  G+ P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 25/167 (14%)

Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSR-----FYLVYDYLQTGSLEDAM--DRIRE 197
           +R  +EL +L  + H N++ L   + P SS       YLV   +    L + +   ++ +
Sbjct: 59  KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSD 117

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
           + +Q        +   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA  
Sbjct: 118 DHIQF-------LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167

Query: 256 --KLMPGSLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGR 299
               M G  +AT  Y APE   N   Y    DI+S G I+A LLTG+
Sbjct: 168 TDDEMTG-YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG---SLEDAMDRIRENQLQLGWEVR 207
           E  +L S+RH  L++L     + S  YLV +Y+  G   S      R  E   +      
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARF----- 105

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIA 264
              A  V+  L+YLH   +  I++ +LKP N++LD++   ++ DFG AK + G   +L  
Sbjct: 106 --YAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           T  Y APE   ++ Y    D ++ G+++  +L G     PFF +
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGY---PPFFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 34/197 (17%)

Query: 120 NGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVP-ESSR- 175
               VA++++ +AF       +N +  +R  +E+  L  L  H N++ L   +  E+ + 
Sbjct: 31  TKEVVALKKIFDAF-------RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83

Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILHYNL 234
            YLV++Y++T    D    IR N L+   +V  R I   ++K L+Y+H   +  ++H +L
Sbjct: 84  IYLVFEYMET----DLHAVIRANILE---DVHKRYIMYQLLKALKYIH---SGNVIHRDL 133

Query: 235 KPTNVMLDAEFTPRLADFGLAKL---MPGSL--------IATSAYSAPEC-FQNRSYTDK 282
           KP+N++L+++   +LADFGLA+    +  +         +AT  Y APE    +  YT  
Sbjct: 134 KPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKG 193

Query: 283 SDIFSFGMILAVLLTGR 299
            D++S G IL  +L G+
Sbjct: 194 VDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 74.2 bits (182), Expect = 4e-15
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL----EDAMDRIRENQLQLGW 204
           ++E  +LA ++H N+++ +         Y+V +Y   G L    +    ++      L W
Sbjct: 46  RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSL 262
            V++ + V      Q++H     ++LH ++K  N+ L      +L DFG A+L+  PG+ 
Sbjct: 106 FVQMCLGV------QHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156

Query: 263 ----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T  Y  PE ++N  Y +KSDI+S G IL  L T + P
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 51/210 (24%)

Query: 119 DNGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR-- 175
           +    VA++++  AF+       N+   +R  +E+++L  L H N+++++  +P   R  
Sbjct: 28  ETNEKVAIKKIANAFD-------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80

Query: 176 ---FYLVYDYLQTGSLEDAMDRIRENQ-----------LQLGWEVRLRIAVGVIKGLQYL 221
               Y+VY+ + T    D    IR +Q            QL     LR       GL+Y+
Sbjct: 81  FNDVYIVYELMDT----DLHQIIRSSQTLSDDHCQYFLYQL-----LR-------GLKYI 124

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQ 275
           H   +  +LH +LKP+N++L+A    ++ DFGLA+            + T  Y APE   
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 276 NRS-YTDKSDIFSFGMILAVLLTGRDPTAP 304
           N S YT   D++S G I A LL GR P  P
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 51/227 (22%)

Query: 104 LLGSSPDGKYYRTV-LDNGLTVAVRRVEAFE-SGSPEKQNKSVKRRIQQELEVLASLRHR 161
           L+GS   G  Y  +   +G  +AV++VE    S S + + +S+   + +E+ +L  L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 162 NLM-----SLRA--------YVPESSRFYLVYDYLQTGSLEDAMDR--IRENQLQLGWEV 206
           N++     SL A        YVP  S   L+ +Y   G+ E+ + R  +R+         
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQ--------- 114

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG------ 260
                  ++KGL YLH   N  I+H ++K  N+++D +   +++DFG++K +        
Sbjct: 115 -------ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164

Query: 261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                 SL  +  + APE  +  SYT K+DI+S G ++  +LTG+ P
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 73.8 bits (181), Expect = 7e-15
 Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 59/297 (19%)

Query: 104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESG--SPEKQNKSVKRRIQQELEVLASLRHR 161
           +LG    G  Y  + + G  +AV++VE   S   + EK+      ++Q+E+++L SL+H 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE----YEKLQEEVDLLKSLKHV 62

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++       + +   +  +++  GS+   ++R       L   V  +    ++ G+ YL
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYL 118

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL------------MPGSLIATSAYS 269
           H  C   ++H ++K  NVML      +L DFG A+             M  S+  T  + 
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGR------DPTAPFFAEAASGGSLGRWLRHLQ 323
           APE      Y  KSDI+S G  +  + TG+      D  A  F   A  G + R      
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235

Query: 324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF 380
            A                       A+     CL+    +RPS+ +L+      H F
Sbjct: 236 AA-----------------------AIDFVTSCLTRDQHERPSALQLLR-----HDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 44/166 (26%), Positives = 85/166 (51%), Gaps = 10/166 (6%)

Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL+  +   +    ++
Sbjct: 45  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK----RI 100

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             E+  ++++ V++GL YL      QI+H ++KP+N+++++    +L DFG    L   M
Sbjct: 101 PEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158

Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  L  GR P  P
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 104 LLGSSPDGKYYRTV-LDNGLTVAVRRVE--AFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           L+G    G+ Y  + +  G  +AV++VE  A  +G  + + K + + ++ E+E L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            N++    +        +  +Y+  GS+   +      + QL   VR      V++GL Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQVLEGLAY 123

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------------LMPGSLIATSAY 268
           LH   +  ILH +LK  N+++DA+   +++DFG++K             M GS+     +
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF----W 176

Query: 269 SAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDP 301
            APE   +  + Y+ K DI+S G ++  +  GR P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 73.3 bits (180), Expect = 7e-15
 Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 105 LGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           +G    G  ++ V   +    A+++++        K N+  +     E  VLA L    +
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDL------SKMNRREREEAIDEARVLAKLDSSYI 61

Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--QLGWEVRLRIAVGVIKGLQYL 221
           +       +  +  +V +Y + G L   +   R   L     W    R  + ++ GL +L
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHL 117

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------LIATSAYSAPECFQ 275
           H   + +ILH ++K  N+ LDA    ++ D G+AKL+  +      ++ T  Y +PE  +
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDP 301
           ++ Y +KSD+++ G++L    TG+ P
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 27/196 (13%)

Query: 120 NGLTVAVR--RVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
            G  VA++  R+E  + G P     S   R   E+ +L  L H N++ L   V   ++ Y
Sbjct: 23  TGEIVALKKIRLETEDEGVP-----STAIR---EISLLKELNHPNIVRLLDVVHSENKLY 74

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           LV+++L    L+  MD        L   +       +++G+ Y H   + ++LH +LKP 
Sbjct: 75  LVFEFLDL-DLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQ 128

Query: 238 NVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPEC-FQNRSYTDKSDIFSFGM 290
           N+++D E   +LADFGLA+     +      + T  Y APE    +R Y+   DI+S G 
Sbjct: 129 NLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGC 188

Query: 291 ILAVLLTGRDPTAPFF 306
           I A ++  R    P F
Sbjct: 189 IFAEMVNRR----PLF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 45/297 (15%)

Query: 103 RLLGSSPDGK--YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           R+LG    GK   Y     N  T  +  V+  +    ++     K    +E+ +L +L H
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK----KEINILKTLYH 65

Query: 161 RNLMSLRAYVPESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
            N++  +    E       L+ +Y+  GSL D + + + N  QL     L  A  + +G+
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGM 120

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSLI--------ATSAYS 269
            YLH   +   +H +L   NV+LD +   ++ DFGLAK +P G           +   + 
Sbjct: 121 AYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR 329
           A EC +   ++  SD++SFG+ L  LLT  D                   +  +  G  +
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDS------------KQSPPKKFEEMIGPKQ 225

Query: 330 EALDRSILGEEVEEDEML-------MAVRIAVV-CLSDSPADRPSSDELVPMLTQLH 378
             +    L E +E    L         V I +  C       RP+   L+P+L ++H
Sbjct: 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 22/157 (14%)

Query: 145 KRRIQQELEVLASLRHRNLMSLR-AYVPESSRFYLVYDYLQTGSL-----EDAMDRIREN 198
           ++  +QE ++L+ L+H N+++ R ++  E    Y+V  + + G L     E     + EN
Sbjct: 43  RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPEN 102

Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL- 257
           Q+ + W V++ +A      LQYLH      ILH +LK  NV L      ++ D G+A++ 
Sbjct: 103 QV-VEWFVQIAMA------LQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152

Query: 258 -----MPGSLIATSAYSAPECFQNRSYTDKSDIFSFG 289
                M  +LI T  Y +PE F N+ Y  KSD+++ G
Sbjct: 153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALG 189

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 49/194 (25%), Positives = 80/194 (41%), Gaps = 44/194 (22%)

Query: 138 EKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           EK+ K VK     E EVL  L  H  ++ L     +    Y V +Y   G L   + +  
Sbjct: 42  EKKVKYVKI----EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG 97

Query: 197 ---ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
              E   +         A  ++  L+YLH   +  I+H +LKP N++LD +   ++ DFG
Sbjct: 98  SLDEKCTRF-------YAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFG 147

Query: 254 LAKLMP--------------------------GSLIATSAYSAPECFQNRSYTDKSDIFS 287
            AK++                            S + T+ Y +PE    +     SD+++
Sbjct: 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207

Query: 288 FGMILAVLLTGRDP 301
            G I+  +LTG+ P
Sbjct: 208 LGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 54/173 (31%), Positives = 93/173 (53%), Gaps = 25/173 (14%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS-----RFYLVYDYLQT--GSLEDA 191
           Q++   +R  +EL +L  ++H N++ L   + P+ S      FYLV  ++ T  G L   
Sbjct: 53  QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK- 111

Query: 192 MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
            +++ E+++Q        +   ++KGL+Y+H      I+H +LKP N+ ++ +   ++ D
Sbjct: 112 HEKLSEDRIQF-------LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD 161

Query: 252 FGLAKL----MPGSLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
           FGLA+     M G ++ T  Y APE   N   YT   DI+S G I+A +LTG+
Sbjct: 162 FGLARQTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 41/265 (15%)

Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY 180
           G  +AV++V    + S E++   V   +++E+ ++A L H +++ +     E S F L  
Sbjct: 25  GTLMAVKQVTYVRNTSSEQEE--VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82

Query: 181 DYLQTGSLEDAMDR---IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +++  GS+   + +    +E        V +     +++GL YLH     QI+H ++K  
Sbjct: 83  EWMAGGSVSHLLSKYGAFKEA-------VIINYTEQLLRGLSYLH---ENQIIHRDVKGA 132

Query: 238 NVMLDAE-FTPRLADFGLAKLMP----------GSLIATSAYSAPECFQNRSYTDKSDIF 286
           N+++D+     R+ADFG A  +           G L+ T A+ APE  +   Y    D++
Sbjct: 133 NLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVW 192

Query: 287 SFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEM 346
           S G ++  + T +    P+ AE  S         HL    +   A     + E +     
Sbjct: 193 SVGCVIIEMATAK---PPWNAEKHSN--------HLALIFKIASATTAPSIPEHLSPGLR 241

Query: 347 LMAVRIAVVCLSDSPADRPSSDELV 371
            + +R    CL   P DRP S EL+
Sbjct: 242 DVTLR----CLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 77/266 (28%), Positives = 116/266 (43%), Gaps = 39/266 (14%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRA-YVP 171
           Y+   +     VA++++      S EK    +K     E+  L  LRH N +  +  Y+ 
Sbjct: 32  YFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-----EVRFLQQLRHPNTIEYKGCYLR 86

Query: 172 ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQIL 230
           E +  +LV +Y   GS  D ++ + +  LQ   EV +  I  G ++GL YLH   + + +
Sbjct: 87  EHTA-WLVMEYC-LGSASDILE-VHKKPLQ---EVEIAAICHGALQGLAYLH---SHERI 137

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSLIATSAYSAPE---CFQNRSYTDKSDI 285
           H ++K  N++L    T +LADFG A L+    S + T  + APE         Y  K D+
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 286 FSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDE 345
           +S G I  + L  R P  P F   A        +  L H  +     D   L      D 
Sbjct: 198 WSLG-ITCIELAERKP--PLFNMNA--------MSALYHIAQN----DSPTLSSNDWSDY 242

Query: 346 MLMAVRIAVVCLSDSPADRPSSDELV 371
               V     CL   P DRPSS+EL+
Sbjct: 243 FRNFVDS---CLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 15/172 (8%)

Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           ++++I  ELE+L       ++         +R  +  +++  GSL D   +I E+ L   
Sbjct: 42  LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLG-- 98

Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL- 262
                RIAV V+KGL YL    + +ILH ++KP+N++++     +L DFG++  +  S+ 
Sbjct: 99  -----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150

Query: 263 ---IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS 311
              + T+AY APE      Y   SD++S G+    L  GR P         S
Sbjct: 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 55/212 (25%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR---- 175
            G+ VA++++  FE       +++  +R  +E+++L   +H N++ +   +   S     
Sbjct: 29  TGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81

Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQL----------QLGWEVRLRIAVGVIKGLQYLHFT 224
             Y+V + ++T    D    I+   L          Q            +++GL+Y+H +
Sbjct: 82  DVYIVQELMET----DLYKLIKTQHLSNDHIQYFLYQ------------ILRGLKYIH-S 124

Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------PGSL---IATSAYSAPECFQ 275
            N  +LH +LKP+N++L+     ++ DFGLA++        G L   +AT  Y APE   
Sbjct: 125 AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182

Query: 276 N-RSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           N + YT   DI+S G ILA +L+ R    P F
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNR----PLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 60/273 (21%), Positives = 121/273 (44%), Gaps = 30/273 (10%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  T L +G+ VA+++V+ F+    + +   +K     E+++L  L H N++   A   E
Sbjct: 19  YRATCLLDGVPVALKKVQIFDLMDAKARADCIK-----EIDLLKQLNHPNVIKYYASFIE 73

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHY 232
            +   +V +    G L   +   ++ +  +  +   +  V +   L+++H   + +++H 
Sbjct: 74  DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHR 130

Query: 233 NLKPTNVMLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIF 286
           ++KP NV + A    +L D GL +          SL+ T  Y +PE      Y  KSDI+
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190

Query: 287 SFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEM 346
           S G +L  +   +   +PF+ +  +  SL + +          E  D   L  +   +E+
Sbjct: 191 SLGCLLYEMAALQ---SPFYGDKMNLYSLCKKI----------EQCDYPPLPSDHYSEEL 237

Query: 347 LMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
              V +   C++  P  RP    +  +  ++H+
Sbjct: 238 RQLVNM---CINPDPEKRPDITYVYDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 8e-14
 Identities = 49/167 (29%), Positives = 86/167 (51%), Gaps = 26/167 (15%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR----IRENQLQLGWEV 206
           E+ +L  L+H N++ L   +    + YLV++Y     L+  +D+    +  N ++     
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK----- 101

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPGSL-- 262
              I   +++GL Y H   + +ILH +LKP N++++ +   +LADFGLA+   +P     
Sbjct: 102 --SIMYQLLRGLAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156

Query: 263 --IATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
             + T  Y APE    ++ Y+   DI+S G I A ++TG+    P F
Sbjct: 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK----PLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.4 bits (172), Expect = 9e-14
 Identities = 49/169 (28%), Positives = 87/169 (51%), Gaps = 14/169 (8%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAY-VPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           +N +  +    E  V+  LRH NL+ L    V E    Y+V +Y+  GSL D + R R  
Sbjct: 38  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGR 96

Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
            + LG +  L+ ++ V + ++YL        +H +L   NV++  +   +++DFGL K  
Sbjct: 97  SV-LGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-- 150

Query: 259 PGSLIATSA-----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
             S    +      ++APE  + + ++ KSD++SFG++L  + + GR P
Sbjct: 151 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 11/166 (6%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           E+  K  +   Q E +VL  L H N++       E     +V +Y   G+L + + + R 
Sbjct: 36  EQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RC 94

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAK 256
           N L L  +  L   V ++  L ++H      ILH +LK  N++LD      ++ DFG++K
Sbjct: 95  NSL-LDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150

Query: 257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++       +++ T  Y +PE  + + Y  KSDI++ G +L  L +
Sbjct: 151 ILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 30/205 (14%)

Query: 111 GKYYRTVLDNGLTVAVR--RVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRA 168
           G+  +T    G  VA++  R+E+ E G P     S   R   E+ +L  L+H N++ L+ 
Sbjct: 19  GRNKKT----GQIVAMKKIRLESEEEGVP-----STAIR---EISLLKELQHPNIVCLQD 66

Query: 169 YVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
            + + SR YL++++L    L+  +D + + Q  +  E+       +++G+ + H   + +
Sbjct: 67  VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQ-YMDAELVKSYLYQILQGILFCH---SRR 121

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPGSL----IATSAYSAPECFQNRS-YTD 281
           +LH +LKP N+++D +   +LADFGLA+   +P  +    + T  Y APE       Y+ 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181

Query: 282 KSDIFSFGMILAVLLTGRDPTAPFF 306
             DI+S G I A + T +    P F
Sbjct: 182 PVDIWSIGTIFAEMATKK----PLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 10/166 (6%)

Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 45  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 100

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 101 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158

Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 53/172 (30%), Positives = 90/172 (52%), Gaps = 24/172 (13%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESS-----RFYLVYDYLQTGSLEDAM- 192
           Q++   +R  +EL +L  ++H N++ L   +    S      FYLV  Y+QT  L+  M 
Sbjct: 53  QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG 111

Query: 193 DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
             + E+++Q        +   ++ GL+Y+H   +  I+H +LKP N+ ++ +   ++ DF
Sbjct: 112 HPLSEDKVQY-------LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDF 161

Query: 253 GLAKL----MPGSLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
           GLA+     M G ++ T  Y APE   N   Y    DI+S G I+A +LTG+
Sbjct: 162 GLARHADAEMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 49/180 (27%), Positives = 92/180 (51%), Gaps = 21/180 (11%)

Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYLVYDYLQTG 186
           V++ +  S       +K+    E+E+L +L H N++  +    E   +   L+ ++L +G
Sbjct: 38  VKSLKPESGGNHIADLKK----EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93

Query: 187 SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT 246
           SL++ + R   N+ ++  + +L+ AV + KG+ YL    + Q +H +L   NV++++E  
Sbjct: 94  SLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147

Query: 247 PRLADFGLAK---------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            ++ DFGL K          +   L +   + APEC     +   SD++SFG+ L  LLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 44/195 (22%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL----------QTGS 187
           +   K+   ++  E ++L+  +   ++ L          YLV +YL            GS
Sbjct: 30  DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89

Query: 188 LEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP 247
           L++ + RI                  ++  L+YLH   +  I+H +LKP N+++D+    
Sbjct: 90  LDEDVARI--------------YIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHL 132

Query: 248 RLADFGLAK-------LMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILA 293
           +L DFGL+K       +           ++ T  Y APE    + ++   D +S G IL 
Sbjct: 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILY 192

Query: 294 VLLTGRDPTAPFFAE 308
             L G     PF  E
Sbjct: 193 EFLVG---IPPFHGE 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 43/282 (15%)

Query: 103 RLLGSSPDGK--YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           R+LG    G+   YR   D+ L V  + V        E+      R    E+ +L+ L+H
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKER------RDALNEIVILSLLQH 58

Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            N+++   +  + +   +  +Y   G+L D +  +R+       E+ L     ++  + Y
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPGSLIATSAYSAPECF 274
           +H      ILH ++K  N+ L      +L DFG++K       M  +++ T  Y +PE  
Sbjct: 117 IH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
           Q   Y  KSDI++ G +L  LLT                     L+    A      + +
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLT---------------------LKRTFDATNPLNLVVK 212

Query: 335 SILGEEVEEDEMLMAVRIAVV--CLSDSPADRPSSDELVPML 374
            + G       +  +  I++V   L   P  RP++DE++   
Sbjct: 213 IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 22/220 (10%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           +LLG    G+ Y     D G  +AV++V+ F+  SPE  +K V   ++ E+++L +L H 
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPET-SKEVNA-LECEIQLLKNLLHE 64

Query: 162 NLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
            ++     +  P      +  +++  GS++D +    ++   L   V  +    +++G+ 
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVS 120

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---------SLIATSAYSA 270
           YLH   +  I+H ++K  N++ D+    +L DFG +K +           S+  T  + +
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 271 PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
           PE      Y  K+DI+S G  +  +LT + P A F A AA
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 21/185 (11%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +  E  VL  + H  ++ L     +    Y++ +Y+  G L   +          G    
Sbjct: 48  VHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG---- 103

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIA 264
           L  A  ++  L+YLH   + +I++ +LKP N++LD E   +L DFG AK +     +L  
Sbjct: 104 LFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG 160

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG-------GSLGR 317
           T  Y APE  Q++ +    D ++ G+++  +L G     PFF +   G       G L  
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY---PPFFDDNPFGIYEKILAGKL-E 216

Query: 318 WLRHL 322
           + RHL
Sbjct: 217 FPRHL 221

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 47/160 (29%), Positives = 81/160 (50%), Gaps = 13/160 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +++  LRH  L+ L A   E    Y+V +Y+  GSL D +      +L+L     + 
Sbjct: 50  QEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVD 107

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +A  + +G+ YL    +   +H +L   N+++      ++ADFGLA+L+           
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164

Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  ++T GR P
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 41/160 (25%), Positives = 79/160 (49%), Gaps = 14/160 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+  L H  L+ L     E S   LV+++++ G L D +   R  + +   E  L 
Sbjct: 48  EEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLG 104

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           + + V +G+ YL  +    ++H +L   N ++      +++DFG+ + +      +S   
Sbjct: 105 MCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161

Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +S+PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)

Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 42  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95

Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 96  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 151

Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 152 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Query: 296 LTGR 299
           LTGR
Sbjct: 212 LTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 26/153 (16%)

Query: 168 AYVPESSRFYLVYDYLQTGSLE------DAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           A+  E + +  + +Y+  GSL+       A + I E+ L+       RI   V+KGL++L
Sbjct: 67  AFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLR-------RITYAVVKGLKFL 118

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL----IATSAYSAPE----- 272
               N  I+H ++KPTNV+++     +L DFG++  +  SL    I   +Y APE     
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 273 -CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
              QN +YT +SD++S G+ +  +  GR P  P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 7e-13
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 36/214 (16%)

Query: 105 LGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    GK Y+      GL  A + ++  ES   E ++  V      E+++L+  +H N+
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQ-IESEE-ELEDFMV------EIDILSECKHPNI 64

Query: 164 MSL-RAYVPESSRFYLVYDYLQTGSLEDAMDR----IRENQLQLGWEVRLRIAVGVIKGL 218
           + L  AY  E+ + +++ ++   G+L+  M      + E Q++        +   +++ L
Sbjct: 65  VGLYEAYFYEN-KLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEAL 116

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPE 272
            +LH   + +++H +LK  N++L  +   +LADFG+ AK         + I T  + APE
Sbjct: 117 NFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173

Query: 273 ---C--FQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              C  F++  Y  K+DI+S G+ L  L     P
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 16/187 (8%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y    L +G  VA+++V+ FE    + +   +K     E+++L  L H N++   A   E
Sbjct: 19  YKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-----EIDLLKQLDHPNVIKYLASFIE 73

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHFTCNPQILH 231
           ++   +V +    G L   +   ++ Q +L  E  + +  V +   L+++H   + +I+H
Sbjct: 74  NNELNIVLELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMH---SKRIMH 129

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDI 285
            ++KP NV + A    +L D GL +          SL+ T  Y +PE      Y  KSDI
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 189

Query: 286 FSFGMIL 292
           +S G +L
Sbjct: 190 WSLGCLL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 28/223 (12%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           +LLG    G+ Y     D G  +AV++V  F+  S E  +K V   ++ E+++L +LRH 
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQV-PFDPDSQET-SKEVNA-LECEIQLLKNLRHD 64

Query: 162 NLMSLRAYV--PESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVIK 216
            ++     +  PE  +  +  +Y+  GS++D   A   + EN       V  R    +++
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN-------VTRRYTRQILQ 117

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPG----SLIATSA 267
           G+ YLH   +  I+H ++K  N++ D+    +L DFG +K      M G    S+  T  
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
           + +PE      Y  K+D++S    +  +LT + P A + A AA
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 26/204 (12%)

Query: 106 GSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           G+S  G+ Y+ T    G  VA++++         +  K  K  I  E+ ++   +H N++
Sbjct: 30  GAS--GEVYKATDRATGKEVAIKKM---------RLRKQNKELIINEILIMKDCKHPNIV 78

Query: 165 S-LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
               +Y+      ++V +Y+  GSL D    I +N +++       +   V++GL+YLH 
Sbjct: 79  DYYDSYLVGDE-LWVVMEYMDGGSLTDI---ITQNFVRMNEPQIAYVCREVLQGLEYLH- 133

Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSLIATSAYSAPECFQNR 277
             +  ++H ++K  N++L  + + +LADFG A      K    S++ T  + APE  + +
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 278 SYTDKSDIFSFGMILAVLLTGRDP 301
            Y  K DI+S G++   +  G  P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 40/159 (25%), Positives = 88/159 (55%), Gaps = 16/159 (10%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLGWEV 206
           +E  V+  L H+NL+ L   +  +   Y+V + +  G+L + +    R   + +QL    
Sbjct: 48  EETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQL---- 102

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS 266
            L+ ++ V +G++YL    + +++H +L   N+++  +   +++DFGLA++    +  + 
Sbjct: 103 -LQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158

Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
               ++APE  +++ ++ KSD++S+G++L  V   GR P
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)

Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 37  YDAVLDR--NVAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88

Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            S   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 89  KSLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 141

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201

Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 202 WSVGCIMGEMVRHKILFPGRD 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 36/211 (17%)

Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRA--YV 170
           Y  + DN G  VAV++++     + E       R  ++E+E+L SL+H N++  +   Y 
Sbjct: 25  YDPLQDNTGEVVAVKKLQ---HSTAEHL-----RDFEREIEILKSLQHDNIVKYKGVCYS 76

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
                  LV +YL  GSL D + + RE   +L     L  A  + KG++YL    + + +
Sbjct: 77  AGRRNLRLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLG---SKRYV 130

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMP------------GSLIATSAYSAPECFQNRS 278
           H +L   N+++++E   ++ DFGL K++P             S I    + APE      
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI---FWYAPESLTESK 187

Query: 279 YTDKSDIFSFGMILAVLLT----GRDPTAPF 305
           ++  SD++SFG++L  L T       P A F
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 60/207 (28%), Positives = 107/207 (51%), Gaps = 26/207 (12%)

Query: 103 RLLGSSPDG---KYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           + +GS   G     + TVL  G+ VAV+++      S   QN++  +R  +EL +L  + 
Sbjct: 27  KPIGSGAQGIVCAAFDTVL--GINVAVKKL------SRPFQNQTHAKRAYRELVLLKCVN 78

Query: 160 HRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK 216
           H+N++SL   + P+ S   F  VY  ++   L DA +  +   ++L  E    +   ++ 
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVME---LMDA-NLCQVIHMELDHERMSYLLYQMLC 134

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAP 271
           G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y AP
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTG 298
           E      Y +  DI+S G I+  L+ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 45/165 (27%), Positives = 83/165 (50%), Gaps = 20/165 (12%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE---NQLQLGW 204
           IQQE+ VL+      +        + ++ +++ +YL  GS   A+D +R    ++ Q+  
Sbjct: 49  IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS---ALDLLRAGPFDEFQIAT 105

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLM 258
            ++      ++KGL YLH   + + +H ++K  NV+L  +   +LADFG+A      ++ 
Sbjct: 106 MLK-----EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
             + + T  + APE  Q  +Y  K+DI+S G+    L  G  P +
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 12/134 (8%)

Query: 177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP 236
           YLV +YL  G     +  +    L   W  +  IA  V+ G++ LH      I+H ++KP
Sbjct: 73  YLVMEYLNGGDCASLIKTL--GGLPEDW-AKQYIA-EVVLGVEDLH---QRGIIHRDIKP 125

Query: 237 TNVMLDAEFTPRLADFGLAK--LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAV 294
            N+++D     +L DFGL++  L     + T  Y APE          SD +S G ++  
Sbjct: 126 ENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185

Query: 295 LLTGRDPTAPFFAE 308
            L G     PF AE
Sbjct: 186 FLFG---YPPFHAE 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 26/222 (11%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           +LLG    G+ Y    +D G  +A ++V+ F+  SPE  +K V   ++ E+++L +L+H 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQ-FDPESPET-SKEVSA-LECEIQLLKNLQHE 64

Query: 162 NLMS----LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
            ++     LR    ++   ++  +Y+  GS++D +         L   V  +    +++G
Sbjct: 65  RIVQYYGCLRDRAEKTLTIFM--EYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEG 118

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPG----SLIATSAY 268
           + YLH   +  I+H ++K  N++ D+    +L DFG +K      M G    S+  T  +
Sbjct: 119 MSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
            +PE      Y  K+D++S G  +  +LT + P A + A AA
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 38/156 (24%), Positives = 78/156 (50%), Gaps = 13/156 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+  L H NL+ L     +    ++V +Y+  G L   ++ +RE + +LG E  L 
Sbjct: 48  EEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL---LNYLRERKGKLGTEWLLD 104

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL        +H +L   N ++  +   +++DFGLA+ +      +S   
Sbjct: 105 MCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161

Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                ++ PE F    ++ KSD++SFG+++  + + 
Sbjct: 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 43/182 (23%), Positives = 88/182 (48%), Gaps = 27/182 (14%)

Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           + VA++     ++GS +KQ    +     E  ++    H N++ L   V +S    ++ +
Sbjct: 33  IDVAIK---TLKAGSSDKQ----RLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85

Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
           Y++ GSL D    +REN  +      + +  G+  G++YL        +H +L   N+++
Sbjct: 86  YMENGSL-DKF--LRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILV 139

Query: 242 DAEFTPRLADFGLAKLMPGSLIATSAY-----------SAPECFQNRSYTDKSDIFSFGM 290
           ++    +++DFGL++ +  S    + Y           +APE    R +T  SD++SFG+
Sbjct: 140 NSNLVCKVSDFGLSRRLEDS---EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 196

Query: 291 IL 292
           ++
Sbjct: 197 VM 198

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 24/220 (10%)

Query: 90  DPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           DP+ L   L      +G    G+ Y+ + +    V   ++   E    E ++      IQ
Sbjct: 1   DPEELFTKLER----IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED------IQ 50

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE+ VL+      +        + ++ +++ +YL  GS   A+D ++   L+  +     
Sbjct: 51  QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS---ALDLLKPGPLEETYIAT-- 105

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSLI 263
           I   ++KGL YLH   + + +H ++K  NV+L  +   +LADFG+A      ++   + +
Sbjct: 106 ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
            T  + APE  +  +Y  K+DI+S G+    L  G  P +
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 11/160 (6%)

Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           RR  +EL +L  ++H N++ L   + P +S       YL T  +   ++ I + Q     
Sbjct: 59  RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE 118

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL----MPG 260
            V+  I   +++GL+Y+H   +  I+H +LKP+NV ++ +   R+ DFGLA+     M G
Sbjct: 119 HVQFLI-YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTG 174

Query: 261 SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
             +AT  Y APE   N   Y    DI+S G I+A LL G+
Sbjct: 175 -YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 46/165 (27%), Positives = 85/165 (51%), Gaps = 16/165 (9%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E+ ++  L+H N++ L   +   ++  LV++Y+    L+  MD     +  L       
Sbjct: 47  REISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMD-THGVRGALDPNTVKS 104

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MP----GSLI 263
               ++KG+ + H     ++LH +LKP N++++     +LADFGLA+   +P     + +
Sbjct: 105 FTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161

Query: 264 ATSAYSAPECFQ-NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
            T  Y AP+    +R+Y+   DI+S G I+A ++TGR    P F 
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR----PLFP 202

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 53/233 (22%), Positives = 105/233 (45%), Gaps = 33/233 (14%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E  V+ +L+H  L+ L A V +    Y++ +++  GSL D +     ++  L     + 
Sbjct: 50  AEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPL--PKLID 106

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            +  + +G+ ++        +H +L+  N+++ A    ++ADFGLA+++  +        
Sbjct: 107 FSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163

Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRH 321
                ++APE     S+T KSD++SFG++L  ++T GR P          G S    +R 
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY--------PGMSNPEVIRA 215

Query: 322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           L+        + R     E   + M+        C  + P +RP+ + +  +L
Sbjct: 216 LERGYR----MPRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 41/227 (18%)

Query: 103 RLLGSSPDGKYYRTVLDNGLT------VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA 156
           R LG    GK +     +         VAV+     +  +        ++  ++E E+L 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVK---TLKETASN----DARKDFEREAELLT 63

Query: 157 SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE--------DAMDRIRENQ--LQLGWEV 206
           + +H N++       E     +V++Y++ G L         DA      +    +L    
Sbjct: 64  NFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123

Query: 207 RLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------- 256
            L+IAV +  G+ YL   HF      +H +L   N ++  +   ++ DFG+++       
Sbjct: 124 LLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177

Query: 257 -LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
             + G  +    +  PE    R +T +SD++SFG++L  + T G+ P
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 13/157 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E+ +L  L H N++ L   +   ++ YLV+++L    L+  MD    + + L       
Sbjct: 48  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLP-----L 101

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------I 263
           I   + + LQ L F  + ++LH +LKP N++++ E   +LADFGLA+     +      +
Sbjct: 102 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 161

Query: 264 ATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            T  Y APE     + Y+   DI+S G I A ++T R
Sbjct: 162 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 39/160 (24%), Positives = 81/160 (50%), Gaps = 14/160 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+  L H  L+ L     +    Y+V ++++ G L   ++ +R+ Q +L  ++ L 
Sbjct: 48  EEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLS 104

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V +G++YL        +H +L   N ++ +    +++DFG+ + +      +S+  
Sbjct: 105 MCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA 161

Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +S PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 50/210 (23%)

Query: 120 NGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS----LRAYVPESS 174
           +G  VA++++  AF+         ++ +R  +EL++L   +H N+++    LR    +  
Sbjct: 29  SGKKVAIKKIPHAFD-------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81

Query: 175 RFYLVYDYLQT---------GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC 225
             Y+V D +++           L +  + IR    QL     LR       GL+Y+H   
Sbjct: 82  DVYVVMDLMESDLHHIIHSDQPLTE--EHIRYFLYQL-----LR-------GLKYIHSAN 127

Query: 226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS----------LIATSAYSAPEC-F 274
              ++H +LKP+N++++ +   R+ DFG+A+ +  S           +AT  Y APE   
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
               YT   D++S G I A +L GR    P
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 50  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 107

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 108 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163

Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 14/168 (8%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           Q +  K  I  E+ V+  L++ N+++           ++V +YL  GSL D +     ++
Sbjct: 55  QKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE 114

Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLM 258
            Q+    R        + LQ L F    Q++H ++K  NV+L  + + +L DFG  A++ 
Sbjct: 115 AQIAAVCR--------ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166

Query: 259 P-----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           P      +++ T  + APE    ++Y  K DI+S G++   ++ G  P
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 30/194 (15%)

Query: 121 GLTVAVRR-VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSRFYL 178
           G  VA+++ ++ F +         + +R  +EL++L  LRH N++SL   ++      Y 
Sbjct: 35  GQNVAIKKIMKPFST-------PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87

Query: 179 VYDYLQTGSLEDAMDRIRENQ-LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           V + L T        R  E Q +Q            +++GL+Y+H   +  ++H +LKP+
Sbjct: 88  VTELLGTDLHRLLTSRPLEKQFIQY-------FLYQILRGLKYVH---SAGVVHRDLKPS 137

Query: 238 NVMLDAEFTPRLADFGLAKL----MPGSLIATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           N++++     ++ DFGLA++    M G  ++T  Y APE     + Y  + DI+S G I 
Sbjct: 138 NILINENCDLKICDFGLARIQDPQMTG-YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIF 196

Query: 293 AVLLTGRDPTAPFF 306
           A +L G+    P F
Sbjct: 197 AEMLEGK----PLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 64.7 bits (157), Expect = 8e-12
 Identities = 45/186 (24%), Positives = 84/186 (45%), Gaps = 14/186 (7%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  T L +   VA+++V+ FE    + +   VK     E+++L  L H N++       E
Sbjct: 19  YRATCLLDRKPVALKKVQIFEMMDAKARQDCVK-----EIDLLKQLNHPNVIKYLDSFIE 73

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHY 232
            +   +V +    G L   +   ++ +  +      +  V +   ++++H   + +++H 
Sbjct: 74  DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHR 130

Query: 233 NLKPTNVMLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIF 286
           ++KP NV + A    +L D GL +          SL+ T  Y +PE      Y  KSDI+
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190

Query: 287 SFGMIL 292
           S G +L
Sbjct: 191 SLGCLL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 43/225 (19%)

Query: 100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEK-----QNKSVKRRIQQELEV 154
           N+  +LG   +G Y       G+ +  R  E  E  + +K     +N+ VK    +EL++
Sbjct: 1   NKFEVLGVVGEGAY-------GVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKM 53

Query: 155 LASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE--------DAMDRIRENQLQLGWEV 206
           L +L+  N++ L+       + YLV++Y++   LE           +++R    QL    
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL---- 109

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-LMPGS---- 261
                   IK + + H      I+H ++KP N+++      +L DFG A+ L  GS    
Sbjct: 110 --------IKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158

Query: 262 --LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
              +AT  Y +PE      Y    D++S G IL  L  G+ P  P
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PLFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 60/201 (29%), Positives = 84/201 (41%), Gaps = 30/201 (14%)

Query: 109 PDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR 167
             G+ Y    L  G  +A   VE+      EK       RI    E   S RH  L++L 
Sbjct: 22  KTGELYAIKALKKGDIIARDEVESLMC---EK-------RI---FETANSERHPFLVNLF 68

Query: 168 AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI-AVGVIKGLQYLHFTCN 226
           A          V +Y   G   D M  I  +      E R    A  V+ GLQYLH    
Sbjct: 69  ACFQTEDHVCFVMEYAAGG---DLMMHIHTDVFS---EPRAVFYAACVVLGLQYLH---E 119

Query: 227 PQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIA----TSAYSAPECFQNRSYT 280
            +I++ +LK  N++LD E   ++ADFGL K  +  G   +    T  + APE     SYT
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179

Query: 281 DKSDIFSFGMILAVLLTGRDP 301
              D +  G+++  +L G  P
Sbjct: 180 RAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 65.5 bits (159), Expect = 9e-12
 Identities = 50/175 (28%), Positives = 90/175 (51%), Gaps = 21/175 (12%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 117

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA------VLLTGRD 300
                 M    + T  Y APE      Y +  DI+S G I+       VL  G D
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 9e-12
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 22/166 (13%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           IQQE++ L+  R   +        + S+ +++ +Y   GS  D +   + ++  + + +R
Sbjct: 46  IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR 105

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA 267
                 V+ GL+YLH       +H ++K  N++L  E   +LADFG++    G L +T +
Sbjct: 106 -----EVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMS 153

Query: 268 ----------YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
                     + APE  +   Y +K+DI+S G+    L  G  P +
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 24/218 (11%)

Query: 90  DPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           DP+ L   L      +G    G+ ++ + +    V   ++   E    E ++      IQ
Sbjct: 1   DPEELFTKLEK----IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED------IQ 50

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE+ VL+      +        + ++ +++ +YL  GS  D ++    ++ Q+   +R  
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-- 108

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSLI 263
               ++KGL YLH   + + +H ++K  NV+L      +LADFG+A      ++   + +
Sbjct: 109 ---EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  + APE  +  +Y  K+DI+S G+    L  G  P
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 63/280 (22%), Positives = 120/280 (42%), Gaps = 41/280 (14%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + LG+   G+ +    +N   VAV+     + G+   Q         +E  ++ +L+H  
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSVQ------AFLEEANLMKTLQHDK 62

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V +    Y++ +Y+  GSL D +      ++ L     +  +  + +G+ Y+ 
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE 120

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-------AYSAPECFQ 275
                  +H +L+  NV++      ++ADFGLA+++  +             ++APE   
Sbjct: 121 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177

Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
             S+T KSD++SFG++L  ++T G+ P  P  + +    +L R  R  +      E  D 
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPY-PGMSNSDVMSALQRGYRMPRMENCPDELYD- 235

Query: 335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
                            I   C  +   +RP+ D L  +L
Sbjct: 236 -----------------IMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 38/204 (18%)

Query: 121 GLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRA-YVPESSR--- 175
           G  VA++++ + FE       + S   RI +E+++L  LRH +++ ++   +P S R   
Sbjct: 25  GEKVAIKKINDVFE-------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77

Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V++ +++    D    I+ N   L  E        +++ L+Y+H T N  + H +L
Sbjct: 78  DIYVVFELMES----DLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH-TAN--VFHRDL 129

Query: 235 KPTNVMLDAEFTPRLADFGLAKLM----PGSL-----IATSAYSAPE---CFQNRSYTDK 282
           KP N++ +A+   ++ DFGLA++     P ++     +AT  Y APE    F ++ YT  
Sbjct: 130 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPA 188

Query: 283 SDIFSFGMILAVLLTGRDPTAPFF 306
            DI+S G I A +LTG+    P F
Sbjct: 189 IDIWSIGCIFAEVLTGK----PLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 29/222 (13%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           ID  ++Q       R LG+   G+ +  + +N   VAV+ ++   +  P+          
Sbjct: 3   IDRTSIQLL-----RKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKD--------F 48

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
             E +++  LRH  L+ L A        Y+V + ++ GSL + +       L+L     +
Sbjct: 49  LAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLI 106

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-- 266
            +A  V  G+ YL        +H +L   NV++      ++ADFGLA+++    I  +  
Sbjct: 107 DMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEARE 162

Query: 267 ------AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                  ++APE      ++ KSD++SFG++L  ++T GR P
Sbjct: 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 14/160 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +++  LRH  L+ L A V E    Y+V +++  GSL D +       L+L   V + 
Sbjct: 50  QEAQIMKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM- 107

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 108 -AAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163

Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L+T GR P
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 78/291 (26%), Positives = 123/291 (42%), Gaps = 42/291 (14%)

Query: 88  KIDPKTLQAALANENRLLGSSPDGK-YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKR 146
           K DP+ L + L    R +G    G  Y+   + N   VA++++    SG   KQ+    +
Sbjct: 10  KDDPEKLFSDL----REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SG---KQSNEKWQ 60

Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
            I +E+  L  LRH N +  R         +LV +Y   GS  D ++ + +  LQ   EV
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE-VHKKPLQ---EV 115

Query: 207 RLR-IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--GSLI 263
            +  +  G ++GL YLH   +  ++H ++K  N++L      +L DFG A +M      +
Sbjct: 116 EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 172

Query: 264 ATSAYSAPE---CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR 320
            T  + APE         Y  K D++S G I  + L  R P  P F   A        + 
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP--PLFNMNA--------MS 221

Query: 321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
            L H  +      +S    E   +           CL   P DRP+S+ L+
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 26/168 (15%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESS--RFYLVYDYLQT--GSLEDAMDR-IRENQLQLGWE 205
           E+ +L +LRH N++ L+  V        +LV +Y +    SL D M     E+Q++    
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC--- 112

Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK---LMPGSL 262
               + + +++GLQYLH      I+H +LK +N++L  +   ++ADFGLA+   L    +
Sbjct: 113 ----LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 263 ---IATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
              + T  Y APE      +YT   D+++ G ILA LL  +    P  
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK----PLL 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 23/174 (13%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYV--PESSRF---YLVYDYLQTGSLEDAMDR 194
           QN    +R+ +EL++L   +H N++S    +  P    F   Y+V + +Q+    D    
Sbjct: 38  QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS----DLHKI 93

Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           I   Q      V++     +++GL+YLH   +  ILH ++KP N+++++    ++ DFGL
Sbjct: 94  IVSPQPLSSDHVKV-FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGL 149

Query: 255 AKL--------MPGSLIATSAYSAPECFQ-NRSYTDKSDIFSFGMILAVLLTGR 299
           A++        M   ++ T  Y APE    +R YT   DI+S G I A LL  R
Sbjct: 150 ARVEEPDESKHMTQEVV-TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 32/209 (15%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVK--RRIQQE-----LEVLASLRHRNLMSLRAYVP 171
           D    VAV+++   +  S +   + +K  RR+  +      EVL          + +   
Sbjct: 28  DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT- 86

Query: 172 ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILH 231
           E +  Y+V +Y++T      +  + E         RL     +++GL+Y+H   +  +LH
Sbjct: 87  ELNSVYIVQEYMETD-----LANVLEQGPLSEEHARL-FMYQLLRGLKYIH---SANVLH 137

Query: 232 YNLKPTNVMLDAE-FTPRLADFGLAKLM------PGSL---IATSAYSAPE-CFQNRSYT 280
            +LKP NV ++ E    ++ DFGLA+++       G L   + T  Y +P       +YT
Sbjct: 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYT 197

Query: 281 DKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
              D+++ G I A +LTG+    P FA A
Sbjct: 198 KAIDMWAAGCIFAEMLTGK----PLFAGA 222

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG+   G+ +    +    VAV+ ++   + SPE           +E +++  LRH  L+
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPES--------FLEEAQIMKKLRHDKLV 64

Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT 224
            L A V E    Y+V +Y+  GSL D +       L+L   V +  A  V  G+ Y+   
Sbjct: 65  QLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYIE-- 119

Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-------AYSAPECFQNR 277
                +H +L+  N+++      ++ADFGLA+L+  +             ++APE     
Sbjct: 120 -RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 278 SYTDKSDIFSFGMILAVLLT-GRDP 301
            +T KSD++SFG++L  L+T GR P
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 15/135 (11%)

Query: 174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHY 232
              + V +YL  G   D M  I+    +   E R R  A  +I GLQ+LH      I++ 
Sbjct: 69  EHLFFVMEYLNGG---DLMFHIQS-SGRFD-EARARFYAAEIICGLQFLH---KKGIIYR 120

Query: 233 NLKPTNVMLDAEFTPRLADFGLAKL------MPGSLIATSAYSAPECFQNRSYTDKSDIF 286
           +LK  NV+LD +   ++ADFG+ K          +   T  Y APE  + + Y +  D +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180

Query: 287 SFGMILAVLLTGRDP 301
           SFG++L  +L G+ P
Sbjct: 181 SFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 49/168 (29%), Positives = 79/168 (47%), Gaps = 19/168 (11%)

Query: 149 QQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
             E  VLA + +H  L  L +      R + V +Y+  G L   + R          E R
Sbjct: 43  MTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD-----EPR 97

Query: 208 LRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG---- 260
            R  A  ++ GLQ+LH      I++ +LK  NV+LD+E   ++ADFG+ K  ++ G    
Sbjct: 98  ARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154

Query: 261 SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +   T  Y APE    + Y    D ++ G++L  +L G+   +PF  +
Sbjct: 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ---SPFEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 39/180 (21%)

Query: 149 QQELEVLASLRHRNLMSL--RAYV--PESSR----FYLVYDYLQ---TGSLEDAMDRIRE 197
            +E+++L  L+H N++ L   A     +S R     Y+V  Y+    +G LE+   ++ E
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE 114

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           +Q++          + +++G+ YLH   N  ILH ++K  N+++D +   ++ADFGLA+ 
Sbjct: 115 SQIKC-------YMLQLLEGINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARP 164

Query: 258 ------MPG-----------SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
                  P            +L+ T  Y  PE     R YT   DI+  G + A + T R
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 24/197 (12%)

Query: 105 LGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H NL
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHPNL 64

Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLH 222
           + L         FY++ +++  G+L   +D +RE N+ ++   V L +A  +   ++YL 
Sbjct: 65  VQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQ 275
                  +H +L   N ++      ++ADFGL++LM G      A       ++APE   
Sbjct: 122 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 178

Query: 276 NRSYTDKSDIFSFGMIL 292
              ++ KSD+++FG++L
Sbjct: 179 YNKFSIKSDVWAFGVLL 195

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 10/149 (6%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE ++L+ L H  ++   A   E   F ++ +Y +   L+  ++ ++     L       
Sbjct: 51  QEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------LI 263
             + ++ G+ Y+H     +ILH +LK  N+ L      ++ DFG+++L+ GS        
Sbjct: 111 WFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT 166

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
            T  Y +PE  +++ Y  KSDI+S G IL
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCIL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 47/176 (26%), Positives = 86/176 (48%), Gaps = 19/176 (10%)

Query: 140 QNKSVKRRIQQ---ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           Q++S ++  Q+    +  + SL H  ++ L    P +S   LV      GSL   +D +R
Sbjct: 45  QDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSL---LDHVR 100

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           +++  L  +  L   V + KG+ YL       ++H NL   N++L ++   ++ADFG+A 
Sbjct: 101 QHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157

Query: 257 LMPG-------SLIATS-AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTA 303
           L+         S   T   + A E      YT +SD++S+G+ +  +++ G +P A
Sbjct: 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 3e-11
 Identities = 60/280 (21%), Positives = 119/280 (42%), Gaps = 47/280 (16%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVR--RVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
             +G    G  Y+ VL     VAV+  R        P+     +KR+  QE E+L    H
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP----PD-----LKRKFLQEAEILKQYDH 51

Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            N++ L     +    Y+V + +  GSL   +  +R+ + +L  +  L++++    G++Y
Sbjct: 52  PNIVKLIGVCVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPE 272
           L        +H +L   N ++      +++DFG+++   G +   S         ++APE
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL 332
                 YT +SD++S+G++L    +  D   P  +                   + RE +
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-----------------QTRERI 208

Query: 333 DRS--ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
           +    +   ++  +E+    R+ + C +  P +RPS  E+
Sbjct: 209 ESGYRMPAPQLCPEEIY---RLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 45/188 (23%), Positives = 94/188 (50%), Gaps = 22/188 (11%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VAV++++        KQ +  +  +  E+ ++    H N++ +          ++V
Sbjct: 46  TGKQVAVKKMDL------RKQQR--RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97

Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
            ++L+ G+L D +   R N+ Q+       + + V++ L YLH   N  ++H ++K  ++
Sbjct: 98  MEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH---NQGVIHRDIKSDSI 149

Query: 240 MLDAEFTPRLADFG----LAKLMPG--SLIATSAYSAPECFQNRSYTDKSDIFSFGMILA 293
           +L ++   +L+DFG    ++K +P   SL+ T  + APE      Y  + DI+S G+++ 
Sbjct: 150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209

Query: 294 VLLTGRDP 301
            ++ G  P
Sbjct: 210 EMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 51/179 (28%), Positives = 88/179 (49%), Gaps = 22/179 (12%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           E++++ V     +E+ +L  ++H N++ L+  V    R YLV++YL    L+  MD    
Sbjct: 38  EQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMD---- 92

Query: 198 NQLQLGWEVRL--RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGL 254
           +        RL       +++G+ Y H   + ++LH +LKP N+++D      +LADFGL
Sbjct: 93  SSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGL 149

Query: 255 AKLMPGSL------IATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           A+     +      + T  Y APE    +R Y+   DI+S G I A ++  +    P F
Sbjct: 150 ARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK----PLF 204

Length = 294

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 42/170 (24%), Positives = 76/170 (44%), Gaps = 24/170 (14%)

Query: 147 RIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
           R ++E  + A L H N+++L  +        + V++Y+   +L + +         L   
Sbjct: 24  RFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL----AADGALPAG 79

Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLAKLMPGS- 261
              R+ + V+  L   H   N  I+H +LKP N+M+         ++ DFG+  L+PG  
Sbjct: 80  ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136

Query: 262 ------------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR 299
                       ++ T  Y APE  +    T  SD++++G+I    LTG+
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 105 LGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           +G    G  Y  + +  G  VA++++        ++Q K  K  I  E+ V+   +H N+
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNL------QQQPK--KELIINEILVMRENKHPNI 78

Query: 164 MS-LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           ++ L +Y+      ++V +YL  GSL D    + E  +  G     +IA    + LQ L 
Sbjct: 79  VNYLDSYLV-GDELWVVMEYLAGGSLTDV---VTETCMDEG-----QIAAVCRECLQALE 129

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQN 276
           F  + Q++H ++K  N++L  + + +L DFG  A++ P      +++ T  + APE    
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDP 301
           ++Y  K DI+S G++   ++ G  P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 41/160 (25%), Positives = 82/160 (51%), Gaps = 14/160 (8%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E  ++  L+H  L+ L A V +    Y++ +Y++ GSL D +       ++L     + 
Sbjct: 50  AEANLMKQLQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PEGIKLTINKLID 106

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
           +A  + +G+ ++        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 107 MAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163

Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 44/182 (24%), Positives = 86/182 (47%), Gaps = 24/182 (13%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE--------DAM 192
             + ++  Q+E E+L +L+H +++       +     +V++Y++ G L         DAM
Sbjct: 47  TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 106

Query: 193 DRI----RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
             +    R+ + +LG    L IA  +  G+ YL    +   +H +L   N ++ A    +
Sbjct: 107 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVK 163

Query: 249 LADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GR 299
           + DFG+++         + G  +    +  PE    R +T +SD++SFG+IL  + T G+
Sbjct: 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223

Query: 300 DP 301
            P
Sbjct: 224 QP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 21/190 (11%)

Query: 126 VRRVEAFESGSP------EKQNKSVKRRIQQELE--VLASLRHRNLMSLRAYVPESSRFY 177
           VR++   ++G        +K    V+ R++ ++E  +LA + H  ++ L        + Y
Sbjct: 15  VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY 74

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           L+ D+L+ G   D   R+ +  +    +V+  +A   +  L +LH   +  I++ +LKP 
Sbjct: 75  LILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELAL-ALDHLH---SLGIIYRDLKPE 127

Query: 238 NVMLDAEFTPRLADFGLAK------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMI 291
           N++LD E   +L DFGL+K          S   T  Y APE    R +T  +D +SFG++
Sbjct: 128 NILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVL 187

Query: 292 LAVLLTGRDP 301
           +  +LTG  P
Sbjct: 188 MFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 39/165 (23%), Positives = 87/165 (52%), Gaps = 17/165 (10%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E+ ++   +H+N++ +          +++ ++LQ G+L D + + R N+ Q+       +
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TV 122

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMPG--SLIA 264
              V++ L YLH   +  ++H ++K  +++L  +   +L+DFG    ++K +P   SL+ 
Sbjct: 123 CESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           T  + APE      Y  + DI+S G+++  ++ G     P+F+++
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE---PPYFSDS 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 23/206 (11%)

Query: 103 RLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANK----EILDEAYVMASVD 67

Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 68  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 123

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL      +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 15/203 (7%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+  L H  L+ L     +    Y+V +Y+  G L   ++ +RE+  +      L 
Sbjct: 48  EEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL---LNYLREHGKRFQPSQLLE 104

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V +G+ YL    + Q +H +L   N ++D +   +++DFGL++ +      +S   
Sbjct: 105 MCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS 161

Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDPTAPFF-AEAASGGSLGRWLR 320
                +S PE      ++ KSD+++FG+++  V   G+ P   F  +E     S G  L 
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY 221

Query: 321 HLQHAGEAREALDRSILGEEVEE 343
               A E   A+  S   E+ EE
Sbjct: 222 RPHLASEKVYAIMYSCWHEKAEE 244

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 14/158 (8%)

Query: 151 ELEVLASLRHRNLMSLRAYVPES-SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           E ++L  +  R ++SL AY  E+     LV   +  G L+  +  + E       E R  
Sbjct: 43  EKKILEKVSSRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAI 98

Query: 210 I-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-----SLI 263
             A  +I GL++LH     +I++ +LKP NV+LD     R++D GLA  + G        
Sbjct: 99  FYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  Q   Y    D F+ G  L  ++ GR P
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 48/186 (25%), Positives = 94/186 (50%), Gaps = 26/186 (13%)

Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  ++G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 37  IKTLKAGYTEKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 92

Query: 189 EDAMDRIRENQ---LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
            DA  R  + Q   +QL   +R     G+  G++YL    +   +H +L   N+++++  
Sbjct: 93  -DAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL---SDMGYVHRDLAARNILVNSNL 143

Query: 246 TPRLADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVL 295
             +++DFGL++++   P +   T        ++APE    R +T  SD++S+G+++  V+
Sbjct: 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203

Query: 296 LTGRDP 301
             G  P
Sbjct: 204 SYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 40/238 (16%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL-QLGWEVRL 208
           +E  ++ SL H NL+ L   V       +V +    GSL   +DR+R++ L         
Sbjct: 45  KEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSL---LDRLRKDALGHFLISTLC 100

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK---------LMP 259
             AV +  G++YL    + + +H +L   N++L ++   ++ DFGL +         +M 
Sbjct: 101 DYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157

Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW 318
             L    A+ APE  + R+++  SD++ FG+ L  + T G +P                W
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP----------------W 201

Query: 319 LRHLQHAGEAREALDRSILGEEVE--EDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
              L    +  + +D+   GE +E  E        + + C + +PADRP+   L   L
Sbjct: 202 A-GLS-GSQILKKIDKE--GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 46/213 (21%), Positives = 105/213 (49%), Gaps = 27/213 (12%)

Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           +++G+   G+ +R +L       + VA++ ++    G  EKQ    ++    E  ++   
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKP---GYTEKQ----RQDFLSEASIMGQF 63

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
            H N++ L   V +     ++ +Y++ G+L+  +   R++  +      + +  G+  G+
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGM 120

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM---PGSLIATSA------YS 269
           +YL    +   +H +L   N+++++    +++DFGL++++   P     TS       ++
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177

Query: 270 APECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
           APE    R +T  SD++SFG+++  V+  G  P
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 47/160 (29%), Positives = 88/160 (55%), Gaps = 17/160 (10%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           E+ +L  L+H N+++++  V  S+  + Y+V +Y++   L+  M+ +++  LQ   EV+ 
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS--EVKC 110

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG------SL 262
            + + ++ G+ +LH   +  ILH +LK +N++L+     ++ DFGLA+           L
Sbjct: 111 -LMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL 166

Query: 263 IATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           + T  Y APE     + Y+   D++S G I A LLT + P
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 61.7 bits (149), Expect = 9e-11
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 105 LGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           +G    G  Y T +D   G  VA+R++          Q +  K  I  E+ V+   ++ N
Sbjct: 28  IGQGASGTVY-TAMDVATGQEVAIRQMNL--------QQQPKKELIINEILVMRENKNPN 78

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           +++           ++V +YL  GSL D +     ++ Q+    R        + LQ L 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR--------ECLQALE 130

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQN 276
           F  + Q++H ++K  N++L  + + +L DFG  A++ P      +++ T  + APE    
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDP 301
           ++Y  K DI+S G++   ++ G  P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 29/171 (16%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +EL+++  ++H N+M L     E     LV D +        + ++ + +++L       
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKC 123

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-------------- 255
           I + ++ GL  LH       +H +L P N+ ++++   ++ADFGLA              
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 256 ------KLMPGSLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
                 +    S + T  Y APE       Y    D++S G I A LLTG+
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 54/239 (22%), Positives = 103/239 (43%), Gaps = 42/239 (17%)

Query: 148 IQQELEVLASLRHRNLMSLRAY---VPESSRFYLVYDYLQTGSLEDAMD--RIRENQLQL 202
           IQ+E+ +L+ LR     ++  Y     +  R +++ +Y + GS+   M    I E  + +
Sbjct: 46  IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV 105

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS- 261
                  I   V+  L+Y+H      ++H ++K  N+++      +L DFG+A L+  + 
Sbjct: 106 -------IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155

Query: 262 -----LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
                 + T  + APE     + Y  K+DI+S G+ +  + TG  P         S    
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY--------SDVDA 207

Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV-CLSDSPADRPSSDELVPM 373
            R +  +  +   R           +E++     +R  V  CL + P +R S++EL+  
Sbjct: 208 FRAMMLIPKSKPPR-----------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 43/198 (21%), Positives = 89/198 (44%), Gaps = 23/198 (11%)

Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES 173
           Y+ + +N   V +R  + F  G      K +    + E++ L  +   N++ +  ++ + 
Sbjct: 37  YKGIFNNKE-VIIRTFKKFHKGH-----KVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90

Query: 174 S----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH-FTCNPQ 228
                R  L+ +Y   G L + +D     +  L ++ +L +A+   KGL  L+ +T  P 
Sbjct: 91  VDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLM---PGSLIATSAYSAPECFQN--RSYTDKS 283
             + NL   + ++   +  ++   GL K++   P   +    Y + +   +    YT K 
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203

Query: 284 DIFSFGMILAVLLTGRDP 301
           DI+S G++L  + TG+ P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 27/168 (16%)

Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           E++ L  L  H N++ L+    E+   Y V++Y++ G+L   M   ++ + +   E  +R
Sbjct: 47  EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLM---KDRKGKPFSESVIR 102

Query: 210 -IAVGVIKGLQYLH----FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            I   +++GL ++H    F       H +LKP N+++      ++ADFGLA+ +      
Sbjct: 103 SIIYQILQGLAHIHKHGFF-------HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155

Query: 263 ---IATSAYSAPECF-QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
              ++T  Y APE   ++ SY+   DI++ G I+A L T R    P F
Sbjct: 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR----PLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 105 LGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           +G    G  Y T +D   G  VA++++          Q +  K  I  E+ V+   ++ N
Sbjct: 27  IGQGASGTVY-TAIDIATGQEVAIKQMNL--------QQQPKKELIINEILVMRENKNPN 77

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           +++           ++V +YL  GSL D +     ++ Q+    R        + LQ L 
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR--------ECLQALD 129

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQN 276
           F  + Q++H ++K  N++L  + + +L DFG  A++ P      +++ T  + APE    
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDP 301
           ++Y  K DI+S G++   ++ G  P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 24/180 (13%)

Query: 145 KRRIQQELEVLASL-RHRNLMSLR-AYVPESSR-----FYLVYDYLQTGSLEDAMDRIRE 197
           +  I++E  +L     H N+ +   A++ ++        +LV +    GS+ D +  +R+
Sbjct: 46  EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK 105

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
              +L  E    I    ++GL YLH     +++H ++K  N++L      +L DFG++  
Sbjct: 106 KGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162

Query: 258 MP------GSLIATSAYSAPE---CFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           +        + I T  + APE   C +    SY  +SD++S G I A+ L    P  P  
Sbjct: 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG-ITAIELADGKP--PLC 219

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 29/173 (16%)

Query: 160 HRNLMSLRAYVPESSRFYLVYDY--------------LQTGSLEDAMDRIRENQLQLGWE 205
            R LM L   +      Y V  Y              +   SL+    ++ +  L +  +
Sbjct: 44  KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPED 103

Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT 265
           +  +IAV ++K L+YLH   +  ++H ++KP+NV+++     +L DFG++  +  S+  T
Sbjct: 104 ILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT 161

Query: 266 -----SAYSAPECF----QNRSYTDKSDIFSFGMILAVLLTGRDPTA----PF 305
                  Y APE        + Y  KSD++S G+ +  L TGR P      PF
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF 214

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 32/177 (18%)

Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQ 201
           +V+R+I +E+E+L  + H N++        +    ++ +++  GSLE     I  E  L 
Sbjct: 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT--HIADEQFLA 171

Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKL 257
                   +A  ++ G+ YLH      I+H ++KP+N+++++    ++ADFG    LA+ 
Sbjct: 172 -------DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221

Query: 258 MP--GSLIATSAYSAPECFQNRSYTD---------KSDIFSFGMILAVLLTGRDPTA 303
           M    S + T AY +PE    R  TD           DI+S G+ +     GR P  
Sbjct: 222 MDPCNSSVGTIAYMSPE----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 8/96 (8%)

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA----KLMPGSLIATS 266
           A  +I GL+++H   N  +++ +LKP N++LD     R++D GLA    K  P + + T 
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159

Query: 267 AYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDP 301
            Y APE  Q   +Y   +D FS G +L  LL G  P
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 62/286 (21%), Positives = 122/286 (42%), Gaps = 47/286 (16%)

Query: 100 NENRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
            E  +LG    G  Y    L   + +A++ +       PE+ ++ V+  + +E+ + + L
Sbjct: 11  GERVVLGKGTYGIVYAARDLSTQVRIAIKEI-------PERDSRYVQP-LHEEIALHSYL 62

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR----IRENQLQLGWEVRLRIAVGV 214
           +HRN++       E+  F +  + +  GSL   +      +++N+  + +  +      +
Sbjct: 63  KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QI 117

Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAKLMPG------SLIATSA 267
           ++GL+YLH   + QI+H ++K  NV+++      +++DFG +K + G      +   T  
Sbjct: 118 LEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174

Query: 268 YSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA 325
           Y APE      R Y   +DI+S G  +  + TG+ P        A+   +G +  H    
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH---- 230

Query: 326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
                         E+ E     A    + C    P  R S+ +L+
Sbjct: 231 -------------PEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 21/154 (13%)

Query: 148 IQQELEVLASLRHRNLMS-LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE--NQLQLGW 204
           IQQE+ +L   RH N+++   +Y+    + ++V +Y   GSL+D     R   ++LQ+ +
Sbjct: 47  IQQEISMLKECRHPNIVAYFGSYL-RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY 105

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
                +    +KGL YLH       +H ++K  N++L  +   +LADFG++  +  ++  
Sbjct: 106 -----VCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157

Query: 263 ----IATSAYSAPECFQNRS---YTDKSDIFSFG 289
               I T  + APE         Y  K DI++ G
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 42/170 (24%), Positives = 83/170 (48%), Gaps = 28/170 (16%)

Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSL------------EDAMDRIRE 197
           E+E++  + +H+N+++L     +    Y++ +Y   G+L            +   D  + 
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
            + QL ++  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 184 VHDIDYYKKTSNGRL--PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 16/159 (10%)

Query: 151 ELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           E  +LA + +H  L +L        R + V +Y+  G L   + R R+       E R R
Sbjct: 45  EKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSR 99

Query: 210 I-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI--- 263
             A  V   L +LH      +++ +LK  N++LDAE   +LADFG+ K  ++ G      
Sbjct: 100 FYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF 156

Query: 264 -ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             T  Y APE  Q   Y    D ++ G+++  ++ G+ P
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 35/178 (19%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSR----------FYLVYDYLQ---TGSLEDAMDRIR 196
           +E+++L  L HRN+++L+  V +             FYLV++Y+     G LE  +    
Sbjct: 55  REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS 114

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           E+ ++            +++GL Y H       LH ++K +N++L+ +   +LADFGLA+
Sbjct: 115 EDHIK-------SFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Query: 257 LMPG-------SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           L          + + T  Y  PE       Y    D++S G IL  L T +    P F
Sbjct: 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK----PIF 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 8/96 (8%)

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA----KLMPGSLIATS 266
           A  +I GL+++H   N  +++ +LKP N++LD     R++D GLA    K  P + + T 
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159

Query: 267 AYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDP 301
            Y APE  Q   +Y   +D FS G +L  LL G  P
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 48/199 (24%), Positives = 98/199 (49%), Gaps = 25/199 (12%)

Query: 116 TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR 175
           TV  +G  VAV++++        KQ +  +  +  E+ ++   +H N++ +         
Sbjct: 40  TVKSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 91

Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            ++V ++L+ G+L D +   R N+ Q+       + + V+K L  LH      ++H ++K
Sbjct: 92  LWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH---AQGVIHRDIK 143

Query: 236 PTNVMLDAEFTPRLADFG----LAKLMP--GSLIATSAYSAPECFQNRSYTDKSDIFSFG 289
             +++L  +   +L+DFG    ++K +P   SL+ T  + APE      Y  + DI+S G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 290 MILAVLLTGRDPTAPFFAE 308
           +++  ++ G     P+F E
Sbjct: 204 IMVIEMVDGE---PPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 44/207 (21%)

Query: 121 GLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAY---VPESSR 175
             TVA++++   F         K + +R  +EL++L   R H+N+  L  Y   +     
Sbjct: 27  EETVAIKKITNVF-------SKKILAKRALRELKLLRHFRGHKNITCL--YDMDIVFPGN 77

Query: 176 FYLVYDYLQTGSLEDAMDR-----IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
           F  +Y Y      E+ M+      IR  Q  L           ++ GL+Y+H   +  +L
Sbjct: 78  FNELYLY------EELMEADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVL 127

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLA-------KLMPGSL---IATSAYSAPEC-FQNRSY 279
           H +LKP N++++A+   ++ DFGLA           G +   +AT  Y APE     +SY
Sbjct: 128 HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSY 187

Query: 280 TDKSDIFSFGMILAVLLTGRDPTAPFF 306
           T   D++S G ILA LL  +    P F
Sbjct: 188 TKAIDVWSVGCILAELLGRK----PVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 19/178 (10%)

Query: 142 KSVKRRIQQELEVL-ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           K  +  I  E  VL  +L+H  L+ L      + + Y V DY+  G L   + R R    
Sbjct: 36  KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL- 94

Query: 201 QLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--L 257
               E R R  A  V   + YLH   +  I++ +LKP N++LD++    L DFGL K  +
Sbjct: 95  ----EPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147

Query: 258 MP----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS 311
            P     +   T  Y APE  +   Y    D +  G +L  +L G     PF++   S
Sbjct: 148 EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG---LPPFYSRDVS 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 49/216 (22%), Positives = 93/216 (43%), Gaps = 40/216 (18%)

Query: 105 LGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           LG    GK Y+  L       +  +VA++ ++  E+  P+ Q +      +QE E+++ L
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLK--ENAEPKVQQE-----FRQEAELMSDL 65

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED------------AMDRIRENQLQLGWEV 206
           +H N++ L     +     ++++YL  G L +            A       +  L    
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 207 RLRIAVGVIKGLQYL--HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL------- 257
            L IA+ +  G++YL  H        H +L   N ++    T +++DFGL++        
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFV-----HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 258 -MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
            +    +    +  PE      +T +SDI+SFG++L
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 43/199 (21%)

Query: 194 RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
           R+     +L  +  L+  V +  G++YL    N   +H +L   N ML  + T  +ADFG
Sbjct: 102 RLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFG 158

Query: 254 LAKL--------------MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-G 298
           L+K               MP   IA       E   +R YT KSD+++FG+ +  + T G
Sbjct: 159 LSKKIYSGDYYRQGRIAKMPVKWIAI------ESLADRVYTSKSDVWAFGVTMWEIATRG 212

Query: 299 RDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLS 358
           + P             +  +LRH     +  + LD      E+ +        +   C  
Sbjct: 213 QTPYP-----GVENHEIYDYLRHGNRLKQPEDCLD------ELYD--------LMYSCWR 253

Query: 359 DSPADRPSSDELVPMLTQL 377
             P DRP+  +L  +L  +
Sbjct: 254 ADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 39/266 (14%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y+ T       VAV+++    SG   KQ     + I +E++ L  L+H N +  +    +
Sbjct: 38  YFATNSHTNEVVAVKKMSY--SG---KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILH 231
               +LV +Y   GS  D ++ + +  LQ   EV +  I  G ++GL YLH      ++H
Sbjct: 93  EHTAWLVMEYC-LGSASDLLE-VHKKPLQ---EVEIAAITHGALQGLAYLHSHN---MIH 144

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLMP--GSLIATSAYSAPE---CFQNRSYTDKSDIF 286
            ++K  N++L      +LADFG A       S + T  + APE         Y  K D++
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVW 204

Query: 287 SFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEM 346
           S G I  + L  R P  P F   A        +  L H  +             ++ +E 
Sbjct: 205 SLG-ITCIELAERKP--PLFNMNA--------MSALYHIAQNDSP--------TLQSNEW 245

Query: 347 LMAVRIAV-VCLSDSPADRPSSDELV 371
             + R  V  CL   P +RP+S EL+
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 16/168 (9%)

Query: 142 KSVKRRIQQELEVL-ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           K  ++ I  E  VL  +++H  L+ L      + + Y V DY+  G L   + R R    
Sbjct: 36  KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---- 91

Query: 201 QLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--L 257
               E R R  A  +   L YLH   +  I++ +LKP N++LD++    L DFGL K  +
Sbjct: 92  -CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 147

Query: 258 MPGS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                      T  Y APE    + Y    D +  G +L  +L G  P
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 27/178 (15%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMS-LRAYVPESS-----RFYLVYDYLQTGSLEDAMD 193
           QN +  +R  +EL ++  + H+N++  L  + P+ S       YLV + L   +L   + 
Sbjct: 54  QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVI- 111

Query: 194 RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
                Q+ L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFG
Sbjct: 112 -----QMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 163

Query: 254 LAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA------VLLTGRD 300
           LA+      M    + T  Y APE      Y +  DI+S G I+       VL  G D
Sbjct: 164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 34/240 (14%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           KQ+    + I +E++ L  ++H N +  +         +LV +Y   GS  D ++ + + 
Sbjct: 63  KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLE-VHKK 120

Query: 199 QLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
            LQ   EV +  I  G ++GL YLH   +  ++H ++K  N++L      +LADFG A +
Sbjct: 121 PLQ---EVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174

Query: 258 MP--GSLIATSAYSAPE---CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
                S + T  + APE         Y  K D++S G I  + L  R P  P F   A  
Sbjct: 175 ASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP--PLFNMNA-- 229

Query: 313 GSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAV-VCLSDSPADRPSSDELV 371
                 +  L H  +             ++ +E     R  V  CL   P DRP+S+EL+
Sbjct: 230 ------MSALYHIAQNESP--------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 11/102 (10%)

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT--- 265
           ++ V ++K L YL       ++H ++KP+N++LDA    +L DFG++  +  S   T   
Sbjct: 118 KMTVAIVKALHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175

Query: 266 --SAYSAPECF----QNRSYTDKSDIFSFGMILAVLLTGRDP 301
             +AY APE       N  Y  ++D++S G+ L  L TG+ P
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVR-RVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           ++LGS   G  Y+ + +  G TV +   ++     +  K N         E  ++AS+ H
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV----EFMDEALIMASMDH 68

Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            +L+ L   V  S    LV   +  G L   +D + E++  +G ++ L   V + KG+ Y
Sbjct: 69  PHLVRLLG-VCLSPTIQLVTQLMPHGCL---LDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPE 272
           L      +++H +L   NV++ +    ++ DFGLA+L+ G     +A        + A E
Sbjct: 125 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT 297
           C   R +T +SD++S+G+ +  L+T
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 21/175 (12%)

Query: 140 QNKSVKRR-----IQQELEVL-ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMD 193
           Q K++ ++     I  E  VL  +++H  L+ L      + + Y V DY+  G L   + 
Sbjct: 29  QKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ 88

Query: 194 RIRENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
           R R        E R R  A  +   L YLH   +  I++ +LKP N++LD++    L DF
Sbjct: 89  RERSFP-----EPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDF 140

Query: 253 GLAKL-MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           GL K  +  S        T  Y APE  + + Y    D +  G +L  +L G  P
Sbjct: 141 GLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 29/178 (16%)

Query: 150 QELEVLASLRHRNLMSL-RAYVPESSR-FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +E+ +L  L+H N++SL + ++  + R  +L++DY +     D    I+ ++     +  
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKP 102

Query: 208 LRIAVGVIKGLQY-----LHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLM 258
           +++  G++K L Y     +H+     +LH +LKP N+++  E   R    +AD G A+L 
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Query: 259 PGSL---------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
              L         + T  Y APE     R YT   DI++ G I A LLT    + P F
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----SEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 49/199 (24%), Positives = 79/199 (39%), Gaps = 54/199 (27%)

Query: 177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIA--VGVIKGLQYLHFTCNPQILHYNL 234
           YLV +Y+  G L + +  IR++        R  IA  V  +  +  L F      +H ++
Sbjct: 77  YLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVLALDSVHKLGF------IHRDI 127

Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP----------------------------------- 259
           KP N+++DA+   +LADFGL K M                                    
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE--AASGGSLGR 317
            S + T  Y APE  +   Y  + D +S G+IL  +L G     PF+++    +   +  
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF---PPFYSDTLQETYNKIIN 244

Query: 318 WLRHLQ---HAGEAREALD 333
           W   L+       + EA+D
Sbjct: 245 WKESLRFPPDPPVSPEAID 263

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 41/196 (20%), Positives = 90/196 (45%), Gaps = 20/196 (10%)

Query: 104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LLG    G+ ++  L +   VAV+  +       E   + +K +   E  +L    H N+
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCK-------EDLPQELKIKFLSEARILKQYDHPNI 54

Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           + L     +    Y+V + +  G   D +  +R+ + +L  +  ++ A+    G+ YL  
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110

Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQN 276
             +   +H +L   N ++      +++DFG+++     + ++S        ++APE    
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY 168

Query: 277 RSYTDKSDIFSFGMIL 292
             Y+ +SD++S+G++L
Sbjct: 169 GRYSSESDVWSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL------MPGSLIA 264
           A  ++ GLQ+LH   +  I++ +LK  NVMLD +   ++ADFG+ K          +   
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           T  Y APE  Q   YT   D +SFG++L  +L G+ P
Sbjct: 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 41/165 (24%), Positives = 80/165 (48%), Gaps = 13/165 (7%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + QE  +L  L H  ++++     + +R Y + +++  G L      +R+   +   +V 
Sbjct: 65  VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL---FTHLRKAG-RFPNDVA 120

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIA 264
                 ++   +YLH   +  I++ +LKP N++LD +   ++ DFG AK +P    +L  
Sbjct: 121 KFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCG 177

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           T  Y APE  Q++ +    D ++ G++L   + G     PFF + 
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGY---PPFFDDT 219

Length = 329

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)

Query: 108 SPDGKYY-RTVLDNGLTVAV---RRVE-----AFESGSPEKQNKSVKRRIQQELEVLASL 158
               KY+   VL +G T  V   +RV      A +    E  +++ K R Q E+  L + 
Sbjct: 29  EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC 88

Query: 159 R-------HRNLMSLRAYVPES-SRFYLVYDYLQTGSL-EDAMDRIRENQLQLGWEVRLR 209
                   H +        PE+     LV DY   G L ++   R + N+     E  L 
Sbjct: 89  DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL- 147

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------- 262
           + + V+  + ++H   +  ++H ++K  N++L +    +L DFG +K+   ++       
Sbjct: 148 LFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 263 -IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              T  Y APE ++ + Y+ K+D+FS G++L  LLT + P
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 19/136 (13%)

Query: 175 RFYLVYDYLQTGSLEDAMDRIRENQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILH 231
           R Y V +Y+  G   D M  I+    Q+G       +  A  +  GL +LH   +  I++
Sbjct: 75  RLYFVMEYVNGG---DLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLH---SKGIIY 124

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLIATSAYSAPECFQNRSYTDKSDI 285
            +LK  NVMLDAE   ++ADFG+ K  +  G    +   T  Y APE    + Y    D 
Sbjct: 125 RDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 286 FSFGMILAVLLTGRDP 301
           ++FG++L  +L G+ P
Sbjct: 185 WAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 42/178 (23%), Positives = 88/178 (49%), Gaps = 27/178 (15%)

Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  +SG  EKQ    +R    E  ++    H N++ L   V +S    ++ ++++ G+L
Sbjct: 37  IKTLKSGYTEKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL 92

Query: 189 EDAMDRIRENQ---LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
            D+  R  + Q   +QL   +R     G+  G++YL        +H +L   N+++++  
Sbjct: 93  -DSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL---SEMNYVHRDLAARNILVNSNL 143

Query: 246 TPRLADFGLAKLM---PGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMIL 292
             +++DFGL++ +         TS+        ++APE    R +T  SD++S+G+++
Sbjct: 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 43/188 (22%), Positives = 91/188 (48%), Gaps = 22/188 (11%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ-QELEVLASLRHRNLMSLRAYVPESSRFY 177
           + G  VA+++         E ++  V ++I  +E+ +L  L+H NL++L        + +
Sbjct: 24  ETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLH 76

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           LV++Y    ++ + +++   N   +   +  +I    ++ + + H       +H ++KP 
Sbjct: 77  LVFEYCDH-TVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPE 129

Query: 238 NVMLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECF-QNRSYTDKSDIFSFGM 290
           N+++  +   +L DFG A+++ G        +AT  Y APE    +  Y    D+++ G 
Sbjct: 130 NILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGC 189

Query: 291 ILAVLLTG 298
           + A LLTG
Sbjct: 190 VFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 13/145 (8%)

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L +    +SR +LV +Y+  G L   M R    Q +L  E     A  +   L +LH
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLH 113

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLIATSAYSAPECFQN 276
                 I++ +LK  NV+LDA+   +L D+G+ K  L PG    +   T  Y APE  + 
Sbjct: 114 ---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDP 301
             Y    D ++ G+++  ++ GR P
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 14/161 (8%)

Query: 148 IQQELEVL-ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +Q E  V   +  H  L+ L +     SR + V +Y+  G L   M R    Q +L  E 
Sbjct: 42  VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEH 97

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGS--- 261
               +  +   L YLH      I++ +LK  NV+LD+E   +L D+G+ K  L PG    
Sbjct: 98  ARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154

Query: 262 -LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               T  Y APE  +   Y    D ++ G+++  ++ GR P
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 38/138 (27%), Positives = 76/138 (55%), Gaps = 17/138 (12%)

Query: 177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP 236
           ++V ++L+ G+L D +   R N+ Q+       + + V+K L +LH      ++H ++K 
Sbjct: 92  WVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLH---AQGVIHRDIKS 143

Query: 237 TNVMLDAEFTPRLADFG----LAKLMP--GSLIATSAYSAPECFQNRSYTDKSDIFSFGM 290
            +++L ++   +L+DFG    ++K +P   SL+ T  + APE      Y  + DI+S G+
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGI 203

Query: 291 ILAVLLTGRDPTAPFFAE 308
           ++  ++ G +P  P+F E
Sbjct: 204 MVIEMVDG-EP--PYFNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 47/236 (19%)

Query: 105 LGSSPDGKYY--RTVLDNGLTVAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           +G    GK +  R + + G  VA++RV  +  E G P    + V       L  L +  H
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-----VLRHLETFEH 63

Query: 161 RNLMSL-----RAYVPESSRFYLVYDYLQ---TGSLEDAMD------RIRENQLQLGWEV 206
            N++ L      +     ++  LV++++    T  L+   +       I++   QL    
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL---- 119

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL-----MPGS 261
                   ++GL +LH   + +++H +LKP N+++ +    +LADFGLA++        S
Sbjct: 120 --------LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 168

Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           ++ T  Y APE     SY    D++S G I A +   +    P F  ++    LG+
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGK 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 67/303 (22%), Positives = 111/303 (36%), Gaps = 69/303 (22%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
                VAV+++      + +  +K   + +QQE+     L+H N++         S  Y+
Sbjct: 23  PTNTLVAVKKI------NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYV 76

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           V   +  GS ED +       L    E+ +  I   V+  L Y+H   +   +H ++K +
Sbjct: 77  VSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH---SKGFIHRSVKAS 130

Query: 238 NVMLDAEFTPRLADFGLAKLM-------------PGSLIATSAYSAPECF-QN-RSYTDK 282
           +++L  +    L+    +  M             P S +    + +PE   QN + Y +K
Sbjct: 131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEK 190

Query: 283 SDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVE 342
           SDI+S G+    L  G  P    F +  +   L   +R     G     LD+S       
Sbjct: 191 SDIYSVGITACELANGHVP----FKDMPATQMLLEKVR-----GTVPCLLDKSTYPL--Y 239

Query: 343 EDEML-----------------MAVR--------IAVVCLSDSPADRPSSDELVPMLTQL 377
           ED M                     R           +CL   P  RPS+ +L   L   
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL---LN-- 294

Query: 378 HSF 380
           HSF
Sbjct: 295 HSF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 15/158 (9%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L SL+       R   V +Y+  G L   + R R     +  E R R 
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER-----VFSEDRTRF 99

Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPGSLI 263
               ++  L YLH   + +I++ +LK  N+MLD +   ++ DFGL K          +  
Sbjct: 100 YGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 37/228 (16%)

Query: 89  IDPKTLQAALANE---NRL-----LGSSPDGK------YYRTVLDNGLTVAVRRVEAFES 134
           IDP  L   L  E   N L     LG+   GK      Y  +  D  + VAV+ ++    
Sbjct: 19  IDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK---- 74

Query: 135 GSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMD 193
                 + S +  +  EL++++ L  H N+++L           ++ +Y   G L + + 
Sbjct: 75  ---PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131

Query: 194 RIRENQLQLGWEVRLRIAVGVIKGLQYLHF-TCNPQILHYNLKPTNVMLDAEFTPRLADF 252
           R RE+ L L  E  L  +  V KG+ +L    C    +H +L   NV+L      ++ DF
Sbjct: 132 RKRESFLTL--EDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDF 185

Query: 253 GLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           GLA+        ++ G+      + APE   N  YT +SD++S+G++L
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 233

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 52/185 (28%), Positives = 86/185 (46%), Gaps = 33/185 (17%)

Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPES-------------SRFYLVYDYLQTGSLEDA 191
           K+ I  + EV  ++  RN++ +R  + ES             S  YLV DY+  G L   
Sbjct: 28  KKEIVAKKEVAHTIGERNIL-VRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWH 86

Query: 192 MDRIRENQLQLGWEVRLRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
           + +  E +     E R +  +  ++  L++LH      I++ +LKP N++LDA     L 
Sbjct: 87  LQK--EGRFS---EDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALC 138

Query: 251 DFGLAKL------MPGSLIATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           DFGL+K          +   T+ Y APE     + YT   D +S G+++  +  G    +
Sbjct: 139 DFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG---WS 195

Query: 304 PFFAE 308
           PF+AE
Sbjct: 196 PFYAE 200

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 12/108 (11%)

Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYS 269
           ++GL +LH  C   I+H +LKP N+++ +    +LADFGLA++    +     + T  Y 
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYR 174

Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           APE     +Y    D++S G I A +   +    P F   +    LG+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGK 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 14/161 (8%)

Query: 148 IQQELEVL-ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +Q E  V   +  H  L+ L +     SR + V +++  G L   M R    Q +L  E 
Sbjct: 42  VQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEH 97

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIA 264
               +  +   L +LH      I++ +LK  NV+LDAE   +L D+G+ K  + PG   +
Sbjct: 98  ARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154

Query: 265 ----TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               T  Y APE  +   Y    D ++ G+++  ++ GR P
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 53/263 (20%), Positives = 108/263 (41%), Gaps = 46/263 (17%)

Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           V+A +  + ++  +S  RR   EL++   L H+N++ L     E+   Y++ +Y   G L
Sbjct: 40  VKALQK-TKDENLQSEFRR---ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95

Query: 189 EDAM--DRIRENQLQ---LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA 243
           +  +   + ++ +L+   L  + ++ +   +  G+ +L    N + +H +L   N ++ +
Sbjct: 96  KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSS 152

Query: 244 EFTPRLADFGLAKLMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL-AVL 295
           +   +++   L+K +  S        +    + APE  Q   ++ KSD++SFG+++  V 
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212

Query: 296 LTGRDPTAPF----FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR 351
             G  P               G L              E     +              +
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKL-ELPVP--------EGCPSRLY-------------K 250

Query: 352 IAVVCLSDSPADRPSSDELVPML 374
           +   C + +P DRPS  ELV  L
Sbjct: 251 LMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)

Query: 104 LLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-R 159
           ++G    G+  R ++      +  A++ ++ F S       ++  R    ELEVL  L  
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-------ENDHRDFAGELEVLCKLGH 61

Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ------------LGWEVR 207
           H N+++L          Y+  +Y   G+L D + + R  +              L  +  
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA 267
           L+ A  V  G+QYL      Q +H +L   NV++      ++ADFGL++     +  T  
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL 292
                + A E      YT KSD++SFG++L
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLL 208

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 28/170 (16%)

Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED------------AMDRIRE 197
           E+E++  + +H+N+++L     +    Y++ +Y   G+L +            + D  + 
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
            + QL ++  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 184 VHNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 23/168 (13%)

Query: 150 QELEVLASLRHRNLMSL-RAYVPESSR-FYLVYDYLQTGSLE----DAMDRIRENQLQLG 203
           +E+ +L  L+H N+++L + ++  S R  +L++DY +             +  +  +QL 
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP 106

Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP 259
             +   +   ++ G+ YLH      +LH +LKP N+++  E   R    +AD G A+L  
Sbjct: 107 RSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 260 GSL---------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLT 297
             L         + T  Y APE     R YT   DI++ G I A LLT
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.8 bits (134), Expect = 9e-09
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 24/167 (14%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG---SLEDAMDRIRENQLQLGWEV 206
           +E+ +L  L+H N+++L   +       LV++YL       L+D  + I  + ++L    
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL---- 108

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL--AKLMP----G 260
                  +++GL Y H     ++LH +LKP N++++     +LADFGL  AK +P     
Sbjct: 109 ---FLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162

Query: 261 SLIATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           + + T  Y  P+     + Y+ + D++  G I   + TGR    P F
Sbjct: 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR----PLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.5 bits (133), Expect = 9e-09
 Identities = 45/175 (25%), Positives = 85/175 (48%), Gaps = 23/175 (13%)

Query: 145 KRRIQQELEVLASL-RHRNLMSLR-AYVPES-----SRFYLVYDYLQTGSLEDAMDRIRE 197
           +  I+QE+ +L     HRN+ +   A++ ++      + +LV ++   GS+ D +   + 
Sbjct: 46  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 105

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           N L+  W     I   +++GL +LH     +++H ++K  NV+L      +L DFG++  
Sbjct: 106 NTLKEEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160

Query: 258 MP------GSLIATSAYSAPE---CFQN--RSYTDKSDIFSFGMILAVLLTGRDP 301
           +        + I T  + APE   C +N   +Y  KSD++S G+    +  G  P
Sbjct: 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 29/184 (15%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE--------DA- 191
           ++S ++  Q+E E+L  L+H++++       E     +V++Y++ G L         DA 
Sbjct: 47  SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAK 106

Query: 192 -MDRIRENQL-QLGWEVRLRIAVGVIKGLQY---LHFTCNPQILHYNLKPTNVMLDAEFT 246
            +    +    QL     L IA  +  G+ Y   LHF      +H +L   N ++     
Sbjct: 107 ILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLV 160

Query: 247 PRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT- 297
            ++ DFG+++         + G  +    +  PE    R +T +SDI+SFG++L  + T 
Sbjct: 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220

Query: 298 GRDP 301
           G+ P
Sbjct: 221 GKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 36/201 (17%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
           +    VA++RV        +  ++ V     +E+ +L  L+H+N++ L   +    +  L
Sbjct: 23  ETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTL 76

Query: 179 VYDYLQTG------SLEDAMDR--IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
           V++Y          S    +D   ++    QL            +KGL + H   +  +L
Sbjct: 77  VFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------------LKGLAFCH---SHNVL 121

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKL--MP----GSLIATSAYSAPEC-FQNRSYTDKS 283
           H +LKP N++++     +LADFGLA+   +P     + + T  Y  P+  F  + Y+   
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 181

Query: 284 DIFSFGMILAVLLTGRDPTAP 304
           D++S G I A L     P  P
Sbjct: 182 DMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 23/175 (13%)

Query: 145 KRRIQQELEVLASL-RHRNLMSLR-AYVPES-----SRFYLVYDYLQTGSLEDAMDRIRE 197
           +  I+ E+ +L     HRN+ +   A++ +S      + +LV ++   GS+ D +   + 
Sbjct: 56  EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG 115

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           N L+  W     I   +++GL +LH     +++H ++K  NV+L      +L DFG++  
Sbjct: 116 NALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170

Query: 258 MP------GSLIATSAYSAPE---CFQN--RSYTDKSDIFSFGMILAVLLTGRDP 301
           +        + I T  + APE   C +N   +Y  +SDI+S G+    +  G  P
Sbjct: 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 21/105 (20%)

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS---- 269
           V KG++YL    + + +H +L   N MLD  FT ++ADFGLA+     +     YS    
Sbjct: 107 VAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNH 159

Query: 270 ----------APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
                     A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 104 LLGSSPDGKYYR-TVLDNGLTVAVR--RVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
            +G    G  Y+   L+ G  VA++  RV   E G P     S  R I   L+ L S  H
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP----LSTLREIAL-LKQLESFEH 60

Query: 161 RNLMSLR--AYVPESSR---FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
            N++ L    + P + R     LV++++    L   + +  +  L    E    +   ++
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGL--PPETIKDLMRQLL 117

Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL----MP-GSLIATSAYSA 270
           +G+ +LH   + +I+H +LKP N+++ ++   ++ADFGLA++    M   S++ T  Y A
Sbjct: 118 RGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRA 174

Query: 271 PECFQNRSYTDKSDIFSFGMILAVL 295
           PE     SY    D++S G I A L
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 33/220 (15%)

Query: 105 LGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRN 162
           +G    GK Y+ T   +G   AV+ ++             V   I+ E  +L SL  H N
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPI---------SDVDEEIEAEYNILQSLPNHPN 80

Query: 163 LMSLRAYVPESSRF-----YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
           ++       ++ +      +LV +    GS+ + +  +     +L   +   I  G + G
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL------AKLMPGSLIATSAYSAP 271
           LQ+LH   N +I+H ++K  N++L  E   +L DFG+       +L   + + T  + AP
Sbjct: 141 LQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 272 E---CFQ--NRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           E   C Q  + SY  + D++S G I A+ L   DP  P F
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLG-ITAIELGDGDP--PLF 234

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 103 RLLGSSPDGKYYRTVLDNG--LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           R LG+   G+       N     VA++R   FE     KQ K V   +  E ++L  + H
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKR---FEKSKIIKQ-KQVDH-VFSERKILNYINH 90

Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
              ++L     + S  YLV +++  G        +R N+ +   +V    A  ++   +Y
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEF---FTFLRRNK-RFPNDVGCFYAAQIVLIFEY 146

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNR 277
           L    +  I++ +LKP N++LD +   ++ DFG AK++     +L  T  Y APE   N 
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNV 203

Query: 278 SYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
            +   +D ++ G+ +  +L G     PF+A
Sbjct: 204 GHGKAADWWTLGIFIYEILVG---CPPFYA 230

Length = 340

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 9/157 (5%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +LA +  R ++SL       +   LV   +  G L   +  + E             
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-KLMPGS-----LIA 264
              +I GL++LH     +I++ +LKP NV+LD +   R++D GLA +L  G         
Sbjct: 103 TAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           T  + APE  Q   Y    D F+ G+ L  ++  R P
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 47/162 (29%), Positives = 83/162 (51%), Gaps = 15/162 (9%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E+ +L +L+H N+++L   +       LV++YL +  L+  +D      L     V++ 
Sbjct: 52  REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC--GNLMSMHNVKI- 107

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL--AKLMP----GSLI 263
               +++GL Y H     +ILH +LKP N++++ +   +LADFGL  AK +P     + +
Sbjct: 108 FMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEV 164

Query: 264 ATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAP 304
            T  Y  P+     + Y+   D++  G IL  + TGR P  P
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR-PMFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)

Query: 141 NKSVKRRIQQELEVL-ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           N+  ++ I  E  VL  +++H  L+ L      + + Y V D++  G L   + R R   
Sbjct: 35  NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP 94

Query: 200 LQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL- 257
                E R R  A  +   L YLH   +  I++ +LKP N++LD++    L DFGL K  
Sbjct: 95  -----EPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 258 -----MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   +   T  Y APE  + + Y +  D +  G +L  +L G  P
Sbjct: 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 18/104 (17%)

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           IAV  +K L YL       I+H ++KP+N++LD     +L DFG++    G L+ + A  
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKT 165

Query: 268 -------YSAPE---CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                  Y APE         Y  +SD++S G+ L  + TG+ P
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 24/187 (12%)

Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY 180
           +  A++R++ + S       K   R    ELEVL  L  H N+++L          YL  
Sbjct: 35  MDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87

Query: 181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN----------PQIL 230
           +Y   G+L D + + R  +    + +    A   +   Q LHF  +           Q +
Sbjct: 88  EYAPHGNLLDFLRKSRVLETDPAFAIANSTA-STLSSQQLLHFAADVARGMDYLSQKQFI 146

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKSDI 285
           H +L   N+++   +  ++ADFGL++     +  T       + A E      YT  SD+
Sbjct: 147 HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 206

Query: 286 FSFGMIL 292
           +S+G++L
Sbjct: 207 WSYGVLL 213

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 28/170 (16%)

Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSL------------EDAMDRIRE 197
           E+E++  + +H+N+++L     +    Y++ +Y   G+L            E + D  R 
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              Q+ ++  +     V +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 187 VNNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 32/203 (15%)

Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG    GK Y+    N  T A+   +  E+ S E+    +      E+E+LA+  H  ++
Sbjct: 20  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYM-----VEIEILATCNHPYIV 72

Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAM---DR-IRENQLQLGWEVRLRIAVGVIKGLQY 220
            L        + +++ ++   G+++  M   DR + E Q+Q+       I   +++ LQY
Sbjct: 73  KLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQY 125

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPEC- 273
           LH   + +I+H +LK  NV+L  +   +LADFG+ AK +       S I T  + APE  
Sbjct: 126 LH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182

Query: 274 ----FQNRSYTDKSDIFSFGMIL 292
                ++  Y  K+DI+S G+ L
Sbjct: 183 MCETMKDTPYDYKADIWSLGITL 205

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 52/179 (29%), Positives = 78/179 (43%), Gaps = 51/179 (28%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV-- 206
           E+ +L  L+H N++SL     E +    YL++DY              E+ L   W++  
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-------------AEHDL---WQIIK 95

Query: 207 ------RLRIAVGVIK--------GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR---- 248
                 R+ I   ++K        G+ YLH   +  +LH +LKP N+++  E   R    
Sbjct: 96  FHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVK 152

Query: 249 LADFGLAKLMPGSL---------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLT 297
           + D GLA+L    L         + T  Y APE     R YT   DI++ G I A LLT
Sbjct: 153 IGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 28/181 (15%)

Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVP----------ESSRFYLVYDYLQTGSLEDAMDR 194
           K  I Q+ +V  ++  + ++SL    P             R + V +++  G L   + +
Sbjct: 30  KDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK 89

Query: 195 IRENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
            R        E R R  A  +   L +LH   +  I++ +LK  NV+LD E   +LADFG
Sbjct: 90  SRRFD-----EARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 254 LAK------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           + K          +   T  Y APE  Q   Y    D ++ G++L  +L G    APF A
Sbjct: 142 MCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH---APFEA 198

Query: 308 E 308
           E
Sbjct: 199 E 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 15/162 (9%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E+ +L  L+H N+++L   V       LV++YL    L+  MD      +     V++ 
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC--GNIMSMHNVKIF 109

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL--AKLMP----GSLI 263
           +   +++GL Y H     ++LH +LKP N++++     +LADFGL  AK +P     + +
Sbjct: 110 L-YQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165

Query: 264 ATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAP 304
            T  Y  P+     S Y+ + D++  G I   + +GR P  P
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFP 206

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 45/173 (26%), Positives = 72/173 (41%), Gaps = 21/173 (12%)

Query: 138 EKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM--DR 194
           E  +K   R    ELEVL  L  H N+++L          YL  +Y   G+L D +   R
Sbjct: 32  EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 91

Query: 195 IRENQLQLGWE----------VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE 244
           + E                    L  A  V +G+ YL      Q +H +L   N+++   
Sbjct: 92  VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN 148

Query: 245 FTPRLADFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKSDIFSFGMIL 292
           +  ++ADFGL++     +  T       + A E      YT  SD++S+G++L
Sbjct: 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 201

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 43/170 (25%), Positives = 83/170 (48%), Gaps = 28/170 (16%)

Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   +         
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL ++  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 190 IHHIDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 52/219 (23%), Positives = 98/219 (44%), Gaps = 46/219 (21%)

Query: 105 LGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           LG    GK Y+  L     D+   VA++ ++   +  P++  +      QQE  ++A L 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGE-----FQQEASLMAELH 65

Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---------------DRIRENQLQLGW 204
           H N++ L   V +     ++++YL  G L + +               D   ++ L  G 
Sbjct: 66  HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG- 124

Query: 205 EVRLRIAVGVIKGLQYL--HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------- 255
              L IA+ +  G++YL  HF      +H +L   N+++  +   +++D GL+       
Sbjct: 125 -DFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 256 --KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
             ++ P SL+    +  PE      ++  SDI+SFG++L
Sbjct: 179 YYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 29/177 (16%)

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM----DRIRENQLQLGW 204
           ++E +VL +  ++ + +L     + +  YLV DY   G L   +    DR+ E+  +  +
Sbjct: 49  REERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-Y 107

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG-LAKLMPGSLI 263
              + IA+  +  L Y+H          ++KP N+++D     RLADFG   KLM    +
Sbjct: 108 LAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 264 ATSA------YSAPECFQNRS-----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
            +S       Y +PE  Q        Y  + D +S G+ +  +L G     PF+AE+
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE---TPFYAES 212

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 47/180 (26%)

Query: 151 ELEVLASLRHRNLMSL--------RAYVPESSRFYLVYDY--------LQTGSLEDAMDR 194
           E+++L  L+H N+++L          Y      FYLV+++        L   +++  +  
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120

Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           I++    L            + GL Y+H     +ILH ++K  N+++  +   +LADFGL
Sbjct: 121 IKKVMKML------------LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165

Query: 255 AKLMPGSL------------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDP 301
           A+    SL            + T  Y  PE     R Y    D++  G I+A + T R P
Sbjct: 166 AR--AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSP 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL-MPG-----SLIA 264
           A  +I GLQ+LH   +  I++ +LK  N++LD +   ++ADFG+ K  M G     +   
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           T  Y APE    + Y    D +SFG++L  +L G+ P
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSAP 271
           GL+ LH     +I++ +LKP N++LD     R++D GLA  +P        + T  Y AP
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           E  +N  YT   D ++ G +L  ++ G+ P
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 8/96 (8%)

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSLI----AT 265
           A  ++ GL+ LH       ++ +LKP N++LD     R++D GLA  +P G  I     T
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT 164

Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             Y APE   N+ YT   D +  G ++  ++ G+ P
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 34/157 (21%), Positives = 74/157 (47%), Gaps = 14/157 (8%)

Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           +K +  QE  +L    H N++ L     +    Y+V + +Q G   D +  +R    +L 
Sbjct: 36  LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGPRLK 92

Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
            +  +++      G++YL        +H +L   N ++  +   +++DFG+++     + 
Sbjct: 93  VKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149

Query: 264 ATSA--------YSAPECFQNRSYTDKSDIFSFGMIL 292
           A++         ++APE      Y+ +SD++SFG++L
Sbjct: 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 15/158 (9%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 99

Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 100 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 44/187 (23%), Positives = 84/187 (44%), Gaps = 30/187 (16%)

Query: 145 KRRIQQELEVLASLRHRNLMSL--RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           K ++  E+ V+  L+H+N++    R     + + Y++ ++   G L   + +  +   ++
Sbjct: 56  KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115

Query: 203 GWEVRLRIAVGVIKGLQYLH-FTCNP---QILHYNLKPTNVML----------------- 241
                + I   ++  L Y H     P   ++LH +LKP N+ L                 
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175

Query: 242 DAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECF--QNRSYTDKSDIFSFGMILAV 294
           +     ++ DFGL+K      M  S + T  Y +PE    + +SY DKSD+++ G I+  
Sbjct: 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235

Query: 295 LLTGRDP 301
           L +G+ P
Sbjct: 236 LCSGKTP 242

Length = 1021

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 23/164 (14%)

Query: 151 ELEVLASLRHRN-LMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLGWEV 206
           E +VL ++R    L++L       ++ +L+ DY+  G L   +   +   E+      EV
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES------EV 107

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-LMPG----- 260
           R+ IA  V+  L +LH      I++ ++K  N++LD+E    L DFGL+K  +       
Sbjct: 108 RVYIAEIVL-ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 261 -SLIATSAYSAPECFQ--NRSYTDKSDIFSFGMILAVLLTGRDP 301
            S   T  Y APE  +  +  +    D +S G++   LLTG  P
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 13/137 (9%)

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-----SLIATSAYSAP 271
           G+ +LH   +  I++ ++KP NV+LD +   RL+D GLA  +           T+ Y AP
Sbjct: 107 GILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR---HLQHAGEA 328
           E  +   Y+   D F+ G  +  ++ GR P      + A      R L      +H    
Sbjct: 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFT 223

Query: 329 REALD--RSILGEEVEE 343
            E+ D  R  L ++ E+
Sbjct: 224 EESKDICRLFLAKKPED 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 16/140 (11%)

Query: 175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
           R Y V +Y+  G L   + ++   +          IA+G       L F  +  I++ +L
Sbjct: 75  RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG-------LFFLHSKGIIYRDL 127

Query: 235 KPTNVMLDAEFTPRLADFGLAK------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSF 288
           K  NVMLD+E   ++ADFG+ K      +   +   T  Y APE    + Y    D ++F
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187

Query: 289 GMILAVLLTGRDPTAPFFAE 308
           G++L  +L G+   APF  E
Sbjct: 188 GVLLYEMLAGQ---APFEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 15/161 (9%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L  L+H N+++L   +       LV++YL T  L+  MD      L +   VRL  
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD-CGGGLSMH-NVRL-F 108

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL--AKLMP----GSLIA 264
              +++GL Y H     ++LH +LKP N+++      +LADFGL  AK +P     + + 
Sbjct: 109 LFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV 165

Query: 265 TSAYSAPECF-QNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           T  Y  P+    +  Y+   D++  G I   + TGR P  P
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR-PLFP 205

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 19/136 (13%)

Query: 175 RFYLVYDYLQTGSLE---DAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILH 231
           R Y V +Y+  G L      + + +E Q           A  +  GL +LH      I++
Sbjct: 75  RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-------YAAEISVGLFFLH---RRGIIY 124

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLIATSAYSAPECFQNRSYTDKSDI 285
            +LK  NVMLD+E   ++ADFG+ K  ++ G    +   T  Y APE    + Y    D 
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 286 FSFGMILAVLLTGRDP 301
           +++G++L  +L G+ P
Sbjct: 185 WAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 45  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARF 99

Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L YLH      +++ +LK  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 100 YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 12/121 (9%)

Query: 192 MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
           M RI E    L  +  +R  + +  G++YL    +   +H +L   N ML+   T  +AD
Sbjct: 100 MSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD 156

Query: 252 FGLA-KLMPGSLIATSAYS-------APECFQNRSYTDKSDIFSFGMILAVLLT-GRDPT 302
           FGL+ K+  G        S       A E   +  YT  SD+++FG+ +  ++T G+ P 
Sbjct: 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Query: 303 A 303
           A
Sbjct: 217 A 217

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 40/237 (16%)

Query: 104 LLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           ++G+   G  Y  + +D    VA+++V       P+ +N+        EL ++ +L H N
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQ----DPQYKNR--------ELLIMKNLNHIN 120

Query: 163 LMSLRAYV-PESSR-------FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGV 214
           ++ L+ Y   E  +         +V +++     +      R N     + V+L  +  +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQL 179

Query: 215 IKGLQYLH--FTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAK-LMPG----SLIATS 266
            + L Y+H  F C     H +LKP N+++D    T +L DFG AK L+ G    S I + 
Sbjct: 180 CRALAYIHSKFIC-----HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234

Query: 267 AYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
            Y APE      +YT   D++S G I+A ++ G     P F+  +S   L R ++ L
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY----PIFSGQSSVDQLVRIIQVL 287

Length = 440

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 47/189 (24%), Positives = 88/189 (46%), Gaps = 24/189 (12%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
            Y       + VAV+ ++       ++   + K+   +E  V+A L H  ++ L   V +
Sbjct: 15  VYLMKSGKEVEVAVKTLK-------QEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCK 66

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHY 232
                LV +    G L   + + RE  +    E+  ++A+G +  L+  HF      +H 
Sbjct: 67  GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMG-MAYLESKHF------VHR 119

Query: 233 NLKPTNVMLDAEFTPRLADFGLAKLM-PGS--LIATSA------YSAPECFQNRSYTDKS 283
           +L   NV+L      +++DFG+++ +  GS    AT+A      + APEC     ++ KS
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKS 179

Query: 284 DIFSFGMIL 292
           D++S+G+ L
Sbjct: 180 DVWSYGVTL 188

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 8/90 (8%)

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSLI----ATSAYSAP 271
           GL+ L      +I++ +LKP N++LD     R++D GLA  +P G  +     T  Y AP
Sbjct: 114 GLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           E   N  YT   D +  G ++  ++ G+ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSLI----AT 265
           A  +  GL+ LH     +I++ +LKP N++LD     R++D GLA  +P G  I     T
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164

Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             Y APE  +N  YT   D +  G ++  ++ G+ P
Sbjct: 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 36/171 (21%), Positives = 72/171 (42%), Gaps = 26/171 (15%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-------EDAMD 193
           + + +    +E+++L+ L   N+  L           ++ +Y++ G L            
Sbjct: 59  SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 194 RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
            +  N   L +   L +A  +  G++YL    +   +H +L   N ++   +T ++ADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFG 175

Query: 254 LAKLMPGSLIATSAY----SAP--------ECFQNRSYTDKSDIFSFGMIL 292
               M  +L ++  Y     AP        E      +T KSD+++FG+ L
Sbjct: 176 ----MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTL 222

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 39/177 (22%), Positives = 79/177 (44%), Gaps = 21/177 (11%)

Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE--------DAMDR 194
           + ++   +E E+L +L+H +++       E     +V++Y++ G L         DA+  
Sbjct: 49  NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLM 108

Query: 195 IREN-QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
              N   +L     L IA  +  G+ YL    +   +H +L   N ++      ++ DFG
Sbjct: 109 AEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFG 165

Query: 254 LAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           +++         + G  +    +  PE    R +T +SD++S G++L  + T G+ P
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 13/162 (8%)

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM-DRIRENQLQLGWEVR 207
           + EL  LA+  H  ++          +  L+ +Y   G L   +  R++E+     +EV 
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
           L +   ++  L  +H      ++H +LK  N+ L      +L DFG +K         + 
Sbjct: 173 L-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S   T  Y APE ++ + Y+ K+D++S G+IL  LLT   P
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 41/192 (21%), Positives = 80/192 (41%), Gaps = 34/192 (17%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE--- 197
           N  +K+R  +E ++ A L H  ++ + +   +    Y    Y++  +L+  +  + +   
Sbjct: 42  NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKES 101

Query: 198 --NQLQLGWEVR--LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
              +L     V   L I   +   ++Y+H   +  +LH +LKP N++L       + D+G
Sbjct: 102 LSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158

Query: 254 LAKL------------------------MPGSLIATSAYSAPECFQNRSYTDKSDIFSFG 289
            A                          +PG ++ T  Y APE       ++ +DI++ G
Sbjct: 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218

Query: 290 MILAVLLTGRDP 301
           +IL  +LT   P
Sbjct: 219 VILYQMLTLSFP 230

Length = 932

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 20/164 (12%)

Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG---SLEDAMDRIRENQLQL 202
           R +  E ++L + +   L+ L     +    YL  +Y+  G   +L + +  + E+    
Sbjct: 46  RHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH--- 102

Query: 203 GWEVRLRIA--VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK---L 257
               R  +A     +  L  L +       H +LKP N ++DA    +L DFGL+K    
Sbjct: 103 ---ARFYMAEMFEAVDALHELGYI------HRDLKPENFLIDASGHIKLTDFGLSKGIVT 153

Query: 258 MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              S++ +  Y APE  + + Y    D +S G +L   L G  P
Sbjct: 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 15/158 (9%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARF 99

Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLI 263
               ++  L YLH +C+  +++ +LK  N+MLD +   ++ DFGL K  +  G    +  
Sbjct: 100 YGAEIVSALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156

Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 27/208 (12%)

Query: 103 RLLGSSPDGKYYRTV-LDNG----LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS 157
           ++LGS   G  Y+ + + +G    + VA++ +   E+ SP K NK     I  E  V+A 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSP-KANK----EILDEAYVMAG 65

Query: 158 LRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
           +    +  L   +  +S   LV   +  G L   +D +REN+ ++G +  L   V + KG
Sbjct: 66  VGSPYVCRLLG-ICLTSTVQLVTQLMPYGCL---LDYVRENKDRIGSQDLLNWCVQIAKG 121

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YS 269
           + YL      +++H +L   NV++ +    ++ DFGLA+L+        A        + 
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLT 297
           A E   +R +T +SD++S+G+ +  L+T
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 26/197 (13%)

Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           V V+ + A  S +P++Q   +     QE++    L H N++       ES  + LV ++ 
Sbjct: 25  VVVKELRA--SATPDEQLLFL-----QEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77

Query: 184 QTGSLEDAMDRIRENQLQLGW-EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD 242
             G L++ +   R    Q+   +V  R+A  V  GL +LH       +H +L   N  L 
Sbjct: 78  PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLT 134

Query: 243 AEFTPRLADFGLA-KLMPGSLIATSA-------YSAPECFQNR-------SYTDKSDIFS 287
           A+ + ++ D+GLA +  P     T         + APE  + R         T KS+I+S
Sbjct: 135 ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194

Query: 288 FGMILAVLLTGRDPTAP 304
            G+ +  L T  D   P
Sbjct: 195 LGVTMWELFTAADQPYP 211

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 20/170 (11%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL-GWEVRL 208
           +E  +L  L+H N++ L   +        V++Y+ T    D    + ++   L  + VRL
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL 107

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA--KLMP----GSL 262
                +++GL Y+H      ILH +LKP N+++      +LADFGLA  K +P     S 
Sbjct: 108 -FMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163

Query: 263 IATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS 311
           + T  Y  P+     + Y+   DI+  G I   +L G+    P F   + 
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ----PAFPGVSD 209

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 25/157 (15%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR----ENQLQLGWEV 206
           E+++LAS  H N++ L       +  +++ ++   G+++  M  +     E Q+++    
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV---- 107

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPG 260
              +    ++ L YLH     +I+H +LK  N++   +   +LADFG++           
Sbjct: 108 ---VCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161

Query: 261 SLIATSAYSAPECF-----QNRSYTDKSDIFSFGMIL 292
           S I T  + APE       ++R Y  K+D++S G+ L
Sbjct: 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 198

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 18/172 (10%)

Query: 140 QNKSVKRRIQQELEVLASLRHRN-LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           Q        + E  VL  +R    L++L       ++ +L+ DY+  G +   +      
Sbjct: 43  QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL-----Y 97

Query: 199 QLQLGWEVRLRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           Q     E  +R   G +I  L++LH      I++ ++K  N++LD+E    L DFGL+K 
Sbjct: 98  QRDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE 154

Query: 258 MPG-------SLIATSAYSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
                     S   T  Y APE  + +    K+ D +S G+++  LLTG  P
Sbjct: 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 21/169 (12%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEV 206
           IQQE+ ++   +H N+++         + ++  +Y   GSL+D        ++LQ+ +  
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG------ 260
           R       ++GL YLH       +H ++K  N++L      +LADFG+A  +        
Sbjct: 113 R-----ETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164

Query: 261 SLIATSAYSAPECF---QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           S I T  + APE     +N  Y    DI++ G I A+ L    P  P F
Sbjct: 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVG-ITAIELAELQP--PMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 48/250 (19%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLV-YDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           QE  +L  L H+N++ +     E      V Y Y+  G+L+  + + R  +      +  
Sbjct: 57  QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 209 R----IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-LMPGSLI 263
           +    +A+ +  G+ YLH      ++H ++   N ++D E   ++ D  L++ L P    
Sbjct: 117 QQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173

Query: 264 ATS-------AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTA---PFFAEAASG 312
                      + A E   N+ Y+  SD++SFG++L  L+T G+ P     PF   A   
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA--- 230

Query: 313 GSLGRWLRHLQHAGEAREALDRSILGEEVE-EDEM--LMAVRIAVVCLSDSPADRPSSDE 369
                +L+            D   L + +   DE+  +MA      C +  P +RPS  +
Sbjct: 231 -----YLK------------DGYRLAQPINCPDELFAVMA-----CCWALDPEERPSFSQ 268

Query: 370 LVPMLTQLHS 379
           LV  LT  H+
Sbjct: 269 LVQCLTDFHA 278

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 43/165 (26%), Positives = 80/165 (48%), Gaps = 28/165 (16%)

Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM------------DRIRE 197
           E+E++  + +H+N+++L     +    Y+V +Y   G+L D +            D  R 
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
            +  L  +  +  A  V +G+++L    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181

Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                   K   G L     + APE   +R YT +SD++SFG++L
Sbjct: 182 IHHIDYYRKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLL 224

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 12/101 (11%)

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI----ATSA 267
           +   L++LH      I++ +LKP N++LDA+   +L DFGL K  +  G++      T  
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE 165

Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           Y APE      +    D +S G ++  +LTG     PF AE
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG---APPFTAE 203

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 60/236 (25%), Positives = 91/236 (38%), Gaps = 48/236 (20%)

Query: 103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           +LLG    G+ +   L   G   A++ ++  E     K+NK   +R+  E E+LA+L H 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM---IKRNKV--KRVLTEQEILATLDHP 61

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI-AVGVIKGLQY 220
            L +L A     +   LV DY   G L   + R     L    E   R  A  V+  L+Y
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS---EEVARFYAAEVLLALEY 118

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--------------------- 259
           LH      I++ +LKP N++L       L+DF L+K                        
Sbjct: 119 LH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 260 --------------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                          S + T  Y APE      +    D ++ G++L  +L G  P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 16/164 (9%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VLA +    ++ L+       + YLV  ++  G L   + R  E +  L    R   
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR--EGRFDL-SRARFYT 99

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL------MPGSLIA 264
           A  ++  L+ LH      +++ +LKP N++LD +    L DFGL KL         +   
Sbjct: 100 A-ELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           T  Y APE      YT   D ++ G++L  +LTG     PF+ E
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG---LPPFYDE 196

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 29/177 (16%)

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM----DRIRENQLQLGW 204
           ++E  VL +   + + +L     + +  YLV DY   G L   +    DR+ E+  +  +
Sbjct: 49  REERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-Y 107

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG--LAKLMPGSL 262
              + +A+  I  L Y+H          ++KP NV+LD     RLADFG  L     G++
Sbjct: 108 IAEMVLAIHSIHQLHYVH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158

Query: 263 -----IATSAYSAPECFQNRS-----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
                + T  Y +PE  Q        Y  + D +S G+ +  +L G     PF+AE+
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---TPFYAES 212

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 45/218 (20%), Positives = 84/218 (38%), Gaps = 46/218 (21%)

Query: 103 RLLGSSPDGKYYRTVLDN------GLTVAVRRVEAFESGSPEKQNKSVKRRIQ--QELEV 154
           R LG    G  Y  +            VA++ V           N S++ RI+   E  V
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE---------NASMRERIEFLNEASV 62

Query: 155 LASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ------LGWEVRL 208
           +      +++ L   V       +V + +  G L+  +   R              +  +
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------------ 256
           ++A  +  G+ YL      + +H +L   N M+  + T ++ DFG+ +            
Sbjct: 123 QMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG 179

Query: 257 --LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
             L+P        + APE  ++  +T KSD++SFG++L
Sbjct: 180 KGLLP------VRWMAPESLKDGVFTTKSDVWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 43/210 (20%)

Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
           TVAV+ ++       E  + S  R +  E  +L  + H +++ L     +     L+ +Y
Sbjct: 32  TVAVKMLK-------ENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY 84

Query: 183 LQTGSLEDAMDRIR----------------------ENQLQLGWEVRLRIAVGVIKGLQY 220
            + GSL   +   R                      E  L +G    +  A  + +G+QY
Sbjct: 85  AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG--DLISFAWQISRGMQY 142

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSLIATS------AYSAPE 272
           L      +++H +L   NV++      +++DFGL++ +    S +  S       + A E
Sbjct: 143 L---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE 199

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +  YT +SD++SFG++L  ++T G +P
Sbjct: 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.8 bits (113), Expect = 4e-06
 Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 22/160 (13%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR----IRENQLQLGWE 205
           +E  +L  L+H N++ L   +       LV++Y+ T  L   MD+    +    ++L   
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKL--- 107

Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL--AKLMPGSL- 262
                   +++GL Y+H      ILH +LKP N+++      +LADFGL  AK +P    
Sbjct: 108 ----FLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160

Query: 263 ---IATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTG 298
              + T  Y  P+     + Y+   D++  G I   ++ G
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 36/221 (16%)

Query: 105 LGSSPDGKYYRTV-LDNGLTVAVR--RVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           +G    GK Y+    + G  VA++  R+E  E G P         R   E+ +L  L   
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-----PTALR---EISLLQMLSES 60

Query: 162 N----LMSLRAYVPESS---RFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRIAVG 213
                L+ +  +V E +     YLV++YL +  L+  MD   R     L  +        
Sbjct: 61  IYIVRLLDVE-HVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLMPGSL------IATS 266
           ++KG+ + H      ++H +LKP N+++D +    ++AD GL +     +      I T 
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175

Query: 267 AYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
            Y APE    +  Y+   DI+S G I A +        P F
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK----QPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 24/84 (28%), Positives = 42/84 (50%), Gaps = 8/84 (9%)

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL-----MPGSLIATSAY 268
           +++GL+YLH     +I+H ++K  N+ ++      + D G A+          L  T   
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222

Query: 269 SAPECFQNRSYTDKSDIFSFGMIL 292
           +APE      Y  K+DI+S G++L
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVL 246

Length = 357

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 34/194 (17%)

Query: 139 KQNKSVKRRIQQ---ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI 195
           KQN  ++ +IQQ   E ++L    +  ++S+           +V +Y++ G     +  I
Sbjct: 36  KQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI 95

Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA 255
               + +    R+  A  V+  L+YLH   N  I+H +LKP N+++ +    +L DFGL+
Sbjct: 96  GALPVDM---ARMYFAETVL-ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148

Query: 256 KL---------------------MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAV 294
           K+                     +   +  T  Y APE    + Y    D ++ G+IL  
Sbjct: 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Query: 295 LLTGRDPTAPFFAE 308
            L G     PFF +
Sbjct: 209 FLVG---CVPFFGD 219

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 25/176 (14%)

Query: 140 QNKSVKRRIQQELEVLASLRHRN-LMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRI 195
           Q        + E +VL  +R    L++L       ++ +L+ DY+  G L   +   +R 
Sbjct: 43  QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF 102

Query: 196 RENQLQLGWEVRLRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           +E ++Q        I  G ++  L++LH      I++ ++K  N++LD+     L DFGL
Sbjct: 103 KEQEVQ--------IYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 151

Query: 255 AKLMPG-------SLIATSAYSAPECFQ-NRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +K           S   T  Y AP+  +      DK+ D +S G+++  LLTG  P
Sbjct: 152 SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 33/179 (18%)

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM----DRIRENQLQLGW 204
           ++E +VL +   R + +L     + +  YLV DY   G L   +    DR+ E+      
Sbjct: 49  REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM----- 103

Query: 205 EVRLRIA--VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG-LAKLMPG- 260
             R  +A  V  I  +  L +      +H ++KP NV+LD     RLADFG   +L+   
Sbjct: 104 -ARFYLAEMVLAIDSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156

Query: 261 ---SLIA--TSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
              S +A  T  Y +PE  Q        Y  + D +S G+ +  +L G     PF+AE+
Sbjct: 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG---ETPFYAES 212

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.0 bits (111), Expect = 9e-06
 Identities = 47/224 (20%), Positives = 92/224 (41%), Gaps = 40/224 (17%)

Query: 103 RLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKR---------RI 148
           R++   P G + +  +           A R V +   G P+ +    KR         ++
Sbjct: 151 RVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQL 210

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLV--------YDYLQTGSLEDAMDRIRENQL 200
           + E+  L  L H N++ +   +   +  Y++        Y ++   +  D  DR      
Sbjct: 211 ENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-DWKDR------ 263

Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
            L  + R  I   ++  ++Y+H   + +++H ++K  N+ L+ +    L DFG A     
Sbjct: 264 PLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 261 SLIA-------TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       T A ++PE      Y + +DI+S G+IL  +L+
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 21/169 (12%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEV 206
           +QQE+ ++   +H N+++         + ++  ++   GSL+D        ++ Q+ +  
Sbjct: 53  VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVS 112

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG------ 260
           R       ++GL YLH   +   +H ++K  N++L      +LADFG++  +        
Sbjct: 113 R-----ETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164

Query: 261 SLIATSAYSAPECF---QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           S I T  + APE     +   Y    DI++ G I A+ L    P  P F
Sbjct: 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVG-ITAIELAELQP--PMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 31/181 (17%)

Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR----IRENQLQLG 203
            ++E ++L+      +  L+    +    YLV +Y   G L   ++R      E+  Q  
Sbjct: 48  FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF- 106

Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-------K 256
           +   L +A+  +  + Y+H          ++KP NV++D     +LADFG A        
Sbjct: 107 YLAELVLAIHSVHQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLTANKM 157

Query: 257 LMPGSLIATSAYSAPECFQ------NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
           +     + T  Y APE           +Y  + D +S G+I   ++ GR P    F E  
Sbjct: 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGT 213

Query: 311 S 311
           S
Sbjct: 214 S 214

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 58/244 (23%), Positives = 104/244 (42%), Gaps = 37/244 (15%)

Query: 77  PIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLD--NGLTVAVRRVEAFES 134
           P+    +IF    DP      +      +G    GK ++ VL+  NG   AV+ ++    
Sbjct: 2   PLSGKTIIFDSFPDPSDTWEIIET----IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHD 56

Query: 135 GSPEKQNKSVKRRIQQELEVLASLR-HRNL-----MSLRAYVPESSRFYLVYDYLQTGSL 188
                    +   I+ E  +L +L  H N+     M  +  V    + +LV +    GS+
Sbjct: 57  ---------IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV 107

Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
            D +    +   ++   +   I    + GLQ+LH     + +H ++K  N++L  E   +
Sbjct: 108 TDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK 164

Query: 249 LADFGLA------KLMPGSLIATSAYSAPE---CFQ--NRSYTDKSDIFSFGMILAVLLT 297
           L DFG++      +L   + + T  + APE   C Q  + +Y  + D++S G I A+ L 
Sbjct: 165 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG-ITAIELG 223

Query: 298 GRDP 301
             DP
Sbjct: 224 DGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 10/89 (11%)

Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYS 269
           +K L ++H      I H ++KP N+++  +   +LADFG  + +         I+T  Y 
Sbjct: 110 LKSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYR 165

Query: 270 APEC-FQNRSYTDKSDIFSFGMILAVLLT 297
           APEC   +  Y  K DI++ G +   +L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 45/190 (23%), Positives = 83/190 (43%), Gaps = 25/190 (13%)

Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           L VA+  + A   G  +KQ    +R    E   L    H N++ L   +   +   +V +
Sbjct: 34  LPVAIHTLRA---GCSDKQ----RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86

Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
           Y+  G+L D+  R  E QL  G    + +  G+  G++YL        +H  L    V++
Sbjct: 87  YMSNGAL-DSFLRKHEGQLVAGQ--LMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLV 140

Query: 242 DAEFTPRLADFG---------LAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           +++   +++ F          +   M G       ++APE  Q   ++  SD++SFG+++
Sbjct: 141 NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAPEAIQYHHFSSASDVWSFGIVM 198

Query: 293 -AVLLTGRDP 301
             V+  G  P
Sbjct: 199 WEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 32/168 (19%), Positives = 75/168 (44%), Gaps = 19/168 (11%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR------ 194
            K+ +    +E+++++ L++ N++ L           ++ +Y++ G L   + +      
Sbjct: 57  TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116

Query: 195 --IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
                N   +     L +AV +  G++YL    +   +H +L   N ++   +T ++ADF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADF 173

Query: 253 GLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           G+++         + G  +    + A E      +T  SD+++FG+ L
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 36/179 (20%), Positives = 80/179 (44%), Gaps = 26/179 (14%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM------DR 194
           NK+ +    +E+++L+ L+  N++ L     +     ++ +Y++ G L   +      D+
Sbjct: 59  NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118

Query: 195 IRENQ---------LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
                           + +   L +A+ +  G++YL  + N   +H +L   N ++    
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-SLN--FVHRDLATRNCLVGENL 175

Query: 246 TPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLL 296
           T ++ADFG+++         + G  +    + A EC     +T  SD+++FG+ L  +L
Sbjct: 176 TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 35/141 (24%), Positives = 63/141 (44%), Gaps = 26/141 (18%)

Query: 178 LVYDYLQTGSLEDAM--DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
           ++  +++ G L   +   R+ +    L  ++ ++    +  G++YL    +   +H +L 
Sbjct: 83  VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLA 139

Query: 236 PTNVMLDAEFTPRLADFGLAKL--------------MPGSLIATSAYSAPECFQNRSYTD 281
             N ML+      +ADFGL+K               MP   IA       E   +R YT 
Sbjct: 140 ARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI------ESLADRVYTT 193

Query: 282 KSDIFSFGMILAVLLT-GRDP 301
           KSD++SFG+ +  + T G+ P
Sbjct: 194 KSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 12/101 (11%)

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA--- 264
           L I   V++ +QYLH     +I+H ++K  N+ ++      L DFG A   P  + A   
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKY 240

Query: 265 -----TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD 300
                T A +APE      Y    DI+S G++L  + T  D
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281

Length = 391

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 37/168 (22%), Positives = 79/168 (47%), Gaps = 25/168 (14%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           +  + ++K  + +E  V+  L +  ++ +   + E+  + LV +  + G L   + + + 
Sbjct: 33  DNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKH 91

Query: 197 ---ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
              +N  +L  +V +        G++YL  T     +H +L   NV+L  +   +++DFG
Sbjct: 92  VTEKNITELVHQVSM--------GMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFG 140

Query: 254 LAKLMPGSLIATSAYS---------APECFQNRSYTDKSDIFSFGMIL 292
           L+K +        A +         APEC     ++ KSD++SFG+++
Sbjct: 141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 37/152 (24%), Positives = 70/152 (46%), Gaps = 16/152 (10%)

Query: 111 GKYYRTVLDNGLT---VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR 167
           GK     +++G T   V V+ +    S S ++Q      +  +E +   SL+H NL+   
Sbjct: 9   GKVILGEVNSGYTPAQVVVKELRV--SASVQEQ-----MKFLEEAQPYRSLQHSNLLQCL 61

Query: 168 AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL--RIAVGVIKGLQYLHFTC 225
               E + + LV ++   G L+  +   R+ +L +  +     R+A  +  GL +LH   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL-MTPDPTTLQRMACEIALGLLHLH--- 117

Query: 226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
               +H +L   N +L A+ T ++ D+GL+  
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 34/169 (20%), Positives = 77/169 (45%), Gaps = 19/169 (11%)

Query: 140 QNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           +  S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R 
Sbjct: 46  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 105

Query: 198 N------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
                  Q     +  +++A  +  G+ YL+     + +H +L   N M+  +FT ++ D
Sbjct: 106 EMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162

Query: 252 FGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           FG+ + +         G  +    + +PE  ++  +T  SD++SFG++L
Sbjct: 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 35/175 (20%), Positives = 82/175 (46%), Gaps = 18/175 (10%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           E  NK+ +    +E+++++ L+  N++ L A    S    ++ +Y++ G L   + R   
Sbjct: 56  EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEP 115

Query: 197 ------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
                  + + + +   + +A  +  G++YL    +   +H +L   N ++   +T ++A
Sbjct: 116 QEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIA 172

Query: 251 DFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           DFG+++         + G  +    + + E      +T  SD+++FG+ L  +LT
Sbjct: 173 DFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 55/247 (22%), Positives = 105/247 (42%), Gaps = 36/247 (14%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +NKS ++R  ++ E       + L S+ +    +S  ++    L     ++  D + +  
Sbjct: 114 RNKSTRKREMKQKEGKK----QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP 169

Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--- 256
           L L  E  +  +  V +G+++L    + + +H +L   N++L      ++ DFGLA+   
Sbjct: 170 LTL--EDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAA 310
                +  G       + APE   ++ YT +SD++SFG++L  + + G  P      +  
Sbjct: 225 KDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE- 283

Query: 311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
                  + R L+     R          E    E+     I + C  ++P DRP+  EL
Sbjct: 284 ------EFCRRLKEGTRMRAP--------EYATPEIY---SIMLDCWHNNPEDRPTFSEL 326

Query: 371 VPMLTQL 377
           V +L  L
Sbjct: 327 VEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 26/87 (29%), Positives = 46/87 (52%), Gaps = 11/87 (12%)

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L      ++ DFGLA+        +  G     
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLL 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 26/149 (17%)

Query: 177 YLVYDYLQTGSLEDAMDR--IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
           Y+V +Y+  G L + M    I E      W  R   A  V+  L  +H   +   +H ++
Sbjct: 119 YMVMEYMPGGDLVNLMSNYDIPEK-----W-ARFYTA-EVVLALDAIH---SMGFIHRDV 168

Query: 235 KPTNVMLDAEFTPRLADFGLAKLMPG-------SLIATSAYSAPECFQNRS----YTDKS 283
           KP N++LD     +LADFG    M         + + T  Y +PE  +++     Y  + 
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 284 DIFSFGMILAVLLTGRDPTAPFFAEAASG 312
           D +S G+ L  +L G D   PF+A++  G
Sbjct: 229 DWWSVGVFLYEMLVG-DT--PFYADSLVG 254

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 103 RLLGSSPDGKYYR----TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
             LGS   G+ Y      +L  G       V+    G+ +++    K+   +E  ++++ 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE----KKEFLKEAHLMSNF 56

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ---LGWEVRLRIAVGVI 215
            H N++ L      +   Y++ + ++ G L   +   R  +     L  +  L I + V 
Sbjct: 57  NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 216 KGLQYL---HFTCNPQILHYNLKPTNVML-----DAEFTPRLADFGLAKLM--------P 259
           KG  YL   HF      +H +L   N ++     DA+   ++ DFGLA+ +         
Sbjct: 117 KGCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           G  +    + APE   +  +T +SD++SFG+++  +LT G+ P
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 12/88 (13%)

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS---LIATSA--- 267
           V  G++YL        +H +L   NV+L  +   +++DFGL+K +        A SA   
Sbjct: 104 VSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160

Query: 268 ---YSAPECFQNRSYTDKSDIFSFGMIL 292
              + APEC   R ++ +SD++S+G+ +
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITM 188

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 25/87 (28%), Positives = 47/87 (54%), Gaps = 11/87 (12%)

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V +G+++L    + + +H +L   N++L      ++ DFGLA+        +  GS    
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   ++ YT +SD++SFG++L
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLL 266

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 41/178 (23%), Positives = 78/178 (43%), Gaps = 30/178 (16%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +++A      ++ L     +    Y+V +Y+  G L + M           ++V  +
Sbjct: 92  EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS---------NYDVPEK 142

Query: 210 IA----VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------ 259
            A      V+  L  +H   +  ++H ++KP N++LD     +LADFG    M       
Sbjct: 143 WAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199

Query: 260 -GSLIATSAYSAPECFQNRS----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
             + + T  Y +PE  +++     Y  + D +S G+ L  +L G     PF+A++  G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG---DTPFYADSLVG 254

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 22/148 (14%)

Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            Y+V +Y+  G L + M     N        R   A  V+  L  +H   +   +H ++K
Sbjct: 118 LYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTA-EVVLALDAIH---SMGFIHRDVK 169

Query: 236 PTNVMLDAEFTPRLADFGLAKLMP-------GSLIATSAYSAPECFQNRS----YTDKSD 284
           P N++LD     +LADFG    M         + + T  Y +PE  +++     Y  + D
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 285 IFSFGMILAVLLTGRDPTAPFFAEAASG 312
            +S G+ L  +L G     PF+A++  G
Sbjct: 230 WWSVGVFLYEMLVG---DTPFYADSLVG 254

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 33/120 (27%), Positives = 60/120 (50%), Gaps = 13/120 (10%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           NK++  ++Q E + LA  +   ++ L   +  ++  YLV +YL  G ++  +        
Sbjct: 44  NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH------- 96

Query: 201 QLGW---EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
             G+   E+ ++    V   L YLH      I+H +LKP N+++  E   +L DFGL+K+
Sbjct: 97  IYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.2 bits (94), Expect = 9e-04
 Identities = 37/145 (25%), Positives = 59/145 (40%), Gaps = 18/145 (12%)

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMD---RIRENQLQLGWEVRLRIAVGVIKGL 218
           N++ L  Y+      +LV  + + G L   +     I E  ++       R A  ++  L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-------RWAAEMVVAL 98

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMPGSLIATSAYSAPECF 274
             LH      I+  +L P N++LD     +L  F     +     G  +  + Y APE  
Sbjct: 99  DALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-ENMYCAPEVG 154

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGR 299
                T+  D +S G IL  LLTG+
Sbjct: 155 GISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 45/189 (23%), Positives = 79/189 (41%), Gaps = 45/189 (23%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG----------- 186
           E+ +  ++   Q+E  ++A   H N++ L           L+++Y+  G           
Sbjct: 45  EEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSP 104

Query: 187 ----SLEDAMDRIR---ENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKP 236
               SL  +    R    N L L    +L IA  V  G+ YL    F      +H +L  
Sbjct: 105 RAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF------VHRDLAT 158

Query: 237 TNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSA------------PEC-FQNRSYTDKS 283
            N ++      ++ADFGL++    ++ +   Y A            PE  F NR YT +S
Sbjct: 159 RNCLVGENMVVKIADFGLSR----NIYSADYYKASENDAIPIRWMPPESIFYNR-YTTES 213

Query: 284 DIFSFGMIL 292
           D++++G++L
Sbjct: 214 DVWAYGVVL 222

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 42/194 (21%)

Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           L VAV+ +   ES S + ++  +      E  +++   H+N++ L     E    +++ +
Sbjct: 37  LQVAVKTLP--ESCSEQDESDFLM-----EALIMSKFNHQNIVRLIGVSFERLPRFILLE 89

Query: 182 YLQTGSLEDAMDRIRENQLQ---LGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLK 235
            +  G L+  +   R    +   L  +  L  A  V KG +YL   HF      +H ++ 
Sbjct: 90  LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF------IHRDIA 143

Query: 236 PTNVMLDAEFTPR---LADFGLAK--------------LMPGSLIATSAYSAPECFQNRS 278
             N +L  +   R   +ADFG+A+              ++P        +  PE F +  
Sbjct: 144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP------IKWMPPEAFLDGI 197

Query: 279 YTDKSDIFSFGMIL 292
           +T K+D++SFG++L
Sbjct: 198 FTSKTDVWSFGVLL 211

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 42/215 (19%), Positives = 89/215 (41%), Gaps = 38/215 (17%)

Query: 105 LGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           LG    GK Y+  L      +    VA++ ++       +K    ++   + E  + + L
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-------DKAEGPLREEFKHEAMMRSRL 65

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED------------AMDRIRENQLQLGWEV 206
           +H N++ L   V +     +++ Y     L +            + D  +  +  L    
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL---------AKL 257
            + I   +  G+++L    +  ++H +L   NV++  +   +++D GL          KL
Sbjct: 126 FVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182

Query: 258 MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           M  SL+    + +PE      ++  SDI+S+G++L
Sbjct: 183 MGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/119 (24%), Positives = 52/119 (43%), Gaps = 13/119 (10%)

Query: 184 QTGSLEDAMDRIRENQLQLGWEVR--LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
             GS +  +  +  +    G      L     V +G+++L    +   +H +L   NV+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 242 DAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGLA+        +  GS      + APE   +  YT  SD++S+G++L
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 11/92 (11%)

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V  G+++L    +   +H +L   NV++      ++ DFGLA+        +  GS    
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
             + APE   N  YT  SD++SFG++L  + T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 30/104 (28%), Positives = 53/104 (50%), Gaps = 11/104 (10%)

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           E++L L  E  L  +  V KG+ +L    +   +H +L   N++L      ++ DFGLA+
Sbjct: 206 EDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 262

Query: 257 --------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                   ++ G+      + APE   N  YT +SD++S+G++L
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 306

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 40/204 (19%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  V VRR+   E+ + E         +Q EL V     H N++  RA     +  ++V
Sbjct: 24  TGEYVTVRRIN-LEACTNEMVT-----FLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77

Query: 180 YDYLQTGSLEDA-----MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             ++  GS +D      MD +  ++L + +     I  GV+K L Y+H   +   +H ++
Sbjct: 78  TSFMAYGSAKDLICTHFMDGM--SELAIAY-----ILQGVLKALDYIH---HMGYVHRSV 127

Query: 235 KPTNVMLDAEFTPRLADFGLAKLM---------------PGSLIATSAYSAPECFQN--R 277
           K +++++  +    L+  GL   +               P   +    + +PE  Q   +
Sbjct: 128 KASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ 185

Query: 278 SYTDKSDIFSFGMILAVLLTGRDP 301
            Y  KSDI+S G+    L  G  P
Sbjct: 186 GYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 24/93 (25%), Positives = 49/93 (52%), Gaps = 11/93 (11%)

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--------P 259
           +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+ + +         
Sbjct: 122 IQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	380
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
smart00090	237	RIO RIO-like kinase.	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG1243	690	consensus Protein kinase [General function predict	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.08
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.05
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.02
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.89
PRK09902	216	hypothetical protein; Provisional	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.76
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.66
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.49
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.41
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.25
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.19
PF01636	239	APH: Phosphotransferase enzyme family This family	98.18
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.05
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.94
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.92
PRK10593	297	hypothetical protein; Provisional	97.91
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.8
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.78
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.64
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.51
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.5
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.47
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.46
PRK05231	319	homoserine kinase; Provisional	97.38
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.15
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.01
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.88
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.81
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.72
PLN02756	418	S-methyl-5-thioribose kinase	96.69
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.69
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.66
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.65
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.26
KOG2270	520	consensus Serine/threonine protein kinase involved	96.25
PRK06148	1013	hypothetical protein; Provisional	96.22
PLN02236	344	choline kinase	96.19
PRK11768	325	serine/threonine protein kinase; Provisional	95.82
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.8
PRK12396	409	5-methylribose kinase; Reviewed	95.78
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.73
COG2334	331	Putative homoserine kinase type II (protein kinase	95.68
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.49
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.65
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	94.52
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.49
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.38

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-60  Score=440.42  Aligned_cols=281  Identities=36%  Similarity=0.617  Sum_probs=247.5

Q ss_pred             CCCCChHHHHHHHhccc--cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc
Q 047245           86 SPKIDPKTLQAALANEN--RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL  163 (380)
Q Consensus        86 ~~~~~~~~l~~~~~~~~--~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  163 (380)
                      ...|++.+|..+|++|+  ++||+|+||.||+|.+++|..||||++......       . .++|.+|+.++.+++|||+
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~-------~-~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ-------G-EREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc-------c-hhHHHHHHHHHhcCCCcCc
Confidence            44589999999999987  799999999999999999999999988652211       0 3569999999999999999


Q ss_pred             ceeeEEEecCC-eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC
Q 047245          164 MSLRAYVPESS-RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD  242 (380)
Q Consensus       164 v~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~  242 (380)
                      |+++|||.+.+ +.+||||||++|||.++|+.....  +++|..|++||.++|+||+|||+.+.++|+||||||+|||+|
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            99999999998 599999999999999999853222  899999999999999999999999999999999999999999


Q ss_pred             CCCceEEeccCCcccCCC-CC------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCH
Q 047245          243 AEFTPRLADFGLAKLMPG-SL------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL  315 (380)
Q Consensus       243 ~~~~~kl~Dfgl~~~~~~-~~------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l  315 (380)
                      +++++||+|||+++..+. ..      .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+...  ......+
T Consensus       212 ~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l  289 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSL  289 (361)
T ss_pred             CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccH
Confidence            999999999999987654 21      68999999999999999999999999999999999999876432  2233459


Q ss_pred             HHHHHHHHhhcchhHhhchhccCCcccH-HHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          316 GRWLRHLQHAGEAREALDRSILGEEVEE-DEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .+|.+.....+.+.+++|+.+....... .+...+.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus       290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            9999999999999999999987444433 68888999999999999999999999999997654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-52  Score=382.53  Aligned_cols=247  Identities=29%  Similarity=0.466  Sum_probs=204.2

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-eEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-RFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  181 (380)
                      +.||+|+||+||+|.+.....||||++.......     .. .+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus        47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~-----~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDD-----ES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhcccCCceeEEEEEeCCceeEEEEEecchhcCh-----HH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            4599999999999999744449999997633221     11 689999999999999999999999999887 7999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC-eEecCCCCCcEEeCCCC-ceEEeccCCcccCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ-ILHYNLKPTNVMLDAEF-TPRLADFGLAKLMP  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-iiH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~  259 (380)
                      |+++|+|.++++..  ....+++..+++++.|||+||.|||   +.+ ||||||||+|+|++.++ ++||+|||+++...
T Consensus       121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            99999999999853  4568999999999999999999999   777 99999999999999997 99999999997654


Q ss_pred             CC------CcCCCcccCccccc--CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 GS------LIATSAYSAPECFQ--NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~--~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ..      ..||+.|||||++.  ..+|+.|+||||||+++|||+||+.||.....        ..-.......+     
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~-----  262 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGG-----  262 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcC-----
Confidence            32      46999999999999  56999999999999999999999999974211        11111111111     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                           .....+..+...+..++.+||+.||..||++.+++..|+.+.
T Consensus       263 -----~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  263 -----LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             -----CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence                 112223336667889999999999999999999999998764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-52  Score=384.17  Aligned_cols=256  Identities=26%  Similarity=0.409  Sum_probs=215.2

Q ss_pred             ChHHHHHHHhccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEE
Q 047245           90 DPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAY  169 (380)
Q Consensus        90 ~~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  169 (380)
                      +..++.+......+.||+|-||.||.|.+.+...||+|.++....         ....|.+|+++|++|+|+|||+++|+
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---------~~~~f~~Ea~iMk~L~H~~lV~l~gV  269 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---------SPEAFLREAQIMKKLRHEKLVKLYGV  269 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---------ChhHHHHHHHHHHhCcccCeEEEEEE
Confidence            334444444456688999999999999998777999999986321         22778899999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          170 VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       170 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                      |...+.++||||||++|||.+||+.  .....+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||
T Consensus       270 ~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKI  344 (468)
T KOG0197|consen  270 CTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKI  344 (468)
T ss_pred             EecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEE
Confidence            9998899999999999999999985  44667899999999999999999999   999999999999999999999999


Q ss_pred             eccCCcccCCCCC-------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHH
Q 047245          250 ADFGLAKLMPGSL-------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       250 ~Dfgl~~~~~~~~-------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      +|||+++...++.       .-+..|.|||.+..+.++.|||||||||+||||+| |+.||..        ....+.+..
T Consensus       345 sDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------msn~ev~~~  416 (468)
T KOG0197|consen  345 SDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------MSNEEVLEL  416 (468)
T ss_pred             cccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------CCHHHHHHH
Confidence            9999999654432       24668999999999999999999999999999999 9999863        122333333


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                                ++.... -+.+..++..+.+++..||+.+|++|||++.+...|+.+.
T Consensus       417 ----------le~GyR-lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  417 ----------LERGYR-LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             ----------HhccCc-CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                      333221 2334567888999999999999999999999999998774

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.1e-51  Score=393.80  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=210.5

Q ss_pred             ccccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC
Q 047245          100 NENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES  173 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  173 (380)
                      .+.+.||+|+||.||+|...      +...||||.++..       .+.+.+++|++|++++..++|||||+++|+|.++
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-------a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-------AENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-------ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            35678999999999999853      4568999999852       2445679999999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhh------c----ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRE------N----QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      +..++|+|||..|||.+||.....      .    ..+++..+.+.||.|||.||+||.   ++.+|||||.++|+||++
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence            999999999999999999986421      1    234889999999999999999999   999999999999999999


Q ss_pred             CCceEEeccCCcccCC--------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCC
Q 047245          244 EFTPRLADFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGS  314 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~  314 (380)
                      +..+||+|||+++..-        +...-+.+|||||.|..++||.+||||||||+|||+++ |+.||....        
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--------  710 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--------  710 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--------
Confidence            9999999999998643        23346789999999999999999999999999999999 999987521        


Q ss_pred             HHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       315 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                                +.++.+.+..+.. -..+++++.++..|+..||+.+|.+|||++||-.+|+..
T Consensus       711 ----------n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  711 ----------NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             ----------hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence                      1122223322221 234567888999999999999999999999999999864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-50  Score=354.89  Aligned_cols=243  Identities=27%  Similarity=0.452  Sum_probs=202.9

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-eEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-RFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~  180 (380)
                      +.||+|..|+|||+.. .++.-+|+|++..       ..+...++++.+|++++++.+|||||.++|.|...+ ...++|
T Consensus        85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-------~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   85 GVLGSGNGGTVYKVRHKPTGKIYALKVILL-------NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             hhcccCCCcEEEEEEEcCCCeEEEEEeecc-------cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            6799999999999997 4688999999954       134566789999999999999999999999999988 599999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      |||++|||++++..    ...+++...-+|+.++++||.|||+  ..+||||||||+|+|++..|++||+|||.++.+. 
T Consensus       158 EYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  158 EYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            99999999999875    3579999999999999999999994  3899999999999999999999999999998654 


Q ss_pred             ---CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          260 ---GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       260 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                         ...+||..|||||.+.+..|+.++||||||++++|+.+|+.||.+.   ........+.+.......          
T Consensus       232 S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~p----------  298 (364)
T KOG0581|consen  232 SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEP----------  298 (364)
T ss_pred             hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCC----------
Confidence               4567999999999999999999999999999999999999998752   111112222222211110          


Q ss_pred             cCCcccH-HHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          337 LGEEVEE-DEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       337 ~~~~~~~-~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .+..+. ..+.++.+++..|+++||.+|||++|+++
T Consensus       299 -pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  299 -PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             011222 36777999999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-49  Score=334.81  Aligned_cols=247  Identities=22%  Similarity=0.385  Sum_probs=204.6

Q ss_pred             cccCccCCeeEEEEE-ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEE-EecCC-eEEEE
Q 047245          103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAY-VPESS-RFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~-~~~lv  179 (380)
                      +.||.|.||.|||+. +.+|..+|.|.++-      +..+...++....|+.+|++|+|||||+++++ +.++. .+++|
T Consensus        25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f------~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQF------GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHcCCcchheEEeeeccCcchhhhhhcch------hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            569999999999988 57899999999874      33456667889999999999999999999983 44444 48999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ||||.+|+|.+.++..+.....+++..+|++..|++.||+++|+.. ++  |.||||||.||+++.+|.+||+|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999988888889999999999999999999999432 44  99999999999999999999999999998


Q ss_pred             CCCC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          258 MPGS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       258 ~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      +...      .+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||...        ++.+.-..+ ..++    
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI-~qgd----  244 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKI-EQGD----  244 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHH-HcCC----
Confidence            7754      46999999999999999999999999999999999999999641        222211111 1111    


Q ss_pred             hchhccCCccc-HHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          332 LDRSILGEEVE-EDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       332 ~~~~~~~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                            -++.+ ...+..+.+++..|+.+||+.||+...++..+.
T Consensus       245 ------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  245 ------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             ------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                  01122 557788999999999999999999655555443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-47  Score=358.45  Aligned_cols=242  Identities=26%  Similarity=0.413  Sum_probs=207.0

Q ss_pred             hccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245           99 ANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      ....++||+|||..+|.++. ..|+.||+|++......     ....++.+.+||++.++|+|||||++++++++.+..|
T Consensus        20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-----k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY   94 (592)
T KOG0575|consen   20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-----KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY   94 (592)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-----CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence            34568999999999999997 89999999999763322     2344578899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +|.|+|++++|.++++.    ..++++.+...+..||+.||.|||   +.+|+|||||..|++++++.++||+|||+|..
T Consensus        95 ivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             EEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeee
Confidence            99999999999999874    557999999999999999999999   99999999999999999999999999999987


Q ss_pred             CCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          258 MPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       258 ~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      +..      ..+|||.|.|||++.....+..+||||+|||+|-|+.|++||...        .+.+-.+.+..+.     
T Consensus       168 le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~-----  234 (592)
T KOG0575|consen  168 LEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNE-----  234 (592)
T ss_pred             ecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcC-----
Confidence            653      246999999999999999999999999999999999999999641        2222222222211     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                             -..+...+....+|+...|+.||.+|||+++|+.
T Consensus       235 -------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 -------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   1223456677889999999999999999999984

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-49  Score=373.93  Aligned_cols=251  Identities=20%  Similarity=0.417  Sum_probs=213.8

Q ss_pred             HHHHhccccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEE
Q 047245           95 QAALANENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV  170 (380)
Q Consensus        95 ~~~~~~~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  170 (380)
                      ........++||.|.||.|++|.++    ....||||.++.   +    ..+..+.+|+.|..+|.+.+||||++|.|+.
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~---G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA---G----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc---C----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            3333457789999999999999973    356899999986   2    2445678999999999999999999999999


Q ss_pred             ecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 047245          171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA  250 (380)
Q Consensus       171 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  250 (380)
                      ......++|+|||+||+|+.||+.   +..++++.++.-++.+||.||.||.   +-++|||||.++|||++.+..+|++
T Consensus       700 Tks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVs  773 (996)
T KOG0196|consen  700 TKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVS  773 (996)
T ss_pred             ecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEec
Confidence            999999999999999999999984   4567999999999999999999999   9999999999999999999999999


Q ss_pred             ccCCcccCCCCCc---------CCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHH
Q 047245          251 DFGLAKLMPGSLI---------ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       251 Dfgl~~~~~~~~~---------~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      |||++|.+.++..         -+.+|.|||.|...++|.+|||||||+++||.++ |..||=+                
T Consensus       774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd----------------  837 (996)
T KOG0196|consen  774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------------  837 (996)
T ss_pred             cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------------
Confidence            9999997754431         2568999999999999999999999999999998 9999843                


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                        ..+.++...+..... -+.+.+++..+.+|++.||++|-.+||.+.+|+..|+++
T Consensus       838 --mSNQdVIkaIe~gyR-LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  838 --MSNQDVIKAIEQGYR-LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             --cchHHHHHHHHhccC-CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence              112223333333322 234467888999999999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=336.76  Aligned_cols=189  Identities=30%  Similarity=0.513  Sum_probs=171.5

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||.|+||+||+|+. .++..||||.+....      .....++.+..|+.+|+.++|||||++++++...+..++|||
T Consensus        16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~------l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK------LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             hhccCcceEEEEEeEeccCCceEEeeeehhhc------cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            4599999999999997 468999999997622      245566788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC------CceEEeccCCc
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE------FTPRLADFGLA  255 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~------~~~kl~Dfgl~  255 (380)
                      ||+||+|.+|++.    ...+++.....++.|+|.||++||   +++||||||||.|||++..      -.+||+|||++
T Consensus        90 yC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   90 YCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999985    447899999999999999999999   9999999999999999765      56899999999


Q ss_pred             ccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       256 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      +.+...     .+|++.|||||++..++|+.|+|+||+|+++|++++|+.||+.
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            987643     4699999999999999999999999999999999999999973

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-47  Score=341.00  Aligned_cols=247  Identities=26%  Similarity=0.430  Sum_probs=196.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .++.||+|+||.|-+|.- .+|+.||||.+.......... .........+|+++|++|+|||||++.+++...+..|+|
T Consensus       176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV  254 (475)
T KOG0615|consen  176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV  254 (475)
T ss_pred             eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence            567899999999999985 679999999997643322111 112224467999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC---CceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfgl~~  256 (380)
                      +||++||+|.+++-.    ...+....-..++.|++.|+.|||   +++|+||||||+|||+..+   ..+||+|||+|+
T Consensus       255 lE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  255 LEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            999999999999874    345666666889999999999999   9999999999999999766   789999999999


Q ss_pred             cCCC-----CCcCCCcccCcccccCCC---CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ...+     ..+||+.|.|||++.+..   +..|.|+||+||+||-+++|.+||......                 ...
T Consensus       328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~-----------------~sl  390 (475)
T KOG0615|consen  328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD-----------------PSL  390 (475)
T ss_pred             ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC-----------------ccH
Confidence            8764     346999999999997654   334889999999999999999999642111                 111


Q ss_pred             hHhhchhcc--CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSIL--GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+.+.....  +.........+..+++.++|.+||++|||++|+++
T Consensus       391 ~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  391 KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            122211111  11233467788999999999999999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.1e-44  Score=379.56  Aligned_cols=255  Identities=29%  Similarity=0.566  Sum_probs=213.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..++||+|+||.||+|.. .+|..||||++.....            ....|++.+++++||||++++|+|.+.+..++|
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            456899999999999997 5789999999864211            112468889999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.++++       .++|..+.+++.|+++||+|||+.++++++||||||+||+++.++.+++. ||......
T Consensus       762 ~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        762 HEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            99999999999986       38999999999999999999998778899999999999999999988876 66554332


Q ss_pred             --CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          260 --GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       260 --~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                        ....+++.|+|||.+.+..++.++|||||||++|||++|+.||+.   +......+..|.+...........+|+.+.
T Consensus       834 ~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA---EFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc---ccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence              234578999999999999999999999999999999999999864   223345678888776666666666676654


Q ss_pred             CC-cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          338 GE-EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       338 ~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .. ....++..++.+++.+||+.||++||||+|+++.|+++.
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            33 234567778899999999999999999999999999873

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-46  Score=371.85  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=207.2

Q ss_pred             ccccccCccCCeeEEEEEecC--Cc----EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC
Q 047245          100 NENRLLGSSPDGKYYRTVLDN--GL----TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES  173 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  173 (380)
                      ...+.||+|.||.||.|.+.+  |.    .||+|.+...       .+.+...+|.+|..+|+.++|||||+++|+|.+.
T Consensus       695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-------~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-------SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-------CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            466889999999999999743  33    4899988752       2345568999999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIREN---QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA  250 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  250 (380)
                      +..++++|||++|+|..||+..+.+   ...++..+.+.++.|||+|+.||+   ++++|||||.++|+|+++...+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999864332   456899999999999999999999   9999999999999999999999999


Q ss_pred             ccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHH
Q 047245          251 DFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       251 Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      |||+|+..-.        ...-+.+|||||.+..+.+|.|+|||||||++||++| |..||...        +-.+....
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--------~n~~v~~~  916 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--------SNFEVLLD  916 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--------chHHHHHH
Confidence            9999994321        1234678999999999999999999999999999999 89998631        01111112


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                      ....++           -..+..++..+.+++..||+.+|++||++..+++.++.+..
T Consensus       917 ~~~ggR-----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  917 VLEGGR-----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             HHhCCc-----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            222221           12234577788899999999999999999999998887643

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-46  Score=348.76  Aligned_cols=257  Identities=21%  Similarity=0.354  Sum_probs=206.3

Q ss_pred             HHHHHHhccccccCccCCeeEEEEEecC--C---cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceee
Q 047245           93 TLQAALANENRLLGSSPDGKYYRTVLDN--G---LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR  167 (380)
Q Consensus        93 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~--g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  167 (380)
                      +|........++||+|+||.||+|.+..  +   ..||||..+...     ...+..+.+|.+|++++++++|||||+++
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-----~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-----ELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-----cccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3333333455889999999999999743  2   238999887411     13456679999999999999999999999


Q ss_pred             EEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCce
Q 047245          168 AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP  247 (380)
Q Consensus       168 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  247 (380)
                      |++.....+++|||+|+||+|.+||..   +...++..+++.++.+.|.||+|||   +.+++||||.++|+|++.++.+
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeE
Confidence            999999999999999999999999985   2336999999999999999999999   9999999999999999999999


Q ss_pred             EEeccCCcccCCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHH
Q 047245          248 RLADFGLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       248 kl~Dfgl~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      ||+|||+++.-..      ...-+.+|+|||.+..+.++.++|||||||++||+++ |..||...        ...+...
T Consensus       302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------~~~~v~~  373 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------KNYEVKA  373 (474)
T ss_pred             EeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--------CHHHHHH
Confidence            9999999886541      1225678999999999999999999999999999999 89998642        1111111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ....++.          ....+...+..+..++.+||..+|++||||.++.+.|+.+.
T Consensus       374 kI~~~~~----------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  374 KIVKNGY----------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             HHHhcCc----------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence            1111111          11122244556778888999999999999999999998764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=328.04  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=196.8

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHH--cCCCCCcceeeEEEecCC----e
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA--SLRHRNLMSLRAYVPESS----R  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~  175 (380)
                      .+++|+|+||.||||.+. ++.||||++..           ...+.|.+|-.+++  .|+|+||+++++.-..+.    +
T Consensus       215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             HHHhhcCccceeehhhcc-CceeEEEecCH-----------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            368999999999999996 59999999964           22366777766655  458999999999976655    8


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC------CCCeEecCCCCCcEEeCCCCceEE
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC------NPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                      ++||+||.++|||.+||.     ...++|....+|+..+++||+|||++.      +++|+|||||++|||+.+|+++.|
T Consensus       283 ywLVt~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             eeEEeeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence            999999999999999998     457999999999999999999999654      578999999999999999999999


Q ss_pred             eccCCcccCCC--------CCcCCCcccCcccccCC-CCC-----CcchhhHHHHHHHHHHhCCCCCC--------chhh
Q 047245          250 ADFGLAKLMPG--------SLIATSAYSAPECFQNR-SYT-----DKSDIFSFGMILAVLLTGRDPTA--------PFFA  307 (380)
Q Consensus       250 ~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~-~~~-----~~sDv~s~Gvil~el~tg~~p~~--------~~~~  307 (380)
                      +|||++..+..        ..+||.+|||||++.+. .+.     .+.||||+|.|+|||++...-++        ..|.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            99999987642        24699999999999753 222     36899999999999999764332        1222


Q ss_pred             -hccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          308 -EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       308 -~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                       +..+...+.+.-....+...     .|.+.........+..+.+.+..||..||+-|-|+.=+-+++.++.
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence             33444444433322222221     1111111112245677899999999999999999999988887764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.3e-45  Score=331.71  Aligned_cols=248  Identities=20%  Similarity=0.369  Sum_probs=201.7

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec----CCeEE
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE----SSRFY  177 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  177 (380)
                      ...||+|++|.||+|.. +|+.||||++.....     ..+...+.|.+|+.++++++||||++++|++.+    ....+
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~   98 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK-----GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS   98 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEecccccc-----ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence            35789999999999998 689999999875321     223345778899999999999999999999876    35789


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      +||||+++|+|.+++..    ...++|.....++.|++.||+|||   + .+++||||||+||++++++.+||+|||+++
T Consensus        99 lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988         99 LILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             EEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence            99999999999999974    346899999999999999999999   6 478899999999999999999999999998


Q ss_pred             cCCCC---CcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPGS---LIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~~---~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .....   ..++..|+|||.+.+  ..++.++||||||+++|||++|+.||...        ...+........+.    
T Consensus       172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~--------~~~~~~~~i~~~~~----  239 (283)
T PHA02988        172 ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL--------TTKEIYDLIINKNN----  239 (283)
T ss_pred             hhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhcCC----
Confidence            65432   357889999999976  68999999999999999999999998641        11222222211110    


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccCC
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHSF  380 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~~  380 (380)
                            ....+......+.+++.+||+.||++|||++|+++.|+.++++
T Consensus       240 ------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~~  282 (283)
T PHA02988        240 ------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY  282 (283)
T ss_pred             ------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHhc
Confidence                  0111123455688999999999999999999999999998764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=343.02  Aligned_cols=248  Identities=22%  Similarity=0.351  Sum_probs=200.2

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .....||+|.||+||+|.+..  .||||++.....      ..+..+.|++|+..+++-+|.||+-+.|+|...+. .+|
T Consensus       395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~p------t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDP------TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             hccceeccccccceeeccccc--ceEEEEEecCCC------CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            356789999999999999963  599999987432      23356999999999999999999999999998776 999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +.+|+|-+|..+++..   ...++....++||.|||+||.|||   .++|||||||+.||++.++++|||+|||++..-.
T Consensus       466 TqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            9999999999999853   346788889999999999999999   9999999999999999999999999999985422


Q ss_pred             --------CCCcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          260 --------GSLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       260 --------~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                              ....|...|||||++..   .+|+..+||||||+++|||++|..||...   ..+      -+-.....|  
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~---~~d------qIifmVGrG--  608 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ---NRD------QIIFMVGRG--  608 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC---Chh------heEEEeccc--
Confidence                    12347788999999964   57999999999999999999999998621   000      000001111  


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .-..|.    .....++...+.+|+..||..++++||++.+|+..|+++
T Consensus       609 ~l~pd~----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  609 YLMPDL----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL  653 (678)
T ss_pred             ccCccc----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence            001111    112245677889999999999999999999999988776

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-45  Score=336.31  Aligned_cols=253  Identities=19%  Similarity=0.306  Sum_probs=204.9

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.+.||+|-||.|..+....+..||||.++..       .++..+++|..|+++|.+++||||++++|+|..++.+++++
T Consensus       542 ~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-------a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  542 FKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-------ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hhhhhcCcccceeEEEEecCceEEEEeecCcc-------cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            56789999999999999988899999999862       34556799999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      |||++|+|.+|+.....  ..+.-..-.+|+.|||.||+||.   +.++|||||.++|+|+|.++++||+|||+++.+- 
T Consensus       615 EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc
Confidence            99999999999985322  22344556789999999999999   9999999999999999999999999999999543 


Q ss_pred             -------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh--CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 -------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT--GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 -------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t--g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                             +..+-+.+|||+|.+..+++|.+||||+||+++||+++  ...||....++.     ..+-...+.+.+....
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~~~~~~~~~~~~  764 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENAGEFFRDQGRQV  764 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhhhhhcCCCCcce
Confidence                   22346789999999999999999999999999999765  788986432221     1111111111111111


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .       ...+.-+...+.+++.+||+.+-.+|||++++...|++.
T Consensus       765 ~-------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 V-------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             e-------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1       112334667788999999999999999999999888764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=338.74  Aligned_cols=241  Identities=24%  Similarity=0.414  Sum_probs=201.7

Q ss_pred             CChHHHHHHHhccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeE
Q 047245           89 IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRA  168 (380)
Q Consensus        89 ~~~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  168 (380)
                      ++.+++.+.     +-||+|+.|.||.|.+. ++.||||+++.               .=..+|+.|++|+||||+.+.|
T Consensus       121 iPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~e---------------lkETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  121 IPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRE---------------LKETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             CCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhh---------------hhhhhHHHHHhccCcceeeEee
Confidence            344455444     67999999999999996 68999999863               1235899999999999999999


Q ss_pred             EEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          169 YVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       169 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      +|.....+++|||||..|-|.+.|+.    ..++.......+..+||.||.|||   .+.|||||||+-||||+.+..+|
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VK  252 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVK  252 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEE
Confidence            99999999999999999999999974    557888889999999999999999   99999999999999999999999


Q ss_pred             EeccCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHH
Q 047245          249 LADFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQ  323 (380)
Q Consensus       249 l~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~  323 (380)
                      |+|||.++...+     ...||..|||||+|.+.+.++|.||||||||||||+||..||........        ++   
T Consensus       253 IsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI--------Iw---  321 (904)
T KOG4721|consen  253 ISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI--------IW---  321 (904)
T ss_pred             eccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--------EE---
Confidence            999999986553     34599999999999999999999999999999999999999864111000        00   


Q ss_pred             hhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                             .+....+.-..+..++..+.-|+.+||+-.|.+|||+.+++.-|+
T Consensus       322 -------GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  322 -------GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             -------eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence                   011111223455667788888999999999999999999998765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=325.12  Aligned_cols=241  Identities=29%  Similarity=0.465  Sum_probs=194.8

Q ss_pred             cccccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC--eEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS--RFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  177 (380)
                      ..+.||+|+||+||.+...+ |...|||.+....        ....+.+.+|+.+|++++|||||+++|......  .++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--------~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--------SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeeccc--------chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            45789999999999999754 8999999997631        111577899999999999999999999854444  699


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCcc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAK  256 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~  256 (380)
                      +.|||+++|||.+++...   ...++...+..+..||++||+|||   +++++||||||+|||++. ++.+||+|||+++
T Consensus        93 i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             eeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccc
Confidence            999999999999999852   226999999999999999999999   999999999999999999 7999999999988


Q ss_pred             cCCC---------CCcCCCcccCcccccCCC-CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPG---------SLIATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~---------~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ....         ...||+.|||||++..+. ...++||||+||++.||+||+.||...       ....++.-......
T Consensus       167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~  239 (313)
T KOG0198|consen  167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGRED  239 (313)
T ss_pred             ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccC
Confidence            6552         245999999999999643 345999999999999999999998642       11112222211111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .          .+..+...+....+++..|+..+|.+|||++++++
T Consensus       240 ~----------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~  275 (313)
T KOG0198|consen  240 S----------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE  275 (313)
T ss_pred             C----------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            0          11334456677899999999999999999999985

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-44  Score=334.49  Aligned_cols=249  Identities=24%  Similarity=0.406  Sum_probs=195.5

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||+|..      .++..||+|++....       .......+.+|+.++.++ +||||++++++|...
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102          11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-------TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             eeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-------chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            457899999999999974      235689999986421       122346788999999999 899999999988764


Q ss_pred             -CeEEEEEeecCCCCHHHHHHHhhhc------------------------------------------------------
Q 047245          174 -SRFYLVYDYLQTGSLEDAMDRIREN------------------------------------------------------  198 (380)
Q Consensus       174 -~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  198 (380)
                       +..+++|||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999999753210                                                      


Q ss_pred             ----ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC--------CCcCCC
Q 047245          199 ----QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATS  266 (380)
Q Consensus       199 ----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~  266 (380)
                          ..++++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....        ...++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                235888899999999999999999   89999999999999999999999999999976432        123567


Q ss_pred             cccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHH
Q 047245          267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDE  345 (380)
Q Consensus       267 ~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (380)
                      .|+|||.+.+..++.++||||||+++|||++ |..||.....       ......... .+..          ...+...
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~~-~~~~----------~~~~~~~  302 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------NEEFCQRLK-DGTR----------MRAPENA  302 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-------cHHHHHHHh-cCCC----------CCCCCCC
Confidence            8999999999999999999999999999997 9999863100       011111111 1110          0111233


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          346 MLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       346 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ...+.+++.+||+.||++|||+.|+++.|+++
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            45688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-44  Score=316.23  Aligned_cols=234  Identities=24%  Similarity=0.358  Sum_probs=196.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      -++||+|+||.||.+.. ++++.+|+|+++.....     .....+...+|..+|.+++||.||.+.-.+.+.+.+|+|+
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv-----~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV-----EKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhh-----hhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            47899999999999986 56889999999874332     2234577889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+.||.|.-+|++    ...+++....-++..|+.||.|||   +.+||||||||+|||+|++|+++|+|||+++..- 
T Consensus       105 d~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  105 DYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             eccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999985    556888888889999999999999   9999999999999999999999999999998532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ...+||+.|||||.+.+..|+..+|.||+|+++|||++|.+||..        .+...+........        
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~--------~~~~~~~~~I~~~k--------  241 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA--------EDVKKMYDKILKGK--------  241 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC--------ccHHHHHHHHhcCc--------
Confidence                 234799999999999999999999999999999999999999963        23344444443332        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                       +  ...+.-......+++...+..||++|-.
T Consensus       242 -~--~~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  242 -L--PLPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             -C--CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence             0  1111224455788999999999999963

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-44  Score=330.22  Aligned_cols=237  Identities=23%  Similarity=0.395  Sum_probs=200.1

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ..||+|+.|.||.+.- .+++.||||++.....        ..++-+.+|+.+|+..+|+|||.++..+..++++++|||
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--------~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--------PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccC--------CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            4699999999999874 6788999999987332        224678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      ||++|+|.|.+.     ...+++.++..|+.++++||+|||   .++|+|||||.+|||++.++.+||+|||++..... 
T Consensus       351 ym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  351 YMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             ecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            999999999987     345899999999999999999999   99999999999999999999999999999976653 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ..+||+.|||||+.....|..|.||||||++++||+-|.+||-.   +     ....-++.+..++.      +.
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E-----~PlrAlyLIa~ng~------P~  488 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---E-----NPLRALYLIATNGT------PK  488 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---C-----ChHHHHHHHhhcCC------CC
Confidence                 34699999999999999999999999999999999999999852   1     11111222222221      11


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         -..++..+..+.+++.+||+.||++||++.|+|+
T Consensus       489 ---lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  489 ---LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               1233456777999999999999999999999985

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=335.04  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=219.4

Q ss_pred             CCCCChHHHHHHHhccccccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcc
Q 047245           86 SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM  164 (380)
Q Consensus        86 ~~~~~~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  164 (380)
                      +|..+.+++++.-.....+||-|-||.||.|++.. ...||||.++.         +....++|..|..+|+.++|||+|
T Consensus       256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---------DtMeveEFLkEAAvMKeikHpNLV  326 (1157)
T KOG4278|consen  256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---------DTMEVEEFLKEAAVMKEIKHPNLV  326 (1157)
T ss_pred             cCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---------cchhHHHHHHHHHHHHhhcCccHH
Confidence            45557777777766778899999999999999854 56899999974         455678999999999999999999


Q ss_pred             eeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC
Q 047245          165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       165 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~  244 (380)
                      +++|+|.....+|+|+|||..|+|.+||+.+.  ...++-..++.+|.||+.||+||.   ..++|||||.++|+|+.++
T Consensus       327 qLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEn  401 (1157)
T KOG4278|consen  327 QLLGVCTHEPPFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGEN  401 (1157)
T ss_pred             HHhhhhccCCCeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHH---Hhhhhhhhhhhhhcccccc
Confidence            99999999999999999999999999998643  445666778999999999999999   9999999999999999999


Q ss_pred             CceEEeccCCcccCCCCCc-------CCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHH
Q 047245          245 FTPRLADFGLAKLMPGSLI-------ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLG  316 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~~~~-------~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~  316 (380)
                      ..+||+|||+++.+.++..       -++.|.|||.+....++.|+|||+|||+|||+.| |..||..        .++.
T Consensus       402 hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--------idlS  473 (1157)
T KOG4278|consen  402 HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLS  473 (1157)
T ss_pred             ceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--------ccHH
Confidence            9999999999999887643       3567999999999999999999999999999999 8889863        2233


Q ss_pred             HHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          317 RWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ....-+...-+           ...++.++..+.+|++.||+++|.+||++.|+-+.++.+
T Consensus       474 qVY~LLEkgyR-----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  474 QVYGLLEKGYR-----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             HHHHHHhcccc-----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            32222222111           123356778899999999999999999999999999876

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=304.24  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=195.5

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      .++|+|+||+|||++. ++|+.||||++....      ++....+-..+|+++|++++|+|+|.++.+|.....++||+|
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese------dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE------DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCC------ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            3689999999999997 569999999997522      345667888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      ||+. ++.+-|.   .....++...+.+++.|++.|+.|+|   ++++|||||||+|||++.++.+||||||+|+.+.. 
T Consensus        82 ~~dh-TvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecch-HHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9988 4444444   33556788889999999999999999   99999999999999999999999999999998763 


Q ss_pred             -----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH-----------HHH
Q 047245          261 -----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR-----------HLQ  323 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~-----------~~~  323 (380)
                           +.+.|..|.|||.+.+ .+|....||||+||++.||++|.+-|...    ++.+++-....           -+.
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~----SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR----SDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc----chHHHHHHHHHHHcccCHHHHHHhc
Confidence                 2457899999999987 78999999999999999999999887632    11111111111           111


Q ss_pred             hhcchhHhhchhc-----cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAGEAREALDRSI-----LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .++......-|..     ....+ +.....+++++..|++.||++|++-++++.
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1111100000100     11111 234556889999999999999999999873

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-42  Score=314.36  Aligned_cols=246  Identities=19%  Similarity=0.359  Sum_probs=198.4

Q ss_pred             ccccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          100 NENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ...+.||+|+||.||+|...    .+..||+|.++...       .......+.+|+..+++++||||+++++++..++.
T Consensus         8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-------SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            35678999999999999863    46689999987521       12334678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+|++|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence            9999999999999999874   2346899999999999999999999   999999999999999999999999999987


Q ss_pred             ccCCCC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          256 KLMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       256 ~~~~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ......       ..++..|+|||.+.+..++.++||||||+++||+++ |..||...        ...+........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~--------~~~~~~~~~~~~--  224 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--------SGQDVIKAVEDG--  224 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHHHHHCC--
Confidence            643221       224568999999999999999999999999999876 99998532        111111111111  


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                              . ....+......+.+++..||+.+|++|||++++.+.|+++
T Consensus       225 --------~-~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 --------F-RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --------C-CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                    0 0111233455688999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-43  Score=318.98  Aligned_cols=243  Identities=30%  Similarity=0.517  Sum_probs=191.9

Q ss_pred             cccccCccCCeeEEEEEec-----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD-----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||.|.||.||+|.+.     .+..|+||.++..       ........|.+|++.+++++||||++++|++...+.
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~   75 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP   75 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-------cccccceeeeeccccccccccccccccccccccccc
Confidence            3467999999999999986     3678999999541       123346889999999999999999999999998888


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+++|+|.+++...  ....+++..++.|+.|++.||+|||   +.+++|+||+++||++++++.+||+|||++
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~  150 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLS  150 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred             cccccccccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            99999999999999999852  3457899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .....        .......|+|||.+.+..++.++||||||+++||+++ |+.||...        ...++........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~~~~~  222 (259)
T PF07714_consen  151 RPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKLKQGQ  222 (259)
T ss_dssp             EETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHHHTTE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccc
Confidence            87622        2236778999999999889999999999999999999 67887531        2222333322111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML  374 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L  374 (380)
                      .           ...+......+.+++..||+.+|++|||++++++.|
T Consensus       223 ~-----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 R-----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             E-----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c-----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1           111223455688999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-42  Score=318.72  Aligned_cols=254  Identities=19%  Similarity=0.309  Sum_probs=195.4

Q ss_pred             cccccCccCCeeEEEEEecC-----------------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-----------------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL  163 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  163 (380)
                      ..+.||+|+||.||++...+                 +..||+|.+....       ......+|.+|+.++.+++||||
T Consensus         9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhhcCCCCe
Confidence            45679999999999997532                 3469999886521       23345789999999999999999


Q ss_pred             ceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhh---------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCC
Q 047245          164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE---------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ  228 (380)
Q Consensus       164 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~  228 (380)
                      +++++++.+.+..++||||+++|+|.+++.....               ....++|..++.++.|++.||+|||   +.+
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLN  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCC
Confidence            9999999999999999999999999999864211               1235788999999999999999999   899


Q ss_pred             eEecCCCCCcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh--C
Q 047245          229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT--G  298 (380)
Q Consensus       229 iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t--g  298 (380)
                      ++||||||+|||+++++.+||+|||+++....        ...++..|+|||.+.++.++.++||||||+++|||++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999999999999999999975432        1234778999999988899999999999999999987  4


Q ss_pred             CCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          299 RDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       299 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ..||....     ....................       ...+...+..+.+++.+||+.||++|||+++|.+.|++
T Consensus       239 ~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         239 EQPYGELT-----DEQVIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCcCC-----HHHHHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            56664311     01111111111111100000       00112234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=337.87  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             HHHHHhccccccCccCCeeEEEEEe-cCCc----EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeE
Q 047245           94 LQAALANENRLLGSSPDGKYYRTVL-DNGL----TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRA  168 (380)
Q Consensus        94 l~~~~~~~~~~lg~G~~g~vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  168 (380)
                      +++.......+||+|+||+||||.+ +.|+    +||+|++.....       .....++.+|+..|.+++|||+++++|
T Consensus       693 ~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-------~~~s~e~LdeAl~masldHpnl~RLLg  765 (1177)
T KOG1025|consen  693 LKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-------PKASIELLDEALRMASLDHPNLLRLLG  765 (1177)
T ss_pred             chhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-------chhhHHHHHHHHHHhcCCCchHHHHhh
Confidence            3444444667899999999999986 4444    688888865321       223478999999999999999999999


Q ss_pred             EEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          169 YVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       169 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      +|..+. ..||++||+.|+|.||++.   ....+.-+..+.|+.|||+||.|||   .++++||||.++|||+.+...+|
T Consensus       766 vc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvk  838 (1177)
T KOG1025|consen  766 VCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVK  838 (1177)
T ss_pred             hcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEE
Confidence            998765 8999999999999999985   3556888999999999999999999   99999999999999999999999


Q ss_pred             EeccCCcccCCCCC--------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPGSL--------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~~~--------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |.|||+++....+.        .-.+.|||-|.+....++.++|||||||++||++| |..||+....            
T Consensus       839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------  906 (1177)
T KOG1025|consen  839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------  906 (1177)
T ss_pred             EEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------
Confidence            99999999876432        24567999999999999999999999999999999 9999874211            


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                            .++.+.+..... -..++.+...+..++.+||..|+..||+++++...+.++
T Consensus       907 ------~eI~dlle~geR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  907 ------EEIPDLLEKGER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ------HHhhHHHhcccc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence                  112222222111 234456788899999999999999999999999888765

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-41  Score=308.09  Aligned_cols=254  Identities=20%  Similarity=0.348  Sum_probs=206.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .++..+|+|.+......     .......+.+|+.++++++||||+++++++.+.+..+++
T Consensus         6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-----DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC-----CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            346799999999999986 47899999988653221     233456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++|+|.+++.........++...+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            9999999999998765444556889999999999999999999   8999999999999999999999999999987654


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...++..|+|||.+.+..++.++|+||||+++|||++|+.||...      ......+........       
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~------~~~~~~~~~~~~~~~-------  224 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLFSLCQKIEQCD-------  224 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc------cccHHHHHHHHhcCC-------
Confidence            3      235788999999999888999999999999999999999998531      111122222211110       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                         ............+.+++.+||+.+|++|||+.++++.|++++
T Consensus       225 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 ---YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               111112234566889999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.5e-42  Score=326.30  Aligned_cols=251  Identities=22%  Similarity=0.401  Sum_probs=197.2

Q ss_pred             hccccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEe
Q 047245           99 ANENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVP  171 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  171 (380)
                      ....+.||+|+||.||++..      .++..||+|++....       .......+.+|+.+++.+ +|+||++++++|.
T Consensus        40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-------HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-------CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            34568899999999999874      234589999996421       122346788999999999 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhhh------------------------------------------------------
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIRE------------------------------------------------------  197 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  197 (380)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            99999999999999999999864221                                                      


Q ss_pred             ------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC----
Q 047245          198 ------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS----  261 (380)
Q Consensus       198 ------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~----  261 (380)
                                  ...++++..+.+++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.....    
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                        0124788899999999999999999   899999999999999999999999999998754321    


Q ss_pred             ----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          262 ----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       262 ----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                          ..++..|+|||.+.+..++.++||||||+++|||++ |+.||......       ..+... ...+     ...  
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-------~~~~~~-~~~~-----~~~--  334 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-------SKFYKM-VKRG-----YQM--  334 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-------HHHHHH-HHcc-----cCc--
Confidence                124567999999998899999999999999999997 99998641100       011111 1111     000  


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                         ..+......+.+++.+||+.||++|||+.++++.|+++
T Consensus       335 ---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         335 ---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               01111235688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-42  Score=327.12  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=196.5

Q ss_pred             ccccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec
Q 047245          100 NENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  172 (380)
                      ...+.||+|+||.||++..      .++..||||+++...       .....+.+.+|+.++..+ +||||++++++|.+
T Consensus        38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-------CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            3467899999999999863      346689999986421       112346788999999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhh-------------------------------------------------------
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRE-------------------------------------------------------  197 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  197 (380)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            9999999999999999999964211                                                       


Q ss_pred             ----------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          198 ----------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       198 ----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                                      ....++|..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                            1125789999999999999999999   899999999999999999999999999998755321


Q ss_pred             --------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          262 --------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       262 --------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                              ..++..|+|||.+.+..++.++||||||+++|||++ |..||.....       ...+..... .+.     
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~-~~~-----  334 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKMIK-EGY-----  334 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHHHH-hCc-----
Confidence                    224567999999999999999999999999999998 8888753110       011111111 110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                          . ...+......+.+++.+||+.||++|||+.|+++.|++.
T Consensus       335 ----~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 ----R-MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----c-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                0 001111234688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.6e-43  Score=322.79  Aligned_cols=236  Identities=26%  Similarity=0.395  Sum_probs=202.1

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||+||||+. .+.+.||+|.+...      +..+...+.+.+|++++++++||||+.++++++...++++|+
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~------gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS------GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhc------CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            35799999999999986 46789999998652      223445678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+.| +|..++..    ...+++..+..++.++..||.|||   +.+|.|||+||+|||++.++++|++|||+++.+..
T Consensus        81 e~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            99977 99999975    557999999999999999999999   99999999999999999999999999999998775


Q ss_pred             CC------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 SL------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~~------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      ..      .|||-|||||...+++|+..+|+||+||++||+.+|++||..                     ..+.+.+..
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---------------------~si~~Lv~~  211 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---------------------RSITQLVKS  211 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---------------------HHHHHHHHH
Confidence            43      499999999999999999999999999999999999999863                     112222222


Q ss_pred             hccCC-cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGE-EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+..+ .++......+..++...+.+||.+|-|..+++.
T Consensus       212 I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  212 ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            22211 334567778899999999999999999988763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.6e-42  Score=314.00  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=194.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+|+.||+|.+......     .......+.+|+.++++++|+||+++.+++.+.+..++|+
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-----hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            46799999999999986 57899999998652211     1122356788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++.....
T Consensus        80 e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          80 TIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             EecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            999999999888642  2346899999999999999999999   99999999999999999999999999999976532


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...|+..|+|||.+.+..++.++|||||||++|||++|+.||.....    ............         .. 
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~~~~~~~~~~---------~~-  220 (285)
T cd05631         155 GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE----RVKREEVDRRVK---------ED-  220 (285)
T ss_pred             CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc----chhHHHHHHHhh---------cc-
Confidence                 23589999999999999999999999999999999999999863110    000001110000         00 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                        ....+......+.+++.+||+.||.+||+     ++++++
T Consensus       221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              01111233456789999999999999997     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=307.15  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=197.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||.|..++||+|.. +.++.||||++...      + +......+.+|++.++.++||||+.++..|..+..+++|
T Consensus        30 L~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE------k-c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   30 LQEVIGVGASAVVYLARCIPTNEVVAIKIINLE------K-CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             EEEEEeccceeEeeeeeecccCCEEEEEEeehh------h-hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            456899999999999984 67899999999762      2 233368899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |.||.+||+.+.+...-  ...+++..+..|+.++++||.|||   .++.||||||+.||||+++|.+||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999998533  345889999999999999999999   9999999999999999999999999999875432


Q ss_pred             ----------CCCcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          260 ----------GSLIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       260 ----------~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                                ....|+++|||||++..  ..|+.|+||||||++..||.+|..||...-+       +......+.....
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~pp  250 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDPP  250 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCCC
Confidence                      33469999999999654  5699999999999999999999999974211       1111111111110


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...  ... ............+.+++..|+..||++|||++++++
T Consensus       251 ~~~--t~~-~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  251 TLL--TSG-LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             Ccc--ccc-CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            000  000 001111223446789999999999999999999974

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.1e-42  Score=319.27  Aligned_cols=238  Identities=22%  Similarity=0.291  Sum_probs=193.1

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||++.. .+|+.+|+|++.....     ........+.+|+.++++++||||+++.+++...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-----IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence            3699999999999986 5789999999875211     122334667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence            9999999999874    346899999999999999999999   99999999999999999999999999999875321 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...|++.|+|||.+.+..++.++|||||||++|||++|..||...        ........... +.        
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------~~~~~~~~~~~-~~--------  211 (323)
T cd05571         149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILM-EE--------  211 (323)
T ss_pred             CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC--------CHHHHHHHHHc-CC--------
Confidence                 234899999999999999999999999999999999999998531        11111111110 00        


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                         ...+......+.+++.+||+.||++||     ++.++++
T Consensus       212 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence               011123445678999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=319.71  Aligned_cols=240  Identities=24%  Similarity=0.374  Sum_probs=195.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      +++.||.|+|++|++++. ..+..+|||++.......     +...+.+..|-..|.+| .||.|++|+-.+.+...+|+
T Consensus        77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-----e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-----EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-----hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            678999999999999985 578999999997532211     12234566788899999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |+||+++|+|.+++++    -+.++......++.+|+.||+|||   +.+||||||||+|||+|+|+++||+|||.++.+
T Consensus       152 vLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999986    356888888999999999999999   999999999999999999999999999999865


Q ss_pred             CC-------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH
Q 047245          259 PG-------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       259 ~~-------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      ..                   ..+||..|++||++.++..+..+|+|+|||++|+|+.|.+||...          .+|.
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----------Neyl  294 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----------NEYL  294 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----------cHHH
Confidence            41                   135899999999999999999999999999999999999999631          1111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      -.    .+ ...++...     ++.-...+.+|+.+.|..||.+|+|.++|-+
T Consensus       295 iF----qk-I~~l~y~f-----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  295 IF----QK-IQALDYEF-----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HH----HH-HHHhcccC-----CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            00    00 01112222     2223356788999999999999999987753

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-41  Score=307.22  Aligned_cols=244  Identities=24%  Similarity=0.391  Sum_probs=198.8

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|++|.||+|...++..||+|.+...         ....+.+.+|+.++++++|+||+++++.+.+.+..++++
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072          10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             EeeecCCcCCceEEEEEecCCceEEEEEccCC---------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            34679999999999999888889999987641         112367889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          81 EYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999999999742  3456889999999999999999999   89999999999999999999999999999986543


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||.+....++.++||||||+++|||++ |..||...        ............      .
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--------~~~~~~~~~~~~------~  221 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM--------SNSDVMSALQRG------Y  221 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC--------CHHHHHHHHHcC------C
Confidence            2       124567999999998889999999999999999998 99998531        111111111111      0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..     .........+.+++.+|++.+|++|||++++.+.|+++
T Consensus       222 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 RM-----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CC-----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            00     11112345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-41  Score=309.66  Aligned_cols=247  Identities=23%  Similarity=0.411  Sum_probs=198.6

Q ss_pred             ccccCccCCeeEEEEEecC------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          102 NRLLGSSPDGKYYRTVLDN------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      .+.||+|+||.||+|....      ...+|+|.+...       ........+.+|+..+++++||||+++++++.+...
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-------CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            4679999999999998632      257999988642       123345678999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      .++++||+++|+|.+++.....            ....+++..++.++.|++.||+|||   +.+++|+||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcC
Confidence            9999999999999999975311            1145888999999999999999999   899999999999999999


Q ss_pred             CCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCC
Q 047245          244 EFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGS  314 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~  314 (380)
                      ++.+||+|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||....        
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--------  231 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--------  231 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--------
Confidence            99999999999875421        2235778999999998899999999999999999998 999986311        


Q ss_pred             HHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       315 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..+....          +..... ...+...+..+.+++.+||+.||.+||+++||++.|+++
T Consensus       232 ~~~~~~~----------i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         232 NQEVIEM----------IRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHH----------HHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1111111          111110 112234567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=317.85  Aligned_cols=241  Identities=27%  Similarity=0.444  Sum_probs=197.3

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.|+.+.. .+|+.||+|.+.......  .. ....+.+.+|+.++++++ ||||++++.++......++
T Consensus        21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~--~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS--KS-QKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc--cc-cccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            567899999999999975 578999999665521110  11 123456668999999998 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccCCccc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKL  257 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfgl~~~  257 (380)
                      ||||+.+|+|.+++..    ..++.+.....+..|++.|++|+|   +.+|+||||||+|+|++.+ +++||+|||++..
T Consensus        98 vmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999974    567888999999999999999999   9999999999999999999 9999999999987


Q ss_pred             CC------CCCcCCCcccCcccccCCC-CC-CcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          258 MP------GSLIATSAYSAPECFQNRS-YT-DKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       258 ~~------~~~~~~~~y~aPE~~~~~~-~~-~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ..      ....|++.|+|||++.+.. |+ .++||||+||+||.|++|..||+.        .......+.....    
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~ki~~~----  238 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRKIRKG----  238 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHHHhcC----
Confidence            72      2356999999999999977 86 789999999999999999999974        1222222221111    


Q ss_pred             HhhchhccCCcccHHH-HHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          330 EALDRSILGEEVEEDE-MLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~-~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                           ..   ..+... ...+..++.+|+..||.+|+|+.+++
T Consensus       239 -----~~---~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 -----EF---KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -----Cc---cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                 00   111222 66788999999999999999999998

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=315.38  Aligned_cols=237  Identities=22%  Similarity=0.301  Sum_probs=191.4

Q ss_pred             cCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||+|+||.||++... ++..||+|.+.....     ........+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-----VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence            799999999999874 578999999864211     12233467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC---
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---  260 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---  260 (380)
                      ++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....   
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  148 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD  148 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence            99999999874    346899999999999999999999   99999999999999999999999999999875321   


Q ss_pred             ---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          261 ---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       261 ---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                         ...|++.|+|||.+.+..++.++|||||||++|||++|..||...        .............           
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--------~~~~~~~~~~~~~-----------  209 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--------NVNEMYRKILQEP-----------  209 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--------CHHHHHHHHHcCC-----------
Confidence               235899999999999999999999999999999999999998531        1222222221110           


Q ss_pred             CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          338 GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       338 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                       ...+......+.+++.+||+.||.+||+...+.+.
T Consensus       210 -~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         210 -LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             -CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence             01112334567899999999999999865444333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=307.04  Aligned_cols=246  Identities=24%  Similarity=0.379  Sum_probs=199.6

Q ss_pred             hccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245           99 ANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ....+.||+|++|.||++...++..||+|.++....         ..+.+.+|+.++++++||||+++++++...+..++
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            345678999999999999988888999999864211         13568899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ++||+++++|.+++...  ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          79 VTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             eeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            99999999999998742  2346899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCC----c---CCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          259 PGSL----I---ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       259 ~~~~----~---~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ....    .   .+..|+|||.+.+..++.++||||||+++|||++ |+.||...        ........         
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~---------  216 (261)
T cd05068         154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM--------TNAEVLQQ---------  216 (261)
T ss_pred             cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHH---------
Confidence            4321    1   2347999999999999999999999999999999 99888531        11111111         


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                       ++... ....+......+.+++.+|++.+|++||+++++++.|+++
T Consensus       217 -~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         217 -VDQGY-RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -HHcCC-CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             11110 0111223456688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-41  Score=305.48  Aligned_cols=241  Identities=21%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..+|+|.+....         .....+.+|+.++++++||||+++++++...+..++||
T Consensus         8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             EeeEecCCcCceEEEEEeccCceEEEEecccCC---------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            346799999999999999888899999876421         11256888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.++++..   ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.++....
T Consensus        79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          79 EFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            999999999998742   236899999999999999999999   89999999999999999999999999999876432


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||.+.+..++.++||||||+++|||++ |+.||...        ...+..........     
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--------~~~~~~~~i~~~~~-----  219 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--------SNYEVVEMISRGFR-----  219 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHCCCC-----
Confidence            1       124567999999998899999999999999999999 88898531        11122222211110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                            ...+......+.+++.+||+.+|++|||++++++.|+
T Consensus       220 ------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 ------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  0011123346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=316.50  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=194.3

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  179 (380)
                      ++||+|.||.|||+.. .+|..||+|++....      ..........+||.+|++|+||||+++.+...+.  +.+|+|
T Consensus       123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~------~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDN------EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHhcCcchhheeEeeecccCcEEEEEEeeccc------CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            5799999999999985 689999999998632      2223346778999999999999999999998766  789999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +|||++ +|.-++.   +..-.++..++..++.|++.||+|+|   ..++.|||||.+|||||.+|.+||+|||+|+.+.
T Consensus       197 FeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            999988 9988886   33457999999999999999999999   9999999999999999999999999999999765


Q ss_pred             CC-------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHHHH
Q 047245          260 GS-------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRHLQ  323 (380)
Q Consensus       260 ~~-------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~~~  323 (380)
                      ..       .+-|..|.|||.+.+ ..|+.+.|+||.|||+.||++|++.|....+...        .......|.....
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            32       346889999999987 5799999999999999999999998864211110        0011112321000


Q ss_pred             hhcchhHhhchhccCC----cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAGEAREALDRSILGE----EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .   ....+.+...-.    ..........++|+...|..||.+|.|+.++++
T Consensus       350 P---~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 P---HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             C---cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            0   000111110000    001123445678999999999999999998874

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.8e-41  Score=323.04  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=197.7

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  173 (380)
                      ..++||+|+||.||+|...      .+..||+|++....       .....+.+.+|+++++++. ||||++++++|.+.
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            4578999999999999852      23479999986421       1233467899999999995 99999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhc-------------------------------------------------------
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIREN-------------------------------------------------------  198 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  198 (380)
                      +..++||||+++|+|.++++.....                                                       
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999998753210                                                       


Q ss_pred             -------------------------------------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe
Q 047245          199 -------------------------------------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML  241 (380)
Q Consensus       199 -------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill  241 (380)
                                                           ...+++..++.++.|++.||+|||   +.+++||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEE
Confidence                                                 124788889999999999999999   8999999999999999


Q ss_pred             CCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCC
Q 047245          242 DAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASG  312 (380)
Q Consensus       242 ~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~  312 (380)
                      ++++.+||+|||+++....        ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....     
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-----  345 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-----  345 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-----
Confidence            9999999999999875432        1235678999999998899999999999999999997 8899853100     


Q ss_pred             CCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          313 GSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       313 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                         ..........+     ..     ...+......+.+++.+||+.+|++|||+.+|.+.|+++-
T Consensus       346 ---~~~~~~~~~~~-----~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         346 ---DSTFYNKIKSG-----YR-----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ---hHHHHHHHhcC-----CC-----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence               00011111111     00     0111234566889999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.1e-41  Score=302.80  Aligned_cols=242  Identities=20%  Similarity=0.347  Sum_probs=195.0

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||++.. .+|+.+|+|.+...       ........+.+|++++++++||||+++++++......++|+|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence            3699999999999987 47889999987531       123344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      |+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++......
T Consensus        74 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          74 LVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             eccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence            9999999999863   2346899999999999999999999   999999999999999999999999999998754422


Q ss_pred             C--------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          262 L--------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       262 ~--------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .        ..+..|+|||.+.++.++.++||||||+++||+++ |..||.....        .....          .+
T Consensus       148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~----------~~  209 (252)
T cd05084         148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTRE----------AI  209 (252)
T ss_pred             cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHH----------HH
Confidence            1        12356999999999999999999999999999998 8888753111        01111          11


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ..... ...+...+..+.+++.+|++.+|++|||+++++++|+.
T Consensus       210 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         210 EQGVR-LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HcCCC-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            11100 11122345578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2e-41  Score=306.08  Aligned_cols=244  Identities=25%  Similarity=0.422  Sum_probs=198.8

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|++|.||++... ++..+|+|.+...         ......+.+|++.+++++||||+++++++...+..+++
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052          10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             EeeecCCcccceEEEEEEecCCceEEEEEecCC---------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            4578999999999999864 5889999987631         11236788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          81 TEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             EEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            999999999999874  22346899999999999999999999   8999999999999999999999999999988654


Q ss_pred             CCC-------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 GSL-------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~~~-------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ...       ..+..|+|||.+.+..++.++||||||+++|||++ |..||...        ...+........      
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--------~~~~~~~~~~~~------  221 (263)
T cd05052         156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQVYELLEKG------  221 (263)
T ss_pred             cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHHCC------
Confidence            321       23567999999999999999999999999999998 88887531        112222221111      


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ...     ..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       222 ~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 YRM-----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCC-----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            000     11122345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-42  Score=323.05  Aligned_cols=240  Identities=26%  Similarity=0.402  Sum_probs=203.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .++-||.|+.|.|-.|+. .+|+.+|||.+......     .+.....+.+|+.+|+-+.|||+++++++|++..++|+|
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-----s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-----SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeecccccc-----ccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            346699999999999986 68999999999764221     223346678999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      .||+++|-|.+++-.    .++++..+..++..||..|+.|+|   ..+|+||||||+|+|+|..+.+||+|||+|....
T Consensus        91 lEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            999999999999975    668999999999999999999999   9999999999999999999999999999997654


Q ss_pred             C-----CCcCCCcccCcccccCCCCC-CcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G-----SLIATSAYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      +     ..+|.+.|.|||++++.+|. .++||||.|||||.|++|+.||++        +++........          
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--------dNir~LLlKV~----------  225 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--------DNIRVLLLKVQ----------  225 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--------ccHHHHHHHHH----------
Confidence            3     45799999999999999985 789999999999999999999974        22222222221          


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+..  ..+.+.+.++.+|+.+++.+||..|-|++||++
T Consensus       226 ~G~f--~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  226 RGVF--EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             cCcc--cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            1111  234566778899999999999999999999975

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.9e-41  Score=311.67  Aligned_cols=189  Identities=25%  Similarity=0.467  Sum_probs=166.9

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|..+|+|.+....       .......+.+|++++++++||||+++++++...+..++||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            357999999999999974 68889999886521       2234577999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++....
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999874    346889999999999999999999   64 69999999999999999999999999987653


Q ss_pred             C----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      .    ...++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       156 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            3    23588999999999999999999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=312.30  Aligned_cols=239  Identities=21%  Similarity=0.276  Sum_probs=194.4

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|+.+|+|++.....     ......+.+.+|+.++++++||||+++++++.+....++||
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-----IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-----hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            467999999999999974 689999999864211     11233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999874    346889999999999999999999   99999999999999999999999999999986543


Q ss_pred             C---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          261 S---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       261 ~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                      .   ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...        .............           
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~-----------  214 (291)
T cd05612         154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD--------NPFGIYEKILAGK-----------  214 (291)
T ss_pred             CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-----------
Confidence            2   35899999999999988999999999999999999999998631        1111111111110           


Q ss_pred             CCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          338 GEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       338 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                       ...+......+.+++.+||+.||.+||+     ++|+++
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence             0111223445789999999999999995     777663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.1e-42  Score=289.36  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.+|+|.||.||+|.. .+|+.||+|+++.....      +.......+||+.|+.++|+||+.+++++...+.+.+|+
T Consensus         7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k------dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK------DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc------cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            35799999999999995 67999999999874322      223367789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |||+. +|...++.   ....++..++..++.++.+|++|||   .+.|.||||||.|+|++++|.+||+|||+++....
T Consensus        81 Efm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             Eeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            99986 99998873   4567889999999999999999999   99999999999999999999999999999998764


Q ss_pred             C------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCH------------HHHHHH
Q 047245          261 S------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL------------GRWLRH  321 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l------------~~~~~~  321 (380)
                      .      .+-|..|.|||.+.+ ..|+...|+||.|||+.||+.|.+-|..    ..+.+++            .+|...
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHHHHcCCCCcccCccc
Confidence            3      246889999999876 5699999999999999999998866542    1111111            122111


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..-+.-..-..-+.-........+...+.+++..++..||.+|+|++|.++
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            100000000000000011122335566789999999999999999999885

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.5e-41  Score=303.00  Aligned_cols=255  Identities=20%  Similarity=0.358  Sum_probs=207.1

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|++|.||+|... +|+.+|+|.++.....     .......+.+|++++++++|+|++++++++.+.+..+++
T Consensus         6 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-----DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             eeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-----chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            4568999999999999986 7899999998753221     122346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++.........+++..++.++.+++.||+|||   +.+++||||+|+||+++.++.++|+|||+++...
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999999999765444566899999999999999999999   8999999999999999999999999999987543


Q ss_pred             CC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 GS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||...      .....++......         
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~---------  222 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEK---------  222 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC------CccHHHHHhhhhc---------
Confidence            22      34788899999999888999999999999999999999998531      1112222221111         


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                       ..............+.+++.+||+.+|++|||+.+++++|++++.
T Consensus       223 -~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~  267 (267)
T cd08224         223 -CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA  267 (267)
T ss_pred             -CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence             001111112345568899999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-41  Score=302.83  Aligned_cols=241  Identities=20%  Similarity=0.339  Sum_probs=193.8

Q ss_pred             ccCccCCeeEEEEEe---cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          104 LLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .||+|+||.||+|..   .++..+|+|++....      ......+.+.+|+.+++.++||||+++++++.. ...++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   74 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVM   74 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEE
Confidence            589999999999975   357889999886421      223445788999999999999999999999854 5678999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          75 ELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence            99999999999864    346889999999999999999999   89999999999999999999999999999976542


Q ss_pred             CC---------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          261 SL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       261 ~~---------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ..         .++..|+|||.+....++.++|+||||+++|||++ |..||...        ....+...... +.   
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~i~~-~~---  215 (257)
T cd05116         148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--------KGNEVTQMIES-GE---  215 (257)
T ss_pred             CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHC-CC---
Confidence            21         13468999999988889999999999999999998 99998631        11122222111 11   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                            . ...+......+.+++.+||+.||++||++++|.+.|++.
T Consensus       216 ------~-~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 ------R-MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ------C-CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                  0 011122445688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=314.68  Aligned_cols=256  Identities=20%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCC-eEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESS-RFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  178 (380)
                      .+.||.|.||+||+|+. .+|..||||+++.....       ...-.=.+|++.|++|+ ||||+++..++.+.+ .+++
T Consensus        15 i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-------~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen   15 IRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-------WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-------HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            35799999999999985 67899999999863321       11133458999999998 999999999998887 9999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||||+. +|.+.++.+   ...++...+..|+.||++||+|+|   .+|++|||+||+|||+.....+||+|||+||..
T Consensus        88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence            9999966 999999853   568999999999999999999999   999999999999999999999999999999987


Q ss_pred             CCC-----CcCCCcccCccccc-CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc--------cCCCCHHHHHHHHHh
Q 047245          259 PGS-----LIATSAYSAPECFQ-NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA--------ASGGSLGRWLRHLQH  324 (380)
Q Consensus       259 ~~~-----~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~--------~~~~~l~~~~~~~~~  324 (380)
                      ...     .+.|..|.|||++. .+-|+.+.|+||+|||++|+.+-++.|....+..        -......+|.....-
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            643     45788999999986 4678999999999999999999888775311100        011111122221110


Q ss_pred             hcchhHhhchhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 AGEAREALDRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ... ...--+...+.   ........+..+++.+|+.+||.+|||++|.++
T Consensus       241 a~~-mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  241 ASA-MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHH-hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            000 00000111111   111235677889999999999999999999886

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-41  Score=307.52  Aligned_cols=248  Identities=21%  Similarity=0.374  Sum_probs=198.7

Q ss_pred             ccccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC
Q 047245          100 NENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES  173 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  173 (380)
                      ...+.||+|+||.||+|...      ++..||+|.+....       .......+.+|++++++++|+||+++++++...
T Consensus         8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-------SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-------CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            34578999999999999863      34789999886421       122457889999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhh----------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIR----------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      ...++||||+++|+|.+++....          .....+++..+..++.|++.|++|||   +.+++||||||+||+++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcC
Confidence            99999999999999999997532          12345789999999999999999999   899999999999999999


Q ss_pred             CCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCC
Q 047245          244 EFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGS  314 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~  314 (380)
                      ++.+||+|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...        .
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~--------~  229 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL--------S  229 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC--------C
Confidence            99999999999875421        2235678999999999999999999999999999998 99997531        1


Q ss_pred             HHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       315 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ..+...... .+.         . ...+......+.+++.+||+.||++||++.|+++.|++
T Consensus       230 ~~~~~~~~~-~~~---------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         230 NEEVIECIT-QGR---------L-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHHHHHHH-cCC---------c-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            111111111 110         0 01112345668899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-41  Score=314.91  Aligned_cols=238  Identities=23%  Similarity=0.302  Sum_probs=191.9

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ++||+|+||.||++.. .+|..||+|.+.....     ........+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence            3699999999999986 4689999999975211     122334677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence            9999999988864    346899999999999999999999   89999999999999999999999999999875321 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...        ...........         ..
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--------~~~~~~~~~~~---------~~  211 (323)
T cd05595         149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILM---------EE  211 (323)
T ss_pred             CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHhc---------CC
Confidence                 234889999999999999999999999999999999999998531        11111111110         00


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                      .   ..+......+.+++.+||+.||++||     ++.++++
T Consensus       212 ~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 I---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             C---CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            0   11122345578999999999999998     7777764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.4e-41  Score=304.04  Aligned_cols=245  Identities=24%  Similarity=0.404  Sum_probs=200.9

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||.|+||.||+|...++..+++|.+...        .......+..|+.+++.++|+||+++++++.+....++||
T Consensus        10 ~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148          10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--------DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             HhhhhccCCCccEEEeEecCCCcEEEEecccc--------chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            34679999999999999988999999998652        1223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          82 ELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999999742  2456899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ..++..|+|||.+.+..++.++||||||+++|+|++ |+.||...        ...+......          
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~----------  218 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM--------NNHEVYDQIT----------  218 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC--------CHHHHHHHHH----------
Confidence            2      235667999999998899999999999999999998 88898531        1111111111          


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .... ...+......+.+++.+||+.||++|||++++++.|+++
T Consensus       219 ~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         219 AGYR-MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             hCCc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            1100 111233456688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-41  Score=315.55  Aligned_cols=239  Identities=21%  Similarity=0.303  Sum_probs=193.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|.+.....     ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus        22 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-----LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            4578999999999999974 688999999875211     1223346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999999874    346788888999999999999999   8999999999999999999999999999998665


Q ss_pred             CC---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          260 GS---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       260 ~~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      ..   ..|++.|+|||.+.+..++.++|||||||++|||++|..||...        ........... +.        .
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~i~~-~~--------~  232 (329)
T PTZ00263        170 DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--------TPFRIYEKILA-GR--------L  232 (329)
T ss_pred             CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC--------CHHHHHHHHhc-CC--------c
Confidence            42   35899999999999999999999999999999999999998531        11111111111 10        0


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELV  371 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl  371 (380)
                         ..+......+.+++.+||+.||++||+     +++++
T Consensus       233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence               011113345789999999999999997     46554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.4e-41  Score=314.33  Aligned_cols=238  Identities=23%  Similarity=0.302  Sum_probs=192.8

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||++.. .+|..+|+|++.....     ........+.+|+.+++.++||||+++.+++...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-----IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence            3689999999999986 4689999999975221     122334678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~  148 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD  148 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence            9999999988864    346899999999999999999999   99999999999999999999999999999875321 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...|++.|+|||.+.+..++.++|||||||++|||++|+.||...        ............       +  
T Consensus       149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~--------~~~~~~~~~~~~-------~--  211 (328)
T cd05593         149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILME-------D--  211 (328)
T ss_pred             ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC--------CHHHHHHHhccC-------C--
Confidence                 234899999999999989999999999999999999999998531        111111111100       0  


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                         ...+......+.+++.+|++.||++||     ++.|+++
T Consensus       212 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 ---IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ---ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence               011122345578899999999999997     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.8e-41  Score=303.51  Aligned_cols=253  Identities=21%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++.. .+|..+++|.+.....     .+.....++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-----hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46799999999999995 5789999998865321     12334568889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++.........+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998754444567899999999999999999999   99999999999999999999999999999876542


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...++..|+|||.+.+..++.++|+||||+++|||++|..||...      ......+......      ...+
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~------~~~~  226 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQ------CDYP  226 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc------cchHHHHhhhhhc------CCCC
Confidence                  235788999999999888999999999999999999999998531      1111111111110      0011


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                          ..........+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       227 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         227 ----PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ----CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                1111234556889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-41  Score=303.47  Aligned_cols=245  Identities=20%  Similarity=0.398  Sum_probs=198.2

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...    +...||+|.+....       .......|.+|+..+++++||||+++++++.+.+..
T Consensus         8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            4678999999999999874    24579999886421       233456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      +++|||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++||||+|+||++++++.++|+|||+++
T Consensus        81 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          81 MIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             EEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence            999999999999999874   2347899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          257 LMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       257 ~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ....        ...++..|+|||.+.+..++.++||||||+++||+++ |..||....        .......... +.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~-~~  225 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--------NQDVIKAVED-GY  225 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--------HHHHHHHHHc-CC
Confidence            7641        1124567999999998899999999999999999998 999985311        1111111111 00


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                                ..+.+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       226 ----------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ----------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      0011123455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=319.67  Aligned_cols=253  Identities=20%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             HHHHHHhccccccCccCCeeEEEEEecC---C--cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceee
Q 047245           93 TLQAALANENRLLGSSPDGKYYRTVLDN---G--LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR  167 (380)
Q Consensus        93 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~---g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  167 (380)
                      ++++.....+++||.|-||.||+|++.+   |  -.||||..+...       +.+..+.|.+|..+|+.++||||++++
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-------t~d~tekflqEa~iMrnfdHphIikLI  457 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-------TPDDTEKFLQEASIMRNFDHPHIIKLI  457 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-------ChhhHHHHHHHHHHHHhCCCcchhhee
Confidence            3444455577899999999999999732   3  368889887522       122358899999999999999999999


Q ss_pred             EEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCce
Q 047245          168 AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP  247 (380)
Q Consensus       168 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  247 (380)
                      |+|.+ ...++|||.++.|.|+.||+.   +...++......++.||+.||+|||   +.++|||||.++|||+.....+
T Consensus       458 Gv~~e-~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CV  530 (974)
T KOG4257|consen  458 GVCVE-QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCV  530 (974)
T ss_pred             eeeec-cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCccee
Confidence            99987 578999999999999999984   4557888899999999999999999   9999999999999999999999


Q ss_pred             EEeccCCcccCCCCCc-------CCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          248 RLADFGLAKLMPGSLI-------ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       248 kl~Dfgl~~~~~~~~~-------~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |++|||+++.+..+..       -+..|||||.+...++|.+||||.|||.+||++. |..||..    ..+        
T Consensus       531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg----vkN--------  598 (974)
T KOG4257|consen  531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG----VKN--------  598 (974)
T ss_pred             eecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc----ccc--------
Confidence            9999999998765432       4667999999999999999999999999999998 9999863    111        


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                            .++.-.+..+ .+.+.++.++..+..++.+||..+|.+||.+.|+...|+++.
T Consensus       599 ------sDVI~~iEnG-eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  599 ------SDVIGHIENG-ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             ------cceEEEecCC-CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                  1111111111 012445667888899999999999999999999999988764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=306.78  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=195.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHH--cCCCCCcceeeEEEecC----C
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA--SLRHRNLMSLRAYVPES----S  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~----~  174 (380)
                      ..+.||+|.||.||+|.++ |+.||||++....           .+.+.+|.+++.  .|+|+||+.+++.-..+    .
T Consensus       215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-----------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-----------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             EEEEecCccccceeecccc-CCceEEEEecccc-----------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            4567999999999999996 8999999996522           144555555555  55999999999885433    3


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHh-----cCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF-----TCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                      +++||+||.++|||.|||.     ...++-...++++..+|.||++||.     +.++.|.|||||+.|||+..++.+.|
T Consensus       283 QLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            7899999999999999998     3468888999999999999999994     35789999999999999999999999


Q ss_pred             eccCCcccCC----------CCCcCCCcccCcccccCCC----C--CCcchhhHHHHHHHHHHhCC----------CCCC
Q 047245          250 ADFGLAKLMP----------GSLIATSAYSAPECFQNRS----Y--TDKSDIFSFGMILAVLLTGR----------DPTA  303 (380)
Q Consensus       250 ~Dfgl~~~~~----------~~~~~~~~y~aPE~~~~~~----~--~~~sDv~s~Gvil~el~tg~----------~p~~  303 (380)
                      +|+|+|-...          +..+||.+|||||++...-    +  -..+||||||.|+||+....          .||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            9999996543          2356999999999997532    2  13589999999999987532          5665


Q ss_pred             chhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          304 PFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       304 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      +..+.   .++..++..     -...+.+.|.+.......+....+.+++..||..||.-|-|+--+-+.|.++
T Consensus       438 d~Vp~---DPs~eeMrk-----VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  438 DVVPS---DPSFEEMRK-----VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             cCCCC---CCCHHHHhc-----ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            43222   222222211     1122334555555566678889999999999999999999998887777665

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.1e-41  Score=313.92  Aligned_cols=242  Identities=23%  Similarity=0.316  Sum_probs=191.2

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ++||+|+||.||++.. .+++.+|+|.+......     .......+.+|+.++.++ +||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-----chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence            4699999999999996 46789999999753211     223345677899988877 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++... 
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            99999999988864    346899999999999999999999   8999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...............+.........       
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------  221 (329)
T cd05618         149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------  221 (329)
T ss_pred             CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-------
Confidence                 12358999999999999999999999999999999999999986321111111122233322221111       


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                          ...+......+.+++.+||+.||++||+.
T Consensus       222 ----~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                01122344567899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-41  Score=327.63  Aligned_cols=243  Identities=21%  Similarity=0.292  Sum_probs=196.6

Q ss_pred             ccccccCccCCeeEEEEEec-C-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-N-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      ...+.||+|++|.||++... + +..||+|.+..        ........+.+|+.+++.++||||+++++++...+..+
T Consensus        70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--------~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--------NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--------CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            35678999999999999853 3 57788887643        12233456788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|.+++........++++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            999999999999998754444557899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          258 MPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       258 ~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ...        ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...        .............   
T Consensus       219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~--------~~~~~~~~~~~~~---  287 (478)
T PTZ00267        219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP--------SQREIMQQVLYGK---  287 (478)
T ss_pred             cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC---
Confidence            532        224899999999999999999999999999999999999998531        1122222211110   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            .  ...+......+.+++.+||+.||++|||+.+++.
T Consensus       288 ------~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 ------Y--DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------C--CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  0  0111223456889999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.2e-41  Score=307.51  Aligned_cols=248  Identities=20%  Similarity=0.385  Sum_probs=198.0

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||++..      .++..+|+|.+..        ........+.+|++++++++||||+++++++...+
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--------ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC--------cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            457899999999999974      2345689998864        12334567899999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhh---------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIR---------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF  245 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~  245 (380)
                      ..++|+||+++++|.+++....         .....+++..++.++.|++.||+|||   +.+++||||||+||++++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            9999999999999999997432         12235899999999999999999999   89999999999999999999


Q ss_pred             ceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHH
Q 047245          246 TPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLG  316 (380)
Q Consensus       246 ~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~  316 (380)
                      .+||+|||+++....        ...++..|+|||.+.+..++.++||||||+++|||++ |..||....        ..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~  229 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NN  229 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HH
Confidence            999999999975432        1224668999999998899999999999999999998 888875311        11


Q ss_pred             HHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          317 RWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      +..... ..+...          ..+......+.+++.+||+.||.+|||++|+++.|+++.
T Consensus       230 ~~~~~i-~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         230 EVIECI-TQGRVL----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHHHH-HcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            111111 111100          001123345899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-40  Score=299.02  Aligned_cols=241  Identities=20%  Similarity=0.354  Sum_probs=195.7

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEee
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY  182 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  182 (380)
                      ++||+|+||.||+|...++..+|+|.+....       .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence            3699999999999998889999999876421       123345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC-
Q 047245          183 LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-  261 (380)
Q Consensus       183 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-  261 (380)
                      +++++|.+++..   ....+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++...... 
T Consensus        74 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (250)
T cd05085          74 VPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI  147 (250)
T ss_pred             CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence            999999998863   2346889999999999999999999   899999999999999999999999999998754322 


Q ss_pred             ------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       262 ------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ..++..|+|||.+.+..++.++||||||+++||+++ |..||...        ........... +.     . 
T Consensus       148 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~--------~~~~~~~~~~~-~~-----~-  212 (250)
T cd05085         148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM--------TNQQAREQVEK-GY-----R-  212 (250)
T ss_pred             cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHHc-CC-----C-
Confidence                  123567999999998899999999999999999998 99998531        11111111111 10     0 


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                          ...+......+.+++.+|++.+|++|||+.|+++.|.
T Consensus       213 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 ----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                0111224566889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-41  Score=312.68  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=193.6

Q ss_pred             ccccccCccCCeeEEEEEec-CCc----EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGL----TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ...+.||+|+||.||+|... +|.    .||+|.+...       ......+++.+|+.+++.++||||++++|+|... 
T Consensus        10 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108          10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             eeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            34578999999999999863 343    3899988641       1223346788999999999999999999999764 


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++++||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccc
Confidence            57899999999999999874   2346889999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          255 AKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       255 ~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      ++.....        ...+..|+|||.+.+..++.++||||||+++|||++ |..||+..        ...++.......
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~--------~~~~~~~~~~~~  227 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKG  227 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhCC
Confidence            9865421        123567999999999999999999999999999998 99998531        111111111111


Q ss_pred             cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..           ...+......+.+++.+||+.+|++|||+.+++..|..+
T Consensus       228 ~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         228 ER-----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             CC-----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00           011112344578899999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-41  Score=312.89  Aligned_cols=239  Identities=22%  Similarity=0.321  Sum_probs=191.1

Q ss_pred             cccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      +.||+|+||.||++..    .+++.||+|.+.....    .........+.+|+.++++++||||+++++++..++..++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l   77 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI----VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYL   77 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH----HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEE
Confidence            4799999999999985    3578999999975211    1112234567889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+.+.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        78 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          78 ILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            9999999999999864    346788888899999999999999   899999999999999999999999999998643


Q ss_pred             CC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..      ...|++.|+|||.+.+..++.++||||||+++|||++|+.||...        ............       
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~--------~~~~~~~~~~~~-------  215 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE--------NRKKTIDKILKG-------  215 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC--------CHHHHHHHHHcC-------
Confidence            21      235889999999999888999999999999999999999998631        111111111111       


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                        ..   ..+......+.+++.+||+.+|++||     +++++++
T Consensus       216 --~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         216 --KL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CC---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              00   11122345578999999999999999     6777654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.1e-41  Score=312.79  Aligned_cols=242  Identities=22%  Similarity=0.307  Sum_probs=191.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ++||+|+||.||++.. .++..||+|.++....     ........+..|..++.++ +||||+++++++.+.+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-----NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence            4699999999999986 4688999999975221     1223346688899999999 7999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++... 
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            99999999988864    346899999999999999999999   9999999999999999999999999999987421 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++|+||||+++|||++|+.||+.............++..........      
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  222 (329)
T cd05588         149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------  222 (329)
T ss_pred             CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------
Confidence                 123589999999999999999999999999999999999999964211111111222333222221110      


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                           ..+......+.+++.+|++.||.+|||+
T Consensus       223 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         223 -----RIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                 1112234557899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-40  Score=300.41  Aligned_cols=240  Identities=19%  Similarity=0.328  Sum_probs=192.2

Q ss_pred             cCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          105 LGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       105 lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ||+|+||.||+|...   ++..||+|.+...       ......+.+.+|+.++++++||||+++++++.. ...++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e   74 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVME   74 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccc-------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEE
Confidence            899999999999763   4557999988642       123345678999999999999999999998854 57899999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      |+++|+|.+++..   ....+++..+++++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        75 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  148 (257)
T cd05115          75 MASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             eCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCC
Confidence            9999999999863   2446899999999999999999999   899999999999999999999999999998754321


Q ss_pred             ---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          262 ---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       262 ---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                               ..++..|+|||.+....++.++||||||+++||+++ |..||...        ...++.........    
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~~~~----  216 (257)
T cd05115         149 DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM--------KGPEVMSFIEQGKR----  216 (257)
T ss_pred             ccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC--------CHHHHHHHHHCCCC----
Confidence                     113568999999988889999999999999999997 99998631        11122211111110    


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                             ...+......+.+++.+||+.+|++||++.+|.+.|+++
T Consensus       217 -------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 -------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                   111123456688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.7e-41  Score=305.15  Aligned_cols=244  Identities=22%  Similarity=0.278  Sum_probs=192.7

Q ss_pred             cCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||+|+||+||++.. .+|+.+|+|.+.....     ......+.+..|+.++++++|+||+++.+++......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-----KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-----hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence            79999999999986 4688999999864211     11223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC---
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---  260 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---  260 (380)
                      ++|+|.+++.........+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.....   
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            999999988654444557899999999999999999999   89999999999999999999999999999875432   


Q ss_pred             ---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          261 ---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       261 ---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                         ...+++.|+|||.+.+..++.++||||||+++|||++|+.||.....    ..........         .+...  
T Consensus       153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~~~~~~~~~~---------~~~~~--  217 (280)
T cd05608         153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQR---------ILNDS--  217 (280)
T ss_pred             cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc----chhHHHHHHh---------hcccC--
Confidence               23578899999999999999999999999999999999999863110    0000111110         01110  


Q ss_pred             CCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          338 GEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       338 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                       ...+......+.+++.+||+.||++||     +++++++
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 -VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence             011223455678999999999999999     5566653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.7e-41  Score=305.93  Aligned_cols=259  Identities=25%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             cccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--
Q 047245          101 ENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  173 (380)
                      ..+.||+|+||.||.+..     .++..||+|.+....       .......+.+|++++++++||||+++++++...  
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-------GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             eceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            446799999999987653     467899999986521       122346788999999999999999999988653  


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...+++|||+++|+|.+++..     ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecc
Confidence            468999999999999999863     35899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          254 LAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       254 l~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      +++.....         ..++..|+|||.+.+..++.++||||||+++|||++|..|+........   ....+......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~  229 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE---EMIGPKQGQMT  229 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh---hhhcccccccc
Confidence            98765421         1245679999999888899999999999999999999999753211000   00000000000


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .....+.++.... ...+......+.+++..||+.+|++|||++++++.|++++
T Consensus       230 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         230 VVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0111111111111 1112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=285.41  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             cccccCccCCeeEEEEE-ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----C
Q 047245          101 ENRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----S  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  174 (380)
                      ..+.||+|||+-||.+. +.++..+|+|++...        ..+..+...+|++..++++|||++++++++..+     .
T Consensus        25 i~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--------~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   25 IQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--------SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EeeeecCCCceeeeeecccCcccchhhheeecc--------chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            45689999999999998 578899999999872        234457888999999999999999999987443     3


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..|++++|+..|||.+.++.....+..+++.+.++|+.++++||++||+. .+++.||||||.|||+++++.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            58999999999999999998777777899999999999999999999932 34599999999999999999999999999


Q ss_pred             cccCCCC---------------CcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHH
Q 047245          255 AKLMPGS---------------LIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLG  316 (380)
Q Consensus       255 ~~~~~~~---------------~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~  316 (380)
                      +...+-.               ...|..|.|||.+.   +...++++|||||||++|+|+-|..||+....   .     
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~-----  247 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---Q-----  247 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---c-----
Confidence            8765421               13788999999986   44578999999999999999999999975322   1     


Q ss_pred             HHHHHHHhhcchhHhhch-hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          317 RWLRHLQHAGEAREALDR-SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                              .+.+.-.+.. .+.-+.. ...+..+.+++.+|+++||.+||+..+++..++.+-
T Consensus       248 --------GgSlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 --------GGSLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------CCeEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                    1111111111 1111111 125677899999999999999999999999998763

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8e-41  Score=304.45  Aligned_cols=247  Identities=21%  Similarity=0.376  Sum_probs=195.2

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|...      ++..+|+|++....       ......++.+|+.+++.++||||+++++++.++.
T Consensus        10 ~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062          10 MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             eeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4578999999999998752      35679999875311       1223467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhc------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIREN------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      ..++|+||+++|+|.+++...+..      ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence            999999999999999999753221      234688899999999999999999   89999999999999999999999


Q ss_pred             EeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++....        ...++..|+|||.+.+..++.++||||||+++|||++ |..||...        ......
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~--------~~~~~~  231 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM--------SNEQVL  231 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHH
Confidence            999999875432        1234678999999998899999999999999999999 67887531        111122


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .......         .  ...+......+.+++.+||+.+|++|||+.|+++.|++
T Consensus       232 ~~~~~~~---------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         232 RFVMEGG---------L--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHcCC---------c--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            1111111         0  01112234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.5e-41  Score=300.86  Aligned_cols=241  Identities=19%  Similarity=0.324  Sum_probs=194.6

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..+|+|.+.....         ....+.+|+.++++++||||+++++++.+....+++|
T Consensus         8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             EeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            3467999999999999987777899998864211         1256889999999999999999999999988999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.++....
T Consensus        79 e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          79 EYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            99999999999874   2336899999999999999999999   99999999999999999999999999999875432


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||.+.+..++.++||||||+++|||++ |..||....        ..+..........     
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~-----  219 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--------NSETVEKVSQGLR-----  219 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--------HHHHHHHHhcCCC-----
Confidence            1       124567999999998889999999999999999999 999985311        1111111111100     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                            ...+......+.+++.+||+.+|.+|||+.++++.|+
T Consensus       220 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                  0111123466889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-40  Score=305.56  Aligned_cols=248  Identities=23%  Similarity=0.410  Sum_probs=198.3

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||++..      .++..+++|.+..        ......+.+.+|++.+++++|+||+++++++....
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--------PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--------ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            346899999999999974      2355688888754        12233467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD  242 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~  242 (380)
                      ..++||||+++++|.+++.....            ....+++..++.++.|++.|++|||   +.+++||||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEc
Confidence            99999999999999999975221            1235899999999999999999999   99999999999999999


Q ss_pred             CCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCC
Q 047245          243 AEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGG  313 (380)
Q Consensus       243 ~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~  313 (380)
                      +++.++|+|||++.....        ...++..|+|||.+.+..++.++||||||+++|||++ |..||...        
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------  229 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--------  229 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence            999999999999875432        2335778999999999999999999999999999999 99997531        


Q ss_pred             CHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       314 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ...+..... ..+...          ......+..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus       230 ~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         230 SNTEVIECI-TQGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             CHHHHHHHH-hCCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            111111111 111100          011223456889999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-40  Score=310.12  Aligned_cols=190  Identities=25%  Similarity=0.474  Sum_probs=166.7

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|..+|+|.+....       .......+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            4567999999999999875 67889999876521       223346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||+++|+|.+++..    ...+++.....++.|++.||+|||   + .+++|+||||+|||++.++.+||+|||++...
T Consensus        82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999999874    345888999999999999999999   5 47999999999999999999999999998754


Q ss_pred             CC----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          259 PG----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       259 ~~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      ..    ...++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         155 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            32    33588899999999988899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-41  Score=313.30  Aligned_cols=247  Identities=21%  Similarity=0.288  Sum_probs=197.3

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|+.||+|++.....     ......+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-----FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            467999999999999975 588999999975211     12233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999974    346889999999999999999999   89999999999999999999999999999986543


Q ss_pred             ---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          261 ---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       261 ---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                         ...|++.|+|||.+.+..++.++|||||||++|||++|..||...        ...+.........   ..+.....
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~---~~~~~~~~  222 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------TPNETWENLKYWK---ETLQRPVY  222 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC--------CHHHHHHHHHhcc---ccccCCCC
Confidence               346899999999999999999999999999999999999998631        1111111111100   00111000


Q ss_pred             CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          338 GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       338 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      . .........+.+++.+|+..+|++||+++++++
T Consensus       223 ~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         223 D-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             C-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            0 000123556789999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-41  Score=313.69  Aligned_cols=234  Identities=24%  Similarity=0.332  Sum_probs=189.9

Q ss_pred             cccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      +.||+|+||.||++..    .+|+.+|+|++.....      .......+..|++++++++||||+++++++.+.+..++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            4699999999999874    4688999999975221      11223567789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        76 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  148 (318)
T cd05582          76 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  148 (318)
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence            9999999999999864    346899999999999999999999   899999999999999999999999999998764


Q ss_pred             CCC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PGS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ...      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||...        ............       
T Consensus       149 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~--------~~~~~~~~i~~~-------  213 (318)
T cd05582         149 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK--------DRKETMTMILKA-------  213 (318)
T ss_pred             CCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC--------CHHHHHHHHHcC-------
Confidence            322      34789999999999888999999999999999999999998631        111111111110       


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHh
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDE  369 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e  369 (380)
                        .   ...+......+.+++.+||+.||++|||+.+
T Consensus       214 --~---~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 --K---LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --C---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              0   0111223455788999999999999999766

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=313.10  Aligned_cols=237  Identities=26%  Similarity=0.409  Sum_probs=197.3

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||||.. ..++.||+|++....       .+....++++|+.+|.+++++||.+++|.+..+..++++||
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-------~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhh-------cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            6799999999999996 568899999997632       33446788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC--
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~--  259 (380)
                      ||.+|++.+.+..    ...+++..+.-++.++..|+.|||   ..+.+|||||+.|||+..+|.+|++|||++-.+.  
T Consensus        92 y~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   92 YCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999873    334477777789999999999999   9999999999999999999999999999986554  


Q ss_pred             ----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                          ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+...                  ++-++.-.+-..
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~------------------hPmrvlflIpk~  226 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL------------------HPMRVLFLIPKS  226 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc------------------CcceEEEeccCC
Confidence                4567999999999999889999999999999999999999998642                  111111111111


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      -. +.........+.+++..|++.||+.|||+.++++
T Consensus       227 ~P-P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  227 AP-PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CC-CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            11 1111234556899999999999999999999984

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.8e-40  Score=298.58  Aligned_cols=243  Identities=26%  Similarity=0.429  Sum_probs=195.8

Q ss_pred             cccCccCCeeEEEEEecC--C--cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLDN--G--LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      +.||+|++|.||+|...+  +  ..+|+|.+.....       ....+.+.+|+..+++++||||+++++++.+ ...++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   72 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-------SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMM   72 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc-------HHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEE
Confidence            368999999999998643  3  3689998865221       1456789999999999999999999999988 88999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ++||+++|+|.+++....  ...++|...+.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++..
T Consensus        73 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          73 VTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EEEecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccc
Confidence            999999999999997522  146899999999999999999999   899999999999999999999999999998765


Q ss_pred             CC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          259 PG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       259 ~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ..         ...++..|+|||.+.+..++.++||||||+++|||++ |..||...        ...+.......... 
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~-  218 (257)
T cd05040         148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--------SGSQILKKIDKEGE-  218 (257)
T ss_pred             cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhcCC-
Confidence            43         1235678999999998899999999999999999999 99998531        11122221111110 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                               ....+...+..+.+++.+|++.+|++|||++++++.|.+
T Consensus       219 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         219 ---------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ---------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence                     011112234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=300.33  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=197.1

Q ss_pred             cccccCccCCeeEEEEEecC----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe-
Q 047245          101 ENRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR-  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  175 (380)
                      ..+.||+|+||.||+|....    +..||+|+++...      ........+.+|+..++.++||||+++++++..... 
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   76 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI------HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSL   76 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc------CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcc
Confidence            34679999999999998742    3679999986521      123335678999999999999999999999866554 


Q ss_pred             -----EEEEEeecCCCCHHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          176 -----FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       176 -----~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                           .++++||+++|+|.+++...+.  ....+++.....++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        77 ~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~k  153 (273)
T cd05035          77 QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVC  153 (273)
T ss_pred             ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEE
Confidence                 7999999999999999865321  2346899999999999999999999   89999999999999999999999


Q ss_pred             EeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++.....        ...+..|+|||.+.+..++.++||||||+++|||++ |..||...        ...+..
T Consensus       154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~--------~~~~~~  225 (273)
T cd05035         154 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV--------ENHEIY  225 (273)
T ss_pred             ECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC--------CHHHHH
Confidence            9999999865322        124567999999988899999999999999999999 88887531        111111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ........           ...+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus       226 ~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         226 DYLRHGNR-----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHcCCC-----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111100           111233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-41  Score=300.39  Aligned_cols=241  Identities=22%  Similarity=0.371  Sum_probs=194.3

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..+|+|.+.....         ....+.+|+.++++++||||+++++++...+..++|+
T Consensus         8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             hhhhhccCCCceEEEeEecCCccEEEEEeccCCC---------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            4567999999999999987777899998754211         1246788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            99999999999874   2336899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||.+.+..++.++||||||+++||+++ |..||.....        .+........      .
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~------~  218 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESVSAG------Y  218 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHHHcC------C
Confidence            2       123457999999999999999999999999999999 7888753100        1111111100      0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      ..     ..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       219 ~~-----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         219 RL-----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             cC-----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            10     111224556889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.9e-41  Score=313.43  Aligned_cols=241  Identities=22%  Similarity=0.277  Sum_probs=193.5

Q ss_pred             ccccccCccCCeeEEEEEecC--CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDN--GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      ...+.||+|+||.||+|...+  +..||+|++.....     ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus        33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-----IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            345789999999999998643  36899999865211     12233467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus       108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999874    346889999999999999999999   99999999999999999999999999999986


Q ss_pred             CCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          258 MPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       258 ~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      ...   ...||+.|+|||.+.+..++.++|||||||++|||++|..||...        .......... .+.       
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--------~~~~~~~~i~-~~~-------  244 (340)
T PTZ00426        181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN--------EPLLIYQKIL-EGI-------  244 (340)
T ss_pred             cCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC--------CHHHHHHHHh-cCC-------
Confidence            543   235899999999999988999999999999999999999998631        1111111111 110       


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                       .   ..+......+.+++.+|++.||++|+     |++++++
T Consensus       245 -~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        245 -I---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -C---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence             0   01122334577899999999999995     7888764

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-40  Score=303.53  Aligned_cols=258  Identities=20%  Similarity=0.275  Sum_probs=192.9

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +++.+|+|++.....      .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE------NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccc------cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            467999999999999974 678999999875321      1223467788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++++.+..+..    ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          80 EYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             ecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9999876655432    2346889999999999999999999   99999999999999999999999999999976542


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHHHHHHHHhhc
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGRWLRHLQHAG  326 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~~~~~~~~~~  326 (380)
                             ...+++.|+|||.+.+..++.++|||||||++|||++|+.||........       .......+........
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence                   23478899999999988899999999999999999999999864211000       0000011111111111


Q ss_pred             chhHhhchhccCC-----cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGE-----EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .......+.....     .........+.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000     001123456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-40  Score=302.66  Aligned_cols=245  Identities=22%  Similarity=0.277  Sum_probs=191.7

Q ss_pred             cCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||+|+||.||++.. .+|+.+|+|++......     .......+..|++++++++||||+++.+++.+....++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-----KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-----cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence            79999999999986 46899999998642111     1112345567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC--
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS--  261 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--  261 (380)
                      ++|+|.+++..  .....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++......  
T Consensus        76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~  150 (277)
T cd05607          76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT  150 (277)
T ss_pred             CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce
Confidence            99999998864  22345889999999999999999999   899999999999999999999999999998765432  


Q ss_pred             ---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccC
Q 047245          262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILG  338 (380)
Q Consensus       262 ---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  338 (380)
                         ..++..|+|||.+.+..++.++||||+||++|||++|..||.....    ............         ..... 
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~---------~~~~~-  216 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTL---------EDEVK-  216 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhh---------ccccc-
Confidence               3578899999999988899999999999999999999999863110    001111111111         00000 


Q ss_pred             CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHH
Q 047245          339 EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML  374 (380)
Q Consensus       339 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L  374 (380)
                       .........+.+++..||+.||++||+++|+++.+
T Consensus       217 -~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         217 -FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence             00012345578999999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=325.25  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=196.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....      .......+.+|+..+..++|+|++++...+....     
T Consensus        36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~------~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM------SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            457899999999999985 5789999999875321      2334567889999999999999999887764322     


Q ss_pred             ---eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          175 ---RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       175 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                         ..++||||+++|+|.+++.........+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence               368999999999999999764444567899999999999999999999   99999999999999999999999999


Q ss_pred             cCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHH
Q 047245          252 FGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQ  323 (380)
Q Consensus       252 fgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~  323 (380)
                      ||+++....        ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...        ..........
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~~  258 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKTL  258 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHh
Confidence            999875432        235899999999999999999999999999999999999998631        2222222221


Q ss_pred             hhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...     .      ...+......+.+++..||+.||.+|||+.++++
T Consensus       259 ~~~-----~------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        259 AGR-----Y------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             cCC-----C------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            110     0      1112234456889999999999999999999875

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.1e-40  Score=300.64  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=194.2

Q ss_pred             cccccCccCCeeEEEEEecCCc---EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC----
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGL---TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES----  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  173 (380)
                      ..+.||+|+||.||+|...+..   .+|+|.++...      ......+.+..|+.+++.++|+||+++++++...    
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCc------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            3468999999999999975432   58999886521      1233457888999999999999999999987432    


Q ss_pred             --CeEEEEEeecCCCCHHHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          174 --SRFYLVYDYLQTGSLEDAMDRIR--ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       174 --~~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                        ...++++||+++|+|.+++...+  .....+++.....++.|++.||+|||   +.+++||||||+||++++++.+||
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl  153 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCV  153 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEE
Confidence              25689999999999999885322  22345899999999999999999999   899999999999999999999999


Q ss_pred             eccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHH
Q 047245          250 ADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       250 ~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +|||+++.....        ...++.|++||...+..++.++||||||+++||+++ |..||...        .......
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~  225 (272)
T cd05075         154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV--------ENSEIYD  225 (272)
T ss_pred             CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHH
Confidence            999999865321        135668999999999999999999999999999999 78887531        1111111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ... .+...          ..+......+.+++.+||+.||++|||++++++.|+++
T Consensus       226 ~~~-~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 YLR-QGNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHH-cCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111 11100          01122345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-40  Score=304.68  Aligned_cols=247  Identities=23%  Similarity=0.362  Sum_probs=196.0

Q ss_pred             ccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          102 NRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      .+.||+|+||.||+|...      ....+++|.+....       .......+.+|+.+++.++||||+++++.+...+.
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-------SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-------CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            467999999999999852      23578888876421       12234678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhh--------------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCC
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRE--------------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK  235 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk  235 (380)
                      .++++||+++|+|.+++...+.                    ....+++..++.++.|++.||+|||   +.+++|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dik  154 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLA  154 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhh
Confidence            9999999999999999875321                    1235889999999999999999999   8999999999


Q ss_pred             CCcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchh
Q 047245          236 PTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFF  306 (380)
Q Consensus       236 ~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~  306 (380)
                      |+||++++++.+||+|||+++....        ...++..|+|||.+.+..++.++||||||+++|||++ |..||... 
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-  233 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-  233 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-
Confidence            9999999999999999999875422        1234668999999988889999999999999999999 99988531 


Q ss_pred             hhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          307 AEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       307 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                             ....+...          +..... ...+......+.+++.+|++.+|++||+++|+++.|+++
T Consensus       234 -------~~~~~~~~----------~~~~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         234 -------APERLFNL----------LKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             -------CHHHHHHH----------HhCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                   11111111          111110 011122345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.8e-40  Score=302.63  Aligned_cols=249  Identities=22%  Similarity=0.342  Sum_probs=199.8

Q ss_pred             cccccCccCCeeEEEEEecC-----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-CC
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-SS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  174 (380)
                      ..++||+|+||.||+|...+     +..|++|++...       ........+.+|+.++++++|+||+++++++.. +.
T Consensus        10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043          10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-------ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            45789999999999999765     788999987631       123345778899999999999999999998766 46


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIREN----QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA  250 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  250 (380)
                      ..++++||+++|+|.+++......    ...+++..++.++.|++.||+|||   +.+++||||+|+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999999753322    156899999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHH
Q 047245          251 DFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       251 Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      |||+++.+..        ...++..|+|||.+.+..++.++||||||+++||+++ |+.||...        ...++...
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~  231 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--------DPFEMAAY  231 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC--------CHHHHHHH
Confidence            9999986532        1235667999999998889999999999999999999 99998631        11122221


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ......      .     .........+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       232 ~~~~~~------~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         232 LKDGYR------L-----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHcCCC------C-----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111110      0     011123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=287.74  Aligned_cols=229  Identities=23%  Similarity=0.319  Sum_probs=191.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||.|+||.|..++. .+|..+|+|++....     -......+...+|..+|+.+.||+++++.+.+.+.+..++|||
T Consensus        50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-----vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-----VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             eeeccCccceEEEEEEccCCceeehhhcCHHH-----HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            6799999999999986 578999999997521     1123344677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      |.+||.|.+++++    ..+++.+...-+|.||+.||+|||   +..|++|||||+|||+|.+|.+||+|||.++.+.+.
T Consensus       125 yv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             ccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999986    457888899999999999999999   999999999999999999999999999999988765


Q ss_pred             ---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccC
Q 047245          262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILG  338 (380)
Q Consensus       262 ---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  338 (380)
                         .+|||.|+|||.++..++..++|-|||||++|||+.|..||...        +.......             .+.+
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~--------~~~~iY~K-------------I~~~  256 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD--------NPIQIYEK-------------ILEG  256 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC--------ChHHHHHH-------------HHhC
Confidence               36999999999999999999999999999999999999999741        11111111             1111


Q ss_pred             C-cccHHHHHHHHHHHHHcccCCCCCC
Q 047245          339 E-EVEEDEMLMAVRIAVVCLSDSPADR  364 (380)
Q Consensus       339 ~-~~~~~~~~~~~~l~~~Cl~~~P~~R  364 (380)
                      . ..+.-....+.+|+...+++|-.+|
T Consensus       257 ~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            1 2233344557788888888888888

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-40  Score=299.90  Aligned_cols=245  Identities=19%  Similarity=0.420  Sum_probs=197.4

Q ss_pred             cccccCccCCeeEEEEEec-CC---cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NG---LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|... ++   ..+++|.+....       .....+.+.+|++++++++|||++++.+++.+.+..
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            4678999999999999974 23   368999886421       123346788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++++|.+++..   ....+++..+..++.|++.|++|||   +.+++|+||||+||++++++.+|++|||++.
T Consensus        82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          82 MIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccce
Confidence            999999999999999863   2356899999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCCC---------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGSL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~~---------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ......         ..+..|+|||.+.+..++.++||||||+++||+++ |..||...        ...++........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~--------~~~~~~~~i~~~~  227 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--------SNHEVMKAINDGF  227 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC--------CHHHHHHHHhcCC
Confidence            654211         12446999999998889999999999999999998 99998531        1112222221110


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                                 ..+........+.+++.+||+.+|++||++.++++.|+++
T Consensus       228 -----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                       0111123445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-40  Score=302.79  Aligned_cols=247  Identities=23%  Similarity=0.393  Sum_probs=195.5

Q ss_pred             cccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||.||+|..     .++..+++|.+....       .......+.+|+.++++++||||+++++++.....
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            446799999999999984     356789999986421       22334678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhh-------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRE-------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD  242 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~  242 (380)
                      .+++|||+++|+|.+++.....             ....+++...+.++.|++.||+|||   +.+++||||||+||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIG  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEc
Confidence            9999999999999999863211             1235788999999999999999999   89999999999999999


Q ss_pred             CCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCC
Q 047245          243 AEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGG  313 (380)
Q Consensus       243 ~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~  313 (380)
                      +++.+||+|||+++....        ...++..|+|||.+.+..++.++||||||+++|||++ |..||...        
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~--------  230 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF--------  230 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------
Confidence            999999999999975432        1235667999999988889999999999999999998 88887531        


Q ss_pred             CHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       314 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .......... ....          ...+......+.+++.+||+.||++||++.++++.|..
T Consensus       231 ~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         231 SNQEVIEMVR-KRQL----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CHHHHHHHHH-cCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            0011111111 1110          01112234568889999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-40  Score=301.27  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=194.4

Q ss_pred             ccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CC
Q 047245          102 NRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SS  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  174 (380)
                      .+.||+|+||.||++..     .++..||+|.+...        .....+.+.+|++++++++||||+++.+++..  ..
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--------TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            46799999999999874     35789999998641        22334678899999999999999999998754  34


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++|+||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcc
Confidence            68999999999999999863   2346899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCCC---------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          255 AKLMPGSL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       255 ~~~~~~~~---------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      ++......         .++..|+|||.+.+..++.++||||||+++|||++|..|+......         +.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---------~~~~~~~~  225 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---------FMRMMGND  225 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---------hhhhcccc
Confidence            98654321         1234599999999888999999999999999999988765321110         00000000


Q ss_pred             c-------chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          326 G-------EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       326 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .       ...+.+..... ...+......+.+++.+||+.+|++|||++|+++.|+.++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         226 KQGQMIVYHLIELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cccccchHHHHHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            0       00111111100 0111223456889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-40  Score=310.33  Aligned_cols=249  Identities=25%  Similarity=0.405  Sum_probs=194.2

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec-
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE-  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  172 (380)
                      ..+.||+|+||.||+|..      .+++.||+|++....       .....+.+..|+.++.++ +|+||++++++|.. 
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054          11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-------TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             hhcccccCcCceEEeccccccccccccceeeeeeccCCC-------CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            357899999999999864      235789999986411       122335678899999999 89999999998864 


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhh-------------------------------------------------------
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRE-------------------------------------------------------  197 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  197 (380)
                      +...++++||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            4578899999999999999864221                                                       


Q ss_pred             --cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC--------CCcCCCc
Q 047245          198 --NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSA  267 (380)
Q Consensus       198 --~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~  267 (380)
                        ....++|..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....        ...++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence              0236899999999999999999999   89999999999999999999999999999986532        1235678


Q ss_pred             ccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHH
Q 047245          268 YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEM  346 (380)
Q Consensus       268 y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (380)
                      |+|||.+.+..++.++|||||||++|||++ |..||....    ..   ....... ..+..          ...+....
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~----~~---~~~~~~~-~~~~~----------~~~~~~~~  302 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ----ID---EEFCRRL-KEGTR----------MRAPEYAT  302 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC----cc---HHHHHHH-hccCC----------CCCCccCC
Confidence            999999999999999999999999999998 999985310    00   0111111 11100          01112234


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          347 LMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       347 ~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            5688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.7e-40  Score=311.49  Aligned_cols=237  Identities=24%  Similarity=0.412  Sum_probs=186.8

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+|+.||+|++...       ........+.+|+++++.++|+||+++++++.+.+..++||
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-------HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecC-------CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            36799999999999986 46899999998541       12334577899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+..        ...+..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus       152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999986532        3456778899999999999999   89999999999999999999999999999876532


Q ss_pred             ------CCcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          261 ------SLIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                            ...|+..|+|||.+..     ...+.++|||||||++|||++|+.||...     .   ..+|........   
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~-----~---~~~~~~~~~~~~---  289 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG-----R---QGDWASLMCAIC---  289 (353)
T ss_pred             ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC-----C---CccHHHHHHHHh---
Confidence                  2358999999998743     22356899999999999999999998621     1   111221111000   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .. ............+.+++.+||+.||++|||+.|+++
T Consensus       290 ----~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        290 ----MS-QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ----cc-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00 001111234556889999999999999999999985

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.2e-41  Score=311.84  Aligned_cols=238  Identities=22%  Similarity=0.287  Sum_probs=191.4

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||++.. .+|..+|+|.+.....     ........+..|++++..++||||+++.+++...+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-----VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence            3699999999999986 5789999999975221     122334667789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||   + .+++||||||+|||++.++.+||+|||+++....
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence            9999999988864    346899999999999999999999   6 7999999999999999999999999999875321


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...|++.|+|||.+.+..++.++||||||+++|||++|..||...        ........... .        
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~--------~~~~~~~~i~~-~--------  211 (325)
T cd05594         149 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILM-E--------  211 (325)
T ss_pred             CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC--------CHHHHHHHHhc-C--------
Confidence                  234899999999999999999999999999999999999998531        11111111110 0        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                      .   ...+......+.+++.+|++.||++|+     ++.++++
T Consensus       212 ~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 E---IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             C---CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            0   011122344578899999999999997     8888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-40  Score=300.49  Aligned_cols=237  Identities=19%  Similarity=0.321  Sum_probs=184.7

Q ss_pred             ccCccCCeeEEEEEecC-------------------------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC
Q 047245          104 LLGSSPDGKYYRTVLDN-------------------------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL  158 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  158 (380)
                      .||+|+||.||+|.+..                         ...|++|.+..        ........+.+|+.+++++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~--------~~~~~~~~~~~~~~~~~~l   73 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP--------SHRDIALAFFETASLMSQV   73 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh--------HHHHHHHHHHHHHHHHhcC
Confidence            69999999999997521                         23588888754        1223346788899999999


Q ss_pred             CCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       159 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      +||||+++++++.+....++||||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|
T Consensus        74 ~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~N  147 (274)
T cd05076          74 SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKN  147 (274)
T ss_pred             CCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCccc
Confidence            999999999999999999999999999999998863   2446889999999999999999999   8999999999999


Q ss_pred             EEeCCCC-------ceEEeccCCcccCCC--CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHH-hCCCCCCchhh
Q 047245          239 VMLDAEF-------TPRLADFGLAKLMPG--SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLL-TGRDPTAPFFA  307 (380)
Q Consensus       239 ill~~~~-------~~kl~Dfgl~~~~~~--~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~-tg~~p~~~~~~  307 (380)
                      |+++.++       .+|++|||++.....  ...++..|+|||.+.+ ..++.++||||||+++||++ +|..||.....
T Consensus       148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         148 ILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             EEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            9997543       489999998865432  3347788999998865 56899999999999999995 68888753110


Q ss_pred             hccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          308 EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       308 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                           .....+             +....   ..+......+.+++.+||+.+|++|||+.++++.|+
T Consensus       228 -----~~~~~~-------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 -----SEKERF-------------YEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----HHHHHH-------------HHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                 001111             11000   001112235789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=299.21  Aligned_cols=246  Identities=24%  Similarity=0.423  Sum_probs=193.5

Q ss_pred             cccCccCCeeEEEEEecC-Cc--EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLDN-GL--TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ++||+|+||.||+|...+ |.  .+++|.+...       ......+.+.+|++++.++ +||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-------CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            469999999999999743 43  4688877531       1223346788999999999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT  246 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  246 (380)
                      +|||+++|+|.+++.....            ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~  150 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  150 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCe
Confidence            9999999999999975321            1235789999999999999999999   899999999999999999999


Q ss_pred             eEEeccCCcccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHH
Q 047245          247 PRLADFGLAKLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +||+|||++......     ...+..|+|||.+....++.++||||||+++|||++ |..||...        ...+...
T Consensus       151 ~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~--------~~~~~~~  222 (270)
T cd05047         151 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELYE  222 (270)
T ss_pred             EEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc--------CHHHHHH
Confidence            999999998643211     123557999999988889999999999999999997 99998531        1111111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .....          .. ...+......+.+++.+||+.+|.+|||+.+++..|+++
T Consensus       223 ~~~~~----------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         223 KLPQG----------YR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             HHhCC----------CC-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            11110          00 011122345678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-40  Score=297.08  Aligned_cols=237  Identities=17%  Similarity=0.307  Sum_probs=185.6

Q ss_pred             cccCccCCeeEEEEEecC-------------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEE
Q 047245          103 RLLGSSPDGKYYRTVLDN-------------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAY  169 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  169 (380)
                      +.||+|+||.||+|...+             ...|++|.+..        ........+.+|+.+++.++||||++++++
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~--------~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~   72 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP--------SHRDISLAFFETASMMRQVSHKHIVLLYGV   72 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh--------hhhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            358999999999998632             23588887654        122344678899999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc---
Q 047245          170 VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT---  246 (380)
Q Consensus       170 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---  246 (380)
                      +......+++|||+++|+|..++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.   
T Consensus        73 ~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~  146 (262)
T cd05077          73 CVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGE  146 (262)
T ss_pred             EecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCC
Confidence            9999999999999999999998763   2346899999999999999999999   999999999999999986654   


Q ss_pred             ----eEEeccCCcccCCC--CCcCCCcccCccccc-CCCCCCcchhhHHHHHHHHHH-hCCCCCCchhhhccCCCCHHHH
Q 047245          247 ----PRLADFGLAKLMPG--SLIATSAYSAPECFQ-NRSYTDKSDIFSFGMILAVLL-TGRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       247 ----~kl~Dfgl~~~~~~--~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~el~-tg~~p~~~~~~~~~~~~~l~~~  318 (380)
                          +|++|||++.....  ...++..|+|||.+. +..++.++||||||+++|||+ +|..|+...        ...+.
T Consensus       147 ~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--------~~~~~  218 (262)
T cd05077         147 CGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK--------TLAEK  218 (262)
T ss_pred             CCceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc--------chhHH
Confidence                89999999876543  345788899999886 467899999999999999998 487776431        01110


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHH
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML  374 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L  374 (380)
                      . .....         .....   ......+.+++.+||+.||++||++.++++.|
T Consensus       219 ~-~~~~~---------~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         219 E-RFYEG---------QCMLV---TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             H-HHHhc---------CccCC---CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0 00000         00000   11234578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.4e-40  Score=298.43  Aligned_cols=245  Identities=22%  Similarity=0.418  Sum_probs=197.4

Q ss_pred             hccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245           99 ANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ....+.||+|+||.||++...+++.+|+|.+.....         ....+.+|+.++++++|+||+++++++. .+..++
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             ceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            345678999999999999998899999999864211         1256889999999999999999999875 456899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ++||+++|+|.+++..  .....+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++...
T Consensus        78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          78 ITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            9999999999999864  23456899999999999999999999   899999999999999999999999999998765


Q ss_pred             CC-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          259 PG-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       259 ~~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ..       ...++..|+|||.+....++.++||||||+++||+++ |..||...        ...+........     
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~~-----  219 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM--------TNPEVIQNLERG-----  219 (260)
T ss_pred             CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC--------ChHHHHHHHHcC-----
Confidence            42       1234568999999998889999999999999999999 99998531        111111111110     


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                           . ....+......+.+++.+|++.+|++|||++++++.|+.+
T Consensus       220 -----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         220 -----Y-RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             -----C-CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                 0 0011122345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.6e-40  Score=308.86  Aligned_cols=234  Identities=24%  Similarity=0.287  Sum_probs=188.2

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ++||+|+||.||++... +++.||+|++.....     ......+.+..|..++..+ +||||+++++++...+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-----hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence            36999999999999874 688999999875211     1122345677888888877 7999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            99999999998874    346889999999999999999999   9999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...        .............        
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--------~~~~~~~~i~~~~--------  212 (320)
T cd05590         149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE--------NEDDLFEAILNDE--------  212 (320)
T ss_pred             CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC--------CHHHHHHHHhcCC--------
Confidence                 1234899999999999999999999999999999999999998631        1112222211110        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD  368 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  368 (380)
                       .   ..+......+.+++.+|++.||.+||++.
T Consensus       213 -~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         213 -V---VYPTWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             -C---CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence             0   11112345578999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-40  Score=300.98  Aligned_cols=245  Identities=22%  Similarity=0.376  Sum_probs=195.1

Q ss_pred             ccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          102 NRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ...||+|+||.||++..      .++..+|+|.+..        ........+.+|+++++.++|+||+++++++.+++.
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--------ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--------CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            46799999999999864      2456888998754        123345789999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhh-----------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRE-----------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~  244 (380)
                      .++++||+++|+|.+++.....           ....+++..++.++.|++.|++|||   +.+++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCC
Confidence            9999999999999999975321           1135889999999999999999999   9999999999999999999


Q ss_pred             CceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCH
Q 047245          245 FTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSL  315 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l  315 (380)
                      +.+||+|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||.....        
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------  230 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------  230 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------
Confidence            9999999999875432        1234678999999999999999999999999999998 8888753110        


Q ss_pred             HHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .+....... +.         . ...+...+..+.+++.+||+.||++||+++||++.|+.
T Consensus       231 ~~~~~~~~~-~~---------~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         231 TEAIECITQ-GR---------E-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHHHHHHc-Cc---------c-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            111111111 00         0 01112234557899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.4e-40  Score=303.73  Aligned_cols=248  Identities=24%  Similarity=0.404  Sum_probs=197.8

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||++...      +...+|+|.+....       .......+.+|++++.++ +|+||+++++++..+
T Consensus        16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-------CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            4568999999999999863      23679999886421       122346688999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhh------------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML  241 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill  241 (380)
                      +..+++|||+++|+|.++++...            .....+++..++.++.|++.||+|||   +.+++||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            99999999999999999997532            22456899999999999999999999   8999999999999999


Q ss_pred             CCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCC
Q 047245          242 DAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASG  312 (380)
Q Consensus       242 ~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~  312 (380)
                      ++++.+||+|||+++.....        ..++..|+|||.+.+..++.++||||||+++||+++ |..||...       
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------  238 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-------  238 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC-------
Confidence            99999999999999865421        124567999999988899999999999999999998 88887531       


Q ss_pred             CCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          313 GSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       313 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                       .......... .+         .. ...+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus       239 -~~~~~~~~~~-~~---------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         239 -PVEELFKLLK-EG---------YR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -CHHHHHHHHH-cC---------Cc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence             1111111111 11         00 011123445688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.9e-40  Score=301.68  Aligned_cols=246  Identities=18%  Similarity=0.326  Sum_probs=196.7

Q ss_pred             ccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          102 NRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      .+.||+|+||.||+|...      ++..||+|++....       .......+.+|+.++++++||||+++++++...+.
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091          10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            367999999999999863      35789999987421       12345678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhh------------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          176 FYLVYDYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      .++++||+++++|.+++....            .....+++..+..++.|++.||+|||   +.+++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecC
Confidence            999999999999999986321            11235888899999999999999999   899999999999999999


Q ss_pred             CCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCC
Q 047245          244 EFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGS  314 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~  314 (380)
                      ++.+||+|||+++....        ...+++.|+|||.+.++.++.++||||||+++|||++ |..||...        .
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~  231 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------S  231 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------C
Confidence            99999999999876432        1235678999999988889999999999999999998 77787531        1


Q ss_pred             HHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       315 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ..++.........           ...+......+.+++..||+.+|.+||+++++++.|+.
T Consensus       232 ~~~~~~~i~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         232 NQDVIEMIRNRQV-----------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1222222221110           11122345568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-40  Score=295.82  Aligned_cols=242  Identities=22%  Similarity=0.338  Sum_probs=193.0

Q ss_pred             cccCccCCeeEEEEEec--C--CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLD--N--GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      +.||+|+||.||+|...  +  +..+|+|.+....       .....+.+.+|+++++++.|+||+++++++. ....++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   72 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-------IAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLML   72 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEE
Confidence            36999999999999752  2  3689999886521       1134467889999999999999999999876 456899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++..
T Consensus        73 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          73 VMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccccccee
Confidence            9999999999999974    236899999999999999999999   899999999999999999999999999998755


Q ss_pred             CCCC---------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          259 PGSL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       259 ~~~~---------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ....         .++..|+|||...+..++.++||||||+++||+++ |..||...        ...+.......... 
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~--------~~~~~~~~~~~~~~-  216 (257)
T cd05060         146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--------KGAEVIAMLESGER-  216 (257)
T ss_pred             ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHHcCCc-
Confidence            3211         12457999999998899999999999999999998 99998641        11111111111100 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                                ...+......+.+++.+||+.+|++|||+.++++.|+++-
T Consensus       217 ----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 ----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                      0111223456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=322.97  Aligned_cols=245  Identities=22%  Similarity=0.278  Sum_probs=200.9

Q ss_pred             cccccCccCCeeEEEEEecCC-cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEE-Ee----c-
Q 047245          101 ENRLLGSSPDGKYYRTVLDNG-LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAY-VP----E-  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~----~-  172 (380)
                      ..+.|.+|||+.||.+....+ ..+|+|++-.        .++...+...+||++|++|+ |+|||.+++. ..    + 
T Consensus        41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~--------~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV--------NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EEEEEccCCcEEEEEEEecCCCceeeeeeeec--------CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            457899999999999998766 9999999976        25566789999999999995 9999999993 21    1 


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          173 -SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       173 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                       .-+.+|+||||.+|+|-|+++.+..  ..|++.++++|+.|+++|+++|| .+.++|||||||-+||||+.++..||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCc
Confidence             1367999999999999999986443  34999999999999999999999 4478899999999999999999999999


Q ss_pred             cCCcccCCC-C--------------CcCCCcccCcccc---cCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCC
Q 047245          252 FGLAKLMPG-S--------------LIATSAYSAPECF---QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG  313 (380)
Q Consensus       252 fgl~~~~~~-~--------------~~~~~~y~aPE~~---~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~  313 (380)
                      ||.+.-... .              ..-|+.|.|||.+   .+.++++|+|||+|||+||-|+-...||+..        
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s--------  261 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES--------  261 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC--------
Confidence            999853211 1              1268999999988   4678999999999999999999999999641        


Q ss_pred             CHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       314 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                                   .-..+++-...-. ..+.....+.+||..||+.||.+||++-+|+..+-++.
T Consensus       262 -------------g~laIlng~Y~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  262 -------------GKLAILNGNYSFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             -------------cceeEEeccccCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                         0112222222112 22467888999999999999999999999998887663

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-40  Score=307.18  Aligned_cols=235  Identities=23%  Similarity=0.286  Sum_probs=185.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|+||.||++.. .+++.||+|+++.....     .....+.+..|..++... +||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-----EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            3699999999999987 45789999999752211     112234455666677654 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++... 
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            99999999998864    346888999999999999999999   8999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....||+.|+|||.+.+..++.++||||||+++|||++|..||...        ............         
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~---------  211 (316)
T cd05592         149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE--------DEDELFDSILND---------  211 (316)
T ss_pred             CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcC---------
Confidence                 1235899999999999999999999999999999999999998631        111111111110         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHh
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDE  369 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e  369 (380)
                         ....+......+.+++.+||+.||++||++.+
T Consensus       212 ---~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         212 ---RPHFPRWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence               01111223455778999999999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9e-40  Score=293.69  Aligned_cols=242  Identities=22%  Similarity=0.381  Sum_probs=197.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|++|.||++.. .+|..+++|.+....      ........+.+|++++++++|||++++++++.+.+..++|
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK------MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV   77 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh------CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence            346799999999999987 468999999986522      1233457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++...  ....+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||+++...
T Consensus        78 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          78 MEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            9999999999999752  2457899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 GS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..      ..+++.|+|||...+..++.++|+||||+++|||++|+.||....        .......... +       
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~-~-------  216 (256)
T cd08529         153 DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIR-G-------  216 (256)
T ss_pred             CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHc-C-------
Confidence            32      247788999999999999999999999999999999999986421        1111111110 0       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        . ....+......+.+++.+||+.+|++||++.++++
T Consensus       217 --~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 --V-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             --C-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence              0 01111234566899999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.2e-40  Score=299.43  Aligned_cols=245  Identities=24%  Similarity=0.348  Sum_probs=194.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCc----EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGL----TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||.||+|.. .+|.    .||+|.+....       .....+.+.+|+.++..++||||+++++++... .
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109          11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-------SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-------CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            346899999999999985 4454    47899886421       223346788999999999999999999999764 5


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++++||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCce
Confidence            7899999999999999873   2346899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +.....        ..++..|+|||...+..++.++||||||+++||+++ |..||+.....     .+..+..    .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~----~~  227 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----EIPDLLE----KG  227 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHH----CC
Confidence            865421        124567999999999999999999999999999998 88998531110     1111111    11


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                               .. ...+......+.+++..||+.||++||++.++++.|+++.
T Consensus       228 ---------~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         228 ---------ER-LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             ---------Cc-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                     00 0111223456789999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-40  Score=308.12  Aligned_cols=237  Identities=23%  Similarity=0.303  Sum_probs=189.7

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ++||+|+||.||+|... +++.||+|++.....     ........+..|..++..+ +||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-----LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence            36999999999999874 578999999875211     1123345677888888876 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.... 
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999998864    346889999999999999999999   8999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++||||||+++|||++|+.||...        .............        
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~--------~~~~~~~~i~~~~--------  212 (321)
T cd05591         149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD--------NEDDLFESILHDD--------  212 (321)
T ss_pred             CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC--------
Confidence                 1234889999999999999999999999999999999999998641        1111222211110        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCC-------CHHhHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRP-------SSDELV  371 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-------s~~evl  371 (380)
                       .   ..+......+.+++..|++.||++||       ++++++
T Consensus       213 -~---~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~  252 (321)
T cd05591         213 -V---LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK  252 (321)
T ss_pred             -C---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence             0   01112345578899999999999999       666665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.2e-40  Score=298.99  Aligned_cols=243  Identities=24%  Similarity=0.362  Sum_probs=189.5

Q ss_pred             ccccCccCCeeEEEEEe-cCCcE----EEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLT----VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~----vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||+|+||.||+|.. .+|+.    +++|.+...       .......++..|+..+++++||||+++++++.. ...
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            46799999999999986 34553    666665421       122334678889999999999999999999864 557


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++++||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++
T Consensus        84 ~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             EEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence            889999999999999974   2346899999999999999999999   8999999999999999999999999999997


Q ss_pred             cCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          257 LMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       257 ~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ....        ...++..|+|||.+.++.++.++||||||+++||+++ |..||.....        .. .......+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~-~~~~~~~~~  228 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HE-VPDLLEKGE  228 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHHCCC
Confidence            6432        1235678999999998899999999999999999998 9999853110        00 011111111


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..          ..+......+.+++.+||..||++|||+.|+++.|..+
T Consensus       229 ~~----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         229 RL----------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             cC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            00          00111234567899999999999999999999998775

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.7e-40  Score=313.92  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=199.6

Q ss_pred             HHHHHhccccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCccee
Q 047245           94 LQAALANENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSL  166 (380)
Q Consensus        94 l~~~~~~~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l  166 (380)
                      +........+.||+|+||.||++...      .+..||+|++....       .....+.+.+|+.++.++. ||||+++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~~H~niv~~  106 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-------RSSEKQALMSELKIMSHLGPHLNIVNL  106 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-------ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence            33333345678999999999999863      34689999997521       1122356889999999997 9999999


Q ss_pred             eEEEecCCeEEEEEeecCCCCHHHHHHHhhh-------------------------------------------------
Q 047245          167 RAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-------------------------------------------------  197 (380)
Q Consensus       167 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------  197 (380)
                      +++|...+..++|+||+++|+|.++++..+.                                                 
T Consensus       107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            9999999999999999999999999975321                                                 


Q ss_pred             ---------------------------------------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEec
Q 047245          198 ---------------------------------------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHY  232 (380)
Q Consensus       198 ---------------------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~  232 (380)
                                                                   ....+++..+..++.|++.||+|||   +.+++||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHr  263 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHR  263 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcc
Confidence                                                         1124778889999999999999999   8999999


Q ss_pred             CCCCCcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCC
Q 047245          233 NLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTA  303 (380)
Q Consensus       233 dlk~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~  303 (380)
                      ||||+|||+++++.+||+|||+++....        ...++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999875421        1235678999999998889999999999999999998 888875


Q ss_pred             chhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          304 PFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       304 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..    .    ..+........+         .. ...+......+.+++..||+.+|++||+++|+++.|+++
T Consensus       344 ~~----~----~~~~~~~~~~~~---------~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         344 EL----P----MNEQFYNAIKRG---------YR-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             CC----C----chHHHHHHHHcC---------CC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            31    0    011111111111         00 011122345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-40  Score=307.96  Aligned_cols=234  Identities=23%  Similarity=0.336  Sum_probs=185.9

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHH-HHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE-VLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ++||+|+||.||++.. .+|+.||+|++.....     ........+..|.. +++.++||||+++++.+.+.+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI-----LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence            3699999999999997 4689999999865211     11122244445544 567899999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            99999999998874    346888999999999999999999   89999999999999999999999999999875321


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...|++.|+|||.+.+..++.++||||||+++|||++|..||...        ...+........         
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~---------  211 (323)
T cd05575         149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------DTAEMYDNILNK---------  211 (323)
T ss_pred             CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC--------CHHHHHHHHHcC---------
Confidence                  234889999999999999999999999999999999999998631        112222221111         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD  368 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  368 (380)
                      ..   .........+.+++.+|++.||.+||++.
T Consensus       212 ~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 PL---RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CC---CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            00   01112345678999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=318.62  Aligned_cols=242  Identities=23%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             cccccCccCCeeEEEEEec--CC--cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD--NG--LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..++||+|.||.|++|.+.  +|  ..||||.++....       .....+|.+|+.+|-+|+|||+++++|+..+ ...
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l-------~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL-------NAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc-------chhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            4478999999999999973  34  3799999976322       1256899999999999999999999999988 778


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      .+|+|+++.|||.+.|++  .....+-...+..++.|||.||.||.   .+++|||||.++|+|+-....+||+|||+.+
T Consensus       186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeeccccee
Confidence            999999999999999986  34556777888999999999999999   9999999999999999999999999999999


Q ss_pred             cCCCCC---------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGSL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~~---------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .++...         .-...|+|||.+....++.+||||+|||++|||+| |..||-.                  ....
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G------------------~~g~  322 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG------------------CRGI  322 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC------------------CCHH
Confidence            876432         24567999999999999999999999999999999 8889853                  1122


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML  374 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L  374 (380)
                      .+.+.+|..- .-.-+..+.+.+.+++..||..+|++|||+.++.+.+
T Consensus       323 qIL~~iD~~e-rLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  323 QILKNIDAGE-RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             HHHHhccccc-cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            2344444221 1122345788899999999999999999999997443

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.9e-40  Score=297.02  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=187.7

Q ss_pred             cccCccCCeeEEEEEecC---CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDN---GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +.||+|+||.||+|...+   +..+|+|.+....       .......+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            358999999999998643   4578999876422       112235788899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||+++|+|.++++..+. .....++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccc
Confidence            999999999999975332 2335677888899999999999999   899999999999999999999999999998754


Q ss_pred             CC--------CCcCCCcccCcccccCC-------CCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHH
Q 047245          259 PG--------SLIATSAYSAPECFQNR-------SYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       259 ~~--------~~~~~~~y~aPE~~~~~-------~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      ..        ...++..|+|||.+.+.       .++.++|+||||+++|||++ |..||......        +-....
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--------~~~~~~  222 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--------QVLTYT  222 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHH
Confidence            32        12356789999998642       35789999999999999997 99998532111        000000


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      .. .......++.     ........+.+++..|| .+|++|||++||++.|+
T Consensus       223 ~~-~~~~~~~~~~-----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 VR-EQQLKLPKPR-----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hh-cccCCCCCCc-----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00 0001111111     11122344677889999 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5e-40  Score=305.23  Aligned_cols=238  Identities=24%  Similarity=0.303  Sum_probs=191.3

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|+||.||++... ++..+|+|.+.....     ........+..|..++..+ +||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-----LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence            36999999999999874 578999999975211     1122345677888999888 7999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            99999999998864    346899999999999999999999   9999999999999999999999999999986432 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....+++.|+|||.+.+..++.++|||||||++|||++|..||...        ............         
T Consensus       149 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~--------~~~~~~~~i~~~---------  211 (318)
T cd05570         149 GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD--------DEDELFQSILED---------  211 (318)
T ss_pred             CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC--------CHHHHHHHHHcC---------
Confidence                 1234789999999999999999999999999999999999998631        111111111110         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCH-----HhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS-----DELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~  372 (380)
                      .   ...+......+.+++.+||+.||.+|||+     .++++
T Consensus       212 ~---~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 E---VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             C---CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            0   01112234567899999999999999999     76653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.1e-40  Score=300.96  Aligned_cols=256  Identities=20%  Similarity=0.300  Sum_probs=189.2

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... ++..||+|.+......       .....+.+|+.++++++||||+++++++...+..++||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-------CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            467999999999999864 6889999998652211       11245678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++ +|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        83 e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          83 EYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99975 99998863   2345788999999999999999999   99999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHHHHhh
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRHLQHA  325 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~~~~~  325 (380)
                            ...+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||........        .......|.. ....
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  234 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG-ITSN  234 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc-cccc
Confidence                  2347889999998865 5689999999999999999999999863211000        0000000100 0000


Q ss_pred             cchhHhhchhccCCcc---cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILGEEV---EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......+.+.......   .........+++.+|++.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000001110000000   0112345789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.8e-40  Score=296.48  Aligned_cols=242  Identities=25%  Similarity=0.421  Sum_probs=195.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|++|.||++...++..+|+|.+.....         ....+.+|+.++++++|+|++++++++.+ ...+++|
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (260)
T cd05070          10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---------SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVT   79 (260)
T ss_pred             hhheeccccCceEEEEEecCCceeEEEEecCCCC---------CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEE
Confidence            3467999999999999988888999999865221         12568899999999999999999998854 5689999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..  .....+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          80 EYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            99999999999874  22346899999999999999999999   89999999999999999999999999999876542


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||.+.+..++.++|+||||+++||+++ |..||...        ...+.........      
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~--------~~~~~~~~~~~~~------  220 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------NNREVLEQVERGY------  220 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC------
Confidence            2       224567999999988889999999999999999999 88887531        1111111111110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                           ....+......+.+++.+|++.+|++|||++++.+.|++
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 -----RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 011122345568899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-39  Score=293.61  Aligned_cols=244  Identities=24%  Similarity=0.342  Sum_probs=189.8

Q ss_pred             cccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe-cCCeEE
Q 047245          103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP-ESSRFY  177 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~  177 (380)
                      ++||+|+||.||+|...    ++..+|+|++...       ........+.+|+.+++.++||||+++++++. .++..+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   73 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL   73 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcE
Confidence            46899999999999863    2457999987531       12233467889999999999999999999875 455689


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +++||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        74 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~  147 (262)
T cd05058          74 VVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARD  147 (262)
T ss_pred             EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccccc
Confidence            99999999999999874   2334678888999999999999999   89999999999999999999999999999875


Q ss_pred             CCC----------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCC-CCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          258 MPG----------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR-DPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       258 ~~~----------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ...          ...++..|+|||.+.+..++.++||||||+++|||++|. .||...        ...+.........
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--------~~~~~~~~~~~~~  219 (262)
T cd05058         148 IYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------DSFDITVYLLQGR  219 (262)
T ss_pred             ccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHhcCC
Confidence            432          123466899999998889999999999999999999965 454321        1112222211110


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .           ...+...+..+.+++..||+.+|++||++.|+++.|+++.
T Consensus       220 ~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 R-----------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             C-----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            0           0011122346889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-40  Score=311.17  Aligned_cols=250  Identities=18%  Similarity=0.211  Sum_probs=188.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+++.||+|....              ..+.+|++++++++||||+++++++......++|
T Consensus        96 ~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         96 ILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             EEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            446799999999999986 5688999997532              4467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +|++. ++|.+++..    ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       162 ~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        162 LPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            99995 689888864    346889999999999999999999   8999999999999999999999999999986532


Q ss_pred             C-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCC---CCHHHHHHHHHh-----
Q 047245          260 G-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG---GSLGRWLRHLQH-----  324 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~---~~l~~~~~~~~~-----  324 (380)
                      .       ...||+.|+|||.+.+..++.++|||||||++|||++|..|+..........   ..+.........     
T Consensus       234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            1       2358999999999999999999999999999999999998864311111000   011111100000     


Q ss_pred             ----hcchhHhh---chh--cc-CC-c---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 ----AGEAREAL---DRS--IL-GE-E---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ----~~~~~~~~---~~~--~~-~~-~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .....+..   ...  .. .. .   ........+.+++.+||+.||++|||++|+++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                00000000   000  00 00 0   00123456889999999999999999999984

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-40  Score=293.92  Aligned_cols=243  Identities=26%  Similarity=0.441  Sum_probs=198.6

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|++|.||++... |+.||+|.+....         ...+++.+|+.++++++|+||+++++++.+.+..++|+
T Consensus        10 ~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039          10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS---------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             ceeeeecCCCceEEEEEec-CcEEEEEEeccch---------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            4578999999999999875 7899999986521         13477899999999999999999999999899999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..  .....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.++....
T Consensus        80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          80 EYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence            99999999999974  22336899999999999999999999   99999999999999999999999999999987643


Q ss_pred             C---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          261 S---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       261 ~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      .   ...+..|+|||.+..+.++.++||||||+++||+++ |..||...        ...+....... +         .
T Consensus       155 ~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~-~---------~  216 (256)
T cd05039         155 GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPHVEK-G---------Y  216 (256)
T ss_pred             ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHhc-C---------C
Confidence            2   224567999999988889999999999999999998 99998532        11111111111 0         0


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                       ....+...+..+.+++.+|++.+|++|||+.|++++|+++
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         217 -RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence             0011122346688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-40  Score=303.26  Aligned_cols=251  Identities=22%  Similarity=0.380  Sum_probs=199.3

Q ss_pred             ccccccCccCCeeEEEEEe--------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVL--------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYV  170 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  170 (380)
                      ...+.||+|+||.||++..        .++..+|+|.+...       ......+.+.+|+.+++.+ +||||+++++++
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-------cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            4567899999999999974        13457999987641       1123346788999999999 899999999999


Q ss_pred             ecCCeEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          171 PESSRFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       171 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      ......+++|||+++|+|.+++...+.            ....++|..+..++.|++.||+|||   +.+++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccce
Confidence            999999999999999999999975321            1235888999999999999999999   8999999999999


Q ss_pred             EEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhc
Q 047245          239 VMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEA  309 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~  309 (380)
                      |++++++.+||+|||+++.....        ..++..|+|||.+.+..++.++||||||+++||+++ |..||...    
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----  243 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----  243 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----
Confidence            99999999999999999765421        224567999999998889999999999999999998 77776421    


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                          ...++.........           ...+......+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       244 ----~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         244 ----PVEELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ----CHHHHHHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                22222222221110           01112344568889999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=292.31  Aligned_cols=242  Identities=22%  Similarity=0.384  Sum_probs=196.0

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEee
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY  182 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  182 (380)
                      ++||+|++|.||++...+++.|++|.+.....       ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            46999999999999987799999998865211       13446789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC-
Q 047245          183 LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-  261 (380)
Q Consensus       183 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-  261 (380)
                      +++++|.+++..   ....+++..+..++.+++.|++|||   +++++||||+|+||+++.++.+||+|||++...... 
T Consensus        74 ~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (251)
T cd05041          74 VPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI  147 (251)
T ss_pred             CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence            999999999864   2346789999999999999999999   899999999999999999999999999998755421 


Q ss_pred             -------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          262 -------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       262 -------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                             ...+..|+|||.+.++.++.++|+||||+++||+++ |..||....        ........          .
T Consensus       148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--------~~~~~~~~----------~  209 (251)
T cd05041         148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--------NQQTRERI----------E  209 (251)
T ss_pred             ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--------HHHHHHHH----------h
Confidence                   123456999999998899999999999999999999 788875311        11111111          1


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ... ....+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus       210 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         210 SGY-RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            100 011122345578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.1e-40  Score=303.83  Aligned_cols=237  Identities=23%  Similarity=0.299  Sum_probs=187.9

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|+||.||+|... ++..||+|.+......     .......+..|..++... +||||+++++++.+.+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-----MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence            36999999999999974 5789999999752110     112234566677788765 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++... 
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            99999999999864    346889999999999999999999   8999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++|||||||++|||++|..||...        ............       .+
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--------~~~~~~~~i~~~-------~~  213 (316)
T cd05619         149 GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH--------DEEELFQSIRMD-------NP  213 (316)
T ss_pred             CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC-------CC
Confidence                 1234899999999999999999999999999999999999998631        111111111110       00


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH-hHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD-ELV  371 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl  371 (380)
                           ..+......+.+++.+||+.||++||++. ++.
T Consensus       214 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 -----CYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                 11122344578899999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.7e-40  Score=294.55  Aligned_cols=242  Identities=24%  Similarity=0.401  Sum_probs=194.3

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|++|.||++...++..+|+|.+....         ...+.+.+|+.++++++|+|++++++++.. +..+++|
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05069          10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---------MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT   79 (260)
T ss_pred             eeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---------ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence            446799999999999998777789999875421         123568889999999999999999998854 5678999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.++++.  .....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          80 EFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            99999999999974  22345899999999999999999999   89999999999999999999999999999975432


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||...+..++.++||||||+++||+++ |..||....        ..+.........      
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~------  220 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--------NREVLEQVERGY------  220 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCC------
Confidence            1       234567999999988889999999999999999999 888885310        111111111110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .     ...+......+.+++.+||+.||++||+++++++.|++
T Consensus       221 ~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 R-----MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             C-----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0     01122345668899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.2e-40  Score=296.47  Aligned_cols=246  Identities=19%  Similarity=0.393  Sum_probs=196.6

Q ss_pred             ccccccCccCCeeEEEEEecC-C---cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          100 NENRLLGSSPDGKYYRTVLDN-G---LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ...+.||+|+||.||+|.... +   ..||+|.+...       ........|..|+..+++++||||+++.+++.++..
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-------CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            356789999999999998742 3   36999998642       123345789999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+++|+|.+++..   ....+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          80 VMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             eEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccc
Confidence            9999999999999999874   2346899999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCCCC--------c---CCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHH
Q 047245          256 KLMPGSL--------I---ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQ  323 (380)
Q Consensus       256 ~~~~~~~--------~---~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~  323 (380)
                      .......        .   .+..|+|||.+.+..++.++||||||+++||+++ |..||....        ..+......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--------~~~~~~~i~  225 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--------NQDVINAIE  225 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--------HHHHHHHHH
Confidence            7543211        1   1346999999999999999999999999999887 999985311        111111111


Q ss_pred             hhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ...           ..+.+.+.+..+.+++.+||+.+|++||++++++..|+++
T Consensus       226 ~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 QDY-----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCC-----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000           0111123445678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.9e-40  Score=301.40  Aligned_cols=248  Identities=23%  Similarity=0.376  Sum_probs=196.9

Q ss_pred             ccccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec
Q 047245          100 NENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  172 (380)
                      ...+.||+|+||.||++..      ..+..+|+|.+....       .....+.+.+|+.+++++ +||||+++++++..
T Consensus        38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-------HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-------ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            3567899999999999874      234579999886421       122346789999999999 79999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      .+..++++||+++|+|.++++.  .....+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++++||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCC
Confidence            9999999999999999999874  22334899999999999999999999   899999999999999999999999999


Q ss_pred             CCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHH
Q 047245          253 GLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQ  323 (380)
Q Consensus       253 gl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~  323 (380)
                      |+++.....        ..++..|+|||.+.+..++.++||||||+++||+++ |..||.....       ..... ...
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~-~~~  257 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFY-KLI  257 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHH-HHH
Confidence            998755321        234677999999999999999999999999999998 9999753100       00111 111


Q ss_pred             hhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..+         .. ...+......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus       258 ~~~---------~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         258 KEG---------YR-MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HcC---------Cc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            111         00 011112345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.7e-40  Score=301.52  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=194.8

Q ss_pred             cccccCccCCeeEEEEEecC-Cc--EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-GL--TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...+ +.  .+++|.++...       .....+.+.+|+.++.++ +||||+++++++...+..
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             eeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            35689999999999998743 33  46888775311       223346788999999999 799999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC
Q 047245          177 YLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~  244 (380)
                      ++++||+++|+|.+++.....            ....+++..+..++.|++.||+|||   +.+++||||||+||+++++
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCC
Confidence            999999999999999975221            1235889999999999999999999   8999999999999999999


Q ss_pred             CceEEeccCCcccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHH
Q 047245          245 FTPRLADFGLAKLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~  318 (380)
                      +.+||+|||++......     ...+..|+|||.+.+..++.++||||||+++|||++ |..||...        ...+.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~--------~~~~~  227 (297)
T cd05089         156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM--------TCAEL  227 (297)
T ss_pred             CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHH
Confidence            99999999998643211     123457999999998889999999999999999998 99998531        11111


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .....          .... ...+......+.+++.+||+.+|.+|||++++++.|+++
T Consensus       228 ~~~~~----------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         228 YEKLP----------QGYR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             HHHHh----------cCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111          1110 011122445688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.6e-40  Score=297.72  Aligned_cols=247  Identities=21%  Similarity=0.343  Sum_probs=194.5

Q ss_pred             cccccCccCCeeEEEEEecC------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLDN------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|++|.||+|...+      +..|++|......       .......|..|+.++++++|+||+++++++.+.+
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036          10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            44689999999999998743      5678888875411       1233467889999999999999999999999989


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC---ceE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRE---NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPR  248 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~k  248 (380)
                      ..++|+||+++++|.+++...+.   ....++|..++.++.|++.||+|||   +.+++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence            99999999999999999975321   1235899999999999999999999   88999999999999998654   699


Q ss_pred             EeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++.....        ...+..|+|||.+.+..++.++|||||||++|||++ |..||...        ......
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~--------~~~~~~  231 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR--------TNQEVM  231 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHH
Confidence            9999999865321        123457999999998999999999999999999997 99998531        111111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ........           ...+...+..+.+++.+|++.+|++|||+.+|++.|++
T Consensus       232 ~~~~~~~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         232 EFVTGGGR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            11111100           01112234568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.9e-40  Score=295.22  Aligned_cols=243  Identities=25%  Similarity=0.378  Sum_probs=194.6

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||+|...++..||+|.+.....         ....+.+|++++++++||||+++++++.+ ...++||
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~   79 (262)
T cd05071          10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   79 (262)
T ss_pred             EeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence            4567999999999999987777899999864211         12568899999999999999999998754 5579999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.++....
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          80 EYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             EcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            999999999999742  2345789999999999999999999   89999999999999999999999999999875432


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||...+..++.++||||||+++||+++ |..||....        ............      
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--------~~~~~~~~~~~~------  220 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGY------  220 (262)
T ss_pred             cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------hHHHHHHHhcCC------
Confidence            2       235567999999988899999999999999999999 777875310        011111111100      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                           ......+....+.+++.+|++.+|++||+++++++.|++.
T Consensus       221 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 -----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                 0111233456688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-40  Score=298.84  Aligned_cols=247  Identities=21%  Similarity=0.336  Sum_probs=196.5

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|...      .+..+|+|.+...       ........+.+|+.+++.++||||+++++++....
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032          10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-------ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-------cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            3467999999999999864      2468999997541       12233467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhc------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIREN------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      ..++|+||+++|+|.+++......      ...++|..++.++.|++.||+|||   +.+++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence            999999999999999999753221      234789999999999999999999   99999999999999999999999


Q ss_pred             EeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++....        ...++..|+|||.+.+..++.++||||||+++||+++ |..||...        ......
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~--------~~~~~~  231 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL--------SNEEVL  231 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC--------CHHHHH
Confidence            999999875432        1235678999999988889999999999999999998 88887531        111111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .... .+.        .  ...+......+.+++.+||+.+|++|||+.++++.|++
T Consensus       232 ~~~~-~~~--------~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 KFVI-DGG--------H--LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHh-cCC--------C--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1111 110        0  01112235668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-40  Score=299.52  Aligned_cols=245  Identities=23%  Similarity=0.286  Sum_probs=194.1

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .++||+|+||.||++.. .+++.||+|.+......     .......+.+|+.++++++||||+++++.+...+..++||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-----hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            46799999999999986 46899999998652211     1222356778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..  .....+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          80 TLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             eccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999998864  22346899999999999999999999   89999999999999999999999999999876542


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...++..|+|||.+.+..++.++||||+|+++||+++|..||....    .........          ..+...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~----~~~~~~~~~----------~~~~~~  220 (285)
T cd05605         155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK----EKVKREEVE----------RRVKED  220 (285)
T ss_pred             CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc----hhhHHHHHH----------HHhhhc
Confidence                 2357889999999998899999999999999999999999986310    000000110          111110


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                        ....+......+.+++..||+.||.+||     +++++++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              0111223455678999999999999999     7777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=292.91  Aligned_cols=244  Identities=27%  Similarity=0.424  Sum_probs=199.8

Q ss_pred             cccCccCCeeEEEEEecC----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      +.||+|+||.||++....    +..+++|.+.....       ....+.+.+|++.+..++|+|++++++++.+....++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   73 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL   73 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc-------hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEE
Confidence            469999999999999754    78999999875221       1145788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          179 VYDYLQTGSLEDAMDRIREN-----QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ++||+++++|.+++......     ...+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg  150 (262)
T cd00192          74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFG  150 (262)
T ss_pred             EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccc
Confidence            99999999999999853211     367999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          254 LAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       254 l~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      .+......        ..++..|+|||.+....++.++||||+|++++||++ |..||...        ...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~  222 (262)
T cd00192         151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLRK  222 (262)
T ss_pred             cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHc
Confidence            99866542        346788999999988889999999999999999999 68888642        11122222111


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      ..           ....+......+.+++.+||+.+|++|||+.++++.|+
T Consensus       223 ~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 GY-----------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CC-----------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            10           01112233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.8e-40  Score=304.77  Aligned_cols=233  Identities=24%  Similarity=0.296  Sum_probs=184.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHH---HcCCCCCcceeeEEEecCCeEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVL---ASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      .+.||+|+||.||++.. .+|+.||+|++.....     ......+.+.+|+.++   +.++||||+++++++..++..+
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~   78 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-----IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC   78 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence            46799999999999986 4689999999975211     1122234566665554   5678999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|..+++     ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        79 lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          79 FVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            9999999999998875     346899999999999999999999   89999999999999999999999999999875


Q ss_pred             CCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          258 MPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       258 ~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ...      ...|++.|+|||.+.+..++.++||||||+++|||++|..||...        ...+.........     
T Consensus       151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~--------~~~~~~~~i~~~~-----  217 (324)
T cd05589         151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD--------DEEEVFDSIVNDE-----  217 (324)
T ss_pred             CCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-----
Confidence            321      235889999999999999999999999999999999999998631        1111221111110     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                             ...+......+.+++.+||+.||.+||++
T Consensus       218 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~  246 (324)
T cd05589         218 -------VRYPRFLSREAISIMRRLLRRNPERRLGS  246 (324)
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence                   01112234557889999999999999953

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.4e-40  Score=295.81  Aligned_cols=245  Identities=20%  Similarity=0.407  Sum_probs=195.6

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...    .+..+|+|.+....       .....+.+.+|+.++++++||||+++.+++..++..
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             eeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4578999999999999863    23479999886411       123356889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++||||||+||+++.++.++++|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          81 MIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence            999999999999999974   2346899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCCCC---------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGSL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~~---------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ......         .++..|+|||.+.+..++.++|+||||+++||+++ |..||.....        .+.........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~  226 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIEEGY  226 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHhCCC
Confidence            654321         12457999999998899999999999999999887 9999853110        11111111100


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                            .     ...+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       227 ------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 ------R-----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------c-----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  0     011122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-40  Score=307.53  Aligned_cols=242  Identities=22%  Similarity=0.358  Sum_probs=204.5

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe-EEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR-FYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  179 (380)
                      .+.+|+|+||.++.... .++..+++|.+......      ...++...+|+.++++++|||||.+.+.|.+++. .++|
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t------~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT------EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccC------chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            46799999999988775 46789999999874433      3334688899999999999999999999999888 8999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |+|++||+|.+.+...+  ..-++...++++..|++.|+.|||   +..|.|||||+.||+++.+..+||+|||+++.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999998643  556889999999999999999999   9999999999999999999999999999999876


Q ss_pred             CC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 GS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..      ..||+.|++||.+.+.+|..|+|||||||++|||++-+++|...        +....+......        
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--------~m~~Li~ki~~~--------  221 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--------NMSELILKINRG--------  221 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--------chHHHHHHHhhc--------
Confidence            54      46999999999999999999999999999999999999998631        222222222111        


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                        . -.+.+......+..++..|+..+|..||++.+++..
T Consensus       222 --~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 --L-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --c-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              1 123445567778899999999999999999999875

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.8e-40  Score=311.77  Aligned_cols=243  Identities=21%  Similarity=0.298  Sum_probs=189.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .++..+|+|++.....     ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-----LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            46799999999999986 5688999999975211     12334567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++... 
T Consensus        81 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          81 DYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            99999999999874    346888888999999999999999   8999999999999999999999999999875321 


Q ss_pred             ----------------------------------------------------CCCcCCCcccCcccccCCCCCCcchhhH
Q 047245          260 ----------------------------------------------------GSLIATSAYSAPECFQNRSYTDKSDIFS  287 (380)
Q Consensus       260 ----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s  287 (380)
                                                                          ....||+.|+|||.+.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence                                                                1135889999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHH--cccCCCCCCC
Q 047245          288 FGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV--CLSDSPADRP  365 (380)
Q Consensus       288 ~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--Cl~~~P~~RP  365 (380)
                      |||++|||++|..||.....        ............     ....  . ........+.+++.+  |+..+|..||
T Consensus       234 lG~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~-----~~~~--~-~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTP--------TETQLKVINWEN-----TLHI--P-PQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCH--------HHHHHHHHcccc-----ccCC--C-CCCCCCHHHHHHHHHHccCcccccCCC
Confidence            99999999999999864110        000001100000     0000  0 001123446667766  6667777799


Q ss_pred             CHHhHHH
Q 047245          366 SSDELVP  372 (380)
Q Consensus       366 s~~evl~  372 (380)
                      +++|++.
T Consensus       298 ~~~~~l~  304 (381)
T cd05626         298 GADDIKA  304 (381)
T ss_pred             CHHHHhc
Confidence            9999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5e-41  Score=297.20  Aligned_cols=252  Identities=25%  Similarity=0.342  Sum_probs=193.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+++|+|+||.||+|.+ .++..||||+......            --.+|+++|+.+.|||||+++-++....     
T Consensus        28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             eeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            457899999999999997 4578999999865221            1126999999999999999988875432     


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFG  253 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg  253 (380)
                      ...+|+||||. +|.++++.....+..++...+.-+..|+.+||+|||   +.+|+||||||.|+|+|.+ +.+||+|||
T Consensus        96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence            34689999988 999999876556677888888889999999999999   8999999999999999986 899999999


Q ss_pred             CcccCCCC-----CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          254 LAKLMPGS-----LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       254 l~~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      .|+.+..+     ...+..|.|||.+.+ ..|+.+.||||.|||+.||+.|++-|..    .+..+++...++.+-.+.+
T Consensus       172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG----~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG----DSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC----CCHHHHHHHHHHHhCCCCH
Confidence            99876532     247888999999976 6799999999999999999999988753    2333344444432222111


Q ss_pred             ---------hhHhhchhccCCc----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 ---------AREALDRSILGEE----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ---------~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                               ..+.-.+.+....    .......+..+++.+++..+|.+|.++.|++.
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                     0011111111111    22345667889999999999999999999873

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.5e-40  Score=300.43  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=185.1

Q ss_pred             ccccCccCCeeEEEEEe--cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC---CCCCcceeeEEEe-----
Q 047245          102 NRLLGSSPDGKYYRTVL--DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL---RHRNLMSLRAYVP-----  171 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  171 (380)
                      .+.||+|+||.||++..  .+|..||+|++.......      .....+.+|+.+++.+   +||||+++++++.     
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE------GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC------CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            46799999999999986  346889999987532211      1123445666666655   6999999999985     


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                      .....++|+||++ ++|.+++...  ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence            3456899999996 5999998742  2345899999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC--------CCCHHHH
Q 047245          252 FGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS--------GGSLGRW  318 (380)
Q Consensus       252 fgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~--------~~~l~~~  318 (380)
                      ||+++....     ...+++.|+|||.+.+..++.++||||||+++|||++|..||........-        .....+|
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999876542     234789999999999889999999999999999999999998642110000        0000011


Q ss_pred             HHHHHhhcchhHhhchhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          319 LRHLQHAGEAREALDRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .......   ...+... ...   .........+.+++.+|++.||++|||+.|+++
T Consensus       234 ~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALP---RQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhccc---chhccCC-CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            1000000   0000000 000   000123345679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.6e-40  Score=302.55  Aligned_cols=252  Identities=22%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             HhccccccCccCCeeEEEEEec--------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeE
Q 047245           98 LANENRLLGSSPDGKYYRTVLD--------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRA  168 (380)
Q Consensus        98 ~~~~~~~lg~G~~g~vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  168 (380)
                      .....+.||+|+||.||++...        ++..+|+|.+....       .......+..|+.+++++ +||||+++++
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            3446678999999999998742        23579999886421       122346788899999999 7999999999


Q ss_pred             EEecCCeEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCC
Q 047245          169 YVPESSRFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP  236 (380)
Q Consensus       169 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~  236 (380)
                      ++...+..++|+||+++|+|.+++...+.            ....++|..++.++.|++.||+|||   +.+++||||||
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp  168 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  168 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccH
Confidence            99999999999999999999999975321            1235899999999999999999999   89999999999


Q ss_pred             CcEEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhh
Q 047245          237 TNVMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFA  307 (380)
Q Consensus       237 ~Nill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~  307 (380)
                      +||+++.++.+||+|||.++.....        ..++..|+|||.+.+..++.++||||||+++|||++ |..||...  
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~--  246 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--  246 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC--
Confidence            9999999999999999998755321        123467999999998889999999999999999998 88887431  


Q ss_pred             hccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          308 EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       308 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                            ...+.........           ....+......+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       247 ------~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         247 ------PVEELFKLLKEGH-----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             ------CHHHHHHHHHcCC-----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                  1122222211110           01111234556889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=292.39  Aligned_cols=244  Identities=23%  Similarity=0.392  Sum_probs=195.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|++|.||++.. .++..+|+|.+......   .........+.+|+.++++++||||+++++++.+....+++
T Consensus         6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            357899999999999986 46899999998753211   11223346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++..    ...+++.....++.|++.||+|||   +.+++||||+|+||++++++.++|+|||+++...
T Consensus        83 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          83 MEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999874    345888899999999999999999   8999999999999999999999999999987543


Q ss_pred             C---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 G---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 ~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .         ...++..|+|||.+.+..++.++||||||+++||+++|+.||...       ...... .......    
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~-~~~~~~~----  223 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF-------EAMAAI-FKIATQP----  223 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc-------chHHHH-HHHhccC----
Confidence            2         133677899999999988999999999999999999999998531       011111 1111000    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           . ....+......+.+++.+||+.+|.+|||+.++++
T Consensus       224 -----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         224 -----T-NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             -----C-CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence                 0 01122234556789999999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.1e-40  Score=299.55  Aligned_cols=247  Identities=22%  Similarity=0.392  Sum_probs=196.9

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||++...      ++..+|+|.+...       ........+.+|+.++++++||||+++++++.++.
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             ecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-------cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            3467999999999999853      4678999988641       12234467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhh------------------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIR------------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP  236 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~  236 (380)
                      ..++++||+++|+|.+++....                  .....+++..++.++.|++.||+|||   +.+++||||+|
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence            9999999999999999997421                  11235788999999999999999999   89999999999


Q ss_pred             CcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhh
Q 047245          237 TNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFA  307 (380)
Q Consensus       237 ~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~  307 (380)
                      +||++++++.++|+|||++.....        ....+..|+|||.+.+..++.++||||||+++|||++ |..||...  
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--  236 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--  236 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--
Confidence            999999999999999999875432        1224567999999998899999999999999999998 88887531  


Q ss_pred             hccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          308 EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       308 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                            ...++...... +..        .  ..+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus       237 ------~~~~~~~~~~~-~~~--------~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 ------AHEEVIYYVRD-GNV--------L--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ------CHHHHHHHHhc-CCC--------C--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                  11222222211 110        0  1112234568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.9e-40  Score=296.10  Aligned_cols=245  Identities=23%  Similarity=0.400  Sum_probs=193.8

Q ss_pred             cccCccCCeeEEEEEecC-------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          103 RLLGSSPDGKYYRTVLDN-------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      +.||+|+||.||+|...+       +..+|+|.+....       .......+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   73 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP   73 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence            469999999999998642       2578999875421       11234678899999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-----ce
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRE---NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-----TP  247 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-----~~  247 (380)
                      .++++||+++|+|.+++.....   ....+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++     .+
T Consensus        74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~  150 (269)
T cd05044          74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVV  150 (269)
T ss_pred             eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcce
Confidence            9999999999999999975322   1234789999999999999999999   89999999999999999877     89


Q ss_pred             EEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHH
Q 047245          248 RLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       248 kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~  318 (380)
                      +++|||+++....        ...++..|+|||.+.++.++.++||||||+++|||++ |..||....        ..+.
T Consensus       151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--------~~~~  222 (269)
T cd05044         151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--------NQEV  222 (269)
T ss_pred             EECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--------HHHH
Confidence            9999999875432        1235678999999999999999999999999999998 999985310        0111


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ........        .   ...+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       223 ~~~~~~~~--------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         223 LQHVTAGG--------R---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HHHHhcCC--------c---cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111100        0   01112345668899999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-39  Score=305.03  Aligned_cols=244  Identities=22%  Similarity=0.276  Sum_probs=190.6

Q ss_pred             ccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||+|+||.||++..    .+|..+|+|++.....    .......+.+..|+.++.++ +|+||+++++++...+..
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            46799999999999875    3688999999865211    11223346678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            999999999999999864    346889999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCC-------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPG-------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~-------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ....       ...||+.|+|||.+.+. .++.++||||||+++|||++|..||...    ...............    
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~----~~~~~~~~~~~~~~~----  225 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE----GERNTQSEVSRRILK----  225 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC----CCCCCHHHHHHHHhc----
Confidence            5421       23489999999999865 4788999999999999999999998531    111111111111111    


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                         .++     ..+......+.+++.+||+.||++||     +++++++
T Consensus       226 ---~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 ---CDP-----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCC-----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               011     11122345578899999999999999     5666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=312.89  Aligned_cols=242  Identities=22%  Similarity=0.312  Sum_probs=194.6

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|+.||+|++.....     ........+.+|+.++..++||||+++++++.+++..++||
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-----IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH-----hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            467999999999999974 689999999975211     11233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999999974    256889999999999999999999   89999999999999999999999999999875432


Q ss_pred             C-----------------------------------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCch
Q 047245          261 S-----------------------------------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF  305 (380)
Q Consensus       261 ~-----------------------------------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~  305 (380)
                      .                                   ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            2                                   24889999999999999999999999999999999999998642


Q ss_pred             hhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC-HHhHHH
Q 047245          306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-SDELVP  372 (380)
Q Consensus       306 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~  372 (380)
                      .        ............       ........ ......+.+++.+|+. +|.+||+ ++++++
T Consensus       234 ~--------~~~~~~~i~~~~-------~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         234 T--------LQETYNKIINWK-------ESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             C--------HHHHHHHHhccC-------CcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            1        111111111100       00000000 1134567889999998 9999999 999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.3e-40  Score=305.52  Aligned_cols=239  Identities=22%  Similarity=0.300  Sum_probs=186.5

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHH-HHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQEL-EVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|+||.||++... ++..+|+|++.....     ........+..|. .+++.++||||+++++++.+.+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI-----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence            36999999999999874 577899999875211     0111223344444 4578889999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+.......++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            99999999999874    345778888889999999999999   8999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++|||||||++|||++|..||...        ............         
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~---------  211 (325)
T cd05602         149 HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------NTAEMYDNILNK---------  211 (325)
T ss_pred             CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC--------CHHHHHHHHHhC---------
Confidence                 1235899999999999999999999999999999999999998531        111222221111         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                      ..   .........+.+++.+|++.+|.+||++.+.+..
T Consensus       212 ~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         212 PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             Cc---CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            00   1112234557889999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-39  Score=300.65  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=188.5

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.+|+|++......       .....+.+|+.++++++||||+++++++.+....++|
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-------GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             EeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-------ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            3467999999999999974 6889999998652211       1124567899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||++ ++|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        82 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          82 FEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            99995 688888763   2346888899999999999999999   9999999999999999999999999999987533


Q ss_pred             C------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh---hcch-
Q 047245          260 G------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH---AGEA-  328 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~-  328 (380)
                      .      ...+++.|+|||.+.+ ..++.++||||+||++|||++|..||....       +..+.......   .... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~  227 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK-------DIQDQLERIFLVLGTPNED  227 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc-------cHHHHHHHHHHHhCCCChh
Confidence            1      2347889999999865 457889999999999999999999996421       11111110000   0000 


Q ss_pred             -------hHhhchhcc----CCcc-----cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 -------REALDRSIL----GEEV-----EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 -------~~~~~~~~~----~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                             ....++...    ....     .......+.+++.+|++.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                   000000000    0000     0011245779999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-39  Score=304.45  Aligned_cols=256  Identities=24%  Similarity=0.406  Sum_probs=187.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----Ce
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----SR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  175 (380)
                      .+.||+|+||.||+|.. .+|..||+|++.....      .......+.+|+.++++++||||+++++++...     ..
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE------HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhc------cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            46799999999999986 4689999999864211      112235688999999999999999999987543     35


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+. ++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        79 ~~lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          79 IYVVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence            799999995 689988863    346899999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCC---------CCcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHH
Q 047245          256 KLMPG---------SLIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGR  317 (380)
Q Consensus       256 ~~~~~---------~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~  317 (380)
                      +....         ...+++.|+|||.+.+  ..++.++|||||||++|||++|+.||........       .+.....
T Consensus       151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  230 (338)
T cd07859         151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE  230 (338)
T ss_pred             cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            75421         2358899999999865  6789999999999999999999999853210000       0000000


Q ss_pred             HHHHHHhhcchhHhhchhccCCccc-----HHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          318 WLRHLQHAGEAREALDRSILGEEVE-----EDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +..... .....+.+..........     ......+.+++.+||+.||++|||++|+++
T Consensus       231 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         231 TISRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000000 000011111000000000     012345679999999999999999999984

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-40  Score=296.63  Aligned_cols=238  Identities=19%  Similarity=0.321  Sum_probs=186.4

Q ss_pred             cccCccCCeeEEEEEecC--------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          103 RLLGSSPDGKYYRTVLDN--------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      +.||+|+||.||+|....        ...+++|.+..        ......+.+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   72 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--------SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD   72 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc--------hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence            369999999999998632        23477777643        12334467889999999999999999999999989


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc--------
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT--------  246 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--------  246 (380)
                      ..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.        
T Consensus        73 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~  146 (258)
T cd05078          73 ESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPF  146 (258)
T ss_pred             CcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCce
Confidence            99999999999999999874   2336899999999999999999999   999999999999999987765        


Q ss_pred             eEEeccCCcccCCC--CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCC-CCCCchhhhccCCCCHHHHHHHH
Q 047245          247 PRLADFGLAKLMPG--SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR-DPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~--~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      ++++|||++.....  ...++..|+|||.+.+ ..++.++||||||+++||+++|. .|+...        ........ 
T Consensus       147 ~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~--------~~~~~~~~-  217 (258)
T cd05078         147 IKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL--------DSQKKLQF-  217 (258)
T ss_pred             EEecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc--------cHHHHHHH-
Confidence            69999999876543  2357889999999986 45789999999999999999985 444321        00011100 


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      ..         ..   ...+......+.+++.+||+.+|++|||++++++.|.
T Consensus       218 ~~---------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YE---------DR---HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HH---------cc---ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00         00   1111123356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.8e-39  Score=292.06  Aligned_cols=247  Identities=19%  Similarity=0.274  Sum_probs=185.8

Q ss_pred             ccCccCCeeEEEEEecCCc---EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          104 LLGSSPDGKYYRTVLDNGL---TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .||+|+||.||++...++.   .+++|.+....       .....+.+.+|+..++.++||||+++++.+.+....++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence            5999999999999865444   34555554311       1223578999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.++++.........++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.... 
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence            999999999999854333345677788899999999999999   8999999999999999999999999999986421 


Q ss_pred             -------CCCcCCCcccCcccccC-------CCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          260 -------GSLIATSAYSAPECFQN-------RSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       260 -------~~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                             ....++..|+|||.+..       ..++.++||||||+++|||++ |..||...        ...+.......
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~--------~~~~~~~~~~~  223 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL--------SDREVLNHVIK  223 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHh
Confidence                   12346788999998743       245789999999999999997 56676431        11222222221


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      .. .....++.+..     .....+.+++..|| .+|++|||+++|++.|.
T Consensus       224 ~~-~~~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         224 DQ-QVKLFKPQLEL-----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             hc-ccccCCCccCC-----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11 11222222211     12345677888999 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1e-39  Score=302.78  Aligned_cols=237  Identities=24%  Similarity=0.272  Sum_probs=187.8

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|+||.||++... +|..||+|.++.....     .......+..|..++... +||||+++++++.+.+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-----IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence            36999999999999974 6889999999752110     112234566788888765 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++... 
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            99999999998864    346889999999999999999999   8999999999999999999999999999987432 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++||||||+++|||++|..||...        ............       .+
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~--------~~~~~~~~~~~~-------~~  213 (316)
T cd05620         149 GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--------DEDELFESIRVD-------TP  213 (316)
T ss_pred             CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC-------CC
Confidence                 1235899999999999999999999999999999999999998631        111111111110       00


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH-hHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD-ELV  371 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl  371 (380)
                           ..+......+.+++.+||+.||++||++. +++
T Consensus       214 -----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 -----HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                 11112344578899999999999999985 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-39  Score=293.00  Aligned_cols=242  Identities=24%  Similarity=0.398  Sum_probs=194.7

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe-cCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP-ESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... |..+|+|.....          ...+.+.+|+.++++++|+|++++++++. +++..+++
T Consensus        10 ~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082          10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             eeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            4578999999999999875 788999987531          11357889999999999999999999764 55678999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          79 TEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             EECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            999999999999874  22345889999999999999999999   8999999999999999999999999999987643


Q ss_pred             C---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 G---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .   ....+..|+|||.+.+..++.++||||||+++|||++ |+.||..        ....+........          
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~~~~----------  215 (256)
T cd05082         154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------IPLKDVVPRVEKG----------  215 (256)
T ss_pred             ccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcC----------
Confidence            2   2234567999999998889999999999999999998 8888753        1222222221110          


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      . ...........+.+++.+||+.+|++|||++++++.|+++
T Consensus       216 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 Y-KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             C-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            0 0111123455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.3e-40  Score=301.43  Aligned_cols=248  Identities=24%  Similarity=0.417  Sum_probs=194.0

Q ss_pred             cccccCccCCeeEEEEEec-CCc--EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGL--TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|... +|.  .+++|.+...       ........+.+|+.++.++ +||||+++++++..++..
T Consensus        11 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088          11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             eeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-------CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            4578999999999999864 454  4577766431       1233457788999999999 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC
Q 047245          177 YLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~  244 (380)
                      ++|+||+++|+|.++++....            ....+++..++.++.|++.|++|||   +.+++||||||+|||++++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCC
Confidence            999999999999999975321            1235889999999999999999999   9999999999999999999


Q ss_pred             CceEEeccCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHH
Q 047245          245 FTPRLADFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~  318 (380)
                      +.+||+|||+++....     ....+..|+|||.+.+..++.++||||||+++|||++ |..||...        ...+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~  232 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAEL  232 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC--------ChHHH
Confidence            9999999999864321     1123567999999988889999999999999999998 99998531        11111


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ......          ... ...+......+.+++.+||+.+|++||+++++++.|+++
T Consensus       233 ~~~~~~----------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         233 YEKLPQ----------GYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHHhc----------CCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111110          000 001112344578999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.8e-39  Score=292.86  Aligned_cols=254  Identities=24%  Similarity=0.388  Sum_probs=201.2

Q ss_pred             ccccCccCCeeEEEEEecC--CcEEEEEEeeeccCCCh--hhhcHHHHHHHHHHHHHHHc-CCCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVLDN--GLTVAVRRVEAFESGSP--EKQNKSVKRRIQQELEVLAS-LRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~--g~~vavK~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||+|+||.||++....  +..+|+|.+........  .........++.+|+.++.+ ++||||+++++++.+++..
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   84 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL   84 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence            3579999999999999754  68899998865332211  11233455677889998875 6999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      +++|||+++++|.+++.........+++..++.++.|++.||.|||   + .+++|+||+|+||+++.++.+||+|||.+
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEecccce
Confidence            9999999999999998765555667999999999999999999999   5 67999999999999999999999999999


Q ss_pred             ccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ......     ..++..|++||...+..++.++||||||+++|||++|..||...        .............    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--------~~~~~~~~~~~~~----  229 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--------NMLSLATKIVEAV----  229 (269)
T ss_pred             eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc--------CHHHHHHHHhhcc----
Confidence            765432     34788899999999888999999999999999999999998531        1111111111110    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                           . ...........+.+++.+||+.||++||++.|+..++++
T Consensus       230 -----~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         230 -----Y-EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             -----C-CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence                 0 000111234568899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=299.89  Aligned_cols=254  Identities=19%  Similarity=0.313  Sum_probs=193.1

Q ss_pred             cccccCccCCeeEEEEEecC---------------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcce
Q 047245          101 ENRLLGSSPDGKYYRTVLDN---------------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS  165 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  165 (380)
                      ..+.||+|+||.||++...+               ...||+|.+....       .......+.+|++++++++|+|+++
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-------TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            34679999999999987532               2358999886421       2234567899999999999999999


Q ss_pred             eeEEEecCCeEEEEEeecCCCCHHHHHHHhhh--------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCC
Q 047245          166 LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE--------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT  237 (380)
Q Consensus       166 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~  237 (380)
                      +++++...+..++||||+++++|.+++.....        ....+++..++.++.|++.||+|||   +.+++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChh
Confidence            99999999999999999999999999864211        1134789999999999999999999   899999999999


Q ss_pred             cEEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh--CCCCCCchhh
Q 047245          238 NVMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT--GRDPTAPFFA  307 (380)
Q Consensus       238 Nill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t--g~~p~~~~~~  307 (380)
                      ||++++++.+||+|||++......        ..++..|+|||.+.++.++.++||||||+++|||++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999998754321        224668999999998899999999999999999998  5566643111


Q ss_pred             hccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          308 EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       308 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .     .............      ..... ...+...+..+.+++.+||+.||++|||+++|++.|++
T Consensus       239 ~-----~~~~~~~~~~~~~------~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 E-----QVIENTGEFFRNQ------GRQIY-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             H-----HHHHHHHHhhhhc------ccccc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            0     0000000101000      00000 00111234568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-40  Score=305.87  Aligned_cols=238  Identities=24%  Similarity=0.329  Sum_probs=187.6

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHH-HHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE-VLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|+||.||++.. .+|+.+|+|++.....     ........+..|.. +++.++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV-----LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence            3699999999999986 4689999999865211     11222344555554 567789999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          76 DFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            99999999988864    446899999999999999999999   89999999999999999999999999999875321


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...|++.|+|||.+.+..++.++|||||||++|||++|..||...        ............         
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--------~~~~~~~~~~~~---------  211 (325)
T cd05604         149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--------DVAEMYDNILHK---------  211 (325)
T ss_pred             CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC--------CHHHHHHHHHcC---------
Confidence                  234889999999999999999999999999999999999998531        111222221111         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+   .........+.+++.+|++.+|++||++.+.++
T Consensus       212 ~~---~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         212 PL---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             Cc---cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            00   011123445778999999999999999864443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.1e-40  Score=303.92  Aligned_cols=234  Identities=24%  Similarity=0.349  Sum_probs=185.4

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHH-HHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE-VLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ++||+|+||.||++.. .+|+.+|+|++.....     ........+..|.. +++.++||||+++++++.+.+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI-----LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence            3699999999999997 4688999999865211     11222344555554 678899999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...++......++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence            99999999988863    346788888999999999999999   89999999999999999999999999999875321


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...|++.|+|||.+.+..++.++|||||||++|||++|..||...        +...........         
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~---------  211 (321)
T cd05603         149 PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------DVSQMYDNILHK---------  211 (321)
T ss_pred             CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC--------CHHHHHHHHhcC---------
Confidence                  234889999999999989999999999999999999999998631        112222221111         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD  368 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  368 (380)
                      ..   ..+......+.+++.+|++.+|.+||+..
T Consensus       212 ~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 PL---QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CC---CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11   11122345678999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-39  Score=295.87  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=195.9

Q ss_pred             cccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--
Q 047245          101 ENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  173 (380)
                      ..+.||+|+||.||.+..     .++..||+|.+....       .......+.+|++++++++|||++++.+++.+.  
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            346799999999999874     357899999986421       122346789999999999999999999998775  


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCc
Confidence            568999999999999999863   2346899999999999999999999   9999999999999999999999999999


Q ss_pred             CcccCCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc-------cCCCCHHH
Q 047245          254 LAKLMPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA-------ASGGSLGR  317 (380)
Q Consensus       254 l~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~-------~~~~~l~~  317 (380)
                      +++....         ...++..|+|||.+.+..++.++||||||+++||+++++.|........       ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            9875432         2235667999999988889999999999999999999877643211100       00001111


Q ss_pred             HHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          318 WLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      +...... +         . ........+..+.+++.+|++.+|++|||++++++.|+++
T Consensus       235 ~~~~~~~-~---------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRVLEE-G---------K-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHc-C---------c-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111110 0         0 0111123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-39  Score=294.58  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=184.8

Q ss_pred             ccCccCCeeEEEEEecCC---cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          104 LLGSSPDGKYYRTVLDNG---LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .||+|+||.||+|...++   ..+++|.+...       ........+.+|+..++.++|+||+++++.+.+....++||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc-------CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence            589999999999976443   45777766431       12233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIREN-QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||+++|+|.+++...... ....++.....++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence            999999999999753321 223567788999999999999999   8999999999999999999999999999986532


Q ss_pred             C--------CCcCCCcccCcccccC-------CCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHH
Q 047245          260 G--------SLIATSAYSAPECFQN-------RSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQ  323 (380)
Q Consensus       260 ~--------~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~  323 (380)
                      .        ...++..|+|||....       ..++.++||||||+++|||++ |..||.....        .+-.....
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~  223 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVV  223 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHh
Confidence            1        1235667999998742       456889999999999999999 7778753110        01111111


Q ss_pred             hhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      .... ....+     ..........+.+++..|| .||++|||+++|++.|.
T Consensus       224 ~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         224 REQD-IKLPK-----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             hccC-ccCCC-----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1110 01111     1111223455667888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-39  Score=307.91  Aligned_cols=191  Identities=22%  Similarity=0.362  Sum_probs=167.8

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+++.+|+|++....     .........+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-----MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH-----HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46799999999999986 468899999996521     112233467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999874    346899999999999999999999   99999999999999999999999999999864321


Q ss_pred             -----------------------------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCC
Q 047245          261 -----------------------------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR  299 (380)
Q Consensus       261 -----------------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~  299 (380)
                                                               ...||+.|+|||.+.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence                                                     235899999999999999999999999999999999999


Q ss_pred             CCCCc
Q 047245          300 DPTAP  304 (380)
Q Consensus       300 ~p~~~  304 (380)
                      .||..
T Consensus       234 ~Pf~~  238 (363)
T cd05628         234 PPFCS  238 (363)
T ss_pred             CCCCC
Confidence            99863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-39  Score=292.26  Aligned_cols=243  Identities=23%  Similarity=0.413  Sum_probs=195.8

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..+++|.+...         ......+.+|++++++++|+||+++.+++.+ ...+++|
T Consensus        10 ~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073          10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             EEeEecCccceEEEEEEecCCccEEEEecCCC---------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            45789999999999999878888999987641         1224678899999999999999999999887 7789999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999999999742  2446889999999999999999999   89999999999999999999999999999875432


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||.+....++.++|+||||+++|++++ |..||...        ...+...... .+.     
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~--------~~~~~~~~~~-~~~-----  220 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVIRALE-RGY-----  220 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHh-CCC-----
Confidence            1       124567999999998889999999999999999999 88888531        0111111111 110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                          . ..........+.+++.+|++.+|++||++.++.+.|+.+
T Consensus       221 ----~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         221 ----R-MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ----C-CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                0 011123445688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=293.79  Aligned_cols=244  Identities=25%  Similarity=0.417  Sum_probs=198.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|++|.||++...++..+|+|.+.....         ...++.+|+.++++++|+||+++++++......++++
T Consensus        10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034          10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             eeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            4568999999999999988888999999864211         1256889999999999999999999999989999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..  .....+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          81 EYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             eccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999974  22346899999999999999999999   89999999999999999999999999999876542


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ...+..|+|||.+.+..++.++|+||||++++|+++ |+.||...        ............       
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~--------~~~~~~~~~~~~-------  220 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM--------TNREVLEQVERG-------  220 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcC-------
Confidence            1       124567999999998889999999999999999999 99987531        111111111110       


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                         . ....+......+.+++.+|++.+|++||+++++.+.|+.+
T Consensus       221 ---~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         221 ---Y-RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             ---C-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence               0 0011122345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-39  Score=297.65  Aligned_cols=248  Identities=21%  Similarity=0.355  Sum_probs=195.2

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|...      .+..||+|.+....       .......+.+|+..+++++||||+++++++.+..
T Consensus        10 i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061          10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             eeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4578999999999998753      24589999875311       1222356788999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhc------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIREN------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      ..++||||+++|+|.+++......      ...+++..+..++.|++.||+|||   +++++||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            999999999999999999753221      234677888999999999999999   99999999999999999999999


Q ss_pred             EeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++.....        ..++..|+|||.+.++.++.++||||||+++|||++ |..||...        ...++.
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~--------~~~~~~  231 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL--------SNEQVL  231 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHH
Confidence            9999998754321        234667999999998899999999999999999999 77787531        111222


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ......+         ..  ..+......+.+++.+|++.+|++|||+.++++.|++.
T Consensus       232 ~~~~~~~---------~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 KFVMDGG---------YL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHcCC---------CC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1111111         00  01122345689999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-39  Score=300.20  Aligned_cols=250  Identities=24%  Similarity=0.413  Sum_probs=196.8

Q ss_pred             ccccccCccCCeeEEEEEe--------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVL--------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYV  170 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  170 (380)
                      ...+.||+|+||.||++..        .+...+|+|.+....       .......+..|+.+++++ +||||+++++++
T Consensus        15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3567899999999999874        134578999876421       122346788999999999 699999999999


Q ss_pred             ecCCeEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          171 PESSRFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       171 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      .+.+..++++||+++|+|.+++.....            ....++|..+..++.|++.||+|||   +.+++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecccccee
Confidence            999999999999999999999975321            1245899999999999999999999   8999999999999


Q ss_pred             EEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhc
Q 047245          239 VMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEA  309 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~  309 (380)
                      |++++++.+||+|||+++.....        ..++..|+|||.+.+..++.++||||||+++||+++ |..||...    
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~----  240 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI----  240 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC----
Confidence            99999999999999999865421        123457999999998899999999999999999999 88887531    


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                          .......... .+..          ...+......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       241 ----~~~~~~~~~~-~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         241 ----PVEELFKLLR-EGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             ----CHHHHHHHHH-cCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence                1111111111 1100          0111223456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-40  Score=309.83  Aligned_cols=242  Identities=21%  Similarity=0.288  Sum_probs=191.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+|+.||+|++.....     ........+.+|+.++..++||||+++++++.+.+..++||
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-----LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46899999999999997 4689999999975211     12233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999874    346899999999999999999999   89999999999999999999999999999864321


Q ss_pred             --------------------------------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHH
Q 047245          261 --------------------------------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLL  296 (380)
Q Consensus       261 --------------------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~  296 (380)
                                                                  ...||+.|+|||.+....++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence                                                        124899999999999999999999999999999999


Q ss_pred             hCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC---HHhHHH
Q 047245          297 TGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS---SDELVP  372 (380)
Q Consensus       297 tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~  372 (380)
                      +|..||...        .............       ..+... ........+.+++.+|+. +|.+|++   ++|+++
T Consensus       234 ~G~~Pf~~~--------~~~~~~~~i~~~~-------~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSD--------NPQETYRKIINWK-------ETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCC--------CHHHHHHHHHcCC-------CccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999998641        1111111111100       000000 001123456788888886 9999998   777764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-39  Score=303.22  Aligned_cols=241  Identities=23%  Similarity=0.311  Sum_probs=190.6

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ++||+|+||.||++.. .+++.+|+|++.....     ......+.+..|+.++.++ +||||+.+++++.+.+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-----HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence            4699999999999987 4678999999975211     1223346788999999998 6999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            99999999998864    346899999999999999999999   8999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ....|++.|+|||.+.+..++.++||||||+++|||++|..||.......  .....++.........       
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~-------  219 (327)
T cd05617         149 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEKP-------  219 (327)
T ss_pred             CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhCC-------
Confidence                 12358999999999999999999999999999999999999996321111  1111222222111110       


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD  368 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  368 (380)
                          ...+......+.+++.+|++.||.+||+++
T Consensus       220 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         220 ----IRIPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                011122345578999999999999999854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.4e-39  Score=297.62  Aligned_cols=251  Identities=19%  Similarity=0.329  Sum_probs=193.9

Q ss_pred             cccccCccCCeeEEEEEec-----------------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc
Q 047245          101 ENRLLGSSPDGKYYRTVLD-----------------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL  163 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  163 (380)
                      ..+.||+|+||.||++...                 ++..+|+|.+...       ........+.+|+.+++.++|+||
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-------~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-------ANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCCc
Confidence            4567999999999997532                 2446899988642       123345788999999999999999


Q ss_pred             ceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhc-------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCC
Q 047245          164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN-------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP  236 (380)
Q Consensus       164 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~  236 (380)
                      +++++++...+..+++|||+++|+|.+++......       ...+++..+..++.|++.||+|||   +.+++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCh
Confidence            99999999999999999999999999999753211       234788899999999999999999   89999999999


Q ss_pred             CcEEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh--CCCCCCchh
Q 047245          237 TNVMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT--GRDPTAPFF  306 (380)
Q Consensus       237 ~Nill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t--g~~p~~~~~  306 (380)
                      +||+++.++.++|+|||+++.....        ...+..|++||...++.++.++||||||+++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999998764321        223568999999888889999999999999999998  667775311


Q ss_pred             hhccCCCCHHHHHHH---HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          307 AEAASGGSLGRWLRH---LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       307 ~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                              .......   ..........+       ..+..+...+.+++.+||+.||.+|||+.||++.|++
T Consensus       239 --------~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         239 --------DEQVIENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --------hHHHHHHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    1111110   00000000000       0112234668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3e-39  Score=294.44  Aligned_cols=242  Identities=24%  Similarity=0.375  Sum_probs=191.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .++||+|+||.||++.. .++..+|+|.+....       .....+.+.+|+.++++++||||+++++++...+..++|+
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36799999999999986 578899999886421       1223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|..+.        .+++.....++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999999997542        3678888999999999999999   99999999999999999999999999999876443


Q ss_pred             ----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          261 ----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       261 ----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                          ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ....+.......      ..+.+
T Consensus       148 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~------~~~~~  220 (279)
T cd06619         148 SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDE------DPPVL  220 (279)
T ss_pred             ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhcc------CCCCC
Confidence                2357889999999999999999999999999999999999986422111110 011111111000      00111


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .    .......+.+++.+|++.+|++||+++|+++
T Consensus       221 ~----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         221 P----VGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             C----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1    1123345789999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.5e-39  Score=297.30  Aligned_cols=254  Identities=20%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             cccccCccCCeeEEEEEecC-----------------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-----------------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL  163 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  163 (380)
                      ..+.||+|+||.||++...+                 +..||+|.+....       .......+.+|++++++++||||
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-------SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhcCCCCE
Confidence            34679999999999988642                 2458999886421       22345788999999999999999


Q ss_pred             ceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhh-------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCC
Q 047245          164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP  236 (380)
Q Consensus       164 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~  236 (380)
                      +++++++..++..++++||+++++|.+++.....       ....+++..++.++.|++.||+|||   +.+++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccch
Confidence            9999999999999999999999999999975321       1236899999999999999999999   89999999999


Q ss_pred             CcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh--CCCCCCchh
Q 047245          237 TNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT--GRDPTAPFF  306 (380)
Q Consensus       237 ~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t--g~~p~~~~~  306 (380)
                      +||++++++.++|+|||+++....        ...++..|+|||.+.+..++.++||||||+++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999875432        2235678999999988889999999999999999998  666764210


Q ss_pred             hhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          307 AEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       307 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .     ...............      .... ...+...+..+.+++.+|++.||++|||+.|+++.|++
T Consensus       239 ~-----~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         239 D-----QQVIENAGHFFRDDG------RQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             h-----HHHHHHHHhcccccc------cccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            0     000011111100000      0000 01112234568999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-39  Score=291.44  Aligned_cols=236  Identities=21%  Similarity=0.311  Sum_probs=186.9

Q ss_pred             cccCccCCeeEEEEEecCCc-----------EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe
Q 047245          103 RLLGSSPDGKYYRTVLDNGL-----------TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP  171 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  171 (380)
                      +.||+|+||.||+|...+..           .+++|.+....         .....+.+|+.++++++||||+++++++.
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---------RDSLAFFETASLMSQLSHKHLVKLYGVCV   71 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---------hhHHHHHHHHHHHHcCCCcchhheeeEEe
Confidence            46999999999999985433           47777665411         11478889999999999999999999998


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC------
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF------  245 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~------  245 (380)
                      . ...++|+||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++      
T Consensus        72 ~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~  144 (259)
T cd05037          72 R-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYV  144 (259)
T ss_pred             c-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCc
Confidence            8 7789999999999999999742   226889999999999999999999   89999999999999999887      


Q ss_pred             -ceEEeccCCcccCCC--CCcCCCcccCcccccCC--CCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          246 -TPRLADFGLAKLMPG--SLIATSAYSAPECFQNR--SYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       246 -~~kl~Dfgl~~~~~~--~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                       .+||+|||++.....  ...++..|+|||.+.+.  .++.++||||||+++||+++ |..|+....        ...+.
T Consensus       145 ~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~--------~~~~~  216 (259)
T cd05037         145 PFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS--------SSEKE  216 (259)
T ss_pred             eeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC--------chhHH
Confidence             799999999986543  33467789999999876  78999999999999999999 566664310        01111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      ......         .....    .....+.+++.+||..+|++|||+.++++.|+
T Consensus       217 ~~~~~~---------~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         217 RFYQDQ---------HRLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHhcC---------CCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            111100         00001    11256889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-39  Score=291.17  Aligned_cols=241  Identities=22%  Similarity=0.378  Sum_probs=194.8

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..+|+|.+.....         ....+.+|++++++++|||++++++++......++++
T Consensus         8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             EEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            3467999999999999987788999998864211         1246888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          79 EFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            99999999999863   2346889999999999999999999   88999999999999999999999999999875432


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..++..|+|||.+.++.++.++||||||+++||+++ |..||...        .............   ...
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~~~---~~~  221 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR--------SNSEVVETINAGF---RLY  221 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC--------CHHHHHHHHhCCC---CCC
Confidence            2       224568999999998889999999999999999998 89998531        1112222211110   000


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      .        +......+.+++.+||+.+|++|||+.|+++.|.
T Consensus       222 ~--------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 K--------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             C--------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            0        1113456889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-40  Score=310.34  Aligned_cols=242  Identities=21%  Similarity=0.287  Sum_probs=189.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+|+.||+|++....     .........+.+|++++++++||||+++++++.+....++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE-----MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-----HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46799999999999986 578999999986421     112334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999874    346888888999999999999999   99999999999999999999999999999853210


Q ss_pred             -----------------------------------------------------CCcCCCcccCcccccCCCCCCcchhhH
Q 047245          261 -----------------------------------------------------SLIATSAYSAPECFQNRSYTDKSDIFS  287 (380)
Q Consensus       261 -----------------------------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s  287 (380)
                                                                           ...||+.|+|||.+.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence                                                                 134889999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCC---
Q 047245          288 FGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADR---  364 (380)
Q Consensus       288 ~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---  364 (380)
                      |||++|||++|..||...        ...+..........       .+.-. ........+.+++.+|+. +|.+|   
T Consensus       234 lGvil~elltG~~Pf~~~--------~~~~~~~~i~~~~~-------~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r  296 (377)
T cd05629         234 LGAIMFECLIGWPPFCSE--------NSHETYRKIINWRE-------TLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGR  296 (377)
T ss_pred             cchhhhhhhcCCCCCCCC--------CHHHHHHHHHccCC-------ccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence            999999999999998531        11111111111000       00000 001234457789999997 67765   


Q ss_pred             CCHHhHHH
Q 047245          365 PSSDELVP  372 (380)
Q Consensus       365 Ps~~evl~  372 (380)
                      ||+.|+++
T Consensus       297 ~~~~~~l~  304 (377)
T cd05629         297 GGAHEIKS  304 (377)
T ss_pred             CCHHHHhc
Confidence            58888775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-40  Score=280.61  Aligned_cols=249  Identities=23%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      .+++||.|..++|-+... ..|.+.|+|++...............++.-.+|+.+|+++ .||||+.+.++++.+...++
T Consensus        21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl  100 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL  100 (411)
T ss_pred             hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence            467899999999988765 5688999999987665544444566777888999999999 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |+|.|+.|.|.|||..    ...+++..-.+|+.|+.+|++|||   ..+|+||||||+|||+|++.++||+|||.+..+
T Consensus       101 VFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen  101 VFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeecc
Confidence            9999999999999974    557899999999999999999999   999999999999999999999999999999887


Q ss_pred             CCC-----CcCCCcccCcccccC------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          259 PGS-----LIATSAYSAPECFQN------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       259 ~~~-----~~~~~~y~aPE~~~~------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ...     .+|||+|+|||.+..      ..|+...|+||+||++|.|+.|.+||--   ...     .-+.+... .|.
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH---RkQ-----mlMLR~Im-eGk  244 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH---RKQ-----MLMLRMIM-EGK  244 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH---HHH-----HHHHHHHH-hcc
Confidence            643     469999999999853      3578889999999999999999999841   000     00111111 110


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            .... .+.-.+.+..+.+++.+|+++||++|-|++|.+.
T Consensus       245 ------yqF~-speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  245 ------YQFR-SPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ------cccC-CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                  0111 1222456778899999999999999999999874

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-39  Score=303.12  Aligned_cols=258  Identities=23%  Similarity=0.367  Sum_probs=202.0

Q ss_pred             HHHHHHHhccccccCccCCeeEEEEEec--------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCC
Q 047245           92 KTLQAALANENRLLGSSPDGKYYRTVLD--------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRN  162 (380)
Q Consensus        92 ~~l~~~~~~~~~~lg~G~~g~vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n  162 (380)
                      .++........+.||+|+||.||++...        .+..+|+|.+...       ......+.+.+|+++++++ +|||
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~   79 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-------ATDKDLSDLVSEMEMMKMIGKHKN   79 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-------cCHHHHHHHHHHHHHHHhhcCCCC
Confidence            3444444556778999999999999742        2246899987641       1223346788999999999 8999


Q ss_pred             cceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeE
Q 047245          163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL  230 (380)
Q Consensus       163 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ii  230 (380)
                      |+++++++...+..++++||+++|+|.+++.....            ....++|..+..++.|++.||+|||   +.+++
T Consensus        80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~giv  156 (334)
T cd05100          80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCI  156 (334)
T ss_pred             eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence            99999999999999999999999999999975321            1235889999999999999999999   89999


Q ss_pred             ecCCCCCcEEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCC
Q 047245          231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP  301 (380)
Q Consensus       231 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p  301 (380)
                      ||||||+||++++++.+||+|||+++.....        ..++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus       157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  236 (334)
T cd05100         157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  236 (334)
T ss_pred             ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999998755321        123457999999999999999999999999999998 8888


Q ss_pred             CCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          302 TAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       302 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      |...        ...++.........           ...+......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       237 ~~~~--------~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         237 YPGI--------PVEELFKLLKEGHR-----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             CCCC--------CHHHHHHHHHcCCC-----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            7531        12222222211100           0111223456889999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-40  Score=294.00  Aligned_cols=239  Identities=21%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +.+.||+|.||.|-++.- ..|+.||||.++....     .+++..-.+.+||++|+.|+||||+.++.+|++.+...+|
T Consensus        57 ~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-----kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   57 ITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-----KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             HHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-----ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            345699999999999885 6799999999976332     2445567889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||..+|.|.||+..    ...++..+..++..||..|+.|+|   .++++|||||.+|||+|.++++||+|||++..+.
T Consensus       132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999986    457999999999999999999999   9999999999999999999999999999998765


Q ss_pred             C-----CCcCCCcccCcccccCCCCC-CcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G-----SLIATSAYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .     ..+|++-|.+||.+.+.+|. +..|-||+||+||-|+.|..||+.        .+....++++.+.        
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG--------~Dhk~lvrQIs~G--------  268 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG--------RDHKRLVRQISRG--------  268 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC--------chHHHHHHHhhcc--------
Confidence            4     45799999999999999984 789999999999999999999974        2233333333221        


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           ....++.+....-|++|++.+||++|.|..+|..
T Consensus       269 -----aYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  269 -----AYREPETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             -----cccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence                 2222233445667999999999999999998863

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-39  Score=310.58  Aligned_cols=250  Identities=20%  Similarity=0.214  Sum_probs=187.1

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... .++.||+|....              ..+.+|++++++++|+||+++++++..++..++|+
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            457999999999999974 478899996432              34568999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |++. ++|.+++..   ....++|..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       240 e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        240 PKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            9995 699988863   2346999999999999999999999   89999999999999999999999999999876432


Q ss_pred             --------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc-----
Q 047245          261 --------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE-----  327 (380)
Q Consensus       261 --------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~-----  327 (380)
                              ...||..|+|||.+.+..++.++|||||||++|||++|..|+.................+.......     
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence                    2348999999999999999999999999999999999887653211111111111111111110000     


Q ss_pred             -------hhHhhch--------hccCCccc--HHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 -------AREALDR--------SILGEEVE--EDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 -------~~~~~~~--------~~~~~~~~--~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                             .......        ........  ......+.+|+.+||+.||.+|||+.|+++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                   0000000        00000000  012235778999999999999999999986

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-39  Score=302.17  Aligned_cols=234  Identities=23%  Similarity=0.282  Sum_probs=187.4

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .+.||+|+||.||++... ++..+|+|.+.....     ......+.+..|..++..+ +|++|+.+.+++.+.+..++|
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-----IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            467999999999999864 578999999875211     1122335567788888877 689999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        80 ~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          80 MEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             EcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            999999999998864    346889999999999999999999   8999999999999999999999999999987532


Q ss_pred             ------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 ------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                            ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...        ............        
T Consensus       153 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~--------~~~~~~~~i~~~--------  216 (323)
T cd05616         153 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEH--------  216 (323)
T ss_pred             CCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC--------
Confidence                  1235899999999999999999999999999999999999998631        111111111110        


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                       .   ...+......+.+++.+|++.+|++|++.
T Consensus       217 -~---~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 -N---VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -C---CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             0   01112344567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-39  Score=308.71  Aligned_cols=243  Identities=21%  Similarity=0.296  Sum_probs=191.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .++..+|+|.+.....     ........+.+|+.+++.++||||+++++++.+....++|
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          47 VIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            457899999999999987 4688999999864211     1122335678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..     ..++......++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999863     24777888889999999999999   8999999999999999999999999999987643


Q ss_pred             C-------CCcCCCcccCcccccCC----CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          260 G-------SLIATSAYSAPECFQNR----SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~----~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .       ...|++.|+|||.+.+.    .++.++|||||||++|||++|..||...        .............. 
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~~-  264 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIMDHKN-  264 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC--------CHHHHHHHHHcCCC-
Confidence            2       23589999999998653    4788999999999999999999998641        11111111111100 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCC--CCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPAD--RPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~  372 (380)
                            .+.- +.....+..+.+++.+|++.+|.+  |||++|+++
T Consensus       265 ------~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         265 ------SLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ------cCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                  0000 011123556789999999999988  999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.3e-39  Score=301.63  Aligned_cols=235  Identities=25%  Similarity=0.286  Sum_probs=187.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC-CCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-RNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||+|... +++.||+|++.....     ......+.+..|..++..++| ++|+.+.+++.+.+..++
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (324)
T cd05587           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   78 (324)
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence            3467999999999999874 577999999875211     112334677889999999976 568889999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          79 VMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            9999999999998864    346889999999999999999999   899999999999999999999999999998643


Q ss_pred             C--C----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P--G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~--~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .  .    ...|++.|+|||.+.+..++.++||||||+++|||++|+.||...        ............       
T Consensus       152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--------~~~~~~~~i~~~-------  216 (324)
T cd05587         152 IFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--------DEDELFQSIMEH-------  216 (324)
T ss_pred             CCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcC-------
Confidence            2  1    234899999999999999999999999999999999999998631        111111111110       


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                        .   ...+......+.+++.+|++.||.+||+.
T Consensus       217 --~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 --N---VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --C---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              0   01112234557899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.6e-39  Score=295.80  Aligned_cols=238  Identities=22%  Similarity=0.362  Sum_probs=192.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|.. .++..+++|.+.....        .....+.+|+.+++.++|+|++++++.+..+...++|+
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            35699999999999985 5688999999865221        12366889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..     ..+++.++..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        97 e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             cccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            99999999999862     35789999999999999999999   89999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...+++.|+|||.+.+..++.++||||||+++|||++|+.||....        ...+.......+.      +
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~--------~~~~~~~~~~~~~------~  234 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGT------P  234 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--------HHHhHHHHhcCCC------C
Confidence                  2357889999999998889999999999999999999999985311        0111111111000      0


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .   ...+......+.+++.+||..+|++|||+.|+++
T Consensus       235 ~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         235 E---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             C---CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            0   0112234456789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.1e-39  Score=291.16  Aligned_cols=245  Identities=27%  Similarity=0.418  Sum_probs=195.7

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      .+.||+|+||.||+|...+|+.+|+|.+.......  .........+.+|++.+++++|+||+++.+++.+.+..++++|
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV--LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccch--hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence            46799999999999998889999999987532211  1123344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++..... 
T Consensus        83 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          83 FVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999864    346789999999999999999999   89999999999999999999999999999865321 


Q ss_pred             -----------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          261 -----------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       261 -----------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                                 ...++..|+|||.+.+..++.++||||||+++||+++|..||...       .............+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-------~~~~~~~~~~~~~~---  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM-------DRLAAMFYIGAHRG---  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC-------ChHHHHHHhhhccC---
Confidence                       234788899999999888999999999999999999999998531       01111110000000   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        ..+     ..+......+.+++.+||+.+|++||++.++++
T Consensus       226 --~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 --LMP-----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --CCC-----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              001     111224455789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.7e-39  Score=292.31  Aligned_cols=246  Identities=20%  Similarity=0.355  Sum_probs=195.0

Q ss_pred             ccccccCccCCeeEEEEEecC----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          100 NENRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ...+.||+|+||.||+|...+    ...+++|......       .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             eeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            356789999999999998643    2468889876421       13345688999999999999999999999876 45


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          81 VWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCcee
Confidence            7899999999999999974   2345899999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCCC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          256 KLMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       256 ~~~~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      +.....       ..++..|+|||.+....++.++||||||+++||+++ |..||.....        .+..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~~~~  226 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGRIENGER  226 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHcCCc
Confidence            765332       123457999999988889999999999999999996 9999864211        111111111000


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                                 ...+......+.+++.+|+..+|++|||+.++++.|++++
T Consensus       227 -----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         227 -----------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                       0111223456889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.5e-39  Score=294.24  Aligned_cols=240  Identities=22%  Similarity=0.293  Sum_probs=189.5

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+++.+|+|.+.....     ........+.+|++++++++|+|++.+.+.+..++..++++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-----KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL   79 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-----hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence            36799999999999987 4688999999865211     11223356788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++...  ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          80 TIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            999999999988642  2346899999999999999999999   89999999999999999999999999999865432


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...++..|+|||.+.+..++.++|+||||+++||+++|..||......    .....+.......         .
T Consensus       155 ~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~~~~~~~~---------~  221 (285)
T cd05632         155 GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEVDRRVLET---------E  221 (285)
T ss_pred             CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhhcc---------c
Confidence                 235789999999999889999999999999999999999998631000    0001111110000         0


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                         ..........+.+++..|++.||++||++
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05632         222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGC  250 (285)
T ss_pred             ---cccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence               01112234457889999999999999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-39  Score=303.02  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=192.8

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec-
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE-  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  172 (380)
                      ..+.||+|+||.||+|..      .+++.||||.++...       .......+.+|+.++.++ +||||+++++++.. 
T Consensus        11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103          11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             ccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-------ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            557899999999999973      457899999986421       122346788999999999 78999999998865 


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhh-------------------------------------------------------
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRE-------------------------------------------------------  197 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  197 (380)
                      +...++++||+++|+|.++++....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            4567999999999999999874210                                                       


Q ss_pred             --------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC--------C
Q 047245          198 --------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------S  261 (380)
Q Consensus       198 --------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~--------~  261 (380)
                              ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....        .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                    0124788899999999999999999   89999999999999999999999999999876432        1


Q ss_pred             CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCc
Q 047245          262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEE  340 (380)
Q Consensus       262 ~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  340 (380)
                      ..++..|+|||.+.+..++.++||||||+++||+++ |..||.....       ....... ...+..     .     .
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~-~~~~~~-----~-----~  302 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRR-LKEGTR-----M-----R  302 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHHHHH-HhccCC-----C-----C
Confidence            234567999999988899999999999999999997 8888753100       0011111 111100     0     0


Q ss_pred             ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          341 VEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       341 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .+......+.+++..||+.+|++|||+.|+++.|+++
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0111234578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-39  Score=324.55  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=196.0

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|... +|+.||+|++.....     ......+++.+|++++++++||||+++++++.+++..+++|
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            468999999999999864 589999999864211     12344578999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhh-------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          181 DYLQTGSLEDAMDRIRE-------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ||+++|+|.+++.....       .....++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999875321       1234677888999999999999999   8999999999999999999999999999


Q ss_pred             CcccCC------------------------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc
Q 047245          254 LAKLMP------------------------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA  309 (380)
Q Consensus       254 l~~~~~------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~  309 (380)
                      +++...                        +...||+.|+|||.+.+..++.++|||||||++|||++|+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            987541                        1124899999999999999999999999999999999999998531000 


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCC-CHHhHHHHHhcc
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-SSDELVPMLTQL  377 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~l  377 (380)
                             .....    .   ...++... . ...+.+..+.+++.+|++.||++|| +++++.+.|+..
T Consensus       238 -------ki~~~----~---~i~~P~~~-~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        238 -------KISYR----D---VILSPIEV-A-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             -------hhhhh----h---hccChhhc-c-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   00000    0   00000000 0 0112345578899999999999996 567777777653

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.6e-39  Score=292.85  Aligned_cols=236  Identities=25%  Similarity=0.399  Sum_probs=192.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||+|.. .++..||+|.+....       .....+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus        10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642          10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            5699999999999986 457889999876421       12334678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      |+++++|.+++.     ...+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++++|||++......
T Consensus        83 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          83 YLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            999999999886     346889999999999999999999   899999999999999999999999999998765432


Q ss_pred             ------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       262 ------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                            ..++..|+|||.+.+..++.++||||||+++|||++|+.|+......        .+...          +...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~----------~~~~  216 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFL----------IPKN  216 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhh----------hhcC
Confidence                  24678899999999988999999999999999999999997531110        01111          0000


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .. ..........+.+++.+||+.+|++|||+.++++
T Consensus       217 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 SP-PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CC-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            00 0111234456889999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.3e-39  Score=292.23  Aligned_cols=253  Identities=26%  Similarity=0.430  Sum_probs=198.6

Q ss_pred             ccccCccCCeeEEEEEec-----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CC
Q 047245          102 NRLLGSSPDGKYYRTVLD-----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SS  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  174 (380)
                      .+.||+|+||.||++...     ++..+|+|.+.....       ......+.+|++.++.++|+||+++++++..  ..
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            367999999999999863     367999999875221       1345789999999999999999999999877  55


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++++||+++++|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence            78999999999999999974   2336899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC-------CCCHHHH
Q 047245          255 AKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS-------GGSLGRW  318 (380)
Q Consensus       255 ~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~-------~~~l~~~  318 (380)
                      +......         ..++..|++||.+.+..++.++||||||++++||++|..|+.........       ......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            9876521         12455699999998889999999999999999999999987542111100       0001111


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ..          .+..... ...+......+.+++.+||+.+|++|||+.||+++|++++
T Consensus       236 ~~----------~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         236 LE----------LLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HH----------HHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            11          1111110 0111233466889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-40  Score=274.69  Aligned_cols=242  Identities=22%  Similarity=0.354  Sum_probs=201.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .++.||+|-||.||.|.. .++-.||+|++...     +-...+..+++.+|+++-+.|+||||+++++++.+....||+
T Consensus        26 igr~LgkgkFG~vYlarekks~~IvalKVlfKs-----qi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKS-----QILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             ccccccCCccccEeEeeeccCCcEEEEeeeeHH-----HHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            568899999999999996 46778999999752     223445668899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||.++|+|...|..  ....+++......+..|+|.|+.|+|   .++++||||||+|+|++.++..|++|||.+-..+
T Consensus       101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            999999999999984  22446777788889999999999999   9999999999999999999999999999986554


Q ss_pred             C----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .    ..+||..|.+||...+...+.+.|+|++|++.||++.|.+||....        -.+-.+.+..       +|  
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k-------~~--  238 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRK-------VD--  238 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHH-------cc--
Confidence            3    3469999999999999999999999999999999999999996411        1111111111       01  


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         -..+......+.+++.+|+..+|.+|.+..|+++
T Consensus       239 ---~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  239 ---LKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ---ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence               1223456667889999999999999999999875

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.6e-39  Score=291.54  Aligned_cols=239  Identities=21%  Similarity=0.318  Sum_probs=189.9

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||++... ++..+++|.+...        .....+.+.+|+++++.++|||++++++++...+..++|+|
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643          11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTK--------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             hhcccCCCeEEEEEEECCCCeEEEEEEeCCC--------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            56999999999999975 4778888887541        22334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++++|.+++..   ....+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++..... 
T Consensus        83 ~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          83 FCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             ecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            9999999998763   2346899999999999999999999   89999999999999999999999999999875432 


Q ss_pred             -----CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          261 -----SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                           ...++..|+|||.+.     +..++.++|||||||++|||++|..||....        ............    
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~----  224 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSE----  224 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhcC----
Confidence                 234788999999984     3557889999999999999999999986311        011111111000    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        .+..   ..+......+.+++.+||+.+|++|||+.++++
T Consensus       225 --~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 --PPTL---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0000   111223456889999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-38  Score=295.02  Aligned_cols=254  Identities=23%  Similarity=0.355  Sum_probs=193.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|..+|+|.+....       .......+.+|++++.+++||||+++++++.+++..++|
T Consensus         5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             EEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            346799999999999986 467888999876421       123346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      +||+++++|.+++..    ...+++..+..++.|++.||+|||   + .+++|+||+|+||++++++.+||+|||++...
T Consensus        78 ~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          78 MEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             eeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            999999999999974    346889999999999999999999   6 58999999999999999999999999998765


Q ss_pred             CC----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh---------
Q 047245          259 PG----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA---------  325 (380)
Q Consensus       259 ~~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~---------  325 (380)
                      ..    ...++..|+|||.+.+..++.++|+||||+++|||++|+.||......     ....+.......         
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         151 IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESHRP  225 (308)
T ss_pred             cccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCccccccccCCccc
Confidence            32    335788999999998888999999999999999999999998531100     000000000000         


Q ss_pred             -----------cchhHhhchhcc---CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          326 -----------GEAREALDRSIL---GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       326 -----------~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                                 ....+..+....   ...........+.+++.+||+.+|++|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       000000100000   000001134458899999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6e-39  Score=290.66  Aligned_cols=241  Identities=22%  Similarity=0.387  Sum_probs=189.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ...+||+|+||.||+|.. .++..|++|.+...        .....+.+.+|+.++++++|+||+++++++..++..+++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--------DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCC--------CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            346899999999999986 46788999987641        223346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQL--GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~  256 (380)
                      +||+++++|.+++...   ...+  ++..+..++.|++.||+|||   +.+++||||||+||+++. ++.++|+|||++.
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          84 MEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999998742   2234  78888999999999999999   899999999999999986 6799999999987


Q ss_pred             cCCC------CCcCCCcccCcccccCCC--CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPG------SLIATSAYSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~------~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ....      ...++..|+|||.+....  ++.++||||||+++|+|++|..||.....     .....+.....     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~~~-----  227 (268)
T cd06624         158 RLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVGMF-----  227 (268)
T ss_pred             ecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhhhh-----
Confidence            5432      234788999999986644  78899999999999999999999853100     00011100000     


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        ..     ....+......+.+++.+||+.+|++|||+.|+++
T Consensus       228 --~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 --KI-----HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --cc-----CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              00     01122234456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-39  Score=304.13  Aligned_cols=244  Identities=19%  Similarity=0.249  Sum_probs=193.3

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.+|+|++.....     ......+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-----LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            346799999999999986 4688999999975221     1223456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          80 MEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             ECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            9999999999998742   346899999999999999999999   9999999999999999999999999999997654


Q ss_pred             CC-------CcCCCcccCccccc------CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          260 GS-------LIATSAYSAPECFQ------NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       260 ~~-------~~~~~~y~aPE~~~------~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ..       ..+++.|+|||.+.      ...++.++||||||+++|||++|..||...        .............
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~--------~~~~~~~~i~~~~  225 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG--------TSAKTYNNIMNFQ  225 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC--------CHHHHHHHHHcCC
Confidence            22       24889999999986      456789999999999999999999998631        1111122211111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..   +.     -.........+.+++..|++ +|.+|||+++++.
T Consensus       226 ~~---~~-----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         226 RF---LK-----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             Cc---cC-----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            10   00     00011234557789999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.8e-39  Score=296.58  Aligned_cols=235  Identities=22%  Similarity=0.339  Sum_probs=191.5

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ..||+|+||.||.+.- .+|..+|+|+++..     +.......+.+..|-.+|...++|+||+++..+.+.+.+|||||
T Consensus       147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS-----~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKS-----EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             eeeccccceeEEEEEEccCCcEEeeecccHH-----HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            5799999999999986 57999999999762     22344556788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC--
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~--  259 (380)
                      |++||++..+|..    ...|+......++.+++.|++-+|   +.|+|||||||+|+|||..|++||+|||++.-..  
T Consensus       222 ylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  222 YLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             ecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999975    557888888999999999999999   9999999999999999999999999999984110  


Q ss_pred             ------------------------C---------------------------CCcCCCcccCcccccCCCCCCcchhhHH
Q 047245          260 ------------------------G---------------------------SLIATSAYSAPECFQNRSYTDKSDIFSF  288 (380)
Q Consensus       260 ------------------------~---------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~  288 (380)
                                              .                           ..+|||.|+|||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                    0                           0139999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          289 GMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       289 Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                      |||+|||+.|.+||...... .....+..|...+..+               .......+..++|.+|+. ||++|-.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~-~T~rkI~nwr~~l~fP---------------~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQ-ETYRKIVNWRETLKFP---------------EEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhhhccCC---------------CcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999741000 0001122332222211               112234678899999999 9999986

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-38  Score=288.63  Aligned_cols=246  Identities=24%  Similarity=0.421  Sum_probs=196.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCCh-hhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSP-EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ....||+|++|.||+|.. .++..+|+|.+........ ........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            346899999999999986 4678999998875432221 11223345678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ++||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.++..
T Consensus        84 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          84 FLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999974    346788899999999999999999   899999999999999999999999999998765


Q ss_pred             CC------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          259 PG------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       259 ~~------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ..            ...++..|+|||.+.+..++.++|+||||+++|+|++|..||....       .... +....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~-~~~~~---  225 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-------QLQA-IFKIG---  225 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-------HHHH-HHHHh---
Confidence            42            1236778999999998889999999999999999999999986310       0000 00000   


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ....     ...+......+.+++.+||+.+|++||++.|+++
T Consensus       226 ---~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 ---ENAS-----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---ccCC-----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               0011     1122234566889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-39  Score=291.46  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=195.3

Q ss_pred             cccccCccCCeeEEEEEec-CCc----EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGL----TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||.||+|... +|.    .+|+|.+....       .......+.+|+..+++++||||+++++++.. ..
T Consensus        11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057          11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-------SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            3468999999999999863 233    58888876421       13345778899999999999999999999987 78


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+++|+|.+++..   ....+++..++.++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||++
T Consensus        83 ~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             eEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccc
Confidence            8999999999999999873   2345899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCC--------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPGSL--------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~~~--------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +......        .++..|+|||.+....++.++|+||||+++||+++ |..||+..        ...++........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~~~  228 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI--------PAVEIPDLLEKGE  228 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHhCCC
Confidence            7654221        13467999999988889999999999999999999 99998641        1122222211110


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .           ...+......+.+++.+||..+|.+|||+.++++.|+++
T Consensus       229 ~-----------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 R-----------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             C-----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0           011112335578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.5e-39  Score=306.36  Aligned_cols=191  Identities=23%  Similarity=0.348  Sum_probs=166.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+++.+|+|++....     .........+.+|+.++++++||||+++++.+.+.+..++||
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-----VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            46799999999999986 568899999986421     112334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.... 
T Consensus        81 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          81 DYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            99999999999874    345788888999999999999999   8999999999999999999999999999974211 


Q ss_pred             ----------------------------------------------------CCCcCCCcccCcccccCCCCCCcchhhH
Q 047245          260 ----------------------------------------------------GSLIATSAYSAPECFQNRSYTDKSDIFS  287 (380)
Q Consensus       260 ----------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s  287 (380)
                                                                          ....||+.|+|||.+.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence                                                                1124889999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCc
Q 047245          288 FGMILAVLLTGRDPTAP  304 (380)
Q Consensus       288 ~Gvil~el~tg~~p~~~  304 (380)
                      |||++|||++|+.||..
T Consensus       234 lGvil~elltG~~Pf~~  250 (382)
T cd05625         234 VGVILYEMLVGQPPFLA  250 (382)
T ss_pred             chHHHHHHHhCCCCCCC
Confidence            99999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.7e-39  Score=290.54  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=190.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.+|+|++....        ......+.+|+.++++++||||+++++++...+..++|
T Consensus        13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646          13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            346799999999999996 578899999986421        11224677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.++++.    ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++....
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          85 MEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            999999999999864    346889999999999999999999   8999999999999999999999999999987543


Q ss_pred             C------CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 G------SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .      ...++..|+|||.+.   ...++.++||||||+++|||++|+.||........    ...+     .    ..
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~----~~~~-----~----~~  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA----LFLM-----S----KS  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh----heee-----e----cC
Confidence            2      234778899999884   45578899999999999999999999853110000    0000     0    00


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                      .+.+...  .........+.+++.+||+.+|++|||++++++.
T Consensus       225 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         225 NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            0000000  0011234568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.8e-39  Score=287.69  Aligned_cols=241  Identities=22%  Similarity=0.376  Sum_probs=195.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .++..+|+|.+....       .....+.+.+|+.++++++|+||+++.+.+.+++..++++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            46799999999999986 468899999986421       1223467788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..  .....++......++.|++.||.|||   +.+++|+||+|+||++++++.++++|||.+.....
T Consensus        78 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          78 EYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             eeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            99999999998864  22445788999999999999999999   99999999999999999999999999999876543


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...        ........... +..      
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~--------~~~~~~~~~~~-~~~------  217 (255)
T cd08219         153 PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--------SWKNLILKVCQ-GSY------  217 (255)
T ss_pred             cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC--------CHHHHHHHHhc-CCC------
Confidence                  234788899999999888999999999999999999999998631        11111111111 100      


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                          ...+......+.+++.+||+.||++|||+.|++..
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                11112234557899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.1e-39  Score=309.50  Aligned_cols=251  Identities=23%  Similarity=0.314  Sum_probs=184.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||+|.. .+++.||+|++....            ....+|+.+++.++||||+++.+++...      
T Consensus        70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            457899999999999987 468899999885411            2234699999999999999998876332      


Q ss_pred             --CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEe
Q 047245          174 --SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLA  250 (380)
Q Consensus       174 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~  250 (380)
                        ...++||||+++ +|.+++.........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence              246799999975 888887654445667999999999999999999999   89999999999999999664 79999


Q ss_pred             ccCCcccCCC-----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          251 DFGLAKLMPG-----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       251 Dfgl~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      |||+++....     ...+++.|+|||.+.+ ..++.++|||||||++|||++|..||......    ..+.........
T Consensus       214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~  289 (440)
T PTZ00036        214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRIIQVLGT  289 (440)
T ss_pred             ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCC
Confidence            9999986532     2357899999999865 46899999999999999999999998642110    011111110000


Q ss_pred             h---------cchhHhhchhccC----CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          325 A---------GEAREALDRSILG----EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       325 ~---------~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                      .         ....+.--+....    ...+...+..+.+++.+||+.||.+|||+.|++
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            0         0000000000000    001112345688999999999999999999987

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.1e-39  Score=291.08  Aligned_cols=239  Identities=22%  Similarity=0.396  Sum_probs=187.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC------
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES------  173 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  173 (380)
                      .+.||+|+||.||+|.. .+++.+|+|.+....         .....+.+|+.++.++ +|+||+++++++...      
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45799999999999986 467899999986521         1125678899999999 799999999998653      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...+++|||+++|+|.+++...  ....+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence            4689999999999999998742  2346899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC------CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          254 LAKLMPG------SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~~------~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      ++.....      ...++..|+|||.+.     +..++.++||||||+++|||++|..||.....       ...... .
T Consensus       157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~~-~  228 (272)
T cd06637         157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL-I  228 (272)
T ss_pred             CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHH-H
Confidence            9875432      234788899999986     34578899999999999999999999853110       111110 0


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...      .....    ........+.+++.+||+.+|.+|||+.|+++
T Consensus       229 ~~~------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRN------PAPRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcC------CCCCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            000      00111    11123446789999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.7e-39  Score=288.03  Aligned_cols=240  Identities=23%  Similarity=0.415  Sum_probs=193.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++.. ++..+|+|.....          .....+.+|+.++++++|||++++++++... ..++++
T Consensus        10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~   77 (254)
T cd05083          10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM   77 (254)
T ss_pred             eeeeeccCCCCceEeccc-CCCceEEEeecCc----------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence            457899999999999875 6788999988541          1125788999999999999999999998765 479999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..++.++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            999999999999742  2345889999999999999999999   89999999999999999999999999999876443


Q ss_pred             C---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          261 S---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       261 ~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      .   ...+..|+|||.+.+..++.++|+||||+++|||++ |+.||...        ...+....... +         .
T Consensus       153 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~~~~~~~~-~---------~  214 (254)
T cd05083         153 GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--------SLKEVKECVEK-G---------Y  214 (254)
T ss_pred             cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC--------CHHHHHHHHhC-C---------C
Confidence            2   234567999999998899999999999999999998 89888531        11222211111 1         0


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      . .......+..+.+++.+||+.+|++||+++++++.|++
T Consensus       215 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 R-MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             C-CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            0 01112344567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-38  Score=288.04  Aligned_cols=237  Identities=24%  Similarity=0.385  Sum_probs=194.5

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|... ++..||+|.+....       .......+.+|+.++++++||||+++++++.++...++||
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            356999999999999874 58899999886421       1233478889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++.     ...+++.....++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          82 EYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            9999999999886     235888999999999999999999   89999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .      ..++..|+|||.+.+..++.++|+||||+++|||++|..||.....        .....          .+..
T Consensus       154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--------~~~~~----------~~~~  215 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--------MRVLF----------LIPK  215 (277)
T ss_pred             CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh--------HhHhh----------hhhc
Confidence            2      2467789999999988899999999999999999999999863110        00000          0000


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      . ............+.+++.+||+.+|++||+++++++
T Consensus       216 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06640         216 N-NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK  252 (277)
T ss_pred             C-CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence            0 011223345677889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-38  Score=297.17  Aligned_cols=192  Identities=22%  Similarity=0.293  Sum_probs=162.4

Q ss_pred             ccccCcc--CCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          102 NRLLGSS--PDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       102 ~~~lg~G--~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      .++||+|  +||+||++.. .+|+.||+|++.....      .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l   76 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV   76 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEE
Confidence            3579999  6789999986 5789999999865221      22334677889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |+||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.....
T Consensus        77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            99999999999998642  2335899999999999999999999   899999999999999999999999999865332


Q ss_pred             C-------------CCCcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          259 P-------------GSLIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       259 ~-------------~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      .             ....++..|+|||.+.+  ..++.++||||||+++|||++|..||..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            1             11235667999999976  4688999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.8e-39  Score=299.22  Aligned_cols=236  Identities=22%  Similarity=0.271  Sum_probs=188.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ......+.+..|..++..+. |++|+++.+++.+.+..++
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l   78 (323)
T cd05615           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-----IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF   78 (323)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence            457899999999999986 4688999999875211     11223456778889998885 5778889999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        79 v~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          79 VMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence            9999999999998864    346899999999999999999999   899999999999999999999999999998753


Q ss_pred             CC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..      ...|++.|+|||.+.+..++.++||||||+++|||++|..||...        ............       
T Consensus       152 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~--------~~~~~~~~i~~~-------  216 (323)
T cd05615         152 MVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE--------DEDELFQSIMEH-------  216 (323)
T ss_pred             CCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC-------
Confidence            21      234899999999999999999999999999999999999998642        111111111110       


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD  368 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  368 (380)
                        ..   ..+......+.+++.+|++.+|.+|++..
T Consensus       217 --~~---~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         217 --NV---SYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             --CC---CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence              00   11122345678899999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-38  Score=290.56  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=197.1

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|..+|+|++....       .....+.+.+|+++++.++||||+++++++...+..++|+
T Consensus        10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620          10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            467999999999999864 68899999886521       1233578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++.....++.+++.||.|||+  ..+++||||+|+||++++++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            99999999998864    3468999999999999999999993  25899999999999999999999999999875432


Q ss_pred             ----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCC---CHHHHHHHHHhhcchhHhhc
Q 047245          261 ----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG---SLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       261 ----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~---~l~~~~~~~~~~~~~~~~~~  333 (380)
                          ...++..|+|||.+.+..++.++|+||||+++||+++|..||...........   .+.++........      .
T Consensus       157 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence                23578899999999888999999999999999999999999974322111000   1111221111100      0


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML  374 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L  374 (380)
                      +    ..........+.+++.+|++.||++|||++|+++..
T Consensus       231 ~----~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 P----RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             C----CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0    011122445688999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-38  Score=286.81  Aligned_cols=243  Identities=22%  Similarity=0.399  Sum_probs=189.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  177 (380)
                      ..+.||+|+||.||++.. .+|..+++|++.......   ........+.+|+.++++++||||+++++++.+  ....+
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP---ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc---hhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            356899999999999986 468899999886532111   122345678899999999999999999998865  35789


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +++||+++++|.+++..    ...+++...+.++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||+++.
T Consensus        83 l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          83 IFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            99999999999999874    335889999999999999999999   89999999999999999999999999999875


Q ss_pred             CCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          258 MPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       258 ~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ...         ...++..|+|||.+.+..++.++||||||+++||+++|+.||...       ..... ........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~-------~~~~~-~~~~~~~~--  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY-------EAMAA-IFKIATQP--  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc-------chHHH-HHHHhcCC--
Confidence            432         123778899999999988999999999999999999999998631       00111 11111000  


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                              .....+......+.+++ .||..+|++||+++|+++
T Consensus       226 --------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 --------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                    01111222334455565 788899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-38  Score=291.66  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=193.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .++||+|+||.||++.. .+++.+|+|.+......     .......+.+|+.++++++|+|++.+.+.+.+.+..++||
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-----KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-----chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            46799999999999886 46889999998652211     1223356778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++.....
T Consensus        80 e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05630          80 TLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  154 (285)
T ss_pred             EecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence            999999999998642  2345889999999999999999999   89999999999999999999999999999876542


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...|+..|+|||.+.+..++.++||||||+++|||++|..||.....    ....... ......      ... 
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~----~~~~~~~-~~~~~~------~~~-  222 (285)
T cd05630         155 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEV-ERLVKE------VQE-  222 (285)
T ss_pred             CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc----cchHHHH-Hhhhhh------hhh-
Confidence                 23578999999999999999999999999999999999999864110    0000000 000000      000 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                          .........+.+++..||+.||++|||     ++|+++
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 ----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                011223445789999999999999999     778775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-39  Score=308.24  Aligned_cols=242  Identities=19%  Similarity=0.266  Sum_probs=187.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+++.+|+|.+....     .........+.+|+.++++++|+||+++++.+.+++..++||
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD-----VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH-----HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            46799999999999986 468899999986421     111223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.... 
T Consensus        81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999999874    345788888899999999999999   8999999999999999999999999999974221 


Q ss_pred             ------------------------------------------------CCCcCCCcccCcccccCCCCCCcchhhHHHHH
Q 047245          260 ------------------------------------------------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMI  291 (380)
Q Consensus       260 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvi  291 (380)
                                                                      ....||+.|+|||.+.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence                                                            01258899999999999999999999999999


Q ss_pred             HHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCC---CHH
Q 047245          292 LAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP---SSD  368 (380)
Q Consensus       292 l~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---s~~  368 (380)
                      +|||++|+.||....        ..++.........       ... ..........+.+++.+|+ .+|.+|+   |+.
T Consensus       234 lyell~G~~Pf~~~~--------~~~~~~~i~~~~~-------~~~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~  296 (376)
T cd05598         234 LYEMLVGQPPFLADT--------PAETQLKVINWET-------TLH-IPSQAKLSREASDLILRLC-CGAEDRLGKNGAD  296 (376)
T ss_pred             eeehhhCCCCCCCCC--------HHHHHHHHhccCc-------ccc-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence            999999999986421        1111111111000       000 0000112344566777765 4999999   778


Q ss_pred             hHHH
Q 047245          369 ELVP  372 (380)
Q Consensus       369 evl~  372 (380)
                      |+++
T Consensus       297 ell~  300 (376)
T cd05598         297 EIKA  300 (376)
T ss_pred             HHhC
Confidence            8763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=9.2e-39  Score=290.46  Aligned_cols=247  Identities=22%  Similarity=0.377  Sum_probs=194.7

Q ss_pred             ccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          102 NRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ...||+|+||.||++...      +...+++|.+...       ........+.+|++++++++|+||+++++++.+.+.
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-------KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-------cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            357999999999999863      3467899987541       122345778999999999999999999999999899


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 047245          176 FYLVYDYLQTGSLEDAMDRIREN-----QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA  250 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  250 (380)
                      .++|+||+++|+|.+++......     ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999999753321     126899999999999999999999   8999999999999999999999999


Q ss_pred             ccCCcccCCC-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHH
Q 047245          251 DFGLAKLMPG-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       251 Dfgl~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      |||++.....       ...++..|+|||.+.+..++.++||||||+++|++++ |..||....        ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--------~~~~~~~~  231 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------DEEVLNRL  231 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--------hHHHHHHH
Confidence            9999864322       2235667999999988889999999999999999999 778874310        11111111


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .. +...         ..........+.+++.+||+.+|++|||+.|+++.|.+
T Consensus       232 ~~-~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         232 QA-GKLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             Hc-CCcC---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            10 1100         00111234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.6e-38  Score=300.05  Aligned_cols=188  Identities=27%  Similarity=0.443  Sum_probs=160.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++.. .+|..||+|++....      ........+.+|+.+++.++||||+++++++...      
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF------QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             EEEEeecCCCEEEEEEEEcCCCceeEEEEecccc------cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            356899999999999986 468899999986421      1223346778999999999999999999998644      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++ +|.+.++.      .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCC
Confidence            357999999975 67666642      4788888999999999999999   9999999999999999999999999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      +++....     ...+++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         169 LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             CccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            9975432     23578899999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-38  Score=286.14  Aligned_cols=243  Identities=25%  Similarity=0.392  Sum_probs=195.7

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|... ++..|++|.+.......   ..+...+.+.+|++++++++|+||+++.+++.++...++++
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc---cchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            467999999999999986 78999999987532211   12344578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          82 ELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999874    345889999999999999999999   89999999999999999999999999999875432


Q ss_pred             -----CCcCCCcccCcccccCCC-CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 -----SLIATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                           ...++..|++||.+.... ++.++|+||||+++|++++|..||....        .............       
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~-------  219 (258)
T cd06632         155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKE-------  219 (258)
T ss_pred             cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhccc-------
Confidence                 234788899999987766 8999999999999999999999986421        0111111111000       


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ....+......+.+++.+||+.+|++||++.++++
T Consensus       220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               01111223455788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.5e-38  Score=290.30  Aligned_cols=240  Identities=24%  Similarity=0.319  Sum_probs=190.8

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|... ++..+++|.+...        .....+.+.+|+..+++++||||+++++.+...+..++||
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hheecCCCCeEEEEEEECCCCceEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            356999999999999874 5889999998641        2334577889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|..++..   ....+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          89 EFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             ecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999888753   2346899999999999999999999   89999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          261 ------SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                            ...++..|+|||.+.     ...++.++||||||+++|||++|..||....        ............   
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~---  231 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSE---  231 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHHhcCC---
Confidence                  224778899999984     3457889999999999999999999985310        011111111100   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .+.   ...+......+.+++.+||+.+|++||+++++++
T Consensus       232 ---~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 ---PPT---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---Ccc---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               000   0111233456789999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-38  Score=285.01  Aligned_cols=241  Identities=22%  Similarity=0.388  Sum_probs=196.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.+|++.. .+|+.+|+|++.....      .....+++.+|+.++++++||||+++.+++.+.+..++|+
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM------SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC------ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            46799999999999886 4688999999875221      1223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..  .....+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          79 DYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             ecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            99999999999874  22346789999999999999999999   89999999999999999999999999999976543


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .      ..+++.|+|||.+.+..++.++|+||||++++++++|..||...        ...+.........        
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~~--------  217 (256)
T cd08218         154 TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------NMKNLVLKIIRGS--------  217 (256)
T ss_pred             chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------CHHHHHHHHhcCC--------
Confidence            2      34788899999999889999999999999999999999998531        1122222211110        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .  ...+......+.+++.+||+.+|++||++.+|++
T Consensus       218 -~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 -Y--PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -C--CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             0  1112234556889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4e-39  Score=304.81  Aligned_cols=243  Identities=21%  Similarity=0.290  Sum_probs=188.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.+|+|.+.....     ........+.+|+.+++.++||||+++++++.+....++|
T Consensus        47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            4567999999999999974 578999999864211     1122335678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..     ..+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         122 MEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999863     35788889999999999999999   8999999999999999999999999999997653


Q ss_pred             C-------CCcCCCcccCcccccCCC----CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          260 G-------SLIATSAYSAPECFQNRS----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~~----~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .       ...||+.|+|||.+.+..    ++.++||||+||++|||++|..||...        .............. 
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~--------~~~~~~~~i~~~~~-  264 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD--------SLVGTYSKIMDHKN-  264 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCc-
Confidence            2       235899999999987543    788999999999999999999998631        11111111111110 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCC--CCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPAD--RPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~  372 (380)
                            .+. -+........+.+++..|+..+|.+  |||++|+++
T Consensus       265 ------~~~-~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         265 ------SLN-FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             ------ccC-CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence                  000 0011123455778888888755543  889998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.6e-38  Score=292.63  Aligned_cols=190  Identities=27%  Similarity=0.450  Sum_probs=157.0

Q ss_pred             cccccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  175 (380)
                      ..+.||+|+||.||++...   ++..+|+|.+.....          ...+.+|+.++++++||||+++++++..  +..
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07868           5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRK   74 (317)
T ss_pred             cccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcE
Confidence            3568999999999999864   567899998864211          1446789999999999999999998854  456


Q ss_pred             EEEEEeecCCCCHHHHHHHhhh-----cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe----CCCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRE-----NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFT  246 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~  246 (380)
                      .++++||++ ++|.+++.....     ....+++..+..++.|++.||+|||   +.+++||||||+|||+    +.++.
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~  150 (317)
T cd07868          75 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR  150 (317)
T ss_pred             EEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCc
Confidence            899999986 488888764221     1235888999999999999999999   8999999999999999    45678


Q ss_pred             eEEeccCCcccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          247 PRLADFGLAKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      +||+|||+++....         ...+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             EEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            99999999976532         2347889999999876 4589999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-38  Score=285.40  Aligned_cols=238  Identities=24%  Similarity=0.386  Sum_probs=194.1

Q ss_pred             ccccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++...+ +..+++|.+...          .....+.+|++.+++++|+||+++++++.+....++++
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            4679999999999999864 789999998641          11478899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            99999999999863   2457899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .      ..++..|+|||.+.+..++.++||||||+++|||++|+.||.......       ... ... .     ....
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~~-~~~-~-----~~~~  217 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AIF-MIP-N-----KPPP  217 (256)
T ss_pred             CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hhh-hhc-c-----CCCC
Confidence            2      237788999999998899999999999999999999999986321100       000 000 0     0000


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ....+......+.+++.+||+.||++|||+.|+++
T Consensus       218 ---~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 ---TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence               00111233456889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.9e-39  Score=279.15  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=192.6

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  179 (380)
                      +.|++|+||.||+|.. .+++.||+|+++......      ..--.-.+||.+|.+.+|||||.+-.+...  -+..|+|
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~------GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE------GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccC------CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            5699999999999996 568899999998743222      222456789999999999999999888654  3579999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||||++ +|.+.++..   ..++...+..-+..|+++|++|||   ..-|+|||||++|+|++..|.+||+|||+||.++
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999988 999999853   357888999999999999999999   8999999999999999999999999999999887


Q ss_pred             CC------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          260 GS------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      +.      .+-|..|.|||.+.+. .|+...|+||+|||+.|++++++-|..    .++.+++...++.+   |...+.+
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G----~sE~dQl~~If~ll---GtPte~i  301 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG----KSEIDQLDKIFKLL---GTPSEAI  301 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC----CchHHHHHHHHHHh---CCCcccc
Confidence            65      3478899999999874 589999999999999999999987753    12112222221111   1111111


Q ss_pred             chhcc------------------CCccc-HHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSIL------------------GEEVE-EDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~------------------~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      -+...                  ...+. ......-++++...+..||.+|-|++|.++
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            11110                  00000 013356789999999999999999998764

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-38  Score=293.34  Aligned_cols=238  Identities=22%  Similarity=0.384  Sum_probs=192.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||.|++|.||++.. .+|+.|++|.+....        ....+.+.+|+..++.++|||++++++++......++|+
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--------QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--------CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            45799999999999985 578999999986421        112366789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..     ..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          96 EYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            99999999998862     35899999999999999999999   89999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...++..|+|||.+.+..++.++||||||+++|++++|..||....        ............      .+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~--------~~~~~~~~~~~~------~~  233 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN--------PLRALYLIATNG------TP  233 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcC------Cc
Confidence                  2347788999999998889999999999999999999999986311        111111111100      00


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+   ..+......+.+++.+||..+|++|||+.+++.
T Consensus       234 ~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         234 EL---QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cc---CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            00   111223455788999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.7e-38  Score=284.31  Aligned_cols=242  Identities=22%  Similarity=0.335  Sum_probs=196.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||.|+||.||.+.. .++..+++|.+.....      .......+.+|++++++++|+||+++++++.+.+..+++|
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL------SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeeccc------chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            46899999999988775 4688999999865321      2233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          79 EYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            999999999998742  2456899999999999999999999   89999999999999999999999999999876533


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        ...+.........        
T Consensus       154 ~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~~~--------  217 (256)
T cd08221         154 EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--------NPLNLVVKIVQGN--------  217 (256)
T ss_pred             ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCC--------
Confidence                  235788999999998888999999999999999999999998531        1122222221110        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                       .  ..........+.+++.+||+.+|.+|||+.++++.
T Consensus       218 -~--~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         218 -Y--TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -C--CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             0  01112344568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-38  Score=300.04  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=187.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++.. ..+..+|+|++....      ........+.+|+.+++.++||||+++++++...      
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc------cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            346799999999999986 468899999986421      1223346778899999999999999999987543      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++ +|.+++..      .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCc
Confidence            357999999965 77776642      4788889999999999999999   9999999999999999999999999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc--
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG--  326 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~--  326 (380)
                      +++....     ...+++.|+|||.+.+..++.++||||||+++|||++|+.||....       ....|.......+  
T Consensus       165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~  237 (355)
T cd07874         165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-------YIDQWNKVIEQLGTP  237 (355)
T ss_pred             ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCC
Confidence            9986543     2358899999999999999999999999999999999999986311       0111110000000  


Q ss_pred             ----------chhHhhc----------h-----hccC--CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 ----------EAREALD----------R-----SILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ----------~~~~~~~----------~-----~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                .....++          +     ....  ..........+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                      0000000          0     0000  0011123456789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-39  Score=306.08  Aligned_cols=233  Identities=24%  Similarity=0.317  Sum_probs=195.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      +..+||+|.||.|+.+.. .+++.+|||+++....-     ..+..+....|-.++... +||.+++++.++...++.+.
T Consensus       372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il-----~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL-----QRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             EEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee-----ccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            457899999999999997 46889999999874332     223346677788887777 69999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+.||++..+.+     ...++.....-+++.|+.||+|||   +++||+||||.+|||+|.+|++||+|||+++..
T Consensus       447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999544333     457899999999999999999999   999999999999999999999999999999864


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      +...||+.|||||++.++.|+.+.|.|||||+||||+.|..||...                     .-.+.+
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---------------------dEee~F  577 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---------------------DEEEVF  577 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---------------------CHHHHH
Confidence            3      2456999999999999999999999999999999999999999631                     113344


Q ss_pred             chhccCC-cccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          333 DRSILGE-EVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       333 ~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                      |..+..+ .++...+.+...++.+.+..+|++|-.+
T Consensus       578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            4444333 3455677888999999999999999877

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-40  Score=309.51  Aligned_cols=241  Identities=24%  Similarity=0.423  Sum_probs=197.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..-+||+|.||+||.|.. ++...+|||.+...        +....+-+..||.+-++|+|.|||+++|.|.+++.+-+.
T Consensus       579 ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--------dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIF  650 (1226)
T KOG4279|consen  579 ERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--------DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIF  650 (1226)
T ss_pred             ceEEeecCceeEEEeeccccceeEEEeeecccc--------cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEE
Confidence            334799999999999996 45668999988652        223346678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQL--GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~  256 (380)
                      ||.++||||.+.|+.   .-+++  .+...--+..||++||.|||   ++.|||||||-.|||++. .|.+||+|||.++
T Consensus       651 MEqVPGGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsK  724 (1226)
T KOG4279|consen  651 MEQVPGGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSK  724 (1226)
T ss_pred             eecCCCCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccch
Confidence            999999999999974   23344  66777788999999999999   999999999999999976 6899999999998


Q ss_pred             cCC------CCCcCCCcccCcccccCCC--CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMP------GSLIATSAYSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~------~~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .+.      +...||..|||||++..++  |..++|||||||++.||-||++||.......      ..+.+        
T Consensus       725 RLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFk--------  790 (1226)
T KOG4279|consen  725 RLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFK--------  790 (1226)
T ss_pred             hhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhhhh--------
Confidence            764      3456999999999997654  7889999999999999999999986421110      00000        


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         +.--...++.+.+...+...++.+|+.++|.+||+++++++
T Consensus       791 ---VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  791 ---VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ---hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence               00111234667888999999999999999999999999975

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=288.05  Aligned_cols=238  Identities=25%  Similarity=0.396  Sum_probs=192.8

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||.|++|.||+|... +++.+|+|.+....       .......+.+|+++++.++|+|++++.+++.++...++|+
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            356999999999999964 68899999986521       1222356789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..     ..+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||+++....
T Consensus        79 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          79 EYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            99999999999873     27899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .      ..++..|+|||.+.+..++.++||||||+++|||++|..||....        .......... .     ..+
T Consensus       151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--------~~~~~~~~~~-~-----~~~  216 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--------PMRVLFLIPK-N-----NPP  216 (274)
T ss_pred             cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--------hHHHHHHhhh-c-----CCC
Confidence            2      347778999999999889999999999999999999999985311        0111111110 0     011


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+. .   ......+.+++.+||+.+|++|||++++++
T Consensus       217 ~~~-~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 SLE-G---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCc-c---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            110 0   113445788999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.5e-38  Score=284.46  Aligned_cols=246  Identities=23%  Similarity=0.387  Sum_probs=198.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CCeEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SSRFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  178 (380)
                      .+.||.|+||.||++.. .+|..+|+|.+.....      .....+.+..|++++++++|+||+++++++..  +...++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM------TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             eeeeccCCCeEEEEeeecCCCCEEEEEEEecccC------CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            35799999999999986 4678999998865221      23334678899999999999999999998753  456899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC--NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||+++++|.+++.........+++..++.++.|++.||+|||..+  +.+++|+||+|+||++++++.+||+|||++.
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence            99999999999999865555668999999999999999999999554  6789999999999999999999999999988


Q ss_pred             cCCCC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          257 LMPGS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       257 ~~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .....      ..++..|+|||.+.+..++.++|+||||+++++|++|..||...        ........... +    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~-~----  225 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR--------NQLQLASKIKE-G----  225 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc--------CHHHHHHHHhc-C----
Confidence            65432      34788999999999888999999999999999999999998641        11111111111 1    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           .. ...+......+.+++.+|++.+|++|||+.+|++
T Consensus       226 -----~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 -----KF-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             -----CC-CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                 00 1122334567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-38  Score=285.11  Aligned_cols=245  Identities=31%  Similarity=0.493  Sum_probs=192.5

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||+||++... +++.+|+|.+....      ..........+|+..+++++||||+++++++.+....+++|
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~   77 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM   77 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhccccccccccccccccccccccccccc
Confidence            468999999999999975 45689999997621      12222334456999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++++|.+++..    ...+++..++.++.|+++||++||   +.+++|+||||+||++++++.++|+|||.+.... 
T Consensus        78 ~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   78 EYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             cccccccccccccc----cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999999972    456899999999999999999999   8899999999999999999999999999987421 


Q ss_pred             -----CCCcCCCcccCccccc-CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 -----GSLIATSAYSAPECFQ-NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                           ....++..|+|||.+. +..++.++||||+|+++++|++|..||......     ............     .+.
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~-----~~~  220 (260)
T PF00069_consen  151 NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-----DQLEIIEKILKR-----PLP  220 (260)
T ss_dssp             TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-----HHHHHHHHHHHT-----HHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccch-----hhhhhhhhcccc-----ccc
Confidence                 2345788999999998 888999999999999999999999998642000     000111111000     000


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...   .........+.+++..||+.||++|||+.++++
T Consensus       221 ~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 SSS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   000011267899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.7e-39  Score=303.70  Aligned_cols=254  Identities=25%  Similarity=0.349  Sum_probs=189.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----e
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----R  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  175 (380)
                      .+.||+|+||.||++.. .+|+.||+|++....      ......+.+.+|+.+++.++|+||+++++++...+     .
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccc------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            46799999999999986 578999999986421      11223467889999999999999999999998766     7


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+. ++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        79 ~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccce
Confidence            899999996 588887753    456899999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCC-------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHH
Q 047245          256 KLMPG-------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWL  319 (380)
Q Consensus       256 ~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~  319 (380)
                      +....       ...+++.|+|||.+.+. .++.++|||||||++|||++|+.||........        .......+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            75432       23468889999998874 478999999999999999999999864211100        000111111


Q ss_pred             HHHHhhcchhHhhchhccCC-------cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          320 RHLQHAGEAREALDRSILGE-------EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....   .....+.......       .........+.+++.+|++.||++|||+.|+++
T Consensus       231 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         231 SACE---GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HhhH---HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            1000   0000000000000       001112456789999999999999999999985

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-38  Score=320.67  Aligned_cols=246  Identities=20%  Similarity=0.330  Sum_probs=191.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  177 (380)
                      ..+.||+|+||.||++.. .++..+|+|.+.....      .......+..|+.++++++||||+++++++.+  ...++
T Consensus        17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l------~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL------KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             EEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc------CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            456799999999999986 4577899998865221      22345778899999999999999999998754  45789


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC----CCCeEecCCCCCcEEeCC----------
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC----NPQILHYNLKPTNVMLDA----------  243 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----~~~iiH~dlk~~Nill~~----------  243 (380)
                      +||||+++|+|.+++.........+++..++.|+.||+.||+|||...    ..+|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999999864444567999999999999999999999322    146999999999999964          


Q ss_pred             -------CCceEEeccCCcccCCC-----CCcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc
Q 047245          244 -------EFTPRLADFGLAKLMPG-----SLIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA  309 (380)
Q Consensus       244 -------~~~~kl~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~  309 (380)
                             ...+||+|||++.....     ...+|+.|+|||.+.+  ..++.++|||||||++|||++|..||...    
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~----  246 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA----  246 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC----
Confidence                   24589999999976542     3458999999999854  45889999999999999999999998531    


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                         ..............        .+.    .......+.+|+..||+.+|.+||++.+++
T Consensus       247 ---~~~~qli~~lk~~p--------~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL  293 (1021)
T PTZ00266        247 ---NNFSQLISELKRGP--------DLP----IKGKSKELNILIKNLLNLSAKERPSALQCL  293 (1021)
T ss_pred             ---CcHHHHHHHHhcCC--------CCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence               11222222211110        000    012345688999999999999999999998

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-38  Score=294.30  Aligned_cols=190  Identities=26%  Similarity=0.460  Sum_probs=156.6

Q ss_pred             cccccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe--cCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP--ESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  175 (380)
                      .+..||+|+||.||++...   ++..+|+|.+....          ....+.+|+.++++++||||+++++++.  ....
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   74 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----------ISMSACREIALLRELKHPNVIALQKVFLSHSDRK   74 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCe
Confidence            3467999999999999864   45789999886421          1145678999999999999999999884  3567


Q ss_pred             EEEEEeecCCCCHHHHHHHhhh-----cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe----CCCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRE-----NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFT  246 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~  246 (380)
                      .++|+||+++ +|.+++.....     ....+++..+..++.|++.||+|||   +.+++||||||+||++    +.++.
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  150 (317)
T cd07867          75 VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR  150 (317)
T ss_pred             EEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCc
Confidence            8999999865 88888753211     1235889999999999999999999   8999999999999999    45679


Q ss_pred             eEEeccCCcccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          247 PRLADFGLAKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      +||+|||+++....         ...+++.|+|||.+.+ ..++.++||||||+++|||++|..||..
T Consensus       151 ~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         151 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             EEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            99999999976532         1247889999999876 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.9e-39  Score=284.85  Aligned_cols=260  Identities=24%  Similarity=0.330  Sum_probs=192.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCC-cceeeEEEecCC------
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN-LMSLRAYVPESS------  174 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  174 (380)
                      +.||+|+||+||+|+. .+|+.||+|++......      +..-....+|+.++++++|+| |+++.+++...+      
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4599999999999996 57899999999874331      112245678999999999999 999999998877      


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      .+++|+||++. +|..|+.........++...+..+..|++.||+|||   +++|+||||||.|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            88999999976 999999864432235666889999999999999999   99999999999999999999999999999


Q ss_pred             cccCCC------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHH
Q 047245          255 AKLMPG------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWL  319 (380)
Q Consensus       255 ~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~  319 (380)
                      ++...-      ..++|..|.|||++.+. .|+...||||+|||+.||++++.-|....+...        .......|.
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            986542      23478899999999886 799999999999999999999888764222100        000111121


Q ss_pred             HHHHhhcchhHhhchhccCCcccHH---HHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          320 RHLQHAGEAREALDRSILGEEVEED---EMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                      .....+..-....... ........   ......+++.+|++.+|.+|.|++..++.
T Consensus       247 ~v~~~~~~k~~f~~~~-~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWP-GPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccccccccccCcCCC-CccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1110000000000000 00001011   11357899999999999999999998864

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.8e-38  Score=292.07  Aligned_cols=238  Identities=21%  Similarity=0.359  Sum_probs=192.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++.. .+|+.||+|.+....        ....+.+.+|+.+++.++|+||+++++++..+...++|+
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--------cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            46799999999999996 578999999986421        112356788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..     ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            99999999999862     35788999999999999999999   89999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...+++.|+|||.+.+..++.++|+||||+++|++++|..||.......       . .......+      .+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~-~~~~~~~~------~~  233 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------A-LYLIATNG------TP  233 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------h-eeeeccCC------CC
Confidence                  2347888999999999889999999999999999999999985311000       0 00000000      00


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .   ...+......+.+++.+||+.+|++||++.++++
T Consensus       234 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 E---LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   0111233455788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-38  Score=293.36  Aligned_cols=243  Identities=24%  Similarity=0.407  Sum_probs=190.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCc----EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGL----TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||+|+||.||+|.. .+|.    .+|+|.+....       .......+.+|+.++++++||||++++++|... ..
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-------GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            46799999999999986 3444    46888775411       122335688999999999999999999998754 46


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++++||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccc
Confidence            799999999999999873   2346889999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          257 LMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       257 ~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      .....        ..++..|+|||.+.+..++.++||||||+++||+++ |..||...        ......... ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~--------~~~~~~~~~-~~~~  228 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPDLL-EKGE  228 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-HCCC
Confidence            65421        124568999999998999999999999999999998 88998531        111111111 1110


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                             ..   ..+......+.+++..||..+|++||+++++++.|+++
T Consensus       229 -------~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         229 -------RL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             -------CC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   00   01112345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.9e-39  Score=303.72  Aligned_cols=191  Identities=23%  Similarity=0.373  Sum_probs=167.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+++.+|+|++....     .........+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-----MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46799999999999987 468899999997421     112334567888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999874    346889999999999999999999   99999999999999999999999999999864321


Q ss_pred             -----------------------------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCC
Q 047245          261 -----------------------------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR  299 (380)
Q Consensus       261 -----------------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~  299 (380)
                                                               ...||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence                                                     135889999999999999999999999999999999999


Q ss_pred             CCCCc
Q 047245          300 DPTAP  304 (380)
Q Consensus       300 ~p~~~  304 (380)
                      .||..
T Consensus       234 ~Pf~~  238 (360)
T cd05627         234 PPFCS  238 (360)
T ss_pred             CCCCC
Confidence            99863

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.8e-38  Score=281.01  Aligned_cols=242  Identities=23%  Similarity=0.381  Sum_probs=194.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-CCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-SSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  178 (380)
                      ..+.||+|++|.||++... +++.+|+|++....      ......+.+.+|++++++++|+|++++.+.+.. ....++
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (257)
T cd08223           4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN------ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI   77 (257)
T ss_pred             EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh------cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence            3467999999999999864 57889999986522      122334678899999999999999999988764 446799


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      +|||+++++|.+++..  .....+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++...
T Consensus        78 v~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          78 VMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            9999999999999974  22446899999999999999999999   899999999999999999999999999998755


Q ss_pred             CC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..      ...+++.|+|||.+.+..++.++||||||++++|+++|+.||...        ....+...... +..    
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--------~~~~~~~~~~~-~~~----  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--------DMNSLVYRIIE-GKL----  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHh-cCC----
Confidence            32      234788999999999999999999999999999999999998531        12222222111 110    


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ...+......+.+++.+|++.+|++|||+.++++
T Consensus       220 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  0112334566889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6e-38  Score=283.63  Aligned_cols=243  Identities=22%  Similarity=0.355  Sum_probs=190.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  177 (380)
                      ..++||+|+||.||++.. .+|..||+|.+.......   ......+.+.+|++++++++||||+++++++.+.  ...+
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP---ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc---ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            357899999999999987 458999999886422111   1223457888999999999999999999988663  4678


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +++||+++++|.+++..    ...+++....+++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||+++.
T Consensus        83 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          83 IFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            99999999999999864    335788889999999999999999   89999999999999999999999999999875


Q ss_pred             CCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          258 MPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       258 ~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ...         ...++..|+|||.+.+..++.++||||||+++|||++|+.||...       ...... .....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-------~~~~~~-~~~~~----  223 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-------EAMAAI-FKIAT----  223 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-------chHHHH-HHHhc----
Confidence            431         134778899999999888999999999999999999999998531       001110 00000    


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           .. .....+......+.+++.+|+. +|.+||+++|+++
T Consensus       224 -----~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 -----QP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -----CC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                 00 0112233455667888999985 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-37  Score=284.63  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=196.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  178 (380)
                      .+.||.|++|.||++.. .+++.+|+|.+....       .......+.+|++++++++||||+++++++.+.  +..++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCC-------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            46799999999999997 467899999886521       123347788999999999999999999988553  47899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++++|.+++.........+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            99999999999998765555567899999999999999999999   899999999999999999999999999998754


Q ss_pred             CC----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          259 PG----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       259 ~~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      ..    ...++..|+|||.+.+..++.++||||||+++|||++|..||.....+   .....+.......... . .+..
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-~-~~~~  230 (287)
T cd06621         156 VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVNMPN-P-ELKD  230 (287)
T ss_pred             cccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhcCCc-h-hhcc
Confidence            32    234678899999999999999999999999999999999998742111   1111222222111110 0 0110


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..   .........+.+++.+||+.+|++|||+.|+++
T Consensus       231 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00   000113456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-38  Score=298.65  Aligned_cols=188  Identities=24%  Similarity=0.411  Sum_probs=160.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++.. ..++.||||++....      ........+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc------cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346799999999999986 468899999986421      1223346678899999999999999999987543      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++ +|.+++..      .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999965 78777642      4788889999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      +++....     ...++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       172 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         172 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             CccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            9986543     23588999999999999999999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.6e-38  Score=290.94  Aligned_cols=256  Identities=20%  Similarity=0.297  Sum_probs=188.9

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|... ++..+|+|.+......       .....+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-------CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            467999999999999864 6788999998753211       11245678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++ +|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        84 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          84 EYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99975 88888763   2345788999999999999999999   89999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHHHHhh
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRHLQHA  325 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~~~~~  325 (380)
                            ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........        .......|.. ....
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  235 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG-ISSN  235 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-hcch
Confidence                  2347889999998865 5688999999999999999999999864211100        0000011110 0000


Q ss_pred             cchhHhhchhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......-.+.....   .........+.+++.+|++.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000000000   000123445789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=291.06  Aligned_cols=246  Identities=22%  Similarity=0.292  Sum_probs=190.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhh------cHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQ------NKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  172 (380)
                      ....||+|.||.|-++.. .++..||+|++...........      ...-.+...+||.+|++++|||||+|+.+..+ 
T Consensus       101 l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP  180 (576)
T KOG0585|consen  101 LIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDP  180 (576)
T ss_pred             hhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCc
Confidence            345699999999999986 5789999999976443221111      01123578899999999999999999999865 


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          173 -SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       173 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                       .+.+|||+|||..|.+...=    .....++..+..+++.++..||+|||   .++||||||||+|+|++++|++||+|
T Consensus       181 ~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  181 ESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             ccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeec
Confidence             46789999999998875421    22333899999999999999999999   99999999999999999999999999


Q ss_pred             cCCcccCCC-----------CCcCCCcccCcccccCCC----CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHH
Q 047245          252 FGLAKLMPG-----------SLIATSAYSAPECFQNRS----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLG  316 (380)
Q Consensus       252 fgl~~~~~~-----------~~~~~~~y~aPE~~~~~~----~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~  316 (380)
                      ||.+.....           ...|||.|+|||...++.    .+.+.||||+||+||-++.|+.||...        ...
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--------~~~  325 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--------FEL  325 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--------hHH
Confidence            999876521           246999999999998743    356889999999999999999999641        111


Q ss_pred             HHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          317 RWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                      +....         ++...+.-. ...++...+.+|+.++|++||++|-+..+|.
T Consensus       326 ~l~~K---------Ivn~pL~fP-~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik  370 (576)
T KOG0585|consen  326 ELFDK---------IVNDPLEFP-ENPEINEDLKDLIKRLLEKDPEQRITLPDIK  370 (576)
T ss_pred             HHHHH---------HhcCcccCC-CcccccHHHHHHHHHHhhcChhheeehhhhe
Confidence            11111         111222111 2234677789999999999999999998875

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.6e-38  Score=289.13  Aligned_cols=244  Identities=21%  Similarity=0.353  Sum_probs=188.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEe-----cC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVP-----ES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~  173 (380)
                      ..+.||+|+||.||++.. .+++.+|+|.+....         .....+.+|+.+++++ +||||+++++++.     .+
T Consensus        22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   92 (286)
T cd06638          22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG   92 (286)
T ss_pred             eeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence            346799999999999986 467899999875411         1125677899999999 7999999999873     44


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      +..++||||+++++|.+++.........+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCC
Confidence            6789999999999999988754334557889999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC------CCcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          254 LAKLMPG------SLIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~~------~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      +++....      ...++..|+|||.+..     ..++.++||||||+++|||++|+.||.....       ...... .
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-------~~~~~~-~  241 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MRALFK-I  241 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-------hHHHhh-c
Confidence            9875432      2348889999998753     4578899999999999999999999853100       001000 0


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                      ..      ...+...   .+......+.+++.+||+.||++|||+.|+++-
T Consensus       242 ~~------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 PR------NPPPTLH---QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cc------cCCCccc---CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00      0000000   111123458899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.2e-38  Score=298.86  Aligned_cols=243  Identities=21%  Similarity=0.281  Sum_probs=188.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.+|+|.+.....     ........+.+|+.+++.++||||+++++.+.+.+..++|
T Consensus        47 i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          47 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             EEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            4578999999999999874 678999999864211     1222345678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..     ..++...+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       122 ~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         122 MEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            999999999999863     34788888899999999999999   9999999999999999999999999999997653


Q ss_pred             C-------CCcCCCcccCcccccCC----CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          260 G-------SLIATSAYSAPECFQNR----SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~----~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .       ...||+.|+|||.+.+.    .++.++|||||||++|||++|..||...        +..............
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~  265 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIMNHKNS  265 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCCCc
Confidence            2       23489999999998754    3788999999999999999999998631        111111221111100


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCC--CCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPAD--RPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~  372 (380)
                      ...        +........+.+++..|+..++.+  ||+++|+++
T Consensus       266 ~~~--------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         266 LTF--------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             ccC--------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            000        111124456778999999844433  678888775

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=302.31  Aligned_cols=240  Identities=27%  Similarity=0.398  Sum_probs=196.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +-||.|+||.||-+.. .+.+.||||++....+.+.++     .+++..|+..|.+++|||++.+-|++......+||||
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK-----WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-----WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHH-----HHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4599999999999985 577899999997744433333     4789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC--
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~--  259 (380)
                      || -||-.|.+.-   ...++....+..|+.+.+.||+|||   +.+.||||||+.|||+++.|.+||+|||.+....  
T Consensus       107 YC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  107 YC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             HH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            99 4598888863   3457889999999999999999999   9999999999999999999999999999997664  


Q ss_pred             CCCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          260 GSLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       260 ~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      +..+|||.|||||++.   .+.|+-|.||||+|++..||--.++|+..   .     +-..-..++-.+       +++.
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn---M-----NAMSALYHIAQN-------esPt  244 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN---M-----NAMSALYHIAQN-------ESPT  244 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC---c-----hHHHHHHHHHhc-------CCCC
Confidence            4678999999999996   47899999999999999999999999742   1     111111111111       1111


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +.   ..+-+..+..++..|+++-|++|||.++++.
T Consensus       245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            11   2334566889999999999999999999874

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.2e-40  Score=306.42  Aligned_cols=244  Identities=23%  Similarity=0.415  Sum_probs=195.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe--EE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR--FY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~  177 (380)
                      +..+||+|+|-+||||.. .+|..||---++.....    ......++|..|+.+|+.|+||||++++.+|.+...  .-
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~----q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT----QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhh----cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            557899999999999997 35777876555432111    233445899999999999999999999999987654  78


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccCCcc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAK  256 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfgl~~  256 (380)
                      +|+|.+..|+|+.|+.+    ....+.+.+.+|+.||+.||.|||+. .++|||||||..||+|+.+ |.+||+|+|+|.
T Consensus       120 ~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHH
Confidence            99999999999999986    44678889999999999999999964 7899999999999999865 899999999998


Q ss_pred             cCCC----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          257 LMPG----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       257 ~~~~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ....    ..+|||.|||||... ..|.+..||||||+.++||+|+..||..    ..+   ... +......|.-.+.+
T Consensus       195 l~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n---~AQ-IYKKV~SGiKP~sl  265 (632)
T KOG0584|consen  195 LLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTN---PAQ-IYKKVTSGIKPAAL  265 (632)
T ss_pred             HhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCC---HHH-HHHHHHcCCCHHHh
Confidence            7653    346999999999886 7899999999999999999999999863    221   112 22223333323332


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..         -...++.+++.+|+.. ..+|||+.|+|.
T Consensus       266 ~k---------V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  266 SK---------VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hc---------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            22         2234578999999999 999999999984

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-38  Score=297.57  Aligned_cols=182  Identities=20%  Similarity=0.312  Sum_probs=157.9

Q ss_pred             ccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++... ++..||+|....              .....|+.++++++||||+++++++......++
T Consensus        69 ~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             EEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            35578999999999999974 567899997533              223468999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |+||+. ++|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus       135 v~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        135 VLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            999995 689888863   3457899999999999999999999   899999999999999999999999999998753


Q ss_pred             CC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCC
Q 047245          259 PG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT  302 (380)
Q Consensus       259 ~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~  302 (380)
                      ..     ...||..|+|||.+.+..++.++|||||||++|||+++..|+
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            32     235889999999999999999999999999999999966554

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.6e-38  Score=285.29  Aligned_cols=241  Identities=21%  Similarity=0.328  Sum_probs=189.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .++..+|+|.++...        ......+.+|+.+++.++||||+++++.+...+..++++
T Consensus        14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645          14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            36799999999999986 468899999986521        122356778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++.....++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          86 EFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999864    346899999999999999999999   89999999999999999999999999999865432


Q ss_pred             ------CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          261 ------SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                            ...++..|+|||.+.   ...++.++|+||||+++|||++|..||......        .........     .
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~~~-----~  225 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTKS-----N  225 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhhcc-----C
Confidence                  235788999999874   456889999999999999999999997531100        000000000     0


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..+.....  .......+.+++.+|++.+|++|||++++++
T Consensus       226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         226 FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00000000  0112345788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-39  Score=318.37  Aligned_cols=256  Identities=25%  Similarity=0.389  Sum_probs=204.9

Q ss_pred             HHHHHHhccccccCccCCeeEEEEEec--------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCc
Q 047245           93 TLQAALANENRLLGSSPDGKYYRTVLD--------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNL  163 (380)
Q Consensus        93 ~l~~~~~~~~~~lg~G~~g~vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni  163 (380)
                      ++.+......+.||+|.||.|++|...        ....||||.++...       .....+.+..|+++|+.+ +|+||
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~-------~~~~~~~~~~El~~m~~~g~H~ni  364 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA-------SSSEKKDLMSELNVLKELGKHPNI  364 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc-------CcHHHHHHHHHHHHHHHhcCCcch
Confidence            333333345568999999999999852        14579999997632       224468899999999999 79999


Q ss_pred             ceeeEEEecCCeEEEEEeecCCCCHHHHHHHhh---hcc---------cCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEe
Q 047245          164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---ENQ---------LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILH  231 (380)
Q Consensus       164 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH  231 (380)
                      +.++|+|.+.+..++|.||+..|+|.+||+..+   ...         ..++..+.+.++.|||.||+||+   +.+++|
T Consensus       365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vH  441 (609)
T KOG0200|consen  365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVH  441 (609)
T ss_pred             hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccc
Confidence            999999999999999999999999999998755   101         23889999999999999999999   999999


Q ss_pred             cCCCCCcEEeCCCCceEEeccCCcccCCCCC-------c--CCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCC
Q 047245          232 YNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-------I--ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP  301 (380)
Q Consensus       232 ~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-------~--~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p  301 (380)
                      |||.++|||++++..+||+|||+++......       .  -+..|||||.+....|+.||||||||+++|||+| |..|
T Consensus       442 RDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  442 RDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             hhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence            9999999999999999999999998543211       1  3456999999999999999999999999999999 8888


Q ss_pred             CCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          302 TAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       302 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      |...       ....+... ....|.          ....+..+..++.+++..||+.+|++||++.++++.++.
T Consensus       522 Yp~~-------~~~~~l~~-~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  522 YPGI-------PPTEELLE-FLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CCCC-------CcHHHHHH-HHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            8530       00111111 222221          112334567778899999999999999999999999886

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.5e-38  Score=286.30  Aligned_cols=259  Identities=22%  Similarity=0.336  Sum_probs=190.1

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|... +|..||+|++.....      .......+.+|+.++++++||||+++++++.+++..++|+
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE------EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             eeEecccCceEEEEEEECCCCcEEEEEEeccccc------cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            467999999999999874 689999999865221      1122356778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ ++|.+++.... ....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        79 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          79 EFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             ecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            9997 68998886422 2356899999999999999999999   89999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC--------CCCHHHHHHHHHhh
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS--------GGSLGRWLRHLQHA  325 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~--------~~~l~~~~~~~~~~  325 (380)
                            ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........        ......|... ...
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  232 (285)
T cd07861         154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV-TSL  232 (285)
T ss_pred             CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc-hhh
Confidence                  2246788999998865 45789999999999999999999998632111000        0000000000 000


Q ss_pred             cchhHhhchhccC--CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......+......  .........++.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000000000  0000113455779999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-38  Score=291.29  Aligned_cols=237  Identities=21%  Similarity=0.398  Sum_probs=191.2

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ..||+|+||.||++.. .++..+|+|.+...        .....+.+.+|+..+++++|+||+++++.+..++..++|||
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecc--------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            4589999999999986 46889999988541        12334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++++|.+++.     ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++..... 
T Consensus       100 ~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658         100 FLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             CCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            999999999875     235889999999999999999999   89999999999999999999999999999875432 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...++..|+|||...+..++.++||||||+++||+++|..||...        ....-....      ...+...
T Consensus       172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~------~~~~~~~  237 (292)
T cd06658         172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--------PPLQAMRRI------RDNLPPR  237 (292)
T ss_pred             cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHH------HhcCCCc
Confidence                 234788999999999888999999999999999999999998531        000101110      1111111


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...   .......+.+++.+||..||.+|||++|+++
T Consensus       238 ~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         238 VKD---SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             ccc---ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111   1123445778999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.5e-38  Score=281.68  Aligned_cols=242  Identities=25%  Similarity=0.443  Sum_probs=195.2

Q ss_pred             ccccCccCCeeEEEEEecC-----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVLDN-----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||.|+||.||++...+     +..+|+|.+....       .....+.+..|+..+..++|+||+++++++.+.+..
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   76 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-------DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL   76 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-------ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence            4679999999999999753     4889999986521       112457889999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      +++|||+++++|.+++....  ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||++.
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCce
Confidence            99999999999999987422  222899999999999999999999   9999999999999999999999999999997


Q ss_pred             cCCCC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .....       ..++..|+|||.+.+..++.++||||+|++++||++ |..||..        ............... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~--------~~~~~~~~~~~~~~~-  222 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG--------MSNEEVLEYLKKGYR-  222 (258)
T ss_pred             ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC--------CCHHHHHHHHhcCCC-
Confidence            65432       235678999999988889999999999999999998 7788753        111222222211110 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML  374 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L  374 (380)
                                ...+......+.+++.+|++.+|++|||+.|+++.|
T Consensus       223 ----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ----------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                      011122455688999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=286.89  Aligned_cols=239  Identities=23%  Similarity=0.379  Sum_probs=190.9

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|++|.||++... ++..+|+|.....        .....+.+.+|++++++++||||+++++.+......++|||
T Consensus        11 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611          11 GELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             HHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            46999999999999974 6889999998641        22334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++..... 
T Consensus        83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999998742   346899999999999999999999   89999999999999999999999999998865432 


Q ss_pred             -----CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          261 -----SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                           ...++..|+|||.+.     ...++.++|+||||+++|||++|..||...        .............    
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~----  224 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL--------NPMRVLLKILKSE----  224 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC--------CHHHHHHHHhcCC----
Confidence                 224788999999875     345788999999999999999999998631        1111111111100    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        .+.+   ..+......+.+++..||+.+|.+|||+.++++
T Consensus       225 --~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         225 --PPTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             --CCCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence              0000   011223456788999999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.1e-38  Score=288.69  Aligned_cols=242  Identities=26%  Similarity=0.370  Sum_probs=191.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|... +|+.||+|.+......     .....+.+.+|+.+++.++||||+++.+++.+.+..++|
T Consensus        19 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          19 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-----cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            3467999999999999874 6899999998642211     223346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||++ |++.+++..   ....+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++....
T Consensus        94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            99997 588777753   2346899999999999999999999   8999999999999999999999999999987654


Q ss_pred             C--CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G--SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~--~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .  ...++..|+|||.+.   ...++.++||||||+++|||++|..||...        .............        
T Consensus       167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~--------~~~~~~~~~~~~~--------  230 (307)
T cd06607         167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQND--------  230 (307)
T ss_pred             CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc--------cHHHHHHHHhcCC--------
Confidence            3  235788999999874   456889999999999999999999998531        1111111111000        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        ............+.+++.+||+.+|++||++.+++.
T Consensus       231 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         231 --SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             --CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              001111234556889999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-39  Score=298.70  Aligned_cols=233  Identities=22%  Similarity=0.299  Sum_probs=180.8

Q ss_pred             cCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC---CCCCcceeeEEEecCCeEEEEE
Q 047245          105 LGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL---RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       105 lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ||+|+||.||++.. .+|..||+|++.....     ........+..|..++.+.   +||||+.+++++.+....++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI-----VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHH-----hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence            79999999999986 4689999999864211     1112234455666666655   6999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++... 
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~  148 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT  148 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence            99999999998864    446889999999999999999999   8999999999999999999999999999987532 


Q ss_pred             -----CCCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 -----GSLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                           ....|++.|+|||.+.+. .++.++|||||||++|||++|..||...        ........... +.      
T Consensus       149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~--------~~~~~~~~i~~-~~------  213 (330)
T cd05586         149 DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE--------DTQQMYRNIAF-GK------  213 (330)
T ss_pred             CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--------CHHHHHHHHHc-CC------
Confidence                 123589999999998764 4789999999999999999999998531        11111111111 10      


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD  368 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  368 (380)
                      ..+..    ......+.+++.+||+.||++||++.
T Consensus       214 ~~~~~----~~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         214 VRFPK----NVLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             CCCCC----ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence            00100    11344567899999999999999543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-38  Score=284.82  Aligned_cols=250  Identities=24%  Similarity=0.432  Sum_probs=194.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCCh--hhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSP--EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      .+.||+|++|.||+|.. .+|+.+|+|.+........  ........+.+.+|+.++++++|||++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            46799999999999986 4689999998864221111  11122344678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |+||+++|+|.+++..    ...+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++++|||+++..
T Consensus        86 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          86 FLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             EEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            9999999999999874    246889999999999999999999   899999999999999999999999999998765


Q ss_pred             CCC--------CcCCCcccCcccccCCC--CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          259 PGS--------LIATSAYSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       259 ~~~--------~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ...        ..++..|+|||.+....  ++.++|+||||+++||+++|..||...       .....+. ...... .
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-------~~~~~~~-~~~~~~-~  229 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-------EAIAAMF-KLGNKR-S  229 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-------chHHHHH-Hhhccc-c
Confidence            421        24678899999987654  789999999999999999999998531       0111111 110000 0


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...+.     ..........+.+++..||+.+|++|||++++++
T Consensus       230 ~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 APPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00011     1111224567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=280.98  Aligned_cols=243  Identities=24%  Similarity=0.352  Sum_probs=193.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|++|.||++.. .++..+++|.+....        ....+.+.+|++++++++||||+++++++.+....+++
T Consensus         7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--------GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--------hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            346799999999999987 457889999987521        12347788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..   ....++...+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++....
T Consensus        79 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  152 (262)
T cd06613          79 MEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT  152 (262)
T ss_pred             EeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhh
Confidence            999999999998874   2246889999999999999999999   8999999999999999999999999999987644


Q ss_pred             C------CCcCCCcccCcccccCC---CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 G------SLIATSAYSAPECFQNR---SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~---~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .      ...++..|+|||.+...   .++.++|+||||+++|||++|..||......        .-......     .
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------~~~~~~~~-----~  219 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------RALFLISK-----S  219 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-----c
Confidence            2      23477789999999776   8899999999999999999999998632100        00000000     0


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+.+..  ..........+.+++.+||+.+|.+|||+++++.
T Consensus       220 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 NFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            001100  0111234556889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.7e-38  Score=284.89  Aligned_cols=248  Identities=23%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             ccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC---
Q 047245          102 NRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS---  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  174 (380)
                      .+.||+|+||.||+|...    ++..+|+|.+.....      .....+++.+|++++++++||||+++++++....   
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF------SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC------ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            457999999999999863    468899999865221      2233467889999999999999999999875432   


Q ss_pred             ---eEEEEEeecCCCCHHHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          175 ---RFYLVYDYLQTGSLEDAMDRIR--ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       175 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                         ..++++||+++|+|.+++....  .....+++.....++.|++.||+|||   +.+++||||||+||++++++.+||
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEE
Confidence               3478899999999999875322  22335788999999999999999999   889999999999999999999999


Q ss_pred             eccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHH
Q 047245          250 ADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       250 ~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +|||+++.....        ..++..|++||.+....++.++||||||+++|||++ |..||...        ...+...
T Consensus       155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~--------~~~~~~~  226 (273)
T cd05074         155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV--------ENSEIYN  226 (273)
T ss_pred             CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC--------CHHHHHH
Confidence            999998865321        124567999999988889999999999999999999 88887531        1111111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .......           ...+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       227 ~~~~~~~-----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         227 YLIKGNR-----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111110           001122345688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-38  Score=286.83  Aligned_cols=245  Identities=24%  Similarity=0.394  Sum_probs=192.6

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|..+|+|.+....       .......+.+|+.++++++||||+++++.+...+..++|+
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            357999999999999975 78999999886411       2223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++... .....+++..+..++.|++.||.|||+  +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          79 EYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             eecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            999999999988742 113368999999999999999999993  25899999999999999999999999999876532


Q ss_pred             ----CCcCCCcccCcccccCCC------CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          261 ----SLIATSAYSAPECFQNRS------YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       261 ----~~~~~~~y~aPE~~~~~~------~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                          ...++..|+|||.+.+..      ++.++|+||||+++|||++|..||...        ....+.....      .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--------~~~~~~~~~~------~  221 (286)
T cd06622         156 SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE--------TYANIFAQLS------A  221 (286)
T ss_pred             CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc--------chhhHHHHHH------H
Confidence                234778899999986543      488999999999999999999998531        0111111110      0


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..+..  ....+......+.+++.+||+.+|++||++++++.
T Consensus       222 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         222 IVDGD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HhhcC--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11100  01122335566889999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.2e-38  Score=287.08  Aligned_cols=243  Identities=24%  Similarity=0.370  Sum_probs=189.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC-----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES-----  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----  173 (380)
                      ..+.||+|+||.||++.. .+++.+|+|.+....         .....+.+|+.++.++ +|||++++++++...     
T Consensus        26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            346799999999999987 568899999886421         1125667899999999 899999999998643     


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      +..++|+||+++|+|.++++........+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg  173 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFG  173 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence            4689999999999999998754444567899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC------CCcCCCcccCcccccCC-----CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          254 LAKLMPG------SLIATSAYSAPECFQNR-----SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~~------~~~~~~~y~aPE~~~~~-----~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      ++.....      ...++..|+|||.+...     .++.++||||||+++|||++|+.||.....       ... ....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~~~-~~~~  245 (291)
T cd06639         174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VKT-LFKI  245 (291)
T ss_pred             cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------HHH-HHHH
Confidence            9875432      23478889999988643     368899999999999999999999854110       000 0010


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ... .     .+.+   ..+......+.+++.+||+.+|++||++.|+++
T Consensus       246 ~~~-~-----~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 PRN-P-----PPTL---LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hcC-C-----CCCC---CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000 0     0000   011223446889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.4e-37  Score=283.07  Aligned_cols=238  Identities=24%  Similarity=0.392  Sum_probs=193.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .++..+|+|.....       ........+.+|+..+++++||||+++++++.++...++|
T Consensus         8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             hheeEeecCCeEEEEEEECCCCcEEEEEEeccc-------cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            345799999999999986 46889999987531       1123346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++.     ...+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          81 MEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            99999999999986     246899999999999999999999   8999999999999999999999999999987554


Q ss_pred             CC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 GS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..      ..++..|+|||.+.+..++.++|+||||+++|++++|..||....        ...+........       
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~-------  217 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFLIPKNN-------  217 (277)
T ss_pred             cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHHHhcCC-------
Confidence            32      246788999999998889999999999999999999999985311        111111111100       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          ...........+.+++.+||+.+|.+||++.++++
T Consensus       218 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         218 ----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                01111234456789999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.3e-38  Score=293.82  Aligned_cols=251  Identities=26%  Similarity=0.343  Sum_probs=185.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------C
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------S  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  174 (380)
                      .+.||+|+||.||++.. .++..||+|++....      ......+.+.+|+.++++++||||+++++++...      .
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF------QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchh------hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            46799999999999986 567899999986421      1122345677899999999999999999887543      4


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++++|++ +++|.+++.     ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        94 ~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence            578999988 779988775     346899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCC---CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh------
Q 047245          255 AKLMPGS---LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH------  324 (380)
Q Consensus       255 ~~~~~~~---~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~------  324 (380)
                      ++.....   ..+++.|+|||.+.+ ..++.++||||||+++|||++|..||......    ..+..+......      
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         165 ARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             ceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCCHHHH
Confidence            9875543   357899999999876 56899999999999999999999998531000    001111000000      


Q ss_pred             ----hcchhHhhchhccCCcc------cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 ----AGEAREALDRSILGEEV------EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .......+. .+.....      .......+.+++.+|++.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         241 KKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                000000000 0000000      0011234679999999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.8e-38  Score=288.32  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=184.2

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC---CCCCcceeeEEEec-----
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL---RHRNLMSLRAYVPE-----  172 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  172 (380)
                      .+.||+|+||.||++... +|+.||+|.+.......      .....+.+|+.+++.+   +||||+++++++..     
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED------GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC------CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            457999999999999864 68899999987532111      1113344566666555   79999999998754     


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      ....++++||+++ +|.+++...  ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+||
T Consensus        79 ~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          79 ETKVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             CceEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcc
Confidence            3457999999974 899988742  2345899999999999999999999   899999999999999999999999999


Q ss_pred             CCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          253 GLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       253 gl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      |+++....     ...++..|+|||.+.+..++.++||||+||++|||++|..||......    ..+............
T Consensus       153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~  228 (288)
T cd07863         153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIFDLIGLPPE  228 (288)
T ss_pred             CccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHHHHhCCCCh
Confidence            99976542     234788999999999889999999999999999999999998531100    001111000000000


Q ss_pred             --------h-hHhhchhccC--CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 --------A-REALDRSILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 --------~-~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                              . ...+.+....  .....+....+.+++.+|++.||++|||+.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                    0 0000000000  0001123455789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.5e-38  Score=290.07  Aligned_cols=237  Identities=20%  Similarity=0.365  Sum_probs=190.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ..||+|+||.||++.. .++..||+|.+....        ....+.+.+|+..++.++||||+++++++..++..++++|
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--------cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            3699999999999986 468999999986421        1123567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++++|.+++.     ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++..... 
T Consensus        99 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          99 FLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             cCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            999999999775     245889999999999999999999   89999999999999999999999999999865432 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...++..|+|||.+.+..++.++||||||+++|||++|..||....        ...-........      ...
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~~------~~~  236 (297)
T cd06659         171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQAMKRLRDSP------PPK  236 (297)
T ss_pred             cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhccC------CCC
Confidence                 2347889999999998899999999999999999999999985310        011111111000      000


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .   .........+.+++.+||+.+|++||+++++++
T Consensus       237 ~---~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         237 L---KNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             c---cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0   001123345788999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-38  Score=291.64  Aligned_cols=245  Identities=20%  Similarity=0.281  Sum_probs=187.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+++.||+|++....     .......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-----MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46799999999999996 458899999986421     112233466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999864   2346888999999999999999999   99999999999999999999999999999865432


Q ss_pred             C-------CcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          261 S-------LIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .       ..|++.|+|||.+..     ..++.++|||||||++|||++|+.||...        ...+...........
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~--------~~~~~~~~i~~~~~~  226 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHKEH  226 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC--------CHHHHHHHHHcCCCc
Confidence            1       248999999999863     45788999999999999999999998531        122222222111110


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccC--CCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSD--SPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~--~P~~RPs~~evl~  372 (380)
                      ..     +  ..........+.+++.+|+..  ++..||+++++++
T Consensus       227 ~~-----~--~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         227 FQ-----F--PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             cc-----C--CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            00     0  001111344566777776644  4444788888764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-37  Score=283.87  Aligned_cols=254  Identities=21%  Similarity=0.313  Sum_probs=190.7

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ...||+|++|.||++... +|+.+|+|++......      ....+.+.+|+.++++++|+|++++++++......++||
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD------PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccC------ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            457999999999999975 5899999998653211      112356789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|..+...    ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        80 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          80 EYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             eccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            99999888877642    346899999999999999999999   89999999999999999999999999999986543


Q ss_pred             C------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH----------H
Q 047245          261 S------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL----------Q  323 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~----------~  323 (380)
                      .      ..++..|+|||.+.+ ..++.++||||||+++|||++|..||.......    .+.......          .
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD----QLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChHHhhhc
Confidence            2      246788999999876 557899999999999999999999986321100    000000000          0


Q ss_pred             hhcchh-HhhchhccCC-c---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAGEAR-EALDRSILGE-E---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~~~~-~~~~~~~~~~-~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...... ..-.+..... .   ........+.+++.+||+.+|++|||+.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000000 0000000000 0   00122456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=284.08  Aligned_cols=256  Identities=25%  Similarity=0.374  Sum_probs=191.0

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-----CCeE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-----SSRF  176 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~  176 (380)
                      +.||+|++|.|.++.. .+|..||+|++....      ......++..+|+.+|++++|+||+.+.+.+..     -...
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F------~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhh------hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            5699999999999986 578999999997422      233445778899999999999999999998755     3578


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      |+|+|+|+ -+|...++.    +..++.....-+..|+++||.|+|   +.+++||||||+|++++.+...||+|||+|+
T Consensus       102 YiV~elMe-tDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             EEehhHHh-hHHHHHHHc----CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccccee
Confidence            99999994 488888873    445888888999999999999999   9999999999999999999999999999999


Q ss_pred             cCCC--------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC------CCCHHHHHHH
Q 047245          257 LMPG--------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS------GGSLGRWLRH  321 (380)
Q Consensus       257 ~~~~--------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~------~~~l~~~~~~  321 (380)
                      ....        ..+.|..|.|||.+.. ..||.+.||||.|||+.||++|++-|........-      -+........
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8742        2357889999999864 67999999999999999999999887631000000      0000000001


Q ss_pred             HHhhcchhHhhchh--ccCCc---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAREALDRS--ILGEE---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...+......+...  ....+   ..+.......+++.+++..||.+|+|++|.++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11111111111110  00011   11133455789999999999999999999874

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.8e-37  Score=278.66  Aligned_cols=241  Identities=21%  Similarity=0.359  Sum_probs=194.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++.. .++..+|+|.+.....      .....+.+.+|++++++++|||++++++.+...+..++|+
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM------TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEecccc------ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            46799999999999886 4688999999875321      2233477889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfgl~~~~~  259 (380)
                      ||+++++|.+++...  ....+++..+..++.|++.|++|||   +.+++|+||+|+||+++++ +.+||+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          79 EYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             ecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            999999999999752  2445899999999999999999999   8999999999999999865 468999999998654


Q ss_pred             CC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 GS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      ..     ..++..|+|||.+.+..++.++||||||+++|+|++|..||...        .............        
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~--------~~~~~~~~~~~~~--------  217 (256)
T cd08220         154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA--------NLPALVLKIMSGT--------  217 (256)
T ss_pred             CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC--------chHHHHHHHHhcC--------
Confidence            32     34788999999999888999999999999999999999998531        1111221111110        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .  ...+......+.+++.+||+.+|++|||+.|+++
T Consensus       218 -~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 -F--APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -C--CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             0  0111223456789999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8e-38  Score=282.25  Aligned_cols=240  Identities=23%  Similarity=0.286  Sum_probs=193.5

Q ss_pred             cCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||.|++|.||++... ++..+++|.+......     .....+.+.+|+.++++++||||+++++.+.++...++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-----ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch-----hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence            699999999999975 4889999998652211     1233467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC--
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS--  261 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--  261 (380)
                      ++++|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~  148 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK  148 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc
Confidence            99999999974    335889999999999999999999   899999999999999999999999999999876542  


Q ss_pred             ---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccC
Q 047245          262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILG  338 (380)
Q Consensus       262 ---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  338 (380)
                         ..++..|++||.+.+..++.++|+||||+++||+++|..||.....      +...........         . ..
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~---------~-~~  212 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKG---------N-GK  212 (262)
T ss_pred             cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhcc---------C-CC
Confidence               3478899999999888899999999999999999999999864210      111222211110         0 01


Q ss_pred             CcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          339 EEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       339 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                      ...+......+.+++.+||+.+|++||+     ++|+++
T Consensus       213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1122223567899999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-37  Score=284.84  Aligned_cols=238  Identities=19%  Similarity=0.353  Sum_probs=193.1

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      -+.||+|++|.||++.. .+++.+++|++...        .....+.+.+|+.++++++||||+++++++...+..++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEecc--------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            35899999999999986 56889999988541        1122456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..     ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||.+.....
T Consensus        96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          96 EFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             eccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            99999999999873     35889999999999999999999   89999999999999999999999999998865432


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .      ..++..|+|||.+.+..++.++||||||+++|||++|..||...        ............      ..+
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~--------~~~~~~~~~~~~------~~~  233 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--------PPLQAMKRIRDN------LPP  233 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC--------CHHHHHHHHHhc------CCC
Confidence            2      34788999999999888999999999999999999999998531        111222221111      001


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...   ........+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         234 KLK---NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCc---ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            110   11123456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-38  Score=299.07  Aligned_cols=251  Identities=21%  Similarity=0.243  Sum_probs=188.2

Q ss_pred             ccccccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          100 NENRLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ...+.||+|+||.||++...   .+..||+|.+...             ....+|+.++++++||||+++++++......
T Consensus        95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             EEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            35578999999999998753   3578999987531             2345799999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      +++||++. ++|.+++..    ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       162 ~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             EEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            99999995 689888842    457899999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc--
Q 047245          257 LMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG--  326 (380)
Q Consensus       257 ~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~--  326 (380)
                      ....        ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+....+......  
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccc
Confidence            5432        2358999999999999999999999999999999999999985321110 0001111111000000  


Q ss_pred             -------chhHh---hchhccCCcc-c-----HHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 -------EAREA---LDRSILGEEV-E-----EDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 -------~~~~~---~~~~~~~~~~-~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                             .....   +......... +     ......+.+++.+|+..||++|||+.|++.
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                   00000   0000000000 0     012345778999999999999999999985

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.8e-38  Score=284.81  Aligned_cols=240  Identities=21%  Similarity=0.376  Sum_probs=187.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE------  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------  172 (380)
                      ..+.||+|+||.||+|.. .+++.+|+|.+...         ......+..|+.+++++ +|+||+++++++..      
T Consensus        20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            346799999999999997 56889999988641         12235678899999999 79999999999843      


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      ....+++|||+++|+|.+++....  ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+||
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence            457899999999999999987422  345788889999999999999999   899999999999999999999999999


Q ss_pred             CCcccCCC------CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHH
Q 047245          253 GLAKLMPG------SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       253 gl~~~~~~------~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      |++.....      ...++..|+|||.+.     ...++.++||||||+++|||++|..||......       .. ...
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~~-~~~  237 (282)
T cd06636         166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------RA-LFL  237 (282)
T ss_pred             cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------hh-hhh
Confidence            99875432      234788999999886     346788999999999999999999998642100       00 000


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .      .....+..    ........+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~------~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 I------PRNPPPKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             H------hhCCCCCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0      00001111    11123456889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.6e-37  Score=286.81  Aligned_cols=246  Identities=19%  Similarity=0.277  Sum_probs=194.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. ..++.|++|.+....     .........+.+|+.+++.++||||+++++.+...+..++||
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-----LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46799999999999986 457899999886521     112233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||+++... 
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999964    346899999999999999999999   8999999999999999999999999999886311 


Q ss_pred             --------------------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH
Q 047245          260 --------------------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       260 --------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~  319 (380)
                                          ....++..|+|||.+.+..++.++|+||||+++||+++|..||...        ....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~--------~~~~~~  225 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------TPEELF  225 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHH
Confidence                                0123677899999998888999999999999999999999998531        112222


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      .......     +..    ..........+.+++.+||+.+|++||++.++.+.|+.
T Consensus       226 ~~~~~~~-----~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDD-----IEW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcc-----cCC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            2211110     000    00001234557899999999999999997777766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-37  Score=280.57  Aligned_cols=244  Identities=27%  Similarity=0.442  Sum_probs=196.2

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... +++.+++|.+....       .......+.+|++++++++||||+++++.+...+..++++
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-------NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-------ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            357999999999999975 68899999987521       1234577889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||+++++|.+++...   ...++...+..++.|++.|++|||   + .+++|+||+|+||++++++.++|+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          79 EYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            999999999998742   257888999999999999999999   8 899999999999999999999999999987543


Q ss_pred             C----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .    ...++..|+|||.+.+..++.++||||||+++|++++|..||.....   ......+.........       . 
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~-------~-  221 (265)
T cd06605         153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNEP-------P-  221 (265)
T ss_pred             HHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcCC-------C-
Confidence            2    24578899999999999999999999999999999999999864211   1111122221111100       0 


Q ss_pred             ccCCcccH-HHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEE-DEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~-~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ...+. .....+.+++.+||..+|++|||+.+++.
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 ---PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               01111 14556889999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=281.94  Aligned_cols=243  Identities=23%  Similarity=0.404  Sum_probs=191.1

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCC----
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESS----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----  174 (380)
                      ..+.||+|++|.||++... +++.+++|.+....         .....+.+|+.+++++ +|+||+++++++....    
T Consensus        10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608          10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             heeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            3467999999999999974 57889999886521         1236788999999999 7999999999986544    


Q ss_pred             --eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          175 --RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       175 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                        ..++||||+++++|.+++.........+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence              589999999999999998764444567899999999999999999999   999999999999999999999999999


Q ss_pred             CCcccCCC------CCcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHH
Q 047245          253 GLAKLMPG------SLIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       253 gl~~~~~~------~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      |++.....      ...++..|+|||.+..     ..++.++||||||++++++++|..||....       ...... .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~-~  229 (275)
T cd06608         158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-------PMRALF-K  229 (275)
T ss_pred             ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-------hHHHHH-H
Confidence            99865432      2347888999998753     346789999999999999999999985310       001110 1


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....      ..+.   ..........+.+++.+||..||++|||+.++++
T Consensus       230 ~~~~------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRN------PPPT---LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhcc------CCCC---CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0000      0001   1111224556889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-37  Score=281.06  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=196.1

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++.. .++..+|+|.+.......  .......+.+.+|+..+++++|+||+++++++.+.+..++|+
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~   82 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS--SEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV   82 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc--hhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence            46799999999999985 678999999987532111  112334578999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~  259 (380)
                      ||+++++|.+++..    ..++++..+..++.|++.||+|||   +.+++|+||+|+||+++.++ .+||+|||.+....
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          83 EWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             eccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999874    346889999999999999999999   89999999999999998775 59999999987543


Q ss_pred             C----------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          260 G----------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       260 ~----------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      .          ...++..|+|||.+.+..++.++||||+|++++++++|..||...     ..............     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~-----  225 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE-----KHSNHLALIFKIAS-----  225 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC-----CCcchHHHHHHHhc-----
Confidence            2          124677899999998888999999999999999999999998531     00111111111000     


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           .......+......+.+++.+|+..+|.+|||+.|++.
T Consensus       226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 00011233345567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.1e-37  Score=285.59  Aligned_cols=243  Identities=24%  Similarity=0.362  Sum_probs=192.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|..+|+|.+.....     ........+.+|++++++++|||++++++++.+....++|
T Consensus        29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-----QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-----CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            346799999999999986 4688999998864211     1223346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||++ |+|.+.+..   ....+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+|||++....
T Consensus       104 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         104 MEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             EeCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            99997 588887753   2456899999999999999999999   8999999999999999999999999999987654


Q ss_pred             C--CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G--SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~--~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .  ...++..|+|||.+.   .+.++.++||||||+++|||++|..||...        .............        
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~--------  240 (317)
T cd06635         177 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNE--------  240 (317)
T ss_pred             CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhcc--------
Confidence            3  335788999999974   456889999999999999999999997531        1111111111110        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                       . ...........+.+++.+||+.+|.+||++.++++.
T Consensus       241 -~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         241 -S-PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             -C-CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence             0 011112344568899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-37  Score=279.03  Aligned_cols=242  Identities=26%  Similarity=0.427  Sum_probs=193.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++.. .++..+++|.+.....      .....+.+.+|++++++++|+||+++++++...+..++|+
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECccc------chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            46799999999999986 4688999999875321      1345678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          79 EYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             ecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            99999999999874    345788999999999999999999   89999999999999999999999999999876532


Q ss_pred             C----------CcCCCcccCcccccCCC---CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          261 S----------LIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       261 ~----------~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      .          ..++..|+|||.+.+..   ++.++||||||+++||+++|+.||....       .  .|........ 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------~--~~~~~~~~~~-  221 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------N--EFQIMFHVGA-  221 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------c--hHHHHHHHhc-
Confidence            1          23677899999998766   8899999999999999999999986310       0  1111100000 


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ...+.+.   ........+.+++.+||+.+|++|||+.+++.
T Consensus       222 ---~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 ---GHKPPIP---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ---CCCCCCC---cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence               0011110   11112455779999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-37  Score=290.48  Aligned_cols=245  Identities=19%  Similarity=0.265  Sum_probs=187.4

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +++.+|+|.+....     .........+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            467999999999999974 57789999986421     112223456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999974   2346889999999999999999999   89999999999999999999999999999865421


Q ss_pred             -------CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          261 -------SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                             ...||+.|+|||.+.     ...++.++|||||||++|||++|+.||...        +..............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~--------~~~~~~~~i~~~~~~  226 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHKER  226 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--------CHHHHHHHHhCCCcc
Confidence                   235899999999986     346789999999999999999999998631        122222222211100


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCC--CCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPA--DRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~--~RPs~~evl~  372 (380)
                      .     ..  ..........+.+++.+|+..+|.  .||+++|+++
T Consensus       227 ~-----~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         227 F-----QF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             c-----cC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            0     00  011112345577788887755443  4688888864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=301.92  Aligned_cols=187  Identities=21%  Similarity=0.303  Sum_probs=153.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC------CCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH------RNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||++.. .+++.||||+++...         ...+.+..|+++++.++|      .+++.+++++...
T Consensus       133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            346799999999999986 457899999986421         112344556666666654      4588888888654


Q ss_pred             -CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCC------
Q 047245          174 -SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEF------  245 (380)
Q Consensus       174 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~------  245 (380)
                       ...++|+|++ +++|.+++..    ...+++..+..++.|++.||+|||   + .+|+||||||+|||++.++      
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccc
Confidence             5789999988 7799998864    346899999999999999999999   6 5999999999999998765      


Q ss_pred             ----------ceEEeccCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          246 ----------TPRLADFGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       246 ----------~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                                .+||+|||.+.....   ...||+.|+|||.+.+..++.++|||||||++|||++|+.||+.
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             cccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                      499999998765332   34689999999999999999999999999999999999999964

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-37  Score=286.38  Aligned_cols=257  Identities=23%  Similarity=0.335  Sum_probs=191.4

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|... +|+.||+|.+.......   ........+..|++++++++|+||+++++++.+.+..++||
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             eeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            457999999999999964 68999999997632211   11223456778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+ +|+|.+++..   ....+++..+..++.|+++||+|||   +.+++|+||+|+||+++.++.++|+|||+++....
T Consensus        82 e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          82 EFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             ccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999 8999999873   1236899999999999999999999   89999999999999999999999999999976543


Q ss_pred             C------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh--------h
Q 047245          261 S------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH--------A  325 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~--------~  325 (380)
                      .      ..++..|+|||.+.+ ..++.++||||||++++||++|..||......    ..+.........        .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI----DQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH----HHHHHHHHHcCCCchhhhhhc
Confidence            2      235678999998864 46789999999999999999997776421100    000000000000        0


Q ss_pred             cchhHhhchhccC----CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILG----EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .............    ..........+.+++.+||+.+|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0000000000000    0011223566889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=288.12  Aligned_cols=243  Identities=26%  Similarity=0.316  Sum_probs=193.7

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... ++..+|+|.+.....     ......+.+..|++.+++++|+||+++++.+.++...+++|
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-----IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-----chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            467999999999999975 489999999875221     11234567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..  .....+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999874  22456899999999999999999999   89999999999999999999999999998764321


Q ss_pred             -----------------------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCch
Q 047245          261 -----------------------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF  305 (380)
Q Consensus       261 -----------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~  305 (380)
                                                         ...|+..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                               124678899999999888999999999999999999999998531


Q ss_pred             hhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC----HHhHHH
Q 047245          306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS----SDELVP  372 (380)
Q Consensus       306 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs----~~evl~  372 (380)
                      ..       ...+..          ......... ........+.+++.+||+.+|++|||    ++|++.
T Consensus       236 ~~-------~~~~~~----------~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NR-------DETFSN----------ILKKEVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             ch-------HHHHHH----------HhcCCccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            10       011111          111111001 11124567899999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=282.69  Aligned_cols=238  Identities=23%  Similarity=0.397  Sum_probs=189.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEecCCeEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  177 (380)
                      .+.||+|+||.||+|.. .++..+|+|.+....       .......+.+|+.++++++   |||++++++++.++...+
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            46799999999999996 578999999986421       1223356788999999996   999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++++|.+++..     ..+++...+.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..
T Consensus        79 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          79 IIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            99999999999998862     36899999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCC------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          258 MPGS------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       258 ~~~~------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ....      ..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...        ....+...... .    
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~--------~~~~~~~~~~~-~----  217 (277)
T cd06917         151 LNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV--------DAFRAMMLIPK-S----  217 (277)
T ss_pred             cCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC--------Chhhhhhcccc-C----
Confidence            5432      247788999998865 44689999999999999999999998631        11111111000 0    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ..+.+..    ......+.+++.+||+.||++||++.|+++
T Consensus       218 -~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 -KPPRLED----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -CCCCCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence             0011111    113456889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.6e-37  Score=283.47  Aligned_cols=243  Identities=22%  Similarity=0.379  Sum_probs=187.0

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHH-HHcCCCCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV-LASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .+.||+|+||.||++... +|..||+|++.....       ......+..|+.. ++.++||||+++++++..++..+++
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-------SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-------cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            457999999999999874 689999999865211       1112345556664 5666899999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      +||++ |+|.+++.........+++..++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||+++..
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99996 6999988764444567899999999999999999999   76 8999999999999999999999999998765


Q ss_pred             CCC-----CcCCCcccCcccccC----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          259 PGS-----LIATSAYSAPECFQN----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       259 ~~~-----~~~~~~y~aPE~~~~----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ...     ..++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.....      ...... ....     
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~~-----  222 (283)
T cd06617         155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLK-QVVE-----  222 (283)
T ss_pred             ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHH-HHHh-----
Confidence            432     347788999998865    4568899999999999999999999853100      011110 0000     


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ...+...    ....+..+.+++.+||..+|++||+++++++
T Consensus       223 -~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 -EPSPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -cCCCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0011111    1123456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.8e-37  Score=284.60  Aligned_cols=256  Identities=20%  Similarity=0.280  Sum_probs=188.8

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... ++..||+|.+......       .....+.+|+.++++++||||+++++++...+..++|+
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-------CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            457999999999999864 6789999998653211       11245678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ ++|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        84 e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          84 EYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            9997 599988864   2346889999999999999999999   99999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHHHHhh
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRHLQHA  325 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~~~~~  325 (380)
                            ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........        .......|... ...
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  235 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI-LSN  235 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh-hcc
Confidence                  2346888999998865 4578899999999999999999999864211100        00000011000 000


Q ss_pred             cchhHhhchhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......-.+.....   .........+.+++.+|++.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000000000   000123445789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.1e-38  Score=286.17  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=190.5

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +++.+|+|++.....      .....+.+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED------DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC------cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            467999999999999985 588999998864221      1123466888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.++...    ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          80 EFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             ecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            99999888887652    335899999999999999999999   88999999999999999999999999999876432


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh----
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR----  329 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~----  329 (380)
                            ...++..|+|||.+.+ ..++.++||||||+++|||++|..||....       ....+.......+...    
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS-------DIDQLYHIIKCLGNLIPRHQ  225 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc-------hHHHHHHHHHHhCCCchhhH
Confidence                  1246788999999875 457889999999999999999998875311       1111111000000000    


Q ss_pred             Hh------h----chhccCC----cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EA------L----DRSILGE----EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~------~----~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..      .    .+.....    .........+.+++.+||+.+|++||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00      0    0000000    001123456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-37  Score=284.90  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=188.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++.. .+|..+|+|++.....      .......+.+|++++++++||||+++++++.+....++++
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeecccc------cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            46799999999999997 4689999999865221      1112256778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ ++|.+++..   ....+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        79 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          79 EYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             ecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            9997 588888763   2346899999999999999999999   89999999999999999999999999999876432


Q ss_pred             ------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc---------CCCCHHHHHHHHHh
Q 047245          261 ------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA---------SGGSLGRWLRHLQH  324 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~---------~~~~l~~~~~~~~~  324 (380)
                            ...++..|+|||.+.+. .++.++||||||+++|||++|..|+........         .......|......
T Consensus       152 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence                  23467889999998764 478999999999999999999988643111000         00000011000000


Q ss_pred             hcc-hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 AGE-AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ... .....................+.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000 000000000000001123456789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-37  Score=278.19  Aligned_cols=242  Identities=24%  Similarity=0.396  Sum_probs=194.5

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|..+|+|.+.....      .....+.+.+|++++++++|+||+++++.+.+.+..+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv   77 (257)
T cd08225           4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM------PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV   77 (257)
T ss_pred             EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc------cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence            3467999999999999974 578999999865211      112236778899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~~~~  258 (380)
                      +||+++++|.+++..  .....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++ .+||+|||.+...
T Consensus        78 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          78 MEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            999999999999874  22346899999999999999999999   89999999999999999885 5699999998765


Q ss_pred             CCC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PGS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ...      ..+++.|+|||...+..++.++|+||||++++|+++|..||...        ....+........     +
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-----~  219 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--------NLHQLVLKICQGY-----F  219 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHhccc-----C
Confidence            432      24788899999998888999999999999999999999998531        1222332222111     0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .      .........+.+++.+|++.+|++|||+.|+++
T Consensus       220 ~------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 A------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             C------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            0      111123446889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.7e-37  Score=289.79  Aligned_cols=245  Identities=20%  Similarity=0.273  Sum_probs=187.8

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +++.+|+|.+....     .........+.+|..++..++|+||+++.+++.+.+..++||
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-----MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            467999999999999864 67889999986421     112233456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999742   346888999999999999999999   99999999999999999999999999999875432


Q ss_pred             C-------CcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          261 S-------LIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .       ..|++.|+|||.+.+     +.++.++||||||+++|||++|+.||...        ...............
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~--------~~~~~~~~i~~~~~~  226 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHEER  226 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC--------CHHHHHHHHHcCCCc
Confidence            1       348999999999875     46788999999999999999999998631        111111111111100


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCC--CCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPAD--RPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~  372 (380)
                         +  ..  ..........+.+++.+|+..++++  |++++++++
T Consensus       227 ---~--~~--p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 ---F--QF--PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ---c--cC--CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence               0  00  0111123456778888888765543  457777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=281.33  Aligned_cols=249  Identities=22%  Similarity=0.290  Sum_probs=201.0

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-C
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-S  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  173 (380)
                      .+.++-+|.||.||+|.+      .+.+.|-||.++..       ..+-....+..|.-.+..+.|||+....+++.+ .
T Consensus       288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            556889999999999965      34556778877641       223345678899999999999999999999855 4


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRE----NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                      ...+.+|.++.-|+|..||..++.    ....++..+...++.|++.|++|||   +.++||.||.++|++||+...+||
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkl  437 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKL  437 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEe
Confidence            567999999999999999985442    2345777889999999999999999   999999999999999999999999


Q ss_pred             eccCCcccCC--------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHH
Q 047245          250 ADFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       250 ~Dfgl~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +|-.++|.+-        ++...+..||+||.+....|+.++|||||||++|||+| |+.||.+.        +.-+...
T Consensus       438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI--------DPfEm~~  509 (563)
T KOG1024|consen  438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--------DPFEMEH  509 (563)
T ss_pred             ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--------CHHHHHH
Confidence            9999998542        23346788999999999999999999999999999999 99998642        1111111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .+.+..+           -..+.+++.+++.++.-||...|++||++++++.-|.+++
T Consensus       510 ylkdGyR-----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  510 YLKDGYR-----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             HHhccce-----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            2221111           1223467888999999999999999999999999998764

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=288.20  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=200.0

Q ss_pred             cccccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|.||.||++.... |+.+|+|.+.......     +.....+.+|+.+|+++. |||||.+.+.+++....++
T Consensus        39 l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-----~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   39 LGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-----KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             ehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-----cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            45789999999999999754 9999999997643322     113468889999999998 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC----CceEEeccCC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE----FTPRLADFGL  254 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kl~Dfgl  254 (380)
                      |||++.||.|.+.+...     .++......++.|++.+++|||   +.+++||||||+|+|+...    +.+|++|||+
T Consensus       114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999753     2899999999999999999999   8999999999999999543    4799999999


Q ss_pred             cccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          255 AKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       255 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      +.....     ..+||+.|+|||++...+|+...||||+|+++|.|++|..||.......       .. .. ...+.  
T Consensus       186 a~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-------~~-~~-i~~~~--  254 (382)
T KOG0032|consen  186 AKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-------IF-LA-ILRGD--  254 (382)
T ss_pred             ceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-------HH-HH-HHcCC--
Confidence            987765     2469999999999999999999999999999999999999986411000       00 01 11111  


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .....+.+ +.....+.+++..++..||.+|+|+.++++
T Consensus       255 ----~~f~~~~w-~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  255 ----FDFTSEPW-DDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ----CCCCCCCc-cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                11122222 456778899999999999999999999986

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.2e-37  Score=282.72  Aligned_cols=238  Identities=23%  Similarity=0.314  Sum_probs=192.7

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... +++.+|+|.+.....     ........+.+|++++++++||||+++++++.++...++||
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-----VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            467999999999999874 689999999864211     12233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999874    346889999999999999999999   89999999999999999999999999999987654


Q ss_pred             C---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          261 S---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       261 ~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                      .   ..+++.|+|||.+.+...+.++||||||+++|+|++|..||....        ......... .+.          
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~----------  214 (290)
T cd05580         154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKIL-EGK----------  214 (290)
T ss_pred             CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHh-cCC----------
Confidence            3   347889999999988888999999999999999999999986311        001011111 000          


Q ss_pred             CCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHH
Q 047245          338 GEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELV  371 (380)
Q Consensus       338 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl  371 (380)
                       ...+......+.+++.+||+.||.+||     +++|++
T Consensus       215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence             011122345678999999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.4e-37  Score=280.93  Aligned_cols=240  Identities=20%  Similarity=0.268  Sum_probs=183.8

Q ss_pred             ccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHH---HHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          104 LLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE---VLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +||+|+||.||++.. .+|+.+|+|.+........     .....+.+|..   .+...+||||+.+.+++...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-----hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence            489999999999987 4688999998865322111     11122333433   44445799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||++....
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            999999999998864    346899999999999999999999   8999999999999999999999999999986543


Q ss_pred             C----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .    ...++..|+|||.+.. ..++.++||||||+++|||++|..||......     ... .......      ... 
T Consensus       149 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~-~~~~~~~------~~~-  215 (279)
T cd05633         149 KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKH-EIDRMTL------TVN-  215 (279)
T ss_pred             ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHH-HHHHHhh------cCC-
Confidence            2    2358899999999864 56889999999999999999999998642110     111 1111000      001 


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                          ...+......+.+++.+|++.||++||     |++|+++
T Consensus       216 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         216 ----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                112233456688999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-37  Score=280.02  Aligned_cols=241  Identities=22%  Similarity=0.338  Sum_probs=193.2

Q ss_pred             cCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||+|+||.||++... +|+.+++|.+.....     ........+.+|++++++++||||+++++.+..+...++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-----IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh-----hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence            689999999999986 489999999865211     12344578889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC--
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS--  261 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~--  261 (380)
                      ++++|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~  148 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ  148 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence            99999999874    236899999999999999999999   899999999999999999999999999998653221  


Q ss_pred             ------------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          262 ------------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       262 ------------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                                  ..++..|++||.......+.++||||||++++|+++|..||...        ........... +   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~-~---  216 (265)
T cd05579         149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE--------TPEEIFQNILN-G---  216 (265)
T ss_pred             cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhc-C---
Confidence                        24677899999998888999999999999999999999998642        11111211111 0   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                           ... ..........+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       217 -----~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         217 -----KIE-WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -----CcC-CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                 000 0000112566789999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.5e-37  Score=283.84  Aligned_cols=238  Identities=22%  Similarity=0.371  Sum_probs=190.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .++..+++|.+...        .....+.+.+|+.++++++|||++++++++...+..++|+
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--------QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--------cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            46799999999999985 46789999998541        1122367889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             ecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            99999999999863     35788999999999999999999   99999999999999999999999999998765432


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...+++.|++||.+.+..++.++|+||||+++||+++|..||......        .........+.      +
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~~~~------~  233 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGT------P  233 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hheeehhcCCC------C
Confidence                  224778899999998888999999999999999999999998631000        00000000000      0


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ...........+.+++.+||..+|++||++.+++.
T Consensus       234 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         234 ---ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00111223456788999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=281.95  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=187.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|++|.||++... +++.||+|.+.......       ....+.+|++++++++|+||+++++++.+....++|
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-------APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-------CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            3467999999999999974 68899999987532111       113466899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++ +|.+++...   ...+++.....++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++...
T Consensus        82 ~e~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          82 FEYLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            999985 999988642   336889999999999999999999   8999999999999999999999999999986542


Q ss_pred             C------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC---------CCCHHHHHHHHH
Q 047245          260 G------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS---------GGSLGRWLRHLQ  323 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~---------~~~l~~~~~~~~  323 (380)
                      .      ...++..|+|||.+.+ ..++.++||||+|+++|||++|..||.........         ......|.. ..
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  233 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG-VS  233 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh-hh
Confidence            1      1236778999999875 45889999999999999999999998532100000         000000000 00


Q ss_pred             hhcchhHhh-----chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAGEAREAL-----DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .........     ...+............+.+++.+|++.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000000000     0000000000011256779999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.5e-37  Score=281.37  Aligned_cols=255  Identities=24%  Similarity=0.339  Sum_probs=189.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||.|++|.||++.. .+|..+|+|++......      ......+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccc------cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            45789999999999987 46889999988642211      122357888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ ++|.+++..  .....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        79 e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          79 EFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             eccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9996 689998874  22456899999999999999999999   89999999999999999999999999999875432


Q ss_pred             C------CcCCCcccCcccccCCC-CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh--------
Q 047245          261 S------LIATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA--------  325 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~--------  325 (380)
                      .      ..++..|+|||.+.+.. ++.++||||||+++|||+||+.||.......    .+..........        
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhhh
Confidence            1      23577899999887644 6889999999999999999999985321100    000101000000        


Q ss_pred             ---cchhHhhchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 ---GEAREALDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ---~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ......+.......  .........+.+++.+|++.||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               00000000000000  000112345678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.4e-37  Score=280.11  Aligned_cols=242  Identities=22%  Similarity=0.305  Sum_probs=195.7

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... ++..+|+|.+.....     ......+.+.+|++.+++++||||+++++++.++...++|
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (258)
T cd05578           4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-----VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV   78 (258)
T ss_pred             EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-----cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence            3467999999999999975 589999999975221     1223457889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++..    ..++++..+..++.|+++||.|||   +.+++|+||+|+||++++++.++|+|||++....
T Consensus        79 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          79 VDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             EeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            999999999999874    247889999999999999999999   8999999999999999999999999999987654


Q ss_pred             CC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 GS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      ..     ..++..|+|||.+.+..++.++|+||||+++|++++|..||.....      ....+.......         
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~---------  216 (258)
T cd05578         152 PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR------TIRDQIRAKQET---------  216 (258)
T ss_pred             CCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc------cHHHHHHHHhcc---------
Confidence            32     3477889999999988899999999999999999999999864211      011121111110         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCH--HhHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS--DELV  371 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~--~evl  371 (380)
                        .....+......+.+++.+||+.||.+||++  +|++
T Consensus       217 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 --ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence              0111222344678899999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6.4e-37  Score=279.77  Aligned_cols=251  Identities=24%  Similarity=0.350  Sum_probs=192.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|.. .+|..+++|++.....      .......+.+|+.++++++||||+++++++......++|+
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRL------EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             EeecccCCCcEEEEEEECCCCceEEEEEEEcccc------cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            46799999999999996 4689999999875321      1223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+ +++|.+++...   ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          79 EYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             ccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            999 99999998742   356899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C-------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh---
Q 047245          261 S-------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR---  329 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~---  329 (380)
                      .       ..++..|+|||.+.+. .++.++||||+|++++||++|..||....       ....+.+....-+...   
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07832         152 EEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-------DIEQLAIVFRTLGTPNEET  224 (286)
T ss_pred             CCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-------HHHHHHHHHHHcCCCChHH
Confidence            2       3478899999998654 46899999999999999999977764311       1111111110000000   


Q ss_pred             -----------HhhchhccC---CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 -----------EALDRSILG---EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 -----------~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                 ....+....   .....+....+.+++.+|++.+|++|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                       000000000   0000123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.5e-37  Score=280.01  Aligned_cols=239  Identities=25%  Similarity=0.415  Sum_probs=193.8

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... ++..+++|++.....         ....+.+|++.+++++|+|++++++.+......++++
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            357999999999999986 688999999875211         3467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++...   ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          95 EYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            999999999999852   247999999999999999999999   89999999999999999999999999998765432


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...++..|++||.+.+..++.++|+||||+++|+|++|..||...        .............        
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~--------~~~~~~~~~~~~~--------  232 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE--------PPLRALFLITTKG--------  232 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC--------
Confidence                  223678899999998888999999999999999999999998531        1011111111100        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .............+.+++.+|++.+|.+|||+.++++
T Consensus       233 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         233 -IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             0000111123456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.8e-37  Score=277.57  Aligned_cols=247  Identities=24%  Similarity=0.406  Sum_probs=194.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||.|++|.||+|.. .++..+++|++.....       ......+.+|++.++.++|+|++++++.+...+..+++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-------QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc-------chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            356799999999999996 4678999999864211       11347789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +|++++++|.+++..... ...+++.....++.|++.|++|||   +.+++||||+|+||++++++.++|+|||++....
T Consensus        78 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~  153 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA  153 (267)
T ss_pred             EeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence            999999999999974221 246899999999999999999999   9999999999999999999999999999986543


Q ss_pred             C----------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          260 G----------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       260 ~----------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .          ...++..|+|||.+... .++.++|+||||+++|||++|..||......       .........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~----  222 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVLMLTLQN----  222 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhHHHHhcC----
Confidence            2          12477889999998876 7899999999999999999999998642110       001111000    


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ..+..............+.+++.+||+.||++|||+.++++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 ---DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ---CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               00111111111234566789999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-37  Score=275.64  Aligned_cols=243  Identities=25%  Similarity=0.388  Sum_probs=198.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++.. .++..+++|.+.....      .......+.+|++++++++|+||+++.+++.+....++|+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM------SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhc------cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            46799999999999875 4678999999865221      1233467788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++.........+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            999999999999764444567899999999999999999999   99999999999999999999999999999876543


Q ss_pred             C----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          261 S----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       261 ~----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      .    ..++..|++||.+.+..++.++|+||||+++||+++|+.||...        .........          ....
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~----------~~~~  217 (256)
T cd08530         156 NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR--------SMQDLRYKV----------QRGK  217 (256)
T ss_pred             CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHH----------hcCC
Confidence            2    34788999999999999999999999999999999999998631        111111111          1111


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      . ...+......+.+++.+|++.+|++|||+.++++
T Consensus       218 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 Y-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             C-CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1 1122345566899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-36  Score=273.87  Aligned_cols=241  Identities=24%  Similarity=0.432  Sum_probs=197.0

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... ++..+++|++.....       ......+.+|+..+.+++|+|++++++++...+..++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            468999999999999975 489999999865211       134578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||+++++|.+++..    ...+++..++.++.|+++|++|||   + .+++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          79 EYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            99999999999974    257899999999999999999999   8 999999999999999999999999999987654


Q ss_pred             CC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 GS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..      ..++..|+|||.+.+..++.++|+||||+++|||++|..||.....     ....+........        
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~--------  218 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDG--------  218 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcC--------
Confidence            32      2467889999999998899999999999999999999999864211     0111111111110        


Q ss_pred             hhccCCcccHH-HHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEED-EMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ..  ...+.. .+..+.+++.+|++.+|++|||+.++++
T Consensus       219 -~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         219 -PP--PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             -CC--CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence             00  111122 4567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=276.15  Aligned_cols=245  Identities=21%  Similarity=0.271  Sum_probs=188.3

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHH-HHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV-LASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|++|.||++.. .+|+.||+|.+.....     ........+..|... ....+|+|++++++++..++..++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-----IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh-----hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence            3589999999999987 4688999999864211     111222334455544 44558999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++....
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            99999999999874    346888999999999999999999   89999999999999999999999999999876542


Q ss_pred             --CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccC
Q 047245          261 --SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILG  338 (380)
Q Consensus       261 --~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  338 (380)
                        ...++..|+|||.+.+..++.++||||||+++||+++|..||...        ........... +.    ..   ..
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~-~~----~~---~~  213 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE--------TPDAVFDNILS-RR----IN---WP  213 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHh-cc----cC---CC
Confidence              345788999999998888899999999999999999999998531        11111111111 00    00   00


Q ss_pred             CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          339 EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       339 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      ..........+.+++.+||+.+|++||++.++.+.|.
T Consensus       214 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         214 EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            1111234566889999999999999998876665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.4e-37  Score=281.48  Aligned_cols=237  Identities=19%  Similarity=0.351  Sum_probs=190.8

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ..||+|+||.||++.. .+|..+|+|++...        .......+.+|+.++++++|+|++++++++...+..+++||
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--------chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            4699999999999987 57899999987531        12234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      |+++++|.+++.     ...+++.....++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus        98 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657          98 FLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             cCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            999999999875     235789999999999999999999   899999999999999999999999999988654321


Q ss_pred             ------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       262 ------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                            ..++..|+|||.+.+..++.++|+||||+++|||++|..||...        ..........      ..+.+.
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--------~~~~~~~~~~------~~~~~~  235 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIR------DNLPPK  235 (292)
T ss_pred             cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH------hhCCcc
Confidence                  34788899999998888999999999999999999999998531        1111111111      011111


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +.   ........+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~---~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         236 LK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cC---CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            10   01123445778999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=271.26  Aligned_cols=242  Identities=24%  Similarity=0.351  Sum_probs=193.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|.|+.||+... ++|+.+|+|.+....-      .....+++.+|+.+.+.|+||||+++...+.+.+..|+|+
T Consensus        16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~------~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL------SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             HHHHccCchHHHHHHHhccchHHHHHHHhhhhhh------ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35699999999999774 6799999998865322      2224578889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEeccCCccc
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADFGLAKL  257 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfgl~~~  257 (380)
                      |+|+|++|..-+-..    ...++...-....||+++|.|+|   .++|||||+||+|+++-.   .--+||+|||++..
T Consensus        90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999998766532    35677778899999999999999   999999999999999943   34689999999987


Q ss_pred             CCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          258 MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      +.+.     ..|||+|||||++...+++..+|||+.||+||-|+.|..||..   +     +-.+....+....      
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~-----~~~rlye~I~~g~------  228 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---E-----DQHRLYEQIKAGA------  228 (355)
T ss_pred             eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---c-----cHHHHHHHHhccc------
Confidence            7643     4699999999999999999999999999999999999999863   1     1111111111110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .... ...-+.......+++.+++..||.+|.|+.|.+.
T Consensus       229 -yd~~-~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  229 -YDYP-SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -cCCC-CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence             0111 1122345667889999999999999999998763

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-37  Score=294.36  Aligned_cols=188  Identities=26%  Similarity=0.423  Sum_probs=165.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-C-----CCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-H-----RNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~  173 (380)
                      ..++||+|+||.|.|+.. .+++.||||+++.         .....++-..|+.+|..|+ |     -|+|++++++...
T Consensus       190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             EEEEecccccceeEEEEecCCCcEEEEEeecc---------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            357899999999999986 5699999999986         3344567778999999997 5     3899999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC--CceEEec
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE--FTPRLAD  251 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kl~D  251 (380)
                      ++.+||+|.+.. ||.++++.  +....++...+..|+.||+.||..||   ..+|||+||||+||||.+.  ..+||+|
T Consensus       261 ~HlciVfELL~~-NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEe
Confidence            999999999865 99999985  44567899999999999999999999   9999999999999999653  4799999


Q ss_pred             cCCcccCCCC---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          252 FGLAKLMPGS---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       252 fgl~~~~~~~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      ||.+......   ...+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.
T Consensus       335 FGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  335 FGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            9999876654   347788999999999999999999999999999999977665

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.9e-37  Score=280.06  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=188.4

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|+||.||++.. .+|+.+|+|.+.....       ......+.+|+..+.++. |+||+++++++...+..++++
T Consensus        10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616          10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-------EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHhCCCCceEEEEEEECCCCCEEEEEEehhccC-------hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            5799999999999986 4689999999865221       133467889999999995 999999999999989999999


Q ss_pred             eecCCCCHHHHHHHh-hhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRI-RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||+.. ++.++.... ......+++.....++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+++...
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            99864 766654321 1223568999999999999999999993  2589999999999999999999999999987543


Q ss_pred             C-----CCcCCCcccCcccccCC---CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 G-----SLIATSAYSAPECFQNR---SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~---~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .     ...++..|+|||.+.+.   .++.++||||||+++|||++|+.||....       ....-.......      
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~------  226 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKG------  226 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCC------
Confidence            2     23478889999999766   68999999999999999999999985311       000111111000      


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..+.+... ........+.+++.+||+.+|++|||++++++
T Consensus       227 ~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         227 DPPILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCCcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00111111 11234567889999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=282.22  Aligned_cols=259  Identities=24%  Similarity=0.351  Sum_probs=192.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|++|.||++... +++.|++|++.....      .......+.+|++++++++|+||+++++++...+..+++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED------DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc------cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            3467999999999999875 578999998865221      223347788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||++++.+..+...    ...+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||++....
T Consensus        79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          79 FEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             EecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            999998777665542    345899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CC-------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC-------CCCHHHHHHHHHh
Q 047245          260 GS-------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS-------GGSLGRWLRHLQH  324 (380)
Q Consensus       260 ~~-------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~-------~~~l~~~~~~~~~  324 (380)
                      ..       ..++..|+|||.+.+. .++.++||||||+++|+|++|..||.........       ......+......
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            32       2467789999999887 7899999999999999999999998632110000       0000000000000


Q ss_pred             hcchh-----HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 AGEAR-----EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .....     +..+........+......+.+++.+||+.+|++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000     0000000000111123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.4e-37  Score=278.79  Aligned_cols=241  Identities=24%  Similarity=0.306  Sum_probs=188.5

Q ss_pred             cCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||+|+||+||++.. .+|+.+|+|.+.....     ........+..|++++++++||||+++++.+...+..++|+||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-----KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-----hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence            69999999999985 4688999999864211     11223456678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC---
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---  260 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---  260 (380)
                      ++++|.+++...  ....+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||.+.....   
T Consensus        76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  150 (277)
T cd05577          76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK  150 (277)
T ss_pred             CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence            999999998742  2346899999999999999999999   89999999999999999999999999999875442   


Q ss_pred             --CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccC
Q 047245          261 --SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILG  338 (380)
Q Consensus       261 --~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  338 (380)
                        ...++..|+|||.+.+..++.++||||||+++++|++|+.||......    .........          ....  .
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~----------~~~~--~  214 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEELKRR----------TLEM--A  214 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHHHhc----------cccc--c
Confidence              234677899999998888999999999999999999999998642110    000000000          0000  0


Q ss_pred             CcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHH
Q 047245          339 EEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELV  371 (380)
Q Consensus       339 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl  371 (380)
                      ...+......+.+++.+||+.+|++||     ++.+++
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll  252 (277)
T cd05577         215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR  252 (277)
T ss_pred             ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence            111122355678999999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-36  Score=272.96  Aligned_cols=243  Identities=23%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||.|++|.||++... ++..+++|++.....      .......+.+|++.+++++|+|++++.+.+..++..++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM------SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC------ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            467999999999999974 688999999875221      2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++.........+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            999999999999864333467999999999999999999999   88999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .      ..+++.|+|||...+..++.++|+||+|+++++|++|..||...        .............      . 
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~--------~~~~~~~~~~~~~------~-  220 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE--------NLLELALKILKGQ------Y-  220 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC--------cHHHHHHHHhcCC------C-
Confidence            2      34788899999998888999999999999999999999998531        1112222211110      0 


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          ...+......+.+++.+||+.+|++|||+.|+++
T Consensus       221 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 ----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1111233456789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-36  Score=272.70  Aligned_cols=241  Identities=27%  Similarity=0.404  Sum_probs=197.3

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  178 (380)
                      .+.||+|++|.||+|... ++..+++|++......      ......+.+|+..+++++|+||+++++.+.+.  ...++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            467999999999999975 6899999998753211      33457889999999999999999999999988  89999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ++||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          79 FLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            9999999999999874    237899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          259 PGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       259 ~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ...        ..++..|+|||.+.....+.++||||||++++++++|..||....       ....-......      
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGS------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccc------
Confidence            432        347788999999998889999999999999999999999986421       01111111110      


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .......+......+.+++.+|++.+|++||++.+++.
T Consensus       219 ----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 ----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                00011222334667899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=277.58  Aligned_cols=234  Identities=23%  Similarity=0.387  Sum_probs=197.3

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ..||+|+||.|||+.. .+|+.+|+|.+...          ...+++..|+.++.+...|++|+++|.+-....+++|||
T Consensus        39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            5699999999999986 57999999998652          234788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      ||..||..|.++.   ...+++..++..++.+.+.||+|||   ...-+|||||+.|||++.+|.+||+|||.+..+.+ 
T Consensus       109 YCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  109 YCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            9999999999874   3568999999999999999999999   88899999999999999999999999999987653 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...||+.|||||++..-.|..++||||+|++..||..|++||...-+.                    ...+--.
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------------------RAIFMIP  242 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------------------RAIFMIP  242 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------------------ceeEecc
Confidence                 456999999999999999999999999999999999999999642100                    0000000


Q ss_pred             c-cCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 I-LGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~-~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      . ...  .-+++-+..+-+++..|+-++|++|-|+-++++
T Consensus       243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            0 000  122445667889999999999999999988875

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-36  Score=278.83  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=189.6

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  178 (380)
                      .+.||+|++|.||+|... +++.+++|.++.....      ......+.+|+.++.+++||||+++.+++...  ...++
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            367999999999999975 5889999999753211      12234567899999999999999999998777  88999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |+||+++ +|.+++...   ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          84 VMEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            9999974 999988742   236899999999999999999999   899999999999999999999999999998865


Q ss_pred             CCC------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHHHH
Q 047245          259 PGS------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRHLQ  323 (380)
Q Consensus       259 ~~~------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~~~  323 (380)
                      ...      ..+++.|+|||.+.+. .++.++|+||||+++|||++|..||........        .......|.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            432      2467889999998764 468999999999999999999999863211000        0000001111000


Q ss_pred             hh----cchhHhhchhccCCcccHH-HHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HA----GEAREALDRSILGEEVEED-EMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~----~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      -.    ..........+ ....+.. ....+.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00    00000000000 0111111 3556789999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=272.82  Aligned_cols=243  Identities=21%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  177 (380)
                      ..+.||+|++|.||++.. .+|..+|+|.+.......   ........+.+|+.++++++|+||+++++++.+.  ...+
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ---ETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccc---hhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            457899999999999986 468999999875421111   1233457889999999999999999999998664  4688


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +++||+++++|.+++..    ...+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||+++.
T Consensus        83 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          83 IFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            99999999999999863    335788999999999999999999   89999999999999999999999999999975


Q ss_pred             CCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          258 MPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       258 ~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ...         ...++..|+|||.+.+..++.++|+||||++++|+++|+.||...       ....... .       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~-~-------  220 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY-------EAMAAIF-K-------  220 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc-------CHHHHHH-H-------
Confidence            432         124788899999999888999999999999999999999998531       0011100 1       


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        ..... .....+......+.+++.+|+. +|..||+..+++.
T Consensus       221 --~~~~~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 --IATQP-TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --HHcCC-CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              11000 0111233455668899999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-36  Score=279.69  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=189.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|.. .++..+|+|.+......     ......++.+|+++++.++|+|++++.+++......++|+
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-----ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            35799999999999996 46788999988642111     1233467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+. |+|.+++..   ....+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 688887753   2345889999999999999999999   89999999999999999999999999999876543


Q ss_pred             --CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 --SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 --~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                        ...++..|+|||.+.   ...++.++||||||+++|||++|..||...        .-...........      .+ 
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~------~~-  232 (308)
T cd06634         168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNE------SP-  232 (308)
T ss_pred             cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc--------cHHHHHHHHhhcC------CC-
Confidence              235788999999974   356788999999999999999999997531        0011111111100      00 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                         ..........+.+++.+||+.+|.+||+++++++-
T Consensus       233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence               11112344567899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-36  Score=270.44  Aligned_cols=240  Identities=23%  Similarity=0.413  Sum_probs=194.7

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... ++..+++|++.....        .....+.+|+..+++++|+|++++++++......++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            367999999999999985 688999999975211        23478889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++...   ...+++..+..++.|++.|++|||   ..+++||||+|+||++++++.++|+|||.+.....
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          77 EFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             ecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            999999999998742   257899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 S-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 ~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .     ..++..|+|||.+.+..++.++||||||++++++++|..||...        ........... .      +..
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~-~------~~~  215 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL--------PPMKALFKIAT-N------GPP  215 (253)
T ss_pred             cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------chHHHHHHHHh-c------CCC
Confidence            2     34788899999999888999999999999999999999998631        01111111110 0      000


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..  .........+.+++.+||+.||++|||+.|+++
T Consensus       216 ~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 GL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             Cc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00  011112456889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=276.80  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=189.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||.|++|.||+|.. .+|..||+|++.....      .......+.+|++.+++++|||++++++++.+.+..++++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~   77 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE------DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF   77 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccc------cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence            35799999999999986 4799999999875321      1122356778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ ++|.+++....  ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        78 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          78 EFLD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             eccC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            9995 69999987422  246899999999999999999999   89999999999999999999999999999876432


Q ss_pred             ------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc-------
Q 047245          261 ------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG-------  326 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-------  326 (380)
                            ...++..|+|||.+.+. .++.++||||||+++|||++|..||.......    .+....+......       
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID----QLFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHHhhhh
Confidence                  12357889999988664 57899999999999999999999985321100    0111111000000       


Q ss_pred             ----chhHhhchhccC--CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 ----EAREALDRSILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ----~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .....+......  ..........+.+++.+|++.+|++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                000000000000  0001123356789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.8e-36  Score=275.66  Aligned_cols=254  Identities=22%  Similarity=0.300  Sum_probs=186.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|.. .+|..+|+|++......       .....+.+|+.+++.++|+||+++.+++......++|+
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-------GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-------CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            46799999999999986 46889999998653211       11245678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ ++|.+++..   ....+.+..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9995 688777653   2345788888999999999999999   88999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHH-H----------HHHH
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR-W----------LRHL  322 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~-~----------~~~~  322 (380)
                            ...++..|+|||.+.+ ..++.++||||||+++|||++|..||+.......   .+.. |          ....
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE---QLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH---HHHHHHHHcCCCChhhhhhh
Confidence                  2346888999999875 4578899999999999999999999864211100   0000 0          0000


Q ss_pred             HhhcchhHhhchhccCCc-----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          323 QHAGEAREALDRSILGEE-----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...........+......     ........+.+++.+|+..||.+|||++|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000000000000     00012345778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-36  Score=277.32  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=188.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCe---
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSR---  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~---  175 (380)
                      ..+.||+|+||.||++.. .+|+.||+|.......      .......+.+|+.+++++ +||||+++++++...+.   
T Consensus         5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD------EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             EeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc------ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            346799999999999997 4689999998765221      112235678899999999 56999999999876655   


Q ss_pred             --EEEEEeecCCCCHHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEec
Q 047245          176 --FYLVYDYLQTGSLEDAMDRIREN-QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLAD  251 (380)
Q Consensus       176 --~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~D  251 (380)
                        .+++|||+++ +|.+++...... ...+++..+..++.|++.||+|||   +.+++||||+|+||+++. ++.+||+|
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEee
Confidence              8999999985 899988753322 346899999999999999999999   899999999999999998 88999999


Q ss_pred             cCCcccCCCC------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          252 FGLAKLMPGS------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       252 fgl~~~~~~~------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      ||+++.....      ..+++.|+|||.+.+ ..++.++||||||+++|||++|..||....       ...........
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-------~~~~~~~~~~~  227 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS-------ELQQLLHIFKL  227 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHHH
Confidence            9998754321      236778999998865 457899999999999999999999985310       11111100000


Q ss_pred             hcchhH-h----------hc-hhccC---CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 AGEARE-A----------LD-RSILG---EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ~~~~~~-~----------~~-~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+.... .          .. +....   ....+.....+.+++.+||+.||.+|||++|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000 0          00 00000   0001124556889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-36  Score=278.48  Aligned_cols=240  Identities=25%  Similarity=0.370  Sum_probs=189.2

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|+||.||+|.. .+|..+++|.+.....     ........+.+|++++++++|||++++++++.+....++|+|
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-----QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEecccc-----CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            4599999999999986 4688999999865221     122334678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+. |++.+++..   ...++++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++..... 
T Consensus       102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~  174 (313)
T cd06633         102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA  174 (313)
T ss_pred             cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence            996 588887753   2446899999999999999999999   89999999999999999999999999999875432 


Q ss_pred             -CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          261 -SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       261 -~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                       ...++..|+|||.+.   ...++.++||||||+++|||++|..||...        .............      .+..
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~------~~~~  240 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQND------SPTL  240 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhcC------CCCC
Confidence             345788999999984   456888999999999999999999998531        1111111111110      0000


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          ........+.+++.+||+.+|.+||++.+++.
T Consensus       241 ----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         241 ----QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                11122345788999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-36  Score=271.73  Aligned_cols=240  Identities=24%  Similarity=0.310  Sum_probs=196.1

Q ss_pred             cccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|.-|+||.+.+.+ +...|+|++.....     ...+...+.+.|-++|+.++||.++.+++.++.....+++||
T Consensus        83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-----~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-----ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHcCCCCceeEEEEEecCCCceEEEEEecHHHH-----hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            679999999999999854 58999999976322     224445778889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC--
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~--  259 (380)
                      ||+||+|...+++  .....++.....-++..++-||+|||   -.|||.|||||+||||.++|++.|+||.++....  
T Consensus       158 yCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  158 YCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             cCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999998884  44667899999999999999999999   9999999999999999999999999999863210  


Q ss_pred             ----------------------------------C--------------------------CCcCCCcccCcccccCCCC
Q 047245          260 ----------------------------------G--------------------------SLIATSAYSAPECFQNRSY  279 (380)
Q Consensus       260 ----------------------------------~--------------------------~~~~~~~y~aPE~~~~~~~  279 (380)
                                                        .                          ..+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                              0                          0127888999999999999


Q ss_pred             CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccC
Q 047245          280 TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSD  359 (380)
Q Consensus       280 ~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  359 (380)
                      +.+.|.|+|||++|||+.|..||-..    ..             ...+..++...+.-... .+.+..+.+||.+.|.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~----~~-------------~~Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGS----NN-------------KETLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCC----Cc-------------hhhHHHHhcCCCcCCCC-CcchhHHHHHHHHHhcc
Confidence            99999999999999999999998631    11             11223333333222222 24567789999999999


Q ss_pred             CCCCCCC----HHhH
Q 047245          360 SPADRPS----SDEL  370 (380)
Q Consensus       360 ~P~~RPs----~~ev  370 (380)
                      ||++|-.    +.||
T Consensus       375 dP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEI  389 (459)
T ss_pred             ChhhhhccccchHHh
Confidence            9999988    5554

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.4e-36  Score=274.26  Aligned_cols=240  Identities=20%  Similarity=0.271  Sum_probs=184.2

Q ss_pred             ccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHH---HHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          104 LLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQE---LEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +||+|+||.||++.. .+++.||+|.+.........     ....+..|   +..++...||||+.+.+++.+.+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-----GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-----hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence            489999999999986 46889999998753221111     11122233   3455556899999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++|+|.+++..    ...+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||++....
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            999999999998863    346999999999999999999999   8999999999999999999999999999987543


Q ss_pred             C----CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G----SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .    ...++..|+|||.+.++ .++.++||||+|+++|||++|+.||......     ..... ....      .....
T Consensus       149 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~------~~~~~  216 (278)
T cd05606         149 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEI-DRMT------LTMAV  216 (278)
T ss_pred             ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHH-HHHh------hccCC
Confidence            2    23588999999998754 6899999999999999999999998642100     00000 0000      00011


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                           ..+......+.+++.+|+..+|.+||     ++.++++
T Consensus       217 -----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                 11122356688999999999999999     8988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.3e-36  Score=279.49  Aligned_cols=257  Identities=19%  Similarity=0.297  Sum_probs=188.3

Q ss_pred             ccCcc--CCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          104 LLGSS--PDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G--~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .||+|  +||+||++.. .+|+.||+|.+.....      .....+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~   78 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVIS   78 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEE
Confidence            46666  8999999986 4789999999865221      2233478889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++....  ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+.....
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence            9999999999987532  335889999999999999999999   89999999999999999999999999975432211


Q ss_pred             -------------CCcCCCcccCcccccCC--CCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-----CCCC------
Q 047245          261 -------------SLIATSAYSAPECFQNR--SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-----SGGS------  314 (380)
Q Consensus       261 -------------~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-----~~~~------  314 (380)
                                   ...++..|+|||.+.+.  .++.++||||||+++|||++|..||........     ....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence                         01245569999999763  478999999999999999999999864211000     0000      


Q ss_pred             ------HHHHHHH--HHhhcch---------hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          315 ------LGRWLRH--LQHAGEA---------REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       315 ------l~~~~~~--~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ...+...  ....+..         ....+..+ ...........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                  0000000  0000000         00000011 11122345677899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=277.15  Aligned_cols=254  Identities=15%  Similarity=0.162  Sum_probs=176.7

Q ss_pred             cccccCccCCeeEEEEEecCC----cEEEEEEeeeccCCChhhhc----HHHHHHHHHHHHHHHcCCCCCcceeeEEEec
Q 047245          101 ENRLLGSSPDGKYYRTVLDNG----LTVAVRRVEAFESGSPEKQN----KSVKRRIQQELEVLASLRHRNLMSLRAYVPE  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g----~~vavK~~~~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  172 (380)
                      ..++||+|+||.||+|...++    ..+|+|...... .......    .........+...+..++|+|++++++++..
T Consensus        16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~-~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   94 (294)
T PHA02882         16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN-ETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF   94 (294)
T ss_pred             EeeEEecCCCceEEEEEEcCCcccccceEEEeccccC-CchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence            457899999999999997543    455555433211 1100000    0001122344556677899999999987654


Q ss_pred             CC----eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          173 SS----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       173 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      ..    ..++++|++. .++.+.+..    ....++..+..++.|++.||+|||   +.+++||||||+|||++.++.++
T Consensus        95 ~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         95 KRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             ecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            43    3467778764 367766653    223577888999999999999999   89999999999999999999999


Q ss_pred             EeccCCcccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCH
Q 047245          249 LADFGLAKLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL  315 (380)
Q Consensus       249 l~Dfgl~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l  315 (380)
                      |+|||+++....             ...||+.|+|||...+..++.++||||||+++|||++|..||....    .....
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~----~~~~~  242 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG----HNGNL  242 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc----cchHH
Confidence            999999875421             1248999999999999999999999999999999999999996421    11111


Q ss_pred             HHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                         ......  .....+...   ..........+.+++..|++.+|++||+++++++.|+
T Consensus       243 ---~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 ---IHAAKC--DFIKRLHEG---KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             ---HHHhHH--HHHHHhhhh---hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence               100000  000111110   0011123456889999999999999999999998764

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-37  Score=284.63  Aligned_cols=241  Identities=22%  Similarity=0.344  Sum_probs=190.2

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .++||+||.+.||++...+.+.+|+|++..      ...+.+...-|.+|+..|.+| .|.+||++++|-..++.+|+||
T Consensus       366 lk~iG~GGSSkV~kV~~s~~~iyalkkv~~------~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  366 LKQIGSGGSSKVFKVLNSDKQIYALKKVVL------LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             HHhhcCCCcceeeeeecCCCcchhhhHHHH------hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            357999999999999998889999998864      234566778899999999999 5999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||= ..+|...|+.  .......| .+..+..|++.++.+.|   ..+|||.||||.|+|+- .|.+||+|||+|.....
T Consensus       440 E~G-d~DL~kiL~k--~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  440 ECG-DIDLNKILKK--KKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             ecc-cccHHHHHHh--ccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            976 4599999985  22334445 67789999999999999   99999999999999985 47899999999987654


Q ss_pred             C--------CcCCCcccCcccccCCC-----------CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHH
Q 047245          261 S--------LIATSAYSAPECFQNRS-----------YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       261 ~--------~~~~~~y~aPE~~~~~~-----------~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      +        .+||+.||+||.+....           .+++|||||+|||||+|+-|+.||..          +.+....
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----------~~n~~aK  581 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----------IINQIAK  581 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH----------HHHHHHH
Confidence            3        46999999999996433           45789999999999999999999864          1211111


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            +..+.++...-+.........+.+++..||..||.+|||..|+|+
T Consensus       582 ------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 ------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                  122333321111111112223889999999999999999999985

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.3e-36  Score=277.83  Aligned_cols=242  Identities=25%  Similarity=0.397  Sum_probs=185.8

Q ss_pred             cccccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|++|.||++...+ +..+|||.+....       .......+..|+..+.+. .||||+++++++.+....++
T Consensus        19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-------NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC-------ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            45789999999999999864 8999999986521       112235566778777777 49999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +|||++ ++|.+++...   ...+++..+..++.|++.||+|||   + .+++||||+|+||++++++.+||+|||++..
T Consensus        92 v~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          92 CMELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EeeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            999985 4787776532   347899999999999999999999   6 5899999999999999999999999999876


Q ss_pred             CCCC-----CcCCCcccCcccccCCC----CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          258 MPGS-----LIATSAYSAPECFQNRS----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~----~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ....     ..++..|+|||.+.+..    ++.++||||||+++|||++|+.||......       .+.....      
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~------  231 (296)
T cd06618         165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKI------  231 (296)
T ss_pred             ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHH------
Confidence            5422     23677899999987554    788999999999999999999998531000       0111111      


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ++...............+.+++.+||+.||++||+++++++
T Consensus       232 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         232 ---LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             ---hcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               11110000011123456889999999999999999999975

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.5e-36  Score=272.55  Aligned_cols=255  Identities=18%  Similarity=0.243  Sum_probs=186.1

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecC--CeEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPES--SRFY  177 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~  177 (380)
                      .+.||+|+||.||++.. .++..+|+|++.......       ......+|+..+.++. |+|++++++++.+.  +..+
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   76 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-------EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA   76 (282)
T ss_pred             EeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-------hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence            45799999999999986 468899999886532111       1123457899999995 99999999999887  8899


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +|+||++ |+|.+++..   ....++|..+..++.|++.||+|||   +.+++||||+|+||+++. +.+||+|||+++.
T Consensus        77 lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~  148 (282)
T cd07831          77 LVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRG  148 (282)
T ss_pred             EEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccc
Confidence            9999997 588888763   2346899999999999999999999   899999999999999999 9999999999976


Q ss_pred             CCCC-----CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHHHHHHHHh
Q 047245          258 MPGS-----LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGRWLRHLQH  324 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~~~~~~~~  324 (380)
                      ....     ..++..|+|||.+.. ..++.++||||||+++|||++|..||........       .+.....|......
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         149 IYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             cccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            5422     246788999997654 5578899999999999999999999853110000       00001111111000


Q ss_pred             hcchhHhhchhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 AGEAREALDRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ........+.....   ......+..+.+++.+||+.+|++|||++++++
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 -SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             -cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence             00000000000000   001134577899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-36  Score=281.15  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=186.1

Q ss_pred             ccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      .+|.|+++.||++.. +|..+|+|++....      ........+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~   81 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDS------CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM   81 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccc------cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence            345556666666655 68999999987521      12234577999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC---
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---  260 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---  260 (380)
                      ++|+|.+++...  ....+++.....++.|++.||+|||   +.+++||||||+||+++.++.+|++|||.+.....   
T Consensus        82 ~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          82 AYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            999999999753  2345888899999999999999999   89999999999999999999999999998764321   


Q ss_pred             ----------CCcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh---
Q 047245          261 ----------SLIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA---  325 (380)
Q Consensus       261 ----------~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~---  325 (380)
                                ...++..|+|||.+..  ..++.++|+||||+++|||++|..||......       ..........   
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~  229 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKVRGTVPC  229 (314)
T ss_pred             cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCcc
Confidence                      1236678999999875  35789999999999999999999998632100       0000000000   


Q ss_pred             -----------cchhH----hhchh---ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 -----------GEARE----ALDRS---ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 -----------~~~~~----~~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                 .....    ..++.   .............+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                       00000    00000   0001112234566889999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-36  Score=276.03  Aligned_cols=194  Identities=26%  Similarity=0.458  Sum_probs=161.9

Q ss_pred             ccccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeE
Q 047245          102 NRLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  176 (380)
                      .+.||+|++|.||+|...   ++..+|+|.+.....     ........+.+|+.++++++||||+++++++.+.  ...
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            457999999999999974   478999999976321     1112235677899999999999999999999888  789


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC----CCceEEec
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQ-LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA----EFTPRLAD  251 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~----~~~~kl~D  251 (380)
                      ++||||+++ +|.+++....... ..++...+..++.|++.||+|||   +.+++||||||+||+++.    ++.+||+|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            999999975 7877775433322 37889999999999999999999   899999999999999999    89999999


Q ss_pred             cCCcccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          252 FGLAKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       252 fgl~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      ||+++....         ...++..|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  218 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG  218 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            999876432         1246788999998876 4578999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-36  Score=272.04  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=188.7

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC---CCCCcceeeEEEecCCe--
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL---RHRNLMSLRAYVPESSR--  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~--  175 (380)
                      .+.||+|+||.||++... ++..+|+|++......      ......+.+|+.+++++   +|+|++++++++.....  
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   77 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR   77 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEecccccc------chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence            467999999999999985 4899999999753221      12234566677766655   59999999999987766  


Q ss_pred             ---EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          176 ---FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       176 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                         .+++|||+++ +|.+++...  ....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+||
T Consensus        78 ~~~~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          78 ELKLTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CceeEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEecc
Confidence               8999999974 899988742  2336899999999999999999999   899999999999999999999999999


Q ss_pred             CCcccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          253 GLAKLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       253 gl~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      |++......     ..++..|+|||.+.+..++.++|+||||+++|||++|..||......    ..+..+.........
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  227 (287)
T cd07838         152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFDVIGLPSE  227 (287)
T ss_pred             CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHHHcCCCCh
Confidence            998765422     23677899999999999999999999999999999999887631110    011111111100000


Q ss_pred             h---------hHhhchhccC--CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 A---------REALDRSILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~---------~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .         ...+......  .....+....+.+++.+||+.||.+||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0         0000000000  0111234466789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.3e-36  Score=274.06  Aligned_cols=244  Identities=22%  Similarity=0.307  Sum_probs=190.0

Q ss_pred             ccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||+|+||.||.+..    .+|..+|+|++.....    .......+.+.+|+.++.++ +|+||+++.+++..+...
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh----hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            46799999999999885    4789999999864211    11223346778899999999 699999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++|+||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999999874    346888899999999999999999   8999999999999999999999999999987


Q ss_pred             cCCC-------CCcCCCcccCcccccCC--CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          257 LMPG-------SLIATSAYSAPECFQNR--SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       257 ~~~~-------~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ....       ...++..|+|||.+...  .++.++||||||+++|+|++|..||...    ........+........ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~----~~~~~~~~~~~~~~~~~-  228 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD----GEKNSQAEISRRILKSE-  228 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC----CccccHHHHHHHhhccC-
Confidence            6543       12478889999998753  4678999999999999999999998521    11112222222211110 


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                                 ...+......+.+++.+||+.+|++||     +..+++.
T Consensus       229 -----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 -----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                       111223445678999999999999997     5566553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.7e-36  Score=274.60  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=193.8

Q ss_pred             ccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||+|++|.||++..    .++..+|+|.+.....    .........+.+|++++.++ +||||+++++.+..+...
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            46799999999999874    3578899999864211    11223346788999999999 699999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..    ...+++..+..++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            999999999999999864    346889999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCCC-------CcCCCcccCcccccCCC--CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          257 LMPGS-------LIATSAYSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       257 ~~~~~-------~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      .....       ..++..|+|||...+..  .+.++||||||+++|||++|..||...    ................  
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~----~~~~~~~~~~~~~~~~--  227 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD----GEQNSQSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC----cccchHHHHHHHHHcc--
Confidence            64321       24788999999987655  788999999999999999999998521    1111111111111110  


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                           .     ...+......+.+++.+||+.+|++|||+.++.+.|..
T Consensus       228 -----~-----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -----K-----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----C-----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                 0     11112234557889999999999999999988877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=273.69  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=192.2

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... +|+.+++|.+.....      .......+.+|++.+++++|+||+++++++..+...++++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   77 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE------SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF   77 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence            357999999999999874 688999999865321      1123467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++ +|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus        78 e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          78 EFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             eccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            99975 89888864   2357899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch-----
Q 047245          261 S------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA-----  328 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~-----  328 (380)
                      .      ..++..|+|||.+.+. .++.++|+||||+++|++++|+.||.....       ..........-+..     
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  223 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-------IDQLFKIFRTLGTPDPEVW  223 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHcCCCchHhc
Confidence            2      3467789999998876 789999999999999999999999853110       00000000000000     


Q ss_pred             ---hH--------hhchh-ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 ---RE--------ALDRS-ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ---~~--------~~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .+        ..+.. ........+....+.+++.+||+.||.+||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence               00        00000 0000112235667899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-36  Score=267.58  Aligned_cols=239  Identities=23%  Similarity=0.415  Sum_probs=194.9

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++... ++..+++|.+.....      .+.....+.+|++++++++|+|++++++++.+.+..++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI------KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc------CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            467999999999999864 678999999976321      1234578999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          79 EYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             ecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            99999999999874    257899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .      ..++..|+|||...+..++.++||||+|++++++++|..||....       ........ .. ..       
T Consensus       152 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~~-~~-~~-------  215 (254)
T cd06627         152 VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFRI-VQ-DD-------  215 (254)
T ss_pred             CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHH-hc-cC-------
Confidence            2      247788999999988888999999999999999999999985311       11111110 00 00       


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ....+......+.+++.+|+..+|++|||+.+++.
T Consensus       216 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 ---HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               01111223456789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.2e-36  Score=280.98  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=188.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++.. .+|..||+|.+.....      .......+.+|+.++++++||||+++++++...      
T Consensus        20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             EEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            346799999999999986 4789999999854211      122335677899999999999999999987543      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++|+||++ ++|.+.+..      .++...+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35799999996 588888753      2788889999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHHHHHH
Q 047245          254 LAKLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGRWLRH  321 (380)
Q Consensus       254 l~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~~~~~  321 (380)
                      +++.....     ..++..|+|||.+.+..++.++||||||+++|+|++|+.||........       -+....++...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         164 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             cceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            99865432     3477889999999999999999999999999999999999853110000       00000011110


Q ss_pred             HH-------hhc------chhHhhchhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQ-------HAG------EAREALDRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~-------~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..       ...      ...+.+.......   .........+.+++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00       000      0000000000000   001124556789999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-36  Score=272.70  Aligned_cols=257  Identities=23%  Similarity=0.356  Sum_probs=189.7

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  178 (380)
                      .+.||+|++|.||+|... +|..+|+|++....      ........+.+|++++++++|+|++++++++.+.  +..++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   77 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMEN------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM   77 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEeccc------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence            457999999999999875 58899999998632      1122236688899999999999999999999888  88999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |+||+++ +|.+++..   ....+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++...
T Consensus        78 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          78 VFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             Eeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            9999975 88888763   2247899999999999999999999   889999999999999999999999999998765


Q ss_pred             CCC-------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHH-
Q 047245          259 PGS-------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRH-  321 (380)
Q Consensus       259 ~~~-------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~-  321 (380)
                      ...       ..++..|+|||.+.+ ..++.++||||||+++|||++|..||........        .......|... 
T Consensus       151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence            432       235778999997764 4678999999999999999999999864211000        00000000000 


Q ss_pred             ---HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 ---LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ..............+. ......+...+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0000000000000000 0000112567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.7e-36  Score=270.39  Aligned_cols=245  Identities=22%  Similarity=0.359  Sum_probs=192.1

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... .+..+++|.++.......   .......+..|+.++++++||||+++++++.+....++|+
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL---NPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEecccccccc---CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            467999999999999864 345566676654332211   1122345678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++.........+++..++.++.|++.||.|||   +.+++|+||+|+||++++ +.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence            999999999999765555667999999999999999999999   899999999999999975 5699999999876532


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...+++.|+|||...+..++.++|+||||+++|+|++|..||...        ........... +        
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------~~~~~~~~~~~-~--------  220 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--------NFLSVVLRIVE-G--------  220 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHc-C--------
Confidence                  234778899999998888899999999999999999999998531        11111111111 0        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .  ....+......+.+++.+||+.+|++||++.|+++
T Consensus       221 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         221 P--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             C--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            0  01122345567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.6e-36  Score=274.91  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=186.2

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|... +|+.+|+|.+.....      .......+.+|++++++++||||+++++++.+....++|+
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccc------cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            467999999999999974 688999998864211      1123356788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~  259 (380)
                      ||++ ++|.+++..  ......++.....++.|++.||+|||   +.+++|+||+|+||+++. ++.+||+|||++....
T Consensus        81 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         81 EYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             eccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            9996 588888753  22334678888899999999999999   899999999999999985 5679999999997543


Q ss_pred             C------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch-h--
Q 047245          260 G------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA-R--  329 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~-~--  329 (380)
                      .      ...+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....       ...........+.. .  
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~  227 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE-------IDELFKIFRILGTPNEET  227 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCCChhh
Confidence            2      2246788999998866 4578999999999999999999999853111       11111100000000 0  


Q ss_pred             --------Hhh--chhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 --------EAL--DRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 --------~~~--~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                              +..  .+.....   .........+.+++.+|++.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    000  0000000   001123445789999999999999999999985

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.4e-36  Score=269.71  Aligned_cols=232  Identities=22%  Similarity=0.231  Sum_probs=181.7

Q ss_pred             cCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEEee
Q 047245          105 LGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDY  182 (380)
Q Consensus       105 lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  182 (380)
                      ||+|+||.||++.. .++..+|+|........           .  .|+.....+ +||||+++++.+...+..++||||
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-----------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~   90 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-----------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY   90 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-----------h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence            59999999999986 46788999998642110           0  122222222 799999999999999999999999


Q ss_pred             cCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCcccCCCC
Q 047245          183 LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMPGS  261 (380)
Q Consensus       183 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~~~  261 (380)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++ .++|+|||++......
T Consensus        91 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         91 IKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            999999999974    237899999999999999999999   89999999999999999988 9999999998765533


Q ss_pred             --CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCC
Q 047245          262 --LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGE  339 (380)
Q Consensus       262 --~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  339 (380)
                        ..++..|+|||.+.+..++.++||||||+++|||++|..||.....   .......+.....          ..   .
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----------~~---~  227 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQQ----------KK---L  227 (267)
T ss_pred             ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhhc----------cc---C
Confidence              3578899999999998999999999999999999999999863211   1111222222110          00   0


Q ss_pred             cccHHHHHHHHHHHHHcccCCCCCCCC-HHhHHH
Q 047245          340 EVEEDEMLMAVRIAVVCLSDSPADRPS-SDELVP  372 (380)
Q Consensus       340 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~  372 (380)
                      .........+.+++.+||+.+|.+||+ ++|+++
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            111234566889999999999999996 588873

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.3e-36  Score=273.52  Aligned_cols=258  Identities=22%  Similarity=0.344  Sum_probs=189.8

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||.|++|.||+|... +|..+|+|.+......       .....+.+|+.++++++|+||+++++++.+.+..++|+
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            467999999999999974 6889999998753211       11255678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++ +|.+++.... ....+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++.....
T Consensus        78 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          78 EYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI  152 (284)
T ss_pred             ecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence            99985 8998886422 1346899999999999999999999   89999999999999999999999999999875432


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC--------CCCHHHHHHHHHhh
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS--------GGSLGRWLRHLQHA  325 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~--------~~~l~~~~~~~~~~  325 (380)
                            ...++..|++||.+.+ ..++.++||||||+++||+++|..||.....+..-        ......|. .....
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH-HHhcC
Confidence                  2346788999998865 45688999999999999999999998632111000        00000000 00000


Q ss_pred             cchhHhhchhc--cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSI--LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......+....  ............+.+++.+|++.||.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000000  000011123456789999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=282.51  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=185.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----C
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----S  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  174 (380)
                      ..+.||+|++|.||+|.. .+|..||+|.+....       .......+.+|+.++++++|+||+++++++...     .
T Consensus         9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            346899999999999985 568999999986421       122346677899999999999999999987544     3


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++++||+++ +|.+++.     ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        82 ~~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          82 DVYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             eEEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence            57999999975 8887775     346899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          255 AKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       255 ~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      ++....         ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......     ...........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-----~~~~~~~~~~~  227 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-----HQLNLILGVLG  227 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcC
Confidence            875432         1246888999998754 56899999999999999999999998531000     00000000000


Q ss_pred             hcc-----------hhHhhchhccCCc-----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          325 AGE-----------AREALDRSILGEE-----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       325 ~~~-----------~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                      ...           ..+.+...-....     ........+.+++.+||+.+|++|||+.|+++-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000           0000000000000     001234568899999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.8e-35  Score=273.50  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=186.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  177 (380)
                      ..+.||+|+||.||++.. .+|+.||+|.+.......      .....+.+|+.++++++|+||+++++++.+.  +..+
T Consensus        11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845          11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD------GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC------CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            346799999999999997 468999999987532111      1123456799999999999999999998654  5689


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +|+||+++ +|.+++...   ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++..
T Consensus        85 lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence            99999964 898888742   356899999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCC------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh-c---
Q 047245          258 MPGS------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA-G---  326 (380)
Q Consensus       258 ~~~~------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~-~---  326 (380)
                      ....      ..++..|+|||.+.+ ..++.++||||||+++|||++|..||....        ..+........ +   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--------~~~~~~~~~~~~~~~~  229 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--------EIEQLDLIIQLLGTPN  229 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcCCCC
Confidence            5432      235677999999865 557899999999999999999999985311        11111111100 0   


Q ss_pred             -chhHhhc-------hhccCCc---c---cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 -EAREALD-------RSILGEE---V---EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 -~~~~~~~-------~~~~~~~---~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .....++       ..+....   .   .......+.+++.+|++.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             0000000       0000000   0   0112455778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.2e-36  Score=274.76  Aligned_cols=254  Identities=23%  Similarity=0.332  Sum_probs=186.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|+||.||+|... +|+.||+|++......      ......+.+|++++++++||||+++++++.+..     
T Consensus        11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864          11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK------EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc------cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            3568999999999999974 5889999998753211      112256778999999999999999999987654     


Q ss_pred             -----eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          175 -----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       175 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                           ..++|+||+++ ++.+++..   ....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence                 78999999976 77777653   2346899999999999999999999   899999999999999999999999


Q ss_pred             eccCCcccCCCC-------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHH
Q 047245          250 ADFGLAKLMPGS-------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       250 ~Dfgl~~~~~~~-------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      +|||++......       ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||......    ..+..... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~----~~~~~~~~-  232 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL----AQLELISR-  232 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHH-
Confidence            999998765421       235678999998865 45789999999999999999999998631000    00000000 


Q ss_pred             HHhhcchh-----------HhhchhccC-C---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAR-----------EALDRSILG-E---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~-----------~~~~~~~~~-~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ........           ...+..... .   .........+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000000           000000000 0   000112456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=287.92  Aligned_cols=239  Identities=24%  Similarity=0.360  Sum_probs=191.0

Q ss_pred             cccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      .-||.|+||.|||++..+ +-..|.|++..        ......+++.-||++|+...||+||.+++.|.-.+.++++.|
T Consensus        38 GELGDGAFGKVyKA~nket~~lAAaKvIet--------kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   38 GELGDGAFGKVYKAVNKETKLLAAAKVIET--------KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             hhhcCccchhhhhhhcccchhhhhhhhhcc--------cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            458999999999999754 34456666644        234456889999999999999999999999888899999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC--
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~--  259 (380)
                      ||.||-....+-..   ...+...++.-++.|++.||.|||   +++|||||||+.|||++-+|.++|+|||.+....  
T Consensus       110 FC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             ecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999998876532   557999999999999999999999   9999999999999999999999999999986432  


Q ss_pred             ----CCCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 ----GSLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 ----~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                          +...|||.|||||+..     ..+|+.++||||||++|.||..+.+|....        +.....-.... .    
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--------npMRVllKiaK-S----  250 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAK-S----  250 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--------chHHHHHHHhh-c----
Confidence                4567999999999875     578999999999999999999999996431        11111111111 1    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        +|..+-  .+..-...+.+++..|+..||..||+++++++
T Consensus       251 --ePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  251 --EPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --CCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence              111111  11233456789999999999999999999875

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.1e-35  Score=271.78  Aligned_cols=250  Identities=20%  Similarity=0.306  Sum_probs=184.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|+||.||++.. .+++.||+|.+......      ......+.+|+.++++++||||+++++++...+     
T Consensus        16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc------CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            346799999999999987 46899999998653211      112245568999999999999999999986543     


Q ss_pred             ---eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          175 ---RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       175 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                         ..++|+||+.+ +|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence               45999999964 88888763   2346899999999999999999999   88999999999999999999999999


Q ss_pred             cCCcccCCC----------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          252 FGLAKLMPG----------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       252 fgl~~~~~~----------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      ||++.....          ...++..|+|||.+.+. .++.++||||||+++|||++|..||......     .......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-----~~~~~~~  237 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-----HQLTLIS  237 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH
Confidence            999875432          12356789999988664 4788999999999999999999998532110     0000000


Q ss_pred             HHHh---------------------hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          321 HLQH---------------------AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       321 ~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....                     .......+...+..    ......+.+++.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~----~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc----ccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000                     00000000000000    012345678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=278.11  Aligned_cols=258  Identities=24%  Similarity=0.301  Sum_probs=188.8

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhc------HHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN------KSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      .+.||+|+||.||++.. .+++.||+|.+............      ......+.+|++++++++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            46799999999999986 46899999998653222100000      001235778999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..+++|||++ |+|.+++..    ...+++.....++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccc
Confidence            9999999997 699998863    446889999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCC--------------------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCC
Q 047245          255 AKLMPG--------------------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG  313 (380)
Q Consensus       255 ~~~~~~--------------------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~  313 (380)
                      +.....                    ...++..|+|||.+.+. .++.++||||||+++|||++|..||......     
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-----  240 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-----  240 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence            875541                    11256789999998764 4689999999999999999999998632110     


Q ss_pred             CHHHHHHHHHhhcchhHh-----------hchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          314 SLGRWLRHLQHAGEAREA-----------LDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       314 ~l~~~~~~~~~~~~~~~~-----------~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .....+...........+           ........  .........+.+++.+|++.+|++|||++|++.
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            000000000000000000           00000000  000122456789999999999999999999985

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=265.53  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             CCChHHHHHHHhccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcce
Q 047245           88 KIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMS  165 (380)
Q Consensus        88 ~~~~~~l~~~~~~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  165 (380)
                      .|+..+|++.     ..||.|+||+|+|-.. +.|+..|||+++...       .....+++..|.+...+- +.||||+
T Consensus        60 ~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-------~~keq~rll~e~d~~mks~~cp~IVk  127 (361)
T KOG1006|consen   60 TFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-------IEKEQKRLLMEHDTVMKSSNCPNIVK  127 (361)
T ss_pred             ccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeecc-------chHHHHHHHHHHHHHHhhcCCcHHHH
Confidence            3555566655     5799999999999775 679999999998733       234457788888866555 7999999


Q ss_pred             eeEEEecCCeEEEEEeecCCCCHHHHHHHh-hhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC
Q 047245          166 LRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       166 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~  244 (380)
                      ++|.+-..+..++-||.|+- ||..+.... ......+++..+-+|......||.||.+  ...|||||+||+|||++..
T Consensus       128 fyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~  204 (361)
T KOG1006|consen  128 FYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRH  204 (361)
T ss_pred             HhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecC
Confidence            99999999999999999964 877665431 2235568888888899999999999996  6789999999999999999


Q ss_pred             CceEEeccCCcccCCCC-----CcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHH
Q 047245          245 FTPRLADFGLAKLMPGS-----LIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR  317 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~~-----~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~  317 (380)
                      |.+||+|||++..+.+.     ..|-..|||||.+..  ..|+.+|||||||++|+|+.||..||..             
T Consensus       205 G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-------------  271 (361)
T KOG1006|consen  205 GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-------------  271 (361)
T ss_pred             CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-------------
Confidence            99999999999766543     347788999999964  3489999999999999999999999864             


Q ss_pred             HHHHHHhhcchhHhhchh-ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          318 WLRHLQHAGEAREALDRS-ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      |...+..-..+.. =|+. +.......+....+.+++..|+.+|..+||...++.+
T Consensus       272 w~svfeql~~Vv~-gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  272 WDSVFEQLCQVVI-GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHHHHHHHHc-CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            2221111111110 1222 2222222346777899999999999999999998864

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-36  Score=266.54  Aligned_cols=233  Identities=24%  Similarity=0.332  Sum_probs=190.0

Q ss_pred             cCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||+|++|.||++... +++.+++|.+......     .......+..|+.++++++||||+++++.+..+...+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII-----KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhc-----chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence            699999999999974 5889999998653211     1234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC---
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---  260 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---  260 (380)
                      ++++|.+++..    ...+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.....   
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~  148 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS  148 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence            99999999974    336899999999999999999999   89999999999999999999999999999876543   


Q ss_pred             ---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          261 ---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       261 ---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                         ...++..|++||...+...+.++|+||||+++||+++|..||....        ..........         ..  
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~---------~~--  209 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--------RKEIYEKILK---------DP--  209 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHhc---------CC--
Confidence               2347888999999988889999999999999999999999985310        0111111111         00  


Q ss_pred             CCcccHHHHHHHHHHHHHcccCCCCCCCCHHh
Q 047245          338 GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDE  369 (380)
Q Consensus       338 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e  369 (380)
                       ...+......+.+++.+||..||++||++.+
T Consensus       210 -~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         210 -LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence             1111223556789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=275.72  Aligned_cols=240  Identities=23%  Similarity=0.326  Sum_probs=197.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+-||+|-|..|-.+.. -.|..||||++....      .+......+.+|+..|+-++|||||+++.+......+|||
T Consensus        22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTK------lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK------LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             hhhhhcCCceehhhhhhhhcccceeEEEEecccc------cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            345699999999987763 579999999997633      2334457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~~~  258 (380)
                      +|.-++|+|.||+-+.   ...+.+....++..||..|+.|+|   +..+|||||||+||.+.+ -|-+||.|||++..+
T Consensus        96 LELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999999753   345888889999999999999999   899999999999998865 589999999999766


Q ss_pred             CC-----CCcCCCcccCcccccCCCCC-CcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PG-----SLIATSAYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~-----~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..     ..+|+..|-|||.+.+..|+ ++.||||+|||||-|++|+.||...    .+.             ..+.-+.
T Consensus       170 ~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA----NDS-------------ETLTmIm  232 (864)
T KOG4717|consen  170 QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA----NDS-------------ETLTMIM  232 (864)
T ss_pred             CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc----cch-------------hhhhhhh
Confidence            43     34688999999999999986 5799999999999999999998641    111             1112222


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      |-..   ..+.....+..+|+..|+..||.+|.|.+|++.
T Consensus       233 DCKY---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  233 DCKY---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cccc---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            2221   234567788899999999999999999999863

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.5e-36  Score=272.53  Aligned_cols=239  Identities=22%  Similarity=0.339  Sum_probs=192.4

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  179 (380)
                      .+.||+|++|.||++... +|..+|+|++......     .......+.+|..++++++ ||||+++++++.+++..++|
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            467999999999999974 7899999998652211     1223467889999999998 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999974    337999999999999999999999   8999999999999999999999999999987543


Q ss_pred             CC--------------------------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCC
Q 047245          260 GS--------------------------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG  313 (380)
Q Consensus       260 ~~--------------------------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~  313 (380)
                      ..                          ..++..|+|||...+..++.++|+||||++++++++|..||....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------  226 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------  226 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-------
Confidence            22                          135788999999988889999999999999999999999986311       


Q ss_pred             CHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH----HhHHH
Q 047245          314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS----DELVP  372 (380)
Q Consensus       314 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~evl~  372 (380)
                      . ........         ..   ....+......+.+++.+||+.+|++|||+    +++++
T Consensus       227 ~-~~~~~~~~---------~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         227 E-YLTFQKIL---------KL---EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H-HHHHHHHH---------hc---CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0 00001110         00   011112235568899999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8e-36  Score=278.96  Aligned_cols=256  Identities=22%  Similarity=0.364  Sum_probs=187.8

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe----cCCeE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP----ESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~  176 (380)
                      .+.||+|++|.||++.. .+|..||+|++.....      .......+.+|+.++++++||||+++.+++.    .....
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc------cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            46799999999999986 4689999999865221      1122466778999999999999999998875    33568


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++|+||+. |+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999995 689888863    345899999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCC----------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHHH
Q 047245          257 LMPG----------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGRW  318 (380)
Q Consensus       257 ~~~~----------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~~  318 (380)
                      ....          ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||........       .+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            5432          1247788999999865 5688999999999999999999999863110000       00000000


Q ss_pred             HHHHHhhcchhHhhchhccCCcc-----cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          319 LRHLQHAGEAREALDRSILGEEV-----EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .... ......+..+..-.....     .......+.+++.+|++.+|++|||+++++.
T Consensus       236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRI-GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhh-chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0000 000111111100000001     1223567899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=270.49  Aligned_cols=258  Identities=22%  Similarity=0.329  Sum_probs=190.2

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  179 (380)
                      .+.||+|++|.||+|... +++.+++|++......       .......+|+..+++++ |+|++++++++.+++..++|
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   76 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-------WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV   76 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccc-------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence            467999999999999985 5788999998652211       11233457899999998 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+ +|+|.+++...  ....+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||++....
T Consensus        77 ~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          77 FEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             EecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            9999 88999988742  2347899999999999999999999   8999999999999999999999999999997654


Q ss_pred             C-----CCcCCCcccCccccc-CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHHHHhh
Q 047245          260 G-----SLIATSAYSAPECFQ-NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRHLQHA  325 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~-~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~~~~~  325 (380)
                      .     ...++..|+|||.+. ...++.++|+||||++++||++|+.||........        ....-..|.......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         151 SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             CCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence            3     234678899999875 45578999999999999999999998853211000        000011121111111


Q ss_pred             cchhHhhchhccC--CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......+......  ..........+.+++.+||+.+|++|||++|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            1111010000000  0000112456889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-36  Score=294.23  Aligned_cols=197  Identities=21%  Similarity=0.275  Sum_probs=152.2

Q ss_pred             cccccCccCCeeEEEEEecC--CcEEEEEEeeeccCC---------ChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN--GLTVAVRRVEAFESG---------SPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAY  169 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~--g~~vavK~~~~~~~~---------~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  169 (380)
                      ..+.||+|+||.||++....  +...+.|.+.....+         ............+.+|+.++++++||||++++++
T Consensus       152 ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  231 (501)
T PHA03210        152 VIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEI  231 (501)
T ss_pred             EEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence            45689999999999987532  222332211110000         0001122345678899999999999999999999


Q ss_pred             EecCCeEEEEEeecCCCCHHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          170 VPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       170 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      +...+..++++|++. ++|.+++..... ............++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~~~~vk  307 (501)
T PHA03210        232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIV  307 (501)
T ss_pred             EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence            999999999999985 588887753211 1122335567789999999999999   89999999999999999999999


Q ss_pred             EeccCCcccCCC-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCC
Q 047245          249 LADFGLAKLMPG-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP  301 (380)
Q Consensus       249 l~Dfgl~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p  301 (380)
                      |+|||+++....       ...|+..|+|||.+.+..++.++|||||||++|||++|..+
T Consensus       308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999999976542       23589999999999999999999999999999999998754

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3e-35  Score=275.47  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=186.0

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC--CeEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES--SRFY  177 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  177 (380)
                      .+.||+|+||.||+|... +|..+|+|++.....      .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR------NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC------cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467999999999999974 688999998854211      112235677899999999 999999999998643  4689


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +|+||++ ++|.+++..     ..++|..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            9999997 599888863     26889999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCC-----------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHH
Q 047245          258 MPGS-----------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGR  317 (380)
Q Consensus       258 ~~~~-----------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~  317 (380)
                      ....           ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||........        .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            4321           236788999998765 5578899999999999999999999853211100        0000000


Q ss_pred             HHHHHHhhcchhHhhchhccCC-----cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          318 WLRHLQHAGEAREALDRSILGE-----EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +.. . ......+.++......     .........+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         237 IES-I-KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHH-H-HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence            000 0 0000011111000000     000113456889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.1e-35  Score=271.37  Aligned_cols=256  Identities=23%  Similarity=0.327  Sum_probs=188.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-CCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-SSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  178 (380)
                      ..+.||.|+||.||++.. .+|..+|+|++.....      .....+.+.+|++++++++||||+++.+++.. ....++
T Consensus        14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856          14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS------TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             EEEeecccCCeEEEEEEECCCCCEEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            347899999999999985 4789999998864211      11233667789999999999999999998865 567899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ++||+ +++|.+++.     ...+++.....++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.+...
T Consensus        88 v~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          88 VTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             Eeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            99998 568988876     335788888899999999999999   899999999999999999999999999998765


Q ss_pred             CCC---CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHHHHHHHHhhcc
Q 047245          259 PGS---LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       259 ~~~---~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~~~~~~~~~~~  327 (380)
                      ...   ..++..|+|||.+.+ ..++.++||||||+++|||++|..||........       ......+|........ 
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (328)
T cd07856         159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN-  237 (328)
T ss_pred             CCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh-
Confidence            432   346788999998765 5689999999999999999999999853211000       0000111111111111 


Q ss_pred             hhHhhchhccCCccc-----HHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVE-----EDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..+.+.........+     ......+.+++.+|++.+|++|||+++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            011111100001111     113456889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-35  Score=275.29  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=187.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|++|.||++.. .+|..||+|++....      ........+.+|+.++++++||||+++++++....     
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             EEEEeeecCCeEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            346799999999999985 578999999985421      12233467889999999999999999999886543     


Q ss_pred             -eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          175 -RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       175 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                       ..++|+||+ +++|.+++.     ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence             468999998 779988875     346899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHHHHHHH
Q 047245          254 LAKLMPGS---LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~~~---~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~~~~~~  322 (380)
                      ++......   ..+++.|+|||.+.+ ..++.++|+||||+++|++++|..||........       .......|....
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         164 LARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            99865433   346888999999876 4588999999999999999999999863210000       000001111111


Q ss_pred             HhhcchhHhhch--hccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          323 QHAGEAREALDR--SILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       323 ~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                      ... .....+..  .....   .........+.+++.+|++.||++|||+.+++
T Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         244 QSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             cch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            000 00000000  00000   00012334578999999999999999999988

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=310.51  Aligned_cols=240  Identities=26%  Similarity=0.430  Sum_probs=194.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .+..||.|.||.||.++. ++|...|+|-++....      .........+|..++..++|||+|+++|+-.+.+..++.
T Consensus      1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~------~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS------DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             cccccCCcceeeeEEeecCCccchhhhhhhhcCcc------ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            456899999999999885 6799999998865221      133456778899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||||++|+|.+.+..    +.-.++.....+..|++.|++|||   +.+||||||||.||+++.+|.+|++|||.|....
T Consensus      1313 MEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999999874    223444445567889999999999   9999999999999999999999999999998765


Q ss_pred             CC----------CcCCCcccCcccccCCC---CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh-h
Q 047245          260 GS----------LIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH-A  325 (380)
Q Consensus       260 ~~----------~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~-~  325 (380)
                      +.          ..||+.|||||.+.+..   ...++||||+|||++||.||+.||...    +     .+|.-...- .
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~----d-----ne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL----D-----NEWAIMYHVAA 1456 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc----c-----chhHHHhHHhc
Confidence            43          35999999999997643   456899999999999999999999642    1     123332221 1


Q ss_pred             cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      |.          .+..+...+..-.+++.+|+..||.+|.++.|+++
T Consensus      1457 gh----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GH----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             cC----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            11          12233446777889999999999999999988875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.5e-36  Score=298.13  Aligned_cols=239  Identities=26%  Similarity=0.456  Sum_probs=180.2

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec---------
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE---------  172 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  172 (380)
                      .+||+||||.|||++.. ||+.+|||++....       ....-..+.+|+..|++|+|||||+++..|.+         
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            58999999999999963 89999999997632       23445778899999999999999998876511         


Q ss_pred             --------------------------------------------------------------------------------
Q 047245          173 --------------------------------------------------------------------------------  172 (380)
Q Consensus       173 --------------------------------------------------------------------------------  172 (380)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhH
Q 047245          173 ----------------------S--------SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH  222 (380)
Q Consensus       173 ----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH  222 (380)
                                            .        ..+|+-||||+.-.|+++++.  + ...-.-...+++..+|++||+|+|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~--N-~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR--N-HFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh--c-ccchhhHHHHHHHHHHHHHHHHHH
Confidence                                  0        124778899998777777763  1 111135567899999999999999


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC------------------------CCCcCCCcccCcccccCC-
Q 047245          223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------------------------GSLIATSAYSAPECFQNR-  277 (380)
Q Consensus       223 ~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~------------------------~~~~~~~~y~aPE~~~~~-  277 (380)
                         +.++|||||||.||++|++..+||+|||++....                        ...+||.-|+|||.+.+. 
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence               9999999999999999999999999999997511                        013489999999999765 


Q ss_pred             --CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHH
Q 047245          278 --SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV  355 (380)
Q Consensus       278 --~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  355 (380)
                        +|+.|+|+||+|+|++||+.   ||...++...       .... .+.+.+..-       .....+....-..++.+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~-------iL~~-LR~g~iP~~-------~~f~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS-------ILTN-LRKGSIPEP-------ADFFDPEHPEEASLIRW  853 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHHHH-------HHHh-cccCCCCCC-------cccccccchHHHHHHHH
Confidence              49999999999999999995   5654322211       0111 111111111       01123445556789999


Q ss_pred             cccCCCCCCCCHHhHHH
Q 047245          356 CLSDSPADRPSSDELVP  372 (380)
Q Consensus       356 Cl~~~P~~RPs~~evl~  372 (380)
                      +++.||.+|||+.|++.
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999985

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-35  Score=274.87  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=187.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----Ce
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----SR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  175 (380)
                      .+.||+|+||.||++.. .+|..||+|.+.....      .......+.+|+.+++.++|+||+++++++...     ..
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999986 4689999999864211      112235567899999999999999999987644     35


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++++||+. ++|.+++..    ...+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999996 689888763    346899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCC------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc--------cCCCCHHHHHH
Q 047245          256 KLMPGS------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA--------ASGGSLGRWLR  320 (380)
Q Consensus       256 ~~~~~~------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~--------~~~~~l~~~~~  320 (380)
                      ......      ..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.......        .....-..|  
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  233 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL--  233 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh--
Confidence            865432      247788999998865 468899999999999999999999985310000        000000000  


Q ss_pred             HHHhhcchhHhhchhc--cC---CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          321 HLQHAGEAREALDRSI--LG---EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                      ...........++..-  ..   ..........+.+++.+||+.+|++|||++|+++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            0000000011110000  00   00112345668899999999999999999999853

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-35  Score=274.65  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=184.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||+|.. .+|+.||+|++.....      .......+.+|+.++++++||||+++++++...      
T Consensus        19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ------SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc------cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            346899999999999986 4689999999864211      112235678899999999999999999998654      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++|+||+.. +|.++..      ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence            356999999964 7766542      35889999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh-----
Q 047245          254 LAKLMPGS---LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH-----  324 (380)
Q Consensus       254 l~~~~~~~---~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~-----  324 (380)
                      +++.....   ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||....       ....+......     
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~  235 (342)
T cd07879         163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-------YLDQLTQILKVTGVPG  235 (342)
T ss_pred             CCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHhcCCCC
Confidence            99865432   346788999999876 468899999999999999999999986311       01111100000     


Q ss_pred             --------hcchhHhhch--hccCCcc---cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 --------AGEAREALDR--SILGEEV---EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 --------~~~~~~~~~~--~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                              .......+..  .......   .......+.+++.+||+.||.+||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    0000000000  0000000   0112345789999999999999999999983

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.6e-35  Score=270.76  Aligned_cols=259  Identities=22%  Similarity=0.308  Sum_probs=183.5

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|++|.||++... +++.+|+|++......+.      ....+.+|++++++++||||+++++++.+.      
T Consensus        12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866          12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC------cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            3467999999999999964 688999999876332211      124567899999999999999999887443      


Q ss_pred             --CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          174 --SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       174 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                        ...++|+||+++ +|.+.+..   ....+++..+..++.|+++||+|||   +.+++|+||||+||++++++.+||+|
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence              346999999965 77777653   2446899999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccCCCC-----------------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC--
Q 047245          252 FGLAKLMPGS-----------------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS--  311 (380)
Q Consensus       252 fgl~~~~~~~-----------------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~--  311 (380)
                      ||+++.....                 ..+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........  
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9998754321                 124677999998765 45789999999999999999999998632111000  


Q ss_pred             ------CCCHHHHHHHHHhhcchhHhhchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          312 ------GGSLGRWLRHLQHAGEAREALDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       312 ------~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ......|.....................  .........+.+++.+|++.||.+|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                  0000000000000000000000000000  000112255789999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=255.18  Aligned_cols=249  Identities=22%  Similarity=0.366  Sum_probs=191.8

Q ss_pred             ChHHHHHHHhccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceee
Q 047245           90 DPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLR  167 (380)
Q Consensus        90 ~~~~l~~~~~~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  167 (380)
                      +..+|+..     ..||.|..|.|++... ..|...|||.+...       .++...+++...+.++..-+ .|+||+.+
T Consensus        90 dindl~~l-----~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-------~Nkee~kRILmDldvv~~s~dcpyIV~c~  157 (391)
T KOG0983|consen   90 DINDLENL-----GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-------GNKEENKRILMDLDVVLKSHDCPYIVQCF  157 (391)
T ss_pred             ChHHhhhH-----HhhcCCCccceEEEEEcccceEEEEEeeccc-------CCHHHHHHHHHhhhHHhhccCCCeeeeee
Confidence            44455544     5699999999999987 45899999999762       23444577888888877774 89999999


Q ss_pred             EEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCce
Q 047245          168 AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP  247 (380)
Q Consensus       168 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  247 (380)
                      |++..+...++-||.|.. .++.++..   ...++++..+-++...+..||.||.+  .++|+|||+||+|||+|+.|++
T Consensus       158 GyFi~n~dV~IcMelMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~Gni  231 (391)
T KOG0983|consen  158 GYFITNTDVFICMELMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNI  231 (391)
T ss_pred             eEEeeCchHHHHHHHHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCE
Confidence            999999999999998843 66666653   34568888888999999999999996  6799999999999999999999


Q ss_pred             EEeccCCcccCCCC-----CcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH
Q 047245          248 RLADFGLAKLMPGS-----LIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       248 kl~Dfgl~~~~~~~-----~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |++|||++..+.+.     ..|-+.|||||.+.-   ..|+.++||||||+.++||.||+.||...    ..  +. +..
T Consensus       232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c----~t--dF-e~l  304 (391)
T KOG0983|consen  232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC----KT--DF-EVL  304 (391)
T ss_pred             EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC----Cc--cH-HHH
Confidence            99999999766543     247788999999963   46888999999999999999999998631    00  00 011


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..... .     .-+.+.+.   ..-+..+.++...|+..|+.+||...++++
T Consensus       305 tkvln-~-----ePP~L~~~---~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  305 TKVLN-E-----EPPLLPGH---MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHh-c-----CCCCCCcc---cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11111 0     01112111   114556889999999999999999999875

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-35  Score=274.96  Aligned_cols=256  Identities=24%  Similarity=0.335  Sum_probs=191.9

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|++|.||++... +|..+|+|++.....      .....+.+.+|+..+++++|+||+++.+++....     
T Consensus         4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   77 (330)
T cd07834           4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN   77 (330)
T ss_pred             eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence            3467999999999999974 489999999875321      1233467889999999999999999999987765     


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++++||++ ++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+
T Consensus        78 ~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          78 DVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             ceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            7899999997 488888863    337899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCCC---------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHH
Q 047245          255 AKLMPGS---------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLG  316 (380)
Q Consensus       255 ~~~~~~~---------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~  316 (380)
                      +......         ..++..|+|||.+.+. .++.++|+||||+++|+|++|..||........        ......
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            8765432         2367789999999887 789999999999999999999999864211100        000000


Q ss_pred             HHHHHHHhhcchhHhhchhccCCc-----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          317 RWLRHLQHAGEAREALDRSILGEE-----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .|..  .......+.+........     ........+.+++.+||+.+|.+|||+.++++
T Consensus       230 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         230 DLKF--ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             Hhhh--ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0000  000000111110000000     01123456789999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=284.53  Aligned_cols=194  Identities=30%  Similarity=0.455  Sum_probs=167.5

Q ss_pred             cccccCccCCeeEEEEE-ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||+|+ -..|+.||||.++...       ...-.+...+|+++|++++|+|||++++.=.+.      
T Consensus        17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             ehhhhcCCccceeeeecccccccchhHHhhhhhc-------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            45679999999999999 4689999999997633       122346677899999999999999999985443      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC--CCC--ceEE
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD--AEF--TPRL  249 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~--~~kl  249 (380)
                      ....+|||||.+|||+..|+.. .+...++..+.+.++.+++.||.|||   .++|+||||||.||++-  ++|  .-||
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEee
Confidence            3679999999999999999864 34557999999999999999999999   99999999999999983  333  4699


Q ss_pred             eccCCcccCCCC-----CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCch
Q 047245          250 ADFGLAKLMPGS-----LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPF  305 (380)
Q Consensus       250 ~Dfgl~~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~  305 (380)
                      +|||.|+.++++     ..||..|.+||.... ..|+...|.|||||++|++.||..||-+.
T Consensus       166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            999999988764     359999999999985 78899999999999999999999999764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-35  Score=265.26  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=190.9

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||+|... +++.+|+|.+.....      .......+..|+.++++++|+|++++++++.+.+..++|+
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   77 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF   77 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence            357999999999999975 589999999976321      1222366778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ ++|.+++...   ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||+++....
T Consensus        78 e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          78 EYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             cCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9997 5999999742   246899999999999999999999   89999999999999999999999999999876543


Q ss_pred             C------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHHHHHHHhh
Q 047245          261 S------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRWLRHLQHA  325 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~~~~~~~~  325 (380)
                      .      ...+..|+|||.+.+. .++.++||||||+++||+++|..||........        ....-..|.......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            2      2356779999998776 789999999999999999999998853110000        000000010000000


Q ss_pred             cchhHhhchhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .....+ +.....   .........+.+++.+||+.+|++||++.+++.
T Consensus       231 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         231 -DYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             -cccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             000000 000000   000112456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-34  Score=270.61  Aligned_cols=256  Identities=24%  Similarity=0.350  Sum_probs=185.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++.. .+|..||+|++.....      .....+.+.+|+.++++++||||+++.+++...      
T Consensus        21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            346799999999999985 5788999999864211      122235677899999999999999999987543      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...+++++++ +++|.+++.     ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg  165 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG  165 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEeccc
Confidence            3467888876 789988775     235899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC-------CCCHHHHHHHH
Q 047245          254 LAKLMPGS---LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS-------GGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~~~---~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~-------~~~l~~~~~~~  322 (380)
                      +++.....   ..++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........       ...........
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         166 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            98865433   347888999998866 56889999999999999999999998531110000       00000000000


Q ss_pred             HhhcchhHhhch--hccCCcc---cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          323 QHAGEAREALDR--SILGEEV---EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       323 ~~~~~~~~~~~~--~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ........+..  .......   .......+.+++.+|++.||++|||+.++++
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         246 -SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             -ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence             00000000000  0000000   0012445789999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.4e-35  Score=260.05  Aligned_cols=218  Identities=21%  Similarity=0.197  Sum_probs=174.5

Q ss_pred             cCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeecCCC
Q 047245          108 SPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG  186 (380)
Q Consensus       108 G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  186 (380)
                      |.+|.||++.. .+|+.+|+|++...             ..+.+|...+....||||+++++++.+....+++|||+++|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~-------------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   70 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKS-------------SEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG   70 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecch-------------hhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence            89999999986 56889999998652             12234555555667999999999999999999999999999


Q ss_pred             CHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC---Cc
Q 047245          187 SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS---LI  263 (380)
Q Consensus       187 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~  263 (380)
                      +|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......   ..
T Consensus        71 ~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~  143 (237)
T cd05576          71 KLWSHISK----FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA  143 (237)
T ss_pred             CHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCC
Confidence            99999864    235899999999999999999999   899999999999999999999999999987665432   33


Q ss_pred             CCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccH
Q 047245          264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEE  343 (380)
Q Consensus       264 ~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (380)
                      ++..|+|||.+....++.++||||+|+++||+++|..|+.......                   .....     ...+.
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~-----~~~~~  199 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTT-----LNIPE  199 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccccc-----cCCcc
Confidence            5667999999988889999999999999999999998864210000                   00000     00112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHh
Q 047245          344 DEMLMAVRIAVVCLSDSPADRPSSDE  369 (380)
Q Consensus       344 ~~~~~~~~l~~~Cl~~~P~~RPs~~e  369 (380)
                      .....+.+++.+|++.||++||++.+
T Consensus       200 ~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         200 WVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             cCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            23455788999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=273.27  Aligned_cols=239  Identities=25%  Similarity=0.325  Sum_probs=196.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .-++||+|+||.||-... .+|..+|.|++..+....     +.......+|-++|.+++.+.||.+--.+...+.+++|
T Consensus       189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-----r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-----RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-----hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            457899999999999886 569999999997643221     22235667899999999999999999899999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +..|+||+|.-++....  ...++.....-++.+|+.||++||   +.+||.|||||+|||+|+.|+++|+|.|+|..++
T Consensus       264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            99999999998887533  357899999999999999999999   9999999999999999999999999999998776


Q ss_pred             CC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 GS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      +.     .+||.+|||||++.+..|+...|.||+||++|||+.|+.||...    .+              ..-.+-+|+
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~----Ke--------------Kvk~eEvdr  400 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR----KE--------------KVKREEVDR  400 (591)
T ss_pred             CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh----hh--------------hhhHHHHHH
Confidence            43     36999999999999999999999999999999999999998531    11              111222333


Q ss_pred             hccC--CcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          335 SILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       335 ~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                      ....  ..+++.-+.+..++....++.||.+|-.-
T Consensus       401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            3222  23344556667888899999999999654

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-35  Score=273.96  Aligned_cols=256  Identities=25%  Similarity=0.366  Sum_probs=187.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe----
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR----  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  175 (380)
                      ..+.||+|++|.||+|... ++..+|+|++....      ........+.+|+.++++++|||++++.+++...+.    
T Consensus        19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF------QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             EEEEeccCCceEEEEEEECCCCcEEEEEeccccc------chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3467999999999999974 57899999886421      112233567789999999999999999988765544    


Q ss_pred             --EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          176 --FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       176 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                        .++|+||+ +++|.+++.     ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 669999886     246899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCHHHHHHHH
Q 047245          254 LAKLMPGS---LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~~~---~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l~~~~~~~  322 (380)
                      ++......   ..++..|+|||.+.+ ..++.++||||||+++||+++|+.||........       .......+....
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         164 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             ccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            99865432   347788999999865 4678999999999999999999999853100000       000000010000


Q ss_pred             HhhcchhHhhchhc-cCC-c---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          323 QHAGEAREALDRSI-LGE-E---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       323 ~~~~~~~~~~~~~~-~~~-~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .. ......+.... ... .   ........+.+++.+|++.+|++|||+.|+++
T Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         244 SS-ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             cc-hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00 00000000000 000 0   00113567889999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-35  Score=275.28  Aligned_cols=239  Identities=23%  Similarity=0.379  Sum_probs=193.3

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ....||+|.|+.|..+.. .+|..||+|.+....      .+...++.+.+|+++|+.++|||||+++.+......+|+|
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~------ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ------LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcc------cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            456799999999999985 468999999886522      2333445689999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+.+|.+.+|+..    ...........+..|+..|++|||   ++.|+|||||++|+|++.+.++||+|||++..+.
T Consensus       134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec
Confidence            999999999999985    344555777889999999999999   9999999999999999999999999999998654


Q ss_pred             -----CCCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 -----GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                           ....|++.|.|||+..+..+ .++.|+||+|+++|-|++|..||+..        .+..          +.+.+-
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~--------~lk~----------Lr~rvl  268 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ--------NLKE----------LRPRVL  268 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc--------cccc----------ccchhe
Confidence                 34569999999999998776 57899999999999999999999731        0000          001010


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....+  .+.-......+++++.+-.+|.+|++++++.+
T Consensus       269 ~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  269 RGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            11111  11223444668889999999999999998864

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.9e-35  Score=271.36  Aligned_cols=257  Identities=24%  Similarity=0.303  Sum_probs=184.3

Q ss_pred             cccccCccCCeeEEEEEec-C--CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC---
Q 047245          101 ENRLLGSSPDGKYYRTVLD-N--GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES---  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---  173 (380)
                      ..+.||+|+||.||++... +  +..+|+|++.....      .....+.+.+|+.+++++ +||||+++++.+...   
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   77 (332)
T cd07857           4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS------KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN   77 (332)
T ss_pred             EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc------cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence            3467999999999999974 3  67899999864211      112345678899999999 599999999875332   


Q ss_pred             -CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          174 -SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       174 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                       ...++++||+. ++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        78 ~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          78 FNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             CCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcC
Confidence             45788889885 689988863    446899999999999999999999   899999999999999999999999999


Q ss_pred             CCcccCCC----------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCC
Q 047245          253 GLAKLMPG----------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGS  314 (380)
Q Consensus       253 gl~~~~~~----------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~  314 (380)
                      |+++....          ...++..|+|||.+.+ ..++.++|+||+|+++|++++|..||........       .+..
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            99875432          1247889999998765 5689999999999999999999999863110000       0000


Q ss_pred             HHHHHHHHHhhcchhHhhchhccCC-----cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          315 LGRWLRHLQHAGEAREALDRSILGE-----EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       315 l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..++........ ........-...     .........+.+++.+|++.||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         230 DEETLSRIGSPK-AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CHHHHHhhhhhh-HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            011111111000 000000000000     000112456889999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-34  Score=269.89  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=182.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||.|+||.||+|.. .+|..||+|.+.....        ...+.+.+|++++++++||||+++++++...      
T Consensus         9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            346799999999999987 4688999999865321        2236678899999999999999999776543      


Q ss_pred             --------CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-C
Q 047245          174 --------SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-E  244 (380)
Q Consensus       174 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~  244 (380)
                              ...++|+||++ ++|.+++.     ...+++.....++.|++.||.|||   +.+++||||||+||+++. +
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~  151 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTED  151 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCC
Confidence                    35799999997 58988875     235889999999999999999999   899999999999999974 5


Q ss_pred             CceEEeccCCcccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCC--
Q 047245          245 FTPRLADFGLAKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG--  312 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~--  312 (380)
                      +.+|++|||+++....         ...++..|+|||.+.. ..++.++||||||+++|||++|+.||..........  
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            6789999999875421         1236778999998754 567889999999999999999999986321100000  


Q ss_pred             -----CCHHHHHHHHHhhcchhHhhchhccCCc-----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          313 -----GSLGRWLRHLQHAGEAREALDRSILGEE-----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       313 -----~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           ............  ..............     ........+.+++.+|++.||.+|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         232 LESVPVVREEDRNELLN--VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhcCCCChHHhhhhhh--hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                 000000000000  00000000000000     00123456789999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.6e-34  Score=287.90  Aligned_cols=144  Identities=27%  Similarity=0.376  Sum_probs=126.7

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.||+|++.....     ........+..|+.++..++||||+++++++......++|
T Consensus         8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-----INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-----cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            3467999999999999975 689999999865221     2334457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      |||+++++|.+++..    ...+++...+.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999874    335788899999999999999999   8899999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.6e-35  Score=251.98  Aligned_cols=193  Identities=28%  Similarity=0.461  Sum_probs=161.1

Q ss_pred             cccccCccCCeeEEEEEecC-----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-CC
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-SS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  174 (380)
                      ....||+|.+|.|||++-.+     ...+|+|+++...++.      ......-+|+.+++.++|||++.+..++.. +.
T Consensus        28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t------GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT------GISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC------CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            44579999999999997432     2379999997643322      223566789999999999999999998876 67


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC----CceEE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE----FTPRL  249 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kl  249 (380)
                      ..++++||.+. +|.+.++..+. ....++...+..|+.||+.|+.|||   ++=|+||||||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            88999999987 88888875432 2357888999999999999999999   8889999999999999887    99999


Q ss_pred             eccCCcccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          250 ADFGLAKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       250 ~Dfgl~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      +|||+++.+.+         ..+-|..|.|||.+.+ ..||.+.||||.|||+.||++-.+.|.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            99999987643         2357889999999987 568999999999999999999877664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.3e-33  Score=250.69  Aligned_cols=233  Identities=28%  Similarity=0.428  Sum_probs=188.5

Q ss_pred             CCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeecCCCC
Q 047245          109 PDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGS  187 (380)
Q Consensus       109 ~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  187 (380)
                      +||.||++... +|+.+++|++......       ...+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK-------KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc-------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence            58999999986 4899999998752211       114788999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC-----C
Q 047245          188 LEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-----L  262 (380)
Q Consensus       188 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-----~  262 (380)
                      |.+++..    ...+++..++.++.+++.++.|||   +.+++|+||+|+||++++++.++++|||.+......     .
T Consensus        74 L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  146 (244)
T smart00220       74 LFDLLKK----RGRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTF  146 (244)
T ss_pred             HHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccc
Confidence            9999874    223889999999999999999999   889999999999999999999999999999876542     3


Q ss_pred             cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCccc
Q 047245          263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVE  342 (380)
Q Consensus       263 ~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (380)
                      .++..|++||...+..++.++||||||++++++++|..||...       ............          ........
T Consensus       147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-------~~~~~~~~~~~~----------~~~~~~~~  209 (244)
T smart00220      147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-------DQLLELFKKIGK----------PKPPFPPP  209 (244)
T ss_pred             cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHhc----------cCCCCccc
Confidence            5788899999999888999999999999999999999998531       111111111111          10000000


Q ss_pred             HH-HHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          343 ED-EMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       343 ~~-~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .. ....+.+++.+|+..+|++||++.++++
T Consensus       210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00 4456889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=248.45  Aligned_cols=254  Identities=20%  Similarity=0.361  Sum_probs=191.6

Q ss_pred             cccccCccCCeeEEEEE-ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      .+++||+|+++.|-.++ +.+|.++|||++..        .....+.+..+|++++.+. .|+||++++.+++++..+||
T Consensus        82 t~e~LGeGAyasVqtcv~i~t~~EYAVKiidK--------q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   82 TSELLGEGAYASVQTCVSIQTGKEYAVKIIDK--------QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             HHHHhcCccceeeeeeeeeccchhhhhhhhhc--------CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            45789999999998876 57899999999975        2344568899999999999 59999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC---ceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfgl~  255 (380)
                      |||-|.||+|.++++.    ..-+++.+..++..+|+.||.+||   .++|.||||||+|||-....   -+||+||.+.
T Consensus       154 VfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg  226 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLG  226 (463)
T ss_pred             EEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccc
Confidence            9999999999999986    335788899999999999999999   99999999999999986543   5899999886


Q ss_pred             ccCC--C-----------CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHH
Q 047245          256 KLMP--G-----------SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR  317 (380)
Q Consensus       256 ~~~~--~-----------~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~  317 (380)
                      .-..  +           ..+|+..|||||+..     ...|+.+.|.||||||+|-|++|.+||.....+.-.++.- +
T Consensus       227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG-e  305 (463)
T KOG0607|consen  227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG-E  305 (463)
T ss_pred             cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC-C
Confidence            4321  1           124777899999874     3457889999999999999999999997533322211100 0


Q ss_pred             HHHHHHhhcchhHhhchhccC--CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          318 WLRHLQHAGEAREALDRSILG--EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      --+..  ...+.+.+......  +..-...+.+..+++...+..++.+|-++.+++.
T Consensus       306 ~Cr~C--Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  306 VCRVC--QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccHHH--HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            00000  00112222221110  0111235666788888889999999999988765

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=248.09  Aligned_cols=241  Identities=21%  Similarity=0.304  Sum_probs=190.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC----Ce
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES----SR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  175 (380)
                      .++||-|-.|.|-.... .+|+.+|+|++..             .....+|+++-=+. .|||||++++++.+.    ..
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhc-------------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            37899999999998875 5788999999864             14456788876555 699999999998653    56


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEecc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADF  252 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Df  252 (380)
                      +.+|||.|+||.|.+.++.  .....+++.+.-.|..||+.|+.|||   +.+|.||||||+|+|.+.   |..+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence            7899999999999999885  33556899999999999999999999   999999999999999964   467899999


Q ss_pred             CCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          253 GLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       253 gl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      |+++....     ....|+.|.|||++...+|+...|+||+||++|-|++|.+||...-..     .+.--++.-...+.
T Consensus       209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----aispgMk~rI~~gq  283 (400)
T KOG0604|consen  209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKRRIRTGQ  283 (400)
T ss_pred             ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----cCChhHHhHhhccC
Confidence            99987653     235789999999999999999999999999999999999999853211     11111222222221


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            .....+.+ ...++...++++..+..+|++|-|..|++.
T Consensus       284 ------y~FP~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 ------YEFPEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ------ccCCChhH-hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                  01111122 446677889999999999999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=270.40  Aligned_cols=229  Identities=25%  Similarity=0.297  Sum_probs=184.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..-+|.|+|+.|-++.. .+++..+||++....            .+-.+|+.++... +||||+.+.+.+.++.+.++|
T Consensus       327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  327 REELGEGSFSAVKYCESSPTDQEPAVKIISKRA------------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             ccccCCCCccceeeeeccccccchhheeccccc------------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            34599999999988875 578899999987531            2233577666666 799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe-CCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-DAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill-~~~~~~kl~Dfgl~~~~  258 (380)
                      ||.+.++-+.+.+..    . +.....+..|+.+|+.|+.|||   .++++||||||+|||+ ++.++++|+|||.++..
T Consensus       395 ~e~l~g~ell~ri~~----~-~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  395 MELLDGGELLRRIRS----K-PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             ehhccccHHHHHHHh----c-chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            999999988777653    1 2222677789999999999999   8999999999999999 68899999999999987


Q ss_pred             CCC---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          259 PGS---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       259 ~~~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      ...   ..-|..|.|||++....+++++|+||||++||+|++|+.||...    ..              +  .+.... 
T Consensus       467 ~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~----P~--------------~--~ei~~~-  525 (612)
T KOG0603|consen  467 ERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH----PA--------------G--IEIHTR-  525 (612)
T ss_pred             chhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC----Cc--------------h--HHHHHh-
Confidence            765   24677899999999999999999999999999999999998631    00              0  111111 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                      +.........+....+|+.+||++||.+||+|+++.
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~  561 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIG  561 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence            111222355677789999999999999999999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=270.00  Aligned_cols=241  Identities=23%  Similarity=0.380  Sum_probs=194.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEe-----cC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVP-----ES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~  173 (380)
                      +.+.||.|.+|.||++.. ++|+.+|+|++....+.         .++...|..+++.. .|||++.++|++.     .+
T Consensus        23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---------deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---------EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             EEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---------cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            457899999999999985 67899999998774433         25566788999988 7999999999984     35


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ++++||||||.+||..|+++...  ...+.|..+.-|+..++.|+++||   ...++|||+|-.|||+++++.+|+.|||
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeee
Confidence            78999999999999999998765  678999999999999999999999   9999999999999999999999999999


Q ss_pred             CcccCC------CCCcCCCcccCcccccCC-----CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          254 LAKLMP------GSLIATSAYSAPECFQNR-----SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~------~~~~~~~~y~aPE~~~~~-----~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      ++..+.      +..+||+.|||||++...     .|+..+|+||||++..||--|.+|+....+.        ...-..
T Consensus       169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~I  240 (953)
T KOG0587|consen  169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFLI  240 (953)
T ss_pred             eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhccC
Confidence            997664      345799999999999643     3677899999999999999999997531000        000000


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .++.      .+.+   .-+..-..++-+++..|+.+|-.+||++.++++
T Consensus       241 pRNP------PPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  241 PRNP------PPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCC------Cccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0000      0111   112345677889999999999999999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=274.80  Aligned_cols=237  Identities=25%  Similarity=0.405  Sum_probs=181.7

Q ss_pred             cccccCccCCee-EEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGK-YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~-vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+++|.|+.|+ ||+|..+ |+.||||++..           .......+|++.|..- +|||||++++.-.+....|+
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI  580 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI  580 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence            456789999875 5999995 89999999864           1224567899999998 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---C--CceEEeccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---E--FTPRLADFG  253 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~--~~~kl~Dfg  253 (380)
                      ..|.|. -+|.+++...........-...+.+..|++.||++||   +.+||||||||.||||+.   +  ..++|+|||
T Consensus       581 alELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  581 ALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            999995 4999999852111111111345678899999999999   899999999999999965   2  579999999


Q ss_pred             CcccCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHH
Q 047245          254 LAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQ  323 (380)
Q Consensus       254 l~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~  323 (380)
                      +++.+..+         ..||.+|+|||.+....-+.+.||+|+||++|+.++ |..||........+          +.
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N----------Il  726 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN----------IL  726 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh----------hh
Confidence            99987643         348999999999999888889999999999999999 58999753222111          01


Q ss_pred             hhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ........+      ... .++  ...+|+.++++++|..||++.+|+.
T Consensus       727 ~~~~~L~~L------~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  727 TGNYTLVHL------EPL-PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cCccceeee------ccC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            111000000      111 112  6789999999999999999999873

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=246.66  Aligned_cols=234  Identities=22%  Similarity=0.260  Sum_probs=188.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +-++||+|.||.|-.+.- ..|+.+|+|.++....     ..++....-..|-.+|+..+||.+..+--.+...+++++|
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-----iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-----IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             HHHHhcCCccceEEEEeecccCceeehhhhhhhhe-----eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            447899999999998875 5789999999976322     1234446677899999999999999998888999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||..||.|.-+|..    ...++.....-+...|..||.|||   +++||.||||.+|.|+|.||++||+|||+++.--
T Consensus       247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999988875    335666666778899999999999   9999999999999999999999999999998532


Q ss_pred             ------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 ------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                            ...+|||.|+|||++....|..+.|.|.+||++|||++|+.||...                  ..+.+.+.+-
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~------------------dh~kLFeLIl  381 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK------------------DHEKLFELIL  381 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc------------------chhHHHHHHH
Confidence                  2457999999999999999999999999999999999999999741                  1111122211


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                      -.  .-.++.....+...++...+..||.+|-.
T Consensus       382 ~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  382 ME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             hh--hccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence            10  01233344555677888899999999963

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=259.83  Aligned_cols=240  Identities=25%  Similarity=0.402  Sum_probs=189.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..++||+|-||+||-|.. .+|+.||||++....-      .......+.+|+.+|.++.||.||.+...|+..+..++|
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrF------p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV  641 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRF------PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV  641 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccC------CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence            457899999999999986 5799999999976332      222237788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC---CceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfgl~~  256 (380)
                      ||-+. |+..+.+-.  .....++...-.-++.||+.||.|||   .++|+|+||||+|||+.+.   ..+||+|||.++
T Consensus       642 MEKl~-GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  642 MEKLH-GDMLEMILS--SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             ehhhc-chHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccccee
Confidence            99995 566665542  34667888888889999999999999   9999999999999999653   479999999999


Q ss_pred             cCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ..++     ..+||+.|+|||++.+..|...-|+||.|||+|--++|..||++.       .++.+-+++   .    +.
T Consensus       716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-------EdIndQIQN---A----aF  781 (888)
T KOG4236|consen  716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-------EDINDQIQN---A----AF  781 (888)
T ss_pred             ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-------cchhHHhhc---c----cc
Confidence            8764     457999999999999999999999999999999999999999741       111111110   0    00


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL  370 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev  370 (380)
                          +.....-.+......+++...+++.=.+|-|.+.-
T Consensus       782 ----MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  782 ----MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             ----ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence                01112224556667788888888887888776543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.7e-32  Score=262.40  Aligned_cols=258  Identities=21%  Similarity=0.254  Sum_probs=175.9

Q ss_pred             cccccCccCCeeEEEEEe-----------------cCCcEEEEEEeeeccCCChhhhc------HHHHHHHHHHHHHHHc
Q 047245          101 ENRLLGSSPDGKYYRTVL-----------------DNGLTVAVRRVEAFESGSPEKQN------KSVKRRIQQELEVLAS  157 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~  157 (380)
                      ..++||+|+||.||+|..                 .+++.||||++........+...      ....+....|+..+.+
T Consensus       149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~  228 (507)
T PLN03224        149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK  228 (507)
T ss_pred             EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence            457899999999999964                 24568999998653211100000      0112334557888888


Q ss_pred             CCCCCc-----ceeeEEEec--------CCeEEEEEeecCCCCHHHHHHHhhh--------------------cccCCCH
Q 047245          158 LRHRNL-----MSLRAYVPE--------SSRFYLVYDYLQTGSLEDAMDRIRE--------------------NQLQLGW  204 (380)
Q Consensus       158 l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~  204 (380)
                      ++|.++     ++++++|..        .+..++||||+++|+|.++++....                    ....++|
T Consensus       229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~  308 (507)
T PLN03224        229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI  308 (507)
T ss_pred             hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence            876654     677787753        3568999999999999999874211                    0123577


Q ss_pred             HHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC-------CcCCCcccCcccccCC
Q 047245          205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-------LIATSAYSAPECFQNR  277 (380)
Q Consensus       205 ~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~-------~~~~~~y~aPE~~~~~  277 (380)
                      ..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....       ..+++.|+|||.+...
T Consensus       309 ~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             HHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            888999999999999999   889999999999999999999999999998754321       1247899999988543


Q ss_pred             CC----------------------CCcchhhHHHHHHHHHHhCCC-CCCch--hhh-cc-CCCCHHHHHHHHHhhcchhH
Q 047245          278 SY----------------------TDKSDIFSFGMILAVLLTGRD-PTAPF--FAE-AA-SGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       278 ~~----------------------~~~sDv~s~Gvil~el~tg~~-p~~~~--~~~-~~-~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ..                      ..+.||||+||+++||++|.. |+...  +.. .. ....+..|......      
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~------  459 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ------  459 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc------
Confidence            21                      234799999999999999875 65421  100 00 01122233221100      


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCC---CCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSP---ADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P---~~RPs~~evl~  372 (380)
                      ..+..     ..........+++.+++..+|   .+|+|++|+++
T Consensus       460 ~~~~~-----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KYDFS-----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCCcc-----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            01111     112234567889999998766   68999999874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.4e-32  Score=268.72  Aligned_cols=252  Identities=17%  Similarity=0.229  Sum_probs=160.6

Q ss_pred             cccccCccCCeeEEEEEec-C----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEE------
Q 047245          101 ENRLLGSSPDGKYYRTVLD-N----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAY------  169 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------  169 (380)
                      ..+.||+|+||.||+|... +    +..||+|++.....          .+....|  .+.+..+.++..+...      
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----------~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----------VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----------hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            4578999999999999974 4    68999998754110          0111111  1112222222222111      


Q ss_pred             EecCCeEEEEEeecCCCCHHHHHHHhhhc----------------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecC
Q 047245          170 VPESSRFYLVYDYLQTGSLEDAMDRIREN----------------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN  233 (380)
Q Consensus       170 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~d  233 (380)
                      +......++|+||+++++|.+++......                ........+..++.|++.||+|||   +.+|+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCc
Confidence            34567899999999999999998742100                001122345679999999999999   89999999


Q ss_pred             CCCCcEEeCC-CCceEEeccCCcccCC-------CCCcCCCcccCcccccCC----------------------CCCCcc
Q 047245          234 LKPTNVMLDA-EFTPRLADFGLAKLMP-------GSLIATSAYSAPECFQNR----------------------SYTDKS  283 (380)
Q Consensus       234 lk~~Nill~~-~~~~kl~Dfgl~~~~~-------~~~~~~~~y~aPE~~~~~----------------------~~~~~s  283 (380)
                      |||+|||+++ ++.+||+|||+++...       ....+++.|+|||.+...                      .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5799999999997543       234578999999965322                      234567


Q ss_pred             hhhHHHHHHHHHHhCCCCCCchhhh-----ccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHccc
Q 047245          284 DIFSFGMILAVLLTGRDPTAPFFAE-----AASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLS  358 (380)
Q Consensus       284 Dv~s~Gvil~el~tg~~p~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~  358 (380)
                      |||||||++|||+++..|++.....     ......+..|........  ..-+....   ...........+|+.+|++
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~---~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA--SPDLRRGF---EVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcccc--chhhhhhh---hhccccchHHHHHHHHHcc
Confidence            9999999999999987775431100     001112333322211110  00000000   0000112235689999999


Q ss_pred             CCCCCCCCHHhHHH
Q 047245          359 DSPADRPSSDELVP  372 (380)
Q Consensus       359 ~~P~~RPs~~evl~  372 (380)
                      .||++|||++|+++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=251.62  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=191.9

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe-cCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP-ESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  180 (380)
                      .+||+|||+.|||+.. ...+.||||+-........++ .++..+...+|..+-+.|.||.||++++++. +.+.++-|+
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEK-KeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEK-KENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHh-hhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            5799999999999984 567899999887655443333 3455677889999999999999999999985 456789999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC---CCCceEEeccCCccc
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD---AEFTPRLADFGLAKL  257 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfgl~~~  257 (380)
                      |||+|.+|.-||..    ...+++.+...|+.||+.||.||.+ .+++|||-||||.|||+-   ..|.+||+|||+++.
T Consensus       548 EYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            99999999999975    4468899999999999999999984 478999999999999994   458999999999998


Q ss_pred             CCCC-------------CcCCCcccCcccccCC----CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          258 MPGS-------------LIATSAYSAPECFQNR----SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       258 ~~~~-------------~~~~~~y~aPE~~~~~----~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +.++             ..||..|++||.+--+    +++.|.||||.|||+|..+-|+.||...    ....++     
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn----qsQQdI-----  693 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN----QSQQDI-----  693 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc----hhHHHH-----
Confidence            7643             2389999999998533    4788999999999999999999999632    111111     


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                        .....+...-.-..   +..+....+...++++|+...-++|....++.
T Consensus       694 --LqeNTIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  694 --LQENTILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             --HhhhchhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence              11111111111111   11123455677899999999999988776654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=249.06  Aligned_cols=256  Identities=20%  Similarity=0.268  Sum_probs=193.0

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-C-C----CcceeeEEEecCC
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-H-R----NLMSLRAYVPESS  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~  174 (380)
                      -.++|+|.||.|-..... .+..||+|+++.         ....++...-|++++.++. + |    -+|.+.+|+.-.+
T Consensus        94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   94 VDLLGEGTFGKVVECWDRETKEHVALKIIKN---------VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             hhhhcCCcccceEEEeecCCCceehHHHHHH---------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            357999999999998763 478999999975         3445577788999999994 2 3    3778888899999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC------------
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD------------  242 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~------------  242 (380)
                      +.++|+|.+ |-|+.+++..  ++-.+++...+..|+.|+++++++||   +.+++|-||||+|||+.            
T Consensus       165 hiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             ceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence            999999988 6699999984  45567888899999999999999999   99999999999999982            


Q ss_pred             --------CCCceEEeccCCcccCCCC---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc--
Q 047245          243 --------AEFTPRLADFGLAKLMPGS---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA--  309 (380)
Q Consensus       243 --------~~~~~kl~Dfgl~~~~~~~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~--  309 (380)
                              .+..++|+|||.+......   .+.|..|.|||++.+-.++..+||||+||||.|+.+|...|.......  
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                    1345899999999876544   368999999999999999999999999999999999998876421000  


Q ss_pred             -----cCCCCHHHHHHHH-----Hhhcc-----------hhHhh---chhccCCcccHHHHHHHHHHHHHcccCCCCCCC
Q 047245          310 -----ASGGSLGRWLRHL-----QHAGE-----------AREAL---DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP  365 (380)
Q Consensus       310 -----~~~~~l~~~~~~~-----~~~~~-----------~~~~~---~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP  365 (380)
                           .-+......+...     ...+.           .....   ++...-....+.+..++++|+..++..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence                 0001111111111     11110           01111   111111123356778899999999999999999


Q ss_pred             CHHhHHH
Q 047245          366 SSDELVP  372 (380)
Q Consensus       366 s~~evl~  372 (380)
                      |+.|++.
T Consensus       399 Tl~EAL~  405 (415)
T KOG0671|consen  399 TLREALS  405 (415)
T ss_pred             cHHHHhc
Confidence            9999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-33  Score=226.96  Aligned_cols=192  Identities=22%  Similarity=0.387  Sum_probs=165.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .-||+|++|.|=+-.+ .+|...|+|++...       .+.+..++..+|+.+..+- .+|.+|.++|...+.+..++.|
T Consensus        52 ~elGrGayG~vekmrh~~sg~imAvKri~~t-------vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-------VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhcCCccchhhheeeccCCeEEEEeeehhh-------cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            4599999999977664 68999999999762       2345567788899887666 7999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |.|+. ||..+....-.....+++..+-+||..+..||.|||+  ...++|||+||+|||++.+|.+|++|||++-.+.+
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99965 9998887665667789999999999999999999996  56899999999999999999999999999977654


Q ss_pred             C-----CcCCCcccCcccccC----CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          261 S-----LIATSAYSAPECFQN----RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       261 ~-----~~~~~~y~aPE~~~~----~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      .     ..|-..|||||.+..    ..|+.||||||||+++.||-+++.||+.
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            3     347778999999853    3689999999999999999999999974

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=221.09  Aligned_cols=187  Identities=25%  Similarity=0.435  Sum_probs=161.0

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +.||+|.+|+|||+.. +.++.||+|+++.....      +..-....+|+-+++.++|.|||++++....+...-+|+|
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrldddd------egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCCC------CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            5799999999999996 56889999999874322      2333667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      ||+. +|..|...   -...++......++.|+.+||.++|   ++++.|||+||.|.|++.+|+.|++|||+++.++-.
T Consensus        82 ~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             HhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            9965 88888874   3456888888999999999999999   999999999999999999999999999999987643


Q ss_pred             ------CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCC
Q 047245          262 ------LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPT  302 (380)
Q Consensus       262 ------~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~  302 (380)
                            .+-|..|.+|.++-+. -|+...|+||-||++.|+-....|.
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence                  3468899999998764 5889999999999999999844443

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=270.33  Aligned_cols=236  Identities=22%  Similarity=0.297  Sum_probs=188.2

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      -++||+|+||.|..++. ..++.+|.|++....     ........-|..|-.+|..-+.+-|+++.-.+.+...+|+||
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e-----MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE-----MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHH-----HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            36899999999999987 568899999997522     112223467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |||+||+|-.++...   . +++.....-++..|.-||.-||   +-|+|||||||.|||+|..|++||+|||.+-.+..
T Consensus       155 dY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            999999999999742   2 6888888889999999999999   99999999999999999999999999999876652


Q ss_pred             -------CCcCCCcccCccccc----C-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          261 -------SLIATSAYSAPECFQ----N-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~----~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                             ..+|||.|.+||++.    + +.|...+|.||+||++|||+.|..||+.        +++++-+..+.+....
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--------dslveTY~KIm~hk~~  299 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--------DSLVETYGKIMNHKES  299 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--------HHHHHHHHHHhchhhh
Confidence                   346999999999995    2 5688999999999999999999999974        2344444433333211


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                         +.-+     .....+....+||.+-+. +|+.|-.
T Consensus       300 ---l~FP-----~~~~VSeeakdLI~~ll~-~~e~RLg  328 (1317)
T KOG0612|consen  300 ---LSFP-----DETDVSEEAKDLIEALLC-DREVRLG  328 (1317)
T ss_pred             ---cCCC-----cccccCHHHHHHHHHHhc-Chhhhcc
Confidence               1111     112355667788887554 6777776

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=244.37  Aligned_cols=235  Identities=24%  Similarity=0.295  Sum_probs=185.1

Q ss_pred             ccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  177 (380)
                      |+-.+||+|+||.|..+... +.+.+|||+++....-.     .+..+--..|-.+|+-. +-|.++++..++..-+++|
T Consensus       352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-----dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             ceEEEeccCccceeeeecccCcchhhhhhhhccceeee-----cCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            57789999999999998863 46789999997632111     11112234566677766 5788999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+.||+|--+++..    ..+.+....-+|..||-||-+||   +++|+.||||..|||+|.+|++||+|||+++.
T Consensus       427 FVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999998888753    35666677889999999999999   99999999999999999999999999999975


Q ss_pred             CC------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          258 MP------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       258 ~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      --      ....||+.|+|||.+..++|....|.|||||+||||+.|++||+..        +-.+..+.+.        
T Consensus       500 ni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe--------DE~elF~aI~--------  563 (683)
T KOG0696|consen  500 NIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE--------DEDELFQAIM--------  563 (683)
T ss_pred             cccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHH--------
Confidence            32      2346999999999999999999999999999999999999999741        1111111111        


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                       +.   .-.++...+.+...+...-+.++|.+|-.
T Consensus       564 -eh---nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  564 -EH---NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -Hc---cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence             11   12345567777888899999999999964

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.9e-33  Score=235.76  Aligned_cols=188  Identities=26%  Similarity=0.470  Sum_probs=156.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--------C
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--------S  173 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  173 (380)
                      .+||+|.||.||++.. +.|+.||+|++.....      ....-....+|+.+|..++|+|++.++..|..        .
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmene------KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENE------KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhcc------ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4799999999999986 4577889987654211      11222456789999999999999999998843        2


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ..+|+|+++|++ +|...|.   +....++..++.++..++..||.|+|   ...|+|||+||.|+||+.++.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccc
Confidence            358999999987 8888886   33457889999999999999999999   9999999999999999999999999999


Q ss_pred             CcccCCCC----------CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          254 LAKLMPGS----------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       254 l~~~~~~~----------~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      +++.+...          .+-|..|.+||.+.+ ..++++.|||.-||++.||++|.+-+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq  230 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ  230 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence            99865421          234788999999986 568999999999999999999998765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.8e-30  Score=222.31  Aligned_cols=205  Identities=35%  Similarity=0.588  Sum_probs=179.9

Q ss_pred             cCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      ||+|++|.||++...+ |+.+++|++......       .....+.+|++.++.++|++++++++++......++++|++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-------SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccch-------hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence            6899999999999854 899999998762211       03467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCcccCCCC-
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAKLMPGS-  261 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~~~-  261 (380)
                      ++++|.+++...   ...+++..+..++.++++++++||   +.+++|+||+|.||+++. ++.++|+|||.+...... 
T Consensus        74 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          74 EGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            999999998742   146889999999999999999999   889999999999999999 899999999999765443 


Q ss_pred             -----CcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          262 -----LIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       262 -----~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ..+...|++||..... ..+.++|+|++|++++++                                        
T Consensus       148 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------  187 (215)
T cd00180         148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------  187 (215)
T ss_pred             chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence                 3477889999999877 788999999999999998                                        


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                                 ..+.+++..|++.+|++||++.++++.
T Consensus       188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                       346789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=250.14  Aligned_cols=234  Identities=21%  Similarity=0.279  Sum_probs=189.5

Q ss_pred             cccCccCCeeEEEEEecCCc-EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVLDNGL-TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      .-||-|+||.|=.+...+.. ..|+|.++....     .+....+....|-.+|...+.|.||+++..+.++...|++||
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI-----VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHI-----VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhc-----cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            45899999999888875433 388888876432     234445788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      -|-||.|-..|+.    ...++.....-++..+.+|++|||   +.+||.|||||+|.+++.+|-+||.|||+++.....
T Consensus       501 aClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  501 ACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999975    445666667778899999999999   999999999999999999999999999999987643


Q ss_pred             -----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          262 -----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       262 -----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                           .+||+.|.|||.+.+...+.+.|.||+|+++|||++|.+||...        +...-...+..      .+|   
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~--------dpmktYn~ILk------Gid---  636 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV--------DPMKTYNLILK------GID---  636 (732)
T ss_pred             CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--------chHHHHHHHHh------hhh---
Confidence                 46999999999999999999999999999999999999999631        11111111111      111   


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                       .-.++........+++.+.+..+|.+|-.
T Consensus       637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 -KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence             12233445666778889888889999976

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.7e-29  Score=236.75  Aligned_cols=190  Identities=23%  Similarity=0.377  Sum_probs=162.2

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +-||-|+||.|..+.- +....+|.|.++....     ...+.......|-.+|..-..+-||+|+-.|.+.+.+|+|||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-----l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-----LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHH-----HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            4599999999998874 4566899999876321     223444677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC--
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~--  259 (380)
                      |.+||++-.+|-+    -.-+.+....-++..++.|+++.|   .-++|||||||.|||||.+|++||+|||++.-+.  
T Consensus       710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999875    334566666678889999999999   9999999999999999999999999999984221  


Q ss_pred             --------C--------------------------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHH
Q 047245          260 --------G--------------------------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILA  293 (380)
Q Consensus       260 --------~--------------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~  293 (380)
                              +                                      ..+||+.|+|||++....++.-+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    0                                      013999999999999999999999999999999


Q ss_pred             HHHhCCCCCCc
Q 047245          294 VLLTGRDPTAP  304 (380)
Q Consensus       294 el~tg~~p~~~  304 (380)
                      ||+.|+.||..
T Consensus       863 em~~g~~pf~~  873 (1034)
T KOG0608|consen  863 EMLVGQPPFLA  873 (1034)
T ss_pred             HHhhCCCCccC
Confidence            99999999964

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.4e-28  Score=214.65  Aligned_cols=189  Identities=31%  Similarity=0.496  Sum_probs=165.4

Q ss_pred             ccccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|++|.||++...+ +..+++|.+......       ...+.+.+|++.+++++|+|++++++++......++++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   76 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM   76 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence            4679999999999999865 889999998752211       24578889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++....   ..+++..+..++.+++.++.+||   +.+++|+|++|+||+++.++.++|+|||.+.....
T Consensus        77 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       77 EYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             eccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            9999999999987421   11789999999999999999999   88999999999999999999999999999886654


Q ss_pred             C-------CcCCCcccCcccc-cCCCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          261 S-------LIATSAYSAPECF-QNRSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~-~~~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      .       ..++..|++||.. ...+++.++|+|+||++++||++|+.||+
T Consensus       151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            3       2467789999998 67778889999999999999999999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=218.60  Aligned_cols=241  Identities=23%  Similarity=0.305  Sum_probs=187.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  179 (380)
                      -++||+|+|..|..+.+ .+.+.+|+|+++..-..+.     ....=.+.|-.+..+- +||.+|-+..++....++++|
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-----edidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-----EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-----ccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            36799999999998886 4578899999876332221     1224455677777777 799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      .||++||+|--+++.    +..+++....-+...|.-||.|||   +.+||.||||..|+|+|..|++|++|+|+++.--
T Consensus       330 ieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999777764    446888888888999999999999   9999999999999999999999999999997532


Q ss_pred             ------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 ------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                            +...|||.|.|||.+.+..|....|.|++||+++||+.|+.||+.....+. ..+..++.-+.....       
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~-d~ntedylfqvilek-------  474 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP-DMNTEDYLFQVILEK-------  474 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc-ccchhHHHHHHHhhh-------
Confidence                  345699999999999999999999999999999999999999985321111 122333333322221       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                       .+   ..+...+.+...++..-+++||.+|-.
T Consensus       475 -qi---riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  475 -QI---RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -cc---cccceeehhhHHHHHHhhcCCcHHhcC
Confidence             11   122334555667888899999999853

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=218.28  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=182.4

Q ss_pred             ccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------CeE
Q 047245          104 LLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------SRF  176 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  176 (380)
                      .+|.|.- .|-.+.. -.++.||+|++....      .+....++..+|...+..++|+||++++.++.-.      .+.
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf------~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF------QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCcc------ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4677766 3433332 247899999986532      2233346778999999999999999999998543      467


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      |+|||+|.. +|.+.+..      .++-..+..|..|++.|++|||   +.+|+||||||+||++..+..+||.|||+++
T Consensus        97 y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   97 YLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence            999999955 99988762      4566677889999999999999   9999999999999999999999999999998


Q ss_pred             cCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....+     .+.+..|.|||++.+..+.+..||||.||++.||++|..-|..       +..+..|.+....-|.....
T Consensus       167 ~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-------~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  167 TEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-------KDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             ccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-------chHHHHHHHHHHHhcCCCHH
Confidence            65533     4578889999999998899999999999999999999987652       23344443322222211111


Q ss_pred             ---------------------------hchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 ---------------------------LDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ---------------------------~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                                 +...+...  ..+.-....+.+++.+++-.||++|-|.+++++
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                       11100000  111224455778999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=222.72  Aligned_cols=188  Identities=28%  Similarity=0.473  Sum_probs=155.9

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----Ce
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----SR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  175 (380)
                      .+-||-|+||.||.+.. ++|+.||.|++....      .+-..-+.+.+|+++|.-.+|.|++..++.....     .+
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf------q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF------QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHH------HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            36799999999999886 579999999986522      1223347788999999999999999998876443     24


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .|+++|.|.. +|...+-    +...++-..+.-+..||++||.|||   +.+|.||||||.|.|++.+...||+|||++
T Consensus       132 iYV~TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHHHHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccc
Confidence            6778887743 6655543    3567888888899999999999999   999999999999999999999999999999


Q ss_pred             ccCCCCC-------cCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          256 KLMPGSL-------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       256 ~~~~~~~-------~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      +....+.       +-|..|.|||.+++ ..|+.+.||||.||++.|++..+..|.
T Consensus       204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ  259 (449)
T KOG0664|consen  204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ  259 (449)
T ss_pred             cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence            9755322       36778999999987 568999999999999999998887765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=234.44  Aligned_cols=194  Identities=23%  Similarity=0.363  Sum_probs=161.4

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+|.|+||.|+.+... +...|++|.+...+.....-......-....||++|..++   |+||+++++++++++.+||
T Consensus       567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl  646 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL  646 (772)
T ss_pred             eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence            46999999999999974 5668999988652211100000011123456999999997   9999999999999999999


Q ss_pred             EEeec-CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          179 VYDYL-QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       179 v~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ++|-. ++.+|.+++..    ...+++.....|..|++.|+++||   +++|||||||-+|+.++.+|-+||+|||.+..
T Consensus       647 ~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  647 ETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             EecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhh
Confidence            99965 46689999874    667999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCC----CcCCCcccCcccccCCCCC-CcchhhHHHHHHHHHHhCCCCCC
Q 047245          258 MPGS----LIATSAYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       258 ~~~~----~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      ..+.    .+||..|.|||++.+.+|- ...|||++|++||.++-..+||.
T Consensus       720 ~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            5543    4699999999999998874 55899999999999999999985

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=5.3e-29  Score=257.41  Aligned_cols=189  Identities=19%  Similarity=0.216  Sum_probs=139.1

Q ss_pred             HcCCC-CCcceeeEEE-------ecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 047245          156 ASLRH-RNLMSLRAYV-------PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP  227 (380)
Q Consensus       156 ~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  227 (380)
                      +.++| +||+++++++       .+...++.++||+ +++|.+++..   ....+++..++.++.||++||+|||   ++
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~   99 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAH---SQ   99 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHH---hC
Confidence            34556 6888888877       2334678888987 5599999973   2346899999999999999999999   99


Q ss_pred             CeEecCCCCCcEEeCC-------------------CCceEEeccCCcccCCC----------------------CCcCCC
Q 047245          228 QILHYNLKPTNVMLDA-------------------EFTPRLADFGLAKLMPG----------------------SLIATS  266 (380)
Q Consensus       228 ~iiH~dlk~~Nill~~-------------------~~~~kl~Dfgl~~~~~~----------------------~~~~~~  266 (380)
                      +|+||||||+|||++.                   ++.+|++|||+++....                      ...+|+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            9999999999999954                   45667777777753211                      023678


Q ss_pred             cccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHH
Q 047245          267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEM  346 (380)
Q Consensus       267 ~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (380)
                      .|+|||.+.+..++.++|||||||++|||++|..|+...          .........     ..+.+..      ....
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----------~~~~~~~~~-----~~~~~~~------~~~~  238 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----------SRTMSSLRH-----RVLPPQI------LLNW  238 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----------HHHHHHHHH-----hhcChhh------hhcC
Confidence            899999999999999999999999999999988875421          001111100     0011110      1123


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          347 LMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       347 ~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....+++.+||+.+|.+|||+.|+++
T Consensus       239 ~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        239 PKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHHHHhCCCChhhCcChHHHhh
Confidence            34567888999999999999999975

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-27  Score=216.68  Aligned_cols=127  Identities=25%  Similarity=0.362  Sum_probs=106.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-----C---CCcceeeEEEe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-----H---RNLMSLRAYVP  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~  171 (380)
                      ..++||-|-|++||.+.. .+.+.||+|+.+.         .+...+....||.+|++++     |   ..||+++++|.
T Consensus        82 v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   82 VQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             EEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            447899999999999985 5678999999874         3344577788999999994     2   36999999985


Q ss_pred             c----CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe
Q 047245          172 E----SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML  241 (380)
Q Consensus       172 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill  241 (380)
                      .    +.+.++|+|++ |.+|..++..  .+-..++...+.+|+.||+.||.|||.+|  +|||-||||+|||+
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            4    56899999998 6799999885  33445888999999999999999999855  99999999999997

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.6e-28  Score=204.45  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=184.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecC--CeEEE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPES--SRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l  178 (380)
                      +.+|+|.++.||.|.. .+.+.++||.+++..           .+.+.+|+.+|..|. ||||+.+++...+.  ....|
T Consensus        44 rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   44 RKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             HHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            5799999999999984 678899999998632           377889999999996 99999999998664  46799


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccCCccc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKL  257 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfgl~~~  257 (380)
                      ++||.++.+......       .++-..+.....+++.||.|+|   +.||.|||+||.|+++|.. ..++|+|+|+|..
T Consensus       113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence            999999988777654       4666777889999999999999   9999999999999999864 6799999999987


Q ss_pred             CCCC-----CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHH--------
Q 047245          258 MPGS-----LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQ--------  323 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~--------  323 (380)
                      .-..     .+.+..|-.||.+-. +.|+..-|+|||||++.+|+..+.||.   ...++.++++....-+-        
T Consensus       183 YHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF---hG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  183 YHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF---HGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             cCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc---CCCCCHHHHHHHHHHhChHHHHHHH
Confidence            6432     345667889999865 557888999999999999999999984   33333333433322110        


Q ss_pred             ------hhcchhHhhchhcc-------CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          324 ------HAGEAREALDRSIL-------GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       324 ------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                            -+....+.+...-.       ......-...++.+++...+..|-++|||++|..
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence                  01111111111000       0011111235678999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=8e-29  Score=233.67  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=191.6

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ..+|+|.+|.|||++. ..++..|+|.++.....        ...-.++|+-+++..+||||+.++|.+......++.||
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--------d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--------DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCc--------cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            4689999999999985 57899999999874332        23556789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC--
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--  259 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~--  259 (380)
                      ||.+|+|++..+.    ..++++.++...+....+|++|||   +.+-+|||||-.||++++.+.+|++|||.+-...  
T Consensus        93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh
Confidence            9999999997764    668999999999999999999999   9999999999999999999999999999987654  


Q ss_pred             ----CCCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          260 ----GSLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       260 ----~~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                          .+..||+.|||||+..   .+.|..++|||+.|+...|+---+.|....          .-.-..+...   ...+
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl----------hpmr~l~LmT---kS~~  232 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL----------HPMRALFLMT---KSGF  232 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc----------chHHHHHHhh---ccCC
Confidence                3457999999999874   466889999999999999998877774321          0000000100   1223


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ++..+.++.  .-...+-+++..|+.++|.+|||+..+++
T Consensus       233 qpp~lkDk~--kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  233 QPPTLKDKT--KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCcccCCc--cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            333332221  12344778999999999999999987654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.8e-27  Score=199.04  Aligned_cols=166  Identities=24%  Similarity=0.252  Sum_probs=124.3

Q ss_pred             CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-CCcC
Q 047245          186 GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-SLIA  264 (380)
Q Consensus       186 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-~~~~  264 (380)
                      |||.++++.   ....++|..++.++.|++.||+|||   +.+      ||+|||++.++.+|+  ||+++.... ...+
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g   66 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRV   66 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccccCCC
Confidence            789999974   2446999999999999999999999   555      999999999999999  999886543 3468


Q ss_pred             CCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHH
Q 047245          265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEED  344 (380)
Q Consensus       265 ~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (380)
                      ++.|+|||.+.+..++.++||||||+++|||++|+.||....       ...............   .++.  .......
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~-------~~~~~~~~~~~~~~~---~~~~--~~~~~~~  134 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER-------ELSAILEILLNGMPA---DDPR--DRSNLES  134 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc-------hhcHHHHHHHHHhcc---CCcc--ccccHHH
Confidence            899999999999999999999999999999999999985311       111111111111000   0000  0011122


Q ss_pred             HHH--HHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          345 EML--MAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       345 ~~~--~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ...  .+.+++.+||+.+|.+|||+.|+++.+..+
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            222  589999999999999999999999877543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.5e-27  Score=214.86  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=188.1

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  175 (380)
                      ..++||.|.|++||++...    ..+.||+|.+......          ....+|++.|..+ .+.||+.+.+++..++.
T Consensus        40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----------~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----------SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhccccccchhhhhhhhHhhhccccceEeeeecccccCc----------hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            4568999999999999863    4678999999774432          5688999999999 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccCC
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGL  254 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfgl  254 (380)
                      ..+|+||+++....+++.       .++..++...++.+..||+++|   .++|||||+||+|+|.+.. +.-.|.|||+
T Consensus       110 v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechh
Confidence            999999999999999886       3678888999999999999999   9999999999999999864 6789999999


Q ss_pred             cccCC--------------------C------------------------------CCcCCCcccCcccccC-CCCCCcc
Q 047245          255 AKLMP--------------------G------------------------------SLIATSAYSAPECFQN-RSYTDKS  283 (380)
Q Consensus       255 ~~~~~--------------------~------------------------------~~~~~~~y~aPE~~~~-~~~~~~s  283 (380)
                      +....                    +                              +..||++|.|||++.. +.-+.+.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            85100                    0                              0128999999999975 5578999


Q ss_pred             hhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH---------HHHHhhcc--hhH---------------hhc-hhc
Q 047245          284 DIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL---------RHLQHAGE--ARE---------------ALD-RSI  336 (380)
Q Consensus       284 Dv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~---------~~~~~~~~--~~~---------------~~~-~~~  336 (380)
                      ||||-|||++.+++++.||....+..   ..+.+.+         ......|.  +.+               .++ ..+
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~---~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDA---DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             ceeeccceeehhhccccccccCcccc---chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence            99999999999999999986422222   1121111         11111111  000               010 000


Q ss_pred             --------cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          337 --------LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       337 --------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                              ......+.....+.++..+|++.||.+|-|++|.|+
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                    011111223346789999999999999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=202.36  Aligned_cols=240  Identities=18%  Similarity=0.309  Sum_probs=177.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEE-EecCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAY-VPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~  177 (380)
                      ..+.||+|.||.+-.+.. ++.+.+++|.+..         .....++|.+|..---.| .|.||+..++. +...+.++
T Consensus        28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~---------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPR---------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             HHHHhcccceeeEEeeeccCCceEEEeeccCc---------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            456799999999999886 4577899998865         234468899999877777 58999987665 56677889


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC--CCCceEEeccCCc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD--AEFTPRLADFGLA  255 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kl~Dfgl~  255 (380)
                      +++||+|.|+|.+-+.     ...+.+..-.+++.|+++|+.|+|   +.++||||||.+||||-  +...+||+|||.+
T Consensus        99 F~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccc
Confidence            9999999999998775     345777778899999999999999   99999999999999994  3358999999999


Q ss_pred             ccCCCCC---cCCCcccCcccccCC-----CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          256 KLMPGSL---IATSAYSAPECFQNR-----SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       256 ~~~~~~~---~~~~~y~aPE~~~~~-----~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      +..+...   ..+-.|.+||.....     ...+.+|+|.||++++.++||..||..   .........+|..+..+.. 
T Consensus       171 ~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk---a~~~d~~Y~~~~~w~~rk~-  246 (378)
T KOG1345|consen  171 RKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK---ASIMDKPYWEWEQWLKRKN-  246 (378)
T ss_pred             cccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh---hhccCchHHHHHHHhcccC-
Confidence            8766432   245568899977532     235679999999999999999999973   2222223455554433221 


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHh
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDE  369 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e  369 (380)
                       .     .+ +..+ ......+.++-.+-+..+|++|--..+
T Consensus       247 -~-----~~-P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  247 -P-----AL-PKKF-NPFSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             -c-----cC-chhh-cccCHHHHHHHHHhcCCcccccchhHH
Confidence             1     11 0111 113445666777788888888844333

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=2.2e-27  Score=218.24  Aligned_cols=188  Identities=23%  Similarity=0.325  Sum_probs=160.8

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC------CCcceeeEEEecCC
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH------RNLMSLRAYVPESS  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~~  174 (380)
                      ....|+|-|++|.+|.. ..|..||||++..         ++...+.=+.|+++|++|+.      -|+++++-.|...+
T Consensus       437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRN---------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             EeccccceeeeeeeccccCCCCeeEEEEeec---------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            34579999999999986 3578999999986         33334556689999999963      48999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFG  253 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfg  253 (380)
                      ++|||+|-+ ..+|.+.|..+..+ ..|....+..++.|+.-||..|.   .-+|+|.||||.|||+++. ..+||||||
T Consensus       508 HLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence            999999987 45999999876543 35777888999999999999999   8999999999999999976 568999999


Q ss_pred             CcccCCCCCc----CCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          254 LAKLMPGSLI----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       254 l~~~~~~~~~----~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      .|.......+    -+..|.|||.+.+-+|+...|+||.||.||||.||+..|.
T Consensus       583 SA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  583 SASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             cccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            9988765543    3457999999999999999999999999999999998876

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.9e-27  Score=199.46  Aligned_cols=249  Identities=21%  Similarity=0.385  Sum_probs=190.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +..+|.....|..|+|.++ |..+++|++....      ......++|..|.-.|+-..||||..++|.|.......++.
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~------~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVRE------VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             hhhhhccCCCccccccccc-Ccchhhhhhhhhh------cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            3456788889999999996 5567778876532      23344578999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEe--ccCCcccC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA--DFGLAKLM  258 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~--Dfgl~~~~  258 (380)
                      .||+.|||...|+.  ......+-.+..+++.++|+|++|||+. ++-|..--|.++.+++|++.+++|+  |--++...
T Consensus       267 q~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe  343 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE  343 (448)
T ss_pred             eeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec
Confidence            99999999999995  4455678888999999999999999943 3445555689999999999998885  32222221


Q ss_pred             CCCCcCCCcccCcccccCCCCC---CcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          259 PGSLIATSAYSAPECFQNRSYT---DKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       259 ~~~~~~~~~y~aPE~~~~~~~~---~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                       ......+.||+||.++..+-+   .++|+|||++++||+.|...||.......-.       ++      -..+.+.. 
T Consensus       344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mk------ialeglrv-  408 (448)
T KOG0195|consen  344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MK------IALEGLRV-  408 (448)
T ss_pred             -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hh------hhhccccc-
Confidence             134467899999999876643   4799999999999999999999753221100       00      01112222 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                          ..++..+..+.+++.-|++.||.+||.++.++-.|+++.
T Consensus       409 ----~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  409 ----HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ----cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                223445566888999999999999999999999999874

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.1e-23  Score=195.65  Aligned_cols=156  Identities=21%  Similarity=0.208  Sum_probs=119.6

Q ss_pred             cccccCccCCeeEEEEEec--CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++...  +++.+|||++......   .......+.|.+|++++++++|+|++..+..+   +..++
T Consensus        22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~---~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~L   95 (365)
T PRK09188         22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW---WSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGL   95 (365)
T ss_pred             EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc---cccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEE
Confidence            4578999999999999864  5778899987531100   01223456799999999999999998633322   45799


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC-CCCcEEeCCCCceEEeccCCccc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL-KPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dl-k~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ||||+++++|... .   . .   .   ...++.|++++|+|||   +.+|+|||| ||+|||++.++.+||+|||+++.
T Consensus        96 VmE~~~G~~L~~~-~---~-~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         96 VRGWTEGVPLHLA-R---P-H---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             EEEccCCCCHHHh-C---c-c---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            9999999999632 1   0 0   1   1467889999999999   999999999 99999999999999999999985


Q ss_pred             CCCC--------------CcCCCcccCcccccC
Q 047245          258 MPGS--------------LIATSAYSAPECFQN  276 (380)
Q Consensus       258 ~~~~--------------~~~~~~y~aPE~~~~  276 (380)
                      ....              ..+++.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            5421              236777999998854

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=9.8e-22  Score=182.47  Aligned_cols=249  Identities=21%  Similarity=0.222  Sum_probs=181.0

Q ss_pred             ccccccCccCCeeEEEEEecCC--cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC----CCcceeeEEE-ec
Q 047245          100 NENRLLGSSPDGKYYRTVLDNG--LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH----RNLMSLRAYV-PE  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~  172 (380)
                      ...+.||+|+||.||.+...+.  ..+|+|.........        ...+..|..++..+..    +++..+++.. ..
T Consensus        21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~   92 (322)
T KOG1164|consen   21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRST   92 (322)
T ss_pred             EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------CccchhHHHHHHHHhhhcCCCCCCEEEEeccCC
Confidence            3557899999999999997543  478888776522211        0246678888888863    5888888888 47


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-----Cce
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-----FTP  247 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-----~~~  247 (380)
                      ....++||+.+ |.||.++.....  ...++....++|+.|++.+|++||   +.+++||||||.|+.+...     ..+
T Consensus        93 ~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   93 EDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             CceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceE
Confidence            77889999977 789999776422  467899999999999999999999   9999999999999999765     468


Q ss_pred             EEeccCCcc--cCC--------------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC
Q 047245          248 RLADFGLAK--LMP--------------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS  311 (380)
Q Consensus       248 kl~Dfgl~~--~~~--------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~  311 (380)
                      .+.|||+++  ...              ....||.+|+++....+...+.+.|+||++.++.|++.|..||......   
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~---  243 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT---  243 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc---
Confidence            999999998  311              0123899999999999999999999999999999999999998531100   


Q ss_pred             CCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          312 GGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       312 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                       ......... ....    ....   ....   ....+.++...+-..+..++|....+...|+..
T Consensus       244 -~~~~~~~~~-~~~~----~~~~---~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  244 -DLKSKFEKD-PRKL----LTDR---FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             -chHHHHHHH-hhhh----cccc---ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence             001111000 0000    0000   0111   223344555555568999999999988877654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=8.2e-23  Score=193.17  Aligned_cols=209  Identities=25%  Similarity=0.418  Sum_probs=160.3

Q ss_pred             HHcCCCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCe-EecC
Q 047245          155 LASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQI-LHYN  233 (380)
Q Consensus       155 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-iH~d  233 (380)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+..   ....++|.....+..+++.||+|||   ..++ .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHh---cCcceeeee
Confidence            3568999999999999999999999999999999999973   4667999999999999999999999   5555 9999


Q ss_pred             CCCCcEEeCCCCceEEeccCCcccCCCC---C-----cCCCcccCcccccCCC-------CCCcchhhHHHHHHHHHHhC
Q 047245          234 LKPTNVMLDAEFTPRLADFGLAKLMPGS---L-----IATSAYSAPECFQNRS-------YTDKSDIFSFGMILAVLLTG  298 (380)
Q Consensus       234 lk~~Nill~~~~~~kl~Dfgl~~~~~~~---~-----~~~~~y~aPE~~~~~~-------~~~~sDv~s~Gvil~el~tg  298 (380)
                      ++++|+++|..+.+|++|||+.......   .     ....-|.|||.+.+..       .+.++||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998776421   1     1233599999997631       46789999999999999999


Q ss_pred             CCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          299 RDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       299 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ..||+......    ...+.+......+  ...+.|.+...   .+....+..++..||..+|.+||+++.+-..++.+.
T Consensus       155 ~~~~~~~~~~~----~~~eii~~~~~~~--~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  155 SGPFDLRNLVE----DPDEIILRVKKGG--SNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cCccccccccC----ChHHHHHHHHhcC--CCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            99997421111    1122222222211  11222222111   123336889999999999999999999998887764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=2.3e-21  Score=179.11  Aligned_cols=253  Identities=29%  Similarity=0.418  Sum_probs=187.7

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC-CcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  180 (380)
                      ...||.|+||.||++...  ..+++|.+.......     ......+.+|+.+++.+.|+ +++++.+.+......++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESK-----SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccc-----hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence            356899999999999986  788999987633221     12457899999999999888 7999999998777789999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~~~~~  259 (380)
                      +++.++++.+++...... ..+.......+..|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++...
T Consensus        78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            999999999766531111 26888899999999999999999   88999999999999999988 79999999987443


Q ss_pred             ------------CCCcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          260 ------------GSLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       260 ------------~~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                                  ....++..|++||.+.+   ...+...|+||+|++++++++|..|+......    ............
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~  229 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILE  229 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHh
Confidence                        23358899999999987   57889999999999999999999996532110    001111111111


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....  ....... ..........+.+++..|+..+|..|.++.+...
T Consensus       230 ~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         230 LPTP--SLASPLS-PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cCCc--ccccccC-ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            1100  0000000 0000112346778999999999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=5.7e-22  Score=169.38  Aligned_cols=147  Identities=13%  Similarity=0.161  Sum_probs=110.5

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhh------------------hcHHHHHHHHHHHHHHHcCCCCCcc
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEK------------------QNKSVKRRIQQELEVLASLRHRNLM  164 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~------------------~~~~~~~~~~~E~~~l~~l~h~niv  164 (380)
                      ..||+|++|.||+|...+|+.||+|+++.........                  ..+........|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            5799999999999998889999999998632111000                  0000112334699999999888775


Q ss_pred             eeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeEecCCCCCcEEeCC
Q 047245          165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL-HFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       165 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiH~dlk~~Nill~~  243 (380)
                      ....+...  ..++||||++++++......    ...++......++.|++.+|.|+ |   +.+++||||||+|||++ 
T Consensus        83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-  152 (190)
T cd05147          83 CPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence            44333222  23899999999877654321    34688889999999999999999 7   78999999999999998 


Q ss_pred             CCceEEeccCCcccCC
Q 047245          244 EFTPRLADFGLAKLMP  259 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~  259 (380)
                      ++.++|+|||++....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=4.1e-22  Score=167.54  Aligned_cols=188  Identities=24%  Similarity=0.336  Sum_probs=158.5

Q ss_pred             cccccCccCCeeEEEEE-ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC-CCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-RNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  178 (380)
                      .-+.||+|+||.+|.|. ..+|+.||+|.-.....          ..++.-|..+.+.|+| ..|..+..+..+...-.+
T Consensus        19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             EEEeecCCchhheeeeeeccCCceEEEEeecccCC----------CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            45789999999999998 47899999998654222          1456779999999975 678888888888888899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC---CceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfgl~  255 (380)
                      |||.+ |.||++.++.+   ...++..+.+-++-|+..-++|+|   ..+++||||||+|+|..-+   ..+.++|||++
T Consensus        89 VMdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccch
Confidence            99988 88999998754   335778899999999999999999   9999999999999999643   56889999999


Q ss_pred             ccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCch
Q 047245          256 KLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF  305 (380)
Q Consensus       256 ~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~  305 (380)
                      +...+             +..||.+|.+-....+...+...|+-|+|.++.+..-|..||...
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            86543             234899999988888888899999999999999999999999753

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4.4e-21  Score=164.40  Aligned_cols=147  Identities=14%  Similarity=0.182  Sum_probs=112.7

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChh------------------hhcHHHHHHHHHHHHHHHcCCCCCcc
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPE------------------KQNKSVKRRIQQELEVLASLRHRNLM  164 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~------------------~~~~~~~~~~~~E~~~l~~l~h~niv  164 (380)
                      ..||+|++|.||+|...+|+.||||++.........                  .........+..|...+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            579999999999999888999999999864211000                  00011123346899999999999886


Q ss_pred             eeeEEEecCCeEEEEEeecCCCCHHHH-HHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeC
Q 047245          165 SLRAYVPESSRFYLVYDYLQTGSLEDA-MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLD  242 (380)
Q Consensus       165 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~  242 (380)
                      ....+....  .++||||++++++... +.     ...++......++.|++.++.++|   . .+++||||||+||+++
T Consensus        83 ~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~  152 (190)
T cd05145          83 VPEPILLKK--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CceEEEecC--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE
Confidence            554444332  4899999998865443 32     235677888999999999999999   7 8999999999999999


Q ss_pred             CCCceEEeccCCcccCCC
Q 047245          243 AEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       243 ~~~~~kl~Dfgl~~~~~~  260 (380)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             88999999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=3.3e-21  Score=169.16  Aligned_cols=187  Identities=21%  Similarity=0.298  Sum_probs=160.3

Q ss_pred             cccccCccCCeeEEEEE-ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      .+++||+|+||..+.|. +-+++.||||.-.....          .-++..|....+.| ..++|...+-|-.++-.-.|
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEeccccCC----------cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            46789999999999998 46799999997654222          14567788888888 57899998888888888899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-----CceEEeccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-----FTPRLADFG  253 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-----~~~kl~Dfg  253 (380)
                      |+|.+ |.||+|++.-+   ...++...+..+|.|+..-++|+|   ++.+|.|||||+|+||...     ..+.++|||
T Consensus       102 VidLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hhhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEecc
Confidence            99988 88999988753   457889999999999999999999   9999999999999999643     468999999


Q ss_pred             CcccCCCC-------------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          254 LAKLMPGS-------------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       254 l~~~~~~~-------------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      +++...+.             ..||.+||+-.-..+..-+.+.|+-|+|-++.+.+-|..||..
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            99876532             3599999999999999999999999999999999999999975

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=1.7e-21  Score=168.70  Aligned_cols=168  Identities=12%  Similarity=0.140  Sum_probs=128.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHH------HHHHHHHHHcCCCCCcceeeEEEecC-
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR------IQQELEVLASLRHRNLMSLRAYVPES-  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~-  173 (380)
                      ..+++|.|+||.||.... ++..+|+|.+.......     +.....      +.+|+..+.+++|++|..+..++... 
T Consensus        35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~-----~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT-----ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             EEEEecCCCceEEEEEec-CCCcEEEEEechhcCch-----HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            567899999999999665 57789999997633221     122222      68999999999999999998885432 


Q ss_pred             -------CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc
Q 047245          174 -------SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT  246 (380)
Q Consensus       174 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  246 (380)
                             +..+++|||++|.+|.++..        ++.    ....+++.++..+|   ..+++|||++|+||++++++ 
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence                   35799999999999988632        221    24568999999999   99999999999999999988 


Q ss_pred             eEEeccCCcccCCCCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHH
Q 047245          247 PRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLL  296 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~  296 (380)
                      ++|+|||...........      ........+..++|+||||+++.-..
T Consensus       173 i~liDfg~~~~~~e~~a~------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988765432211      11333445667999999999887655

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.5e-22  Score=198.31  Aligned_cols=249  Identities=18%  Similarity=0.226  Sum_probs=179.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+++|.|++|.|+.... ......+.|..... ....+ ........+..|..+-..+.|+|++..+..+.+....+-.
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~-s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTE-SERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcc-cHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence            567899999997776553 23333444433311 00111 1122223377888999999999998887777776666666


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||||++ +|..++..    ...+...++..+..|+..|+.|+|   ..++.|||+|++|++++.++.+||+|||.+....
T Consensus       400 mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            999999 99998873    235777788889999999999999   9999999999999999999999999999986432


Q ss_pred             ----------CCCcCCCcccCcccccCCCCCC-cchhhHHHHHHHHHHhCCCCCCchhhhccCC--CCHHHHHHHHHhhc
Q 047245          260 ----------GSLIATSAYSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDPTAPFFAEAASG--GSLGRWLRHLQHAG  326 (380)
Q Consensus       260 ----------~~~~~~~~y~aPE~~~~~~~~~-~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~--~~l~~~~~~~~~~~  326 (380)
                                .+..|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||-.........  .....|......  
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~--  549 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG--  549 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC--
Confidence                      2345888999999999999876 5899999999999999999986422111110  000011110000  


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                 ..............++.++++++|.+|-|+++|++
T Consensus       550 -----------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 -----------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -----------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                       01122334555678899999999999999999975

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=6.2e-20  Score=155.63  Aligned_cols=179  Identities=19%  Similarity=0.068  Sum_probs=134.1

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ...|++|+||+||.+.- ++..++.+.+....    .-...-....+.+|+++|++++ |+++++++++    +..+++|
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~----~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAP----WWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccch----hhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            46799999999996655 67888877776421    1111111236889999999995 5889999886    3469999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC-CCCcEEeCCCCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL-KPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dl-k~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||++|.+|.+....           ....+..|++++++++|   +.+++|||| ||+|||++.++.++|+|||++....
T Consensus        78 eyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         78 SYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             eeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            99999998654321           11357789999999999   999999999 7999999999999999999998543


Q ss_pred             CCC-------------------cCCCcccCcccccCC-CCC-CcchhhHHHHHHHHHHhCCCCCC
Q 047245          260 GSL-------------------IATSAYSAPECFQNR-SYT-DKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       260 ~~~-------------------~~~~~y~aPE~~~~~-~~~-~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      ...                   ..++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-
T Consensus       144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            221                   146667777654322 233 56788899999999999998853

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=2.2e-20  Score=166.51  Aligned_cols=231  Identities=20%  Similarity=0.257  Sum_probs=149.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC----------CCcceeeEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH----------RNLMSLRAY  169 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~  169 (380)
                      ..+.||.|+++.||.+... +|+.+|+|.......     ......+++.+|......+.+          -.++-.++.
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-----~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-----ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-----THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccc-----cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            4578999999999999974 589999999976442     222335666666655555432          122222222


Q ss_pred             Ee---------cC---C-----eEEEEEeecCCCCHHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 047245          170 VP---------ES---S-----RFYLVYDYLQTGSLEDAMDRIRENQ---LQLGWEVRLRIAVGVIKGLQYLHFTCNPQI  229 (380)
Q Consensus       170 ~~---------~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  229 (380)
                      ..         ..   +     ..+++|+-+ .+||.+++.......   ..+....++.+..|+.+.+++||   ..++
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~Gl  166 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGL  166 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcce
Confidence            11         11   1     236778877 459998876433222   23445567778899999999999   9999


Q ss_pred             EecCCCCCcEEeCCCCceEEeccCCcccCCCC---CcCCCcccCcccccC--------CCCCCcchhhHHHHHHHHHHhC
Q 047245          230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS---LIATSAYSAPECFQN--------RSYTDKSDIFSFGMILAVLLTG  298 (380)
Q Consensus       230 iH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~~y~aPE~~~~--------~~~~~~sDv~s~Gvil~el~tg  298 (380)
                      +|+||+|+|++++.+|.+.|+||+.....+..   ...+..|.+||....        -.++.+.|.|++|+++|.|+||
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999999999999999999887655432   234567899997743        2478899999999999999999


Q ss_pred             CCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCC
Q 047245          299 RDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADR  364 (380)
Q Consensus       299 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R  364 (380)
                      ..||+....+....     |                ..  .... +.++.+..|+...++.||.+|
T Consensus       247 ~lPf~~~~~~~~~~-----~----------------~f--~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPE-----W----------------DF--SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSG-----G----------------GG--TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCcccccc-----c----------------cc--hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99997432221110     0                11  1122 567778999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=2.1e-21  Score=192.94  Aligned_cols=243  Identities=23%  Similarity=0.265  Sum_probs=174.3

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||++.|=.|.++..++|. |+||++-.....   -.-... .+-..|++ ...++|||++++..+-......|+|-
T Consensus        27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~---~sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPT---ISLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             eecccCchhhhhhhhccCCCce-EEEEEEeccCCC---CCchHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            4567999999999999998887 999998663211   111111 22233444 66669999999888876667778888


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc--C
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--M  258 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~--~  258 (380)
                      +|..+ +|.|.+..    .+-+...+..-|+.|+..|+.-+|   ..+|+|||||.+|||++.-..+.|+||..-+.  +
T Consensus       101 qyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             HHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccC
Confidence            88865 89888863    334666778889999999999999   99999999999999999999999999987653  2


Q ss_pred             CCCC-----------cCCCcccCcccccCC----------C-CCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCH
Q 047245          259 PGSL-----------IATSAYSAPECFQNR----------S-YTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSL  315 (380)
Q Consensus       259 ~~~~-----------~~~~~y~aPE~~~~~----------~-~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l  315 (380)
                      +++.           ..-.+|.|||.+...          + .+++-||||.||++.||++ |++||.-.        ++
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------QL  244 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------QL  244 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------HH
Confidence            2221           133469999987431          2 5778999999999999999 78887521        11


Q ss_pred             HHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      -.+.+..   ....+.+-..+        +...+.+++..|++.||.+|-|+++.++.-..
T Consensus       245 ~aYr~~~---~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  245 LAYRSGN---ADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HhHhccC---ccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1111110   11111111111        11246789999999999999999999987544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.6e-19  Score=157.60  Aligned_cols=142  Identities=20%  Similarity=0.370  Sum_probs=117.0

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEee
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY  182 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  182 (380)
                      +.||+|++|.||+|.. +|..+++|+.........+.........+.+|+..+..++|+|+.....++.+.+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999987 678899998764322222222223345788999999999999998887777777788999999


Q ss_pred             cCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          183 LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       183 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ++|++|.+++...       .+ .+..++.+++.+|.++|   +.+++|||++|+||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988631       12 77899999999999999   99999999999999999 78999999998865

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=1.6e-19  Score=155.84  Aligned_cols=136  Identities=19%  Similarity=0.270  Sum_probs=102.9

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-----CCCCcceeeEEEecCC-
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-----RHRNLMSLRAYVPESS-  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~-  174 (380)
                      ...+||+|+||.||. .-.++. .+||++.....        ...+.+.+|+..++++     +||||++++|++.++. 
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~--------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGD--------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcC-eEEEEEecccc--------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            457899999999996 323333 46888765211        1236789999999999     5799999999998763 


Q ss_pred             --e-EEEEEee--cCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHH-HHhHhcCCCCeEecCCCCCcEEeCC----C
Q 047245          175 --R-FYLVYDY--LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL-QYLHFTCNPQILHYNLKPTNVMLDA----E  244 (380)
Q Consensus       175 --~-~~lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~iiH~dlk~~Nill~~----~  244 (380)
                        . +.+|+||  +++|+|.+++..     ..+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    +
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~  145 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESE  145 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCC
Confidence              3 3478999  557999999963     134444  35677888777 9999   999999999999999974    3


Q ss_pred             CceEEeccCCcc
Q 047245          245 FTPRLADFGLAK  256 (380)
Q Consensus       245 ~~~kl~Dfgl~~  256 (380)
                      ..++|+||+.+.
T Consensus       146 ~~~~LiDg~G~~  157 (210)
T PRK10345        146 VIPVVCDNIGES  157 (210)
T ss_pred             CcEEEEECCCCc
Confidence            489999955443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=4.2e-19  Score=153.46  Aligned_cols=138  Identities=20%  Similarity=0.314  Sum_probs=109.8

Q ss_pred             ccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeec
Q 047245          104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  183 (380)
                      +||+|++|.||+|.. +|..+++|..........+........++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 5789999987543221111112233467889999999999887665555555666779999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +|++|.+++....           ..++.+++.+|++||   +.+++|||++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-----------HHHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999876311           078999999999999   99999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.7e-20  Score=177.67  Aligned_cols=225  Identities=24%  Similarity=0.286  Sum_probs=176.7

Q ss_pred             ccCccCCeeEEEEE----ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEE
Q 047245          104 LLGSSPDGKYYRTV----LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       104 ~lg~G~~g~vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  178 (380)
                      .+|+|++|.|+.+.    ...|..+|.|+++.........      .....|-.++...+ ||.++++.-.+......++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~------~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR------THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccc------cccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            37999999998754    2457889999887654332221      14556888899996 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      +.++..+|.|...+..    ....+..........++-+++++|   +.+++|||+|++||+++.+|++++.|||+++..
T Consensus        75 ~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~  147 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEA  147 (612)
T ss_pred             hhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHh
Confidence            9999999999887763    334555666677788899999999   999999999999999999999999999999865


Q ss_pred             CCC--CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          259 PGS--LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       259 ~~~--~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      -..  .+||..|||||.+.  .....+|-||||++++||+||..||..            +....         ++..  
T Consensus       148 v~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~---------Il~~--  202 (612)
T KOG0603|consen  148 VKEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKR---------ILKA--  202 (612)
T ss_pred             HhhhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHH---------Hhhh--
Confidence            433  36799999999998  567899999999999999999999853            11111         1111  


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                       ....+.+....+.++....+..+|.+|--.
T Consensus       203 -~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 -ELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence             123445667777788888888888888765

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.3e-19  Score=158.78  Aligned_cols=188  Identities=18%  Similarity=0.218  Sum_probs=135.0

Q ss_pred             CCCCcceeeEEEec---------------------------CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHH
Q 047245          159 RHRNLMSLRAYVPE---------------------------SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIA  211 (380)
Q Consensus       159 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  211 (380)
                      +|||||++.+++.+                           +..+|+||.-++. +|++|+..     ...+.....-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            59999999987643                           2467999988866 99999973     345556667789


Q ss_pred             HHHHHHHHHhHhcCCCCeEecCCCCCcEEe--CCCC--ceEEeccCCcccCCC------------CCcCCCcccCccccc
Q 047245          212 VGVIKGLQYLHFTCNPQILHYNLKPTNVML--DAEF--TPRLADFGLAKLMPG------------SLIATSAYSAPECFQ  275 (380)
Q Consensus       212 ~~ia~~l~~LH~~~~~~iiH~dlk~~Nill--~~~~--~~kl~Dfgl~~~~~~------------~~~~~~~y~aPE~~~  275 (380)
                      .|+++|+.|||   .+++.|||+|+.|||+  |+|.  ...|+|||++-.-..            +..|.-.-||||...
T Consensus       348 aQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99999999999   9999999999999998  4444  567899998742211            123677789999987


Q ss_pred             CCCC------CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHH
Q 047245          276 NRSY------TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMA  349 (380)
Q Consensus       276 ~~~~------~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (380)
                      ..+-      -.|+|.|+.|.+.||+++..+||......     .        .......+.--     ...++.....+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----~--------L~~r~Yqe~qL-----Palp~~vpp~~  486 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----L--------LDTRTYQESQL-----PALPSRVPPVA  486 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----e--------echhhhhhhhC-----CCCcccCChHH
Confidence            6442      35899999999999999999999751100     0        00001111111     12233445567


Q ss_pred             HHHHHHcccCCCCCCCCHHhHHHH
Q 047245          350 VRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       350 ~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                      .+++...++.||.+|||..-....
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhH
Confidence            889999999999999997644433

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.1e-18  Score=172.84  Aligned_cols=141  Identities=18%  Similarity=0.263  Sum_probs=112.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..++||+|+||.||+|...+ ..+++|+.................+.+.+|++++.+++|+|++....++.+....++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            35789999999999998754 44555543322111111112233467889999999999999998888887777889999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||+++++|.+++.            ....++.+++.+|+|||   +.+++||||||+|||+ +++.++|+|||+++..
T Consensus       416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999875            23678999999999999   9999999999999999 6789999999999763

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=4.2e-18  Score=150.47  Aligned_cols=147  Identities=14%  Similarity=0.165  Sum_probs=109.9

Q ss_pred             cccccCccCCeeEEEEE--ecCCcEEEEEEeeeccCCChh----------------hhcHHHHHHHHHHHHHHHcCCCCC
Q 047245          101 ENRLLGSSPDGKYYRTV--LDNGLTVAVRRVEAFESGSPE----------------KQNKSVKRRIQQELEVLASLRHRN  162 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~--~~~g~~vavK~~~~~~~~~~~----------------~~~~~~~~~~~~E~~~l~~l~h~n  162 (380)
                      ..+.||+|++|.||+|.  ..+|+.||+|.+.........                ...+.....+..|+..+.++.+.+
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~  111 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG  111 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            45689999999999998  578999999999753211000                000112345678999999997533


Q ss_pred             --cceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC-eEecCCCCCcE
Q 047245          163 --LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ-ILHYNLKPTNV  239 (380)
Q Consensus       163 --iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-iiH~dlk~~Ni  239 (380)
                        +...+++    ...++||||+++++|......    ...........++.|++.++++||   ..+ ++||||||+||
T Consensus       112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             CCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence              3444443    235899999999888765421    224455567789999999999999   899 99999999999


Q ss_pred             EeCCCCceEEeccCCcccCC
Q 047245          240 MLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       240 ll~~~~~~kl~Dfgl~~~~~  259 (380)
                      +++ ++.++|+|||.+....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999987543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=2.2e-18  Score=174.21  Aligned_cols=183  Identities=22%  Similarity=0.283  Sum_probs=142.7

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEecCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  177 (380)
                      ..+.||+|+||.||+|...+|+.||+|+=+........           -=.+++.+|+   -+-|..+.....-.+.-+
T Consensus       702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY-----------I~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY-----------ICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             EEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee-----------ehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            56789999999999999988999999998764332211           1122333333   122222222233345679


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC-------CCCceEEe
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD-------AEFTPRLA  250 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~-------~~~~~kl~  250 (380)
                      +|+||.+.|+|.++++    ....++|.....+..|++..+++||   ..+||||||||+|+||.       +...++|+
T Consensus       771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            9999999999999987    3567899999999999999999999   99999999999999994       23568999


Q ss_pred             ccCCcccC---CCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCC
Q 047245          251 DFGLAKLM---PGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP  301 (380)
Q Consensus       251 Dfgl~~~~---~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p  301 (380)
                      |||.+..+   ++.     ..+|-.+-.+|...+.+++...|.|.++.+++-|+.|+.-
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99998643   332     2467788999999999999999999999999999999853

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=7.4e-18  Score=145.51  Aligned_cols=143  Identities=14%  Similarity=0.134  Sum_probs=108.2

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhh--------------cHHHHHHHHHHHHHHHcCCCCC--c
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQ--------------NKSVKRRIQQELEVLASLRHRN--L  163 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~n--i  163 (380)
                      ...+.||+|+||.||++...+|+.||||++...........              .......+..|+..+..+.|++  +
T Consensus        18 ~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v   97 (198)
T cd05144          18 SLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV   97 (198)
T ss_pred             hcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence            34578999999999999988899999999765221100000              0012234678999999998774  4


Q ss_pred             ceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       164 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      ...++.    ...++||||+++++|.+....          .....++.+++.++.++|   ..+++||||+|+||++++
T Consensus        98 ~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          98 PKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             Cceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcC
Confidence            444432    345899999999998765320          234578899999999999   899999999999999999


Q ss_pred             CCceEEeccCCcccCC
Q 047245          244 EFTPRLADFGLAKLMP  259 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~  259 (380)
                      ++.++|+|||++....
T Consensus       161 ~~~~~liDfg~~~~~~  176 (198)
T cd05144         161 DEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcEEEEECCccccCC
Confidence            9999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=2.7e-18  Score=159.97  Aligned_cols=116  Identities=28%  Similarity=0.515  Sum_probs=103.0

Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      .+++.|++|...+|.+++...+ .....+|...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            4789999999999999997532 34467888999999999999999      6799999999999999999999999999


Q ss_pred             cccCCCC------------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh
Q 047245          255 AKLMPGS------------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT  297 (380)
Q Consensus       255 ~~~~~~~------------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t  297 (380)
                      .......            ..||..||+||.+.+..|+.|+||||||++++|++.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8765432            248999999999999999999999999999999997

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=6.3e-16  Score=136.86  Aligned_cols=144  Identities=18%  Similarity=0.181  Sum_probs=108.0

Q ss_pred             cccccC-ccCCeeEEEEEecCCcEEEEEEeeeccC-----CChhhhcHHHHHHHHHHHHHHHcCCCCCc--ceeeEEEec
Q 047245          101 ENRLLG-SSPDGKYYRTVLDNGLTVAVRRVEAFES-----GSPEKQNKSVKRRIQQELEVLASLRHRNL--MSLRAYVPE  172 (380)
Q Consensus       101 ~~~~lg-~G~~g~vy~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~  172 (380)
                      ...+|| .|+.|+||++... +..++||+......     .............+.+|+.++.+++|+++  +..+++...
T Consensus        35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            356788 8999999999885 78899998864110     00000112234678899999999998875  667776433


Q ss_pred             C-C---eEEEEEeecCC-CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCce
Q 047245          173 S-S---RFYLVYDYLQT-GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP  247 (380)
Q Consensus       173 ~-~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  247 (380)
                      . .   ..++|+|++++ .+|.+++..     ..++..    .+.+++.++.+||   +.+|+||||||.|||++.++.+
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v  181 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKF  181 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCE
Confidence            2 2   23599999997 689988753     234433    3578999999999   9999999999999999999999


Q ss_pred             EEeccCCccc
Q 047245          248 RLADFGLAKL  257 (380)
Q Consensus       248 kl~Dfgl~~~  257 (380)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998876

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=4.2e-16  Score=133.23  Aligned_cols=144  Identities=15%  Similarity=0.202  Sum_probs=99.5

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhc----------------HHHHHHHHHHHHHHHcCCCCC--c
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQN----------------KSVKRRIQQELEVLASLRHRN--L  163 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~n--i  163 (380)
                      .+.||+|+||.||++...+|+.||||++............                .........|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999888999999998753221111000                000011235666666665443  4


Q ss_pred             ceeeEEEecCCeEEEEEeecCCCCHHH-HHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEe
Q 047245          164 MSLRAYVPESSRFYLVYDYLQTGSLED-AMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVML  241 (380)
Q Consensus       164 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill  241 (380)
                      ...+++    ...++||||++++++.. .+....     .. .....++.+++.++.++|   . .+++|+||+|+||++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEE
Confidence            444443    23589999999954321 121100     01 456789999999999999   7 899999999999999


Q ss_pred             CCCCceEEeccCCcccCC
Q 047245          242 DAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       242 ~~~~~~kl~Dfgl~~~~~  259 (380)
                      + ++.++++|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=9.9e-16  Score=125.64  Aligned_cols=133  Identities=18%  Similarity=0.197  Sum_probs=110.9

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC--CCcceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH--RNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.||+|.++.||++...+ ..+++|.......          ...+..|+..++.++|  .++++++++....+..++++
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~   72 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM   72 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence            569999999999999854 7899998754111          3578889999999976  58999999888888899999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ||++++.+..+           +......++.+++.+++++|.....+++|+|++|+||++++++.++++|||.+..
T Consensus        73 e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          73 EWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99998777543           4456677899999999999944346799999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.63  E-value=4.8e-16  Score=136.82  Aligned_cols=198  Identities=23%  Similarity=0.381  Sum_probs=143.8

Q ss_pred             HHHHHcCCCCCcceeeEEEecC-----CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC
Q 047245          152 LEVLASLRHRNLMSLRAYVPES-----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN  226 (380)
Q Consensus       152 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~  226 (380)
                      ..-+-++-|.|||++..||.+.     .+..++.|||..|++.++|++.+.+...+......+++.||..||.||| .|+
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccC
Confidence            4455666799999999998654     4578999999999999999988888888888888999999999999999 668


Q ss_pred             CCeEecCCCCCcEEeCCCCceEEeccCCcccCC----------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHH
Q 047245          227 PQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP----------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLL  296 (380)
Q Consensus       227 ~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~  296 (380)
                      ++++|+++..+.|++..++-+|++--.-.....          ....+.++|.+||.-....-+.++|||+||...+||-
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            999999999999999999999986432211111          1123678899999887777888999999999999998


Q ss_pred             hCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          297 TGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       297 tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+..-...    ..+......      ........+...+            -..++..|++..|..||+|.+++.
T Consensus       277 ilEiq~tn----seS~~~~ee------~ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTN----SESKVEVEE------NIANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCC----Ccceeehhh------hhhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence            77643110    000000000      0000000011111            124667899999999999998763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=9.8e-16  Score=152.84  Aligned_cols=134  Identities=27%  Similarity=0.355  Sum_probs=101.3

Q ss_pred             HHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC---------------------CCCcCCCcccCccc
Q 047245          215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP---------------------GSLIATSAYSAPEC  273 (380)
Q Consensus       215 a~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~---------------------~~~~~~~~y~aPE~  273 (380)
                      +.+++|||   +.+|+|||+||.|.+|+.-|++|+.|||+.+...                     ...+||+.|.|||+
T Consensus       153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            67899999   9999999999999999999999999999986421                     12359999999999


Q ss_pred             ccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHH
Q 047245          274 FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIA  353 (380)
Q Consensus       274 ~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  353 (380)
                      +....|....|.|++|+|+||.+-|..||+....+        +.+..+...        .....+. .+....++.+++
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--------elfg~visd--------~i~wpE~-dea~p~Ea~dli  292 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELFGQVISD--------DIEWPEE-DEALPPEAQDLI  292 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--------HHHhhhhhh--------hcccccc-CcCCCHHHHHHH
Confidence            99999999999999999999999999998753111        111111110        0011111 233445577888


Q ss_pred             HHcccCCCCCCCCHH
Q 047245          354 VVCLSDSPADRPSSD  368 (380)
Q Consensus       354 ~~Cl~~~P~~RPs~~  368 (380)
                      .+.++.+|..|--..
T Consensus       293 ~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  293 EQLLRQNPLCRLGTG  307 (1205)
T ss_pred             HHHHHhChHhhcccc
Confidence            999999999996443

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=1.6e-14  Score=138.74  Aligned_cols=150  Identities=17%  Similarity=0.156  Sum_probs=103.1

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhh--------------------------hcHHHH------HHHH
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEK--------------------------QNKSVK------RRIQ  149 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~--------------------------~~~~~~------~~~~  149 (380)
                      .+.||.|++|.||+|++.+|+.||||+.+.........                          ..+...      -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            35799999999999999999999999986532110000                          000000      1355


Q ss_pred             HHHHHHHcCC----CCCcceeeEEE-ecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHH-HHHHhHh
Q 047245          150 QELEVLASLR----HRNLMSLRAYV-PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK-GLQYLHF  223 (380)
Q Consensus       150 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~  223 (380)
                      +|...+.+++    |.+-+.+-.++ ...+..++||||++|++|.++.....   ...   .+.+++.+++. .+..+| 
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~-  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVL-  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHH-
Confidence            5666666652    33333333333 33456799999999999998765311   112   23456666666 467888 


Q ss_pred             cCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       224 ~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                        ..+++|+|++|.||++++++.++++|||++..+..
T Consensus       275 --~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 --RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence              89999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=2.7e-15  Score=148.61  Aligned_cols=245  Identities=21%  Similarity=0.298  Sum_probs=176.0

Q ss_pred             ccccCccCCeeEEEEEecC--CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDN--GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  178 (380)
                      .+-||+|+|+.|-......  ...+|+|.+....      ...........|..+-..+. |+|++.+++...+.+..++
T Consensus        25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3458999999998776533  3456666554422      11222345556777777786 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCccc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKL  257 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~~~  257 (380)
                      ..+|.++|++.+.+..  ......+....-....|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|||++..
T Consensus        99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999999887721  112133444556788999999999995  57899999999999999999 999999999976


Q ss_pred             CCC---------CCcC-CCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          258 MPG---------SLIA-TSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       258 ~~~---------~~~~-~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ...         ...| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++......   .....|......  
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~--  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGR--  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccc--
Confidence            543         1247 8999999999884 44678999999999999999999987421111   122222222100  


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                           .     .............++...++..+|..|.+.+++.
T Consensus       250 -----~-----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 -----F-----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -----c-----ccCccccCChhhhhcccccccCCchhcccccccc
Confidence                 0     0111122334466778888889999999988764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.46  E-value=1e-12  Score=127.97  Aligned_cols=148  Identities=14%  Similarity=0.165  Sum_probs=93.1

Q ss_pred             cccCccCCeeEEEEEecC-CcEEEEEEeeeccCCC--------------------------hhhhcHHHHH------HHH
Q 047245          103 RLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGS--------------------------PEKQNKSVKR------RIQ  149 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~--------------------------~~~~~~~~~~------~~~  149 (380)
                      +.||+|++|.||++++.+ |+.||||+.+......                          .....++..+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999987 9999999997531100                          0000011122      244


Q ss_pred             HHHHHHHcCC----CCCcceeeEEEec-CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHH-HHHhHh
Q 047245          150 QELEVLASLR----HRNLMSLRAYVPE-SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG-LQYLHF  223 (380)
Q Consensus       150 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~  223 (380)
                      +|+..+.+++    +.+.+.+-.++.+ .+..++||||++|+.+.+.-.- ..  ...+.   ..++...+.. +.-+. 
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~--~g~d~---~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RA--AGTDM---KLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hh--cCCCH---HHHHHHHHHHHHHHHH-
Confidence            4555555542    4444444344333 4567999999999999875321 11  11111   1222222221 22233 


Q ss_pred             cCCCCeEecCCCCCcEEeCCCC----ceEEeccCCcccCC
Q 047245          224 TCNPQILHYNLKPTNVMLDAEF----TPRLADFGLAKLMP  259 (380)
Q Consensus       224 ~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfgl~~~~~  259 (380)
                        ..+++|+|++|.||+++.++    .+++.|||++..++
T Consensus       278 --~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 --RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             --hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence              68999999999999999888    99999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=2.5e-13  Score=129.28  Aligned_cols=247  Identities=19%  Similarity=0.215  Sum_probs=174.1

Q ss_pred             HHHHHHHhccccccCc--cCCeeEEEEEe---cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcce
Q 047245           92 KTLQAALANENRLLGS--SPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMS  165 (380)
Q Consensus        92 ~~l~~~~~~~~~~lg~--G~~g~vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~  165 (380)
                      .+..+........+|.  |.+|.+|++..   .++..+|+|+=+........      ...=.+|+.....+ .|+|.++
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------~~~k~~~~~s~~~i~~~~~~v~  182 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------SKRKLREFLSHHKIDSHENPVR  182 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------cccccchhhcccccCccccccc
Confidence            3444444556667999  99999999886   46788999885443322111      12334577777777 5999999


Q ss_pred             eeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHH----HHHHhHhcCCCCeEecCCCCCcEEe
Q 047245          166 LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML  241 (380)
Q Consensus       166 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~iiH~dlk~~Nill  241 (380)
                      ....+..++..++-+|++. .+|.++.+...   ..++....+....+..+    |+.++|   ..+++|-|+||.||+.
T Consensus       183 ~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~  255 (524)
T KOG0601|consen  183 DSPAWEGSGILFIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFT  255 (524)
T ss_pred             cCcccccCCcceeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheec
Confidence            9999999999999999885 69988887432   22445556667777777    999999   9999999999999999


Q ss_pred             CCC-CceEEeccCCcccCCCCC-----------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc
Q 047245          242 DAE-FTPRLADFGLAKLMPGSL-----------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA  309 (380)
Q Consensus       242 ~~~-~~~kl~Dfgl~~~~~~~~-----------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~  309 (380)
                      ..+ ...+++|||+...+....           .+...|++||... +.++.++|+|++|.++.+..++..+...     
T Consensus       256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~-----  329 (524)
T KOG0601|consen  256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV-----  329 (524)
T ss_pred             ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC-----
Confidence            999 889999999987665432           3667799999875 4568899999999999999998866431     


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                      .   ....|..           ++.......+.......+...+..+++.+|..|++.+.+.
T Consensus       330 g---~~~~W~~-----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  330 G---KNSSWSQ-----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             C---CCCCccc-----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            0   0011111           1111111111111223344477889999999999977554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=1.3e-11  Score=101.51  Aligned_cols=139  Identities=24%  Similarity=0.335  Sum_probs=107.6

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEee
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY  182 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  182 (380)
                      .++++|+-+.+|.+.+. |..+.+|.=..+.-..++-..+-...+-.+|+.++.+++--.|....-+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            36889999999999774 45566665444333344444444556788899999999766666555566677778999999


Q ss_pred             cCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          183 LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       183 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      .+|-.|.+++...           +..++..+-.-+.-||   ..+|+||||.++||++.++. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999998741           2556777778888899   99999999999999998766 99999999875

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=1.3e-11  Score=118.94  Aligned_cols=225  Identities=18%  Similarity=0.207  Sum_probs=147.8

Q ss_pred             ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhh
Q 047245          118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE  197 (380)
Q Consensus       118 ~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~  197 (380)
                      ..++.+|.|...+....        .......+-++.|+.++||||++++..+...+..|+|+|-+.  -|..++..   
T Consensus        34 k~~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---  100 (690)
T ss_pred             eccCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---
Confidence            35688899888875211        122445677889999999999999999999999999999874  57777764   


Q ss_pred             cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCCCc------CCCcccCc
Q 047245          198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI------ATSAYSAP  271 (380)
Q Consensus       198 ~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~------~~~~y~aP  271 (380)
                          ++-......+.||+.||.+||+  +.+++|++|.-..|+++..|+.||++|.++....+...      .--.|..|
T Consensus       101 ----l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P  174 (690)
T KOG1243|consen  101 ----LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDP  174 (690)
T ss_pred             ----hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccCh
Confidence                2244556688999999999986  56899999999999999999999999998866543221      11124555


Q ss_pred             ccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHH
Q 047245          272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR  351 (380)
Q Consensus       272 E~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (380)
                      +.+....  -..|.|-||++++|++.|..+-...........            ....+.....+.....  .... .++
T Consensus       175 ~~~~~s~--~s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ip------------k~~~~~~~k~~~~~~~--~r~n-~~~  237 (690)
T KOG1243|consen  175 EEIDPSE--WSIDSWGLGCLIEELFNGSLLTKTDLSNTGKIP------------KALIELYCKKLGATEL--KRPN-KLR  237 (690)
T ss_pred             hhcCccc--cchhhhhHHHHHHHHhCcccCcchhhhccCccc------------hhHHHHHHHHhccccc--cccc-hhh
Confidence            5432211  346999999999999999433111000000000            0011111111111110  0111 456


Q ss_pred             HHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          352 IAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       352 l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ++..|....+--|=-.-+++..|++++
T Consensus       238 ~~~~~~~~~gff~n~fvd~~~fLeel~  264 (690)
T KOG1243|consen  238 FILECRLLGGFFRNDFVDTLLFLEELR  264 (690)
T ss_pred             HHHHHHhccccccchHHHHHHHHHhcc
Confidence            667777777777777777777777664

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=3.1e-12  Score=107.38  Aligned_cols=127  Identities=20%  Similarity=0.189  Sum_probs=93.3

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcc-eeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM-SLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  181 (380)
                      +.++.|.++.||++... |..+++|.......         ....+..|+..++.+.+.+++ +++.+..  ...++|||
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e   71 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITE   71 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEE
Confidence            45789999999999875 78899998754211         113456788999988655554 4454433  34589999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC-----eEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ-----ILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      |+++.++.+. .        .   ....++.+++++|+.||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        72 ~i~G~~l~~~-~--------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          72 FIEGSELLTE-D--------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ecCCCccccc-c--------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9999887542 0        0   11345678999999999   555     59999999999999 6689999999876


Q ss_pred             c
Q 047245          257 L  257 (380)
Q Consensus       257 ~  257 (380)
                      .
T Consensus       136 ~  136 (170)
T cd05151         136 M  136 (170)
T ss_pred             C
Confidence            3

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=1.8e-11  Score=103.90  Aligned_cols=144  Identities=10%  Similarity=0.106  Sum_probs=100.5

Q ss_pred             cccCccCCeeEEEEEecC-------CcEEEEEEeeeccCC----C-----hhhh-----cHHHHHHHH----HHHHHHHc
Q 047245          103 RLLGSSPDGKYYRTVLDN-------GLTVAVRRVEAFESG----S-----PEKQ-----NKSVKRRIQ----QELEVLAS  157 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-------g~~vavK~~~~~~~~----~-----~~~~-----~~~~~~~~~----~E~~~l~~  157 (380)
                      ..||.|..+.||.|.-.+       +..+|||..+.....    .     ....     ..+-++.+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653       479999998642211    0     0000     011123333    89999999


Q ss_pred             CCC--CCcceeeEEEecCCeEEEEEeecCCCCHHH-HHHHhhhcccCCCHHHHHHHHHHHHHHHHHh-HhcCCCCeEecC
Q 047245          158 LRH--RNLMSLRAYVPESSRFYLVYDYLQTGSLED-AMDRIRENQLQLGWEVRLRIAVGVIKGLQYL-HFTCNPQILHYN  233 (380)
Q Consensus       158 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiH~d  233 (380)
                      +..  -++..++++    ..-++||||+.++.+.. .+.     ...++......+..+++.+|..| |   ..+++|||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            953  566677765    45689999997654422 222     11234445667889999999999 7   88999999


Q ss_pred             CCCCcEEeCCCCceEEeccCCcccCC
Q 047245          234 LKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       234 lk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |++.||+++ ++.+.|+|||.+-...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4679999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.35  E-value=2.1e-11  Score=99.82  Aligned_cols=150  Identities=20%  Similarity=0.263  Sum_probs=114.5

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      -.++-||+.+.|+++... |+...||.=..+.-..+.-..+-.+++..+|+..+.+++--.|....-++.+...-.++||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            357899999999999985 7888888655544445555556677888999999999976666655556666667789999


Q ss_pred             ecCC-CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC---ceEEeccCCccc
Q 047245          182 YLQT-GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAKL  257 (380)
Q Consensus       182 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfgl~~~  257 (380)
                      |.++ .++.+++...-+  ....-.....++..+-+.+.-||   ...++||||.++||++..++   .+.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9977 478888875322  12222233678888999999999   99999999999999996554   458999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.2e-10  Score=102.08  Aligned_cols=143  Identities=21%  Similarity=0.240  Sum_probs=105.9

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC--CCcceeeEEEecCC---eEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH--RNLMSLRAYVPESS---RFY  177 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~  177 (380)
                      +.|+.|..+.+|++...+|..+++|........       .....+..|.++++.+++  .++.+++.+.....   ..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            458999999999999877789999987542110       123567889999999965  44677788776642   568


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhc---------------------------------
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT---------------------------------  224 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------  224 (380)
                      +||||+++.++.+.+.     ...++...+..++.+++++|++||+.                                 
T Consensus        77 ~v~e~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (223)
T cd05154          77 YVMERVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT  151 (223)
T ss_pred             EEEEEeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence            9999999988866542     02355666667777777777777732                                 


Q ss_pred             --------------------CCCCeEecCCCCCcEEeCC--CCceEEeccCCccc
Q 047245          225 --------------------CNPQILHYNLKPTNVMLDA--EFTPRLADFGLAKL  257 (380)
Q Consensus       225 --------------------~~~~iiH~dlk~~Nill~~--~~~~kl~Dfgl~~~  257 (380)
                                          ....++|+|+.+.||++++  ++.+.|+||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                1246799999999999998  66789999988764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=2.1e-11  Score=116.29  Aligned_cols=240  Identities=17%  Similarity=0.193  Sum_probs=170.1

Q ss_pred             cccccCccCCeeEEEEEe--cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL--DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  177 (380)
                      ....||.|.|+.|++...  .++..+++|.+.....+..+      ...-..|+.+...+ .|.++++....|......+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~------di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS------DIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccccchHh------hhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            445789999999998765  46788999988763322211      12334577777777 6999999888888888889


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccCCcc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAK  256 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfgl~~  256 (380)
                      +=-||++++++.....    ....++...++++..|++.++.++|   +..++|+|++|+||++..+ +..+++|||+..
T Consensus       343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            9999999999877653    2345677788999999999999999   9999999999999999886 888999999986


Q ss_pred             cCC---CCCcCCCccc--CcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMP---GSLIATSAYS--APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~---~~~~~~~~y~--aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .+.   ......-++.  +++......+-.+.|++|||.-+.|..+|..--..          ...|..           
T Consensus       416 ~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----------~~~~~~-----------  474 (524)
T KOG0601|consen  416 RLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----------GVQSLT-----------  474 (524)
T ss_pred             ccceecccccccccccccchhhccccccccccccccccccccccccCcccCcc----------ccccee-----------
Confidence            432   1222333444  45555556778899999999999999988743211          011110           


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      +..... ... ......+..++......++..||++.++....+.
T Consensus       475 i~~~~~-p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  475 IRSGDT-PNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eecccc-cCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            011100 001 1122556677888899999999999888765443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.08  E-value=6.3e-09  Score=95.53  Aligned_cols=258  Identities=15%  Similarity=0.144  Sum_probs=153.0

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEE----E--e-c
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAY----V--P-E  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~--~-~  172 (380)
                      .++-||+|+.+.+|..--  -...+.|+......    .       .-.+-+..|... .||-+-.-+.|    .  . .
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Ppp----a-------~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~   81 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPP----A-------AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRR   81 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCc----h-------HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence            456799999999995322  12233455543111    0       011123334444 46544331222    1  1 1


Q ss_pred             CCeEEEEEeecCCC-CHHHHHHH--hhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          173 SSRFYLVYDYLQTG-SLEDAMDR--IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       173 ~~~~~lv~e~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                      +...-++|..+++. -..++++-  .+.+-...+|...++.+..+|.+.+.||   ..+.+-||+.++|+|+++++.+.|
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEE
Confidence            22355667766553 23333321  2233446899999999999999999999   899999999999999999999999


Q ss_pred             eccCCcccCCC-----CCcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhC-CCCCCchhhhccCCCCHHHH
Q 047245          250 ADFGLAKLMPG-----SLIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTG-RDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       250 ~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg-~~p~~~~~~~~~~~~~l~~~  318 (380)
                      .|-..-....+     ..+|.+.|.+||...-     -.-+...|-|.+|+++++++.| +.||............+..-
T Consensus       159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            87543322222     2357889999998752     2346789999999999999985 89987543222222111100


Q ss_pred             HHHHHhhcchhHhhch--hcc---CCcccHHHHHHHHHHHHHcccC--CCCCCCCHHhHHHHHhccc
Q 047245          319 LRHLQHAGEAREALDR--SIL---GEEVEEDEMLMAVRIAVVCLSD--SPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~l~~~Cl~~--~P~~RPs~~evl~~L~~l~  378 (380)
                      +.    .+.....-|.  .+.   ......-....+..+-.+|+..  +++-|||++..+..|..++
T Consensus       239 Ia----~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         239 IA----HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hh----cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            00    0111111010  000   0111122334456667778754  4679999999999887764

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=4.7e-09  Score=94.13  Aligned_cols=152  Identities=14%  Similarity=0.106  Sum_probs=104.4

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhh---cHHHHHHHHHHHHHHHcCCCCC--cceeeEEEec--
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQ---NKSVKRRIQQELEVLASLRHRN--LMSLRAYVPE--  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~--  172 (380)
                      -..+.+-......|++..+ +|+.+.||+.........-+.   ...-...+.+|...+.++...+  ...++++...  
T Consensus        25 ~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~  103 (268)
T PRK15123         25 LQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS  103 (268)
T ss_pred             cCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC
Confidence            3455666556666778776 578999997743110000000   0000114778999888885433  3445556543  


Q ss_pred             ---CCeEEEEEeecCCC-CHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-----
Q 047245          173 ---SSRFYLVYDYLQTG-SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-----  243 (380)
Q Consensus       173 ---~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-----  243 (380)
                         ....++|+|++++. +|.+++....  ..+.+...+..++.+++..+.-||   ..+++|+|++++|||++.     
T Consensus       104 ~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        104 NPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             CCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCC
Confidence               23578999999886 8999986322  234455667789999999999999   999999999999999975     


Q ss_pred             --CCceEEeccCCccc
Q 047245          244 --EFTPRLADFGLAKL  257 (380)
Q Consensus       244 --~~~~kl~Dfgl~~~  257 (380)
                        +..+.++||+.+..
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46899999998864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=2.4e-09  Score=90.66  Aligned_cols=134  Identities=20%  Similarity=0.236  Sum_probs=84.8

Q ss_pred             eEEEEEecCCcEEEEEEeeeccCC----------Ch--------hhhcHHHHHHHHHHHHHHHcCCCC--CcceeeEEEe
Q 047245          112 KYYRTVLDNGLTVAVRRVEAFESG----------SP--------EKQNKSVKRRIQQELEVLASLRHR--NLMSLRAYVP  171 (380)
Q Consensus       112 ~vy~~~~~~g~~vavK~~~~~~~~----------~~--------~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  171 (380)
                      .||.|...+|..+|+|..+.....          ..        ............+|...|.++..-  ++.+++++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            389999999999999998653211          00        111223345677899999999765  566666553 


Q ss_pred             cCCeEEEEEeecC--CCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHH-hHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          172 ESSRFYLVYDYLQ--TGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY-LHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       172 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                         .-++||||++  |..+...... .     ++......++.++...+.. +|   ..+++||||++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-D-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-G-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-c-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEE
Confidence               3489999998  5444443221 1     1122345567777775554 57   8899999999999999988 999


Q ss_pred             EeccCCcccCC
Q 047245          249 LADFGLAKLMP  259 (380)
Q Consensus       249 l~Dfgl~~~~~  259 (380)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.02  E-value=1e-08  Score=96.40  Aligned_cols=170  Identities=19%  Similarity=0.281  Sum_probs=128.1

Q ss_pred             CeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe----cCCeEEEEEeecC
Q 047245          110 DGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP----ESSRFYLVYDYLQ  184 (380)
Q Consensus       110 ~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~  184 (380)
                      ..+.||+.. .||..+.+|++.........+        -..-++.++++.|.|+|++..++.    .+..+++||+|++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk--------~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP  360 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK--------DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP  360 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCccc--------chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence            356788875 589999999995433332221        123477899999999999988875    3457899999998


Q ss_pred             C-CCHHHHHHHhh-----------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          185 T-GSLEDAMDRIR-----------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       185 ~-gsL~~~l~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      + ++|.++.-...           .....+++..+|.++.|++.||.++|   +.|+..+-|.+++|+++.+.+++|+..
T Consensus       361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C  437 (655)
T KOG3741|consen  361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGC  437 (655)
T ss_pred             CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecc
Confidence            6 56777543211           12334777889999999999999999   999999999999999999999999999


Q ss_pred             CCcccCCCCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCC
Q 047245          253 GLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP  301 (380)
Q Consensus       253 gl~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p  301 (380)
                      |.......+..        |-+.+   -.+-|.=.||.+++.|-||..-
T Consensus       438 ~i~Dvl~~d~~--------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  438 GIMDVLQEDPT--------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cceeeecCCCC--------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            98876654431        11111   2367999999999999999643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=9.4e-09  Score=89.74  Aligned_cols=142  Identities=18%  Similarity=0.158  Sum_probs=101.4

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCC--------h----hh--hcHHHHHHHHHHHHHHHcCCCC--Cc
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGS--------P----EK--QNKSVKRRIQQELEVLASLRHR--NL  163 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~--------~----~~--~~~~~~~~~~~E~~~l~~l~h~--ni  163 (380)
                      ..++.||-|.-+.||.|..++|.++|||.-+...+.-        .    +.  ...-.+....+|.+.|.+|...  .+
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            3678999999999999999999999999765422110        0    00  0122345677899999999654  67


Q ss_pred             ceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       164 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      ...+++    +...+||||.+|--|...         +++-...-.++..|.+-+.-+-   ..++||||+++-||++++
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence            766655    566899999988555432         1122233445556666555555   678999999999999999


Q ss_pred             CCceEEeccCCccc
Q 047245          244 EFTPRLADFGLAKL  257 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~  257 (380)
                      ||.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999975543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.89  E-value=9.6e-10  Score=110.77  Aligned_cols=186  Identities=24%  Similarity=0.296  Sum_probs=129.9

Q ss_pred             CCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       159 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      ++|-++...-.+......+|+++|+.+++|...|+...    ..+..-.......+.++++|||   ...+.|+|++|.|
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~  934 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDS  934 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccc---cchhhcccccccc
Confidence            34555544434445678899999999999999988522    2222222334556778899999   7889999999999


Q ss_pred             EEeCCCCceEEeccCCcccCC-------------------------------------CCCcCCCcccCcccccCCCCCC
Q 047245          239 VMLDAEFTPRLADFGLAKLMP-------------------------------------GSLIATSAYSAPECFQNRSYTD  281 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~  281 (380)
                      .+...++..+++|||......                                     ....+|+.|.+||...+.....
T Consensus       935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen  935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred             hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence            999999999999998432210                                     0013789999999999999999


Q ss_pred             cchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCC
Q 047245          282 KSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSP  361 (380)
Q Consensus       282 ~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P  361 (380)
                      .+|.|+.|++++|.++|..||.....+..        +         ...+.........+........+++..-+..+|
T Consensus      1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~~--------f---------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQI--------F---------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred             cchhhhhhhhhhhhhcCCCCCCCcchhhh--------h---------hccccCCCCCCCCccccChhhhhhhhhhhccCc
Confidence            99999999999999999999874211110        0         111111111122333445556777788888888


Q ss_pred             CCCCCHH
Q 047245          362 ADRPSSD  368 (380)
Q Consensus       362 ~~RPs~~  368 (380)
                      .+|-.+.
T Consensus      1078 ~qr~~a~ 1084 (1205)
T KOG0606|consen 1078 TQRLGAK 1084 (1205)
T ss_pred             hhccCcc
Confidence            8887665

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1.9e-07  Score=79.76  Aligned_cols=146  Identities=14%  Similarity=0.056  Sum_probs=105.4

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC--CCcceeeEEEe-c----CCe
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH--RNLMSLRAYVP-E----SSR  175 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~----~~~  175 (380)
                      ..-|+||-+.|++..+. |..+-+|+-......+...  ......|.+|+..+.+|..  -.+.+.+ ++. .    .-.
T Consensus        24 pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~--P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~r   99 (216)
T PRK09902         24 PNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRY--PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWR   99 (216)
T ss_pred             CCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccC--CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceE
Confidence            34678999999998775 5578899876322222110  1124789999999999953  2344444 332 1    124


Q ss_pred             EEEEEeecCC-CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc--eEEecc
Q 047245          176 FYLVYDYLQT-GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT--PRLADF  252 (380)
Q Consensus       176 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kl~Df  252 (380)
                      .+||+|-+++ -+|.+++..  ....+.+...+..++.+++..++-||   +.++.|+|+.+.||+++.++.  ++++||
T Consensus       100 A~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEh
Confidence            6899997764 589888863  12335677778899999999999999   999999999999999986666  999999


Q ss_pred             CCccc
Q 047245          253 GLAKL  257 (380)
Q Consensus       253 gl~~~  257 (380)
                      --++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            87764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=8.4e-08  Score=83.14  Aligned_cols=106  Identities=25%  Similarity=0.318  Sum_probs=83.4

Q ss_pred             HHHHHHHHHHHcCCC--CCcceeeEEEecC----CeEEEEEeecCCC-CHHHHHHHhhhcccCCCHHHHHHHHHHHHHHH
Q 047245          146 RRIQQELEVLASLRH--RNLMSLRAYVPES----SRFYLVYDYLQTG-SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL  218 (380)
Q Consensus       146 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l  218 (380)
                      ....+|...+.++..  -.+...+++....    ...++|+|++++. +|.+++....    ..+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            467788888888853  3455667776542    2458999999884 7999887421    255566788999999999


Q ss_pred             HHhHhcCCCCeEecCCCCCcEEeCCCC---ceEEeccCCcccC
Q 047245          219 QYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAKLM  258 (380)
Q Consensus       219 ~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfgl~~~~  258 (380)
                      +-||   ..+++|+|++++|||++.+.   .+.++||+-++..
T Consensus       132 ~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   99999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.76  E-value=5.1e-08  Score=94.71  Aligned_cols=152  Identities=16%  Similarity=0.197  Sum_probs=99.9

Q ss_pred             ccc-cccCccCCeeEEEEEecCCcEEEEEEeeeccCCC--------------------------hhhhcHHHHH------
Q 047245          100 NEN-RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGS--------------------------PEKQNKSVKR------  146 (380)
Q Consensus       100 ~~~-~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~~~~~------  146 (380)
                      .++ +-|+.++-|.||+|++.+|+.||||+.++.-...                          ......+..+      
T Consensus       127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El  206 (517)
T COG0661         127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL  206 (517)
T ss_pred             HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence            344 6799999999999999999999999997632211                          0000011111      


Q ss_pred             HHHHHHHHHHcCC-----CCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHH-HHH
Q 047245          147 RIQQELEVLASLR-----HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG-LQY  220 (380)
Q Consensus       147 ~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-l~~  220 (380)
                      ++.+|..-+.+++     .+++.-.-=+++-.+...++|||++|-.+.+.....   ...++-   ..++..++++ +.-
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~---k~ia~~~~~~f~~q  280 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDR---KELAELLVRAFLRQ  280 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCH---HHHHHHHHHHHHHH
Confidence            2344555555552     344433333444467789999999999888874321   123442   3344444432 333


Q ss_pred             hHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       221 LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      +-   ..+++|.|..|.||+++.++.+.+.|||+....+.
T Consensus       281 ~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            33   67899999999999999999999999999877654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.66  E-value=7.2e-09  Score=100.68  Aligned_cols=143  Identities=23%  Similarity=0.315  Sum_probs=97.8

Q ss_pred             HHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCCC---------------cCCCcccCcccccC
Q 047245          212 VGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL---------------IATSAYSAPECFQN  276 (380)
Q Consensus       212 ~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~---------------~~~~~y~aPE~~~~  276 (380)
                      .+++.|+.|+|.  +.++||++|.|++|.++..+..||+.|+.+-...+..               .....|.|||.+.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999995  6789999999999999999999999999875443311               13456999999999


Q ss_pred             CCCCCcchhhHHHHHHHHHHhCCCC-CCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHH
Q 047245          277 RSYTDKSDIFSFGMILAVLLTGRDP-TAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV  355 (380)
Q Consensus       277 ~~~~~~sDv~s~Gvil~el~tg~~p-~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  355 (380)
                      ...+.++|+||+|+++|.+..|..+ +..    . .........+.         ..+...  .....+...++.+=+.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a----~-~~~~~~~~~~~---------~~~~~~--~~~s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA----N-GGLLSYSFSRN---------LLNAGA--FGYSNNLPSELRESLKK  247 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhc----c-CCcchhhhhhc---------cccccc--ccccccCcHHHHHHHHH
Confidence            8889999999999999999965544 221    0 00000000000         001000  11123345556677788


Q ss_pred             cccCCCCCCCCHHhHHH
Q 047245          356 CLSDSPADRPSSDELVP  372 (380)
Q Consensus       356 Cl~~~P~~RPs~~evl~  372 (380)
                      .+..++.-||++.++..
T Consensus       248 ~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HhcCCcccCcchhhhhc
Confidence            89999999998776654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.56  E-value=1.4e-06  Score=76.49  Aligned_cols=140  Identities=11%  Similarity=0.104  Sum_probs=83.4

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCC--cceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN--LMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~  180 (380)
                      ..||+|..+.||+.   .|..+++|......          ......+|.+.++.+..-+  +.+.++++.+++...+||
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC----------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeee
Confidence            46899999999984   24567778765311          1134578999998885433  466788888888889999


Q ss_pred             eecCCCC-HHHHHH--------------H----hhhc-ccCCCHHHHHH-HHH----------HHHH-HHHHhHh-cCCC
Q 047245          181 DYLQTGS-LEDAMD--------------R----IREN-QLQLGWEVRLR-IAV----------GVIK-GLQYLHF-TCNP  227 (380)
Q Consensus       181 e~~~~gs-L~~~l~--------------~----~~~~-~~~l~~~~~~~-i~~----------~ia~-~l~~LH~-~~~~  227 (380)
                      |+++|.. +.+.+.              .    ...- ........... +-.          .+.. ...+|.. ....
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            9999863 221111              0    0000 00111111100 000          0011 1222221 1134


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          228 QILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       228 ~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      .++|+|+.|.||++++++ +.|+||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            678999999999999888 9999998775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.49  E-value=1.4e-06  Score=84.65  Aligned_cols=151  Identities=15%  Similarity=0.159  Sum_probs=92.9

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCCh-------------------h----hhcHHHHH------HHHHHH
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSP-------------------E----KQNKSVKR------RIQQEL  152 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~-------------------~----~~~~~~~~------~~~~E~  152 (380)
                      .+-||.-+.|.||++++++|+.||||+-++.-....                   +    ...++..+      +|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            367999999999999999999999999866221110                   0    00011111      233444


Q ss_pred             HHHHcC----CCCC---cceeeEE-EecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhc
Q 047245          153 EVLASL----RHRN---LMSLRAY-VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT  224 (380)
Q Consensus       153 ~~l~~l----~h~n---iv~l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~  224 (380)
                      +-..+.    .|-+   -|.+-.+ +.-.....|+||||+|..+.|.-.- +  ...++...   ++..+.++  |++.-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~--~~gi~~~~---i~~~l~~~--~~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-D--KRGISPHD---ILNKLVEA--YLEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-H--HcCCCHHH---HHHHHHHH--HHHHH
Confidence            433322    3444   1222222 2334678999999999877765321 1  22344443   33333332  22222


Q ss_pred             CCCCeEecCCCCCcEEeCC----CCceEEeccCCcccCCC
Q 047245          225 CNPQILHYNLKPTNVMLDA----EFTPRLADFGLAKLMPG  260 (380)
Q Consensus       225 ~~~~iiH~dlk~~Nill~~----~~~~kl~Dfgl~~~~~~  260 (380)
                      ...|++|+|-.|.||+++.    ++.+.+.|||+......
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3568999999999999983    67899999999876654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.41  E-value=1.3e-06  Score=74.26  Aligned_cols=104  Identities=21%  Similarity=0.245  Sum_probs=82.5

Q ss_pred             HHHHHHHHcCCC-CCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 047245          149 QQELEVLASLRH-RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP  227 (380)
Q Consensus       149 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  227 (380)
                      ..|.-++..+++ +++.+++|+|-+    +++.||...+++...-.. -..-...+|..|.+||.++++.+.+|++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888999976 699999999943    778999987765421000 00112478999999999999999999976667


Q ss_pred             CeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          228 QILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       228 ~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      .+.-.|++++|+-+++++++|++|......
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            799999999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=8.5e-06  Score=70.78  Aligned_cols=145  Identities=17%  Similarity=0.180  Sum_probs=94.5

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChh--------------hhc--HHHHHHHHHHHHHHHcCC--CCCcc
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPE--------------KQN--KSVKRRIQQELEVLASLR--HRNLM  164 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~--------------~~~--~~~~~~~~~E~~~l~~l~--h~niv  164 (380)
                      ..|.+|....||+|.-.++..+|||+.+.....-..              ..+  +....=...|..-|.++.  +-.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            357788889999999888999999999763221000              000  000011235777788773  45566


Q ss_pred             eeeEEEecCCeEEEEEeecCCCC-HHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          165 SLRAYVPESSRFYLVYDYLQTGS-LEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       165 ~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      +.+++..    -.|||||+.... -.-.|.     ..++...+...+..++.+.+.-|-.  ..++||+||+.=|||+. 
T Consensus       134 ~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         134 EPIAFRN----NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             CceeecC----CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-
Confidence            6666643    389999986531 111111     1122222455667778888887772  37899999999999999 


Q ss_pred             CCceEEeccCCcccCC
Q 047245          244 EFTPRLADFGLAKLMP  259 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~  259 (380)
                      ++.+.|+|||-+-...
T Consensus       202 ~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CCeEEEEECccccccC
Confidence            8899999999876544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.25  E-value=1.6e-05  Score=70.74  Aligned_cols=140  Identities=13%  Similarity=0.096  Sum_probs=83.9

Q ss_pred             cCccCC-eeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEEEee
Q 047245          105 LGSSPD-GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDY  182 (380)
Q Consensus       105 lg~G~~-g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  182 (380)
                      |..|.. ..||+.... +..+.+|......           .....+|+++++.+. +--+.+++++....+..++|||+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   73 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSA   73 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEe
Confidence            334444 788998764 4678888775411           134567888888883 44466778887776778999999


Q ss_pred             cCCCCHHHHHH---------H-------hhh---cccCCC--HHHHHHHHH--------------------HHHHHHHHh
Q 047245          183 LQTGSLEDAMD---------R-------IRE---NQLQLG--WEVRLRIAV--------------------GVIKGLQYL  221 (380)
Q Consensus       183 ~~~gsL~~~l~---------~-------~~~---~~~~l~--~~~~~~i~~--------------------~ia~~l~~L  221 (380)
                      ++|.++.+...         .       ...   ...+..  .........                    .+......|
T Consensus        74 i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  153 (244)
T cd05150          74 VPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL  153 (244)
T ss_pred             eCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence            99987764321         0       000   000111  001110000                    011112222


Q ss_pred             Hh----cCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          222 HF----TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       222 H~----~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      -.    .....++|+|+.|.|||++++..+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            11    114568999999999999998888999998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.19  E-value=4e-05  Score=65.92  Aligned_cols=137  Identities=15%  Similarity=0.223  Sum_probs=82.9

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHH--HHHHHHHHHHHHcCCC---CCcceeeEEE-----ec
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSV--KRRIQQELEVLASLRH---RNLMSLRAYV-----PE  172 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~--~~~~~~E~~~l~~l~h---~niv~l~~~~-----~~  172 (380)
                      +++-......|.+... +|..+.+|........ .+..-...  -....+++..+.+++.   -....++.+.     .-
T Consensus        37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~  114 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY  114 (229)
T ss_pred             EeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence            4555555666666665 5788899987652211 11000000  0012234444444432   2222222222     22


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      ....+++|||++|..|.++..        ++.    .++..+.+++.-||   ..|+.|||..|.|+++++++ ++++||
T Consensus       115 ~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~  178 (229)
T PF06176_consen  115 TSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDT  178 (229)
T ss_pred             eeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEEC
Confidence            245678999999988876543        221    24566778899999   99999999999999998654 999999


Q ss_pred             CCccc
Q 047245          253 GLAKL  257 (380)
Q Consensus       253 gl~~~  257 (380)
                      +..+.
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            87664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.18  E-value=2.9e-05  Score=68.22  Aligned_cols=143  Identities=20%  Similarity=0.248  Sum_probs=83.2

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC--CcceeeEEEe---cCCeEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR--NLMSLRAYVP---ESSRFY  177 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~---~~~~~~  177 (380)
                      +.++.|..+.||+....+ ..+++|....          ......+..|..+++.+...  .+.+++.+..   .....+
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~----------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~   71 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRP----------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY   71 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESS----------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCC----------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence            458889999999999877 6899998754          12346677888888888533  3456666442   234579


Q ss_pred             EEEeecCCCCHHH----------------HHHHhhhc---ccCCCHHH---------HHHH------------HHHHHH-
Q 047245          178 LVYDYLQTGSLED----------------AMDRIREN---QLQLGWEV---------RLRI------------AVGVIK-  216 (380)
Q Consensus       178 lv~e~~~~gsL~~----------------~l~~~~~~---~~~l~~~~---------~~~i------------~~~ia~-  216 (380)
                      ++|+++++..+.+                .+......   .....+..         ....            ...+.. 
T Consensus        72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (239)
T PF01636_consen   72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER  151 (239)
T ss_dssp             EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence            9999999988777                11111111   11111111         0000            111222 


Q ss_pred             HHHHhHh----cCCCCeEecCCCCCcEEeC-CCCceEEeccCCcc
Q 047245          217 GLQYLHF----TCNPQILHYNLKPTNVMLD-AEFTPRLADFGLAK  256 (380)
Q Consensus       217 ~l~~LH~----~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfgl~~  256 (380)
                      .++.++.    .....++|+|+.++||+++ +++.+-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  152 LLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2333332    2356799999999999999 56666899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.17  E-value=4.2e-07  Score=87.84  Aligned_cols=175  Identities=16%  Similarity=0.107  Sum_probs=125.8

Q ss_pred             ccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCC-cceeeEEEecCCeEEEEEee
Q 047245          104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN-LMSLRAYVPESSRFYLVYDY  182 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~  182 (380)
                      -+++|+.+.++|.+-...+...++.+...             ....-++++|.+++||| .+..++-+......++++++
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            37889999999876543344445554320             33456899999999999 77777777777888999999


Q ss_pred             cCCC-CHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          183 LQTG-SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       183 ~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      +.+| +-..-..   ...-.+...+...++..-+++++|+|   +..=+|+|    ||+..+ +..|..||+....+.. 
T Consensus       316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCcc
Confidence            9887 2222111   00112333344556667778999999   66568888    776655 7889999999876653 


Q ss_pred             ----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCC
Q 047245          261 ----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT  302 (380)
Q Consensus       261 ----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~  302 (380)
                          ...+++.|+|||......+..+.|+|+.|+-..++--|..|-
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence                345899999999999999999999999998777777676663

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.16  E-value=7e-05  Score=64.04  Aligned_cols=141  Identities=18%  Similarity=0.218  Sum_probs=93.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChh--------hhcHHHHHHHHHHHHHHHcCC------CCCccee
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPE--------KQNKSVKRRIQQELEVLASLR------HRNLMSL  166 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~------h~niv~l  166 (380)
                      ...+||+|+.-.||  ..+++....||+..........        .......++..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            45689999999999  4566777889998764300000        000112345556666555555      7899999


Q ss_pred             eEEEecCCeEEEEEeecCC------CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEE
Q 047245          167 RAYVPESSRFYLVYDYLQT------GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM  240 (380)
Q Consensus       167 ~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nil  240 (380)
                      +|+...+...-+|+|...+      -+|.+++.     ...++. ...   ..+-+-..||-   +..|+.+|++|+||+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~---~~L~~f~~~l~---~~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELR---QALDEFKRYLL---DHHIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHH---HHHHHHHHHHH---HcCCeecCCCcccEE
Confidence            9999999888999987653      35778775     223444 333   33334456676   778999999999999


Q ss_pred             eCCC--C--ceEEec-cCCc
Q 047245          241 LDAE--F--TPRLAD-FGLA  255 (380)
Q Consensus       241 l~~~--~--~~kl~D-fgl~  255 (380)
                      +...  +  .+.|+| ||-.
T Consensus       151 ~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEecCCCceEEEEEeCCCCc
Confidence            9532  2  466676 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.05  E-value=8.1e-05  Score=77.92  Aligned_cols=78  Identities=14%  Similarity=0.267  Sum_probs=54.6

Q ss_pred             cccCccCCeeEEEEEecCC---cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCc--ceeeEEEecC---
Q 047245          103 RLLGSSPDGKYYRTVLDNG---LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNL--MSLRAYVPES---  173 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---  173 (380)
                      +.++.|.++.+|+....++   ..+++|+.......       .....+.+|.++++.+. |.++  .+++++|.+.   
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-------~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~  116 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-------QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVI  116 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-------ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcC
Confidence            4578899999999877554   36677765431100       11246778999999995 6665  7778888764   


Q ss_pred             CeEEEEEeecCCCC
Q 047245          174 SRFYLVYDYLQTGS  187 (380)
Q Consensus       174 ~~~~lv~e~~~~gs  187 (380)
                      +..++||||++|..
T Consensus       117 G~~flVME~v~G~~  130 (822)
T PLN02876        117 GTAFYIMEYLEGRI  130 (822)
T ss_pred             CCceEEEEecCCcc
Confidence            46789999998754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.94  E-value=6.9e-05  Score=77.59  Aligned_cols=195  Identities=21%  Similarity=0.250  Sum_probs=134.7

Q ss_pred             HHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE----EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHH
Q 047245          143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF----YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL  218 (380)
Q Consensus       143 ~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l  218 (380)
                      .......-|+..+....|+|++.+++|-.+....    .+..+++..-++.+.+..    ...++......+..+...|+
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL  299 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGL  299 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhH
Confidence            3344555678888889999999999987554322    344578888788777763    45677788888999999999


Q ss_pred             HHhHhcCCCCeEecCCCCC---cEEeCCCCceEEe--ccCCcccCCCCC-----cCCCcccCcccccCCCCCC--cchhh
Q 047245          219 QYLHFTCNPQILHYNLKPT---NVMLDAEFTPRLA--DFGLAKLMPGSL-----IATSAYSAPECFQNRSYTD--KSDIF  286 (380)
Q Consensus       219 ~~LH~~~~~~iiH~dlk~~---Nill~~~~~~kl~--Dfgl~~~~~~~~-----~~~~~y~aPE~~~~~~~~~--~sDv~  286 (380)
                      +|+|   +....|.-+..+   +.-.+.++.+.++  ||+.....+...     ..+..|.+||......+..  ..|+|
T Consensus       300 ~~~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  300 AYLH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHHH---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHH
Confidence            9999   665666555555   4455666777777  888887765432     2455678888877665544  47999


Q ss_pred             HHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC
Q 047245          287 SFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS  366 (380)
Q Consensus       287 s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs  366 (380)
                      .+|.....+..|..+-...                    ......++     ...    .....+....|+..++++|++
T Consensus       377 ~lgll~~~~~~~~~i~~~~--------------------~~~~~~l~-----~~~----~~~~~d~~~~~~~~~~~~Rl~  427 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKS--------------------AVPVSLLD-----VLS----TSELLDALPKCLDEDSEERLS  427 (1351)
T ss_pred             HHHHHHhhhhhcCcccccc--------------------cchhhhhc-----ccc----chhhhhhhhhhcchhhhhccc
Confidence            9999999999987653210                    00011111     111    113566778899999999999


Q ss_pred             HHhHHHH
Q 047245          367 SDELVPM  373 (380)
Q Consensus       367 ~~evl~~  373 (380)
                      ..+++..
T Consensus       428 ~~~ll~~  434 (1351)
T KOG1035|consen  428 ALELLTH  434 (1351)
T ss_pred             hhhhhhc
Confidence            9998753

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.92  E-value=0.00013  Score=62.09  Aligned_cols=130  Identities=19%  Similarity=0.333  Sum_probs=89.3

Q ss_pred             ccccccCccCC-eeEEEEEecCCcEEEEEEeeeccCCChhh-------hc------HHHHHHHHHHHHHHHcCC---CCC
Q 047245          100 NENRLLGSSPD-GKYYRTVLDNGLTVAVRRVEAFESGSPEK-------QN------KSVKRRIQQELEVLASLR---HRN  162 (380)
Q Consensus       100 ~~~~~lg~G~~-g~vy~~~~~~g~~vavK~~~~~~~~~~~~-------~~------~~~~~~~~~E~~~l~~l~---h~n  162 (380)
                      .+-+.||.|.. |.|||+... |..+|+|.+....-.....       ..      .....-|..|.....+|+   +.+
T Consensus        40 ~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~  118 (207)
T PF13095_consen   40 EFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREG  118 (207)
T ss_pred             eeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccC
Confidence            35678999999 999999994 7899999943321111100       00      123346888999888885   445


Q ss_pred             c--ceeeEEEecC------------------CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhH
Q 047245          163 L--MSLRAYVPES------------------SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH  222 (380)
Q Consensus       163 i--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH  222 (380)
                      +  |+.+||..-.                  ....+|.||.+...             .+.    .+-+.++.+-+..+|
T Consensus       119 ~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  119 LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHHHHH
Confidence            6  8899987221                  23478888876533             111    223446667778899


Q ss_pred             hcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       223 ~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                         ..+|+-+|++++|..     .-||+|||.+
T Consensus       182 ---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 ---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ---HCCeeeccCcccccc-----CCEEEecccC
Confidence               999999999999986     5689999864

>PRK10593 hypothetical protein; Provisional

Probab=97.91  E-value=0.00032  Score=64.36  Aligned_cols=76  Identities=14%  Similarity=0.107  Sum_probs=55.3

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC---CCcceeeEEEecC---Ce
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH---RNLMSLRAYVPES---SR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~  175 (380)
                      .+-||.|..+.||+....++ .+.+|..+...          ....+..|...|+.+.-   ..+.+++++|...   +.
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~----------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARSFS----------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEecccc----------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            35699999999999877666 45666643200          01568889999998843   3678888887543   66


Q ss_pred             EEEEEeecCCCCH
Q 047245          176 FYLVYDYLQTGSL  188 (380)
Q Consensus       176 ~~lv~e~~~~gsL  188 (380)
                      .++|||+++++++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998765

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.80  E-value=0.00025  Score=58.48  Aligned_cols=126  Identities=19%  Similarity=0.226  Sum_probs=86.9

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcce-eeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS-LRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~  180 (380)
                      ...|++|.+|.||+|.+. |..+|+|+-...          .-+..+..|+++|..++-.++.+ ++.|-.    -++.|
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d----------s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m   91 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRD----------SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM   91 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCC----------cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence            467999999999999986 568999987541          12477889999999998777655 343322    34559


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCC-C-CcEEeCCCCceEEeccCCccc
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK-P-TNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk-~-~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ||.+|-.|.+....       .+-..    ...+++.---|-   ..+|-|+.|. | .||++. +..+.|+||..|..
T Consensus        92 e~i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~  155 (201)
T COG2112          92 EYIDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATF  155 (201)
T ss_pred             hhhcCcchhhhhhc-------ccHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEec-CCcEEEEEccchhh
Confidence            99999888776542       12222    233444434444   6678888887 3 455554 44999999998873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.78  E-value=0.00019  Score=63.57  Aligned_cols=32  Identities=25%  Similarity=0.442  Sum_probs=26.7

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ...++|+|+.+.||+++++...-|+||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            45589999999999998776667999998653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.64  E-value=0.0018  Score=61.53  Aligned_cols=81  Identities=17%  Similarity=0.124  Sum_probs=52.7

Q ss_pred             cccCccCCeeEEEEEecCC-cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNG-LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  178 (380)
                      +.||.|.+..||++...+| +.+.||.-........+. ......++..|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~-wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGES-WPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCccccccccc-ccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999999877 489999854321111110 0112245666777777762   2456667766  3355789


Q ss_pred             EEeecCCC
Q 047245          179 VYDYLQTG  186 (380)
Q Consensus       179 v~e~~~~g  186 (380)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.51  E-value=0.0028  Score=55.93  Aligned_cols=72  Identities=17%  Similarity=0.124  Sum_probs=45.2

Q ss_pred             ccCccCCeeEEEEEecC--CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCC-cceeeEEEecCCeEEEEE
Q 047245          104 LLGSSPDGKYYRTVLDN--GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN-LMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  180 (380)
                      .|..|-...+|+....+  +..+++|........         .....+|+.++..+...+ ..++++... +   .++|
T Consensus         5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~   71 (235)
T cd05157           5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIY   71 (235)
T ss_pred             EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEE
Confidence            46778888999988764  678888876431110         012236888888885433 344444432 2   3799


Q ss_pred             eecCCCCH
Q 047245          181 DYLQTGSL  188 (380)
Q Consensus       181 e~~~~gsL  188 (380)
                      ||++|-++
T Consensus        72 e~i~G~~l   79 (235)
T cd05157          72 EFIPGRTL   79 (235)
T ss_pred             EeeCCCcC
Confidence            99998665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.50  E-value=0.0011  Score=59.34  Aligned_cols=139  Identities=14%  Similarity=0.187  Sum_probs=76.6

Q ss_pred             cCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc-ceeeEEEecCCeEEEEEeec
Q 047245          105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL-MSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       105 lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  183 (380)
                      +..|-.+.+|+... +|..+++|.......        .......+|..+++.+...++ .++++...    -.+|+||+
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~--------~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i   70 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCK--------ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWL   70 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccc--------cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEec
Confidence            45677889998874 567788886543110        000124568888888854333 34444432    36899999


Q ss_pred             CCCCHHH--------------HHHHh---hhcccCCCHHHHH-HHHHHH---------HHHHHHhHhc-----CCCCeEe
Q 047245          184 QTGSLED--------------AMDRI---RENQLQLGWEVRL-RIAVGV---------IKGLQYLHFT-----CNPQILH  231 (380)
Q Consensus       184 ~~gsL~~--------------~l~~~---~~~~~~l~~~~~~-~i~~~i---------a~~l~~LH~~-----~~~~iiH  231 (380)
                      +|..+..              .+...   .....+++...+. ....++         ...+..+-..     ....++|
T Consensus        71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H  150 (256)
T TIGR02721        71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH  150 (256)
T ss_pred             cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence            9866532              11111   1111122222211 111111         1112222111     1346899


Q ss_pred             cCCCCCcEEeCCCCceEEeccCCccc
Q 047245          232 YNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       232 ~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +|+.|.||++++++ +.|+||..+..
T Consensus       151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       151 MDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCcCcEEEeCCC-CEEEeccccCc
Confidence            99999999999877 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.47  E-value=0.0021  Score=59.24  Aligned_cols=143  Identities=17%  Similarity=0.188  Sum_probs=80.0

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC--CcceeeEEE------ecCC
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR--NLMSLRAYV------PESS  174 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~  174 (380)
                      +.++.|....+|+....+| .+++|......  .        ......|.+++..|...  .+.+++...      ...+
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~--------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g   96 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--K--------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG   96 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCCC--C--------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence            4567777789998876555 57778764310  0        12334566666666322  234444321      2245


Q ss_pred             eEEEEEeecCCCCHH----HH----------HHHhhhc---c-----cCCCHHHHHH------------HHHHHHHHHHH
Q 047245          175 RFYLVYDYLQTGSLE----DA----------MDRIREN---Q-----LQLGWEVRLR------------IAVGVIKGLQY  220 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~----~~----------l~~~~~~---~-----~~l~~~~~~~------------i~~~ia~~l~~  220 (380)
                      ..++++||++|..+.    +.          +|.....   .     ..-.|.....            ....+.+.+++
T Consensus        97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~  176 (307)
T TIGR00938        97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY  176 (307)
T ss_pred             eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence            678999999885431    11          1111110   0     0112221110            11123334555


Q ss_pred             hHh----cCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          221 LHF----TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       221 LH~----~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      +..    ....+++|+|+.+.|+++++++...|+||+.+.
T Consensus       177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            542    235789999999999999988877899998774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.46  E-value=0.00093  Score=61.24  Aligned_cols=143  Identities=16%  Similarity=0.127  Sum_probs=83.1

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC--CcceeeEE------EecCC
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR--NLMSLRAY------VPESS  174 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~  174 (380)
                      +.+..|....+|+....+ ..+++|+...   ..        ......|+.++..+.+.  .+.+++..      ....+
T Consensus        20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~--------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          20 EGISAGIENTNYFVTTDS-GRYVLTLFEK---VS--------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             ecccCccccceEEEEeCC-CcEEEEEcCC---CC--------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            356777778999987654 4688887653   10        13455677777777432  24444432      12335


Q ss_pred             eEEEEEeecCCCCHHH----H----------HHHhhhc-------ccCCCHHHHHH----------HHHHHHHHHHHhHh
Q 047245          175 RFYLVYDYLQTGSLED----A----------MDRIREN-------QLQLGWEVRLR----------IAVGVIKGLQYLHF  223 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~----~----------l~~~~~~-------~~~l~~~~~~~----------i~~~ia~~l~~LH~  223 (380)
                      ..+.|++|++|..+..    .          +|.....       .....|.....          ....+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6689999999866421    1          1111000       01123332210          11122334445442


Q ss_pred             ----cCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          224 ----TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       224 ----~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                          .....++|+|+.|.|++++++..+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                1235799999999999999987789999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.38  E-value=0.0092  Score=55.30  Aligned_cols=32  Identities=22%  Similarity=0.306  Sum_probs=27.3

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ..+++|+|+.+.||+++++...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45899999999999999776668999998753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.27  E-value=0.00056  Score=61.90  Aligned_cols=154  Identities=11%  Similarity=0.064  Sum_probs=101.5

Q ss_pred             CCCChHHHHHHHh-----ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCCh--------------hhhcHHHHHH
Q 047245           87 PKIDPKTLQAALA-----NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSP--------------EKQNKSVKRR  147 (380)
Q Consensus        87 ~~~~~~~l~~~~~-----~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~--------------~~~~~~~~~~  147 (380)
                      ..+++..|.....     ..++.||-|.-+.+|.+...+|.+.++|.-+.....-.              ...---.+-.
T Consensus        77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla  156 (465)
T KOG2268|consen   77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA  156 (465)
T ss_pred             ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence            3456666665544     36789999999999999999999999886543211100              0000011224


Q ss_pred             HHHHHHHHHcCC-CCC-cceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC
Q 047245          148 IQQELEVLASLR-HRN-LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC  225 (380)
Q Consensus       148 ~~~E~~~l~~l~-h~n-iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~  225 (380)
                      ...|...|+.|. |.. +...+++    ++.++|||+..+-.|.+.-+       .-+.   -.+...+..-+--|.   
T Consensus       157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~---~~ly~~lm~~Iv~la---  219 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDP---PTLYDDLMGLIVRLA---  219 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-------cCCh---HHHHHHHHHHHHHHH---
Confidence            557888999884 433 3334443    46689999998877755322       1112   233444444555666   


Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ..++||||..-=||++++++.++++||--.-.
T Consensus       220 ~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  220 NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             HcCceecccchheeEEecCCCEEEeechHhhc
Confidence            89999999999999999999999999975443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.15  E-value=0.0056  Score=56.28  Aligned_cols=141  Identities=20%  Similarity=0.206  Sum_probs=80.1

Q ss_pred             ccCccCCeeEEEEEecC-------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc-ceeeEEEecCCe
Q 047245          104 LLGSSPDGKYYRTVLDN-------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL-MSLRAYVPESSR  175 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~  175 (380)
                      .+..|-...+|+....+       +..+++|.......         ......+|..++..+...++ .++++++..   
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---   72 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---------LLIDRERELVVFARLSERNLGPKLYGIFPN---   72 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---------ceechHHHHHHHHHHHhCCCCCceEEEeCC---
Confidence            35566677899988765       47888888654111         11334568888887743333 345555542   


Q ss_pred             EEEEEeecCCCCHHHH-------H----------HHhhhcc-------cCCCHHHHHH----------------------
Q 047245          176 FYLVYDYLQTGSLEDA-------M----------DRIRENQ-------LQLGWEVRLR----------------------  209 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~-------l----------~~~~~~~-------~~l~~~~~~~----------------------  209 (380)
                       ..|+||++|..+...       +          |......       .+.-|..+..                      
T Consensus        73 -~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (302)
T cd05156          73 -GRIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEV  151 (302)
T ss_pred             -CchhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhh
Confidence             358999988765431       1          1000000       0001111111                      


Q ss_pred             ----HHHHHHHHHHHhHh------cCCCCeEecCCCCCcEEeCCC----CceEEeccCCccc
Q 047245          210 ----IAVGVIKGLQYLHF------TCNPQILHYNLKPTNVMLDAE----FTPRLADFGLAKL  257 (380)
Q Consensus       210 ----i~~~ia~~l~~LH~------~~~~~iiH~dlk~~Nill~~~----~~~kl~Dfgl~~~  257 (380)
                          +...+...+.++..      .....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       152 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         152 ELSLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             hHHHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence                11122222334431      135678999999999999985    8899999988753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.01  E-value=0.002  Score=61.76  Aligned_cols=48  Identities=29%  Similarity=0.371  Sum_probs=38.8

Q ss_pred             HHHHHHHHHHHcCCCCCcceeeEEEecC-CeEEEEEeecCCCCHHHHHHH
Q 047245          146 RRIQQELEVLASLRHRNLMSLRAYVPES-SRFYLVYDYLQTGSLEDAMDR  194 (380)
Q Consensus       146 ~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~  194 (380)
                      .++....+.++.++|+|....+.+-... .+..+|+|++ +.||.+.+..
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            4566778899999999999999887554 4578899998 5599998874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.88  E-value=0.00025  Score=75.52  Aligned_cols=168  Identities=17%  Similarity=0.119  Sum_probs=118.0

Q ss_pred             ChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHH
Q 047245          136 SPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG  213 (380)
Q Consensus       136 ~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~  213 (380)
                      +.+.-.+-.++....|...++...|+++.....-...  +.+-+.+++|+.+|.+.+.+-+-....+.++.........+
T Consensus      1264 d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kv 1343 (2724)
T KOG1826|consen 1264 DFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKV 1343 (2724)
T ss_pred             hHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHH
Confidence            3344444555666677777777889988775554433  34568899999999999988653333333333333322223


Q ss_pred             HHHHHHHhHhc--CCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC------CCCcCCCcccCcccccCCCCCCcchh
Q 047245          214 VIKGLQYLHFT--CNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPECFQNRSYTDKSDI  285 (380)
Q Consensus       214 ia~~l~~LH~~--~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv  285 (380)
                      ......-.|..  ...-.+|+++|+-|.+|..+..+|++++|+.+...      +...+++.|+.|+......++.++|+
T Consensus      1344 svl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1344 SVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDI 1423 (2724)
T ss_pred             HHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHH
Confidence            24444444422  23457999999999999999999999999999333      23457888999999888889999999


Q ss_pred             hHHHHHHHHHHhCCCCCC
Q 047245          286 FSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       286 ~s~Gvil~el~tg~~p~~  303 (380)
                      |..|+-+|+..-|..+|-
T Consensus      1424 lr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHHHHHhcccHHHH
Confidence            999999999988887653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.81  E-value=0.015  Score=53.31  Aligned_cols=32  Identities=28%  Similarity=0.552  Sum_probs=28.8

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ...++|||+.+.|++++++..+=|.||+++..
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            35799999999999999998899999999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.72  E-value=0.018  Score=52.22  Aligned_cols=32  Identities=25%  Similarity=0.507  Sum_probs=26.2

Q ss_pred             CCCeEecCCCCCcEEeCCCCc-eEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFT-PRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~-~kl~Dfgl~~~  257 (380)
                      ...++|+|+.+.||++++++. .-|+||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            346899999999999997555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.69  E-value=0.054  Score=51.51  Aligned_cols=79  Identities=13%  Similarity=0.089  Sum_probs=48.3

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  179 (380)
                      +.||.|....||+.... +..++||.-........+.. .....+-..|...|+.+.   ..++.+++.++.+  ..+++
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~w-pl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESW-PMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccc-cCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            46899999999998764 56788998753221111100 001122233455555553   3577888888874  45788


Q ss_pred             EeecCC
Q 047245          180 YDYLQT  185 (380)
Q Consensus       180 ~e~~~~  185 (380)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.69  E-value=0.048  Score=50.22  Aligned_cols=30  Identities=17%  Similarity=0.202  Sum_probs=25.8

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ..+++|||+.+.||++++ +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            467899999999999988 678899998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.66  E-value=0.039  Score=51.51  Aligned_cols=79  Identities=11%  Similarity=0.065  Sum_probs=46.6

Q ss_pred             ccCccCCeeEEEEEecCC-cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--CCC-cceeeEEEecCCeEEEE
Q 047245          104 LLGSSPDGKYYRTVLDNG-LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--HRN-LMSLRAYVPESSRFYLV  179 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv  179 (380)
                      -||.|....||++..++| ..|+||.-........+. ..-...+..-|...|+...  -|. +.+++.+  +.+...+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~-wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGES-WPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCC-CCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence            379999999999998655 589999765432211100 0111233345666666653  343 4444433  44556799


Q ss_pred             EeecCC
Q 047245          180 YDYLQT  185 (380)
Q Consensus       180 ~e~~~~  185 (380)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.65  E-value=0.013  Score=53.22  Aligned_cols=72  Identities=17%  Similarity=0.201  Sum_probs=45.9

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  179 (380)
                      +-++.|....+|+.. .++..+.||.-....           ...|..|..-|+.|.   --.+.+.+++....+..+++
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~-----------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSESG-----------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEGGG-----------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecChhh-----------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            457878889999877 678899999875311           156778888888883   34577888888777777999


Q ss_pred             EeecCCC
Q 047245          180 YDYLQTG  186 (380)
Q Consensus       180 ~e~~~~g  186 (380)
                      +||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.26  E-value=0.085  Score=48.68  Aligned_cols=32  Identities=16%  Similarity=0.237  Sum_probs=28.5

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ..+++|+|+.+.|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999987753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.25  E-value=0.052  Score=50.41  Aligned_cols=147  Identities=14%  Similarity=0.193  Sum_probs=95.5

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCC--C------hh---------hh-cHHHHHHHHHHHHHHHcCCCCC
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESG--S------PE---------KQ-NKSVKRRIQQELEVLASLRHRN  162 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~--~------~~---------~~-~~~~~~~~~~E~~~l~~l~h~n  162 (380)
                      ....|..|.-..||.+.-.+|..+|||+.+.....  +      .+         .. .+...-=...|+.-|++|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            45568889999999999999999999988541100  0      00         00 0111222345788888887655


Q ss_pred             cceeeEEEecCCeEEEEEeecCCCC-HHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe
Q 047245          163 LMSLRAYVPESSRFYLVYDYLQTGS-LEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML  241 (380)
Q Consensus       163 iv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill  241 (380)
                      |...--...  ..-.|||+|+.... ..-.|.     ...++......+..|++.-|.-|.+.|  ++||.||+-=|+|+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            443221211  23479999985321 111122     234666677788888888888888644  79999999999998


Q ss_pred             CCCCceEEeccCCccc
Q 047245          242 DAEFTPRLADFGLAKL  257 (380)
Q Consensus       242 ~~~~~~kl~Dfgl~~~  257 (380)
                      .+ |.+.|+|.+-+-.
T Consensus       299 hd-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 HD-GKLYIIDVSQSVE  313 (520)
T ss_pred             EC-CEEEEEEcccccc
Confidence            54 6889999887644

>PRK06148 hypothetical protein; Provisional

Probab=96.22  E-value=0.15  Score=54.83  Aligned_cols=160  Identities=20%  Similarity=0.311  Sum_probs=86.1

Q ss_pred             CCCCChHHHHHHHhc------cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-
Q 047245           86 SPKIDPKTLQAALAN------ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-  158 (380)
Q Consensus        86 ~~~~~~~~l~~~~~~------~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  158 (380)
                      .|.++..++......      ..+.|+ |..-..|+....+|..+++|+......          ......|.+.+..| 
T Consensus         8 ~p~~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~----------~~~~~~q~~~L~hL~   76 (1013)
T PRK06148          8 APEFTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP----------RVESDFQTAALDHLA   76 (1013)
T ss_pred             CCCCCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc----------hhHHHHHHHHHHHHH
Confidence            455666666555443      113454 345778988888888999999875210          12223344455444 


Q ss_pred             ------CCCCcceee-E----EEec-CC--eEEEEEeecCCCCHHHH-------HHHh-----------h-----hcccC
Q 047245          159 ------RHRNLMSLR-A----YVPE-SS--RFYLVYDYLQTGSLEDA-------MDRI-----------R-----ENQLQ  201 (380)
Q Consensus       159 ------~h~niv~l~-~----~~~~-~~--~~~lv~e~~~~gsL~~~-------l~~~-----------~-----~~~~~  201 (380)
                            .-|.+++.. |    .... .+  ..+-+++|.+|..+.+.       +...           .     .....
T Consensus        77 ~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~  156 (1013)
T PRK06148         77 AVAPDLPVPRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRD  156 (1013)
T ss_pred             hhCCCCCcCeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Confidence                  223333221 1    1111 22  46778999999777651       1110           0     00112


Q ss_pred             CCHHH-----------------HHHHHHHHHHHHH-----HhHhcCCCCeEecCCCCCcEEeCCCC--ceE-EeccCCcc
Q 047245          202 LGWEV-----------------RLRIAVGVIKGLQ-----YLHFTCNPQILHYNLKPTNVMLDAEF--TPR-LADFGLAK  256 (380)
Q Consensus       202 l~~~~-----------------~~~i~~~ia~~l~-----~LH~~~~~~iiH~dlk~~Nill~~~~--~~k-l~Dfgl~~  256 (380)
                      +.|..                 ...++.++.....     .+ ......+||+|+.+.||+++.+.  .+. |+|||-+.
T Consensus       157 ~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l-~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        157 LDWDLRHAGRARDRLHFIDDPEDRALVERFLARFERNVAPRL-AALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cccccccchhhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHH-hcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            33421                 1122222222221     12 12356799999999999999875  454 99999875


Q ss_pred             c
Q 047245          257 L  257 (380)
Q Consensus       257 ~  257 (380)
                      .
T Consensus       236 ~  236 (1013)
T PRK06148        236 H  236 (1013)
T ss_pred             c
Confidence            4

>PLN02236 choline kinase

Probab=96.19  E-value=0.079  Score=49.71  Aligned_cols=140  Identities=15%  Similarity=0.166  Sum_probs=77.2

Q ss_pred             cCccCCeeEEEEEecC-----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcc-eeeEEEecCCeEEE
Q 047245          105 LGSSPDGKYYRTVLDN-----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM-SLRAYVPESSRFYL  178 (380)
Q Consensus       105 lg~G~~g~vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~l  178 (380)
                      +..|-...+|+....+     +..+.+|.......        .. -.-.+|..+++.+...++. ++++.+..+    .
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--------~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~  110 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--------LF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----R  110 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--------ee-echHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence            4457778889877532     35788887654211        11 1225688888888544443 456666433    4


Q ss_pred             EEeecCCCCHHHH-----------------HHHhhhcc-c-CCCHHHHHHHHHHH-----------------HHHHHHhH
Q 047245          179 VYDYLQTGSLEDA-----------------MDRIRENQ-L-QLGWEVRLRIAVGV-----------------IKGLQYLH  222 (380)
Q Consensus       179 v~e~~~~gsL~~~-----------------l~~~~~~~-~-~l~~~~~~~i~~~i-----------------a~~l~~LH  222 (380)
                      |+||+++.++...                 +|...... . ...|....++..++                 ...+..|.
T Consensus       111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~  190 (344)
T PLN02236        111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE  190 (344)
T ss_pred             EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence            7999987665421                 11100000 0 11122222222111                 11122221


Q ss_pred             ----h-cCCCCeEecCCCCCcEEeCC-CCceEEeccCCccc
Q 047245          223 ----F-TCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAKL  257 (380)
Q Consensus       223 ----~-~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~~  257 (380)
                          . .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                1 22457899999999999986 46899999987753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.82  E-value=0.36  Score=44.88  Aligned_cols=93  Identities=13%  Similarity=0.097  Sum_probs=51.9

Q ss_pred             CCCCChHHHHHHHhccc-----c-ccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC
Q 047245           86 SPKIDPKTLQAALANEN-----R-LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR  159 (380)
Q Consensus        86 ~~~~~~~~l~~~~~~~~-----~-~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  159 (380)
                      .+.+++..+.++....+     + ..=.+....||+....+|..+++|.......         .......|.+.+..|.
T Consensus         8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~---------~~~~i~~E~~~l~~L~   78 (325)
T PRK11768          8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERW---------SDAQILEEHAFALELA   78 (325)
T ss_pred             CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccC---------CHHHHHHHHHHHHHHH
Confidence            34566667766665431     1 1112345678998888888899998753110         1244555666666663


Q ss_pred             C--CCcceee---E--EEecCCeEEEEEeecCCCC
Q 047245          160 H--RNLMSLR---A--YVPESSRFYLVYDYLQTGS  187 (380)
Q Consensus       160 h--~niv~l~---~--~~~~~~~~~lv~e~~~~gs  187 (380)
                      .  -.++...   |  ....++..+.++++++|..
T Consensus        79 ~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         79 EAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             HCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            1  1122211   1  1222456788999998753

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.80  E-value=0.082  Score=49.29  Aligned_cols=31  Identities=26%  Similarity=0.299  Sum_probs=26.2

Q ss_pred             CCeEecCCCCCcEEeCC-CCceEEeccCCccc
Q 047245          227 PQILHYNLKPTNVMLDA-EFTPRLADFGLAKL  257 (380)
Q Consensus       227 ~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~~  257 (380)
                      .-++|+|+.+.|||+++ ++.++++||..+..
T Consensus       182 ~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        182 VVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             eEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            35799999999999975 57899999988753

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.78  E-value=0.084  Score=49.97  Aligned_cols=79  Identities=19%  Similarity=0.171  Sum_probs=48.0

Q ss_pred             cccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--CCC-cceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--HRN-LMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~l  178 (380)
                      +.||.|.-..||++...+ +..|+||.-........+-  .-...+..-|.+.|+...  -|. +.+++.+  +.....+
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~sw--pL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~  110 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEF--KLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC  110 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCC--CCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence            468999999999999743 5689999765432221111  111234445666666652  343 4445444  4456688


Q ss_pred             EEeecCC
Q 047245          179 VYDYLQT  185 (380)
Q Consensus       179 v~e~~~~  185 (380)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9998854

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.73  E-value=0.092  Score=48.74  Aligned_cols=104  Identities=21%  Similarity=0.206  Sum_probs=70.5

Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..|+++++. |+++..        .....|.+.+.+..+-+..++-+..  ..+.-|||+.-.||||+ +|.+.|+||-+
T Consensus       300 y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         300 YLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             EEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence            446677754 445432        2235688889999998887777764  56889999999999999 99999999999


Q ss_pred             cccCCCC-CcCCCcccCcccccCCCCCCcchhhHHHHH
Q 047245          255 AKLMPGS-LIATSAYSAPECFQNRSYTDKSDIFSFGMI  291 (380)
Q Consensus       255 ~~~~~~~-~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvi  291 (380)
                      +|...+. ..-.-+.--|-.+.|. -+.+-|||-+--.
T Consensus       368 sRl~~~q~~isy~rldhp~lF~G~-dd~QFeIYrlMr~  404 (488)
T COG5072         368 SRLSYSQGIISYNRLDHPDLFNGV-DDYQFEIYRLMRR  404 (488)
T ss_pred             eecccCCceeeccccCchhhhcCc-cceeeeHHHHHHH
Confidence            9964432 2222233345555432 2566677764433

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.68  E-value=0.46  Score=44.15  Aligned_cols=140  Identities=22%  Similarity=0.325  Sum_probs=80.2

Q ss_pred             cCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-C--CC---cceeeEE----EecCC
Q 047245          105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-H--RN---LMSLRAY----VPESS  174 (380)
Q Consensus       105 lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~n---iv~l~~~----~~~~~  174 (380)
                      |.+ .-..+|+....+|.. ++|.....          ....+...|...+..|. +  +=   +..+-|-    .....
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~----------~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~  101 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG----------WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGP  101 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC----------CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCc
Confidence            444 567789988887777 88877652          11245566777777773 2  11   1122121    11113


Q ss_pred             eEEEEEeecCCCCHHH-----HH----------HHhh--------hcccCCCHHH-------------HHHHHHHHHHHH
Q 047245          175 RFYLVYDYLQTGSLED-----AM----------DRIR--------ENQLQLGWEV-------------RLRIAVGVIKGL  218 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~-----~l----------~~~~--------~~~~~l~~~~-------------~~~i~~~ia~~l  218 (380)
                      ..+-+++|++|..+..     .+          |...        +......|..             ......++...+
T Consensus       102 r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~  181 (331)
T COG2334         102 RPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAAL  181 (331)
T ss_pred             eeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHH
Confidence            7789999999977772     11          1100        0111244431             011223333344


Q ss_pred             HHhHhc----CCCC---eEecCCCCCcEEeCCCCc-eEEeccCCcc
Q 047245          219 QYLHFT----CNPQ---ILHYNLKPTNVMLDAEFT-PRLADFGLAK  256 (380)
Q Consensus       219 ~~LH~~----~~~~---iiH~dlk~~Nill~~~~~-~kl~Dfgl~~  256 (380)
                      ..+...    ....   +||+|+.|.||+++++.. +.+.||+-+.
T Consensus       182 ~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         182 DRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            444421    1223   999999999999999885 8999999775

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.49  E-value=0.077  Score=49.93  Aligned_cols=62  Identities=18%  Similarity=0.168  Sum_probs=41.3

Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD  242 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~  242 (380)
                      ....++=+|++|-++..++..     ...+.....+++.-.+.|+--+-.  -.+++|.|+.|.||++.
T Consensus       318 ~~~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  318 TDLVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ccceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            345677788889999988873     122333445555555555433321  56899999999999994

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.65  E-value=0.43  Score=41.61  Aligned_cols=59  Identities=22%  Similarity=0.238  Sum_probs=43.8

Q ss_pred             CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC---CCcceeeEEEecCCeEEEEEeecCCCCHH
Q 047245          120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH---RNLMSLRAYVPESSRFYLVYDYLQTGSLE  189 (380)
Q Consensus       120 ~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~~~~gsL~  189 (380)
                      +..++-||+-.           ......|..|+.-|..|.-   -++.+.+.+-.+.+.-|+|+||++-|.+.
T Consensus        38 g~~~~FvK~n~-----------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          38 GTDPFFVKCNQ-----------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             CCcceEEEecc-----------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            45678888643           2334778889888777743   45777888888889999999999986655

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=94.52  E-value=0.34  Score=44.18  Aligned_cols=31  Identities=23%  Similarity=0.312  Sum_probs=25.3

Q ss_pred             CCeEecCCCCCcEEeCCC--C---ceEEeccCCccc
Q 047245          227 PQILHYNLKPTNVMLDAE--F---TPRLADFGLAKL  257 (380)
Q Consensus       227 ~~iiH~dlk~~Nill~~~--~---~~kl~Dfgl~~~  257 (380)
                      .-++|||+.+.|||+..+  +   .+++.||-+++.
T Consensus       215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence            458999999999999654  3   689999987753

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.49  E-value=0.023  Score=34.29  Aligned_cols=29  Identities=17%  Similarity=0.056  Sum_probs=15.2

Q ss_pred             CceeEEehhhHHHHHHHHHHHHHHHHHHh
Q 047245           40 GVKKIILSIALGVVTGLIGAILFACFVRC   68 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~   68 (380)
                      ...++..++++.++++++++.+++++++|
T Consensus         9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~r   37 (40)
T PF08693_consen    9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYR   37 (40)
T ss_pred             ceEEEEEEEEechHHHHHHHHHHhheEEe
Confidence            34456666666665555554444444333

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.38  E-value=0.027  Score=43.92  Aligned_cols=37  Identities=22%  Similarity=0.258  Sum_probs=30.3

Q ss_pred             HHHHhc-cccccCccCCeeEEEEEecCCcEEEEEEeee
Q 047245           95 QAALAN-ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEA  131 (380)
Q Consensus        95 ~~~~~~-~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~  131 (380)
                      .+.... ..+-||.|+.|.||+|++.+|+.||||+.++
T Consensus         8 ~~~F~~fd~~PlasASiaQVh~a~l~~g~~VaVKV~rP   45 (119)
T PF03109_consen    8 DEIFDEFDPEPLASASIAQVHRARLKDGEEVAVKVQRP   45 (119)
T ss_pred             HHHHHHCCcchhhheehhhheeeeecccchhhhhhcch
Confidence            334443 3457999999999999999999999999876

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	380
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-34
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-34
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-25
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		6e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-11
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-10
3soa_A	444	Full-Length Human Camkii Length = 444		8e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-10
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-09
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		9e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		9e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		9e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-05
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-05
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-05
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-05
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 159/295 (53%), Gaps = 23/295 (7%)
Query: 92  KTLQAA---LANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           + LQ A    +N+N +LG    GK Y+  L +G  VAV+R++       E++ +  + + 
Sbjct: 31  RELQVASDNFSNKN-ILGRGGFGKVYKGRLADGTLVAVKRLK-------EERXQGGELQF 82
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           Q E+E+++   HRNL+ LR +    +   LVY Y+  GS+   +    E+Q  L W  R 
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 142
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GS 261
           RIA+G  +GL YLH  C+P+I+H ++K  N++LD EF   + DFGLAKLM         +
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 202
Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGS--LGRWL 319
           +  T  + APE       ++K+D+F +G++L  L+TG+   A   A  A+     L  W+
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ--RAFDLARLANDDDVMLLDWV 260
Query: 320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           + L    +    +D  + G   +++E+   +++A++C   SP +RP   E+V ML
Sbjct: 261 KGLLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 155/294 (52%), Gaps = 21/294 (7%)
Query: 92  KTLQAALAN--ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           + LQ A  N     +LG    GK Y+  L +G  VAV+R++       E++ +  + + Q
Sbjct: 23  RELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLK-------EERTQGGELQFQ 75
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E+E+++   HRNL+ LR +    +   LVY Y+  GS+   +    E+Q  L W  R R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSL 262
           IA+G  +GL YLH  C+P+I+H ++K  N++LD EF   + DFGLAKLM         ++
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGS--LGRWLR 320
                + APE       ++K+D+F +G++L  L+TG+   A   A  A+     L  W++
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ--RAFDLARLANDDDVMLLDWVK 253
Query: 321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
            L    +    +D  + G   +++E+   +++A++C   SP +RP   E+V ML
Sbjct: 254 GLLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           L+G    GK Y+ VL +G  VA++R       +PE      +   + E+E L+  RH +L
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKR------RTPESSQGIEE--FETEIETLSFCRHPHL 97
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           +SL  +  E +   L+Y Y++ G+L+  +       + + WE RL I +G  +GL YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH- 156
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQ 275
                I+H ++K  N++LD  F P++ DFG++K         +   +  T  Y  PE F 
Sbjct: 157 --TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFI 214
Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
               T+KSD++SFG++L  +L  R              +L  W     + G+  + +D +
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV--NLAEWAVESHNNGQLEQIVDPN 272
Query: 336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPS 366
            L +++  + +      AV CL+ S  DRPS
Sbjct: 273 -LADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 132/271 (48%), Gaps = 22/271 (8%)
Query: 104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           L+G    GK Y+ VL +G  VA++R       +PE      +   + E+E L+  RH +L
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKR------RTPESSQGIEE--FETEIETLSFCRHPHL 97
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           +SL  +  E +   L+Y Y++ G+L+  +       + + WE RL I +G  +GL YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH- 156
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQ 275
                I+H ++K  N++LD  F P++ DFG++K         +   +  T  Y  PE F 
Sbjct: 157 --TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFI 214
Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
               T+KSD++SFG++L  +L  R              +L  W     + G+  + +D +
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV--NLAEWAVESHNNGQLEQIVDPN 272
Query: 336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPS 366
            L +++  + +      AV CL+ S  DRPS
Sbjct: 273 -LADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 18/202 (8%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+  ++N  TVAV+++ A    + E+    +K++  QE++V+A  +H NL+
Sbjct: 39  MGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEE----LKQQFDQEIKVMAKCQHENLV 93
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT 224
            L  +  +     LVY Y+  GSL D +  + +    L W +R +IA G   G+ +LH  
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLH-- 150
Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQN 276
                +H ++K  N++LD  FT +++DFGLA+        +M   ++ T+AY APE  + 
Sbjct: 151 -ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG 209
Query: 277 RSYTDKSDIFSFGMILAVLLTG 298
              T KSDI+SFG++L  ++TG
Sbjct: 210 E-ITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 18/202 (8%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+  ++N  TVAV+++ A    + E+    +K++  QE++V+A  +H NL+
Sbjct: 33  MGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEE----LKQQFDQEIKVMAKCQHENLV 87
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT 224
            L  +  +     LVY Y+  GSL D +  + +    L W +R +IA G   G+ +LH  
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLH-- 144
Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQN 276
                +H ++K  N++LD  FT +++DFGLA+        +M   ++ T+AY APE  + 
Sbjct: 145 -ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG 203
Query: 277 RSYTDKSDIFSFGMILAVLLTG 298
              T KSDI+SFG++L  ++TG
Sbjct: 204 E-ITPKSDIYSFGVVLLEIITG 224

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 18/202 (8%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+  ++N  TVAV+++ A    + E+    +K++  QE++V+A  +H NL+
Sbjct: 39  MGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEE----LKQQFDQEIKVMAKCQHENLV 93
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT 224
            L  +  +     LVY Y+  GSL D +  + +    L W +R +IA G   G+ +LH  
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLH-- 150
Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQN 276
                +H ++K  N++LD  FT +++DFGLA+        +M   ++ T+AY APE  + 
Sbjct: 151 -ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG 209
Query: 277 RSYTDKSDIFSFGMILAVLLTG 298
              T KSDI+SFG++L  ++TG
Sbjct: 210 E-ITPKSDIYSFGVVLLEIITG 230

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 62/187 (33%), Positives = 101/187 (54%), Gaps = 17/187 (9%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
           N  TVAV+++ A    + E+    +K++  QE++V A  +H NL+ L  +  +     LV
Sbjct: 44  NNTTVAVKKLAAMVDITTEE----LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLV 99
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           Y Y   GSL D +  + +    L W  R +IA G   G+ +LH       +H ++K  N+
Sbjct: 100 YVYXPNGSLLDRLSCL-DGTPPLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANI 155
Query: 240 MLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMI 291
           +LD  FT +++DFGLA+        +    ++ T+AY APE  +    T KSDI+SFG++
Sbjct: 156 LLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGE-ITPKSDIYSFGVV 214
Query: 292 LAVLLTG 298
           L  ++TG
Sbjct: 215 LLEIITG 221

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 88/158 (55%), Gaps = 8/158 (5%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E+ ++  LRH N++     V +     +V +YL  GSL   + +    + QL    RL 
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLS 141
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA----- 264
           +A  V KG+ YLH   NP I+H NLK  N+++D ++T ++ DFGL++L   + ++     
Sbjct: 142 MAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 265 -TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  + APE  ++    +KSD++SFG+IL  L T + P
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 86/158 (54%), Gaps = 8/158 (5%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E+ ++  LRH N++     V +     +V +YL  GSL   + +    + QL    RL 
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLS 141
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI------ 263
           +A  V KG+ YLH   NP I+H +LK  N+++D ++T ++ DFGL++L     +      
Sbjct: 142 MAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA 200
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  + APE  ++    +KSD++SFG+IL  L T + P
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 141/302 (46%), Gaps = 38/302 (12%)
Query: 91  PKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFES---GSPEKQNKSVKR- 146
           PK+    LA+ N +      GK    ++  G  V  + V A +S   G  E + + +++ 
Sbjct: 9   PKSRLPTLAD-NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 147 -RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
              Q+E+ ++++L H N++ L   +    R  +V +++  G   D   R+ +    + W 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCG---DLYHRLLDKAHPIKWS 122
Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-----DAEFTPRLADFGLAKLMPG 260
           V+LR+ + +  G++Y+    NP I+H +L+  N+ L     +A    ++ADFGL++    
Sbjct: 123 VKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181
Query: 261 S---LIATSAYSAPECF--QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
           S   L+    + APE    +  SYT+K+D +SF MIL  +LTG  P    F E + G   
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKI- 236
Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
            +++  ++  G          L   + ED       +  +C S  P  RP    +V  L+
Sbjct: 237 -KFINMIREEG----------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 376 QL 377
           +L
Sbjct: 286 EL 287

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 107/203 (52%), Gaps = 31/203 (15%)
Query: 110 DGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS 165
           +G + + +L    ++G    ++ +      S E++        ++E+ VLA+++H N++ 
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES------RREVAVLANMKHPNIVQ 87
Query: 166 LRAYVPESSRFYLVYDYLQTGSLEDAMDR-----IRENQLQLGWEVRLRIAVGVIKGLQY 220
            R    E+   Y+V DY + G L   ++       +E+Q+ L W V++ +A      L++
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQICLA------LKH 140
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECF 274
           +H   + +ILH ++K  N+ L  + T +L DFG+A+++  ++      I T  Y +PE  
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 275 QNRSYTDKSDIFSFGMILAVLLT 297
           +N+ Y +KSDI++ G +L  L T
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCT 220

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 140/302 (46%), Gaps = 38/302 (12%)
Query: 91  PKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFES---GSPEKQNKSVKR- 146
           PK+    LA+ N +      GK    ++  G  V  + V A +S   G  E + + +++ 
Sbjct: 9   PKSRLPTLAD-NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 147 -RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
              Q+E+ ++++L H N++ L   +    R  +V +++  G   D   R+ +    + W 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCG---DLYHRLLDKAHPIKWS 122
Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-----DAEFTPRLADFGLAKLMPG 260
           V+LR+ + +  G++Y+    NP I+H +L+  N+ L     +A    ++ADFG ++    
Sbjct: 123 VKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH 181
Query: 261 S---LIATSAYSAPECF--QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
           S   L+    + APE    +  SYT+K+D +SF MIL  +LTG  P    F E + G   
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKI- 236
Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
            +++  ++  G          L   + ED       +  +C S  P  RP    +V  L+
Sbjct: 237 -KFINMIREEG----------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 376 QL 377
           +L
Sbjct: 286 EL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 140/302 (46%), Gaps = 38/302 (12%)
Query: 91  PKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFES---GSPEKQNKSVKR- 146
           PK+    LA+ N +      GK    ++  G  V  + V A +S   G  E + + +++ 
Sbjct: 9   PKSRLPTLAD-NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 147 -RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
              Q+E+ ++++L H N++ L   +    R  +V +++  G   D   R+ +    + W 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCG---DLYHRLLDKAHPIKWS 122
Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-----DAEFTPRLADFGLAKLMPG 260
           V+LR+ + +  G++Y+    NP I+H +L+  N+ L     +A    ++ADF L++    
Sbjct: 123 VKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH 181
Query: 261 S---LIATSAYSAPECF--QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
           S   L+    + APE    +  SYT+K+D +SF MIL  +LTG  P    F E + G   
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSYGKI- 236
Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
            +++  ++  G          L   + ED       +  +C S  P  RP    +V  L+
Sbjct: 237 -KFINMIREEG----------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 376 QL 377
           +L
Sbjct: 286 EL 287

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR--AYV 170
           Y  + DN G  VAV++++   SG P++Q     R  Q+E+++L +L    ++  R  +Y 
Sbjct: 28  YDPLGDNTGALVAVKQLQ--HSG-PDQQ-----RDFQREIQILKALHSDFIVKYRGVSYG 79
Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
           P      LV +YL +G L D + R R    +L     L  +  + KG++YL    + + +
Sbjct: 80  PGRPELRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG---SRRCV 133
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMP----GSLIATSAYS-----APECFQNRSYTD 281
           H +L   N+++++E   ++ADFGLAKL+P      ++     S     APE   +  ++ 
Sbjct: 134 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSR 193
Query: 282 KSDIFSFGMILAVLLTGRD----PTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL 337
           +SD++SFG++L  L T  D    P+A F         +    R L+   E +        
Sbjct: 194 QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPAC 253
Query: 338 GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
             EV E        +  +C + SP DRPS   L P L  L S
Sbjct: 254 PAEVHE--------LMKLCWAPSPQDRPSFSALGPQLDMLWS 287

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 22/171 (12%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLG 203
           +I++E++ L   RH +++ L   +   + F++V +Y+  G L D +    R+ E + +  
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-- 114
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSL 262
                R+   ++  + Y H      ++H +LKP NV+LDA    ++ADFGL+ +M  G  
Sbjct: 115 -----RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 263 IATSA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + TS     Y+APE    R Y   + DI+S G+IL  LL G   T PF  E
Sbjct: 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG---TLPFDDE 214

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 134/282 (47%), Gaps = 38/282 (13%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR--AYV 170
           Y  + DN G  VAV++++   SG P++Q     R  Q+E+++L +L    ++  R  +Y 
Sbjct: 31  YDPLGDNTGALVAVKQLQ--HSG-PDQQ-----RDFQREIQILKALHSDFIVKYRGVSYG 82
Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
           P      LV +YL +G L D + R R    +L     L  +  + KG++YL    + + +
Sbjct: 83  PGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG---SRRCV 136
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGS----LIATSAYS-----APECFQNRSYTD 281
           H +L   N+++++E   ++ADFGLAKL+P      ++     S     APE   +  ++ 
Sbjct: 137 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR 196
Query: 282 KSDIFSFGMILAVLLTGRD----PTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL 337
           +SD++SFG++L  L T  D    P+A F     S   +    R L+   E +        
Sbjct: 197 QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPAC 256
Query: 338 GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
             EV E        +  +C + SP DRPS   L P L  L S
Sbjct: 257 PAEVHE--------LMKLCWAPSPQDRPSFSALGPQLDMLWS 290

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 103 RLLGSSPDGKYYRTVLDNGLT---VAVRRVEAFESGSPEKQNKSVKR---RIQQELEVLA 156
           R LGS   G+       NG +   + V +   F+ G     NK++++    I  E+ +L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 157 SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGWEVRLRIAVGVI 215
           SL H N++ L     +   FYLV ++ + G L E  ++R + ++          I   ++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-----NIMKQIL 156
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPGSL-----IATSA 267
            G+ YLH      I+H ++KP N++L+ +      ++ DFGL+            + T+ 
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213
Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           Y APE  + + Y +K D++S G+I+ +LL G  P
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +S+R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR--AYV 170
           Y  + DN G  VAV++++   SG P++Q     R  Q+E+++L +L    ++  R  +Y 
Sbjct: 32  YDPLGDNTGALVAVKQLQ--HSG-PDQQ-----RDFQREIQILKALHSDFIVKYRGVSYG 83
Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
           P      LV +YL +G L D + R R    +L     L  +  + KG++YL    + + +
Sbjct: 84  PGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG---SRRCV 137
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGS----LIATSAYS-----APECFQNRSYTD 281
           H +L   N+++++E   ++ADFGLAKL+P      ++     S     APE   +  ++ 
Sbjct: 138 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR 197
Query: 282 KSDIFSFGMILAVLLTGRD----PTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL 337
           +SD++SFG++L  L T  D    P+A F         +    R L+   E +        
Sbjct: 198 QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPAC 257
Query: 338 GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
             EV E        +  +C + SP DRPS   L P L  L S
Sbjct: 258 PAEVHE--------LMKLCWAPSPQDRPSFSALGPQLDMLWS 291

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 56  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKEAKRI 111
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             E+  ++++ V++GL YL      QI+H ++KP+N+++++    +L DFG    L   M
Sbjct: 112 PEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 169
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y APE  Q   Y+ +SDI+S G+ L  L  GR P  P
Sbjct: 170 ANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 101/194 (52%), Gaps = 21/194 (10%)
Query: 137 PEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           P ++ +   +R ++E+   + L H+N++S+     E   +YLV +Y++  +L + +    
Sbjct: 47  PPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---- 102
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           E+   L  +  +     ++ G+++ H   + +I+H ++KP N+++D+  T ++ DFG+AK
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
Query: 257 LMP-------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
            +          ++ T  Y +PE  +  +  + +DI+S G++L  +L G     PF  E 
Sbjct: 160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE---PPFNGET 216
Query: 310 ASGGSLGRWLRHLQ 323
           A    +   ++H+Q
Sbjct: 217 A----VSIAIKHIQ 226

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 90/171 (52%), Gaps = 18/171 (10%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDA-MDRIREN 198
           + K+ K  + +E+++L  L H N+M L  +  +   FYLV +    G L D  + R R +
Sbjct: 71  KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 130
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLA 255
           ++        RI   V+ G+ Y+H     +I+H +LKP N++L+++      R+ DFGL+
Sbjct: 131 EVDAA-----RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 182
Query: 256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                S      I T+ Y APE     +Y +K D++S G+IL +LL+G  P
Sbjct: 183 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 133/282 (47%), Gaps = 38/282 (13%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR--AYV 170
           Y  + DN G  VAV++++   SG P++Q     R  Q+E+++L +L    ++  R  +Y 
Sbjct: 44  YDPLGDNTGALVAVKQLQ--HSG-PDQQ-----RDFQREIQILKALHSDFIVKYRGVSYG 95
Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
           P      LV +YL +G L D + R R    +L     L  +  + KG++YL    + + +
Sbjct: 96  PGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG---SRRCV 149
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGS----LIATSAYS-----APECFQNRSYTD 281
           H +L   N+++++E   ++ADFGLAKL+P      ++     S     APE   +  ++ 
Sbjct: 150 HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR 209
Query: 282 KSDIFSFGMILAVLLTGRD----PTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL 337
           +SD++SFG++L  L T  D    P+A F         +    R L+   E +        
Sbjct: 210 QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPAC 269
Query: 338 GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
             EV E        +  +C + SP DRPS   L P L  L S
Sbjct: 270 PAEVHE--------LMKLCWAPSPQDRPSFSALGPQLDMLWS 303

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 18/171 (10%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIREN 198
           + K+ K  + +E+++L  L H N+M L  +  +   FYLV +    G L ++ + R R +
Sbjct: 65  KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADFGLA 255
           ++        RI   V+ G+ Y+H     +I+H +LKP N++L++   +   R+ DFGL+
Sbjct: 125 EVDAA-----RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                S      I T+ Y APE     +Y +K D++S G+IL +LL+G  P
Sbjct: 177 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 18/171 (10%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIREN 198
           + K+ K  + +E+++L  L H N+M L  +  +   FYLV +    G L ++ + R R +
Sbjct: 88  KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 147
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLA 255
           ++        RI   V+ G+ Y+H     +I+H +LKP N++L+++      R+ DFGL+
Sbjct: 148 EVDAA-----RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 199
Query: 256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                S      I T+ Y APE     +Y +K D++S G+IL +LL+G  P
Sbjct: 200 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 249

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 52  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 111
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 112 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 165 SSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 18/171 (10%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIREN 198
           + K+ K  + +E+++L  L H N+M L  +  +   FYLV +    G L ++ + R R +
Sbjct: 89  KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 148
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLA 255
           ++        RI   V+ G+ Y+H     +I+H +LKP N++L+++      R+ DFGL+
Sbjct: 149 EVDAA-----RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 200
Query: 256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                S      I T+ Y APE     +Y +K D++S G+IL +LL+G  P
Sbjct: 201 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 250

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 51  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 110
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 111 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 163
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 164 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 50  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 110 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 162
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 163 SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 96/191 (50%), Gaps = 28/191 (14%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           V+     S + ++ S    I +E+E+L  L H N+M L   + +SS FY+V +    G L
Sbjct: 52  VKVINKASAKNKDTST---ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 189 EDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-- 243
            D +    R  E+          RI   V  G+ Y+H      I+H +LKP N++L++  
Sbjct: 109 FDEIIKRKRFSEHDAA-------RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKE 158
Query: 244 -EFTPRLADFGLAKLMPGSL-----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            +   ++ DFGL+     +      I T+ Y APE  +  +Y +K D++S G+IL +LL+
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217
Query: 298 GRDPTAPFFAE 308
           G   T PF+ +
Sbjct: 218 G---TPPFYGK 225

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 50  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 110 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 162
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 163 SSRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 22/171 (12%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLG 203
           +I++E++ L   RH +++ L   +   + F++V +Y+  G L D +    R+ E + +  
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-- 114
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSL 262
                R+   ++  + Y H      ++H +LKP NV+LDA    ++ADFGL+ +M  G  
Sbjct: 115 -----RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 263 IATSA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +  S     Y+APE    R Y   + DI+S G+IL  LL G   T PF  E
Sbjct: 167 LRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG---TLPFDDE 214

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 52  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 111
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 112 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 165 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 50  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 110 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 162
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 24/189 (12%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           V+     S + ++ S    I +E+E+L  L H N+M L   + +SS FY+V +    G L
Sbjct: 52  VKVINKASAKNKDTST---ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 189 -EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---E 244
            ++ + R R ++         RI   V  G+ Y+H      I+H +LKP N++L++   +
Sbjct: 109 FDEIIKRKRFSEHDAA-----RIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKD 160
Query: 245 FTPRLADFGLAKLMPGSL-----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR 299
              ++ DFGL+     +      I T+ Y APE  +  +Y +K D++S G+IL +LL+G 
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG- 218
Query: 300 DPTAPFFAE 308
             T PF+ +
Sbjct: 219 --TPPFYGK 225

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 44  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 103
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 104 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 156
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 157 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 46  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 105
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 106 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 158
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 159 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G +   + ++ +  
Sbjct: 52  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD 111
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 112 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 165 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 48  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 107
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 108 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 161 SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 48  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 107
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 108 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 50  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 110 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 162
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 163 SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 52  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 111
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 112 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 165 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 47  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 106
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 107 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 159
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 160 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 49  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 108
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 109 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 161
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 162 SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 86/162 (53%), Gaps = 11/162 (6%)
Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +   Q  
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ-- 134
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-- 261
                R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P S  
Sbjct: 135 -----RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 189
Query: 262 --LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 190 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 50  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 110 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 162
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G +   + ++ +  
Sbjct: 52  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFD 111
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 112 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 165 SSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 89/169 (52%), Gaps = 19/169 (11%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I +E+E+L  L H N+M L   + +SS FY+V +    G L D + + +    +      
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDA 123
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPGSL-- 262
            RI   V  G+ Y+H      I+H +LKP N++L+++      ++ DFGL+     +   
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 263 ---IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
              I T+ Y APE  +  +Y +K D++S G+IL +LL+G   T PF+ +
Sbjct: 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG---TPPFYGK 225

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 86/162 (53%), Gaps = 11/162 (6%)
Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +   Q  
Sbjct: 68  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ-- 125
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-- 261
                R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P S  
Sbjct: 126 -----RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 180
Query: 262 --LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 181 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 86/162 (53%), Gaps = 11/162 (6%)
Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +   Q  
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ-- 134
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-- 261
                R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P S  
Sbjct: 135 -----RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 189
Query: 262 --LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 190 DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 16/165 (9%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +I++E++ L   RH +++ L   +   S  ++V +Y+  G L    D I +N  +L  + 
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL---FDYICKNG-RLDEKE 117
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSLIAT 265
             R+   ++ G+ Y H      ++H +LKP NV+LDA    ++ADFGL+ +M  G  +  
Sbjct: 118 SRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRX 174
Query: 266 SA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDPTAPF 305
           S     Y+APE    R Y   + DI+S G+IL  LL G   T PF
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG---TLPF 216

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 48  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 107
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 108 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP 160
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 161 SSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 31/233 (13%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGK-----YYRTVLDNGLTVAVRRVEAFESGSPEKQ 140
           SP  DP         + R LG    GK     Y  T    G  VAV+ ++A     P+ +
Sbjct: 3   SPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--DCGPQHR 60
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR--FYLVYDYLQTGSLEDAMDRIREN 198
           +       +QE+++L +L H +++  +    +       LV +Y+  GSL D + R    
Sbjct: 61  SG-----WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG 115
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
             QL     L  A  + +G+ YLH   +   +H NL   NV+LD +   ++ DFGLAK +
Sbjct: 116 LAQL-----LLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 259 PGSL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT 302
           P             +   + APEC +   +   SD++SFG+ L  LLT  D +
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 220

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 29/226 (12%)
Query: 88  KIDPKTLQAALANENRLLGSSPDGKY----YRTVLDN-GLTVAVRRVEAFESGSPEKQNK 142
           ++DP   +       R LG    GK     Y    DN G  VAV+ ++  ESG     + 
Sbjct: 12  EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP-ESGGNHIAD- 69
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYLVYDYLQTGSLEDAMDRIRENQL 200
                +++E+E+L +L H N++  +    E   +   L+ ++L +GSL++ + +   N+ 
Sbjct: 70  -----LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKN 121
Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
           ++  + +L+ AV + KG+ YL    + Q +H +L   NV++++E   ++ DFGL K +  
Sbjct: 122 KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 261 SLIATSA---------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                +          + APEC     +   SD++SFG+ L  LLT
Sbjct: 179 DKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 101
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 102 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 101
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 102 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKY----YRTVLDN-GLTVAVRRVEAFESGSPEKQNKS 143
           +DP   +       R LG    GK     Y    DN G  VAV+ ++  ESG     +  
Sbjct: 1   VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP-ESGGNHIAD-- 57
Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYLVYDYLQTGSLEDAMDRIRENQLQ 201
               +++E+E+L +L H N++  +    E   +   L+ ++L +GSL++ + +   N+ +
Sbjct: 58  ----LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNK 110
Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS 261
           +  + +L+ AV + KG+ YL    + Q +H +L   NV++++E   ++ DFGL K +   
Sbjct: 111 INLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 167
Query: 262 LIATSA---------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
               +          + APEC     +   SD++SFG+ L  LLT
Sbjct: 168 KEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 101
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 102 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 101
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 102 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 108 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 163
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 164 PEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 221
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P
Sbjct: 222 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 89/173 (51%), Gaps = 10/173 (5%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 101
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 102 PEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS 311
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P  A+  S
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDS 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 73  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 128
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 129 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++    
Sbjct: 51  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD 110
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 111 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP 163
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G  P
Sbjct: 164 SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++    
Sbjct: 51  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFD 110
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++ADFG +   P
Sbjct: 111 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP 163
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G  P
Sbjct: 164 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 50  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 109
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++A+FG +   P
Sbjct: 110 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP 162
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 163 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 31/233 (13%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGK-----YYRTVLDNGLTVAVRRVEAFESGSPEKQ 140
           SP  DP         + R LG    GK     Y  T    G  VAV+ ++A     P+ +
Sbjct: 3   SPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--DCGPQHR 60
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR--FYLVYDYLQTGSLEDAMDRIREN 198
           +       +QE+++L +L H +++  +    +       LV +Y+  GSL D + R    
Sbjct: 61  SG-----WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG 115
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
             QL     L  A  + +G+ YLH       +H NL   NV+LD +   ++ DFGLAK +
Sbjct: 116 LAQL-----LLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 259 PGSL---------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT 302
           P             +   + APEC +   +   SD++SFG+ L  LLT  D +
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 220

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++   + ++ +  
Sbjct: 49  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD 108
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    L +  + +++H ++KP N++L +    ++A+FG +   P
Sbjct: 109 EQ-------RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP 161
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    L  T  Y  PE  + R + +K D++S G++    L G+ P
Sbjct: 162 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 104 LLGSSPDGKYYRT-VLDNGLTVAVRRVEA---FESGSPEKQNKSVKRRIQQELEVLASLR 159
           LLG       YR   +  GL VA++ ++    +++G        + +R+Q E+++   L+
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--------MVQRVQNEVKIHCQLK 69
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGL 218
           H +++ L  Y  +S+  YLV +    G     M+R  +N+++   E   R     +I G+
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGE----MNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPG----SLIATSAYSAPE 272
            YLH   +  ILH +L  +N++L      ++ADFGLA    MP     +L  T  Y +PE
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 273 CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  +SD++S G +   LL GR P
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 101/191 (52%), Gaps = 31/191 (16%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS----LRAYVPESSR-FYL 178
           VA++++  FE       +++  +R  +E+++L   RH N++     LRA   E+ R  Y+
Sbjct: 71  VAIKKISPFE-------HQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYI 123
Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V D ++T      + ++ ++Q QL  +        +++GL+Y+H   +  +LH +LKP+N
Sbjct: 124 VQDLMETD-----LYKLLKSQ-QLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSN 174
Query: 239 VMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSDIFSF 288
           ++++     ++ DFGLA++              +AT  Y APE   N + YT   DI+S 
Sbjct: 175 LLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSV 234
Query: 289 GMILAVLLTGR 299
           G ILA +L+ R
Sbjct: 235 GCILAEMLSNR 245

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 77  PIIKGPVIF--SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFE 133
           P    P I+  SP  D   ++         LG    G+ Y  V     LTVAV+ +    
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---- 253
Query: 134 SGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMD 193
                K++        +E  V+  ++H NL+ L         FY++ +++  G+L   +D
Sbjct: 254 -----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LD 305
Query: 194 RIRE-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
            +RE N+ ++   V L +A  +   ++YL        +H NL   N ++      ++ADF
Sbjct: 306 YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADF 362
Query: 253 GLAKLMPGSLIATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           GL++LM G      A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 31/236 (13%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGK-----YYRTVLDNGLTVAVRRVEAFESGSP 137
           V+F    DP         + R LG    GK     Y  T    G  VAV+ ++A     P
Sbjct: 17  VLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--DAGP 74
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYLVYDYLQTGSLEDAMDRI 195
           + ++       +QE+++L +L H +++  +    ++  +   LV +Y+  GSL D + R 
Sbjct: 75  QHRSG-----WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH 129
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA 255
                QL     L  A  + +G+ YLH       +H +L   NV+LD +   ++ DFGLA
Sbjct: 130 SIGLAQL-----LLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 256 KLMPGSLIATSA---------YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT 302
           K +P                 + APEC +   +   SD++SFG+ L  LLT  D +
Sbjct: 182 KAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 145 KRRIQQELEVLASLRHRNLMSL--RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           K+ +  E+ +L  L+H N++    R     ++  Y+V +Y + G L   + +  + +  L
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCN--PQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-- 258
             E  LR+   +   L+  H   +    +LH +LKP NV LD +   +L DFGLA+++  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 259 ----PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
                 + + T  Y +PE     SY +KSDI+S G +L  L     P   F  +  +G
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 145 KRRIQQELEVLASLRHRNLMSL--RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           K+ +  E+ +L  L+H N++    R     ++  Y+V +Y + G L   + +  + +  L
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCN--PQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-- 258
             E  LR+   +   L+  H   +    +LH +LKP NV LD +   +L DFGLA+++  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 259 ----PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
                 + + T  Y +PE     SY +KSDI+S G +L  L     P   F  +  +G
Sbjct: 169 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 98/193 (50%), Gaps = 21/193 (10%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
           D G  VA+++    ES      +K VK+   +E+++L  LRH NL++L     +  R+YL
Sbjct: 48  DTGRIVAIKKF--LESDD----DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101
Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V++++    L+D    +  N L   ++V  +    +I G+ + H   +  I+H ++KP N
Sbjct: 102 VFEFVDHTILDDL--ELFPNGLD--YQVVQKYLFQIINGIGFCH---SHNIIHRDIKPEN 154
Query: 239 VMLDAEFTPRLADFGLAKLM--PGSL----IATSAYSAPECF-QNRSYTDKSDIFSFGMI 291
           +++      +L DFG A+ +  PG +    +AT  Y APE    +  Y    D+++ G +
Sbjct: 155 ILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCL 214
Query: 292 LAVLLTGRDPTAP 304
           +  +  G +P  P
Sbjct: 215 VTEMFMG-EPLFP 226

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 90/181 (49%), Gaps = 19/181 (10%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VA+++++    G   +    + R   +E+++L  L H N++ L       S   LV+D++
Sbjct: 38  VAIKKIKL---GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA 243
           +T    D    I++N L L         +  ++GL+YLH      ILH +LKP N++LD 
Sbjct: 95  ET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDE 147
Query: 244 EFTPRLADFGLAKLMPGS-------LIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVL 295
               +LADFGLAK   GS        + T  Y APE  F  R Y    D+++ G ILA L
Sbjct: 148 NGVLKLADFGLAKSF-GSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 296 L 296
           L
Sbjct: 207 L 207

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 77  PIIKGPVIF--SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFE 133
           P    P ++  SP  D   ++         LG    G+ Y  V     LTVAV+ +    
Sbjct: 237 PKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---- 292
Query: 134 SGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMD 193
                K++        +E  V+  ++H NL+ L         FY++ +++  G+L   +D
Sbjct: 293 -----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LD 344
Query: 194 RIRE-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
            +RE N+ ++   V L +A  +   ++YL        +H NL   N ++      ++ADF
Sbjct: 345 YLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADF 401
Query: 253 GLAKLMPGSLIATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           GL++LM G      A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 402 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           ++ E+ VL  ++H N+++L          YL+   +  G L    DRI E       +  
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDAS 119
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM---LDAEFTPRLADFGLAKLM-PGSLI 263
            R+   V+  ++YLH   +  I+H +LKP N++   LD +    ++DFGL+K+  PGS++
Sbjct: 120 -RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 264 ATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +T+     Y APE    + Y+   D +S G+I  +LL G     PF+ E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG---YPPFYDE 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 49  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 104
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 105 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM 162
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
               + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P 
Sbjct: 163 ANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 89/171 (52%), Gaps = 18/171 (10%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIREN 198
           + K+ K  + +E+++L  L H N+  L  +  +   FYLV +    G L ++ + R R +
Sbjct: 65  KQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLA 255
           ++        RI   V+ G+ Y H     +I+H +LKP N++L+++      R+ DFGL+
Sbjct: 125 EVDAA-----RIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                S      I T+ Y APE     +Y +K D++S G+IL +LL+G  P
Sbjct: 177 THFEASKKXKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           ++ E+ VL  ++H N+++L          YL+   +  G L    DRI E       +  
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDAS 119
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM---LDAEFTPRLADFGLAKLM-PGSLI 263
            R+   V+  ++YLH   +  I+H +LKP N++   LD +    ++DFGL+K+  PGS++
Sbjct: 120 -RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 264 ATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +T+     Y APE    + Y+   D +S G+I  +LL G     PF+ E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG---YPPFYDE 221

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           ++ E+ VL  ++H N+++L          YL+   +  G L    DRI E       +  
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDAS 119
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM---LDAEFTPRLADFGLAKLM-PGSLI 263
            R+   V+  ++YLH   +  I+H +LKP N++   LD +    ++DFGL+K+  PGS++
Sbjct: 120 -RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 264 ATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +T+     Y APE    + Y+   D +S G+I  +LL G     PF+ E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG---YPPFYDE 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 10/178 (5%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPE--SSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           K+ +  E+ +L  L+H N++     + +  ++  Y+V +Y + G L   + +  + +  L
Sbjct: 49  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCN--PQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-- 258
             E  LR+   +   L+  H   +    +LH +LKP NV LD +   +L DFGLA+++  
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 259 ----PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
                   + T  Y +PE     SY +KSDI+S G +L  L     P   F  +  +G
Sbjct: 169 DEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 86/169 (50%), Gaps = 18/169 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           ++ E+ VL  ++H N+++L          YL+   +  G L    DRI E       +  
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKGFYTERDAS 119
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM---LDAEFTPRLADFGLAKLM-PGSLI 263
            R+   V+  ++YLH   +  I+H +LKP N++   LD +    ++DFGL+K+  PGS++
Sbjct: 120 -RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 264 ATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +T+     Y APE    + Y+   D +S G+I  +LL G     PF+ E
Sbjct: 176 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG---YPPFYDE 221

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/318 (22%), Positives = 139/318 (43%), Gaps = 37/318 (11%)
Query: 75  QTPIIKGPVI--FSPK--IDPKTLQAALAN--ENRLLGSSPDGKYYRT-VLDNGLTVAVR 127
           Q+  ++GP +  F P+  + P      LAN    + +G     + YR   L +G+ VA++
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALK 63
Query: 128 RVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGS 187
           +V+ F+    + +   +K     E+++L  L H N++   A   E +   +V +    G 
Sbjct: 64  KVQIFDLMDAKARADCIK-----EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118
Query: 188 LEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP 247
           L   +   ++ +  +      +  V +   L+++H   + +++H ++KP NV + A    
Sbjct: 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV 175
Query: 248 RLADFGLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           +L D GL +          SL+ T  Y +PE      Y  KSDI+S G +L  +   +  
Sbjct: 176 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ-- 233
Query: 302 TAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSP 361
            +PF+ +  +  SL + +          E  D   L  +   +E+   V +   C++  P
Sbjct: 234 -SPFYGDKMNLYSLCKKI----------EQCDYPPLPSDHYSEELRQLVNM---CINPDP 279
Query: 362 ADRPSSDELVPMLTQLHS 379
             RP    +  +  ++H+
Sbjct: 280 EKRPDVTYVYDVAKRMHA 297

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA+R++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 51  NKVRVAIRKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 104 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 154
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 215 IWSVGCILAEMLSNR-PIFP 233

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 85/165 (51%), Gaps = 10/165 (6%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +++ +I +EL+VL       ++             +  +++  GSL    D++ +   ++
Sbjct: 65  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL----DQVLKKAGRI 120
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLM 258
             ++  ++++ VIKGL YL      +I+H ++KP+N+++++    +L DFG    L   M
Sbjct: 121 PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 178
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
             S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  
Sbjct: 179 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 18/168 (10%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQ 201
           S   ++ +E+ VL  L H N+M L  +  +   +YLV +  + G L ++ + R++ N++ 
Sbjct: 78  SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD 137
Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLM 258
                   I   V+ G+ YLH      I+H +LKP N++L+++      ++ DFGL+ + 
Sbjct: 138 AAV-----IIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189
Query: 259 PG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                    + T+ Y APE  + + Y +K D++S G+IL +LL G  P
Sbjct: 190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 52
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 53  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL---LDYLRECNRQEVS 109
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 110 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L + RH N++ +    RA   E  +
Sbjct: 49  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMK 101
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 102 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 152
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 153 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 212
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 213 IWSVGCILAEMLSNR-PIFP 231

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 23/174 (13%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           ++ E+ VL  ++H N+++L      ++ +YLV   +  G L    DRI E  +    +  
Sbjct: 53  LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL---FDRILERGVYTEKDAS 109
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR------LADFGLAKLMPGS 261
           L I   V+  ++YLH      I+H +LKP N++     TP       + DFGL+K+    
Sbjct: 110 LVIQ-QVLSAVKYLH---ENGIVHRDLKPENLLY---LTPEENSKIMITDFGLSKMEQNG 162
Query: 262 LIATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS 311
           +++T+     Y APE    + Y+   D +S G+I  +LL G     PF+ E  S
Sbjct: 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY---PPFYEETES 213

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 52
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 53  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL---LDYLRECNRQEVS 109
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 110 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 52
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 53  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVS 109
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 110 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 53
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 54  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL---LDYLRECNRQEVN 110
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 111 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX 167
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 168 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 57
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 114
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 51  NKVRVAIKKISPFE-------HQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 104 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 154
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 155 KPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 215 IWSVGCILAEMLSNR-PIFP 233

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 54
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 55  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 111
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 112 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 168
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 169 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 24/245 (9%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +++S ++    EL  L+ + H N++ L  Y    +   LV +Y + GSL + +       
Sbjct: 41  ESESERKAFIVELRQLSRVNHPNIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLP 98
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM 258
                   +   +   +G+ YLH      ++H +LKP N++L A  T  ++ DFG A  +
Sbjct: 99  YYTAAHA-MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 157
Query: 259 PGSLI---ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
              +     ++A+ APE F+  +Y++K D+FS+G+IL  ++T R P    F E       
Sbjct: 158 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFR 213
Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
             W  H        + L + I        E LM       C S  P+ RPS +E+V ++T
Sbjct: 214 IMWAVHNGTRPPLIKNLPKPI--------ESLM-----TRCWSKDPSQRPSMEEIVKIMT 260
Query: 376 QLHSF 380
            L  +
Sbjct: 261 HLMRY 265

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 52
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 53  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVS 109
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 110 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 26/176 (14%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           ++  +R   +E++V+  L H N++     + +  R   + +Y++ G+L      I+    
Sbjct: 47  DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGI---IKSMDS 103
Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
           Q  W  R+  A  +  G+ YLH   +  I+H +L   N ++       +ADFGLA+LM  
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160
Query: 261 --------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLL 296
                               +++    + APE    RSY +K D+FSFG++L  ++
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 112/245 (45%), Gaps = 24/245 (9%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +++S ++    EL  L+ + H N++ L  Y    +   LV +Y + GSL + +       
Sbjct: 40  ESESERKAFIVELRQLSRVNHPNIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLP 97
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM 258
                   +   +   +G+ YLH      ++H +LKP N++L A  T  ++ DFG A  +
Sbjct: 98  YYTAAHA-MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156
Query: 259 PGSLI---ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
              +     ++A+ APE F+  +Y++K D+FS+G+IL  ++T R P    F E       
Sbjct: 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFR 212
Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
             W  H        + L + I        E LM       C S  P+ RPS +E+V ++T
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPI--------ESLM-----TRCWSKDPSQRPSMEEIVKIMT 259
Query: 376 QLHSF 380
            L  +
Sbjct: 260 HLMRY 264

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 52
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 53  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 109
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 110 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
              A       ++APE      ++ KSD+++FG++L  + T G  P
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 57
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 114
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX 171
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 57
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL---LDYLRECNRQEVN 114
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 15  SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 65
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 66  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 122
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 123 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 179
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 180 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 2   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 52
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 53  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 109
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 110 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
              A       ++APE      ++ KSD+++FG++L  + T G  P
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 57
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVS 114
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 56
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 57  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 113
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 114 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 3   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 53
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 54  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 110
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 111 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 167
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 168 TAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 101/195 (51%), Gaps = 31/195 (15%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L + RH N++ +    RA   E  +
Sbjct: 49  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMK 101
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 102 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 152
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 153 KPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 212
Query: 285 IFSFGMILAVLLTGR 299
           I+S G ILA +L+ R
Sbjct: 213 IWSVGCILAEMLSNR 227

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 4   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 54
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 55  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 111
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 112 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 168
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 169 TAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
           SP  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 7   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 57
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 114
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           RLL +   G + +  L      G  VAVR ++        + N S  +++ +E+ ++  L
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK------TQLNSSSLQKLFREVRIMKVL 70
Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVI 215
            H N++ L   +      YLV +Y   G + D   A  R++E + +  +         ++
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-------QIV 123
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
             +QY H      I+H +LK  N++LDA+   ++ADFG +          +   +  Y+A
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 271 PECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
           PE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 51  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 104 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 154
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 155 KPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 215 IWSVGCILAEMLSNR-PIFP 233

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 55  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 107
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 108 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 158
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 159 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 218
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 219 IWSVGCILAEMLSNR-PIFP 237

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 47  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 99
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 100 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 150
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 151 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 210
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 211 IWSVGCILAEMLSNR-PIFP 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 47  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 99
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 100 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 150
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 151 KPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 210
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 211 IWSVGCILAEMLSNR-PIFP 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 52  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 104
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 105 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 155
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 156 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 215
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 216 IWSVGCILAEMLSNR-PIFP 234

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 53  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 105
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 106 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 156
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 157 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 216
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 217 IWSVGCILAEMLSNR-PIFP 235

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 44  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 96
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 97  DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 147
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 148 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 207
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 208 IWSVGCILAEMLSNR-PIFP 226

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 51  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 104 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 154
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 215 IWSVGCILAEMLSNR-PIFP 233

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 49  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 101
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 102 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 152
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 153 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 212
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 213 IWSVGCILAEMLSNR-PIFP 231

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 45  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 97
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 98  DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 148
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 149 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 208
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 209 IWSVGCILAEMLSNR-PIFP 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 47  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 99
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 100 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 150
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 151 KPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 210
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 211 IWSVGCILAEMLSNR-PIFP 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 47  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 99
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 100 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 150
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 151 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 210
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 211 IWSVGCILAEMLSNR-PIFP 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 51  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 104 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 154
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSID 214
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 215 IWSVGCILAEMLSNR-PIFP 233

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 52  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 104
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 105 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 155
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 156 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSID 215
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 216 IWSVGCILAEMLSNR-PIFP 234

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 45  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 97
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 98  DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 148
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 149 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 208
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 209 IWSVGCILAEMLSNR-PIFP 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 67  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 119
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 120 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 170
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 171 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 230
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 231 IWSVGCILAEMLSNR-PIFP 249

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAY-VPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           +N +  +    E  V+  LRH NL+ L    V E    Y+V +Y+  GSL D + R R  
Sbjct: 53  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGR 111
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
            + LG +  L+ ++ V + ++YL        +H +L   NV++  +   +++DFGL K  
Sbjct: 112 SV-LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167
Query: 259 PGSLIATS---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
             +         ++APE  + + ++ KSD++SFG++L  + + GR P
Sbjct: 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           ++G    GK YR     G  VAV+         P++        ++QE ++ A L+H N+
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARH----DPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           ++LR    +     LV ++ + G L   +   R     +  ++ +  AV + +G+ YLH 
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHD 123
Query: 224 TCNPQILHYNLKPTNVML-----DAEFTPRL---ADFGLAK----LMPGSLIATSAYSAP 271
                I+H +LK +N+++     + + + ++    DFGLA+        S     A+ AP
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAP 183
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           E  +   ++  SD++S+G++L  LLTG  P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 14/161 (8%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           R+++E+  L  LRH +++ L   +   +   +V +Y   G L    D I E +     E 
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGEL---FDYIVEKKRMTEDEG 110
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGSLIAT 265
           R R    +I  ++Y H     +I+H +LKP N++LD     ++ADFGL+ +M  G+ + T
Sbjct: 111 R-RFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166
Query: 266 SA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
           S     Y+APE    + Y   + D++S G++L V+L GR P
Sbjct: 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 47  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 99
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 100 DVYIVQDLMETD-----LYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 150
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 151 KPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 210
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 211 IWSVGCILAEMLSNR-PIFP 229

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAY-VPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           +N +  +    E  V+  LRH NL+ L    V E    Y+V +Y+  GSL D + R R  
Sbjct: 38  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGR 96
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
            + LG +  L+ ++ V + ++YL        +H +L   NV++  +   +++DFGL K  
Sbjct: 97  SV-LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152
Query: 259 PGSLIATS---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
             +         ++APE  + + ++ KSD++SFG++L  + + GR P
Sbjct: 153 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           RLL +   G + +  L      G  VAVR ++        + N S  +++ +E+ ++  L
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK------TQLNSSSLQKLFREVRIMKVL 70
Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVI 215
            H N++ L   +      YLV +Y   G + D   A  R++E + +  +         ++
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-------QIV 123
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
             +QY H      I+H +LK  N++LDA+   ++ADFG +              +  Y+A
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 271 PECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
           PE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 91/172 (52%), Gaps = 23/172 (13%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS-----RFYLVYDYLQT--GSLEDA 191
           Q++   +R  +EL +L  +RH N++ L   + P+ +      FYLV  ++ T  G L   
Sbjct: 63  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-K 121
Query: 192 MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
            +++ E+++Q        +   ++KGL+Y+H      I+H +LKP N+ ++ +   ++ D
Sbjct: 122 HEKLGEDRIQF-------LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD 171
Query: 252 FGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
           FGLA+     +   + T  Y APE   N   YT   DI+S G I+A ++TG+
Sbjct: 172 FGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 32/200 (16%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL----RAYVPESSR 175
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +    RA   E  +
Sbjct: 51  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
             Y+V D ++T      + ++ + Q  L  +        +++GL+Y+H   +  +LH +L
Sbjct: 104 DVYIVQDLMETD-----LYKLLKCQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDL 154
Query: 235 KPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSD 284
           KP+N++L+     ++ DFGLA++              +AT  Y APE   N + YT   D
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214
Query: 285 IFSFGMILAVLLTGRDPTAP 304
           I+S G ILA +L+ R P  P
Sbjct: 215 IWSVGCILAEMLSNR-PIFP 233

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 59  GLRVAVKKL------SKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 112
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 113 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 168
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 169 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 296 LTGR 299
           LTGR
Sbjct: 229 LTGR 232

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAY-VPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           +N +  +    E  V+  LRH NL+ L    V E    Y+V +Y+  GSL D + R R  
Sbjct: 225 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGR 283
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
            + LG +  L+ ++ V + ++YL        +H +L   NV++  +   +++DFGL K  
Sbjct: 284 SV-LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 259 PGSLIATS---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
             +         ++APE  + + ++ KSD++SFG++L  + + GR P
Sbjct: 340 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 105 LGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H NL
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLH 222
           + L         FY++ +++  G+L   +D +RE N+ ++   V L +A  +   ++YL 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQ 275
                  +H +L   N ++      ++ADFGL++LM G      A       ++APE   
Sbjct: 127 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLA 183
Query: 276 NRSYTDKSDIFSFGMILAVLLT-------GRDPTAPF 305
              ++ KSD+++FG++L  + T       G DP+  +
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 86  SPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSV 144
            P  D   ++         LG    G+ Y  V     LTVAV+ +         K++   
Sbjct: 4   DPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTME 54
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLG 203
                +E  V+  ++H NL+ L         FY++ +++  G+L   +D +RE N+ ++ 
Sbjct: 55  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVN 111
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
             V L +A  +   ++YL        +H +L   N ++      ++ADFGL++LM G   
Sbjct: 112 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 168
Query: 264 ATSA-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              A       ++APE      ++ KSD+++FG++L  + T
Sbjct: 169 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 98/195 (50%), Gaps = 22/195 (11%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
           N + VA++++  FE       +++  +R  +E+++L   RH N++ +   +   +   + 
Sbjct: 67  NKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 119
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   + ++ + Q  L  +        +++GL+Y+H   +  +LH +LKP+N+
Sbjct: 120 DVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNL 175
Query: 240 MLDAEFTPRLADFGLAKLMP---------GSLIATSAYSAPECFQN-RSYTDKSDIFSFG 289
           +L+     ++ DFGLA++              +AT  Y APE   N + YT   DI+S G
Sbjct: 176 LLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 235
Query: 290 MILAVLLTGRDPTAP 304
            ILA +L+ R P  P
Sbjct: 236 CILAEMLSNR-PIFP 249

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 105 LGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H NL
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLH 222
           + L         FY++ +++  G+L   +D +RE N+ ++   V L +A  +   ++YL 
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNL---LDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQ 275
                  +H +L   N ++      ++ADFGL++LM G      A       ++APE   
Sbjct: 127 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 276 NRSYTDKSDIFSFGMILAVLLT-------GRDPTAPF 305
              ++ KSD+++FG++L  + T       G DP+  +
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           RLL +   G + +  L      G  VAV+ ++        + N S  +++ +E+ ++  L
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK------TQLNSSSLQKLFREVRIMKVL 70
Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVI 215
            H N++ L   +      YLV +Y   G + D   A  R++E + +  +         ++
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-------QIV 123
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
             +QY H      I+H +LK  N++LDA+   ++ADFG +          +   +  Y+A
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 271 PECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
           PE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 54  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 163
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 296 LTGR 299
           LTGR
Sbjct: 224 LTGR 227

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 92  KTLQAALANENRLLGSSPDGK--YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           + ++A+  +  +++GS   G+  Y R  +     V V  ++A ++G  E+Q    +R   
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA-IKALKAGYTERQ----RRDFL 98
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E  ++    H N++ L   V       +V +Y++ GSL D   R  + Q  +   V + 
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGML 157
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM---PGSLIATS 266
             VG   G++YL    +   +H +L   NV++D+    +++DFGL++++   P +   T+
Sbjct: 158 RGVGA--GMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 267 A------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                  ++APE    R+++  SD++SFG+++  VL  G  P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           RLL +   G + +  L      G  VAV+ ++        + N S  +++ +E+ ++  L
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK------TQLNSSSLQKLFREVRIMKVL 70
Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVI 215
            H N++ L   +      YLV +Y   G + D   A  R++E + +  +         ++
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-------QIV 123
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
             +QY H      I+H +LK  N++LDA+   ++ADFG +          +   +  Y+A
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 271 PECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
           PE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 44  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 97
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 98  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 153
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 154 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213
Query: 296 LTGR 299
           LTGR
Sbjct: 214 LTGR 217

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 52  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 105
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 106 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 161
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 162 AVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 296 LTGR 299
           LTGR
Sbjct: 222 LTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 58  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 111
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 112 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 167
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 168 AVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227
Query: 296 LTGR 299
           LTGR
Sbjct: 228 LTGR 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQNR-SYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 32  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 83
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 84  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 135
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H NL   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 136 YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 195
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 196 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 54  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 163
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 296 LTGR 299
           LTGR
Sbjct: 224 LTGR 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 52  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 105
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 106 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 161
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 162 AVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 296 LTGR 299
           LTGR
Sbjct: 222 LTGR 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 110/222 (49%), Gaps = 23/222 (10%)
Query: 92  KTLQAALANENRLLGSSPDGK--YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           + ++A+  +  +++GS   G+  Y R  +     V V  ++A ++G  E+Q    +R   
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA-IKALKAGYTERQ----RRDFL 98
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E  ++    H N++ L   V       +V +Y++ GSL D   R  + Q  +   V + 
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGML 157
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM---PGSLIATS 266
             VG   G++YL    +   +H +L   NV++D+    +++DFGL++++   P +   T+
Sbjct: 158 RGVGA--GMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTT 212
Query: 267 A------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                  ++APE    R+++  SD++SFG+++  VL  G  P
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 54  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 163
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 296 LTGR 299
           LTGR
Sbjct: 224 LTGR 227

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 70  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 123
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 124 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 179
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 180 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 296 LTGR 299
           LTGR
Sbjct: 240 LTGR 243

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 52  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 105
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 106 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 161
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 162 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 296 LTGR 299
           LTGR
Sbjct: 222 LTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 46  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 99
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 100 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 155
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 156 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 215
Query: 296 LTGR 299
           LTGR
Sbjct: 216 LTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 53  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 106
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 107 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 162
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 163 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 296 LTGR 299
           LTGR
Sbjct: 223 LTGR 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 54  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 108 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 163
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 164 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 296 LTGR 299
           LTGR
Sbjct: 224 LTGR 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 44  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 97
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 98  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 153
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 154 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 213
Query: 296 LTGR 299
           LTGR
Sbjct: 214 LTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 45  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 98
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 99  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 154
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 155 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 214
Query: 296 LTGR 299
           LTGR
Sbjct: 215 LTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 43  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 97  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 152
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 153 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 296 LTGR 299
           LTGR
Sbjct: 213 LTGR 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 58  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 111
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 112 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 167
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 168 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 227
Query: 296 LTGR 299
           LTGR
Sbjct: 228 LTGR 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 52  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 105
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 106 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 161
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 162 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 221
Query: 296 LTGR 299
           LTGR
Sbjct: 222 LTGR 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 87/170 (51%), Gaps = 19/170 (11%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRE 197
           N +  +++ +E+ ++  L H N++ L   +      YL+ +Y   G + D   A  R++E
Sbjct: 54  NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE 113
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK- 256
            + +  +         ++  +QY H     +I+H +LK  N++LDA+   ++ADFG +  
Sbjct: 114 KEARSKFR-------QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163
Query: 257 -LMPGSLIATSA---YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
             + G L A      Y+APE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 164 FTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 49  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 102
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 103 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 158
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 159 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 296 LTGR 299
           LTGR
Sbjct: 219 LTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 49  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 102
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 103 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 158
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 159 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 296 LTGR 299
           LTGR
Sbjct: 219 LTGR 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 70  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 123
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 124 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 179
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 180 AVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 239
Query: 296 LTGR 299
           LTGR
Sbjct: 240 LTGR 243

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 67  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 120
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 121 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 176
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 177 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 236
Query: 296 LTGR 299
           LTGR
Sbjct: 237 LTGR 240

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 18/177 (10%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           RI++E+  L  LRH +++ L   +       +V +Y    +  +  D I +       E 
Sbjct: 60  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEA 115
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGSLIAT 265
           R R    +I  ++Y H     +I+H +LKP N++LD     ++ADFGL+ +M  G+ + T
Sbjct: 116 R-RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 171
Query: 266 SA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGR----DPTAPFFAEAASGG 313
           S     Y+APE    + Y   + D++S G+IL V+L  R    D + P   +  S G
Sbjct: 172 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 228

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 18/177 (10%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           RI++E+  L  LRH +++ L   +       +V +Y    +  +  D I +       E 
Sbjct: 59  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEA 114
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSLIAT 265
           R R    +I  ++Y H     +I+H +LKP N++LD     ++ADFGL+ +M  G+ + T
Sbjct: 115 R-RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170
Query: 266 SA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGR----DPTAPFFAEAASGG 313
           S     Y+APE    + Y   + D++S G+IL V+L  R    D + P   +  S G
Sbjct: 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 59  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 112
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 113 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 168
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 169 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 296 LTGR 299
           LTGR
Sbjct: 229 LTGR 232

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 49  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 102
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 103 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 158
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 159 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 296 LTGR 299
           LTGR
Sbjct: 219 LTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 59  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 112
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 113 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 168
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 169 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 228
Query: 296 LTGR 299
           LTGR
Sbjct: 229 LTGR 232

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 105 LGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H NL
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLH 222
           + L         FY+V +Y+  G+L   +D +RE N+ ++   V L +A  +   ++YL 
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNL---LDYLRECNREEVTAVVLLYMATQISSAMEYLE 147
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQ 275
                  +H +L   N ++      ++ADFGL++LM G      A       ++APE   
Sbjct: 148 ---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 204
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
             +++ KSD+++FG++L  + T G  P
Sbjct: 205 YNTFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAY-VPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           +N +  +    E  V+  LRH NL+ L    V E    Y+V +Y+  GSL D + R R  
Sbjct: 44  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGR 102
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
            + LG +  L+ ++ V + ++YL        +H +L   NV++  +   +++DFGL K  
Sbjct: 103 SV-LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 158
Query: 259 PGSLIATS---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
             +         ++APE  +  +++ KSD++SFG++L  + + GR P
Sbjct: 159 SSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 53  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 106
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 107 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 162
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 163 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 296 LTGR 299
           LTGR
Sbjct: 223 LTGR 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 18/177 (10%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           RI++E+  L  LRH +++ L   +       +V +Y    +  +  D I +       E 
Sbjct: 54  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEA 109
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGSLIAT 265
           R R    +I  ++Y H     +I+H +LKP N++LD     ++ADFGL+ +M  G+ + T
Sbjct: 110 R-RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 165
Query: 266 SA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGR----DPTAPFFAEAASGG 313
           S     Y+APE    + Y   + D++S G+IL V+L  R    D + P   +  S G
Sbjct: 166 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 222

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 18/177 (10%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           RI++E+  L  LRH +++ L   +       +V +Y    +  +  D I +       E 
Sbjct: 50  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY----AGNELFDYIVQRDKMSEQEA 105
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GSLIAT 265
           R R    +I  ++Y H     +I+H +LKP N++LD     ++ADFGL+ +M  G+ + T
Sbjct: 106 R-RFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 161
Query: 266 SA----YSAPECFQNRSYTD-KSDIFSFGMILAVLLTGR----DPTAPFFAEAASGG 313
           S     Y+APE    + Y   + D++S G+IL V+L  R    D + P   +  S G
Sbjct: 162 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 218

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 105 LGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H NL
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLH 222
           + L         FY++ +++  G+L   +D +RE N+ ++   V L +A  +   ++YL 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNL---LDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQ 275
                  +H +L   N ++      ++ADFGL++LM G      A       ++APE   
Sbjct: 127 ---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLA 183
Query: 276 NRSYTDKSDIFSFGMILAVLLT-------GRDPTAPF 305
              ++ KSD+++FG++L  + T       G DP+  +
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVY 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 66  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 119
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 120 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 175
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 176 AVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 235
Query: 296 LTGR 299
           LTGR
Sbjct: 236 LTGR 239

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 53  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 106
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 107 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 162
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 163 AVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 222
Query: 296 LTGR 299
           LTGR
Sbjct: 223 LTGR 226

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           RLL +   G + +  L      G  VAV+ ++        + N S  +++ +E+ ++  L
Sbjct: 10  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK------TQLNSSSLQKLFREVRIMKVL 63
Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW----EVRLRIAVGV 214
            H N++ L   +      YLV +Y   G + D +       +  GW    E R +    +
Sbjct: 64  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-------VAHGWMKEKEARAKFR-QI 115
Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYS 269
           +  +QY H      I+H +LK  N++LDA+   ++ADFG +          +   +  Y+
Sbjct: 116 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYA 172
Query: 270 APECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
           APE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 49  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 102
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 103 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 158
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 159 AVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 218
Query: 296 LTGR 299
           LTGR
Sbjct: 219 LTGR 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           R + E ++L  + H  ++ L        + YL+ D+L+ G   D   R+ +  +    +V
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDV 128
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPG 260
           +  +A   +  L +LH   +  I++ +LKP N++LD E   +L DFGL+K          
Sbjct: 129 KFYLAELAL-ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 261 SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
           S   T  Y APE    R +T  +D +SFG+++  +LTG   T PF
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG---TLPF 226

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           R + E ++L  + H  ++ L        + YL+ D+L+ G   D   R+ +  +    +V
Sbjct: 73  RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDV 129
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPG 260
           +  +A   +  L +LH   +  I++ +LKP N++LD E   +L DFGL+K          
Sbjct: 130 KFYLAELAL-ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 185
Query: 261 SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
           S   T  Y APE    R +T  +D +SFG+++  +LTG   T PF
Sbjct: 186 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG---TLPF 227

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           RLL +   G + +  L      G  VAV+ ++        + N S  +++ +E+ ++  L
Sbjct: 17  RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK------TQLNSSSLQKLFREVRIMKVL 70
Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVI 215
            H N++ L   +      YLV +Y   G + D   A  R++E + +  +         ++
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-------QIV 123
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
             +QY H      I+H +LK  N++LDA+   ++ADFG +          +      Y+A
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 271 PECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
           PE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           R + E ++L  + H  ++ L        + YL+ D+L+ G   D   R+ +  +    +V
Sbjct: 72  RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDV 128
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPG 260
           +  +A   +  L +LH   +  I++ +LKP N++LD E   +L DFGL+K          
Sbjct: 129 KFYLAELAL-ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 184
Query: 261 SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
           S   T  Y APE    R +T  +D +SFG+++  +LTG   T PF
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG---TLPF 226

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 85/170 (50%), Gaps = 19/170 (11%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRE 197
           N +  +++ +E+ ++  L H N++ L   +      YL+ +Y   G + D   A  R++E
Sbjct: 51  NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE 110
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
            + +  +         ++  +QY H     +I+H +LK  N++LDA+   ++ADFG +  
Sbjct: 111 KEARSKFR-------QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE 160
Query: 258 MP-----GSLIATSAYSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
                   +   +  Y+APE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 161 FTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 109/226 (48%), Gaps = 26/226 (11%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+   + G T A++++        EK+++ +     +E+ +L  L+H N++
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILKELKHSNIV 63
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHF 223
            L   +    R  LV+++L    L+  +D + E  L+    V  +   + ++ G+ Y H 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLE---SVTAKSFLLQLLNGIAYCH- 117
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQ-N 276
             + ++LH +LKP N++++ E   ++ADFGLA+     +      + T  Y AP+    +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
           + Y+   DI+S G I A ++ G    AP F   +    L R  R L
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG----APLFPGVSEADQLMRIFRIL 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 18/183 (9%)
Query: 137 PEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           P+K  K  +  I+ E+ VL  ++H N+++L       +  YLV   +  G L    DRI 
Sbjct: 56  PKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGEL---FDRIV 112
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFG 253
           E       +    I   V+  + YLH      I+H +LKP N++    D E    ++DFG
Sbjct: 113 EKGFYTEKDASTLIR-QVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFG 168
Query: 254 LAKLM-PGSLIATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           L+K+   G +++T+     Y APE    + Y+   D +S G+I  +LL G     PF+ E
Sbjct: 169 LSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG---YPPFYDE 225
Query: 309 AAS 311
             S
Sbjct: 226 NDS 228

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 62  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 113
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 165
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 225
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 255

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 29  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 80
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 81  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 132
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 193 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 222

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 49  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 100
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 101 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 152
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 242

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 15/185 (8%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYL 178
           +GL +AV+++      S   Q+    +R  +EL +L  ++H N++ L   + P +S    
Sbjct: 75  SGLKIAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEF 128
Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
              YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N
Sbjct: 129 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSN 184
Query: 239 VMLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAV 294
           + ++ +   ++ DFGLA+     +   +AT  Y APE   N   Y    DI+S G I+A 
Sbjct: 185 LAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAE 244
Query: 295 LLTGR 299
           LLTGR
Sbjct: 245 LLTGR 249

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           RR  +EL +L  L+H N++ L   + P +S       YL T  +   ++ I ++Q     
Sbjct: 72  RRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDE 131
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  +   +++GL+Y+H   +  I+H +LKP+NV ++ +   R+ DFGLA+     +  
Sbjct: 132 HVQF-LVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTG 187
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LL G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 102/193 (52%), Gaps = 23/193 (11%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           + TVL  G+ VAV+++      S   QN++  +R  +EL +L  + H+N++SL   + P+
Sbjct: 42  FDTVL--GINVAVKKL------SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 93
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +   ++L  E    +   ++ G+++LH   +  I+
Sbjct: 94  KTLEEFQDVYLVME---LMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGII 146
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 147 HRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDI 206
Query: 286 FSFGMILAVLLTG 298
           +S G I+  L+ G
Sbjct: 207 WSVGCIMGELVKG 219

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 38  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 89
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 90  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 141
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 142 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 201
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 202 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 231

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 34/196 (17%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VAV+ +E       EK +++VKR I        SLRH N++  +  +   +   +V +Y 
Sbjct: 47  VAVKYIE-----RGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 184 QTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
             G L + +    R  E++ +  ++        +I G+ Y H     Q+ H +LK  N +
Sbjct: 98  SGGELFERICNAGRFSEDEARFFFQ-------QLISGVSYAHAM---QVAHRDLKLENTL 147
Query: 241 LDAEFTPRL--ADFGLAKL-----MPGSLIATSAYSAPECFQNRSYTDK-SDIFSFGMIL 292
           LD    PRL  ADFG +K       P S + T AY APE    + Y  K +D++S G+ L
Sbjct: 148 LDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207
Query: 293 AVLLTG----RDPTAP 304
            V+L G     DP  P
Sbjct: 208 YVMLVGAYPFEDPEEP 223

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 49  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 100
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 101 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 152
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 213 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 242

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I ++Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKSQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ DFGL +     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 90/175 (51%), Gaps = 16/175 (9%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           +K  +   + +   +  + SL H +++ L    P SS   LV  YL  GSL   +D +R+
Sbjct: 52  DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSL---LDHVRQ 107
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           ++  LG ++ L   V + KG+ YL       ++H NL   NV+L +    ++ADFG+A L
Sbjct: 108 HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164
Query: 258 MP---GSLIATSA-----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTA 303
           +P     L+ + A     + A E      YT +SD++S+G+ +  L+T G +P A
Sbjct: 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 31  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 82
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 83  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 134
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 31  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 82
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 83  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 134
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 37  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 88
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 89  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 140
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 141 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 200
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 201 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 36  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 87
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 88  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 139
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 140 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 199
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 200 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 34  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 85
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 86  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 137
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 198 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 30  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 81
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 82  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 133
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 134 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 193
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 194 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 223

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 35  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 86
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 87  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 138
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 139 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 198
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 199 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 228

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 90/175 (51%), Gaps = 16/175 (9%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           +K  +   + +   +  + SL H +++ L    P SS   LV  YL  GSL   +D +R+
Sbjct: 70  DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSL---LDHVRQ 125
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           ++  LG ++ L   V + KG+ YL       ++H NL   NV+L +    ++ADFG+A L
Sbjct: 126 HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 182
Query: 258 MP---GSLIATSA-----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTA 303
           +P     L+ + A     + A E      YT +SD++S+G+ +  L+T G +P A
Sbjct: 183 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 237

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 93/185 (50%), Gaps = 22/185 (11%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  +SG  EKQ    +R    E  ++    H N++ L   V +S+   ++ ++++ GSL
Sbjct: 66  IKTLKSGYTEKQ----RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 121
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R+N  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 122 DSFL---RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCK 175
Query: 249 LADFGLAKLMPGSL---IATSA--------YSAPECFQNRSYTDKSDIFSFGMIL-AVLL 296
           ++DFGL++ +         TSA        ++APE  Q R +T  SD++S+G+++  V+ 
Sbjct: 176 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235
Query: 297 TGRDP 301
            G  P
Sbjct: 236 YGERP 240

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 146 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 201
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ D+GLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/240 (21%), Positives = 114/240 (47%), Gaps = 27/240 (11%)
Query: 69  FVGYMNQTPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL--DNGLTVAV 126
           F G M   P  +  + F+ +I P     +     +++G+   G+ Y+ +L   +G     
Sbjct: 22  FQGAMGSDPN-QAVLKFTTEIHP-----SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP 75
Query: 127 RRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG 186
             ++  ++G  EKQ    +     E  ++    H N++ L   + +     ++ +Y++ G
Sbjct: 76  VAIKTLKAGYTEKQ----RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 131
Query: 187 SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT 246
           +L+  +   RE   +      + +  G+  G++YL    N   +H +L   N+++++   
Sbjct: 132 ALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLV 185
Query: 247 PRLADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            +++DFGL++++   P +   TS       ++APE    R +T  SD++SFG+++  ++T
Sbjct: 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 126 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 122 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 177
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 126 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 126 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 122 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+   + G T A++++        EK+++ +     +E+ +L  L+H N++
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILKELKHSNIV 63
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHF 223
            L   +    R  LV+++L    L+  +D + E  L+    V  +   + ++ G+ Y H 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLE---SVTAKSFLLQLLNGIAYCH- 117
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQ-N 276
             + ++LH +LKP N++++ E   ++ADFGLA+     +      I T  Y AP+    +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
           + Y+   DI+S G I A ++ G     P F   +    L R  R L
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG----TPLFPGVSEADQLMRIFRIL 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 146 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 76  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 135
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 136 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 191
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 85  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 144
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 145 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+     +  
Sbjct: 132 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 35/204 (17%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 37  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88
Query: 173 SS-----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
            +       YLV + L   +L   +      Q++L  E    +   ++ G+++LH   + 
Sbjct: 89  KTLEEFQDVYLVME-LMDANLXQVI------QMELDHERMSYLLYQMLXGIKHLH---SA 138
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK 282
            I+H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y + 
Sbjct: 139 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 283 SDIFSFGMILA------VLLTGRD 300
            DI+S G I+       +L  GRD
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRD 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           RR  +EL +L  L+H N++ L   + P +S       YL T  +   ++ I + Q     
Sbjct: 64  RRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDE 123
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  +   +++GL+Y+H   +  I+H +LKP+NV ++ +   R+ DFGLA+     +  
Sbjct: 124 HVQF-LVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTG 179
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LL G+
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 101/193 (52%), Gaps = 23/193 (11%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           + TVL  G+ VAV+++      S   QN++  +R  +EL +L  + H+N++SL   + P+
Sbjct: 44  FDTVL--GINVAVKKL------SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 95
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +   ++L  E    +   ++ G+++LH   +  I+
Sbjct: 96  KTLEEFQDVYLVME---LMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGII 148
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y    DI
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDI 208
Query: 286 FSFGMILAVLLTG 298
           +S G I+  L+ G
Sbjct: 209 WSVGCIMGELVKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 35/204 (17%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 44  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 95
Query: 173 SS-----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
            +       YLV + L   +L   +      Q++L  E    +   ++ G+++LH   + 
Sbjct: 96  KTLEEFQDVYLVME-LMDANLXQVI------QMELDHERMSYLLYQMLXGIKHLH---SA 145
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK 282
            I+H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y + 
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 283 SDIFSFGMILA------VLLTGRD 300
            DI+S G I+       +L  GRD
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 82  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 134 KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 186
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 247 WSVGCIMGEMVRHKILFPGRD 267

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 35/204 (17%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 44  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQ 95
Query: 173 SS-----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
            +       YLV + L   +L   +      Q++L  E    +   ++ G+++LH   + 
Sbjct: 96  KTLEEFQDVYLVME-LMDANLXQVI------QMELDHERMSYLLYQMLXGIKHLH---SA 145
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK 282
            I+H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y + 
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 283 SDIFSFGMILA------VLLTGRD 300
            DI+S G I+       +L  GRD
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           RR  +EL +L  L+H N++ L   + P +S       YL T  +   ++ I + Q     
Sbjct: 72  RRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDE 131
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  +   +++GL+Y+H   +  I+H +LKP+NV ++ +   R+ DFGLA+     +  
Sbjct: 132 HVQF-LVYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTG 187
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LL G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 96/195 (49%), Gaps = 21/195 (10%)
Query: 121 GLTVAVRRVEAFESGSP------EKQNKSVKRRIQQELE--VLASLRHRNLMSLRAYVPE 172
           G    VR+V   +SG        +K    V+ R++ ++E  +LA + H  ++ L      
Sbjct: 42  GKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQT 101
Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHY 232
             + YL+ D+L+ G   D   R+ +  +    +V+  +A   + GL +LH   +  I++ 
Sbjct: 102 EGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELAL-GLDHLH---SLGIIYR 154
Query: 233 NLKPTNVMLDAEFTPRLADFGLAK------LMPGSLIATSAYSAPECFQNRSYTDKSDIF 286
           +LKP N++LD E   +L DFGL+K          S   T  Y APE    + ++  +D +
Sbjct: 155 DLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWW 214
Query: 287 SFGMILAVLLTGRDP 301
           S+G+++  +LTG  P
Sbjct: 215 SYGVLMFEMLTGSLP 229

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 90  DPKTLQAALANENRLLGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRR 147
           DP         + R LG    GK      D  N  T  +  V+A + G        ++  
Sbjct: 1   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGC----GPQLRSG 56
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
            Q+E+E+L +L H +++  +    +       LV +Y+  GSL D + R      QL   
Sbjct: 57  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL--- 113
Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT 265
             L  A  + +G+ YLH       +H  L   NV+LD +   ++ DFGLAK +P      
Sbjct: 114 --LLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 168
Query: 266 SA---------YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD 300
                      + APEC +   +   SD++SFG+ L  LLT  D
Sbjct: 169 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCD 212

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 91/196 (46%), Gaps = 34/196 (17%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VAV+ +E       EK +++VKR I        SLRH N++  +  +   +   +V +Y 
Sbjct: 46  VAVKYIE-----RGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYA 96
Query: 184 QTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
             G L + +    R  E++ +  ++        +I G+ Y H     Q+ H +LK  N +
Sbjct: 97  SGGELFERICNAGRFSEDEARFFFQ-------QLISGVSYCHAM---QVCHRDLKLENTL 146
Query: 241 LDAEFTPRL--ADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK-SDIFSFGMIL 292
           LD    PRL   DFG +K       P S + T AY APE    + Y  K +D++S G+ L
Sbjct: 147 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTL 206
Query: 293 AVLLTG----RDPTAP 304
            V+L G     DP  P
Sbjct: 207 YVMLVGAYPFEDPEEP 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 101 ENRLLGSSPDGKY-----------YRTV---LDNGLTVAVRRVEAFESGSPEKQNKSVKR 146
           E + +G S DG++           ++TV   LD   TV V   E        K  KS ++
Sbjct: 15  ETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL----QDRKLTKSERQ 70
Query: 147 RIQQELEVLASLRHRNLM----SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           R ++E E L  L+H N++    S  + V       LV +   +G+L+  + R +  ++++
Sbjct: 71  RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV 130
Query: 203 --GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMP 259
              W         ++KGLQ+LH T  P I+H +LK  N+ +     + ++ D GLA L  
Sbjct: 131 LRSW------CRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183
Query: 260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            S    +I T  + APE ++ + Y +  D+++FG       T   P
Sbjct: 184 ASFAKAVIGTPEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSEYP 228

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 90  DPKTLQAALANENRLLGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRR 147
           DP         + R LG    GK      D  N  T  +  V+A + G        ++  
Sbjct: 2   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGC----GPQLRSG 57
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
            Q+E+E+L +L H +++  +    +       LV +Y+  GSL D + R      QL   
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL--- 114
Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT 265
             L  A  + +G+ YLH       +H  L   NV+LD +   ++ DFGLAK +P      
Sbjct: 115 --LLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 169
Query: 266 SA---------YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD 300
                      + APEC +   +   SD++SFG+ L  LLT  D
Sbjct: 170 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCD 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 31  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 82
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ +YL  GSL D + + +E  + ++L     L+    + KG++YL      +
Sbjct: 83  AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 134
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 224

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 19/170 (11%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRE 197
           N +  +++ +E+ ++  L H N++ L   +      YLV +Y   G + D   A  R++E
Sbjct: 54  NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE 113
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
            + +  +         ++  +QY H      I+H +LK  N++LD +   ++ADFG +  
Sbjct: 114 KEARAKFR-------QIVSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNE 163
Query: 258 MP-----GSLIATSAYSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
                   +   +  Y+APE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 164 FTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 82  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 134 KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 186
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 247 WSVGCIMGEMVRHKILFPGRD 267

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 99/191 (51%), Gaps = 28/191 (14%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS---- 174
           +G  VA++++      S   Q++   +R  +EL +L  ++H N++ L   + P SS    
Sbjct: 48  SGEKVAIKKL------SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 175 -RFYLVYDYLQTGSLEDAMD-RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHY 232
             FYLV  ++QT  L+  M  +  E ++Q        +   ++KGL+Y+H   +  ++H 
Sbjct: 102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-------LVYQMLKGLKYIH---SAGVVHR 150
Query: 233 NLKPTNVMLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSF 288
           +LKP N+ ++ +   ++ DFGLA+     +   + T  Y APE   +   Y    DI+S 
Sbjct: 151 DLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSV 210
Query: 289 GMILAVLLTGR 299
           G I+A +LTG+
Sbjct: 211 GCIMAEMLTGK 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 44  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQ 95
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 96  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 148
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 149 HRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 209 WSVGCIMGEMVRHKILFPGRD 229

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 108/226 (47%), Gaps = 26/226 (11%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+   + G T A++++        EK+++ +     +E+ +L  L+H N++
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILKELKHSNIV 63
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHF 223
            L   +    R  LV+++L    L+  +D + E  L+    V  +   + ++ G+ Y H 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLE---SVTAKSFLLQLLNGIAYCH- 117
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQ-N 276
             + ++LH +LKP N++++ E   ++ADFGLA+     +      + T  Y AP+    +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
           + Y+   DI+S G I A ++ G     P F   +    L R  R L
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG----TPLFPGVSEADQLMRIFRIL 217

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 37  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 89  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 141
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 142 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 202 WSVGCIMGEMVRHKILFPGRD 222

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 38  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 89
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 90  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 142
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 202
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 203 WSVGCIMGEMVRHKILFPGRD 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 45  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 96
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 97  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 149
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 210 WSVGCIMGEMVRHKILFPGRD 230

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 38  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 89
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 90  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 142
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 202
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 203 WSVGCIMGEMVRHKILFPGRD 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 45  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 96
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 97  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 149
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 209
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 210 WSVGCIMGEMVRHKILFPGRD 230

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 44  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 95
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 96  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 148
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 209 WSVGCIMGEMVRHKILFPGRD 229

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 44  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 95
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 96  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 148
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 209 WSVGCIMGEMVRHKILFPGRD 229

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 29/201 (14%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 43  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 94
Query: 173 SS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +   F  VY  ++   L DA +  +  Q++L  E    +   ++ G+++LH   +  I+
Sbjct: 95  KTLEEFQDVYLVME---LMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGII 147
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDKSDI 285
           H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y +  DI
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 207
Query: 286 FSFGMILA------VLLTGRD 300
           +S G I+       +L  GRD
Sbjct: 208 WSVGCIMGEMVRHKILFPGRD 228

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 35/204 (17%)
Query: 114 YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPE 172
           Y  VLD    VA++++      S   QN++  +R  +EL ++  + H+N++SL   + P+
Sbjct: 44  YDAVLDRN--VAIKKL------SRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQ 95
Query: 173 SS-----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
            +       YLV + L   +L   +      Q++L  E    +   ++ G+++LH   + 
Sbjct: 96  KTLEEFQDVYLVME-LMDANLXQVI------QMELDHERMSYLLYQMLCGIKHLH---SA 145
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK 282
            I+H +LKP+N+++ ++ T ++ DFGLA+      M    + T  Y APE      Y + 
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 283 SDIFSFGMILA------VLLTGRD 300
            DI+S G I+       +L  GRD
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 92  KTLQAALANENRLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQ 150
           +TL         L+ S  +G+YY   VL   + V +++VE                    
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE----------------HTND 55
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L+ + H  ++ +     ++ + +++ DY++ G L      +R++Q +    V    
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL---FSLLRKSQ-RFPNPVAKFY 111
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSA 267
           A  V   L+YLH   +  I++ +LKP N++LD     ++ DFG AK +P     L  T  
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPD 168
Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           Y APE    + Y    D +SFG+++  +L G  P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE---NQLQLGWE 205
           QQE+ VL+      +        + S+ +++ +YL  GS   A+D +R    ++ Q+   
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS---ALDLLRAGPFDEFQIATM 125
Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMP 259
           ++      ++KGL YLH   + + +H ++K  NV+L  +   +LADFG+A      ++  
Sbjct: 126 LK-----EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 177
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
            + + T  + APE  Q  +Y  K+DI+S G+    L  G  P +
Sbjct: 178 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/185 (24%), Positives = 92/185 (49%), Gaps = 22/185 (11%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  +SG  EKQ    +R    E  ++    H N++ L   V +S+   ++ ++++ GSL
Sbjct: 40  IKTLKSGYTEKQ----RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 95
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R+N  Q      + +  G+  G++YL    +   +H  L   N+++++    +
Sbjct: 96  DSFL---RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRALAARNILVNSNLVCK 149
Query: 249 LADFGLAKLMPGSL---IATSA--------YSAPECFQNRSYTDKSDIFSFGMIL-AVLL 296
           ++DFGL++ +         TSA        ++APE  Q R +T  SD++S+G+++  V+ 
Sbjct: 150 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209
Query: 297 TGRDP 301
            G  P
Sbjct: 210 YGERP 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 18/187 (9%)
Query: 121 GLTVAVRRVE-AFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
           G+ VA++ V+   E G+P    +        E+ ++  L+H N++ L   +   ++  LV
Sbjct: 30  GVYVALKEVKLDSEEGTPSTAIR--------EISLMKELKHENIVRLYDVIHTENKLTLV 81
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           ++++    L+  MD         G E+ L +     + LQ L F    +ILH +LKP N+
Sbjct: 82  FEFMDN-DLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQGLAFCHENKILHRDLKPQNL 139
Query: 240 MLDAEFTPRLADFGLAKL--MP----GSLIATSAYSAPECFQ-NRSYTDKSDIFSFGMIL 292
           +++     +L DFGLA+   +P     S + T  Y AP+    +R+Y+   DI+S G IL
Sbjct: 140 LINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199
Query: 293 AVLLTGR 299
           A ++TG+
Sbjct: 200 AEMITGK 206

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 23/166 (13%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVP-----ESSRFYLVYDYLQTGSLEDAMD--RIRE 197
           +R  +EL +L  ++H N++ L   + P     E +  YLV  +L    L + +   ++ +
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKCAKLTD 120
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           + +Q        +   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DFGLA+ 
Sbjct: 121 DHVQF-------LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170
Query: 258 MPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
               +   +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 89/171 (52%), Gaps = 22/171 (12%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS-----RFYLVYDYLQTGSLEDAMD 193
           Q++   +R  +EL +L  ++H N++ L   + P SS      FYLV  ++QT  L+  M 
Sbjct: 80  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG 138
Query: 194 -RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
               E ++Q        +   ++KGL+Y+H   +  ++H +LKP N+ ++ +   ++ DF
Sbjct: 139 MEFSEEKIQY-------LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 188
Query: 253 GLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
           GLA+     +   + T  Y APE   +   Y    DI+S G I+A +LTG+
Sbjct: 189 GLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 16/159 (10%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E+ VL  L H N+M L  +  +   +YLV +  + G L D +  +R+   ++   V   I
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAV---I 126
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMP--GSL--- 262
              V+ G  YLH      I+H +LKP N++L+++      ++ DFGL+      G +   
Sbjct: 127 MKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 183
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           + T+ Y APE  + + Y +K D++S G+IL +LL G  P
Sbjct: 184 LGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPP 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 83/159 (52%), Gaps = 16/159 (10%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E+ VL  L H N+M L  +  +   +YLV +  + G L D +  +R+   ++   V   I
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAV---I 109
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMP--GSL--- 262
              V+ G  YLH      I+H +LKP N++L+++      ++ DFGL+      G +   
Sbjct: 110 MKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 166
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           + T+ Y APE  + + Y +K D++S G+IL +LL G  P
Sbjct: 167 LGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPP 204

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 94/192 (48%), Gaps = 29/192 (15%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
           +GL   ++ +    S  P +Q       I+ E+EVL SL H N++ +     +    Y+V
Sbjct: 46  SGLERVIKTINKDRSQVPMEQ-------IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98
Query: 180 YDYLQTGSLEDAMDRI-----RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL 234
            +  + G L   ++RI     R   L  G+   L     ++  L Y H   +  ++H +L
Sbjct: 99  METCEGGEL---LERIVSAQARGKALSEGYVAEL--MKQMMNALAYFH---SQHVVHKDL 150
Query: 235 KPTNVMLD--AEFTP-RLADFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKSDIF 286
           KP N++    +  +P ++ DFGLA+L      +T+A     Y APE F+ R  T K DI+
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIW 209
Query: 287 SFGMILAVLLTG 298
           S G+++  LLTG
Sbjct: 210 SAGVVMYFLLTG 221

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRE 197
           N S  +++ +E+ +   L H N++ L   +      YLV +Y   G + D   A  R +E
Sbjct: 53  NSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKE 112
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
            + +  +         ++  +QY H      I+H +LK  N++LDA+   ++ADFG +  
Sbjct: 113 KEARAKFR-------QIVSAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNE 162
Query: 258 MP-----GSLIATSAYSAPECFQNRSYTD-KSDIFSFGMILAVLLTGRDP 301
                   +      Y+APE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 163 FTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 105 LGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           +G    G  Y T +D   G  VA+R++          Q +  K  I  E+ V+   ++ N
Sbjct: 29  IGQGASGTVY-TAMDVATGQEVAIRQMNL--------QQQPKKELIINEILVMRENKNPN 79
Query: 163 LMS-LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           +++ L +Y+      ++V +YL  GSL D    + E  +  G     +IA    + LQ L
Sbjct: 80  IVNYLDSYLV-GDELWVVMEYLAGGSLTDV---VTETCMDEG-----QIAAVCRECLQAL 130
Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQ 275
            F  + Q++H N+K  N++L  + + +L DFG  A++ P      +++ T  + APE   
Sbjct: 131 EFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 190
Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDP 301
            ++Y  K DI+S G++   ++ G  P
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++  FGLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILGFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 63  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 118
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 119 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 55  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM- 112
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 113 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 168
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 169 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 64  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 119
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 120 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 176
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 177 TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ D GLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDAGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM- 285
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 286 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 87/170 (51%), Gaps = 18/170 (10%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           KR   +E+E+L    +H N+++L+    +    YLV + ++ G L   +D+I   +    
Sbjct: 64  KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSE 120
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM-LDAEFTP---RLADFGLAKLM- 258
            E    +   + K ++YLH   +  ++H +LKP+N++ +D    P   R+ DFG AK + 
Sbjct: 121 REASFVLHT-IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR 176
Query: 259 -PGSLIATSAYSA----PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
               L+ T  Y+A    PE  + + Y +  DI+S G++L  +L G  P A
Sbjct: 177 AENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFA 226

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 111/223 (49%), Gaps = 25/223 (11%)
Query: 92  KTLQAALANENRLLGSSPDGKYY--RTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           K L A+     R++G+   G+    R  L     VAV  ++  + G  EKQ    +R   
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVA-IKTLKVGYTEKQ----RRDFL 92
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E  ++    H N++ L   V       +V ++++ G+L DA  R  + Q  +   ++L 
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTV---IQL- 147
Query: 210 IAVGVIKGLQY-LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM---PGSLIAT 265
             VG+++G+   + +  +   +H +L   N+++++    +++DFGL++++   P ++  T
Sbjct: 148 --VGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT 205
Query: 266 SA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
           +       ++APE  Q R +T  SD++S+G+++  V+  G  P
Sbjct: 206 TGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM- 285
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 286 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 53  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 110
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 111 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 166
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 167 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+D MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKDFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPENL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 31/203 (15%)
Query: 117 VLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF 176
           ++ + LT  +  V+  E G+      ++   +Q+E+    SLRH N++  +  +   +  
Sbjct: 38  LMRDKLTKELVAVKYIERGA------AIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 91
Query: 177 YLVYDYLQTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
            ++ +Y   G L + +    R  E++ +  ++        ++ G+ Y H   + QI H +
Sbjct: 92  AIIMEYASGGELYERICNAGRFSEDEARFFFQ-------QLLSGVSYCH---SMQICHRD 141
Query: 234 LKPTNVMLDAEFTPRL--ADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK-SDI 285
           LK  N +LD    PRL   DFG +K       P S + T AY APE    + Y  K +D+
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADV 201
Query: 286 FSFGMILAVLLTG----RDPTAP 304
           +S G+ L V+L G     DP  P
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEP 224

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 51  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 108
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 109 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 164
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 165 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E S  YLV+D +  G L ED + R   ++     
Sbjct: 49  QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 108
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPGS 261
            ++      +++ + Y H   +  I+H NLKP N++L ++      +LADFGLA  +  S
Sbjct: 109 CIQ-----QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 160
Query: 262 -----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   T  Y +PE  +   Y+   DI++ G+IL +LL G  P
Sbjct: 161 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E S  YLV+D +  G L ED + R   ++     
Sbjct: 50  QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 109
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPGS 261
            ++      +++ + Y H   +  I+H NLKP N++L ++      +LADFGLA  +  S
Sbjct: 110 CIQ-----QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 262 -----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   T  Y +PE  +   Y+   DI++ G+IL +LL G  P
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 105/203 (51%), Gaps = 22/203 (10%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+     G  VA++R+        + +++ +     +E+ +L  L H N++
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRL------DAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV-GVIKGLQYLHF 223
           SL   +       LV+++++   L+  +D   EN+  L  + +++I +  +++G+ + H 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEK-DLKKVLD---ENKTGLQ-DSQIKIYLYQLLRGVAHCH- 136
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQ-N 276
               +ILH +LKP N++++++   +LADFGLA+     +      + T  Y AP+    +
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 277 RSYTDKSDIFSFGMILAVLLTGR 299
           + Y+   DI+S G I A ++TG+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ D GLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDRGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM- 368
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 369 -AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E S  YLV+D +  G L ED + R   ++     
Sbjct: 50  QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 109
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPGS 261
            ++      +++ + Y H   +  I+H NLKP N++L ++      +LADFGLA  +  S
Sbjct: 110 CIQ-----QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 262 -----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   T  Y +PE  +   Y+   DI++ G+IL +LL G  P
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 257 LMPGSL-----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
               S      + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 175 TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 17/165 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E S  YLV+D +  G L ED + R   ++     
Sbjct: 73  QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPGS 261
            ++      +++ + Y H   +  I+H NLKP N++L ++      +LADFGLA  +  S
Sbjct: 133 CIQ-----QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 262 -----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   T  Y +PE  +   Y+   DI++ G+IL +LL G  P
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 29  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 82
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+D MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 83  FEFLSM-DLKDFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 136
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 137 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 197 AEMVTRR 203

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 105/203 (51%), Gaps = 22/203 (10%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +G    G  Y+     G  VA++R+        + +++ +     +E+ +L  L H N++
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRL------DAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV-GVIKGLQYLHF 223
           SL   +       LV+++++   L+  +D   EN+  L  + +++I +  +++G+ + H 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEK-DLKKVLD---ENKTGLQ-DSQIKIYLYQLLRGVAHCH- 136
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQ-N 276
               +ILH +LKP N++++++   +LADFGLA+     +      + T  Y AP+    +
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 277 RSYTDKSDIFSFGMILAVLLTGR 299
           + Y+   DI+S G I A ++TG+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 30  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 83
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+D MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 84  FEFLSM-DLKDFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 138 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 198 AEMVTRR 204

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDM- 285
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 286 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 87/170 (51%), Gaps = 18/170 (10%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           KR   +E+E+L    +H N+++L+    +    YLV + ++ G L   +D+I   +    
Sbjct: 64  KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---LDKILRQKFFSE 120
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM-LDAEFTP---RLADFGLAKLM- 258
            E    +   + K ++YLH   +  ++H +LKP+N++ +D    P   R+ DFG AK + 
Sbjct: 121 REASFVLHT-IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLR 176
Query: 259 -PGSLIATSAYSA----PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
               L+ T  Y+A    PE  + + Y +  DI+S G++L  +L G  P A
Sbjct: 177 AENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFA 226

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 93/184 (50%), Gaps = 15/184 (8%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLV 179
           GL VAV+++      S   Q+    +R  +EL +L  ++H N++ L   + P  S     
Sbjct: 47  GLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 100
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
             YL T  +   ++ I + Q      V+  I   +++GL+Y+H   +  I+H +LKP+N+
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNL 156
Query: 240 MLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVL 295
            ++ +   ++ D GLA+     +   +AT  Y APE   N   Y    DI+S G I+A L
Sbjct: 157 AVNEDCELKILDGGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 216
Query: 296 LTGR 299
           LTGR
Sbjct: 217 LTGR 220

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 91/175 (52%), Gaps = 21/175 (12%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 257 LMPGSL-----IATSAYSAPECFQNRSYTDKSDIFSFGMILA------VLLTGRD 300
               S      + T  Y APE      Y +  DI+S G I+       +L  GRD
Sbjct: 175 TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRD 229

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 34/196 (17%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VAV+ +E       EK   +VKR I        SLRH N++  +  +   +   +V +Y 
Sbjct: 47  VAVKYIE-----RGEKIAANVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 184 QTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
             G L + +    R  E++ +  ++        +I G+ Y H     Q+ H +LK  N +
Sbjct: 98  SGGELFERICNAGRFSEDEARFFFQ-------QLISGVSYCHAM---QVCHRDLKLENTL 147
Query: 241 LDAEFTPRL--ADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK-SDIFSFGMIL 292
           LD    PRL   DFG +K       P S + T AY APE    + Y  K +D++S G+ L
Sbjct: 148 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207
Query: 293 AVLLTG----RDPTAP 304
            V+L G     DP  P
Sbjct: 208 YVMLVGAYPFEDPEEP 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 90/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLSQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G+I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 90/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLSQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G+I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 38/212 (17%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 34  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 85
Query: 173 SSR--FYLVYDYLQTGSLEDAM----DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN 226
           + R    L+ +YL  GSL D +    +RI   +L       L+    + KG++YL     
Sbjct: 86  AGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-------LQYTSQICKGMEYL---GT 135
Query: 227 PQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNR 277
            + +H +L   N++++ E   ++ DFGL K++P                 + APE     
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 278 SYTDKSDIFSFGMILAVLLT----GRDPTAPF 305
            ++  SD++SFG++L  L T     + P A F
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q 
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQG 56
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K+ K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 57  KAFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYS 113
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 170 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 54  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 110
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H NL+  N+++    + ++ADFGLA+L+  +         
Sbjct: 111 AAQIAEGMAFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL 322
               ++APE     ++T KSD++SFG++L  ++T GR P  P         +L R  R +
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMV 226
Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           +                    +E+   +R+   C  + P DRP+ D L  +L
Sbjct: 227 RPDNCP---------------EELYQLMRL---CWKERPEDRPTFDYLRSVL 260

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 59  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM- 116
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            +  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 117 -SAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 172
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 173 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLSQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 21/175 (12%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 56  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 111
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 112 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA------VLLTGRD 300
                 M    + T  Y APE      Y +  D++S G I+       +L  GRD
Sbjct: 169 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRD 223

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 37/210 (17%)
Query: 105 LGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G+ Y+ +      TVA++R+        E + + V     +E+ +L  L+HRN+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRL------EHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY--- 220
           + L++ +  + R +L+++Y              EN L+   +    +++ VIK   Y   
Sbjct: 96  IELKSVIHHNHRLHLIFEYA-------------ENDLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 221 --LHFTCNPQILHYNLKPTNVML---DAEFTP--RLADFGLAKLMPGSL------IATSA 267
             ++F  + + LH +LKP N++L   DA  TP  ++ DFGLA+     +      I T  
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 268 YSAPEC-FQNRSYTDKSDIFSFGMILAVLL 296
           Y  PE    +R Y+   DI+S   I A +L
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 52/229 (22%)
Query: 121 GLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSL-RAYVPESSR-F 176
           G  VAV+++ +AF       QN +  +R  +E+ +L  L  H N+++L      ++ R  
Sbjct: 34  GEVVAVKKIFDAF-------QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86
Query: 177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP 236
           YLV+DY++T    D    IR N L+     +  +   +IK ++YLH   +  +LH ++KP
Sbjct: 87  YLVFDYMET----DLHAVIRANILEPVH--KQYVVYQLIKVIKYLH---SGGLLHRDMKP 137
Query: 237 TNVMLDAEFTPRLADFGLAKL----------MPGSL-----------------IATSAYS 269
           +N++L+AE   ++ADFGL++           +P S+                 +AT  Y 
Sbjct: 138 SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYR 197
Query: 270 APECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           APE     + YT   D++S G IL  +L G+    P F  +++   L R
Sbjct: 198 APEILLGSTKYTKGIDMWSLGCILGEILCGK----PIFPGSSTMNQLER 242

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 59  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM- 116
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            +  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 117 -SAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGA 172
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 173 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q 
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQG 56
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K+ K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 57  KAFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 24/192 (12%)
Query: 125 AVRRVEAFESGS-PEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDY 182
           AV+ ++    GS   ++ + ++    +E+++L  +  H N++ L+     ++ F+LV+D 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 183 LQTGSLEDAMDRIRENQLQLGWEVR--LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
           ++ G L    D + E       E R  +R  + VI  L  L+      I+H +LKP N++
Sbjct: 106 MKKGEL---FDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENIL 156
Query: 241 LDAEFTPRLADFGLA-KLMPG----SLIATSAYSAP---ECFQNRS---YTDKSDIFSFG 289
           LD +   +L DFG + +L PG    S+  T +Y AP   EC  N +   Y  + D++S G
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216
Query: 290 MILAVLLTGRDP 301
           +I+  LL G  P
Sbjct: 217 VIMYTLLAGSPP 228

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  +RH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 62  QEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 21/175 (12%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 67  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 122
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 123 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 179
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA------VLLTGRD 300
                 M    + T  Y APE      Y +  D++S G I+       +L  GRD
Sbjct: 180 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRD 234

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q 
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQG 56
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K+ K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 57  KAFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 34/210 (16%)
Query: 114 YRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y  + DN G  VAV++++     S E+  +  +R    E+E+L SL+H N++  +     
Sbjct: 34  YDPLQDNTGEVVAVKKLQH----STEEHLRDFER----EIEILKSLQHDNIVKYKGVCYS 85
Query: 173 SSR--FYLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + R    L+ ++L  GSL + + + +E  + ++L     L+    + KG++YL      +
Sbjct: 86  AGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEYL---GTKR 137
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA---------YSAPECFQNRSY 279
            +H +L   N++++ E   ++ DFGL K++P                 + APE      +
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 280 TDKSDIFSFGMILAVLLT----GRDPTAPF 305
           +  SD++SFG++L  L T     + P A F
Sbjct: 198 SVASDVWSFGVVLYELFTYIEKSKSPPAEF 227

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 11  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 61
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 62  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 118
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 119 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 174
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 175 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLSQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFGLA+++   P +   T        +++PE    R +T  SD++S+G++L  +++
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 85  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 135
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 136 KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 192
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 193 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 248
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 249 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 34  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 84
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 85  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 141
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 142 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 197
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 198 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +       L+L   V + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L   N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +++E+ +L   RHRN++ L           ++++++   S  D  +RI  +  +L     
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFI---SGLDIFERINTSAFELNEREI 104
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE--FTPRLADFGLAK-LMPGS--- 261
           +     V + LQ+LH   +  I H++++P N++       T ++ +FG A+ L PG    
Sbjct: 105 VSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161
Query: 262 -LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
            L     Y APE  Q+   +  +D++S G ++ VLL+G +   PF AE 
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN---PFLAET 207

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 56
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 57  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 170 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 56
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 57  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 170 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 44  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 94
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 95  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 151
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 152 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 207
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 208 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 10  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 60
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 61  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 117
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 118 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 173
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 174 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 56
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 57  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLSQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 40  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 90
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 91  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 147
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 148 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 204 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 40  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 90
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 91  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 147
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 148 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 19  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 69
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 70  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 126
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 127 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 182
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 183 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 42  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 92
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 93  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 149
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 150 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 205
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 206 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 56
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 57  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYS 113
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 170 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 25  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 75
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 76  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 132
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 133 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 188
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 189 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL- 208
           QE +V+  LRH  L+ L A V E    Y+V +Y+  GSL D +      + ++G  +RL 
Sbjct: 229 QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL------KGEMGKYLRLP 281
Query: 209 ---RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT 265
               +A  +  G+ Y+        +H +L+  N+++      ++ADFGL +L+  +    
Sbjct: 282 QLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTA 338
Query: 266 S-------AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                    ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 339 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 7   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 57
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 58  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 114
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 115 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 170
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 171 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 105 LGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           +G    G  Y T +D   G  VA+R++          Q +  K  I  E+ V+   ++ N
Sbjct: 28  IGQGASGTVY-TAMDVATGQEVAIRQMNL--------QQQPKKELIINEILVMRENKNPN 78
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           +++           ++V +YL  GSL D    + E  +  G     +IA    + LQ L 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEG-----QIAAVCRECLQALE 130
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQN 276
           F  + Q++H ++K  N++L  + + +L DFG  A++ P      +++ T  + APE    
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 277 RSYTDKSDIFSFGMILAVLLTGRDP 301
           ++Y  K DI+S G++   ++ G  P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 18  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 68
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 69  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 125
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 126 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 181
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 182 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 14  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 64
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 65  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 121
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 122 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 177
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 178 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 111/232 (47%), Gaps = 49/232 (21%)
Query: 138 EKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           EKQ   ++ R+ +E+E+L   + HRN++ L  +  E  RFYLV++ ++ GS+   + + R
Sbjct: 47  EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR 106
Query: 197 E-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA--EFTP-RLADF 252
             N+L+    V+      V   L +LH   N  I H +LKP N++ +   + +P ++ DF
Sbjct: 107 HFNELEASVVVQ-----DVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDF 158
Query: 253 GLAK----------------LMPGSLIATSAYSAPECFQNRS-----YTDKSDIFSFGMI 291
           GL                  L P     ++ Y APE  +  S     Y  + D++S G+I
Sbjct: 159 GLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 292 LAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEE 343
           L +LL+G     PF       GS   W R     GEA  A  +++L E ++E
Sbjct: 216 LYILLSG---YPPFVGRC---GSDCGWDR-----GEACPAC-QNMLFESIQE 255

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  L D+G  VA+++V          Q+
Sbjct: 18  VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---------LQD 68
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
           K  K R   EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 69  KRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 125
Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGL 254
           R  Q      V+L +   + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 126 RAKQTLPVIYVKLYM-YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 181
Query: 255 AK-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           AK L+ G    S I +  Y APE  F    YT   D++S G +LA LL G+
Sbjct: 182 AKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 9/159 (5%)
Query: 146 RRIQQELEVLASLRHRNLMSL-RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +R  +EL +L  ++H N++ L   + P  S       YL T  +   ++ I + Q     
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-- 262
            V+  I   +++GL+Y+H   +  I+H +LKP+N+ ++ +   ++ DF LA+     +  
Sbjct: 126 HVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTG 181
Query: 263 -IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            +AT  Y APE   N   Y    DI+S G I+A LLTGR
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 89/167 (53%), Gaps = 15/167 (8%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLSQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
                 M    + T  Y APE      Y +  DI+S G I+  ++ G
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  G L D +       L+L   V + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 21/175 (12%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPESS--RFYLVYDYLQTGSLEDAMDRIR 196
           QN++  +R  +EL ++  + H+N++ L   + P+ S   F  VY  ++   L DA +  +
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME---LMDA-NLCQ 117
Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
             Q++L  E    +   ++ G+++LH   +  I+H +LKP+N+++ ++ T ++ DFGLA+
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
Query: 257 LMPGSL-----IATSAYSAPECFQNRSYTDKSDIFSFGMILA------VLLTGRD 300
               S      + T  Y APE      Y +  D++S G I+       +L  GRD
Sbjct: 175 TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRD 229

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E    Y+V +Y+  G L D +       L+L   V + 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM- 119
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 120 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 175
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 84/164 (51%), Gaps = 17/164 (10%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E+ ++    H N++ + +        ++V ++L+ G+L D +   R N+ Q+       +
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TV 146
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMPG--SLIA 264
            + V++ L YLH   N  ++H ++K  +++L ++   +L+DFG    ++K +P    L+ 
Sbjct: 147 CLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVG 203
Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           T  + APE      Y  + DI+S G+++  ++ G     P+F E
Sbjct: 204 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE---PPYFNE 244

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 105 LGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G  Y+ +  + G  VA+++V            +S  + I +E+ ++      ++
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV----------ESDLQEIIKEISIMQQCDSPHV 86
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           +       +++  ++V +Y   GS+ D + R+R   L    E+   I    +KGL+YLHF
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDII-RLRNKTLTED-EI-ATILQSTLKGLEYLHF 143
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQNR 277
               + +H ++K  N++L+ E   +LADFG+A  +   +      I T  + APE  Q  
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 278 SYTDKSDIFSFGMILAVLLTGRDPTA 303
            Y   +DI+S G+    +  G+ P A
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYA 226

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 22/172 (12%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           KR   +E+E+L    +H N+++L+    +    Y+V + ++ G L D + R      Q  
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR------QKF 112
Query: 204 WEVRLRIAV--GVIKGLQYLHFTCNPQILHYNLKPTNVM-LDAEFTP---RLADFGLAKL 257
           +  R   AV   + K ++YLH      ++H +LKP+N++ +D    P   R+ DFG AK 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 258 M--PGSLIATSAYSA----PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           +     L+ T  Y+A    PE  + + Y    DI+S G++L  +LTG  P A
Sbjct: 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 24/180 (13%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE--------DAMDR 194
           + ++  Q+E E+L +L+H +++       +     +V++Y++ G L         DAM  
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 195 I----RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
           +    R+ + +LG    L IA  +  G+ YL    +   +H +L   N ++ A    ++ 
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIG 175
Query: 251 DFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           DFG+++         + G  +    +  PE    R +T +SD++SFG+IL  + T G+ P
Sbjct: 176 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + LG+   G+ +    +    VA++ ++   + SPE           +E +++  L+H  
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKP-GTMSPES--------FLEEAQIMKKLKHDK 65
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V E    Y+V +Y+  GSL D +       L+L     + +A  V  G+ Y+ 
Sbjct: 66  LVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE 122
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-------AYSAPECFQ 275
                  +H +L+  N+++      ++ADFGLA+L+  +             ++APE   
Sbjct: 123 RM---NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 179
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +T KSD++SFG++L  L+T GR P
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 91/183 (49%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  V+  G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 299 RDP 301
             P
Sbjct: 248 ERP 250

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 19/174 (10%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  +RH N+++L       +   L+ + +  G L D +      +  L  
Sbjct: 73  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTE 128
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLA-KLMP 259
           +   +    ++ G+ YLH   + +I H++LKP N+ML  +  P    +L DFG+A K+  
Sbjct: 129 DEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 185
Query: 260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           G    ++  T  + APE         ++D++S G+I  +LL+G    +PF  E 
Sbjct: 186 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGET 236

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 34/196 (17%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VAV+ +E       EK +++VKR I        SLRH N++  +  +   +   +V +Y 
Sbjct: 47  VAVKYIE-----RGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 184 QTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
             G L + +    R  E++ +  ++        +I G+ Y H     Q+ H +LK  N +
Sbjct: 98  SGGELFERICNAGRFSEDEARFFFQ-------QLISGVSYCHAM---QVCHRDLKLENTL 147
Query: 241 LDAEFTPRL--ADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK-SDIFSFGMIL 292
           LD    PRL    FG +K       P S + T AY APE    + Y  K +D++S G+ L
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207
Query: 293 AVLLTG----RDPTAP 304
            V+L G     DP  P
Sbjct: 208 YVMLVGAYPFEDPEEP 223

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E EV+  L H  L+ L     E +   LV+++++ G L D +   R  +     E  L 
Sbjct: 51  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLG 107
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           + + V +G+ YL   C   ++H +L   N ++      +++DFG+ + +      +S   
Sbjct: 108 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +++PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 165 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E EV+  L H  L+ L     E +   LV+++++ G L D +   R  +     E  L 
Sbjct: 54  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLG 110
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           + + V +G+ YL   C   ++H +L   N ++      +++DFG+ + +      +S   
Sbjct: 111 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 167
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +++PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 168 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 207

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG+   G+ +    +    VAV+ +         KQ          E  ++  L+H+ L+
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSL---------KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT 224
            L A V +    Y++ +Y++ GSL D +     + ++L     L +A  + +G+ ++   
Sbjct: 72  RLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-------AYSAPECFQNR 277
                +H +L+  N+++    + ++ADFGLA+L+  +             ++APE     
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYG 185
Query: 278 SYTDKSDIFSFGMILAVLLT-GRDP 301
           ++T KSD++SFG++L  ++T GR P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 126/289 (43%), Gaps = 54/289 (18%)
Query: 115 RTVLDNGLTVAVRRVEAFESGSPEKQNKSVKR-----------RIQQELEVLASLRHRNL 163
           + V+ +G T  V+        +P+K+  ++KR            + +E++ ++   H N+
Sbjct: 15  QEVIGSGATAVVQAAYC----APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRIAV---GVIKGLQ 219
           +S           +LV   L  GS+ D +  I  + + + G      IA     V++GL+
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 130
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----------GSLIATSAY 268
           YLH   N QI H ++K  N++L  + + ++ADFG++  +             + + T  +
Sbjct: 131 YLHK--NGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 269 SAPECF-QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE 327
            APE   Q R Y  K+DI+SFG+    L TG  P   +         +   +  LQ+   
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-------PPMKVLMLTLQN--- 237
Query: 328 AREALDRSILGEEVEEDEMLMAV-----RIAVVCLSDSPADRPSSDELV 371
                D   L   V++ EML        ++  +CL   P  RP++ EL+
Sbjct: 238 -----DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E EV+  L H  L+ L     E +   LV+++++ G L D +   R  +     E  L 
Sbjct: 49  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLG 105
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           + + V +G+ YL   C   ++H +L   N ++      +++DFG+ + +      +S   
Sbjct: 106 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +++PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 19/174 (10%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  +RH N+++L       +   L+ + +  G L D +      +  L  
Sbjct: 59  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTE 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLA-KLMP 259
           +   +    ++ G+ YLH   + +I H++LKP N+ML  +  P    +L DFG+A K+  
Sbjct: 115 DEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 171
Query: 260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           G    ++  T  + APE         ++D++S G+I  +LL+G    +PF  E 
Sbjct: 172 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGET 222

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 105 LGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           +G    G  Y T +D   G  VA+R++          Q +  K  I  E+ V+   ++ N
Sbjct: 28  IGQGASGTVY-TAMDVATGQEVAIRQMNL--------QQQPKKELIINEILVMRENKNPN 78
Query: 163 LMS-LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           +++ L +Y+      ++V +YL  GSL D    + E  +  G     +IA    + LQ L
Sbjct: 79  IVNYLDSYLV-GDELWVVMEYLAGGSLTDV---VTETCMDEG-----QIAAVCRECLQAL 129
Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQ 275
            F  + Q++H ++K  N++L  + + +L DFG  A++ P       ++ T  + APE   
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVT 189
Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDP 301
            ++Y  K DI+S G++   ++ G  P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E EV+  L H  L+ L     E +   LV+++++ G L D +   R  +     E  L 
Sbjct: 71  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLG 127
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           + + V +G+ YL   C   ++H +L   N ++      +++DFG+ + +      +S   
Sbjct: 128 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 184
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +++PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 185 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 224

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 19/174 (10%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  +RH N+++L       +   L+ + +  G L D +      +  L  
Sbjct: 52  REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTE 107
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLA-KLMP 259
           +   +    ++ G+ YLH   + +I H++LKP N+ML  +  P    +L DFG+A K+  
Sbjct: 108 DEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           G    ++  T  + APE         ++D++S G+I  +LL+G    +PF  E 
Sbjct: 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGET 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 105 LGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           +G    G  Y T +D   G  VA+R++          Q +  K  I  E+ V+   ++ N
Sbjct: 29  IGQGASGTVY-TAMDVATGQEVAIRQMNL--------QQQPKKELIINEILVMRENKNPN 79
Query: 163 LMS-LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           +++ L +Y+      ++V +YL  GSL D    + E  +  G     +IA    + LQ L
Sbjct: 80  IVNYLDSYLV-GDELWVVMEYLAGGSLTDV---VTETCMDEG-----QIAAVCRECLQAL 130
Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQ 275
            F  + Q++H ++K  N++L  + + +L DFG  A++ P       ++ T  + APE   
Sbjct: 131 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVT 190
Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDP 301
            ++Y  K DI+S G++   ++ G  P
Sbjct: 191 RKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 105 LGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           +G    G  Y T +D   G  VA+R++          Q +  K  I  E+ V+   ++ N
Sbjct: 28  IGQGASGTVY-TAMDVATGQEVAIRQMNL--------QQQPKKELIINEILVMRENKNPN 78
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           +++           ++V +YL  GSL D    + E  +  G     +IA    + LQ L 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEG-----QIAAVCRECLQALE 130
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQN 276
           F  + Q++H ++K  N++L  + + +L DFG  A++ P       ++ T  + APE    
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR 190
Query: 277 RSYTDKSDIFSFGMILAVLLTGRDP 301
           ++Y  K DI+S G++   ++ G  P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 91/183 (49%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 66  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 121
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 122 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 175
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  V+  G
Sbjct: 176 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 235
Query: 299 RDP 301
             P
Sbjct: 236 ERP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 91/183 (49%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 49  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 104
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 105 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 158
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  V+  G
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 218
Query: 299 RDP 301
             P
Sbjct: 219 ERP 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 88/168 (52%), Gaps = 13/168 (7%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           ++S K  +++E++ ++ LRH  L++L     + +   ++Y+++  G L    +++ +   
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHN 250
Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--RLADFGL-AKL 257
           ++  +  +     V KGL ++H       +H +LKP N+M   + +   +L DFGL A L
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 258 MPGSLI----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            P   +     T+ ++APE  + +     +D++S G++  +LL+G  P
Sbjct: 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/178 (22%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  +++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/178 (22%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  +++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/178 (22%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  +++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR 147
           +DP+T++  +    R LG     K Y  T +D     A + V       P ++ K     
Sbjct: 36  VDPRTMKRYM--RGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----- 88
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +  E+ +  SL + +++    +  +    Y+V +  +  SL +   R R+   +      
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKR-RKAVTEPEARYF 147
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------PGS 261
           +R     I+G+QYLH   N +++H +LK  N+ L+ +   ++ DFGLA  +        +
Sbjct: 148 MR---QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT 201
Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           L  T  Y APE    + ++ + DI+S G IL  LL G+ P
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 63  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 119
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 120 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL 322
               ++APE     ++T KSD++SFG++L  ++T GR P  P         +L R  R +
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMV 235
Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           +                    +E+   +R+   C  + P DRP+ D L  +L
Sbjct: 236 RPDNCP---------------EELYQLMRL---CWKERPEDRPTFDYLRSVL 269

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/313 (22%), Positives = 130/313 (41%), Gaps = 82/313 (26%)
Query: 101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           E  L+GS   G+ ++     +G T  +RRV            K    + ++E++ LA L 
Sbjct: 16  EIELIGSGGFGQVFKAKHRIDGKTYVIRRV------------KYNNEKAEREVKALAKLD 63
Query: 160 HRNLMSLRA--------------------YVPESSR---------FYLVYDYLQTGSLED 190
           H N++                        Y PE+S+          ++  ++   G+LE 
Sbjct: 64  HVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQ 123
Query: 191 AMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
            +++ R  +L     + L +   + KG+ Y+H   + +++H +LKP+N+ L      ++ 
Sbjct: 124 WIEKRRGEKLDKV--LALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 251 DFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD---PT 302
           DFGL   +      T +     Y +PE   ++ Y  + D+++ G+ILA LL   D    T
Sbjct: 179 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 238
Query: 303 APFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPA 362
           + FF +   G                       I+ +  ++ E  +  ++    LS  P 
Sbjct: 239 SKFFTDLRDG-----------------------IISDIFDKKEKTLLQKL----LSKKPE 271
Query: 363 DRPSSDELVPMLT 375
           DRP++ E++  LT
Sbjct: 272 DRPNTSEILRTLT 284

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 64  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 120
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 121 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL 322
               ++APE     ++T KSD++SFG++L  ++T GR P  P         +L R  R +
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMV 236
Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           +                    +E+   +R+   C  + P DRP+ D L  +L
Sbjct: 237 RPDNCP---------------EELYQLMRL---CWKERPEDRPTFDYLRSVL 270

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 114
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 115 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 21/194 (10%)
Query: 121 GLTVAVRRVE-AFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYL 178
           G   AV+ +E   E  SPE Q + V+   ++E  +L  +  H ++++L      SS  +L
Sbjct: 119 GHEFAVKIMEVTAERLSPE-QLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177
Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V+D ++ G L D +      ++ L  +    I   +++ + +LH      I+H +LKP N
Sbjct: 178 VFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPEN 230
Query: 239 VMLDAEFTPRLADFGLA-KLMPG----SLIATSAYSAPECFQ------NRSYTDKSDIFS 287
           ++LD     RL+DFG +  L PG     L  T  Y APE  +      +  Y  + D+++
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 288 FGMILAVLLTGRDP 301
            G+IL  LL G  P
Sbjct: 291 CGVILFTLLAGSPP 304

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 59  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 115
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 116 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 125 AVRRVEAFESGS-PEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDY 182
           AV+ ++    GS   ++ + ++    +E+++L  +  H N++ L+     ++ F+LV+D 
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 92
Query: 183 LQTGSLEDAMDRIRENQLQLGWEVR--LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
           ++ G L    D + E       E R  +R  + VI  L  L+      I+H +LKP N++
Sbjct: 93  MKKGEL---FDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENIL 143
Query: 241 LDAEFTPRLADFGLA-KLMPG----SLIATSAYSAP---ECFQNRS---YTDKSDIFSFG 289
           LD +   +L DFG + +L PG     +  T +Y AP   EC  N +   Y  + D++S G
Sbjct: 144 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 203
Query: 290 MILAVLLTGRDP 301
           +I+  LL G  P
Sbjct: 204 VIMYTLLAGSPP 215

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 91/183 (49%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 76  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 131
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 132 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 185
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  V+  G
Sbjct: 186 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 245
Query: 299 RDP 301
             P
Sbjct: 246 ERP 248

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/178 (22%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFGL +++   P +   T        +++PE    R +T  SD++S+G++L  +++
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 91/183 (49%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V +Y++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  V+  G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 299 RDP 301
             P
Sbjct: 248 ERP 250

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLSFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 31  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 84
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 85  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 138
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 139 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 198
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 199 AEMVTRR 205

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 114
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 115 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 125 AVRRVEAFESGS-PEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDY 182
           AV+ ++    GS   ++ + ++    +E+++L  +  H N++ L+     ++ F+LV+D 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 183 LQTGSLEDAMDRIRENQLQLGWEVR--LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
           ++ G L    D + E       E R  +R  + VI  L  L+      I+H +LKP N++
Sbjct: 106 MKKGEL---FDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENIL 156
Query: 241 LDAEFTPRLADFGLA-KLMPG----SLIATSAYSAP---ECFQNRS---YTDKSDIFSFG 289
           LD +   +L DFG + +L PG     +  T +Y AP   EC  N +   Y  + D++S G
Sbjct: 157 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 216
Query: 290 MILAVLLTGRDP 301
           +I+  LL G  P
Sbjct: 217 VIMYTLLAGSPP 228

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 88/168 (52%), Gaps = 13/168 (7%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           ++S K  +++E++ ++ LRH  L++L     + +   ++Y+++  G L    +++ +   
Sbjct: 88  HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHN 144
Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--RLADFGL-AKL 257
           ++  +  +     V KGL ++H       +H +LKP N+M   + +   +L DFGL A L
Sbjct: 145 KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 201
Query: 258 MPGSLI----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            P   +     T+ ++APE  + +     +D++S G++  +LL+G  P
Sbjct: 202 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 60  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 116
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 117 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 34  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 87
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 88  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 141
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 142 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 201
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 202 AEMVTRR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 110/237 (46%), Gaps = 33/237 (13%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 53  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 109
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 110 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL 322
               ++APE     ++T KSD++SFG++L  ++T GR P  P         +L R  R +
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMV 225
Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
           +                    +E+   +R+   C  + P DRP+ D L  +L    +
Sbjct: 226 RPDNCP---------------EELYQLMRL---CWKERPEDRPTFDYLRSVLEDFFT 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 66  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 122
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 123 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 114
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 115 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL 322
               ++APE     ++T KSD++SFG++L  ++T GR P  P         +L R  R +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMV 230
Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           +                    +E+   +R+   C  + P DRP+ D L  +L
Sbjct: 231 RPDNCP---------------EELYQLMRL---CWKERPEDRPTFDYLRSVL 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 67  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 123
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 124 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 38/223 (17%)
Query: 102 NRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR- 159
           + LLG     K    V L NG   AV+ +E        KQ    + R+ +E+E L   + 
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIE--------KQAGHSRSRVFREVETLYQCQG 69
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           ++N++ L  +  + +RFYLV++ LQ GS+   + +    Q         R+   V   L 
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQK----QKHFNEREASRVVRDVAAALD 125
Query: 220 YLHFTCNPQILHYNLKPTNVMLDA--EFTP-RLADFGLAKLMP-------------GSLI 263
           +LH      I H +LKP N++ ++  + +P ++ DF L   M               +  
Sbjct: 126 FLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 264 ATSAYSAPECF-----QNRSYTDKSDIFSFGMILAVLLTGRDP 301
            ++ Y APE       Q   Y  + D++S G++L ++L+G  P
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 28  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 81
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 82  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 135
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 136 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 196 AEMVTRR 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 126/289 (43%), Gaps = 54/289 (18%)
Query: 115 RTVLDNGLTVAVRRVEAFESGSPEKQNKSVKR-----------RIQQELEVLASLRHRNL 163
           + V+ +G T  V+        +P+K+  ++KR            + +E++ ++   H N+
Sbjct: 20  QEVIGSGATAVVQAAYC----APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRIAV---GVIKGLQ 219
           +S           +LV   L  GS+ D +  I  + + + G      IA     V++GL+
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----------GSLIATSAY 268
           YLH   N QI H ++K  N++L  + + ++ADFG++  +             + + T  +
Sbjct: 136 YLHK--NGQI-HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 269 SAPECF-QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE 327
            APE   Q R Y  K+DI+SFG+    L TG  P   +         +   +  LQ+   
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-------PPMKVLMLTLQN--- 242
Query: 328 AREALDRSILGEEVEEDEMLMAV-----RIAVVCLSDSPADRPSSDELV 371
                D   L   V++ EML        ++  +CL   P  RP++ EL+
Sbjct: 243 -----DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 20/187 (10%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
           D G  VA+++    ES    + +  +K+   +E+ +L  L+H NL++L        R +L
Sbjct: 26  DTGQIVAIKKF--LES----EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79
Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V++Y     L + +DR      Q G    L  ++   + LQ ++F      +H ++KP N
Sbjct: 80  VFEYCDHTVLHE-LDR-----YQRGVPEHLVKSI-TWQTLQAVNFCHKHNCIHRDVKPEN 132
Query: 239 VMLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECF-QNRSYTDKSDIFSFGMI 291
           +++      +L DFG A+L+ G        +AT  Y +PE    +  Y    D+++ G +
Sbjct: 133 ILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCV 192
Query: 292 LAVLLTG 298
            A LL+G
Sbjct: 193 FAELLSG 199

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 30  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 83
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 84  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 138 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 198 AEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 29  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 82
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 83  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 136
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 137 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 197 AEMVTRR 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 28  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 81
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 82  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 135
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 136 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 196 AEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 30  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 83
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 84  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 138 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 198 AEMVTRR 204

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 28  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 81
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 82  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 135
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 136 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 196 AEMVTRR 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           QQE+ VL+      +        + ++ +++ +YL  GS  D ++    ++ Q+   +R 
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR- 111
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSL 262
                ++KGL YLH   + + +H ++K  NV+L      +LADFG+A      ++   + 
Sbjct: 112 ----EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 164
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           + T  + APE  +  +Y  K+DI+S G+    L  G  P
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           QQE+ VL+      +        + ++ +++ +YL  GS  D ++    ++ Q+   +R 
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR- 131
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSL 262
                ++KGL YLH   + + +H ++K  NV+L      +LADFG+A      ++   + 
Sbjct: 132 ----EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 184
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           + T  + APE  +  +Y  K+DI+S G+    L  G  P
Sbjct: 185 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 26  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 80  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 194 AEMVTRR 200

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 64  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 120
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 121 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHL 322
               ++APE     ++T KSD++SFG++L  ++T GR P  P         +L R  R +
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNLERGYRMV 236
Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           +                    +E+   +R+   C  + P DRP+ D L  +L
Sbjct: 237 RPDNCP---------------EELYQLMRL---CWKERPEDRPTFDYLRSVL 270

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 26  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 80  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 194 AEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 29  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 82
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 83  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPENL 136
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 137 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 197 AEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 26  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 80  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 194 AEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 34  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 87
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 88  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 141
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 142 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIF 201
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 202 AEMVTRR 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 28  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 81
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 82  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPENL 135
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 136 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 196 AEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 14/159 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  ++  L+H+ L+ L A V +    Y++ +Y++ GSL D +     + ++L     L +
Sbjct: 68  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKT--PSGIKLTINKLLDM 124
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS---- 266
           A  + +G+ ++        +H +L+  N+++    + ++ADFGLA+L+  +         
Sbjct: 125 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 267 ---AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++APE     ++T KSD++SFG++L  ++T GR P
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 30  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 83
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 84  FEFLHQ-DLKTFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 138 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 198 AEMVTRR 204

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE +V+  LRH  L+ L A V E     +V +Y+  GSL D +       L+L   V + 
Sbjct: 52  QEAQVMKKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM- 109
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS--- 266
            A  +  G+ Y+        +H +L+  N+++      ++ADFGLA+L+  +        
Sbjct: 110 -AAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGA 165
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                ++APE      +T KSD++SFG++L  L T GR P
Sbjct: 166 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 29  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 82
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 83  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 136
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 137 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 196
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 197 AEMVTRR 203

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 26  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 80  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 194 AEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 31  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 84
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 85  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 138
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 139 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 198
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 199 AEMVTRR 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 28  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 81
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 82  FEFLSM-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPENL 135
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 136 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 195
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 196 AEMVTRR 202

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 21/220 (9%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR 147
           +DP+T++  +    R LG     K Y  T +D     A + V       P ++ K     
Sbjct: 20  VDPRTMKRYM--RGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----- 72
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +  E+ +  SL + +++    +  +    Y+V +  +  SL +   R R+   +      
Sbjct: 73  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKR-RKAVTEPEARYF 131
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------PGS 261
           +R     I+G+QYLH   N +++H +LK  N+ L+ +   ++ DFGLA  +         
Sbjct: 132 MR---QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD 185
Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           L  T  Y APE    + ++ + DI+S G IL  LL G+ P
Sbjct: 186 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 30  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 83
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 84  FEFLSM-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPENL 137
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 138 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 198 AEMVTRR 204

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 27  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 80
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           +++L    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 81  FEFLHQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 134
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 135 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIF 194
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 195 AEMVTRR 201

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/300 (22%), Positives = 128/300 (42%), Gaps = 69/300 (23%)
Query: 101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           E  L+GS   G+ ++     +G T  ++RV            K    + ++E++ LA L 
Sbjct: 15  EIELIGSGGFGQVFKAKHRIDGKTYVIKRV------------KYNNEKAEREVKALAKLD 62
Query: 160 HRNLMSLRA------YVPESSR----------FYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           H N++          Y PE+S            ++  ++   G+LE  +++ R  +L   
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK- 121
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-- 261
             + L +   + KG+ Y+H   + ++++ +LKP+N+ L      ++ DFGL   +     
Sbjct: 122 -VLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD---PTAPFFAEAASGGSL 315
                 T  Y +PE   ++ Y  + D+++ G+ILA LL   D    T+ FF +   G   
Sbjct: 178 RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG--- 234
Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
                               I+ +  ++ E  +  ++    LS  P DRP++ E++  LT
Sbjct: 235 --------------------IISDIFDKKEKTLLQKL----LSKKPEDRPNTSEILRTLT 270

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 91/176 (51%), Gaps = 26/176 (14%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYV--PESSRFYLVYDYLQTGSLED--AMDRIRENQLQ 201
            ++ QE+ +L  L H N++ L   +  P     Y+V++ +  G + +   +  + E+Q +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS 261
             ++        +IKG++YLH+    +I+H ++KP+N+++  +   ++ADFG++    GS
Sbjct: 141 FYFQ-------DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 262 ------LIATSAYSAPECFQN--RSYTDKS-DIFSFGMILAVLLTGRDPTAPFFAE 308
                  + T A+ APE      + ++ K+ D+++ G+ L   + G+    PF  E
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ---CPFMDE 243

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/166 (24%), Positives = 79/166 (47%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           + + V+ ++++E+E+ A L H N++ L  Y  +  R YL+ +Y   G L   + +     
Sbjct: 62  EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK----S 117
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
                +    I   +   L Y H     +++H ++KP N++L  +   ++ADFG +   P
Sbjct: 118 CTFDEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAP 174
Query: 260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  Y  PE  + R + +K D++  G++   LL G  P
Sbjct: 175 SLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 21/220 (9%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR 147
           +DP+T++  +    R LG     K Y  T +D     A + V       P ++ K     
Sbjct: 36  VDPRTMKRYM--RGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----- 88
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +  E+ +  SL + +++    +  +    Y+V +  +  SL +   R R+   +      
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKR-RKAVTEPEARYF 147
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------PGS 261
           +R     I+G+QYLH   N +++H +LK  N+ L+ +   ++ DFGLA  +         
Sbjct: 148 MR---QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD 201
Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           L  T  Y APE    + ++ + DI+S G IL  LL G+ P
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 21/220 (9%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR 147
           +DP+T++  +    R LG     K Y  T +D     A + V       P ++ K     
Sbjct: 36  VDPRTMKRYM--RGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK----- 88
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +  E+ +  SL + +++    +  +    Y+V +  +  SL +   R R+   +      
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKR-RKAVTEPEARYF 147
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------PGS 261
           +R     I+G+QYLH   N +++H +LK  N+ L+ +   ++ DFGLA  +         
Sbjct: 148 MR---QTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX 201
Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           L  T  Y APE    + ++ + DI+S G IL  LL G+ P
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           + + + V     +E+ +L  L H N++ L   +   ++ YLV+++L    L+  MD    
Sbjct: 39  DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASAL 97
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
             + L       I   + + LQ L F  + ++LH +LKP N++++ E   +LADFGLA+ 
Sbjct: 98  TGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152
Query: 258 MPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
               +      + T  Y APE     + Y+   DI+S G I A ++T R
Sbjct: 153 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           + + + V     +E+ +L  L H N++ L   +   ++ YLV+++L    L+  MD    
Sbjct: 38  DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASAL 96
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
             + L       I   + + LQ L F  + ++LH +LKP N++++ E   +LADFGLA+ 
Sbjct: 97  TGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 151
Query: 258 MPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
               +      + T  Y APE     + Y+   DI+S G I A ++T R
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 147 RIQQELEVLASLRHRNLMSL----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           R ++E +  A+L H  ++++     A  P     Y+V +Y+   +L D +        + 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS- 261
             EV       +    Q L+F+    I+H ++KP N+M+ A    ++ DFG+A+ +  S 
Sbjct: 118 AIEV-------IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 262 --------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   +I T+ Y +PE  +  S   +SD++S G +L  +LTG  P
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 147 RIQQELEVLASLRHRNLMSL----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           R ++E +  A+L H  ++++     A  P     Y+V +Y+   +L D +        + 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS- 261
             EV       +    Q L+F+    I+H ++KP N+M+ A    ++ DFG+A+ +  S 
Sbjct: 118 AIEV-------IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 262 --------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   +I T+ Y +PE  +  S   +SD++S G +L  +LTG  P
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           + + V+ ++++E+E+ + LRH N++ +  Y  +  R YL+ ++   G L   + +     
Sbjct: 54  EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 113
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    LH+    +++H ++KP N+++  +   ++ADFG +   P
Sbjct: 114 EQ-------RSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 166
Query: 260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                 +  T  Y  PE  + +++ +K D++  G++    L G  P
Sbjct: 167 SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/215 (22%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 92  KTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRR-----VEAFESGSPEKQNKSVKR 146
           K ++A+     R++G+   G+    V    L +  +R     ++  + G  EKQ    +R
Sbjct: 17  KEIEASCITIERVIGAGEFGE----VCSGRLKLPGKRELPVAIKTLKVGYTEKQ----RR 68
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
               E  ++    H N++ L   V +S    +V +Y++ GSL+  +   ++N  Q     
Sbjct: 69  DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL---KKNDGQFTVIQ 125
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM---PGSLI 263
            + +  G+  G++YL    +   +H +L   N+++++    +++DFGL++++   P +  
Sbjct: 126 LVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 264 ATSA------YSAPECFQNRSYTDKSDIFSFGMIL 292
            T        ++APE    R +T  SD++S+G+++
Sbjct: 183 TTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVM 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 147 RIQQELEVLASLRHRNLMSL----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           R ++E +  A+L H  ++++     A  P     Y+V +Y+   +L D +        + 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS- 261
             EV       +    Q L+F+    I+H ++KP N+M+ A    ++ DFG+A+ +  S 
Sbjct: 118 AIEV-------IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 262 --------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   +I T+ Y +PE  +  S   +SD++S G +L  +LTG  P
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 147 RIQQELEVLASLRHRNLMSL----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           R ++E +  A+L H  ++++     A  P     Y+V +Y+   +L D +        + 
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 134
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS- 261
             EV       +    Q L+F+    I+H ++KP N+M+ A    ++ DFG+A+ +  S 
Sbjct: 135 AIEV-------IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 262 --------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   +I T+ Y +PE  +  S   +SD++S G +L  +LTG  P
Sbjct: 188 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/166 (22%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           + + V+ ++++E+E+ + LRH N++ +  Y  +  R YL+ ++   G L   + +     
Sbjct: 53  EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 112
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
            Q       R A  + +    LH+    +++H ++KP N+++  +   ++ADFG +   P
Sbjct: 113 EQ-------RSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165
Query: 260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                 +  T  Y  PE  + +++ +K D++  G++    L G  P
Sbjct: 166 SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 34/196 (17%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VAV+ +E       EK +++VKR I        SLRH N++  +  +   +   +V +Y 
Sbjct: 47  VAVKYIE-----RGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYA 97
Query: 184 QTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM 240
             G L + +    R  E++ +  ++        +I G+ Y H     Q+ H +LK  N +
Sbjct: 98  SGGELFERICNAGRFSEDEARFFFQ-------QLISGVSYCHAM---QVCHRDLKLENTL 147
Query: 241 LDAEFTPRL--ADFGLAK-----LMPGSLIATSAYSAPECFQNRSYTDK-SDIFSFGMIL 292
           LD    PRL    FG +K       P   + T AY APE    + Y  K +D++S G+ L
Sbjct: 148 LDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207
Query: 293 AVLLTG----RDPTAP 304
            V+L G     DP  P
Sbjct: 208 YVMLVGAYPFEDPEEP 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 147 RIQQELEVLASLRHRNLMSL----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           R ++E +  A+L H  ++++     A  P     Y+V +Y+   +L D +        + 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS- 261
             EV       +    Q L+F+    I+H ++KP N+M+ A    ++ DFG+A+ +  S 
Sbjct: 118 AIEV-------IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 262 --------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   +I T+ Y +PE  +  S   +SD++S G +L  +LTG  P
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           QQE+ VL+      +        + ++ +++ +YL  GS  D ++    ++ Q+   +R 
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR- 111
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSL 262
                ++KGL YLH   + + +H ++K  NV+L      +LADFG+A      ++     
Sbjct: 112 ----EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF 164
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           + T  + APE  +  +Y  K+DI+S G+    L  G  P
Sbjct: 165 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           QQE+ VL+      +        + ++ +++ +YL  GS  D ++    ++ Q+   +R 
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR- 126
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSL 262
                ++KGL YLH   + + +H ++K  NV+L      +LADFG+A      ++     
Sbjct: 127 ----EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF 179
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           + T  + APE  +  +Y  K+DI+S G+    L  G  P
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 85/172 (49%), Gaps = 22/172 (12%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           KR   +E+E+L    +H N+++L+    +    Y+V +  + G L D + R      Q  
Sbjct: 59  KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILR------QKF 112
Query: 204 WEVRLRIAV--GVIKGLQYLHFTCNPQILHYNLKPTNVM-LDAEFTP---RLADFGLAKL 257
           +  R   AV   + K ++YLH      ++H +LKP+N++ +D    P   R+ DFG AK 
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 258 M--PGSLIATSAYSA----PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           +     L+ T  Y+A    PE  + + Y    DI+S G++L   LTG  P A
Sbjct: 170 LRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFA 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 141 NKSVKRRI-QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
            K+V ++I + E+ VL  L H N++ L+      +   LV + +  G L    DRI E  
Sbjct: 87  KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL---FDRIVEK- 142
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLA 255
              G+      A  V + L+ + +     I+H +LKP N +L A   P    ++ADFGL+
Sbjct: 143 ---GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPEN-LLYATPAPDAPLKIADFGLS 198
Query: 256 KLMPGSLI-----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           K++   ++      T  Y APE  +  +Y  + D++S G+I  +LL G +P
Sbjct: 199 KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
           R + +EL+++  L H  L++L     +    ++V D L  G L   +    +  +    E
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFKEE 115
Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----G 260
                   ++  L YL    N +I+H ++KP N++LD      + DF +A ++P      
Sbjct: 116 TVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172
Query: 261 SLIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDP 301
           ++  T  Y APE F +R    Y+   D +S G+    LL GR P
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           QQE+ VL+      +        +S++ +++ +YL  GS   A+D ++   L+  +    
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGS---ALDLLKPGPLEETYIAT- 120
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA------KLMPGSL 262
            I   ++KGL YLH   + + +H ++K  NV+L  +   +LADFG+A      ++     
Sbjct: 121 -ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF 176
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           + T  + APE  +  +Y  K+DI+S G+    L  G  P +
Sbjct: 177 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E EV+  L H  L+ L     E +   LV ++++ G L D +   R  +     E  L 
Sbjct: 52  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLG 108
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           + + V +G+ YL   C   ++H +L   N ++      +++DFG+ + +      +S   
Sbjct: 109 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +++PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 49/232 (21%)
Query: 138 EKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           EKQ   ++ R+ +E+E+L   + HRN++ L  +  E  RFYLV++ ++ GS+   + + R
Sbjct: 47  EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR 106
Query: 197 E-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA--EFTP-RLADF 252
             N+L+    V+      V   L +LH   N  I H +LKP N++ +   + +P ++ DF
Sbjct: 107 HFNELEASVVVQ-----DVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDF 158
Query: 253 GLAK----------------LMPGSLIATSAYSAPECFQNRS-----YTDKSDIFSFGMI 291
            L                  L P     ++ Y APE  +  S     Y  + D++S G+I
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTP---CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 292 LAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEE 343
           L +LL+G     PF       GS   W R     GEA  A  +++L E ++E
Sbjct: 216 LYILLSG---YPPFVGRC---GSDCGWDR-----GEACPAC-QNMLFESIQE 255

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 147 RIQQELEVLASLRHRNLMSL----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           R ++E +  A+L H  ++++     A  P     Y+V +Y+   +L D +        + 
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS- 261
             EV       +    Q L+F+    I+H ++KP N+++ A    ++ DFG+A+ +  S 
Sbjct: 118 AIEV-------IADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSG 170
Query: 262 --------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                   +I T+ Y +PE  +  S   +SD++S G +L  +LTG  P
Sbjct: 171 NSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E    YLV+D +  G L ED + R   ++     
Sbjct: 75  QKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 134
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAKLMPGS 261
            +       +++ + ++H      I+H +LKP N++L ++      +LADFGLA  + G 
Sbjct: 135 CIH-----QILESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE 186
Query: 262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                    T  Y +PE  +   Y    DI++ G+IL +LL G  P
Sbjct: 187 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +L  ++H N+++L       +   L+ + +  G L D +      +  L  E  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP---- 259
                 ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +     
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 260 -GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             ++  T A+ APE         ++D++S G+I  +LL+G  P
Sbjct: 174 FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E EV+  L H  L+ L     E +   LV+++++ G L D +   R  +     E  L 
Sbjct: 51  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLLG 107
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           + + V +G+ YL       ++H +L   N ++      +++DFG+ + +      +S   
Sbjct: 108 MCLDVCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 164
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +++PE F    Y+ KSD++SFG+++  V   G+ P
Sbjct: 165 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 88  KIDPKTLQAALANENRLLGSSPDGK-YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKR 146
           K DP+ L + L    R +G    G  Y+   + N   VA++++      S EK    +K 
Sbjct: 10  KDDPEKLFSDL----REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK- 64
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
               E+  L  LRH N +  R         +LV +Y   GS  D ++ + +  LQ   EV
Sbjct: 65  ----EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE-VHKKPLQ---EV 115
Query: 207 RLR-IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSLI 263
            +  +  G ++GL YLH   +  ++H ++K  N++L      +L DFG A +M      +
Sbjct: 116 EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 172
Query: 264 ATSAYSAPE---CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR 320
            T  + APE         Y  K D++S G I  + L  R P  P F   A        L 
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP--PLFNMNAMSA-----LY 224
Query: 321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
           H+  A     AL      E                CL   P DRP+S+ L+
Sbjct: 225 HI--AQNESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLL 265

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + LG+   G+ +    +N   VAV+ +         K      +   +E  ++ +L+H  
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTL---------KPGTMSVQAFLEEANLMKTLQHDK 69
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V      Y++ +Y+  GSL D +      ++ L     +  +  + +G+ Y+ 
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE 127
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-------AYSAPECFQ 275
                  +H +L+  NV++      ++ADFGLA+++  +             ++APE   
Sbjct: 128 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 184
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +T KSD++SFG++L  ++T G+ P
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 30  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 83
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           ++++    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 84  FEHVDQ-DLKKFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 137
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 138 LINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 197
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 198 AEMVTRR 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
            G  VA++++        + + + V     +E+ +L  L H N++ L   +   ++ YLV
Sbjct: 26  TGEVVALKKIRL------DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79
Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
           ++++    L+  MD      + L       I   + + LQ L F  + ++LH +LKP N+
Sbjct: 80  FEHVHQ-DLKTFMDASALTGIPLPL-----IKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 133
Query: 240 MLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPECFQN-RSYTDKSDIFSFGMIL 292
           +++ E   +LADFGLA+     +      + T  Y APE     + Y+   DI+S G I 
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 293 AVLLTGR 299
           A ++T R
Sbjct: 194 AEMVTRR 200

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           K  ++ E+ ++  L H  L++L     +     L+ ++L  G L    DRI     ++  
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSE 148
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE--FTPRLADFGLA-KLMPGS 261
              +       +GL+++H      I+H ++KP N+M + +   + ++ DFGLA KL P  
Sbjct: 149 AEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
Query: 262 LI----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           ++    AT+ ++APE          +D+++ G++  VLL+G  P A
Sbjct: 206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 88  KIDPKTLQAALANENRLLGSSPDGK-YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKR 146
           K DP+ L + L    R +G    G  Y+   + N   VA++++      S EK    +K 
Sbjct: 49  KDDPEKLFSDL----REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK- 103
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
               E+  L  LRH N +  R         +LV +Y   GS  D ++ + +  LQ   EV
Sbjct: 104 ----EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE-VHKKPLQ---EV 154
Query: 207 RLR-IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSLI 263
            +  +  G ++GL YLH   +  ++H ++K  N++L      +L DFG A +M      +
Sbjct: 155 EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 211
Query: 264 ATSAYSAPE---CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR 320
            T  + APE         Y  K D++S G I  + L  R P  P F   A        L 
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKP--PLFNMNAMSA-----LY 263
Query: 321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
           H+  A     AL      E                CL   P DRP+S+ L+
Sbjct: 264 HI--AQNESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLL 304

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ + A L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 80/154 (51%), Gaps = 14/154 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM--DRIRENQLQLGWEVRL 208
           E  V+ +L+H  L+ L A V +    Y++ +++  GSL D +  D   +  L    +   
Sbjct: 227 EANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 285
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAY 268
           +IA G       + F      +H +L+  N+++ A    ++ADFGLA++     I    +
Sbjct: 286 QIAEG-------MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK---W 335
Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           +APE     S+T KSD++SFG++L  ++T GR P
Sbjct: 336 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 38/254 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           ++VAV+ ++      PE  +  ++     E+  + SL HRNL+ L   V  +    +V +
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIR-----EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTE 90
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
               GSL   +DR+R++Q         R AV V +G+ YL    + + +H +L   N++L
Sbjct: 91  LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 144
Query: 242 DAEFTPRLADFGLAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGL + +P +              A+ APE  + R+++  SD + FG+ L
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 293 AVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRI 352
             + T       +  E   G +  + L  +   GE      R    E+  +D       +
Sbjct: 205 WEMFT-------YGQEPWIGLNGSQILHKIDKEGE------RLPRPEDCPQD----IYNV 247
Query: 353 AVVCLSDSPADRPS 366
            V C +  P DRP+
Sbjct: 248 MVQCWAHKPEDRPT 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 38/254 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           ++VAV+ ++      PE  +  ++     E+  + SL HRNL+ L   V  +    +V +
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIR-----EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTE 90
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
               GSL   +DR+R++Q         R AV V +G+ YL    + + +H +L   N++L
Sbjct: 91  LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 144
Query: 242 DAEFTPRLADFGLAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGL + +P +              A+ APE  + R+++  SD + FG+ L
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 293 AVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRI 352
             + T       +  E   G +  + L  +   GE      R    E+  +D       +
Sbjct: 205 WEMFT-------YGQEPWIGLNGSQILHKIDKEGE------RLPRPEDCPQD----IYNV 247
Query: 353 AVVCLSDSPADRPS 366
            V C +  P DRP+
Sbjct: 248 MVQCWAHKPEDRPT 261

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFD-----ETC 133
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-------- 258
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++        
Sbjct: 134 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             S + T+ Y +PE    +S +  SD+++ G I+  L+ G  P
Sbjct: 191 ANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 40/255 (15%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           ++VAV+ ++      PE  +  ++     E+  + SL HRNL+ L   V  +    +V +
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIR-----EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTE 90
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
               GSL   +DR+R++Q         R AV V +G+ YL    + + +H +L   N++L
Sbjct: 91  LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 144
Query: 242 DAEFTPRLADFGLAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGL + +P +              A+ APE  + R+++  SD + FG+ L
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 204
Query: 293 AVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR 351
             + T G++P         +G  +      L    +  E L R    E+  +D       
Sbjct: 205 WEMFTYGQEPWI-----GLNGSQI------LHKIDKEGERLPRP---EDCPQD----IYN 246
Query: 352 IAVVCLSDSPADRPS 366
           + V C +  P DRP+
Sbjct: 247 VMVQCWAHKPEDRPT 261

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 38/254 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           ++VAV+ ++      PE  +  ++     E+  + SL HRNL+ L   V  +    +V +
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIR-----EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTE 100
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
               GSL   +DR+R++Q         R AV V +G+ YL    + + +H +L   N++L
Sbjct: 101 LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 154
Query: 242 DAEFTPRLADFGLAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGL + +P +              A+ APE  + R+++  SD + FG+ L
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 293 AVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRI 352
             + T       +  E   G +  + L  +   GE      R    E+  +D       +
Sbjct: 215 WEMFT-------YGQEPWIGLNGSQILHKIDKEGE------RLPRPEDCPQD----IYNV 257
Query: 353 AVVCLSDSPADRPS 366
            V C +  P DRP+
Sbjct: 258 MVQCWAHKPEDRPT 271

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E    YL++D +  G L ED + R   ++     
Sbjct: 55  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAKLMPGS 261
            ++      +++ + + H      ++H NLKP N++L ++      +LADFGLA  + G 
Sbjct: 115 CIQ-----QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                    T  Y +PE  +   Y    D+++ G+IL +LL G  P
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 38/254 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           ++VAV+ ++      PE  +  ++     E+  + SL HRNL+ L   V  +    +V +
Sbjct: 41  VSVAVKCLKPDVLSQPEAMDDFIR-----EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTE 94
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
               GSL   +DR+R++Q         R AV V +G+ YL    + + +H +L   N++L
Sbjct: 95  LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 148
Query: 242 DAEFTPRLADFGLAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGL + +P +              A+ APE  + R+++  SD + FG+ L
Sbjct: 149 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 208
Query: 293 AVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRI 352
             + T       +  E   G +  + L  +   GE      R    E+  +D       +
Sbjct: 209 WEMFT-------YGQEPWIGLNGSQILHKIDKEGE------RLPRPEDCPQD----IYNV 251
Query: 353 AVVCLSDSPADRPS 366
            V C +  P DRP+
Sbjct: 252 MVQCWAHKPEDRPT 265

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E    YLV+D +  G L ED + R   ++     
Sbjct: 48  QKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 107
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAKLMPGS 261
            ++      +++ + + H      ++H +LKP N++L ++      +LADFGLA  + G 
Sbjct: 108 CIQ-----QILEAVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD 159
Query: 262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                    T  Y +PE  +  +Y    DI++ G+IL +LL G  P
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 18/161 (11%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM--DRIRENQLQLGWEVRL 208
           E  V+ +L+H  L+ L A V +    Y++ +++  GSL D +  D   +  L    +   
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 118
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-- 266
           +IA G       + F      +H +L+  N+++ A    ++ADFGLA+++  +       
Sbjct: 119 QIAEG-------MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 171
Query: 267 -----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                 ++APE     S+T KSD++SFG++L  ++T GR P
Sbjct: 172 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 111/254 (43%), Gaps = 38/254 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           ++VAV+ ++      PE  +  ++     E+  + SL HRNL+ L   V  +    +V +
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIR-----EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTE 100
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
               GSL   +DR+R++Q         R AV V +G+ YL    + + +H +L   N++L
Sbjct: 101 LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 154
Query: 242 DAEFTPRLADFGLAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGL + +P +              A+ APE  + R+++  SD + FG+ L
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 293 AVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRI 352
             + T       +  E   G +  + L  +   GE      R    E+  +D       +
Sbjct: 215 WEMFT-------YGQEPWIGLNGSQILHKIDKEGE------RLPRPEDCPQD----IYNV 257
Query: 353 AVVCLSDSPADRPS 366
            V C +  P DRP+
Sbjct: 258 MVQCWAHKPEDRPT 271

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 105 LGSSPDGKYY--RTVLDNGLTVAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           +G    GK +  R + + G  VA++RV  +  E G P    + V       L  L +  H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-----VLRHLETFEH 73
Query: 161 RNLMSL-----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
            N++ L      +     ++  LV++++    L   +D++ E  +    E    +   ++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLL 130
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
           +GL +LH   + +++H +LKP N+++ +    +LADFGLA++        S++ T  Y A
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 271 PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE 327
           PE     SY    D++S G I A +   +    P F  ++    LG+ L  +   GE
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKILDVIGLPGE 240

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  + H N+++L       +   L+ + +  G L D + +    +  L  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLAKLMPG 260
           E        ++ G+ YLH     +I H++LKP N+ML  +  P    +L DFGLA  +  
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/178 (21%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V + ++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  +++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 92/183 (50%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  ++G  +KQ    +R    E  ++    H N++ L   V +     ++ +Y++ GSL
Sbjct: 41  IKTLKAGYTDKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 96
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
            DA   +R+N  +      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 97  -DAF--LRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCK 150
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFG+++++   P +   T        ++APE    R +T  SD++S+G+++  V+  G
Sbjct: 151 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 210
Query: 299 RDP 301
             P
Sbjct: 211 ERP 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVR-RVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           ++LGS   G  Y+ + +  G TV +   ++     +  K N         E  ++AS+ H
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE----FMDEALIMASMDH 99
Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            +L+ L   V  S    LV   +  G L   ++ + E++  +G ++ L   V + KG+ Y
Sbjct: 100 PHLVRLLG-VCLSPTIQLVTQLMPHGCL---LEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPE 272
           L      +++H +L   NV++ +    ++ DFGLA+L+ G     +A        + A E
Sbjct: 156 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT 297
           C   R +T +SD++S+G+ +  L+T
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 90/183 (49%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V + ++ GSL
Sbjct: 49  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 104
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 105 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 158
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  V+  G
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 218
Query: 299 RDP 301
             P
Sbjct: 219 ERP 221

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 105 LGSSPDGKYY--RTVLDNGLTVAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           +G    GK +  R + + G  VA++RV  +  E G P    + V       L  L +  H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-----VLRHLETFEH 73
Query: 161 RNLMSL-----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
            N++ L      +     ++  LV++++    L   +D++ E  +    E    +   ++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLL 130
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
           +GL +LH   + +++H +LKP N+++ +    +LADFGLA++        S++ T  Y A
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 271 PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE 327
           PE     SY    D++S G I A +   +    P F  ++    LG+ L  +   GE
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKILDVIGLPGE 240

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 40/255 (15%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           ++VAV+ ++      PE  +  ++     E+  + SL HRNL+ L   V  +    +V +
Sbjct: 41  VSVAVKCLKPDVLSQPEAMDDFIR-----EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTE 94
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
               GSL   +DR+R++Q         R AV V +G+ YL    + + +H +L   N++L
Sbjct: 95  LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 148
Query: 242 DAEFTPRLADFGLAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
                 ++ DFGL + +P +              A+ APE  + R+++  SD + FG+ L
Sbjct: 149 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 208
Query: 293 AVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR 351
             + T G++P         +G  +      L    +  E L R    E+  +D       
Sbjct: 209 WEMFTYGQEPWI-----GLNGSQI------LHKIDKEGERLPRP---EDCPQD----IYN 250
Query: 352 IAVVCLSDSPADRPS 366
           + V C +  P DRP+
Sbjct: 251 VMVQCWAHKPEDRPT 265

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 134
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-------- 258
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++        
Sbjct: 135 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 191
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             S + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 192 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/178 (21%), Positives = 91/178 (51%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  ++G  +KQ    +R    E  ++    H N++ L   V +     ++ +Y++ GSL
Sbjct: 62  IKTLKAGYTDKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 117
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
            DA   +R+N  +      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 118 -DAF--LRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCK 171
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFG+++++   P +   T        ++APE    R +T  SD++S+G+++  +++
Sbjct: 172 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/178 (21%), Positives = 91/178 (51%), Gaps = 19/178 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  ++G  +KQ    +R    E  ++    H N++ L   V +     ++ +Y++ GSL
Sbjct: 47  IKTLKAGYTDKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 102
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
            DA   +R+N  +      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 103 -DAF--LRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCK 156
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           ++DFG+++++   P +   T        ++APE    R +T  SD++S+G+++  +++
Sbjct: 157 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  + H N+++L       +   L+ + +  G L D + +    +  L  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLAKLMPG 260
           E        ++ G+ YLH     +I H++LKP N+ML  +  P    +L DFGLA  +  
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E+ ++   +H N++ +          +++ ++LQ G+L D + ++R N+ Q+       +
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-----TV 146
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMPG--SLIA 264
              V++ L YLH      ++H ++K  +++L  +   +L+DFG    ++K +P    L+ 
Sbjct: 147 CEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVG 203
Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           T  + APE      Y  + DI+S G+++  ++ G     P+F+++
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE---PPYFSDS 245

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  + H N+++L       +   L+ + +  G L D + +    +  L  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLAKLMPG 260
           E        ++ G+ YLH     +I H++LKP N+ML  +  P    +L DFGLA  +  
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 90/183 (49%), Gaps = 20/183 (10%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  EKQ    +R    E  ++    H N++ L   V +S    +V + ++ GSL
Sbjct: 78  IKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL 133
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
           +  +   R++  Q      + +  G+  G++YL    +   +H +L   N+++++    +
Sbjct: 134 DSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCK 187
Query: 249 LADFGLAKLM---PGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTG 298
           ++DFGL++++   P +   T        +++PE    R +T  SD++S+G++L  V+  G
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 299 RDP 301
             P
Sbjct: 248 ERP 250

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  + H N+++L       +   L+ + +  G L D + +    +  L  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLAKLMPG 260
           E        ++ G+ YLH     +I H++LKP N+ML  +  P    +L DFGLA  +  
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  + H N+++L       +   L+ + +  G L D + +    +  L  
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLAKLMPG 260
           E        ++ G+ YLH     +I H++LKP N+ML  +  P    +L DFGLA  +  
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 105 LGSSPDGKYY--RTVLDNGLTVAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           +G    GK +  R + + G  VA++RV  +  E G P    + V       L  L +  H
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-----VLRHLETFEH 73
Query: 161 RNLMSL-----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
            N++ L      +     ++  LV++++    L   +D++ E  +    E    +   ++
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT--ETIKDMMFQLL 130
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYSA 270
           +GL +LH   + +++H +LKP N+++ +    +LADFGLA++        S++ T  Y A
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 271 PECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE 327
           PE     SY    D++S G I A +   +    P F  ++    LG+ L  +   GE
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKILDVIGLPGE 240

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVR-RVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           ++LGS   G  Y+ + +  G TV +   ++     +  K N         E  ++AS+ H
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE----FMDEALIMASMDH 76
Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            +L+ L   V  S    LV   +  G L   ++ + E++  +G ++ L   V + KG+ Y
Sbjct: 77  PHLVRLLG-VCLSPTIQLVTQLMPHGCL---LEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPE 272
           L      +++H +L   NV++ +    ++ DFGLA+L+ G     +A        + A E
Sbjct: 133 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT 297
           C   R +T +SD++S+G+ +  L+T
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 18/161 (11%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM--DRIRENQLQLGWEVRL 208
           E  V+ +L+H  L+ L A V +    Y++ +++  GSL D +  D   +  L    +   
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-- 266
           +IA G       + F      +H +L+  N+++ A    ++ADFGLA+++  +       
Sbjct: 292 QIAEG-------MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 267 -----AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                 ++APE     S+T KSD++SFG++L  ++T GR P
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 130
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-------- 258
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++        
Sbjct: 131 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 187
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             S + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 188 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 112
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 113 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 57  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 112
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 113 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 25/171 (14%)
Query: 146 RRIQQELEVLASLRHRNLMS----LRAYVP--ESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +R  +EL++L   +H N+++    LR  VP  E    Y+V D +     E  + +I  + 
Sbjct: 99  KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-----ESDLHQIIHSS 153
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
             L  E        +++GL+Y+H   + Q++H +LKP+N++++     ++ DFG+A+ + 
Sbjct: 154 QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 210
Query: 260 GS----------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            S           +AT  Y APE   +   YT   D++S G I   +L  R
Sbjct: 211 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L D +      +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E    YLV+D +  G L ED + R   ++     
Sbjct: 48  QKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH 107
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPGS 261
            ++      +++ + + H      I+H +LKP N++L ++      +LADFGLA  + G 
Sbjct: 108 CIQ-----QILESVNHCHLN---GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD 159
Query: 262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                    T  Y +PE  +   Y    D+++ G+IL +LL G  P
Sbjct: 160 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 25/171 (14%)
Query: 146 RRIQQELEVLASLRHRNLMS----LRAYVP--ESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +R  +EL++L   +H N+++    LR  VP  E    Y+V D +++      + +I  + 
Sbjct: 98  KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD-----LHQIIHSS 152
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
             L  E        +++GL+Y+H   + Q++H +LKP+N++++     ++ DFG+A+ + 
Sbjct: 153 QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209
Query: 260 GS----------LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGR 299
            S           +AT  Y APE   +   YT   D++S G I   +L  R
Sbjct: 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 26/202 (12%)
Query: 118 LDNGLTVAVRRVEAFESG--------SPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAY 169
           L  G    VRR     +G        + +K +    +++++E  +   L+H N++ L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 170 VPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           + E    YLV+D +  G L ED + R   ++      ++      +++ + + H      
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-----QILESVNHCHLN---G 123
Query: 229 ILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPGS------LIATSAYSAPECFQNRSY 279
           I+H +LKP N++L ++      +LADFGLA  + G          T  Y +PE  +   Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 280 TDKSDIFSFGMILAVLLTGRDP 301
               D+++ G+IL +LL G  P
Sbjct: 184 GKPVDMWACGVILYILLVGYPP 205

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +L  ++H N+++L       +   L+ + +  G L D +      +  L  E  
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEA 116
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP---- 259
                 ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +     
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 260 -GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           L N + +A++ +       PE+ ++   + + +E+ +   L+H+N++       E+    
Sbjct: 44  LSNQVRIAIKEI-------PERDSR-YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95
Query: 178 LVYDYLQTGSLEDAMDR----IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
           +  + +  GSL   +      +++N+  +G+  +      +++GL+YLH   + QI+H +
Sbjct: 96  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLH---DNQIVHRD 147
Query: 234 LKPTNVMLDA-EFTPRLADFGLAKLMPG------SLIATSAYSAPECFQN--RSYTDKSD 284
           +K  NV+++      +++DFG +K + G      +   T  Y APE      R Y   +D
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 285 IFSFGMILAVLLTGRDP 301
           I+S G  +  + TG+ P
Sbjct: 208 IWSLGCTIIEMATGKPP 224

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/197 (22%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           L N + +A++ +       PE+ ++   + + +E+ +   L+H+N++       E+    
Sbjct: 30  LSNQVRIAIKEI-------PERDSR-YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 81
Query: 178 LVYDYLQTGSLEDAMDR----IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
           +  + +  GSL   +      +++N+  +G+  +      +++GL+YLH   + QI+H +
Sbjct: 82  IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLH---DNQIVHRD 133
Query: 234 LKPTNVMLDA-EFTPRLADFGLAKLMPG------SLIATSAYSAPECFQN--RSYTDKSD 284
           +K  NV+++      +++DFG +K + G      +   T  Y APE      R Y   +D
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 193
Query: 285 IFSFGMILAVLLTGRDP 301
           I+S G  +  + TG+ P
Sbjct: 194 IWSLGCTIIEMATGKPP 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 131
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-------- 258
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++        
Sbjct: 132 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             + + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 189 ANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E +  L  
Sbjct: 58  REDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGEL---FDFLAEKE-SLTE 113
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMP- 259
           E        ++ G+ YLH   + QI H++LKP N+ML     P+    + DFGLA  +  
Sbjct: 114 EEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 260 ----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA----KLMPGSLIATS 266
           A  +I GL+++H   N  +++ +LKP N++LD     R++D GLA    K  P + + T 
Sbjct: 297 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 353
Query: 267 AYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDP 301
            Y APE  Q   +Y   +D FS G +L  LL G  P
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA----KLMPGSLIATS 266
           A  +I GL+++H   N  +++ +LKP N++LD     R++D GLA    K  P + + T 
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 267 AYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDP 301
            Y APE  Q   +Y   +D FS G +L  LL G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           +  I++E+ +L  + H N+++L       +   L+ + +  G L D + +    +  L  
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSE 114
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----RLADFGLAKLMPG 260
           E        ++ G+ YLH     +I H++LKP N+ML  +  P    +L DFGLA  +  
Sbjct: 115 EEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++  T  + APE         ++D++S G+I  +LL+G  P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           QE + +  L H  L+       +    Y+V +Y+  G L   ++ +R +   L     L 
Sbjct: 52  QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL---LNYLRSHGKGLEPSQLLE 108
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V +G+ +L    + Q +H +L   N ++D +   +++DFG+ + +      +S   
Sbjct: 109 MCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
                +SAPE F    Y+ KSD+++FG+++  V   G+ P
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA----KLMPGSLIATS 266
           A  +I GL+++H   N  +++ +LKP N++LD     R++D GLA    K  P + + T 
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 267 AYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDP 301
            Y APE  Q   +Y   +D FS G +L  LL G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 8/96 (8%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA----KLMPGSLIATS 266
           A  +I GL+++H   N  +++ +LKP N++LD     R++D GLA    K  P + + T 
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 267 AYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDP 301
            Y APE  Q   +Y   +D FS G +L  LL G  P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 137
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 138 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKT 194
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 195 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 50  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 105
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 106 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 80/163 (49%), Gaps = 13/163 (7%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           + ++  E+ +  SL H++++    +  ++   ++V +  +  SL +   R R+   +   
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEA 119
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------ 258
              LR    ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  +      
Sbjct: 120 RYYLR---QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 173
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             +L  T  Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 80/163 (49%), Gaps = 13/163 (7%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           + ++  E+ +  SL H++++    +  ++   ++V +  +  SL +   R R+   +   
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEA 119
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------ 258
              LR    ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  +      
Sbjct: 120 RYYLR---QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 173
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             +L  T  Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 174 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           +DP   ++ L N  ++   S       TV  +G  VAV++++        KQ +  +  +
Sbjct: 17  VDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELL 68
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
             E+ ++   +H N++ +          ++V ++L+ G+L D +   R N+ Q+      
Sbjct: 69  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 123
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMP--GSL 262
            + + V++ L  LH      ++H ++K  +++L  +   +L+DFG    ++K +P    L
Sbjct: 124 AVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 180
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + T  + APE      Y  + DI+S G+++  ++ G     P+F E
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNE 223

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 107
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 108 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 102 NRLLGSSPDGKYYRTVLDNGLTVAVRR-VEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
            ++LG   +G +  TVL   L  +    ++  E     K+NK     + +E +V++ L H
Sbjct: 35  GKILG---EGSFSTTVLARELATSREYAIKILEKRHIIKENKVP--YVTRERDVMSRLDH 89
Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG-VIKGLQ 219
              + L     +  + Y    Y + G L   + +I         E   R     ++  L+
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETCTRFYTAEIVSALE 144
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS-------LIATSAYSAP 271
           YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S        + T+ Y +P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 201
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           E    +S    SD+++ G I+  L+ G  P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 80/163 (49%), Gaps = 13/163 (7%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           + ++  E+ +  SL H++++    +  ++   ++V +  +  SL +   R R+   +   
Sbjct: 65  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEA 123
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------ 258
              LR    ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  +      
Sbjct: 124 RYYLR---QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 177
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             +L  T  Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 178 KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 133
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 134 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 133
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 134 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 135
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 136 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 192
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 193 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYS 269
           ++GL +LH  C   I+H +LKP N+++ +  T +LADFGLA++         ++ T  Y 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYR 178
Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           APE     +Y    D++S G I A +   +    P F   +    LG+
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGK 222

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 138
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 139 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 196 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 136
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 137 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 193
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 194 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-EDAMDRIRENQLQLGW 204
           +++++E  +   L+H N++ L   + E    YL++D +  G L ED + R   ++     
Sbjct: 66  QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 125
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAKLMPGS 261
            ++      +++ + + H      ++H +LKP N++L ++      +LADFGLA  + G 
Sbjct: 126 CIQ-----QILEAVLHCH---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE 177
Query: 262 ------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                    T  Y +PE  +   Y    D+++ G+IL +LL G  P
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 82  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 136
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 137 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 193
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 194 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV----PES 173
           L +G   A++R+   E    E+         Q+E ++     H N++ L AY        
Sbjct: 51  LHDGHFYALKRILCHEQQDREE--------AQREADMHRLFNHPNILRLVAYCLRERGAK 102
Query: 174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
              +L+  + + G+L + ++R+++    L  +  L + +G+ +GL+ +H        H +
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRD 159
Query: 234 LKPTNVMLDAEFTPRLADFGLAK----LMPGSLIA-----------TSAYSAPECFQNRS 278
           LKPTN++L  E  P L D G        + GS  A           T +Y APE F  +S
Sbjct: 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219
Query: 279 YT---DKSDIFSFGMILAVLLTGRDPTAPFFAEAAS 311
           +    +++D++S G +L  ++ G  P    F +  S
Sbjct: 220 HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 103 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 157
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 158 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 214
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 215 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           +DP   ++ L N  ++   S       TV  +G  VAV++++        KQ +  +  +
Sbjct: 13  VDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELL 64
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
             E+ ++   +H N++ +          ++V ++L+ G+L D +   R N+ Q+      
Sbjct: 65  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 119
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMP--GSL 262
            + + V++ L  LH      ++H ++K  +++L  +   +L+DFG    ++K +P    L
Sbjct: 120 AVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 176
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + T  + APE      Y  + DI+S G+++  ++ G     P+F E
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNE 219

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 133
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 134 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 84  VTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 138
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 139 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 195
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 196 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 76  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 130
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 131 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 187
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 188 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 131
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 132 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 133
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 134 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 80  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 134
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 135 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 191
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 192 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 102 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 156
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 157 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 213
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 214 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 79  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 133
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 134 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 190
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 191 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 133
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 134 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 191 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + LG+   G+ +    +N   VAV+ +         K      +   +E  ++ +L+H  
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTL---------KPGTMSVQAFLEEANLMKTLQHDK 68
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V +    Y++ +++  GSL D +      ++ L     +  +  + +G+ Y+ 
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE 126
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-------AYSAPECFQ 275
                  +H +L+  NV++      ++ADFGLA+++  +             ++APE   
Sbjct: 127 ---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +T KS+++SFG++L  ++T G+ P
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 138
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 139 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 196 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 131
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 132 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 189 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           +DP   ++ L N  ++   S       TV  +G  VAV++++        KQ +  +  +
Sbjct: 24  VDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELL 75
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
             E+ ++   +H N++ +          ++V ++L+ G+L D +   R N+ Q+      
Sbjct: 76  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 130
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMP--GSL 262
            + + V++ L  LH      ++H ++K  +++L  +   +L+DFG    ++K +P    L
Sbjct: 131 AVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 187
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + T  + APE      Y  + DI+S G+++  ++ G     P+F E
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNE 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 83  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 137
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG++YL    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 138 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 194
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 195 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           I++E+ +   L H N++    +  E +  YL  +Y   G L    DRI E  + +     
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL---FDRI-EPDIGMPEPDA 106
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--------MP 259
            R    ++ G+ YLH      I H ++KP N++LD     +++DFGLA +        + 
Sbjct: 107 QRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 260 GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDP 301
             +  T  Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYS 269
           ++GL +LH  C   I+H +LKP N+++ +  T +LADFGLA++         ++ T  Y 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYR 178
Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           APE     +Y    D++S G I A +   +    P F   +    LG+
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGK 222

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 107/226 (47%), Gaps = 25/226 (11%)
Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           +DP   ++ L N  ++   S       TV  +G  VAV++++        KQ +  +  +
Sbjct: 22  VDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDL------RKQQR--RELL 73
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
             E+ ++   +H N++ +          ++V ++L+ G+L D +   R N+ Q+      
Sbjct: 74  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 128
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG----LAKLMP--GSL 262
            + + V++ L  LH      ++H ++K  +++L  +   +L+DFG    ++K +P    L
Sbjct: 129 AVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 185
Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + T  + APE      Y  + DI+S G+++  ++ G     P+F E
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFNE 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 61  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 115
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 116 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 172
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 173 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 25/168 (14%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLGW 204
           ++ E+E+L  L H  ++ ++ +  ++  +Y+V + ++ G L D +    R++E   +L +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-Y 119
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPG- 260
             ++ +AV      QYLH      I+H +LKP NV+L ++      ++ DFG +K++   
Sbjct: 120 FYQMLLAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 261 ----SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDP 301
               +L  T  Y APE   +     Y    D +S G+IL + L+G  P
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 25/168 (14%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLGW 204
           ++ E+E+L  L H  ++ ++ +  ++  +Y+V + ++ G L D +    R++E   +L +
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-Y 125
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPG- 260
             ++ +AV      QYLH      I+H +LKP NV+L ++      ++ DFG +K++   
Sbjct: 126 FYQMLLAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 261 ----SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDP 301
               +L  T  Y APE   +     Y    D +S G+IL + L+G  P
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 54  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 108
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 109 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 165
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 166 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 25/168 (14%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLGW 204
           ++ E+E+L  L H  ++ ++ +  ++  +Y+V + ++ G L D +    R++E   +L +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-Y 119
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPG- 260
             ++ +AV      QYLH      I+H +LKP NV+L ++      ++ DFG +K++   
Sbjct: 120 FYQMLLAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 261 ----SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDP 301
               +L  T  Y APE   +     Y    D +S G+IL + L+G  P
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 56  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 110
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 111 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 167
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 168 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 25/168 (14%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLGW 204
           ++ E+E+L  L H  ++ ++ +  ++  +Y+V + ++ G L D +    R++E   +L +
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-Y 119
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPG- 260
             ++ +AV      QYLH      I+H +LKP NV+L ++      ++ DFG +K++   
Sbjct: 120 FYQMLLAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 261 ----SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDP 301
               +L  T  Y APE   +     Y    D +S G+IL + L+G  P
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 109
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 110 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 167 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 76  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 130
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 131 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 187
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 188 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           + +E +V++ L H   + L     +  + Y    Y + G L   + +I         E  
Sbjct: 57  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-----ETC 111
Query: 208 LRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGS---- 261
            R     ++  L+YLH      I+H +LKP N++L+ +   ++ DFG AK++ P S    
Sbjct: 112 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 168
Query: 262 ---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + T+ Y +PE    +S    SD+++ G I+  L+ G  P
Sbjct: 169 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 25/168 (14%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRIRENQLQLGW 204
           ++ E+E+L  L H  ++ ++ +  ++  +Y+V + ++ G L D +    R++E   +L +
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-Y 118
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPG- 260
             ++ +AV      QYLH      I+H +LKP NV+L ++      ++ DFG +K++   
Sbjct: 119 FYQMLLAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 261 ----SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDP 301
               +L  T  Y APE   +     Y    D +S G+IL + L+G  P
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 116 TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR 175
           TV  +G  VAV++++        KQ +  +  +  E+ ++   +H N++ +         
Sbjct: 94  TVRSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 145
Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            ++V ++L+ G+L D +   R N+ Q+       + + V++ L  LH      ++H ++K
Sbjct: 146 LWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQG---VIHRDIK 197
Query: 236 PTNVMLDAEFTPRLADFG----LAKLMP--GSLIATSAYSAPECFQNRSYTDKSDIFSFG 289
             +++L  +   +L+DFG    ++K +P    L+ T  + APE      Y  + DI+S G
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 290 MILAVLLTGRDPTAPFFAE 308
           +++  ++ G     P+F E
Sbjct: 258 IMVIEMVDG---EPPYFNE 273

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 17/167 (10%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           R +QE+E++ SL H N++ L     +++  YLV +    G L    +R+   ++    + 
Sbjct: 52  RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDA 108
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML--DAEFTP-RLADFGL-AKLMPGSL 262
             RI   V+  + Y H      + H +LKP N +   D+  +P +L DFGL A+  PG +
Sbjct: 109 -ARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164
Query: 263 ----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP-TAP 304
               + T  Y +P+  +   Y  + D +S G+++ VLL G  P +AP
Sbjct: 165 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP 210

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 98/194 (50%), Gaps = 29/194 (14%)
Query: 124 VAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           VA+R +    F  GS  + + ++   ++ E+E+L  L H  ++ ++ +  ++  +Y+V +
Sbjct: 177 VAIRIISKRKFAIGSAREADPALN--VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLE 233
Query: 182 YLQTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
            ++ G L D +    R++E   +L +  ++ +AV      QYLH      I+H +LKP N
Sbjct: 234 LMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV------QYLH---ENGIIHRDLKPEN 283
Query: 239 VMLDAEFTP---RLADFGLAKLMPG-----SLIATSAYSAPECFQN---RSYTDKSDIFS 287
           V+L ++      ++ DFG +K++       +L  T  Y APE   +     Y    D +S
Sbjct: 284 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 343
Query: 288 FGMILAVLLTGRDP 301
            G+IL + L+G  P
Sbjct: 344 LGVILFICLSGYPP 357

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 98/194 (50%), Gaps = 29/194 (14%)
Query: 124 VAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           VA+R +    F  GS  + + ++   ++ E+E+L  L H  ++ ++ +  ++  +Y+V +
Sbjct: 163 VAIRIISKRKFAIGSAREADPALN--VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLE 219
Query: 182 YLQTGSLEDAM---DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
            ++ G L D +    R++E   +L +  ++ +AV      QYLH      I+H +LKP N
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAV------QYLH---ENGIIHRDLKPEN 269
Query: 239 VMLDAEFTP---RLADFGLAKLMPG-----SLIATSAYSAPECFQN---RSYTDKSDIFS 287
           V+L ++      ++ DFG +K++       +L  T  Y APE   +     Y    D +S
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 288 FGMILAVLLTGRDP 301
            G+IL + L+G  P
Sbjct: 330 LGVILFICLSGYPP 343

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYS 269
           ++GL +LH  C   I+H +LKP N+++ +  T +LADFGLA++    +     + T  Y 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYR 178
Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           APE     +Y    D++S G I A +   +    P F   +    LG+
Sbjct: 179 APEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGK 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 215 IKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIATSAYS 269
           ++GL +LH  C   I+H +LKP N+++ +  T +LADFGLA++         ++ T  Y 
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           APE     +Y    D++S G I A +   +    P F   +    LG+
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGNSEADQLGK 230

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 17/167 (10%)
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           R +QE+E++ SL H N++ L     +++  YLV +    G L    +R+   ++    + 
Sbjct: 69  RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESDA 125
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML--DAEFTP-RLADFGL-AKLMPGSL 262
             RI   V+  + Y H      + H +LKP N +   D+  +P +L DFGL A+  PG +
Sbjct: 126 -ARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 181
Query: 263 ----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP-TAP 304
               + T  Y +P+  +   Y  + D +S G+++ VLL G  P +AP
Sbjct: 182 MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAP 227

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           + ++  E+ +  SL H++++    +  ++   ++V +  +  SL +   R R+   +   
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEA 117
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------ 258
              LR    ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  +      
Sbjct: 118 RYYLR---QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              L  T  Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           + ++  E+ +  SL H++++    +  ++   ++V +  +  SL +   R R+   +   
Sbjct: 85  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEA 143
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------ 258
              LR    ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  +      
Sbjct: 144 RYYLR---QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              L  T  Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 116 TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR 175
           TV  +G  VAV++++        KQ +  +  +  E+ ++   +H N++ +         
Sbjct: 171 TVRSSGKLVAVKKMDL------RKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 222
Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            ++V ++L+ G+L D +   R N+ Q+       + + V++ L  LH      ++H ++K
Sbjct: 223 LWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQG---VIHRDIK 274
Query: 236 PTNVMLDAEFTPRLADFG----LAKLMP--GSLIATSAYSAPECFQNRSYTDKSDIFSFG 289
             +++L  +   +L+DFG    ++K +P    L+ T  + APE      Y  + DI+S G
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 290 MILAVLLTGRDPTAPFFAE 308
           +++  ++ G     P+F E
Sbjct: 335 IMVIEMVDG---EPPYFNE 350

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 16/168 (9%)
Query: 142 KSVKRRIQQELEVL-ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           K  ++ I  E  VL  +++H  L+ L      + + Y V DY+  G L   + R R    
Sbjct: 79  KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER---- 134
Query: 201 QLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--- 256
               E R R  A  +   L YLH   +  I++ +LKP N++LD++    L DFGL K   
Sbjct: 135 -CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190
Query: 257 ---LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                  +   T  Y APE    + Y    D +  G +L  +L G  P
Sbjct: 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 100 NENRLLGSSPDGKYYRTVL---DNGLTVAVRRVEA--------FESGSPEKQN-KSVKRR 147
           N+ R++ +   GK+ + +L   DN    A+++ E         F   + +K + KS    
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKDNKF-YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
            + EL+++  +++   ++    +      Y++Y+Y++     D++ +  E    L     
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEN----DSILKFDEYFFVLDKNYT 145
Query: 208 LRIAVGVIK--------GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
             I + VIK           Y+H   N  I H ++KP+N+++D     +L+DFG ++ M 
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 260 GSLI----ATSAYSAPECFQNRSYTD--KSDIFSFGMILAVLLTGRDPTAPF 305
              I     T  +  PE F N S  +  K DI+S G+ L V+        PF
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN---VVPF 252

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +GS   G  Y+      + V +  V A     P  Q        + E+ VL   RH N++
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTA-----PTPQQLQA---FKNEVGVLRKTRHVNIL 67
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHF 223
               Y   + +  +V  + +  SL   +  I E + ++   ++L  IA    +G+ YLH 
Sbjct: 68  LFMGY-STAPQLAIVTQWCEGSSLYHHL-HIIETKFEM---IKLIDIARQTAQGMDYLHA 122
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS-----LIATSAYSAPECF- 274
                I+H +LK  N+ L  + T ++ DFGLA +     GS     L  +  + APE   
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 275 -QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
            Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 26/235 (11%)
Query: 119 DNGLTVAVRRVEAFE-SGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           + G   AV+ V+  + + SP    + +KR    E  +   L+H +++ L          Y
Sbjct: 47  ETGQQFAVKIVDVAKFTSSPGLSTEDLKR----EASICHMLKHPHIVELLETYSSDGMLY 102
Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +V++++    L   + +  +        V       +++ L+Y H   +  I+H ++KP 
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPE 159
Query: 238 NVMLDAEFTP---RLADFGLA------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSF 288
           NV+L ++      +L DFG+A       L+ G  + T  + APE  +   Y    D++  
Sbjct: 160 NVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGC 219
Query: 289 GMILAVLLTGRDPTAPFFA------EAASGGSLGRWLRHLQHAGEAREALDRSIL 337
           G+IL +LL+G     PF+       E    G      R   H  E+ + L R +L
Sbjct: 220 GVILFILLSG---CLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRML 271

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ADFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ADFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           + ++  E+ +  SL H++++    +  ++   ++V +  +  SL +   R R+   +   
Sbjct: 83  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEA 141
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------ 258
              LR    ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  +      
Sbjct: 142 RYYLR---QIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 195
Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              L  T  Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 196 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 139
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG+++L    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 140 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT 196
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 197 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +GS   G  Y+      + V +  V A     P  Q        + E+ VL   RH N++
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTA-----PTPQQLQA---FKNEVGVLRKTRHVNIL 72
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHF 223
               Y  +  +  +V  + +  SL   +  I E + ++   ++L  IA    +G+ YLH 
Sbjct: 73  LFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKLIDIARQTAQGMDYLHA 127
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS-----LIATSAYSAPECF- 274
                I+H +LK  N+ L  + T ++ DFGLA +     GS     L  +  + APE   
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 275 -QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
            Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 138
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG+++L    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 139 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 196 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 85  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 139
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG+++L    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 140 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 196
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 197 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 89  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 143
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG+++L    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 144 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 200
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 201 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +GS   G  Y+      + V +  V A     P  Q        + E+ VL   RH N++
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTA-----PTPQQLQA---FKNEVGVLRKTRHVNIL 69
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHF 223
               Y  +  +  +V  + +  SL   +  I E + ++   ++L  IA    +G+ YLH 
Sbjct: 70  LFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKLIDIARQTAQGMDYLHA 124
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS-----LIATSAYSAPECF- 274
                I+H +LK  N+ L  + T ++ DFGLA +     GS     L  +  + APE   
Sbjct: 125 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 275 -QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
            Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +GS   G  Y+      + V +  V A     P  Q        + E+ VL   RH N++
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTA-----PTPQQLQA---FKNEVGVLRKTRHVNIL 72
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHF 223
               Y  +  +  +V  + +  SL   +  I E + ++   ++L  IA    +G+ YLH 
Sbjct: 73  LFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKLIDIARQTAQGMDYLHA 127
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS-----LIATSAYSAPECF- 274
                I+H +LK  N+ L  + T ++ DFGLA +     GS     L  +  + APE   
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 275 -QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
            Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V  +E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSP-KANKE----ILDEAYVMASVD 109
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 110 NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 165
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 166 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 223 ESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +GS   G  Y+      + V +  V A     P  Q        + E+ VL   RH N++
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTA-----PTPQQLQA---FKNEVGVLRKTRHVNIL 67
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHF 223
               Y  +  +  +V  + +  SL   +  I E + ++   ++L  IA    +G+ YLH 
Sbjct: 68  LFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKLIDIARQTAQGMDYLHA 122
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS-----LIATSAYSAPECFQ 275
                I+H +LK  N+ L  + T ++ DFGLA +     GS     L  +  + APE  +
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 276 NRS---YTDKSDIFSFGMILAVLLTGRDP 301
            +    Y+ +SD+++FG++L  L+TG+ P
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 75
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           E   +R YT +SD++S+G+ +  L+T G  P
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 82  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 136
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG+++L    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 137 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 193
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 194 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 84  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 138
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG+++L    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 139 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 196 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E  +L ++    L+ L     ++S  Y+V +Y   G +   + RI         E   R
Sbjct: 90  NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-----EPHAR 144
Query: 210 I-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIAT 265
             A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFGLAK + G    L  T
Sbjct: 145 FYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGT 201
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
             Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ADFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 148 IQQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +Q E  V   +  H  L+ L +     SR + V +Y+  G L   M R    Q +L  E 
Sbjct: 99  VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEH 154
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG---- 260
               +  +   L YLH      I++ +LK  NV+LD+E   +L D+G+ K  L PG    
Sbjct: 155 ARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 211
Query: 261 SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           +   T  Y APE  +   Y    D ++ G+++  ++ GR P
Sbjct: 212 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 154 VLASLRHRNLMSLRAYVPESSRFYLVY-DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++    H N++SL      S    LV   Y++ G L + +     N       V+  I  
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-----TVKDLIGF 197
Query: 213 G--VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-----------P 259
           G  V KG+++L    + + +H +L   N MLD +FT ++ADFGLA+ M            
Sbjct: 198 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           G+ +    + A E  Q + +T KSD++SFG++L  L+T   P  P
Sbjct: 255 GAKLPVK-WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 20/165 (12%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y  +  +  +V  + +  SL   +  I E + ++   ++L
Sbjct: 80  KNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKL 134
Query: 209 -RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS--- 261
             IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA +     GS   
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 191
Query: 262 --LIATSAYSAPECF--QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
             L  +  + APE    Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 20/165 (12%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y  +  +  +V  + +  SL   +  I E + ++   ++L
Sbjct: 79  KNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKL 133
Query: 209 -RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS--- 261
             IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA +     GS   
Sbjct: 134 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 190
Query: 262 --LIATSAYSAPECF--QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
             L  +  + APE    Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 191 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 32/203 (15%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG    GK Y+    N  T A+   +  E+ S E+    +      E+E+LA+  H  ++
Sbjct: 19  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYI-----VEIEILATCDHPYIV 71
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAM---DR-IRENQLQLGWEVRLRIAVGVIKGLQY 220
            L        + +++ ++   G+++  M   DR + E Q+Q+       +   +++ L +
Sbjct: 72  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALNF 124
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPEC- 273
           LH   + +I+H +LK  NV++  E   RLADFG+ AK +       S I T  + APE  
Sbjct: 125 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 181
Query: 274 ----FQNRSYTDKSDIFSFGMIL 292
                ++  Y  K+DI+S G+ L
Sbjct: 182 MCETMKDTPYDYKADIWSLGITL 204

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 69
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 70  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 82
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 83  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 78
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 79  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 79
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 80  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 81
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 82  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 137
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 138 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 75
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 76  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 77
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 78  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 77
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 78
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 76
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 77  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y+ + +   +V  + +  SL   +  ++E + Q+     +
Sbjct: 80  RNEVAVLRKTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHL-HVQETKFQMF--QLI 135
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGSL--- 262
            IA    +G+ YLH      I+H ++K  N+ L    T ++ DFGLA +     GS    
Sbjct: 136 DIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE 192
Query: 263 --IATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDP 301
               +  + APE  +   N  ++ +SD++S+G++L  L+TG  P
Sbjct: 193 QPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 78
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFGLAK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 75
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 78
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 135 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 76
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 77  NPHVCRLLG-ICLTSTVQLIMQLMPFGXL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 133 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 85
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 86  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 142 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 83/169 (49%), Gaps = 25/169 (14%)
Query: 150 QELEVLASLRHRNLMSL-RAYVPESSR-FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +E+ +L  L+H N++SL + ++  + R  +L++DY +     D    I+ ++     +  
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKP 122
Query: 208 LRIAVGVIKGLQY-----LHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLM 258
           +++  G++K L Y     +H+     +LH +LKP N+++  E   R    +AD G A+L 
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 259 PGSL---------IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLT 297
              L         + T  Y APE     R YT   DI++ G I A LLT
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 28/194 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSLRAYVPESSRFYLVY 180
           +  A++R++ + S       K   R    ELEVL  L H  N+++L          YL  
Sbjct: 50  MDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 102
Query: 181 DYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           +Y   G+L D + + R                 L  +  L  A  V +G+ YL      Q
Sbjct: 103 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQ 159
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKS 283
            +H NL   N+++   +  ++ADFGL++     +  T       + A E      YT  S
Sbjct: 160 FIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 219
Query: 284 DIFSFGMILAVLLT 297
           D++S+G++L  +++
Sbjct: 220 DVWSYGVLLWEIVS 233

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L 
Sbjct: 52  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLE 108
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL    + Q LH +L   N +++ +   +++DFGL++ +      +S   
Sbjct: 109 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 165
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF 305
                +S PE      ++ KSDI++FG+++  + + G+ P   F
Sbjct: 166 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 209

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 148 IQQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +Q E  V   +  H  L+ L +     SR + V +Y+  G L   M R    Q +L  E 
Sbjct: 67  VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEH 122
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGS--- 261
               +  +   L YLH      I++ +LK  NV+LD+E   +L D+G+ K  L PG    
Sbjct: 123 ARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 179
Query: 262 -LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               T  Y APE  +   Y    D ++ G+++  ++ GR P
Sbjct: 180 XFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 100
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 101 NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 157 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 18/164 (10%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y  +  +  +V  + +  SL      +  ++ +   +  +
Sbjct: 56  KNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL---YHHLHASETKFEMKKLI 111
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---MPGS---- 261
            IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA +     GS    
Sbjct: 112 DIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE 168
Query: 262 -LIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDP 301
            L  +  + APE  +   +  Y+ +SD+++FG++L  L+TG+ P
Sbjct: 169 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L 
Sbjct: 59  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLE 115
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL    + Q LH +L   N +++ +   +++DFGL++ +      +S   
Sbjct: 116 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 172
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF 305
                +S PE      ++ KSDI++FG+++  + + G+ P   F
Sbjct: 173 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 32/203 (15%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG    GK Y+    N  T A+   +  E+ S E+    +      E+E+LA+  H  ++
Sbjct: 27  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYI-----VEIEILATCDHPYIV 79
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAM---DR-IRENQLQLGWEVRLRIAVGVIKGLQY 220
            L        + +++ ++   G+++  M   DR + E Q+Q+       +   +++ L +
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALNF 132
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPEC- 273
           LH   + +I+H +LK  NV++  E   RLADFG+ AK +       S I T  + APE  
Sbjct: 133 LH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVV 189
Query: 274 ----FQNRSYTDKSDIFSFGMIL 292
                ++  Y  K+DI+S G+ L
Sbjct: 190 MCETMKDTPYDYKADIWSLGITL 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 200 IHHIDXXKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L 
Sbjct: 48  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLE 104
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL    + Q LH +L   N +++ +   +++DFGL++ +      +S   
Sbjct: 105 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF 305
                +S PE      ++ KSDI++FG+++  + + G+ P   F
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L 
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLE 124
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL    + Q LH +L   N +++ +   +++DFGL++ +      +S   
Sbjct: 125 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF 305
                +S PE      ++ KSDI++FG+++  + + G+ P   F
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 200 IHHIDYYKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 33/217 (15%)
Query: 104 LLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHR 161
           L+G+   G+ Y+   +  G   A++ ++   +G  E++       I+QE+ +L     HR
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TGDEEEE-------IKQEINMLKKYSHHR 81
Query: 162 NLMSLR-AYVPES-----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
           N+ +   A++ ++      + +LV ++   GS+ D +   + N L+  W     I   ++
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREIL 139
Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYS 269
           +GL +LH     +++H ++K  NV+L      +L DFG++  +        + I T  + 
Sbjct: 140 RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 270 APE---CFQN--RSYTDKSDIFSFGMILAVLLTGRDP 301
           APE   C +N   +Y  KSD++S G+    +  G  P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 75
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGXL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 148 IQQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +Q E  V   +  H  L+ L +     SR + V +Y+  G L   M R    Q +L  E 
Sbjct: 52  VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEH 107
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGS--- 261
               +  +   L YLH      I++ +LK  NV+LD+E   +L D+G+ K  L PG    
Sbjct: 108 ARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 164
Query: 262 -LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               T  Y APE  +   Y    D ++ G+++  ++ GR P
Sbjct: 165 XFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L 
Sbjct: 53  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLE 109
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL    + Q LH +L   N +++ +   +++DFGL++ +      +S   
Sbjct: 110 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 166
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF 305
                +S PE      ++ KSDI++FG+++  + + G+ P   F
Sbjct: 167 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 210

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 192 IHHIDYYKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 193 IHHIDYYKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 148 IQQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +Q E  V   +  H  L+ L +     SR + V +Y+  G L   M R    Q +L  E 
Sbjct: 56  VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEH 111
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGS--- 261
               +  +   L YLH      I++ +LK  NV+LD+E   +L D+G+ K  L PG    
Sbjct: 112 ARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168
Query: 262 -LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               T  Y APE  +   Y    D ++ G+++  ++ GR P
Sbjct: 169 XFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 185 IHHIDYYKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 28/181 (15%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVP----------ESSRFYLVYDYLQTGSLEDAMDR 194
           K  I Q+ +V  ++  + ++SL    P             R + V +++  G L   + +
Sbjct: 58  KDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK 117
Query: 195 IRENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
            R        E R R  A  +I  L +LH   +  I++ +LK  NV+LD E   +LADFG
Sbjct: 118 SRRFD-----EARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 254 LAK------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           + K      +   +   T  Y APE  Q   Y    D ++ G++L  +L G    APF A
Sbjct: 170 MCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH---APFEA 226
Query: 308 E 308
           E
Sbjct: 227 E 227

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 166
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G   +L  T 
Sbjct: 167 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTP 223
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 262

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           +K +  QE  +L    H N++ L     +    Y+V + +Q G   D +  +R    +L 
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGARLR 211
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
            +  L++      G++YL   C    +H +L   N ++  +   +++DFG+++     + 
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVX 268
Query: 264 ATSA--------YSAPECFQNRSYTDKSDIFSFGMIL 292
           A S         ++APE      Y+ +SD++SFG++L
Sbjct: 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 189 IHHIDYYKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 241 IHHIDYYKKTTNGRLPV--KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           +K +  QE  +L    H N++ L     +    Y+V + +Q G   D +  +R    +L 
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGARLR 211
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
            +  L++      G++YL   C    +H +L   N ++  +   +++DFG+++     + 
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268
Query: 264 ATSA--------YSAPECFQNRSYTDKSDIFSFGMIL 292
           A S         ++APE      Y+ +SD++SFG++L
Sbjct: 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           +GS   G  Y+      + V +  V A     P  Q        + E+ VL   RH N++
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTA-----PTPQQLQA---FKNEVGVLRKTRHVNIL 67
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHF 223
               Y  +  +  +V  + +  SL   +  I E + ++   ++L  IA    +G+ YLH 
Sbjct: 68  LFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKLIDIARQTAQGMDYLHA 122
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLA---KLMPGS-----LIATSAYSAPECF- 274
                I+H +LK  N+ L  + T ++ DFGLA       GS     L  +  + APE   
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 275 -QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
            Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--------- 200
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   L         
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 201 ---QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
              QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 200 IHHIDYYKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 20/165 (12%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y  +  +  +V  + +  SL   +  I E + ++   ++L
Sbjct: 80  KNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKL 134
Query: 209 -RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA---KLMPGS--- 261
             IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA       GS   
Sbjct: 135 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 191
Query: 262 --LIATSAYSAPECF--QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
             L  +  + APE    Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 192 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L 
Sbjct: 53  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLE 109
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL    + Q LH +L   N +++ +   +++DFGL++ +      +S   
Sbjct: 110 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGS 166
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF 305
                +S PE      ++ KSDI++FG+++  + + G+ P   F
Sbjct: 167 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 210

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y   + +  +V  + +  SL      +  ++ +   +  +
Sbjct: 68  KNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSL---YHHLHASETKFEMKKLI 123
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA---KLMPGS---- 261
            IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA       GS    
Sbjct: 124 DIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 262 -LIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDP 301
            L  +  + APE  +   +  Y+ +SD+++FG++L  L+TG+ P
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFX-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 20/165 (12%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y  +  +  +V  + +  SL   +  I E + ++   ++L
Sbjct: 72  KNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HIIETKFEM---IKL 126
Query: 209 -RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA---KLMPGS--- 261
             IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA       GS   
Sbjct: 127 IDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQF 183
Query: 262 --LIATSAYSAPECF--QNRS-YTDKSDIFSFGMILAVLLTGRDP 301
             L  +  + APE    Q+++ Y+ +SD+++FG++L  L+TG+ P
Sbjct: 184 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 82/181 (45%), Gaps = 34/181 (18%)
Query: 145 KRRIQQELEVLAS--LRHRNLMSLRAYVPESS----RFYLVYDYLQTGSLEDAMDRIREN 198
           K+  Q E E+ ++  ++H NL+   A     S      +L+  +   GSL    D ++ N
Sbjct: 51  KQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSL---TDYLKGN 107
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTC--------NPQILHYNLKPTNVMLDAEFTPRLA 250
            +   W     +A  + +GL YLH            P I H + K  NV+L ++ T  LA
Sbjct: 108 IIT--WNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLA 165
Query: 251 DFGLA-KLMPG-------SLIATSAYSAPEC------FQNRSYTDKSDIFSFGMILAVLL 296
           DFGLA +  PG         + T  Y APE       FQ  ++  + D+++ G++L  L+
Sbjct: 166 DFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFL-RIDMYAMGLVLWELV 224
Query: 297 T 297
           +
Sbjct: 225 S 225

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y  +  +  +V  + +  SL      +  ++ +   +  +
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSL---YHHLHASETKFEMKKLI 123
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA---KLMPGS---- 261
            IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA       GS    
Sbjct: 124 DIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180
Query: 262 -LIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDP 301
            L  +  + APE  +   +  Y+ +SD+++FG++L  L+TG+ P
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 32/193 (16%)
Query: 138 EKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSL-------- 188
           EK + S +  +  EL+++  L  H N+++L      S   YL+++Y   G L        
Sbjct: 85  EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 189 ----EDAMDRIRENQLQ-------LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
               ED ++   + +L+       L +E  L  A  V KG+++L F      +H +L   
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201
Query: 238 NVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFG 289
           NV++      ++ DFGLA+        ++ G+      + APE      YT KSD++S+G
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261
Query: 290 MILAVLLT-GRDP 301
           ++L  + + G +P
Sbjct: 262 ILLWEIFSLGVNP 274

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L 
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLE 124
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-- 267
           +   V + ++YL    + Q LH +L   N +++ +   +++DFGL++ +      +S   
Sbjct: 125 MCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGS 181
Query: 268 -----YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF 305
                +S PE      ++ KSDI++FG+++  + + G+ P   F
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 31/200 (15%)
Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
           Y   +LD    V ++++E          +   ++RIQQ      ++    L+ L     +
Sbjct: 70  YAMKILDKQKVVKLKQIE----------HTLNEKRIQQ------AVNFPFLVKLEFSFKD 113
Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILH 231
           +S  Y+V +Y   G +   + RI         E   R  A  ++   +YLH   +  +++
Sbjct: 114 NSNLYMVLEYAPGGEMFSHLRRIGRFS-----EPHARFYAAQIVLTFEYLH---SLDLIY 165
Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSF 288
            +LKP N+++D +   ++ADFG AK + G    L  T  Y APE   ++ Y    D ++ 
Sbjct: 166 RDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 289 GMILAVLLTGRDPTAPFFAE 308
           G+++  +  G     PFFA+
Sbjct: 226 GVLIYEMAAG---YPPFFAD 242

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G   +L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 131
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G   +L  T 
Sbjct: 132 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 188
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 189 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 227

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL-- 178
           G++VA+++V          Q+   + R  Q ++ LA L H N++ L++Y      FY   
Sbjct: 48  GMSVAIKKV---------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSY------FYTLG 92
Query: 179 ------VYDYLQTGSLEDAMDRIRENQLQLGWE---VRLRIAV-GVIKGLQYLHFTCNPQ 228
                 +Y  +    + D + R   N  +       + +++ +  +I+ +  LH   +  
Sbjct: 93  ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVN 151
Query: 229 ILHYNLKPTNVML-DAEFTPRLADFGLAKLMPGS-----LIATSAYSAPE-CFQNRSYTD 281
           + H ++KP NV++ +A+ T +L DFG AK +  S      I +  Y APE  F N+ YT 
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTT 211
Query: 282 KSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
             DI+S G I A ++ G     P F    S G L   +R L     +RE L +
Sbjct: 212 AVDIWSVGCIFAEMMLGE----PIFRGDNSAGQLHEIVRVL--GCPSREVLRK 258

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTG---SLEDAMDRIRENQLQLGWEV 206
           +E+ +L  L+H N+++L   +       LV++YL       L+D  + I  + ++L    
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL---- 104
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL--AKLMPGSL-- 262
                  +++GL Y H     ++LH +LKP N++++     +LADFGL  AK +P     
Sbjct: 105 ---FLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158
Query: 263 --IATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGR 299
             + T  Y  P+     + Y+ + D++  G I   + TGR
Sbjct: 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/181 (20%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  E+Q    +R    E  ++    H N++ L   V  S    ++ ++++ G+L
Sbjct: 49  IKTLKGGYTERQ----RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY-LHFTCNPQILHYNLKPTNVMLDAEFTP 247
            D+  R+ + Q  +   ++L   VG+++G+   + +      +H +L   N+++++    
Sbjct: 105 -DSFLRLNDGQFTV---IQL---VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVC 157
Query: 248 RLADFGLAKLM---PGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMILAVLL 296
           +++DFGL++ +         TS+        ++APE    R +T  SD +S+G+++  ++
Sbjct: 158 KVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217
Query: 297 T 297
           +
Sbjct: 218 S 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/181 (20%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 129 VEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL 188
           ++  + G  E+Q    +R    E  ++    H N++ L   V  S    ++ ++++ G+L
Sbjct: 47  IKTLKGGYTERQ----RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
Query: 189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY-LHFTCNPQILHYNLKPTNVMLDAEFTP 247
            D+  R+ + Q  +   ++L   VG+++G+   + +      +H +L   N+++++    
Sbjct: 103 -DSFLRLNDGQFTV---IQL---VGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVC 155
Query: 248 RLADFGLAKLM---PGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMILAVLL 296
           +++DFGL++ +         TS+        ++APE    R +T  SD +S+G+++  ++
Sbjct: 156 KVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 215
Query: 297 T 297
           +
Sbjct: 216 S 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 72
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + +G+ 
Sbjct: 73  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFGLAKL+        A        + A 
Sbjct: 129 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L  L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-----EPHARF 166
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 167 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 223
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 262

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L  L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYQMAAG---YPPFFAD 241

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L  L     ++S  Y+V +Y   G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFX-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+M+D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 132
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 133 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTP 189
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 190 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 228

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-----EPHARF 140
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 141 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 197
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 198 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 236

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 166
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 167 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 223
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 262

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARF 252
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLI 263
               ++  L YLH   N  +++ +LK  N+MLD +   ++ DFGL K  +  G    +  
Sbjct: 253 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 310
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 83/194 (42%), Gaps = 28/194 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSLRAYVPESSRFYLVY 180
           +  A++R++ + S       K   R    ELEVL  L H  N+++L          YL  
Sbjct: 53  MDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105
Query: 181 DYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           +Y   G+L D + + R                 L  +  L  A  V +G+ YL      Q
Sbjct: 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQ 162
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKS 283
            +H +L   N+++   +  ++ADFGL++     +  T       + A E      YT  S
Sbjct: 163 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 222
Query: 284 DIFSFGMILAVLLT 297
           D++S+G++L  +++
Sbjct: 223 DVWSYGVLLWEIVS 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 201 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARF 255
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLI 263
               ++  L YLH   N  +++ +LK  N+MLD +   ++ DFGL K  +  G    +  
Sbjct: 256 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 313
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIIISKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 146
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 242

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 83/194 (42%), Gaps = 28/194 (14%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSLRAYVPESSRFYLVY 180
           +  A++R++ + S       K   R    ELEVL  L H  N+++L          YL  
Sbjct: 43  MDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 95
Query: 181 DYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           +Y   G+L D + + R                 L  +  L  A  V +G+ YL      Q
Sbjct: 96  EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQ 152
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKS 283
            +H +L   N+++   +  ++ADFGL++     +  T       + A E      YT  S
Sbjct: 153 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 212
Query: 284 DIFSFGMILAVLLT 297
           D++S+G++L  +++
Sbjct: 213 DVWSYGVLLWEIVS 226

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-----EPHARF 138
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 139 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 195
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 84/171 (49%), Gaps = 30/171 (17%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN----------- 198
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + + + RE            
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QAREPPGLEYSYNPSH 141
Query: 199 --QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA- 255
             + QL  +  +  A  V +G++YL    + + +H +L   NV++  +   ++ADFGLA 
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 256 ---------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                    K   G L     + APE   +R YT +SD++SFG++L  + T
Sbjct: 199 DIHHIDYYKKTTNGRLPVK--WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-----EPHARF 138
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 139 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 195
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 234

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 78/179 (43%), Gaps = 40/179 (22%)
Query: 148 IQQELEVLASLRH-------------RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR 194
           I  E+ +LASL H             RN +     V + S  ++  +Y + G+L D +  
Sbjct: 49  ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS 108
Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
              NQ +   +   R+   +++ L Y+H   +  I+H +LKP N+ +D     ++ DFGL
Sbjct: 109 ENLNQQR---DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGL 162
Query: 255 AK--------------LMPG------SLIATSAYSAPECFQNRS-YTDKSDIFSFGMIL 292
           AK               +PG      S I T+ Y A E       Y +K D++S G+I 
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 92/184 (50%), Gaps = 22/184 (11%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           + VA++  E  E+ SP K NK     I  E  V+AS+ + ++  L   +  +S   L+  
Sbjct: 52  IPVAIK--ELREATSP-KANKE----ILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQ 103
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
            +  G L   +D +RE++  +G +  L   V + KG+ YL    + +++H +L   NV++
Sbjct: 104 LMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLV 157
Query: 242 DAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMILA 293
                 ++ DFGLAKL+        A        + A E   +R YT +SD++S+G+ + 
Sbjct: 158 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 217
Query: 294 VLLT 297
            L+T
Sbjct: 218 ELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 92/184 (50%), Gaps = 22/184 (11%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           + VA++  E  E+ SP K NK     I  E  V+AS+ + ++  L   +  +S   L+  
Sbjct: 52  IPVAIK--ELREATSP-KANKE----ILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQ 103
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
            +  G L   +D +RE++  +G +  L   V + KG+ YL    + +++H +L   NV++
Sbjct: 104 LMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLV 157
Query: 242 DAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMILA 293
                 ++ DFGLAKL+        A        + A E   +R YT +SD++S+G+ + 
Sbjct: 158 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 217
Query: 294 VLLT 297
            L+T
Sbjct: 218 ELMT 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 77
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFG AKL+        A        + A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 79
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 80  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFG AKL+        A        + A 
Sbjct: 136 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 59  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARF 113
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L YLH   N  +++ +LK  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 114 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC 171
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 60  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARF 114
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L YLH   N  +++ +LK  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 115 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC 172
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 77
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFG AKL+        A        + A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 75
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFG AKL+        A        + A 
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 92/184 (50%), Gaps = 22/184 (11%)
Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           + VA++  E  E+ SP K NK     I  E  V+AS+ + ++  L   +  +S   L+  
Sbjct: 45  IPVAIK--ELREATSP-KANKE----ILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQ 96
Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML 241
            +  G L   +D +RE++  +G +  L   V + KG+ YL    + +++H +L   NV++
Sbjct: 97  LMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLV 150
Query: 242 DAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMILA 293
                 ++ DFGLAKL+        A        + A E   +R YT +SD++S+G+ + 
Sbjct: 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210
Query: 294 VLLT 297
            L+T
Sbjct: 211 ELMT 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 58  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-----VFSEDRARF 112
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L YLH   N  +++ +LK  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 113 YGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC 170
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E ++LA +  R ++SL       +   LV   +  G +   +  + E+         +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS- 269
              ++ GL++LH      I++ +LKP NV+LD +   R++D GLA  +      T  Y+ 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 270 -----APECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                APE      Y    D F+ G+ L  ++  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E ++LA +  R ++SL       +   LV   +  G +   +  + E+         +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS- 269
              ++ GL++LH      I++ +LKP NV+LD +   R++D GLA  +      T  Y+ 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 270 -----APECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                APE      Y    D F+ G+ L  ++  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 82
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 83  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 138
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFG AKL+        A        + A 
Sbjct: 139 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA 264
           E+  +I +  +K L   H   N +I+H ++KP+N++LD     +L DFG++  +  S+  
Sbjct: 125 EILGKITLATVKALN--HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182
Query: 265 T-----SAYSAPE----CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           T       Y APE        + Y  +SD++S G+ L  L TGR P
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E ++LA +  R ++SL       +   LV   +  G +   +  + E+         +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS- 269
              ++ GL++LH      I++ +LKP NV+LD +   R++D GLA  +      T  Y+ 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 270 -----APECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                APE      Y    D F+ G+ L  ++  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VA++RV        +  ++ V     +E+ +L  L+H+N++ L   +    +  LV+++ 
Sbjct: 30  VALKRVRL------DDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83
Query: 184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA 243
                +D           L  E+       ++KGL + H   +  +LH +LKP N++++ 
Sbjct: 84  D----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINR 136
Query: 244 EFTPRLADFGLAKL--MP----GSLIATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLL 296
               +LADFGLA+   +P     + + T  Y  P+  F  + Y+   D++S G I A L 
Sbjct: 137 NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 297 TGRDPTAP 304
               P  P
Sbjct: 197 NAARPLFP 204

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E ++LA +  R ++SL       +   LV   +  G +   +  + E+         +  
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS- 269
              ++ GL++LH      I++ +LKP NV+LD +   R++D GLA  +      T  Y+ 
Sbjct: 295 TAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 270 -----APECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                APE      Y    D F+ G+ L  ++  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      R+ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 41/229 (17%)
Query: 91  PKTLQAALANENRLLGSSPDGKYYRTVLDN--GLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           P  +Q  +A + +++     G+Y    +    G  VAV+     E  S  ++        
Sbjct: 28  PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRET------- 80
Query: 149 QQELEVLASLRHRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
             E+     +RH N++   A         ++ YL+ DY + GSL D +         L  
Sbjct: 81  --EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDA 133
Query: 205 EVRLRIAVGVIKGLQYLH---FTC--NPQILHYNLKPTNVMLDAEFTPRLADFGLA---- 255
           +  L++A   + GL +LH   F+    P I H +LK  N+++    T  +AD GLA    
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193
Query: 256 ------KLMPGSLIATSAYSAPECFQ---NRSYTDK---SDIFSFGMIL 292
                  + P + + T  Y  PE      NR++      +D++SFG+IL
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 103 RLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
           ++LGS   G  Y+ +       + + V   E  E+ SP K NK     I  E  V+AS+ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKE----ILDEAYVMASVD 77
Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           + ++  L   +  +S   L+   +  G L   +D +RE++  +G +  L   V + KG+ 
Sbjct: 78  NPHVCRLLG-ICLTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAP 271
           YL    + +++H +L   NV++      ++ DFG AKL+        A        + A 
Sbjct: 134 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++S+G+ +  L+T
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           K  ++ E+ V+  L H NL+ L       +   LV +Y+  G L    DRI +    L  
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL---FDRIIDESYNLTE 186
Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLAK-LMPG 260
              +     + +G++++H      ILH +LKP N++    DA+   ++ DFGLA+   P 
Sbjct: 187 LDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPR 242
Query: 261 SLI----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             +     T  + APE       +  +D++S G+I  +LL+G  P
Sbjct: 243 EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY- 177
           D G  VA+++    +  SP+      + R   E++++  L H N++S R  VP+  +   
Sbjct: 38  DTGEQVAIKQCR--QELSPKN-----RERWCLEIQIMKKLNHPNVVSARE-VPDGLQKLA 89
Query: 178 ------LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK-GLQYLHFTCNPQIL 230
                 L  +Y + G L   +++  EN   L  E  +R  +  I   L+YLH     +I+
Sbjct: 90  PNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLK-EGPIRTLLSDISSALRYLHEN---RII 144
Query: 231 HYNLKPTNVMLD---AEFTPRLADFGLAK-LMPGSL----IATSAYSAPECFQNRSYTDK 282
           H +LKP N++L         ++ D G AK L  G L    + T  Y APE  + + YT  
Sbjct: 145 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 204
Query: 283 SDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
            D +SFG +    +TG  P  P +      G +
Sbjct: 205 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 237

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY- 177
           D G  VA+++    +  SP+      + R   E++++  L H N++S R  VP+  +   
Sbjct: 37  DTGEQVAIKQCR--QELSPKN-----RERWCLEIQIMKKLNHPNVVSARE-VPDGLQKLA 88
Query: 178 ------LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK-GLQYLHFTCNPQIL 230
                 L  +Y + G L   +++  EN   L  E  +R  +  I   L+YLH     +I+
Sbjct: 89  PNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLK-EGPIRTLLSDISSALRYLHEN---RII 143
Query: 231 HYNLKPTNVMLD---AEFTPRLADFGLAK-LMPGSL----IATSAYSAPECFQNRSYTDK 282
           H +LKP N++L         ++ D G AK L  G L    + T  Y APE  + + YT  
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVT 203
Query: 283 SDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
            D +SFG +    +TG  P  P +      G +
Sbjct: 204 VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIAT 265
           A  +  GL+ LH     +I++ +LKP N++LD     R++D GLA  +P        + T
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             Y APE  +N  YT   D ++ G +L  ++ G+ P
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-----GSLIAT 265
           A  +  GL+ LH     +I++ +LKP N++LD     R++D GLA  +P        + T
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             Y APE  +N  YT   D ++ G +L  ++ G+ P
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPGSLIA 264
           A  +I GLQ+LH   +  I++ +LK  N++LD +   ++ADFG+ K              
Sbjct: 125 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCG 181
Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           T  Y APE    + Y    D +SFG++L  +L G+ P
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 40/179 (22%)
Query: 148 IQQELEVLASLRH-------------RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR 194
           I  E+ +LASL H             RN +     V + S  ++  +Y +  +L D +  
Sbjct: 49  ILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS 108
Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
              NQ +  +    R+   +++ L Y+H   +  I+H NLKP N+ +D     ++ DFGL
Sbjct: 109 ENLNQQRDEY---WRLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGL 162
Query: 255 AK--------------LMPG------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMIL 292
           AK               +PG      S I T+ Y A E       Y +K D +S G+I 
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIF 221

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 109
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLI 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G    +  
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 82/170 (48%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSL------------EDAMDRIRE 197
           E+E++  + +H+N+++L     +    Y++ +Y   G+L            E + D  R 
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRV 149
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
            + Q+ ++  +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDXXKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 141 NKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +K ++   Q+E+  L     H N++ L     +    +LV + L  G L    +RI++ +
Sbjct: 45  SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKK 101
Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAK 256
                E    I   ++  + ++H   +  ++H +LKP N++   E      ++ DFG A+
Sbjct: 102 HFSETEASY-IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 257 LMP------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           L P       +   T  Y+APE      Y +  D++S G+IL  +L+G+ P
Sbjct: 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 95/201 (47%), Gaps = 38/201 (18%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPES----SR 175
           G  VA++++E F+             R  +E+++L   +H N++++     P+S    + 
Sbjct: 36  GEIVAIKKIEPFDK-------PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88
Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            Y++ + +QT      + R+   Q+     ++  I    ++ ++ LH +    ++H +LK
Sbjct: 89  VYIIQELMQTD-----LHRVISTQMLSDDHIQYFI-YQTLRAVKVLHGS---NVIHRDLK 139
Query: 236 PTNVMLDAEFTPRLADFGLAKLMPGS----------------LIATSAYSAPEC-FQNRS 278
           P+N+++++    ++ DFGLA+++  S                 +AT  Y APE    +  
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK 199
Query: 279 YTDKSDIFSFGMILAVLLTGR 299
           Y+   D++S G ILA L   R
Sbjct: 200 YSRAMDVWSCGCILAELFLRR 220

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 58  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 112
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLI 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G    +  
Sbjct: 113 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 169
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 170 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 60  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 114
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 115 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 171
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 109
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 166
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPGSLIA 264
           A  +I GLQ+LH   +  I++ +LK  N++LD +   ++ADFG+ K              
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCG 180
Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           T  Y APE    + Y    D +SFG++L  +L G+ P
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 109
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLI 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G    +  
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 166
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 11/102 (10%)
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT--- 265
           +IAV ++K L++LH   +  ++H ++KP+NV+++A    ++ DFG++  +  S+  T   
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 266 --SAYSAPEC----FQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               Y APE        + Y+ KSDI+S G+ +  L   R P
Sbjct: 215 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 256

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 109
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 166
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 154 VLASLRHRNLMSLRA-YVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           ++  L H N+++L    +P     +++  Y+  G   D +  IR  Q     +  +   +
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHG---DLLQFIRSPQRNPTVKDLISFGL 131
Query: 213 GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-LMPGSLIATS----- 266
            V +G++YL      + +H +L   N MLD  FT ++ADFGLA+ ++     +       
Sbjct: 132 QVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                ++A E  Q   +T KSD++SFG++L  LLT   P
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  VL + RH  L +L+       R   V +Y   G L   + R R     +  E R R 
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARF 109
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLI---- 263
               ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G+ +    
Sbjct: 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC 166
Query: 264 ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y APE  ++  Y    D +  G+++  ++ GR P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 158 LRHRNLMSLRAYVPES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           LRH N++   A   +     ++ +LV DY + GSL D +     N+  +  E  +++A+ 
Sbjct: 60  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALS 114
Query: 214 VIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLA----------KLM 258
              GL +LH         P I H +LK  N+++    T  +AD GLA           + 
Sbjct: 115 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 174
Query: 259 PGSLIATSAYSAPECFQNR------SYTDKSDIFSFGMIL 292
           P   + T  Y APE   +           ++DI++ G++ 
Sbjct: 175 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 214

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 77  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 136
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARD 193
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 194 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 32/203 (15%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG    GK Y+    N  T  +   +  ++ S E+    +      E+++LAS  H N++
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYM-----VEIDILASCDHPNIV 97
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR----ENQLQLGWEVRLRIAVGVIKGLQY 220
            L       +  +++ ++   G+++  M  +     E+Q+Q+       +    +  L Y
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALNY 150
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPECF 274
           LH   + +I+H +LK  N++   +   +LADFG++           S I T  + APE  
Sbjct: 151 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 207
Query: 275 -----QNRSYTDKSDIFSFGMIL 292
                ++R Y  K+D++S G+ L
Sbjct: 208 MCETSKDRPYDYKADVWSLGITL 230

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 158 LRHRNLMSLRAYVPES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           LRH N++   A   +     ++ +LV DY + GSL D +     N+  +  E  +++A+ 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALS 147
Query: 214 VIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLA----------KLM 258
              GL +LH         P I H +LK  N+++    T  +AD GLA           + 
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 259 PGSLIATSAYSAPECFQNR------SYTDKSDIFSFGMIL 292
           P   + T  Y APE   +           ++DI++ G++ 
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 79  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 138
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 139 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 195
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 196 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 158 LRHRNLMSLRAYVPES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           LRH N++   A   +     ++ +LV DY + GSL D +     N+  +  E  +++A+ 
Sbjct: 80  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALS 134
Query: 214 VIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLA----------KLM 258
              GL +LH         P I H +LK  N+++    T  +AD GLA           + 
Sbjct: 135 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 194
Query: 259 PGSLIATSAYSAPECFQNR------SYTDKSDIFSFGMIL 292
           P   + T  Y APE   +           ++DI++ G++ 
Sbjct: 195 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 32/203 (15%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG    GK Y+    N  T  +   +  ++ S E+    +      E+++LAS  H N++
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYM-----VEIDILASCDHPNIV 97
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR----ENQLQLGWEVRLRIAVGVIKGLQY 220
            L       +  +++ ++   G+++  M  +     E+Q+Q+       +    +  L Y
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALNY 150
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPECF 274
           LH   + +I+H +LK  N++   +   +LADFG++           S I T  + APE  
Sbjct: 151 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVV 207
Query: 275 -----QNRSYTDKSDIFSFGMIL 292
                ++R Y  K+D++S G+ L
Sbjct: 208 MCETSKDRPYDYKADVWSLGITL 230

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 73/163 (44%), Gaps = 36/163 (22%)
Query: 158 LRHRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           LRH N++   A        S++ +L+  Y + GSL D + R       L   + LR+AV 
Sbjct: 59  LRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQR-----QTLEPHLALRLAVS 113
Query: 214 VIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-GS------ 261
              GL +LH         P I H + K  NV++ +     +AD GLA +   GS      
Sbjct: 114 AACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIG 173
Query: 262 ---LIATSAYSAPE---------CFQNRSYTDKSDIFSFGMIL 292
               + T  Y APE         CF++  +T   DI++FG++L
Sbjct: 174 NNPRVGTKRYMAPEVLDEQIRTDCFESYKWT---DIWAFGLVL 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 158 LRHRNLMSLRAYVPES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           LRH N++   A   +     ++ +LV DY + GSL D +     N+  +  E  +++A+ 
Sbjct: 57  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALS 111
Query: 214 VIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLA----------KLM 258
              GL +LH         P I H +LK  N+++    T  +AD GLA           + 
Sbjct: 112 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 171
Query: 259 PGSLIATSAYSAPECFQNR------SYTDKSDIFSFGMIL 292
           P   + T  Y APE   +           ++DI++ G++ 
Sbjct: 172 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 211

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 82  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 141
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 142 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 198
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 199 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 253 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 95/201 (47%), Gaps = 38/201 (18%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPES----SR 175
           G  VA++++E F+             R  +E+++L   +H N++++     P+S    + 
Sbjct: 36  GEIVAIKKIEPFDK-------PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88
Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            Y++ + +QT      + R+   Q+     ++  I    ++ ++ LH +    ++H +LK
Sbjct: 89  VYIIQELMQTD-----LHRVISTQMLSDDHIQYFI-YQTLRAVKVLHGS---NVIHRDLK 139
Query: 236 PTNVMLDAEFTPRLADFGLAKLMPGS----------------LIATSAYSAPEC-FQNRS 278
           P+N+++++    ++ DFGLA+++  S                 +AT  Y APE    +  
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAK 199
Query: 279 YTDKSDIFSFGMILAVLLTGR 299
           Y+   D++S G ILA L   R
Sbjct: 200 YSRAMDVWSCGCILAELFLRR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 101/223 (45%), Gaps = 50/223 (22%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSL-RAYVPES----SR 175
           G  VA++++E F+             R  +E+++L   +H N++++     P+S    + 
Sbjct: 36  GEIVAIKKIEPFDK-------PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88
Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            Y++ + +QT      + R+   Q+     ++  I    ++ ++ LH +    ++H +LK
Sbjct: 89  VYIIQELMQTD-----LHRVISTQMLSDDHIQYFI-YQTLRAVKVLHGS---NVIHRDLK 139
Query: 236 PTNVMLDAEFTPRLADFGLAKLMPGS----------------LIATSAYSAPEC-FQNRS 278
           P+N+++++    ++ DFGLA+++  S                 +AT  Y APE    +  
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAK 199
Query: 279 YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH 321
           Y+   D++S G ILA L   R    P F         GR  RH
Sbjct: 200 YSRAMDVWSCGCILAELFLRR----PIFP--------GRDYRH 230

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 158 LRHRNLMSLRAYVPES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           LRH N++   A   +     ++ +LV DY + GSL D +     N+  +  E  +++A+ 
Sbjct: 54  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALS 108
Query: 214 VIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLA----------KLM 258
              GL +LH         P I H +LK  N+++    T  +AD GLA           + 
Sbjct: 109 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 168
Query: 259 PGSLIATSAYSAPECFQNR------SYTDKSDIFSFGMIL 292
           P   + T  Y APE   +           ++DI++ G++ 
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 30/160 (18%)
Query: 158 LRHRNLMSLRAYVPES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           LRH N++   A   +     ++ +LV DY + GSL D +     N+  +  E  +++A+ 
Sbjct: 55  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALS 109
Query: 214 VIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLA----------KLM 258
              GL +LH         P I H +LK  N+++    T  +AD GLA           + 
Sbjct: 110 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 169
Query: 259 PGSLIATSAYSAPECFQNR------SYTDKSDIFSFGMIL 292
           P   + T  Y APE   +           ++DI++ G++ 
Sbjct: 170 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 209

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 21/174 (12%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
            ++E +VL +   + + +L     + +  YLV DY   G L   + +  +   +      
Sbjct: 121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-KLMPGSLIATS 266
           L   V  I  +  LH+      +H ++KP N+++D     RLADFG   KLM    + +S
Sbjct: 181 LAEMVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 267 A------YSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
                  Y +PE  Q        Y  + D +S G+ +  +L G     PF+AE+
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE---TPFYAES 285

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 16/152 (10%)
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L  L +      R Y V +Y+  G L   + ++   +          IA+G       L 
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-------LF 456
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPGSLIATSAYSAPECFQN 276
           F  +  I++ +LK  NVMLD+E   ++ADFG+ K      +       T  Y APE    
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + Y    D ++FG++L  +L G+   APF  E
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQ---APFEGE 545

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDXXKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 16/152 (10%)
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L  L +      R Y V +Y+  G L   + ++   +          IA+G       L 
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG-------LF 135
Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK------LMPGSLIATSAYSAPECFQN 276
           F  +  I++ +LK  NVMLD+E   ++ADFG+ K      +       T  Y APE    
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + Y    D ++FG++L  +L G+   APF  E
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQ---APFEGE 224

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            Y AP    ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EYLAPAIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N++ L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVR-RVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           ++LGS   G  Y+ + + +G  V +   ++     +  K NK     I  E  V+A +  
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE----ILDEAYVMAGVGS 78
Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
             +  L   +  +S   LV   +  G L   +D +REN+ +LG +  L   + + KG+ Y
Sbjct: 79  PYVSRLLG-ICLTSTVQLVTQLMPYGCL---LDHVRENRGRLGSQDLLNWCMQIAKGMSY 134
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPE 272
           L    + +++H +L   NV++ +    ++ DFGLA+L+        A        + A E
Sbjct: 135 LE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT 297
               R +T +SD++S+G+ +  L+T
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/168 (20%), Positives = 81/168 (48%), Gaps = 24/168 (14%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++ +Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA+ 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 258 MPGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           +       +         + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 124 VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL 183
           VA++RV        +  ++ V     +E+ +L  L+H+N++ L   +    +  LV+++ 
Sbjct: 30  VALKRVRL------DDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83
Query: 184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA 243
                +D           L  E+       ++KGL + H   +  +LH +LKP N++++ 
Sbjct: 84  D----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINR 136
Query: 244 EFTPRLADFGLAKL--MP----GSLIATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLL 296
               +LA+FGLA+   +P     + + T  Y  P+  F  + Y+   D++S G I A L 
Sbjct: 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196
Query: 297 TGRDPTAP 304
               P  P
Sbjct: 197 NAGRPLFP 204

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 17/170 (10%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR--IRE 197
           +N       + E  +L  ++H  ++ L        + YL+ +YL  G L   ++R  I  
Sbjct: 60  RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK- 256
                 +   + +A+G      +LH      I++ +LKP N+ML+ +   +L DFGL K 
Sbjct: 120 EDTACFYLAEISMALG------HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170
Query: 257 -----LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                 +  +   T  Y APE      +    D +S G ++  +LTG  P
Sbjct: 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++  Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDYYKKTTNGRLPVK--WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 19/148 (12%)
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLE---DAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           L  L +      R Y V +Y+  G L      + + +E Q        +  A  +  GL 
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA-------VFYAAEISIGLF 134
Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPG----SLIATSAYSAPEC 273
           +LH      I++ +LK  NVMLD+E   ++ADFG+ K  +M G        T  Y APE 
Sbjct: 135 FLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEI 191
Query: 274 FQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              + Y    D +++G++L  +L G+ P
Sbjct: 192 IAYQPYGKSVDWWAYGVLLYEMLAGQPP 219

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 87/189 (46%), Gaps = 33/189 (17%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE-------- 189
           ++ ++S ++  Q+E E+L  L+H++++       E     +V++Y++ G L         
Sbjct: 80  KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 139
Query: 190 DAM-----DRIRENQLQLGWEVRLRIAVGVIKGLQY---LHFTCNPQILHYNLKPTNVML 241
           DA      + +    L LG    L +A  V  G+ Y   LHF      +H +L   N ++
Sbjct: 140 DAKLLAGGEDVAPGPLGLG--QLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLV 191
Query: 242 DAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA 293
                 ++ DFG+++         + G  +    +  PE    R +T +SD++SFG++L 
Sbjct: 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251
Query: 294 VLLT-GRDP 301
            + T G+ P
Sbjct: 252 EIFTYGKQP 260

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 95  QAALANEN-RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE 153
           Q  +A  N +++G+   G  ++  L     VA+++V          Q+K  K R   EL+
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV---------LQDKRFKNR---ELQ 84
Query: 154 VLASLRHRNLMSLRAYV------PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           ++  ++H N++ L+A+        +     LV +Y+       +    +  Q      ++
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK 144
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD-AEFTPRLADFGLAKLMPG-----S 261
           L +   +++ L Y+H      I H ++KP N++LD      +L DFG AK++       S
Sbjct: 145 LYM-YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 262 LIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
            I +  Y APE  F   +YT   DI+S G ++A L+ G+
Sbjct: 201 XICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 43/228 (18%)
Query: 93  TLQAALANENRLLGSSPDGKY---YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           ++Q  +A++  LL     G+Y   +R     G  VAV+    F S    +  KS  R  +
Sbjct: 1   SMQRTVAHQITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSS----RDEKSWFR--E 50
Query: 150 QELEVLASLRHRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
            EL     LRH N++   A        S++ +L+  Y + GSL D +     + +     
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC--- 107
Query: 206 VRLRIAVGVIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
             LRI + +  GL +LH         P I H +LK  N+++       +AD GLA +   
Sbjct: 108 --LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 261 SL----------IATSAYSAPECFQNRSYTD------KSDIFSFGMIL 292
           S           + T  Y APE        D      + DI++FG++L
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 40/185 (21%)
Query: 145 KRRIQQELEVLASLRHRNLMS-LRAYVPESSRFYL------VYDYLQ-----TGSLEDAM 192
           + ++ +E++ LA L H  ++    A++ +++   L      VY Y+Q       +L+D M
Sbjct: 47  REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 193 D---RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL 249
           +    I E +  +   + L+IA  V    ++LH   +  ++H +LKP+N+    +   ++
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAV----EFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159
Query: 250 ADFGLAKLMPGS------------------LIATSAYSAPECFQNRSYTDKSDIFSFGMI 291
            DFGL   M                      + T  Y +PE     SY+ K DIFS G+I
Sbjct: 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLI 219
Query: 292 LAVLL 296
           L  LL
Sbjct: 220 LFELL 224

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 23/175 (13%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFY--LVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +E EVL  L H+N++ L A   E++  +  L+ ++   GSL   ++    N   L     
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEF 114
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFTPRLADFGLAKLMPG--- 260
           L +   V+ G+ +L       I+H N+KP N+M     D +   +L DFG A+ +     
Sbjct: 115 LIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 261 --SLIATSAYSAPECFQ--------NRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
             SL  T  Y  P+ ++         + Y    D++S G+      TG  P  PF
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 99/235 (42%), Gaps = 26/235 (11%)
Query: 119 DNGLTVAVRRVEAFE-SGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           + G   AV+ V+  + + SP    + +KR    E  +   L+H +++ L          Y
Sbjct: 47  ETGQQFAVKIVDVAKFTSSPGLSTEDLKR----EASICHMLKHPHIVELLETYSSDGMLY 102
Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +V++++    L   + +  +        V       +++ L+Y H   +  I+H ++KP 
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPH 159
Query: 238 NVMLDAEFTP---RLADFGLA------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSF 288
            V+L ++      +L  FG+A       L+ G  + T  + APE  +   Y    D++  
Sbjct: 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGC 219
Query: 289 GMILAVLLTGRDPTAPFFA------EAASGGSLGRWLRHLQHAGEAREALDRSIL 337
           G+IL +LL+G     PF+       E    G      R   H  E+ + L R +L
Sbjct: 220 GVILFILLSG---CLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRML 271

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 99/235 (42%), Gaps = 26/235 (11%)
Query: 119 DNGLTVAVRRVEAFE-SGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           + G   AV+ V+  + + SP    + +KR    E  +   L+H +++ L          Y
Sbjct: 49  ETGQQFAVKIVDVAKFTSSPGLSTEDLKR----EASICHMLKHPHIVELLETYSSDGMLY 104
Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +V++++    L   + +  +        V       +++ L+Y H   +  I+H ++KP 
Sbjct: 105 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPH 161
Query: 238 NVMLDAEFTP---RLADFGLA------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSF 288
            V+L ++      +L  FG+A       L+ G  + T  + APE  +   Y    D++  
Sbjct: 162 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGC 221
Query: 289 GMILAVLLTGRDPTAPFFA------EAASGGSLGRWLRHLQHAGEAREALDRSIL 337
           G+IL +LL+G     PF+       E    G      R   H  E+ + L R +L
Sbjct: 222 GVILFILLSG---CLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRML 273

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 15/162 (9%)
Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145
Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G    L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
              APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAG---YPPFFAD 241

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 151 ELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-- 207
           E+E++  + +H+N+++L     +    Y++  Y   G+L + +   R   ++  +++   
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 208 ----------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-- 255
                     +     + +G++YL    + + +H +L   NV++      ++ADFGLA  
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 256 --------KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
                   K   G L     + APE   +R YT +SD++SFG+++  + T
Sbjct: 207 INNIDYYKKTTNGRLPV--KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 87/189 (46%), Gaps = 33/189 (17%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE-------- 189
           ++ ++S ++  Q+E E+L  L+H++++       E     +V++Y++ G L         
Sbjct: 51  KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 110
Query: 190 DAM-----DRIRENQLQLGWEVRLRIAVGVIKGLQY---LHFTCNPQILHYNLKPTNVML 241
           DA      + +    L LG    L +A  V  G+ Y   LHF      +H +L   N ++
Sbjct: 111 DAKLLAGGEDVAPGPLGLG--QLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLV 162
Query: 242 DAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA 293
                 ++ DFG+++         + G  +    +  PE    R +T +SD++SFG++L 
Sbjct: 163 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 222
Query: 294 VLLT-GRDP 301
            + T G+ P
Sbjct: 223 EIFTYGKQP 231

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 29/214 (13%)
Query: 104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LLG    GK  + VLD+      RR          ++  + +  +++E+++L  LRH+N+
Sbjct: 12  LLGEGSYGKV-KEVLDS--ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 164 MSLRA--YVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL----GWEVRLRIAVGVIKG 217
           + L    Y  E  + Y+V +Y   G +++ +D + E +  +    G+  +L      I G
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQL------IDG 121
Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-LMPGSLIATS-------AYS 269
           L+YLH   +  I+H ++KP N++L    T +++  G+A+ L P +   T        A+ 
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 270 APECFQNRSYTD--KSDIFSFGMILAVLLTGRDP 301
            PE           K DI+S G+ L  + TG  P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 87/189 (46%), Gaps = 33/189 (17%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE-------- 189
           ++ ++S ++  Q+E E+L  L+H++++       E     +V++Y++ G L         
Sbjct: 57  KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP 116
Query: 190 DAM-----DRIRENQLQLGWEVRLRIAVGVIKGLQY---LHFTCNPQILHYNLKPTNVML 241
           DA      + +    L LG    L +A  V  G+ Y   LHF      +H +L   N ++
Sbjct: 117 DAKLLAGGEDVAPGPLGLG--QLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLV 168
Query: 242 DAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILA 293
                 ++ DFG+++         + G  +    +  PE    R +T +SD++SFG++L 
Sbjct: 169 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 228
Query: 294 VLLT-GRDP 301
            + T G+ P
Sbjct: 229 EIFTYGKQP 237

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 75/170 (44%), Gaps = 17/170 (10%)
Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR--IRE 197
           +N       + E  +L  ++H  ++ L        + YL+ +YL  G L   ++R  I  
Sbjct: 60  RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK- 256
                 +   + +A+G      +LH      I++ +LKP N+ML+ +   +L DFGL K 
Sbjct: 120 EDTACFYLAEISMALG------HLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170
Query: 257 -LMPGSLI----ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
            +  G++      T  Y APE      +    D +S G ++  +LTG  P
Sbjct: 171 SIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 32/203 (15%)
Query: 105 LGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           LG    GK Y+    N  T  +   +  ++ S E+    +      E+++LAS  H N++
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYM-----VEIDILASCDHPNIV 97
Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR----ENQLQLGWEVRLRIAVGVIKGLQY 220
            L       +  +++ ++   G+++  M  +     E+Q+Q+       +    +  L Y
Sbjct: 98  KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-------VCKQTLDALNY 150
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPECF 274
           LH   + +I+H +LK  N++   +   +LADFG++             I T  + APE  
Sbjct: 151 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVV 207
Query: 275 -----QNRSYTDKSDIFSFGMIL 292
                ++R Y  K+D++S G+ L
Sbjct: 208 MCETSKDRPYDYKADVWSLGITL 230

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 91  PKTLQAALANENRLLGSSPDGKY---YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRR 147
           P  +Q  +A +  LL     G+Y   +R     G  VAV+    F S    +  KS  R 
Sbjct: 28  PFLVQRTVARQITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSS----RDEKSWFR- 78
Query: 148 IQQELEVLASLRHRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
            + EL     LRH N++   A        S++ +L+  Y + GSL D +     + +   
Sbjct: 79  -ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC- 136
Query: 204 WEVRLRIAVGVIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
               LRI + +  GL +LH         P I H +LK  N+++       +AD GLA + 
Sbjct: 137 ----LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 192
Query: 259 PGSL----------IATSAYSAPECFQNRSYTD------KSDIFSFGMIL 292
             S           + T  Y APE        D      + DI++FG++L
Sbjct: 193 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 242

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 29/241 (12%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           R   +E   L    H N++ +      P +    L+  ++  GSL + +         + 
Sbjct: 52  RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVD 109
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR--LADFGLAKLMPGS 261
               ++ A+ + +G+ +LH T  P I  + L   +VM+D + T R  +AD   +   PG 
Sbjct: 110 QSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR 168
Query: 262 LIATSAYSAPECFQNR---SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRW 318
           + A  A+ APE  Q +   +    +D++SF ++L  L+T   P    FA+  S   +G  
Sbjct: 169 MYA-PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----FADL-SNMEIG-- 220
Query: 319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH 378
                    A E L  +I          LM +     C+++ PA RP  D +VP+L ++ 
Sbjct: 221 ------MKVALEGLRPTIPPGISPHVSKLMKI-----CMNEDPAKRPKFDMIVPILEKMQ 269
Query: 379 S 379
Sbjct: 270 D 270

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 40/179 (22%)
Query: 148 IQQELEVLASLRH-------------RNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR 194
           I  E+ +LASL H             RN +     V + S  ++  +Y +  +L D +  
Sbjct: 49  ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS 108
Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
              NQ +  +    R+   +++ L Y+H   +  I+H +LKP N+ +D     ++ DFGL
Sbjct: 109 ENLNQQRDEY---WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGL 162
Query: 255 AK--------------LMPG------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMIL 292
           AK               +PG      S I T+ Y A E       Y +K D++S G+I 
Sbjct: 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 93  TLQAALANENRLLGSSPDGKY---YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ 149
           ++Q  +A +  LL     G+Y   +R     G  VAV+    F S    +  KS  R  +
Sbjct: 1   SMQRTVARDITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSS----RDEKSWFR--E 50
Query: 150 QELEVLASLRHRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
            EL     LRH N++   A        S++ +L+  Y + GSL D +     + +     
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC--- 107
Query: 206 VRLRIAVGVIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
             LRI + +  GL +LH         P I H +LK  N+++       +AD GLA +   
Sbjct: 108 --LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 261 SL----------IATSAYSAPECFQNRSYTD------KSDIFSFGMIL 292
           S           + T  Y APE        D      + DI++FG++L
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/177 (22%), Positives = 79/177 (44%), Gaps = 21/177 (11%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE--------DAMDR 194
           + ++   +E E+L +L+H +++       E     +V++Y++ G L         DA+  
Sbjct: 57  NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLM 116
Query: 195 IREN-QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
              N   +L     L IA  +  G+ YL    +   +H +L   N ++      ++ DFG
Sbjct: 117 AEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFG 173
Query: 254 LAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           +++         + G  +    +  PE    R +T +SD++S G++L  + T G+ P
Sbjct: 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 86/167 (51%), Gaps = 20/167 (11%)
Query: 145 KRRIQQELEVLASLRHR-NLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRIRENQLQ 201
           K +I++E+++L +LR   N+++L   V  P S    LV++++     +         Q  
Sbjct: 75  KNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTL 128
Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-P 259
             +++R  +   ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   P
Sbjct: 129 TDYDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 184
Query: 260 GS----LIATSAYSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           G      +A+  +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 185 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 77/159 (48%), Gaps = 26/159 (16%)
Query: 163 LMSLRAYVPESSRFYLVYDYLQTGS-----LEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
           +++L      +S   L+ +Y   G      L +  + + EN +       +R+   +++G
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-------IRLIKQILEG 143
Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAKLMPGS-----LIATSAYS 269
           + YLH      I+H +LKP N++L + +     ++ DFG+++ +  +     ++ T  Y 
Sbjct: 144 VYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200
Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           APE       T  +D+++ G+I  +LLT    T+PF  E
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTH---TSPFVGE 236

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 90/183 (49%), Gaps = 35/183 (19%)
Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYV-PESSRF-------------YLVYDYLQTGS 187
           +SVK  ++ E++++  L H N++ +   + P  S+              Y+V +Y++T  
Sbjct: 50  QSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD- 107
Query: 188 LEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FT 246
               +  + E    L    RL     +++GL+Y+H   +  +LH +LKP N+ ++ E   
Sbjct: 108 ----LANVLEQGPLLEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLV 159
Query: 247 PRLADFGLAKLM------PGSL---IATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLL 296
            ++ DFGLA++M       G L   + T  Y +P    +  +YT   D+++ G I A +L
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
Query: 297 TGR 299
           TG+
Sbjct: 220 TGK 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 95/254 (37%), Gaps = 52/254 (20%)
Query: 98  LANENRLLGSSPDGKY--YRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVL 155
           L  +  L G+   G Y   R  ++N  T A+R ++        + N     RI+ E+ ++
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 156 ASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED-------------AMDRIRENQLQL 202
             L H N+  L     +     LV +    G L D             AMD ++  Q+  
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK-TQICP 141
Query: 203 GWEVRLRIAVGVIKGLQ---------------------YLHFTCNPQILHYNLKPTNVML 241
             E       G I G +                      LH+  N  I H ++KP N + 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 242 --DAEFTPRLADFGLA----KLMPGSLI------ATSAYSAPECFQ--NRSYTDKSDIFS 287
             +  F  +L DFGL+    KL  G          T  + APE     N SY  K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 288 FGMILAVLLTGRDP 301
            G++L +LL G  P
Sbjct: 262 AGVLLHLLLMGAVP 275

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 29/178 (16%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
            ++E +VL +   + + +L     + +  YLV DY   G L   + +  E++L    E  
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKF-EDKLP---EDM 176
Query: 208 LRIAVG----VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGS 261
            R  +G     I  +  LH+      +H ++KP NV+LD     RLADFG    M   G+
Sbjct: 177 ARFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT 230
Query: 262 L-----IATSAYSAPECFQNRS-----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           +     + T  Y +PE  Q        Y  + D +S G+ +  +L G     PF+AE+
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---TPFYAES 285

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 23/175 (13%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFY--LVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
           +E EVL  L H+N++ L A   E++  +  L+ ++   GSL   ++    N   L     
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEF 114
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFTPRLADFGLAKLMPGS-- 261
           L +   V+ G+ +L       I+H N+KP N+M     D +   +L DFG A+ +     
Sbjct: 115 LIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 262 ---LIATSAYSAPECFQ--------NRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
              L  T  Y  P+ ++         + Y    D++S G+      TG  P  PF
Sbjct: 172 FVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 29/178 (16%)
Query: 148 IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
            ++E +VL +   + + +L     + +  YLV DY   G L   + +  E++L    E  
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKF-EDKLP---EDM 192
Query: 208 LRIAVG----VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGS 261
            R  +G     I  +  LH+      +H ++KP NV+LD     RLADFG    M   G+
Sbjct: 193 ARFYIGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT 246
Query: 262 L-----IATSAYSAPECFQNRS-----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           +     + T  Y +PE  Q        Y  + D +S G+ +  +L G     PF+AE+
Sbjct: 247 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---TPFYAES 301

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----I 263
           +IAV ++K L++LH   +  ++H ++KP+NV+++A    ++ DFG++  +   +      
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 264 ATSAYSAPE----CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               Y APE        + Y+ KSDI+S G+ +  L   R P
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 33/180 (18%)
Query: 145 KRRIQQELEV--LASLRHRNLMSLRAYVPESSR----FYLVYDYLQTGSLEDAMDRIREN 198
           K+  Q E EV  L  ++H N++         +      +L+  + + GSL D +   + N
Sbjct: 60  KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KAN 116
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTC-------NPQILHYNLKPTNVMLDAEFTPRLAD 251
            +   W     IA  + +GL YLH           P I H ++K  NV+L    T  +AD
Sbjct: 117 VVS--WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 252 FGLA-KLMPG-------SLIATSAYSAPEC------FQNRSYTDKSDIFSFGMILAVLLT 297
           FGLA K   G         + T  Y APE       FQ  ++  + D+++ G++L  L +
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL-RIDMYAMGLVLWELAS 233

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 30/149 (20%)
Query: 171 PESSRFYLVYDYLQ-----TGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC 225
           P S + YL   Y+Q       +L+D M+R R +       V L I + + + +++LH   
Sbjct: 129 PSSPKVYL---YIQMQLCRKENLKDWMNR-RCSLEDREHGVCLHIFIQIAEAVEFLH--- 181
Query: 226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------------------LIATSA 267
           +  ++H +LKP+N+    +   ++ DFGL   M                      + T  
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKL 241
Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLL 296
           Y +PE     +Y+ K DIFS G+IL  LL
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 41/247 (16%)
Query: 139 KQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESS-----RFYLVYDYLQTGSLED 190
           K + S +R I++ L   A ++   H N++ L     E S     +  ++  +++ G L  
Sbjct: 71  KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT 130
Query: 191 AM--DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR 248
            +   R+      +  +  L+  V +  G++YL    N   LH +L   N ML  + T  
Sbjct: 131 YLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVC 187
Query: 249 LADFGLA-KLMPGSLIATS-------AYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GR 299
           +ADFGL+ K+  G              + A E   +R YT KSD+++FG+ +  + T G 
Sbjct: 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247
Query: 300 DPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSD 359
            P             +  +L H     +  + LD      E+ E        I   C   
Sbjct: 248 TPYP-----GVQNHEMYDYLLHGHRLKQPEDCLD------ELYE--------IMYSCWRT 288
Query: 360 SPADRPS 366
            P DRP+
Sbjct: 289 DPLDRPT 295

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 33/174 (18%)
Query: 150 QELEVLASLRHRNLMSL--------RAYVPESSRFYLVYDYLQ---TGSLEDAMDRIREN 198
           +E+++L  L+H N+++L          Y    +  YLV+D+ +    G L + + +   +
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
           +++       R+   ++ GL Y+H     +ILH ++K  NV++  +   +LADFGLA+  
Sbjct: 126 EIK-------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 259 P----------GSLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                       + + T  Y  PE     R Y    D++  G I+A + T R P
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP 228

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 150 QELEVLASLRHRNLMSL--------RAYVPESSRFYLVYDYLQ---TGSLEDAMDRIREN 198
           +E+++L  L+H N+++L          Y       YLV+D+ +    G L + + +   +
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
           +++       R+   ++ GL Y+H     +ILH ++K  NV++  +   +LADFGLA+  
Sbjct: 126 EIK-------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 259 P----------GSLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                       + + T  Y  PE     R Y    D++  G I+A + T R P
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP 228

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----I 263
           +IAV ++K L++LH   +  ++H ++KP+NV+++A    +  DFG++  +   +      
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 264 ATSAYSAPE----CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               Y APE        + Y+ KSDI+S G+    L   R P
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 49/116 (42%), Gaps = 31/116 (26%)
Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----------------------- 247
            + ++K L YL       + H +LKP N++LD  +                         
Sbjct: 143 CIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 248 --RLADFGLAKL---MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
             +L DFG A       GS+I T  Y APE   N  +   SD++SFG +LA L TG
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 150 QELEVLASLRHRNLMSL--------RAYVPESSRFYLVYDYLQ---TGSLEDAMDRIREN 198
           +E+++L  L+H N+++L          Y       YLV+D+ +    G L + + +   +
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
           +++       R+   ++ GL Y+H     +ILH ++K  NV++  +   +LADFGLA+  
Sbjct: 125 EIK-------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 259 P----------GSLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                       + + T  Y  PE     R Y    D++  G I+A + T R P
Sbjct: 175 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 150 QELEVLASLRHRNLMSL--------RAYVPESSRFYLVYDYLQ---TGSLEDAMDRIREN 198
           +E+++L  L+H N+++L          Y       YLV+D+ +    G L + + +   +
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 199 QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
           +++       R+   ++ GL Y+H     +ILH ++K  NV++  +   +LADFGLA+  
Sbjct: 126 EIK-------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 259 P----------GSLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                       + + T  Y  PE     R Y    D++  G I+A + T R P
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP 228

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +EL   A L    ++ L   V E     +  + L+ GSL     ++ + Q  L  +  L 
Sbjct: 134 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL----GQLVKEQGCLPEDRALY 189
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-PRLADFGLA----------KLM 258
                ++GL+YLH   + +ILH ++K  NV+L ++ +   L DFG A           L+
Sbjct: 190 YLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLL 246
Query: 259 PGSLI-ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
            G  I  T  + APE    RS   K D++S   ++  +L G  P   FF
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFF 295

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 25/176 (14%)
Query: 140 QNKSVKRRIQQELEVLASLRHRN-LMSLRAYVPESSRFYLVYDYLQTGSLEDAM---DRI 195
           Q        + E +VL  +R    L++L       ++ +L+ DY+  G L   +   +R 
Sbjct: 97  QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 156
Query: 196 RENQLQLGWEVRLRIAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
            E+++Q        I VG ++  L++LH      I++ ++K  N++LD+     L DFGL
Sbjct: 157 TEHEVQ--------IYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 255 AKLMPG-------SLIATSAYSAPECFQ-NRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +K               T  Y AP+  +   S  DK+ D +S G+++  LLTG  P
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 139 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +EL   A L    ++ L   V E     +  + L+ GSL     ++ + Q  L  +  L 
Sbjct: 115 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL----GQLVKEQGCLPEDRALY 170
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-PRLADFGLA----------KLM 258
                ++GL+YLH   + +ILH ++K  NV+L ++ +   L DFG A           L+
Sbjct: 171 YLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLL 227
Query: 259 PGSLI-ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
            G  I  T  + APE    RS   K D++S   ++  +L G  P   FF
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFF 276

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 139 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLAKLMPGSLIATSAYS---- 269
            +Q+LH   +  I H ++KP N++    + +   +L DFG AK    + + T  Y+    
Sbjct: 121 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYV 177
Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLG 316
           APE      Y    D++S G+I+ +LL G     PF++      S G
Sbjct: 178 APEVLGPEKYDKSCDMWSLGVIMYILLCG---FPPFYSNTGQAISPG 221

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 138 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 194
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H      I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 145 ILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 201
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 202 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 236

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLAKLMPGSLIATSAYS---- 269
            +Q+LH   +  I H ++KP N++    + +   +L DFG AK    + + T  Y+    
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYV 196
Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLG 316
           APE      Y    D++S G+I+ +LL G     PF++      S G
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCG---FPPFYSNTGQAISPG 240

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--Q 201
           K  +  EL++++ L +H N+++L           ++ +Y   G L + + R  E  L  +
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 202 LGWEVRLR----IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK- 256
            G  + LR     +  V +G+ +L    +   +H ++   NV+L      ++ DFGLA+ 
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 201
Query: 257 -------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                  ++ G+      + APE   +  YT +SD++S+G++L  + + G +P
Sbjct: 202 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 254

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 12/119 (10%)
Query: 194 RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
           RI EN   L  +  +R  V +  G++YL    +   +H +L   N ML  + T  +ADFG
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 254 LA-KLMPGSLIATSAYS-------APECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTA 303
           L+ K+  G        S       A E   +  YT  SD+++FG+ +  ++T G+ P A
Sbjct: 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEK-----QNKSVKRRIQQELEVLAS 157
           R + S   G     V   G+ VA++RV  F + S  +      +  + +R+ +E+ +L  
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRV--FNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 158 LRHRNLMSLRAYV-----PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
             H N++ LR        P   + YLV + ++T    D    I + ++ +  +       
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMY 141
Query: 213 GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSA 267
            ++ GL  LH      ++H +L P N++L       + DF LA+           +    
Sbjct: 142 HILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 268 YSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           Y APE   Q + +T   D++S G ++A +   +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEK-----QNKSVKRRIQQELEVLAS 157
           R + S   G     V   G+ VA++RV  F + S  +      +  + +R+ +E+ +L  
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRV--FNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 158 LRHRNLMSLRAYV-----PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
             H N++ LR        P   + YLV + ++T    D    I + ++ +  +       
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMY 141
Query: 213 GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-----LMPGSLIATSA 267
            ++ GL  LH      ++H +L P N++L       + DF LA+           +    
Sbjct: 142 HILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 268 YSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGR 299
           Y APE   Q + +T   D++S G ++A +   +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--Q 201
           K  +  EL++++ L +H N+++L           ++ +Y   G L + + R  E  L  +
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 202 LGWEVRLR----IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK- 256
            G  + LR     +  V +G+ +L    +   +H ++   NV+L      ++ DFGLA+ 
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 209
Query: 257 -------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                  ++ G+      + APE   +  YT +SD++S+G++L  + + G +P
Sbjct: 210 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 262

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 139 KQNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
            ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R
Sbjct: 57  NESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLR 116
Query: 197 -ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
            E +   G      +  +++A  +  G+ YL+     + +H NL   N M+  +FT ++ 
Sbjct: 117 PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIG 173
Query: 251 DFGLAKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           DFG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 174 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 223

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/170 (22%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 139 KQNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
            ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R
Sbjct: 56  NESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLR 115
Query: 197 -ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
            E +   G      +  +++A  +  G+ YL+     + +H NL   N M+  +FT ++ 
Sbjct: 116 PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIG 172
Query: 251 DFGLAKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           DFG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 173 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 20/107 (18%)
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI----- 263
           ++ V ++K L YL       ++H ++KP+N++LD     +L DFG++    G L+     
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS----GRLVDDKAK 181
Query: 264 ----ATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDP 301
                 +AY APE           Y  ++D++S G+ L  L TG+ P
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NV++D E    RL D+GLA+   PG      +A+  
Sbjct: 140 ILKALDYCH---SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 196
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  ++P
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 59  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 181 DYLQTGSLEDAMDRIRENQLQ---------LGWEVRLRIAVGVIKGLQYLHFTCNPQILH 231
           ++ + G+L   + R + N+           L  E  +  +  V KG+++L    + + +H
Sbjct: 112 EFCKFGNLSTYL-RSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIH 167
Query: 232 YNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKS 283
            +L   N++L  +   ++ DFGLA+        +  G       + APE   +R YT +S
Sbjct: 168 RDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 227
Query: 284 DIFSFGMIL 292
           D++SFG++L
Sbjct: 228 DVWSFGVLL 236

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           + SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L
Sbjct: 51  SDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKFSL 108
Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
            L     +  A  +   L YL    + + +H ++   NV++ A    +L DFGL++ M  
Sbjct: 109 DLA--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMED 163
Query: 261 SLIATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
           S    ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 164 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 140 QNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R 
Sbjct: 57  ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP 116
Query: 197 ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
           E +   G      +  +++A  +  G+ YL+     + +H +L   N M+  +FT ++ D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 252 FGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           FG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 174 FGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 81/179 (45%), Gaps = 25/179 (13%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--- 200
           K  +  EL++++ L +H N+++L           ++ +Y   G L + + R R   L   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYS 152
Query: 201 ---------QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
                    QL     L  +  V +G+ +L    +   +H ++   NV+L      ++ D
Sbjct: 153 YNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 209
Query: 252 FGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           FGLA+        ++ G+      + APE   +  YT +SD++S+G++L  + + G +P
Sbjct: 210 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 268

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 140 QNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R 
Sbjct: 54  ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP 113
Query: 197 ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
           E +   G      +  +++A  +  G+ YL+     + +H +L   N M+  +FT ++ D
Sbjct: 114 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 170
Query: 252 FGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           FG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 171 FGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 219

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/170 (21%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 139 KQNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
            ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R
Sbjct: 56  NESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLR 115
Query: 197 -ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
            E +   G      +  +++A  +  G+ YL+     + +H +L   N M+  +FT ++ 
Sbjct: 116 PEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 172
Query: 251 DFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           DFG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 173 DFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/177 (22%), Positives = 79/177 (44%), Gaps = 23/177 (12%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           K  +  EL++++ L +H N+++L           ++ +Y   G   D ++ +R     L 
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG---DLLNFLRRKSRVLE 149
Query: 204 WEVRLRIAVGVIKGLQYLHFT----------CNPQILHYNLKPTNVMLDAEFTPRLADFG 253
            +    IA   +     LHF+           +   +H ++   NV+L      ++ DFG
Sbjct: 150 TDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209
Query: 254 LAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           LA+        ++ G+      + APE   +  YT +SD++S+G++L  + + G +P
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 88/191 (46%), Gaps = 32/191 (16%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 61  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 113
Query: 181 DYLQTGSLEDAMDRIRENQLQ-----------LGWEVRLRIAVGVIKGLQYLHFTCNPQI 229
           ++ + G+L   + R + N+             L  E  +  +  V KG+++L    + + 
Sbjct: 114 EFCKFGNLSTYL-RSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKX 169
Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTD 281
           +H +L   N++L  +   ++ DFGLA+        +  G       + APE   +R YT 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 282 KSDIFSFGMIL 292
           +SD++SFG++L
Sbjct: 230 QSDVWSFGVLL 240

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +EL   A L    ++ L   V E     +  + L+ GSL   +      Q+    E R  
Sbjct: 115 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRAL 169
Query: 210 IAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-PRLADFGLA----------KL 257
             +G  ++GL+YLH     +ILH ++K  NV+L ++ +   L DFG A           L
Sbjct: 170 YYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 226
Query: 258 MPGSLI-ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           + G  I  T  + APE    +    K DI+S   ++  +L G  P   +F
Sbjct: 227 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 276

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 53  SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKFSLDL 110
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  S 
Sbjct: 111 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 165
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 166 XXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 59  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 181 DYLQTGSLEDAMDRIRENQLQ---------LGWEVRLRIAVGVIKGLQYLHFTCNPQILH 231
           ++ + G+L   + R + N+           L  E  +  +  V KG+++L    + + +H
Sbjct: 112 EFCKFGNLSTYL-RSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIH 167
Query: 232 YNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKS 283
            +L   N++L  +   ++ DFGLA+        +  G       + APE   +R YT +S
Sbjct: 168 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 227
Query: 284 DIFSFGMIL 292
           D++SFG++L
Sbjct: 228 DVWSFGVLL 236

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 136 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 192
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 193 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 227

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +EL   A L    ++ L   V E     +  + L+ GSL   +      Q+    E R  
Sbjct: 99  EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRAL 153
Query: 210 IAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-PRLADFGLA----------KL 257
             +G  ++GL+YLH     +ILH ++K  NV+L ++ +   L DFG A           L
Sbjct: 154 YYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 258 MPGSLI-ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           + G  I  T  + APE    +    K DI+S   ++  +L G  P   +F
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 134 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 135 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 226

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 135 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 191
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 192 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 226

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           + SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L
Sbjct: 56  SDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKYSL 113
Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
            L     +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  
Sbjct: 114 DLA--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
Query: 261 SLIATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
           S    ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +EL   A L    ++ L   V E     +  + L+ GSL   +      Q+    E R  
Sbjct: 113 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRAL 167
Query: 210 IAVG-VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-PRLADFGLA----------KL 257
             +G  ++GL+YLH     +ILH ++K  NV+L ++ +   L DFG A           L
Sbjct: 168 YYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 224
Query: 258 MPGSLI-ATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           + G  I  T  + APE    +    K DI+S   ++  +L G  P   +F
Sbjct: 225 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 274

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 134 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 49/95 (51%), Gaps = 13/95 (13%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS---LIATSA------ 267
           G++YL        +H +L   NV+L      +++DFGL+K +        A SA      
Sbjct: 122 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           + APEC   R ++ +SD++S+G+ +   L+ G+ P
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 134 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 134 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 56  SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDL 113
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  S 
Sbjct: 114 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 168
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 169 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 134 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 155 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 211
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 212 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 246

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 50  SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDL 107
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  S 
Sbjct: 108 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLM-PGS----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   PG      +A+  
Sbjct: 134 LLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 190
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G + A ++  ++P
Sbjct: 191 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 140 QNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R 
Sbjct: 56  ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP 115
Query: 197 ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
           E +   G      +  +++A  +  G+ YL+     + +H +L   N M+  +FT ++ D
Sbjct: 116 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 172
Query: 252 FGLAKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           FG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 173 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 221

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 140 QNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R 
Sbjct: 57  ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP 116
Query: 197 ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
           E +   G      +  +++A  +  G+ YL+     + +H +L   N M+  +FT ++ D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 252 FGLAKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           FG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 174 FGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMP--GSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 278

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSLIATSAYSAPECFQNRSYTDKS 283
           H ++KP N+++ A+    L DFG+A           G+ + T  Y APE F     T ++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 284 DIFSFGMILAVLLTGRDP 301
           DI++   +L   LTG  P
Sbjct: 217 DIYALTCVLYECLTGSPP 234

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMP--GSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 178
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 179 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 234

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAK--LMPGSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 178
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 179 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 234

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAK--LMPGSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 172 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 228
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 229 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 284

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAK--LMPGSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 176
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 232

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 53  SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDL 110
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  S 
Sbjct: 111 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 165
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDPTAPFFAEAASGGS 314
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P    F    +   
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDV 221
Query: 315 LGR 317
           +GR
Sbjct: 222 IGR 224

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS---LIATSA--- 267
           V  G++YL        +H NL   NV+L      +++DFGL+K +        A SA   
Sbjct: 445 VSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 268 ---YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
              + APEC   R ++ +SD++S+G+ +   L+ G+ P
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/169 (22%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           + SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L
Sbjct: 79  SDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKYSL 136
Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
            L     +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  
Sbjct: 137 DLA--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 191
Query: 261 SLIATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
           S    ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 192 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAK--LMPGSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 121 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 177
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 178 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 233

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 55  SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDL 112
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  S 
Sbjct: 113 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 167
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 168 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/169 (21%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 140 QNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           ++ S++ RI+   E  V+      +++ L   V +     +V + +  G L+  +  +R 
Sbjct: 57  ESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRP 116
Query: 197 ENQLQLG-----WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD 251
           E +   G      +  +++A  +  G+ YL+     + +H +L   N M+  +FT ++ D
Sbjct: 117 EAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 173
Query: 252 FGLAKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
           FG+ + +         G  +    + APE  ++  +T  SD++SFG++L
Sbjct: 174 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 53  SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKYSLDL 110
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  S 
Sbjct: 111 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 165
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDPTAPFFAEAASGGS 314
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P    F    +   
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDV 221
Query: 315 LGR 317
           +GR
Sbjct: 222 IGR 224

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMP--GSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 127 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 183
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 184 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 239

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAK--LMPGSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 126 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 182
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 183 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 238

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/302 (20%), Positives = 127/302 (42%), Gaps = 53/302 (17%)
Query: 95  QAALANE----NRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKR 146
           Q  +A E    NR+LG    G+ Y  V  N     + VAV+  +       +      K 
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-------KDCTLDNKE 70
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +   E  ++ +L H +++ L   + E    +++ +    G L   ++R   N+  L    
Sbjct: 71  KFMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLER---NKNSLKVLT 126
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS 266
            +  ++ + K + YL    +   +H ++   N+++ +    +L DFGL++ +       +
Sbjct: 127 LVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 183
Query: 267 A-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW 318
           +       + +PE    R +T  SD++ F + +  +L+ G+    PFF           W
Sbjct: 184 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK---QPFF-----------W 229
Query: 319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV--CLSDSPADRPSSDELVPMLTQ 376
           L +    G     L++   G+ + + ++   V   ++  C    P+DRP   ELV  L+ 
Sbjct: 230 LENKDVIG----VLEK---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 282
Query: 377 LH 378
           ++
Sbjct: 283 VY 284

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLMPGS-----LIATSA 267
           ++K L Y H   +  I+H ++KP NVM+D +    RL D+GLA+    +      +A+  
Sbjct: 141 LLKALDYCH---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRY 197
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  R+P
Sbjct: 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREP 232

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 12/85 (14%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------- 267
           G++YL        +H +L   NV+L  +   +++DFGL+K +        A         
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 268 YSAPECFQNRSYTDKSDIFSFGMIL 292
           + APEC     ++ KSD++SFG+++
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAK--LMPGSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTE 176
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 232

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 255 AKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 179 TRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/302 (20%), Positives = 127/302 (42%), Gaps = 53/302 (17%)
Query: 95  QAALANE----NRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKR 146
           Q  +A E    NR+LG    G+ Y  V  N     + VAV+  +       +      K 
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-------KDCTLDNKE 58
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +   E  ++ +L H +++ L   + E    +++ +    G L   ++R   N+  L    
Sbjct: 59  KFMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLER---NKNSLKVLT 114
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS 266
            +  ++ + K + YL    +   +H ++   N+++ +    +L DFGL++ +       +
Sbjct: 115 LVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171
Query: 267 A-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW 318
           +       + +PE    R +T  SD++ F + +  +L+ G+    PFF           W
Sbjct: 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK---QPFF-----------W 217
Query: 319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV--CLSDSPADRPSSDELVPMLTQ 376
           L +    G     L++   G+ + + ++   V   ++  C    P+DRP   ELV  L+ 
Sbjct: 218 LENKDVIG----VLEK---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270
Query: 377 LH 378
           ++
Sbjct: 271 VY 272

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 52/116 (44%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMP--GSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 128 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 184
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D++S G+I+ +LL G  P       A S G   R
Sbjct: 185 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 240

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/302 (20%), Positives = 127/302 (42%), Gaps = 53/302 (17%)
Query: 95  QAALANE----NRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKR 146
           Q  +A E    NR+LG    G+ Y  V  N     + VAV+  +       +      K 
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-------KDCTLDNKE 54
Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           +   E  ++ +L H +++ L   + E    +++ +    G L   ++R   N+  L    
Sbjct: 55  KFMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLER---NKNSLKVLT 110
Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS 266
            +  ++ + K + YL    +   +H ++   N+++ +    +L DFGL++ +       +
Sbjct: 111 LVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 167
Query: 267 A-------YSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW 318
           +       + +PE    R +T  SD++ F + +  +L+ G+    PFF           W
Sbjct: 168 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK---QPFF-----------W 213
Query: 319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV--CLSDSPADRPSSDELVPMLTQ 376
           L +    G     L++   G+ + + ++   V   ++  C    P+DRP   ELV  L+ 
Sbjct: 214 LENKDVIG----VLEK---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 266
Query: 377 LH 378
           ++
Sbjct: 267 VY 268

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 10/95 (10%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLMPGSL-----IATSA 267
           ++K L Y H   +  I+H ++KP NVM+D +    RL D+GLA+    +      +A+  
Sbjct: 146 LLKALDYCH---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRY 202
Query: 268 YSAPECFQNRSYTDKS-DIFSFGMILAVLLTGRDP 301
           +  PE   +    D S D++S G +LA ++  R+P
Sbjct: 203 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREP 237

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 53  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 112
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 113 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 169
Query: 255 AKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 170 TRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKFSLDL 490
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ A    +L DFGL++ M  S 
Sbjct: 491 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDST 545
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDP 301
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 11/100 (11%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAK--LMPGSLIA 264
           I   + + +QYLH   +  I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 136 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 192
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
              T  Y APE      Y    D++S G+I+ +LL G  P
Sbjct: 193 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 88/192 (45%), Gaps = 33/192 (17%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 60  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 112
Query: 181 DYLQTGSLEDAMDRIRENQLQ------------LGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
           ++ + G+L   + R + N+              L  E  +  +  V KG+++L    + +
Sbjct: 113 EFCKFGNLSTYL-RSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 168
Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYT 280
            +H +L   N++L  +   ++ DFGLA+        +  G       + APE   +R YT
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT 228
Query: 281 DKSDIFSFGMIL 292
            +SD++SFG++L
Sbjct: 229 IQSDVWSFGVLL 240

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 12/85 (14%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------- 267
           G++YL        +H +L   NV+L  +   +++DFGL+K +        A         
Sbjct: 129 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 268 YSAPECFQNRSYTDKSDIFSFGMIL 292
           + APEC     ++ KSD++SFG+++
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLM 210

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 12/85 (14%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------- 267
           G++YL        +H +L   NV+L  +   +++DFGL+K +        A         
Sbjct: 119 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 268 YSAPECFQNRSYTDKSDIFSFGMIL 292
           + APEC     ++ KSD++SFG+++
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLM 200

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLL 283

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/177 (22%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           K  +  EL++++ L +H N+++L           ++ +Y   G   D ++ +R     L 
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG---DLLNFLRRKSRVLE 149
Query: 204 WEVRLRIAVGVIKGLQYLHFT----------CNPQILHYNLKPTNVMLDAEFTPRLADFG 253
            +    IA         LHF+           +   +H ++   NV+L      ++ DFG
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209
Query: 254 LAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
           LA+        ++ G+      + APE   +  YT +SD++S+G++L  + + G +P
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 44/88 (50%), Gaps = 12/88 (13%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA------ 267
           V  G++YL        +H +L   NV+L  +   +++DFGL+K +        A      
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 268 ---YSAPECFQNRSYTDKSDIFSFGMIL 292
              + APEC     ++ KSD++SFG+++
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLM 198

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLL 285

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 34/193 (17%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 59  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 181 DYLQTGSLEDAMDRIRENQLQ-------------LGWEVRLRIAVGVIKGLQYLHFTCNP 227
           ++ + G+L   + R + N+               L  E  +  +  V KG+++L    + 
Sbjct: 112 EFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSY 279
           + +H +L   N++L  +   ++ DFGLA+        +  G       + APE   +R Y
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 280 TDKSDIFSFGMIL 292
           T +SD++SFG++L
Sbjct: 228 TIQSDVWSFGVLL 240

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 12/85 (14%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------- 267
           G++YL        +H +L   NV+L  +   +++DFGL+K +        A         
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 268 YSAPECFQNRSYTDKSDIFSFGMIL 292
           + APEC     ++ KSD++SFG+++
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 55  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 114
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 115 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 171
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 172 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 179 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLL 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLL 292

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 47/87 (54%), Gaps = 11/87 (12%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIAT 265
           V KG+++L    + + +H +L   N++L  +   ++ DFGLA+        +  G     
Sbjct: 148 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMIL 292
             + APE   +R YT +SD++SFG++L
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLL 231

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 43/210 (20%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
           TVAV+ ++  E+ SP     S  R +  E  VL  + H +++ L     +     L+ +Y
Sbjct: 55  TVAVKMLK--ENASP-----SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107
Query: 183 LQTGSLED----------------------AMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            + GSL                        ++D   E  L +G    +  A  + +G+QY
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQY 165
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSLIATS------AYSAPE 272
           L      +++H +L   N+++      +++DFGL++ +    S +  S       + A E
Sbjct: 166 L---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIE 222
Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +  YT +SD++SFG++L  ++T G +P
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 43/210 (20%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
           TVAV+ ++  E+ SP     S  R +  E  VL  + H +++ L     +     L+ +Y
Sbjct: 55  TVAVKMLK--ENASP-----SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107
Query: 183 LQTGSLED----------------------AMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            + GSL                        ++D   E  L +G    +  A  + +G+QY
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQY 165
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSLIATS------AYSAPE 272
           L      +++H +L   N+++      +++DFGL++ +    S +  S       + A E
Sbjct: 166 L---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222
Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +  YT +SD++SFG++L  ++T G +P
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 45/88 (51%), Gaps = 12/88 (13%)
Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA------ 267
           V  G++YL  +     +H +L   NV+L  +   +++DFGL+K +        A      
Sbjct: 134 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 268 ---YSAPECFQNRSYTDKSDIFSFGMIL 292
              + APEC     ++ KSD++SFG+++
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLM 218

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 34/193 (17%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 59  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 181 DYLQTGSLEDAMDRIRENQLQ-------------LGWEVRLRIAVGVIKGLQYLHFTCNP 227
           ++ + G+L   + R + N+               L  E  +  +  V KG+++L    + 
Sbjct: 112 EFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSY 279
           + +H +L   N++L  +   ++ DFGLA+        +  G       + APE   +R Y
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVY 227
Query: 280 TDKSDIFSFGMIL 292
           T +SD++SFG++L
Sbjct: 228 TIQSDVWSFGVLL 240

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 12/85 (14%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------- 267
           G++YL  +     +H +L   NV+L  +   +++DFGL+K +        A         
Sbjct: 139 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 268 YSAPECFQNRSYTDKSDIFSFGMIL 292
           + APEC     ++ KSD++SFG+++
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 12/85 (14%)
Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------- 267
           G++YL  +     +H +L   NV+L  +   +++DFGL+K +        A         
Sbjct: 139 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 268 YSAPECFQNRSYTDKSDIFSFGMIL 292
           + APEC     ++ KSD++SFG+++
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 59  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 118
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 119 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 175
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 176 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 34/193 (17%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 96  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148
Query: 181 DYLQTGSLEDAMDRIRENQLQ-------------LGWEVRLRIAVGVIKGLQYLHFTCNP 227
           ++ + G+L   + R + N+               L  E  +  +  V KG+++L    + 
Sbjct: 149 EFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 204
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSY 279
           + +H +L   N++L  +   ++ DFGLA+        +  G       + APE   +R Y
Sbjct: 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264
Query: 280 TDKSDIFSFGMIL 292
           T +SD++SFG++L
Sbjct: 265 TIQSDVWSFGVLL 277

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 34/193 (17%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 61  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 113
Query: 181 DYLQTGSLEDAMDRIRENQLQ-------------LGWEVRLRIAVGVIKGLQYLHFTCNP 227
           ++ + G+L   + R + N+               L  E  +  +  V KG+++L    + 
Sbjct: 114 EFCKFGNLSTYL-RSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 169
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSY 279
           + +H +L   N++L  +   ++ DFGLA+        +  G       + APE   +R Y
Sbjct: 170 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 229
Query: 280 TDKSDIFSFGMIL 292
           T +SD++SFG++L
Sbjct: 230 TIQSDVWSFGVLL 242

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 34/193 (17%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR-NLMSL-RAYVPESSRFYLVY 180
           TVAV+ ++       E    S  R +  EL++L  + H  N+++L  A         ++ 
Sbjct: 59  TVAVKMLK-------EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111
Query: 181 DYLQTGSLEDAMDRIRENQLQ-------------LGWEVRLRIAVGVIKGLQYLHFTCNP 227
           ++ + G+L   + R + N+               L  E  +  +  V KG+++L    + 
Sbjct: 112 EFCKFGNLSTYL-RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 167
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSY 279
           + +H +L   N++L  +   ++ DFGLA+        +  G       + APE   +R Y
Sbjct: 168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227
Query: 280 TDKSDIFSFGMIL 292
           T +SD++SFG++L
Sbjct: 228 TIQSDVWSFGVLL 240

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           SV+ +  QE   +    H +++ L   + E+   +++ +    G L   + ++R+  L L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL-QVRKFSLDL 490
Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                +  A  +   L YL    + + +H ++   NV++ +    +L DFGL++ M  S 
Sbjct: 491 A--SLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 263 IATSA-------YSAPECFQNRSYTDKSDIFSFGMIL-AVLLTGRDPTAPFFAEAASGGS 314
              ++       + APE    R +T  SD++ FG+ +  +L+ G  P    F    +   
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDV 601
Query: 315 LGR 317
           +GR
Sbjct: 602 IGR 604

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 68  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 127
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           E  + ++K  +  E  V+  L +  ++ +   + E+  + LV +  + G L   + + R 
Sbjct: 407 EANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH 465
Query: 197 ---ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
              +N ++L  +V +        G++YL  +     +H +L   NV+L  +   +++DFG
Sbjct: 466 VKDKNIIELVHQVSM--------GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 514
Query: 254 LAKLMPGSLIATSA---------YSAPECFQNRSYTDKSDIFSFGMIL 292
           L+K +        A         + APEC     ++ KSD++SFG+++
Sbjct: 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 562

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/168 (22%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR- 196
           E  + ++K  +  E  V+  L +  ++ +   + E+  + LV +  + G L   + + R 
Sbjct: 408 EANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH 466
Query: 197 ---ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
              +N ++L  +V +        G++YL  +     +H +L   NV+L  +   +++DFG
Sbjct: 467 VKDKNIIELVHQVSM--------GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 515
Query: 254 LAKLMPGSLIATSA---------YSAPECFQNRSYTDKSDIFSFGMIL 292
           L+K +        A         + APEC     ++ KSD++SFG+++
Sbjct: 516 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 563

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 49/116 (42%), Gaps = 11/116 (9%)
Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMP--GSLIA 264
           I   + + +QYLH      I H ++KP N++  ++      +L DFG AK      SL  
Sbjct: 166 IXKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
              T  Y APE      Y    D +S G+I  +LL G  P       A S G   R
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTR 278

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 26/176 (14%)
Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR--IRENQLQLGWEVR 207
           +E +++A      ++ L     +    Y+V +Y+  G L + M    + E   +      
Sbjct: 124 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF----- 178
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------G 260
                 V+  L  +H   +  ++H ++KP N++LD     +LADFG    M         
Sbjct: 179 --YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 261 SLIATSAYSAPECFQNRS----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
           + + T  Y +PE  +++     Y  + D +S G+ L  +L G     PF+A++  G
Sbjct: 234 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG---DTPFYADSLVG 286

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 43/210 (20%)
Query: 123 TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDY 182
           TVAV+ ++  E+ SP     S  R +  E  VL  + H +++ L     +     L+ +Y
Sbjct: 55  TVAVKMLK--ENASP-----SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107
Query: 183 LQTGSLED----------------------AMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
            + GSL                        ++D   E  L +G    +  A  + +G+QY
Sbjct: 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG--DLISFAWQISQGMQY 165
Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSLIATS------AYSAPE 272
           L       ++H +L   N+++      +++DFGL++ +    S +  S       + A E
Sbjct: 166 L---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIE 222
Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +  YT +SD++SFG++L  ++T G +P
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/171 (21%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 90  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 149
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+
Sbjct: 150 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 206
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 207 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--------P 259
           +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+ + +         
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 188 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--------P 259
           +++A  +  G+ YL+     + +H +L   N M+  +FT ++ DFG+ + +         
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 23/156 (14%)
Query: 169 YVPESSRF-YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
           Y  +  R+ Y+V +Y+  G L + M       +   W  R   A  V+  L  +H   + 
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKW-ARFYTA-EVVLALDAIH---SM 192
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSLIATSAYSAPECFQNRS-- 278
             +H ++KP N++LD     +LADFG    M         + + T  Y +PE  +++   
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 279 --YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
             Y  + D +S G+ L  +L G     PF+A++  G
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG---DTPFYADSLVG 285

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 23/156 (14%)
Query: 169 YVPESSRF-YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
           Y  +  R+ Y+V +Y+  G L + M       +   W  R   A  V+  L  +H   + 
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKW-ARFYTA-EVVLALDAIH---SM 192
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSLIATSAYSAPECFQNRS-- 278
             +H ++KP N++LD     +LADFG    M         + + T  Y +PE  +++   
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 279 --YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
             Y  + D +S G+ L  +L G     PF+A++  G
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVG---DTPFYADSLVG 285

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 23/156 (14%)
Query: 169 YVPESSRF-YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
           Y  +  R+ Y+V +Y+  G L + M       +   W  R   A  V+  L  +H   + 
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKW-ARFYTA-EVVLALDAIH---SM 187
Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSLIATSAYSAPECFQNRS-- 278
             +H ++KP N++LD     +LADFG    M         + + T  Y +PE  +++   
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 279 --YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
             Y  + D +S G+ L  +L G     PF+A++  G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG---DTPFYADSLVG 280

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/176 (21%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED------- 190
           +K    ++   + E  + A L+H N++ L   V +     +++ Y   G L +       
Sbjct: 49  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 108
Query: 191 -----AMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
                + D  R  +  L     + +   +  G++YL    +  ++H +L   NV++  + 
Sbjct: 109 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL 165
Query: 246 TPRLADFGL---------AKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
             +++D GL          KL+  SL+    + APE      ++  SDI+S+G++L
Sbjct: 166 NVKISDLGLFREVYAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVL 220

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/176 (21%), Positives = 76/176 (43%), Gaps = 25/176 (14%)
Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED------- 190
           +K    ++   + E  + A L+H N++ L   V +     +++ Y   G L +       
Sbjct: 66  DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125
Query: 191 -----AMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
                + D  R  +  L     + +   +  G++YL    +  ++H +L   NV++  + 
Sbjct: 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKL 182
Query: 246 TPRLADFGL---------AKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMIL 292
             +++D GL          KL+  SL+    + APE      ++  SDI+S+G++L
Sbjct: 183 NVKISDLGLFREVYAADYYKLLGNSLLPIR-WMAPEAIMYGKFSIDSDIWSYGVVL 237

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL--EDAMDRIR 196
           +  K   R+  +E+ +L  LR ++  +    +     F        T  L   +  + I+
Sbjct: 131 RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK 190
Query: 197 ENQLQLGWEVRL--RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--RLADF 252
           +N+ Q G+ + L  + A  +++ L  LH     +I+H +LKP N++L  +     ++ DF
Sbjct: 191 KNKFQ-GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 253 GLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
           G +        + I +  Y APE      Y    D++S G ILA LLTG
Sbjct: 247 GSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL--EDAMDRIR 196
           +  K   R+  +E+ +L  LR ++  +    +     F        T  L   +  + I+
Sbjct: 131 RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK 190
Query: 197 ENQLQLGWEVRL--RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--RLADF 252
           +N+ Q G+ + L  + A  +++ L  LH     +I+H +LKP N++L  +     ++ DF
Sbjct: 191 KNKFQ-GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 253 GLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
           G +        + I +  Y APE      Y    D++S G ILA LLTG
Sbjct: 247 GSSCYEHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 13/169 (7%)
Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL--EDAMDRIR 196
           +  K   R+  +E+ +L  LR ++  +    +     F        T  L   +  + I+
Sbjct: 131 RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK 190
Query: 197 ENQLQLGWEVRL--RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--RLADF 252
           +N+ Q G+ + L  + A  +++ L  LH     +I+H +LKP N++L  +     ++ DF
Sbjct: 191 KNKFQ-GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 253 GLAKLMPGSL---IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
           G +      +   I +  Y APE      Y    D++S G ILA LLTG
Sbjct: 247 GSSCYEHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 32/143 (22%)
Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC------NPQI 229
           + LV +Y   GSL   +     +     W    R+A  V +GL YLH          P I
Sbjct: 87  YLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------------SLIATSAYSAPECFQ 275
            H +L   NV++  + T  ++DFGL+  + G              S + T  Y APE  +
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201
Query: 276 N-------RSYTDKSDIFSFGMI 291
                    S   + D+++ G+I
Sbjct: 202 GAVNLRDXESALKQVDMYALGLI 224

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 39/186 (20%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYV-PESS-RFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           +RI +E+ +L  L+   ++ L   + PE   +F  +Y  L+    +  + ++ +  + L 
Sbjct: 72  KRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA--DSDLKKLFKTPIFLT 129
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM----- 258
            +    I   ++ G +++H      I+H +LKP N +L+ + + ++ DFGLA+ +     
Sbjct: 130 EQHVKTILYNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186
Query: 259 ---------------PG-----------SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMI 291
                          PG           S + T  Y APE      +YT+  DI+S G I
Sbjct: 187 IHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCI 246
Query: 292 LAVLLT 297
            A LL 
Sbjct: 247 FAELLN 252

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/186 (22%), Positives = 83/186 (44%), Gaps = 32/186 (17%)
Query: 145 KRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL--- 200
           K  +  EL++++ L +H N+++L           ++ +Y   G L + + R  E  L   
Sbjct: 78  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPS 137
Query: 201 ------------QLGWEVRLR----IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE 244
                       + G  + LR     +  V +G+ +L    +   +H ++   NV+L   
Sbjct: 138 LAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG 194
Query: 245 FTPRLADFGLAK--------LMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLL 296
              ++ DFGLA+        ++ G+      + APE   +  YT +SD++S+G++L  + 
Sbjct: 195 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254
Query: 297 T-GRDP 301
           + G +P
Sbjct: 255 SLGLNP 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
           D  +TVAV+ ++          + + +  +  EL+VL+ L  H N+++L           
Sbjct: 67  DAAMTVAVKMLKP-------SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 119
Query: 178 LVYDYLQTGSLEDAMDRIRENQL--------------QLGWEVRLRIAVGVIKGLQYLHF 223
           ++ +Y   G L + + R R++ +               L  E  L  +  V KG+ +L  
Sbjct: 120 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-- 177
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQ 275
             +   +H +L   N++L      ++ DFGLA+        ++ G+      + APE   
Sbjct: 178 -ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 236
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
           N  YT +SD++S+G+ L  L + G  P
Sbjct: 237 NCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 85/196 (43%), Gaps = 41/196 (20%)
Query: 146 RRIQQELEVLASLRHRNLMSLRAYV-PESS-RFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           +RI +E+ +L  L+   ++ L   + P+   +F  +Y  L+    +  + ++ +  + L 
Sbjct: 70  KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLT 127
Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM----- 258
            E    I   ++ G  ++H +    I+H +LKP N +L+ + + ++ DFGLA+ +     
Sbjct: 128 EEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 259 ------------PG-----------SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAV 294
                       PG           S + T  Y APE      +YT   DI+S G I A 
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244
Query: 295 LLTG-----RDPTAPF 305
           LL        DPT  F
Sbjct: 245 LLNMLQSHINDPTNRF 260

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/171 (21%), Positives = 78/171 (45%), Gaps = 19/171 (11%)
Query: 143 SVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---E 197
           S++ RI+   E  V+      +++ L   V +     ++ + +  G L+  +  +R   E
Sbjct: 55  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 114
Query: 198 NQLQLG---WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           N   L        +++A  +  G+ YL+     + +H +L   N  +  +FT ++ DFG+
Sbjct: 115 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGM 171
Query: 255 AKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
            + +         G  +    + +PE  ++  +T  SD++SFG++L  + T
Sbjct: 172 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
           D  +TVAV+ ++          + + +  +  EL+VL+ L  H N+++L           
Sbjct: 51  DAAMTVAVKMLKP-------SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103
Query: 178 LVYDYLQTGSLEDAMDRIRENQL--------------QLGWEVRLRIAVGVIKGLQYLHF 223
           ++ +Y   G L + + R R++ +               L  E  L  +  V KG+ +L  
Sbjct: 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-- 161
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQ 275
             +   +H +L   N++L      ++ DFGLA+        ++ G+      + APE   
Sbjct: 162 -ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
           N  YT +SD++S+G+ L  L + G  P
Sbjct: 221 NCVYTFESDVWSYGIFLWELFSLGSSP 247

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
           D  +TVAV+ ++          + + +  +  EL+VL+ L  H N+++L           
Sbjct: 69  DAAMTVAVKMLKP-------SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 121
Query: 178 LVYDYLQTGSLEDAMDRIRENQL--------------QLGWEVRLRIAVGVIKGLQYLHF 223
           ++ +Y   G L + + R R++ +               L  E  L  +  V KG+ +L  
Sbjct: 122 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-- 179
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQ 275
             +   +H +L   N++L      ++ DFGLA+        ++ G+      + APE   
Sbjct: 180 -ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 238
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
           N  YT +SD++S+G+ L  L + G  P
Sbjct: 239 NCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
           D  +TVAV+ ++          + + +  +  EL+VL+ L  H N+++L           
Sbjct: 74  DAAMTVAVKMLKP-------SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 126
Query: 178 LVYDYLQTGSLEDAMDRIRENQL--------------QLGWEVRLRIAVGVIKGLQYLHF 223
           ++ +Y   G L + + R R++ +               L  E  L  +  V KG+ +L  
Sbjct: 127 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-- 184
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQ 275
             +   +H +L   N++L      ++ DFGLA+        ++ G+      + APE   
Sbjct: 185 -ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIF 243
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
           N  YT +SD++S+G+ L  L + G  P
Sbjct: 244 NCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 34/207 (16%)
Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
           D  +TVAV+ ++          + + +  +  EL+VL+ L  H N+++L           
Sbjct: 74  DAAMTVAVKMLKP-------SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 126
Query: 178 LVYDYLQTGSLEDAMDRIRENQL--------------QLGWEVRLRIAVGVIKGLQYLHF 223
           ++ +Y   G L + + R R++ +               L  E  L  +  V KG+ +L  
Sbjct: 127 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-- 184
Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--------LMPGSLIATSAYSAPECFQ 275
             +   +H +L   N++L      ++ DFGLA+        ++ G+      + APE   
Sbjct: 185 -ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 243
Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
           N  YT +SD++S+G+ L  L + G  P
Sbjct: 244 NCVYTFESDVWSYGIFLWELFSLGSSP 270

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 11/99 (11%)
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP------RLADFGLAKLMPGSL 262
           +I+  ++ GL Y+H  C   I+H ++KP NV+++   +P      ++AD G A       
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 263 ---IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
              I T  Y +PE      +   +DI+S   ++  L+TG
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 11/99 (11%)
Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP------RLADFGLAKLMPGSL 262
           +I+  ++ GL Y+H  C   I+H ++KP NV+++   +P      ++AD G A       
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 263 ---IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
              I T  Y +PE      +   +DI+S   ++  L+TG
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 36/201 (17%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY 180
           G  V VRR+        E  +  +   +Q EL V     H N++  RA     +  ++V 
Sbjct: 52  GEYVTVRRINL------EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105
Query: 181 DYLQTGSLEDA-----MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            ++  GS +D      MD +  N+L + +     I  GV+K L Y+H       +H ++K
Sbjct: 106 SFMAYGSAKDLICTHFMDGM--NELAIAY-----ILQGVLKALDYIHHM---GYVHRSVK 155
Query: 236 PTNVMLDAEFTPRLADFG-------------LAKLMPGSLIATSAYSAPECFQN--RSYT 280
            +++++  +    L+                +    P   +    + +PE  Q   + Y 
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 215
Query: 281 DKSDIFSFGMILAVLLTGRDP 301
            KSDI+S G+    L  G  P
Sbjct: 216 AKSDIYSVGITACELANGHVP 236

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 36/201 (17%)
Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY 180
           G  V VRR+        E  +  +   +Q EL V     H N++  RA     +  ++V 
Sbjct: 36  GEYVTVRRINL------EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 89
Query: 181 DYLQTGSLEDA-----MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK 235
            ++  GS +D      MD +  N+L + +     I  GV+K L Y+H       +H ++K
Sbjct: 90  SFMAYGSAKDLICTHFMDGM--NELAIAY-----ILQGVLKALDYIHHM---GYVHRSVK 139
Query: 236 PTNVMLDAEFTPRLADFG-------------LAKLMPGSLIATSAYSAPECFQN--RSYT 280
            +++++  +    L+                +    P   +    + +PE  Q   + Y 
Sbjct: 140 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 199
Query: 281 DKSDIFSFGMILAVLLTGRDP 301
            KSDI+S G+    L  G  P
Sbjct: 200 AKSDIYSVGITACELANGHVP 220

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	380
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	8e-70
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-61
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-42
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-41
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-33
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-33
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-32
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-23
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-20
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-20
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-20
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-18
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-18
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-17
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-15
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-15
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-14
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-14
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-14
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-14
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-13
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-12
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-12
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-12
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-10
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-10
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-10
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-10
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-10
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-09
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-09
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-09
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-09
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-09
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-08
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-04
1qzv_F	154	Plant photosystem I: subunit PSAF; photosynthesis,	7e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  221 bits (565), Expect = 8e-70
 Identities = 86/272 (31%), Positives = 139/272 (51%), Gaps = 15/272 (5%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           GK Y+  L +G  VAV+R++   +   E Q        Q E+E+++   HRNL+ LR + 
Sbjct: 44  GKVYKGRLADGTLVAVKRLKEERTQGGELQ-------FQTEVEMISMAVHRNLLRLRGFC 96

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
              +   LVY Y+  GS+   +    E+Q  L W  R RIA+G  +GL YLH  C+P+I+
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-------LIATSAYSAPECFQNRSYTDKS 283
           H ++K  N++LD EF   + DFGLAKLM          +  T  + APE       ++K+
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 216

Query: 284 DIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEE 343
           D+F +G++L  L+TG+               L  W++ L    +    +D   L    ++
Sbjct: 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD-LQGNYKD 275

Query: 344 DEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
           +E+   +++A++C   SP +RP   E+V ML 
Sbjct: 276 EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  198 bits (506), Expect = 5e-61
 Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 28/293 (9%)

Query: 94  LQAALAN--ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFES--GSPEKQNKSVKRRIQ 149
           L+ A  N     L+G    GK Y+ VL +G  VA++R    ES  G  E +         
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFET-------- 84

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
            E+E L+  RH +L+SL  +  E +   L+Y Y++ G+L+  +       + + WE RL 
Sbjct: 85  -EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-------- 261
           I +G  +GL YLH      I+H ++K  N++LD  F P++ DFG++K             
Sbjct: 144 ICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200

Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH 321
           +  T  Y  PE F     T+KSD++SFG++L  +L  R       +      +L  W   
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ--SLPREMVNLAEWAVE 258

Query: 322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
             + G+  + +D + L +++  + +      AV CL+ S  DRPS  +++  L
Sbjct: 259 SHNNGQLEQIVDPN-LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  184 bits (469), Expect = 1e-55
 Identities = 70/281 (24%), Positives = 129/281 (45%), Gaps = 31/281 (11%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           G  Y+  ++   TVAV+++    +   +   + +K++  QE++V+A  +H NL+ L  + 
Sbjct: 45  GVVYKGYVN-NTTVAVKKL----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS 99

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
            +     LVY Y+  GSL D +    +    L W +R +IA G   G+ +LH       +
Sbjct: 100 SDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHI 155

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDK 282
           H ++K  N++LD  FT +++DFGLA+             ++ T+AY APE  +    T K
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPK 214

Query: 283 SDIFSFGMILAVLLTGR---DPTAPFFAEAASGGSLGRWLR-HLQHAGEAREALDRSILG 338
           SDI+SFG++L  ++TG    D              L               + +D+ +  
Sbjct: 215 SDIYSFGVVLLEIITGLPAVDEHRE-------PQLLLDIKEEIEDEEKTIEDYIDKKM-- 265

Query: 339 EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
            + +   +     +A  CL +    RP   ++  +L ++ +
Sbjct: 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  153 bits (389), Expect = 5e-44
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 34/265 (12%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
           +G  VAV+ +        +  +        +E+ ++  LRH N++     V +     +V
Sbjct: 59  HGSDVAVKILM------EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112

Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
            +YL  GSL   +      + QL    RL +A  V KG+ YLH   NP I+H NLK  N+
Sbjct: 113 TEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNL 170

Query: 240 MLDAEFTPRLADFGLAKLMPGSLIA------TSAYSAPECFQNRSYTDKSDIFSFGMILA 293
           ++D ++T ++ DFGL++L   + ++      T  + APE  ++    +KSD++SFG+IL 
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230

Query: 294 VLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEED-EMLMAVRI 352
            L T + P    +            L   Q          R  +   +      ++    
Sbjct: 231 ELATLQQP----WGN----------LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE--- 273

Query: 353 AVVCLSDSPADRPSSDELVPMLTQL 377
              C ++ P  RPS   ++ +L  L
Sbjct: 274 --GCWTNEPWKRPSFATIMDLLRPL 296

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  148 bits (375), Expect = 6e-42
 Identities = 71/294 (24%), Positives = 126/294 (42%), Gaps = 42/294 (14%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           ID K ++        ++G    G   +        VA++++E          ++S ++  
Sbjct: 5   IDYKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQIE----------SESERKAF 48

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
             EL  L+ + H N++ L           LV +Y + GSL + +    E          +
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAM 105

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-PRLADFGLAKLMPGSLIA--- 264
              +   +G+ YLH      ++H +LKP N++L A  T  ++ DFG A  +   +     
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKG 165

Query: 265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH 324
           ++A+ APE F+  +Y++K D+FS+G+IL  ++T R P    F E              + 
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGP--------AFRI 213

Query: 325 AGEAREALDRSILGEEVEED-EMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
                    R  L + + +  E LM       C S  P+ RPS +E+V ++T L
Sbjct: 214 MWAVHNGT-RPPLIKNLPKPIESLMT-----RCWSKDPSQRPSMEEIVKIMTHL 261

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  146 bits (370), Expect = 1e-41
 Identities = 58/296 (19%), Positives = 116/296 (39%), Gaps = 41/296 (13%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           ID K L          L  +  G+ ++     G  + V+ ++          +    R  
Sbjct: 7   IDFKQLN-----FLTKLNENHSGELWKGRW-QGNDIVVKVLK------VRDWSTRKSRDF 54

Query: 149 QQELEVLASLRHRNLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
            +E   L    H N++ +      P +    L+  ++  GSL + +         +    
Sbjct: 55  NEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQ 112

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK-LMPGSLIAT 265
            ++ A+ + +G+ +LH T  P I  + L   +VM+D + T R++   +         +  
Sbjct: 113 AVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA 171

Query: 266 SAYSAPECFQNRSY---TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
            A+ APE  Q +        +D++SF ++L  L+T   P    FA+          L ++
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----FAD----------LSNM 217

Query: 323 QHAGEAREALDRSILGEEVEED-EMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
           +   +      R  +   +      LM      +C+++ PA RP  D +VP+L ++
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMK-----ICMNEDPAKRPKFDMIVPILEKM 268

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  145 bits (368), Expect = 9e-41
 Identities = 63/309 (20%), Positives = 109/309 (35%), Gaps = 54/309 (17%)

Query: 104 LLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           +      G  ++  L     VAV+         P +  +S +     E+  L  ++H N+
Sbjct: 31  VKARGRFGCVWKAQL-LNEYVAVKIF-------PIQDKQSWQNE--YEVYSLPGMKHENI 80

Query: 164 MSLRAYVPESS----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           +         +      +L+  + + GSL D    ++ N +   W     IA  + +GL 
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF---LKANVVS--WNELCHIAETMARGLA 135

Query: 220 YLH-------FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA-------- 264
           YLH           P I H ++K  NV+L    T  +ADFGLA        A        
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 265 TSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPT--------APFFAEAAS 311
           T  Y APE  +      R    + D+++ G++L  L +              PF  E   
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255

Query: 312 GGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAV-RIAVVCLSDSPADRPSSDEL 370
             SL      + H  +      R +L +  ++   +  +      C       R S+  +
Sbjct: 256 HPSLEDMQEVVVHKKK------RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 371 VPMLTQLHS 379
              +TQ+  
Sbjct: 310 GERITQMQR 318

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  143 bits (362), Expect = 3e-40
 Identities = 63/308 (20%), Positives = 128/308 (41%), Gaps = 41/308 (13%)

Query: 82  PVIFSPKIDPKTLQAALANENRLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQ 140
           P    P +    ++       + +G    G  ++  ++ +   VA++ +        E +
Sbjct: 9   PKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL-GDSEGETE 62

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
                +  Q+E+ ++++L H N++ L   +       +V +++  G L      + +   
Sbjct: 63  MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHR---LLDKAH 117

Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD-----AEFTPRLADFGLA 255
            + W V+LR+ + +  G++Y+    NP I+H +L+  N+ L      A    ++ADFGL+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

Query: 256 KLMPGSLIA---TSAYSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
           +    S+        + APE        YT+K+D +SF MIL  +LTG  P   +     
Sbjct: 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236

Query: 311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEED-EMLMAVRIAVVCLSDSPADRPSSDE 369
                  ++  ++  G       R  + E+       ++      +C S  P  RP    
Sbjct: 237 K------FINMIREEGL------RPTIPEDCPPRLRNVIE-----LCWSGDPKKRPHFSY 279

Query: 370 LVPMLTQL 377
           +V  L++L
Sbjct: 280 IVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  140 bits (354), Expect = 3e-39
 Identities = 70/302 (23%), Positives = 119/302 (39%), Gaps = 47/302 (15%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           ID   L         ++G    GK YR     G  VAV+         P++        +
Sbjct: 4   IDFAELT-----LEEIIGIGGFGKVYRAFW-IGDEVAVKAARH----DPDEDISQTIENV 53

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           +QE ++ A L+H N+++LR    +     LV ++ + G L   +   R     +  ++ +
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILV 108

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR--------LADFGLAKLMPG 260
             AV + +G+ YLH      I+H +LK +N+++  +            + DFGLA+    
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168

Query: 261 ----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLG 316
               S     A+ APE  +   ++  SD++S+G++L  LLTG  P    F          
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------- 216

Query: 317 RWLRHLQHAGEAREALDRSILGEEVEED-EMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
             +  L  A           +     E    LM       C +  P  RPS   ++  LT
Sbjct: 217 --IDGLAVAYGVAMNKLALPIPSTCPEPFAKLME-----DCWNPDPHSRPSFTNILDQLT 269

Query: 376 QL 377
            +
Sbjct: 270 TI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  126 bits (318), Expect = 1e-33
 Identities = 60/309 (19%), Positives = 108/309 (34%), Gaps = 58/309 (18%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           I  + L+        L+G    G+ Y         VA+R ++       E+ N+   +  
Sbjct: 30  IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLID------IERDNEDQLKAF 76

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           ++E+      RH N++             ++    +  +L      +R+ ++ L      
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSV---VRDAKIVLDVNKTR 133

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA---- 264
           +IA  ++KG+ YLH      ILH +LK  NV  D      + DFGL  +           
Sbjct: 134 QIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRED 189

Query: 265 -------TSAYSAPECFQNRS---------YTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                     + APE  +  S         ++  SD+F+ G I   L     P     AE
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249

Query: 309 AASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD 368
           A     +G  ++         + +                   I + C +    +RP+  
Sbjct: 250 AIIWQ-MGTGMKPNLSQIGMGKEI-----------------SDILLFCWAFEQEERPTFT 291

Query: 369 ELVPMLTQL 377
           +L+ ML +L
Sbjct: 292 KLMDMLEKL 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  125 bits (315), Expect = 2e-33
 Identities = 57/262 (21%), Positives = 99/262 (37%), Gaps = 43/262 (16%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
            + ++  +R   +E++V+  L H N++     + +  R   + +Y++ G+L      I+ 
Sbjct: 44  IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG---IIKS 100

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
              Q  W  R+  A  +  G+ YLH + N  I+H +L   N ++       +ADFGLA+L
Sbjct: 101 MDSQYPWSQRVSFAKDIASGMAYLH-SMN--IIHRDLNSHNCLVRENKNVVVADFGLARL 157

Query: 258 MPG--------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
           M                      +++    + APE    RSY +K D+FSFG++L  ++ 
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

Query: 298 GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCL 357
             +    +       G   R             +                    I V C 
Sbjct: 218 RVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSF-----------------FPITVRCC 260

Query: 358 SDSPADRPSSDELVPMLTQLHS 379
              P  RPS  +L   L  L  
Sbjct: 261 DLDPEKRPSFVKLEHWLETLRM 282

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (309), Expect = 1e-32
 Identities = 60/305 (19%), Positives = 119/305 (39%), Gaps = 55/305 (18%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           I    +        + +GS   G  Y+        VAV+ +                +  
Sbjct: 21  IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLN------VTAPTPQQLQAF 67

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           + E+ VL   RH N++    Y     +  +V  + +  SL      +  ++ +   +  +
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHH---LHASETKFEMKKLI 123

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--------G 260
            IA    +G+ YLH      I+H +LK  N+ L  + T ++ DFGLA             
Sbjct: 124 DIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180

Query: 261 SLIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
            L  +  + APE  + +    Y+ +SD+++FG++L  L+TG+ P                
Sbjct: 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP---------------- 224

Query: 318 WLRHLQHAGEAREALDRSILGEEVEE-----DEMLMAVRIAVVCLSDSPADRPSSDELVP 372
           +  ++ +  +  E + R  L  ++ +      + +   R+   CL     +RPS   ++ 
Sbjct: 225 Y-SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--KRLMAECLKKKRDERPSFPRILA 281

Query: 373 MLTQL 377
            + +L
Sbjct: 282 EIEEL 286

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  120 bits (303), Expect = 2e-31
 Identities = 57/315 (18%), Positives = 102/315 (32%), Gaps = 69/315 (21%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV--LASLRHRNLMSL-- 166
           G  Y+  L +   VAV+    F   +        ++    E  +  +  + H N+     
Sbjct: 27  GAVYKGSL-DERPVAVKV---FSFAN--------RQNFINEKNIYRVPLMEHDNIARFIV 74

Query: 167 ---RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH- 222
              R        + LV +Y   GSL   +     +     W    R+A  V +GL YLH 
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHT 129

Query: 223 -----FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA------------- 264
                    P I H +L   NV++  + T  ++DFGL+  + G+ +              
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 265 -TSAYSAPECFQN-------RSYTDKSDIFSFGMIL---AVLLTGRDPT-------APFF 306
            T  Y APE  +         S   + D+++ G+I     +  T   P          F 
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 307 AEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAV--RIAVVCLSDSPADR 364
            E  +  +       +    +      R    E  +E+ + +         C       R
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQ------RPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303

Query: 365 PSSDELVPMLTQLHS 379
            ++      + +L  
Sbjct: 304 LTAQXAEERMAELMM 318

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  117 bits (295), Expect = 1e-30
 Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 41/249 (16%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRA--YVPESSRFYLVYDYLQTGSLEDAMDRI 195
               ++ K+ +  E+ +L  L+H N++          ++  Y+V +Y + G L   + + 
Sbjct: 42  GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG 101

Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLH--FTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
            + +  L  E  LR+   +   L+  H        +LH +LKP NV LD +   +L DFG
Sbjct: 102 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161

Query: 254 LAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           LA+++        + + T  Y +PE     SY +KSDI+S G +L  L        PF A
Sbjct: 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM---PPFTA 218

Query: 308 EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEE------DEMLMAVRIAVVCLSDSP 361
                 S               + L   I   +         DE+   +      L+   
Sbjct: 219 F-----SQ--------------KELAGKIREGKFRRIPYRYSDELNEIITR---MLNLKD 256

Query: 362 ADRPSSDEL 370
             RPS +E+
Sbjct: 257 YHRPSVEEI 265

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  117 bits (295), Expect = 1e-30
 Identities = 69/295 (23%), Positives = 129/295 (43%), Gaps = 54/295 (18%)

Query: 101 ENRLLGSSPDGKYYR-----------TV-----LDNGLTVAVRRVEAFESGSPEKQNKSV 144
           E + +G S DG++ +           TV      +  + VA   ++        K  KS 
Sbjct: 15  ETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD------RKLTKSE 68

Query: 145 KRRIQQELEVLASLRHRNLM----SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           ++R ++E E+L  L+H N++    S  + V       LV + + +G+L+  + R +    
Sbjct: 69  RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---- 124

Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMP 259
            +  +V       ++KGLQ+LH T  P I+H +LK  N+ +     + ++ D GLA L  
Sbjct: 125 VMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183

Query: 260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSL 315
                ++I T  + APE ++   Y +  D+++FGM +  + T   P    ++E  +   +
Sbjct: 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP----YSECQNAAQI 238

Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
            R       +G    + D  +   EV+E        I   C+  +  +R S  +L
Sbjct: 239 YR----RVTSGVKPASFD-KVAIPEVKE--------IIEGCIRQNKDERYSIKDL 280

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (295), Expect = 2e-30
 Identities = 55/269 (20%), Positives = 116/269 (43%), Gaps = 30/269 (11%)

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
           L +G+ VA+++V+ F+    +      +    +E+++L  L H N++   A   E +   
Sbjct: 54  LLDGVPVALKKVQIFDLMDAKA-----RADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +V +    G L   +   ++ +  +      +  V +   L+++H   + +++H ++KP 
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPA 165

Query: 238 NVMLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMI 291
           NV + A    +L D GL +          SL+ T  Y +PE      Y  KSDI+S G +
Sbjct: 166 NVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 225

Query: 292 LAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR 351
           L  +   +   +PF+ +  +  SL + +    +       L      EE+ +        
Sbjct: 226 LYEMAALQ---SPFYGDKMNLYSLCKKIEQCDY-----PPLPSDHYSEELRQ-------- 269

Query: 352 IAVVCLSDSPADRPSSDELVPMLTQLHSF 380
           +  +C++  P  RP    +  +  ++H+ 
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHAC 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  116 bits (292), Expect = 9e-30
 Identities = 55/266 (20%), Positives = 93/266 (34%), Gaps = 46/266 (17%)

Query: 149 QQELEV--LASLRHRNLMSLRAYVPESS----RFYLVYDYLQTGSLEDAMDRIRENQLQL 202
            +E E+     +RH N++   A   + +    + YL+ DY + GSL D +         L
Sbjct: 77  FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTL 131

Query: 203 GWEVRLRIAVGVIKGLQYLH-----FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
             +  L++A   + GL +LH         P I H +LK  N+++    T  +AD GLA  
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191

Query: 258 MPGSLIA----------TSAYSAPE------CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                            T  Y  PE         +      +D++SFG+IL  +      
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251

Query: 302 T-------APFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR-IA 353
                    P+     S  S       +           R         DE L  +  + 
Sbjct: 252 GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL------RPSFPNRWSSDECLRQMGKLM 305

Query: 354 VVCLSDSPADRPSSDELVPMLTQLHS 379
             C + +PA R ++  +   L ++  
Sbjct: 306 TECWAHNPASRLTALRVKKTLAKMSE 331

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  116 bits (293), Expect = 9e-30
 Identities = 57/250 (22%), Positives = 108/250 (43%), Gaps = 52/250 (20%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR--- 194
            + +   +   ++E+ VLA+++H N++  R    E+   Y+V DY + G L   ++    
Sbjct: 60  SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119

Query: 195 --IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
              +E+Q+       L   V +   L+++H   + +ILH ++K  N+ L  + T +L DF
Sbjct: 120 VLFQEDQI-------LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDF 169

Query: 253 GLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           G+A+++        + I T  Y +PE  +N+ Y +KSDI++ G +L  L T +     F 
Sbjct: 170 GIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK---HAFE 226

Query: 307 AEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEE------DEMLMAVRIAVVCLSDS 360
           A                    + + L   I+             ++   V         +
Sbjct: 227 A-------------------GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ---LFKRN 264

Query: 361 PADRPSSDEL 370
           P DRPS + +
Sbjct: 265 PRDRPSVNSI 274

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (284), Expect = 5e-29
 Identities = 62/291 (21%), Positives = 105/291 (36%), Gaps = 53/291 (18%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV----PESSR 175
            G  VAV+           +  KS  R  + EL     LRH N++   A        S++
Sbjct: 30  QGENVAVKIF-------SSRDEKSWFR--ETELYNTVMLRHENILGFIASDMTSRHSSTQ 80

Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH-----FTCNPQIL 230
            +L+  Y + GSL D    ++   L       LRI + +  GL +LH         P I 
Sbjct: 81  LWLITHYHEMGSLYDY---LQLTTLD--TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA----------TSAYSAPE------CF 274
           H +LK  N+++       +AD GLA +   S             T  Y APE        
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTA-------PFFAEAASGGSLGRWLRHLQHAGE 327
                  + DI++FG++L  +               PF+    +  S     + +    +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQ 255

Query: 328 AREALDRSILGEEVEEDEMLMAVR-IAVVCLSDSPADRPSSDELVPMLTQL 377
                 R  +      D  L ++  +   C   +P+ R ++  +   LT++
Sbjct: 256 ------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (283), Expect = 1e-28
 Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 57/293 (19%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV--LASLRHRNLMSLRAYV----PES 173
            G  VAV+   + E           +R   +E E+     LRH N++   A         
Sbjct: 64  RGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112

Query: 174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH-----FTCNPQ 228
           ++ +LV DY + GSL D +     N+  +  E  +++A+    GL +LH         P 
Sbjct: 113 TQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIA----------TSAYSAPE------ 272
           I H +LK  N+++    T  +AD GLA     +             T  Y APE      
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLTGRDPT-------APFFAEAASGGSLGRWLRHLQHA 325
             ++     ++DI++ G++   +               P++    S  S+    + +   
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287

Query: 326 GEAREALDRSILGEEVEEDEMLMAVR-IAVVCLSDSPADRPSSDELVPMLTQL 377
                   R  +    +  E L  +  I   C   + A R ++  +   L+QL
Sbjct: 288 KL------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (278), Expect = 9e-28
 Identities = 42/196 (21%), Positives = 85/196 (43%), Gaps = 21/196 (10%)

Query: 126 VRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQT 185
            ++ +  +S + +   KS     + EL+++  +++   ++    +      Y++Y+Y++ 
Sbjct: 68  EKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEN 127

Query: 186 GSLEDAMDRIRENQ-LQLGWEVRL------RIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
            S+   +        L   +   +       I   V+    Y+H   N  I H ++KP+N
Sbjct: 128 DSI---LKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSN 182

Query: 239 VMLDAEFTPRLADFGLAKLMPGSLIATS----AYSAPECFQNRSYTD--KSDIFSFGMIL 292
           +++D     +L+DFG ++ M    I  S     +  PE F N S  +  K DI+S G+ L
Sbjct: 183 ILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

Query: 293 AVLLTGRDPTAPFFAE 308
            V+        PF  +
Sbjct: 243 YVMFYNV---VPFSLK 255

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  110 bits (276), Expect = 1e-27
 Identities = 50/222 (22%), Positives = 95/222 (42%), Gaps = 36/222 (16%)

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS--- 174
           L +G   A++R+            +  +   Q+E ++     H N++ L AY        
Sbjct: 51  LHDGHFYALKRIL--------CHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102

Query: 175 -RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
              +L+  + + G+L + ++R+++    L  +  L + +G+ +GL+ +H        H +
Sbjct: 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRD 159

Query: 234 LKPTNVMLDAEFTPRLADFGLAK------------LMPGSLIA---TSAYSAPECFQNRS 278
           LKPTN++L  E  P L D G               L      A   T +Y APE F  +S
Sbjct: 160 LKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219

Query: 279 Y---TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
           +    +++D++S G +L  ++ G     P+      G S+  
Sbjct: 220 HCVIDERTDVWSLGCVLYAMMFG---EGPYDMVFQKGDSVAL 258

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  106 bits (266), Expect = 1e-26
 Identities = 40/179 (22%), Positives = 82/179 (45%), Gaps = 28/179 (15%)

Query: 145 KRRIQQELEVLASLRHRN----------------LMSLRAYVPESSRFYLVYDYLQTGSL 188
             + ++E++ LA L H N                  S  +   ++   ++  ++   G+L
Sbjct: 48  NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL 107

Query: 189 EDAMDRIRENQLQLGWEVR-LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP 247
           E  +++ R  +L    +V  L +   + KG+ Y+H   + ++++ +LKP+N+ L      
Sbjct: 108 EQWIEKRRGEKLD---KVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV 161

Query: 248 RLADFGLAKLMPGSLIATSA-----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           ++ DFGL   +      T +     Y +PE   ++ Y  + D+++ G+ILA LL   D 
Sbjct: 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  105 bits (264), Expect = 3e-26
 Identities = 41/169 (24%), Positives = 82/169 (48%), Gaps = 14/169 (8%)

Query: 144 VKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
           V+ ++++E+E+ + LRH N++ L  Y  +++R YL+ +Y   G++      +++      
Sbjct: 52  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV---YRELQKLSKFDE 108

Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLI 263
                     +   L Y H   + +++H ++KP N++L +    ++ADFG +   P S  
Sbjct: 109 QRTA-TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164

Query: 264 ATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                   Y  PE  + R + +K D++S G++    L G+    PF A 
Sbjct: 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK---PPFEAN 210

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (267), Expect = 4e-26
 Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 42/262 (16%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMS-LRAYVPESSRFYLVYDYLQTGSLEDAM---DRIR 196
             +++ +I +EL+VL       ++    A+  +     +  +++  GSL+  +    RI 
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIP 129

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG--- 253
           E  L        ++++ VIKGL YL       I+H ++KP+N+++++    +L DFG   
Sbjct: 130 EQILG-------KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG 180

Query: 254 -LAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
            L   M  S + T +Y +PE  Q   Y+ +SDI+S G+ L  +  GR P  P  A+    
Sbjct: 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

Query: 313 GSLGRWLRHLQHAGEAREALDRSILGEEVEEDEM--LMAVRIAVV--------------- 355
               +                R +    ++      +  +   +V               
Sbjct: 241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 300

Query: 356 -------CLSDSPADRPSSDEL 370
                  CL  +PA+R    +L
Sbjct: 301 FQDFVNKCLIKNPAERADLKQL 322

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (264), Expect = 6e-26
 Identities = 37/168 (22%), Positives = 77/168 (45%), Gaps = 13/168 (7%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
                + ++  E+ +  SL H++++    +  ++   ++V +  +  SL   ++  +  +
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRK 136

Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM- 258
                E R      ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  + 
Sbjct: 137 ALTEPEAR-YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192

Query: 259 -PGSLIATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             G           Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (262), Expect = 7e-26
 Identities = 37/168 (22%), Positives = 77/168 (45%), Gaps = 13/168 (7%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
                + ++  E+ +  SL H++++    +  ++   ++V +  +  SL   ++  +  +
Sbjct: 54  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL---LELHKRRK 110

Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM- 258
                E R      ++ G QYLH     +++H +LK  N+ L+ +   ++ DFGLA  + 
Sbjct: 111 ALTEPEAR-YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166

Query: 259 -PGSLIATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             G           Y APE    + ++ + D++S G I+  LL G+ P
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  104 bits (262), Expect = 7e-26
 Identities = 54/272 (19%), Positives = 97/272 (35%), Gaps = 70/272 (25%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSL-------------RAYVPESSRFYLVYDYLQT 185
           +  +     I  E+ +LASL H+ ++                  V + S  ++  +Y + 
Sbjct: 40  RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN 99

Query: 186 GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
           G+L    D I    L    +   R+   +++ L Y+H   +  I+H +LKP N+ +D   
Sbjct: 100 GTL---YDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESR 153

Query: 246 TPRLADFGLAKLMPGSLIA--------------------TSAYSAPECFQNRS-YTDKSD 284
             ++ DFGLAK +  SL                      T+ Y A E       Y +K D
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKID 213

Query: 285 IFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEED 344
           ++S G+I   ++       PF                    G  R  + + +    +E  
Sbjct: 214 MYSLGIIFFEMIY------PFS------------------TGMERVNILKKLRSVSIEFP 249

Query: 345 EML------MAVRIAVVCLSDSPADRPSSDEL 370
                    +  +I  + +   P  RP +  L
Sbjct: 250 PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (261), Expect = 7e-26
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 14/169 (8%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
               + +R+Q E+++   L+H +++ L  Y  +S+  YLV +    G +      ++   
Sbjct: 50  YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM---NRYLKNRV 106

Query: 200 LQLG-WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
                 E R      +I G+ YLH   +  ILH +L  +N++L      ++ADFGLA  +
Sbjct: 107 KPFSENEAR-HFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

Query: 259 --PGSLIATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
             P     T      Y +PE     ++  +SD++S G +   LL GR P
Sbjct: 163 KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (259), Expect = 2e-25
 Identities = 36/173 (20%), Positives = 80/173 (46%), Gaps = 14/173 (8%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           + + V+ ++++E+E+ + LRH N++ +  Y  +  R YL+ ++   G L      ++++ 
Sbjct: 53  EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHG 109

Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
                         +   L Y H     +++H ++KP N+++  +   ++ADFG +   P
Sbjct: 110 RFDEQRSA-TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165

Query: 260 GSLIATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                T      Y  PE  + +++ +K D++  G++    L G     PF + 
Sbjct: 166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM---PPFDSP 215

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  102 bits (257), Expect = 5e-25
 Identities = 51/265 (19%), Positives = 91/265 (34%), Gaps = 55/265 (20%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
           ++G   AV+R  +   G  ++       R   E+     + +H   + L     E    Y
Sbjct: 80  EDGRLYAVKRSMSPFRGPKDRA------RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133

Query: 178 LVYDYLQTGSLEDAMDR----IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN 233
           L  +     SL+   +     + E Q+              +  L +LH   +  ++H +
Sbjct: 134 LQTELCG-PSLQQHCEAWGASLPEAQV-------WGYLRDTLLALAHLH---SQGLVHLD 182

Query: 234 LKPTNVMLDAEFTPRLADFGLAKLMPGSLIA-----TSAYSAPECFQNRSYTDKSDIFSF 288
           +KP N+ L      +L DFGL   +  +           Y APE  Q  SY   +D+FS 
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSL 241

Query: 289 GMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEE---DE 345
           G+ +  +    +   P                     GE  + L +  L  E       E
Sbjct: 242 GLTILEVACNMEL--PH-------------------GGEGWQQLRQGYLPPEFTAGLSSE 280

Query: 346 MLMAVRIAVVCLSDSPADRPSSDEL 370
           +   +    + L   P  R +++ L
Sbjct: 281 LRSVLV---MMLEPDPKLRATAEAL 302

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (262), Expect = 8e-25
 Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 18/180 (10%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSL------RAYVPESSRFYLVYDYLQTGSLEDAM 192
           + +   + R   E++++  L H N++S          +  +    L  +Y + G L   +
Sbjct: 50  ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL 109

Query: 193 DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR---L 249
           ++  EN   L       +   +   L+YLH     +I+H +LKP N++L          +
Sbjct: 110 NQ-FENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKI 165

Query: 250 ADFGLAKLM-PGSLIATS----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
            D G AK +  G L         Y APE  + + YT   D +SFG +    +TG  P  P
Sbjct: 166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  101 bits (253), Expect = 1e-24
 Identities = 43/194 (22%), Positives = 75/194 (38%), Gaps = 40/194 (20%)

Query: 145 KRRIQQELEVLASLRHRN------------LMSLRAYVPESSRFYLVYDYLQTGSLEDAM 192
           + ++ +E++ LA L H                            Y+     +  +L+D M
Sbjct: 47  REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106

Query: 193 DRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
           +  R    +    V L I + + + +++LH   +  ++H +LKP+N+    +   ++ DF
Sbjct: 107 NG-RCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDF 162

Query: 253 GLAKLM------------------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAV 294
           GL   M                      + T  Y +PE     SY+ K DIFS G+IL  
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

Query: 295 LLTGRDPTAPFFAE 308
           LL       PF  +
Sbjct: 223 LLY------PFSTQ 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (254), Expect = 2e-24
 Identities = 31/184 (16%), Positives = 66/184 (35%), Gaps = 23/184 (12%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           +  N        Q +E L        M   +     +   LV +    G+L +A++  + 
Sbjct: 104 KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN 163

Query: 198 NQLQLGWE-VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--------- 247
              ++  + + +  A+ ++  ++ +H   + +I+H ++KP N +L   F           
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220

Query: 248 --RLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT 297
              L D G +  M          +   TS +   E   N+ +  + D F     +  +L 
Sbjct: 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280

Query: 298 GRDP 301
           G   
Sbjct: 281 GTYM 284

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 99.6 bits (248), Expect = 1e-23
 Identities = 50/259 (19%), Positives = 97/259 (37%), Gaps = 43/259 (16%)

Query: 130 EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLE 189
              ES      + S       ++  +     +N +            Y+     +  +L+
Sbjct: 90  LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149

Query: 190 DAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL 249
           D M+R R +       V L I + + + +++LH   +  ++H +LKP+N+    +   ++
Sbjct: 150 DWMNR-RCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 205

Query: 250 ADFGLAKLMPGSLIA------------------TSAYSAPECFQNRSYTDKSDIFSFGMI 291
            DFGL   M                        T  Y +PE     +Y+ K DIFS G+I
Sbjct: 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265

Query: 292 LAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVR 351
           L  LL        F  +      +   +R+L+            +  ++  ++ M++   
Sbjct: 266 LFELLY------SFSTQMERVRIITD-VRNLKFP---------LLFTQKYPQEHMMVQ-- 307

Query: 352 IAVVCLSDSPADRPSSDEL 370
                LS SP +RP + ++
Sbjct: 308 ---DMLSPSPTERPEATDI 323

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 47/173 (27%), Positives = 84/173 (48%), Gaps = 19/173 (10%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDR 194
            + N +  +++ +E+ ++  L H N++ L   +      YL+ +Y   G + D   A  R
Sbjct: 51  TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110

Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           ++E       E R      ++  +QY H      I+H +LK  N++LDA+   ++ADFG 
Sbjct: 111 MKEK------EAR-SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGF 160

Query: 255 AKLM-PGSLIATS----AYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           +     G  +        Y+APE FQ + Y   + D++S G+IL  L++G  P
Sbjct: 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 98.2 bits (245), Expect = 1e-23
 Identities = 38/207 (18%), Positives = 80/207 (38%), Gaps = 32/207 (15%)

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF 176
             +G   A++R +   +GS ++QN        +E+   A L +H +++   +   E    
Sbjct: 33  RLDGCIYAIKRSKKPLAGSVDEQN------ALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86

Query: 177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKP 236
            +  +Y   GSL DA+                 + + V +GL+Y+H   +  ++H ++KP
Sbjct: 87  LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKP 143

Query: 237 TNVMLD-------------------AEFTPRLADFGLAKLM--PGSLIATSAYSAPE-CF 274
           +N+ +                     +   ++ D G    +  P      S + A E   
Sbjct: 144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ 203

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDP 301
           +N ++  K+DIF+  + +         
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAEPL 230

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 41/227 (18%), Positives = 81/227 (35%), Gaps = 38/227 (16%)

Query: 100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVL-ASL 158
               +LG   +G      + +   VAV+R+                    +E+++L  S 
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-----------LPECFSFADREVQLLRESD 75

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
            H N++       +    Y+  +     +L++    + +          + +      GL
Sbjct: 76  EHPNVIRYFCTEKDRQFQYIAIELC-AATLQE---YVEQKDFAHLGLEPITLLQQTTSGL 131

Query: 219 QYLHFTCNPQILHYNLKPTNVML-----DAEFTPRLADFGLAKLMPG---------SLIA 264
            +LH   +  I+H +LKP N+++       +    ++DFGL K +            +  
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 265 TSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           T  + APE        + T   DIFS G +   +++      PF   
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--PFGKS 233

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 42/191 (21%), Positives = 70/191 (36%), Gaps = 30/191 (15%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRI- 195
                      +E EVL  L H+N++ L A      +    L+ ++   GSL      + 
Sbjct: 45  ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL---YTVLE 101

Query: 196 -RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFTPRLA 250
              N   L     L +   V+ G+ +L       I+H N+KP N+M     D +   +L 
Sbjct: 102 EPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158

Query: 251 DFGLAKLM-PGSLIATS----AYSAPECFQ--------NRSYTDKSDIFSFGMILAVLLT 297
           DFG A+ +       +      Y  P+ ++         + Y    D++S G+      T
Sbjct: 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 298 GRDPTAPFFAE 308
           G     PF   
Sbjct: 219 GS---LPFRPF 226

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.0 bits (244), Expect = 7e-23
 Identities = 42/191 (21%), Positives = 70/191 (36%), Gaps = 30/191 (15%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRI- 195
                      +E EVL  L H+N++ L A      +    L+ ++   GSL      + 
Sbjct: 45  ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL---YTVLE 101

Query: 196 -RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFTPRLA 250
              N   L     L +   V+ G+ +L       I+H N+KP N+M     D +   +L 
Sbjct: 102 EPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158

Query: 251 DFGLAKLM-PGSLIATS----AYSAPECFQ--------NRSYTDKSDIFSFGMILAVLLT 297
           DFG A+ +       +      Y  P+ ++         + Y    D++S G+      T
Sbjct: 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 298 GRDPTAPFFAE 308
           G     PF   
Sbjct: 219 GS---LPFRPF 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 99.2 bits (247), Expect = 9e-23
 Identities = 49/241 (20%), Positives = 88/241 (36%), Gaps = 50/241 (20%)

Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRF-----YLVYDYLQTGSLEDAMDRIRENQL 200
                E + LA + H +++ +  +V  + R      Y+V +Y+   SL+ +  +      
Sbjct: 124 AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------ 177

Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-- 258
           +L     +   + ++  L YLH   +  +++ +LKP N+ML  E   +L D G    +  
Sbjct: 178 KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233

Query: 259 PGSLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR 317
            G L  T  + APE    R   T  +DI++ G  LA L                      
Sbjct: 234 FGYLYGTPGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDL---PTRNGR--------- 279

Query: 318 WLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS-DELVPMLTQ 376
              ++    E    L      +           R+    +   P  R ++ +E   M  Q
Sbjct: 280 ---YVDGLPEDDPVLKTY---DSYG--------RLLRRAIDPDPRQRFTTAEE---MSAQ 322

Query: 377 L 377
           L
Sbjct: 323 L 323

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 34/205 (16%)

Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY 180
              VA+R +   +      +       ++ E+E+L  L H  ++ ++ +  ++  +Y+V 
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218

Query: 181 DYLQTGSLEDAMDRIRENQLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNL 234
           + ++ G L    D++  N+       RL               +QYLH      I+H +L
Sbjct: 219 ELMEGGEL---FDKVVGNK-------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDL 265

Query: 235 KPTNVML---DAEFTPRLADFGLAKLM-PGSLIATSA----YSAPECFQN---RSYTDKS 283
           KP NV+L   + +   ++ DFG +K++   SL+ T      Y APE   +     Y    
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 325

Query: 284 DIFSFGMILAVLLTGRDPTAPFFAE 308
           D +S G+IL + L+G     PF   
Sbjct: 326 DCWSLGVILFICLSG---YPPFSEH 347

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 27/184 (14%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
            +++    +I+ E+EVL SL H N++ +     +    Y+V +  + G L   ++RI   
Sbjct: 58  DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL---LERIVSA 114

Query: 199 QLQLGW--EVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRL 249
           Q +     E        ++K     L Y H   +  ++H +LKP N++          ++
Sbjct: 115 QARGKALSE---GYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKI 168

Query: 250 ADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
            DFGLA+L         +A    Y APE F+ R  T K DI+S G+++  LLTG     P
Sbjct: 169 IDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGC---LP 224

Query: 305 FFAE 308
           F   
Sbjct: 225 FTGT 228

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 95.9 bits (238), Expect = 3e-22
 Identities = 30/303 (9%), Positives = 77/303 (25%), Gaps = 53/303 (17%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             L        +    ++     A++           + ++S   R+ +     A L   
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFT-----MGAENSRSELERLHEATFAAARLLGE 122

Query: 162 NLMSLRAY--------------------------VPESSRFYLVYDYLQT--GSLEDAMD 193
           +    R                                + + L+          L   +D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 194 RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
            +   +   G      +   +I+    L    +  ++H +  P N+ +  +    L D  
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239

Query: 254 LAKLMP--GSLIATSA-YSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
               +   G   +    Y+  E     +  +T   + +  G+ +  +        PF   
Sbjct: 240 ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF---LPFGLV 296

Query: 309 AASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD 368
                   +         ++      + L + V+   ++         L+     R    
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK--TLIGR------FLNFDRRRRLLPL 348

Query: 369 ELV 371
           E +
Sbjct: 349 EAM 351

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 37/226 (16%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAV-----RRVEAFESGSPEKQNKSVKRRIQQELEVLA 156
           R LGS   G+       +     A+      + +        K  +     I  E+ +L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 157 SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL--RIAVGV 214
           SL H N++ L     +   FYLV ++ + G L    ++I           +     A  +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---FEQIINRH-------KFDECDAANI 151

Query: 215 IK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLAKLM-PGSLIATS 266
           +K    G+ YLH      I+H ++KP N++L   ++    ++ DFGL+        +   
Sbjct: 152 MKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 267 A----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                Y APE  + + Y +K D++S G+I+ +LL G     PF  +
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY---PPFGGQ 250

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 95.2 bits (237), Expect = 3e-22
 Identities = 47/213 (22%), Positives = 82/213 (38%), Gaps = 39/213 (18%)

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSL-------RAY 169
           + +G   A++R+            +   R I QE+  +  L  H N++         +  
Sbjct: 50  VGSGREYALKRLL--------SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101

Query: 170 VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQI 229
                  +L+   L  G L + + ++          V L+I     + +Q++H    P I
Sbjct: 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-LKIFYQTCRAVQHMH-RQKPPI 159

Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAKLM----PGSLIA--------------TSAYSAP 271
           +H +LK  N++L  + T +L DFG A  +      S  A              T  Y  P
Sbjct: 160 IHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTP 219

Query: 272 E---CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           E    + N    +K DI++ G IL +L   + P
Sbjct: 220 EIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.4 bits (240), Expect = 6e-22
 Identities = 42/181 (23%), Positives = 89/181 (49%), Gaps = 24/181 (13%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
             ++S K  +++E++ ++ LRH  L++L     + +   ++Y+++  G L    +++ + 
Sbjct: 192 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADE 248

Query: 199 QLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL--ADF 252
             ++  E     AV  ++    GL ++H       +H +LKP N+M   + +  L   DF
Sbjct: 249 HNKMS-E---DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF 301

Query: 253 GLA-KLMPGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           GL   L P   +  +     ++APE  + +     +D++S G++  +LL+G    +PF  
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG---LSPFGG 358

Query: 308 E 308
           E
Sbjct: 359 E 359

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 24/181 (13%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
                 K  ++ E+ ++  L H  L++L     +     L+ ++L  G L    DRI   
Sbjct: 86  TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAE 142

Query: 199 QLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL--ADF 252
             ++  E      +  ++    GL+++H      I+H ++KP N+M + +    +   DF
Sbjct: 143 DYKMS-E---AEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF 195

Query: 253 GLA-KLMPGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           GLA KL P  ++  +     ++APE          +D+++ G++  VLL+G    +PF  
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG---LSPFAG 252

Query: 308 E 308
           E
Sbjct: 253 E 253

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 63/297 (21%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
            +Y     + G  VAV+     +   P++Q     R  Q+E+++L +L    ++  R   
Sbjct: 42  CRYDPLGDNTGALVAVK---QLQHSGPDQQ-----RDFQREIQILKALHSDFIVKYRGVS 93

Query: 171 PESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
               R    LV +YL +G L    D ++ ++ +L     L  +  + KG++YL    + +
Sbjct: 94  YGPGRQSLRLVMEYLPSGCL---RDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------APECFQN 276
            +H +L   N+++++E   ++ADFGLAKL+P        Y             APE   +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLD---KDYYVVREPGQSPIFWYAPESLSD 204

Query: 277 RSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
             ++ +SD++SFG++L  L T      +P                 L+  G  R+    S
Sbjct: 205 NIFSRQSDVWSFGVVLYELFTYCDKSCSP-------------SAEFLRMMGCERDVPALS 251

Query: 336 ILGEEVEEDE-------------MLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
            L E +EE +              LM      +C + SP DRPS   L P L  L S
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELM-----KLCWAPSPQDRPSFSALGPQLDMLWS 303

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 54/171 (31%), Positives = 88/171 (51%), Gaps = 19/171 (11%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIR 196
           ++  V  +I++E++ L   RH +++ L   +   + F++V +Y+  G L D      R+ 
Sbjct: 50  RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE 109

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           E       E R R+   ++  + Y H      ++H +LKP NV+LDA    ++ADFGL+ 
Sbjct: 110 EM------EAR-RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN 159

Query: 257 LM-PGSLIATS----AYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           +M  G  + TS     Y+APE    R Y   + DI+S G+IL  LL G  P
Sbjct: 160 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 34/205 (16%)

Query: 121 GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY 180
              VA++ +   +      +       ++ E+E+L  L H  ++ ++ +  ++  +Y+V 
Sbjct: 35  CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93

Query: 181 DYLQTGSLEDAMDRIRENQLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNL 234
           + ++ G L    D++  N+       RL               +QYLH      I+H +L
Sbjct: 94  ELMEGGEL---FDKVVGNK-------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDL 140

Query: 235 KPTNVML---DAEFTPRLADFGLAKLM-PGSLIATSA----YSAPECFQN---RSYTDKS 283
           KP NV+L   + +   ++ DFG +K++   SL+ T      Y APE   +     Y    
Sbjct: 141 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200

Query: 284 DIFSFGMILAVLLTGRDPTAPFFAE 308
           D +S G+IL + L+G  P  PF   
Sbjct: 201 DCWSLGVILFICLSGY-P--PFSEH 222

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.2 bits (230), Expect = 3e-21
 Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 29/184 (15%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           +K        ++ E+ VL  ++H N+++L      ++ +YLV   +  G L    DRI E
Sbjct: 43  KKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL---FDRILE 99

Query: 198 NQLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPR 248
                        + A  VI+     ++YLH      I+H +LKP N++    +      
Sbjct: 100 RG-------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIM 149

Query: 249 LADFGLAKLMPGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           + DFGL+K+    +++T+     Y APE    + Y+   D +S G+I  +LL G  P  P
Sbjct: 150 ITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY-P--P 206

Query: 305 FFAE 308
           F+ E
Sbjct: 207 FYEE 210

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 47/231 (20%), Positives = 84/231 (36%), Gaps = 35/231 (15%)

Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
            R+Q+E      L+  +++ +  +     + Y+    +  G   D    +R     L   
Sbjct: 79  TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLIN-G--VDLAAMLRRQG-PLAPP 134

Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM------- 258
             + I   +   L   H        H ++KP N+++ A+    L DFG+A          
Sbjct: 135 RAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191

Query: 259 PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRW 318
            G+ + T  Y APE F     T ++DI++   +L   LTG     P+      G  L   
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS---PPY-----QGDQLSVM 243

Query: 319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVV--CLSDSPADRPSS 367
             H+  A      +   I     +          AV+   ++ +P DR  +
Sbjct: 244 GAHINQAIPRPSTVRPGI-PVAFD----------AVIARGMAKNPEDRYVT 283

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.1 bits (229), Expect = 4e-21
 Identities = 39/200 (19%), Positives = 76/200 (38%), Gaps = 32/200 (16%)

Query: 118 LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY 177
            +    V V+ ++  +             ++  E+ +L+ + H N++ +         F 
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105

Query: 178 LV----------YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP 227
           LV          + ++      D   R+ E            I   ++  + YL      
Sbjct: 106 LVMEKHGSGLDLFAFI------DRHPRLDEP------LAS-YIFRQLVSAVGYLR---LK 149

Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAKLM-PGSLIATS----AYSAPECFQNRSYT-D 281
            I+H ++K  N+++  +FT +L DFG A  +  G L  T      Y APE      Y   
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209

Query: 282 KSDIFSFGMILAVLLTGRDP 301
           + +++S G+ L  L+   +P
Sbjct: 210 ELEMWSLGVTLYTLVFEENP 229

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 44/221 (19%), Positives = 85/221 (38%), Gaps = 41/221 (18%)

Query: 106 GSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL-- 163
           G S   K ++ + +     A++ V      + E+ +       + E+  L  L+  +   
Sbjct: 39  GGS--SKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           + L  Y       Y+V +      L      +++ +  +    R      +++ +  +H 
Sbjct: 91  IRLYDYEITDQYIYMVMECGN-IDL---NSWLKKKK-SIDPWERKSYWKNMLEAVHTIH- 144

Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQ 275
                I+H +LKP N ++  +   +L DFG+A  M          S + T  Y  PE  +
Sbjct: 145 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 276 NRS-----------YTDKSDIFSFGMILAVLLTGRDPTAPF 305
           + S            + KSD++S G IL  +  G+    PF
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---TPF 239

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 91.7 bits (228), Expect = 6e-21
 Identities = 44/221 (19%), Positives = 85/221 (38%), Gaps = 41/221 (18%)

Query: 106 GSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL-- 163
           G S   K ++ + +     A++ V      + E+ +       + E+  L  L+  +   
Sbjct: 20  GGS--SKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           + L  Y       Y+V +      L      +++ +  +    R      +++ +  +H 
Sbjct: 72  IRLYDYEITDQYIYMVMECGN-IDL---NSWLKKKK-SIDPWERKSYWKNMLEAVHTIH- 125

Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQ 275
                I+H +LKP N ++  +   +L DFG+A  M          S + T  Y  PE  +
Sbjct: 126 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 276 NRS-----------YTDKSDIFSFGMILAVLLTGRDPTAPF 305
           + S            + KSD++S G IL  +  G+    PF
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---TPF 220

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 27/175 (15%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
             ++   +Q+E+    SLRH N++  +  +   +   ++ +Y   G L    +RI     
Sbjct: 56  GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL---YERICNAG- 111

Query: 201 QLGWEVRLRIAVG------VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL--ADF 252
                 R            ++ G+ Y H   + QI H +LK  N +LD    PRL   DF
Sbjct: 112 ------RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDF 162

Query: 253 GLAKLM-PGSLIATS----AYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           G +K     S   ++    AY APE    + Y    +D++S G+ L V+L G  P
Sbjct: 163 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 30/184 (16%)

Query: 142 KSVKRR------IQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI 195
           K VK +      +++E+ +L   RHRN++ L           ++++++    +    +RI
Sbjct: 36  KFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI---FERI 92

Query: 196 RENQLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL-- 249
             +  +L  E   R  V  +      LQ+LH      I H++++P N++     +  +  
Sbjct: 93  NTSAFELN-E---REIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145

Query: 250 ADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
            +FG A+ + PG           Y APE  Q+   +  +D++S G ++ VLL+G     P
Sbjct: 146 IEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG---INP 202

Query: 305 FFAE 308
           F AE
Sbjct: 203 FLAE 206

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 89.9 bits (224), Expect = 1e-20
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 31/185 (16%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
            +    +  I++E+ +L  +RH N+++L       +   L+ + +  G L    D + E 
Sbjct: 46  SRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL---FDFLAE- 101

Query: 199 QLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----R 248
                 +  L    A   +K    G+ YLH     +I H++LKP N+ML  +  P    +
Sbjct: 102 ------KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIK 152

Query: 249 LADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           L DFG+A  +  G+          + APE         ++D++S G+I  +LL+G    +
Sbjct: 153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---AS 209

Query: 304 PFFAE 308
           PF  E
Sbjct: 210 PFLGE 214

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 18/175 (10%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLR--AYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           ++  + +  +++E+++L  LRH+N++ L    Y  E  + Y+V +Y   G  E  +D + 
Sbjct: 44  RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE-MLDSVP 102

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           E +  +  +        +I GL+YLH   +  I+H ++KP N++L    T +++  G+A+
Sbjct: 103 EKRFPV-CQAH-GYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157

Query: 257 LM----PGSLIATS----AYSAPECFQNRSYTD--KSDIFSFGMILAVLLTGRDP 301
            +          TS    A+  PE           K DI+S G+ L  + TG  P
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 31/182 (17%)

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
            K+ K  + +E+++L  L H N+M L  +  +   FYLV +    G L    D I   + 
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRK- 121

Query: 201 QLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLAD 251
                 R     A  +I+    G+ Y+H     +I+H +LKP N++L     +   R+ D
Sbjct: 122 ------RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIID 172

Query: 252 FGLAKLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           FGL+     S      I T+ Y APE     +Y +K D++S G+IL +LL+G     PF 
Sbjct: 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC---PPFN 228

Query: 307 AE 308
             
Sbjct: 229 GA 230

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 31/184 (16%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           K       R +QE+E++ SL H N++ L     +++  YLV +    G L    +R+   
Sbjct: 44  KYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHK 100

Query: 199 QLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRL 249
           +             A  ++K     + Y H      + H +LKP N +      +   +L
Sbjct: 101 R-------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKL 150

Query: 250 ADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
            DFGLA    PG ++ T      Y +P+  +   Y  + D +S G+++ VLL G     P
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGY---PP 206

Query: 305 FFAE 308
           F A 
Sbjct: 207 FSAP 210

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 24/181 (13%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
            +    K  ++ E+ V+  L H NL+ L       +   LV +Y+  G L    DRI + 
Sbjct: 124 TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL---FDRIIDE 180

Query: 199 QLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL--ADF 252
              L  E      +  +K    G++++H      ILH +LKP N++       ++   DF
Sbjct: 181 SYNLT-E---LDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDF 233

Query: 253 GLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           GLA+   P   +  +     + APE       +  +D++S G+I  +LL+G    +PF  
Sbjct: 234 GLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG---LSPFLG 290

Query: 308 E 308
           +
Sbjct: 291 D 291

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 31/265 (11%), Positives = 76/265 (28%), Gaps = 46/265 (17%)

Query: 126 VRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYL-- 183
           ++            +N+   +   + +     ++      +     +    +++  +   
Sbjct: 125 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 184 --QTGSLEDAMDRIRENQLQ---LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
                +L+   + +  +      L    RL++ + VI+ L  LH   +  ++H  L+P +
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVD 241

Query: 239 VMLDAEFTPRLADFGLAKLM--PGSLIATSAYSAPE----------CFQNRSYTDKSDIF 286
           ++LD      L  F                 ++ PE                 T   D +
Sbjct: 242 IVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301

Query: 287 SFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEM 346
           + G+ +  +        P   +AA    LG      +      + +   + G        
Sbjct: 302 TLGLAIYWIWCAD---LPNTDDAA----LGGSEWIFRSCKNIPQPVRALLEG-------- 346

Query: 347 LMAVRIAVVCLSDSPADRPSSDELV 371
                     L     DR    + +
Sbjct: 347 ---------FLRYPKEDRLLPLQAM 362

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 43/221 (19%), Positives = 84/221 (38%), Gaps = 41/221 (18%)

Query: 106 GSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL-- 163
           G S   K ++ + +     A++ V      + E+ +       + E+  L  L+  +   
Sbjct: 67  GGS--SKVFQVLNEKKQIYAIKYV------NLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 164 MSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF 223
           + L  Y       Y+V +      L      +++ +  +    R      +++ +  +H 
Sbjct: 119 IRLYDYEITDQYIYMVMECGN-IDL---NSWLKKKK-SIDPWERKSYWKNMLEAVHTIH- 172

Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQ 275
                I+H +LKP N ++  +   +L DFG+A  M          S +    Y  PE  +
Sbjct: 173 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 276 NRSYTD-----------KSDIFSFGMILAVLLTGRDPTAPF 305
           + S +            KSD++S G IL  +  G+    PF
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---TPF 267

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 31/184 (16%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
             + S   ++ +E+ VL  L H N+M L  +  +   +YLV +  + G L    D I   
Sbjct: 74  SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---FDEIIHR 130

Query: 199 QLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRL 249
                   +     A  +IK    G+ YLH      I+H +LKP N++L   + +   ++
Sbjct: 131 M-------KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKI 180

Query: 250 ADFGLAKLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
            DFGL+ +          + T+ Y APE  + + Y +K D++S G+IL +LL G     P
Sbjct: 181 VDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY---PP 236

Query: 305 FFAE 308
           F  +
Sbjct: 237 FGGQ 240

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 41/180 (22%), Positives = 87/180 (48%), Gaps = 21/180 (11%)

Query: 134 SGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR--AYVPESSRFYLVYDYLQTGSLEDA 191
           +     Q +    ++ QE+ +L  L H N++ L      P     Y+V++ +  G +   
Sbjct: 69  APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--- 125

Query: 192 MDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
           M+      L    E + R     +IKG++YLH+    +I+H ++KP+N+++  +   ++A
Sbjct: 126 MEVPTLKPLS---EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIA 179

Query: 251 DFGLAKLM--PGSLIATS----AYSAPECFQN--RSYT-DKSDIFSFGMILAVLLTGRDP 301
           DFG++       +L++ +    A+ APE      + ++    D+++ G+ L   + G+ P
Sbjct: 180 DFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 20/171 (11%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIR 196
           +   +  R+++E+  L  LRH +++ L   +   +   +V +Y   G L D      R+ 
Sbjct: 48  KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMT 106

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           E+      E R R    +I  ++Y H     +I+H +LKP N++LD     ++ADFGL+ 
Sbjct: 107 ED------EGR-RFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN 156

Query: 257 LM-PGSLIATS----AYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           +M  G+ + TS     Y+APE    + Y   + D++S G++L V+L GR P
Sbjct: 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 88.4 bits (220), Expect = 4e-20
 Identities = 48/235 (20%), Positives = 109/235 (46%), Gaps = 29/235 (12%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           + +   +R ++E+   + L H+N++S+     E   +YLV +Y++  +L +    I  + 
Sbjct: 50  EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE---YIESHG 106

Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM- 258
             L  +  +     ++ G+++ H   + +I+H ++KP N+++D+  T ++ DFG+AK + 
Sbjct: 107 -PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162

Query: 259 ------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
                    ++ T  Y +PE  +  +  + +DI+S G++L  +L G     PF  E A  
Sbjct: 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE---PPFNGETA-- 217

Query: 313 GSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS 367
             +   ++H+Q +        R  + + +          + +       A+R  +
Sbjct: 218 --VSIAIKHIQDSVPNVTTDVRKDIPQSLSN--------VILRATEKDKANRYKT 262

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 90.6 bits (225), Expect = 4e-20
 Identities = 55/171 (32%), Positives = 88/171 (51%), Gaps = 19/171 (11%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIR 196
           ++  V  +I++E++ L   RH +++ L   +   S  ++V +Y+  G L D      R+ 
Sbjct: 55  RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD 114

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           E       E R R+   ++ G+ Y H      ++H +LKP NV+LDA    ++ADFGL+ 
Sbjct: 115 EK------ESR-RLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSN 164

Query: 257 LM-PGSLIATS----AYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           +M  G  + TS     Y+APE    R Y   + DI+S G+IL  LL G  P
Sbjct: 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 31/206 (15%)

Query: 116 TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR 175
                G++VA+++V          Q+   + R  Q ++ LA L H N++ L++Y      
Sbjct: 43  KEKSTGMSVAIKKV---------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93

Query: 176 -------FYLVYDYLQTGSLEDAMDRIRENQLQLGWE-VRLRIAVGVIKGLQYLHFTCNP 227
                    +V +Y+   +L          Q+      +++ +   +I+ +  LH     
Sbjct: 94  RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL-FQLIRSIGCLHLPS-V 150

Query: 228 QILHYNLKPTNVMLD-AEFTPRLADFGLAK-LMPG----SLIATSAYSAPE-CFQNRSYT 280
            + H ++KP NV+++ A+ T +L DFG AK L P     + I +  Y APE  F N+ YT
Sbjct: 151 NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYT 210

Query: 281 DKSDIFSFGMILAVLLTGRDPTAPFF 306
              DI+S G I A ++ G     P F
Sbjct: 211 TAVDIWSVGCIFAEMMLGE----PIF 232

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 31/186 (16%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
             +    +  I++E+ +L  + H N+++L       +   L+ + +  G L    D + +
Sbjct: 52  ASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL---FDFLAQ 108

Query: 198 NQLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---- 247
                  +  L    A   IK    G+ YLH     +I H++LKP N+ML  +  P    
Sbjct: 109 -------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158

Query: 248 RLADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT 302
           +L DFGLA  +  G           + APE         ++D++S G+I  +LL+G    
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---A 215

Query: 303 APFFAE 308
           +PF  +
Sbjct: 216 SPFLGD 221

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 88.1 bits (219), Expect = 5e-20
 Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 31/184 (16%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
                    I +E+E+L  L H N+M L   + +SS FY+V +    G L    D I + 
Sbjct: 59  SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKR 115

Query: 199 QLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRL 249
           +       R     A  +IK    G+ Y+H      I+H +LKP N++L   + +   ++
Sbjct: 116 K-------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKI 165

Query: 250 ADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
            DFGL+      + +        Y APE  +  +Y +K D++S G+IL +LL+G  P  P
Sbjct: 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT-P--P 221

Query: 305 FFAE 308
           F+ +
Sbjct: 222 FYGK 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 88.1 bits (219), Expect = 6e-20
 Identities = 47/210 (22%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
            +LG    G  Y    L N + +A++ +         +++    + + +E+ +   L+H+
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIP--------ERDSRYSQPLHEEIALHKHLKHK 79

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++       E+    +  + +  GSL   + R +   L+   +        +++GL+YL
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYL 138

Query: 222 HFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMPG------SLIATSAYSAPECF 274
           H   + QI+H ++K  NV+++      +++DFG +K + G      +   T  Y APE  
Sbjct: 139 H---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII 195

Query: 275 Q--NRSYTDKSDIFSFGMILAV-LLTGRDP 301
               R Y   +DI+S G    + + TG+ P
Sbjct: 196 DKGPRGYGKAADIWSLG-CTIIEMATGKPP 224

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 31/186 (16%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
             +    +  I++E+ +L  + H N+++L       +   L+ + +  G L    D + +
Sbjct: 52  ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL---FDFLAQ 108

Query: 198 NQLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---- 247
                  +  L    A   IK    G+ YLH     +I H++LKP N+ML  +  P    
Sbjct: 109 -------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158

Query: 248 RLADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPT 302
           +L DFGLA  +  G           + APE         ++D++S G+I  +LL+G    
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---A 215

Query: 303 APFFAE 308
           +PF  +
Sbjct: 216 SPFLGD 221

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 47/241 (19%), Positives = 84/241 (34%), Gaps = 51/241 (21%)

Query: 102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVL-ASLRH 160
            ++LG    G         G  VAV+R+                     E+++L  S  H
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM-----------LIDFCDIALMEIKLLTESDDH 68

Query: 161 RNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEVRLRIAVGVIKG 217
            N++            Y+  +     +L+D   + +   EN         + +   +  G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPR-------------LADFGLAKLMPGSLIA 264
           + +LH   + +I+H +LKP N+++                    ++DFGL K +     +
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 265 ----------TSAYSAPECFQN-------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
                     TS + APE  +        R  T   DIFS G +   +L+      PF  
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGD 242

Query: 308 E 308
           +
Sbjct: 243 K 243

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 30/181 (16%)

Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ 201
              K+ ++ E+ VL  L H N++ L+      +   LV + +  G L    DRI E    
Sbjct: 89  TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL---FDRIVEKG-- 143

Query: 202 LGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADF 252
                    R A   +K     + YLH      I+H +LKP N++      +   ++ADF
Sbjct: 144 -----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF 195

Query: 253 GLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           GL+K++    L+ T      Y APE  +  +Y  + D++S G+I  +LL G     PF+ 
Sbjct: 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF---EPFYD 252

Query: 308 E 308
           E
Sbjct: 253 E 253

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 31/184 (16%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
                    I +E+E+L  L H N+M L   + +SS FY+V +    G L    D I + 
Sbjct: 59  SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKR 115

Query: 199 QLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRL 249
           +       R     A  +IK    G+ Y+H      I+H +LKP N++L   + +   ++
Sbjct: 116 K-------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKI 165

Query: 250 ADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
            DFGL+      + +        Y APE  +  +Y +K D++S G+IL +LL+G     P
Sbjct: 166 IDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT---PP 221

Query: 305 FFAE 308
           F+ +
Sbjct: 222 FYGK 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 88.1 bits (219), Expect = 8e-20
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 31/185 (16%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
            +    +  I++E+ +L  ++H N+++L       +   L+ + +  G L    D + E 
Sbjct: 52  SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAE- 107

Query: 199 QLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTP----R 248
                 +  L    A   +K    G+ YLH     QI H++LKP N+ML     P    +
Sbjct: 108 ------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIK 158

Query: 249 LADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           + DFGLA  +  G+          + APE         ++D++S G+I  +LL+G    +
Sbjct: 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---AS 215

Query: 304 PFFAE 308
           PF  +
Sbjct: 216 PFLGD 220

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 44/201 (21%), Positives = 84/201 (41%), Gaps = 27/201 (13%)

Query: 121 GLTVAVRRVEAFESGSPEK---QNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR- 175
           G+ VA++RV    S         +  + +R+ +E+ +L    H N++ LR  +V      
Sbjct: 46  GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105

Query: 176 ---FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILH 231
               YLV + ++T    D    I + ++ +     ++     ++ GL  LH      ++H
Sbjct: 106 MHKLYLVTELMRT----DLAQVIHDQRIVIS-PQHIQYFMYHILLGLHVLH-EAG--VVH 157

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYSAPE-CFQNRSYTDKSDI 285
            +L P N++L       + DF LA+           +    Y APE   Q + +T   D+
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217

Query: 286 FSFGMILAVLLTGRDPTAPFF 306
           +S G ++A +   +      F
Sbjct: 218 WSAGCVMAEMFNRK----ALF 234

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 48/290 (16%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
            +Y     + G  VAV+     +  + E          ++E+E+L SL+H N++  +   
Sbjct: 29  CRYDPLQDNTGEVVAVK---KLQHSTEEHLRD-----FEREIEILKSLQHDNIVKYKGVC 80

Query: 171 PESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
             + R    L+ +YL  GSL    D +++++ ++     L+    + KG++YL      +
Sbjct: 81  YSAGRRNLKLIMEYLPYGSL---RDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------APECFQN 276
            +H +L   N++++ E   ++ DFGL K++P        +             APE    
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWYAPESLTE 191

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI 336
             ++  SD++SFG++L  L T  + +    AE        +  +         E L    
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLIELLKN-- 247

Query: 337 LGEEVEE-----DEM--LMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
               +       DE+  +M       C +++   RPS  +L   + Q+  
Sbjct: 248 -NGRLPRPDGCPDEIYMIM-----TECWNNNVNQRPSFRDLALRVDQIRD 291

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 33/200 (16%)

Query: 119 DNGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR- 175
             G  VA++++   F       Q++   +R  +EL +L  +RH N++ L   + P+ +  
Sbjct: 48  RTGAKVAIKKLYRPF-------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100

Query: 176 ----FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQIL 230
               FYLV  ++ T    D    ++  +L    E R++ +   ++KGL+Y+H      I+
Sbjct: 101 DFTDFYLVMPFMGT----DLGKLMKHEKLG---EDRIQFLVYQMLKGLRYIH-AAG--II 150

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPE-CFQNRSYTDKSDIF 286
           H +LKP N+ ++ +   ++ DFGLA+     +   + T  Y APE       YT   DI+
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIW 210

Query: 287 SFGMILAVLLTGRDPTAPFF 306
           S G I+A ++TG+      F
Sbjct: 211 SVGCIMAEMITGK----TLF 226

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 48/290 (16%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
            +Y     + G  VAV+     +  + E          ++E+E+L SL+H N++  +   
Sbjct: 60  CRYDPLQDNTGEVVAVK---KLQHSTEEHLRD-----FEREIEILKSLQHDNIVKYKGVC 111

Query: 171 PESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
             + R    L+ +YL  GSL    D +++++ ++     L+    + KG++YL      +
Sbjct: 112 YSAGRRNLKLIMEYLPYGSL---RDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------APECFQN 276
            +H +L   N++++ E   ++ DFGL K++P        Y             APE    
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWYAPESLTE 222

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI 336
             ++  SD++SFG++L  L T  + +    AE        +  +         E L    
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ--MIVFHLIELLKN-- 278

Query: 337 LGEEVEE-----DEM--LMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
               +       DE+  +M       C +++   RPS  +L   + Q+  
Sbjct: 279 -NGRLPRPDGCPDEIYMIM-----TECWNNNVNQRPSFRDLALRVDQIRD 322

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 29/183 (15%), Positives = 65/183 (35%), Gaps = 23/183 (12%)

Query: 147 RIQQELEVLASLRHRNLMSLRAY--VPESSRFYLVYDYLQT--GSLEDAMDRIRENQLQL 202
           R     +++   + + ++ +R           + +Y  +Q+   +  + +         L
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPG 260
               RL++ + VI+ L  LH   +  ++H  L+P +++LD      L  F          
Sbjct: 204 VHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260

Query: 261 SLIATSAYSAPECFQNRS-----------YTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
               +  +  PE    R+            T   D ++ G+++  +        P   +A
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD---LPITKDA 317

Query: 310 ASG 312
           A G
Sbjct: 318 ALG 320

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 46/207 (22%), Positives = 91/207 (43%), Gaps = 35/207 (16%)

Query: 121 GLTVAVRRVE-AFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL 178
               AV+ ++         ++ + ++    +E+++L  +  H N++ L+     ++ F+L
Sbjct: 42  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHY 232
           V+D ++ G L    D + E          L  +    +++     +  LH      I+H 
Sbjct: 102 VFDLMKKGEL---FDYLTEKV-------TLSEKETRKIMRALLEVICALHKL---NIVHR 148

Query: 233 NLKPTNVMLDAEFTPRLADFGLAKLM-PGSLIATSA----YSAPE------CFQNRSYTD 281
           +LKP N++LD +   +L DFG +  + PG  +        Y APE         +  Y  
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 208

Query: 282 KSDIFSFGMILAVLLTGRDPTAPFFAE 308
           + D++S G+I+  LL G   + PF+  
Sbjct: 209 EVDMWSTGVIMYTLLAG---SPPFWHR 232

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 84.9 bits (211), Expect = 5e-19
 Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 40/217 (18%)

Query: 103 RLLGSSPDGK-YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           + LG    G+            VAV+ V+        K+       I++E+ +   L H 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVD-------MKRAVDCPENIKKEICINKMLNHE 65

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQ-----LQLGWEVRLRIAVG 213
           N++    +  E +  YL  +Y   G L D       + E        QL           
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL----------- 114

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM----PGSLIATS--- 266
            + G+ YLH      I H ++KP N++LD     +++DFGLA +        L+      
Sbjct: 115 -MAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 267 -AYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
             Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 41/215 (19%)

Query: 104 LLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
            +G    G+ +R      G   AV++V              ++    +EL   A L    
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR-------------LEVFRVEELVACAGLSSPR 111

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR---IRENQLQLGWEVRLRIAVGVIKGLQ 219
           ++ L   V E     +  + L+ GSL   + +   + E++               ++GL+
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-------YLGQALEGLE 164

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAKLMPGSLIATSAYS--------- 269
           YLH     +ILH ++K  NV+L ++ +   L DFG A  +    +  S  +         
Sbjct: 165 YLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221

Query: 270 --APECFQNRSYTDKSDIFSFGMILAV-LLTGRDP 301
             APE    +    K DI+S    + + +L G  P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSC-CMMLHMLNGCHP 255

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 41/183 (22%), Positives = 79/183 (43%), Gaps = 25/183 (13%)

Query: 139 KQNKSVKRRIQQELEVLASLRHR-NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
           ++ +  +  I  E+ VL   +    +++L      +S   L+ +Y   G +         
Sbjct: 66  RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI---FSLCLP 122

Query: 198 NQLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLA 250
              ++  E      + +IK    G+ YLH      I+H +LKP N++L + +     ++ 
Sbjct: 123 ELAEMVSE---NDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176

Query: 251 DFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
           DFG+++ +     +        Y APE       T  +D+++ G+I  +LLT    T+PF
Sbjct: 177 DFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH---TSPF 233

Query: 306 FAE 308
             E
Sbjct: 234 VGE 236

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.9 bits (211), Expect = 6e-19
 Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 30/184 (16%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           K +    +++++E  +   L+H N++ L   + E S  YLV+D +  G L    + I   
Sbjct: 43  KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAR 99

Query: 199 QLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLD--AEFTP-RL 249
           +             A   I+     + Y H      I+H NLKP N++L   A+    +L
Sbjct: 100 E-------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 149

Query: 250 ADFGLAKLM-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           ADFGLA  +         A    Y +PE  +   Y+   DI++ G+IL +LL G     P
Sbjct: 150 ADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG---YPP 206

Query: 305 FFAE 308
           F+ E
Sbjct: 207 FWDE 210

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 41/193 (21%), Positives = 91/193 (47%), Gaps = 22/193 (11%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV-LASLRHRNLMSLR-AYVPESSRFY 177
           +G  +AV+R+           N   ++R+  +L++ + ++     ++   A   E    +
Sbjct: 31  SGQIMAVKRI-------RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD-VW 82

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +  + +   SL+    ++ +    +  ++  +IAV ++K L++LH      ++H ++KP+
Sbjct: 83  ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPS 139

Query: 238 NVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYSAPE----CFQNRSYTDKSDIFSF 288
           NV+++A    ++ DFG++  +   +          Y APE        + Y+ KSDI+S 
Sbjct: 140 NVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSL 199

Query: 289 GMILAVLLTGRDP 301
           G+ +  L   R P
Sbjct: 200 GITMIELAILRFP 212

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 33/199 (16%)

Query: 120 NGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR-- 175
            GL VAV+++   F       Q+    +R  +EL +L  ++H N++ L   + P  S   
Sbjct: 53  TGLRVAVKKLSRPF-------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105

Query: 176 ---FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILH 231
               YLV   +      D  + ++  +L    +  ++ +   +++GL+Y+H + +  I+H
Sbjct: 106 FNDVYLVTHLMGA----DLNNIVKCQKLT---DDHVQFLIYQILRGLKYIH-SAD--IIH 155

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPE-CFQNRSYTDKSDIFS 287
            +LKP+N+ ++ +   ++ DFGLA+     +   +AT  Y APE       Y    DI+S
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 215

Query: 288 FGMILAVLLTGRDPTAPFF 306
            G I+A LLTGR      F
Sbjct: 216 VGCIMAELLTGR----TLF 230

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.9 bits (213), Expect = 9e-19
 Identities = 46/200 (23%), Positives = 92/200 (46%), Gaps = 35/200 (17%)

Query: 120 NGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR-- 175
               VA++++   F       QN++  +R  +EL ++  + H+N++ L   + P+ S   
Sbjct: 49  LERNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101

Query: 176 ---FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILH 231
               Y+V + +      +    I+          R+  +   ++ G+++LH +    I+H
Sbjct: 102 FQDVYIVMELMDA----NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH-SAG--IIH 150

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYSAPECFQNRSYTDKSDIF 286
            +LKP+N+++ ++ T ++ DFGLA+    S      + T  Y APE      Y +  DI+
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210

Query: 287 SFGMILAVLLTGRDPTAPFF 306
           S G I+  ++ G       F
Sbjct: 211 SVGCIMGEMIKGG----VLF 226

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 85.1 bits (211), Expect = 9e-19
 Identities = 40/180 (22%), Positives = 77/180 (42%), Gaps = 25/180 (13%)

Query: 141 NKSVKRRIQQELEVL-ASLRHRNLMSLR-AYVPESSRFYLVYDYLQTGSLED---AMDRI 195
           NK   +RI  +L+V+  S     ++     ++  +   ++  + + T + +        I
Sbjct: 63  NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD-VFIAMELMGTCAEKLKKRMQGPI 121

Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA 255
            E  L        ++ V ++K L YL       ++H ++KP+N++LD     +L DFG++
Sbjct: 122 PERILG-------KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172

Query: 256 KLMPGSL-----IATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
             +            +AY APE           Y  ++D++S G+ L  L TG+ P    
Sbjct: 173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 52/203 (25%), Positives = 98/203 (48%), Gaps = 37/203 (18%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR--- 175
           N + VA++++  F       ++++  +R  +E+++L   RH N++ +       +     
Sbjct: 51  NKVRVAIKKISPF-------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103

Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILHYN 233
             Y+V D ++T    D    ++   L       +      +++GL+Y+H + N  +LH +
Sbjct: 104 DVYIVQDLMET----DLYKLLKTQHLS---NDHICYFLYQILRGLKYIH-SAN--VLHRD 153

Query: 234 LKPTNVMLDAEFTPRLADFGLAKLMPGSL---------IATSAYSAPE-CFQNRSYTDKS 283
           LKP+N++L+     ++ DFGLA++              +AT  Y APE    ++ YT   
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213

Query: 284 DIFSFGMILAVLLTGRDPTAPFF 306
           DI+S G ILA +L+ R    P F
Sbjct: 214 DIWSVGCILAEMLSNR----PIF 232

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 34/208 (16%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFY 177
             G   AV+ +E        +Q + V+   ++E  +L  +  H ++++L      SS  +
Sbjct: 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILH 231
           LV+D ++ G L    D + E        V L  +    +++     + +LH      I+H
Sbjct: 177 LVFDLMRKGEL---FDYLTEK-------VALSEKETRSIMRSLLEAVSFLHAN---NIVH 223

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLM-PGSLIATSA----YSAPE------CFQNRSYT 280
            +LKP N++LD     RL+DFG +  + PG  +        Y APE         +  Y 
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYG 283

Query: 281 DKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            + D+++ G+IL  LL G   + PF+  
Sbjct: 284 KEVDLWACGVILFTLLAG---SPPFWHR 308

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 35/205 (17%)

Query: 116 TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR 175
            + D+G  VA+++V               KR   +EL+++  L H N++ LR +   S  
Sbjct: 74  KLCDSGELVAIKKVLQD------------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121

Query: 176 ------FYLVYDYLQTGSLEDAMDRIRENQLQLGWE-VRLRIAVGVIKGLQYLHFTCNPQ 228
                   LV DY+   ++          +  L    V+L +   + + L Y+H   +  
Sbjct: 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSLAYIH---SFG 176

Query: 229 ILHYNLKPTNVMLDAEFTP-RLADFGLAK-LMPG----SLIATSAYSAPE-CFQNRSYTD 281
           I H ++KP N++LD +    +L DFG AK L+ G    S I +  Y APE  F    YT 
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 236

Query: 282 KSDIFSFGMILAVLLTGRDPTAPFF 306
             D++S G +LA LL G+    P F
Sbjct: 237 SIDVWSAGCVLAELLLGQ----PIF 257

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 32/180 (17%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRI 195
           K+       I++E+ +   L H N++    +  E +  YL  +Y   G L D       +
Sbjct: 43  KRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102

Query: 196 RENQ-----LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA 250
            E        QL            + G+ YLH      I H ++KP N++LD     +++
Sbjct: 103 PEPDAQRFFHQL------------MAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 147

Query: 251 DFGLAKLM----PGSLIATS----AYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           DFGLA +        L+        Y APE  + R +  +  D++S G++L  +L G  P
Sbjct: 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 44/212 (20%), Positives = 85/212 (40%), Gaps = 25/212 (11%)

Query: 103 RLLGSSPDGK-YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
            LLGS   G  Y    + + L VA++ VE  +    +        R+  E+ +L  +   
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVE--KDRISDWGELPNGTRVPMEVVLLKKVSSG 106

Query: 162 --NLMSLRAYVPESSRFYLVYDYLQ-TGSLED---AMDRIRENQLQLGWEVRLRIAVGVI 215
              ++ L  +      F L+ +  +    L D       ++E         R      V+
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE------LAR-SFFWQVL 159

Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKLMPGSLIATS----AYSA 270
           + +++ H   N  +LH ++K  N+++D      +L DFG   L+  ++         YS 
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP 216

Query: 271 PECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           PE  +   Y    + ++S G++L  ++ G  P
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 34/200 (17%)

Query: 119 DNGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR- 175
            +G  VA++++   F       Q++   +R  +EL +L  ++H N++ L   + P SS  
Sbjct: 47  RSGEKVAIKKLSRPF-------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99

Query: 176 ----FYLVYDYLQTGSLEDAMD-RIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
               FYLV  ++QT  L+  M  +  E ++Q        +   ++KGL+Y+H +    ++
Sbjct: 100 NFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-------LVYQMLKGLKYIH-SAG--VV 148

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPE-CFQNRSYTDKSDIF 286
           H +LKP N+ ++ +   ++ DFGLA+     +   + T  Y APE       Y    DI+
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 208

Query: 287 SFGMILAVLLTGRDPTAPFF 306
           S G I+A +LTG+      F
Sbjct: 209 SVGCIMAEMLTGK----TLF 224

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 50/289 (17%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
            +Y     + G  VAV+   + +  S           +++E+E+L +L H N++  +   
Sbjct: 40  CRYDPEGDNTGEQVAVK---SLKPESGGNH----IADLKKEIEILRNLYHENIVKYKGIC 92

Query: 171 PESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
            E       L+ ++L +GSL    + + +N+ ++  + +L+ AV + KG+ YL    + Q
Sbjct: 93  TEDGGNGIKLIMEFLPSGSL---KEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQ 146

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------APECFQN 276
            +H +L   NV++++E   ++ DFGL K +         Y+            APEC   
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 277 RSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
             +   SD++SFG+ L  LLT     ++P        G     +            L   
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT----RLVNTLKE- 258

Query: 336 ILGEEVEE-----DEM--LMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
             G+ +       DE+  LM       C    P++R S   L+     L
Sbjct: 259 --GKRLPCPPNCPDEVYQLM-----RKCWEFQPSNRTSFQNLIEGFEAL 300

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 23/176 (13%)

Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPESSRF------YLVYDYLQTGSLEDAMDRIREN 198
           KR   +EL+++  ++H N++ L+A+   +          LV +Y+   ++  A     + 
Sbjct: 76  KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL 134

Query: 199 QLQLGWE-VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP-RLADFGLAK 256
           +  +    ++L +   +++ L Y+H   +  I H ++KP N++LD      +L DFG AK
Sbjct: 135 KQTMPMLLIKLYM-YQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190

Query: 257 -LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
            L+ G    S I +  Y APE  F   +YT   DI+S G ++A L+ G+    P F
Sbjct: 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ----PLF 242

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 47/224 (20%), Positives = 76/224 (33%), Gaps = 62/224 (27%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRE 197
            + N     RI+ E+ ++  L H N+  L     +     LV +    G L   +D++  
Sbjct: 65  RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL---LDKLNV 121

Query: 198 NQLQLGWEVRL-----------------------------------RIAVGVIK----GL 218
                  +  +                                   ++   +++     L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 219 QYLHFTCNPQILHYNLKPTNVML--DAEFTPRLADFGLAKLMPGSLIA----------TS 266
            YLH   N  I H ++KP N +   +  F  +L DFGL+K                  T 
Sbjct: 182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238

Query: 267 AYSAPE--CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            + APE     N SY  K D +S G++L +LL G     PF   
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA-V--PFPGV 279

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 44/214 (20%), Positives = 78/214 (36%), Gaps = 27/214 (12%)

Query: 103 RLLGSSPDGK-YYRTVLDNGLTVAVRRV--EAFESGSPEKQNKSVKRRIQQELEVLASLR 159
            LLG    G  +    L + L VA++ +        SP   + +    +    +V A   
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL------RIAVG 213
           H  ++ L  +      F LV +       +D  D I E          L           
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKG-------PLGEGPSRCFFGQ 147

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKLMPGSLIATS----AY 268
           V+  +Q+ H   +  ++H ++K  N+++D      +L DFG   L+             Y
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVY 204

Query: 269 SAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDP 301
           S PE      Y    + ++S G++L  ++ G  P
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 71/284 (25%), Positives = 112/284 (39%), Gaps = 38/284 (13%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
             Y  T    G  VAV+ ++              +   +QE+++L +L H +++  +   
Sbjct: 50  YCYDPTNDGTGEMVAVKALK-------ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102

Query: 171 PESSR--FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ 228
            ++      LV +Y+  GSL D + R      QL     L  A  + +G+ YLH      
Sbjct: 103 EDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---AQH 154

Query: 229 ILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS---------APECFQNRSY 279
            +H +L   NV+LD +   ++ DFGLAK +P                   APEC +   +
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF 214

Query: 280 TDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGS--LGRWLRHLQHAGEAREALDR-S 335
              SD++SFG+ L  LLT      +P        G       +  L    E  E L R  
Sbjct: 215 YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPD 274

Query: 336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
               EV     LM       C     + RP+ + L+P+L  +H 
Sbjct: 275 KCPAEVYH---LM-----KNCWETEASFRPTFENLIPILKTVHE 310

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 59/321 (18%), Positives = 105/321 (32%), Gaps = 66/321 (20%)

Query: 106 GSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           G               G  V VRR+      + E  +  +   +Q EL V     H N++
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRI------NLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 165 SLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV---GVIKGLQYL 221
             RA     +  ++V  ++  GS +D +     + +         IA    GV+K L Y+
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYI 144

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA-------------KLMPGSLIATSAY 268
           H   +   +H ++K +++++  +    L+                     P   +    +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 269 SAPECFQ--NRSYTDKSDIFSFGMILAV-LLTGRDP----------------TAPFFAEA 309
            +PE  Q   + Y  KSDI+S G I A  L  G  P                T P   + 
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVG-ITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAV----------VCLSD 359
           ++  +    +   +    +  +   +         +                    CL  
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320

Query: 360 SPADRPSSDELVPMLTQLHSF 380
           +P  RPS+  L   L   HSF
Sbjct: 321 NPDARPSASTL---LN--HSF 336

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 30/176 (17%)

Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           ++++E  +   L+H N++ L   + E S  YLV+D +  G L    + I   +       
Sbjct: 74  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVARE------- 123

Query: 207 RL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLD--AEFTP-RLADFGLAKL 257
                 A   I+     + Y H      I+H NLKP N++L   A+    +LADFGLA  
Sbjct: 124 FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 258 M-PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +         A    Y +PE  +   Y+   DI++ G+IL +LL G     PF+ E
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP---PFWDE 233

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 44/194 (22%), Positives = 89/194 (45%), Gaps = 23/194 (11%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV-LASLRHRNLMSLR-AYVPESSRFY 177
           +G  +AV+R+ +         ++  ++++  +L+V + S     ++    A   E    +
Sbjct: 46  SGQIMAVKRIRSTV-------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-CW 97

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-RIAVGVIKGLQYLHFTCNPQILHYNLKP 236
           +  + + + S +     +      +  E  L +I +  +K L +L    N +I+H ++KP
Sbjct: 98  ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLKIIHRDIKP 154

Query: 237 TNVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYSAPECFQ----NRSYTDKSDIFS 287
           +N++LD     +L DFG++  +  S+          Y APE        + Y  +SD++S
Sbjct: 155 SNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWS 214

Query: 288 FGMILAVLLTGRDP 301
            G+ L  L TGR P
Sbjct: 215 LGITLYELATGRFP 228

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 46/200 (23%), Positives = 93/200 (46%), Gaps = 35/200 (17%)

Query: 120 NGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR-- 175
               VA++++   F       QN++  +R  +EL ++  + H+N++SL   + P+ +   
Sbjct: 86  LDRNVAIKKLSRPF-------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138

Query: 176 ---FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV-GVIKGLQYLHFTCNPQILH 231
               YLV + +      +    I+          R+   +  ++ G+++LH   +  I+H
Sbjct: 139 FQDVYLVMELMDA----NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIH 187

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----IATSAYSAPECFQNRSYTDKSDIF 286
            +LKP+N+++ ++ T ++ DFGLA+    S      + T  Y APE      Y +  DI+
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247

Query: 287 SFGMILAVLLTGRDPTAPFF 306
           S G I+  ++  +      F
Sbjct: 248 SVGCIMGEMVRHK----ILF 263

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 41/185 (22%), Positives = 78/185 (42%), Gaps = 30/185 (16%)

Query: 142 KSVKRR--IQQELEVLASL-RHRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDR 194
           K +      +QE++         +++ +               ++ + ++ G L     R
Sbjct: 60  KLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSR 116

Query: 195 IRENQLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTP 247
           I+E   Q   E   R A  +++     +Q+LH   +  I H ++KP N++    + +   
Sbjct: 117 IQERGDQAFTE---REAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVL 170

Query: 248 RLADFGLAKLMPGSLIATSAYS----APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           +L DFG AK    + + T  Y+    APE      Y    D++S G+I+ +LL G     
Sbjct: 171 KLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF---P 227

Query: 304 PFFAE 308
           PF++ 
Sbjct: 228 PFYSN 232

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 62/219 (28%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR--- 175
            G  VA++++E F              R  +E+++L   +H N++++     P+S     
Sbjct: 35  TGEIVAIKKIEPF-------DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87

Query: 176 -FYLVYDYLQTGSLEDAMDRIRENQL----------QLGWEVRLRIAVGVIKGLQYLHFT 224
             Y++ + +QT    D    I    L          Q             ++ ++ LH  
Sbjct: 88  EVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQT------------LRAVKVLH-G 130

Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL----------------IATSAY 268
            N  ++H +LKP+N+++++    ++ DFGLA+++  S                 +AT  Y
Sbjct: 131 SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 269 SAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
            APE    +  Y+   D++S G ILA L   R    P F
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR----PIF 223

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 46/235 (19%), Positives = 101/235 (42%), Gaps = 36/235 (15%)

Query: 146 RRIQQELEVLASLRHRNLMSL----RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ 201
            R ++E +  A+L H  ++++     A  P     Y+V +Y+   +L D    +      
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD---IVHTEG-P 112

Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--- 258
           +  +  + +     + L + H      I+H ++KP N+M+ A    ++ DFG+A+ +   
Sbjct: 113 MTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169

Query: 259 ------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG 312
                   ++I T+ Y +PE  +  S   +SD++S G +L  +LTG     PF  ++   
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE---PPFTGDSP-- 224

Query: 313 GSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS 367
             +    +H++       A    +   +++         + +  L+ +P +R  +
Sbjct: 225 --VSVAYQHVREDPIPPSARHEGL-SADLDA--------VVLKALAKNPENRYQT 268

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 27/177 (15%)

Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW-- 204
            +++E  +   L+H +++ L          Y+V++++    L      I +         
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYS 128

Query: 205 EVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLD--AEFTP-RLADFGLAKL 257
           E    +A   ++     L+Y H      I+H ++KP  V+L       P +L  FG+A  
Sbjct: 129 E---AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182

Query: 258 M--PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +   G +         + APE  +   Y    D++  G+IL +LL+G     PF+  
Sbjct: 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC-L--PFYGT 236

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 42/184 (22%), Positives = 81/184 (44%), Gaps = 32/184 (17%)

Query: 141 NKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +K ++   Q+E+  L     H N++ L     +    +LV + L  G L    +RI++  
Sbjct: 45  SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKK- 100

Query: 200 LQLGW--EVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLA 250
                  E     A  +++     + ++H      ++H +LKP N++    +     ++ 
Sbjct: 101 ---KHFSE---TEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKII 151

Query: 251 DFGLAKLMP--GSLIATSAYS----APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
           DFG A+L P     + T  ++    APE      Y +  D++S G+IL  +L+G+    P
Sbjct: 152 DFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ---VP 208

Query: 305 FFAE 308
           F + 
Sbjct: 209 FQSH 212

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 39/213 (18%)

Query: 145 KRRIQQ---------ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI 195
           K+RI++         E ++L  +  R ++SL           LV   +  G L+  +  +
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278

Query: 196 RENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
            +       E R    A  +  GL+ LH     +I++ +LKP N++LD     R++D GL
Sbjct: 279 GQAGFP---EARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGL 332

Query: 255 AK-LMPGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
           A  +  G  I        Y APE  +N  YT   D ++ G +L  ++ G+   +PF    
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ---SPFQQRK 389

Query: 310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVE 342
                              RE ++R +     E
Sbjct: 390 KK---------------IKREEVERLVKEVPEE 407

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 62/243 (25%), Positives = 109/243 (44%), Gaps = 39/243 (16%)

Query: 73  MNQTPIIKG-PVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTV-LDNGLTVAVRRVE 130
           M  +P+  G P + + K DP+ L   L      +G    G+ ++ +       VA++ ++
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEELFTKL----EKIGKGSFGEVFKGIDNRTQKVVAIKIID 56

Query: 131 AFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED 190
             E    E ++      IQQE+ VL+      +        + ++ +++ +YL  GS  D
Sbjct: 57  -LEEAEDEIED------IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 109

Query: 191 AM--DRIRENQLQLGWEVRLRIAV---GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
            +    + E Q          IA     ++KGL YLH   + + +H ++K  NV+L    
Sbjct: 110 LLEPGPLDETQ----------IATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHG 156

Query: 246 TPRLADFGLAKLMPGSL------IATSAYSAPECFQNRSYTDKSDIFSFGMILAV-LLTG 298
             +LADFG+A  +  +       + T  + APE  +  +Y  K+DI+S G I A+ L  G
Sbjct: 157 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELARG 215

Query: 299 RDP 301
             P
Sbjct: 216 EPP 218

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 60/285 (21%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           G +        + VA++ +      +  K      + I  E  V+AS+ + ++  L    
Sbjct: 34  GLWIPEGEKVKIPVAIKELRE---ATSPKA----NKEILDEAYVMASVDNPHVCRLLGIC 86

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNP 227
             S+   L+   +  G L   +D +RE++  +G +  L   V + KG+ YL         
Sbjct: 87  LTST-VQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL---- 138

Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSY 279
             +H +L   NV++      ++ DFGLAKL+        A        + A E   +R Y
Sbjct: 139 --VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 280 TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGE 339
           T +SD++S+G    V +           E  + GS            E    L++   GE
Sbjct: 197 THQSDVWSYG----VTVW----------ELMTFGSKPYDGIPAS---EISSILEK---GE 236

Query: 340 EVEEDE-------MLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
            + +         M+M       C       RP   EL+   +++
Sbjct: 237 RLPQPPICTIDVYMIM-----RKCWMIDADSRPKFRELIIEFSKM 276

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 42/195 (21%), Positives = 80/195 (41%), Gaps = 30/195 (15%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV 179
           +   VAV+          E     +K +  QE  +L    H N++ L     +    Y+V
Sbjct: 138 DNTLVAVKSC-------RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190

Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV 239
            + +Q G        +R    +L  +  L++      G++YL    +   +H +L   N 
Sbjct: 191 MELVQGGDFLT---FLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNC 244

Query: 240 MLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSYTDKSDIFSFGMI 291
           ++  +   +++DFG+++     + A S         ++APE      Y+ +SD++SFG  
Sbjct: 245 LVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG-- 302

Query: 292 LAVLLT-----GRDP 301
             +LL      G  P
Sbjct: 303 --ILLWETFSLGASP 315

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + LG+   G+ +    +    VAV+ +         K           E  V+ +L+H  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM---------KPGSMSVEAFLAEANVMKTLQHDK 244

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V +    Y++ +++  GSL D + +  E   +      +  +  + +G+ ++ 
Sbjct: 245 LVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGS-KQPLPKLIDFSAQIAEGMAFIE 301

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-------APECFQ 275
                  +H +L+  N+++ A    ++ADFGLA+++  +       +       APE   
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358

Query: 276 NRSYTDKSDIFSFGMILAVLLT-----GRDP 301
             S+T KSD++SFG    +LL      GR P
Sbjct: 359 FGSFTIKSDVWSFG----ILLMEIVTYGRIP 385

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 81.0 bits (200), Expect = 7e-17
 Identities = 47/216 (21%), Positives = 80/216 (37%), Gaps = 42/216 (19%)

Query: 145 KRRIQQ---------ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI 195
           K+R+++         E ++LA +  R ++SL       +   LV   +  G +      I
Sbjct: 220 KKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI---RYHI 276

Query: 196 RENQLQLGW--EVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
                      E R       ++ GL++LH      I++ +LKP NV+LD +   R++D 
Sbjct: 277 YNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDL 333

Query: 253 GLAKLMPGSLIATSA------YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           GLA  +      T        + APE      Y    D F+ G+ L  ++  R    PF 
Sbjct: 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFR 390

Query: 307 AEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVE 342
           A                      + L + +L + V 
Sbjct: 391 ARGEK---------------VENKELKQRVLEQAVT 411

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 80.6 bits (199), Expect = 8e-17
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
             LG    G+ +    +    VA++ +         K          QE +V+  LRH  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL---------KPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V E    Y+V +Y+  GSL D + +    +  L     + +A  +  G+ Y+ 
Sbjct: 241 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFL-KGETGK-YLRLPQLVDMAAQIASGMAYVE 297

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-------APECFQ 275
                  +H +L+  N+++      ++ADFGLA+L+  +       +       APE   
Sbjct: 298 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +T KSD++SFG++L  L T GR P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 44/177 (24%), Positives = 76/177 (42%), Gaps = 31/177 (17%)

Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           ++++E  +   L+H N++ L   + E    YL++D +  G L    + I   +       
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVARE------- 105

Query: 207 RL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVMLD--AEFTP-RLADFGLAKL 257
                 A   I+     + + H      ++H NLKP N++L    +    +LADFGLA  
Sbjct: 106 YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162

Query: 258 M--PGSLIATSA----YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           +          A    Y +PE  +   Y    D+++ G+IL +LL G     PF+ E
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP---PFWDE 216

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 80.6 bits (199), Expect = 8e-17
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 23/208 (11%)

Query: 103 RLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHP 276

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           NL+ L         FY++ +++  G+L D + R    Q ++   V L +A  +   ++YL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQ-EVSAVVLLYMATQISSAMEYL 334

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-------APECF 274
                   +H NL   N ++      ++ADFGL++LM G      A +       APE  
Sbjct: 335 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391

Query: 275 QNRSYTDKSDIFSFGMILAVLLT-GRDP 301
               ++ KSD+++FG++L  + T G  P
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 46/199 (23%), Positives = 93/199 (46%), Gaps = 32/199 (16%)

Query: 106 GSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           GS+  G         +G  VAV+ ++        KQ +  +  +  E+ ++   +H N++
Sbjct: 56  GST--GIVCLAREKHSGRQVAVKMMD------LRKQQR--RELLFNEVVIMRDYQHFNVV 105

Query: 165 S-LRAYVPESSRFYLVYDYLQTGSLEDAMD--RIRENQLQLGWEVRLRIAVGVIKGLQYL 221
              ++Y+      +++ ++LQ G+L D +   R+ E Q+         +   V++ L YL
Sbjct: 106 EMYKSYLVGE-ELWVLMEFLQGGALTDIVSQVRLNEEQIAT-------VCEAVLQALAYL 157

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQ 275
           H      ++H ++K  +++L  +   +L+DFG  A++        SL+ T  + APE   
Sbjct: 158 H---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 276 NRSYTDKSDIFSFGMILAV 294
              Y  + DI+S G I+ +
Sbjct: 215 RSLYATEVDIWSLG-IMVI 232

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 80.7 bits (199), Expect = 8e-17
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
             LG    G+ +    +    VA++ +         K          QE +V+  LRH  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL---------KPGTMSPEAFLQEAQVMKKLRHEK 323

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V E    Y+V +Y+  GSL D + +    +  L     + +A  +  G+ Y+ 
Sbjct: 324 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFL-KGETGK-YLRLPQLVDMAAQIASGMAYVE 380

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-------APECFQ 275
                  +H +L+  N+++      ++ADFGLA+L+  +       +       APE   
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

Query: 276 NRSYTDKSDIFSFGMILAVLLT-GRDP 301
              +T KSD++SFG++L  L T GR P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 23/200 (11%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           G +        + V ++ +E     S  +  ++    +   +  + SL H +++ L    
Sbjct: 32  GVWIPEGESIKIPVCIKVIED---KSGRQSFQA----VTDHMLAIGSLDHAHIVRLLGLC 84

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL 230
           P SS   LV  YL  GSL   +D +R+++  LG ++ L   V + KG+ YL       ++
Sbjct: 85  PGSS-LQLVTQYLPLGSL---LDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMV 137

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSYTDK 282
           H NL   NV+L +    ++ADFG+A L+P                + A E      YT +
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ 197

Query: 283 SDIFSFGMILAVLLT-GRDP 301
           SD++S+G+ +  L+T G +P
Sbjct: 198 SDVWSYGVTVWELMTFGAEP 217

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 44/214 (20%), Positives = 90/214 (42%), Gaps = 37/214 (17%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + LG+   G            VA++ +         K+    +    +E +V+ +L H  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI---------KEGSMSEDEFIEEAKVMMNLSHEK 80

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL- 221
           L+ L     +    +++ +Y+  G L + +   RE + +   +  L +   V + ++YL 
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 222 --HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPE 272
              F      LH +L   N +++ +   +++DFGL++ +      +S        +S PE
Sbjct: 138 SKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 191

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-----GRDP 301
                 ++ KSDI++FG    VL+      G+ P
Sbjct: 192 VLMYSKFSSKSDIWAFG----VLMWEIYSLGKMP 221

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 29/203 (14%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           G +        + VA++ +      +  K      + I  E  V+AS+ + ++  L    
Sbjct: 34  GLWIPEGEKVKIPVAIKELRE---ATSPKA----NKEILDEAYVMASVDNPHVCRLLGIC 86

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNP 227
             S+   L+   +  G L   +D +RE++  +G +  L   V + KG+ YL         
Sbjct: 87  LTST-VQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL---- 138

Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA--------YSAPECFQNRSY 279
             +H +L   NV++      ++ DFGLAKL+        A        + A E   +R Y
Sbjct: 139 --VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 280 TDKSDIFSFGMILAVLLT-GRDP 301
           T +SD++S+G+ +  L+T G  P
Sbjct: 197 THQSDVWSYGVTVWELMTFGSKP 219

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 37/214 (17%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + +GS   G  +     N   VA++ +         ++    +    +E EV+  L H  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI---------REGAMSEEDFIEEAEVMMKLSHPK 64

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL- 221
           L+ L     E +   LV ++++ G L D +   R  +     E  L + + V +G+ YL 
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 222 --HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPE 272
                     +H +L   N ++      +++DFG+ + +      +S        +++PE
Sbjct: 122 EACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 175

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-----GRDP 301
            F    Y+ KSD++SFG    VL+      G+ P
Sbjct: 176 VFSFSRYSSKSDVWSFG----VLMWEVFSEGKIP 205

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 44/192 (22%), Positives = 87/192 (45%), Gaps = 28/192 (14%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
             R      + VA++   A ++G  E+Q    +R    E  ++    H N++ L   V  
Sbjct: 69  RLRVPGQRDVPVAIK---ALKAGYTERQ----RRDFLSEASIMGQFDHPNIIRLEGVVTR 121

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQI 229
                +V +Y++ GSL      +R +  Q      + +  GV  G++YL    +      
Sbjct: 122 GRLAMIVTEYMENGSL---DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY------ 172

Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS---------APECFQNRSYT 280
           +H +L   NV++D+    +++DFGL++++     A    +         APE    R+++
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232

Query: 281 DKSDIFSFGMIL 292
             SD++SFG+++
Sbjct: 233 SASDVWSFGVVM 244

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 77.6 bits (192), Expect = 4e-16
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 24/195 (12%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
           D G  VA+++            +K VK+   +E+++L  LRH NL++L     +  R+YL
Sbjct: 48  DTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V++++   ++ D ++    N L     V+ +    +I G+ + H   +  I+H ++KP N
Sbjct: 102 VFEFVDH-TILDDLELFP-NGLDYQ-VVQ-KYLFQIINGIGFCH---SHNIIHRDIKPEN 154

Query: 239 VMLDAEFTPRLADFGLAKL--MPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMI 291
           +++      +L DFG A+    PG      +AT  Y APE    +  Y    D+++ G +
Sbjct: 155 ILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCL 214

Query: 292 LAVLLTGRDPTAPFF 306
           +  +  G     P F
Sbjct: 215 VTEMFMGE----PLF 225

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 47/213 (22%), Positives = 92/213 (43%), Gaps = 48/213 (22%)

Query: 120 NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR--- 175
               VA++++           +    +   +E++++  L H N++ +     P  S+   
Sbjct: 35  CDKRVAIKKI-VL-------TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86

Query: 176 ----------FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFT 224
                      Y+V +Y++T    D  + + +  L    E   R     +++GL+Y+H +
Sbjct: 87  DVGSLTELNSVYIVQEYMET----DLANVLEQGPLL---EEHARLFMYQLLRGLKYIH-S 138

Query: 225 CNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMPGSL---------IATSAYSAPE-C 273
            N  +LH +LKP N+ ++ E    ++ DFGLA++M             + T  Y +P   
Sbjct: 139 AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196

Query: 274 FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
               +YT   D+++ G I A +LTG+      F
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGK----TLF 225

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 55/213 (25%), Positives = 107/213 (50%), Gaps = 34/213 (15%)

Query: 106 GSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           G+S  G  Y    +  G  VA+R++      + ++Q K  K  I  E+ V+   ++ N++
Sbjct: 31  GAS--GTVYTAMDVATGQEVAIRQM------NLQQQPK--KELIINEILVMRENKNPNIV 80

Query: 165 S-LRAYVPESSRFYLVYDYLQTGSLEDAMD--RIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           + L +Y+      ++V +YL  GSL D +    + E Q+         +    ++ L++L
Sbjct: 81  NYLDSYLVGD-ELWVVMEYLAGGSLTDVVTETCMDEGQIAA-------VCRECLQALEFL 132

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPECFQ 275
           H   + Q++H ++K  N++L  + + +L DFG  A++ P      +++ T  + APE   
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            ++Y  K DI+S G I+A+ +   +P  P+  E
Sbjct: 190 RKAYGPKVDIWSLG-IMAIEMIEGEP--PYLNE 219

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 39/196 (19%), Positives = 89/196 (45%), Gaps = 32/196 (16%)

Query: 111 GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV 170
           G    +     + VA++ ++A   G  EKQ    +     E  ++    H N++ L   +
Sbjct: 63  GMLKTSSGKKEVPVAIKTLKA---GYTEKQ----RVDFLGEAGIMGQFSHHNIIRLEGVI 115

Query: 171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNP 227
            +     ++ +Y++ G+L      +RE   +      + +  G+  G++YL   ++    
Sbjct: 116 SKYKPMMIITEYMENGAL---DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY---- 168

Query: 228 QILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-----------APECFQN 276
             +H +L   N+++++    +++DFGL++++       + Y+           APE    
Sbjct: 169 --VHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEAISY 224

Query: 277 RSYTDKSDIFSFGMIL 292
           R +T  SD++SFG+++
Sbjct: 225 RKFTSASDVWSFGIVM 240

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 53/172 (30%), Positives = 77/172 (44%), Gaps = 34/172 (19%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQT---GSLEDAMDRIRENQ-----LQL 202
           E+++L  L H N++ L       S   LV+D+++T     ++D    +  +      L  
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PG 260
                       ++GL+YLH      ILH +LKP N++LD     +LADFGLAK    P 
Sbjct: 122 ------------LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166

Query: 261 ----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
                 + T  Y APE  F  R Y    D+++ G ILA LL       PF  
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV----PFLP 214

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.1 bits (188), Expect = 6e-16
 Identities = 46/210 (21%), Positives = 88/210 (41%), Gaps = 29/210 (13%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + LGS   G            VAV+ +         K+    +    QE + +  L H  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMI---------KEGSMSEDEFFQEAQTMMKLSHPK 64

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL- 221
           L+       +    Y+V +Y+  G L + +   R +   L     L +   V +G+ +L 
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 222 --HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPE 272
              F      +H +L   N ++D +   +++DFG+ + +      +S        +SAPE
Sbjct: 122 SHQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE 175

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
            F    Y+ KSD+++FG+++  + + G+ P
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 76.8 bits (190), Expect = 6e-16
 Identities = 45/195 (23%), Positives = 89/195 (45%), Gaps = 24/195 (12%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
           D G  VA+++          + +  +K+   +E+ +L  L+H NL++L        R +L
Sbjct: 26  DTGQIVAIKKFLE------SEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
           V++Y    ++   +DR  +  +     V+  I    ++ + + H       +H ++KP N
Sbjct: 80  VFEYCDH-TVLHELDR-YQRGVPEH-LVK-SITWQTLQAVNFCH---KHNCIHRDVKPEN 132

Query: 239 VMLDAEFTPRLADFGLAKLMPGSL------IATSAYSAPE-CFQNRSYTDKSDIFSFGMI 291
           +++      +L DFG A+L+ G        +AT  Y +PE    +  Y    D+++ G +
Sbjct: 133 ILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCV 192

Query: 292 LAVLLTGRDPTAPFF 306
            A LL+G     P +
Sbjct: 193 FAELLSGV----PLW 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 34/185 (18%)

Query: 141 NKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +KS KR   +E+E+L    +H N+++L+    +    Y+V + ++ G L   +D+I   +
Sbjct: 56  DKS-KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQK 111

Query: 200 LQLGWEVRL--RIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML----DAEFTPRL 249
                      R A  V+      ++YLH      ++H +LKP+N++         + R+
Sbjct: 112 -------FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRI 161

Query: 250 ADFGLAKLM--PGSLIATSAYS----APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
            DFG AK +     L+ T  Y+    APE  + + Y    DI+S G++L  +LTG     
Sbjct: 162 CDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY---T 218

Query: 304 PFFAE 308
           PF   
Sbjct: 219 PFANG 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 31/183 (16%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V   + +E +V++ L H   + L     +  + Y    Y + G L   +  IR+  
Sbjct: 70  KENKVPY-VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIG 125

Query: 200 LQLGWEVRLRIAVG------VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
                               ++  L+YLH      I+H +LKP N++L+ +   ++ DFG
Sbjct: 126 -------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG 175

Query: 254 LAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
            AK++          S + T+ Y +PE    +S    SD+++ G I+  L+ G     PF
Sbjct: 176 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL---PPF 232

Query: 306 FAE 308
            A 
Sbjct: 233 RAG 235

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 45/202 (22%), Positives = 83/202 (41%), Gaps = 34/202 (16%)

Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
           R +   L ++++     ++ +        +   + D +  G   D    + ++ +    +
Sbjct: 240 RIM---LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEAD 293

Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG----S 261
           +R   A  +I GL+++H   N  +++ +LKP N++LD     R++D GLA         +
Sbjct: 294 MRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349

Query: 262 LIATSAYSAPECFQ-NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR 320
            + T  Y APE  Q   +Y   +D FS G +L  LL G    +PF               
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH---SPFRQH------------ 394

Query: 321 HLQHAGEAREALDRSILGEEVE 342
                 + +  +DR  L   VE
Sbjct: 395 ----KTKDKHEIDRMTLTMAVE 412

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 44/208 (21%)

Query: 138 EKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
           EKQ   ++ R+ +E+E+L   + HRN++ L  +  E  RFYLV++ ++ GS+   +  I 
Sbjct: 47  EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIH 103

Query: 197 ENQLQLGW--EVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTP 247
           +         E     A  V++     L +LH   N  I H +LKP N++    +     
Sbjct: 104 KR----RHFNE---LEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPV 153

Query: 248 RLADFGLAKLMPGSLIATSA-------------YSAPE-----CFQNRSYTDKSDIFSFG 289
           ++ DF L   +  +   +               Y APE       +   Y  + D++S G
Sbjct: 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213

Query: 290 MILAVLLTGRDPTAPFFAEAASGGSLGR 317
           +IL +LL+G     PF     S     R
Sbjct: 214 VILYILLSGY---PPFVGRCGSDCGWDR 238

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 45/171 (26%), Positives = 85/171 (49%), Gaps = 34/171 (19%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQT---GSLEDAMDRIRENQ-----LQL 202
           E+ +L  L H N++SL   +       LV+++++      L++    ++++Q      QL
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPG 260
                       ++G+ + H     +ILH +LKP N++++++   +LADFGLA+   +P 
Sbjct: 129 ------------LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173

Query: 261 ----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
                 + T  Y AP+    ++ Y+   DI+S G I A ++TG+    P F
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK----PLF 220

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 75.2 bits (186), Expect = 2e-15
 Identities = 39/166 (23%), Positives = 72/166 (43%), Gaps = 30/166 (18%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQT---GSLEDAMDRIRENQ-----LQL 202
           E+ +L  L+H+N++ L   +    +  LV+++         +     +          QL
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPG 260
                       +KGL + H   +  +LH +LKP N++++     +LA+FGLA+   +P 
Sbjct: 111 ------------LKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

Query: 261 ----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
               + + T  Y  P+  F  + Y+   D++S G I A L     P
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 40/176 (22%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDR--------IRENQLQL 202
           E+ +L  L+HRN++ L++ +  + R +L+++Y +   L+  MD+        I+    QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR-----LADFGLAKL 257
                       I G+ + H   + + LH +LKP N++L            + DFGLA+ 
Sbjct: 142 ------------INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

Query: 258 M--PG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
              P       I T  Y  PE    +R Y+   DI+S   I A +L       P F
Sbjct: 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT----PLF 238

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 33/215 (15%)

Query: 106 GSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           G++                VA++R+   E              + +E++ ++   H N++
Sbjct: 26  GAT--AVVQAAYCAPKKEKVAIKRIN-LEKCQTSMDE------LLKEIQAMSQCHHPNIV 76

Query: 165 SLR-AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR-LRIAV---GVIKGLQ 219
           S   ++V      +LV   L  GS+ D +  I          +    IA     V++GL+
Sbjct: 77  SYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS---------- 269
           YLH       +H ++K  N++L  + + ++ADFG++  +      T              
Sbjct: 136 YLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 270 -APECF-QNRSYTDKSDIFSFGMILAV-LLTGRDP 301
            APE   Q R Y  K+DI+SFG I A+ L TG  P
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFG-ITAIELATGAAP 226

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 34/171 (19%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQT---GSLEDAMDRIRENQ-----LQL 202
           E+ +L  L+H N+++L   +       LV++YL       L+D  + I  +       QL
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPG 260
                       ++GL Y H     ++LH +LKP N++++     +LADFGLA+   +P 
Sbjct: 110 ------------LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154

Query: 261 ----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
               + + T  Y  P+    +  Y+ + D++  G I   + TGR    P F
Sbjct: 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR----PLF 201

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 47/173 (27%), Positives = 88/173 (50%), Gaps = 25/173 (14%)

Query: 145 KRRIQQELEVLASLR-HRNLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRIRENQLQ 201
           K++I++E+++L +LR   N+++L   V  P S    LV++++     +     + +  ++
Sbjct: 74  KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR 133

Query: 202 -LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKL-M 258
              +E+        +K L Y H   +  I+H ++KP NVM+D E    RL D+GLA+   
Sbjct: 134 FYMYEI--------LKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182

Query: 259 PGSL----IATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           PG      +A+  +  PE     + Y    D++S G +LA ++  ++   PFF
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE---PFF 232

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 41/278 (14%), Positives = 77/278 (27%), Gaps = 54/278 (19%)

Query: 103 RLLGSSPDGKYYR---TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR 159
              G  P  ++++   T LD    VA+  V+       +     V +        L+ + 
Sbjct: 37  IFHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDD-----VLQETLSRTLRLSRID 89

Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
              +  +   V   +   +V ++++ GSL++  D              +R    +     
Sbjct: 90  KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAAD 143

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSY 279
             H      +      P+ V +  +    LA                             
Sbjct: 144 AAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------------TMPDA------- 179

Query: 280 TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGE 339
             + DI   G  L  LL  R P      EA     L    R           +DR I   
Sbjct: 180 NPQDDIRGIGASLYALLVNRWP----LPEAGVRSGLAPAERDTAGQPIEPADIDRDI-PF 234

Query: 340 EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
           ++          +A   +      R  +  L+ ++ Q 
Sbjct: 235 QISA--------VAARSVQGDGGIRS-ASTLLNLMQQA 263

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 55/261 (21%), Positives = 99/261 (37%), Gaps = 47/261 (18%)

Query: 76  TPIIKGPVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRT---VLDNGLTVAVRRVEAF 132
           TP +  P    P   P+            +  +     Y+    VL  G+   V ++   
Sbjct: 25  TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIF-- 82

Query: 133 ESGSPEKQN------KSVKR--RIQQELEVLASL-RHRNLMSLRAY----VPESSRFYLV 179
                 K+       K ++   + ++E+E+     +  +++ +               +V
Sbjct: 83  -----NKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137

Query: 180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLK 235
            + L  G L     RI++   Q   E   R A  ++K     +QYLH   +  I H ++K
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTE---REASEIMKSIGEAIQYLH---SINIAHRDVK 188

Query: 236 PTNVML---DAEFTPRLADFGLAKLM-PGSLIATSAYS----APECFQNRSYTDKSDIFS 287
           P N++          +L DFG AK     + + T  Y+    APE      Y    D++S
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248

Query: 288 FGMILAVLLTGRDPTAPFFAE 308
            G+I+ +LL G     PF++ 
Sbjct: 249 LGVIMYILLCGY---PPFYSN 266

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 73.8 bits (182), Expect = 5e-15
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 31/169 (18%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR 209
           +E+  + SL HRNL+ L   V       +V +    GSL   +DR+R++Q         R
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSL---LDRLRKHQGHFLLGTLSR 125

Query: 210 IAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS 266
            AV V +G+ YL    F      +H +L   N++L      ++ DFGL + +P +     
Sbjct: 126 YAVQVAEGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179

Query: 267 AYS---------APECFQNRSYTDKSDIFSFGMILAVLLT-----GRDP 301
                       APE  + R+++  SD + FG    V L      G++P
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFG----VTLWEMFTYGQEP 224

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 73.3 bits (181), Expect = 6e-15
 Identities = 47/172 (27%), Positives = 79/172 (45%), Gaps = 36/172 (20%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN---------QLQ 201
           E+ +L  L+H N++ L   +    R  LV+++L    L+  +D               LQ
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MP 259
           L            + G+ Y H   + ++LH +LKP N++++ E   ++ADFGLA+   +P
Sbjct: 109 L------------LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

Query: 260 G----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
                  I T  Y AP+    ++ Y+   DI+S G I A ++ G     P F
Sbjct: 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT----PLF 201

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 41/196 (20%), Positives = 84/196 (42%), Gaps = 36/196 (18%)

Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
           + VA++     + G+ +         + +E +++  L +  ++ L   V ++    LV +
Sbjct: 364 IDVAIK---VLKQGTEKAD----TEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVME 415

Query: 182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTN 238
               G L      +   + ++       +   V  G++YL   +F      +H NL   N
Sbjct: 416 MAGGGPLHKF---LVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARN 466

Query: 239 VMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------APECFQNRSYTDKSDIF 286
           V+L      +++DFGL+K +       S Y+            APEC   R ++ +SD++
Sbjct: 467 VLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 523

Query: 287 SFGMILAVLLT-GRDP 301
           S+G+ +   L+ G+ P
Sbjct: 524 SYGVTMWEALSYGQKP 539

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 73.2 bits (180), Expect = 9e-15
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 31/196 (15%)

Query: 105 LGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL 163
           LG    G  Y+ +  + G  VA+++V        E   +     I +E+ ++      ++
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVP------VESDLQE----IIKEISIMQQCDSPHV 86

Query: 164 MS-LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV---GVIKGLQ 219
           +    +Y   +   ++V +Y   GS+ D + R+R   L         IA      +KGL+
Sbjct: 87  VKYYGSYFKNT-DLWIVMEYCGAGSVSDII-RLRNKTLTEDE-----IATILQSTLKGLE 139

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPEC 273
           YLH     + +H ++K  N++L+ E   +LADFG+  +L        ++I T  + APE 
Sbjct: 140 YLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEV 196

Query: 274 FQNRSYTDKSDIFSFG 289
            Q   Y   +DI+S G
Sbjct: 197 IQEIGYNCVADIWSLG 212

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 17/165 (10%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL-- 208
           E+ ++  L+H N++ L   +   ++  LV++++    L+  MD         G E+ L  
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPG----SL 262
                +++GL + H     +ILH +LKP N++++     +L DFGLA+   +P     S 
Sbjct: 112 YFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168

Query: 263 IATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           + T  Y AP+    +R+Y+   DI+S G ILA ++TG+    P F
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK----PLF 209

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 35/180 (19%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESS--RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
           E+ +L  L+H N++SL+      +  + +L++DY +   L   +   R ++     +  +
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN---KKPV 123

Query: 209 RIAVGVIK--------GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAK 256
           ++  G++K        G+ YLH      +LH +LKP N+++  E   R    +AD G A+
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180

Query: 257 LM---------PGSLIATSAYSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           L             ++ T  Y APE     R YT   DI++ G I A LLT      P F
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE----PIF 236

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 40/200 (20%), Positives = 82/200 (41%), Gaps = 38/200 (19%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL 178
              + VA++     + G+ +         + +E +++  L +  ++ L   V ++    L
Sbjct: 35  KKQIDVAIK---VLKQGTEKAD----TEEMMREAQIMHQLDNPYIVRLIG-VCQAEALML 86

Query: 179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLK 235
           V +    G L      +   + ++       +   V  G++YL   +F      +H +L 
Sbjct: 87  VMEMAGGGPL---HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRDLA 137

Query: 236 PTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS---------APECFQNRSYTDKSDIF 286
             NV+L      +++DFGL+K +       +A S         APEC   R ++ +SD++
Sbjct: 138 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 197

Query: 287 SFGMILAVLLT-----GRDP 301
           S+G    V +      G+ P
Sbjct: 198 SYG----VTMWEALSYGQKP 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 72.2 bits (178), Expect = 1e-14
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 31/211 (14%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
             LG+   G+ +    +    VAV+ +         KQ          E  ++  L+H+ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL---------KQGSMSPDAFLAEANLMKQLQHQR 69

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V +    Y++ +Y++ GSL D +      +L +     L +A  + +G+ ++ 
Sbjct: 70  LVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFIE 126

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-------APECFQ 275
                  +H +L+  N+++    + ++ADFGLA+L+  +       +       APE   
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 276 NRSYTDKSDIFSFGMILAVLLT-----GRDP 301
             ++T KSD++SFG    +LLT     GR P
Sbjct: 184 YGTFTIKSDVWSFG----ILLTEIVTHGRIP 210

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 37/212 (17%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + +G    G         G  VAV+ +         K + + +  +  E  V+  LRH N
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI---------KNDATAQAFLA-EASVMTQLRHSN 247

Query: 163 LMSLRAYVPESS-RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           L+ L   + E     Y+V +Y+  GSL D + R R     LG +  L+ ++ V + ++YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYL 305

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS-------APECF 274
                   +H +L   NV++  +   +++DFGL K       +T           APE  
Sbjct: 306 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEAL 358

Query: 275 QNRSYTDKSDIFSFGMILAVLLT-----GRDP 301
           + + ++ KSD++SFG    +LL      GR P
Sbjct: 359 REKKFSTKSDVWSFG----ILLWEIYSFGRVP 386

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 19/180 (10%)

Query: 140 QNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQ 199
           +   V R + +EL+++  L H  L++L     +    ++V D L  G L      +++N 
Sbjct: 55  ERNEV-RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL---RYHLQQNV 110

Query: 200 LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
                 V+L I   ++  L YL    N +I+H ++KP N++LD      + DF +A ++P
Sbjct: 111 HFKEETVKLFIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166

Query: 260 G-----SLIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS 311
                 ++  T  Y APE F +R    Y+   D +S G+    LL GR    P+   +++
Sbjct: 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR---RPYHIRSST 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 19/166 (11%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLR 209
           E  VL + RH  L +L+       R   V +Y   G L      + RE       E R R
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS---EDRAR 251

Query: 210 I-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIA-- 264
                ++  L YLH   N  +++ +LK  N+MLD +   ++ DFGL K  +  G+ +   
Sbjct: 252 FYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 309

Query: 265 --TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
             T  Y APE  ++  Y    D +  G+++  ++ GR    PF+ +
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR---LPFYNQ 352

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 41/192 (21%), Positives = 88/192 (45%), Gaps = 28/192 (14%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
             +      ++VA++ ++    G  EKQ    +R    E  ++    H N++ L   V +
Sbjct: 65  RLKLPSKKEISVAIKTLKV---GYTEKQ----RRDFLGEASIMGQFDHPNIIRLEGVVTK 117

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQI 229
           S    +V +Y++ GSL+     +R++  Q      + +  G+  G++YL    +      
Sbjct: 118 SKPVMIVTEYMENGSLDSF---LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY------ 168

Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS---------APECFQNRSYT 280
           +H +L   N+++++    +++DFGL +++     A              +PE    R +T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228

Query: 281 DKSDIFSFGMIL 292
             SD++S+G++L
Sbjct: 229 SASDVWSYGIVL 240

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 52/212 (24%), Positives = 90/212 (42%), Gaps = 31/212 (14%)

Query: 103 RLLGSSPDGKYYRTVLDNG-LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHP 69

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           NL+ L         FY++ +++  G+L D +      ++     V L +A  +   ++YL
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYL 127

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECF 274
                   +H +L   N ++      ++ADFGL++LM G      A       ++APE  
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 184

Query: 275 QNRSYTDKSDIFSFGMILAVLLT-----GRDP 301
               ++ KSD+++FG    VLL      G  P
Sbjct: 185 AYNKFSIKSDVWAFG----VLLWEIATYGMSP 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 70.7 bits (174), Expect = 5e-14
 Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 32/182 (17%)

Query: 137 PEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR 196
            E  + ++K  +  E  V+  L +  ++ +   + E+  + LV +  + G L      ++
Sbjct: 54  NEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPL---NKYLQ 109

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
           +N+  +  +  + +   V  G++YL   +F      +H +L   NV+L  +   +++DFG
Sbjct: 110 QNR-HVKDKNIIELVHQVSMGMKYLEESNF------VHRDLAARNVLLVTQHYAKISDFG 162

Query: 254 LAKLMPGSLIATSAYS---------APECFQNRSYTDKSDIFSFGMILAVLLT-----GR 299
           L+K +        A +         APEC     ++ KSD++SFG    VL+      G+
Sbjct: 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG----VLMWEAFSYGQ 218

Query: 300 DP 301
            P
Sbjct: 219 KP 220

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 43/237 (18%), Positives = 89/237 (37%), Gaps = 67/237 (28%)

Query: 116 TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR 175
             +++G   A+++V                R   +EL+++  L H N++ L  Y   +  
Sbjct: 27  FDIESGKRFALKKVLQD------------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGD 74

Query: 176 --------------------------------------FYLVYDYLQTGSLEDAMDRIRE 197
                                                   ++ +Y+   +L   +     
Sbjct: 75  EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR 133

Query: 198 NQLQLGWE-VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLA 255
           +   +    + + I   + + + ++H +    I H ++KP N++++++  T +L DFG A
Sbjct: 134 SGRSIPMNLISIYI-YQLFRAVGFIH-SLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSA 189

Query: 256 K-LMPG----SLIATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           K L+P     + I +  Y APE       YT   D++S G +   L+ G+    P F
Sbjct: 190 KKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK----PLF 242

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 69.9 bits (172), Expect = 1e-13
 Identities = 36/209 (17%), Positives = 75/209 (35%), Gaps = 46/209 (22%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
            Y       + VAV+  +              K +   E  ++ +L H +++ L   + E
Sbjct: 32  VYTNHKGEKINVAVKTCKK---DCTLDN----KEKFMSEAVIMKNLDHPHIVKLIGIIEE 84

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQI 229
               +++ +    G L      +  N+  L     +  ++ + K + YL   +       
Sbjct: 85  EP-TWIIMELYPYGEL---GHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC------ 134

Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAY------------SAPECFQNR 277
           +H ++   N+++ +    +L DFGL++      I    Y             +PE    R
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRY-----IEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 278 SYTDKSDIFSFGMILAVLLT-----GRDP 301
            +T  SD++ F     V +      G+ P
Sbjct: 190 RFTTASDVWMFA----VCMWEILSFGKQP 214

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 38/201 (18%)

Query: 106 GSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLM 164
           G+   GK Y+    + G   A + +E       + + +        E+E+LA+  H  ++
Sbjct: 30  GAF--GKVYKAKNKETGALAAAKVIE------TKSEEE--LEDYIVEIEILATCDHPYIV 79

Query: 165 SLR-AYVPESSRFYLVYDYLQTGSLEDAMD----RIRENQLQLGWEVRLRIAVGVIKGLQ 219
            L  AY  +  + +++ ++   G+++  M      + E Q+Q+       +   +++ L 
Sbjct: 80  KLLGAYYHDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALN 131

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL-AKLMP-----GSLIATSAYSAPE- 272
           +LH   + +I+H +LK  NV++  E   RLADFG+ AK +       S I T  + APE 
Sbjct: 132 FLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188

Query: 273 ----CFQNRSYTDKSDIFSFG 289
                 ++  Y  K+DI+S G
Sbjct: 189 VMCETMKDTPYDYKADIWSLG 209

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 29/163 (17%)

Query: 148 IQQELEVLASL-RHRNLMSL------RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
           I+QE+ +L     HRN+ +       +       + +LV ++   GS+ D +   + N L
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126

Query: 201 QLGWEVRLRIAV---GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL 257
           +  W     IA     +++GL +LH     +++H ++K  NV+L      +L DFG++  
Sbjct: 127 KEEW-----IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 258 MPGSL------IATSAYSAPE-----CFQNRSYTDKSDIFSFG 289
           +  ++      I T  + APE        + +Y  KSD++S G
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 36/190 (18%), Positives = 76/190 (40%), Gaps = 27/190 (14%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE 172
            Y +  +  L VA++  +     + +      + +  QE   +    H +++ L   V  
Sbjct: 35  IYMSPENPALAVAIKTCKN---CTSDSV----REKFLQEALTMRQFDHPHIVKLIG-VIT 86

Query: 173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQI 229
            +  +++ +    G L      ++  +  L     +  A  +   L YL    F      
Sbjct: 87  ENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF------ 137

Query: 230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECFQNRSYTDK 282
           +H ++   NV++ +    +L DFGL++ M  S    ++       + APE    R +T  
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197

Query: 283 SDIFSFGMIL 292
           SD++ FG+ +
Sbjct: 198 SDVWMFGVCM 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 42/183 (22%), Positives = 73/183 (39%), Gaps = 46/183 (25%)

Query: 151 ELEVLASLRHRNLMSLR--------AYVPESSRFYLVYDYLQ---TGSLEDAMDRIRENQ 199
           E+++L  L+H N+++L          Y       YLV+D+ +    G L + + +   ++
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125

Query: 200 -----LQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
                  L            + GL Y+H     +ILH ++K  NV++  +   +LADFGL
Sbjct: 126 IKRVMQML------------LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170

Query: 255 AKLMPGSLIATSA----------YSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTA 303
           A+    +  +             Y  PE     R Y    D++  G I+A + T      
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS---- 226

Query: 304 PFF 306
           P  
Sbjct: 227 PIM 229

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 20/166 (12%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLR 209
           E  VL + RH  L +L+       R   V +Y   G L      + RE       E R R
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT---EERAR 108

Query: 210 I-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIA-- 264
                ++  L+YLH   +  +++ ++K  N+MLD +   ++ DFGL K  +  G+ +   
Sbjct: 109 FYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165

Query: 265 --TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
             T  Y APE  ++  Y    D +  G+++  ++ GR    PF+ +
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR---LPFYNQ 208

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 37/204 (18%), Positives = 82/204 (40%), Gaps = 31/204 (15%)

Query: 103 RLLGSSPDGKYYRTVLDNG----LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           R +G    G  ++ +  +     + VA++  +     + +      + +  QE   +   
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSV----REKFLQEALTMRQF 448

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
            H +++ L   + E+   +++ +    G L      ++  +  L     +  A  +   L
Sbjct: 449 DHPHIVKLIGVITENP-VWIIMELCTLGEL---RSFLQVRKFSLDLASLILYAYQLSTAL 504

Query: 219 QYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------Y 268
            YL    F      +H ++   NV++ +    +L DFGL++ M  S    ++       +
Sbjct: 505 AYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558

Query: 269 SAPECFQNRSYTDKSDIFSFGMIL 292
            APE    R +T  SD++ FG+ +
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCM 582

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 44/231 (19%), Positives = 78/231 (33%), Gaps = 72/231 (31%)

Query: 120 NGLTVAVRRVE-AFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVPESSR-- 175
               VA+++V   F       ++    +RI +E+ +L  L+   ++ L    +P+     
Sbjct: 50  TEKNVAIKKVNRMF-------EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102

Query: 176 --FYLVYDYLQTGSLEDAMDRIRENQL-----------QLGWEVRLRIAVGVIKGLQYLH 222
              Y+V +   +    D     +                L            + G  ++H
Sbjct: 103 DELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNL------------LLGENFIH 146

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-------------------- 262
                 I+H +LKP N +L+ + + ++ DFGLA+ +                        
Sbjct: 147 -ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203

Query: 263 --------IATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP 304
                   + T  Y APE      +YT   DI+S G I A LL        
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 68.1 bits (167), Expect = 4e-13
 Identities = 29/174 (16%), Positives = 66/174 (37%), Gaps = 37/174 (21%)

Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
           +      +   +++ L H++L+             LV ++++ GSL+  +   ++N+  +
Sbjct: 54  NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCI 110

Query: 203 GWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPR--------LAD 251
               +L +A  +   + +L           +H N+   N++L  E   +        L+D
Sbjct: 111 NILWKLEVAKQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSD 164

Query: 252 FGLAKLMPGSLIATSAY-------SAPECFQN-RSYTDKSDIFSFGMILAVLLT 297
            G++       +              PEC +N ++    +D +SFG      L 
Sbjct: 165 PGISI-----TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG----TTLW 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 32/211 (15%)

Query: 140 QNKSVKRRIQQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RE 197
            ++ +   +Q E  V   +  H  L+ L +     SR + V +Y+  G L   M  + R+
Sbjct: 92  DDEDIDW-VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQ 147

Query: 198 NQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
            +L    E   R  +  +   L YLH      I++ +LK  NV+LD+E   +L D+G+ K
Sbjct: 148 RKLP---EEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201

Query: 257 --LMPGSLIA----TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
             L PG   +    T  Y APE  +   Y    D ++ G+++  ++ GR   +PF    +
Sbjct: 202 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR---SPFDIVGS 258

Query: 311 SGGSLGRWLRHLQHAGEAREALDRSILGEEV 341
           S                  + L + IL +++
Sbjct: 259 SDNP----------DQNTEDYLFQVILEKQI 279

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 54/220 (24%)

Query: 120 NGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLR-AYVPESSR- 175
            G  VAV+++ +AF       QN +  +R  +E+ +L  L  H N+++L      ++ R 
Sbjct: 33  TGEVVAVKKIFDAF-------QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85

Query: 176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLR-IAVGVIKGLQYLHFTCNPQILHYNL 234
            YLV+DY++T    D    IR N L+    V  + +   +IK ++YLH +    +LH ++
Sbjct: 86  VYLVFDYMET----DLHAVIRANILE---PVHKQYVVYQLIKVIKYLH-SGG--LLHRDM 135

Query: 235 KPTNVMLDAEFTPRLADFGLAKLMPGSL---------------------------IATSA 267
           KP+N++L+AE   ++ADFGL++                                 +AT  
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRW 195

Query: 268 YSAPEC-FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
           Y APE    +  YT   D++S G IL  +L G+    P F
Sbjct: 196 YRAPEILLGSTKYTKGIDMWSLGCILGEILCGK----PIF 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 21/167 (12%)

Query: 151 ELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRL 208
           E  VLA   +   L  L +      R Y V +Y+  G L   M  I +  + +   E   
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFK---EPHA 444

Query: 209 RI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIA- 264
              A  +  GL +L    +  I++ +LK  NVMLD+E   ++ADFG+ K  +  G     
Sbjct: 445 VFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501

Query: 265 ---TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
              T  Y APE    + Y    D ++FG++L  +L G+   APF  E
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ---APFEGE 545

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 15/162 (9%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L ++    L+ L     ++S  Y+V +Y+  G +   + RI         E   R 
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-----EPHARF 145

Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATS 266
            A  ++   +YLH   +  +++ +LKP N+++D +   ++ DFG AK + G   +L  T 
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 202

Query: 267 AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
              APE   ++ Y    D ++ G+++  +  G     PFFA+
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGY---PPFFAD 241

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 67.3 bits (165), Expect = 9e-13
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 43/210 (20%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ--QELEVLASLRHRNLMSLRAYV 170
            Y     N +  A++ +          +   +++     +E  ++  L H N+++L   +
Sbjct: 41  EYIDQAQNRIQCAIKSL---------SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91

Query: 171 -PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCN 226
            P     +++  Y+  G L   +  IR  Q     +  +   + V +G++YL    F   
Sbjct: 92  LPPEGLPHVLLPYMCHGDL---LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF--- 145

Query: 227 PQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS--------------APE 272
              +H +L   N MLD  FT ++ADFGLA+ +    +    YS              A E
Sbjct: 146 ---VHRDLAARNCMLDESFTVKVADFGLARDI----LDREYYSVQQHRHARLPVKWTALE 198

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
             Q   +T KSD++SFG++L  LLT G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.6 bits (166), Expect = 9e-13
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 32/211 (15%)

Query: 140 QNKSVKRRIQQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RE 197
            ++ +   +Q E  V   +  H  L+ L +     SR + V +Y+  G L   M  + R+
Sbjct: 49  DDEDIDW-VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQ 104

Query: 198 NQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
            +L    E   R  +  +   L YLH      I++ +LK  NV+LD+E   +L D+G+ K
Sbjct: 105 RKLP---EEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

Query: 257 --LMPGSLIA----TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA 310
             L PG   +    T  Y APE  +   Y    D ++ G+++  ++ GR   +PF    +
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR---SPFDIVGS 215

Query: 311 SGGSLGRWLRHLQHAGEAREALDRSILGEEV 341
           S                  + L + IL +++
Sbjct: 216 SDNP----------DQNTEDYLFQVILEKQI 236

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 20/165 (12%)

Query: 152 LEVLASLRHRNLMSLR-----AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           L  L +  H N++ L      +      +  LV++++    L   +D+     L     +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAE-TI 122

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL--MPGSL-- 262
           +  +    ++GL +LH      I+H +LKP N+++ +  T +LADFGLA++     +L  
Sbjct: 123 K-DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

Query: 263 -IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
            + T  Y APE     +Y    D++S G I A +   +    P F
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLF 219

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 33/190 (17%)

Query: 113 YYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR-AYVP 171
           Y+   + N   VA++++      S EK        I +E+  L  LRH N +  R  Y+ 
Sbjct: 71  YFARDVRNSEVVAIKKMSYSGKQSNEKWQD-----IIKEVRFLQKLRHPNTIQYRGCYL- 124

Query: 172 ESSRFYLVYDYLQTGSLEDAMD----RIRENQLQLGWEVRLRIAV---GVIKGLQYLHFT 224
                +LV +Y   GS  D ++     ++E +          IA    G ++GL YLH  
Sbjct: 125 REHTAWLVMEYCL-GSASDLLEVHKKPLQEVE----------IAAVTHGALQGLAYLH-- 171

Query: 225 CNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--GSLIATSAYSAPE---CFQNRSY 279
            +  ++H ++K  N++L      +L DFG A +M    S + T  + APE         Y
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 230

Query: 280 TDKSDIFSFG 289
             K D++S G
Sbjct: 231 DGKVDVWSLG 240

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.8 bits (164), Expect = 1e-12
 Identities = 41/165 (24%), Positives = 80/165 (48%), Gaps = 20/165 (12%)

Query: 152 LEVLASLRHRNLMSLR-----AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
           L  L +  H N++ L      +     ++  LV++++    L   +D++ E  +     +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE-TI 122

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM--PGSL-- 262
           +  +   +++GL +LH   + +++H +LKP N+++ +    +LADFGLA++     +L  
Sbjct: 123 K-DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query: 263 -IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFF 306
            + T  Y APE     SY    D++S G I A +   +    P F
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLF 219

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 65.6 bits (161), Expect = 4e-12
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLR 209
           E ++L  + H  ++ L        + YL+ D+L+ G L     R+ +E       E  ++
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFT---EEDVK 129

Query: 210 I-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL-MPGSLIATS- 266
                +   L +LH   +  I++ +LKP N++LD E   +L DFGL+K  +     A S 
Sbjct: 130 FYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186

Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                Y APE    R +T  +D +SFG+++  +LTG     PF  +
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT---LPFQGK 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.6 bits (161), Expect = 4e-12
 Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 20/166 (12%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLR 209
           E  +L  ++H  ++ L        + YL+ +YL  G L     ++ RE       E    
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFM---EDTAC 124

Query: 210 I-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL-MPGSLIATS- 266
                +   L +LH      I++ +LKP N+ML+ +   +L DFGL K  +    +  + 
Sbjct: 125 FYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181

Query: 267 ----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                Y APE      +    D +S G ++  +LTG     PF  E
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA---PPFTGE 224

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 64.9 bits (159), Expect = 4e-12
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 39/213 (18%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + +G    G         G  VAV+ ++     + +            E  V+  LRH N
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQA--------FLAEASVMTQLRHSN 75

Query: 163 LMSLRAYVPESS-RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           L+ L   + E     Y+V +Y+  GSL D + R R     LG +  L+ ++ V + ++YL
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRS-VLGGDCLLKFSLDVCEAMEYL 133

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAY--------SAPEC 273
                   +H +L   NV++  +   +++DFGL K       +++          +APE 
Sbjct: 134 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEA 185

Query: 274 FQNRSYTDKSDIFSFGMILAVLLT-----GRDP 301
            + + ++ KSD++SFG    +LL      GR P
Sbjct: 186 LREKKFSTKSDVWSFG----ILLWEIYSFGRVP 214

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 35/175 (20%)

Query: 139 KQNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPESSR-FYLVYDYLQTGSLEDAMDRI 195
            +   +    Q   E  ++    H N++SL      S     +V  Y++ G L +    I
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---I 182

Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADF 252
           R        +  +   + V KG+++L    F      +H +L   N MLD +FT ++ADF
Sbjct: 183 RNETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADF 236

Query: 253 GLAKLMPGSLIATSAYS---------------APECFQNRSYTDKSDIFSFGMIL 292
           GLA+      +    +                A E  Q + +T KSD++SFG++L
Sbjct: 237 GLARD-----MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 31/161 (19%)

Query: 150 QELEVLASLRHRNLMSLRAYV-PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
            E  ++    H N++SL            +V  Y++ G L +    IR        +  +
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLI 131

Query: 209 RIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT 265
              + V KG++YL    F      +H +L   N MLD +FT ++ADFGLA+ M       
Sbjct: 132 GFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDM----YDK 181

Query: 266 SAYS--------------APECFQNRSYTDKSDIFSFGMIL 292
             YS              A E  Q + +T KSD++SFG++L
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 36/166 (21%), Positives = 66/166 (39%), Gaps = 33/166 (19%)

Query: 150 QELEVLASLRHRNLMSL------RAYVPESSRFYLVYDYLQTGSLEDAM--DRIRENQLQ 201
           +E   +    H ++  L                 ++  +++ G L   +   RI EN   
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133

Query: 202 LGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM 258
           L  +  +R  V +  G++YL   +F      +H +L   N ML  + T  +ADFGL++ +
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKI 187

Query: 259 PGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMIL 292
                +   Y             A E   +  YT  SD+++FG+ +
Sbjct: 188 ----YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 64.6 bits (158), Expect = 7e-12
 Identities = 38/169 (22%), Positives = 66/169 (39%), Gaps = 36/169 (21%)

Query: 150 QELEVLASLRHRNLMSL-----RAYVPESSRFYLVYDYLQTGSLED--AMDRIRENQLQL 202
            E   +    H N++ L             +  ++  +++ G L       R+      +
Sbjct: 85  SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144

Query: 203 GWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP 259
             +  L+  V +  G++YL   +F      LH +L   N ML  + T  +ADFGL+K + 
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKI- 197

Query: 260 GSLIATSAYS------------APECFQNRSYTDKSDIFSFGMILAVLL 296
               +   Y             A E   +R YT KSD+++FG    V +
Sbjct: 198 ---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG----VTM 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 65.5 bits (160), Expect = 7e-12
 Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 23/175 (13%)

Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
             ++E +VL +   + + +L     + +  YLV DY   G L   + +  E++L    E 
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLP---EE 175

Query: 207 RLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG----- 260
             R     ++  +  +H       +H ++KP N+++D     RLADFG    +       
Sbjct: 176 MARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 261 --SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
               + T  Y +PE  Q        Y  + D +S G+ +  +L G     PF+AE
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE---TPFYAE 284

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 46/240 (19%), Positives = 86/240 (35%), Gaps = 77/240 (32%)

Query: 120 NGLTVAVRRV-EAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLR--AYVPESSRF 176
               VA++++   FE       +    +RI +E+ +L  L H +++ +       +  +F
Sbjct: 77  EKRVVAIKKILRVFE-------DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129

Query: 177 ---YLVYDYLQTGSLEDAMDRIRENQL-----------QLGWEVRLRIAVGVIKGLQYLH 222
              Y+V +   +    D     R                L            + G++Y+H
Sbjct: 130 DELYVVLEIADS----DFKKLFRTPVYLTELHIKTLLYNL------------LVGVKYVH 173

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-------------------- 262
            +    ILH +LKP N +++ + + ++ DFGLA+ +                        
Sbjct: 174 -SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230

Query: 263 -------------IATSAYSAPE-CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                        + T  Y APE      +YT+  D++S G I A LL        + A+
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 25/173 (14%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E +VL +   R +  L     + +  YLV +Y   G L   + +    ++        R 
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIP---AEMARF 166

Query: 211 -AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIATSA 267
               ++  +  +H       +H ++KP N++LD     RLADFG        G++ +  A
Sbjct: 167 YLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223

Query: 268 -----YSAPECFQNRS-------YTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
                Y +PE  Q          Y  + D ++ G+    +  G+    PF+A+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ---TPFYAD 273

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 43/167 (25%), Positives = 77/167 (46%), Gaps = 25/167 (14%)

Query: 151 ELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRI 210
           E  +L+ + H  ++ +     ++ + +++ DY++ G L      +R+         R   
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL---FSLLRK-------SQRFPN 105

Query: 211 AVG------VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---S 261
            V       V   L+YLH   +  I++ +LKP N++LD     ++ DFG AK +P    +
Sbjct: 106 PVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 162

Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           L  T  Y APE    + Y    D +SFG+++  +L G     PF+  
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY---TPFYDS 206

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 47/144 (32%), Positives = 68/144 (47%), Gaps = 20/144 (13%)

Query: 173 SSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQIL 230
             R + V +++  G L   M  I +  +     E R R  A  +I  L +LH   +  I+
Sbjct: 96  PDRLFFVMEFVNGGDL---MFHIQKSRRFD---EARARFYAAEIISALMFLH---DKGII 146

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIA----TSAYSAPECFQNRSYTDKSD 284
           + +LK  NV+LD E   +LADFG+ K  +  G   A    T  Y APE  Q   Y    D
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVD 206

Query: 285 IFSFGMILAVLLTGRDPTAPFFAE 308
            ++ G++L  +L G    APF AE
Sbjct: 207 WWAMGVLLYEMLCGH---APFEAE 227

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 40/174 (22%), Positives = 72/174 (41%), Gaps = 24/174 (13%)

Query: 147 RIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEV 206
              +E +++A      ++ L     +    Y+V +Y+  G L + M            E 
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP------EK 168

Query: 207 RLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG----- 260
             R     V+  L  +H   +   +H ++KP N++LD     +LADFG    M       
Sbjct: 169 WARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 261 --SLIATSAYSAPECFQNR----SYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
             + + T  Y +PE  +++     Y  + D +S G+ L  +L G     PF+A+
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD---TPFYAD 276

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 22/178 (12%)

Query: 140 QNKSVKRRIQQELEVLA-SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRI-RE 197
            +  V+     E  VL+ +  H  L  +          + V +YL  G L   M  I   
Sbjct: 57  MDDDVEC-TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSC 112

Query: 198 NQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
           ++       R    A  +I GLQ+LH   +  I++ +LK  N++LD +   ++ADFG+ K
Sbjct: 113 HKFD---LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

Query: 257 --LMPGSLIA----TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
             ++  +       T  Y APE    + Y    D +SFG++L  +L G+   +PF  +
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ---SPFHGQ 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 20/143 (13%)

Query: 174 SRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILH 231
            R Y V +Y+  G L   M  I +  + +   E      A  +  GL +L    +  I++
Sbjct: 94  DRLYFVMEYVNGGDL---MYHIQQVGRFK---EPHAVFYAAEIAIGLFFLQ---SKGIIY 144

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAK--LMPGSLIA----TSAYSAPECFQNRSYTDKSDI 285
            +LK  NVMLD+E   ++ADFG+ K  +  G        T  Y APE    + Y    D 
Sbjct: 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204

Query: 286 FSFGMILAVLLTGRDPTAPFFAE 308
           ++FG++L  +L G+   APF  E
Sbjct: 205 WAFGVLLYEMLAGQ---APFEGE 224

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 62.2 bits (152), Expect = 5e-11
 Identities = 41/176 (23%), Positives = 76/176 (43%), Gaps = 41/176 (23%)

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL------------EDAMDRIR 196
           Q+E E+L +L+H +++       +     +V++Y++ G L                 + R
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 197 ENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFG 253
           + + +LG    L IA  +  G+ YL   HF      +H +L   N ++ A    ++ DFG
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFG 178

Query: 254 LAKLMPGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMILAVLLT 297
           +++ +     +T  Y              PE    R +T +SD++SFG    V+L 
Sbjct: 179 MSRDV----YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG----VILW 226

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 20/143 (13%)

Query: 174 SRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQILH 231
            + Y V DY+  G L      + RE       E R R  A  +   L YLH   +  I++
Sbjct: 112 DKLYFVLDYINGGEL---FYHLQRERCFL---EPRARFYAAEIASALGYLH---SLNIVY 162

Query: 232 YNLKPTNVMLDAEFTPRLADFGLAKL-MPGSLIA-----TSAYSAPECFQNRSYTDKSDI 285
            +LKP N++LD++    L DFGL K  +  +        T  Y APE    + Y    D 
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222

Query: 286 FSFGMILAVLLTGRDPTAPFFAE 308
           +  G +L  +L G     PF++ 
Sbjct: 223 WCLGAVLYEMLYGL---PPFYSR 242

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 40/181 (22%), Positives = 71/181 (39%), Gaps = 42/181 (23%)

Query: 142 KSVKRR--IQQELEVLASL-RHRNLMSLR-AY---VPESSRFYLVYDYLQTGSLEDAMDR 194
           K ++     ++E+E+     +  +++ +   Y           +V + L  G L     R
Sbjct: 49  KMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL---FSR 105

Query: 195 IRENQLQLGWEVRLRIAVGVIK----GLQYLHFTCNPQILHYNLKPTNVML---DAEFTP 247
           I++   Q   E   R A  ++K     +QYLH   +  I H ++KP N++          
Sbjct: 106 IQDRGDQAFTE---REASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 159

Query: 248 RLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA 307
           +L DFG A                E      Y    D++S G+I+ +LL G     PF++
Sbjct: 160 KLTDFGFA---------------KE-TTGEKYDKSCDMWSLGVIMYILLCGY---PPFYS 200

Query: 308 E 308
            
Sbjct: 201 N 201

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 30/125 (24%), Positives = 54/125 (43%), Gaps = 19/125 (15%)

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP------RLADFGLAKLMPG-- 260
           +I+  ++ GL Y+H  C   I+H ++KP NV+++   +P      ++AD G A       
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 261 -SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL 319
            + I T  Y +PE      +   +DI+S   ++  L+TG       F           + 
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD----FLF----EPDEGHSYT 244

Query: 320 RHLQH 324
           +   H
Sbjct: 245 KDDDH 249

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 39/204 (19%), Positives = 76/204 (37%), Gaps = 39/204 (19%)

Query: 111 GKYYRTVLDNG-LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAY 169
           G     V D     VA++ V        E  +   +     E  V+      +++ L   
Sbjct: 44  GVAKGVVKDEPETRVAIKTV-------NEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96

Query: 170 VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL------RIAVGVIKGLQYL-- 221
           V +     ++ + +  G L+  +  +R                  ++A  +  G+ YL  
Sbjct: 97  VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156

Query: 222 -HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS----------- 269
             F      +H +L   N M+  +FT ++ DFG+ + +      T  Y            
Sbjct: 157 NKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDI----YETDYYRKGGKGLLPVRW 206

Query: 270 -APECFQNRSYTDKSDIFSFGMIL 292
            +PE  ++  +T  SD++SFG++L
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVL 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 38/171 (22%)

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL-----------EDAMDRIRE 197
           Q+E E+L  L+H++++       E     +V++Y++ G L           +        
Sbjct: 91  QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
               LG    L +A  V  G+ YL   HF      +H +L   N ++      ++ DFG+
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGM 204

Query: 255 AKLMPGSLIATSAY-------------SAPECFQNRSYTDKSDIFSFGMIL 292
           ++      I ++ Y               PE    R +T +SD++SFG++L
Sbjct: 205 SRD-----IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 35/170 (20%), Positives = 66/170 (38%), Gaps = 37/170 (21%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL------------EDAMDRIRE 197
            E  + A L+H N++ L   V +     +++ Y   G L              + D  R 
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 198 NQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
            +  L     + +   +  G++YL   H       +H +L   NV++  +   +++D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGL 174

Query: 255 AKLMPGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMIL 292
            +     + A   Y             APE      ++  SDI+S+G++L
Sbjct: 175 FRE----VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 45/218 (20%)

Query: 103 RLLGSSPDGKYYRTVLDNG---LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL- 158
            ++G    G+  +  +      +  A++R++     + +       R    ELEVL  L 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDD----HRDFAGELEVLCKLG 83

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED------------AMDRIRENQLQLGWEV 206
            H N+++L          YL  +Y   G+L D            A          L  + 
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 207 RLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS 266
            L  A  V +G+ YL      Q +H +L   N+++   +  ++ADFGL++          
Sbjct: 144 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQE 193

Query: 267 AYS------------APECFQNRSYTDKSDIFSFGMIL 292
            Y             A E      YT  SD++S+G++L
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 35/174 (20%), Positives = 67/174 (38%), Gaps = 40/174 (22%)

Query: 150 QELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSL----------EDAMDRIREN 198
            EL++++ L +H N+++L           ++ +Y   G L           +        
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 199 QLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA 255
                    L  +  V +G+ +L   +       +H ++   NV+L      ++ DFGLA
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLA 211

Query: 256 KLMPGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMILAVLLT 297
           + +    +  S Y             APE   +  YT +SD++S+G    +LL 
Sbjct: 212 RDI----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG----ILLW 257

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 47/206 (22%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRI--QQELEVLASL-RHRNLMSLRAYVPESSR 175
           +    VAV+ +         K + + K       E+E++  + +H+N+++L     +   
Sbjct: 99  NRVTKVAVKML---------KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149

Query: 176 FYLVYDYLQTGSLED--------AMDRIRENQLQLGWEVRLR----IAVGVIKGLQYLHF 223
            Y++ +Y   G+L +         ++           ++  +     A  V +G++YL  
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA- 208

Query: 224 TCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------AP 271
             + + +H +L   NV++  +   ++ADFGLA+ +         Y             AP
Sbjct: 209 --SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKKTTNGRLPVKWMAP 262

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT 297
           E   +R YT +SD++SFG    VLL 
Sbjct: 263 EALFDRIYTHQSDVWSFG----VLLW 284

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 33/165 (20%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLED---AMDRIRENQLQLGWEV 206
            E  +++   H+N++       +S   +++ + +  G L+               L    
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 207 RLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPG 260
            L +A  +  G QYL   HF      +H ++   N +L         ++ DFG+A+    
Sbjct: 142 LLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--- 192

Query: 261 SLIATSAY-------------SAPECFQNRSYTDKSDIFSFGMIL 292
             I  ++Y               PE F    +T K+D +SFG++L
Sbjct: 193 --IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 44/204 (21%), Positives = 89/204 (43%), Gaps = 43/204 (21%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
              +TVAV+ +        +   +     +  E+E++  + +H+N+++L     +    Y
Sbjct: 65  KEAVTVAVKML-------KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 117

Query: 178 LVYDYLQTGSL------------EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC 225
           ++ +Y   G+L            E + D  R  + Q+ ++  +     + +G++YL    
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--- 174

Query: 226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------APEC 273
           + + +H +L   NV++      ++ADFGLA+ +         Y             APE 
Sbjct: 175 SQKCIHRDLAARNVLVTENNVMKIADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEA 230

Query: 274 FQNRSYTDKSDIFSFGMILAVLLT 297
             +R YT +SD++SFG    VL+ 
Sbjct: 231 LFDRVYTHQSDVWSFG----VLMW 250

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 23/147 (15%)

Query: 173 SSRFYLVYDYLQTGSLEDAMDRI-RENQLQLGWEVRLRI-AVGVIKGLQYLHFTCNPQIL 230
            ++ +L+ DY+  G L      + +  +     E  ++I    ++  L++LH      I+
Sbjct: 131 ETKLHLILDYINGGEL---FTHLSQRERFT---EHEVQIYVGEIVLALEHLH---KLGII 181

Query: 231 HYNLKPTNVMLDAEFTPRLADFGLAKL-MPGSLIATSA------YSAPECFQNRSY-TDK 282
           + ++K  N++LD+     L DFGL+K  +               Y AP+  +      DK
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 241

Query: 283 S-DIFSFGMILAVLLTGRDPTAPFFAE 308
           + D +S G+++  LLTG    +PF  +
Sbjct: 242 AVDWWSLGVLMYELLTGA---SPFTVD 265

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 38/175 (21%)

Query: 150 QELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSL--------------EDAMDR 194
            EL+VL+ L  H N+++L           ++ +Y   G L              + +   
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 195 IRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL 254
           + +++L L  E  L  +  V KG+ +L        +H +L   N++L      ++ DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGL 191

Query: 255 AKLMPGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMILAVLLT 297
           A+ +       S Y             APE   N  YT +SD++S+G    + L 
Sbjct: 192 ARDI----KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG----IFLW 238

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 33/165 (20%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR---ENQLQLGWEV 206
            E  +++   H+N++       +S   +++ + +  G L+  +   R        L    
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 207 RLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAKLMPG 260
            L +A  +  G QYL   HF      +H ++   N +L         ++ DFG+A+    
Sbjct: 183 LLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARD--- 233

Query: 261 SLIATSAY-------------SAPECFQNRSYTDKSDIFSFGMIL 292
             I  + Y               PE F    +T K+D +SFG++L
Sbjct: 234 --IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 49/206 (23%)

Query: 119 DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFY 177
              +TVAV+ +        +   +     +  E+E++  + +H+N+++L     +    Y
Sbjct: 111 KEAVTVAVKML-------KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163

Query: 178 LVYDYLQTGSL------------EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---H 222
           ++ +Y   G+L            E + D  R  + Q+ ++  +     + +G++YL    
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS------------A 270
                  +H +L   NV++      ++ADFGLA+ +         Y             A
Sbjct: 224 C------IHRDLAARNVLVTENNVMKIADFGLARDI----NNIDYYKKTTNGRLPVKWMA 273

Query: 271 PECFQNRSYTDKSDIFSFGMILAVLL 296
           PE   +R YT +SD++SFG    VL+
Sbjct: 274 PEALFDRVYTHQSDVWSFG----VLM 295

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 55.7 bits (135), Expect = 6e-09
 Identities = 36/182 (19%), Positives = 68/182 (37%), Gaps = 49/182 (26%)

Query: 150 QELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSL--------------------E 189
            E  VL  + H +++ L     +     L+ +Y + GSL                     
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 190 DAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL---HFTCNPQILHYNLKPTNVMLDAEFT 246
           ++      ++  L     +  A  + +G+QYL           +H +L   N+++     
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRK 188

Query: 247 PRLADFGLAKLMPGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMILAV 294
            +++DFGL++ +        +Y             A E   +  YT +SD++SFG    V
Sbjct: 189 MKISDFGLSRDV----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG----V 240

Query: 295 LL 296
           LL
Sbjct: 241 LL 242

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 12/103 (11%)

Query: 208 LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA 267
           +  +  V KG+++L      + +H +L   N++L  +   ++ DFGLA+ +         
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252

Query: 268 YS--------APECFQNRSYTDKSDIFSFGMILAVLLT-GRDP 301
                     APE   +R YT +SD++SFG++L  + + G  P
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 37/174 (21%), Positives = 72/174 (41%), Gaps = 37/174 (21%)

Query: 150 QELEVLASL-RHRNLMSLRAYVPESSR-FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR 207
            EL++L  +  H N+++L     +      ++ ++ + G+L   +   R   +       
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138

Query: 208 ------------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA 255
                       +  +  V KG+++L    + + +H +L   N++L  +   ++ DFGLA
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 195

Query: 256 KLMPGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMILAVLLT 297
           + +         Y             APE   +R YT +SD++SFG    VLL 
Sbjct: 196 RDI----YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG----VLLW 241

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 43/179 (24%)

Query: 150 QELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR- 207
            EL+++  L  H N+++L      S   YL+++Y   G L + +   RE   +   E   
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 208 ------------------LRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL 249
                             L  A  V KG+++L        +H +L   NV++      ++
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI 213

Query: 250 ADFGLAKLMPGSLIATSAYS------------APECFQNRSYTDKSDIFSFGMILAVLL 296
            DFGLA+ +    ++ S Y             APE      YT KSD++S+G    +LL
Sbjct: 214 CDFGLARDI----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG----ILL 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 40/210 (19%), Positives = 75/210 (35%), Gaps = 56/210 (26%)

Query: 122 LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD 181
             VAV+ +        E+ +  ++   Q+E  ++A   + N++ L           L+++
Sbjct: 78  TMVAVKML-------KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE 130

Query: 182 YLQTGSL--------------------EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           Y+  G L                                 L    +L IA  V  G+ YL
Sbjct: 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190

Query: 222 ---HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYS--------- 269
               F      +H +L   N ++      ++ADFGL++    ++ +   Y          
Sbjct: 191 SERKF------VHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYKADGNDAIPI 240

Query: 270 ---APECFQNRSYTDKSDIFSFGMILAVLL 296
               PE      YT +SD++++G    V+L
Sbjct: 241 RWMPPESIFYNRYTTESDVWAYG----VVL 266

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 21/174 (12%)

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY------LVYDYLQTGSLEDAM 192
           +  K   R+  +E+ +L  LR ++  +    +     F       + ++ L   +L +  
Sbjct: 131 RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYEL- 188

Query: 193 DRIRENQLQLGWEVRL--RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--R 248
             I++N+ Q G+ + L  + A  +++ L  LH     +I+H +LKP N++L  +     +
Sbjct: 189 --IKKNKFQ-GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIK 242

Query: 249 LADFGLAKL---MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR 299
           + DFG +        + I +  Y APE      Y    D++S G ILA LLTG 
Sbjct: 243 VIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 9/114 (7%)

Query: 193 DRIRENQLQLGWEVRL--RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP--R 248
           D +R    + G  + L  + A  +   L +L  T    I+H +LKP N++L        +
Sbjct: 144 DLLRNTNFR-GVSLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIK 201

Query: 249 LADFGLAKL---MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR 299
           + DFG +          I +  Y +PE      Y    D++S G IL  + TG 
Sbjct: 202 IVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 40/199 (20%), Positives = 62/199 (31%), Gaps = 62/199 (31%)

Query: 178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT 237
           +V++ L    L   + +     L L      +I   V++GL YLH  C  +I+H ++KP 
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPL--PCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPE 176

Query: 238 NVMLDAE-------------------------------------------------FTPR 248
           N++L                                                       +
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236

Query: 249 LADFGLAKLM---PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF 305
           +AD G A  +       I T  Y + E      Y   +DI+S   +   L TG       
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD----YL 292

Query: 306 FAEAASGGSLGRWLRHLQH 324
           F E  SG    R   H+  
Sbjct: 293 F-EPHSGEEYTRDEDHIAL 310

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 25/112 (22%)

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-DAEFTP------------------RL 249
            +A  +   L++LH     Q+ H +LKP N++  ++EF                    R+
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 250 ADFGLA---KLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
           ADFG A        +++AT  Y  PE      +    D++S G IL     G
Sbjct: 184 ADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 9/37 (24%), Positives = 16/37 (43%), Gaps = 17/37 (45%)

Query: 138 EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS 174
           EKQ  ++K+     L+           SL+ Y  +S+
Sbjct: 18  EKQ--ALKK-----LQA----------SLKLYADDSA 37

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 26/112 (23%), Positives = 49/112 (43%), Gaps = 25/112 (22%)

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-DAEFTP------------------RL 249
           ++A  + K + +LH   + ++ H +LKP N++   +++T                   ++
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 250 ADFGLAKL---MPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTG 298
            DFG A        +L++T  Y APE      ++   D++S G IL     G
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	380
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.91
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.69
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.26
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.87
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.67
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.65
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.64
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.44
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.25
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.19
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.1
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.99
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.99
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.88
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.67
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.67
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.24
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	94.94
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.3
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	92.88
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.38
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	90.77
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.31

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-59  Score=430.21  Aligned_cols=252  Identities=19%  Similarity=0.341  Sum_probs=206.1

Q ss_pred             HhccccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe
Q 047245           98 LANENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP  171 (380)
Q Consensus        98 ~~~~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  171 (380)
                      ...+.+.||+|+||.||+|.+      .+++.||||+++...       .....++|.+|+.++++++|||||+++|+|.
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-------~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-------EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-------CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-------ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            334667899999999999986      356899999996522       1223478999999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhh------------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcE
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV  239 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Ni  239 (380)
                      +.+..++|||||++|||.++|....            .....++|..+++|+.|||+||+|||   +.+|+||||||+||
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NI  176 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNV  176 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccce
Confidence            9999999999999999999997432            12346999999999999999999999   89999999999999


Q ss_pred             EeCCCCceEEeccCCcccCC--------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhcc
Q 047245          240 MLDAEFTPRLADFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAA  310 (380)
Q Consensus       240 ll~~~~~~kl~Dfgl~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~  310 (380)
                      |+++++.+||+|||+++...        ....||+.|||||.+.++.++.++|||||||++|||+| |..||...     
T Consensus       177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-----  251 (308)
T 4gt4_A          177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-----  251 (308)
T ss_dssp             EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-----
T ss_pred             EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----
Confidence            99999999999999998542        23458999999999999999999999999999999999 89998642     


Q ss_pred             CCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                         ...+..........           .+.+.+++..+.+++.+||+.||++|||++||++.|+...
T Consensus       252 ---~~~~~~~~i~~~~~-----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          252 ---SNQDVVEMIRNRQV-----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ---CHHHHHHHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---CHHHHHHHHHcCCC-----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence               11222222221110           1122345667889999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.9e-59  Score=425.19  Aligned_cols=248  Identities=20%  Similarity=0.371  Sum_probs=203.9

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|.+.      ++..||||+++.        ......++|.+|++++++++|||||+++|+|.+.+
T Consensus        17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--------~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--------ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--------CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            4578999999999999863      478899999964        12344678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhh---------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIR---------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF  245 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~  245 (380)
                      ..++|||||++|+|.++++...         .....++|..+++|+.|+|.||+|||   +++|+||||||+|||+++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCC
Confidence            9999999999999999998532         22357999999999999999999999   89999999999999999999


Q ss_pred             ceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHH
Q 047245          246 TPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLG  316 (380)
Q Consensus       246 ~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~  316 (380)
                      .+||+|||+++....        ...||+.|||||.+.+..++.++|||||||++|||+| |+.||...        ...
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--------~~~  237 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------SNN  237 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHH
Confidence            999999999975432        2348999999999999999999999999999999999 89998641        112


Q ss_pred             HHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          317 RWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      +..........           ...+...+..+.+++.+||+.||++|||++||++.|+++.
T Consensus       238 ~~~~~i~~~~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          238 EVIECITQGRV-----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCC-----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            22222221110           1122334566889999999999999999999999998863

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.3e-58  Score=426.31  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=201.1

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|.+.      ++..||||+++.        ......++|.+|+++|++++|||||+++|+|.+.+
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--------~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--------ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--------CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4567999999999999864      478999999964        12344678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhh-----------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRE-----------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      ..++|||||++|+|.++++....           ...+++|.+++.|+.|+|.||+|||   +++|+||||||+|||+++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECC
Confidence            99999999999999999975321           2346999999999999999999999   899999999999999999


Q ss_pred             CCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCC
Q 047245          244 EFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGS  314 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~  314 (380)
                      ++.+||+|||+++....        ...||+.|||||.+.+..++.++|||||||++|||+| |+.||...        .
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--------~  265 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--------S  265 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--------C
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--------C
Confidence            99999999999986532        2358999999999999999999999999999999999 89998641        1


Q ss_pred             HHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       315 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ..+.........+           ...+...+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus       266 ~~~~~~~i~~g~~-----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          266 NTEAIDCITQGRE-----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCC-----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            1222222221110           1122334566889999999999999999999999998874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-57  Score=414.86  Aligned_cols=249  Identities=21%  Similarity=0.377  Sum_probs=199.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||+||+|.+.+  .||||+++...      ......+.|.+|+.++++++|||||+++|+|.+ +..++||
T Consensus        40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD------PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             EEEECCCCSSSEEEEEESSS--EEEEEECCCSS------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EeeEEeeCCCcEEEEEEECC--cEEEEEEEecC------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            56789999999999998753  59999987522      223446789999999999999999999999865 5689999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |||++|+|.++++.   ....++|..++.|+.|+|.||+|||   +++|+||||||+|||+++++.+||+|||+++....
T Consensus       111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999999973   3457999999999999999999999   89999999999999999999999999999986532


Q ss_pred             --------CCcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          261 --------SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       261 --------~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                              ...||+.|||||.+.+   ++++.++|||||||++|||+||+.||...        ............+.  
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~--------~~~~~~~~~~~~~~--  254 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI--------NNRDQIIFMVGRGY--  254 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC--------CCHHHHHHHHHTTC--
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcCC--
Confidence                    2359999999999863   46899999999999999999999998631        11111222111111  


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                        ..+.+  ...+.+++..+.+++.+||+.||++|||++||++.|+.|+
T Consensus       255 --~~p~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          255 --ASPDL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             --CCCCS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             --CCCCc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence              11111  1122334567889999999999999999999999998874

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.1e-56  Score=408.82  Aligned_cols=258  Identities=23%  Similarity=0.303  Sum_probs=196.7

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC----eE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS----RF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  176 (380)
                      ..+.||+|+||.||+|.+ +|+.||||++...         ......+..|+..+.+++|||||+++|+|.+.+    .+
T Consensus         7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---------~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             EEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---------chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            356899999999999998 5899999998641         111233446777778899999999999997653    68


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhc-----CCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT-----CNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                      ++|||||++|+|.++++.     ..++|..+.+++.|++.||+|||+.     ..++|+||||||+|||+++++++||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            999999999999999973     4689999999999999999999943     134999999999999999999999999


Q ss_pred             cCCcccCCC----------CCcCCCcccCcccccCC------CCCCcchhhHHHHHHHHHHhCCCCCCchhh-------h
Q 047245          252 FGLAKLMPG----------SLIATSAYSAPECFQNR------SYTDKSDIFSFGMILAVLLTGRDPTAPFFA-------E  308 (380)
Q Consensus       252 fgl~~~~~~----------~~~~~~~y~aPE~~~~~------~~~~~sDv~s~Gvil~el~tg~~p~~~~~~-------~  308 (380)
                      ||+++....          ...||+.|||||.+.+.      .++.++|||||||++|||+||..|+.....       .
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            999975432          23599999999999764      467899999999999999999887642111       0


Q ss_pred             ccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          309 AASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       309 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .........+......     +.+++.+.......+....+.+++.+||+.||++||||.||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCSSCCHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccchHHHHHHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1111122222222111     1122222222223456778899999999999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-55  Score=397.11  Aligned_cols=241  Identities=22%  Similarity=0.373  Sum_probs=193.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec----CCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE----SSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  175 (380)
                      +.+.||+|+||.||+|.. .++..||+|++....      ......+.|.+|+.++++++|||||++++++.+    ...
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            345699999999999987 468899999997532      233445789999999999999999999999864    346


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeCC-CCceEEecc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLDA-EFTPRLADF  252 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~~-~~~~kl~Df  252 (380)
                      +++|||||++|+|.+++..    ...+++..+..++.||+.||+|||   +++  |+||||||+|||+++ ++.+||+||
T Consensus       104 ~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeC
Confidence            8999999999999999974    457999999999999999999999   766  999999999999985 789999999


Q ss_pred             CCcccCCCC----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          253 GLAKLMPGS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       253 gl~~~~~~~----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      |+|+.....    ..||+.|||||.+.+ +++.++|||||||++|||+||+.||...       ..............  
T Consensus       177 Gla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~-------~~~~~~~~~i~~~~--  246 (290)
T 3fpq_A          177 GLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGV--  246 (290)
T ss_dssp             TGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTC--
T ss_pred             cCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CcHHHHHHHHHcCC--
Confidence            999865543    359999999998865 6999999999999999999999998531       11222222221111  


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .+    ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       247 ----~~----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 ----KP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----CC----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CC----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                01    1111122345789999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.7e-55  Score=403.30  Aligned_cols=242  Identities=24%  Similarity=0.396  Sum_probs=197.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||||++....      ......+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus        28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR------MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEEEECTT------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH------CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            346799999999999996 579999999997532      2234467899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||||+||+|.+++..  .....+++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       102 mEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          102 MDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            999999999999974  22446789999999999999999999   8999999999999999999999999999999775


Q ss_pred             CC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 GS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..      ..||+.|||||.+.+..|+.++|||||||++|||++|+.||..        .+..+..........      
T Consensus       177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~~~------  242 (350)
T 4b9d_A          177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA--------GSMKNLVLKIISGSF------  242 (350)
T ss_dssp             HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHTCC------
T ss_pred             CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcCCC------
Confidence            42      3599999999999999999999999999999999999999963        122333333222110      


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           ...+...+..+.+|+.+||+.||++|||++|+++
T Consensus       243 -----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 -----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0112234456889999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-55  Score=402.15  Aligned_cols=239  Identities=23%  Similarity=0.284  Sum_probs=196.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||||+++...             ...+|+.++++++|||||++++++.+.+..|+|
T Consensus        62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            345799999999999996 568999999997521             123699999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~~~~  258 (380)
                      ||||+||+|.++++.    ...+++.....++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+++..
T Consensus       129 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            999999999999974    347999999999999999999999   99999999999999999987 6999999999865


Q ss_pred             CC-----------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          259 PG-----------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       259 ~~-----------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ..           ...||+.|||||.+.+.+++.++|||||||++|||++|+.||...    ......    ........
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----~~~~~~----~~i~~~~~  273 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY----FRGPLC----LKIASEPP  273 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT----CCSCCH----HHHHHSCC
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC----CHHHHH----HHHHcCCC
Confidence            32           135999999999999999999999999999999999999999642    111111    11111110


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ..         ...+...+..+.+++.+||+.||++|||+.|+++.|..
T Consensus       274 ~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          274 PI---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             GG---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Cc---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            00         01122345568899999999999999999999887754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-54  Score=401.86  Aligned_cols=238  Identities=19%  Similarity=0.343  Sum_probs=197.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|.. .+|+.||||++......        ..+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus        79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--------SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35699999999999997 47999999999753221        1245789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |||++|+|.+++..     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       151 Ey~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          151 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             CCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            99999999999873     36899999999999999999999   89999999999999999999999999999986542


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ..+||+.|||||++.+..|+.++|||||||++|||++|+.||...        ...+........      ..+
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~------~~~  288 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIRDN------LPP  288 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHS------SCC
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcC------CCC
Confidence                  346999999999999999999999999999999999999998631        112222222111      111


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+   ......+..+.+|+.+||+.||++|||++|+++
T Consensus       289 ~~---~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          289 RL---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CC---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11   111234556889999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.3e-55  Score=406.53  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=201.5

Q ss_pred             ccccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC-CCcceeeEEEec
Q 047245          100 NENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-RNLMSLRAYVPE  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  172 (380)
                      ...+.||+|+||.||+|...      .++.||||++...       ......+.|.+|+.+|.+++| ||||+++|+|.+
T Consensus        67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-------~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-------cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            35678999999999999863      2357999998642       123345789999999999965 999999999966


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHHhhhc------------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcE
Q 047245          173 -SSRFYLVYDYLQTGSLEDAMDRIREN------------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV  239 (380)
Q Consensus       173 -~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Ni  239 (380)
                       ++.+++|||||++|+|.++|+..+..            ...++|..++.++.|||.||+|||   +++||||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccce
Confidence             45789999999999999999864321            345899999999999999999999   89999999999999


Q ss_pred             EeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhcc
Q 047245          240 MLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAA  310 (380)
Q Consensus       240 ll~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~  310 (380)
                      |+++++.+||+|||+++.....        ..||+.|||||.+.+..++.++|||||||++|||+| |+.||...     
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~-----  291 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-----  291 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC-----
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC-----
Confidence            9999999999999999875432        247899999999999999999999999999999998 99998631     


Q ss_pred             CCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                         .....+......+.     .     ...+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus       292 ---~~~~~~~~~i~~g~-----~-----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          292 ---KIDEEFCRRLKEGT-----R-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             ---CCSHHHHHHHHHTC-----C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHcCC-----C-----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence               00111111111111     0     111223455688999999999999999999999999876

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.4e-54  Score=389.78  Aligned_cols=239  Identities=20%  Similarity=0.318  Sum_probs=199.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ......+.+.+|++++++++|||||++++++.+.+..|+|
T Consensus        36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            567899999999999996 5789999999975211     1122346789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++.....++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       111 mEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            999999999999974    347999999999999999999999   8999999999999999999999999999998653


Q ss_pred             C--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 G--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .        ..+||+.|||||.+.+..++.++||||+||++|||++|+.||...        +............     
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~~-----  250 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEGLIFAKIIKLE-----  250 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC-----
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC-----
Confidence            1        246999999999999999999999999999999999999999631        2222222222211     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                        .     ..+...+..+.+++.+||+.||++|||++|++
T Consensus       251 --~-----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 --Y-----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --C-----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --C-----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence              0     11122345678999999999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8e-53  Score=378.43  Aligned_cols=239  Identities=24%  Similarity=0.377  Sum_probs=187.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++......     .......+.+|++++++++|||||++++++.+.+..++|
T Consensus        17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-----KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             EEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            457899999999999986 57999999999753221     122346789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+ +|+|.+++..    ...+++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++...
T Consensus        92 mEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             EECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             EeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            9999 6899999874    457999999999999999999999   8999999999999999999999999999998654


Q ss_pred             C-----CCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G-----SLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .     ...||+.|+|||.+.+..+ +.++||||+||++|||++|+.||..        .+............       
T Consensus       164 ~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~--------~~~~~~~~~i~~~~-------  228 (275)
T 3hyh_A          164 DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD--------ESIPVLFKNISNGV-------  228 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHHTC-------
T ss_pred             CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC--------CCHHHHHHHHHcCC-------
Confidence            3     3469999999999998886 5799999999999999999999963        12233333222211       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .     ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       229 ~-----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 Y-----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             C-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C-----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0     111223455789999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-53  Score=402.29  Aligned_cols=238  Identities=19%  Similarity=0.343  Sum_probs=197.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|.. .+|+.||||++......        ..+.+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus       156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--------SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--------HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            45799999999999997 56999999999753221        1256789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |||++|+|.+++..     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       228 Ey~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          228 EFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             ECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999863     35899999999999999999999   89999999999999999999999999999986542


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ..+||+.|||||++.+..|+.++|||||||++|||++|+.||...        ...+........      ..+
T Consensus       300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~~~------~~~  365 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMIRDN------LPP  365 (423)
T ss_dssp             SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHS------CCC
T ss_pred             CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHcC------CCC
Confidence                  346999999999999999999999999999999999999998531        112222222111      111


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+   ......+..+.+|+.+||+.||++|||++|+++
T Consensus       366 ~~---~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          366 RL---KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CC---SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11   111223456889999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-53  Score=386.17  Aligned_cols=235  Identities=24%  Similarity=0.306  Sum_probs=188.0

Q ss_pred             ccccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          100 NENRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ...+.||+|+||.||++..    ..++.||+|++........      ....+.+|++++++++|||||++++++.+.+.
T Consensus        27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR------DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE------ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH------HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            3557899999999999985    2478999999975321111      12457789999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .|+|||||+||+|.+++..    ...+++.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       101 ~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             EEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            9999999999999999975    347999999999999999999999   899999999999999999999999999999


Q ss_pred             ccCC------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          256 KLMP------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       256 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      +...      ....||+.|||||.+.+..++.++||||+||++|||++|+.||...        +..+.........   
T Consensus       174 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~---  242 (304)
T 3ubd_A          174 KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--------DRKETMTMILKAK---  242 (304)
T ss_dssp             EC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC---
T ss_pred             eeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--------CHHHHHHHHHcCC---
Confidence            8643      2346999999999999999999999999999999999999999631        2222222222111   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                               ...+...+..+.+++.+||+.||++|||+
T Consensus       243 ---------~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 ---------LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                     01122344568899999999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-51  Score=377.01  Aligned_cols=240  Identities=23%  Similarity=0.352  Sum_probs=184.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|+||.||++.. .+|+.||||++....       .+...+.+.+|++++++++|||||++++++.+.+     
T Consensus         9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             EEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            456899999999999986 578999999997521       2334578899999999999999999999986543     


Q ss_pred             -------eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCce
Q 047245          175 -------RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP  247 (380)
Q Consensus       175 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  247 (380)
                             ..|+|||||++|+|.+++.... .....++...+.++.|++.||+|||   +++|+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~v  157 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVV  157 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcE
Confidence                   3699999999999999997422 2234677788999999999999999   8999999999999999999999


Q ss_pred             EEeccCCcccCCC------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc
Q 047245          248 RLADFGLAKLMPG------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA  309 (380)
Q Consensus       248 kl~Dfgl~~~~~~------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~  309 (380)
                      ||+|||+++....                  ..+||+.|||||.+.+..++.++|||||||++|||++   ||...... 
T Consensus       158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-  233 (299)
T 4g31_A          158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-  233 (299)
T ss_dssp             EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred             EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-
Confidence            9999999986542                  1259999999999999999999999999999999996   76431100 


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ........ ...          .+.........+.+++.+||+.||++|||+.|+++
T Consensus       234 ------~~~~~~~~-~~~----------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 ------VRTLTDVR-NLK----------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ------HHHHHHHH-TTC----------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHHh-cCC----------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  00001100 000          01111233445678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-48  Score=365.89  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=191.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec------C
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE------S  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  173 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++....      ......+.+.+|+++|++++|||||++++++..      .
T Consensus        58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF------DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEECccc------cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            346899999999999996 579999999996422      123345678899999999999999999999753      3


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      +..|+|||||+ |+|.+++..    ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             CEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecc
Confidence            67899999996 689999863    457999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC----------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          254 LAKLMPG----------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       254 l~~~~~~----------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      +++....          ...||+.|+|||++.+. .++.++||||+||++|||++|+.||...        +..+.....
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~--------~~~~~l~~I  275 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK--------NYVHQLQLI  275 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS--------SHHHHHHHH
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC--------CHHHHHHHH
Confidence            9986532          34699999999998875 5689999999999999999999999631        111111111


Q ss_pred             Hh-hcc-------------hhHhhchhccCCccc-----HHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          323 QH-AGE-------------AREALDRSILGEEVE-----EDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       323 ~~-~~~-------------~~~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .. .+.             ....+...-.....+     ......+.+|+.+||+.||++|||++|+++
T Consensus       276 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          276 MMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00 000             000000000000000     112356789999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-48  Score=362.26  Aligned_cols=282  Identities=32%  Similarity=0.553  Sum_probs=234.3

Q ss_pred             CCChHHHHHHHhc--cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcce
Q 047245           88 KIDPKTLQAALAN--ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS  165 (380)
Q Consensus        88 ~~~~~~l~~~~~~--~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  165 (380)
                      .++..+++....+  ..+.||+|+||.||++...+|+.||+|++......       .....+.+|+.++++++||||++
T Consensus        19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-------GGELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-------hHHHHHHHHHHHHHhccCCCccc
Confidence            4566677666655  45789999999999999888999999999753211       11136889999999999999999


Q ss_pred             eeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC
Q 047245          166 LRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF  245 (380)
Q Consensus       166 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~  245 (380)
                      +++++.+.+..++||||+++|+|.+++.........++|..+..++.|++.||+|||+.+..+++||||||+|||+++++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~  171 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF  171 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence            99999999999999999999999999986544555699999999999999999999944334999999999999999999


Q ss_pred             ceEEeccCCcccCCC-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHH
Q 047245          246 TPRLADFGLAKLMPG-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       246 ~~kl~Dfgl~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~  318 (380)
                      .+||+|||+++....       ...||+.|+|||.+.+..++.++||||||+++|||++|..||+.............+|
T Consensus       172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  251 (326)
T 3uim_A          172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW  251 (326)
T ss_dssp             CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred             CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence            999999999986542       2348999999999998899999999999999999999999997543344445567777


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..............+..+.. ....+....+.+++.+||+.||.+|||++|+++.|++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          252 VKGLLKEKKLEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HTTTTSSCCSTTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHhhchhhhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            77766666666666665543 34577889999999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-47  Score=358.99  Aligned_cols=184  Identities=23%  Similarity=0.360  Sum_probs=161.0

Q ss_pred             cccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||+||+|..    ..++.||+|++....          ...++.+|+++++.+ +||||+++++++.+.+.
T Consensus        25 i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           25 IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----------CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            456899999999999985    246789999986421          124577899999999 69999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEeccCC
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGL  254 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Dfgl  254 (380)
                      .++||||+++|+|.+++.       .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+
T Consensus        95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            999999999999999885       4889999999999999999999   9999999999999999877 7999999999


Q ss_pred             cccCCC----------------------------------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCC
Q 047245          255 AKLMPG----------------------------------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGR  299 (380)
Q Consensus       255 ~~~~~~----------------------------------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~  299 (380)
                      |+....                                  ..+||+.|+|||.+.+. .++.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            974321                                  12599999999999875 4899999999999999999999


Q ss_pred             CCCCc
Q 047245          300 DPTAP  304 (380)
Q Consensus       300 ~p~~~  304 (380)
                      .||..
T Consensus       245 ~Pf~~  249 (361)
T 4f9c_A          245 YPFYK  249 (361)
T ss_dssp             SSSSC
T ss_pred             CCCCC
Confidence            99953

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-47  Score=355.32  Aligned_cols=264  Identities=29%  Similarity=0.521  Sum_probs=222.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||+|...+|..||+|++....        ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--------SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--------SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             ccceeecCCCeeEEEEEECCCCEEEEEEecccC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            356899999999999998889999999886521        123467899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++.........++|..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999998753333446999999999999999999999   89999999999999999999999999999975432


Q ss_pred             --------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 --------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 --------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                              ...|++.|+|||.+.+..++.++||||||+++|||++|+.||....  .........|.......+...+.+
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL--PREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS--SSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC--cHHHHHHHHHhhhccccccHHHhc
Confidence                    1237899999999998999999999999999999999999986422  223345667766666666655666


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ++.... ....+....+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       270 ~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          270 DPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             SSSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Chhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            555433 345678889999999999999999999999999998763

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.5e-47  Score=374.41  Aligned_cols=245  Identities=21%  Similarity=0.265  Sum_probs=193.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..++||+|+||.||++.. .+|+.||+|++......  .............++.+++.++|||||++++++.+.+.+|+|
T Consensus       193 i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~--~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV  270 (689)
T 3v5w_A          193 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI  270 (689)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcc--hhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence            347899999999999997 56999999999752210  111122233344567788889999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||++||+|.+++..    ...+++.....++.||+.||+|||   +.+|+||||||+|||++.+|++||+|||+|+...
T Consensus       271 mEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          271 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             ECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999974    356999999999999999999999   9999999999999999999999999999998654


Q ss_pred             C----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .    ..+||+.|||||++.. ..|+.++|+||+||++|||++|..||...     ...............         
T Consensus       344 ~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~-----~~~~~~~i~~~i~~~---------  409 (689)
T 3v5w_A          344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-----KTKDKHEIDRMTLTM---------  409 (689)
T ss_dssp             SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG-----GCCCHHHHHHHHHHC---------
T ss_pred             CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhhcCC---------
Confidence            3    3569999999999975 57999999999999999999999999631     111111111111111         


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELV  371 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl  371 (380)
                      .   ...+...+..+.+|+.+||+.||.+|++     ++|++
T Consensus       410 ~---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          410 A---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             C---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             C---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            0   1112234456889999999999999998     46654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.7e-47  Score=374.40  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++...        .....+.+.+|+.+|+.++|||||++++++.+.+..++|
T Consensus       161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--------HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--------chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            456799999999999997 57999999998651        223346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC--CceEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE--FTPRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kl~Dfgl~~~  257 (380)
                      ||||++|+|.+++..   ....+++.....++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+++.
T Consensus       233 ~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          233 YEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            999999999999863   2446899999999999999999999   8999999999999999854  8999999999987


Q ss_pred             CCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          258 MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ....     ..||+.|||||++.+.+++.++||||+||++|||++|..||...        ...+..........     
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--------~~~~~~~~i~~~~~-----  373 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDW-----  373 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHTTCC-----
T ss_pred             ccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHHHhCCC-----
Confidence            7543     35999999999999999999999999999999999999999631        11222222221110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        .. ........+..+.+|+.+||+.||.+|||++|+++
T Consensus       374 --~~-~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 --NM-DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             --CC-CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CC-CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00 01111223456789999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-46  Score=346.84  Aligned_cols=249  Identities=28%  Similarity=0.429  Sum_probs=197.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++.. +|..||||++....      ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQD------FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCC------CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCC------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            457899999999999987 58899999986522      12344578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+  ++||||||+||+++.++.+||+|||+++..
T Consensus       114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            9999999999997421 1234899999999999999999999   888  999999999999999999999999999754


Q ss_pred             CC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...        .............      
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~--------~~~~~~~~~~~~~------  255 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--------NPAQVVAAVGFKC------  255 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHHSC------
T ss_pred             cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcC------
Confidence            33      245899999999999999999999999999999999999998641        1111111111000      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                          .....+......+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       256 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          256 ----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                011122234456889999999999999999999999998763

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.7e-46  Score=340.92  Aligned_cols=247  Identities=25%  Similarity=0.456  Sum_probs=203.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|..||+|++..        ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--------FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEESC--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceecCCCCEEEEEEEECCCCcEEEEEEecc--------CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            457899999999999997 4689999998854        2344567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        86 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           86 TEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            999999999999974   2456999999999999999999999   8999999999999999999999999999997543


Q ss_pred             C--------------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH
Q 047245          260 G--------------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       260 ~--------------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      .                    ...||+.|+|||.+.+..++.++||||||+++|||++|..|+............     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-----  234 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-----  234 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB-----
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh-----
Confidence            2                    235899999999999999999999999999999999999998643222111110     


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                             ......+....     ......+.+++.+||+.||++|||+.|+++.|++++
T Consensus       235 -------~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          235 -------NVRGFLDRYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             -------CHHHHHHHTCC-----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------hhhccccccCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   01111111111     112334788999999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-45  Score=337.99  Aligned_cols=278  Identities=27%  Similarity=0.497  Sum_probs=224.1

Q ss_pred             CCCCChHHHHHHHhccc--------cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHc
Q 047245           86 SPKIDPKTLQAALANEN--------RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS  157 (380)
Q Consensus        86 ~~~~~~~~l~~~~~~~~--------~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  157 (380)
                      ...++..++..++.++.        +.||+|+||.||+|.. ++..||+|++......    ......+.+.+|+.++++
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~   86 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI----TTEELKQQFDQEIKVMAK   86 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS----CTTTHHHHHHHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc----chHHHHHHHHHHHHHHHh
Confidence            34578888999888754        5699999999999987 6889999998753211    123345788999999999


Q ss_pred             CCCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCC
Q 047245          158 LRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPT  237 (380)
Q Consensus       158 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~  237 (380)
                      ++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+++||||||+
T Consensus        87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~  162 (307)
T 2nru_A           87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSA  162 (307)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred             cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHH
Confidence            999999999999999999999999999999999997532 2456999999999999999999999   899999999999


Q ss_pred             cEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc
Q 047245          238 NVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA  309 (380)
Q Consensus       238 Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~  309 (380)
                      ||++++++.+||+|||+++....        ...|++.|+|||.+.+ .++.++||||||+++|||++|..||...    
T Consensus       163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~----  237 (307)
T 2nru_A          163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH----  237 (307)
T ss_dssp             GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT----
T ss_pred             HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC----
Confidence            99999999999999999876542        2358999999998865 5889999999999999999999998642    


Q ss_pred             cCCCCHHHHHHHHHhh-cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          310 ASGGSLGRWLRHLQHA-GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                      .....+..+....... ..+.+.+++.+  ...+......+.+++.+||+.||.+|||+.++++.|+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          238 REPQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BSSSBTTHHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cchHHHHHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1112233333333222 22344444433  22345677889999999999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.6e-46  Score=345.77  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=198.7

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC----eE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS----RF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  176 (380)
                      ..+.||+|+||.||+|... ++.||||++...         ......+..|+.++++++||||+++++++.+..    ..
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             EEEEEECSTTCEEEEEEET-TEEEEEEEECGG---------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             hhheecccCceEEEEEEEC-CCEEEEEEeecC---------chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            4578999999999999875 799999998641         122345567999999999999999999997743    47


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC----------CeEecCCCCCcEEeCCCCc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP----------QILHYNLKPTNVMLDAEFT  246 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~----------~iiH~dlk~~Nill~~~~~  246 (380)
                      ++||||+++|+|.+++..     ..+++..++.++.|++.||+|||   +.          +++||||||+|||++.++.
T Consensus        98 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            999999999999999973     35899999999999999999999   77          9999999999999999999


Q ss_pred             eEEeccCCcccCCC--------CCcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc----
Q 047245          247 PRLADFGLAKLMPG--------SLIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA----  309 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~----  309 (380)
                      +||+|||+++....        ...||+.|+|||.+.+     ..++.++||||||+++|||++|+.||.......    
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~  249 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF  249 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence            99999999965432        2358999999999986     345678999999999999999999986421111    


Q ss_pred             ----cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          310 ----ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       310 ----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                          ........+........     ..+.+............+.+++.+||+.||++|||++|+++.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          250 EEEIGQHPSLEDMQEVVVHKK-----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             HHHHCSSCCHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhhccCCchhhhhhhhhccc-----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                11112222222211111     11111111122345677999999999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.1e-46  Score=349.47  Aligned_cols=249  Identities=21%  Similarity=0.381  Sum_probs=202.2

Q ss_pred             cccccCccCCeeEEEEEe--------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEe
Q 047245          101 ENRLLGSSPDGKYYRTVL--------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVP  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  171 (380)
                      ..+.||+|+||.||++..        .++..||+|++...       ......+.+.+|+.+++++ +||||+++++++.
T Consensus        85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-------CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-------cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            457899999999999985        24567999998642       1234457899999999999 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcE
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV  239 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Ni  239 (380)
                      +.+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||   +.+++||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence            99999999999999999999985321            1235899999999999999999999   89999999999999


Q ss_pred             EeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhcc
Q 047245          240 MLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAA  310 (380)
Q Consensus       240 ll~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~  310 (380)
                      |++.++.+||+|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...     
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~-----  309 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----  309 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC-----
Confidence            999999999999999985432        1236778999999999999999999999999999999 99998631     


Q ss_pred             CCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                         ...+.......          ... ...+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       310 ---~~~~~~~~~~~----------~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          310 ---PVEELFKLLKE----------GHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ---CGGGHHHHHHT----------TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHhc----------CCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               11111111111          100 1112234456889999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-46  Score=356.20  Aligned_cols=246  Identities=20%  Similarity=0.333  Sum_probs=202.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|... +++.||||++...       ........|.+|+.++++++||||+++++++.+.+..++|
T Consensus       118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-------SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            4578999999999999985 7899999998641       1233456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       191 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999974   2346899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 GS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 ~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ..        ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...        ........ ...+    
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~--------~~~~~~~~-~~~~----  331 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL--------SNQQTREF-VEKG----  331 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS--------CHHHHHHH-HHTT----
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH-HHcC----
Confidence            32        124667999999998899999999999999999998 99998641        11111111 1111    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                           . ....+...+..+.+++.+||+.||++|||++++++.|++++
T Consensus       332 -----~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          332 -----G-RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             -----C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----C-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                 0 01112224456889999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=344.81  Aligned_cols=246  Identities=21%  Similarity=0.381  Sum_probs=201.2

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...    .+..||||++...       ......+.+.+|+.++++++||||+++++++.+.+..
T Consensus        53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-------YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            4578999999999999973    4556999999641       1234457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       126 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            999999999999999963   2456999999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .....         ..+|+.|+|||.+.+..++.++||||||+++|||++ |..||...        ...+........ 
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~--------~~~~~~~~~~~~-  270 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM--------TNRDVISSVEEG-  270 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHHHHTT-
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHHcC-
Confidence            65432         235678999999998999999999999999999999 99998531        111111111111 


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                               . ....+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       271 ---------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          271 ---------Y-RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             ---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------C-CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     0 01112234556889999999999999999999999999863

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.8e-45  Score=337.26  Aligned_cols=239  Identities=22%  Similarity=0.362  Sum_probs=196.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++......        ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus        24 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             CCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--------HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            346799999999999985 67899999999753221        135688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..     ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++....
T Consensus        96 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999999999873     35899999999999999999999   8899999999999999999999999999987654


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        ............+.      
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~~~~~~~------  233 (297)
T 3fxz_A          168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGT------  233 (297)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHHCS------
T ss_pred             CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCC------
Confidence            2      235899999999999999999999999999999999999998531        11111111111110      


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +   ....+......+.+++.+||+.||++|||++|+++
T Consensus       234 ~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 P---ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             C---CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C---CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0   01112234556889999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.8e-46  Score=351.71  Aligned_cols=245  Identities=20%  Similarity=0.413  Sum_probs=193.1

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...    ++..||||++...       ......+.|.+|+.++++++||||+++++++.+.+..
T Consensus        49 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-------YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             eeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            5678999999999999864    5778999998642       1234457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.++++.   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       122 ~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            999999999999999973   2446899999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .....         ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...        ...+....     
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~--------~~~~~~~~-----  262 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM--------SNQDVIKA-----  262 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC--------CHHHHHHH-----
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH-----
Confidence            65432         124678999999999999999999999999999998 99998531        11111111     


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                           +...... ..+......+.+++.+||+.||++|||+.++++.|+++
T Consensus       263 -----i~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          263 -----VDEGYRL-PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             -----HHTTEEC-CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHcCCCC-CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                 1111111 11123456688999999999999999999999999876

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.7e-45  Score=338.34  Aligned_cols=239  Identities=21%  Similarity=0.338  Sum_probs=198.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....      ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ------LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            446899999999999997 679999999997532      2334457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            999999999999974    346899999999999999999999   8999999999999999999999999999997644


Q ss_pred             C-----CCcCCCcccCcccccCCCCC-CcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G-----SLIATSAYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .     ...||+.|+|||.+.+..++ .++||||||+++|||++|+.||...        .............       
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~-------  230 (328)
T 3fe3_A          166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--------NLKELRERVLRGK-------  230 (328)
T ss_dssp             SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-------
T ss_pred             CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC-------
Confidence            2     34589999999999988775 7999999999999999999998641        2222222222111       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           ...+......+.+++.+||+.||.+|||++|+++
T Consensus       231 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 -----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0111223455789999999999999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.2e-45  Score=338.46  Aligned_cols=253  Identities=21%  Similarity=0.350  Sum_probs=205.2

Q ss_pred             CCCChHHHHHHHhc------------cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHH
Q 047245           87 PKIDPKTLQAALAN------------ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE  153 (380)
Q Consensus        87 ~~~~~~~l~~~~~~------------~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~  153 (380)
                      +.++..+++.++..            ..+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|+.
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~   94 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVV   94 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CSHHHHHHHHH
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--------hHHHHHHHHHH
Confidence            45677888877753            3457999999999999975 799999999975221        12366889999


Q ss_pred             HHHcCCCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecC
Q 047245          154 VLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN  233 (380)
Q Consensus       154 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~d  233 (380)
                      ++++++||||+++++++...+..++||||+++|+|.+++.     ...+++..+..++.|++.||+|||   +.+++|||
T Consensus        95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~D  166 (321)
T 2c30_A           95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH---AQGVIHRD  166 (321)
T ss_dssp             HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred             HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH---HCCeecCC
Confidence            9999999999999999999999999999999999999986     346899999999999999999999   88999999


Q ss_pred             CCCCcEEeCCCCceEEeccCCcccCCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhh
Q 047245          234 LKPTNVMLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA  307 (380)
Q Consensus       234 lk~~Nill~~~~~~kl~Dfgl~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~  307 (380)
                      |||+||+++.++.+||+|||++.....      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...  
T Consensus       167 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~--  244 (321)
T 2c30_A          167 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD--  244 (321)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--
T ss_pred             CCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--
Confidence            999999999999999999999876543      235899999999999999999999999999999999999998631  


Q ss_pred             hccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          308 EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       308 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ............      ..+...   ........+.+++.+||+.||++|||++|+++
T Consensus       245 ------~~~~~~~~~~~~------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          245 ------SPVQAMKRLRDS------PPPKLK---NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ------CHHHHHHHHHHS------SCCCCT---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------CHHHHHHHHhcC------CCCCcC---ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  111122211111      011110   11123455789999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.8e-45  Score=331.91  Aligned_cols=245  Identities=21%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..||+|++.....         ..+++.+|++++.+++||||+++++++.+.+..++||
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A           12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eeeeeccCCCceEEEEEecCceeEEEEEeccCCC---------cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            4568999999999999998888999999975221         1256889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...   ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           83 EYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             ECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999999999999742   346899999999999999999999   89999999999999999999999999999976543


Q ss_pred             C-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 S-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 ~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...        .............      
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~------  222 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY--------TNSEVVLKVSQGH------  222 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHHHHHTTC------
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc--------ChHHHHHHHHcCC------
Confidence            2       235677999999998899999999999999999999 99998631        1111111111110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                       .    ...+......+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus       223 -~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          223 -R----LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -C----CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -C----CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence             0    01111234458899999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-45  Score=332.20  Aligned_cols=244  Identities=21%  Similarity=0.347  Sum_probs=202.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..||+|++.....         ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A           14 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eeheecCCCccEEEEEEecCCCeEEEEEeccccc---------CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            4568999999999999998899999999975211         1256889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        85 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           85 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             ECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999963   2446899999999999999999999   89999999999999999999999999999976532


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                             ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...        .............      
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~--------~~~~~~~~~~~~~------  224 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--------SNSEVVEDISTGF------  224 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTTC------
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC--------CHHHHHHHHhcCc------
Confidence                   2346778999999998999999999999999999999 99998631        1122222221110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .     ...+......+.+++.+||+.||++|||++|+++.|+++.
T Consensus       225 ~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          225 R-----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c-----CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            0     1111223455889999999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-45  Score=357.25  Aligned_cols=245  Identities=23%  Similarity=0.400  Sum_probs=202.3

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ...+.||+|+||.||+|...++..||||+++....         ..+.|.+|+.++++++||||+++++++. .+..++|
T Consensus       191 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          191 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             EEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            35678999999999999998889999999975211         1367899999999999999999999986 5678999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       261 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             ECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999999742  2346889999999999999999999   8899999999999999999999999999998654


Q ss_pred             C-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 G-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .       ...++..|+|||.+....++.++||||||+++|||++ |+.||...        ...+.........     
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~-----  402 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------SNPEVIRALERGY-----  402 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHHHHHTC-----
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCC-----
Confidence            2       2336778999999998999999999999999999999 99998631        1122222211111     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                       .     ...+...+..+.+++.+||+.||++|||+++|++.|+++.
T Consensus       403 -~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          403 -R-----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             -C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -C-----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             0     1112234556889999999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.6e-45  Score=351.84  Aligned_cols=243  Identities=23%  Similarity=0.391  Sum_probs=199.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-eEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-RFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv  179 (380)
                      ..+.||+|+||.||+|... |+.||||+++...          ..+.|.+|+.++++++||||+++++++.+.. ..++|
T Consensus       197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            4578999999999999985 7899999997521          1367899999999999999999999987665 79999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       266 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            9999999999999852  2335799999999999999999999   8999999999999999999999999999998654


Q ss_pred             C---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 G---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .   ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...     .....   .......          
T Consensus       341 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~~~~---~~~i~~~----------  402 (450)
T 1k9a_A          341 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDV---VPRVEKG----------  402 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS-----CTTTH---HHHHHTT----------
T ss_pred             ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHH---HHHHHcC----------
Confidence            3   2346789999999999999999999999999999999 99998631     11111   1111111          


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      . ....+...+..+.+++.+||+.||++|||+.++++.|++++
T Consensus       403 ~-~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          403 Y-KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            0 01122334566889999999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.2e-45  Score=335.01  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             cccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--
Q 047245          101 ENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  173 (380)
                      ..+.||+|+||.||++..     .+|+.||+|++..        ......+.+.+|+.++++++||||+++++++...  
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A           14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--------STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             hhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            457899999999999984     3688999999864        1234457899999999999999999999998543  


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            5689999999999999999742   345899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc----cCCCCHHHHHH
Q 047245          254 LAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA----ASGGSLGRWLR  320 (380)
Q Consensus       254 l~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~----~~~~~l~~~~~  320 (380)
                      +++.....         ..++..|+|||.+.+..++.++||||||+++|||++|..|+.....+.    ...........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            99865422         236677999999999999999999999999999999999986422110    00000000000


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                            ...+.+.... ....+...+..+.+++.+||+.||++|||++|+++.|++++
T Consensus       240 ------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          240 ------HLIELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             ------HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                  0011111111 01122334566889999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.9e-46  Score=362.35  Aligned_cols=247  Identities=26%  Similarity=0.417  Sum_probs=203.5

Q ss_pred             hccccccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245           99 ANENRLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      ....+.||+|+||.||+|...+ +..||||.+.....         ..+.|.+|+.++++++||||++++++|.+.+..+
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---------chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            3456789999999999999864 88999999865211         1367899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus       293 lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             EEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            99999999999999974  23456899999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          258 MPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       258 ~~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ....       ..++..|+|||.+.+..++.++||||||+++|||++ |..||....        ....          .
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~--------~~~~----------~  429 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQV----------Y  429 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC--------GGGH----------H
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC--------HHHH----------H
Confidence            6432       235678999999999999999999999999999999 999986311        1111          1


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      +.+..... ...+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       430 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          430 ELLEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHcCCC-CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            11111111 1112234566889999999999999999999999999863

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.8e-45  Score=330.27  Aligned_cols=246  Identities=24%  Similarity=0.387  Sum_probs=189.7

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++... |..+|+|++......    ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        11 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A           11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             eeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            4578999999999999975 899999998753221    11233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC---eEecCCCCCcEEeCC--------CCceEE
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ---ILHYNLKPTNVMLDA--------EFTPRL  249 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~---iiH~dlk~~Nill~~--------~~~~kl  249 (380)
                      ||+++++|.+++.     ...+++..++.++.|++.||+|||   +.+   ++||||||+||+++.        ++.+||
T Consensus        86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            9999999999985     347899999999999999999999   666   999999999999986        678999


Q ss_pred             eccCCcccCCC----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          250 ADFGLAKLMPG----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       250 ~Dfgl~~~~~~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      +|||++.....    ...+++.|+|||.+.+..++.++||||||+++|||++|+.||...        ............
T Consensus       158 ~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~  229 (271)
T 3dtc_A          158 TDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--------DGLAVAYGVAMN  229 (271)
T ss_dssp             CCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHTS
T ss_pred             ccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHhhhcC
Confidence            99999976543    245899999999999999999999999999999999999998631        111111111111


Q ss_pred             cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .          .....+......+.+++.+||+.||++|||+.|+++.|++|
T Consensus       230 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 K----------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             C----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             C----------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            0          01112223445688999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.9e-45  Score=328.60  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=201.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC--CeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES--SRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  178 (380)
                      ..+.||+|+||.||+|... |..||+|++....      ......+.+.+|+.++++++||||+++++++.+.  +..++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A           14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD------WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEECCTT------CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHHhcCCCcceEEEEEEC-CeeEEEEEecccc------cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            4578999999999999985 8999999997622      2234457899999999999999999999999887  78899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ||||+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+  ++||||||+||+++.++.++|+|||+..
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            9999999999999974  22336899999999999999999999   778  9999999999999999999999888876


Q ss_pred             cCC-CCCcCCCcccCcccccCCCCCC---cchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          257 LMP-GSLIATSAYSAPECFQNRSYTD---KSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       257 ~~~-~~~~~~~~y~aPE~~~~~~~~~---~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ... ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||...        ............+     .
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~-----~  228 (271)
T 3kmu_A          162 SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--------SNMEIGMKVALEG-----L  228 (271)
T ss_dssp             TTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--------CHHHHHHHHHHSC-----C
T ss_pred             eecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--------ChHHHHHHHHhcC-----C
Confidence            543 3456899999999998765544   799999999999999999998631        1111111111111     0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                      .     ...+......+.+++..||+.||++|||++|+++.|++++.
T Consensus       229 ~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 R-----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             C-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1     11122344568899999999999999999999999998863

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=345.21  Aligned_cols=249  Identities=21%  Similarity=0.342  Sum_probs=200.5

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|...      ++..||||++...       ........+.+|+.++++++||||+++++++.+..
T Consensus        75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-------CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-------cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4578999999999999853      4678999998641       12334467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC---ceE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRE---NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPR  248 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~k  248 (380)
                      ..++||||+++|+|.+++.....   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEE
Confidence            99999999999999999986432   2245999999999999999999999   89999999999999999554   599


Q ss_pred             EeccCCcccC--------CCCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLM--------PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++..        .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||...        ......
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--------~~~~~~  296 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVL  296 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHH
Confidence            9999998632        122347889999999999999999999999999999998 99998631        112222


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ........           ...+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       297 ~~i~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          297 EFVTSGGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCC-----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            22221110           1111233456889999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.5e-44  Score=325.31  Aligned_cols=251  Identities=20%  Similarity=0.331  Sum_probs=201.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .++..||+|++.....     ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-----EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-----CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-----ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            346899999999999986 4688999999865322     2344567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            999999999999974    346899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          260 GS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       260 ~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..       ..||+.|+|||.+.+..++.++||||||+++|||++|+.||...        .............. .. .
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--------~~~~~~~~~~~~~~-~~-~  232 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE--------TAVSIAIKHIQDSV-PN-V  232 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS--------CHHHHHHHHHSSCC-CC-H
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhhccC-CC-c
Confidence            32       34899999999999999999999999999999999999998641        11111111111110 00 0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCC-CHHhHHHHHhccc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-SSDELVPMLTQLH  378 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~l~  378 (380)
                      ..     ......+..+.+++.+|++.||.+|| +++++.+.|+.+.
T Consensus       233 ~~-----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          233 TT-----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HH-----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ch-----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            00     01112345688999999999999999 8999999998763

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-44  Score=330.62  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=193.7

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHc--CCCCCcceeeEEEec----CC
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS--LRHRNLMSLRAYVPE----SS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~  174 (380)
                      ..+.||+|+||.||+|.. +|+.||||++...           ....+..|.+++..  ++||||+++++++..    ..
T Consensus        12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A           12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             EEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            457899999999999988 6899999998641           11344556666555  799999999998644    34


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEecCCCCCcEEeCCCCceEE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                      ..++||||+++|+|.++++     ...+++..++.++.|++.||+|||+..     +.+++||||||+|||++.++.+||
T Consensus        80 ~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             eeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence            6899999999999999996     346899999999999999999999432     678999999999999999999999


Q ss_pred             eccCCcccCCC----------CCcCCCcccCcccccCC------CCCCcchhhHHHHHHHHHHhC----------CCCCC
Q 047245          250 ADFGLAKLMPG----------SLIATSAYSAPECFQNR------SYTDKSDIFSFGMILAVLLTG----------RDPTA  303 (380)
Q Consensus       250 ~Dfgl~~~~~~----------~~~~~~~y~aPE~~~~~------~~~~~sDv~s~Gvil~el~tg----------~~p~~  303 (380)
                      +|||+++....          ...||+.|+|||.+.+.      .++.++||||||+++|||++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            99999864321          23689999999999876      455799999999999999999          77765


Q ss_pred             chhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          304 PFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       304 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..   ..................     ..+..............+.+++.+||+.||++|||+.|+++.|+++
T Consensus       235 ~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DV---VPNDPSFEDMRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TT---SCSSCCHHHHHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc---CCCCcchhhhhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            32   111122222222111111     1111111122345678899999999999999999999999999876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-44  Score=328.29  Aligned_cols=243  Identities=19%  Similarity=0.335  Sum_probs=198.3

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..||+|++......         .+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             EEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            45789999999999999988889999999752211         256889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999973   2346999999999999999999999   89999999999999999999999999999976532


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                             ...+++.|+|||.+.+..++.++||||||+++|||++ |+.||...        ............      .
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~--------~~~~~~~~~~~~------~  238 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEHIAQG------L  238 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHHHHHTT------C
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc--------ChhHHHHHHhcc------c
Confidence                   2346778999999998899999999999999999998 99998642        111111111111      0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .     ...+......+.+++.+||+.||.+|||++|+++.|+++
T Consensus       239 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          239 R-----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0     111122345688999999999999999999999999876

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=343.17  Aligned_cols=250  Identities=22%  Similarity=0.375  Sum_probs=203.3

Q ss_pred             ccccccCccCCeeEEEEEe--------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVL--------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYV  170 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  170 (380)
                      ...+.||+|+||.||++..        .++..||+|++...       ......+.+.+|+++++++ +||||+++++++
T Consensus        72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-------ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-------cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3557899999999999985        23467999998642       1234457889999999999 999999999999


Q ss_pred             ecCCeEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          171 PESSRFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       171 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      .+.+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence            999999999999999999999986331            1245999999999999999999999   8899999999999


Q ss_pred             EEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhc
Q 047245          239 VMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEA  309 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~  309 (380)
                      ||++.++.+||+|||+++....        ...+|+.|+|||.+.+..++.++||||||+++|||++ |..||...    
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~----  297 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----  297 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----
Confidence            9999999999999999986532        2246788999999999999999999999999999999 99998531    


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                          ...+..........           ...+......+.+++.+||+.||++|||++|+++.|+++.
T Consensus       298 ----~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          298 ----PVEELFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             ----CHHHHHHHHHTTCC-----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CHHHHHHHHHcCCC-----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                12222222221110           0111223456889999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-45  Score=339.03  Aligned_cols=249  Identities=21%  Similarity=0.369  Sum_probs=202.7

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||++...      ++..||+|++...       ......+.+.+|+.++++++||||+++++++.+.+
T Consensus        51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-------cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            4578999999999999974      3478999998642       12344578999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhc--------------------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIREN--------------------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL  234 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dl  234 (380)
                      ..++||||+++|+|.+++......                    ...+++..++.++.|++.||+|||   +.+++||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            999999999999999999853211                    257999999999999999999999   899999999


Q ss_pred             CCCcEEeCCCCceEEeccCCcccCC--------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCch
Q 047245          235 KPTNVMLDAEFTPRLADFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF  305 (380)
Q Consensus       235 k~~Nill~~~~~~kl~Dfgl~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~  305 (380)
                      ||+||+++.++.+||+|||+++...        ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999986432        22357889999999998899999999999999999999 99998631


Q ss_pred             hhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       306 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                              ...+........ ..          ...+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       281 --------~~~~~~~~~~~~-~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          281 --------AHEEVIYYVRDG-NI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             --------CHHHHHHHHHTT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --------ChHHHHHHHhCC-Cc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence                    112222221111 10          0111233456889999999999999999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-44  Score=333.94  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||++..      .++..||+|++...       ......+.+.+|+.++++++||||+++++++.+.+
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-------ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-------CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            457899999999999986      34578999998641       12344578899999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhh--------------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRE--------------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL  234 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dl  234 (380)
                      ..++||||+++|+|.+++.....                    ....+++..++.++.|++.||+|||   +.+++||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence            99999999999999999986332                    1234889999999999999999999   899999999


Q ss_pred             CCCcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCch
Q 047245          235 KPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF  305 (380)
Q Consensus       235 k~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~  305 (380)
                      ||+||+++.++.+||+|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999976532        2246778999999999899999999999999999999 99998631


Q ss_pred             hhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       306 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..        ........          .... ...+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus       257 ~~--------~~~~~~~~----------~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          257 PP--------ERLFNLLK----------TGHR-MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CG--------GGHHHHHH----------TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CH--------HHHHHHhh----------cCCc-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11        01111111          1100 111123445688999999999999999999999999876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.6e-44  Score=335.55  Aligned_cols=251  Identities=20%  Similarity=0.292  Sum_probs=198.9

Q ss_pred             hccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245           99 ANENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      ....+.||+|+||.||++.. .+|+.||+|++.......   ......+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS---SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHT---SSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccc---cccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34567899999999999986 468999999986421100   00112367889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc---eEEeccCC
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT---PRLADFGL  254 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfgl  254 (380)
                      +||||+++|+|.+++.........+++..+..++.|++.||+|||   +.+++||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999998765444556899999999999999999999   899999999999999986654   99999999


Q ss_pred             cccCCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          255 AKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       255 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ++....      ...||+.|+|||.+.+..++.++||||||+++|||++|..||....         .............
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKYK  250 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCCC
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCCC
Confidence            976543      2458999999999999999999999999999999999999986411         1111111111000


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ..+.     ........+.+++.+||+.||++|||+.|+++
T Consensus       251 ---~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 ---MNPR-----QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ---CCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---CCcc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               0000     00123456889999999999999999999974

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-44  Score=330.34  Aligned_cols=241  Identities=20%  Similarity=0.339  Sum_probs=196.8

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|..+|+|.+...         ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---------GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            3567999999999999974 6889999998641         12236688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC--CCceEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA--EFTPRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kl~Dfgl~~~  257 (380)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.  ++.+||+|||+++.
T Consensus        80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            999999999999863   2346899999999999999999999   899999999999999987  78999999999987


Q ss_pred             CCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          258 MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ....     ..+|+.|+|||.+.+..++.++||||||+++|||++|..||...        ...............   .
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~---~  222 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYT---F  222 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCC---C
T ss_pred             CCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC--------CHHHHHHHHHcCCCC---C
Confidence            6543     24899999999999988999999999999999999999998631        112222222211100   0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +.     ......+..+.+++.+||+.||.+|||+.|+++
T Consensus       223 ~~-----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 DE-----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CH-----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Ch-----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00     000123456889999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.7e-45  Score=352.91  Aligned_cols=245  Identities=24%  Similarity=0.378  Sum_probs=198.8

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ...+.||+|+||.||+|...++..||||++.....         ..+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            35678999999999999998888999999875221         12578999999999999999999999976 678999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus       257 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             ECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            9999999999999742  2346899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 GS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ..       ..++..|+|||.+.+..++.++||||||+++|||++ |+.||...        ...+.........     
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~-----  398 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVERGY-----  398 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTTC-----
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCC-----
Confidence            32       236778999999999999999999999999999999 99998531        1112222211110     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                            ....+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       399 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          399 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                  01112234556889999999999999999999999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-43  Score=323.54  Aligned_cols=252  Identities=25%  Similarity=0.440  Sum_probs=198.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+++.||+|++......... ......+.+.+|+.++++++||||+++++++.+..  ++|
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv   99 (287)
T 4f0f_A           23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET-EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV   99 (287)
T ss_dssp             EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCH-HHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred             ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccch-hHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence            457899999999999997 57899999998753222111 01111267889999999999999999999997665  699


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeCCCCc-----eEEecc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLDAEFT-----PRLADF  252 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~-----~kl~Df  252 (380)
                      |||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+  ++||||||+||+++.++.     +||+||
T Consensus       100 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A          100 MEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             EEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            999999999998863   3457999999999999999999999   888  999999999999988776     999999


Q ss_pred             CCcccCCCC---CcCCCcccCccccc--CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          253 GLAKLMPGS---LIATSAYSAPECFQ--NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       253 gl~~~~~~~---~~~~~~y~aPE~~~--~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      |+++.....   ..+++.|+|||.+.  ...++.++||||||+++|||++|+.||....      ..-..........+ 
T Consensus       174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~-  246 (287)
T 4f0f_A          174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS------YGKIKFINMIREEG-  246 (287)
T ss_dssp             TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC------CCHHHHHHHHHHSC-
T ss_pred             CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc------ccHHHHHHHHhccC-
Confidence            999865543   45899999999984  4567899999999999999999999986311      11111111111111 


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                               .....+......+.+++.+||+.||++|||++|+++.|++|
T Consensus       247 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 ---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                     01112233455688999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.9e-44  Score=329.46  Aligned_cols=255  Identities=20%  Similarity=0.378  Sum_probs=199.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|..||+|++.....     ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus        36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            457899999999999996 5789999999975222     1234557889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999999876555677999999999999999999999   8999999999999999999999999999987654


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...+++.|+|||.+.+..++.++||||||+++|||++|..||...      ...............      .
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~------~  255 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQCD------Y  255 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHHTTC------S
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc------chhHHHHHHHhhccc------C
Confidence            3      235889999999999999999999999999999999999998531      112222222221111      0


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                      +...    .......+.+++.+||+.||++|||+.++++.|+++++
T Consensus       256 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          256 PPLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             CCCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            0111    11234468899999999999999999999999998863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.8e-45  Score=337.54  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=191.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcE----EEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLT----VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~----vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||.||+|.. .+|+.    ||+|.+....       .....+.+.+|+.++++++||||+++++++.++. 
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            457899999999999996 34444    5777765311       1223477899999999999999999999998765 


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        91 ~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcce
Confidence            7899999999999999974   2456999999999999999999999   889999999999999999999999999998


Q ss_pred             ccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +....        ...+|+.|+|||.+.+..++.++||||||+++|||++ |..||......                  
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------------  226 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------------  226 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------------------
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH------------------
Confidence            75432        1236778999999999999999999999999999999 99998641110                  


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .....+..... ...+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       227 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          227 EISSILEKGER-LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             GHHHHHHTTCC-CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11111111110 1112234456889999999999999999999999998763

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.7e-44  Score=330.78  Aligned_cols=240  Identities=22%  Similarity=0.348  Sum_probs=191.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|+||.||++... +|+.||||++....       .....+.+.+|+.++++++||||+++++++.+..     
T Consensus        10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B           10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            4578999999999999985 79999999997522       1223477899999999999999999999985543     


Q ss_pred             ----------------------------------------------------eEEEEEeecCCCCHHHHHHHhhhcccCC
Q 047245          175 ----------------------------------------------------RFYLVYDYLQTGSLEDAMDRIRENQLQL  202 (380)
Q Consensus       175 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l  202 (380)
                                                                          ..++||||+++|+|.+++.... .....
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~  161 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR  161 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence                                                                3899999999999999997532 23456


Q ss_pred             CHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC------------------CcC
Q 047245          203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------------------LIA  264 (380)
Q Consensus       203 ~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~------------------~~~  264 (380)
                      ++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....                  ..|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            77889999999999999999   899999999999999999999999999999765432                  348


Q ss_pred             CCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHH
Q 047245          265 TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEED  344 (380)
Q Consensus       265 ~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (380)
                      |+.|+|||.+.+..++.++||||||+++|||++|..|+...          ........ ..          ........
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~-~~----------~~~~~~~~  297 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVR-NL----------KFPLLFTQ  297 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHH-TT----------CCCHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhh-cc----------CCCccccc
Confidence            99999999999999999999999999999999988774210          00000000 00          00111233


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          345 EMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       345 ~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            4556789999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=329.33  Aligned_cols=239  Identities=21%  Similarity=0.261  Sum_probs=188.4

Q ss_pred             hccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245           99 ANENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      ....+.||+|+||+||+|... +|+.||||++.....      .......+..|+..+.++ +||||+++++++.+++..
T Consensus        59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~  132 (311)
T 3p1a_A           59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR------GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL  132 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC------SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             eeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc------ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence            345678999999999999985 799999999764221      122234455566655555 999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+ +++|.+++...   ...++|..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++.
T Consensus       133 ~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             EEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeee
Confidence            9999999 67999988742   456999999999999999999999   8899999999999999999999999999987


Q ss_pred             cCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....     ...||+.|+|||.+.+ .++.++||||||+++|||++|..|+...          ..|. .. ..+..   
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~-~~-~~~~~---  269 (311)
T 3p1a_A          206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQ-QL-RQGYL---  269 (311)
T ss_dssp             ECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHH-HH-TTTCC---
T ss_pred             ecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHH-HH-hccCC---
Confidence            6543     2348999999998876 7899999999999999999997765421          1111 11 11110   


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ...........+.+++.+||+.||++|||++|+++
T Consensus       270 ------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 ------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                  00111123456889999999999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-43  Score=330.16  Aligned_cols=240  Identities=22%  Similarity=0.281  Sum_probs=196.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++.....     ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            3568999999999999974 689999999975210     0112246788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999874    346899999999999999999999   8999999999999999999999999999998532


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        .............       
T Consensus       157 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~-------  221 (337)
T 1o6l_A          157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILMEE-------  221 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-------
T ss_pred             cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC-------
Confidence            1      235899999999999999999999999999999999999998631        1122222221110       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                           ...+......+.+++.+||+.||++||     +++|+++
T Consensus       222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 011122345678999999999999999     8888864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.3e-45  Score=330.62  Aligned_cols=246  Identities=25%  Similarity=0.412  Sum_probs=202.2

Q ss_pred             hccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245           99 ANENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      ....+.||+|+||.||++... ++..||+|.+...         ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            345678999999999999975 4889999998641         122467889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        86 ~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            99999999999999974  23456899999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCC-------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          258 MPGSL-------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       258 ~~~~~-------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      .....       .+++.|+|||.+.+..++.++||||||+++|+|++ |..||....        ......         
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--------~~~~~~---------  223 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYE---------  223 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------GGGHHH---------
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHH---------
Confidence            65332       35778999999999999999999999999999999 999986311        111111         


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                       .+..... ...+...+..+.+++.+|++.||.+|||++|+++.|+++
T Consensus       224 -~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          224 -LLEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             -HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHhccCC-CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence             1111111 111123445688999999999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-43  Score=333.44  Aligned_cols=247  Identities=22%  Similarity=0.333  Sum_probs=198.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|.+.........  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--RGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc--chhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            4578999999999999974 6899999999764322111  111236788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC----ceEEeccCCc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF----TPRLADFGLA  255 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfgl~  255 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||+++++    .+||+|||++
T Consensus        94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999863    457999999999999999999999   89999999999999998876    7999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .....     ...||+.|+|||.+.+..++.++||||||+++|+|++|..||...        ..............   
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--------~~~~~~~~i~~~~~---  235 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANITAVSY---  235 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHTTCC---
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcCC---
Confidence            86543     345899999999999999999999999999999999999998631        11122222111100   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+++.     ........+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 DFDEE-----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCch-----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00000     00123455789999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.6e-45  Score=341.65  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=198.9

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||++..      .+++.||||++...       ......+.+.+|++++.++ +||||+++++++.+.
T Consensus        26 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             eceeecCCCCceEEEEEeccccccccceEEEEEEecCc-------CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            567899999999999974      35679999999641       1233457899999999999 799999999999875


Q ss_pred             C-eEEEEEeecCCCCHHHHHHHhhhc------------------------------------------------------
Q 047245          174 S-RFYLVYDYLQTGSLEDAMDRIREN------------------------------------------------------  198 (380)
Q Consensus       174 ~-~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------  198 (380)
                      + ..++||||+++|+|.+++......                                                      
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 489999999999999999753221                                                      


Q ss_pred             --------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC--------CC
Q 047245          199 --------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SL  262 (380)
Q Consensus       199 --------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~--------~~  262 (380)
                              ...+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....        ..
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                    112889999999999999999999   88999999999999999999999999999986532        23


Q ss_pred             cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcc
Q 047245          263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEV  341 (380)
Q Consensus       263 ~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (380)
                      .+|+.|+|||.+.+..++.++||||||+++|||++ |..||....       ........... +.     .     ...
T Consensus       256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~~~~-~~-----~-----~~~  317 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------IDEEFCRRLKE-GT-----R-----MRA  317 (359)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-------CSHHHHHHHHH-TC-----C-----CCC
T ss_pred             CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc-------hhHHHHHHHHc-CC-----C-----CCC
Confidence            47888999999999999999999999999999998 999985310       00111111111 10     0     111


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          342 EEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       342 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      +......+.+++..||+.||++|||++|+++.|+++.
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1223455889999999999999999999999998763

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=328.28  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe----cCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP----ESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~  175 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++...        .....+.+.+|+.++++++||||+++++++.    ....
T Consensus        33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--------EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             EEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            457899999999999997 67899999998651        2344578899999999999999999999986    3457


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+++|+|.+++.........+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            89999999999999999876555678999999999999999999999   889999999999999999999999999998


Q ss_pred             ccCCCC---------------CcCCCcccCcccccCCC---CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHH
Q 047245          256 KLMPGS---------------LIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR  317 (380)
Q Consensus       256 ~~~~~~---------------~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~  317 (380)
                      ......               ..+++.|+|||.+.+..   ++.++||||||+++|||++|..||......   ......
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~  258 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVAL  258 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhH
Confidence            765421               12689999999987654   689999999999999999999998532111   111111


Q ss_pred             HHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          318 WLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                      .             +..... ..........+.+++.+||+.||.+|||++++++.|+.++.
T Consensus       259 ~-------------~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 A-------------VQNQLS-IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             H-------------HHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             H-------------hhccCC-CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            1             111000 01112234568899999999999999999999999998753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=341.62  Aligned_cols=243  Identities=22%  Similarity=0.307  Sum_probs=196.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.+|+|++....      ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK------LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCS------CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEeccCCCeEEEEEEECCCCcEEEEEEEEccc------CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            457899999999999986 578999999987522      1233456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC---CCCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD---AEFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++   +++.+||+|||+++
T Consensus        89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999874    456999999999999999999999   89999999999999998   46789999999997


Q ss_pred             cCCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          257 LMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       257 ~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ....      ...||+.|+|||.+.+..++.++||||+|+++|+|++|..||...        ..............   
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~---  230 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--------DQHRLYQQIKAGAY---  230 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHTCC---
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhCCC---
Confidence            6543      235899999999999999999999999999999999999998531        11222222211110   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        +  .. ..........+.+++.+||+.||.+|||+.|+++
T Consensus       231 --~--~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          231 --D--FP-SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             --C--CC-TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --C--CC-ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              0  00 0011123456889999999999999999999985

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-43  Score=336.41  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=192.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..++||+|+||.||++... +++.||+|++.......     ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-----~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-----HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4578999999999999974 57899999997633221     12235677899999887 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999999874    346999999999999999999999   899999999999999999999999999999853


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...............+.........     
T Consensus       204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  278 (396)
T 4dc2_A          204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  278 (396)
T ss_dssp             CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred             ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence            2      23458999999999999999999999999999999999999996321111111111111111111111     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                            ...+......+.+++.+||+.||.+||++
T Consensus       279 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                  11122344568899999999999999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4e-44  Score=331.94  Aligned_cols=250  Identities=23%  Similarity=0.314  Sum_probs=190.6

Q ss_pred             cccccCccCCeeEEEEEecCC----cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNG----LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||++.....    ..||+|++.....      .....+.+.+|+.++++++||||+++++++......
T Consensus        27 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII------ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             EEEEEEEETTEEEEEEEC-------CEEEEEEC------------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             EeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc------CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            557899999999999987433    2799999865221      223357899999999999999999999999877655


Q ss_pred             ------EEEEeecCCCCHHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          177 ------YLVYDYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       177 ------~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                            ++|+||+++|+|.+++.....  ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  999999999999999975332  2236899999999999999999999   88999999999999999999999


Q ss_pred             EeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++.....        ..+++.|+|||.+.+..++.++||||||+++|||++ |..||.....        ....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~  249 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------AEIY  249 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--------HHHH
Confidence            9999999765321        236778999999999999999999999999999999 8999863110        1111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .......           ....+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       250 ~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          250 NYLIGGN-----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             HHHHTTC-----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcCC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111111           01112234456889999999999999999999999998863

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-43  Score=327.51  Aligned_cols=254  Identities=22%  Similarity=0.363  Sum_probs=194.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...+|+.||+|++....      ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus        25 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           25 KLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA------EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             EEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hhhhccCCCCeEEEEEEECCCCEEEEEEEeccc------ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            346899999999999999889999999996522      12233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++ +|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++....
T Consensus        99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            99985 88888763   3446899999999999999999999   89999999999999999999999999999976542


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH---
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE---  330 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~---  330 (380)
                            ...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...    .....+..... .........   
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~-~~~~~~~~~~~~  246 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV----TDDDQLPKIFS-ILGTPNPREWPQ  246 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS----STTTHHHHHHH-HHCCCCTTTSGG
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHH-HHCCCChHHhhh
Confidence                  2358999999999876 56899999999999999999999998632    11111111111 111100000   


Q ss_pred             ------hhchhc---cCCc---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ------ALDRSI---LGEE---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ------~~~~~~---~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ..+...   ....   ........+.+++.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  000000   0000   00112346789999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.1e-43  Score=334.17  Aligned_cols=244  Identities=24%  Similarity=0.349  Sum_probs=197.8

Q ss_pred             ccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++.. .+|..||+|++.....      .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        32 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL------SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3567899999999999987 4689999999975221      23345778999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC---CceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfgl~  255 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.+   +.+||+|||++
T Consensus       106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            9999999999998863    446899999999999999999999   8899999999999999865   45999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .....     ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        ..............   
T Consensus       179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--------~~~~~~~~i~~~~~---  247 (362)
T 2bdw_A          179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--------DQHRLYAQIKAGAY---  247 (362)
T ss_dssp             BCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCC---
T ss_pred             eEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCC---
Confidence            86653     245899999999999999999999999999999999999998631        11122222211110   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        +  . ...........+.+++.+||+.||++|||+.|+++
T Consensus       248 --~--~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          248 --D--Y-PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             --C--C-CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --C--C-CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              0  0 00111223456889999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.6e-44  Score=325.82  Aligned_cols=244  Identities=20%  Similarity=0.345  Sum_probs=189.9

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...    .+..||+|++...       ......+.+.+|+.++++++||||+++++++.+ +..
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   90 (281)
T 1mp8_A           19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   90 (281)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             EEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-Ccc
Confidence            4578999999999999874    2457999988641       123455789999999999999999999999854 568


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccc
Confidence            999999999999999974   2346899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .....       ..+++.|+|||.+.+..++.++||||||+++|||++ |..||.....        .+.......... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--------~~~~~~i~~~~~-  235 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGER-  235 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCC-
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH--------HHHHHHHHcCCC-
Confidence            65432       236778999999998899999999999999999997 9999863211        011111111100 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                                ...+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus       236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          236 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                      111223445688999999999999999999999999876

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=327.26  Aligned_cols=260  Identities=21%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC--eEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS--RFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  177 (380)
                      ..+.||+|+||.||++... +|+.||+|++.....       ....+.+.+|++++++++||||+++++++....  ..+
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A           13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             EEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-------cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            4578999999999999975 589999999975221       112366789999999999999999999987655  789


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe----CCCCceEEeccC
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFTPRLADFG  253 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kl~Dfg  253 (380)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+++||||||+|||+    +.++.+||+|||
T Consensus        86 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            9999999999999997532 2334999999999999999999999   8999999999999999    788889999999


Q ss_pred             CcccCCCC-----CcCCCcccCccccc--------CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          254 LAKLMPGS-----LIATSAYSAPECFQ--------NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       254 l~~~~~~~-----~~~~~~y~aPE~~~--------~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +++.....     ..+|+.|+|||.+.        +..++.++||||||+++|||++|..||.......    .......
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~  237 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMY  237 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG----GCHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc----hhHHHHH
Confidence            99865432     35899999999986        5778999999999999999999999986421111    1122222


Q ss_pred             HHHhhcchhHhh-------------chhc-cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhc
Q 047245          321 HLQHAGEAREAL-------------DRSI-LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQ  376 (380)
Q Consensus       321 ~~~~~~~~~~~~-------------~~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~  376 (380)
                      ....... ...+             ...+ ............+.+++.+||+.||++|||++|+++-..+
T Consensus       238 ~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          238 KIITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HHhcCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            2222111 0000             0000 1113346677889999999999999999999999987654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.1e-44  Score=327.43  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=192.6

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++... ++.||+|.+..          ....+.+.+|+.++++++||||+++++++.+  ..++||
T Consensus        12 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~   78 (307)
T 2eva_A           12 VEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM   78 (307)
T ss_dssp             EEEEEECCSSSEEEEEEET-TEEEEEEECSS----------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred             eeeEeecCCCceEEEEEEC-CeeEEEEEecC----------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence            4578999999999999985 78999999853          1124678999999999999999999998874  479999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc-eEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-PRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-~kl~Dfgl~~~~~  259 (380)
                      ||+++|+|.+++.... ....+++..++.++.|+++||+|||+....+++||||||+||+++.++. +||+|||++....
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             ECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            9999999999997421 2235789999999999999999999332289999999999999988876 7999999997654


Q ss_pred             C---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          260 G---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       260 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      .   ...|++.|+|||.+.+..++.++||||||+++|||++|+.||....      ..............      .   
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~------~---  222 (307)
T 2eva_A          158 THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVHNGT------R---  222 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHHTTC------C---
T ss_pred             cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHhcCC------C---
Confidence            3   3458999999999999999999999999999999999999986311      11111111111110      0   


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                        ..........+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       223 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          223 --PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             --CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             --CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence              11112234567899999999999999999999999998753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-43  Score=333.51  Aligned_cols=260  Identities=14%  Similarity=0.146  Sum_probs=197.2

Q ss_pred             cccccCccCCeeEEEEEecC------CcEEEEEEeeeccCCChhhh----cHHHHHHHHHHHHHHHcCCCCCcceeeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN------GLTVAVRRVEAFESGSPEKQ----NKSVKRRIQQELEVLASLRHRNLMSLRAYV  170 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~------g~~vavK~~~~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  170 (380)
                      ..+.||+|+||.||+|...+      +..||+|++...... ...+    .......+..|+..+..++||||+++++++
T Consensus        39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~  117 (364)
T 3op5_A           39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG  117 (364)
T ss_dssp             EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred             EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence            45789999999999998754      478999998652110 0000    000112344577788889999999999998


Q ss_pred             ecC----CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC--CC
Q 047245          171 PES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD--AE  244 (380)
Q Consensus       171 ~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~--~~  244 (380)
                      ...    ...++||||+ +++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++  .+
T Consensus       118 ~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          118 LHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCT
T ss_pred             eeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCC
Confidence            664    4589999999 9999999974   2457999999999999999999999   88999999999999999  88


Q ss_pred             CceEEeccCCcccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC
Q 047245          245 FTPRLADFGLAKLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS  311 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~  311 (380)
                      +.+||+|||+++....             ...||+.|+|||.+.+..++.++||||||+++|||++|+.||....    .
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~----~  266 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL----K  266 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT----T
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc----c
Confidence            9999999999965431             1238999999999999999999999999999999999999986311    1


Q ss_pred             CCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          312 GGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       312 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ......+.... ....+.+.+++.+....    .+..+.+++..||+.||.+||+++++++.|+++
T Consensus       267 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DPKYVRDSKIR-YRENIASLMDKCFPAAN----APGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CHHHHHHHHHH-HHHCHHHHHHHHSCTTC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHH-hhhhHHHHHHHhccccc----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            11111111111 11233444444332222    234578999999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-44  Score=334.00  Aligned_cols=259  Identities=26%  Similarity=0.388  Sum_probs=202.3

Q ss_pred             cccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--C
Q 047245          101 ENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--S  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  173 (380)
                      ..+.||+|+||.||++.+     .+|+.||+|++...       ......+.+.+|+.++++++||||+++++++.+  .
T Consensus        35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-------AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-------cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            457899999999999865     36889999999752       123445789999999999999999999999987  4


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++|+|.+++..     ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             ceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcc
Confidence            678999999999999999863     35899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          254 LAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       254 l~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      ++......         ..++..|+|||.+.+..++.++||||||+++|||++|..||.........   ...+......
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~---~~~~~~~~~~  256 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE---LIGIAQGQMT  256 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH---HHCSCCHHHH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh---hhcccccchh
Confidence            99865432         24677899999999989999999999999999999999998642111000   0000000000


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .....+.+..... ...+......+.+++.+||+.||++|||++|+++.|+++.
T Consensus       257 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          257 VLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            1111222222211 1122334567889999999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=335.15  Aligned_cols=253  Identities=20%  Similarity=0.283  Sum_probs=188.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHH--HHHHHHHcCCCCCcceeeEEEec-----C
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQ--QELEVLASLRHRNLMSLRAYVPE-----S  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~-----~  173 (380)
                      ..+.||+|+||.||+|.. +++.||||++....           ...+.  .|+..+..++||||+++++.+..     .
T Consensus        17 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             eeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----------hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            457899999999999987 68999999986411           12333  34444556899999999986532     2


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC---------CeEecCCCCCcEEeCCC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP---------QILHYNLKPTNVMLDAE  244 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~---------~iiH~dlk~~Nill~~~  244 (380)
                      ...++||||+++|+|.+++..     ...++..++.++.|++.||+|||   +.         +++||||||+|||++.+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKND  156 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred             ceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCC
Confidence            367899999999999999973     34589999999999999999999   77         99999999999999999


Q ss_pred             CceEEeccCCcccCCC--------------CCcCCCcccCcccccC-------CCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          245 FTPRLADFGLAKLMPG--------------SLIATSAYSAPECFQN-------RSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~--------------~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      +.+||+|||+++....              ...||+.|+|||.+.+       ..++.++||||||+++|||++|..|+.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            9999999999975532              2348999999999976       456778999999999999999987765


Q ss_pred             chhhhccCC----------CCHHHHHHHHHhhcchhHhhchhccCC-cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          304 PFFAEAASG----------GSLGRWLRHLQHAGEAREALDRSILGE-EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       304 ~~~~~~~~~----------~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +........          .....+... ......    .+.+... .........+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVL-VSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHH-HTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhh-hccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            321111100          111111111 111100    0111000 111235667999999999999999999999999


Q ss_pred             HHhccc
Q 047245          373 MLTQLH  378 (380)
Q Consensus       373 ~L~~l~  378 (380)
                      .|+++.
T Consensus       312 ~L~~ll  317 (336)
T 3g2f_A          312 RMAELM  317 (336)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999873

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-44  Score=329.10  Aligned_cols=244  Identities=20%  Similarity=0.308  Sum_probs=195.2

Q ss_pred             cccccCccCCeeEEEEEecC-C-------cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec
Q 047245          101 ENRLLGSSPDGKYYRTVLDN-G-------LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  172 (380)
                      ..+.||+|+||.||++.... +       ..||+|++...        .....+.+.+|+.++++++||||+++++++.+
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A           12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--------HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--------GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            45789999999999998642 3       47999998642        22234678999999999999999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc------
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT------  246 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~------  246 (380)
                      .+..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.      
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~  157 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNP  157 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred             CCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccc
Confidence            9999999999999999999974   2334899999999999999999999   899999999999999998877      


Q ss_pred             --eEEeccCCcccCCCC--CcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHH
Q 047245          247 --PRLADFGLAKLMPGS--LIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       247 --~kl~Dfgl~~~~~~~--~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                        +||+|||++......  ..+++.|+|||.+.+ ..++.++||||||+++|||++|..|+...       .........
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~~~  230 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-------LDSQRKLQF  230 (289)
T ss_dssp             CEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHHHH
T ss_pred             ceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-------cchHHHHHH
Confidence              999999999765442  247889999999987 77899999999999999999965554321       011111111


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .....        .     .+......+.+++.+||+.||++|||++|+++.|+++-
T Consensus       231 ~~~~~--------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          231 YEDRH--------Q-----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HHTTC--------C-----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             hhccC--------C-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            11100        0     01112334778999999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.1e-44  Score=330.14  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=201.4

Q ss_pred             ccccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec
Q 047245          100 NENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  172 (380)
                      ...+.||+|+||.||++..      .++..||+|++...       ......+.+.+|+.+++++ +||||+++++++.+
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-------AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-------hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            3567899999999999985      35789999999642       1223457889999999999 99999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhh--------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRE--------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      .+..++||||+++|+|.+++.....              ....+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccce
Confidence            9999999999999999999985321              1225899999999999999999999   8899999999999


Q ss_pred             EEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhc
Q 047245          239 VMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEA  309 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~  309 (380)
                      |+++.++.+||+|||+++.....        ..+++.|+|||.+.+..++.++||||||+++|||++ |..||....   
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---  252 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---  252 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc---
Confidence            99999999999999999865432        235678999999999999999999999999999999 999985310   


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                       .   ....... ...+     ..     ...+......+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       253 -~---~~~~~~~-~~~~-----~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          253 -V---DSKFYKM-IKEG-----FR-----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             -S---SHHHHHH-HHHT-----CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -c---hhHHHHH-hccC-----CC-----CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence             0   0111111 1111     00     111122345688999999999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=332.41  Aligned_cols=241  Identities=23%  Similarity=0.295  Sum_probs=192.1

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+|..||+|++...        .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--------GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC--------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--------ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            45799999999999986 56899999999751        1233477899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe--CCCCceEEeccCCcccC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML--DAEFTPRLADFGLAKLM  258 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill--~~~~~~kl~Dfgl~~~~  258 (380)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||+  ++++.+||+|||+++..
T Consensus       166 E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          166 EYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             ECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             eCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            99999999998864   2346899999999999999999999   8999999999999999  66789999999999865


Q ss_pred             CC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          259 PG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       259 ~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..     ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        ...+...........     
T Consensus       240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~i~~~~~~-----  306 (373)
T 2x4f_A          240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD--------NDAETLNNILACRWD-----  306 (373)
T ss_dssp             CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCC-----
T ss_pred             CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhccCC-----
Confidence            43     235899999999999999999999999999999999999998631        111222222211100     


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        . ...........+.+++.+||+.||.+|||++|+++
T Consensus       307 --~-~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          307 --L-EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             --S-CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --C-ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0 00111223456889999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-44  Score=323.01  Aligned_cols=244  Identities=21%  Similarity=0.338  Sum_probs=202.0

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||++...++..||+|++.....         ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A           12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---------CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeEecCCCceeEEEEEecCCCeEEEEEccccCC---------CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            4568999999999999998889999999975221         1257889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           83 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            99999999999974   2346899999999999999999999   89999999999999999999999999999976532


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                             ...++..|+|||.+.+..++.++||||||+++|||++ |..||...        .............      
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~i~~~~------  222 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--------SNSEVVEDISTGF------  222 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTTC------
T ss_pred             ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC--------CHHHHHHHHhcCC------
Confidence                   2346778999999998899999999999999999999 89998531        1122222221110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .     ...+......+.+++.+||+.||++|||++++++.|+++.
T Consensus       223 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          223 R-----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             c-----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0     0111223456789999999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-43  Score=326.86  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=193.5

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC--CCCCcceeeEEEecC----
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL--RHRNLMSLRAYVPES----  173 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----  173 (380)
                      ...+.||+|+||.||+|... |+.||||++...         .  ...+..|.+++...  +||||+++++++...    
T Consensus        40 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---------~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           40 QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---------E--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---------G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             EEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---------c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            35678999999999999985 899999998641         1  13344455555554  899999999999877    


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC--------CeEecCCCCCcEEeCCCC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP--------QILHYNLKPTNVMLDAEF  245 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~--------~iiH~dlk~~Nill~~~~  245 (380)
                      ...++||||+++|+|.+++..     ..+++..++.++.|++.||+|||   +.        +++||||||+|||++.++
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCC
Confidence            789999999999999999963     36899999999999999999999   66        999999999999999999


Q ss_pred             ceEEeccCCcccCCC----------CCcCCCcccCcccccCCCCCCc------chhhHHHHHHHHHHhC----------C
Q 047245          246 TPRLADFGLAKLMPG----------SLIATSAYSAPECFQNRSYTDK------SDIFSFGMILAVLLTG----------R  299 (380)
Q Consensus       246 ~~kl~Dfgl~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~------sDv~s~Gvil~el~tg----------~  299 (380)
                      .+||+|||+++....          ...||+.|+|||.+.+...+.+      +||||||+++|||++|          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            999999999965432          2358999999999987766665      9999999999999999          5


Q ss_pred             CCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          300 DPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       300 ~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .||...   .........+... .....    ..+.........+....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       260 ~p~~~~---~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          260 LPYHDL---VPSDPSYEDMREI-VCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CTTTTT---SCSSCCHHHHHHH-HTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccHhhh---cCCCCchhhhHHH-Hhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            555421   1111112222111 11111    11111111122367788999999999999999999999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=326.83  Aligned_cols=248  Identities=22%  Similarity=0.337  Sum_probs=198.5

Q ss_pred             ccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++... +|..||+|.+.........  .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   91 (326)
T 2y0a_A           14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   91 (326)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            35678999999999999974 6899999999764322111  11124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC----ceEEeccCC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF----TPRLADFGL  254 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfgl  254 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++    .+||+|||+
T Consensus        92 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           92 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999863    456899999999999999999999   89999999999999999887    899999999


Q ss_pred             cccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          255 AKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       255 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ++....     ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        ..............  
T Consensus       165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~~~~~~~--  234 (326)
T 2y0a_A          165 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANVSAVNY--  234 (326)
T ss_dssp             CEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHHTCC--
T ss_pred             CeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--------CHHHHHHHHHhcCC--
Confidence            976542     345899999999999999999999999999999999999998531        11111111111100  


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ....     .........+.+++.+||+.||++|||++|+++
T Consensus       235 -~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 -EFED-----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -CCCH-----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CcCc-----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0000     000123455789999999999999999999986

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.4e-43  Score=328.65  Aligned_cols=244  Identities=23%  Similarity=0.307  Sum_probs=193.8

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... +|+.||+|++......     .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        13 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A           13 LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-----DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC-----SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc-----chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4578999999999999974 6889999999763221     234456788999999998 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            9999999999999974    346899999999999999999999   899999999999999999999999999999853


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................     
T Consensus       161 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  235 (345)
T 3a8x_A          161 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  235 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred             cCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence            2      23458999999999999999999999999999999999999996321111000011111111111110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                            ...+......+.+++.+||+.||++||++
T Consensus       236 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 ------IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                  01112334568899999999999999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=330.53  Aligned_cols=244  Identities=20%  Similarity=0.421  Sum_probs=195.1

Q ss_pred             ccccCccCCeeEEEEEecC-----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          102 NRLLGSSPDGKYYRTVLDN-----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      .+.||+|+||.||+|....     +..||+|.+...       ........+.+|+.++++++||||+++++++.+.+..
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-------YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            4789999999999998642     235999998641       1233456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus       122 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          122 MIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            999999999999999974   2456899999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .....         ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...        ...+.........
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--------~~~~~~~~~~~~~  267 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--------SNHEVMKAINDGF  267 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHHCCC
Confidence            65432         125678999999999999999999999999999999 99998531        1111111111110


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .           ...+......+.+++.+||+.||++|||+.++++.|+++
T Consensus       268 ~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          268 R-----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             C-----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             c-----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0           011123445688999999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-43  Score=324.95  Aligned_cols=239  Identities=21%  Similarity=0.316  Sum_probs=196.7

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++.....     ......+.+.+|..+++.++||||+++++++.+....++|
T Consensus        10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A           10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            4578999999999999974 689999999975210     0112236678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999974    346899999999999999999999   9999999999999999999999999999998665


Q ss_pred             C---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          260 G---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       260 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      .   ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        .............         .
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~---------~  220 (318)
T 1fot_A          158 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAE---------L  220 (318)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCC---------C
T ss_pred             CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC---------C
Confidence            3   346899999999999999999999999999999999999998631        1122222222111         0


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELV  371 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl  371 (380)
                         ..+......+.+++.+|++.||++||     +++|++
T Consensus       221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~  257 (318)
T 1fot_A          221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK  257 (318)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence               11122345678999999999999999     788876

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.9e-44  Score=332.29  Aligned_cols=239  Identities=23%  Similarity=0.372  Sum_probs=193.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B           13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-----KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-----cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356899999999999996 6789999999864210     0111235788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+ +|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 7899999874    346999999999999999999999   8899999999999999999999999999998654


Q ss_pred             C-----CCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G-----SLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .     ...||+.|+|||.+.+..+ +.++||||||+++|||++|..||.......                  ....+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------------~~~~i~  221 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------------LFKKVN  221 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------------CBCCCC
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------------HHHHHH
Confidence            3     3458999999999988776 689999999999999999999996421110                  000011


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...  ...+......+.+++.+||+.||.+|||++|+++
T Consensus       222 ~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 SCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            000  0111223455789999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-44  Score=335.66  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=198.8

Q ss_pred             ccccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec
Q 047245          100 NENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  172 (380)
                      ...+.||+|+||.||++..      .++..||+|.+....       .....+.+.+|+.+++++ +||||+++++++..
T Consensus        48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             eeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-------CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            3567899999999999996      246689999997421       122347788999999999 89999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhc-------------------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecC
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIREN-------------------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYN  233 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~d  233 (380)
                      .+..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||   +.+++|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence            99999999999999999999753211                   134899999999999999999999   89999999


Q ss_pred             CCCCcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCc
Q 047245          234 LKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAP  304 (380)
Q Consensus       234 lk~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~  304 (380)
                      |||+||+++.++.+||+|||++.....        ...+|+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999975432        2236778999999999999999999999999999998 9999864


Q ss_pred             hhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          305 FFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       305 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ..    .   ... .......+         .. ...+......+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus       278 ~~----~---~~~-~~~~~~~~---------~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          278 IP----V---DAN-FYKLIQNG---------FK-MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CC----C---SHH-HHHHHHTT---------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CC----c---HHH-HHHHHhcC---------CC-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            10    0   011 11111111         00 1111223456889999999999999999999999998763

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-43  Score=332.46  Aligned_cols=242  Identities=25%  Similarity=0.380  Sum_probs=196.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++.....     ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            446799999999999996 6789999999975321     1233457889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||++ |+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       133 ~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            99997 689888863   2457999999999999999999999   8899999999999999999999999999998654


Q ss_pred             C--CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G--SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~--~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .  ...||+.|+|||.+.   ...++.++||||||+++|||++|..||...        .............      .+
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~--------~~~~~~~~~~~~~------~~  271 (348)
T 1u5q_A          206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNE------SP  271 (348)
T ss_dssp             SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSC------CC
T ss_pred             CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhcC------CC
Confidence            3  346899999999984   567899999999999999999999998531        1112222222111      11


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....    ......+.+++.+||+.||++|||++++++
T Consensus       272 ~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          272 ALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            1111    123345788999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.6e-44  Score=327.67  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             hccccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC
Q 047245           99 ANENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES  173 (380)
Q Consensus        99 ~~~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  173 (380)
                      ....+.||+|+||.||++..     .+|+.||+|++.....       ....+.+.+|+.++++++||||+++++++.+.
T Consensus        23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-------chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            34557899999999999983     4689999999975221       11236788999999999999999999999876


Q ss_pred             --CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          174 --SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       174 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                        ...++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             CCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECc
Confidence              668999999999999999964   2456899999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccCCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-------CCCCH
Q 047245          252 FGLAKLMPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-------SGGSL  315 (380)
Q Consensus       252 fgl~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-------~~~~l  315 (380)
                      ||++.....         ...+|..|+|||.+.+..++.++||||||+++|||++|..|+........       .....
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            999976543         23477789999999999999999999999999999999998653211100       00000


Q ss_pred             HHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ....          ..+.... ....+......+.+++.+||+.||.+|||++++++.|+++.
T Consensus       250 ~~~~----------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLV----------NTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHH----------HHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH----------HHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0111          1111111 01122234566889999999999999999999999999863

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=326.71  Aligned_cols=246  Identities=19%  Similarity=0.304  Sum_probs=188.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChh------------------hhcHHHHHHHHHHHHHHHcCCCC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPE------------------KQNKSVKRRIQQELEVLASLRHR  161 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~------------------~~~~~~~~~~~~E~~~l~~l~h~  161 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.........                  .......+.+.+|++++++++||
T Consensus        17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   96 (298)
T 2zv2_A           17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP   96 (298)
T ss_dssp             EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence            457899999999999986 46889999999753211100                  00112246788999999999999


Q ss_pred             CcceeeEEEec--CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcE
Q 047245          162 NLMSLRAYVPE--SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV  239 (380)
Q Consensus       162 niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Ni  239 (380)
                      ||+++++++.+  .+..++||||+++|+|.+++.     ...+++..+..++.|++.||+|||   +.+++||||||+||
T Consensus        97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNL  168 (298)
T ss_dssp             TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred             CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHE
Confidence            99999999986  568999999999999987653     447999999999999999999999   88999999999999


Q ss_pred             EeCCCCceEEeccCCcccCCC------CCcCCCcccCcccccCCC---CCCcchhhHHHHHHHHHHhCCCCCCchhhhcc
Q 047245          240 MLDAEFTPRLADFGLAKLMPG------SLIATSAYSAPECFQNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA  310 (380)
Q Consensus       240 ll~~~~~~kl~Dfgl~~~~~~------~~~~~~~y~aPE~~~~~~---~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~  310 (380)
                      |++.++.+||+|||+++....      ...||+.|+|||.+.+..   ++.++||||||+++|||++|+.||...     
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----  243 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-----  243 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-----
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-----
Confidence            999999999999999976543      245899999999998765   377899999999999999999998631     


Q ss_pred             CCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ....+........     ..     ..........+.+++.+||+.||++|||+.|+++
T Consensus       244 ---~~~~~~~~~~~~~-----~~-----~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 ---RIMCLHSKIKSQA-----LE-----FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             ---SHHHHHHHHHHCC-----CC-----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---cHHHHHHHHhccc-----CC-----CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence               1222222211110     00     0011123455889999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-44  Score=324.32  Aligned_cols=242  Identities=19%  Similarity=0.282  Sum_probs=198.2

Q ss_pred             cccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +.||+|+||.||+|...   ++..||+|++...       ......+.+.+|+.++++++||||+++++++. .+..++|
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv   87 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   87 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCc-------cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence            47999999999999853   6788999999752       12344578999999999999999999999994 4668999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            999999999999863   3456899999999999999999999   8999999999999999999999999999997654


Q ss_pred             CC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          260 GS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       260 ~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ..         ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...        ...+.........   
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~~~i~~~~---  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMAFIEQGK---  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHHHHHHHTTC---
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--------CHHHHHHHHhcCC---
Confidence            21         235788999999998889999999999999999999 99998631        1111111111110   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                              ....+......+.+++..||+.||++|||+.++++.|+++
T Consensus       231 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          231 --------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                    0111223455688999999999999999999999999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.1e-44  Score=325.12  Aligned_cols=241  Identities=20%  Similarity=0.312  Sum_probs=195.4

Q ss_pred             ccCccCCeeEEEEEe---cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          104 LLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .||+|+||.||++..   .++..||||++....      ......+.+.+|+.++++++||||+++++++ +.+..++||
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccc------cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            899999999999964   346889999997522      2234457899999999999999999999999 556789999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        97 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           97 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999974    346899999999999999999999   88999999999999999999999999999976543


Q ss_pred             C---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          261 S---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       261 ~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .         ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...        .............    
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~----  237 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAMLEKGE----  237 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTTC----
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC----
Confidence            2         235678999999998889999999999999999999 99998641        1111111111110    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                            . ...+......+.+++.+||+.||++|||+.++++.|+++
T Consensus       238 ------~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          238 ------R-MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             ------C-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  0 111223455688999999999999999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.9e-43  Score=328.56  Aligned_cols=247  Identities=19%  Similarity=0.226  Sum_probs=198.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++.....          ...+.+|+.+++++ +||||+++++++...+..++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A           13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             EEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            356899999999999996 6789999999865221          13577899999999 99999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc-----eEEeccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-----PRLADFG  253 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~Dfg  253 (380)
                      ||||+ +++|.+++...   ...+++..++.++.|++.||+|||   +.+++||||||+|||++.++.     +||+|||
T Consensus        83 v~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             EEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            99999 99999999742   457999999999999999999999   889999999999999998887     9999999


Q ss_pred             CcccCC-------------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          254 LAKLMP-------------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       254 l~~~~~-------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +++...             ....||+.|+|||.+.+..++.++||||||+++|||++|..||...     ..........
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~-----~~~~~~~~~~  230 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL-----KADTLKERYQ  230 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-----CCSSHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc-----ccccHHHHHH
Confidence            997542             1335899999999999999999999999999999999999998642     1122222222


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .......   ..........    .+ .+.+++..||+.||.+||++++|++.|+++
T Consensus       231 ~i~~~~~---~~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          231 KIGDTKR---ATPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHHHHHH---HSCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHhhhc---cCCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            2211100   0000000011    12 688999999999999999999999999865

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.3e-43  Score=321.85  Aligned_cols=248  Identities=17%  Similarity=0.193  Sum_probs=197.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....          ...+.+|+..++++ +|+|++++++++.+....++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A           14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            456899999999999995 6789999999864221          14567899999999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc-----eEEeccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT-----PRLADFG  253 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~-----~kl~Dfg  253 (380)
                      ||||+ +++|.+++...   ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.     +||+|||
T Consensus        84 v~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            99999 99999999742   346999999999999999999999   999999999999999987766     9999999


Q ss_pred             CcccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          254 LAKLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       254 l~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +++....             ...||+.|+|||.+.+..++.++||||||+++|||++|+.||....     .........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~~~  231 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-----AATNKQKYE  231 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC-----SCCHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh-----ccccHHHHH
Confidence            9975432             2348999999999999999999999999999999999999986421     111111111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ....... . ...+.+     ....+..+.+++.+||+.||++|||+++|++.|+++
T Consensus       232 ~~~~~~~-~-~~~~~~-----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          232 RIGEKKQ-S-TPLREL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHHHH-H-SCHHHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHhhcc-C-ccHHHH-----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            1111100 0 000000     012345688999999999999999999999999876

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.6e-44  Score=356.39  Aligned_cols=241  Identities=19%  Similarity=0.284  Sum_probs=195.9

Q ss_pred             ccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          104 LLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .||+|+||.||+|...   ++..||||+++....       ....+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-------STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            6999999999999874   566899999975311       1224778999999999999999999999976 5689999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus       415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            99999999999963   3456999999999999999999999   89999999999999999999999999999987542


Q ss_pred             C---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          261 S---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       261 ~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .         ..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...        ...+.........    
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--------~~~~~~~~i~~~~----  556 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMAFIEQGK----  556 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CSHHHHHHHHTTC----
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHHcCC----
Confidence            2         125678999999999999999999999999999998 99998641        1111111111111    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                            . ...+......+.+++..||+.||++|||+.++++.|+.+
T Consensus       557 ------~-~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          557 ------R-MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ------C-CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------C-CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  0 112233456688999999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.7e-44  Score=359.22  Aligned_cols=242  Identities=19%  Similarity=0.305  Sum_probs=196.6

Q ss_pred             cccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +.||+|+||.||+|...   .+..||||+++...      ......+++.+|+.++++++||||+++++++.+ +..++|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv  447 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV  447 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG------GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence            47999999999999763   46789999997522      222335789999999999999999999999975 458899


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       448 ~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~  520 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  520 (635)
T ss_dssp             EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred             EEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence            999999999999974    456899999999999999999999   8899999999999999999999999999997654


Q ss_pred             CC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          260 GS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       260 ~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ..         ..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...        ...+.......     
T Consensus       521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~--------~~~~~~~~i~~-----  587 (635)
T 4fl3_A          521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAMLEK-----  587 (635)
T ss_dssp             C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHT-----
T ss_pred             cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHc-----
Confidence            21         235678999999999999999999999999999998 99998641        11111111111     


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                           ... ...+......+.+++..||+.||++|||+++|++.|+++
T Consensus       588 -----~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          588 -----GER-MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             -----TCC-CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----CCC-CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 110 111233456688999999999999999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.3e-44  Score=330.81  Aligned_cols=241  Identities=22%  Similarity=0.331  Sum_probs=192.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.||+|++.....       ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A           11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-------cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            3568999999999999874 789999999965221       12235688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999998863    446899999999999999999999   8999999999999999999999999999997542


Q ss_pred             --------CCCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 --------GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 --------~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                              ....||+.|+|||.+.+..+ +.++||||||+++|||++|..||......      ...+... .....   
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~-~~~~~---  226 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDW-KEKKT---  226 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHHH-HTTCT---
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHH-hcccc---
Confidence                    23458999999999988775 77899999999999999999999642110      0111111 11000   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            . ..........+.+++.+||+.||++|||++|+++
T Consensus       227 ------~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          227 ------Y-LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ------T-STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------c-CCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  0 0011223455778999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.5e-43  Score=323.04  Aligned_cols=250  Identities=23%  Similarity=0.409  Sum_probs=191.3

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ...+.||+|+||.||++...  ..+|+|++....      ......+.+.+|+.++++++||||+++++++ .....++|
T Consensus        27 ~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           27 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             EEEEEEEECSSEEEEEEESS--SEEEEEEESCSS------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             eeeeEecCCCCeEEEEEEEc--CceEEEEEeccC------CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            35578999999999999864  359999997532      2334457899999999999999999999976 44568999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999999863   3456899999999999999999999   8999999999999999999999999999987543


Q ss_pred             C--------CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          260 G--------SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       260 ~--------~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .        ...|++.|+|||.+.   +..++.++||||||+++|||++|+.||...       ........... .+..
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-------~~~~~~~~~~~-~~~~  243 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIEMVG-RGSL  243 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC-------CCHHHHHHHHH-HTSC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc-------chHHHHHHHhc-cccc
Confidence            2        235899999999986   567888999999999999999999998631       11111111111 1111


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .    +..  .......+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       244 ~----~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          244 S----PDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             C----CCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             C----cch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            0    000  1111234566889999999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.9e-43  Score=326.66  Aligned_cols=243  Identities=21%  Similarity=0.329  Sum_probs=178.6

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  179 (380)
                      .+.||+|+||.||++... +|+.||||++...           ....+.+|+.+++.++ ||||+++++++.+....++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            467999999999999974 6899999998641           1256778999999996 99999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC---ceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++   .+||+|||+++
T Consensus        85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           85 MELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             ECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            999999999999974    457999999999999999999999   89999999999999997665   89999999997


Q ss_pred             cCCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          257 LMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       257 ~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ....      ...+|+.|+|||.+.+..++.++||||||+++|||++|..||....... ......+..........   
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~~~---  233 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKGDF---  233 (325)
T ss_dssp             ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCC---
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcCCC---
Confidence            6542      2347899999999999999999999999999999999999996421111 11112222222111100   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                          .. ...........+.+++.+||+.||.+|||++|++
T Consensus       234 ----~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          234 ----SF-EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             ----CC-CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             ----CC-CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence                00 0011122456688999999999999999999987

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=332.19  Aligned_cols=235  Identities=23%  Similarity=0.270  Sum_probs=191.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....     .......+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus        27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH-----hcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            457899999999999997 468999999997521     01122346678899999998 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999975    346899999999999999999999   899999999999999999999999999999853


Q ss_pred             CC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..      ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        ...+.........      
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~------  240 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--------NEDDLFEAILNDE------  240 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC------
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC------
Confidence            32      235899999999999989999999999999999999999999641        1222222222111      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                         .   ..+......+.+++.+||+.||++||++
T Consensus       241 ---~---~~p~~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          241 ---V---VYPTWLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ---C---CCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ---C---CCCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence               0   1112234557899999999999999998

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-44  Score=337.83  Aligned_cols=245  Identities=24%  Similarity=0.362  Sum_probs=188.7

Q ss_pred             cccccCccCCeeEEEEEec--CC--cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-CCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD--NG--LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-SSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  175 (380)
                      ..+.||+|+||.||+|...  ++  ..||+|.+....       .....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus        93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-------CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            3468999999999999863  22  368999886421       22345789999999999999999999998754 457


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++
T Consensus       166 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccc
Confidence            8999999999999999963   3456889999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCC----------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          256 KLMPG----------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       256 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      +....          ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...     ........   ...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~-----~~~~~~~~---~~~  311 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITVY---LLQ  311 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CSSCHHHH---HHT
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC-----CHHHHHHH---HHc
Confidence            75432          1236778999999999999999999999999999999 66666431     11111111   111


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ...           ...+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       312 ~~~-----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          312 GRR-----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             TCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            110           011122345688999999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-43  Score=330.61  Aligned_cols=250  Identities=21%  Similarity=0.386  Sum_probs=200.9

Q ss_pred             ccccccCccCCeeEEEEEe--------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVL--------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYV  170 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  170 (380)
                      ...+.||+|+||.||++..        .++..||+|++...       ......+.+.+|+.+++++ +||||+++++++
T Consensus        38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-------CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            3567899999999999986        35678999998642       1234457889999999999 899999999999


Q ss_pred             ecCCeEEEEEeecCCCCHHHHHHHhhh------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          171 PESSRFYLVYDYLQTGSLEDAMDRIRE------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       171 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      .+.+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccce
Confidence            999999999999999999999975321            1234899999999999999999999   8999999999999


Q ss_pred             EEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhc
Q 047245          239 VMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEA  309 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~  309 (380)
                      |+++.++.+||+|||+++.....        ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...    
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----  263 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----  263 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC----
Confidence            99999999999999999765432        236778999999998889999999999999999999 99998531    


Q ss_pred             cCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       310 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                          ...+..........           ...+......+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus       264 ----~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          264 ----PVEELFKLLKEGHR-----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             ----CHHHHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CHHHHHHHHhcCCC-----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                12222222211110           1111223456889999999999999999999999998863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.6e-44  Score=354.11  Aligned_cols=245  Identities=24%  Similarity=0.379  Sum_probs=201.8

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ...+.||+|+||.||+|...++..||||++.....         ..+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            35678999999999999998888999999975221         12578999999999999999999999976 678999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus       340 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             ECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            9999999999999742  2346899999999999999999999   8999999999999999999999999999998764


Q ss_pred             C-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 G-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .       ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...        ...+..........    
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--------~~~~~~~~i~~~~~----  482 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVLDQVERGYR----  482 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--------CHHHHHHHHHTTCC----
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCC----
Confidence            3       2346778999999999999999999999999999999 89998531        11122222111100    


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                             ...+......+.+++.+||+.||++|||+++|++.|+++.
T Consensus       483 -------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          483 -------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                   1112234556889999999999999999999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.7e-43  Score=328.38  Aligned_cols=260  Identities=26%  Similarity=0.366  Sum_probs=201.7

Q ss_pred             cccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe--cC
Q 047245          101 ENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP--ES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~  173 (380)
                      ..+.||+|+||.||++..     .++..||+|++..        ......+.+.+|++++++++||||+++++++.  +.
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--------SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--------CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            457899999999999984     4688999999865        12344577899999999999999999999886  45


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccc
Confidence            6789999999999999999742   336899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          254 LAKLMPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       254 l~~~~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      +++....         ...+++.|+|||.+.+..++.++||||||+++|||++|..||.....+........   .....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~  249 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE---RDVPA  249 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CCH
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc---ccccc
Confidence            9986542         22477789999999998899999999999999999999999864222110000000   00000


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .....+.+..... ...+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       250 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          250 LSRLLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHHHHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0001111111111 1122334566889999999999999999999999998763

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4e-43  Score=328.72  Aligned_cols=240  Identities=18%  Similarity=0.252  Sum_probs=197.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++.....     ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-----ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            3468999999999999974 689999999965210     1112246788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceecc
Confidence            999999999999974    346899999999999999999999   8999999999999999999999999999998665


Q ss_pred             C---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          260 G---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       260 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      .   ...||+.|+|||.+.+..++.++||||||+++|||++|..||...        .............         .
T Consensus       193 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~---------~  255 (350)
T 1rdq_E          193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGK---------V  255 (350)
T ss_dssp             SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC---------C
T ss_pred             CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC--------CHHHHHHHHHcCC---------C
Confidence            4   345899999999999999999999999999999999999998631        1222222222111         0


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                         ..+......+.+++.+||+.||.+||+     ++|+++
T Consensus       256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence               111223456889999999999999998     777653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-43  Score=331.92  Aligned_cols=193  Identities=22%  Similarity=0.286  Sum_probs=169.9

Q ss_pred             cccccCcc--CCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245          101 ENRLLGSS--PDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G--~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      ..+.||+|  +||.||++... +|+.||||++....      ......+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA------CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc------cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45789999  99999999975 78999999997632      23345678889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+..
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            999999999999999752  2356899999999999999999999   89999999999999999999999999998753


Q ss_pred             CC-------------CCCcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          258 MP-------------GSLIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       258 ~~-------------~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      ..             ....||+.|+|||.+.+  ..++.++|||||||++|||++|+.||..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            21             12358889999999987  6789999999999999999999999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=9.6e-43  Score=317.79  Aligned_cols=241  Identities=22%  Similarity=0.372  Sum_probs=193.3

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec----CCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE----SSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  175 (380)
                      ..+.||+|+||.||+|.. .++..||+|.+....      ......+.+.+|+.++++++||||+++++++..    ...
T Consensus        30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eeeeccCCCCeEEEEeEecCCceEEEEEEecchh------hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            345799999999999987 467899999987522      233446789999999999999999999998865    456


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeC-CCCceEEecc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLD-AEFTPRLADF  252 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~Df  252 (380)
                      .++||||+++|+|.+++..    ...+++..++.++.|++.||+|||   +.+  ++||||||+||+++ +++.+||+||
T Consensus       104 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            8999999999999999974    356899999999999999999999   777  99999999999998 7899999999


Q ss_pred             CCcccCCCC----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          253 GLAKLMPGS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       253 gl~~~~~~~----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      |++......    ..+++.|+|||.+. +.++.++||||||+++|+|++|..||...       ............... 
T Consensus       177 g~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~-  247 (290)
T 1t4h_A          177 GLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVK-  247 (290)
T ss_dssp             TGGGGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCC-
T ss_pred             CCcccccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHHHHHhccCC-
Confidence            999765543    34899999999886 45899999999999999999999998531       112222222211111 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                               ....+......+.+++.+||+.||.+|||++|+++
T Consensus       248 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 ---------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                     11111122345889999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.7e-44  Score=322.79  Aligned_cols=243  Identities=23%  Similarity=0.426  Sum_probs=198.6

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||+|...++..||+|.+.....         ..+.+.+|++++++++||||+++++++.+ +..++||
T Consensus        17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             heeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---------cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            4578999999999999998888999999864211         13678899999999999999999999875 4589999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++...  ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++.....
T Consensus        87 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           87 EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             ECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            999999999999742  2336899999999999999999999   89999999999999999999999999999976543


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                             ...++..|+|||.+.+..++.++||||||+++|||++ |..||...        ...+.........      
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~~~~~~~~~------  227 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--------TNPEVIQNLERGY------  227 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHTTC------
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc--------CHHHHHHHHhccc------
Confidence                   2236778999999998889999999999999999999 89998531        1112222211110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .     ...+......+.+++.+||+.||++|||++++++.|+++
T Consensus       228 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          228 R-----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            0     011122345688999999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-43  Score=322.74  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=195.8

Q ss_pred             cccccCccCCeeEEEEEec-C---CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-N---GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|... +   +..+|+|.+...       ......+.+.+|+.++++++||||+++++++.+.+..
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   97 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-------TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL   97 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeecccc-------ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence            3478999999999999863 2   237999998641       1234457889999999999999999999999766555


Q ss_pred             -EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          177 -YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       177 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                       ++|+||+.+|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++
T Consensus        98 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  171 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLA  171 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred             cEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence             999999999999999973   3456899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCC----------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          256 KLMPG----------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       256 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      +....          ...+++.|+|||.+.+..++.++||||||+++|||++|..|+....    +   ..+........
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~---~~~~~~~~~~~  244 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----D---PFDLTHFLAQG  244 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----C---GGGHHHHHHTT
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----C---HHHHHHHhhcC
Confidence            75432          2346789999999999999999999999999999999666643211    0   01111111111


Q ss_pred             cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .           ....+......+.+++.+||+.||.+|||++++++.|+++.
T Consensus       245 ~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          245 R-----------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             C-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-----------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0           01111223456889999999999999999999999998863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-43  Score=321.44  Aligned_cols=237  Identities=24%  Similarity=0.429  Sum_probs=196.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-------
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-------  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  172 (380)
                      ..+.||+|+||.||++... +|+.||+|++....            ..+.+|++++++++||||+++++++..       
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            4578999999999999985 78999999997521            345689999999999999999998854       


Q ss_pred             ---------CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          173 ---------SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       173 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                               ....++||||+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+++||||||+||++++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcC
Confidence                     34589999999999999999752  2457999999999999999999999   889999999999999999


Q ss_pred             CCceEEeccCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHH
Q 047245          244 EFTPRLADFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~  318 (380)
                      ++.+||+|||++.....     ...+++.|+|||.+.+..++.++||||||+++|||++|..|+...          ..+
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~  227 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKF  227 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHH
T ss_pred             CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHH
Confidence            99999999999876543     235899999999999999999999999999999999999886321          011


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ....          .......    .....+.+++.+||+.||.+|||+.|+++.|+.++
T Consensus       228 ~~~~----------~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          228 FTDL----------RDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHH----------HTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHHh----------hcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1111          1111111    12344778999999999999999999999998775

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=330.20  Aligned_cols=242  Identities=23%  Similarity=0.342  Sum_probs=195.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-----VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-----ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457899999999999986 4588999999965211     1122346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            999999999999874    446999999999999999999999   8999999999999999999999999999998654


Q ss_pred             C-----CCcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 G-----SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .     ...||+.|+|||.+.+   ..++.++||||||+++|||++|..||...     ................     
T Consensus       167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~~~~~~~~~-----  236 (384)
T 4fr4_A          167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR-----SSTSSKEIVHTFETTV-----  236 (384)
T ss_dssp             TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC-----TTSCHHHHHHHHHHCC-----
T ss_pred             CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC-----CCccHHHHHHHHhhcc-----
Confidence            3     3459999999999974   45899999999999999999999998631     1112222222211110     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC-HHhHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-SDELV  371 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl  371 (380)
                             ...+......+.+++.+||+.||.+||+ +++++
T Consensus       237 -------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          237 -------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             -------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence                   1112233456889999999999999998 66654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.1e-44  Score=331.21  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=191.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcE----EEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLT----VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~----vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||.||+|.. .+|..    ||+|.+......       ...+.+.+|+.++++++||||+++++++.+ +.
T Consensus        17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~   88 (325)
T 3kex_A           17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-------QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SS   88 (325)
T ss_dssp             EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-------SCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SS
T ss_pred             eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-------HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Cc
Confidence            346899999999999986 34554    777776532211       112456789999999999999999999864 56


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++|+||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        89 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             cEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcc
Confidence            8999999999999999873   2346889999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +.....        ..++..|+|||.+.+..++.++||||||+++|||++ |..||....        ............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~  234 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR--------LAEVPDLLEKGE  234 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------TTHHHHHHHTTC
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC--------HHHHHHHHHcCC
Confidence            865422        236778999999999999999999999999999999 999986410        011111111110


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .           ...+......+.+++.+||+.||.+|||++|+++.|+++.
T Consensus       235 ~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 R-----------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             B-----------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             C-----------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0           0111122334778999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-43  Score=323.90  Aligned_cols=250  Identities=25%  Similarity=0.351  Sum_probs=193.1

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC--
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS--  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  174 (380)
                      ..+.||+|+||.||+|...    ++..||+|.+....      ......+.+.+|+.++++++||||+++++++.+.+  
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN------SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc------cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            5578999999999999863    34589999987522      12344577899999999999999999999997755  


Q ss_pred             ---eEEEEEeecCCCCHHHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEE
Q 047245          175 ---RFYLVYDYLQTGSLEDAMDRIR--ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRL  249 (380)
Q Consensus       175 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl  249 (380)
                         ..++|+||+++|+|.+++....  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               3599999999999999986432  23456999999999999999999999   999999999999999999999999


Q ss_pred             eccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHH
Q 047245          250 ADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       250 ~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||.....        .....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~  260 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------HEMYD  260 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GGHHH
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHH
Confidence            99999976532        1236778999999999999999999999999999999 8888753110        11111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ......           ....+......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       261 ~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          261 YLLHGH-----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HHHTTC-----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCC-----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111110           01112234456889999999999999999999999998863

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.6e-43  Score=325.58  Aligned_cols=241  Identities=22%  Similarity=0.286  Sum_probs=188.0

Q ss_pred             cccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||++..    .+|+.||+|++......    ........+.+|+.++++++||||+++++++.+.+..
T Consensus        21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh----hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            457899999999999987    57899999999753211    1122345678899999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999974    346889999999999999999999   8899999999999999999999999999987


Q ss_pred             cCC------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          257 LMP------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       257 ~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      ...      ....||+.|+|||.+.+..++.++||||||+++|||++|..||...        ............     
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~-----  236 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--------NRKKTIDKILKC-----  236 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHT-----
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhC-----
Confidence            542      2345899999999999999999999999999999999999998641        111222222111     


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                          ..   ..+......+.+++.+||+.||++||     ++.|+++
T Consensus       237 ----~~---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 ----KL---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CC---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CC---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                00   11122345678999999999999999     6667654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=329.96  Aligned_cols=242  Identities=21%  Similarity=0.299  Sum_probs=196.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.+|+|.+...        .......+.+|+.++++++||||+++++++.+....++|
T Consensus        55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--------YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--------chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            4568999999999999874 6889999998651        122346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC--CCceEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA--EFTPRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kl~Dfgl~~~  257 (380)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.  ++.+||+|||+++.
T Consensus       127 ~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          127 LEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            999999999999863   2346899999999999999999999   899999999999999974  47899999999987


Q ss_pred             CCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          258 MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ....     ..+|+.|+|||.+.+..++.++||||||+++|||++|..||...        ..............     
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------~~~~~~~~i~~~~~-----  267 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--------DDLETLQNVKRCDW-----  267 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHHCCC-----
T ss_pred             cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCC-----
Confidence            6543     35899999999999999999999999999999999999998641        11111222111110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        ... ..........+.+++.+||+.||++|||+.|+++
T Consensus       268 --~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          268 --EFD-EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --CCC-SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --CCC-ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence              000 1111223456889999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-42  Score=316.64  Aligned_cols=245  Identities=26%  Similarity=0.367  Sum_probs=194.7

Q ss_pred             ccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++.. .+|..+|+|++......       ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-------VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-------hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            3567899999999999987 46889999999763221       123678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe---CCCCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfgl~  255 (380)
                      ||||+++|+|.+++.........+++..++.++.|++.||+|||   +.+++||||||+||++   +.++.+||+|||++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999999765555678999999999999999999999   8999999999999999   45688999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .....     ...+++.|+|||.+. ..++.++||||||+++|||++|..||...        .............    
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~--------~~~~~~~~~~~~~----  241 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT--------SLEEVQQKATYKE----  241 (285)
T ss_dssp             CC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC----
T ss_pred             eecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC--------CHHHHHhhhccCC----
Confidence            76543     235899999999885 56899999999999999999999998641        1111111111110    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         +.....  .......+.+++.+||+.||++|||+.|+++
T Consensus       242 ---~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 ---PNYAVE--CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---CCCCC----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---cccccc--cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000000  0012345779999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-42  Score=316.13  Aligned_cols=243  Identities=24%  Similarity=0.346  Sum_probs=196.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|..||+|++....      ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A           10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK------LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc------CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            346899999999999987 468999999997532      2234457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc---eEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT---PRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.   +||+|||++.
T Consensus        84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999998874    346899999999999999999999   899999999999999986655   9999999997


Q ss_pred             cCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....     ...+++.|+|||.+.+..++.++||||||+++|+|++|..||...        ..............    
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--------~~~~~~~~~~~~~~----  224 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--------DQHRLYAQIKAGAY----  224 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCC----
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC--------chhHHHHHHHhccc----
Confidence            6543     245899999999999999999999999999999999999998531        11122221111110    


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ..   ...........+.+++.+||+.||++|||++|+++
T Consensus       225 -~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 -DY---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -CC---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cC---CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00   00011123455789999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-42  Score=315.02  Aligned_cols=240  Identities=22%  Similarity=0.396  Sum_probs=195.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... ++..||+|++....     .........+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A           13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            3468999999999999864 57799999986521     11122346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999974    346899999999999999999999   9999999999999999999999999999986554


Q ss_pred             C----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .    ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        ............       .. 
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~-------~~-  224 (279)
T 3fdn_A          161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRISRV-------EF-  224 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHT-------CC-
T ss_pred             cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC--------cHHHHHHHHHhC-------CC-
Confidence            3    345899999999999999999999999999999999999998631        111111111111       00 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          ..+......+.+++.+||+.||.+|||++|+++
T Consensus       225 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                111223455789999999999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=329.47  Aligned_cols=239  Identities=21%  Similarity=0.302  Sum_probs=195.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++..................+.+|+.++++++||||+++++++.+.+..++|
T Consensus        28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv  107 (335)
T 3dls_A           28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV  107 (335)
T ss_dssp             EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence            457899999999999985 5789999999976432211101111234567899999999999999999999999999999


Q ss_pred             EeecCCC-CHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTG-SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||+.+| +|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus       108 ~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            9999777 99999873    446999999999999999999999   889999999999999999999999999999866


Q ss_pred             CCC-----CcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PGS-----LIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~~-----~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ...     ..||+.|+|||.+.+..+ +.++||||||+++|||++|..||.....                       ..
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------------~~  237 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------------TV  237 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------------GT
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------------HH
Confidence            543     248999999999988877 7899999999999999999999864211                       01


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .......   ......+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~---~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          238 EAAIHPP---YLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             TTCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCC---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111   113345789999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-43  Score=322.19  Aligned_cols=246  Identities=24%  Similarity=0.340  Sum_probs=193.8

Q ss_pred             cccccCccCCeeEEEEEecC----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe-cCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP-ESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  175 (380)
                      ..+.||+|+||.||+|...+    +..+|+|.+...       ......+.+.+|+.++++++||||+++++++. ..+.
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             hcceeeecCCceEEEEEEecCCCceeEEEEEecccC-------CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            45789999999999998632    235889988641       12344578899999999999999999999864 4567


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||++
T Consensus       102 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             eEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccc
Confidence            8999999999999999963   3456899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCC----------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCC-CCCCchhhhccCCCCHHHHHHHHHh
Q 047245          256 KLMPG----------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR-DPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       256 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      +....          ...+|+.|+|||.+.+..++.++||||||+++|||++|. .||...     .......   ....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~~~---~~~~  247 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----NTFDITV---YLLQ  247 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-----CTTTHHH---HHHT
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-----CHHHHHH---HHhc
Confidence            76532          223677899999999999999999999999999999955 454321     1111111   1111


Q ss_pred             hcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          325 AGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ..       .    ...+......+.+++.+||+.||++|||++|+++.|+++.
T Consensus       248 ~~-------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  290 (298)
T 3f66_A          248 GR-------R----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  290 (298)
T ss_dssp             TC-------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-------C----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            10       0    0111223456889999999999999999999999999863

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-43  Score=320.12  Aligned_cols=247  Identities=24%  Similarity=0.371  Sum_probs=198.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe--cCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP--ESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  177 (380)
                      ..+.||+|+||.||++... +|+.||+|.+....      ......+.+.+|+.++++++||||+++++++.  .....+
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A           10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             eehhccCCCCcEEEEEEECCCCcEEEEEEEEccc------CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            3468999999999999974 68999999997522      12344578999999999999999999999874  467899


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC-----eEecCCCCCcEEeCCCCceEEecc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ-----ILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      +||||+++|+|.+++.........+++..++.++.|++.||+|||   +.+     ++||||||+||+++.++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            999999999999999875555566999999999999999999999   666     999999999999999999999999


Q ss_pred             CCcccCCCC------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          253 GLAKLMPGS------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       253 gl~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      |+++.....      ..+++.|+|||.+.+..++.++||||||+++|||++|..||...        ...+....... +
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~i~~-~  231 (279)
T 2w5a_A          161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGKIRE-G  231 (279)
T ss_dssp             CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-T
T ss_pred             chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc--------CHHHHHHHHhh-c
Confidence            999876543      24889999999999999999999999999999999999998642        11111111111 1


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                      ..          ...+......+.+++.+||+.||++|||++|+++.+.
T Consensus       232 ~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          232 KF----------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             cc----------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            10          0111223456889999999999999999999997654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.2e-44  Score=331.65  Aligned_cols=249  Identities=21%  Similarity=0.334  Sum_probs=199.5

Q ss_pred             cccccCccCCeeEEEEEecC------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVLDN------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||++....      +..||+|.+....       .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        50 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-------HADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             EEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             eeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-------ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            56789999999999998632      2479999986521       233457889999999999 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhc----------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIREN----------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA  243 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~  243 (380)
                      +..++||||+++|+|.+++......          ...+++..++.++.|++.||+|||   +.+++||||||+||+++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECC
Confidence            9999999999999999999754321          346899999999999999999999   889999999999999999


Q ss_pred             CCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCC
Q 047245          244 EFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGS  314 (380)
Q Consensus       244 ~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~  314 (380)
                      ++.+||+|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||....    .   
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~----~---  272 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL----V---  272 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----S---
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc----h---
Confidence            99999999999975432        2236778999999999999999999999999999999 889985310    0   


Q ss_pred             HHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       315 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                       ..........+         .. ...+......+.+++.+||+.||.+|||+.|+++.|+++
T Consensus       273 -~~~~~~~~~~~---------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          273 -NSKFYKLVKDG---------YQ-MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -SHHHHHHHHHT---------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hHHHHHHHhcC---------CC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence             01111111111         00 011122345678999999999999999999999999876

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-42  Score=326.67  Aligned_cols=242  Identities=23%  Similarity=0.285  Sum_probs=188.1

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++......         .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            4578999999999999974 7899999999752211         15678999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc--eEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT--PRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kl~Dfgl~~~  257 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.  +||+|||+++.
T Consensus        95 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           95 MEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            999999999999874    346999999999999999999999   899999999999999987765  99999999874


Q ss_pred             CC-----CCCcCCCcccCcccccCCCCCCc-chhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          258 MP-----GSLIATSAYSAPECFQNRSYTDK-SDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       258 ~~-----~~~~~~~~y~aPE~~~~~~~~~~-sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ..     ....||+.|+|||.+.+..++.+ +||||||+++|||++|+.||...    ..................    
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----~~~~~~~~~~~~~~~~~~----  239 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP----EEPRDYRKTIQRILSVKY----  239 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCC----
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC----ccHHHHHHHHHHHhcCCC----
Confidence            32     23458999999999988887665 89999999999999999998631    111222222222221110    


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ..   .........+.+++.+||+.||++|||+.|+++
T Consensus       240 ---~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 ---SI---PDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ---CC---CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ---CC---CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence               00   000113455789999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.8e-42  Score=318.07  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=185.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|.. .+|+.||+|++......       .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A           10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-------GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------CEEEEEECSSSCCEEEEEEEECCSTT-------CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             eeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-------ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            46799999999999986 46899999999753211       11256778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          181 DYLQTGSLEDAMDRIRE--NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||++ |+|.+++.....  ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 599999875332  1245899999999999999999999   899999999999999999999999999999765


Q ss_pred             CC------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc-----
Q 047245          259 PG------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG-----  326 (380)
Q Consensus       259 ~~------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~-----  326 (380)
                      ..      ...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......    .+.. +.......     
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~-i~~~~~~~~~~~~  233 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKL-IFDIMGTPNESLW  233 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH-HHHHHCSCCTTTC
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHH-HHHHhCCCChhHh
Confidence            32      2358999999999976 468999999999999999999999986421110    0000 10100000     


Q ss_pred             -------------------chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 -------------------EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                         ...+.+.+..     .......+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHT-----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGC-----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccc-----cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                               0000011100     0112346889999999999999999999874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=328.61  Aligned_cols=240  Identities=22%  Similarity=0.317  Sum_probs=191.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC--CCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH--RNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++...+++.||+|++....      ........+.+|+.++.+++|  |||+++++++.+.+..++
T Consensus        13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A           13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             EEEEESCCSSEEEEEEECTTSCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            356899999999999999889999999997522      233455788999999999976  999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||| +.+|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++ ++.+||+|||+++..
T Consensus        87 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEe-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            999 568899999974    457899999999999999999999   88999999999999997 578999999999865


Q ss_pred             CC--------CCcCCCcccCcccccC-----------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH
Q 047245          259 PG--------SLIATSAYSAPECFQN-----------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       259 ~~--------~~~~~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      ..        ...||+.|+|||.+.+           ..++.++||||||+++|||++|+.||....       ......
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~  230 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKL  230 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHH
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------hHHHHH
Confidence            42        2358999999999864           678899999999999999999999986311       111111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                               ...+++.... ..+......+.+++.+||+.||.+|||+.|+++
T Consensus       231 ---------~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          231 ---------HAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             ---------HHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHHhcCCccc-CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                     1112211111 111122345789999999999999999999974

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-43  Score=326.45  Aligned_cols=249  Identities=20%  Similarity=0.362  Sum_probs=202.0

Q ss_pred             ccccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC
Q 047245          100 NENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES  173 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  173 (380)
                      ...+.||+|+||.||+|...      ++..||+|.+...       ........+.+|+.++++++||||+++++++.+.
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-------ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-------SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-------cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            35678999999999999864      3678999998641       1223456789999999999999999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhc------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCce
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIREN------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP  247 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~  247 (380)
                      +..++||||+++|+|.+++......      ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeE
Confidence            9999999999999999999864321      245789999999999999999999   8899999999999999999999


Q ss_pred             EEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHH
Q 047245          248 RLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       248 kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~  318 (380)
                      ||+|||+++....        ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...        .....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~~~~~  249 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQV  249 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHHHH
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--------CHHHH
Confidence            9999999975432        2236788999999999999999999999999999999 88887531        11222


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ........         .  ...+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus       250 ~~~~~~~~---------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          250 LRFVMEGG---------L--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             HHHHHTTC---------C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHcCC---------c--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            22221111         0  011123345688999999999999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.2e-43  Score=319.53  Aligned_cols=245  Identities=21%  Similarity=0.342  Sum_probs=195.9

Q ss_pred             cccccCccCCeeEEEEEecC----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...+    +..||+|.+...       ......+.+.+|+.++++++||||+++++++.++ ..
T Consensus        16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-------CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-------SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-------cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            45789999999999998643    336999998642       1233457899999999999999999999998754 56


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++++|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        88 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence            899999999999999974   2446899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .....       ..+++.|+|||.+.+..++.++||||||+++|||++ |+.||......     .   .......... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~---~~~~~~~~~~-  232 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----D---VIGVLEKGDR-  232 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----G---HHHHHHHTCC-
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----H---HHHHHhcCCC-
Confidence            65432       246778999999998899999999999999999998 99998531110     1   1111111100 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                                ...+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       233 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          233 ----------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence                      0111223455889999999999999999999999998864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.1e-43  Score=318.32  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=192.8

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|+.||+|++.....      .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEecCCCCeEEEEEEECCCCceEEEEeeeccCC------cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            467999999999999974 689999999975322      2233467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++ ++.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        81 e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             ecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            99975 67666653   2457999999999999999999999   88999999999999999999999999999976542


Q ss_pred             ------CCcCCCcccCcccccCCC-CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh---hcchhH
Q 047245          261 ------SLIATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH---AGEARE  330 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~  330 (380)
                            ...+|+.|+|||.+.+.. ++.++||||||+++|||++|..|+...       ....+.......   ......
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~-------~~~~~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-------NDVDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-------SSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC-------CCHHHHHHHHHHHhCCCChhh
Confidence                  235799999999998765 799999999999999999998886431       111111111111   000000


Q ss_pred             h--hch------------hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 A--LDR------------SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~--~~~------------~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +  ...            ..............+.+++.+|++.||++|||++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0  000            00000111223456789999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-43  Score=320.61  Aligned_cols=243  Identities=24%  Similarity=0.387  Sum_probs=192.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-CeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-SRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv  179 (380)
                      ..+.||+|+||.||++... |+.||+|.+....          ..+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus        25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             EEeEEecCCCceEEEEEEc-CCEEEEEEecchh----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            4578999999999999874 8999999986421          236788999999999999999999997554 478999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++....  ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            99999999999997522  334889999999999999999999   8999999999999999999999999999987654


Q ss_pred             C---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 G---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .   ...+++.|+|||.+.+..++.++||||||+++|||++ |..||....        ..+......          ..
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~~----------~~  230 (278)
T 1byg_A          169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVE----------KG  230 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--------GGGHHHHHT----------TT
T ss_pred             ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHh----------cC
Confidence            3   2347889999999998999999999999999999998 999986311        111111111          11


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .. ...+......+.+++.+||+.||++|||+.|+++.|++++
T Consensus       231 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          231 YK-MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            00 1111234456889999999999999999999999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.5e-43  Score=326.90  Aligned_cols=239  Identities=21%  Similarity=0.287  Sum_probs=194.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... +|+.||+|++.....     ........+..|..++..+ +||||+++++++.+.+..++
T Consensus        21 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           21 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            4578999999999999974 689999999975210     0112235677899999877 99999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        96 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999974    346899999999999999999999   899999999999999999999999999999754


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      ....||+.|+|||.+.+..++.++||||||+++|||++|..||...        +............      
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~------  234 (345)
T 1xjd_A          169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------DEEELFHSIRMDN------  234 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC------
T ss_pred             ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHhCC------
Confidence            2      2345899999999999999999999999999999999999998631        1122222221110      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH-hHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD-ELV  371 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl  371 (380)
                            ...+......+.+++.+||+.||++||++. |++
T Consensus       235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  011122345678999999999999999997 554

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-42  Score=316.39  Aligned_cols=241  Identities=20%  Similarity=0.303  Sum_probs=195.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... +++.||+|++......      ......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG------SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT------SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc------cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999975 7899999999753221      22346788999999999 99999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---------------
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---------------  243 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---------------  243 (380)
                      ||||+++|+|.+++.........+++..++.++.|++.||+|||   +.+++||||||+||+++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999865544567999999999999999999999   899999999999999984               


Q ss_pred             ----CCceEEeccCCcccCCC--CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHH
Q 047245          244 ----EFTPRLADFGLAKLMPG--SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLG  316 (380)
Q Consensus       244 ----~~~~kl~Dfgl~~~~~~--~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~  316 (380)
                          ...+||+|||.+.....  ...+++.|+|||.+.+. .++.++||||||+++|||++|..|+...          .
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----------D  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----------H
T ss_pred             ccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----------h
Confidence                44799999999986653  34589999999999875 5668999999999999999998775421          0


Q ss_pred             HHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          317 RWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+. ... .+.     .+     ..+......+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~-~~~-~~~-----~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 QWH-EIR-QGR-----LP-----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHH-HHH-TTC-----CC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH-HHH-cCC-----CC-----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            111 111 110     01     111223456889999999999999999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=326.89  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=191.3

Q ss_pred             cccccCccCCeeEEEEEe-cCCcE----EEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLT----VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~----vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||.||+|.. .+++.    ||+|.+.....       ....+.+.+|+.++++++||||+++++++.... 
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-------PKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS-------CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC-------HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            457899999999999996 34554    46666643211       112367889999999999999999999998765 


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++++||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            7899999999999999974   2446899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +.....        ..+++.|+|||.+.+..++.++||||||+++|||++ |..||......        .         
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~---------  227 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------E---------  227 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------G---------
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------H---------
Confidence            865321        236778999999999999999999999999999999 99998642110        1         


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                       ..+.+..... ...+......+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus       228 -~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          228 -ISSILEKGER-LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -HHHHHHTTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             1111111110 1112224456889999999999999999999999998864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.8e-43  Score=321.11  Aligned_cols=253  Identities=22%  Similarity=0.357  Sum_probs=192.1

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      .+.||+|+||.||++...+|+.||+|++.....      .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSG------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             hhhcccCCCEEEEEEEcCCCCEEEEEEEecccc------ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            467999999999999998899999999965321      11123667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++ +|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.... 
T Consensus        81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9975 99998863   2356899999999999999999999   89999999999999999999999999999875432 


Q ss_pred             -----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh-----
Q 047245          261 -----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR-----  329 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----  329 (380)
                           ...+|+.|+|||.+.+ ..++.++||||||+++|||++|..||.......    .+....+. .......     
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~-~~~~~~~~~~~~  228 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRI-LGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH-HCCCCTTTSTTG
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHH-HCCCChhhchhh
Confidence                 2358999999999976 458999999999999999999999986421100    01111110 0000000     


Q ss_pred             ---HhhchhccC------CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 ---EALDRSILG------EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ---~~~~~~~~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ...++....      ..........+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               000100000      0001123456789999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5e-43  Score=328.19  Aligned_cols=240  Identities=22%  Similarity=0.312  Sum_probs=183.1

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.||+|++....          ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            4568999999999999985 57899999997521          125678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.   ++.+||+|||+++
T Consensus       127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999863    446899999999999999999999   889999999999999975   8899999999998


Q ss_pred             cCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....     ...||+.|+|||.+.+..++.++||||||+++|||++|..||....       ..............    
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~i~~~~~----  268 (349)
T 2w4o_A          200 IVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER-------GDQFMFRRILNCEY----  268 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT-------CHHHHHHHHHTTCC----
T ss_pred             ccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc-------ccHHHHHHHHhCCC----
Confidence            6543     2358999999999999999999999999999999999999986311       11111111111100    


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .. ...........+.+++.+||+.||++|||+.|+++
T Consensus       269 ---~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          269 ---YF-ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ---CC-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cc-CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00 00111234456889999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-43  Score=325.85  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=191.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC----e
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS----R  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  175 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ........+.+|+.++++++||||+++++++....    .
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-----RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-----TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             EEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-----CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            457899999999999996 6789999999975322     23345578899999999999999999999986543    3


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+++|+|.++++.    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            4999999999999999974    346899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +....         ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...        .............
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--------~~~~~~~~~~~~~  235 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVRED  235 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhcCC
Confidence            76532         134899999999999999999999999999999999999998641        1112222211111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH-HHHhc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV-PMLTQ  376 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl-~~L~~  376 (380)
                      ...    +..    ........+.+++.+||+.||++||++.+++ ..+.+
T Consensus       236 ~~~----~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          236 PIP----PSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             CCC----HHH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCC----ccc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            100    000    0011345578999999999999999776654 44443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.3e-43  Score=316.99  Aligned_cols=241  Identities=25%  Similarity=0.387  Sum_probs=177.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|.+.....     ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-----YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeeeecCCCceEEEEEEEccCCceEEEEEeehhhh-----hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            456899999999999997 5789999999964210     1112246788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999873   3457899999999999999999999   8899999999999999999999999999997654


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...+++.|+|||.+.+..++.++||||||+++|||++|+.||......    .    ...         ....
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~----~~~---------~~~~  226 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK----N----TLN---------KVVL  226 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH----H----HHH---------HHhh
Confidence            2      235889999999999989999999999999999999999998641100    0    000         0000


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..   ...+......+.+++.+||+.||++|||++++++
T Consensus       227 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          227 AD---YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SC---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc---cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            00   0111223456789999999999999999999975

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=325.99  Aligned_cols=257  Identities=23%  Similarity=0.335  Sum_probs=200.4

Q ss_pred             cccccCccCCeeEEEEEe-----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-
Q 047245          101 ENRLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  174 (380)
                      ..+.||+|+||.||++..     .+|+.||+|++...        .....+.+.+|+.++++++||||+++++++...+ 
T Consensus        45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--------CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            457899999999999984     46899999998651        2234578999999999999999999999987654 


Q ss_pred             -eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          175 -RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       175 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                       ..++|+||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCc
Confidence             68999999999999999974   2346899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhc----cCCCCHHHHHH
Q 047245          254 LAKLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA----ASGGSLGRWLR  320 (380)
Q Consensus       254 l~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~----~~~~~l~~~~~  320 (380)
                      ++......         ..++..|+|||.+.+..++.++||||||+++|||++|..|+.....+.    ...........
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            99865432         236677999999998889999999999999999999999876321110    00000000000


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                            ...+.+..... ...+...+..+.+++.+||+.||++|||+.|+++.|++++
T Consensus       271 ------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          271 ------HLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             ------HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  01111111110 1112234566889999999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-43  Score=340.45  Aligned_cols=240  Identities=22%  Similarity=0.274  Sum_probs=189.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus       152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-----VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----C-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-----hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            457899999999999986 5689999999975211     1223346678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++..
T Consensus       227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999999999874    346899999999999999999999   7 89999999999999999999999999999764


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...        .............      
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~------  365 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMEE------  365 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC------
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC--------CHHHHHHHHHhCC------
Confidence            3      2345899999999999999999999999999999999999998631        1112222211111      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                            ...+......+.+++.+||+.||.+||     |++|+++
T Consensus       366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  011122345688999999999999999     9999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.6e-42  Score=314.16  Aligned_cols=240  Identities=22%  Similarity=0.321  Sum_probs=193.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... ++..+|+|++......        ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A           13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--------DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            4568999999999999974 5778999998753221        136788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe---CCCCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfgl~~  256 (380)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++   +.++.+||+|||++.
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           85 MELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999874    346899999999999999999999   8999999999999999   788999999999997


Q ss_pred             cCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....     ...+|+.|+|||.+.+. ++.++||||||+++|||++|..||...        ...............   
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~---  225 (277)
T 3f3z_A          158 RFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP--------TDSEVMLKIREGTFT---  225 (277)
T ss_dssp             ECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCC---
T ss_pred             eccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCCC---
Confidence            6542     34589999999998654 899999999999999999999998641        111111111111000   


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           ............+.+++.+|++.||++|||+.++++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 -----FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000000023456889999999999999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.7e-43  Score=337.88  Aligned_cols=240  Identities=25%  Similarity=0.400  Sum_probs=196.9

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|... +|+.||||++.....     ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-----RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH-----HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4568999999999999974 799999999975210     1112346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999863    456999999999999999999999   9999999999999999999999999999998654


Q ss_pred             C-----CCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G-----SLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .     ...||+.|+|||.+.+..+ +.++||||||+++|||++|..||...        ............        
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~--------~~~~~~~~i~~~--------  231 (476)
T 2y94_A          168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD--------HVPTLFKKICDG--------  231 (476)
T ss_dssp             TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS--------SSHHHHHHHHTT--------
T ss_pred             ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC--------CHHHHHHHHhcC--------
Confidence            3     2458999999999988765 68999999999999999999998641        112222222111        


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ..   ..+......+.+++.+||+.||.+|||++|+++
T Consensus       232 -~~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          232 -IF---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -Cc---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence             00   011123345789999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.5e-43  Score=331.04  Aligned_cols=240  Identities=21%  Similarity=0.313  Sum_probs=191.4

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--CCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++...+++.||||++....      ........+.+|+.++++++  ||||+++++++...+..++
T Consensus        60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc------ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            457899999999999998889999999997522      13345678999999999996  5999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||| +.+++|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus       134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            999 568899999974    347899999999999999999999   99999999999999995 589999999999865


Q ss_pred             CC--------CCcCCCcccCcccccC-----------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH
Q 047245          259 PG--------SLIATSAYSAPECFQN-----------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       259 ~~--------~~~~~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      ..        ...||+.|+|||.+.+           ..++.++|||||||++|||++|..||....       ......
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~  277 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKL  277 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHH
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHH
Confidence            32        2458999999999865           468899999999999999999999986311       111111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .         ..+++.... ..+......+.+++.+||+.||++|||+.|+++
T Consensus       278 ~---------~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          278 H---------AIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             H---------HHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H---------HHhCccccC-CCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1         112211110 111112345789999999999999999999974

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9e-43  Score=325.28  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHc--CCCCCcceeeEEEecCC---
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS--LRHRNLMSLRAYVPESS---  174 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---  174 (380)
                      ...+.||+|+||.||++.. +|+.||+|++...           ....+.+|.+++..  ++||||+++++++....   
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           45 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             EEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             EEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            3567899999999999998 5899999998541           12566778888887  78999999999998776   


Q ss_pred             -eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeEecCCCCCcEEeCCCCceE
Q 047245          175 -RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC-----NPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       175 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                       ..++||||+++|+|.+++..     ..+++..++.++.|++.||+|||...     +.+++||||||+||+++.++.+|
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence             78999999999999999973     36899999999999999999999321     46899999999999999999999


Q ss_pred             EeccCCcccCCC----------CCcCCCcccCcccccCC------CCCCcchhhHHHHHHHHHHhC----------CCCC
Q 047245          249 LADFGLAKLMPG----------SLIATSAYSAPECFQNR------SYTDKSDIFSFGMILAVLLTG----------RDPT  302 (380)
Q Consensus       249 l~Dfgl~~~~~~----------~~~~~~~y~aPE~~~~~------~~~~~sDv~s~Gvil~el~tg----------~~p~  302 (380)
                      |+|||++.....          ...+++.|+|||.+.+.      .++.++||||||+++|||++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            999999865332          23589999999999765      234689999999999999999          6676


Q ss_pred             CchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          303 APFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       303 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ...   .........+........     ..+.+.......+....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       268 ~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          268 YDL---VPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             TTT---SCSSCCHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccc---CcCcccHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            531   111222333333222111     11111111122356778999999999999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.5e-42  Score=324.39  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=198.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... +|+.||||++................+.+.+|+.+++++ +||||+++++++...+..++
T Consensus        98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  177 (365)
T 2y7j_A           98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL  177 (365)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred             cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence            4478999999999999985 799999999976433222223344567889999999999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus       178 v~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          178 VFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             EECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            9999999999999974    346899999999999999999999   889999999999999999999999999998765


Q ss_pred             CC-----CCcCCCcccCcccccC------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          259 PG-----SLIATSAYSAPECFQN------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       259 ~~-----~~~~~~~y~aPE~~~~------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ..     ...||+.|+|||.+.+      ..++.++||||||+++|||++|..||...        ..............
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--------~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--------RQILMLRMIMEGQY  322 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCC
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCC
Confidence            43     2458999999999863      35889999999999999999999998631        11111111111100


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .  ....     ........+.+++.+||+.||++|||+.|+++
T Consensus       323 -~--~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          323 -Q--FSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -C--CCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -C--CCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0  0000     00112345889999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.2e-42  Score=315.96  Aligned_cols=248  Identities=20%  Similarity=0.248  Sum_probs=194.8

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.||+|++.....     ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-----SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-----GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-----cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            4578999999999999974 688999999865221     2344567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++..    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999974    346899999999999999999999   8899999999999999999999999999987654


Q ss_pred             C-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          260 G-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .       ...+++.|+|||.+.+..++.++||||||+++|||++|..||....         .............    
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~~~~~~~----  252 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---------LSVMGAHINQAIP----  252 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---------HHHHHHHHHSCCC----
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---------HHHHHHHhccCCC----
Confidence            3       2358899999999999999999999999999999999999986411         1111111111100    


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCC-CHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-SSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~l  377 (380)
                      .+    .......+..+.+++.+||+.||++|| |++++++.|++.
T Consensus       253 ~~----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          253 RP----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             CG----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             Cc----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence            00    011122344578899999999999999 999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=331.72  Aligned_cols=260  Identities=14%  Similarity=0.127  Sum_probs=192.0

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhc----HHHHHHHHHHHHHHHcCCCCCcceeeEEEec
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQN----KSVKRRIQQELEVLASLRHRNLMSLRAYVPE  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  172 (380)
                      ..+.||+|+||.||++...    ++..+|+|+....... ...+.    ......+.+|+..++.++||||+++++++..
T Consensus        41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~  119 (345)
T 2v62_A           41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-LFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLT  119 (345)
T ss_dssp             EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH-HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEE
T ss_pred             EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc-hHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccc
Confidence            4578999999999999975    5788999998753210 00000    0112346789999999999999999999887


Q ss_pred             ----CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC--c
Q 047245          173 ----SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF--T  246 (380)
Q Consensus       173 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~--~  246 (380)
                          ....++||||+ +++|.+++..    ...+++..++.++.|++.||+|||   +.+++||||||+|||++.++  .
T Consensus       120 ~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          120 EFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             ESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             ccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence                67899999999 9999999874    237999999999999999999999   88999999999999998877  9


Q ss_pred             eEEeccCCcccCC-------------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCC
Q 047245          247 PRLADFGLAKLMP-------------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG  313 (380)
Q Consensus       247 ~kl~Dfgl~~~~~-------------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~  313 (380)
                      +||+|||+++...             ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......    .
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~  267 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD----P  267 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC----H
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc----c
Confidence            9999999997542             1235899999999999999999999999999999999999998531100    0


Q ss_pred             CHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       314 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ........... ......+......    ...+..+.+++.+||+.||++|||+++|++.|+++.
T Consensus       268 ~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 VAVQTAKTNLL-DELPQSVLKWAPS----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHH-HTTTHHHHHHSCT----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHHHhhc-ccccHHHHhhccc----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            00111111111 0111111111100    023446889999999999999999999999998763

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.6e-43  Score=326.27  Aligned_cols=248  Identities=24%  Similarity=0.421  Sum_probs=197.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcE--EEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLT--VAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||++... +|..  +|+|.+....       .....+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             ceeeeecCCCceEEEEEEccCCcccceeeeeecccc-------chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            4578999999999999864 5554  4899886421       122346788999999999 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHhh------------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC
Q 047245          177 YLVYDYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~  244 (380)
                      ++||||+++|+|.+++....            .....+++..++.++.|++.||+|||   +.+++||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCC
Confidence            99999999999999997532            12347999999999999999999999   8999999999999999999


Q ss_pred             CceEEeccCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHH
Q 047245          245 FTPRLADFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~  318 (380)
                      +.+||+|||+++....     ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...        .....
T Consensus       179 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--------~~~~~  250 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAEL  250 (327)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHH
T ss_pred             CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC--------cHHHH
Confidence            9999999999875331     2346788999999998889999999999999999998 99998631        11111


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .....          .... ...+......+.+++.+||+.||++|||++|+++.|+++
T Consensus       251 ~~~~~----------~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          251 YEKLP----------QGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             HHHGG----------GTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhh----------cCCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111          1100 011122345688999999999999999999999998875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-42  Score=325.19  Aligned_cols=235  Identities=23%  Similarity=0.268  Sum_probs=192.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... +|+.||+|++.....     ......+.+..|..++..+ +||||+++++++.+.+..++
T Consensus        24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4578999999999999975 478999999975211     0112246678899999998 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999974    346899999999999999999999   899999999999999999999999999999863


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...        .............      
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~~------  237 (353)
T 2i0e_A          172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHN------  237 (353)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC------
T ss_pred             ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCC------
Confidence            2      2345899999999999999999999999999999999999998631        1222222222111      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                            ...+......+.+++.+||+.||++||++
T Consensus       238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                  01112344568899999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=317.92  Aligned_cols=258  Identities=21%  Similarity=0.325  Sum_probs=192.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++....      ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            3468999999999999974 58999999986521      2334457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           81 FEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            999999999988763    456899999999999999999999   8999999999999999999999999999997654


Q ss_pred             C------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC-------CCCHHHHHHHHHhh
Q 047245          260 G------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS-------GGSLGRWLRHLQHA  325 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~-------~~~l~~~~~~~~~~  325 (380)
                      .      ...+++.|+|||.+.+ ..++.++||||||+++|||++|..||.........       ......+.......
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          154 GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            2      2358899999999976 67899999999999999999999998642111000       00000000000000


Q ss_pred             cchhHhhchhccCCc-----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILGEE-----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ..............     ........+.+++.+||+.||++|||++|+++
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 -QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             -GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             -cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             00000000000000     00123445789999999999999999999984

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-42  Score=324.24  Aligned_cols=189  Identities=29%  Similarity=0.392  Sum_probs=167.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-----CCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-----HRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||++.. .+++.||||++..         .....+.+..|+.+++.++     ||||+++++++...+
T Consensus        39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECS---------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             EEEEEcccCCeEEEEEEECCCCeEEEEEEecc---------chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            457899999999999997 5788999999863         2233466778999999997     999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-----------
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-----------  243 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-----------  243 (380)
                      ..++||||+ +++|.+++..  .....+++..+..++.|++.||+|||   +.+++||||||+|||++.           
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchh
Confidence            999999999 8999999985  22345899999999999999999999   899999999999999975           


Q ss_pred             --------------CCceEEeccCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          244 --------------EFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       244 --------------~~~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                                    ++.+||+|||+++....   ...||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                          78999999999986543   34689999999999999999999999999999999999999964

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.5e-42  Score=318.76  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=198.9

Q ss_pred             ccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++... +|+.||+|.+.........  .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (321)
T 2a2a_A           15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--RGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL   92 (321)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc--cchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            35678999999999999974 6899999999764332211  11124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC----ceEEeccCC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF----TPRLADFGL  254 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfgl  254 (380)
                      ||||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++    .+||+|||+
T Consensus        93 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999973    446899999999999999999999   88999999999999999887    799999999


Q ss_pred             cccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          255 AKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       255 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      +.....     ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        ...+..........  
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~~--  235 (321)
T 2a2a_A          166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANITSVSY--  235 (321)
T ss_dssp             CEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHTTCC--
T ss_pred             ceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhccc--
Confidence            976543     235899999999999999999999999999999999999998631        11122222111100  


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ..++..     .......+.+++.+||+.||++|||++|+++
T Consensus       236 -~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 -DFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -CCCHHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -ccChhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             000000     0123345789999999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.6e-43  Score=322.71  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=190.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  179 (380)
                      .++||+|+||.||++.. .+|+.||||++.....        .....+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--------HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--------CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            36799999999999985 5789999999975321        1236788999999995 799999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc---eEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT---PRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.   +||+|||++.
T Consensus        90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999975    346899999999999999999999   889999999999999998766   9999999987


Q ss_pred             cCCC-------------CCcCCCcccCcccccC-----CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCC---H
Q 047245          257 LMPG-------------SLIATSAYSAPECFQN-----RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGS---L  315 (380)
Q Consensus       257 ~~~~-------------~~~~~~~y~aPE~~~~-----~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~---l  315 (380)
                      ....             ...||+.|+|||.+.+     ..++.++||||||+++|||++|..||............   .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            5431             1248999999999875     56889999999999999999999999642211100000   0


Q ss_pred             HHHHHHHHhhcchhHhhchhccCCcc--cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          316 GRWLRHLQHAGEAREALDRSILGEEV--EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......      ..+.+.........  .......+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          243 PACQNM------LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHH------HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhHHHH------HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            000000      00111110000000  0113456889999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-42  Score=331.28  Aligned_cols=240  Identities=20%  Similarity=0.298  Sum_probs=184.7

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHc-CCCCCcceeeEEEec----CCeE
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS-LRHRNLMSLRAYVPE----SSRF  176 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~  176 (380)
                      ++||+|+||.||++.. .+|+.||||++...             ..+.+|+.++.+ .+||||+++++++..    ....
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            6799999999999987 46889999998631             346678888744 489999999998865    5678


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEeccC
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADFG  253 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg  253 (380)
                      ++||||+++|+|.+++..  .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            999999999999999974  22346899999999999999999999   899999999999999997   7899999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      +++....     ...||+.|+|||.+.+..++.++|||||||++|||++|..||......... ......+   . .+..
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i---~-~~~~  284 (400)
T 1nxk_A          210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRI---R-MGQY  284 (400)
T ss_dssp             TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHH---H-HTCC
T ss_pred             cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHH---H-cCcc
Confidence            9986543     235899999999999999999999999999999999999999642111100 0111111   1 0100


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .  .. ..........+.+++.+||+.||++|||+.|+++
T Consensus       285 ----~--~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          285 ----E--FP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             ----C--CC-TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----c--CC-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                0  00 0001223456889999999999999999999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.7e-43  Score=324.20  Aligned_cols=250  Identities=23%  Similarity=0.356  Sum_probs=198.6

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||++..      .+++.||+|++...       ......+.+.+|+.++.++ +||||+++++++...
T Consensus        31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  103 (316)
T 2xir_A           31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  103 (316)
T ss_dssp             EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-------CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence            567899999999999984      35689999998642       1233456789999999999 799999999998765


Q ss_pred             C-eEEEEEeecCCCCHHHHHHHhhhc------------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEE
Q 047245          174 S-RFYLVYDYLQTGSLEDAMDRIREN------------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM  240 (380)
Q Consensus       174 ~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nil  240 (380)
                      + ..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||   +.+++||||||+||+
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil  180 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL  180 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEE
Confidence            4 589999999999999999753221            122789999999999999999999   889999999999999


Q ss_pred             eCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccC
Q 047245          241 LDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAAS  311 (380)
Q Consensus       241 l~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~  311 (380)
                      ++.++.+||+|||+++.....        ..+++.|+|||.+.+..++.++||||||+++|||++ |..||....     
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----  255 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-----  255 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc-----
Confidence            999999999999999865432        236778999999999999999999999999999998 999985310     


Q ss_pred             CCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          312 GGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       312 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                        ..............           ...+......+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus       256 --~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          256 --IDEEFCRRLKEGTR-----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             --CSHHHHHHHHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --hhHHHHHHhccCcc-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              00111111111110           0111223455889999999999999999999999998763

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.5e-42  Score=313.93  Aligned_cols=240  Identities=22%  Similarity=0.338  Sum_probs=197.5

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.+|+|.+......     .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-----KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-----CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            4578999999999999975 5789999998753221     234457888999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999998864    346899999999999999999999   8899999999999999999999999999997653


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        ...+.........       
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~-------  231 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--------CLKETYLRIKKNE-------  231 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTTC-------
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhhcc-------
Confidence            2      235889999999999989999999999999999999999998641        1111111111110       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        .   ..+......+.+++.+||+.||++|||++|+++
T Consensus       232 --~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          232 --Y---SIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             --C---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --C---CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence              0   111223345788999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=323.42  Aligned_cols=243  Identities=22%  Similarity=0.313  Sum_probs=181.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEe-------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVP-------  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------  171 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++...        .....+.+.+|+.++.++. ||||+++++++.       
T Consensus        32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             EEEEEccCCceEEEEEEECCCCcEEEEEEecCC--------chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            557899999999999996 47899999998651        2334577889999999995 999999999983       


Q ss_pred             -cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeCCCCceE
Q 047245          172 -ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       172 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~~~~~~k  248 (380)
                       .....++|+||++ |+|.+++.... ....+++..++.++.|++.||+|||   +.+  ++||||||+|||++.++.+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence             3456899999996 79999987533 2446999999999999999999999   888  99999999999999999999


Q ss_pred             EeccCCcccCCC------------------CCcCCCcccCcccc---cCCCCCCcchhhHHHHHHHHHHhCCCCCCchhh
Q 047245          249 LADFGLAKLMPG------------------SLIATSAYSAPECF---QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA  307 (380)
Q Consensus       249 l~Dfgl~~~~~~------------------~~~~~~~y~aPE~~---~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~  307 (380)
                      |+|||+++....                  ...+++.|+|||.+   .+..++.++||||||+++|||++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            999999986543                  22388899999998   567789999999999999999999999863100


Q ss_pred             hccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          308 EAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       308 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .                     +.+...... .........+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus       259 ~---------------------~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          259 L---------------------RIVNGKYSI-PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             ----------------------------CCC-CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---------------------HhhcCcccC-CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0                     000000000 000112233778999999999999999999999998763

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-42  Score=328.01  Aligned_cols=241  Identities=22%  Similarity=0.295  Sum_probs=186.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHH-HHcCCCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV-LASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... ++..||+|++......     .......+..|..+ ++.++||||+++++++.+.+..++
T Consensus        42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4578999999999999974 5889999999763321     11223556667776 577899999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999999999999974    346889999999999999999999   899999999999999999999999999999752


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      ....||+.|+|||.+.+..++.++|+||||+++|||++|..||...        ............       
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~-------  254 (373)
T 2r5t_A          190 IEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------NTAEMYDNILNK-------  254 (373)
T ss_dssp             BCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------BHHHHHHHHHHS-------
T ss_pred             ccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhc-------
Confidence            2      2346899999999999999999999999999999999999998631        112222222211       


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM  373 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~  373 (380)
                        ..   ..+......+.+++.+||+.||.+||++.+.++.
T Consensus       255 --~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          255 --PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             --CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             --cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence              11   1112234557899999999999999998654433

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.1e-43  Score=319.47  Aligned_cols=248  Identities=27%  Similarity=0.387  Sum_probs=191.5

Q ss_pred             cccccCccCCeeEEEEEec--CCc--EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD--NGL--TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||++...  ++.  .||+|++.....     ......+.+.+|+.++++++||||+++++++.+.. .
T Consensus        22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4578999999999999853  333  689998865221     12234578899999999999999999999998765 8


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++|+||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence            9999999999999999742   346899999999999999999999   8899999999999999999999999999997


Q ss_pred             cCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .....         ..++..|+|||.+.+..++.++||||||+++|||++ |..||...        .............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~  241 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEG  241 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC--------CHHHHHHHHHccC
Confidence            65432         236778999999998889999999999999999999 99998631        1122222222111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .          ....+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus       242 ~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          242 E----------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             C----------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            0          01111234456889999999999999999999999998864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-43  Score=326.68  Aligned_cols=250  Identities=20%  Similarity=0.278  Sum_probs=192.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .++..||+|++.....   ........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  106 (345)
T 3hko_A           30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI---RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV  106 (345)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecceeeecCCeEEEEEEECCCCceEEEeehhhhhh---cccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence            567899999999999987 5688999999875211   001223457889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhc------------------------------------ccCCCHHHHHHHHHHHHHHHHHhHh
Q 047245          180 YDYLQTGSLEDAMDRIREN------------------------------------QLQLGWEVRLRIAVGVIKGLQYLHF  223 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~  223 (380)
                      |||+++|+|.+++......                                    ...+++..+..++.|++.||+||| 
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-  185 (345)
T 3hko_A          107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-  185 (345)
T ss_dssp             EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence            9999999999998521100                                    112356678899999999999999 


Q ss_pred             cCCCCeEecCCCCCcEEeCCCC--ceEEeccCCcccCC----------CCCcCCCcccCcccccC--CCCCCcchhhHHH
Q 047245          224 TCNPQILHYNLKPTNVMLDAEF--TPRLADFGLAKLMP----------GSLIATSAYSAPECFQN--RSYTDKSDIFSFG  289 (380)
Q Consensus       224 ~~~~~iiH~dlk~~Nill~~~~--~~kl~Dfgl~~~~~----------~~~~~~~~y~aPE~~~~--~~~~~~sDv~s~G  289 (380)
                        +.+++||||||+||+++.++  .+||+|||+++...          ....+|+.|+|||.+.+  ..++.++||||||
T Consensus       186 --~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          186 --NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             --HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             --HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence              88999999999999998776  89999999997532          13358999999999975  6789999999999


Q ss_pred             HHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHh
Q 047245          290 MILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDE  369 (380)
Q Consensus       290 vil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e  369 (380)
                      +++|||++|+.||...        ...+...........        ............+.+++.+||+.||.+|||+.|
T Consensus       264 ~il~el~~g~~pf~~~--------~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  327 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGV--------NDADTISQVLNKKLC--------FENPNYNVLSPLARDLLSNLLNRNVDERFDAMR  327 (345)
T ss_dssp             HHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCC--------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             HHHHHHHHCCCCCCCC--------ChHHHHHHHHhcccc--------cCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            9999999999998642        111112222211100        001111123456889999999999999999999


Q ss_pred             HHH
Q 047245          370 LVP  372 (380)
Q Consensus       370 vl~  372 (380)
                      +++
T Consensus       328 ~l~  330 (345)
T 3hko_A          328 ALQ  330 (345)
T ss_dssp             HHH
T ss_pred             Hhc
Confidence            986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.9e-42  Score=315.93  Aligned_cols=241  Identities=21%  Similarity=0.352  Sum_probs=195.1

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|.+....        ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A           13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--------AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--------ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            5578999999999999974 78999999997521        11235688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe---CCCCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++   ++++.+||+|||++.
T Consensus        85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           85 MQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             ECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999874    346899999999999999999999   8899999999999999   788999999999998


Q ss_pred             cCCCCC----cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          257 LMPGSL----IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       257 ~~~~~~----~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ......    .+++.|+|||.+.+..++.++||||||+++|||++|..||...        ..............     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i~~~~~-----  224 (304)
T 2jam_A          158 MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE--------TESKLFEKIKEGYY-----  224 (304)
T ss_dssp             CCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHCCC-----
T ss_pred             ecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCCC-----
Confidence            655432    3899999999999999999999999999999999999998631        11112222111110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .  . ...........+.+++.+||+.||++|||++|+++
T Consensus       225 ~--~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 E--F-ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             C--C-CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             C--C-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  0 01111223456889999999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.9e-43  Score=335.75  Aligned_cols=243  Identities=21%  Similarity=0.297  Sum_probs=193.8

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.||+|++.....     ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        73 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh-----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            4578999999999999974 588999999965210     0011124577899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       148 ~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             ECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            999999999999863     35889999999999999999999   8999999999999999999999999999997654


Q ss_pred             C-------CCcCCCcccCcccccCCC----CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          260 G-------SLIATSAYSAPECFQNRS----YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~~~~----~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .       ...||+.|+|||.+.+..    ++.++||||||+++|||++|+.||...        +............. 
T Consensus       220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~-  290 (410)
T 3v8s_A          220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKIMNHKN-  290 (410)
T ss_dssp             TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTHHH-
T ss_pred             cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--------ChhhHHHHHHhccc-
Confidence            3       345999999999998765    789999999999999999999999631        22222222221100 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCC--CCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPAD--RPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~  372 (380)
                        .+.  .  . ........+.+++.+|++.+|.+  ||+++|+++
T Consensus       291 --~~~--~--p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          291 --SLT--F--P-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             --HCC--C--C-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             --ccc--C--C-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence              000  0  0 00123456789999999999988  999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-42  Score=339.12  Aligned_cols=242  Identities=19%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ++||+|+||.||++.. .+|+.||+|++.....     ........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            5699999999999997 4699999999965211     111223678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+++|+|.+++.........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            99999999999754333557999999999999999999999   89999999999999999999999999999976542 


Q ss_pred             -----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          261 -----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                           ...||+.|+|||.+.+..++.++|||||||++|||++|..||...    .................         
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~----~~~~~~~~~~~~i~~~~---------  409 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR----GEKVENKELKQRVLEQA---------  409 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT----TCCCCHHHHHHHHHHCC---------
T ss_pred             CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC----ccchhHHHHHHHHhhcc---------
Confidence                 236999999999999999999999999999999999999998642    11112222222222111         


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD  368 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~  368 (380)
                         ...+......+.+++.+||+.||++||++.
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence               011123445678999999999999999763

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=330.81  Aligned_cols=261  Identities=21%  Similarity=0.304  Sum_probs=203.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC--eEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS--RFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~  177 (380)
                      ..+.||+|+||.||+|... +|+.||+|++.....       ....+.+.+|++++++++||||+++++++.+.+  ..+
T Consensus        13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A           13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-------cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            4578999999999999975 589999999975221       112366788999999999999999999998755  789


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe----CCCCceEEeccC
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFTPRLADFG  253 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~~kl~Dfg  253 (380)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+++||||||+|||+    +.++.+||+|||
T Consensus        86 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            9999999999999997532 2334899999999999999999999   8999999999999999    778889999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccC--------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQN--------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~--------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +++....     ...||+.|+|||.+.+        ..++.++||||||+++|||++|+.||......    ....+...
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~----~~~~~~~~  237 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY  237 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT----TTCHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc----cchHHHHH
Confidence            9986543     2458999999999865        56788999999999999999999998642111    11122222


Q ss_pred             HHHhhcchhHhhc--------------hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALD--------------RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ....... ...+.              ..-............+.+++.+||+.||++|||++|+++.++++
T Consensus       238 ~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          238 KIITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHHHSCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHhcCCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            2222111 00000              00001123466778889999999999999999999999988876

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=315.99  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=190.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC---CCCCcceeeEEEecCC--
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL---RHRNLMSLRAYVPESS--  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~--  174 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++...........   ....+.+|+.+++++   +||||+++++++....  
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG---LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC---CCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccc---cchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            457899999999999996 5789999999976432211111   113455666666666   5999999999997755  


Q ss_pred             ---eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          175 ---RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       175 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                         ..++||||++ |+|.+++..  .....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           90 REIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEee
Confidence               5799999997 599999974  22334899999999999999999999   88999999999999999999999999


Q ss_pred             cCCcccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh-
Q 047245          252 FGLAKLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA-  325 (380)
Q Consensus       252 fgl~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~-  325 (380)
                      ||+++.....     ..+|+.|+|||.+.+..++.++||||||+++|||++|+.||....        ..+........ 
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~  235 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--------EADQLGKIFDLI  235 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--------HHHHHHHHHHHH
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHh
Confidence            9999865432     358999999999999999999999999999999999999986421        11111111100 


Q ss_pred             --cchhHh----------hchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 --GEAREA----------LDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 --~~~~~~----------~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        .....+          +.+.....  ....+....+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence              000000          00000000  000123456789999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.6e-42  Score=318.46  Aligned_cols=240  Identities=22%  Similarity=0.337  Sum_probs=197.7

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.+|+|.+......     .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-----KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4578999999999999974 5789999998753221     234457889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999998864    346899999999999999999999   8899999999999999999999999999997653


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        ...+.........       
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~~~~~~-------  257 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--------CLKETYLRIKKNE-------  257 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTC-------
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC--------CHHHHHHHHhcCC-------
Confidence            2      235899999999999999999999999999999999999998631        1112111111110       


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .     ..+......+.+++.+||+.||++|||++|+++
T Consensus       258 ~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 Y-----SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0     011123345788999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=325.88  Aligned_cols=239  Identities=17%  Similarity=0.187  Sum_probs=193.1

Q ss_pred             cccccCccCCeeEEEEE------ecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEe
Q 047245          101 ENRLLGSSPDGKYYRTV------LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVP  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  171 (380)
                      ..+.||+|+||.||+|.      ..+++.||+|++....           ..++..|++++.+++   |+||+.+++++.
T Consensus        69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            45689999999999994      4578999999986411           256778888888886   999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-------
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-------  243 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-------  243 (380)
                      ..+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999986443 2457999999999999999999999   899999999999999998       


Q ss_pred             ----CCceEEeccCCcccCC--------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC
Q 047245          244 ----EFTPRLADFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS  311 (380)
Q Consensus       244 ----~~~~kl~Dfgl~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~  311 (380)
                          ++.+||+|||+++...        ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence                8999999999996432        23458999999999999999999999999999999999999985421110  


Q ss_pred             CCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCC-CCHHhHHHHHhcc
Q 047245          312 GGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADR-PSSDELVPMLTQL  377 (380)
Q Consensus       312 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R-Ps~~evl~~L~~l  377 (380)
                                        ..+..... ...   ....+.+++..|++.+|.+| |+++++.+.|+++
T Consensus       293 ------------------~~~~~~~~-~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 ------------------CKPEGLFR-RLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             ------------------EEECSCCT-TCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ------------------eeechhcc-ccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                              00111111 111   13346678899999999999 6778888877754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.3e-42  Score=310.99  Aligned_cols=240  Identities=20%  Similarity=0.346  Sum_probs=196.5

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... ++..||+|++.....     ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus        18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-----chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            4578999999999999974 578999999865210     1112236788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            999999999999975    346899999999999999999999   9999999999999999999999999999986544


Q ss_pred             C----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 G----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      .    ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        ............       +. 
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~~~~~-------~~-  229 (284)
T 2vgo_A          166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP--------SHTETHRRIVNV-------DL-  229 (284)
T ss_dssp             SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTT-------CC-
T ss_pred             ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC--------CHhHHHHHHhcc-------cc-
Confidence            3    345899999999999999999999999999999999999998641        111111111110       01 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          ..+......+.+++.+|++.||.+|||++|+++
T Consensus       230 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 ----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                111223455789999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=315.40  Aligned_cols=242  Identities=21%  Similarity=0.361  Sum_probs=192.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+||+|+||.||+|.. .++..||+|.+....        ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   98 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM   98 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--------C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence            34899999999999996 568899999987521        223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCcccCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLAKLMP  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~~~~~  259 (380)
                      ||+++++|.+++... .....+++..+..++.|++.||+|||   +.+++||||||+||+++. ++.+||+|||++....
T Consensus        99 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           99 EQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             ECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            999999999999752 22345678899999999999999999   889999999999999987 8999999999997654


Q ss_pred             C------CCcCCCcccCcccccCCC--CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 G------SLIATSAYSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .      ...+++.|+|||.+.+..  ++.++||||||+++|||++|+.||......      .........      ..
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~------~~  242 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGM------FK  242 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHH------HC
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhcc------cc
Confidence            2      345889999999997654  789999999999999999999998531100      000000000      00


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..     ...+......+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 VH-----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CC-----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cc-----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            01     1112233456789999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.7e-43  Score=323.65  Aligned_cols=249  Identities=21%  Similarity=0.340  Sum_probs=196.5

Q ss_pred             cccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|..      .++..||+|++...       ........+.+|+.++++++||||+++++++.+..
T Consensus        34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-------CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             EEEECC--CSSCEEEEEC--------CCEEEEEECCSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-------cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            557899999999999984      35778999998641       12334467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIREN---QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPR  248 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~k  248 (380)
                      ..++||||+++|+|.+++......   ...+++..++.++.|++.||+|||   +.+++||||||+||+++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence            999999999999999999863321   245899999999999999999999   889999999999999984   45699


Q ss_pred             EeccCCcccCC--------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++...        ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...        ......
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~--------~~~~~~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVL  255 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc--------CHHHHH
Confidence            99999986421        22347889999999998899999999999999999998 98998531        111222


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ........           ...+......+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       256 ~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          256 EFVTSGGR-----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcCCC-----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            22111110           0111223456889999999999999999999999998763

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.1e-42  Score=311.95  Aligned_cols=248  Identities=20%  Similarity=0.235  Sum_probs=194.3

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEE-ecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV-PESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++......          ..+.+|+.+++.++|++++..++++ .+....++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A           13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----------hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            456899999999999996 67899999998652211          3578899999999988877666655 66778899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC---CCCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD---AEFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfgl~  255 (380)
                      ||||+ +++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++   +++.+||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            99999 8999999974   2346999999999999999999999   89999999999999994   7889999999999


Q ss_pred             ccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          256 KLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       256 ~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      +....             ...+++.|+|||.+.+..++.++||||||+++|||++|+.||.....  .............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~  233 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--ATKRQKYERISEK  233 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC--SSSSSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc--hhhhhhhhhhccc
Confidence            75432             23589999999999999999999999999999999999999864211  1111111111111


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ...... ..+     .    ...+..+.+++.+||+.||++|||++++++.|+++
T Consensus       234 ~~~~~~-~~~-----~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          234 KMSTPI-EVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHSCH-HHH-----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ccCCch-HHH-----H----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            100000 000     0    11234588999999999999999999999999876

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.2e-42  Score=310.02  Aligned_cols=247  Identities=21%  Similarity=0.340  Sum_probs=197.1

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|.+.........  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   86 (283)
T 3bhy_A            9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR--RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLI   86 (283)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc--cchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEE
Confidence            4578999999999999975 6899999999764322111  111246788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC----ceEEeccCCc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF----TPRLADFGLA  255 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfgl~  255 (380)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++    .+||+|||++
T Consensus        87 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           87 LELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999974    346899999999999999999999   89999999999999998877    8999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      .....     ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        ..............   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~---  228 (283)
T 3bhy_A          160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE--------TKQETLTNISAVNY---  228 (283)
T ss_dssp             EECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTTCC---
T ss_pred             eeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc--------chHHHHHHhHhccc---
Confidence            86543     235889999999999999999999999999999999999998641        11111111111000   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .....     ........+.+++.+||+.||++|||+.|+++
T Consensus       229 ~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 DFDEE-----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCCHH-----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcch-----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00000     00123445789999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.6e-42  Score=312.74  Aligned_cols=248  Identities=20%  Similarity=0.235  Sum_probs=193.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEE-ecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV-PESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+++.||+|++.....          ...+.+|+.+++.++|+|++..++.+ .+.+..++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A           13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             EeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----------chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            457899999999999996 6789999998754221          13577899999999988877766655 66778899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe---CCCCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfgl~  255 (380)
                      ||||+ +++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||+   ++++.+||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            99999 9999999874   2446999999999999999999999   8999999999999999   78899999999999


Q ss_pred             ccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          256 KLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       256 ~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      +....             ...+|+.|+|||.+.+..++.++||||||+++|||++|+.||......  ............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~  233 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--TKRQKYERISEK  233 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SSSSHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh--hhhhhhhhhhcc
Confidence            75432             235899999999999999999999999999999999999999642111  111111111111


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ...... ..+     .    ...+..+.+++..||+.||++|||++++++.|+++
T Consensus       234 ~~~~~~-~~~-----~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          234 KMSTPI-EVL-----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHHSCH-HHH-----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             cccchh-hhh-----h----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            100000 000     0    11235688999999999999999999999999876

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-42  Score=316.22  Aligned_cols=245  Identities=21%  Similarity=0.332  Sum_probs=185.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....      ......+.+.++...++.++||||+++++++.+.+..++|
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A           11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             hHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            456899999999999997 578999999996521      1223334455566668888999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||++ |+|.+++.........+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 5999998865556678999999999999999999999   76 9999999999999999999999999999765


Q ss_pred             CCC-----CcCCCcccCcccc----cCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          259 PGS-----LIATSAYSAPECF----QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       259 ~~~-----~~~~~~y~aPE~~----~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ...     ..+++.|+|||.+    .+..++.++||||||+++|||++|..||...       ..............   
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~~~---  230 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW-------GTPFQQLKQVVEEP---  230 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC-------SCHHHHHHHHHHSC---
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc-------CchHHHHHHHhccC---
Confidence            432     3589999999996    5567899999999999999999999998631       11111111111111   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .+..    ........+.+++.+||+.||++|||++|+++
T Consensus       231 ---~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ---SPQL----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---CCCC----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCc----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence               0111    11223456889999999999999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.4e-43  Score=336.36  Aligned_cols=246  Identities=19%  Similarity=0.269  Sum_probs=194.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..++||+|+||.||++... +++.||+|++.....     ........+.+|..++..++||||+++++++.+.+..++|
T Consensus        78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh-----hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            4578999999999999975 478999999965210     0111123478899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       153 ~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             ECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            999999999999973   2356999999999999999999999   8999999999999999999999999999997653


Q ss_pred             C-------CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          260 G-------SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      .       ...||+.|+|||.+.     ...++.++|||||||++|||++|+.||...        +..+......... 
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--------~~~~~~~~i~~~~-  297 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHK-  297 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTHH-
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--------ChhHHHHhhhhcc-
Confidence            2       246899999999997     567899999999999999999999999631        1122222221110 


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCC--CCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPAD--RPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~  372 (380)
                        ..+.  .  ..........+.+++.+|++.+|++  ||+++|+++
T Consensus       298 --~~~~--~--p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          298 --ERFQ--F--PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             --HHCC--C--CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             --cccc--C--CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence              0000  0  1110123455788999999888888  999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.8e-42  Score=311.28  Aligned_cols=241  Identities=22%  Similarity=0.329  Sum_probs=194.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|.+.....       ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A           11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-------TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-------hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4568999999999999974 689999999975321       12346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      +||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            999999999998863    346899999999999999999999   8999999999999999999999999999987542


Q ss_pred             --------CCCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 --------GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 --------~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                              ....+++.|+|||.+.+..+ +.++||||||+++|||++|..||......      ...+.. .......  
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~--  227 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSD-WKEKKTY--  227 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHHH-HHTTCTT--
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHHH-hhhcccc--
Confidence                    23458999999999987765 77999999999999999999998642110      011111 1110000  


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                              ..........+.+++.+||+.||++|||++|+++
T Consensus       228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 --------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             --------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                    0011123445788999999999999999999875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-42  Score=326.22  Aligned_cols=189  Identities=30%  Similarity=0.488  Sum_probs=155.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCC--eE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESS--RF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~  176 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....      ......+.+.+|+.++.++. ||||+++++++...+  ..
T Consensus        13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A           13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF------QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             EEEC-------CEEEEEETTTCCEEEEEEECC--------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc------cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            456899999999999986 578999999986421      22344577889999999997 999999999997543  78


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||++ |+|.+++..     ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            99999997 599998873     36899999999999999999999   8999999999999999999999999999997


Q ss_pred             cCCC---------------------------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          257 LMPG---------------------------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       257 ~~~~---------------------------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      ....                           ...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            5421                           2358999999999976 6789999999999999999999999964

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.9e-42  Score=339.43  Aligned_cols=246  Identities=24%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus       188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            346899999999999997 4799999999965211     1112235678999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..  .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       263 mEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999874  22345899999999999999999999   8899999999999999999999999999998764


Q ss_pred             C-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .     ...||+.|+|||.+.+..++.++|||||||++|||++|..||...    .................        
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~----~~~~~~~~i~~~i~~~~--------  405 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR----KKKIKREEVERLVKEVP--------  405 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS----SSCCCHHHHHHHHHHCC--------
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc----ccchhHHHHHHHhhccc--------
Confidence            3     246899999999999999999999999999999999999998641    11111222222111110        


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                          ...+......+.+++.+||+.||.+||     +++|+++
T Consensus       406 ----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 ----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                111122345688999999999999999     6777763

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.3e-42  Score=323.95  Aligned_cols=258  Identities=23%  Similarity=0.387  Sum_probs=196.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|..||+|++...       ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        37 ~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           37 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-------cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            3467999999999999974 6899999998752       1234457899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++...
T Consensus       110 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            999999999999975    346899999999999999999999   64 8999999999999999999999999998643


Q ss_pred             ----CCCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC--------C-------------C
Q 047245          259 ----PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS--------G-------------G  313 (380)
Q Consensus       259 ----~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~--------~-------------~  313 (380)
                          .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.........        .             .
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             HHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             ccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence                23456899999999999999999999999999999999999998642111000        0             0


Q ss_pred             CHHHHHHHHHhhcchhHhhchhccC---CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          314 SLGRWLRHLQHAGEAREALDRSILG---EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       314 ~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....+...........+.++.....   ..........+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            0000000000001111111111100   1111123456889999999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2e-42  Score=331.83  Aligned_cols=249  Identities=23%  Similarity=0.362  Sum_probs=186.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+++.||+|++..................+.+|+.++++++||||+++++++.. +..++|
T Consensus       139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv  217 (419)
T 3i6u_A          139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIV  217 (419)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEE
T ss_pred             EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEE
Confidence            567899999999999986 468899999997633221111122233468899999999999999999999864 568999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC---CceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.+   ..+||+|||+++
T Consensus       218 ~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          218 LELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence            999999999888763    457999999999999999999999   8899999999999999754   459999999998


Q ss_pred             cCCCC-----CcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPGS-----LIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~~-----~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .....     ..||+.|+|||.+.+   ..++.++||||||+++|||++|..||...    .....+...+.    .+..
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~~i~----~~~~  362 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH----RTQVSLKDQIT----SGKY  362 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC----SSSCCHHHHHH----TTCC
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC----cchHHHHHHHh----cCCC
Confidence            76532     358999999999863   66788999999999999999999998631    11111111111    0100


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .  ..+.     ........+.+++.+||+.||++|||++|+++
T Consensus       363 ~--~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          363 N--FIPE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             C--CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C--CCch-----hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0  0000     00123456889999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-43  Score=334.55  Aligned_cols=237  Identities=17%  Similarity=0.212  Sum_probs=184.3

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHH---HHHHcCCCCCcceee-------EEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQEL---EVLASLRHRNLMSLR-------AYV  170 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~  170 (380)
                      .+.||+|+||.||+|.. .+|+.||||++......     .....+.+.+|+   +.+++++||||++++       +++
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-----PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-----CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-----chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            47899999999999996 56999999999753222     122347788999   566666899999998       666


Q ss_pred             ecCC-----------------eEEEEEeecCCCCHHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeE
Q 047245          171 PESS-----------------RFYLVYDYLQTGSLEDAMDRIREN---QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQIL  230 (380)
Q Consensus       171 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ii  230 (380)
                      .+.+                 ..++||||+ +|+|.+++......   ...+++..++.++.|++.||+|||   +.+++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            5543                 279999999 68999999853221   123456888999999999999999   88999


Q ss_pred             ecCCCCCcEEeCCCCceEEeccCCcccCCC---CCcCCCcccCcccccCC-----------CCCCcchhhHHHHHHHHHH
Q 047245          231 HYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNR-----------SYTDKSDIFSFGMILAVLL  296 (380)
Q Consensus       231 H~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~~~~-----------~~~~~sDv~s~Gvil~el~  296 (380)
                      ||||||+|||++.++.+||+|||+++....   ...| +.|+|||.+.+.           .++.++||||||+++|||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            999999999999999999999999986543   2346 999999999887           8999999999999999999


Q ss_pred             hCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          297 TGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       297 tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +|+.||......                  ...+.+....  .    .....+.+++.+||+.||++|||+.|+++
T Consensus       308 tg~~Pf~~~~~~------------------~~~~~~~~~~--~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          308 CADLPITKDAAL------------------GGSEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HSSCCC------------------------CCSGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HCCCCCcccccc------------------cchhhhhhhc--c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999998531100                  0011111100  1    12345788999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-42  Score=316.25  Aligned_cols=238  Identities=24%  Similarity=0.397  Sum_probs=195.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.||+|++.....       ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-------STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            456799999999999986 4689999999975321       12246788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++.     ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        99 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           99 MEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence            99999999999986     346899999999999999999999   8899999999999999999999999999997654


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        .............      .
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~------~  236 (303)
T 3a7i_A          171 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--------HPMKVLFLIPKNN------P  236 (303)
T ss_dssp             TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSC------C
T ss_pred             ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc--------CHHHHHHHhhcCC------C
Confidence            2      235889999999999999999999999999999999999998631        1111111111110      0


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +     .........+.+++.+||+.||++|||+.|+++
T Consensus       237 ~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          237 P-----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             C-----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C-----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1     111123445889999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.1e-42  Score=319.73  Aligned_cols=259  Identities=23%  Similarity=0.371  Sum_probs=193.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++....      ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             EEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeeEEeecCCEEEEEEEECCCCceEEEEEEecCC------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            3468999999999999974 58999999986522      2334457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.++...    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus       103 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          103 FEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            999999999887652    446999999999999999999999   8999999999999999999999999999997643


Q ss_pred             C------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccC-------CCCHHHHHHHHHhh
Q 047245          260 G------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAAS-------GGSLGRWLRHLQHA  325 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~-------~~~l~~~~~~~~~~  325 (380)
                      .      ...+++.|+|||.+.+. .++.++||||||+++|||++|+.||.........       ......+.......
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2      34589999999999875 7899999999999999999999998642111000       00000000000000


Q ss_pred             cchhHhhchhccCCcc----cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREALDRSILGEEV----EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ........+.......    .......+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000000000000    0123566889999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-41  Score=329.52  Aligned_cols=249  Identities=23%  Similarity=0.365  Sum_probs=188.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++.. .+|+.||||++...      .......+.+.+|+.+++.++||||+++++++...      
T Consensus        66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEESG------GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEECcc------ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            346799999999999986 46899999999752      12344557888999999999999999999998654      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+++ +|.+.+.      ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence            467999999976 5666664      24899999999999999999999   8899999999999999999999999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc-
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE-  327 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~-  327 (380)
                      +++....     ...||+.|+|||.+.+..++.++|||||||++|||++|+.||....       ....+.......+. 
T Consensus       210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-------~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-------YIDQWNKVIEQLGTP  282 (464)
T ss_dssp             CC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHHHCSC
T ss_pred             eeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHhcCCC
Confidence            9986543     2458999999999999999999999999999999999999996421       01111111100000 


Q ss_pred             --------------------------hhHhhchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 --------------------------AREALDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 --------------------------~~~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                                ....+...+...  .........+.+|+.+||+.||++|||++|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                      000000000000  011223567899999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=320.99  Aligned_cols=249  Identities=25%  Similarity=0.389  Sum_probs=187.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....      ......+.+.+|+.++++++||||+++++++...      
T Consensus        29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            346799999999999997 578999999986421      2334457889999999999999999999999765      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++||||+ +++|.+++..     ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence            3469999999 7899999873     46899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC---CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHH-hhcch
Q 047245          254 LAKLMPG---SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQ-HAGEA  328 (380)
Q Consensus       254 l~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~-~~~~~  328 (380)
                      +++....   ...+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||....        ..+...... ..+..
T Consensus       174 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          174 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--------HLDQLKEIMKVTGTP  245 (367)
T ss_dssp             TCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCCC
T ss_pred             cccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcCCC
Confidence            9987643   3458999999999887 679999999999999999999999986421        111111110 00000


Q ss_pred             hH-------------hhc--hhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 RE-------------ALD--RSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~-------------~~~--~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..             .+.  +.....   .........+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            00             000  000000   011123456889999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-41  Score=308.22  Aligned_cols=240  Identities=25%  Similarity=0.400  Sum_probs=190.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|.+....     .......+.+.+|+..++.++||||+++++++.+.+..++|
T Consensus        15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEeeecCCCCeEEEEEEECCCCceEEEEEecccc-----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            3468999999999999975 78999999986521     01112346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            999999999999974    346899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CC-----CcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 GS-----LIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~~-----~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      ..     ..+++.|+|||.+.+..+ +.++||||||+++|||++|..||...        ........... +.      
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~-~~------  227 (276)
T 2h6d_A          163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--------HVPTLFKKIRG-GV------  227 (276)
T ss_dssp             C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-CC------
T ss_pred             CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHHhhc-Cc------
Confidence            32     358899999999988765 68999999999999999999998641        11122221111 10      


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           ...+......+.+++.+||+.||++|||++|+++
T Consensus       228 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 -----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                 0011123345789999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=328.01  Aligned_cols=249  Identities=15%  Similarity=0.146  Sum_probs=193.7

Q ss_pred             cccccCccCCeeEEEEEec---------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcce------
Q 047245          101 ENRLLGSSPDGKYYRTVLD---------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS------  165 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------  165 (380)
                      ..+.||+|+||.||++...         +++.||+|.+...             ..+.+|+.++++++||||++      
T Consensus        46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            4578999999999999975         3889999998641             35778999999999999887      


Q ss_pred             ---------eeEEEec-CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCC
Q 047245          166 ---------LRAYVPE-SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLK  235 (380)
Q Consensus       166 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk  235 (380)
                               +++++.. ....++||||+ +++|.+++...  ....+++..++.++.|++.||+|||   +.+++|||||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dik  186 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVT  186 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCC
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCC
Confidence                     6777765 78899999999 99999999852  2357999999999999999999999   8899999999


Q ss_pred             CCcEEeCCCC--ceEEeccCCcccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCC
Q 047245          236 PTNVMLDAEF--TPRLADFGLAKLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD  300 (380)
Q Consensus       236 ~~Nill~~~~--~~kl~Dfgl~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~  300 (380)
                      |+||+++.++  .+||+|||+++....             ...+|+.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  999999999975431             2358999999999999999999999999999999999999


Q ss_pred             CCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          301 PTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       301 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ||.....   ....+...........  ....+..    .........+.+++.+||+.||++|||++++++.|+++
T Consensus       267 pf~~~~~---~~~~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          267 PWTNCLP---NTEDIMKQKQKFVDKP--GPFVGPC----GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TTGGGTT---CHHHHHHHHHHHHHSC--CCEECTT----SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CcccCCc---CHHHHHHHHHhccCCh--hhhhhhc----cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            9864210   0001111111111100  0000000    00011245688999999999999999999999999876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=328.56  Aligned_cols=245  Identities=20%  Similarity=0.280  Sum_probs=193.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ......+.+.+|..++..++||||+++++++.+.+..++|
T Consensus        65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-----LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            457899999999999997 4789999999964110     1111234578899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       140 mE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            9999999999999742   346899999999999999999999   8999999999999999999999999999997654


Q ss_pred             C-------CCcCCCcccCccccc-------CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          260 G-------SLIATSAYSAPECFQ-------NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       260 ~-------~~~~~~~y~aPE~~~-------~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      .       ...||+.|+|||.+.       ...++.++|||||||++|||++|+.||...        +..+........
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~  285 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--------STAETYGKIVHY  285 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTH
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhc
Confidence            3       236899999999997       457899999999999999999999998641        112222222111


Q ss_pred             cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCC---CCHHhHHH
Q 047245          326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADR---PSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps~~evl~  372 (380)
                      .   ..+.    ........+..+.+++.+||+ +|.+|   |+++|+++
T Consensus       286 ~---~~~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          286 K---EHLS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             H---HHCC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             c---cCcC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0   0000    011112234568899999999 99998   58888763

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=313.03  Aligned_cols=239  Identities=23%  Similarity=0.367  Sum_probs=191.7

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|.+.....          .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             EEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            4568999999999999974 589999999975211          25688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++....
T Consensus       103 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          103 MEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             eecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999999863   2457899999999999999999999   8999999999999999999999999999997654


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...+++.|+|||.+.+..++.++||||||+++|||++|..||...        .............      .
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~------~  242 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI--------HPMRAIFMIPTNP------P  242 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSC------C
T ss_pred             hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhcCC------C
Confidence            2      235889999999999999999999999999999999999998631        1111111111110      0


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +..   ..+......+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          243 PTF---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCC---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000   011223456889999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-41  Score=333.36  Aligned_cols=242  Identities=25%  Similarity=0.399  Sum_probs=190.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... ++..+|+|++.......      .....+.+|+.++++++||||+++++++.+....++|
T Consensus        41 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST------SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             EEEEEECC---EEEEEEETTTCCEEEEEEEEC-----------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc------hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4578999999999999974 68899999997632211      1136788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC---CceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.+   +.+||+|||+++
T Consensus       115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999998874    346899999999999999999999   8999999999999999764   559999999997


Q ss_pred             cCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....     ...||+.|+|||.+. ..++.++||||+|+++|+|++|..||...        ...+...........   
T Consensus       188 ~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~---  255 (494)
T 3lij_A          188 VFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ--------TDQEILRKVEKGKYT---  255 (494)
T ss_dssp             ECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCC---
T ss_pred             ECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCC---
Confidence            6543     345899999999886 56899999999999999999999998641        112222222211100   


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ++     .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       256 ~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 FD-----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CC-----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC-----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            00     0111223456889999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-42  Score=325.45  Aligned_cols=245  Identities=21%  Similarity=0.291  Sum_probs=193.6

Q ss_pred             cccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||.||++..    .+|+.||||++.......    .....+.+.+|+++++++ +||||+++++++...+.
T Consensus        58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE----EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh----hhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            457899999999999997    478999999986522100    011124566799999999 79999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999974    346899999999999999999999   889999999999999999999999999999


Q ss_pred             ccCCC-------CCcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPG-------SLIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~-------~~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +....       ...||+.|+|||.+.+  ..++.++||||||+++|||++|+.||...    .................
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~  282 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD----GEKNSQAEISRRILKSE  282 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT----TSCCCHHHHHHHHHHCC
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC----CccchHHHHHHHHhccC
Confidence            76532       2358999999999985  34789999999999999999999998631    11222233322222110


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                                  ...+......+.+++.+||+.||.+||     |++|+++
T Consensus       283 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          283 ------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence                        112223445678999999999999999     8888875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-41  Score=332.70  Aligned_cols=243  Identities=26%  Similarity=0.362  Sum_probs=195.4

Q ss_pred             ccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++... +|+.||+|++......      ......+.+|+.++++++||||+++++++.+....++
T Consensus        25 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK------NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc------chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            35678999999999999974 7899999999652211      1123678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC---CCCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD---AEFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfgl~  255 (380)
                      |+||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++   .++.+||+|||++
T Consensus        99 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            9999999999998874    346899999999999999999999   89999999999999995   4568999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      +....     ...||+.|+|||.+.+ .++.++||||+|+++|+|++|..||...        ...+...........  
T Consensus       172 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~--  240 (486)
T 3mwu_A          172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--------NEYDILKRVETGKYA--  240 (486)
T ss_dssp             TTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCC--
T ss_pred             eECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCC--
Confidence            76543     3458999999999875 5899999999999999999999998631        112222222111100  


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .   ..+.....+..+.+++.+||+.||.+|||+.|+++
T Consensus       241 ---~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          241 ---F---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ---S---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---C---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               0   00111223456889999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.3e-42  Score=319.82  Aligned_cols=245  Identities=20%  Similarity=0.325  Sum_probs=195.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... +|+.||+|++......      ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        33 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG------QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT------EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            3478999999999999874 6899999999763322      11236788999999999 57999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfgl~  255 (380)
                      ||||+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.   ++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a  181 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS  181 (327)
T ss_dssp             EEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred             EEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence            9999999999998853  22457999999999999999999999   889999999999999988   789999999999


Q ss_pred             ccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      +.....     ..+++.|+|||.+.+..++.++||||||+++|||++|..||...        .............    
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~----  249 (327)
T 3lm5_A          182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE--------DNQETYLNISQVN----  249 (327)
T ss_dssp             EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC----
T ss_pred             cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CchHHHHHHHhcc----
Confidence            865432     35899999999999999999999999999999999999998641        1111111111100    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .... ..........+.+++.+||+.||++|||++|+++
T Consensus       250 ---~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 ---VDYS-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ---CCCC-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---cccC-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence               0000 1111224456889999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.5e-42  Score=335.04  Aligned_cols=244  Identities=27%  Similarity=0.386  Sum_probs=196.6

Q ss_pred             ccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++... +|+.||||++.......     ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        29 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-----KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-----SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-----chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            35678999999999999974 78999999996532211     1224678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe---CCCCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfgl~  255 (380)
                      |+||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||+   +.++.+||+|||++
T Consensus       104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999999864    456899999999999999999999   8899999999999999   56789999999999


Q ss_pred             ccCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      +.....     ..||+.|+|||.+.+ .++.++||||+|+++|+|++|..||...        ...+...........  
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~~~--  245 (484)
T 3nyv_A          177 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA--------NEYDILKKVEKGKYT--  245 (484)
T ss_dssp             HHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCC--
T ss_pred             EEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCCCC--
Confidence            765433     248999999999876 6899999999999999999999998641        111222222111100  


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .   ..+.....+..+.+++.+||+.||.+|||+.|+++
T Consensus       246 ---~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 ---F---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---C---CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               0   00111234456889999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-41  Score=314.65  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=189.6

Q ss_pred             ccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||++.. .+|+.||||.+..................+.+|+.++++++||||+++++++.... .++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~l   91 (322)
T 2ycf_A           13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYI   91 (322)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEE
Confidence            3567899999999999987 46889999998653211111112233456889999999999999999999997765 899


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc---eEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT---PRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl~Dfgl~  255 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.   +||+|||++
T Consensus        92 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           92 VLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            9999999999998863    457899999999999999999999   899999999999999987654   999999999


Q ss_pred             ccCCCC-----CcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          256 KLMPGS-----LIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       256 ~~~~~~-----~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      +.....     ..+++.|+|||.+.   ...++.++||||||+++|||++|..||...    .....+...+..    +.
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~~~~~----~~  236 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH----RTQVSLKDQITS----GK  236 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST----TCSSCHHHHHHH----TC
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc----chHHHHHHHHHh----Cc
Confidence            876643     24899999999974   567899999999999999999999998631    111122221111    10


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..  ..+..     .......+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~--~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          237 YN--FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CC--CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cc--cCchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            00  00000     0123456889999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-41  Score=329.11  Aligned_cols=185  Identities=24%  Similarity=0.392  Sum_probs=149.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-----CC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-----SS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~  174 (380)
                      ..+.||+|+||.||++.. .+|+.||||++....      ......+.+.+|+.++++++||||+++++++..     ..
T Consensus        57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             ECCC-------CEEEEEECC--CEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             EeeEeeecCCeEEEEEEECCCCcEEEEEEechhh------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            457899999999999986 478999999986421      233445788999999999999999999999843     35


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++||||+ +|+|.+++..    ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence            789999998 5699998863    456999999999999999999999   88999999999999999999999999999


Q ss_pred             cccCCC---------------------------------CCcCCCcccCcccc-cCCCCCCcchhhHHHHHHHHHHhCC
Q 047245          255 AKLMPG---------------------------------SLIATSAYSAPECF-QNRSYTDKSDIFSFGMILAVLLTGR  299 (380)
Q Consensus       255 ~~~~~~---------------------------------~~~~~~~y~aPE~~-~~~~~~~~sDv~s~Gvil~el~tg~  299 (380)
                      ++....                                 ...||+.|+|||.+ ....++.++|||||||++|||++|.
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            986531                                 12479999999986 4667999999999999999999943

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.8e-42  Score=320.64  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=185.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....      ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH------EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEEecCCeEEEEEEECCCCceEEEEEEcccc------cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            457899999999999985 578999999996522      1223346778999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe-----CCCCceEEeccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-----DAEFTPRLADFGL  254 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill-----~~~~~~kl~Dfgl  254 (380)
                      |||++ |+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||+     +.++.+||+|||+
T Consensus       112 ~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            99997 499999874    346899999999999999999999   8899999999999999     4555699999999


Q ss_pred             cccCCC------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh-c
Q 047245          255 AKLMPG------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA-G  326 (380)
Q Consensus       255 ~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~-~  326 (380)
                      ++....      ...+|+.|+|||.+.+. .++.++||||||+++|||++|..||....        ..+........ +
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~~  255 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--------EIDQLFKIFEVLG  255 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHC
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--------HHHHHHHHHHHhC
Confidence            875432      23579999999999874 48999999999999999999999986421        11111111100 0


Q ss_pred             chhHh----h------c---hhccCCc----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREA----L------D---RSILGEE----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~----~------~---~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .....    .      .   +......    ........+.+++.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000    0      0   0000000    00112356789999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-42  Score=321.93  Aligned_cols=240  Identities=23%  Similarity=0.353  Sum_probs=190.5

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++... +|+.||+|++....            ....+|++++.++ +||||+++++++.+.+..++
T Consensus        26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            4578999999999999974 68899999997522            1234688888888 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC----CceEEeccCC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE----FTPRLADFGL  254 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~----~~~kl~Dfgl  254 (380)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||+.++    +.+||+|||+
T Consensus        94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999874    346899999999999999999999   8999999999999998543    3599999999


Q ss_pred             cccCCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          255 AKLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       255 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ++....      ...+|+.|+|||.+.+..++.++||||||+++|||++|..||...     ................ .
T Consensus       167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-----~~~~~~~~~~~i~~~~-~  240 (342)
T 2qr7_A          167 AKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG-----PDDTPEEILARIGSGK-F  240 (342)
T ss_dssp             CEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS-----TTSCHHHHHHHHHHCC-C
T ss_pred             cccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC-----CcCCHHHHHHHHccCC-c
Confidence            976532      235899999999998888999999999999999999999998631     1112222222222111 0


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            ... ..........+.+++.+||+.||++|||+.|+++
T Consensus       241 ------~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 ------SLS-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ------CCC-STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------ccC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  000 0111224456889999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.4e-43  Score=322.02  Aligned_cols=245  Identities=20%  Similarity=0.286  Sum_probs=191.5

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||+|...+  .+|+|++........      ..+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus        37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED------QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC------CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH------HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            45789999999999998753  599999875332211      1245678999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++ ++.+||+|||+++....
T Consensus       109 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          109 SLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             BCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            99999999999863   2346899999999999999999999   88999999999999998 67999999999765421


Q ss_pred             -----------CCcCCCcccCcccccC---------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          261 -----------SLIATSAYSAPECFQN---------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       261 -----------~~~~~~~y~aPE~~~~---------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                                 ...|++.|+|||.+.+         ..++.++||||||+++|||++|..||...        .......
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~  253 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------PAEAIIW  253 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--------CHHHHHH
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHH
Confidence                       1247889999999874         45788999999999999999999998641        1112222


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .....      ..+....    ......+.+++.+||+.||++|||+.++++.|++++
T Consensus       254 ~~~~~------~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          254 QMGTG------MKPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             HHHTT------CCCCCCC----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             HhccC------CCCCCCc----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            21111      1111111    112344789999999999999999999999999885

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.3e-41  Score=317.73  Aligned_cols=249  Identities=21%  Similarity=0.348  Sum_probs=186.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC-----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS-----  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  174 (380)
                      ..+.||+|+||.||++.. .+|+.||||++....      ......+.+.+|+.+++.++||||+++++++...+     
T Consensus        29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             EeeeeEecCCEEEEEEEECCCCceEEEEEecccc------CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            346799999999999986 468899999997521      12344577889999999999999999999997654     


Q ss_pred             -eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          175 -RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       175 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                       ..++||||+++ +|.+++.      ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence             78999999975 8888775      25889999999999999999999   8899999999999999999999999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh----
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH----  324 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~----  324 (380)
                      +++....     ...+|+.|+|||.+.+..++.++||||||+++|||++|+.||.....       ...+......    
T Consensus       173 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          173 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-------IDQWNKVIEQLGTP  245 (371)
T ss_dssp             C----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHC-CCCC
T ss_pred             cccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCC
Confidence            9986543     24589999999999999999999999999999999999999864211       1111110000    


Q ss_pred             -----------------hc------chhHhhchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 -----------------AG------EAREALDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 -----------------~~------~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                       ..      .....+.......  .........+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                             00      0000000000000  111234667899999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.5e-41  Score=315.86  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=189.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-------  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  172 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.......      .....+.+|+.++++++||||+++++++..       
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            457899999999999997 578999999986533221      112567789999999999999999999876       


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          173 -SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       173 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                       .+..++||||+++ +|.+.+..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             CCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence             4568999999975 88887763   2356999999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccCC----------CCCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          252 FGLAKLMP----------GSLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       252 fgl~~~~~----------~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      ||+++...          ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..||......     .....+.
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~  242 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALIS  242 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHH
Confidence            99997543          12347899999999876 55899999999999999999999998642111     0001111


Q ss_pred             HHHhhcc--hhHhhc---------hhccCCcccHH------HHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          321 HLQHAGE--AREALD---------RSILGEEVEED------EMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       321 ~~~~~~~--~~~~~~---------~~~~~~~~~~~------~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .......  .....+         ..........+      ....+.+++.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1100000  000000         00000000001      1344789999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=322.10  Aligned_cols=190  Identities=27%  Similarity=0.450  Sum_probs=152.9

Q ss_pred             cccccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe--cCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP--ESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  175 (380)
                      .+++||+|+||.||++...   ++..||+|++.....          ...+.+|+.++++++||||+++++++.  ....
T Consensus        25 ~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             SSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             cCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            4668999999999999964   578999999864211          146778999999999999999999994  4678


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe----CCCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIREN-----QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML----DAEFT  246 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill----~~~~~  246 (380)
                      .++||||++ |+|.+++......     ...+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCc
Confidence            999999996 5898888643321     224899999999999999999999   8999999999999999    67789


Q ss_pred             eEEeccCCcccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          247 PRLADFGLAKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      +||+|||+++....         ...||+.|+|||.+.+ ..++.++|||||||++|||++|..||..
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999986542         2358999999999987 4589999999999999999999999964

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-41  Score=341.95  Aligned_cols=244  Identities=20%  Similarity=0.347  Sum_probs=197.8

Q ss_pred             cccccCccCCeeEEEEEec----CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...    .+..||+|++...       ......+.+.+|+.++++++||||+++++++.+ +..
T Consensus       394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~  465 (656)
T 2j0j_A          394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-------TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV  465 (656)
T ss_dssp             EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-------TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence            4567999999999999873    2457999988641       123455789999999999999999999999854 568


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus       466 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            999999999999999974   2446899999999999999999999   8899999999999999999999999999998


Q ss_pred             cCCCC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPGS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      .....       ..+++.|+|||.+.+..++.++||||||+++|||++ |..||...        ...+.......... 
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--------~~~~~~~~i~~~~~-  610 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--------KNNDVIGRIENGER-  610 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHHTCC-
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHcCCC-
Confidence            76432       236678999999998999999999999999999997 99998631        11222222211110 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                                ...+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       611 ----------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                      111223445688999999999999999999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-41  Score=325.21  Aligned_cols=189  Identities=23%  Similarity=0.363  Sum_probs=164.1

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC------CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL------RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||++... +++.||||++..         .....+.+.+|+.+++.+      +|+||+++++++...
T Consensus       101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A          101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---------EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             EEEEEEESSSEEEEEEEETTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             EEEEcccCccEEEEEEEECCCCcEEEEEEECC---------ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            4578999999999999864 588999999964         223345677788877776      577999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc--eEEec
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT--PRLAD  251 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~--~kl~D  251 (380)
                      +..++||||+. ++|.+++..  .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             CeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEee
Confidence            99999999996 699999875  22345899999999999999999999   889999999999999999887  99999


Q ss_pred             cCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          252 FGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       252 fgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      ||+++....   ...+|+.|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus       246 FG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          246 FGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             CTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            999976543   34689999999999999999999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=318.17  Aligned_cols=252  Identities=20%  Similarity=0.288  Sum_probs=187.4

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++... +|+.||+|++......       .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-------ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            467999999999999974 7899999999652211       11123457999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++ |+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        80 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           80 EYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             ECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9997 599998874   2446899999999999999999999   89999999999999999999999999999876542


Q ss_pred             ------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh---H
Q 047245          261 ------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR---E  330 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~---~  330 (380)
                            ...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......     ....+..........   .
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-----QLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTT
T ss_pred             CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChHhchh
Confidence                  2357999999999876 568999999999999999999999986421110     011111111000000   0


Q ss_pred             hhc---------hhccCCc---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALD---------RSILGEE---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~---------~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...         +......   ........+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000         0000000   00112355789999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.7e-41  Score=308.28  Aligned_cols=249  Identities=23%  Similarity=0.378  Sum_probs=198.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCCh-hhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSP-EKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  177 (380)
                      ..+.||+|+||.||++... +|+.||+|.+........ ........+.+.+|+.++++++ ||||+++++++.+.+..+
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (298)
T 1phk_A           21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF  100 (298)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence            4578999999999999974 689999999976432211 1122345678889999999995 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++..
T Consensus       101 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A          101 LVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            99999999999999974    346899999999999999999999   89999999999999999999999999999976


Q ss_pred             CCC-----CCcCCCcccCccccc------CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          258 MPG-----SLIATSAYSAPECFQ------NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       258 ~~~-----~~~~~~~y~aPE~~~------~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ...     ...+++.|+|||.+.      ...++.++||||||+++|||++|..||...        .............
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~  245 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------KQMLMLRMIMSGN  245 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--------cHHHHHHHHhcCC
Confidence            543     235889999999985      456889999999999999999999998531        1111112111111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .       .. ...........+.+++.+||+.||++|||+.|+++
T Consensus       246 ~-------~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 Y-------QF-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             C-------CC-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             c-------cc-CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            0       00 00111234456889999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-41  Score=331.03  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=192.4

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCCh-----hhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSP-----EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||++... ++..||+|++........     ........+.+.+|+.++++++||||+++++++.+..
T Consensus        40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  119 (504)
T 3q5i_A           40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK  119 (504)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            4578999999999999974 578999999976322110     0001123467889999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC---ceEEec
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF---TPRLAD  251 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~---~~kl~D  251 (380)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++   .+||+|
T Consensus       120 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          120 YFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999999999999874    346999999999999999999999   89999999999999998775   699999


Q ss_pred             cCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          252 FGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       252 fgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ||++.....     ...||+.|+|||.+. +.++.++||||+|+++|+|++|..||...        .............
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~~  263 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ--------NDQDIIKKVEKGK  263 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCC
Confidence            999986543     345899999999987 46899999999999999999999998641        1122222222111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..   .+..     .....+..+.+++.+||+.||.+|||++|+++
T Consensus       264 ~~---~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          264 YY---FDFN-----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CC---CCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC---CCcc-----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00   0000     00123456889999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.6e-42  Score=312.79  Aligned_cols=241  Identities=23%  Similarity=0.329  Sum_probs=190.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|..+|+|.+....        ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--------EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             EEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            3467999999999999985 58899999986521        11236788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC-
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~-  258 (380)
                      |||+++++|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++... 
T Consensus        95 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999874   2446899999999999999999999   889999999999999999999999999987432 


Q ss_pred             -----CCCCcCCCcccCcccc-----cCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          259 -----PGSLIATSAYSAPECF-----QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       259 -----~~~~~~~~~y~aPE~~-----~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                           .....+++.|+|||.+     .+..++.++||||||+++|||++|..||...        .............. 
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~-  239 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSDP-  239 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCC-
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC--------CHHHHHHHHhccCC-
Confidence                 2334689999999998     4677899999999999999999999998642        11111111111110 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           +.   ...+......+.+++.+||+.||++|||+.++++
T Consensus       240 -----~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 -----PT---LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----CC---CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----cc---cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 00   0111223456889999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=318.71  Aligned_cols=254  Identities=25%  Similarity=0.306  Sum_probs=190.3

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++.......   ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            4578999999999999974 68999999987522111   1112235678999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++ +|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        91 ~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           91 FDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             EECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             EEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999986 89888863   3456888999999999999999999   8999999999999999999999999999998654


Q ss_pred             C------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh-hcc--hh
Q 047245          260 G------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH-AGE--AR  329 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~-~~~--~~  329 (380)
                      .      ...+|+.|+|||.+.+. .++.++||||||+++|||++|..||...        ...+....... .+.  ..
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~--------~~~~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--------SDLDQLTRIFETLGTPTEE  235 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHHHCCCCTT
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHHcCCCChh
Confidence            2      23589999999999764 5889999999999999999999998632        11111111111 000  00


Q ss_pred             Hhhc------hhccC--Ccc-----cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALD------RSILG--EEV-----EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~------~~~~~--~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+-+      .....  ...     .......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0000      00000  000     0123456889999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.5e-42  Score=325.21  Aligned_cols=248  Identities=11%  Similarity=0.023  Sum_probs=176.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHH---HHHHcCCCCCcceee-------EE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQEL---EVLASLRHRNLMSLR-------AY  169 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  169 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++......     .....+.+.+|+   ..++. +||||++++       ++
T Consensus        66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-----SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-----HHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-----cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            457899999999999996 47899999999863221     233456677784   55555 799988754       44


Q ss_pred             EecC-----------------CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHH------HHHHHHHHHHHHHhHhcCC
Q 047245          170 VPES-----------------SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVR------LRIAVGVIKGLQYLHFTCN  226 (380)
Q Consensus       170 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~  226 (380)
                      +...                 ...++||||++ |+|.+++....   ..+.+..+      +.++.|++.||+|||   +
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~  212 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQ---S  212 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHH---H
Confidence            4322                 34799999998 89999998532   23455566      788899999999999   8


Q ss_pred             CCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC---CcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCC
Q 047245          227 PQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS---LIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDP  301 (380)
Q Consensus       227 ~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~---~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p  301 (380)
                      .+++||||||+|||++.++.+||+|||+++.....   ..+++.|+|||.+.+  ..++.++||||||+++|||++|+.|
T Consensus       213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999999876643   357799999999987  7799999999999999999999999


Q ss_pred             CCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          302 TAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       302 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      |...........          ............... .........+.+++.+||+.||++|||+.|+++
T Consensus       293 f~~~~~~~~~~~----------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          293 FGLVTPGIKGSW----------KRPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TTBCCTTCTTCC----------CBCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCcCcccccch----------hhhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            975311111000          000000000000000 001123556889999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.1e-41  Score=313.38  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEec--CCeE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPE--SSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~  176 (380)
                      ..+.||+|+||.||++.. .+++.||+|++....           .+.+.+|+.++++++ ||||+++++++.+  ....
T Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             EEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            456899999999999986 678999999986411           266889999999996 9999999999987  6678


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLA  255 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~  255 (380)
                      ++||||+++++|.+++.       .+++..+..++.|++.||+|||   +.+++||||||+|||++.++ .+||+|||++
T Consensus       109 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a  178 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  178 (330)
T ss_dssp             EEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence            99999999999999875       3888999999999999999999   89999999999999999776 8999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          256 KLMPG-----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      +....     ...+++.|+|||.+.+ ..++.++||||||+++|||++|..||.......   ..+..... ........
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~l~~~~~-~~~~~~~~  254 (330)
T 3nsz_A          179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAK-VLGTEDLY  254 (330)
T ss_dssp             EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH---HHHHHHHH-HHCHHHHH
T ss_pred             eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH---HHHHHHHH-hcCCchhh
Confidence            76542     2358889999999977 678999999999999999999999985311110   00111100 00111111


Q ss_pred             Hhhchhc----------------------cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSI----------------------LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~----------------------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +.++...                      ............+.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111000                      000111123566889999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.2e-41  Score=316.01  Aligned_cols=257  Identities=21%  Similarity=0.325  Sum_probs=191.0

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCCh---hhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe-----c
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSP---EKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP-----E  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----~  172 (380)
                      ..+.||+|+||.||++...+|..||||++........   ........+.+.+|+.++++++||||+++++++.     .
T Consensus        26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (362)
T 3pg1_A           26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA  105 (362)
T ss_dssp             EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred             EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence            4578999999999999988899999999976433221   1123445578999999999999999999999984     3


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      ....++||||++ |+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+||
T Consensus       106 ~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          106 MHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             CCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             cceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEec
Confidence            347899999997 689888863   3446999999999999999999999   889999999999999999999999999


Q ss_pred             CCcccCCC-----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHH---
Q 047245          253 GLAKLMPG-----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQ---  323 (380)
Q Consensus       253 gl~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~---  323 (380)
                      |+++....     ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....        ..+......   
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~  250 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--------FYNQLNKIVEVV  250 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHc
Confidence            99975432     2358889999999877 678999999999999999999999986421        111111110   


Q ss_pred             hhc-----------chhHhhchhccCC------cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAG-----------EAREALDRSILGE------EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~-----------~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...           ...+.+.......      .........+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            000           0011111111000      001122455889999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-41  Score=320.41  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=188.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-------  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  172 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....            ....+|+++++.++||||+++++++..       
T Consensus        11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A           11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------------TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            457899999999999986 678999999986521            112369999999999999999999843       


Q ss_pred             -------------------------------CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHh
Q 047245          173 -------------------------------SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL  221 (380)
Q Consensus       173 -------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L  221 (380)
                                                     ....++||||++ |+|.+.+.........+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999998 599998886555667899999999999999999999


Q ss_pred             HhcCCCCeEecCCCCCcEEeC-CCCceEEeccCCcccCCC-----CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHH
Q 047245          222 HFTCNPQILHYNLKPTNVMLD-AEFTPRLADFGLAKLMPG-----SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAV  294 (380)
Q Consensus       222 H~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~e  294 (380)
                      |   +.+++||||||+|||++ .++.+||+|||+++....     ...+|+.|+|||.+.+. .++.++||||+|+++||
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            9   99999999999999997 688999999999986532     23588999999998764 48999999999999999


Q ss_pred             HHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh--c--------hhccCCc----ccHHHHHHHHHHHHHcccCC
Q 047245          295 LLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL--D--------RSILGEE----VEEDEMLMAVRIAVVCLSDS  360 (380)
Q Consensus       295 l~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~--------~~~~~~~----~~~~~~~~~~~l~~~Cl~~~  360 (380)
                      |++|+.||......    ..+....... .........  +        +......    .+......+.+++.+||+.|
T Consensus       235 ll~g~~pf~~~~~~----~~~~~i~~~~-g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          235 LILGKPLFSGETSI----DQLVRIIQIM-GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHSSCSSCCSSHH----HHHHHHHHHH-CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHhCCCCCCCCChH----HHHHHHHHHh-CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999998642110    0111111100 000000000  0        0000000    11123455889999999999


Q ss_pred             CCCCCCHHhHHH
Q 047245          361 PADRPSSDELVP  372 (380)
Q Consensus       361 P~~RPs~~evl~  372 (380)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999973

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=313.30  Aligned_cols=240  Identities=23%  Similarity=0.382  Sum_probs=188.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE------  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------  172 (380)
                      ..+.||+|+||.||+|.. .+|+.||+|++.....         ....+.+|+.+++++ +||||+++++++..      
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---------cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            457899999999999997 5789999999875221         125688999999999 89999999999876      


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEecc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADF  252 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Df  252 (380)
                      .+..++||||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeC
Confidence            46889999999999999999853  2457899999999999999999999   889999999999999999999999999


Q ss_pred             CCcccCCC------CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHH
Q 047245          253 GLAKLMPG------SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       253 gl~~~~~~------~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      |++.....      ...+++.|+|||.+.     +..++.++||||||+++|||++|..||...        ....-...
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~  245 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM--------HPMRALFL  245 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHH
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC--------cHHHHHHH
Confidence            99876542      235899999999987     567899999999999999999999998531        11111111


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .....      .+....    ......+.+++.+||+.||.+|||++++++
T Consensus       246 ~~~~~------~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 IPRNP------APRLKS----KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHSC------CCCCSC----SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhcCc------cccCCc----cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11110      111111    122345789999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.1e-41  Score=340.96  Aligned_cols=235  Identities=23%  Similarity=0.268  Sum_probs=193.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+++.||||++.....     ......+.+..|..++..+ +||||+.+++++.+.+..++
T Consensus       345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-----HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             EEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            346899999999999997 4688999999975211     0112236678899999998 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       420 V~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999975    346999999999999999999999   899999999999999999999999999999853


Q ss_pred             C------CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 P------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~------~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      .      ....||+.|+|||.+.+..++.++||||||+++|||++|..||...        +..+.........      
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~------  558 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHN------  558 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHSSC------
T ss_pred             ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCC------
Confidence            2      2345899999999999999999999999999999999999999641        1222222222111      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS  367 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~  367 (380)
                            ...+......+.+++.+||+.||++||++
T Consensus       559 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          559 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence                  11222345568899999999999999998

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-42  Score=317.16  Aligned_cols=252  Identities=23%  Similarity=0.385  Sum_probs=179.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+++.||+|++....       .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-------CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             EEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             hhheeccccceEEEEEEECCCCcEEEEEEEEhhh-------cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            457899999999999986 468999999886421       122346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          180 YDYLQTGSLEDAMDRIRE----NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      |||+++|+|.+++.....    ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999975322    2345899999999999999999999   889999999999999999999999999998


Q ss_pred             ccCCC-----------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHH
Q 047245          256 KLMPG-----------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQ  323 (380)
Q Consensus       256 ~~~~~-----------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~  323 (380)
                      .....           ...+++.|+|||.+.+ ..++.++||||||+++|||++|..||......       ...... .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~-~  240 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-------KVLMLT-L  240 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-------GHHHHH-H
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-------hHHHHH-h
Confidence            65432           2358899999999876 56899999999999999999999998642111       000111 1


Q ss_pred             hhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          324 HAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .... . .+................+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 QNDP-P-SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TSSC-C-CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCC-C-ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000 0 000000000011122345789999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-40  Score=309.32  Aligned_cols=258  Identities=20%  Similarity=0.243  Sum_probs=197.1

Q ss_pred             cccccCccCCeeEEEEEe--cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC------CcceeeEEEec
Q 047245          101 ENRLLGSSPDGKYYRTVL--DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR------NLMSLRAYVPE  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~  172 (380)
                      ..+.||+|+||.||++..  .+|+.||+|++..         .....+.+.+|+.+++.++|+      +++++++++.+
T Consensus        18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             EEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            456899999999999986  4688999999864         123346788899999888765      49999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---------
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---------  243 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---------  243 (380)
                      .+..++||||+ +++|.+++..  .....+++..+..++.|++.||+|||   +.+++||||||+|||++.         
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             CCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCC
Confidence            99999999999 8899999974  22346899999999999999999999   899999999999999987         


Q ss_pred             ----------CCceEEeccCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc
Q 047245          244 ----------EFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA  310 (380)
Q Consensus       244 ----------~~~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~  310 (380)
                                ++.+||+|||+++....   ...+|+.|+|||.+.+..++.++||||||+++|||++|..||....... 
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             ccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                      66899999999986543   3468999999999999999999999999999999999999986421110 


Q ss_pred             CCCCHHHHHHHHHhhcc-----------------------------hhHhhchhccCCcccHHHHHHHHHHHHHcccCCC
Q 047245          311 SGGSLGRWLRHLQHAGE-----------------------------AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSP  361 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P  361 (380)
                          ....+........                             ......+..............+.+++.+||+.||
T Consensus       242 ----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          242 ----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             ----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence                0000111000000                             0000000000011123456778999999999999


Q ss_pred             CCCCCHHhHHH--HHhccc
Q 047245          362 ADRPSSDELVP--MLTQLH  378 (380)
Q Consensus       362 ~~RPs~~evl~--~L~~l~  378 (380)
                      ++|||++|+++  .+++++
T Consensus       318 ~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          318 AKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             TTSCCHHHHTTSGGGGGGG
T ss_pred             ccccCHHHHhcCHHHHHHh
Confidence            99999999984  354443

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.6e-41  Score=320.58  Aligned_cols=256  Identities=21%  Similarity=0.261  Sum_probs=194.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--------CCCcceeeEEEe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--------HRNLMSLRAYVP  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~  171 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++..         .....+.+.+|+.++++++        |+||+++++++.
T Consensus        41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---------AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             EEEEeeecCCeeEEEEEecCCCeEEEEEEEec---------CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            456899999999999986 5688999999864         1234567889999999985        788999999987


Q ss_pred             ----cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeCCCC-
Q 047245          172 ----ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLDAEF-  245 (380)
Q Consensus       172 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~-  245 (380)
                          +....++||||+ +++|.+++..  .....+++..+..++.|++.||+|||   +. +++||||||+|||++.++ 
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccch
Confidence                566889999999 6677777764  22356999999999999999999999   77 999999999999999775 


Q ss_pred             ------------------------------------------------ceEEeccCCcccCCC---CCcCCCcccCcccc
Q 047245          246 ------------------------------------------------TPRLADFGLAKLMPG---SLIATSAYSAPECF  274 (380)
Q Consensus       246 ------------------------------------------------~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~  274 (380)
                                                                      .+||+|||+++....   ...+|+.|+|||.+
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhh
Confidence                                                            799999999976543   34589999999999


Q ss_pred             cCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch-h----------Hhhch---------
Q 047245          275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA-R----------EALDR---------  334 (380)
Q Consensus       275 ~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~-~----------~~~~~---------  334 (380)
                      .+..++.++|||||||++|||++|+.||......... .............+.. .          +.+..         
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT-RDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC-HHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC-chHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            9999999999999999999999999999642111100 0000000000000000 0          00000         


Q ss_pred             ---------hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 ---------SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ---------~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                               .......+.+....+.+++.+||+.||++|||++|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     00001234567788999999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.3e-41  Score=323.32  Aligned_cols=189  Identities=26%  Similarity=0.425  Sum_probs=161.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----C
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----S  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  174 (380)
                      ..+.||+|+||.||++.. .+|+.||||++....      ......+.+.+|+.++++++||||+++++++...     .
T Consensus        30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            457899999999999986 468899999996421      2334457889999999999999999999998766     5


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++||||++ |+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            7899999986 599999863    456999999999999999999999   88999999999999999999999999999


Q ss_pred             cccCC----------------------------CCCcCCCcccCcccc-cCCCCCCcchhhHHHHHHHHHHhCCCCCC
Q 047245          255 AKLMP----------------------------GSLIATSAYSAPECF-QNRSYTDKSDIFSFGMILAVLLTGRDPTA  303 (380)
Q Consensus       255 ~~~~~----------------------------~~~~~~~~y~aPE~~-~~~~~~~~sDv~s~Gvil~el~tg~~p~~  303 (380)
                      ++...                            ....||+.|+|||.+ ....++.++||||+||++|||++|..||.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            98643                            223589999999986 56679999999999999999998766554

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.7e-41  Score=325.54  Aligned_cols=248  Identities=21%  Similarity=0.282  Sum_probs=194.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC-CCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-RNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+|+.||||++......          ..+..|+++++.++| +++..+..++.+.+..++
T Consensus        11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             EEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            457899999999999996 67899999987653211          346789999999976 556666777778889999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe---CCCCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML---DAEFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill---~~~~~~kl~Dfgl~  255 (380)
                      ||||+ +++|.+++...   ...+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||++
T Consensus        81 vme~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99999 99999999742   346999999999999999999999   8999999999999999   58899999999999


Q ss_pred             ccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          256 KLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       256 ~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      +....             ...||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     ..........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~i  228 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEKI  228 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----SSHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----hhHHHHHHHH
Confidence            75432             34589999999999999999999999999999999999999964211     1111111111


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ... .....+.. +.     ......+.+++..||+.+|++||++++|++.|+++
T Consensus       229 ~~~-~~~~~~~~-l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          229 SEK-KVATSIEA-LC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHH-HHHSCHHH-HH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             hhc-cccccHHH-Hh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            110 00000000 00     11235688999999999999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.6e-41  Score=304.81  Aligned_cols=242  Identities=26%  Similarity=0.373  Sum_probs=193.8

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +++.||+|++.......      .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus        26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch------HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            5678999999999999974 78999999997533221      1236788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC---CceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE---FTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~---~~~kl~Dfgl~~  256 (380)
                      +||+++++|.+++..    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.+   +.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999998874    346899999999999999999999   8899999999999999754   479999999987


Q ss_pred             cCCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .....     ..+++.|+|||.+.+ .++.++||||||+++|+|++|..||...        ...+...........   
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~---  240 (287)
T 2wei_A          173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--------NEYDILKRVETGKYA---  240 (287)
T ss_dssp             TBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCC---
T ss_pred             eecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCCCC---
Confidence            65432     237888999998875 4899999999999999999999998641        112222222111100   


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+     ..........+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FD-----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CC-----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00     0011123456889999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.5e-41  Score=317.60  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=176.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++....      ......+.+.+|+.++++++||||+++++++...      
T Consensus        33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EEEECC----CCEEEEEETTTTEEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            346799999999999985 578999999986421      1234457788999999999999999999998654      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                      ...++|+|++ +++|.+++..     ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence            5679999999 6899998862     46999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccCCC---CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh-hcch
Q 047245          254 LAKLMPG---SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH-AGEA  328 (380)
Q Consensus       254 l~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~-~~~~  328 (380)
                      +++....   ...+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....        ..+....... .+..
T Consensus       178 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          178 LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLKLILRLVGTP  249 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHCSC
T ss_pred             ccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHHHhCCC
Confidence            9987543   3468999999999877 678999999999999999999999986421        1111111100 0000


Q ss_pred             -------------hHhhchhccCCccc-----HHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 -------------REALDRSILGEEVE-----EDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 -------------~~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                                   ...+..........     ......+.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                         00000000000000     112355789999999999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=305.31  Aligned_cols=242  Identities=22%  Similarity=0.317  Sum_probs=190.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe--cCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP--ESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  177 (380)
                      ..+.||+|+||.||++.. .++..+|+|++.....    .........+.+|+.++++++||||+++++++.  +....+
T Consensus         9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL----RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH----HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc----cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            457899999999999997 4688999999975211    111233577899999999999999999999984  456789


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||++++ |.+++...  ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            999999876 88877642  2457899999999999999999999   88999999999999999999999999999976


Q ss_pred             CCC--------CCcCCCcccCcccccCCC--CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          258 MPG--------SLIATSAYSAPECFQNRS--YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       258 ~~~--------~~~~~~~y~aPE~~~~~~--~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      ...        ...+++.|+|||.+.+..  ++.++||||||+++|||++|..||...        ............. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~i~~~~-  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--------NIYKLFENIGKGS-  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCC-
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--------hHHHHHHHHhcCC-
Confidence            532        234899999999997644  377999999999999999999998631        1222222221110 


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            .     ..+......+.+++.+||+.||++|||++|+++
T Consensus       230 ------~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          230 ------Y-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             ------C-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------C-----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                  0     111123455789999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.5e-41  Score=315.28  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=190.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----C
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----S  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  174 (380)
                      ..+.||+|+||.||++.. .++..||+|++...       ......+.+.+|++++++++||||+++++++...     .
T Consensus        31 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             EEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            456899999999999986 46889999998641       1234457788999999999999999999998654     4


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++|+||++ |+|.+++..     ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence            6899999997 599998863     36899999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          255 AKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       255 ~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      ++....         ...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......    ..+.... ....
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~-~~~~  249 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL----DQLNHIL-GILG  249 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG----GHHHHHH-HHHC
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH----HHHHHHH-HHhC
Confidence            976542         2368999999998754 45899999999999999999999998642110    0011111 0000


Q ss_pred             hcchh-----------HhhchhccCCcc-----cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 AGEAR-----------EALDRSILGEEV-----EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 ~~~~~-----------~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .....           ............     .......+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000           000000000000     0112456789999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-40  Score=304.44  Aligned_cols=239  Identities=24%  Similarity=0.429  Sum_probs=186.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-------  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  172 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++..         .....+.+.+|+.++++++||||+++++++.+       
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A           10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             hhheeccCCcEEEEEEEEcCCCeEEEEEEEec---------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            457899999999999996 4789999999964         22345788999999999999999999998854       


Q ss_pred             ------CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc
Q 047245          173 ------SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT  246 (380)
Q Consensus       173 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~  246 (380)
                            .+..++||||+++|+|.+++..   ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCC
Confidence                  3568999999999999999974   2346788899999999999999999   889999999999999999999


Q ss_pred             eEEeccCCcccCCC--------------------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCch
Q 047245          247 PRLADFGLAKLMPG--------------------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPF  305 (380)
Q Consensus       247 ~kl~Dfgl~~~~~~--------------------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~  305 (380)
                      +||+|||++.....                    ...+++.|+|||.+.+. .++.++||||||+++|||++   ||...
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~  231 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG  231 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence            99999999976532                    22478899999999764 68999999999999999998   54321


Q ss_pred             hhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       306 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...       ..........       .... ...........+.+++.+||+.||.+|||++++++
T Consensus       232 ~~~-------~~~~~~~~~~-------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 MER-------VNILKKLRSV-------SIEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHH-------HHHHHHHHST-------TCCC-CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhH-------HHHHHhcccc-------cccc-CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            100       1111111110       0001 11122334456789999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.3e-41  Score=322.08  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=187.5

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC------
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES------  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  173 (380)
                      ..+.||+|+||.||++... +|+.||||++....            ....+|++++++++||||+++++++...      
T Consensus        58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            4578999999999999984 68999999986421            1223699999999999999999988432      


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-CceEEecc
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADF  252 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-~~~kl~Df  252 (380)
                      ...++||||+++ +|.+.+.........+++..+..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DF  201 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF  201 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccc
Confidence            236799999975 777777655555678999999999999999999999   9999999999999999965 67899999


Q ss_pred             CCcccCCC-----CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          253 GLAKLMPG-----SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       253 gl~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      |+++....     ...+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......    ..+...+.....+ 
T Consensus       202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~----~~l~~i~~~lg~p-  276 (420)
T 1j1b_A          202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTP-  276 (420)
T ss_dssp             TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCSC-
T ss_pred             hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCC-
Confidence            99986532     24589999999998764 7899999999999999999999998642110    0111111111000 


Q ss_pred             chhH--hhch--------hccCCc----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EARE--ALDR--------SILGEE----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~--~~~~--------~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....  ...+        .+....    ........+.+|+.+||+.||.+|||+.|+++
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0000  0000        000000    01122456889999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.7e-41  Score=308.99  Aligned_cols=240  Identities=22%  Similarity=0.311  Sum_probs=190.0

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--CCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--HRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++...+|+.||+|++....      ........+.+|+.++.+++  ||||+++++++.+.+..++
T Consensus        32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECSS------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             EEEEecCCCCEEEEEEEcCCCcEEEEEEecccc------ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            456899999999999999889999999997522      12344578899999999997  5999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||| +.+++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+||++++ +.+||+|||+++..
T Consensus       106 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            999 568899999974    347899999999999999999999   889999999999999964 89999999999865


Q ss_pred             CC--------CCcCCCcccCcccccC-----------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHH
Q 047245          259 PG--------SLIATSAYSAPECFQN-----------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       259 ~~--------~~~~~~~y~aPE~~~~-----------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~  319 (380)
                      ..        ...+++.|+|||.+.+           ..++.++||||||+++|||++|..||....       ......
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~~  249 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKL  249 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------HHHHHH
Confidence            42        2358999999999875           468889999999999999999999986311       111111


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .         ..+++.... ..+......+.+++.+||+.||++|||+.|+++
T Consensus       250 ~---------~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          250 H---------AIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             H---------HHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H---------HHHhccccc-CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            1         111111110 111112345789999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-40  Score=313.43  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=189.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE---
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF---  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  176 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....      ......+.+.+|+.++++++||||+++++++...+..   
T Consensus        46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             EEeEEecCCCeEEEEEEECCCCCEEEEEEecccc------cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            346799999999999986 468999999996521      2334557888999999999999999999999877654   


Q ss_pred             ---EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          177 ---YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       177 ---~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                         ++||||++ ++|.+++.      ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence               99999997 68888764      24899999999999999999999   8899999999999999999999999999


Q ss_pred             CcccCCC---CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh-hcch
Q 047245          254 LAKLMPG---SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH-AGEA  328 (380)
Q Consensus       254 l~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~-~~~~  328 (380)
                      +++....   ...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...        ...+....... .+..
T Consensus       190 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          190 LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------DYLDQLTQILKVTGVP  261 (371)
T ss_dssp             CC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHHHCCC
T ss_pred             cccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHHHhCCC
Confidence            9986553   3458999999999987 77899999999999999999999999642        11111111110 0000


Q ss_pred             -hHh-----------hchhccCC---c---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 -REA-----------LDRSILGE---E---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 -~~~-----------~~~~~~~~---~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .+.           ....+...   .   ........+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             000           00000000   0   00123456889999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-41  Score=317.96  Aligned_cols=259  Identities=20%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhh---------hcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEK---------QNKSVKRRIQQELEVLASLRHRNLMSLRAYVP  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  171 (380)
                      ..+.||+|+||.||++.. +|+.||+|++..........         ......+.+.+|+.++++++||||+++++++.
T Consensus        35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            456899999999999999 89999999997532111000         00112267889999999999999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHH------HHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCC
Q 047245          172 ESSRFYLVYDYLQTGSLEDA------MDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~  244 (380)
                      +.+..++||||+++|+|.++      +..  .....+++..++.++.|++.||+|||   + .+++||||+|+||+++.+
T Consensus       114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          114 NYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTT
T ss_pred             eCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCC
Confidence            99999999999999999998      442  22467999999999999999999999   7 899999999999999999


Q ss_pred             CceEEeccCCcccCCC----CCcCCCcccCcccccCC-CCCC-cchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHH
Q 047245          245 FTPRLADFGLAKLMPG----SLIATSAYSAPECFQNR-SYTD-KSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~----~~~~~~~y~aPE~~~~~-~~~~-~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~  318 (380)
                      +.+||+|||++.....    ...+++.|+|||.+.+. .++. ++||||||+++|||++|..||.....       ..+.
T Consensus       189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~  261 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-------LVEL  261 (348)
T ss_dssp             SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-------SHHH
T ss_pred             CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHH
Confidence            9999999999986543    34589999999999887 6666 99999999999999999999864211       0111


Q ss_pred             HHHHHhhcchhH-----hhchhcc--CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          319 LRHLQHAGEARE-----ALDRSIL--GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       319 ~~~~~~~~~~~~-----~~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ............     ...+...  ...........+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111111100000     0000000  00000224456889999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=307.37  Aligned_cols=247  Identities=22%  Similarity=0.373  Sum_probs=184.0

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe--------
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP--------  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------  171 (380)
                      ..+.||+|+||.||++... +|+.||+|++...        .....+.+.+|+.++++++||||+++++++.        
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--------DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             EEEECC-----CEEEEEETTTTEEEEEEEEECC--------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             EEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--------ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            3467999999999999985 4899999998651        2344578889999999999999999999873        


Q ss_pred             ------cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC-CC
Q 047245          172 ------ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD-AE  244 (380)
Q Consensus       172 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~-~~  244 (380)
                            +....++||||++ |+|.+++.     ...+++..+..++.|++.||+|||   +.+++||||||+||+++ ++
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTED  157 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCC
Confidence                  4468899999997 69999986     346899999999999999999999   89999999999999997 56


Q ss_pred             CceEEeccCCcccCCC---------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCC
Q 047245          245 FTPRLADFGLAKLMPG---------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGS  314 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~  314 (380)
                      +.+||+|||+++....         ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....       
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------  230 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-------  230 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-------
Confidence            7999999999986532         1236888999998865 6789999999999999999999999864211       


Q ss_pred             HHHHHHHHHhhc-------------chhHhhchhccCCc-----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          315 LGRWLRHLQHAG-------------EAREALDRSILGEE-----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       315 l~~~~~~~~~~~-------------~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .+.........             .....+........     ........+.+++.+||+.||++|||++|+++
T Consensus       231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          231 -LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             -HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence             11111111100             00000000000000     00123456889999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.9e-41  Score=323.09  Aligned_cols=241  Identities=20%  Similarity=0.319  Sum_probs=182.0

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .++||+|+||+||.+...+|+.||||++...           ....+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            4679999999998766678999999998641           124567899999886 8999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccC---CCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC-------------
Q 047245          181 DYLQTGSLEDAMDRIRENQLQ---LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-------------  244 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~-------------  244 (380)
                      ||++ |+|.+++.........   .++..++.++.|++.||+|||   +.+++||||||+|||++.+             
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCc
Confidence            9995 6999999753221111   133346789999999999999   8999999999999999654             


Q ss_pred             CceEEeccCCcccCCC----------CCcCCCcccCcccccC-------CCCCCcchhhHHHHHHHHHHh-CCCCCCchh
Q 047245          245 FTPRLADFGLAKLMPG----------SLIATSAYSAPECFQN-------RSYTDKSDIFSFGMILAVLLT-GRDPTAPFF  306 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~----------~~~~~~~y~aPE~~~~-------~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~  306 (380)
                      +.+||+|||+++....          ...||+.|+|||.+.+       ..++.++|||||||++|||++ |..||....
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            4899999999986543          2358999999999975       668999999999999999999 999986421


Q ss_pred             hhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          307 AEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       307 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...      ..    ....     ..................+.+++.+||+.||.+|||+.|+++
T Consensus       245 ~~~------~~----i~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          245 SRE------SN----IIRG-----IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             THH------HH----HHHT-----CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhH------HH----HhcC-----CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            110      01    1100     000000011123456678899999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.6e-41  Score=318.06  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=186.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC------
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS------  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  174 (380)
                      ..+.||+|+||.||++...++..+|+|++.....            ...+|+++++.++||||+++++++...+      
T Consensus        44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            4578999999999999997777899999865211            1226999999999999999999985433      


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC-CCCceEEeccC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD-AEFTPRLADFG  253 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfg  253 (380)
                      ..++||||+++ ++.+.+.........+++..+..++.|++.||+|||   +.+++||||||+|||++ .++.+||+|||
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            37899999987 554444433444567999999999999999999999   89999999999999999 78999999999


Q ss_pred             CcccCCC-----CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          254 LAKLMPG-----SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       254 l~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      +++....     ...+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......    ..+........ ...
T Consensus       188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~~g-~p~  262 (394)
T 4e7w_A          188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKVLG-TPS  262 (394)
T ss_dssp             TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHC-CCC
T ss_pred             CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhC-CCC
Confidence            9976532     34589999999998764 5899999999999999999999998642110    01111111100 000


Q ss_pred             hh--Hhhchh--------ccCCc----ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AR--EALDRS--------ILGEE----VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~--~~~~~~--------~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ..  ....+.        .....    ........+.+++.+||+.||.+|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00  000000        00000    01113456889999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2e-40  Score=307.25  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=189.8

Q ss_pred             cccccCccCCeeEEEEEe--cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC---CCCCcceeeEEEe----
Q 047245          101 ENRLLGSSPDGKYYRTVL--DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL---RHRNLMSLRAYVP----  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  171 (380)
                      ..+.||+|+||.||++..  .+|+.||+|++.........      ...+.+|+.+++.+   +||||+++++++.    
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------CchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456899999999999997  46889999999764322111      12345566666555   8999999999987    


Q ss_pred             -cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 047245          172 -ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA  250 (380)
Q Consensus       172 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  250 (380)
                       .....++|+||++ |+|.+++...  ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999998 6999999752  2345899999999999999999999   8899999999999999999999999


Q ss_pred             ccCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh-
Q 047245          251 DFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH-  324 (380)
Q Consensus       251 Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~-  324 (380)
                      |||+++....     ...+++.|+|||.+.+..++.++||||||+++|||++|+.||.....        .+....... 
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~  234 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--------VDQLGKILDV  234 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHH
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHHH
Confidence            9999986542     34589999999999999999999999999999999999999864211        111111110 


Q ss_pred             --hcchhHh----------hchhcc--CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 --AGEAREA----------LDRSIL--GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 --~~~~~~~----------~~~~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        ......+          +.....  ...........+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000000          000000  00011123456789999999999999999999984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.4e-40  Score=309.33  Aligned_cols=257  Identities=24%  Similarity=0.310  Sum_probs=179.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR----  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  175 (380)
                      ..+.||+|+||.||++.. .+|..||||++......         ...+.+|++.++.++||||+++++++...+.    
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             EC----------CEEEEETTTCCEEEEEEEECCTTC---------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---------cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            567899999999999997 46899999998652211         1345678888899999999999999865333    


Q ss_pred             ---EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEec
Q 047245          176 ---FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLAD  251 (380)
Q Consensus       176 ---~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~D  251 (380)
                         .++||||+++ +|.+.+.........+++..+..++.|++.||+|||. ++.+++||||||+|||++. ++.+||+|
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence               7899999976 6666665444456678999999999999999999993 3678999999999999997 89999999


Q ss_pred             cCCcccCCC-----CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          252 FGLAKLMPG-----SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       252 fgl~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      ||+++....     ...+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......    ..+....+.....
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~  251 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA----GQLHEIVRVLGCP  251 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCC
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH----HHHHHHHHHcCCC
Confidence            999986543     23589999999998664 4899999999999999999999998642111    0111111110000


Q ss_pred             c-chhHhhchhcc--------C-------CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 G-EAREALDRSIL--------G-------EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~-~~~~~~~~~~~--------~-------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      . .....+++...        .       ..........+.+++.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0 00000000000        0       0011124567899999999999999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4e-40  Score=308.72  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=190.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----C
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----S  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  174 (380)
                      ..+.||+|+||.||++... +|+.||||++...       ........+.+|+.++++++||||+++++++...     .
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-------DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             EeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            4568999999999999974 6899999999641       1233456788999999999999999999998654     6


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++|+||++ |+|.+++..     ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            7899999997 599998873     46899999999999999999999   88999999999999999999999999999


Q ss_pred             cccCCC----------------CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHH
Q 047245          255 AKLMPG----------------SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGR  317 (380)
Q Consensus       255 ~~~~~~----------------~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~  317 (380)
                      ++....                ...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......    .+..
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~  234 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH----QLLL  234 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHH
Confidence            976532                1247889999998764 778999999999999999999999986421000    0000


Q ss_pred             HHHHHHhhc------------chhHhhchhcc--CC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          318 WLRHLQHAG------------EAREALDRSIL--GE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       318 ~~~~~~~~~------------~~~~~~~~~~~--~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       +.......            ...+.+.....  ..   .........+.+++.+||+.||++|||++|+++
T Consensus       235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          235 -IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             -HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             00000000            00000000000  00   000123456789999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-40  Score=309.52  Aligned_cols=247  Identities=21%  Similarity=0.343  Sum_probs=174.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHH-HHHcCCCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELE-VLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++....       .......+..|+. +++.++||||+++++++.+.+..++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-------CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-------CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            346799999999999997 478999999997521       1223345556665 7777899999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          179 VYDYLQTGSLEDAMDRIRE-NQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ||||+++ +|.+++..... ....+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999985 88888864322 2457899999999999999999999   77 99999999999999999999999999998


Q ss_pred             cCCCC-----CcCCCcccCcccc----cCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          257 LMPGS-----LIATSAYSAPECF----QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       257 ~~~~~-----~~~~~~y~aPE~~----~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      .....     ..+++.|+|||.+    .+..++.++||||||+++|||++|..||........       ..      ..
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~------~~  241 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QL------TQ  241 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------CC
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-------HH------HH
Confidence            65432     2588999999998    456789999999999999999999999864211000       00      00


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......+.+. ..........+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          242 VVKGDPPQLS-NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCSCCCCCC-CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HhcCCCCCCC-CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000000110 0011123456889999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-40  Score=314.25  Aligned_cols=256  Identities=20%  Similarity=0.250  Sum_probs=192.9

Q ss_pred             ccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-----------CCCcceee
Q 047245          100 NENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-----------HRNLMSLR  167 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~  167 (380)
                      ...+.||+|+||.||++.. .+|+.||+|++..         .......+.+|+.++++++           ||||++++
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             EEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---------CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            3557899999999999996 5789999999864         2233467788999998886           89999999


Q ss_pred             EEEecCC----eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeC
Q 047245          168 AYVPESS----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLD  242 (380)
Q Consensus       168 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~  242 (380)
                      +++...+    ..++||||+ +++|.+++....  ...+++..+..++.|++.||+|||   +. +++||||||+|||++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~  166 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLME  166 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEe
Confidence            9987543    789999999 889999997532  345899999999999999999999   77 999999999999994


Q ss_pred             ------CCCceEEeccCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCC
Q 047245          243 ------AEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG  313 (380)
Q Consensus       243 ------~~~~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~  313 (380)
                            ..+.+||+|||+++....   ...+|+.|+|||.+.+..++.++||||||+++|||++|..||.........  
T Consensus       167 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--  244 (373)
T 1q8y_A          167 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT--  244 (373)
T ss_dssp             EEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC--
Confidence                  445899999999976543   346899999999999999999999999999999999999999742111000  


Q ss_pred             CHHHHHHHHH-hhcchh-----------Hhhch------------------hccCCcccHHHHHHHHHHHHHcccCCCCC
Q 047245          314 SLGRWLRHLQ-HAGEAR-----------EALDR------------------SILGEEVEEDEMLMAVRIAVVCLSDSPAD  363 (380)
Q Consensus       314 ~l~~~~~~~~-~~~~~~-----------~~~~~------------------~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~  363 (380)
                      ...+...... ..+...           ..+..                  .......+......+.+++.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence            0000010000 000000           00000                  00011234567788999999999999999


Q ss_pred             CCCHHhHHH
Q 047245          364 RPSSDELVP  372 (380)
Q Consensus       364 RPs~~evl~  372 (380)
                      |||++|+++
T Consensus       325 Rpt~~ell~  333 (373)
T 1q8y_A          325 RADAGGLVN  333 (373)
T ss_dssp             CBCHHHHHT
T ss_pred             cCCHHHHhh
Confidence            999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.8e-41  Score=311.08  Aligned_cols=242  Identities=19%  Similarity=0.288  Sum_probs=167.1

Q ss_pred             ccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec----CCeE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE----SSRF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  176 (380)
                      .++||+|+||.||++... +|+.||+|++...         .   ....+....++.++||||+++++++..    ....
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---------P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESS---------H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---------H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            457999999999999975 6899999998641         1   111222334566799999999999865    4558


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEeccC
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADFG  253 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfg  253 (380)
                      ++||||+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            999999999999999974  22346999999999999999999999   889999999999999976   4559999999


Q ss_pred             CcccCCC----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          254 LAKLMPG----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       254 l~~~~~~----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      +++....    ...+|+.|+|||.+.+..++.++||||||+++|||++|..||.........    ........ .+   
T Consensus       177 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~-~~---  248 (336)
T 3fhr_A          177 FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS----PGMKRRIR-LG---  248 (336)
T ss_dssp             TCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred             cceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh----hhHHHhhh-cc---
Confidence            9976543    235799999999998888999999999999999999999998642111100    00000000 00   


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ..... ..........+.+++.+||+.||.+|||++|+++
T Consensus       249 ---~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 ---QYGFP-NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -----CCC-TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---ccccC-chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               00000 0111223456889999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.8e-40  Score=311.22  Aligned_cols=191  Identities=22%  Similarity=0.334  Sum_probs=163.2

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CC-----CcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HR-----NLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||+|... +|+.||||++..         .......+..|+.+++.++ |+     +|+++.+++...
T Consensus        58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECS---------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             EEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            4568999999999999864 688999999964         1233466778888888884 55     499999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC--CCCceEEec
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD--AEFTPRLAD  251 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kl~D  251 (380)
                      +..++||||++ |+|.+++...  ....+++..+..++.|++.||+|||.. ..+|+||||||+|||++  .++.+||+|
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999996 5999999752  234689999999999999999999931 46899999999999995  478899999


Q ss_pred             cCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          252 FGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       252 fgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                      ||+++....   ...+|+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       205 FG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          205 FGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             CTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999987653   34689999999999999999999999999999999999999964

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-39  Score=304.57  Aligned_cols=252  Identities=18%  Similarity=0.229  Sum_probs=191.9

Q ss_pred             cccccCccCCeeEEEEEec-CC-cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCC------cceeeEEEec
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NG-LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN------LMSLRAYVPE  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~  172 (380)
                      ..+.||+|+||.||++... ++ ..||+|++..         .....+.+.+|+.++++++|+|      ++.+.+++..
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---------VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             EEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---------cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            4568999999999999873 34 7899999864         1233467888999999987665      8999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEe-----------
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVML-----------  241 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill-----------  241 (380)
                      .+..++||||+ +++|.+++..  .....+++..+..++.|++.||+|||   +.+++||||||+|||+           
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             CCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccc
Confidence            99999999999 6788888764  22346899999999999999999999   9999999999999999           


Q ss_pred             --------CCCCceEEeccCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc
Q 047245          242 --------DAEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA  310 (380)
Q Consensus       242 --------~~~~~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~  310 (380)
                              +.++.+||+|||+++....   ...+|+.|+|||.+.+..++.++||||||+++|||++|..||....... 
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             cccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence                    5678999999999986543   3468999999999999999999999999999999999999996421110 


Q ss_pred             CCCCHHHHHHHHHhhc--------c---------------------hhHhhchhccCCcccHHHHHHHHHHHHHcccCCC
Q 047245          311 SGGSLGRWLRHLQHAG--------E---------------------AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSP  361 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~--------~---------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P  361 (380)
                          ....+.......        .                     ..+...+..........+...+.+++.+||+.||
T Consensus       247 ----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          247 ----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             ----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence                000111100000        0                     0000000000001122346678999999999999


Q ss_pred             CCCCCHHhHHH
Q 047245          362 ADRPSSDELVP  372 (380)
Q Consensus       362 ~~RPs~~evl~  372 (380)
                      ++|||+.|+++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999973

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=309.08  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=189.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe----
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR----  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  175 (380)
                      ..+.||+|+||.||++.. .+|+.||||++....      ......+.+.+|+.++++++||||+++++++...+.    
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             EeeeEecCCCeEEEEEEECCCCCEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            346799999999999997 468999999986521      233445788899999999999999999999987653    


Q ss_pred             --EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          176 --FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       176 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                        .++||||++ |+|.+++.      ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence              499999997 58877664      24899999999999999999999   8899999999999999999999999999


Q ss_pred             CcccCCC---CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh-hcch
Q 047245          254 LAKLMPG---SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH-AGEA  328 (380)
Q Consensus       254 l~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~-~~~~  328 (380)
                      +++....   ...+++.|+|||.+.+ ..++.++||||||+++|||++|..||...        ...+....... .+..
T Consensus       172 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~--------~~~~~~~~i~~~~~~~  243 (353)
T 3coi_A          172 LARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------DYLDQLTQILKVTGVP  243 (353)
T ss_dssp             CTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS--------CHHHHHHHHHHHHCBC
T ss_pred             cccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHHHhCCC
Confidence            9986543   2358999999999877 67899999999999999999999998642        11111111110 0000


Q ss_pred             -h------------Hhhch---hcc--CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 -R------------EALDR---SIL--GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 -~------------~~~~~---~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       .            ..+..   ...  -..........+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0            00000   000  00111234566889999999999999999999974

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.7e-40  Score=304.35  Aligned_cols=243  Identities=21%  Similarity=0.298  Sum_probs=174.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++....      ......+.+.++..+++.++||||+++++++.+.+..++|
T Consensus        29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG------NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEEEETTS------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeecCCeeEEEEEEecCCeEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3467999999999999974 78999999997521      1222334455566678888999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCC-CeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNP-QILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      |||+ ++.+..+...   ....+++..+..++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          103 MELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             ECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             Eecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999 4455555442   2457899999999999999999999   74 9999999999999999999999999999765


Q ss_pred             CC-----CCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          259 PG-----SLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       259 ~~-----~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ..     ...+++.|+|||.+.     ...++.++||||||+++|||++|..||...       ..............  
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~~~~~~~--  246 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC-------KTDFEVLTKVLQEE--  246 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHHHHHHHSC--
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC-------CccHHHHHHHhccC--
Confidence            43     235899999999994     456889999999999999999999998631       11111122211111  


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .+....   .......+.+++.+||+.||.+|||++|+++
T Consensus       247 ----~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 ----PPLLPG---HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ----CCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----CCCCCc---cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                000100   0113345789999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-40  Score=307.59  Aligned_cols=237  Identities=22%  Similarity=0.342  Sum_probs=191.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--CCCcceeeEEEecCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--HRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  177 (380)
                      ..+.||+|+||.||+|.. .+|+.||+|.+..........  ......+.+|+.++++++  |+||+++++++.+.+..+
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~  124 (320)
T 3a99_A           47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV  124 (320)
T ss_dssp             EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh--hhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence            457899999999999985 578999999997643221100  011244667999999996  599999999999999999


Q ss_pred             EEEeecCC-CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC-CCCceEEeccCCc
Q 047245          178 LVYDYLQT-GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD-AEFTPRLADFGLA  255 (380)
Q Consensus       178 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Dfgl~  255 (380)
                      +|+|++.+ ++|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++ +++.+||+|||++
T Consensus       125 lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          125 LILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             EEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            99999986 899999974    346899999999999999999999   89999999999999999 7899999999999


Q ss_pred             ccCCC----CCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG----SLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~----~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      +....    ...+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.....              ... +    
T Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------------~~~-~----  258 (320)
T 3a99_A          198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIR-G----  258 (320)
T ss_dssp             EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHH-C----
T ss_pred             cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------------hhc-c----
Confidence            86653    2358999999999987665 6789999999999999999999864100              000 0    


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ......    .....+.+++.+||+.||++|||++|+++
T Consensus       259 ---~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          259 ---QVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---CCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cccccc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000111    12345789999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-40  Score=315.73  Aligned_cols=237  Identities=21%  Similarity=0.314  Sum_probs=179.3

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..++||+|+||+|+.....+|+.||||++.....           ..+.+|+++++++ +||||+++++++.+....++|
T Consensus        28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            4578999999996655556799999999864110           2245799999999 899999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-----CCceEEeccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-----EFTPRLADFGL  254 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~Dfgl  254 (380)
                      |||++ |+|.+++...   .....+..++.++.|++.||+|||   +.+|+||||||+|||++.     ...+||+|||+
T Consensus        97 ~E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           97 IELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99996 5999999742   233444556789999999999999   889999999999999953     34688999999


Q ss_pred             cccCCC---------CCcCCCcccCccccc---CCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHH
Q 047245          255 AKLMPG---------SLIATSAYSAPECFQ---NRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRH  321 (380)
Q Consensus       255 ~~~~~~---------~~~~~~~y~aPE~~~---~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~  321 (380)
                      ++....         ...||+.|+|||.+.   ...++.++|||||||++|||++ |..||.....         .....
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~~~  240 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQANI  240 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHHHH
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHHHH
Confidence            976542         235899999999997   4567889999999999999999 8888853110         01111


Q ss_pred             HHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...... ...       ..........+.+++.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~-~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          241 LLGACS-LDC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HTTCCC-CTT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhccCC-ccc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            110000 000       1111234555789999999999999999999983

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=305.07  Aligned_cols=238  Identities=21%  Similarity=0.299  Sum_probs=186.0

Q ss_pred             ccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC----CCCCcceeeEEEecCC
Q 047245          100 NENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL----RHRNLMSLRAYVPESS  174 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~l~~~~~~~~  174 (380)
                      ...+.||+|+||.||++.. .+|+.||+|++........  ........+.+|+.++.++    +||||+++++++.+.+
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~  111 (312)
T 2iwi_A           34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW--SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE  111 (312)
T ss_dssp             EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred             EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccc--ccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence            3567899999999999986 5788999999965322110  0111234566789999888    8999999999999999


Q ss_pred             eEEEEEee-cCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC-CCCceEEecc
Q 047245          175 RFYLVYDY-LQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD-AEFTPRLADF  252 (380)
Q Consensus       175 ~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~-~~~~~kl~Df  252 (380)
                      ..++|+|| +++++|.+++..    ...+++..++.++.|++.||+|||   +.+++||||||+||+++ .++.+||+||
T Consensus       112 ~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          112 GFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             -CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99999999 789999999975    346899999999999999999999   88999999999999999 8899999999


Q ss_pred             CCcccCCC----CCcCCCcccCcccccCCCCC-CcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          253 GLAKLMPG----SLIATSAYSAPECFQNRSYT-DKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       253 gl~~~~~~----~~~~~~~y~aPE~~~~~~~~-~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      |++.....    ...++..|+|||.+.+..+. .++||||||+++|||++|+.||....          .          
T Consensus       185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~----------  244 (312)
T 2iwi_A          185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------E----------  244 (312)
T ss_dssp             SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H----------
T ss_pred             chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------H----------
Confidence            99886543    23588999999999876664 58999999999999999999986410          0          


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         ......   ..+......+.+++.+||+.||++|||++|+++
T Consensus       245 ---~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ---ILEAEL---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---HHHTCC---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---Hhhhcc---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000000   011223445789999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.8e-40  Score=325.93  Aligned_cols=253  Identities=22%  Similarity=0.309  Sum_probs=192.4

Q ss_pred             ccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec------
Q 047245          100 NENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE------  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  172 (380)
                      ...+.||+|+||.||++.. .+|+.||+|++...       ......+.+.+|+.++++++||||+++++++..      
T Consensus        17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-------LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-------CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-------CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            3567899999999999987 56899999998641       123445788999999999999999999999765      


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCc---eEE
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFT---PRL  249 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~---~kl  249 (380)
                      ++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.   +||
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEE
Confidence            677899999999999999997422 2335888999999999999999999   899999999999999987664   999


Q ss_pred             eccCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh
Q 047245          250 ADFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH  324 (380)
Q Consensus       250 ~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~  324 (380)
                      +|||++.....     ...+++.|+|||.+.+..++.++||||||+++|||++|..||......       ..|......
T Consensus       166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-------~~~~~~i~~  238 (676)
T 3qa8_A          166 IDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-------VQWHGKVRE  238 (676)
T ss_dssp             CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-------HHSSTTCC-
T ss_pred             cccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-------hhhhhhhhc
Confidence            99999987543     235899999999999999999999999999999999999999642111       111100000


Q ss_pred             hcchhHhhc----------hhc-cCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhH
Q 047245          325 AGEAREALD----------RSI-LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL  370 (380)
Q Consensus       325 ~~~~~~~~~----------~~~-~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ev  370 (380)
                      .........          ... ............+.+++..||+.||++|||+.|+
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence            000000000          000 0111233466778999999999999999999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-39  Score=326.91  Aligned_cols=232  Identities=21%  Similarity=0.318  Sum_probs=185.7

Q ss_pred             cccccCccCCeeEEEEEec--CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe---
Q 047245          101 ENRLLGSSPDGKYYRTVLD--NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR---  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  175 (380)
                      ..+.||+|+||.||++...  +|+.||||++...       ........+.+|+.++++++||||+++++++...+.   
T Consensus        84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-------GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-------CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            4568999999999999975  6899999988641       123445778999999999999999999999987654   


Q ss_pred             --EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          176 --FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       176 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                        .++||||+++++|.+++..      .+++..++.++.|++.||+|||   +.+|+||||||+|||++.+ .+||+|||
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecc
Confidence              7999999999999987642      6999999999999999999999   8999999999999999986 89999999


Q ss_pred             CcccCCC--CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          254 LAKLMPG--SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       254 l~~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      +++....  ...||+.|+|||.+.+.. +.++||||||+++|||++|..|+.......                      
T Consensus       227 ~a~~~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------------  283 (681)
T 2pzi_A          227 AVSRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------------  283 (681)
T ss_dssp             TCEETTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------------
T ss_pred             cchhcccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------------
Confidence            9987653  345899999999987654 889999999999999999988865311000                      


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC-HHhHHHHHhc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-SDELVPMLTQ  376 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~~L~~  376 (380)
                          +............+.+++.+||+.||++||+ ++++.+.|..
T Consensus       284 ----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 ----LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ----CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                0001111223456789999999999999995 5556666554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.9e-38  Score=290.77  Aligned_cols=223  Identities=19%  Similarity=0.274  Sum_probs=173.8

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHH-HcCCCCCcceeeEEEec----CCe
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVL-ASLRHRNLMSLRAYVPE----SSR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~  175 (380)
                      .++||+|+||.||++.. .+|+.||+|++..             ...+.+|+.++ +..+||||+++++++..    ...
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CcccccCCCeEEEEEEEcCCCcEEEEEEecc-------------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            36799999999999987 5789999999864             14566788888 55699999999999876    677


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEecc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADF  252 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Df  252 (380)
                      .++||||+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||+++.   ++.+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            8999999999999999985  22346999999999999999999999   899999999999999998   789999999


Q ss_pred             CCcccCCCCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          253 GLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       253 gl~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      |++....                +..++.++||||||+++|||++|..||.........              ......+
T Consensus       165 g~a~~~~----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--------------~~~~~~~  214 (299)
T 3m2w_A          165 GFAKETT----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------------PGMKTRI  214 (299)
T ss_dssp             TTCEECT----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------------CCSCCSS
T ss_pred             ccccccc----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh--------------HHHHHHH
Confidence            9986543                245678999999999999999999998642111000              0000000


Q ss_pred             chhccCCc--ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEE--VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ........  ........+.+++.+||+.||++|||++|+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00000000  00123556889999999999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.8e-38  Score=289.05  Aligned_cols=228  Identities=15%  Similarity=0.115  Sum_probs=177.6

Q ss_pred             cccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++... +|+.||+|++......     .....+.+.+|+..+.+++||||+++++++.+.+..++|
T Consensus        35 i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL-----PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             EEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEcccCCeEEEEEEecCCCceEEEEEECccccc-----CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            4568999999999999975 4899999999753221     234557899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++++|.+++..     . .......+++.|++.||+|||   +.+++||||||+|||++.++.+||+++|      
T Consensus       110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999999852     1 355578899999999999999   8999999999999999999999998554      


Q ss_pred             CCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccC-
Q 047245          260 GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILG-  338 (380)
Q Consensus       260 ~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-  338 (380)
                              |++       +++.++||||||+++|||++|+.||..........              .....+...... 
T Consensus       175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------------~~~~~~~~~~~~~  225 (286)
T 3uqc_A          175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------------PAERDTAGQPIEP  225 (286)
T ss_dssp             --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------------ECCBCTTSCBCCH
T ss_pred             --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------------HHHHHhccCCCCh
Confidence                    333       36889999999999999999999987421110000              000000000000 


Q ss_pred             CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          339 EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       339 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      ..........+.+++.+||+.||++| |+.|+++.|+++.
T Consensus       226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            00011234558899999999999999 9999999998864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.3e-39  Score=306.18  Aligned_cols=238  Identities=17%  Similarity=0.155  Sum_probs=175.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC-CCcc---------eeeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-RNLM---------SLRAY  169 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv---------~l~~~  169 (380)
                      ..++||+|+||.||+|.. .+|+.||||++......     .....+.+.+|+.+++.++| +|..         .....
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-----PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-----cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            346899999999999995 57999999998742221     11224678899999999987 3221         11111


Q ss_pred             ------------Eec-----CCeEEEEEeecCCCCHHHHHHHhh---hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 047245          170 ------------VPE-----SSRFYLVYDYLQTGSLEDAMDRIR---ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQI  229 (380)
Q Consensus       170 ------------~~~-----~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  229 (380)
                                  ...     ....+++|+++ +++|.+++....   .....+++..++.++.|++.||+|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                        111     22457777765 679999986432   22445788899999999999999999   8999


Q ss_pred             EecCCCCCcEEeCCCCceEEeccCCcccCCC---CCcCCCcccCcccc----------cCCCCCCcchhhHHHHHHHHHH
Q 047245          230 LHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSAYSAPECF----------QNRSYTDKSDIFSFGMILAVLL  296 (380)
Q Consensus       230 iH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~----------~~~~~~~~sDv~s~Gvil~el~  296 (380)
                      +||||||+|||++.++.+||+|||+++....   ...| +.|+|||.+          ....++.++|||||||++|||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999999999999876543   3457 999999999          5566889999999999999999


Q ss_pred             hCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          297 TGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       297 tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +|+.||.......                     .....+....   ..+..+.+++.+||+.||++|||+.++++
T Consensus       312 tg~~Pf~~~~~~~---------------------~~~~~~~~~~---~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          312 CADLPNTDDAALG---------------------GSEWIFRSCK---NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HSSCCCCTTGGGS---------------------CSGGGGSSCC---CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCcchhh---------------------hHHHHHhhcc---cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999986421110                     0111111110   12355889999999999999999887753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.7e-38  Score=291.47  Aligned_cols=245  Identities=13%  Similarity=0.150  Sum_probs=182.1

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---------CCCcceeeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---------HRNLMSLRAYV  170 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h~niv~l~~~~  170 (380)
                      ...+.||+|+||.||++.. +|+.||||++................+.+.+|+.++++++         ||||+++.+.+
T Consensus        23 ~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~  101 (336)
T 2vuw_A           23 QRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH  101 (336)
T ss_dssp             HTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred             hheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence            3567899999999999998 6899999999874322111112223466788888888885         88888887764


Q ss_pred             e------------------------------cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHH
Q 047245          171 P------------------------------ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY  220 (380)
Q Consensus       171 ~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~  220 (380)
                      .                              +.+..++||||+++|++.+.+.     ...+++..+..++.|++.||+|
T Consensus       102 ~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A          102 CVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHH
Confidence            2                              2678999999999998766664     2468999999999999999999


Q ss_pred             hHhcCCCCeEecCCCCCcEEeCCCC--------------------ceEEeccCCcccCCCC-CcCCCcccCcccccCCCC
Q 047245          221 LHFTCNPQILHYNLKPTNVMLDAEF--------------------TPRLADFGLAKLMPGS-LIATSAYSAPECFQNRSY  279 (380)
Q Consensus       221 LH~~~~~~iiH~dlk~~Nill~~~~--------------------~~kl~Dfgl~~~~~~~-~~~~~~y~aPE~~~~~~~  279 (380)
                      ||+  +.+|+||||||+|||++.++                    .+||+|||+++..... ..||+.|+|||.+.+.. 
T Consensus       177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~-  253 (336)
T 2vuw_A          177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG-  253 (336)
T ss_dssp             HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-
T ss_pred             HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-
Confidence            993  36799999999999999887                    8999999999876543 46999999999998766 


Q ss_pred             CCcchhhHHHHH-HHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc-hhccCCcccHHHHHHHHHHHHHcc
Q 047245          280 TDKSDIFSFGMI-LAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD-RSILGEEVEEDEMLMAVRIAVVCL  357 (380)
Q Consensus       280 ~~~sDv~s~Gvi-l~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl  357 (380)
                      +.++||||++.+ .+++++|..||..           ..|.......  ...... ...............+.+++.+||
T Consensus       254 ~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          254 DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDK--MLKQMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHH--HHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHh--hhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            889999998776 7778889998742           1221111100  000000 001111223457788999999999


Q ss_pred             cCCCCCCCCHHhHH
Q 047245          358 SDSPADRPSSDELV  371 (380)
Q Consensus       358 ~~~P~~RPs~~evl  371 (380)
                      +.|     |++|++
T Consensus       321 ~~d-----sa~e~l  329 (336)
T 2vuw_A          321 NFS-----SATDLL  329 (336)
T ss_dssp             GSS-----SHHHHH
T ss_pred             ccC-----CHHHHH
Confidence            866     898887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.2e-31  Score=263.72  Aligned_cols=186  Identities=18%  Similarity=0.113  Sum_probs=130.3

Q ss_pred             cCccCCeeEEEEE-ecCCcEEEEEEeeeccCC--ChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeEEEEE
Q 047245          105 LGSSPDGKYYRTV-LDNGLTVAVRRVEAFESG--SPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       105 lg~G~~g~vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.|++|.+..+. ..-|+.+++|++......  ......+...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4556665554433 234788999999753211  11223345567899999999999 7999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||++|++|.+++..    ..+++..   +|+.||+.||+|+|   +++||||||||+|||+++++.+||+|||+++....
T Consensus       322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999974    3456553   58899999999999   99999999999999999999999999999987654


Q ss_pred             C------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCC
Q 047245          261 S------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP  301 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p  301 (380)
                      .      .+||+.|+|||.+.+ .+..++|+||+|++++++.++..+
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            3      248999999999875 457789999999998887665544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.5e-29  Score=249.12  Aligned_cols=183  Identities=17%  Similarity=0.234  Sum_probs=149.1

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      .++||+|+||.||++.. .+..+++|+.................+++.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999955 57899999886643333333334456779999999999999999976666667777899999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCC
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS  261 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~  261 (380)
                      |+++|+|.+++..            +..++.|+++||+|||   +.+|+||||||+|||+++  .+||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999873            4689999999999999   899999999999999999  9999999999987642


Q ss_pred             -------------CcCCCcccCcccccC--CCCCCcchhhHHHHHHHHHHhCCCCC
Q 047245          262 -------------LIATSAYSAPECFQN--RSYTDKSDIFSFGMILAVLLTGRDPT  302 (380)
Q Consensus       262 -------------~~~~~~y~aPE~~~~--~~~~~~sDv~s~Gvil~el~tg~~p~  302 (380)
                                   ..||+.|+|||.+..  ..|+...|+||...-.++-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                         248999999999987  66888899999999999988887776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.2e-24  Score=194.18  Aligned_cols=148  Identities=12%  Similarity=0.124  Sum_probs=115.2

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhh-hc---------HHHHHHHHHHHHHHHcCCCCCcceeeEEEe
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEK-QN---------KSVKRRIQQELEVLASLRHRNLMSLRAYVP  171 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~-~~---------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  171 (380)
                      .+.||+|+||.||+|...+|+.||+|.+.......... ..         ......+.+|+.++++++  | +++.+++.
T Consensus        95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~  171 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA  171 (282)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred             cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence            47899999999999999779999999996422111000 00         024577899999999999  4 56666554


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                      . +..++||||+++|+|.+ +..          .....++.|++.||+|||   +.+++||||||+|||++ ++.+||+|
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             c-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            3 45699999999999987 421          123569999999999999   89999999999999999 99999999


Q ss_pred             cCCcccCCCCCcCCCcccCccccc
Q 047245          252 FGLAKLMPGSLIATSAYSAPECFQ  275 (380)
Q Consensus       252 fgl~~~~~~~~~~~~~y~aPE~~~  275 (380)
                      ||+++..       ..+.|||.+.
T Consensus       236 FG~a~~~-------~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVEV-------GEEGWREILE  252 (282)
T ss_dssp             CTTCEET-------TSTTHHHHHH
T ss_pred             CCCCeEC-------CCCCHHHHHH
Confidence            9999743       4568898874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=1.4e-19  Score=161.56  Aligned_cols=143  Identities=15%  Similarity=0.148  Sum_probs=105.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcE--EEEEEeeeccCCChh----------------hhcHHHHHHHHHHHHHHHcCCCC
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLT--VAVRRVEAFESGSPE----------------KQNKSVKRRIQQELEVLASLRHR  161 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~--vavK~~~~~~~~~~~----------------~~~~~~~~~~~~E~~~l~~l~h~  161 (380)
                      ..+.||+|+||.||+|.. .+|+.  ||||+++........                .........+.+|+..+.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            456899999999999998 78999  999987542111000                00112334688999999999887


Q ss_pred             Cc--ceeeEEEecCCeEEEEEeecCC-C----CHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 047245          162 NL--MSLRAYVPESSRFYLVYDYLQT-G----SLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL  234 (380)
Q Consensus       162 ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dl  234 (380)
                      |+  ..++++    ...++||||+.+ |    +|.++...       .++.....++.|++.||.|||.  +.+++||||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            64  334432    346899999942 4    67766431       1234567899999999999994  468999999


Q ss_pred             CCCcEEeCCCCceEEeccCCcccC
Q 047245          235 KPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       235 k~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||+|||+++  .++|+|||++...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=2.1e-16  Score=147.21  Aligned_cols=143  Identities=10%  Similarity=0.114  Sum_probs=99.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCC----Chh--------hh--cHHHHHHHHHHHHHHHcCCCCCccee
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESG----SPE--------KQ--NKSVKRRIQQELEVLASLRHRNLMSL  166 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~----~~~--------~~--~~~~~~~~~~E~~~l~~l~h~niv~l  166 (380)
                      ..+.||+|++|.||+|...+|+.||||+++.....    ...        ..  ....+.....|...|.++.+.++...
T Consensus        99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp  178 (397)
T 4gyi_A           99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP  178 (397)
T ss_dssp             EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred             ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            56789999999999999999999999987642111    000        00  00111223457778888865554322


Q ss_pred             eEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-
Q 047245          167 RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-  245 (380)
Q Consensus       167 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-  245 (380)
                      .-+...  ..++||||+++++|.++..        .  .....++.|++.+|.|||   +.++|||||||.|||+++++ 
T Consensus       179 ~p~~~~--~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          179 EPIAQS--RHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CEEEEE--TTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             eeeecc--CceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            212111  2379999999988855432        1  123568899999999999   88999999999999998776 


Q ss_pred             ---------ceEEeccCCcccC
Q 047245          246 ---------TPRLADFGLAKLM  258 (380)
Q Consensus       246 ---------~~kl~Dfgl~~~~  258 (380)
                               .+.|+||+-+-..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999976543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=1e-11  Score=110.65  Aligned_cols=137  Identities=10%  Similarity=0.094  Sum_probs=104.7

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ...++.|+.+.||+.... |..+++|+........        ...+.+|+.+++.+. +.++.++++++.+.+..++||
T Consensus        19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC--------HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            456777888999998764 6899999986421111        134778999999884 677889999999889999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhc------------------------------------
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT------------------------------------  224 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------  224 (380)
                      ||++|.+|.+.+.         +......++.+++++|+.||..                                    
T Consensus        90 e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           90 SEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             ECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            9999999877531         0112346888999999999951                                    


Q ss_pred             --------------------CCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          225 --------------------CNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       225 --------------------~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                                          ....++|||+++.||+++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                01458999999999999876667799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=2.3e-11  Score=107.93  Aligned_cols=128  Identities=16%  Similarity=0.115  Sum_probs=94.1

Q ss_pred             CccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCC--cceeeEEEecCCeEEEEEeec
Q 047245          106 GSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN--LMSLRAYVPESSRFYLVYDYL  183 (380)
Q Consensus       106 g~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  183 (380)
                      +.|..+.||+....+|..+++|.....   .        ...+..|+..++.+.+.+  +.+++++...++..++||||+
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~--------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---A--------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---T--------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---c--------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            455669999998877888999987541   0        134677899888885444  556888888888899999999


Q ss_pred             CCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------------------
Q 047245          184 QTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC--------------------------------------  225 (380)
Q Consensus       184 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------  225 (380)
                      +|.+|.  ..       ..+   ...++.++++.|+.||...                                      
T Consensus        98 ~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           98 PGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             SSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             CCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            998884  21       011   1356677777777777321                                      


Q ss_pred             -----------------CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 -----------------NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 -----------------~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                                       ...++|||++|.||+++++..+.|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             1229999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=1.8e-10  Score=107.43  Aligned_cols=141  Identities=15%  Similarity=0.176  Sum_probs=104.1

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEee--eccCCChhhhcHHHHHHHHHHHHHHHcCC--CCCcceeeEEEecC---Ce
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVE--AFESGSPEKQNKSVKRRIQQELEVLASLR--HRNLMSLRAYVPES---SR  175 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~  175 (380)
                      +.|+.|.++.||+....+ ..+++|+..  ...       .......+.+|..+++.+.  +..+.++++++.+.   +.
T Consensus        44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~-------~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK-------LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             EECCC-CCSCEEEEECSS-CEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             EEcCCcccceEEEEEECC-ceEEEEeCCCCCCC-------CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            468899999999988754 678888765  211       0011246778999999996  45688899998776   45


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC------------------------------
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC------------------------------  225 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------  225 (380)
                      .++||||++|..+.+..      ...++...+..++.++++.|+.||...                              
T Consensus       116 ~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             CEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            89999999997774311      224677788889999999999999521                              


Q ss_pred             -------------------------CCCeEecCCCCCcEEeCCCCc--eEEeccCCccc
Q 047245          226 -------------------------NPQILHYNLKPTNVMLDAEFT--PRLADFGLAKL  257 (380)
Q Consensus       226 -------------------------~~~iiH~dlk~~Nill~~~~~--~kl~Dfgl~~~  257 (380)
                                               ...++|||+++.||++++++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     256999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.91  E-value=1.4e-09  Score=99.02  Aligned_cols=180  Identities=14%  Similarity=0.110  Sum_probs=117.1

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCC--cceeeEEEecCC---eE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRN--LMSLRAYVPESS---RF  176 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~  176 (380)
                      +.++.|....||+..    ..+++|....          ......+.+|...++.+ .+..  +.+.+......+   ..
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~----------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~   91 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKH----------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS   91 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESS----------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCC----------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence            457889999999752    5688887542          12346788999999888 4433  344555543333   34


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhc--------------------------------
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT--------------------------------  224 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------  224 (380)
                      |+|||+++|.+|.+...      ..++..++..++.++++.++.||..                                
T Consensus        92 ~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL  165 (304)
T ss_dssp             CEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred             eEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence            88999999988765322      1356666777777777777777741                                


Q ss_pred             -----------------------CCCCeEecCCCCCcEEeCC--CCceEEeccCCcccCCCCC--cCCCcc---cCcccc
Q 047245          225 -----------------------CNPQILHYNLKPTNVMLDA--EFTPRLADFGLAKLMPGSL--IATSAY---SAPECF  274 (380)
Q Consensus       225 -----------------------~~~~iiH~dlk~~Nill~~--~~~~kl~Dfgl~~~~~~~~--~~~~~y---~aPE~~  274 (380)
                                             ....++|+|+++.||++++  +..+.|+||+.+..-....  ......   ..|+..
T Consensus       166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~  245 (304)
T 3sg8_A          166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFV  245 (304)
T ss_dssp             CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHH
T ss_pred             CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHH
Confidence                                   1245899999999999998  4567899999876422110  001111   222221


Q ss_pred             cC-----CCC---------CCcchhhHHHHHHHHHHhCCCCC
Q 047245          275 QN-----RSY---------TDKSDIFSFGMILAVLLTGRDPT  302 (380)
Q Consensus       275 ~~-----~~~---------~~~sDv~s~Gvil~el~tg~~p~  302 (380)
                      ..     +..         ....+.|+++.++|.+.+|..+|
T Consensus       246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            10     111         11268999999999999998775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=4.5e-07  Score=80.65  Aligned_cols=133  Identities=15%  Similarity=0.161  Sum_probs=93.7

Q ss_pred             cCccCCe-eEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEEEe
Q 047245          105 LGSSPDG-KYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       105 lg~G~~g-~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +..|..| .||+.... ++..+.+|+-..           .....+.+|...|+.+. +--+.++++++.+.+..++|||
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme  100 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT  100 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET-----------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC-----------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence            4445554 68987754 466788898643           12356788999998884 4446788999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC------------------------------------
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC------------------------------------  225 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------  225 (380)
                      +++|.++.+.....        ......++.+++..|+-||...                                    
T Consensus       101 ~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             eeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99998887754321        1112345556666666666210                                    


Q ss_pred             -------------------CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 -------------------NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 -------------------~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                                         ...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                               1237999999999999988777899998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.51  E-value=1e-06  Score=79.94  Aligned_cols=135  Identities=16%  Similarity=0.174  Sum_probs=86.9

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC---CcceeeEEEe-cCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR---NLMSLRAYVP-ESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~l  178 (380)
                      +.++.|....||+.    |..+++|.-..          ......+.+|..+|+.+.+.   .+.+.+.++. ..+..++
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~----------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~   90 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS----------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV   90 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS----------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC----------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence            35778888899987    56788887421          12346788999999999642   2556677764 4456789


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHh-----------------------------------
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHF-----------------------------------  223 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----------------------------------  223 (380)
                      |||+++|..+.+...      ..++...+..++.++++.|+.||.                                   
T Consensus        91 v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             EEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            999999988765211      011222222223333333333321                                   


Q ss_pred             ----------------------cCCCCeEecCCCCCcEEeCC---CCc-eEEeccCCccc
Q 047245          224 ----------------------TCNPQILHYNLKPTNVMLDA---EFT-PRLADFGLAKL  257 (380)
Q Consensus       224 ----------------------~~~~~iiH~dlk~~Nill~~---~~~-~kl~Dfgl~~~  257 (380)
                                            .....++|+|+++.||++++   ++. +.|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                  12456799999999999987   455 48999997753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.19  E-value=1.8e-05  Score=72.59  Aligned_cols=31  Identities=16%  Similarity=0.272  Sum_probs=28.2

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ...++|||+.+.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5789999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=5.5e-06  Score=76.70  Aligned_cols=82  Identities=11%  Similarity=0.055  Sum_probs=52.5

Q ss_pred             ccc-CccCCeeEEEEEec-------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-C--CCcceeeEEEe
Q 047245          103 RLL-GSSPDGKYYRTVLD-------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-H--RNLMSLRAYVP  171 (380)
Q Consensus       103 ~~l-g~G~~g~vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~  171 (380)
                      +.| +.|....+|+....       ++..+++|.-..........     ...+.+|..+++.+. +  ..+.++++++.
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~-----~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP-----TYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS-----CCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc-----hhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            356 77888999988764       26678888764311000000     134567888888773 3  35677888876


Q ss_pred             cC---CeEEEEEeecCCCCHH
Q 047245          172 ES---SRFYLVYDYLQTGSLE  189 (380)
Q Consensus       172 ~~---~~~~lv~e~~~~gsL~  189 (380)
                      +.   +..++||||++|..+.
T Consensus       101 ~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          101 TGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSTTTSSCEEEEECCCCBCCC
T ss_pred             CCCccCCceEEEEecCCCChh
Confidence            65   3568999999886543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.87  E-value=6.9e-05  Score=70.40  Aligned_cols=81  Identities=9%  Similarity=-0.005  Sum_probs=47.2

Q ss_pred             cccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC--CC-cceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH--RN-LMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  178 (380)
                      +.+|.|..+.||++... ++..+++|..........+ ........+..|.++++.+..  +. +.+++.+.  .+..++
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~-~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC-CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            46899999999999754 4688999986532110000 000011345668888887732  33 34555443  344689


Q ss_pred             EEeecCCC
Q 047245          179 VYDYLQTG  186 (380)
Q Consensus       179 v~e~~~~g  186 (380)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.67  E-value=0.00027  Score=63.21  Aligned_cols=74  Identities=15%  Similarity=0.119  Sum_probs=51.7

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-C--CCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-H--RNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+|.|..+.||+..+.||+.+.+|+-......   .     ...|..|...|+.|. .  --+.+.+++.    .-++|
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~---~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPA---L-----DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCC---C-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc---h-----hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            458999999999999999999999986432111   0     145778999888884 2  2344555543    23789


Q ss_pred             EeecCCCCH
Q 047245          180 YDYLQTGSL  188 (380)
Q Consensus       180 ~e~~~~gsL  188 (380)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.65  E-value=0.0012  Score=59.77  Aligned_cols=138  Identities=19%  Similarity=0.166  Sum_probs=90.1

Q ss_pred             cccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC---CCCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR---HRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  179 (380)
                      +.|+.|....+|+... ++..+++|+....           ....+..|...|+.|.   ...+.+.++++...+..++|
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS-----------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG-----------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc-----------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            3578899999999876 4678888886531           1356788988888883   35678889988888899999


Q ss_pred             EeecCCCCHH--------H---HHHHhhh-cc-----------------cCCCHHHHH---HHHHH--------------
Q 047245          180 YDYLQTGSLE--------D---AMDRIRE-NQ-----------------LQLGWEVRL---RIAVG--------------  213 (380)
Q Consensus       180 ~e~~~~gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~~~--------------  213 (380)
                      |||+++..+.        +   .+|.... ..                 -.-+|....   ++..+              
T Consensus       110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~  189 (312)
T 3jr1_A          110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI  189 (312)
T ss_dssp             EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred             EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence            9999987642        1   1222111 00                 012465322   11111              


Q ss_pred             --HHHH-HHHhH-hcCCCCeEecCCCCCcEEeCCCCceEEeccC
Q 047245          214 --VIKG-LQYLH-FTCNPQILHYNLKPTNVMLDAEFTPRLADFG  253 (380)
Q Consensus       214 --ia~~-l~~LH-~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfg  253 (380)
                        +... ...|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence              1111 22332 12357799999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.64  E-value=0.00033  Score=66.27  Aligned_cols=73  Identities=16%  Similarity=0.129  Sum_probs=47.3

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCCC-----c--CCCcccCcccccCC---CCCCcchhhHHHHHHHHH
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL-----I--ATSAYSAPECFQNR---SYTDKSDIFSFGMILAVL  295 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~-----~--~~~~y~aPE~~~~~---~~~~~sDv~s~Gvil~el  295 (380)
                      ...++|||+++.|||+++++ ++|+||+.+..-....     .  -...|.+|+.....   ......++.+....+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            67899999999999998876 9999999886532110     0  11235555544311   111235566778888887


Q ss_pred             HhCC
Q 047245          296 LTGR  299 (380)
Q Consensus       296 ~tg~  299 (380)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.00057  Score=62.39  Aligned_cols=32  Identities=25%  Similarity=0.314  Sum_probs=27.7

Q ss_pred             CCCeEecCCCCCcEEeCCC----CceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAE----FTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~----~~~kl~Dfgl~~~  257 (380)
                      ...++|||+.+.||+++.+    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            5679999999999999875    6789999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.44  E-value=0.001  Score=56.13  Aligned_cols=103  Identities=15%  Similarity=0.016  Sum_probs=67.6

Q ss_pred             CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCCCCcCC
Q 047245          186 GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIAT  265 (380)
Q Consensus       186 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~~~~~~  265 (380)
                      -||.+.|..   ...++++.+.|.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.+.+.+ ..+.      ...
T Consensus        33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------~~~  100 (229)
T 2yle_A           33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------AGE  100 (229)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------ccc
Confidence            479999874   467899999999999999988776211011  1222446899999999998874 2111      123


Q ss_pred             CcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCC
Q 047245          266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP  301 (380)
Q Consensus       266 ~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p  301 (380)
                      ..+.+||... ...+.+.=|||+|+++|.-+--..|
T Consensus       101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            3466888763 3457788999999999999984444

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.25  E-value=0.00071  Score=60.81  Aligned_cols=31  Identities=13%  Similarity=0.117  Sum_probs=25.7

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ...++|+|+.+.||+ .+++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            455899999999999 5666789999987753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.19  E-value=0.0017  Score=58.73  Aligned_cols=157  Identities=17%  Similarity=0.155  Sum_probs=83.5

Q ss_pred             CChHHHHHHHhcc-------ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC
Q 047245           89 IDPKTLQAALANE-------NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR  161 (380)
Q Consensus        89 ~~~~~l~~~~~~~-------~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  161 (380)
                      ++..++.......       -+.|+.|....+|+....+| .+++|......          ....+..|..++..+...
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----------~~~~l~~e~~~l~~L~~~   75 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV----------EKNDLPFFLGLMQHLAAK   75 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------------CCHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC----------CHHHHHHHHHHHHHHHHC
Confidence            4455555554432       12356677789999887666 67888875410          012344566666666321


Q ss_pred             C--cceeeEE------EecCCeEEEEEeecCCCCHH-----H---------HHHHhhhc-ccC-------CCHHHHHHH-
Q 047245          162 N--LMSLRAY------VPESSRFYLVYDYLQTGSLE-----D---------AMDRIREN-QLQ-------LGWEVRLRI-  210 (380)
Q Consensus       162 n--iv~l~~~------~~~~~~~~lv~e~~~~gsL~-----~---------~l~~~~~~-~~~-------l~~~~~~~i-  210 (380)
                      +  +.+++..      ....+..+++++|++|..+.     .         .+|..... ..+       ..|...+.- 
T Consensus        76 g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~  155 (322)
T 2ppq_A           76 GLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKS  155 (322)
T ss_dssp             TCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHH
T ss_pred             CCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHH
Confidence            2  2333321      12235679999999885431     1         12211100 000       123321110 


Q ss_pred             -----------HHHHHHHHHHhHhc----CCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          211 -----------AVGVIKGLQYLHFT----CNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       211 -----------~~~ia~~l~~LH~~----~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                                 ...+...+++++..    ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          156 EERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                       11234445555532    23578999999999999987666899998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.10  E-value=0.0038  Score=56.61  Aligned_cols=158  Identities=14%  Similarity=0.173  Sum_probs=85.8

Q ss_pred             CCChHHHHHHHhcc-------ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC
Q 047245           88 KIDPKTLQAALANE-------NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH  160 (380)
Q Consensus        88 ~~~~~~l~~~~~~~-------~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  160 (380)
                      ..+...+.......       -..++ |....||+....+|..+++|.......      .   ...+..|..++..+..
T Consensus        10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~------~---~~~~~~E~~~~~~L~~   79 (328)
T 1zyl_A           10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW------T---ADQILEEHQFALQLVN   79 (328)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS------C---HHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC------C---HHHHHHHHHHHHHHHH
Confidence            44555565554431       12355 777899988777787899999853110      0   1345567777776632


Q ss_pred             C--CcceeeEE-----EecCCeEEEEEeecCCCCHH-----H------H---HHHhhhc-----ccCCCHHHH----HHH
Q 047245          161 R--NLMSLRAY-----VPESSRFYLVYDYLQTGSLE-----D------A---MDRIREN-----QLQLGWEVR----LRI  210 (380)
Q Consensus       161 ~--niv~l~~~-----~~~~~~~~lv~e~~~~gsL~-----~------~---l~~~~~~-----~~~l~~~~~----~~i  210 (380)
                      .  .+.+++..     ....+..++++++++|..+.     .      .   +|.....     ....++...    ..+
T Consensus        80 ~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T 1zyl_A           80 DEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKL  159 (328)
T ss_dssp             TTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHH
T ss_pred             cCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHH
Confidence            1  23334432     12245678899999874321     1      1   1211110     011222211    001


Q ss_pred             ---------------HHHHHHHHHHhHhc----CCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          211 ---------------AVGVIKGLQYLHFT----CNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       211 ---------------~~~ia~~l~~LH~~----~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                                     ...+...++.+...    ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       160 l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          160 FEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                           01111223333211    245689999999999999 4 899999987753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.99  E-value=0.0016  Score=61.74  Aligned_cols=71  Identities=13%  Similarity=0.111  Sum_probs=46.2

Q ss_pred             cccCccCCeeEEEEEecC--------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc-ceeeEEEecC
Q 047245          103 RLLGSSPDGKYYRTVLDN--------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL-MSLRAYVPES  173 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~  173 (380)
                      +.|+.|....+|+....+        +..+.+|+....   .    .   ...+..|..+++.+...++ .++++.+.+ 
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~----~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~-  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E----T---ESHLVAESVIFTLLSERHLGPKLYGIFSG-  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C----C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---C----c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-
Confidence            347778889999998753        478888887321   0    0   0234468888888843333 567776643 


Q ss_pred             CeEEEEEeecCCCC
Q 047245          174 SRFYLVYDYLQTGS  187 (380)
Q Consensus       174 ~~~~lv~e~~~~gs  187 (380)
                         .+|+||++|.+
T Consensus       148 ---g~v~e~l~G~~  158 (429)
T 1nw1_A          148 ---GRLEEYIPSRP  158 (429)
T ss_dssp             ---EEEECCCCEEE
T ss_pred             ---CEEEEEeCCcc
Confidence               28999998633

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.99  E-value=0.0022  Score=59.64  Aligned_cols=140  Identities=16%  Similarity=0.147  Sum_probs=79.5

Q ss_pred             ccCccCCeeEEEEEec--------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCC
Q 047245          104 LLGSSPDGKYYRTVLD--------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESS  174 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  174 (380)
                      .|..|-...+|+....        ++..+.+|+.....         .....+.+|..+++.+. +.-..++++++.++ 
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---------~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g-  126 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---------QGVDSLVLESVMFAILAERSLGPQLYGVFPEG-  126 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE-
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---------chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc-
Confidence            4666777889998874        24688888753210         01244558888888884 33345677776542 


Q ss_pred             eEEEEEeecCCCCHHH--------------HHHHhhhc----ccCCC--HHHHHHHHHHHHH------------------
Q 047245          175 RFYLVYDYLQTGSLED--------------AMDRIREN----QLQLG--WEVRLRIAVGVIK------------------  216 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~--------------~l~~~~~~----~~~l~--~~~~~~i~~~ia~------------------  216 (380)
                         +|+||++|.+|..              .|...-..    .....  |.++.++..++..                  
T Consensus       127 ---~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  203 (379)
T 3feg_A          127 ---RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK  203 (379)
T ss_dssp             ---EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred             ---cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence               8999999754421              11111111    11122  3444444443321                  


Q ss_pred             -HHHHhH----h-cCCCCeEecCCCCCcEEeCCC----CceEEeccCCcc
Q 047245          217 -GLQYLH----F-TCNPQILHYNLKPTNVMLDAE----FTPRLADFGLAK  256 (380)
Q Consensus       217 -~l~~LH----~-~~~~~iiH~dlk~~Nill~~~----~~~kl~Dfgl~~  256 (380)
                       .+..|.    . .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence             223332    1 123568999999999999876    789999998775

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.88  E-value=0.0018  Score=59.34  Aligned_cols=32  Identities=19%  Similarity=0.265  Sum_probs=27.9

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45799999999999999888899999987653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.67  E-value=0.01  Score=56.58  Aligned_cols=73  Identities=8%  Similarity=0.102  Sum_probs=45.2

Q ss_pred             cccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCc-ceeeEEEecCCeEEEEE
Q 047245          103 RLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNL-MSLRAYVPESSRFYLVY  180 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  180 (380)
                      +.|+.|-...+|+....+ +..+.+|+......   ..      -.-.+|..++..|...++ .++++.+..    .+|+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~------idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~  180 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EI------INREREKKISCILYNKNIAKKIYVFFTN----GRIE  180 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SC------SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hh------cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEE
Confidence            357778889999988765 47788887643110   00      011468888888865455 456776632    2499


Q ss_pred             eecCCCCH
Q 047245          181 DYLQTGSL  188 (380)
Q Consensus       181 e~~~~gsL  188 (380)
                      ||++|.+|
T Consensus       181 e~I~G~~l  188 (458)
T 2qg7_A          181 EFMDGYAL  188 (458)
T ss_dssp             ECCCSEEC
T ss_pred             EeeCCccC
Confidence            99987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.50  E-value=0.0032  Score=58.29  Aligned_cols=30  Identities=23%  Similarity=0.348  Sum_probs=24.9

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ...++|+|+.+.|||++++. +.|+||..+.
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            45689999999999998655 8999998775

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.32  E-value=0.016  Score=35.16  Aligned_cols=26  Identities=19%  Similarity=0.148  Sum_probs=10.8

Q ss_pred             EEehhhHHHHHHHHHHHHHHHHHHhh
Q 047245           44 IILSIALGVVTGLIGAILFACFVRCF   69 (380)
Q Consensus        44 ~~~~~~~~~~~~l~~~~~~~~~~~~~   69 (380)
                      |..+++.|+++++++++++++++|++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr   38 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRR   38 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhh
Confidence            33334444444444443444444443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.24  E-value=0.16  Score=47.67  Aligned_cols=30  Identities=17%  Similarity=0.357  Sum_probs=26.3

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ...++|+|+.+.||+ ++++.+.++||..+.
T Consensus       261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             CEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             CceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            356899999999999 788899999998875

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=94.94  E-value=0.02  Score=34.57  Aligned_cols=26  Identities=15%  Similarity=0.384  Sum_probs=12.7

Q ss_pred             EEehhhHHHHHHHHHHHHHHHHHHhh
Q 047245           44 IILSIALGVVTGLIGAILFACFVRCF   69 (380)
Q Consensus        44 ~~~~~~~~~~~~l~~~~~~~~~~~~~   69 (380)
                      .+.+.++|++++++++++++++.||+
T Consensus        13 ~Ia~~vVGvll~vi~~l~~~~~~RRR   38 (44)
T 2jwa_A           13 SIISAVVGILLVVVLGVVFGILIKRR   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHHHHhheehh
Confidence            35556666544444444444444444

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.30  E-value=0.027  Score=34.02  Aligned_cols=19  Identities=32%  Similarity=0.441  Sum_probs=7.2

Q ss_pred             HHHHHHHHHHHHHHHHHhh
Q 047245           51 GVVTGLIGAILFACFVRCF   69 (380)
Q Consensus        51 ~~~~~l~~~~~~~~~~~~~   69 (380)
                      |++++++++++.++++|++
T Consensus        19 Gv~~v~ii~~~~~~~~RRR   37 (44)
T 2l2t_A           19 GLFILVIVGLTFAVYVRRK   37 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHhhhh
Confidence            3333333333334444443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=92.88  E-value=0.054  Score=31.72  Aligned_cols=22  Identities=18%  Similarity=0.329  Sum_probs=11.7

Q ss_pred             EEehhhHHHHHHHHHHHHHHHH
Q 047245           44 IILSIALGVVTGLIGAILFACF   65 (380)
Q Consensus        44 ~~~~~~~~~~~~l~~~~~~~~~   65 (380)
                      .+.++++|+++++++++.+.++
T Consensus        12 aIAGiVvG~v~gv~li~~l~~~   33 (38)
T 2k1k_A           12 EIVAVIFGLLLGAALLLGILVF   33 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceeeeehHHHHHHHHHHHHHHH
Confidence            4556777766655444443333

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.38  E-value=0.61  Score=39.13  Aligned_cols=118  Identities=9%  Similarity=0.135  Sum_probs=79.9

Q ss_pred             CCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       159 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      .||+.+.. .+-.+.+.+.+.|+.-++  ..+|-.     -...+...+++++..++....+++     .-+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecce
Confidence            57888866 455666677777765442  222211     235778889999999988765554     34677899999


Q ss_pred             EEeCCCCceEEeccCCcccCCCCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCch
Q 047245          239 VMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPF  305 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~  305 (380)
                      ++++.++.+++.-.|+...           ++|.     ..+...=.-.+=+++..+++++..|+..
T Consensus       110 L~f~~~~~p~i~~RGik~~-----------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-----------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-----------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             EEEcCCCCEEEEEccCccC-----------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            9999999999987776443           2232     1122222345788999999999988754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=90.77  E-value=2.2  Score=35.87  Aligned_cols=118  Identities=13%  Similarity=0.172  Sum_probs=80.2

Q ss_pred             CCCCcceeeEEEecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHH-HhHhcCCCCeEecCCCCC
Q 047245          159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ-YLHFTCNPQILHYNLKPT  237 (380)
Q Consensus       159 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~iiH~dlk~~  237 (380)
                      .||+.  -...-.+.+.+.+.|+.-+++.=.+.++       ..+...+++++..++.... ++     ..-+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~-----~~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHS-----ARRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCC-----SSSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhh-----hCceeEEEeCc
Confidence            57777  3444467778888888665543333333       4777889999988877544 33     45577789999


Q ss_pred             cEEeCCCCceEEeccCCcccCCCCCcCCCcccCcccccCCCCCCcchh-hHHHHHHHHHHhCCCCCCchhh
Q 047245          238 NVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPECFQNRSYTDKSDI-FSFGMILAVLLTGRDPTAPFFA  307 (380)
Q Consensus       238 Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv-~s~Gvil~el~tg~~p~~~~~~  307 (380)
                      |+++|.++.+++.-.|+-..           ++|..+     + ..|. -.+=+++..++.++..|+....
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-----------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe~l~~  167 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-----------LPPDEW-----D-DERLLREVKATVLALTEGEYRFDEYLK  167 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-----------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHHHHHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-----------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHHHHHh
Confidence            99999999999997776543           233221     1 2233 3577888899999888765433

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.31  E-value=0.089  Score=50.14  Aligned_cols=61  Identities=5%  Similarity=-0.037  Sum_probs=16.6

Q ss_pred             ccccCccCCeeEEEEEecC-CcEEEE------EEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEe
Q 047245          102 NRLLGSSPDGKYYRTVLDN-GLTVAV------RRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVP  171 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~-g~~vav------K~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  171 (380)
                      .+.||   ||.||+|.+.. ..+|||      |..+..      ....+....|.+|..+++.++|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~------~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQD------GVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccc------cccccccccccccccccccccccccCCCcceEE
Confidence            34565   99999999854 367888      655431      112233467888999999999999999988753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	380
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-43
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-42
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-38
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-37
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-35
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-34
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-33
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-32
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-32
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-31
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-30
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-29
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-29
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-29
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-28
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-28
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-27
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-27
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-24
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-20
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-19
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-15
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-12

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 3e-48
 Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 40/286 (13%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + +GS   G  Y+        VAV+ +      +         +  + E+ VL   RH N
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKML------NVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           ++    Y   + +  +V  + +  SL      +   + +      + IA    +G+ YLH
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYH---HLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--------GSLIATSAYSAPECF 274
                 I+H +LK  N+ L  + T ++ DFGLA +            L  +  + APE  
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 275 QNRS---YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA 331
           + +    Y+ +SD+++FG++L  L+TG+ P         S  +    +  +   G     
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRGYLSPD 230

Query: 332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
           L       +V  +      R+   CL     +RP   +++  +  L
Sbjct: 231 LS------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 55/292 (18%), Positives = 124/292 (42%), Gaps = 25/292 (8%)

Query: 98  LANEN----RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQEL 152
           L +++      LG+   G  ++ +   +GL +A + +         +   +++ +I +EL
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-------EIKPAIRNQIIREL 55

Query: 153 EVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
           +VL       ++             +  +++  GSL+  + +      ++  ++  ++++
Sbjct: 56  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSI 111

Query: 213 GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL----IATSAY 268
            VIKGL YL       I+H ++KP+N+++++    +L DFG++  +  S+    + T +Y
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169

Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA 328
            +PE  Q   Y+ +SDI+S G+ L  +  GR P  P  A+        +           
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229

Query: 329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS---SDELVPMLTQL 377
                R +    ++    +    +    +++ P   PS   S E    + + 
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-44
 Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 36/280 (12%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +G+   G+  +     +G  +  + +            ++ K+ +  E+ +L  L+H 
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKEL------DYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 162 NLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           N++     +    ++  Y+V +Y + G L   + +  + +  L  E  LR+   +   L+
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 220 YLH--FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL------MPGSLIATSAYSAP 271
             H        +LH +LKP NV LD +   +L DFGLA++         + + T  Y +P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA 331
           E     SY +KSDI+S G +L  L     P         +  S       ++        
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPF--------TAFSQKELAGKIREG------ 229

Query: 332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
                +     ++       I    L+     RPS +E++
Sbjct: 230 -KFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-44
 Identities = 66/292 (22%), Positives = 123/292 (42%), Gaps = 54/292 (18%)

Query: 105 LGSSPDGKYYR-----------TV-----LDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           +G S DG++ +           TV      +  + VA   +         K  KS ++R 
Sbjct: 2   VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL------QDRKLTKSERQRF 55

Query: 149 QQELEVLASLRHRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGW 204
           ++E E+L  L+H N++         V       LV + + +G+L+  + R +     +  
Sbjct: 56  KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKI 111

Query: 205 EVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKLMPGSL- 262
           +V       ++KGLQ+LH T  P I+H +LK  N+ +     + ++ D GLA L   S  
Sbjct: 112 KVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170

Query: 263 ---IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWL 319
              I T  + APE ++ + Y +  D+++FGM +  + T   P    ++E  +   + R +
Sbjct: 171 KAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP----YSECQNAAQIYRRV 225

Query: 320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
                 G    + D+  + E            I   C+  +  +R S  +L+
Sbjct: 226 TS----GVKPASFDKVAIPE---------VKEIIEGCIRQNKDERYSIKDLL 264

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-43
 Identities = 60/279 (21%), Positives = 123/279 (44%), Gaps = 40/279 (14%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
             LG+   G+ +    +    VAV+ +         KQ          E  ++  L+H+ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL---------KQGSMSPDAFLAEANLMKQLQHQR 69

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V      Y++ +Y++ GSL D +     + ++L     L +A  + +G+ ++ 
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-------LIATSAYSAPECFQ 275
                  +H +L+  N+++    + ++ADFGLA+L+  +             ++APE   
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
             ++T KSD++SFG++L  ++T      P+      G +    +++L+          R 
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI--PY-----PGMTNPEVIQNLERG-------YRM 229

Query: 336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           +  +   E+      ++  +C  + P DRP+ D L  +L
Sbjct: 230 VRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-43
 Identities = 55/296 (18%), Positives = 111/296 (37%), Gaps = 45/296 (15%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           IDP  L        + +GS   G  +     N   VA++ +         ++    +   
Sbjct: 2   IDPSEL-----TFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---------REGAMSEEDF 47

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
            +E EV+  L H  L+ L     E +   LV+++++ G L D +   R  +     E  L
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL---RTQRGLFAAETLL 104

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------- 261
            + + V +G+ YL       ++H +L   N ++      +++DFG+ + +          
Sbjct: 105 GMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161

Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH 321
                 +++PE F    Y+ KSD++SFG+++  + +         + +     +    R 
Sbjct: 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221

Query: 322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
            +    +                       I   C  + P DRP+   L+  L ++
Sbjct: 222 YKPRLASTHVYQ------------------IMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 8e-43
 Identities = 58/302 (19%), Positives = 106/302 (35%), Gaps = 42/302 (13%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
             +G    G+ +R     G  VAV+              +      + E+     LRH N
Sbjct: 9   ESIGKGRFGEVWR-GKWRGEEVAVKIF---------SSREERSWFREAEIYQTVMLRHEN 58

Query: 163 LMSLRAYVPES----SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
           ++   A   +     ++ +LV DY + GSL D ++R       +  E  +++A+    GL
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGL 113

Query: 219 QYLHFTC-----NPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM----------PGSLI 263
            +LH         P I H +LK  N+++    T  +AD GLA             P   +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 264 ATSAYSAPECFQNR------SYTDKSDIFSFGMILAVLLTGRDPTA--PFFAEAASGGSL 315
            T  Y APE   +           ++DI++ G++   +            +         
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 316 GRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT 375
                         + L  +I       + + +  +I   C   + A R ++  +   L+
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

Query: 376 QL 377
           QL
Sbjct: 294 QL 295

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-42
 Identities = 58/281 (20%), Positives = 111/281 (39%), Gaps = 38/281 (13%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
           + +G    G         G  VAV+ +          +N +  +    E  V+  LRH N
Sbjct: 13  QTIGKGEFGDVML-GDYRGNKVAVKCI----------KNDATAQAFLAEASVMTQLRHSN 61

Query: 163 LMSLR-AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           L+ L    V E    Y+V +Y+  GSL D +      +  LG +  L+ ++ V + ++YL
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRS 278
                   +H +L   NV++  +   +++DFGL K       +      ++APE  + + 
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKK 176

Query: 279 YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILG 338
           ++ KSD++SFG++L  + +      P+         L   +  ++   +           
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRV--PY-----PRIPLKDVVPRVEKGYK----------- 218

Query: 339 EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS 379
            +  +        +   C     A RPS  +L   L  + +
Sbjct: 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 4e-42
 Identities = 52/296 (17%), Positives = 110/296 (37%), Gaps = 45/296 (15%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRI 148
           IDPK L        + LG+   G            VA++ +         K+    +   
Sbjct: 1   IDPKDLT-----FLKELGTGQFGVVKYGKWRGQYDVAIKMI---------KEGSMSEDEF 46

Query: 149 QQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRL 208
            +E +V+ +L H  L+ L     +    +++ +Y+  G L   ++ +RE + +   +  L
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLL 103

Query: 209 RIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------- 261
            +   V + ++YL      Q LH +L   N +++ +   +++DFGL++ +          
Sbjct: 104 EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160

Query: 262 LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRH 321
                 +S PE      ++ KSDI++FG+++  + +      P+        +      H
Sbjct: 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM--PY-----ERFTNSETAEH 213

Query: 322 LQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
           +              L              I   C  +   +RP+   L+  +  +
Sbjct: 214 IAQG-----------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 9e-42
 Identities = 55/276 (19%), Positives = 114/276 (41%), Gaps = 41/276 (14%)

Query: 103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R LG    G  Y      +   +A++ +        + +   V+ ++++E+E+ + LRH 
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLF-----KAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L  Y  +++R YL+ +Y   G++   + ++     +   +        +   L Y 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYC 122

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS----LIATSAYSAPECFQNR 277
           H   + +++H ++KP N++L +    ++ADFG +   P S    L  T  Y  PE  + R
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 179

Query: 278 SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL 337
            + +K D++S G++    L G+ P                            +   + I 
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP----------------------FEANTYQETYKRIS 217

Query: 338 GEEVEEDEML--MAVRIAVVCLSDSPADRPSSDELV 371
             E    + +   A  +    L  +P+ RP   E++
Sbjct: 218 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 49/308 (15%), Positives = 122/308 (39%), Gaps = 51/308 (16%)

Query: 85  FSPKIDPKTLQAALANENRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQ 140
           F+ +ID   ++       +++G+   G+     L       + VA++ +           
Sbjct: 19  FAKEIDISCVK-----IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-------KSGY 66

Query: 141 NKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQL 200
            +  +R    E  ++    H N++ L   V +S+   ++ ++++ GSL+  +   R+N  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL---RQNDG 123

Query: 201 QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG 260
           Q      + +  G+  G++YL        +H +L   N+++++    +++DFGL++ +  
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 261 S-----------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEA 309
                             ++APE  Q R +T  SD++S+G+++  +++  +   P+    
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--PY---- 234

Query: 310 ASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDE 369
               +    +  ++                    D      ++ + C       RP   +
Sbjct: 235 -WDMTNQDVINAIEQD-----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 370 LVPMLTQL 377
           +V  L ++
Sbjct: 283 IVNTLDKM 290

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-41
 Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 40/279 (14%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
             LG    G+ +    +    VA++ +         K          QE +V+  LRH  
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTL---------KPGTMSPEAFLQEAQVMKKLRHEK 73

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           L+ L A V      Y+V +Y+  GSL D +    E    L     + +A  +  G+ Y+ 
Sbjct: 74  LVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-------GSLIATSAYSAPECFQ 275
                  +H +L+  N+++      ++ADFGLA+L+                ++APE   
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
              +T KSD++SFG++L  L T      P+      G      L  ++            
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV--PY-----PGMVNREVLDQVERG---------- 230

Query: 336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
                   +       +   C    P +RP+ + L   L
Sbjct: 231 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (360), Expect = 2e-40
 Identities = 62/275 (22%), Positives = 104/275 (37%), Gaps = 36/275 (13%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R +G    G  Y    + N   VA++++         KQ+    + I +E+  L  LRH 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSY-----SGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N +  R         +LV +Y    +     D +  ++  L       +  G ++GL YL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSAS----DLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--GSLIATSAYSAPECFQNRS- 278
           H   +  ++H ++K  N++L      +L DFG A +M    S + T  + APE       
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDE 188

Query: 279 --YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI 336
             Y  K D++S G+    L   +    P F       +    L H+            ++
Sbjct: 189 GQYDGKVDVWSLGITCIELAERK---PPLF-----NMNAMSALYHIAQNE------SPAL 234

Query: 337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV 371
                 E            CL   P DRP+S+ L+
Sbjct: 235 QSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLL 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 1e-39
 Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 40/283 (14%)

Query: 103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LG    G+ Y  V     LTVAV+ +         K++        +E  V+  ++H 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAAVMKEIKHP 73

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           NL+ L         FY++ +++  G+L D +      ++     V L +A  +   ++YL
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS--AVVLLYMATQISSAMEYL 131

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATS-------AYSAPECF 274
                   +H +L   N ++      ++ADFGL++LM G              ++APE  
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
               ++ KSD+++FG++L  + T      P+                     +  E L++
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMS--PYPGI---------------DLSQVYELLEK 231

Query: 335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
                E  E        +   C   +P+DRPS  E+      +
Sbjct: 232 D-YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-39
 Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 42/288 (14%)

Query: 103 RLLGSSPDGKYYRTVLD----NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
             LG    G   R   D      ++VAV+ ++      PE           +E+  + SL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM-----DDFIREVNAMHSL 68

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
            HRNL+ L   V  +    +V +    GSL   +DR+R++Q         R AV V +G+
Sbjct: 69  DHRNLIRLYGVV-LTPPMKMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAYS 269
            YL    + + +H +L   N++L      ++ DFGL + +P                A+ 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR 329
           APE  + R+++  SD + FG+ L  + T      P+                  +  +  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGL---------------NGSQIL 224

Query: 330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
             +D+        ED       + V C +  P DRP+   L   L + 
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-39
 Identities = 45/286 (15%), Positives = 98/286 (34%), Gaps = 44/286 (15%)

Query: 101 ENRLLGSSPDGKYYRTVL---DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS 157
            +  LG    G   + V       + VA++ +        +   K+    + +E +++  
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-------KQGTEKADTEEMMREAQIMHQ 65

Query: 158 LRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
           L +  ++ L     ++    LV +    G L      +   + ++       +   V  G
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK---FLVGKREEIPVSNVAELLHQVSMG 121

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAY 268
           ++YL        +H +L   NV+L      +++DFGL+K +           +      +
Sbjct: 122 MKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA 328
            APEC   R ++ +SD++S+G+ +   L+      P+             +  ++     
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQK--PY-----KKMKGPEVMAFIEQG--- 228

Query: 329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
                R     E   +       +   C      DRP    +   +
Sbjct: 229 ----KRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-38
 Identities = 55/298 (18%), Positives = 109/298 (36%), Gaps = 48/298 (16%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDN---GLTVAVRRVEAFESGSPEKQNKSVK 145
           +D K L      E++ LGS   G   +          TVAV+ +        E  + ++K
Sbjct: 3   LDRKLLTL----EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL------KNEANDPALK 52

Query: 146 RRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWE 205
             +  E  V+  L +  ++ +     E+  + LV +  + G L   + + R     +  +
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR----HVKDK 107

Query: 206 VRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG----- 260
             + +   V  G++YL        +H +L   NV+L  +   +++DFGL+K +       
Sbjct: 108 NIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164

Query: 261 ----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLG 316
                      + APEC     ++ KSD++SFG+++    +      P+      G    
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK--PY-----RGMKGS 217

Query: 317 RWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
                L+         +R         +       +  +C +    +RP    +   L
Sbjct: 218 EVTAMLEKG-------ERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 1e-38
 Identities = 51/280 (18%), Positives = 102/280 (36%), Gaps = 43/280 (15%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LG    GK Y+    +  +  A + ++         +++        E+++LAS  H 
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVID--------TKSEEELEDYMVEIDILASCDHP 69

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L       +  +++ ++   G+++     + E +  L       +    +  L YL
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDA---VMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPECFQ 275
           H   + +I+H +LK  N++   +   +LADFG++           S I T  + APE   
Sbjct: 127 H---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183

Query: 276 -----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE 330
                +R Y  K+D++S G+ L  +        P         +  R L  +  +     
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE---PPH-----HELNPMRVLLKIAKSEPPTL 235

Query: 331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
           A                        CL  +   R ++ +L
Sbjct: 236 AQPSRWSSN---------FKDFLKKCLEKNVDARWTTSQL 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 66/306 (21%), Positives = 116/306 (37%), Gaps = 49/306 (16%)

Query: 89  IDPKTLQAALANENRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSV 144
           I P +L   + + N ++G    G  Y   L +     +  AV+ +           +   
Sbjct: 22  IGPSSL---IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-------RITDIGE 71

Query: 145 KRRIQQELEVLASLRHRNLMSLRAYVPES-SRFYLVYDYLQTGSLEDAMDRIRENQLQLG 203
             +   E  ++    H N++SL      S     +V  Y++ G L + +     N     
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PT 128

Query: 204 WEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--- 260
            +  +   + V KG+    F  + + +H +L   N MLD +FT ++ADFGLA+ M     
Sbjct: 129 VKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185

Query: 261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG 313
                         + A E  Q + +T KSD++SFG++L  L+T   P  P+        
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PY-----PDV 238

Query: 314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM 373
           +      +L           R +  E   +        + + C       RPS  ELV  
Sbjct: 239 NTFDITVYLLQG-------RRLLQPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSR 287

Query: 374 LTQLHS 379
           ++ + S
Sbjct: 288 ISAIFS 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (347), Expect = 1e-38
 Identities = 59/327 (18%), Positives = 121/327 (37%), Gaps = 66/327 (20%)

Query: 89  IDPKTLQAALANEN----RLLGSSPDGKYYR------TVLDNGLTVAVRRVEAFESGSPE 138
           ++PK L       N    R +G    G+ ++         +    VAV+ +        E
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-------KE 53

Query: 139 KQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIREN 198
           + +  ++   Q+E  ++A   + N++ L           L+++Y+  G L + +  +  +
Sbjct: 54  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 199 QL--------------------QLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN 238
            +                     L    +L IA  V  G+ YL      + +H +L   N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRN 170

Query: 239 VMLDAEFTPRLADFGLAKLMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGM 290
            ++      ++ADFGL++ +         G+      +  PE      YT +SD++++G+
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230

Query: 291 ILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAV 350
           +L  + +      P++  A         + +    G                E+  L   
Sbjct: 231 VLWEIFSYGLQ--PYYGMAH------EEVIYYVRDGNIL----------ACPENCPLELY 272

Query: 351 RIAVVCLSDSPADRPSSDELVPMLTQL 377
            +  +C S  PADRPS   +  +L ++
Sbjct: 273 NLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-38
 Identities = 51/304 (16%), Positives = 120/304 (39%), Gaps = 50/304 (16%)

Query: 88  KIDPKTLQAALANENRLLGSSPDGKYYRTVLDNG-----LTVAVRRVEAFESGSPEKQNK 142
           +I P  +        +++G+   G+ Y+ +L        + VA++ ++           +
Sbjct: 3   EIHPSCVT-----RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-------AGYTE 50

Query: 143 SVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQL 202
             +     E  ++    H N++ L   + +     ++ +Y++ G+       +RE   + 
Sbjct: 51  KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEF 107

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL 262
                + +  G+  G++YL    N   +H +L   N+++++    +++DFGL++++    
Sbjct: 108 SVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164

Query: 263 IA---------TSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG 313
            A            ++APE    R +T  SD++SFG+++  ++T                
Sbjct: 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTY--------------- 209

Query: 314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM 373
             G          E  +A++          D      ++ + C     A RP   ++V +
Sbjct: 210 --GERPYWELSNHEVMKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 266

Query: 374 LTQL 377
           L +L
Sbjct: 267 LDKL 270

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  135 bits (340), Expect = 4e-37
 Identities = 58/286 (20%), Positives = 119/286 (41%), Gaps = 40/286 (13%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LG+   G  +R T    G   A + V           ++S K  +++E++ ++ LRH 
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVM--------TPHESDKETVRKEIQTMSVLRHP 83

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
            L++L     + +   ++Y+++  G L    +++ +   ++  +  +     V KGL ++
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPR--LADFGLAKLMPG-----SLIATSAYSAPECF 274
           H       +H +LKP N+M   + +    L DFGL   +           T+ ++APE  
Sbjct: 141 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
           + +     +D++S G++  +LL+G    +PF      G +    LR+++      +    
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL---SPF-----GGENDDETLRNVKSCDWNMDDSAF 249

Query: 335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV--PMLTQLH 378
           S + E+                L   P  R +  + +  P LT  +
Sbjct: 250 SGISED--------GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-37
 Identities = 53/275 (19%), Positives = 103/275 (37%), Gaps = 40/275 (14%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +G    G  Y    +  G  VA+R++          Q +  K  I  E+ V+   ++ 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNP 77

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N+++           ++V +YL  GSL D +     +           +    ++ L++L
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFL 132

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPECFQ 275
           H   + Q++H ++K  N++L  + + +L DFG    +        +++ T  + APE   
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS 335
            ++Y  K DI+S G++   ++ G     P+        +  R L  +   G         
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE---PPY-----LNENPLRALYLIATNGTPELQNPEK 241

Query: 336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
           +                   CL      R S+ EL
Sbjct: 242 LSAI---------FRDFLNRCLDMDVEKRGSAKEL 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-37
 Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 61/306 (19%)

Query: 103 RLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA 156
           ++LGS   GK               + VAV+ +        EK + S +  +  EL+++ 
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-------KEKADSSEREALMSELKMMT 95

Query: 157 SL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ-------------- 201
            L  H N+++L      S   YL+++Y   G L + +   RE   +              
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 202 -----LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK 256
                L +E  L  A  V KG+++L        +H +L   NV++      ++ DFGLA+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 257 LMP--------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
            +         G+      + APE      YT KSD++S+G++L  + +      P+   
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PY--- 267

Query: 309 AASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD 368
              G  +      L   G       +        E+       I   C +     RPS  
Sbjct: 268 --PGIPVDANFYKLIQNGF------KMDQPFYATEE----IYIIMQSCWAFDSRKRPSFP 315

Query: 369 ELVPML 374
            L   L
Sbjct: 316 NLTSFL 321

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-36
 Identities = 63/317 (19%), Positives = 117/317 (36%), Gaps = 55/317 (17%)

Query: 82  PVIFSPKIDPKTLQAALANENRLLGSSPDGKYYRTVLDNG---LTVAVRRVEAFESGSPE 138
           P I+ P +D   ++        ++G    G+  +  +      +  A++R++ + S    
Sbjct: 1   PTIY-PVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---- 50

Query: 139 KQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLED------- 190
              K   R    ELEVL  L  H N+++L          YL  +Y   G+L D       
Sbjct: 51  ---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 107

Query: 191 -----AMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF 245
                A          L  +  L  A  V +G+ YL      Q +H +L   N+++   +
Sbjct: 108 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENY 164

Query: 246 TPRLADFGLAKLMPGSLIATS-----AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD 300
             ++ADFGL++     +  T       + A E      YT  SD++S+G++L  +++   
Sbjct: 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

Query: 301 PTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDS 360
              P+      G +       L                 E   +       +   C  + 
Sbjct: 225 T--PY-----CGMTCAELYEKLPQGYR-----------LEKPLNCDDEVYDLMRQCWREK 266

Query: 361 PADRPSSDELVPMLTQL 377
           P +RPS  +++  L ++
Sbjct: 267 PYERPSFAQILVSLNRM 283

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 6e-36
 Identities = 64/306 (20%), Positives = 117/306 (38%), Gaps = 56/306 (18%)

Query: 103 RLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA 156
           + LG+   GK            D  +TVAV+ ++          + + +  +  EL+VL+
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-------PSAHLTEREALMSELKVLS 81

Query: 157 SL-RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIR--------------ENQLQ 201
            L  H N+++L           ++ +Y   G L + + R R              +++L 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 202 LGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-- 259
           L  E  L  +  V KG+ +L    +   +H +L   N++L      ++ DFGLA+ +   
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 260 ------GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGG 313
                 G+      + APE   N  YT +SD++S+G+ L  L +      P       G 
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GM 251

Query: 314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPM 373
            +      +   G       R +  E    +       I   C    P  RP+  ++V +
Sbjct: 252 PVDSKFYKMIKEGF------RMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 374 LTQLHS 379
           + +  S
Sbjct: 302 IEKQIS 307

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 2e-35
 Identities = 55/278 (19%), Positives = 109/278 (39%), Gaps = 41/278 (14%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           + LG    G+            VAV+ V+        K+       I++E+ +   L H 
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-------KRAVDCPENIKKEICINKMLNHE 63

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++    +  E +  YL  +Y   G   +  DRI  +   +      R    ++ G+ YL
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGG---ELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYL 119

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--------GSLIATSAYSAPEC 273
           H      I H ++KP N++LD     +++DFGLA +            +  T  Y APE 
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 274 FQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL 332
            + R +  +  D++S G++L  +L G       + + +            Q   + +E  
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE----LPWDQPSD---------SCQEYSDWKEKK 223

Query: 333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
                 ++++       + +    L ++P+ R +  ++
Sbjct: 224 TYLNPWKKIDSA----PLALLHKILVENPSARITIPDI 257

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-34
 Identities = 54/290 (18%), Positives = 99/290 (34%), Gaps = 46/290 (15%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           ++LG            L      A++ +E        K        + +E +V++ L H 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV-----PYVTRERDVMSRLDHP 68

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
             + L     +  + Y    Y + G L   + +I                  ++  L+YL
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYL 124

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--------GSLIATSAYSAPEC 273
           H      I+H +LKP N++L+ +   ++ DFG AK++          S + T+ Y +PE 
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 274 FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD 333
              +S    SD+++ G I+  L+ G  P                              + 
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPP----------------------FRAGNEYLIF 219

Query: 334 RSILGEEVEEDEML--MAVRIAVVCLSDSPADRPSSDELVPMLTQL-HSF 380
           + I+  E +  E     A  +    L      R   +E+        H F
Sbjct: 220 QKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-34
 Identities = 51/287 (17%), Positives = 105/287 (36%), Gaps = 45/287 (15%)

Query: 103 RLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           R +G    G  ++ +     +  L VA++  +          + SV+ +  QE   +   
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQF 65

Query: 159 RHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
            H +++ L   + E+   +++ +    G L   +      +  L     +  A  +   L
Sbjct: 66  DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTAL 121

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-------LIATSAYSAP 271
            YL    + + +H ++   NV++ +    +L DFGL++ M  S             + AP
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 272 ECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE 330
           E    R +T  SD++ FG+ +  +L  G  P          G      +  +++      
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF--------QGVKNNDVIGRIENG----- 225

Query: 331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
             +R  +              +   C +  P+ RP   EL   L+ +
Sbjct: 226 --ERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 1e-34
 Identities = 53/282 (18%), Positives = 106/282 (37%), Gaps = 51/282 (18%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LG    G  +R V   +  T   + V         K   + +  +++E+ +L   RHR
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFV---------KVKGTDQVLVKKEISILNIARHR 61

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L           ++++++    +    +RI  +  +L     +     V + LQ+L
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDI---FERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPR--LADFGLAKLMP-----GSLIATSAYSAPECF 274
           H   +  I H++++P N++     +    + +FG A+ +        L     Y APE  
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
           Q+   +  +D++S G ++ VLL+G +P                         E  + +  
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP----------------------FLAETNQQIIE 213

Query: 335 SILGEEVEEDEMLM------AVRIAVVCLSDSPADRPSSDEL 370
           +I+  E   DE         A+      L      R ++ E 
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-34
 Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 45/288 (15%)

Query: 103 RLLGSSPDGKYYRTVL-----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLAS 157
           ++LGS   G  Y+ +         + VA++ +        E  +    + I  E  V+AS
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMAS 67

Query: 158 LRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
           + + ++  L      +S   L+   +  G L D +   ++N    G +  L   V + KG
Sbjct: 68  VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKG 123

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYS 269
           + YL    + +++H +L   NV++      ++ DFGLAKL+                 + 
Sbjct: 124 MNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 270 APECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR 329
           A E   +R YT +SD++S+G+ +  L+T      P+    AS               E  
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPAS---------------EIS 223

Query: 330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
             L++            +    I V C       RP   EL+   +++
Sbjct: 224 SILEKG-ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  126 bits (317), Expect = 1e-33
 Identities = 61/287 (21%), Positives = 106/287 (36%), Gaps = 40/287 (13%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LGS   G  +R V    G     + +               K  ++ E+ ++  L H 
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFIN--------TPYPLDKYTVKNEISIMNQLHHP 86

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
            L++L     +     L+ ++L  G L    DRI     ++     +       +GL+++
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPR--LADFGLAKLMPGS-----LIATSAYSAPECF 274
           H      I+H ++KP N+M + +      + DFGLA  +          AT+ ++APE  
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
                   +D+++ G++  VLL+G    +PF  E      L       +   E  E    
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL---SPFAGE----DDLETLQNVKRCDWEFDEDAFS 253

Query: 335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV--PMLTQLHS 379
           S+  E         A       L   P  R +  + +  P L   HS
Sbjct: 254 SVSPE---------AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 9e-33
 Identities = 51/274 (18%), Positives = 98/274 (35%), Gaps = 33/274 (12%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
            +LG+    +            VA++ +        +K  +  +  ++ E+ VL  ++H 
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCI-------AKKALEGKEGSMENEIAVLHKIKHP 67

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N+++L          YL+   +  G L    DRI E           R+   V+  ++YL
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGEL---FDRIVEKG-FYTERDASRLIFQVLDAVKYL 123

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL-----MPGSLIATSAYSAPECFQN 276
           H                  LD +    ++DFGL+K+     +  +   T  Y APE    
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI 336
           + Y+   D +S G+I  +LL G     PF+ E     +  +    +  A    ++     
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGY---PPFYDE-----NDAKLFEQILKAEYEFDSPYWDD 235

Query: 337 LGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
           + +         A       +   P  R + ++ 
Sbjct: 236 ISDS--------AKDFIRHLMEKDPEKRFTCEQA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  121 bits (304), Expect = 1e-32
 Identities = 55/292 (18%), Positives = 118/292 (40%), Gaps = 43/292 (14%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
            +LG     + +    L     VAV+ + A        ++ S   R ++E +  A+L H 
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRA-----DLARDPSFYLRFRREAQNAAALNHP 67

Query: 162 NLMSLRAYV----PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
            ++++        P     Y+V +Y+   +L D +         +  +  + +     + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQA 123

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP---------GSLIATSAY 268
           L +        I+H ++KP N+M+ A    ++ DFG+A+ +           ++I T+ Y
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 269 SAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA 328
            +PE  +  S   +SD++S G +L  +LTG     PF  +      +    +H++     
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGE---PPFTGD----SPVSVAYQHVREDPIP 233

Query: 329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSS-DELVPMLTQLHS 379
             A    +  +            + +  L+ +P +R  +  E+   L ++H+
Sbjct: 234 PSARHEGLSAD---------LDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 4e-32
 Identities = 56/284 (19%), Positives = 111/284 (39%), Gaps = 49/284 (17%)

Query: 115 RTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES 173
           +   +    VAV+ +            +     +  E+E++  + +H+N+++L     + 
Sbjct: 39  KDKPNRVTKVAVKML-------KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91

Query: 174 SRFYLVYDYLQTGSLEDAMDRIRENQL------------QLGWEVRLRIAVGVIKGLQYL 221
              Y++ +Y   G+L + +   R   L            QL  +  +  A  V +G++YL
Sbjct: 92  GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 151

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPEC 273
               + + +H +L   NV++  +   ++ADFGLA+ +                 + APE 
Sbjct: 152 A---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA 208

Query: 274 FQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD 333
             +R YT +SD++SFG++L  + T      P+       G     L  L   G       
Sbjct: 209 LFDRIYTHQSDVWSFGVLLWEIFTLGGS--PY------PGVPVEELFKLLKEGHR----- 255

Query: 334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
                 +   +       +   C    P+ RP+  +LV  L ++
Sbjct: 256 -----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 6e-32
 Identities = 54/295 (18%), Positives = 111/295 (37%), Gaps = 48/295 (16%)

Query: 103 RLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA 156
           R LG    G  Y  V       +    VA++ V        E  +   +     E  V+ 
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRERIEFLNEASVMK 78

Query: 157 SLRHRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ------LGWEVRLRI 210
                +++ L   V +     ++ + +  G L+  +  +R                 +++
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 211 AVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--------GSL 262
           A  +  G+ YL      + +H +L   N M+  +FT ++ DFG+ + +         G  
Sbjct: 139 AGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
           +    + +PE  ++  +T  SD++SFG++L  + T  +   P+      G S  + LR +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PY-----QGLSNEQVLRFV 248

Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
              G             +  ++   M   +  +C   +P  RPS  E++  + + 
Sbjct: 249 MEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  119 bits (300), Expect = 6e-32
 Identities = 57/282 (20%), Positives = 112/282 (39%), Gaps = 37/282 (13%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQN-KSVKRRIQQELEVLASLR- 159
            +LG        R          AV+ ++    GS   +  + ++    +E+++L  +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
           H N++ L+     ++ F+LV+D ++ G L    D + E    L  +   +I   +++ + 
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGEL---FDYLTEKV-TLSEKETRKIMRALLEVIC 124

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-----LIATSAYSAPECF 274
            LH      I+H +LKP N++LD +   +L DFG +  +        +  T +Y APE  
Sbjct: 125 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181

Query: 275 Q------NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA 328
           +      +  Y  + D++S G+I+  LL G     PF+            LR +      
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHR-----KQMLMLRMIMSGNYQ 233

Query: 329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
             + +     +            +    L   P  R +++E 
Sbjct: 234 FGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  120 bits (301), Expect = 2e-31
 Identities = 46/205 (22%), Positives = 86/205 (41%), Gaps = 15/205 (7%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R++G    G+ Y     D G   A++ ++  +     KQ +++    +  L ++++    
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKMKQGETLALNERIMLSLVSTGDCP 67

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
            ++ +        +   + D +  G L   + +                A  +I GL+++
Sbjct: 68  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGLEHM 123

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS----LIATSAYSAPECFQ-N 276
           H   N  +++ +LKP N++LD     R++D GLA           + T  Y APE  Q  
Sbjct: 124 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 277 RSYTDKSDIFSFGMILAVLLTGRDP 301
            +Y   +D FS G +L  LL G  P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSP 205

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 6e-30
 Identities = 59/303 (19%), Positives = 109/303 (35%), Gaps = 55/303 (18%)

Query: 103 RLLGSSPDGKYYRTV------LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA 156
           + LG    G+                TVAV+ +        E    S  R +  EL++L 
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-------KEGATHSEHRALMSELKILI 71

Query: 157 SLRHRNLMSLR--AYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQ------------L 202
            + H   +     A         ++ ++ + G+L   +   R   +             L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 203 GWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP--- 259
             E  +  +  V KG+++L    + + +H +L   N++L  +   ++ DFGLA+ +    
Sbjct: 132 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 260 -----GSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGS 314
                G       + APE   +R YT +SD++SFG++L  + +      P+      G  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PY-----PGVK 241

Query: 315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPML 374
           +          G       R    +    +      +  + C    P+ RP+  ELV  L
Sbjct: 242 IDEEFCRRLKEGT------RMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 375 TQL 377
             L
Sbjct: 292 GNL 294

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-29
 Identities = 72/325 (22%), Positives = 120/325 (36%), Gaps = 49/325 (15%)

Query: 83  VIFSPKIDPKTLQAALANENRLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQN 141
           V+ +P   P   Q     + +++G+   G  Y+  + D+G  VA+++V            
Sbjct: 6   VVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------------ 53

Query: 142 KSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR------FYLVYDYLQTGSLEDAMDRI 195
              KR   +EL+++  L H N++ LR +   S          LV DY+       A    
Sbjct: 54  LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113

Query: 196 RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGL 254
           R  Q  L           + + L Y+H   +  I H ++KP N++LD +    +L DFG 
Sbjct: 114 RAKQ-TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169

Query: 255 AKLM-----PGSLIATSAYSAP-ECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAE 308
           AK +       S I +  Y AP   F    YT   D++S G +LA LL G+    P F  
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPG 225

Query: 309 AASGGSLGRWLRHLQHAGEAREA-------------LDRSILGEEVEEDEMLMAVRIAVV 355
            +    L   ++ L      +               +      +         A+ +   
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285

Query: 356 CLSDSPADRPSSDELV--PMLTQLH 378
            L  +P  R +  E        +L 
Sbjct: 286 LLEYTPTARLTPLEACAHSFFDELR 310

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 66/288 (22%), Positives = 108/288 (37%), Gaps = 34/288 (11%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LG       Y+    +    VA+++++    G   +    + R   +E+++L  L H 
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKL---GHRSEAKDGINRTALREIKLLQELSHP 60

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L       S   LV+D+++T         I++N L L         +  ++GL+YL
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------LIATSAYSAPE-CF 274
           H      ILH +LKP N++LD     +LADFGLAK            + T  Y APE  F
Sbjct: 117 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFA------------EAASGGSLGRWLRHL 322
             R Y    D+++ G ILA LL       PF              E     +  +W    
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRV----PFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
                        I    +        + +       +P  R ++ + 
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-29
 Identities = 51/278 (18%), Positives = 101/278 (36%), Gaps = 35/278 (12%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             LGS       +      GL  A + ++  +  +   +    +  I++E+ +L  ++H 
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIK--KRRTKSSRRGVSREDIEREVSILKEIQHP 73

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N+++L       +   L+ + +  G L D +         L  E        ++ G   +
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNG---V 126

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPR----LADFGLAKLMPGS-----LIATSAYSAPE 272
           ++  + QI H++LKP N+ML     P+    + DFGLA  +        +  T  + APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 273 CFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL 332
                    ++D++S G+I  +LL+G     PF  +             L +        
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGAS---PFLGD--------TKQETLANVSAVNYEF 235

Query: 333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
           +           +  +        L   P  R +  + 
Sbjct: 236 EDEYFSNTSALAKDFIR-----RLLVKDPKKRMTIQDS 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  112 bits (281), Expect = 3e-29
 Identities = 44/295 (14%), Positives = 94/295 (31%), Gaps = 49/295 (16%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R +G    G  +  T L N   VA++              +S   +++ E      L   
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEP----------RRSDAPQLRDEYRTYKLLAGC 60

Query: 162 N-LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
             + ++  +  E     LV D L         D +     +   +     A  ++  +Q 
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTP-----RLADFGLAKL-------------MPGSL 262
           +H      +++ ++KP N ++    +       + DFG+ K                 +L
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 263 IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL 322
             T+ Y +      R  + + D+ + G +    L G  P     A            +  
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--------KQKY 225

Query: 323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
           +  GE +++     L     E+      +      + +    P  D L  + +++
Sbjct: 226 ERIGEKKQSTPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (278), Expect = 2e-28
 Identities = 42/203 (20%), Positives = 87/203 (42%), Gaps = 16/203 (7%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R LG+   G+ +      NG   A++ ++       ++           E  +L+ + H 
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-----VEHTNDERLMLSIVTHP 64

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
            ++ +     ++ + +++ DY++ G L   + + +     +       +          L
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC-------LAL 117

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRS 278
            +  +  I++ +LKP N++LD     ++ DFG AK +P    +L  T  Y APE    + 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP 177

Query: 279 YTDKSDIFSFGMILAVLLTGRDP 301
           Y    D +SFG+++  +L G  P
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTP 200

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 63/306 (20%), Positives = 125/306 (40%), Gaps = 47/306 (15%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +G    G         N + VA++++  FE       +++  +R  +E+++L   RH 
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHE 66

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ +   +   +   +   YL T  +   + ++ + Q  L  +        +++GL+Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL---------MPGSLIATSAYSAPE 272
           H   +  +LH +LKP+N++L+     ++ DFGLA++              +AT  Y APE
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 273 CFQNRSYTDKS-DIFSFGMILAVLLTGRDP-----------------TAPFFAEAASGGS 314
              N     KS DI+S G ILA +L+ R                    +P   +     +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 315 LGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV--P 372
           L      L    + +   +R     + +  ++L         L+ +P  R   ++ +  P
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK------MLTFNPHKRIEVEQALAHP 296

Query: 373 MLTQLH 378
            L Q +
Sbjct: 297 YLEQYY 302

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 2e-28
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 18/206 (8%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           ++LG    GK +           A++ ++          +  V+  + ++  +  +  H 
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKK----DVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
            L  +          + V +YL  G L   M  I+    +         A  +I GLQ+L
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCH-KFDLSRATFYAAEIILGLQFL 119

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL------MPGSLIATSAYSAPECFQ 275
               +  I++ +LK  N++LD +   ++ADFG+ K          +   T  Y APE   
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDP 301
            + Y    D +SFG++L  +L G+ P
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-27
 Identities = 62/294 (21%), Positives = 120/294 (40%), Gaps = 42/294 (14%)

Query: 103 RLLGSSPDGKYY--RTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEV---LAS 157
             +G    GK +  R + + G  VA++RV        +   + +     +E+ V   L +
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLET 66

Query: 158 LRHRNLMSLRAYVPESS-----RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAV 212
             H N++ L      S      +  LV++++            +  +  +  E    +  
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY---LDKVPEPGVPTETIKDMMF 123

Query: 213 GVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-----SLIATSA 267
            +++GL +LH   + +++H +LKP N+++ +    +LADFGLA++        S++ T  
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 180

Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE 327
           Y APE     SY    D++S G I A +   +    P F  ++    LG+ L  +   GE
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDVDQLGKILDVIGLPGE 236

Query: 328 AREALDRSILGEEVEEDEML-----------MAVRIAVVCLSDSPADRPSSDEL 370
                D ++  +                   +   + + CL+ +PA R S+   
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  107 bits (268), Expect = 2e-27
 Identities = 60/288 (20%), Positives = 116/288 (40%), Gaps = 37/288 (12%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRN 162
             +G    G  Y+   + G T A++++        EK+++ +     +E+ +L  L+H N
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKI------RLEKEDEGIPSTTIREISILKELKHSN 61

Query: 163 LMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLH 222
           ++ L   +    R  LV+++L     +     +   +  L         + ++ G+ Y H
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 223 FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP------GSLIATSAYSAPECFQN 276
              + ++LH +LKP N++++ E   ++ADFGLA+            I T  Y AP+    
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 277 RS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL--------QHAGE 327
              Y+   DI+S G I A ++ G     P F   +    L R  R L         +  E
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT----PLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 328 AREALDRSILGEEVEEDEMLMAVRIAVV-----CLSDSPADRPSSDEL 370
             +      + E +  +  L  +  + +      L   P  R ++ + 
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-27
 Identities = 57/277 (20%), Positives = 107/277 (38%), Gaps = 43/277 (15%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-- 159
            LLGS   G  Y  + + + L VA++ VE  +    +        R+  E+ +L  +   
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVE--KDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 160 HRNLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQ 219
              ++ L  +      F L+ +  +     D  D I E    L  E+       V++ ++
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQ--DLFDFITERG-ALQEELARSFFWQVLEAVR 124

Query: 220 YLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKLMPG----SLIATSAYSAPECF 274
           +     N  +LH ++K  N+++D      +L DFG   L+          T  YS PE  
Sbjct: 125 HC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181

Query: 275 QNRSYTDKS-DIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD 333
           +   Y  +S  ++S G++L  ++ G     PF  +       G+     + + E +  + 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHDEEI--IRGQVFFRQRVSSECQHLIR 236

Query: 334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
                                 CL+  P+DRP+ +E+
Sbjct: 237 W---------------------CLALRPSDRPTFEEI 252

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (263), Expect = 1e-26
 Identities = 49/292 (16%), Positives = 96/292 (32%), Gaps = 45/292 (15%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R +GS   G  Y  T +  G  VA++              K+   ++  E ++   ++  
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLE----------CVKTKHPQLHIESKIYKMMQGG 62

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
             +    +      + ++   L   SLED  +       +   +  L +A  +I  ++Y+
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYI 119

Query: 222 HFTCNPQILHYNLKPTNVM---LDAEFTPRLADFGLAKLM-------------PGSLIAT 265
           H   +   +H ++KP N +           + DFGLAK                 +L  T
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 266 SAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA 325
           + Y++         + + D+ S G +L     G  P     A            +  +  
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT--------KRQKYERI 228

Query: 326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL 377
            E + +    +L +    +           C S    D+P    L  +   L
Sbjct: 229 SEKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-26
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 20/207 (9%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +G    G  Y+      G  VA++++        + + + V     +E+ +L  L H 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKI------RLDTETEGVPSTAIREISLLKELNHP 61

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L   +   ++ YLV+++L     +            +   +       +++GL + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKF---MDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL------MPGSLIATSAYSAPECFQ 275
               + ++LH +LKP N++++ E   +LADFGLA+            + T  Y APE   
Sbjct: 119 ---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 276 NRSYTD-KSDIFSFGMILAVLLTGRDP 301
              Y     DI+S G I A ++T R  
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 9e-26
 Identities = 49/283 (17%), Positives = 94/283 (33%), Gaps = 44/283 (15%)

Query: 102 NRLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-R 159
           +++LG   +GK  +          A++ ++                + ++E+E+     +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQ 63

Query: 160 HRNLMSLRAY----VPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
             +++ +               +V + L  G L   +                 I   + 
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIG 121

Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTP---RLADFGLAKLMPG-----SLIATSA 267
           + +QYLH   +  I H ++KP N++  ++      +L DFG AK         +   T  
Sbjct: 122 EAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178

Query: 268 YSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE 327
           Y APE      Y    D++S G+I+ +LL G  P    F               ++    
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQY 234

Query: 328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
                + S + EE           +    L   P  R +  E 
Sbjct: 235 EFPNPEWSEVSEE--------VKMLIRNLLKTEPTQRMTITEF 269

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 1e-25
 Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 29/295 (9%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           + +GS   G     V    G  VA++++          Q++   +R  +EL +L  +RH 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKL------YRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 162 NLMSLRAYVPESSRFYLVYD-YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQY 220
           N++ L              D YL    +   + ++ +++ +LG +    +   ++KGL+Y
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRY 136

Query: 221 LHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSL---IATSAYSAPECFQN- 276
           +H      I+H +LKP N+ ++ +   ++ DFGLA+     +   + T  Y APE   N 
Sbjct: 137 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNW 193

Query: 277 RSYTDKSDIFSFGMILAVLLTGR------DPTAPFFAEAASGGSLGRWLRHLQHAGEARE 330
             YT   DI+S G I+A ++TG+      D            G+          + EA+ 
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 331 ALDRSILGEEVEEDEML-----MAVRIAVVCLSDSPADRPSSDELV--PMLTQLH 378
            +      E+ +   +L     +AV +    L      R ++ E +  P    LH
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-25
 Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 33/219 (15%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +G    G+ ++      G  VA+++V        E + +       +E+++L  L+H 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKV------LMENEKEGFPITALREIKILQLLKHE 69

Query: 162 NLMSL--------RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVG 213
           N+++L          Y       YLV+D+ +        + + +           R+   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125

Query: 214 VIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL----------MPGSLI 263
           ++ GL Y+      +ILH ++K  NV++  +   +LADFGLA+              + +
Sbjct: 126 LLNGLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 264 ATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDP 301
            T  Y  PE     R Y    D++  G I+A + T    
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (248), Expect = 1e-24
 Identities = 57/299 (19%), Positives = 107/299 (35%), Gaps = 39/299 (13%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +G    G  ++    +    VA++RV        +  ++ V     +E+ +L  L+H+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHK 61

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L   +    +  LV+++      +       +       E+       ++KGL + 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFC 117

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSA-------YSAPECF 274
           H      +LH +LKP N++++     +LA+FGLA+     +   SA             F
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 275 QNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR 334
             + Y+   D++S G I A L        P F        L R  R L    E +     
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAG---RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 335 SILGEEVEEDEMLMAVRIAVV-------------CLSDSPADRPSSDELV--PMLTQLH 378
            +   +           + VV              L  +P  R S++E +  P  +   
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 43/206 (20%), Positives = 77/206 (37%), Gaps = 19/206 (9%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           +LLG    GK         G   A++ +      + ++           E  VL + RH 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-----AHTVTESRVLQNTRHP 65

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
            L +L+       R   V +Y   G L   + R    +     E        ++  L   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSAL--- 118

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS------LIATSAYSAPECFQ 275
            +  +  +++ ++K  N+MLD +   ++ DFGL K              T  Y APE  +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 276 NRSYTDKSDIFSFGMILAVLLTGRDP 301
           +  Y    D +  G+++  ++ GR P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.1 bits (246), Expect = 6e-24
 Identities = 41/203 (20%), Positives = 89/203 (43%), Gaps = 16/203 (7%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           + LG+   G+       ++G   A++ ++  +    ++           E  +L ++   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI-----EHTLNEKRILQAVNFP 101

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
            L+ L     ++S  Y+V +Y+  G +   + RI     +         A  ++   +YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG---SLIATSAYSAPECFQNRS 278
           H   +  +++ +LKP N+++D +   ++ DFG AK + G   +L  T    APE   ++ 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG 214

Query: 279 YTDKSDIFSFGMILAVLLTGRDP 301
           Y    D ++ G+++  +  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 95.7 bits (237), Expect = 7e-23
 Identities = 55/297 (18%), Positives = 109/297 (36%), Gaps = 50/297 (16%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-H 160
           R LG     + +  + + N   V V+ +               K++I++E+++L +LR  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKIL-----------KPVKKKKIKREIKILENLRGG 89

Query: 161 RNLMSLRAYV--PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGL 218
            N+++L   V  P S    LV++++     +     + +  ++            ++K L
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-------FYMYEILKAL 142

Query: 219 QYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLAKLMPGS-----LIATSAYSAPE 272
            Y H      I+H ++KP NVM+D E    RL D+GLA+           +A+  +  PE
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199

Query: 273 CFQN-RSYTDKSDIFSFGMILAVLLTGRDP------------------TAPFFAEAASGG 313
              + + Y    D++S G +LA ++  ++P                        +     
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 314 SLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDEL 370
           ++    R     G          +  E +      A+      L      R ++ E 
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.0 bits (222), Expect = 1e-20
 Identities = 45/211 (21%), Positives = 93/211 (44%), Gaps = 28/211 (13%)

Query: 103 RLLGSSPDGKYYRTV-LDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           + +GS   G             VA++++      S   QN++  +R  +EL ++  + H+
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 162 NLMSL------RAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVI 215
           N++SL      +  + E    YLV + +     +     +   ++         +   ++
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-------YLLYQML 129

Query: 216 KGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGS-----LIATSAYSA 270
            G+++LH       +H +LKP+N+++ ++ T ++ DFGLA+    S      + T  Y A
Sbjct: 130 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 271 PECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
           PE      Y +  DI+S G I+  ++  +  
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.6 bits (221), Expect = 1e-20
 Identities = 65/294 (22%), Positives = 113/294 (38%), Gaps = 27/294 (9%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
             +GS   G          GL VAV+++      S   Q+    +R  +EL +L  ++H 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 162 NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYL 221
           N++ L      +       D      L  A         +L  +    +   +++GL+Y+
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 222 HFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM---PGSLIATSAYSAPECFQNRS 278
           H   +  I+H +LKP+N+ ++ +   ++ DFGLA+         +AT  Y APE   N  
Sbjct: 138 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194

Query: 279 YTD-KSDIFSFGMILAVLLTGR------DPTAPFFAEAASGGSLGRWLRHLQHAGEAREA 331
           + +   DI+S G I+A LLTGR      D            G+ G  L     +  AR  
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 332 LDRSILGEEVEEDEMLMAVRIAVV-----CLSDSPADRPSSDELV--PMLTQLH 378
           +       ++    + +      V      L      R ++ + +      Q H
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 2e-19
 Identities = 54/281 (19%), Positives = 107/281 (38%), Gaps = 45/281 (16%)

Query: 103 RLLGSSPDGKYYR----TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL 158
           ++LG+   GK +     +  D G   A++ +      +   Q        + E +VL  +
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVL----KKATIVQKAKTTEHTRTERQVLEHI 85

Query: 159 RHR-NLMSLRAYVPESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKG 217
           R    L++L       ++ +L+ DY+  G L      + + +     EV++ +     + 
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGEL---FTHLSQRERFTEHEVQIYVG----EI 138

Query: 218 LQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-------SLIATSAYSA 270
           +  L       I++ ++K  N++LD+     L DFGL+K               T  Y A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 271 PECFQ--NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA 328
           P+  +  +  +    D +S G+++  LLTG    +PF  +                   +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGA---SPFTVD---------------GEKNS 240

Query: 329 REALDRSILGEEVEEDEMLMAVRIAVV--CLSDSPADRPSS 367
           +  + R IL  E    + + A+   ++   L   P  R   
Sbjct: 241 QAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 75.5 bits (184), Expect = 1e-15
 Identities = 35/221 (15%), Positives = 74/221 (33%), Gaps = 33/221 (14%)

Query: 103 RLLGSSPDGKYYR-TVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR 161
           R LG       +    + N   VA++ V         + +K      + E+++L  +   
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIV---------RGDKVYTEAAEDEIKLLQRVNDA 69

Query: 162 NLMSLRAY-VPESSRFYLVYDYLQTGSLEDAM-----------DRIRENQLQLGWEVRLR 209
           +     +       +    +++     +   M              +     +      +
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 210 IAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE-FTPRLADFGLAKLMPGSLIATS-- 266
           I+  ++ GL Y+H  C   I+H ++KP NV+++       L    +A L           
Sbjct: 130 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 267 ------AYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDP 301
                  Y +PE      +   +DI+S   ++  L+TG   
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 61.3 bits (148), Expect = 9e-12
 Identities = 28/207 (13%), Positives = 61/207 (29%), Gaps = 39/207 (18%)

Query: 103 RLLGSSPDGKYYRTVLDNGLTVAVR--RVEAFESGSPEKQNKSVKRRIQQELEVLASLRH 160
           +L+G   +   +    +      V+  +V        +++               A    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 161 RNLMSLR-AYVP---ESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIK 216
           R L  L+   VP         ++ + +    L                E    +   +++
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR-----------VENPDEVLDMILE 114

Query: 217 GLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPGSLIATSAYSAPE---- 272
            +   +   +  I+H +L   NV++  E    + DF  +       +        E    
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQS-------VEVGEEGWREILER 163

Query: 273 ------CFQNRSYTDKSDIFS-FGMIL 292
                  + +R+Y  + DI S    IL
Sbjct: 164 DVRNIITYFSRTYRTEKDINSAIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	380
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.39
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.2
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.61
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.4
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.39

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=394.31  Aligned_cols=245  Identities=20%  Similarity=0.328  Sum_probs=196.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||+|...+++.||||++.....         ..++|.+|++++++++|||||+++|+|.+.+..++||
T Consensus         9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             EEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---------cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            4567999999999999998899999999864211         1267899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....++|..++.++.|+|.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        80 E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          80 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             ECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             EecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccC
Confidence            99999999999873   3456899999999999999999999   89999999999999999999999999999986543


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                             ...||+.|+|||.+.+..++.++|||||||++|||+|+..|+..       ................      
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~-------~~~~~~~~~~i~~~~~------  220 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFR------  220 (263)
T ss_dssp             -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC-------SCCHHHHHHHHHHTCC------
T ss_pred             CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC-------CCCHHHHHHHHHhcCC------
Confidence                   23478999999999999999999999999999999996555432       1122222222222111      


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                           ...+......+.+++.+||+.||++|||++||++.|++++
T Consensus       221 -----~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         221 -----LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                 1111233456889999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-55  Score=401.49  Aligned_cols=244  Identities=19%  Similarity=0.399  Sum_probs=193.1

Q ss_pred             ccccCccCCeeEEEEEec-CC---cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEE
Q 047245          102 NRLLGSSPDGKYYRTVLD-NG---LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  177 (380)
                      .++||+|+||.||+|... +|   ..||||++...       ......+.|.+|+++|++++|||||+++|+|.+.+..+
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-------YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-------cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            468999999999999974 23   35888887541       12344578999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|.+++..   ....++|.+++.++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++.
T Consensus       104 iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             EEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceE
Confidence            99999999999998873   3456999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCC-----------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          258 MPGS-----------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       258 ~~~~-----------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      ....           ..+|+.|+|||.+.++.++.++|||||||++|||+| |+.||...        ...+........
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--------~~~~~~~~i~~~  249 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------TNQDVINAIEQD  249 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTT
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcC
Confidence            5422           236889999999999999999999999999999998 89998631        112222222211


Q ss_pred             cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..           .+.+.+.+..+.+++.+||+.||++|||++||++.|+++
T Consensus       250 ~~-----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         250 YR-----------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             CC-----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CC-----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            10           112233556688999999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-55  Score=398.29  Aligned_cols=247  Identities=24%  Similarity=0.386  Sum_probs=203.6

Q ss_pred             ccccccCccCCeeEEEEEec-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLD-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ...+.||+|+||.||+|... +|+.||||+++....         ..++|.+|++++++++|||||+++|+|.+++..++
T Consensus        20 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---------hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            45678999999999999974 588999999864211         13678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..  .....+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++..
T Consensus        91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999974  33567999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCC-------cCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          259 PGSL-------IATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       259 ~~~~-------~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....       .+++.|+|||.+.+..++.++|||||||++|||++|..|+...       .........          
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-------~~~~~~~~~----------  228 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQVYEL----------  228 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHHH----------
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-------chHHHHHHH----------
Confidence            5432       3788899999999999999999999999999999987776431       111221111          


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      +..... ...+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       229 i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         229 LEKDYR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HhcCCC-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111111 1112234556889999999999999999999999998763

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=390.72  Aligned_cols=249  Identities=23%  Similarity=0.390  Sum_probs=197.1

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||+|...  ..||||+++....      .....+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus        12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~------~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_          12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CCSEEEECSSCEEEEEESS--SEEEEEECCCSSC------CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            4578999999999999874  3599999875322      22335789999999999999999999999865 5689999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.++++.   ....+++..++.++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999999973   2456999999999999999999999   88999999999999999999999999999976542


Q ss_pred             --------CCcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          261 --------SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       261 --------~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                              ...||+.|+|||.+.+   .+++.++|||||||++|||+||+.||...       .. ..........+.. 
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~-------~~-~~~~~~~~~~~~~-  227 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------NN-RDQIIFMVGRGYL-  227 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC-------CC-HHHHHHHHHHTSC-
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC-------Ch-HHHHHHHHhcCCC-
Confidence                    2358999999999864   45899999999999999999999998631       11 1111111111110 


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                         .+.+  ...+.+.+..+.+++.+||+.||++|||++|+++.|+.++
T Consensus       228 ---~p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         228 ---SPDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             ---CCCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCcc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               1110  0112234456889999999999999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=390.18  Aligned_cols=244  Identities=23%  Similarity=0.395  Sum_probs=199.0

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      ..+.||+|+||.||+|.+.++..||||++.....         ..+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus        17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             EeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            4577999999999999998889999999864211         12578999999999999999999998865 5679999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++...  ....++|..+++|+.||++||+|||   +++|+||||||+|||+++++.+||+|||+++....
T Consensus        87 Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          87 EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             ECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC
Confidence            999999999988642  2446999999999999999999999   89999999999999999999999999999987643


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                             ...+|+.|+|||.+.++.++.++|||||||++|||+||..|+...       ....+.........      .
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-------~~~~~~~~~i~~~~------~  228 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGY------R  228 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC------C
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcC------C
Confidence                   235888999999999999999999999999999999976665421       11122222221111      1


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      +     ..+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus       229 ~-----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 M-----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             C-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            1     11123445688999999999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=390.12  Aligned_cols=242  Identities=20%  Similarity=0.324  Sum_probs=196.4

Q ss_pred             cccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          103 RLLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      +.||+|+||.||+|.+.   .++.||||+++...      .+....++|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lv   85 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV   85 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEE
Confidence            57999999999999864   34689999996521      223445789999999999999999999999965 457899


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...++|..++.++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        86 mE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~  158 (277)
T d1xbba_          86 MEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  158 (277)
T ss_dssp             EECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence            999999999999874    456999999999999999999999   8999999999999999999999999999998654


Q ss_pred             CC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          260 GS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       260 ~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      ..         ..||+.|+|||.+.+..++.++|||||||++|||+| |+.||...        ...+....... +.  
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--------~~~~~~~~i~~-~~--  227 (277)
T d1xbba_         159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTAMLEK-GE--  227 (277)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHHHHHT-TC--
T ss_pred             ccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--------CHHHHHHHHHc-CC--
Confidence            22         248899999999999999999999999999999998 89998631        11122222111 11  


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                              ....+...+..+.+++.+||+.||++|||+++|++.|+..
T Consensus       228 --------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         228 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence                    0112223456688999999999999999999999988763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=382.75  Aligned_cols=243  Identities=19%  Similarity=0.323  Sum_probs=203.3

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      +.+.||+|+||+||+|..++++.||||+++....         ..++|.+|+.++++++||||++++|+|.+.+..++||
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            4578999999999999998889999999975221         1257899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..+.+++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        79 Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          79 EYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             ECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             EccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            99999999999763   3457899999999999999999999   89999999999999999999999999999976432


Q ss_pred             -------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          261 -------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       261 -------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                             ...+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...        ...+..........     
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--------~~~~~~~~i~~~~~-----  219 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEHIAQGLR-----  219 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHHHHTTCC-----
T ss_pred             CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--------CHHHHHHHHHhCCC-----
Confidence                   2347889999999999999999999999999999998 89898632        12222222221110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                            ...+......+.+++.+||+.||++|||++|+++.|.+|
T Consensus       220 ------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 ------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                  112223445688999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=388.50  Aligned_cols=241  Identities=19%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             ccCccCCeeEEEEEec---CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          104 LLGSSPDGKYYRTVLD---NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       104 ~lg~G~~g~vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .||+|+||.||+|...   ++..||||+++..       ......++|.+|++++++++|||||+++|++.+ +..++||
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChh-------cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            3999999999999863   4568999999642       123445789999999999999999999999975 4689999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||   +++++||||||+|||++.++.+||+|||+++....
T Consensus        88 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          88 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999863   3457999999999999999999999   89999999999999999999999999999986542


Q ss_pred             ---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          261 ---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       261 ---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                               ...||+.|+|||.+.++.++.++|||||||++|||+| |+.||...        ...+.........+   
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~--------~~~~~~~~i~~~~~---  230 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------KGPEVMAFIEQGKR---  230 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CTHHHHHHHHTTCC---
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC--------CHHHHHHHHHcCCC---
Confidence                     2347889999999999999999999999999999998 89998631        11122222211110   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                              ...+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       231 --------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             --------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                    112233456688999999999999999999999998754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=384.68  Aligned_cols=246  Identities=19%  Similarity=0.384  Sum_probs=196.6

Q ss_pred             cccccCccCCeeEEEEEecCC-----cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLDNG-----LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..++||+|+||.||+|.+.+.     ..||||++...       ..+....+|.+|+.++++++|||||+++|++.+.+.
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-------YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-------cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            567899999999999997532     37999998641       123345679999999999999999999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+++|++.+++..   ....++|..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          84 MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchh
Confidence            9999999999999998763   3457999999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +.....         ..||+.|+|||.+.+..++.++|||||||++|||++|..|+...       ....+......   
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-------~~~~~~~~~i~---  227 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-------LSNHEVMKAIN---  227 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-------CCHHHHHHHHH---
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-------CCHHHHHHHHh---
Confidence            865421         24788999999999999999999999999999999976665421       11122222211   


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                             .... ...+.+.+..+.+++.+||+.||++|||++||++.|+++
T Consensus       228 -------~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         228 -------DGFR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             -------TTCC-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------ccCC-CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence                   1111 112233456688999999999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=379.21  Aligned_cols=240  Identities=22%  Similarity=0.394  Sum_probs=199.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1          10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc-----cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            456899999999999997 4689999999864211     1122346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        85 mEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          85 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             EeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            999999999999974    346999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CC----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 GS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~~----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      ..    ..||+.|+|||.+.+..++.++|||||||++|||++|+.||...        +..+.........       . 
T Consensus       158 ~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~-------~-  221 (263)
T d2j4za1         158 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRISRVE-------F-  221 (263)
T ss_dssp             CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTTC-------C-
T ss_pred             CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC--------CHHHHHHHHHcCC-------C-
Confidence            43    35899999999999999999999999999999999999998631        1222222211111       0 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       222 ----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                111223456789999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=378.63  Aligned_cols=241  Identities=22%  Similarity=0.372  Sum_probs=193.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec----CCe
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE----SSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  175 (380)
                      +.+.||+|+||+||+|.. .++..||+|++....      ......+.|.+|++++++++|||||++++++.+    ...
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            445799999999999997 468899999987632      233445789999999999999999999999864    356


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCC--eEecCCCCCcEEeC-CCCceEEecc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQ--ILHYNLKPTNVMLD-AEFTPRLADF  252 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--iiH~dlk~~Nill~-~~~~~kl~Df  252 (380)
                      .++||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +++  |+||||||+|||++ +++.+||+||
T Consensus        87 ~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            7999999999999999974    347899999999999999999999   776  99999999999997 4789999999


Q ss_pred             CCcccCCCC----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          253 GLAKLMPGS----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       253 gl~~~~~~~----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      |+++.....    ..||+.|+|||.+.+ +++.++|||||||++|||++|+.||...       ............... 
T Consensus       160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~~~~~i~~~~~-  230 (270)
T d1t4ha_         160 GLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIYRRVTSGVK-  230 (270)
T ss_dssp             TGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHHHHHTTTCC-
T ss_pred             CcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHHHHHHHHcCCC-
Confidence            999865543    359999999998865 6999999999999999999999998531       111222222211110 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                               ....+......+.+++.+||+.||++|||++|+++
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 ---------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                     11111123345789999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=384.79  Aligned_cols=247  Identities=24%  Similarity=0.379  Sum_probs=191.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec--CCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE--SSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  177 (380)
                      ..+.||+|+||.||++.. .+|+.||+|.+....      ..+...+.+.+|++++++++|||||++++++.+  .+..+
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT------SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh------CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            346899999999999986 578999999997632      123445789999999999999999999999865  45689


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC--NPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      +||||+++|+|.+++.........+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            999999999999999876556678999999999999999999999432  245999999999999999999999999999


Q ss_pred             ccCCC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          256 KLMPG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       256 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                      +....      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...        +..+....... +.. 
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--------~~~~~~~~i~~-~~~-  231 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGKIRE-GKF-  231 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHH-TCC-
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--------CHHHHHHHHHc-CCC-
Confidence            86543      245899999999999999999999999999999999999998631        11222222211 110 


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                               ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       232 ---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                     0111223456889999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=382.06  Aligned_cols=238  Identities=22%  Similarity=0.365  Sum_probs=197.1

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|.. .+|+.||||++......        ..+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--------HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            45799999999999986 57999999998753211        1367889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+++|+|.+++..     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        97 Ey~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            99999999998762     36899999999999999999999   89999999999999999999999999999986532


Q ss_pred             ------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          261 ------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                            ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...        ...+........+.      +
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~~~~~~~------~  234 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGT------P  234 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHHCS------C
T ss_pred             ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC--------CHHHHHHHHHhCCC------C
Confidence                  235999999999999999999999999999999999999998531        11122222221111      0


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .   ...+......+.+++.+||+.||++|||++|+++
T Consensus       235 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 E---LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             C---CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             C---CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   1112234556889999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=380.45  Aligned_cols=241  Identities=22%  Similarity=0.332  Sum_probs=193.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++.....       ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-------chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            346899999999999997 5789999999975221       12235688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          82 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            999999999999863    447999999999999999999999   8999999999999999999999999999998643


Q ss_pred             --------CCCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          260 --------GSLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       260 --------~~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                              ....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||....    .  ....+ .........  
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~----~--~~~~~-~~~~~~~~~--  225 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS----D--SCQEY-SDWKEKKTY--  225 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS----T--TSHHH-HHHHTTCTT--
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC----h--HHHHH-HHHhcCCCC--
Confidence                    23469999999999988876 578999999999999999999996311    0  11111 111111100  


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                              .......+..+.+++.+||+.||++|||++|+++
T Consensus       226 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 --------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    0111223456778999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-53  Score=380.29  Aligned_cols=240  Identities=21%  Similarity=0.299  Sum_probs=195.6

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||+|.. .+|+.||||++.....        ...+.+.+|++++++++|||||++++++.+.+..++||
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--------GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--------HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46799999999999997 5789999999875211        12356889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP-  259 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~-  259 (380)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++... 
T Consensus        89 Ey~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          89 EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             ECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             ecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            99999999999864   2456999999999999999999999   8999999999999999999999999999997653 


Q ss_pred             -----CCCcCCCcccCccccc-----CCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchh
Q 047245          260 -----GSLIATSAYSAPECFQ-----NRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAR  329 (380)
Q Consensus       260 -----~~~~~~~~y~aPE~~~-----~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~  329 (380)
                           ....||+.|+|||.+.     +..++.++|||||||++|||++|+.||....        ..+..........  
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--------~~~~~~~i~~~~~--  232 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--------PMRVLLKIAKSEP--  232 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------GGGHHHHHHHSCC--
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCC--
Confidence                 3456999999999984     4568999999999999999999999986411        0111111111110  


Q ss_pred             HhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          330 EALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          +   ....+...+..+.+++.+||+.||++|||++|+++
T Consensus       233 ----~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 ----P---TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----C---CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----C---CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0   01112234556889999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=376.39  Aligned_cols=244  Identities=24%  Similarity=0.393  Sum_probs=193.2

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-CCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-SSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  179 (380)
                      +.+.||+|+||.||+|... |..||||+++..          ...+.|.+|++++++++||||++++|+|.+ .+.+++|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_          11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCC----------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             EeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            4577999999999999984 789999998641          123678899999999999999999999865 4568999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++...  ....++|..+++++.||+.||+|||   +.+++||||||+|||++.++.+|++|||+++...
T Consensus        80 ~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          80 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             ECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecC
Confidence            9999999999999752  2346899999999999999999999   8999999999999999999999999999998755


Q ss_pred             CC---CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchh
Q 047245          260 GS---LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRS  335 (380)
Q Consensus       260 ~~---~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  335 (380)
                      ..   ..++..|+|||.+.+..++.++||||||+++|||+| |+.||...     ....+..+   ... +     ..+ 
T Consensus       155 ~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~---i~~-~-----~~~-  219 (262)
T d1byga_         155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPR---VEK-G-----YKM-  219 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHH---HTT-T-----CCC-
T ss_pred             CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHH---HHc-C-----CCC-
Confidence            32   357889999999999999999999999999999998 67776431     11111111   111 1     111 


Q ss_pred             ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          336 ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       336 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                          ..+......+.+++.+||+.||++|||+.|+++.|+++++
T Consensus       220 ----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         220 ----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                1222344568899999999999999999999999998863

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=378.36  Aligned_cols=245  Identities=24%  Similarity=0.358  Sum_probs=198.5

Q ss_pred             ccccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          100 NENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ...+.||+|+||.||+|...++..||||++.....         ..+.|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus        20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---------~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---------CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            35678999999999999998888999999864211         12678999999999999999999999965 567999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..  .....++|..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        90 ~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          90 TEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             ECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            999999999999875  23446999999999999999999999   8899999999999999999999999999998654


Q ss_pred             CC-------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          260 GS-------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       260 ~~-------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..       ..+|+.|+|||.+..+.++.++||||||+++|||++|..|+...       ....+.........      
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-------~~~~~~~~~i~~~~------  231 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVLDQVERGY------  231 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTC------
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcC------
Confidence            22       34889999999999999999999999999999999977765431       12222222222111      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .     ...+......+.+++.+||+.||++|||+++|+++|++.
T Consensus       232 ~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         232 R-----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             C-----CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            0     112233455688999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-52  Score=381.64  Aligned_cols=242  Identities=24%  Similarity=0.345  Sum_probs=197.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++.....     ......+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus        19 ~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            446799999999999986 5789999999975322     1234457799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      ||||++|+|..++..    ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            999999999776643    457999999999999999999999   8999999999999999999999999999998654


Q ss_pred             C--CCcCCCcccCcccccC---CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G--SLIATSAYSAPECFQN---RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~--~~~~~~~y~aPE~~~~---~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .  ...||+.|+|||++.+   ..++.++|||||||++|||++|..||...        ...+.........      .+
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--------~~~~~~~~i~~~~------~~  232 (309)
T d1u5ra_         167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNE------SP  232 (309)
T ss_dssp             SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSC------CC
T ss_pred             CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCC------CC
Confidence            3  4569999999999864   46899999999999999999999998531        1111112111111      11


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....    ...+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCC----CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1111    123456889999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=387.07  Aligned_cols=247  Identities=25%  Similarity=0.367  Sum_probs=195.9

Q ss_pred             cccccCccCCeeEEEEEecC------CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVLDN------GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||+||+|....      ...||+|.+....       .......+.+|+.++.++ +|||||++++++.+.
T Consensus        41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-------CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            56789999999999998642      2369999886421       223346789999999998 899999999999999


Q ss_pred             CeEEEEEeecCCCCHHHHHHHhhh-------------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 047245          174 SRFYLVYDYLQTGSLEDAMDRIRE-------------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL  234 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dl  234 (380)
                      +..++||||+++|+|.++++..+.                   ....++|..++.++.|++.||+|||   +.+|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence            999999999999999999975321                   1245899999999999999999999   899999999


Q ss_pred             CCCcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCch
Q 047245          235 KPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPF  305 (380)
Q Consensus       235 k~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~  305 (380)
                      ||+|||++.++.+||+|||+++....        ...||+.|+|||.+.++.++.++|||||||++|||+| |..||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999976432        2237899999999999999999999999999999998 89998531


Q ss_pred             hhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHh
Q 047245          306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLT  375 (380)
Q Consensus       306 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~  375 (380)
                          ...   .. .......+.     .     ...+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus       271 ----~~~---~~-~~~~~~~~~-----~-----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 ----PVD---AN-FYKLIQNGF-----K-----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ----CCS---HH-HHHHHHTTC-----C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CHH---HH-HHHHHhcCC-----C-----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                110   11 111111110     0     1112234556889999999999999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=379.13  Aligned_cols=247  Identities=24%  Similarity=0.328  Sum_probs=199.3

Q ss_pred             cccccCccCCeeEEEEEecCC----cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-CCe
Q 047245          101 ENRLLGSSPDGKYYRTVLDNG----LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-SSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  175 (380)
                      ++++||+|+||+||+|.+.++    ..||||+++..       .+....++|.+|++++++++||||++++|+|.+ .+.
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~  103 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  103 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCc
Confidence            567899999999999997432    36899998641       133446889999999999999999999999865 568


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++||||+++|+|.+++..   ....+++..+++++.|++.||.|||   +.+++||||||+|||+++++.+||+|||++
T Consensus       104 ~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~  177 (311)
T d1r0pa_         104 PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA  177 (311)
T ss_dssp             EEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred             eEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccch
Confidence            9999999999999999873   3456788999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCC----------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          256 KLMPGS----------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       256 ~~~~~~----------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      +.....          ..||+.|+|||.+....++.++||||||+++|||+||..||....    +   ..++.......
T Consensus       178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~----~---~~~~~~~i~~g  250 (311)
T d1r0pa_         178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----N---TFDITVYLLQG  250 (311)
T ss_dssp             CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTT
T ss_pred             hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC----C---HHHHHHHHHcC
Confidence            865422          247889999999999999999999999999999999888875311    1   11122222211


Q ss_pred             cchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          326 GEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                      .+           ...+......+.+++.+||+.||++|||+.||++.|+++.
T Consensus       251 ~~-----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         251 RR-----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             CC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-----------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11           0111223456889999999999999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=381.12  Aligned_cols=189  Identities=25%  Similarity=0.480  Sum_probs=168.5

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||+||+|.. .+|+.||+|+++...       .......+.+|+.+|++++|||||++++++.+.+..++||
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            46799999999999996 578999999997522       1223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCC-CCeEecCCCCCcEEeCCCCceEEeccCCcccC-
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCN-PQILHYNLKPTNVMLDAEFTPRLADFGLAKLM-  258 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~-  258 (380)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||   + ++|+||||||+|||+++++.+||+|||+|+.. 
T Consensus        84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            99999999999974    346999999999999999999999   6 48999999999999999999999999999754 


Q ss_pred             ---CCCCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCc
Q 047245          259 ---PGSLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAP  304 (380)
Q Consensus       259 ---~~~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~  304 (380)
                         .....||+.|+|||++.+.+++.++||||+||++|||++|+.||..
T Consensus       157 ~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         157 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence               2345799999999999999999999999999999999999999964

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-52  Score=374.27  Aligned_cols=239  Identities=20%  Similarity=0.306  Sum_probs=197.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++.....     ......+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_          12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-----cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            457899999999999997 5789999999964211     1122346789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        87 mEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          87 LSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence            999999999999874    457999999999999999999999   8999999999999999999999999999998654


Q ss_pred             C--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          260 G--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       260 ~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      .        ...||+.|+|||.+.+..++.++|||||||++|||++|..||...        +............     
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~-----  226 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEYLIFQKIIKLE-----  226 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHTTC-----
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--------CHHHHHHHHHcCC-----
Confidence            2        235999999999999999999999999999999999999999631        1112122211110     


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELV  371 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl  371 (380)
                        .     ..+...+..+.+++.+||+.||++|||++|++
T Consensus       227 --~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 --Y-----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             --C-----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             --C-----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence              0     11122345678999999999999999999974

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-51  Score=376.28  Aligned_cols=250  Identities=21%  Similarity=0.341  Sum_probs=202.6

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||+||+|...      +++.||||++...       ......++|.+|++++++++||||++++++|.+.+
T Consensus        17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-------~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-------cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            4567999999999999863      4578999998641       12344678999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhh--------------------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIR--------------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNL  234 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dl  234 (380)
                      ..+++|||+++|+|.+++....                    .....+++..++.++.|++.||+|||   +.+++||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEE
Confidence            9999999999999999997522                    11235899999999999999999999   899999999


Q ss_pred             CCCcEEeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCC-CCCch
Q 047245          235 KPTNVMLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD-PTAPF  305 (380)
Q Consensus       235 k~~Nill~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~-p~~~~  305 (380)
                      ||+|||++.++.+||+|||+++....        ...+++.|+|||.+.+..++.++|||||||++|||++|.. ||.. 
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~-  245 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG-  245 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT-
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC-
Confidence            99999999999999999999975422        2357889999999999999999999999999999999864 5542 


Q ss_pred             hhhccCCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcccC
Q 047245          306 FAEAASGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLHS  379 (380)
Q Consensus       306 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~~  379 (380)
                             ....+....... +..          ...+...+..+.+++.+||+.||++||||.||+++|++++.
T Consensus       246 -------~~~~e~~~~v~~-~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         246 -------MAHEEVIYYVRD-GNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             -------SCHHHHHHHHHT-TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -------CCHHHHHHHHHc-CCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                   112222222221 111          11222344568899999999999999999999999999863

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-51  Score=375.08  Aligned_cols=242  Identities=21%  Similarity=0.314  Sum_probs=185.6

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||||++.....       ......+.+|+.++++++|||||++++++.+++..++|
T Consensus        13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_          13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-------EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh-------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457899999999999997 4689999999975221       12235688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC---CCCceEEeccCCcc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD---AEFTPRLADFGLAK  256 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~---~~~~~kl~Dfgl~~  256 (380)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++   +++.+||+|||+++
T Consensus        86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999999973    457999999999999999999999   89999999999999994   57899999999998


Q ss_pred             cCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh
Q 047245          257 LMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA  331 (380)
Q Consensus       257 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  331 (380)
                      ....     ...||+.|+|||.+.+..++.++|||||||++|||++|..||...        ...+..........    
T Consensus       159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~~----  226 (307)
T d1a06a_         159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--------NDAKLFEQILKAEY----  226 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHTTCC----
T ss_pred             EccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHhccCC----
Confidence            6543     245999999999999999999999999999999999999999631        11111112111110    


Q ss_pred             hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .. ........+..+.+++.+||+.||++|||++|+++
T Consensus       227 ---~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         227 ---EF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ---CC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CC-CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               00 01111234456889999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=376.82  Aligned_cols=258  Identities=23%  Similarity=0.307  Sum_probs=195.9

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC----eE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS----RF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  176 (380)
                      ..+.||+|+||.||+|+. +|+.||||++...         .........|+..+.+++||||++++|+|.+.+    .+
T Consensus         7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            346799999999999997 5899999998641         111223345666777889999999999997643    68


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhc-----CCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFT-----CNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                      ++||||+++|+|.++++.     ..++|..+++++.|+|.||+|||+.     .+++|+||||||+|||+++++.+||+|
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D  151 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence            999999999999999973     3689999999999999999999942     136999999999999999999999999


Q ss_pred             cCCcccCCC----------CCcCCCcccCcccccCCC------CCCcchhhHHHHHHHHHHhCCCCCCchhhhcc-----
Q 047245          252 FGLAKLMPG----------SLIATSAYSAPECFQNRS------YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA-----  310 (380)
Q Consensus       252 fgl~~~~~~----------~~~~~~~y~aPE~~~~~~------~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~-----  310 (380)
                      ||+++....          ...||+.|+|||.+.+..      ++.++|||||||++|||+||..|+........     
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~  231 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence            999975422          235899999999987643      57789999999999999999988753111110     


Q ss_pred             --CCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          311 --SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       311 --~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                        ..... .........    +.+++.+.......+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus       232 ~~~~~~~-~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         232 VPSDPSV-EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCSSCCH-HHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccchH-HHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence              11111 222222211    1122222222223456677899999999999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=370.59  Aligned_cols=247  Identities=27%  Similarity=0.395  Sum_probs=191.3

Q ss_pred             cccccCccCCeeEEEEEec--CC--cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD--NG--LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|...  ++  ..||||++.....     ......++|.+|+.++++++||||++++|++.+ ...
T Consensus        12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-----~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_          12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-----CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            3457999999999999863  22  3789998865221     123445789999999999999999999999976 467


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|++.+++..   ....+++..++.++.|+|.||+|||   +++++||||||+||+++.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence            899999999999998874   2446999999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCCC---------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMPGS---------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .....         ..++..|+|||.+.+..++.++||||||+++|||+| |..||...        +..+........+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~  231 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEG  231 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------CHHHHHHHHHhCC
Confidence            76432         237789999999999999999999999999999998 89998531        2222222222221


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .          ....+...+..+.+++.+||+.||++|||++||++.|++.
T Consensus       232 ~----------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 E----------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1          0111223445688999999999999999999999999874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=369.35  Aligned_cols=245  Identities=20%  Similarity=0.341  Sum_probs=191.2

Q ss_pred             cccccCccCCeeEEEEEecC----CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLDN----GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|....    +..||||.++..       ......+.|.+|+.++++++||||++++|++.+ +..
T Consensus        11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~   82 (273)
T d1mp8a_          11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV   82 (273)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred             EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence            45789999999999998632    356888887541       234456789999999999999999999999964 678


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ++||||+++|+|.+++..   ....+++..++.++.|+++||+|||   +++++||||||+||++++++.+||+|||+++
T Consensus        83 ~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhe
Confidence            999999999999998763   3457899999999999999999999   8999999999999999999999999999998


Q ss_pred             cCCC-------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhcch
Q 047245          257 LMPG-------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAGEA  328 (380)
Q Consensus       257 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~  328 (380)
                      ....       ...+|+.|+|||.+.+..++.++|||||||++|||++ |..||.....        .+.......... 
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~i~~~~~-  227 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGER-  227 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCC-
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC-
Confidence            6542       2347889999999999999999999999999999998 8888753111        111111111110 


Q ss_pred             hHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          329 REALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                                ...+...+..+.+++.+||+.||++|||++||++.|+++.
T Consensus       228 ----------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         228 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                      1122334566889999999999999999999999998763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-50  Score=374.58  Aligned_cols=242  Identities=21%  Similarity=0.324  Sum_probs=198.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||||++...        .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus        30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--------HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--------chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457899999999999996 57999999998641        223347788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC--CCceEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA--EFTPRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~--~~~~kl~Dfgl~~~  257 (380)
                      ||||++|+|.+++..   ....+++..+..++.||+.||+|||   +.+++||||||+|||++.  ++.+||+|||+++.
T Consensus       102 mE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         102 YEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             ECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            999999999999852   2446999999999999999999999   899999999999999964  57899999999987


Q ss_pred             CCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          258 MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ....     ..||+.|+|||++.+.+++.++|||||||++|||++|+.||...        +..+..........     
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~-----  242 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDW-----  242 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCC-----
T ss_pred             cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCC-----
Confidence            6543     35899999999999999999999999999999999999998531        22222222221110     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                        .. ........+..+.+++.+||+.||++|||++|+++
T Consensus       243 --~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 --NM-DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             --CS-CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             --CC-CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00 01111223456789999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=374.09  Aligned_cols=244  Identities=24%  Similarity=0.364  Sum_probs=192.8

Q ss_pred             cccccCccCCeeEEEEEec-CCc----EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGL----TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  175 (380)
                      ..++||+|+||+||+|... +|+    .||+|++....       .....++|.+|+.++++++|||||+++|+|.++ .
T Consensus        13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_          13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            3478999999999999863 444    58888876421       122347799999999999999999999999875 5


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++++||+.+|+|.+++..   ....+++..+++++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccc
Confidence            6788899999999998863   3567999999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +....        ...||+.|+|||.+.++.++.++|||||||++|||+| |..||+...     ...+           
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~-----------  222 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEI-----------  222 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGH-----------
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHH-----------
Confidence            86532        1247899999999999999999999999999999999 788875310     0011           


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                        ...+..... ...+...+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       223 --~~~i~~~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         223 --SSILEKGER-LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             --HHHHHHTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHHHcCCC-CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence              111111110 112233455688999999999999999999999988765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=366.04  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=199.2

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++.........  .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus        14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (293)
T d1jksa_          14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   91 (293)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh--hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457899999999999997 57899999999764322211  112347789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC----ceEEeccCCc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF----TPRLADFGLA  255 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~----~~kl~Dfgl~  255 (380)
                      ||||++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++    .+|++|||++
T Consensus        92 ~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          92 LELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            999999999999974    347999999999999999999999   89999999999999998776    4999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      +....     ...+|+.|+|||.+.+..++.++|||||||++|||++|+.||...        ...+..........   
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~~---  233 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANVSAVNY---  233 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHTTCC---
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC--------CHHHHHHHHHhcCC---
Confidence            86543     245899999999999999999999999999999999999998631        11122222111110   


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          .. ........+..+.+++.+||+.||++|||++|+++
T Consensus       234 ----~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 ----EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----CC-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CC-CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00 00011123456789999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=371.11  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=197.1

Q ss_pred             cccccCccCCeeEEEEEec-CCc--EEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecCCeE
Q 047245          101 ENRLLGSSPDGKYYRTVLD-NGL--TVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPESSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  176 (380)
                      ..+.||+|+||.||+|... +|.  .||||++....       .....+.|.+|++++.++ +|||||+++|+|.+.+..
T Consensus        14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-------ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            4578999999999999974 344  57788875421       122346799999999999 799999999999999999


Q ss_pred             EEEEeecCCCCHHHHHHHh------------hhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC
Q 047245          177 YLVYDYLQTGSLEDAMDRI------------RENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE  244 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~  244 (380)
                      ++||||+++|+|.++++..            ......++|..+.+++.||+.||.|||   +.+++||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCC
Confidence            9999999999999999742            123467999999999999999999999   8999999999999999999


Q ss_pred             CceEEeccCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCC-CCCchhhhccCCCCHHHH
Q 047245          245 FTPRLADFGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRD-PTAPFFAEAASGGSLGRW  318 (380)
Q Consensus       245 ~~~kl~Dfgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~-p~~~~~~~~~~~~~l~~~  318 (380)
                      +.+||+|||+++....     ...+|..|+|||.+.+..++.++||||||+++|||++|.. ||..        ....+.
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--------~~~~~~  235 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAEL  235 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHH
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC--------CCHHHH
Confidence            9999999999976542     2358899999999999999999999999999999999765 5532        112222


Q ss_pred             HHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          319 LRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ........      .     ...+...+..+.+++.+||+.||++||||+||++.|+++
T Consensus       236 ~~~i~~~~------~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         236 YEKLPQGY------R-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             HHHGGGTC------C-----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcC------C-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            22211110      1     111223455688999999999999999999999998876

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.8e-50  Score=371.78  Aligned_cols=242  Identities=21%  Similarity=0.306  Sum_probs=198.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++...        .....+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus        33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--------YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--------chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457899999999999996 57999999998751        122346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeC--CCCceEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLD--AEFTPRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~--~~~~~kl~Dfgl~~~  257 (380)
                      |||+++|+|.+++..   ....+++..+..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+++.
T Consensus       105 mE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         105 LEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeeccccee
Confidence            999999999988752   3446999999999999999999999   89999999999999998  578999999999987


Q ss_pred             CCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          258 MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ....     ..+|+.|+|||.+.+..++.++|||||||++|||++|+.||...        ...+.........      
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~------  244 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--------DDLETLQNVKRCD------  244 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHHCC------
T ss_pred             cCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCC------
Confidence            6543     35899999999999999999999999999999999999998631        1112222221111      


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ... ........+..+.+|+.+||+.||++|||++|+++
T Consensus       245 -~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         245 -WEF-DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -CCC-CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -CCC-CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000 01111234456789999999999999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=367.18  Aligned_cols=249  Identities=22%  Similarity=0.331  Sum_probs=189.2

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEecC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPES  173 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  173 (380)
                      ..+.||+|+||.||+|...      +++.||||+++..       ......+.+.+|...+.++ +|+||+.+++++.+.
T Consensus        17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-------cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            5678999999999999853      3568999998641       1233456788888888887 789999999998654


Q ss_pred             -CeEEEEEeecCCCCHHHHHHHhhhc------------ccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEE
Q 047245          174 -SRFYLVYDYLQTGSLEDAMDRIREN------------QLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVM  240 (380)
Q Consensus       174 -~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nil  240 (380)
                       ...++||||+++|+|.++++..+..            ...+++..++.++.|++.||+|||   +++|+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence             5689999999999999999864321            235899999999999999999999   899999999999999


Q ss_pred             eCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCC-CCCCchhhhccC
Q 047245          241 LDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR-DPTAPFFAEAAS  311 (380)
Q Consensus       241 l~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~-~p~~~~~~~~~~  311 (380)
                      +++++.+||+|||+++....        ...||+.|+|||.+.+..++.++|||||||++|||++|. .||...    . 
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~----~-  241 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----K-  241 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----C-
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC----C-
Confidence            99999999999999975432        235899999999999999999999999999999999975 465421    0 


Q ss_pred             CCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          312 GGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       312 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                        . ..........+.     .+     ..+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       242 --~-~~~~~~~~~~~~-----~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         242 --I-DEEFCRRLKEGT-----RM-----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             --C-SHHHHHHHHHTC-----CC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --H-HHHHHHHHhcCC-----CC-----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1 111111111111     11     11223345688999999999999999999999999876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-49  Score=364.47  Aligned_cols=240  Identities=21%  Similarity=0.307  Sum_probs=198.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||||++.....     ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            356899999999999997 5699999999964211     1112246788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        83 mE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          83 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence            999999999998874    456888889999999999999999   9999999999999999999999999999998765


Q ss_pred             C---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhc
Q 047245          260 G---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSI  336 (380)
Q Consensus       260 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  336 (380)
                      .   ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...        +..+.........          
T Consensus       156 ~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~----------  217 (316)
T d1fota_         156 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAE----------  217 (316)
T ss_dssp             SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCC----------
T ss_pred             cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--------CHHHHHHHHHcCC----------
Confidence            4   346999999999999999999999999999999999999999631        1222222222111          


Q ss_pred             cCCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          337 LGEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       337 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                        ...+...+..+.+++.+||+.||.+||     |++|+++
T Consensus       218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence              011122345578999999999999996     8888874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=365.42  Aligned_cols=248  Identities=21%  Similarity=0.337  Sum_probs=202.7

Q ss_pred             cccccCccCCeeEEEEEec------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC
Q 047245          101 ENRLLGSSPDGKYYRTVLD------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS  174 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  174 (380)
                      ..+.||+|+||.||+|...      +++.||||+++..       ........|.+|+.++++++||||++++|+|...+
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-------~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-------ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-------SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-------cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            5578999999999999863      3578999998641       12334567999999999999999999999999999


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhh------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceE
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRE------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPR  248 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~k  248 (380)
                      ..++||||+++|+|.+++...+.      ....+++..+.+++.|+++||+|||   +.+|+||||||+|||+++++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence            99999999999999999875432      1235799999999999999999999   88999999999999999999999


Q ss_pred             EeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCC-CCCCchhhhccCCCCHHHHH
Q 047245          249 LADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGR-DPTAPFFAEAASGGSLGRWL  319 (380)
Q Consensus       249 l~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~-~p~~~~~~~~~~~~~l~~~~  319 (380)
                      |+|||+++....        ...+|+.|+|||.+.+..++.++||||||+++|||+||. .||..        .....+.
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~~~~  245 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQVL  245 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHHHHH
Confidence            999999986532        234789999999999999999999999999999999985 55532        1223333


Q ss_pred             HHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          320 RHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ........           ...+...+..+.+++.+||+.||++|||+++|++.|++.
T Consensus       246 ~~i~~~~~-----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         246 RFVMEGGL-----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHhCCC-----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            33322111           111223445689999999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=369.18  Aligned_cols=249  Identities=23%  Similarity=0.379  Sum_probs=195.6

Q ss_pred             cccccCccCCeeEEEEEec--------CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEe
Q 047245          101 ENRLLGSSPDGKYYRTVLD--------NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVP  171 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  171 (380)
                      ..+.||+|+||.||+|...        ++..||||++...       .......++.+|...+.++ +|||||+++++|.
T Consensus        17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-------ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-------cChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            4578999999999999852        2357999998641       1234457788999999888 8999999999999


Q ss_pred             cCCeEEEEEeecCCCCHHHHHHHhh------------hcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcE
Q 047245          172 ESSRFYLVYDYLQTGSLEDAMDRIR------------ENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNV  239 (380)
Q Consensus       172 ~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Ni  239 (380)
                      +.+..++||||+++|+|.+++....            .....+++..++.++.|++.||+|||   +.+++||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence            9999999999999999999997532            12346899999999999999999999   99999999999999


Q ss_pred             EeCCCCceEEeccCCcccCCC--------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHh-CCCCCCchhhhcc
Q 047245          240 MLDAEFTPRLADFGLAKLMPG--------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLT-GRDPTAPFFAEAA  310 (380)
Q Consensus       240 ll~~~~~~kl~Dfgl~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~t-g~~p~~~~~~~~~  310 (380)
                      |++.++.+||+|||+++....        ...+++.|+|||.+.++.++.++||||||+++|||++ |..||...     
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~-----  241 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-----  241 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC-----
Confidence            999999999999999985532        2358889999999999999999999999999999998 67776431     


Q ss_pred             CCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhccc
Q 047245          311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQLH  378 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l~  378 (380)
                         ...... .....+.     .     ...+...+..+.+++.+||+.||++|||+.||++.|+++-
T Consensus       242 ---~~~~~~-~~i~~~~-----~-----~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         242 ---PVEELF-KLLKEGH-----R-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ---CHHHHH-HHHHTTC-----C-----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CHHHHH-HHHHcCC-----C-----CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence               111111 1111111     0     1111223456889999999999999999999999999873

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-49  Score=358.79  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=198.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC----e
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS----R  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  175 (380)
                      ..+.||+|+||.||++.. .+|+.||||++.....     .+......+.+|++++++++||||+++++++...+    .
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_          11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-----RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-----TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            456899999999999996 5799999999975322     23345578999999999999999999999986543    4


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .|+||||+++|+|.+++..    ...+++..+..++.|++.||+|||   +.+++||||||+|||++.++..+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhh
Confidence            7999999999999998864    447999999999999999999999   899999999999999999999999999988


Q ss_pred             ccCCC---------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPG---------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~---------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      .....         ...||+.|+|||.+.+..++.++|||||||++|||+||+.||...        ...+.........
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~~~~~~  230 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVRED  230 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc--------CHHHHHHHHHhcC
Confidence            65432         235899999999999999999999999999999999999998631        1122222222221


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCC-CHHhHHHHHhccc
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRP-SSDELVPMLTQLH  378 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~l~  378 (380)
                      ...    +..    .....+..+.+++.+||+.||.+|| |++++++.|.+++
T Consensus       231 ~~~----~~~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         231 PIP----PSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCC----GGG----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCC----Cch----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            110    001    1112345688999999999999999 8999999998875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=363.88  Aligned_cols=240  Identities=23%  Similarity=0.286  Sum_probs=197.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||.||++.. .+|+.||+|++.....     ......+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            456899999999999996 5799999999975211     1112346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++.....++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            999999999999875    446889999999999999999999   9999999999999999999999999999998653


Q ss_pred             C------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          260 G------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       260 ~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                      .      ...||+.|+|||.+.+..++.++||||+||++|||++|+.||...        +........... .      
T Consensus       157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~--------~~~~~~~~i~~~-~------  221 (337)
T d1o6la_         157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILME-E------  221 (337)
T ss_dssp             CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHC-C------
T ss_pred             cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc--------CHHHHHHHHhcC-C------
Confidence            2      245899999999999999999999999999999999999998641        122222222111 0      


Q ss_pred             hhccCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          334 RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                           ...+...+..+.+++.+||+.||.+||+     ++|+++
T Consensus       222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                 0112234456789999999999999995     666654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-50  Score=366.39  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             ccccccCccCCeeEEEEEe------cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec
Q 047245          100 NENRLLGSSPDGKYYRTVL------DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE  172 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  172 (380)
                      ...+.||+|+||.||+|..      .+++.||||+++..       ........|.+|+.+++++ +|||||+++|+|.+
T Consensus        26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-------~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-------AHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-------cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            3567899999999999985      35678999999652       1233456899999999999 79999999999999


Q ss_pred             CCeEEEEEeecCCCCHHHHHHHhhh--------------cccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCc
Q 047245          173 SSRFYLVYDYLQTGSLEDAMDRIRE--------------NQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTN  238 (380)
Q Consensus       173 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~N  238 (380)
                      ....++||||+++|+|.++++....              ....+++..+..++.||+.||+|||   +++++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccc
Confidence            9999999999999999999975321              2346999999999999999999999   8999999999999


Q ss_pred             EEeCCCCceEEeccCCcccCCCC--------CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc
Q 047245          239 VMLDAEFTPRLADFGLAKLMPGS--------LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA  310 (380)
Q Consensus       239 ill~~~~~~kl~Dfgl~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~  310 (380)
                      |+++.++.+|++|||+++.....        ..+|+.|+|||.+.++.++.++||||||+++|||+|+..|+...   ..
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~---~~  252 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---MP  252 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT---CC
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC---CC
Confidence            99999999999999999876532        34789999999999999999999999999999999955554321   11


Q ss_pred             CCCCHHHHHHHHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          311 SGGSLGRWLRHLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       311 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ..    .-+...         +..... ...+...+..+.+|+.+||+.||++|||++||+++|+++
T Consensus       253 ~~----~~~~~~---------i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         253 VD----SKFYKM---------IKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SS----HHHHHH---------HHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----HHHHHH---------HhcCCC-CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            00    111111         111111 111123445688999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.6e-49  Score=354.85  Aligned_cols=249  Identities=23%  Similarity=0.374  Sum_probs=200.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChh-hhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPE-KQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  177 (380)
                      ..+.||+|+||+||++.. .+|+.||||++......... ...+...+.+.+|+.++++++ ||||+++++++.+++..+
T Consensus         7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~   86 (277)
T d1phka_           7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF   86 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence            356899999999999986 57999999999764433222 123445667999999999996 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          178 LVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       178 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                      +||||+++|+|.+++..    ...+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus        87 ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          87 LVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            99999999999999974    447999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCC-----CCcCCCcccCcccccC------CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          258 MPG-----SLIATSAYSAPECFQN------RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       258 ~~~-----~~~~~~~y~aPE~~~~------~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ...     ...||+.|+|||.+.+      ..++.++||||+||++|||++|+.||...        ...+-........
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--------~~~~~~~~i~~~~  231 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------KQMLMLRMIMSGN  231 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--------CHHHHHHHHHhCC
Confidence            653     2458999999999853      34688999999999999999999999641        1111112222111


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .       . .........+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~-------~-~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 Y-------Q-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             C-------C-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C-------C-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0       0 011111234566889999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-48  Score=362.32  Aligned_cols=239  Identities=18%  Similarity=0.248  Sum_probs=197.8

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||.||++.. .+|+.||||++.....     ......+.+.+|+.++++++||||+++++++.+....++|+
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            46899999999999997 5799999999864210     11122467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+.+|+|.+++..    ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...+
T Consensus       121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999874    346899999999999999999999   89999999999999999999999999999987654


Q ss_pred             ---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhchhcc
Q 047245          261 ---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDRSIL  337 (380)
Q Consensus       261 ---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  337 (380)
                         ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...        .............           
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~-----------  254 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGK-----------  254 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-----------
T ss_pred             ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------CHHHHHHHHhcCC-----------
Confidence               345999999999999999999999999999999999999998631        2222222222111           


Q ss_pred             CCcccHHHHHHHHHHHHHcccCCCCCCC-----CHHhHHH
Q 047245          338 GEEVEEDEMLMAVRIAVVCLSDSPADRP-----SSDELVP  372 (380)
Q Consensus       338 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~  372 (380)
                       ...+......+.+++.+||+.||.+|+     |++|+++
T Consensus       255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             011122345688999999999999994     8888874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=358.19  Aligned_cols=241  Identities=20%  Similarity=0.335  Sum_probs=196.1

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..+.||+|+||+||+|.. .+|+.||+|.+...         ......+.+|+++|++++||||+++++++.+.+..|+|
T Consensus         9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---------GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            346899999999999997 46889999999651         11235688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCC--CceEEeccCCccc
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAE--FTPRLADFGLAKL  257 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~--~~~kl~Dfgl~~~  257 (380)
                      ||||++|+|.+++..   ....+++.++..++.||+.||+|||   +.+|+||||||+|||++.+  ..+||+|||+++.
T Consensus        80 mE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          80 FEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             ECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence            999999999999863   2446999999999999999999999   8999999999999999854  5899999999987


Q ss_pred             CCCC-----CcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          258 MPGS-----LIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       258 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ....     ..+++.|+|||.+.+..++.++||||+||++|||++|..||...        ...+...........   +
T Consensus       154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--------~~~~~~~~i~~~~~~---~  222 (321)
T d1tkia_         154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYT---F  222 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCC---C
T ss_pred             cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCC---C
Confidence            6543     24899999999999999999999999999999999999998641        112222222211100   0


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      +..     .....+..+.+++.+||..||++|||++|+++
T Consensus       223 ~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 DEE-----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CHH-----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Chh-----hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000     00123455789999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-48  Score=364.51  Aligned_cols=246  Identities=21%  Similarity=0.262  Sum_probs=192.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLV  179 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  179 (380)
                      ..++||+|+||.||+|.. .+|+.||||++......  .............|+.+++.++|||||++++++.+.+..++|
T Consensus         8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc--hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            357899999999999997 46999999998642110  011122223334567888888999999999999999999999


Q ss_pred             EeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCC
Q 047245          180 YDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMP  259 (380)
Q Consensus       180 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~  259 (380)
                      |||+++|+|.+++..    ...+++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        86 mE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             ECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999974    456889999999999999999999   9999999999999999999999999999998654


Q ss_pred             C----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhch
Q 047245          260 G----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALDR  334 (380)
Q Consensus       260 ~----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  334 (380)
                      .    ...||+.|+|||.+.. ..++.++|||||||++|||++|+.||...     .........+...         ..
T Consensus       159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~~~~~~---------~~  224 (364)
T d1omwa3         159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-----KTKDKHEIDRMTL---------TM  224 (364)
T ss_dssp             SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS-----CSSCHHHHHHHSS---------SC
T ss_pred             CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcc---------cC
Confidence            3    3459999999999975 56899999999999999999999999641     1111111111100         00


Q ss_pred             hccCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          335 SILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       335 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                      .   ...+...+..+.+++.+||+.||++|||     ++|+++
T Consensus       225 ~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 A---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             C---CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             C---CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            0   0111223456889999999999999999     567653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-49  Score=361.73  Aligned_cols=241  Identities=19%  Similarity=0.288  Sum_probs=189.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CCCCcceeeEEEec----CCe
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RHRNLMSLRAYVPE----SSR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  175 (380)
                      .++||+|+||.||+|.. .+|+.||||+++.             ...+.+|+.++.++ +|||||++++++.+    ...
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             eEEeeeccCeEEEEEEECCCCCEEEEEEECC-------------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            35799999999999986 6789999999864             14567899987655 89999999999865    466


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEecc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADF  252 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Df  252 (380)
                      +|+|||||+||+|.+++..  .....+++..+..++.|++.||+|||   +.+|+||||||+|||+++   ++.+||+||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccc
Confidence            8999999999999999973  22346999999999999999999999   899999999999999985   467999999


Q ss_pred             CCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc
Q 047245          253 GLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE  327 (380)
Q Consensus       253 gl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~  327 (380)
                      |+++....     ...||+.|+|||.+.+..++.++|||||||++|||+||+.||......     ............+.
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~~~~i~~~~  233 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKTRIRMGQ  233 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCS
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHHHHHHhcCC
Confidence            99986543     345999999999999999999999999999999999999999642100     00000000000000


Q ss_pred             hhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 AREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                            .. .........+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ------~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 ------YE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ------SS-CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ------CC-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                  00 001111234567899999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=357.58  Aligned_cols=239  Identities=21%  Similarity=0.287  Sum_probs=192.8

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHH-cCCCCCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLA-SLRHRNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||+||+|.. .+|+.||||++.....     ......+.+..|..++. .++||||+++++++.+++..|+
T Consensus         6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            457899999999999997 4689999999964110     01112345666777665 6899999999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLM  258 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~  258 (380)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++..
T Consensus        81 vmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence            9999999999999974    446889999999999999999999   899999999999999999999999999999865


Q ss_pred             CC------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhh
Q 047245          259 PG------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREAL  332 (380)
Q Consensus       259 ~~------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  332 (380)
                      ..      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...        +.......... +.     
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~-~~-----  219 (320)
T d1xjda_         154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------DEEELFHSIRM-DN-----  219 (320)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-CC-----
T ss_pred             ccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHHc-CC-----
Confidence            42      235899999999999999999999999999999999999999631        11122222111 10     


Q ss_pred             chhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHH-hHH
Q 047245          333 DRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSD-ELV  371 (380)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl  371 (380)
                            ...+...+..+.+++.+||+.||++|||+. |++
T Consensus       220 ------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence                  111122345688999999999999999995 665

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-49  Score=358.40  Aligned_cols=252  Identities=25%  Similarity=0.300  Sum_probs=188.8

Q ss_pred             cccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          103 RLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      ++||+|+||+||+|.. .+|+.||||++......   .......+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh---hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            5799999999999996 56899999998653211   1112234578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |++++++..+..    ....+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.... 
T Consensus        81 ~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          81 FMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             CCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             hhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC
Confidence            999877665543    3456888899999999999999999   89999999999999999999999999999976543 


Q ss_pred             -----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh---hcchhHh
Q 047245          261 -----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH---AGEAREA  331 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~  331 (380)
                           ...||+.|+|||.+.. ..++.++|||||||++|||++|..||.....        .+-......   .......
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--------~~~l~~i~~~~~~~~~~~~  225 (299)
T d1ua2a_         154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--------LDQLTRIFETLGTPTEEQW  225 (299)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCCCCTTTS
T ss_pred             cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--------HHHHHHHHHhcCCCChhhc
Confidence                 2358999999999875 4579999999999999999999999863111        111111110   0000000


Q ss_pred             hch----------hccCCc---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 LDR----------SILGEE---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 ~~~----------~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .+.          ......   ........+.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000          000000   00122456889999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=347.35  Aligned_cols=257  Identities=23%  Similarity=0.357  Sum_probs=192.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||+||+|.. .+|+.||||++.....      .+.....+.+|++++++++|||||++++++.+++..++||
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc------ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            46799999999999996 6799999999965211      1222467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      ||+.+ ++.+++..  .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             ECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             eecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence            99975 55555543  33556999999999999999999999   89999999999999999999999999999975432


Q ss_pred             ------CCcCCCcccCcccccCCC-CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHhhc
Q 047245          261 ------SLIATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREALD  333 (380)
Q Consensus       261 ------~~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  333 (380)
                            ...||+.|+|||.+.... ++.++||||+||++|||++|+.||.....       ...+.......+...+...
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~  227 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-------IDQLFRIFRTLGTPDEVVW  227 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHHHCCCCTTTS
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-------HHHHHHHHHhcCCCchhhc
Confidence                  236899999999887665 57899999999999999999999863110       1111111111010000000


Q ss_pred             hh-------------ccCCc---ccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH--HHhcc
Q 047245          334 RS-------------ILGEE---VEEDEMLMAVRIAVVCLSDSPADRPSSDELVP--MLTQL  377 (380)
Q Consensus       334 ~~-------------~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~l  377 (380)
                      +.             .....   ........+.+++.+||+.||++|||++|+++  .++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00             00000   00122356789999999999999999999986  34443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-48  Score=345.95  Aligned_cols=237  Identities=22%  Similarity=0.329  Sum_probs=190.0

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--CCCcceeeEEEecCCeEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--HRNLMSLRAYVPESSRFY  177 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~  177 (380)
                      ..++||+|+||.||+|.. .+|+.||||++..........  .....++.+|+.++++++  ||||+++++++.+.+..+
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh--hhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            357899999999999996 578999999997533222111  011134668999999996  899999999999999999


Q ss_pred             EEEeecCC-CCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-CCceEEeccCCc
Q 047245          178 LVYDYLQT-GSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-EFTPRLADFGLA  255 (380)
Q Consensus       178 lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-~~~~kl~Dfgl~  255 (380)
                      +||||+.+ +++.+++..    ...+++..+..++.|++.||+|||   +++++||||||+|||++. ++.+||+|||++
T Consensus        86 lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999976 678888764    457999999999999999999999   899999999999999985 479999999999


Q ss_pred             ccCCC----CCcCCCcccCcccccCCCC-CCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhH
Q 047245          256 KLMPG----SLIATSAYSAPECFQNRSY-TDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEARE  330 (380)
Q Consensus       256 ~~~~~----~~~~~~~y~aPE~~~~~~~-~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  330 (380)
                      +....    ...||+.|+|||.+.+..+ +.++||||+||++|||++|+.||....              .....     
T Consensus       159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~~-----  219 (273)
T d1xwsa_         159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRG-----  219 (273)
T ss_dssp             EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHC-----
T ss_pred             eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhhc-----
Confidence            86543    3458999999999987765 567899999999999999999986410              00100     


Q ss_pred             hhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          331 ALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                          ..   ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       220 ----~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         220 ----QV---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ----CC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----cc---CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                00   011122345789999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.5e-47  Score=343.78  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=191.6

Q ss_pred             ccccCccCCeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEEe
Q 047245          102 NRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      -+.||+|+||+||+|...+|+.||||++.....      .+...+.+.+|+.++++++||||+++++++.+.+..++++|
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSG------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc------ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            357999999999999999999999999965321      12223678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC-
Q 047245          182 YLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG-  260 (380)
Q Consensus       182 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~-  260 (380)
                      |+.++.+..+..    ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||.+..... 
T Consensus        81 ~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          81 HLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             eehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            998766666544    2457999999999999999999999   88999999999999999999999999999865432 


Q ss_pred             -----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcchhHh---
Q 047245          261 -----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGEAREA---  331 (380)
Q Consensus       261 -----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~---  331 (380)
                           ...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......    .+...... .........   
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~----~~~~i~~~-~~~~~~~~~~~~  228 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRI-LGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH-HCCCCTTTSTTG
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH----HHHHHHHh-hCCCChhhccch
Confidence                 2358889999999876 456899999999999999999999996421100    00110000 000000000   


Q ss_pred             -----hchhcc------CCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          332 -----LDRSIL------GEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       332 -----~~~~~~------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                           .+....      ...........+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 000000      00111223456789999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=340.27  Aligned_cols=255  Identities=24%  Similarity=0.328  Sum_probs=185.3

Q ss_pred             ccccCccCCeeEEEEEe-c-CCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC---CCCCcceeeEEEec----
Q 047245          102 NRLLGSSPDGKYYRTVL-D-NGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL---RHRNLMSLRAYVPE----  172 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  172 (380)
                      .+.||+|+||+||+|.. . +++.||||++..........      ..+.+|+.+++.+   +||||+++++++..    
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH------HHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46799999999999986 3 36779999997643222111      2344566665554   89999999999853    


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          173 -SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       173 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                       ....++++||++++++.....   .....+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence             357899999998877654433   33556899999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          252 FGLAKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       252 fgl~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ||+++....     ...||+.|+|||.+.+.+++.++||||+||++|||++|+.||.......    .+...........
T Consensus       160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~  235 (305)
T d1blxa_         160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIGLPG  235 (305)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCC
T ss_pred             hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhhCCCc
Confidence            999886542     3469999999999999999999999999999999999999996421100    0111111000000


Q ss_pred             c--------hhHhhchhccC---CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 E--------AREALDRSILG---EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~--------~~~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .        ...........   ..........+.+|+.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0        00000000000   0011123455788999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-45  Score=337.65  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=185.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC------
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS------  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  174 (380)
                      .+.||+|+||+||+|.. .+|+.||||++....      ..+...+.+.+|+++|++++|||||++++++...+      
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhh------cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            35799999999999996 569999999996421      23344578899999999999999999999997654      


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..++||||+ +++|..+.+     ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccc
Confidence            579999999 567877665     346999999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCC---CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHh------
Q 047245          255 AKLMPG---SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQH------  324 (380)
Q Consensus       255 ~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~------  324 (380)
                      ++....   ...+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......    .+.........      
T Consensus       168 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         168 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHH
T ss_pred             eeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH----HHHHHHhccCCCcHHHH
Confidence            987654   34589999999998764 56899999999999999999999986421100    00000000000      


Q ss_pred             -hcc--hhHhhc---hhccCC---cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          325 -AGE--AREALD---RSILGE---EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       325 -~~~--~~~~~~---~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                       ...  ......   +.....   .........+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             000  000000   000000   011123345789999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=332.93  Aligned_cols=254  Identities=21%  Similarity=0.277  Sum_probs=184.9

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec-------
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE-------  172 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  172 (380)
                      ..+.||+|+||+||+|.. .+|+.||||++......      +....++.+|+++|++++||||+++++++..       
T Consensus        14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1          14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT------TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            346799999999999996 57999999998653221      1223668899999999999999999999855       


Q ss_pred             -CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEec
Q 047245          173 -SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLAD  251 (380)
Q Consensus       173 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~D  251 (380)
                       .+..++||||++++.+..+..    ....++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             cCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence             346799999998876655433    3456888999999999999999999   89999999999999999999999999


Q ss_pred             cCCcccCCC----------CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          252 FGLAKLMPG----------SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       252 fgl~~~~~~----------~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      ||+++....          ...||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......     ...-+.
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-----~~~~i~  235 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-----QLALIS  235 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHH
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-----HHHHHH
Confidence            999975432          23589999999998765 68999999999999999999999986311000     000000


Q ss_pred             HHHhhcc-----------hhHhhchhccCCcccH------HHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          321 HLQHAGE-----------AREALDRSILGEEVEE------DEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       321 ~~~~~~~-----------~~~~~~~~~~~~~~~~------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      .......           ....+...........      .....+.+|+.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1000000           0000000000000001      11335678999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-45  Score=339.03  Aligned_cols=251  Identities=26%  Similarity=0.357  Sum_probs=185.9

Q ss_pred             ccccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----
Q 047245          100 NENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----  173 (380)
Q Consensus       100 ~~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  173 (380)
                      +..++||+|+||+||+|.. .+|+.||||++....            ....+|++++++++||||+++++++...     
T Consensus        23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc------------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            3456899999999999997 469999999997522            1123699999999999999999998432     


Q ss_pred             -CeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEec
Q 047245          174 -SRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLAD  251 (380)
Q Consensus       174 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~D  251 (380)
                       ...++||||++++ +.+.+.........+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|
T Consensus        91 ~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          91 EVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             CCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECC
T ss_pred             ceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEec
Confidence             3579999999865 44444433344667999999999999999999999   99999999999999999775 899999


Q ss_pred             cCCcccCCC-----CCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh
Q 047245          252 FGLAKLMPG-----SLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA  325 (380)
Q Consensus       252 fgl~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~  325 (380)
                      ||+++....     ...|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.......    .+....+.. . 
T Consensus       167 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~----~l~~i~~~~-g-  240 (350)
T d1q5ka_         167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVL-G-  240 (350)
T ss_dssp             CTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHH-C-
T ss_pred             ccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH----HHHHHHHHh-C-
Confidence            999976542     3458999999998875 568999999999999999999999986421110    011111000 0 


Q ss_pred             cchhHhh--------ch---hccC----CcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          326 GEAREAL--------DR---SILG----EEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       326 ~~~~~~~--------~~---~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ....+.+        +.   ....    ..........+.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000        00   0000    0011123455789999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=333.59  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=184.7

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCC----eE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESS----RF  176 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  176 (380)
                      .+.||+|+||+||+|.. .+|+.||||++...       ......+.+.+|+.+|++++||||+++++++....    ..
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-------~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCT-------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehh-------cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            36899999999999986 57999999999642       12344578899999999999999999999986543    23


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      +++++|+.+|+|.+++..     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            455566779999999863     36899999999999999999999   8999999999999999999999999999997


Q ss_pred             cCC---------CCCcCCCcccCcccccC-CCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          257 LMP---------GSLIATSAYSAPECFQN-RSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       257 ~~~---------~~~~~~~~y~aPE~~~~-~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      ...         ....||+.|+|||.+.. ..++.++||||+||++|||++|+.||.......     ............
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-----~~~~~~~~~~~~  232 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-----QLNHILGILGSP  232 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCSC
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-----HHHHHhhhccCC
Confidence            543         23458999999999854 567889999999999999999999996421100     000000000000


Q ss_pred             chh-----------Hhh--chhccCCcc---cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          327 EAR-----------EAL--DRSILGEEV---EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       327 ~~~-----------~~~--~~~~~~~~~---~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ...           ...  .+.......   .......+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000           000  000000000   0112345789999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-45  Score=331.60  Aligned_cols=248  Identities=20%  Similarity=0.227  Sum_probs=187.7

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcce-eeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMS-LRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||+|.. .+|+.||||++.....          ..++..|++++++++|+|++. +.++..+++..++
T Consensus        11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_          11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----------SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----------CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            456899999999999986 5689999998865211          134678999999998776554 5556677888999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC---CCceEEeccCCc
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA---EFTPRLADFGLA  255 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~---~~~~kl~Dfgl~  255 (380)
                      ||||+ +|+|.+.+..   ....+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..+||+|||++
T Consensus        81 vme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          81 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             EEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence            99999 5677776653   3457999999999999999999999   899999999999999864   557999999999


Q ss_pred             ccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHH
Q 047245          256 KLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHL  322 (380)
Q Consensus       256 ~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~  322 (380)
                      +....             ...||+.|+|||.+.+.+++.++|||||||++|||++|+.||......... .....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~  232 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKK  232 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhccc
Confidence            86532             235899999999999999999999999999999999999999642111110 0111111110


Q ss_pred             HhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          323 QHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      .. .. .    +.+ .    ...+..+.+++..||+.+|++||+++++.+.|+.+
T Consensus       233 ~~-~~-~----~~~-~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         233 MS-TP-I----EVL-C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HH-SC-H----HHH-T----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             CC-CC-h----hHh-c----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            00 00 0    000 0    12335578999999999999999999998888764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=329.01  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=197.5

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecCCeEEEEE
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPESSRFYLVY  180 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  180 (380)
                      .+.||+|+||+||+|+. .+|+.||||+++....      ......++.+|+.++++++||||+++++++.+....++++
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC------ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            36799999999999996 5789999999975321      2234578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCcccCCC
Q 047245          181 DYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKLMPG  260 (380)
Q Consensus       181 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~~~~  260 (380)
                      |++.+++|..++..    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++....
T Consensus        81 ~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          81 EFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             ECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eecccccccccccc----ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            99999988887753    457889999999999999999999   89999999999999999999999999999986543


Q ss_pred             C------CcCCCcccCcccccCCC-CCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhh-cch----
Q 047245          261 S------LIATSAYSAPECFQNRS-YTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHA-GEA----  328 (380)
Q Consensus       261 ~------~~~~~~y~aPE~~~~~~-~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~-~~~----  328 (380)
                      .      ..+++.|+|||.+.... ++.++||||+||++|||++|+.||..       ..+..+........ +..    
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~  226 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-------GNDVDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC-------CSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC-------CCCHHHHHHHHHhhcCCCChhh
Confidence            2      24678899999987665 68999999999999999999999743       11222222211110 000    


Q ss_pred             ----hHh--------hchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH--HHhcc
Q 047245          329 ----REA--------LDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP--MLTQL  377 (380)
Q Consensus       329 ----~~~--------~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~l  377 (380)
                          ...        .................+.+|+.+|++.||.+|||++|+++  .++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                000        00000001111223456789999999999999999999985  44443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-44  Score=325.65  Aligned_cols=248  Identities=17%  Similarity=0.191  Sum_probs=193.4

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC-CCcceeeEEEecCCeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-RNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  178 (380)
                      ..+.||+|+||.||+|+. .+|+.||||++......          ..+.+|++.++.++| +|++.+++++.++...++
T Consensus         9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            456899999999999996 46899999988652211          346678999999965 899999999999999999


Q ss_pred             EEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCC-----CCceEEeccC
Q 047245          179 VYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDA-----EFTPRLADFG  253 (380)
Q Consensus       179 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~-----~~~~kl~Dfg  253 (380)
                      ||||+ +|+|.+++..   ....+++..+..++.|++.||+|||   +.+++||||||+|||++.     ++.+||+|||
T Consensus        79 vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          79 VIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccc
Confidence            99999 6899998864   2446899999999999999999999   999999999999999974     5789999999


Q ss_pred             CcccCCC-------------CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHH
Q 047245          254 LAKLMPG-------------SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLR  320 (380)
Q Consensus       254 l~~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~  320 (380)
                      +++....             ...||+.|+|||.+.+..++.++||||||+++|||++|..||...     ..........
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~-----~~~~~~~~~~  226 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-----KAATNKQKYE  226 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC-----CSCCHHHHHH
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc-----cchhHHHHHH
Confidence            9975431             235899999999999999999999999999999999999999631     1111111111


Q ss_pred             HHHhhcchhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHHHHhcc
Q 047245          321 HLQHAGEAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVPMLTQL  377 (380)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~l  377 (380)
                      ......   ...........    .+.++.+++..|+..+|++||+++.+.+.|+++
T Consensus       227 ~i~~~~---~~~~~~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         227 RIGEKK---QSTPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHHH---HHSCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHhcc---CCCChHHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            111100   00000000111    234578899999999999999999998887764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-45  Score=332.94  Aligned_cols=245  Identities=21%  Similarity=0.296  Sum_probs=191.6

Q ss_pred             cccccCccCCeeEEEEEe----cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCC-CCcceeeEEEecCCe
Q 047245          101 ENRLLGSSPDGKYYRTVL----DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRH-RNLMSLRAYVPESSR  175 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  175 (380)
                      ..+.||+|+||+||+|..    .+|+.||||.++......    +....+.+.+|++++++++| |||+++++++.+...
T Consensus        28 ~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~----~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE----EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             EEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc----chHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            457899999999999985    258899999986532111    11123567789999999966 899999999999999


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .++++||+.+|+|.+++..    ...++......++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999999875    335678888999999999999999   899999999999999999999999999999


Q ss_pred             ccCCC-------CCcCCCcccCcccccCC--CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhc
Q 047245          256 KLMPG-------SLIATSAYSAPECFQNR--SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAG  326 (380)
Q Consensus       256 ~~~~~-------~~~~~~~y~aPE~~~~~--~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~  326 (380)
                      +....       ...|++.|++||.+.+.  .++.++|||||||++|||++|..||...    .................
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~----~~~~~~~~i~~~~~~~~  252 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD----GEKNSQAEISRRILKSE  252 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT----TSCCCHHHHHHHHHHCC
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHhcccCC
Confidence            76542       23589999999999764  4688999999999999999999998642    11112222222111110


Q ss_pred             chhHhhchhccCCcccHHHHHHHHHHHHHcccCCCCCCCC-----HHhHHH
Q 047245          327 EAREALDRSILGEEVEEDEMLMAVRIAVVCLSDSPADRPS-----SDELVP  372 (380)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~  372 (380)
                                  ...+...+..+.+++.+||+.||++|||     ++|+++
T Consensus       253 ------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                        1112234567889999999999999995     677764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-43  Score=326.25  Aligned_cols=255  Identities=22%  Similarity=0.304  Sum_probs=184.0

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEec------CC
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPE------SS  174 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  174 (380)
                      .++||+|+||+||+|.. .+|+.||||++....      .......++.+|+.++++++||||+++++++..      ..
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~------~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             EEEeecCcCeEEEEEEECCCCCEEEEEEEChhh------cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            35899999999999996 469999999997522      123445678999999999999999999999853      46


Q ss_pred             eEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCC
Q 047245          175 RFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGL  254 (380)
Q Consensus       175 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl  254 (380)
                      ..|+||||+.++ +.+.+.      ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence            889999999765 444443      35889999999999999999999   89999999999999999999999999999


Q ss_pred             cccCCC-----CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhcc--------CCCCHHHH---
Q 047245          255 AKLMPG-----SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAA--------SGGSLGRW---  318 (380)
Q Consensus       255 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~--------~~~~l~~~---  318 (380)
                      ++....     ...+|+.|+|||.+.+..++.++||||+||+++||++|+.||........        .......|   
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            876543     23589999999999999999999999999999999999999853110000        00000000   


Q ss_pred             ---HHHHHhhcc------hhHhhchhccCC--cccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          319 ---LRHLQHAGE------AREALDRSILGE--EVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       319 ---~~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                         .........      ....+.......  .........+.+|+.+|++.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               000000000      000111111111  122345677899999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9e-44  Score=328.23  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=186.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEec--CCeE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPE--SSRF  176 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~  176 (380)
                      ..+.||+|+||+||+|.. .+|+.||||+++...           .+++.+|+++|++++ ||||+++++++..  ....
T Consensus        39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            346799999999999997 578999999986411           256789999999995 9999999999874  4568


Q ss_pred             EEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-ceEEeccCCc
Q 047245          177 YLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-TPRLADFGLA  255 (380)
Q Consensus       177 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-~~kl~Dfgl~  255 (380)
                      ++||||+++|+|.++.       ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||++
T Consensus       108 ~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a  177 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA  177 (328)
T ss_dssp             EEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred             eEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccc
Confidence            9999999999986653       35899999999999999999999   99999999999999998655 6999999999


Q ss_pred             ccCCC-----CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCC---------HHHHHH
Q 047245          256 KLMPG-----SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGS---------LGRWLR  320 (380)
Q Consensus       256 ~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~---------l~~~~~  320 (380)
                      +....     ...+|+.|+|||.+.+. .++.++||||+|++++|+++|+.||............         ...|..
T Consensus       178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            76543     23589999999998765 4799999999999999999999998642111100000         000000


Q ss_pred             HHHhhc--chhHhhc-------hhccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          321 HLQHAG--EAREALD-------RSILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       321 ~~~~~~--~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                      ......  .......       ...............+.+|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000  0000000       000011111223456889999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=327.04  Aligned_cols=252  Identities=24%  Similarity=0.305  Sum_probs=185.4

Q ss_pred             ccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEEecC-----Ce
Q 047245          102 NRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYVPES-----SR  175 (380)
Q Consensus       102 ~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  175 (380)
                      .+.||+|+||+||+|.. .+|+.||||++....      .+....+.+.+|++++++++|||||++++++...     ..
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchh------cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999996 579999999997522      2233446788999999999999999999998532     34


Q ss_pred             EEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEeccCCc
Q 047245          176 FYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLADFGLA  255 (380)
Q Consensus       176 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~  255 (380)
                      .+++++|+.+|+|.+++.     ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchh
Confidence            466777888999999986     346999999999999999999999   899999999999999999999999999998


Q ss_pred             ccCCC---CCcCCCcccCcccccCC-CCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCCCCHHHHHHHHHhhcc----
Q 047245          256 KLMPG---SLIATSAYSAPECFQNR-SYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASGGSLGRWLRHLQHAGE----  327 (380)
Q Consensus       256 ~~~~~---~~~~~~~y~aPE~~~~~-~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~~~l~~~~~~~~~~~~----  327 (380)
                      .....   ...|++.|+|||...+. .++.++||||+||++|||++|+.||.......     ....+........    
T Consensus       169 ~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-----~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         169 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-----QLKLILRLVGTPGAELL  243 (348)
T ss_dssp             -CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCHHHH
T ss_pred             cccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCChHHh
Confidence            76553   34588899999987765 46889999999999999999999986311000     0000000000000    


Q ss_pred             -------hhHhhchhccCCcc-----cHHHHHHHHHHHHHcccCCCCCCCCHHhHHH
Q 047245          328 -------AREALDRSILGEEV-----EEDEMLMAVRIAVVCLSDSPADRPSSDELVP  372 (380)
Q Consensus       328 -------~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~  372 (380)
                             ..............     .......+.+|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                   00000000000000     0112345789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-38  Score=295.25  Aligned_cols=260  Identities=19%  Similarity=0.224  Sum_probs=184.5

Q ss_pred             cccccCccCCeeEEEEEe-cCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-----------CCCcceeeE
Q 047245          101 ENRLLGSSPDGKYYRTVL-DNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-----------HRNLMSLRA  168 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~  168 (380)
                      ..+.||+|+||+||+|+. .+|+.||||+++.         +....+.+.+|+.++++++           |+||+++++
T Consensus        17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~---------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEec---------cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            457899999999999996 5799999999964         1223356778888888775           578999998


Q ss_pred             EEec--CCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCC-
Q 047245          169 YVPE--SSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEF-  245 (380)
Q Consensus       169 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~-  245 (380)
                      ++..  ....+++++++..+........ ......+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++ 
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEET
T ss_pred             Eeeeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCc
Confidence            8754  3566777777666554433332 2335578889999999999999999993  37899999999999997654 


Q ss_pred             -----ceEEeccCCcccCCC---CCcCCCcccCcccccCCCCCCcchhhHHHHHHHHHHhCCCCCCchhhhccCC--CCH
Q 047245          246 -----TPRLADFGLAKLMPG---SLIATSAYSAPECFQNRSYTDKSDIFSFGMILAVLLTGRDPTAPFFAEAASG--GSL  315 (380)
Q Consensus       246 -----~~kl~Dfgl~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~s~Gvil~el~tg~~p~~~~~~~~~~~--~~l  315 (380)
                           .+|++|||.+.....   ...||+.|+|||.+.+..++.++||||+||+++||++|+.||.+........  ..+
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence                 399999999875543   3468999999999999999999999999999999999999987421111000  001


Q ss_pred             HHHHHHH--------HhhcchhHhhchh------------------ccCCcccHHHHHHHHHHHHHcccCCCCCCCCHHh
Q 047245          316 GRWLRHL--------QHAGEAREALDRS------------------ILGEEVEEDEMLMAVRIAVVCLSDSPADRPSSDE  369 (380)
Q Consensus       316 ~~~~~~~--------~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e  369 (380)
                      ...+...        ..........+..                  .............+.+|+.+|+..||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1111100        0000000000000                  0011223567788999999999999999999999


Q ss_pred             HHH
Q 047245          370 LVP  372 (380)
Q Consensus       370 vl~  372 (380)
                      +++
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4.6e-25  Score=186.26  Aligned_cols=171  Identities=13%  Similarity=0.095  Sum_probs=121.8

Q ss_pred             cccccCccCCeeEEEEEecCCcEEEEEEeeeccCCC----------hhhhcHHHHHHHHHHHHHHHcCCCCCcceeeEEE
Q 047245          101 ENRLLGSSPDGKYYRTVLDNGLTVAVRRVEAFESGS----------PEKQNKSVKRRIQQELEVLASLRHRNLMSLRAYV  170 (380)
Q Consensus       101 ~~~~lg~G~~g~vy~~~~~~g~~vavK~~~~~~~~~----------~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  170 (380)
                      .++.||+|+||.||+|...+|+.||||+++......          ..............|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            467899999999999999899999999876421110          0001122234566789999999999999887664


Q ss_pred             ecCCeEEEEEeecCCCCHHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcCCCCeEecCCCCCcEEeCCCCceEEe
Q 047245          171 PESSRFYLVYDYLQTGSLEDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTCNPQILHYNLKPTNVMLDAEFTPRLA  250 (380)
Q Consensus       171 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH~dlk~~Nill~~~~~~kl~  250 (380)
                      .    .+++|||++++.+.+           ++......++.|++.+++|||   +.+++||||||+|||++++ .++|+
T Consensus        84 ~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            2    379999998755422           333445679999999999999   8999999999999999865 58999


Q ss_pred             ccCCcccCCCCCcCCCcccCc--ccc---cCCCCCCcchhhHHHHHH
Q 047245          251 DFGLAKLMPGSLIATSAYSAP--ECF---QNRSYTDKSDIFSFGMIL  292 (380)
Q Consensus       251 Dfgl~~~~~~~~~~~~~y~aP--E~~---~~~~~~~~sDv~s~Gvil  292 (380)
                      |||.+.........  .|...  +.+   -...|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~--~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR--EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH--HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH--HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999765433211  11111  000   125678899999976444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.39  E-value=1.6e-06  Score=74.48  Aligned_cols=129  Identities=11%  Similarity=0.120  Sum_probs=86.5

Q ss_pred             CeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecCCeEEEEEeecCCCCH
Q 047245          110 DGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPESSRFYLVYDYLQTGSL  188 (380)
Q Consensus       110 ~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  188 (380)
                      .+.||+... ++..+.+|+........        ...+.+|...+..+. +--+.+++.+..+++..++||++.+|.++
T Consensus        27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~--------~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~   97 (263)
T d1j7la_          27 PAKVYKLVG-ENENLYLKMTDSRYKGT--------TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             SSEEEEEEC-SSCEEEEEEECGGGTTS--------TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             CCcEEEEEe-CCCeEEEEEcCCCcccc--------hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccc
Confidence            368998865 45667888876432221        124567888877773 44467788888888899999999999887


Q ss_pred             HHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHhHhcC-------------------------------------------
Q 047245          189 EDAMDRIRENQLQLGWEVRLRIAVGVIKGLQYLHFTC-------------------------------------------  225 (380)
Q Consensus       189 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------------  225 (380)
                      .+....      ...   ...++.++++.++.||...                                           
T Consensus        98 ~~~~~~------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T d1j7la_          98 SEEYED------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             HHHTTT------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred             cccccc------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence            654321      011   1234455555555555210                                           


Q ss_pred             -------------CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 -------------NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 -------------~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                                   ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                         1237999999999999987777899998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.20  E-value=2.4e-06  Score=73.00  Aligned_cols=73  Identities=15%  Similarity=0.074  Sum_probs=51.1

Q ss_pred             cCccCC-eeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC--CCCcceeeEEEecCCeEEEEEe
Q 047245          105 LGSSPD-GKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR--HRNLMSLRAYVPESSRFYLVYD  181 (380)
Q Consensus       105 lg~G~~-g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e  181 (380)
                      +..|.. +.||+....++..+.+|.-.....           ..+..|...++.+.  .-.+.+++++..+.+..++||+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~   86 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   86 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence            344443 678999888888888887654211           23556777777663  3336677888888888999999


Q ss_pred             ecCCCCH
Q 047245          182 YLQTGSL  188 (380)
Q Consensus       182 ~~~~gsL  188 (380)
                      +++|-++
T Consensus        87 ~i~G~~~   93 (255)
T d1nd4a_          87 EVPGQDL   93 (255)
T ss_dssp             CCSSEET
T ss_pred             eeecccc
Confidence            9987554

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.61  E-value=0.00011  Score=66.69  Aligned_cols=82  Identities=10%  Similarity=0.014  Sum_probs=46.4

Q ss_pred             cccCccCCeeEEEEEecC-CcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcC-CC--CCcceeeEEEecCCeEEE
Q 047245          103 RLLGSSPDGKYYRTVLDN-GLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASL-RH--RNLMSLRAYVPESSRFYL  178 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l  178 (380)
                      +.||.|....||+....+ |+.++||.-........+... ....+...|...|+.+ .+  ..+.+++.+.  .+..++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~-~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP-LTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCC-CCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCC-CCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            458999999999998754 678999965432111111000 0012234577777666 23  3455566554  345689


Q ss_pred             EEeecCCCC
Q 047245          179 VYDYLQTGS  187 (380)
Q Consensus       179 v~e~~~~gs  187 (380)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997644

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.0012  Score=57.93  Aligned_cols=159  Identities=13%  Similarity=0.165  Sum_probs=85.5

Q ss_pred             CCChHHHHHHHhcc-----ccccCccC-CeeEEEEEecCCcEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCCCC
Q 047245           88 KIDPKTLQAALANE-----NRLLGSSP-DGKYYRTVLDNGLTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLRHR  161 (380)
Q Consensus        88 ~~~~~~l~~~~~~~-----~~~lg~G~-~g~vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  161 (380)
                      .+++..+.++..+.     .+++--++ .-.||++...+|..+++|.......         ..+++..|...+..|...
T Consensus         7 ~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~~---------s~~~i~~E~~~l~~L~~~   77 (325)
T d1zyla1           7 TLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERW---------TADQILEEHQFALQLVND   77 (325)
T ss_dssp             CCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTTS---------CHHHHHHHHHHHHHHHHT
T ss_pred             ccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCCC---------CHHHHHHHHHHHHHHHhc
Confidence            45566666665542     12221222 3589999999999999999764211         125566788877777422


Q ss_pred             Cc--ceeeE-----EEecCCeEEEEEeecCCCC-----HHHH---------HHHhhh-----cccCCCHHH---------
Q 047245          162 NL--MSLRA-----YVPESSRFYLVYDYLQTGS-----LEDA---------MDRIRE-----NQLQLGWEV---------  206 (380)
Q Consensus       162 ni--v~l~~-----~~~~~~~~~lv~e~~~~gs-----L~~~---------l~~~~~-----~~~~l~~~~---------  206 (380)
                      ++  +..+.     .....+..+.++++++|..     ...+         ++....     .....++..         
T Consensus        78 gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~  157 (325)
T d1zyla1          78 EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLF  157 (325)
T ss_dssp             TCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHH
T ss_pred             CCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHH
Confidence            22  11111     1234567889999997632     1111         111100     001122111         


Q ss_pred             ----------HHHHHHHHHHHHHHhH----hcCCCCeEecCCCCCcEEeCCCCceEEeccCCccc
Q 047245          207 ----------RLRIAVGVIKGLQYLH----FTCNPQILHYNLKPTNVMLDAEFTPRLADFGLAKL  257 (380)
Q Consensus       207 ----------~~~i~~~ia~~l~~LH----~~~~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~~  257 (380)
                                +-.+...+...++.+.    .....+++|+|+.+.|||++++  ..++||+-+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         158 EDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence                      1111112222233332    2224578999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.40  E-value=0.006  Score=54.80  Aligned_cols=72  Identities=11%  Similarity=0.057  Sum_probs=44.9

Q ss_pred             cccCccCCeeEEEEEecCC--------cEEEEEEeeeccCCChhhhcHHHHHHHHHHHHHHHcCC-CCCcceeeEEEecC
Q 047245          103 RLLGSSPDGKYYRTVLDNG--------LTVAVRRVEAFESGSPEKQNKSVKRRIQQELEVLASLR-HRNLMSLRAYVPES  173 (380)
Q Consensus       103 ~~lg~G~~g~vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  173 (380)
                      +.|+.|-.-.+|+....++        ..|.++.... .  .  .     .....+|..+++.+. +.-..++++++.+ 
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~--~--~-----~idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P--E--T-----ESHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C--C--C-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c--c--h-----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            3577788889999887543        3455555431 1  1  1     123446888888884 4334467777754 


Q ss_pred             CeEEEEEeecCCCCH
Q 047245          174 SRFYLVYDYLQTGSL  188 (380)
Q Consensus       174 ~~~~lv~e~~~~gsL  188 (380)
                         .+|+||+++.++
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               578999987443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.39  E-value=0.022  Score=49.08  Aligned_cols=31  Identities=26%  Similarity=0.297  Sum_probs=27.7

Q ss_pred             CCCeEecCCCCCcEEeCCCCceEEeccCCcc
Q 047245          226 NPQILHYNLKPTNVMLDAEFTPRLADFGLAK  256 (380)
Q Consensus       226 ~~~iiH~dlk~~Nill~~~~~~kl~Dfgl~~  256 (380)
                      ..++||+|+.+.|++++++...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5689999999999999998877899999875